PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Harris, C; Morlais, I; Churcher, TS; Awono-Ambene, P; Gouagna, LC; Dabire, RK; Fontenille, D; Cohuet, A				Harris, Caroline; Morlais, Isabelle; Churcher, Thomas S.; Awono-Ambene, Parfait; Gouagna, Louis Clement; Dabire, Roch K.; Fontenille, Didier; Cohuet, Anna			Plasmodium falciparum Produce Lower Infection Intensities in Local versus Foreign Anopheles gambiae Populations	PLOS ONE			English	Article							MOSQUITO-MALARIA INTERACTIONS; MOLECULAR-FORMS; BODY-SIZE; LABORATORY MODELS; GENETIC-STRUCTURE; ADAPTATION; SELECTION; PATTERNS; FECUNDITY; PARASITES	Both Plasmodium falciparum and Anopheles gambiae show great diversity in Africa, in their own genetic makeup and population dynamics. The genetics of the individual mosquito and parasite are known to play a role in determining the outcome of infection in the vector, but whether differences in infection phenotype vary between populations remains to be investigated. Here we established two A. gambiae s.s. M molecular form colonies from Cameroon and Burkina Faso, representing a local and a foreign population for each of the geographical sites. Experimental infections of both colonies were conducted in Cameroon and Burkina Faso using local wild P. falciparum, giving a sympatric and allopatric vector-parasite combination in each site. Infection phenotype was determined in terms of oocyst prevalence and intensity for at least nine infections for each vector-parasite combination. Sympatric infections were found to produce 25% fewer oocysts per midgut than allopatric infections, while prevalence was not affected by local/foreign interactions. The reduction in oocyst numbers in sympatric couples may be the result of evolutionary processes where the mosquito populations have locally adapted to their parasite populations. Future research on vector-parasite interactions must take into account the geographic scale of adaptation revealed here by conducting experiments in natural sympatric populations to give epidemiologically meaningful results.	[Harris, Caroline; Morlais, Isabelle; Gouagna, Louis Clement; Fontenille, Didier; Cohuet, Anna] Inst Rech Dev, UMR Malad Infect & Vecteurs Ecol Genet Evolut & C, Montpellier, France; [Morlais, Isabelle; Awono-Ambene, Parfait] IRD OCEAC, Inst Rech Dev, Lab Rech Paludisme, Yaounde, Cameroon; [Churcher, Thomas S.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London, England; [Gouagna, Louis Clement; Dabire, Roch K.; Cohuet, Anna] Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Imperial College London	Harris, C (corresponding author), Ifakara Hlth Inst, Ifakara, Tanzania.	anna.cohuet@ird.fr	FONTENILLE, didier/G-4091-2013; Dabire, Roch Kounbobr/ABF-3525-2020; Cohuet, Anna/B-2745-2017; Morlais, Isabelle/Q-2171-2019; Morlais, Isabelle/F-5078-2014	Cohuet, Anna/0000-0002-1876-5656; Morlais, Isabelle/0000-0002-2962-7670; Morlais, Isabelle/0000-0002-2962-7670; Churcher, Thomas/0000-0002-8442-0525; Gouagna, Louis Clement/0000-0003-0957-4484; FONTENILLE, didier/0000-0002-0544-3885	French "Agence Nationale pour la Recherche'' [ANR-06-MIME-001-01]; European Community [242095, 223736]; Yaounde district; Valle e du Kou	French "Agence Nationale pour la Recherche''(French National Research Agency (ANR)); European Community(European Commission); Yaounde district; Valle e du Kou	The research leading to these results has received funding from the French "Agence Nationale pour la Recherche'' (ANR-06-MIME-001-01) and the European Community's Seventh Framework Programme(FP7/2007-2013) under grant agreements N<SUP>o</SUP> 242095 and N<SUP>o</SUP>223736. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all the primary school participants from the Yaounde district and Valle e du Kou and their parents for participating in this study, as well as to the local authorities for their support. We thank staff at OCEAC in Cameroon and IRSS in Burkina Faso for blood smear readings and mosquito rearing and dissections. We appreciate constructive comments from three reviewers who helped significantly improve the clarity of the manuscript.	Aboagye-Antwi F, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-243; Ahmed AM, 2006, MICROBES INFECT, V8, P308, DOI 10.1016/j.micinf.2005.06.026; Ahouidi AD, 2010, INFECT GENET EVOL, V10, P200, DOI 10.1016/j.meegid.2009.11.008; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Annan Z, 2007, P NATL ACAD SCI USA, V104, P7987, DOI 10.1073/pnas.0702715104; Antonio-Nkondjio C, 2002, J MED ENTOMOL, V39, P350, DOI 10.1603/0022-2585-39.2.350; BABIKER HA, 1994, PARASITOLOGY, V109, P413, DOI 10.1017/S0031182000080665; Baldet Thierry, 2003, Sante, V13, P55; Bharti AR, 2006, AM J TROP MED HYG, V75, P610, DOI 10.4269/ajtmh.2006.75.610; Blackmore MS, 2000, J VECTOR ECOL, V25, P212; Boete C, 2005, TRENDS PARASITOL, V21, P445, DOI 10.1016/j.pt.2005.08.012; Bonizzoni M, 2009, INFECT GENET EVOL, V9, P806, DOI 10.1016/j.meegid.2009.04.015; Bonnet S, 2000, T ROY SOC TROP MED H, V94, P103, DOI 10.1016/S0035-9203(00)90456-5; BRIEGEL H, 1990, J MED ENTOMOL, V27, P839, DOI 10.1093/jmedent/27.5.839; Charlwood JD, 1996, MEM I OSWALDO CRUZ, V91, P391, DOI 10.1590/S0074-02761996000400001; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Dabire RK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-12; Dawes EJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-228; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Ferguson HM, 2002, TRENDS PARASITOL, V18, P256, DOI 10.1016/S1471-4922(02)02281-X; Gandon S, 2008, J EVOLUTION BIOL, V21, P1861, DOI 10.1111/j.1420-9101.2008.01598.x; Gandon S, 1998, TRENDS ECOL EVOL, V13, P214, DOI 10.1016/S0169-5347(98)01358-5; Gomulkiewicz R, 2000, AM NAT, V156, P156, DOI 10.1086/303382; Gouagna LC, 2004, TROP MED INT HEALTH, V9, P937, DOI 10.1111/j.1365-3156.2004.01300.x; Greischar MA, 2007, ECOL LETT, V10, P418, DOI 10.1111/j.1461-0248.2007.01028.x; Harris C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001112; Hereford J, 2010, AM J BOT, V97, P298, DOI 10.3732/ajb.0900224; HUGHES AL, 1992, MOL BIOL EVOL, V9, P381; HUGHES MK, 1995, MOL BIOCHEM PARASIT, V71, P99, DOI 10.1016/0166-6851(95)00037-2; Hurd H, 2004, INT J PARASITOL, V34, P1459, DOI 10.1016/j.ijpara.2004.10.002; Jambou R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009424; Joy DA, 2008, MOL BIOL EVOL, V25, P1245, DOI 10.1093/molbev/msn073; Kaltz O, 1998, HEREDITY, V81, P361, DOI 10.1046/j.1365-2540.1998.00435.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; KELLY R, 1992, J AM MOSQUITO CONTR, V8, P386; KERSHAW W. E., 1955, ANN TROP MED AND PARASITOL, V49, P203; Lambrechts L, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-3; Lambrechts L, 2007, AM J TROP MED HYG, V76, P475, DOI 10.4269/ajtmh.2007.76.475; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Lively CM, 1996, P ROY SOC B-BIOL SCI, V263, P891, DOI 10.1098/rspb.1996.0132; LYIMO EO, 1993, MED VET ENTOMOL, V7, P328, DOI 10.1111/j.1365-2915.1993.tb00700.x; MEDLEY GF, 1993, PARASITOLOGY, V106, P441, DOI 10.1017/S0031182000076721; Michel K, 2005, INSECT BIOCHEM MOLEC, V35, P677, DOI 10.1016/j.ibmb.2005.02.009; Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824; Nei M., 1987, MOL EVOLUTIONARY GEN; Norris DE, 2001, J MED ENTOMOL, V38, P336, DOI 10.1603/0022-2585-38.2.336; Nuismer SL, 2000, EVOLUTION, V54, P1102; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Paul REL, 2007, INFECT GENET EVOL, V7, P577, DOI 10.1016/j.meegid.2007.04.004; PAUL REL, 1995, SCIENCE, V269, P1709, DOI 10.1126/science.7569897; Pombi M, 2008, BMC EVOL BIOL, V8, P309, DOI DOI 10.1186/1471-2148-8-309; R Core Team, 2020, R LANG ENV STAT COMP; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Sinden RE, 2004, INSECT BIOCHEM MOLEC, V34, P625, DOI 10.1016/j.ibmb.2004.03.015; Slotman MA, 2007, MOL ECOL, V16, P639, DOI 10.1111/j.1365-294X.2006.03172.x; Snounou Georges, 2002, Methods Mol Med, V72, P103, DOI 10.1385/1-59259-271-6:103; Sogoba N, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-205; Takahasi KR, 2007, GENETICS, V176, P501, DOI 10.1534/genetics.106.063636; Takken W, 1998, J MED ENTOMOL, V35, P639, DOI 10.1093/jmedent/35.5.639; Thompson JD., 1994, COEVOLUTIONARY PROCE; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; Tosta CE, 2007, MEM I OSWALDO CRUZ, V102, P385, DOI 10.1590/S0074-02762007005000042; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Tripet F, 2009, PARASITOLOGY, V136, P1935, DOI 10.1017/S0031182009006234; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Warren M, 1991, PARASITOLOGICAL TOPI, P266; White NJ, 2006, PLOS MED, V3, P589, DOI 10.1371/journal.pmed.0030111; WOKE PAUL A., 1956, ANN ENT SOC AMER, V49, P435; Wondji C, 2005, J MED ENTOMOL, V42, P998, DOI 10.1603/0022-2585(2005)042[0998:SAPOTA]2.0.CO;2; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569	78	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30849	10.1371/journal.pone.0030849	http://dx.doi.org/10.1371/journal.pone.0030849			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292059	Green Published, Green Submitted, gold			2022-12-27	WOS:000301703800035
J	Plantard, O; Bouju-Albert, A; Malard, MA; Hermouet, A; Capron, G; Verheyden, H				Plantard, Olivier; Bouju-Albert, Agnes; Malard, Marie-Astrid; Hermouet, Axelle; Capron, Gilles; Verheyden, Helene			Detection of Wolbachia in the Tick Ixodes ricinus is Due to the Presence of the Hymenoptera Endoparasitoid Ixodiphagus hookeri	PLOS ONE			English	Article							MIDICHLORIA-MITOCHONDRII; REPRODUCTIVE PARASITES; MICROBIAL COMMUNITIES; SCAPULARIS ACARI; ENDOSYMBIONT; WIDESPREAD; SYMBIONT; DIVERSITY; BACTERIA; IXODIDAE	The identification of micro-organisms carried by ticks is an important issue for human and animal health. In addition to their role as pathogen vectors, ticks are also the hosts for symbiotic bacteria whose impact on tick biology is poorly known. Among these, the bacterium Wolbachia pipientis has already been reported associated with Ixodes ricinus and other tick species. However, the origins of Wolbachia in ticks and their consequences on tick biology (known to be very diverse in invertebrates, ranging from nutritional symbionts in nematodes to reproductive manipulators in insects) are unknown. Here we report that the endoparasitoid wasp Ixodiphagus hookeri (Hymenoptera, Chalcidoidea, Encyrtidae) - strictly associated with ticks for their development - is infested at almost 100% prevalence by a W. pipientis strain belonging to a Wolbachia supergroup that has already been reported as associated with other hymenopteran parasitoids. In a natural population of I. ricinus that suffers high parasitism rates due to I. hookeri, we used specific PCR primers for both hymenopteran and W. pipientis gene fragments to show that all unfed tick nymphs parasitized by I. hookeri also harbored Wolbachia, while unparasitized ticks were Wolbachia-free. We demonstrated experimentally that unfed nymphs obtained from larvae exposed to I. hookeri while gorging on their vertebrate host also harbor Wolbachia. We hypothesize that previous studies that have reported W. pipientis in ticks are due to the cryptic presence of the endoparasitoid wasp I. hookeri. This association has remained hidden until now because parasitoids within ticks cannot be detected until engorgement of the nymphs brings the wasp eggs out of diapause. Finally, we discuss the consequences of this finding for our understanding of the tick microbiome, and their possible role in horizontal gene transfer among pathogenic and symbiotic bacteria.	[Plantard, Olivier; Bouju-Albert, Agnes; Malard, Marie-Astrid; Hermouet, Axelle] INRA, UMR 1300, BioEpAR, F-44026 Nantes, France; [Plantard, Olivier; Bouju-Albert, Agnes; Malard, Marie-Astrid; Hermouet, Axelle] LUNAM Univ, Oniris, Nantes, France; [Capron, Gilles] DIR Poitou Charentes Limousin, ONCFS, Paris, France; [Verheyden, Helene] INRA, UR 035, F-31326 Castanet Tolosan, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE	Plantard, O (corresponding author), INRA, UMR 1300, BioEpAR, F-44026 Nantes, France.	olivier.plantard@oniris-nantes.fr		DURAND, Axelle/0000-0002-4291-2281; Plantard, Olivier/0000-0001-6473-4271	Jeune Equipe INRA Varibabix	Jeune Equipe INRA Varibabix	This work was supported by "Jeune Equipe INRA Varibabix". Action Incitative Programme du Centre International pour la Recherche Agronomique et le Developpement (CIRAD) et de l'Institut National de la Recherche Agronomique (INRA) "Dynamique et diversite genetique des tiques et pathogenes transmis" INRA, Animal Health Division. http://www.inra.fr/sante_animale/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Baldo L, 2006, MOL BIOL EVOL, V23, P437, DOI 10.1093/molbev/msj049; Benson MJ, 2004, APPL ENVIRON MICROB, V70, P616, DOI 10.1128/AEM.70.1.616-620.2004; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Bonnet S, 2007, PARASITOLOGY, V134, P197, DOI 10.1017/S0031182006001545; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; BREEUWER JAJ, 1993, GENETICS, V135, P565; Brumpi E, 1930, CR HEBD ACAD SCI, V191, P1085; Brumpt E., 1913, PRESSE MED PARIS, V36, P359; Carpi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025604; Casiraghi M, 2004, INT J PARASITOL, V34, P191, DOI 10.1016/j.ijpara.2003.10.004; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Clay K, 2008, MOL ECOL, V17, P4371, DOI 10.1111/j.1365-294X.2008.03914.x; Collatz J, 2011, J APPL ENTOMOL, V135, P351, DOI 10.1111/j.1439-0418.2010.01560.x; Cooley RA, 1919, SCIENCE, V68, P656; Dib L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040007; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; EGGLETON P, 1992, PHILOS T R SOC B, V337, P1, DOI 10.1098/rstb.1992.0079; Engelstadter J, 2007, GENETICS, V175, P245, DOI 10.1534/genetics.106.060921; Epis S, 2008, PARASITOLOGY, V135, P485, DOI 10.1017/S0031182007004052; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Haine ER, 2008, P ROY SOC B-BIOL SCI, V275, P353, DOI 10.1098/rspb.2007.1211; Hartelt K, 2004, INT J MED MICROBIOL, V293, P86, DOI 10.1016/S1433-1128(04)80013-5; Heath ACG, 2010, NEW ZEAL J ZOOL, V37, P147, DOI 10.1080/03014223.2010.482973; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hu R, 1998, SYSTEMATIC APPL ACAR, V3, P1362; Hu RJ, 1998, J MED ENTOMOL, V35, P1050, DOI 10.1093/jmedent/35.6.1050; Inokuma H, 2000, J CLIN MICROBIOL, V38, P4219, DOI 10.1128/JCM.38.11.4219-4221.2000; Ishmael N, 2009, MICROBIOL-SGM, V155, P2211, DOI 10.1099/mic.0.027581-0; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Lo N, 2006, ENVIRON MICROBIOL, V8, P1280, DOI 10.1111/j.1462-2920.2006.01024.x; MATHER TN, 1987, MED VET ENTOMOL, V1, P3, DOI 10.1111/j.1365-2915.1987.tb00317.x; Mediannikov O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011478; Moreno CX, 2006, ENVIRON MICROBIOL, V8, P761, DOI 10.1111/j.1462-2920.2005.00955.x; Mousson L, 2010, MOL ECOL, V19, P1953, DOI 10.1111/j.1365-294X.2010.04606.x; Niebylski ML, 1997, APPL ENVIRON MICROB, V63, P3933, DOI 10.1128/AEM.63.10.3933-3940.1997; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; QUARAISHI M. S., 1958, AMER MIDLAND NAT, V59, P489, DOI 10.2307/2422494; Randolph SE, 2004, PARASITOLOGY, V129, pS37, DOI 10.1017/S0031182004004925; Raychoudhury R, 2010, HEREDITY, V104, P318, DOI 10.1038/hdy.2009.160; Reis C, 2011, VECTOR-BORNE ZOONOT, V11, P907, DOI 10.1089/vbz.2010.0103; Sacchi L, 2004, TISSUE CELL, V36, P43, DOI 10.1016/j.tice.2003.08.004; Sarih MH, 2005, J CLIN MICROBIOL, V43, P1127, DOI 10.1128/JCM.43.3.1127-1132.2005; Sassera D, 2011, MOL BIOL EVOLUTION; Sassera D, 2006, INT J SYST EVOL MICR, V56, P2535, DOI 10.1099/ijs.0.64386-0; Scheffer SJ, 2003, MOL ECOL, V12, P415, DOI 10.1046/j.1365-294X.2003.01725.x; Sonenshine DE., 1991, BIOL TICKS; Stafford KC, 2003, J MED ENTOMOL, V40, P642, DOI 10.1603/0022-2585-40.5.642; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOLUTION; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V66, P72, DOI 10.1111/j.1574-6941.2008.00468.x; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Wood HP, 1911, J ECON ENTOMOL, V4, P425, DOI 10.1093/jee/4.5.425; Zhong JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000405	62	64	64	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30692	10.1371/journal.pone.0030692	http://dx.doi.org/10.1371/journal.pone.0030692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292021	Green Published, gold, Green Submitted			2022-12-27	WOS:000301703800026
J	Bajaj, G; Van Alstine, WG; Yeo, Y				Bajaj, Gaurav; Van Alstine, William G.; Yeo, Yoon			Zwitterionic Chitosan Derivative, a New Biocompatible Pharmaceutical Excipient, Prevents Endotoxin-Mediated Cytokine Release	PLOS ONE			English	Article							POLYVINYL PYRROLIDONE HYDROGEL; WATER-SOLUBLE CHITOSAN; PHOTOCROSSLINKABLE CHITOSAN; GLYCOL CHITOSAN; MOLECULAR-WEIGHT; CHITIN; NANOPARTICLES; DELIVERY; DRUG; PEPTIDE	Chitosan is a cationic polymer of natural origin and has been widely explored as a pharmaceutical excipient for a broad range of biomedical applications. While generally considered safe and biocompatible, chitosan has the ability to induce inflammatory reactions, which varies with the physical and chemical properties. We hypothesized that the previously reported zwitterionic chitosan (ZWC) derivative had relatively low pro-inflammatory potential because of the aqueous solubility and reduced amine content. To test this, we compared various chitosans with different aqueous solubilities or primary amine contents with respect to the intraperitoneal (IP) biocompatibility and the propensity to induce proinflammatory cytokine production from macrophages. ZWC was relatively well tolerated in ICR mice after IP administration and had no pro-inflammatory effect on naive macrophages. Comparison with other chitosans indicates that these properties are mainly due to the aqueous solubility at neutral pH and relatively low molecular weight of ZWC. Interestingly, ZWC had a unique ability to suppress cytokine/chemokine production in macrophages challenged with lipopolysaccharide (LPS). This effect is likely due to the strong affinity of ZWC to LPS, which inactivates the pro-inflammatory function of LPS, and appears to be related to the reduced amine content. Our finding warrants further investigation of ZWC as a functional biomaterial.	[Bajaj, Gaurav; Yeo, Yoon] Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA; [Van Alstine, William G.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Yeo, Yoon] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Yeo, Y (corresponding author), Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA.	yyeo@purdue.edu	Yeo, Y/GWV-3316-2022		National Institutes of Health [R21 CA135130]; Lilly Endowment, Inc.; Direct For Mathematical & Physical Scien [1056997] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R21CA135130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lilly Endowment, Inc.; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health R21 CA135130 and a grant from the Lilly Endowment, Inc., to the College of Pharmacy, Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsden BG, 2007, BIOMACROMOLECULES, V8, P3758, DOI 10.1021/bm700691e; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; [Anonymous], 2010, USP33NF28 US PHARM C; Azab AK, 2007, J BIOMED MATER RES A, V83A, P414, DOI 10.1002/jbm.a.31256; Baldrick P, 2009, REGUL TOXICOL PHARM; Bowman K, 2006, INT J NANOMED, V1, P117, DOI 10.2147/nano.2006.1.2.117; Canali MM, 2010, VACCINE, V28, P5718, DOI 10.1016/j.vaccine.2010.06.027; Chellat F, 2000, J BIOMED MATER RES, V51, P107, DOI 10.1002/(SICI)1097-4636(200007)51:1<107::AID-JBM14>3.0.CO;2-F; Chellat F, 2005, BIOMATERIALS, V26, P961, DOI 10.1016/j.biomaterials.2004.04.006; Chen CL, 2008, BIOMATERIALS, V29, P2173, DOI 10.1016/j.biomaterials.2008.01.023; Dobrovolskaia MA, 2008, MOL PHARMACEUT, V5, P487, DOI 10.1021/mp800032f; Dufrane D, 2006, BIOMATERIALS, V27, P3201, DOI 10.1016/j.biomaterials.2006.01.028; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hall JC, 1998, GASTROENTEROLOGY, V114, P185, DOI 10.1016/S0016-5085(98)70646-8; HIRANO S, 1994, ABSTR PAP AM CHEM S, V207, P118; Hirano S, 1996, Biotechnol Annu Rev, V2, P237, DOI 10.1016/S1387-2656(08)70012-7; Illum L, 1998, PHARM RES-DORDR, V15, P1326; Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2; Kawashima Y, 2000, PHARM DEV TECHNOL, V5, P77, DOI 10.1081/PDT-100100522; Kim MS, 2002, NEUROSCI LETT, V321, P105, DOI 10.1016/S0304-3940(02)00066-6; Kohane DS, 2006, J BIOMED MATER RES A, V77A, P351, DOI 10.1002/jbm.a.30654; LEE J, 1995, J IMMUNOL, V155, P2158; Liu HT, 2010, BASIC CLIN PHARMACOL, V106, P362, DOI 10.1111/j.1742-7843.2009.00493.x; Mathews S, 2006, J BIOMED MATER RES A, V79A, P147, DOI 10.1002/jbm.a.30710; Min KH, 2008, J CONTROL RELEASE, V127, P208, DOI 10.1016/j.jconrel.2008.01.013; Minami S, 1998, CARBOHYD POLYM, V36, P151, DOI 10.1016/S0144-8617(98)00015-0; Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3; Mori T, 1998, J BIOMED MATER RES, V43, P469; Muzzarelli RAA, 2010, MAR DRUGS, V8, P292, DOI 10.3390/md8020292; Nam KS, 2007, J MICROBIOL BIOTECHN, V17, P2042; Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100; NISHIMURA K, 1986, VACCINE, V4, P151, DOI 10.1016/0264-410X(86)90002-2; Obara K, 2003, BIOMATERIALS, V24, P3437, DOI 10.1016/S0142-9612(03)00220-5; Ono K, 2000, J BIOMED MATER RES, V49, P289; Ono K, 2001, SURGERY, V130, P844, DOI 10.1067/msy.2001.117197; Park JH, 2004, J CONTROL RELEASE, V95, P579, DOI 10.1016/j.jconrel.2003.12.020; Park K, 2007, J CONTROL RELEASE, V122, P305, DOI 10.1016/j.jconrel.2007.04.009; PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0; Qin CQ, 2006, FOOD CHEM TOXICOL, V44, P855, DOI 10.1016/j.fct.2005.11.009; RAGHOEBAR M, 1987, AGENTS ACTIONS, V22, P314, DOI 10.1007/BF02009062; Risbud M, 2001, CELL TRANSPLANT, V10, P195; Risbud MV, 2001, J BIOMED MATER RES, V57, P300, DOI 10.1002/1097-4636(200111)57:2<300::AID-JBM1171>3.0.CO;2-Q; Roy K, 1999, NAT MED, V5, P387, DOI 10.1038/7385; Ryu JH, 2011, BIOMACROMOLECULES, V12, P2653, DOI 10.1021/bm200464x; Sagnella S, 2005, COLLOID SURFACE B, V42, P147, DOI 10.1016/j.colsurfb.2004.07.001; Tanaka Y, 1997, BIOMATERIALS, V18, P591, DOI 10.1016/S0142-9612(96)00182-2; USAMI Y, 1994, J VET MED SCI, V56, P1215, DOI 10.1292/jvms.56.1215; van der Merwe SM, 2004, EUR J PHARM BIOPHARM, V58, P225, DOI 10.1016/j.ejpb.2004.03.023; VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270; Wiegand C, 2010, SKIN PHARMACOL PHYS, V23, P164, DOI 10.1159/000276996; Xu P, 2010, BIOMACROMOLECULES; Yeo Y, 2006, J BIOMED MATER RES A, V78A, P668, DOI 10.1002/jbm.a.30740; Yoon HJ, 2007, BIOCHEM BIOPH RES CO, V358, P954, DOI 10.1016/j.bbrc.2007.05.042	53	39	50	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30899	10.1371/journal.pone.0030899	http://dx.doi.org/10.1371/journal.pone.0030899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292072	gold, Green Published, Green Submitted			2022-12-27	WOS:000301639600065
J	Lin, H; Hu, L; Chen, LL; Yu, H; Wang, Q; Chen, P; Hu, XT; Cai, XJ; Guan, XY				Lin, Hui; Hu, Liang; Chen, Leilei; Yu, Hong; Wang, Qi; Chen, Ping; Hu, Xiao-Tong; Cai, Xiu-Jun; Guan, Xin-Yuan			Chemically-Induced Cancers Do Not Originate from Bone Marrow-Derived Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; HEPATOCELLULAR-CARCINOMA; PROSPECTIVE IDENTIFICATION; IN-VIVO; ENGRAFTMENT; FUSION; LIVER; MICE; HEPATOCYTES; REPAIR	Background: The identification and characterization of cancer stem cells (CSCs) is imperative to understanding the mechanism of cancer pathogenesis. Growing evidence suggests that CSCs play critical roles in the development and progression of cancer. However, controversy exists as to whether CSCs arise from bone marrow-derived cells (BMDCs). Methodology and Principal Findings: In the present study, n-nitrosodiethylamine (DEN) was used to induce tumor formation in female mice that received bone marrow from male mice. Tumor formation was induced in 20/26 mice, including 12 liver tumors, 6 lung tumors, 1 bladder tumor and 1 nasopharyngeal tumor. Through comparison of fluorescence in situ hybridization (FISH) results in corresponding areas from serial tumor sections stained with H&E, we determined that BMDCs were recruited to both tumor tissue and normal surrounding tissue at a very low frequency (0.2-1% in tumors and 0-0.3% in normal tissues). However, approximately 3-70% of cells in the tissues surrounding the tumor were BMDCs, and the percentage of BMDCs was highly associated with the inflammatory status of the tissue. In the present study, no evidence was found to support the existence of fusion cells formed form BMDCs and tissue-specific stem cells. Conclusions: In summary, our data suggest that although BMDCs may contribute to tumor progression, they are unlike to contribute to tumor initiation.	[Lin, Hui; Yu, Hong; Cai, Xiu-Jun] Zhejiang Univ, Sch Med, Dept Gen Surg, Sir RunRun Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Liang; Chen, Leilei; Guan, Xin-Yuan] Univ Hong Kong, Dept Clin Oncol, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Hu, Liang] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China; [Hu, Liang] Natl Engn Res Ctr Human Stem Cells, Changsha, Hunan, Peoples R China; [Wang, Qi; Chen, Ping; Hu, Xiao-Tong] Zhejiang Univ, Sch Med, Biomed Res Ctr, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; University of Hong Kong; Central South University; Zhejiang University	Lin, H (corresponding author), Zhejiang Univ, Sch Med, Dept Gen Surg, Sir RunRun Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China.	cxjzu@zju.edu.cn; xyguan@hkucc.hku.hk	/A-3639-2009	/0000-0003-1874-9805; Chen, Polly Leilei/0000-0002-1987-3878	Zhejiang Provincial Natural Science Foundation of China [Y2100464]; National Key Sci-Tech Special Project of Infectious Diseases [2012ZX10002-013]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Key Sci-Tech Special Project of Infectious Diseases	This work was supported by Zhejiang Provincial Natural Science Foundation of China (Y2100464) and the National Key Sci-Tech Special Project of Infectious Diseases (2012ZX10002-013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ando S, 2009, AM J PATHOL, V174, P595, DOI 10.2353/ajpath.2009.080362; Borue X, 2004, AM J PATHOL, V165, P1767, DOI 10.1016/S0002-9440(10)63431-1; Brittan M, 2005, J PATHOL, V205, P1, DOI 10.1002/path.1682; Cantz T, 2004, CELL TRANSPLANT, V13, P659, DOI 10.3727/000000004783983521; Chantrain CF, 2008, CANCER MICROENVIRON, V1, P23, DOI 10.1007/s12307-008-0010-7; Cogle CR, 2007, STEM CELLS, V25, P1881, DOI 10.1634/stemcells.2007-0163; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fan QY, 2006, EXP HEMATOL, V34, P672, DOI 10.1016/j.exphem.2006.02.002; Gilchrist ES, 2010, LIVER TRANSPLANT, V16, P118, DOI 10.1002/lt.21965; Haemmerling GJ, 2006, CELL CYCLE, V5, P509, DOI 10.4161/cc.5.5.2517; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Ishikawa H, 2004, GUT, V53, P884, DOI 10.1136/gut.2003.026047; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kotton DN, 2005, AM J RESP CELL MOL, V33, P328, DOI 10.1165/rcmb.2005-0175RC; Krause Diane S, 2008, Proc Am Thorac Soc, V5, P323, DOI 10.1513/pats.200712-169DR; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; SELL S, 1989, AM J PATHOL, V134, P1347; Singh SK, 2003, CANCER RES, V63, P5821; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Wang Y, 2002, CANCER-AM CANCER SOC, V95, P2346, DOI 10.1002/cncr.10963; WARD JM, 1980, CANCER LETT, V9, P319, DOI 10.1016/0304-3835(80)90024-5	32	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30493	10.1371/journal.pone.0030493	http://dx.doi.org/10.1371/journal.pone.0030493			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291966	Green Submitted, Green Published, gold			2022-12-27	WOS:000301639600026
J	Zeeberg, BR; Reinhold, W; Snajder, R; Thallinger, GG; Weinstein, JN; Kohn, KW; Pommier, Y				Zeeberg, Barry R.; Reinhold, William; Snajder, Rene; Thallinger, Gerhard G.; Weinstein, John N.; Kohn, Kurt W.; Pommier, Yves			Functional Categories Associated with Clusters of Genes That Are Co-Expressed across the NCI-60 Cancer Cell Lines	PLOS ONE			English	Article							MICROARRAY DATA; DIFFERENTIAL COEXPRESSION; MOLECULAR PHARMACOLOGY; EXPRESSION PROFILES; ONTOLOGY; DATABASE; TOOL; RESOURCE; GOMINER	Background: The NCI-60 is a panel of 60 diverse human cancer cell lines used by the U.S. National Cancer Institute to screen compounds for anticancer activity. In the current study, gene expression levels from five platforms were integrated to yield a single composite transcriptome profile. The comprehensive and reliable nature of that dataset allows us to study gene co-expression across cancer cell lines. Methodology/Principal Findings: Hierarchical clustering revealed numerous clusters of genes in which the genes co-vary across the NCI-60. To determine functional categorization associated with each cluster, we used the Gene Ontology (GO) Consortium database and the GoMiner tool. GO maps genes to hierarchically-organized biological process categories. GoMiner can leverage GO to perform ontological analyses of gene expression studies, generating a list of significant functional categories. Conclusions/Significance: GoMiner analysis revealed many clusters of coregulated genes that are associated with functional groupings of GO biological process categories. Notably, those categories arising from coherent co-expression groupings reflect cancer-related themes such as adhesion, cell migration, RNA splicing, immune response and signal transduction. Thus, these clusters demonstrate transcriptional coregulation of functionally-related genes.	[Zeeberg, Barry R.; Reinhold, William; Weinstein, John N.; Kohn, Kurt W.; Pommier, Yves] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Snajder, Rene; Thallinger, Gerhard G.] Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Graz University of Technology	Zeeberg, BR (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	zeebergb@mail.nih.gov	zeeberg, barry/AAO-1246-2020; Reinhold, William/J-6704-2017	Snajder, Rene/0000-0002-7318-976X; Reinhold, William/0000-0001-5513-9323; Thallinger, Gerhard G./0000-0002-2864-5404; Weinstein, John/0000-0001-9401-6908	National Institutes of Health, National Cancer Institute, Center for Cancer Research, Research; Austrian Ministry of Science and Research, GEN-AU; NATIONAL CANCER INSTITUTE [ZIABC006150, ZIABC006192] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research, Research; Austrian Ministry of Science and Research, GEN-AU; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, Research and the Austrian Ministry of Science and Research, GEN-AU project Bioinformatics Integration Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CELLMINER; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Cho SB, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-109; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; Eyre TA, 2006, NUCLEIC ACIDS RES, V34, pD319, DOI 10.1093/nar/gkj147; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Holbeck S, 2010, MOL ENDOCRINOL, V24, P1287, DOI 10.1210/me.2010-0040; Lai YL, 2004, BIOINFORMATICS, V20, P3146, DOI 10.1093/bioinformatics/bth379; LARSEN RJ, INTRO MATH STAT ITS; Liu HF, 2007, BIOINFORMATICS, V23, P2385, DOI 10.1093/bioinformatics/btm360; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Reinhold WC, 2010, CANCER RES, V70, P2191, DOI 10.1158/0008-5472.CAN-09-3528; Ryan MC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-313; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shankavaram UT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-277; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zoppoli G, ONCOGENE; 2006, NUCL ACIDS RES, V34, pD322	25	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30317	10.1371/journal.pone.0030317	http://dx.doi.org/10.1371/journal.pone.0030317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291933	Green Published, gold, Green Submitted			2022-12-27	WOS:000301639600012
J	Aung, T; Montagu, D; Schlein, K; Khine, TM; McFarland, W				Aung, Tin; Montagu, Dominic; Schlein, Karen; Khine, Thin Myat; McFarland, Willi			Validation of a New Method for Testing Provider Clinical Quality in Rural Settings in Low- and Middle-Income Countries: The Observed Simulated Patient	PLOS ONE			English	Article							HEALTH-SERVICES; CARE QUALITY; OF-CARE; VIGNETTES; PERFORMANCE; SKILLS; ABSTRACTION; COMPETENCE; TRAINEES; RECORDS	Background: Assessing the quality of care provided by individual health practitioners is critical to identifying possible risks to the health of the public. However, existing assessment methods can be inaccurate, expensive, or infeasible in many developing country settings, particularly in rural areas and especially for children. Following an assessment of the strengths and weaknesses of the existing methods for provider assessment, we developed a synthesis method combining components of direct observation, clinical vignettes, and medical mannequins which we have termed "Observed Simulated Patient" or OSP. An OSP assessment involves a trained actor playing the role of a 'mother', a life-size doll representing a 5-year old boy, and a trained observer. The provider being assessed was informed in advance of the role-playing, and told to conduct the diagnosis and treatment as he normally would while verbally describing the examinations. Methodology/Principal Findings: We tested the validity of OSP by conducting parallel scoring of medical providers in Myanmar, assessing the quality of their diagnosis and treatment of pediatric malaria, first by direct observation of true patients and second by OSP. Data were collected from 20 private independent medical practitioners in Mon and Kayin States, Myanmar between December 26, 2010 and January 12, 2011. All areas of assessment showed agreement between OSP and direct observation above 90% except for history taking related to past experience with malaria medicines. In this area, providers did not ask questions of the OSP to the same degree that they questioned real patients (agreement 82.8%). Conclusions/Significance: The OSP methodology may provide a valuable option for quality assessment of providers in places, or for health conditions, where other assessment tools are unworkable.	[Aung, Tin; Khine, Thin Myat] Populat Serv Int, Res Dept, Yangon, Myanmar; [Montagu, Dominic; Schlein, Karen; McFarland, Willi] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Aung, T (corresponding author), Populat Serv Int, Res Dept, Yangon, Myanmar.	montagud@globalhealth.ucsf.edu			Bill and Melinda Gates Foundation; PSI/Myanmar	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); PSI/Myanmar	This study was supported through funding from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Tin Aung and Thin Myat Khine work for PSI/Myanmar, an NGO supporting the provision of medical care in Myanmar using private sector channels. PSI/Myanmar provided direct and indirect support for this study using funds from external donors. The employment of two authors by PSI/Myanmar does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Badger L W, 1995, Fam Med, V27, P126; Charman N, 2010, COMMUNICATION; Das J, 2008, J ECON PERSPECT, V22, P93, DOI 10.1257/jep.22.2.93; Fleiss J. L., 1981, STAT METHODS RATES P, V2, P22; Franco LM, 2002, INT J QUAL HEALTH C, V14, P17, DOI 10.1093/intqhc/14.suppl_1.17; Hong TT, 2009, HEALTH INF MANAG J, V38, P15, DOI 10.1177/183335830903800103; Kogan JR, 2009, JAMA-J AM MED ASSOC, V302, P1316, DOI 10.1001/jama.2009.1365; Leonard KL, 2008, J HEALTH ECON, V27, P444, DOI 10.1016/j.jhealeco.2007.07.004; Leonard KL, 2007, J HUM RESOUR, V42, P682; Leonard KL, 2005, SOC SCI MED, V61, P1944, DOI 10.1016/j.socscimed.2005.03.043; Luck J, 2006, INT J MED INFORM, V75, P701, DOI 10.1016/j.ijmedinf.2005.10.005; Ministry of Health M, 2008, NAT POL TREATM MAL U; Onishi J, 2011, INT J QUAL HEALTH C, V23, P76, DOI 10.1093/intqhc/mzq074; Organization WH, 2009, GUID DIAGN MAN MAL M; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Peabody JW, 2004, HEALTH SERV RES, V39, P1951, DOI 10.1111/j.1475-6773.2004.00327.x; PIETERS HM, 1994, MED EDUC, V28, P226, DOI 10.1111/j.1365-2923.1994.tb02703.x; Reisch LM, 2003, AM J EPIDEMIOL, V157, P546, DOI 10.1093/aje/kwg016; RETHANS JJ, 1991, BRIT MED J, V303, P1377, DOI 10.1136/bmj.303.6814.1377; Schnelle JF, 2006, J AM MED DIR ASSOC, V7, P541, DOI 10.1016/j.jamda.2006.03.009; Shah NM, 2011, HEALTH POLICY PLANN, V26, P275, DOI 10.1093/heapol/czq074; Shah R, 2007, OPHTHAL PHYSL OPT, V27, P113, DOI 10.1111/j.1475-1313.2006.00481.x; Stillman PL, 1997, MED EDUC, V31, P33, DOI 10.1111/j.1365-2923.1997.tb00040.x; THOMPSON HC, 1976, MED CARE, V14, P294, DOI 10.1097/00005650-197604000-00002; Viera AJ, 2005, FAM MED, V37, P360; Wallace P, 1997, Caduceus, V13, P5	26	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30196	10.1371/journal.pone.0030196	http://dx.doi.org/10.1371/journal.pone.0030196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	909NE	22291918	gold, Green Published, Green Submitted			2022-12-27	WOS:000301570600024
J	Chan, HS; Chang, SJ; Wang, TY; Ko, HJ; Lin, YC; Lin, KT; Chang, KM; Chuang, YJ				Chan, Hau-Shien; Chang, Shing-Jyh; Wang, Tao-Yeuan; Ko, Hung-Ju; Lin, Yu-Chih; Lin, Kuan-Ting; Chang, Kuo-Ming; Chuang, Yung-Jen			Serine Protease PRSS23 Is Upregulated by Estrogen Receptor alpha and Associated with Proliferation of Breast Cancer Cells	PLOS ONE			English	Article							SIGNALING PATHWAYS; GENE-EXPRESSION; CATHEPSIN-D; ER-ALPHA; ACTIVATION; GROWTH; BETA; TRANSACTIVATION; LOCALIZATION; PROGRESSION	Serine protease PRSS23 is a newly discovered protein that has been associated with tumor progression in various types of cancers. Interestingly, PRSS23 is coexpressed with estrogen receptor alpha (ER alpha), which is a prominent biomarker and therapeutic target for human breast cancer. Estrogen signaling through ER alpha is also known to affect cell proliferation, apoptosis, and survival, which promotes tumorigenesis by regulating the production of numerous downstream effector proteins. In the present study, we aimed to clarify the correlation between and functional implication of ER alpha and PRSS23 in breast cancer. Analysis of published breast cancer microarray datasets revealed that the gene expression correlation between ER alpha and PRSS23 is highly significant among all ER alpha-associated proteases in breast cancer. We then assessed PRSS23 expression in 56 primary breast cancer biopsies and 8 cancer cell lines. The results further confirmed the coexpression of PRSS23 and ER alpha and provided clinicopathological significance. In vitro assays in MCF-7 breast cancer cells demonstrated that PRSS23 expression is induced by 17 beta-estradiol-activated ER alpha through an interaction with an upstream promoter region of PRSS23 gene. In addition, PRSS23 knockdown may suppress estrogen-driven cell proliferation of MCF-7 cells. Our findings imply that PRSS23 might be a critical component of estrogen-mediated cell proliferation of ER alpha-positive breast cancer cells. In conclusion, the present study highlights the potential for PRSS23 to be a novel therapeutic target in breast cancer research.	[Chan, Hau-Shien; Ko, Hung-Ju; Lin, Yu-Chih; Chuang, Yung-Jen] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Dept Med Sci, Hsinchu, Taiwan; [Chang, Shing-Jyh] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Chang, Shing-Jyh] Hsinchu Mackay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan; [Wang, Tao-Yeuan] Mackay Mem Hosp, Dept Pathol, Taipei, Taiwan; [Wang, Tao-Yeuan] Mackay Med Coll, Taipei, Taiwan; [Wang, Tao-Yeuan] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Lin, Kuan-Ting] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Chang, Kuo-Ming] Hsinchu Mackay Mem Hosp, Dept Pathol, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management; National Tsing Hua University; Mackay Memorial Hospital	Chan, HS (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Dept Med Sci, Hsinchu, Taiwan.	yjchuang@life.nthu.edu.tw	Chuang, Yung-Jen/D-2362-2013	Chuang, Yung-Jen/0000-0002-6022-0107	National Science Council of Taiwan [95-2752-B-007-002-PAE]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Program for Promoting Academic Excellence of Universities (grant number 95-2752-B-007-002-PAE), National Science Council of Taiwan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 1998, MODERN PATHOL, V11, P155; Berchem G, 2002, ONCOGENE, V21, P5951, DOI 10.1038/sj.onc.1205745; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; Cho SD, 2010, MOL PHARMACOL, V77, P396, DOI 10.1124/mol.109.061143; Coser KR, 2003, P NATL ACAD SCI USA, V100, P13994, DOI 10.1073/pnas.2235866100; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellis CM, 2005, J CLIN PATHOL, V58, P710, DOI 10.1136/jcp.2004.023424; Eng FCS, 1997, MOL CELL BIOL, V17, P4644, DOI 10.1128/MCB.17.8.4644; Fan MY, 2004, MOL ENDOCRINOL, V18, P2603, DOI 10.1210/me.2004-0164; Fritz WA, 2002, MOL CELL ENDOCRINOL, V186, P89, DOI 10.1016/S0303-7207(01)00663-3; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Grisouard J, 2007, MOL ENDOCRINOL, V21, P2427, DOI 10.1210/me.2007-0129; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Ifon ET, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-19; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Katzenellenbogen BS, 1996, BIOL REPROD, V54, P287, DOI 10.1095/biolreprod54.2.287; Kazi AA, 2007, ENDOCRINOLOGY, V148, P2363, DOI 10.1210/en.2006-1394; Khaleque MA, 2007, HEAT SHOCK FACTOR 1; KING WJ, 1984, NATURE, V307, P745, DOI 10.1038/307745a0; KRISHNAN V, 1994, J BIOL CHEM, V269, P15912; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Latil A, 2001, CANCER RES, V61, P1919; Lecomte J, 2008, BREAST CANCER RES TR, V112, P437, DOI 10.1007/s10549-007-9886-z; Li SJ, 2010, J HISTOCHEM CYTOCHEM, V58, P509, DOI 10.1369/jhc.2009.954644; Lippman Marc E, 2008, Trans Am Clin Climatol Assoc, V119, P77; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Matthews Jason, 2003, Mol Interv, V3, P281, DOI 10.1124/mi.3.5.281; Miyakoshi K, 2006, BIOL REPROD, V75, P823, DOI 10.1095/biolreprod.106.052290; Moggs JG, 2005, J MOL ENDOCRINOL, V34, P535, DOI 10.1677/jme.1.01677; Onn I, 2007, EMBO J, V26, P1024, DOI 10.1038/sj.emboj.7601562; Pentecost BT, 2005, MOL CELL ENDOCRINOL, V238, P9, DOI 10.1016/j.mce.2005.04.005; Rich RL, 2002, P NATL ACAD SCI USA, V99, P8562, DOI 10.1073/pnas.142288199; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Schulltz-Norton JR, 2011, TRENDS ENDOCRIN MET, V22, P124, DOI 10.1016/j.tem.2010.11.005; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Sommer S, 2001, SEMIN CANCER BIOL, V11, P339, DOI 10.1006/scbi.2001.0389; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; TANDON AK, 1990, NEW ENGL J MED, V322, P297, DOI 10.1056/NEJM199002013220504; Toillon RA, 2007, INT J RADIAT ONCOL, V67, P1187, DOI 10.1016/j.ijrobp.2006.11.040; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Tsunoda N, 2009, CANCER SCI, V100, P111, DOI 10.1111/j.1349-7006.2008.01007.x; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wahlberg P, 2008, ENDOCRINOLOGY, V149, P5070, DOI 10.1210/en.2007-1736; Wood JL, 2008, J BIOL CHEM, V283, P29586, DOI 10.1074/jbc.M804080200	49	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30397	10.1371/journal.pone.0030397	http://dx.doi.org/10.1371/journal.pone.0030397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291950	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600040
J	de Boer, FK; Hogeweg, P				de Boer, Folkert K.; Hogeweg, Paulien			Less Can Be More: RNA-Adapters May Enhance Coding Capacity of Replicators	PLOS ONE			English	Article							SECONDARY STRUCTURES; EVOLUTIONARY DYNAMICS; MOLECULAR CHAPERONES; SELF-ORGANIZATION; GENE-EXPRESSION; ERROR THRESHOLD; RIBOSWITCHES; RIBOZYMES; ORIGIN; WORLD	It is still not clear how prebiotic replicators evolved towards the complexity found in present day organisms. Within the most realistic scenario for prebiotic evolution, known as the RNA world hypothesis, such complexity has arisen from replicators consisting solely of RNA. Within contemporary life, remarkably many RNAs are involved in modifying other RNAs. In hindsight, such RNA-RNA modification might have helped in alleviating the limits of complexity posed by the information threshold for RNA-only replicators. Here we study the possible role of such self-modification in early evolution, by modeling the evolution of protocells as evolving replicators, which have the opportunity to incorporate these mechanisms as a molecular tool. Evolution is studied towards a set of 25 arbitrary 'functional' structures, while avoiding all other (misfolded) structures, which are considered to be toxic and increase the death-rate of a protocell. The modeled protocells contain a genotype of different RNA-sequences while their phenotype is the ensemble of secondary structures they can potentially produce from these RNA-sequences. One of the secondary structures explicitly codes for a simple sequence-modification tool. This 'RNA-adapter' can block certain positions on other RNA-sequences through antisense base-pairing. The altered sequence can produce an alternative secondary structure, which may or may not be functional. We show that the modifying potential of interacting RNA-sequences enables these protocells to evolve high fitness under high mutation rates. Moreover, our model shows that because of toxicity of misfolded molecules, redundant coding impedes the evolution of self-modification machinery, in effect restraining the evolvability of coding structures. Hence, high mutation rates can actually promote the evolution of complex coding structures by reducing redundant coding. Protocells can successfully use RNA-adapters to modify their genotype-phenotype mapping in order to enhance the coding capacity of their genome and fit more information on smaller sized genomes.	[de Boer, Folkert K.; Hogeweg, Paulien] Univ Utrecht, Utrecht, Netherlands	Utrecht University	de Boer, FK (corresponding author), Univ Utrecht, Utrecht, Netherlands.	fkdeboer@gmail.com			Netherlands Science Organizationsimilar to(NWO) [612.060.522]	Netherlands Science Organizationsimilar to(NWO)	This research is funded by the Netherlands Science Organization similar to(NWO) under grant number 612.060.522. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BOERLIJST MC, 1991, PHYSICA D, V48, P17, DOI 10.1016/0167-2789(91)90049-F; Brennicke A, 1999, FEMS MICROBIOL REV, V23, P297, DOI 10.1111/j.1574-6976.1999.tb00401.x; Chen PQ, 2009, GENETICS, V183, P639, DOI 10.1534/genetics.109.106492; Csermely P, 1997, TRENDS BIOCHEM SCI, V22, P147, DOI 10.1016/S0968-0004(97)01026-8; de Boer FK, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-361; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EIGEN M, 1980, J THEOR BIOL, V85, P407, DOI 10.1016/0022-5193(80)90315-X; EIGEN M, 1978, NATURWISSENSCHAFTEN, V65, P7, DOI 10.1007/BF00420631; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; Ferre-D'Amare AR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003574; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fontana W, 1998, SCIENCE, V280, P1451, DOI 10.1126/science.280.5368.1451; Fontana W, 2002, BIOESSAYS, V24, P1164, DOI 10.1002/bies.10190; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; HOGEWEG P, 1992, COMPUT CHEM, V16, P171, DOI 10.1016/0097-8485(92)80044-Z; Hogeweg P, 2003, ORIGINS LIFE EVOL B, V33, P375, DOI 10.1023/A:1025754907141; HUYNEN MA, 1994, J MOL EVOL, V39, P71; HUYNEN MA, 1993, J THEOR BIOL, V165, P251, DOI 10.1006/jtbi.1993.1188; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; Irimia M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-188; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Knight R, 2005, NUCLEIC ACIDS RES, V33, P5924, DOI 10.1093/nar/gki886; Kun A, 2005, NAT GENET, V37, P1008, DOI 10.1038/ng1621; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Maynard-Smith J., 1979, NATURE, V280, P445; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Philpott A, 2000, SEMIN CELL DEV BIOL, V11, P7, DOI 10.1006/scdb.1999.0346; Richter AS, 2011, P GERM C BIOINF GCB; Sanjuan R, 2011, MOL BIOL EVOL, V28, P1333, DOI 10.1093/molbev/msq329; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; SHAPIRO BA, 1988, COMPUT APPL BIOSCI, V4, P387; Silvestre DGM, 2005, EUR PHYS J B, V47, P423, DOI 10.1140/epjb/e2005-00346-5; Sontheimer EJ, 2005, CELL, V122, P9, DOI 10.1016/j.cell.2005.06.030; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; Szathmary E, 1997, J THEOR BIOL, V187, P555, DOI 10.1006/jtbi.1996.0389; Takeuchi N, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-9; Takeuchi N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000542; Takeuchi N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-11; Tiana G, 1998, J CHEM PHYS, V108, P757, DOI 10.1063/1.475435; Turk RM, 2010, P NATL ACAD SCI USA, V107, P4585, DOI 10.1073/pnas.0912895107; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; Wochner A, 2011, SCIENCE, V332, P209, DOI 10.1126/science.1200752; Zhang J, 2010, BIOCHEMISTRY-US, V49, P9123, DOI 10.1021/bi1012645	52	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e29952	10.1371/journal.pone.0029952	http://dx.doi.org/10.1371/journal.pone.0029952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291898	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600009
J	Wu, VC; Huang, TM; Wu, PC; Wang, WJ; Chao, CT; Yang, SY; Shiao, CC; Hu, FC; Lai, CF; Lin, YF; Han, YY; Chen, YS; Hsu, RB; Young, GH; Wang, SS; Tsai, PR; Chen, YM; Chao, TT; Ko, WJ; Wu, KD				Wu, Vin-Cent; Huang, Tao-Min; Wu, Pei-Chen; Wang, Wei-Jie; Chao, Chia-Ter; Yang, Shao-Yu; Shiao, Chih-Chung; Hu, Fu-Chang; Lai, Chun-Fu; Lin, Yu-Feng; Han, Yin-Yi; Chen, Yih-Sharng; Hsu, Ron-Bin; Young, Guang-Huar; Wang, Shoei-Shen; Tsai, Pi-Ru; Chen, Yung-Ming; Chao, Ting-Ting; Ko, Wen-Je; Wu, Kwan-Dun		NSARF Grp	Preoperative Proteinuria Is Associated with Long-Term Progression to Chronic Dialysis and Mortality after Coronary Artery Bypass Grafting Surgery	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; ACUTE KIDNEY INJURY; ACUTE-RENAL-FAILURE; CARDIOTHORACIC SURGERY; REPLACEMENT THERAPY; GENERAL-POPULATION; PROSPECTIVE COHORT; SERUM CREATININE; ALL-CAUSE; RISK	Aims: Preoperative proteinuria is associated with post-operative acute kidney injury (AKI), but whether it is also associated with increased long-term mortality and end -stage renal disease (ESRD) is unknown. Methods and Results: We studied 925 consecutive patients undergoing CABG. Demographic and clinical data were collected prospectively, and patients were followed for a median of 4.71 years after surgery. Proteinuria, according to dipstick tests, was defined as mild (trace to 1+) or heavy (2+ to 4+) according to the results of the dipstick test. A total of 276 (29.8%) patients had mild proteinuria before surgery and 119 (12.9%) patients had heavy proteinuria. During the follow-up, the Cox proportional hazards model demonstrated that heavy proteinuria (hazard ratio [HR], 27.17) was an independent predictor of long-term ESRD. There was a progressive increased risk for mild proteinuria ([HR], 1.88) and heavy proteinuria ([HR], 2.28) to predict all-cause mortality compared to no proteinuria. Mild ([HR], 2.57) and heavy proteinuria ([HR], 2.70) exhibited a stepwise increased ratio compared to patients without proteinuria for long-term composite catastrophic outcomes (mortality and ESRD), which were independent of the baseline GFR and postoperative acute kidney injury (AKI). Conclusion: Our study demonstrated that proteinuria is a powerful independent risk factor of long-term all-cause mortality and ESRD after CABG in addition to preoperative GFR and postoperative AKI. Our study demonstrated that proteinuria should be integrated into clinical risk prediction models for long-term outcomes after CABG. These results provide a high priority for future renal protective strategies and methods for post-operative CABG patients.	[Wu, Vin-Cent; Chao, Chia-Ter; Yang, Shao-Yu; Lai, Chun-Fu; Chen, Yung-Ming; Wu, Kwan-Dun] Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei 100, Taiwan; [Huang, Tao-Min] Natl Taiwan Univ Hosp, Div Nephrol, Dept Internal Med, Yun Lin Branch, Touliu, Taiwan; [Wu, Pei-Chen] Da Chien Gen Hosp, Div Nephrol, Dept Internal Med, Miaoli, Taiwan; [Wang, Wei-Jie] Taoyuan Gen Hosp, Dept Internal Med, Dept Hlth, Tao Yuan, Taiwan; [Chen, Yih-Sharng; Hsu, Ron-Bin; Young, Guang-Huar; Wang, Shoei-Shen; Tsai, Pi-Ru; Ko, Wen-Je] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Shiao, Chih-Chung] St Marys Hosp, Div Nephrol, Dept Internal Med, Luodong, Yilan, Taiwan; [Shiao, Chih-Chung] St Marys Med Nursing & Management Coll, Luodong, Yilan, Taiwan; [Hu, Fu-Chang] Int Harvard Stat Consulting Co, Taipei, Taiwan; [Lin, Yu-Feng; Han, Yin-Yi; Ko, Wen-Je] Natl Taiwan Univ Hosp, Dept Raumatol, Taipei 100, Taiwan; [Chao, Ting-Ting] Fu Jen Catholic Univ, Med Res Ctr, Cardinal Tien Hosp, Coll Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Fu Jen Catholic University	Wu, VC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei 100, Taiwan.	q91421028@ntu.edu.tw; kowj@ntu.edu.tw	Chao, Chia-Ter/H-7994-2019; Huang, Tao Min/C-5379-2011; Shiao, Chih-Chung/AAM-2716-2020; Yang, SY/AAN-1918-2021	Chao, Chia-Ter/0000-0003-2892-7986; Huang, Tao Min/0000-0002-9387-0798; Shiao, Chih-Chung/0000-0003-2220-7574; YANG, SHAO-YU/0000-0001-9170-2566; WU, VIN-CENT/0000-0001-7935-0991; LIN, YU-FENG/0000-0002-4350-7755; CHEN, YUNG-MING/0000-0002-9241-1258; Chen, Yih-Sharng/0000-0003-3846-8162; Wang, Shoei-Shen/0000-0003-3201-4143; WU, KWAN-DUN/0000-0002-3339-1509; HAN, YIN-YI/0000-0001-8831-7835; LAI, CHUN-FU/0000-0003-2109-1522	Ta-Tung Kidney Foundation; Taiwan National Science Council [NSC 96-2314-B-002-164, NSC 96-2314-B-002-033-MY3, NSC 97-2314-B-002-155-MY2, NSC 98-2314-B-002-155-MY4]; National Taiwan University Hospital [NTUH.098-001177, NTUH 100-001667]	Ta-Tung Kidney Foundation; Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This study was supported by The Ta-Tung Kidney Foundation, Taiwan National Science Council (grant NSC 96-2314-B-002-164, NSC 96-2314-B-002-033-MY3, NSC 97-2314-B-002-155-MY2, NSC 98-2314-B-002-155-MY4) and National Taiwan University Hospital grant, NTUH.098-001177, NTUH 100-001667. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Bove T, 2005, CIRCULATION, V111, P3230, DOI 10.1161/CIRCULATIONAHA.104.509141; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cooper WA, 2006, CIRCULATION, V113, P1063, DOI 10.1161/CIRCULATIONAHA.105.580084; DeRose JJ, 2005, J THORAC CARDIOV SUR, V129, P314, DOI 10.1016/j.jtcvs.2004.05.022; Donadelli R, 2000, AM J KIDNEY DIS, V36, P1226, DOI 10.1053/ajkd.2000.19838; Eagle KA, 1999, J AM COLL CARDIOL, V34, P1262, DOI 10.1016/S0735-1097(99)00389-7; Grams ME, 2010, J AM SOC NEPHROL, V21, P1757, DOI 10.1681/ASN.2010010128; Haase M, 2009, J THORAC CARDIOV SUR, V138, P1370, DOI 10.1016/j.jtcvs.2009.07.007; Halbesma N, 2006, J AM SOC NEPHROL, V17, P2582, DOI 10.1681/ASN.2005121352; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hillis GS, 2006, CIRCULATION, V113, P1056, DOI 10.1161/CIRCULATIONAHA.105.591990; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Huang TM, 2011, J AM SOC NEPHROL, V22, P156, DOI 10.1681/ASN.2010050553; James MT, 2010, LANCET, V376, P2096, DOI 10.1016/S0140-6736(10)61271-8; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Konta Tsuneo, 2007, Clin Exp Nephrol, V11, P51, DOI 10.1007/s10157-006-0458-z; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Orii K, 2009, J NIHON MED SCH, V78, P156; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; PARFREY PS, 1989, NEW ENGL J MED, V320, P143, DOI 10.1056/NEJM198901193200303; Ruggenenti P, 2006, KIDNEY INT, V70, P1214, DOI 10.1038/sj.ki.5001729; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wu VC, 2011, KIDNEY INT IN PRESS; Wu VC, 2008, INTENS CARE MED, V34, P101, DOI 10.1007/s00134-007-0813-x; Wu VC, 2007, J AM COLL SURGEONS, V205, P266, DOI 10.1016/j.jamcollsurg.2007.04.006	34	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e27687	10.1371/journal.pone.0027687	http://dx.doi.org/10.1371/journal.pone.0027687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276092	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100001
J	Rosche, B; Laurent, S; Conradi, S; Hofmann, J; Ruprecht, K; Harms, L				Rosche, Berit; Laurent, Sarah; Conradi, Silja; Hofmann, Joerg; Ruprecht, Klemens; Harms, Lutz			Measles IgG Antibody Index Correlates with T2 Lesion Load on MRI in Patients with Early Multiple Sclerosis	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; IMMUNE-RESPONSE; CONVERSION; PATTERNS; CRITERIA; DISEASES	Background: B cells and humoral immune responses play an important role in the pathogenesis and diagnosis of multiple sclerosis (MS). A characteristic finding in patients with MS is a polyspecific intrathecal B cell response against neurotropic viruses, specifically against measles virus, rubella virus, and varicella zoster virus, also known as an MRZ reaction (MRZR). Here, we correlated from the routine clinical diagnostics individual IgG antibody indices (AIs) of MRZR with magnetic resonance imaging (MRI) findings in patients with first MS diagnosis. Methods/Results: MRZR was determined in 68 patients with a clinically isolated syndrome (CIS) or early relapsing-remitting MS (RRMS). Absolute AI values for measles virus, rubella virus, and varicella zoster virus were correlated with T2 lesion load and gadolinium enhancing lesions on cerebral MRI (cMRI) and cMRI combined with spinal MRI (sMRI). Measles virus AI correlated significantly with T2 lesion load on cMRI (p = 0.0312, Mann-Whitney U test) and the sum of lesions on cMRI and sMRI (p = 0.0413). Varicella zoster virus AI also showed a correlation with T2 lesion load on cMRI but did not reach statistical significance (p = 0.2893). Conclusion: The results confirm MRZR as part of the polyspecific immune reaction in MS with possible prognostic impact on MRI and clinical parameters. Furthermore, the data indicate that intrathecal measles virus IgG production correlates with disease activity on cMRI and sMRI in patients with early MS.	[Rosche, Berit; Laurent, Sarah; Conradi, Silja; Ruprecht, Klemens; Harms, Lutz] Charite, Dept Neurol & Expt Neurol, D-13353 Berlin, Germany; [Hofmann, Joerg] Charite, Dept Virol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rosche, B (corresponding author), Charite, Dept Neurol & Expt Neurol, D-13353 Berlin, Germany.	berit.rosche@charite.de		Hofmann, Joerg/0000-0003-3966-515X; Laurent, Sarah Anne/0000-0001-8997-3017	Bayer Schering Pharma; Merck Serono; Biogen Idec; Teva Pharmaceuticals; Novartis	Bayer Schering Pharma(Bayer AG); Merck Serono(Merck & Company); Biogen Idec(Biogen); Teva Pharmaceuticals(Teva Pharmaceutical Industries); Novartis(Novartis)	BR receives research funding from Bayer Schering Pharma and Merck Serono. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BR receives research funding from Bayer Schering Pharma and Merck Serono. BR has participated in meetings sponsored by and received lecture fees from Biogen Idec, Bayer Schering Pharma, Merck Sorono and Teva Pharmaceuticals. KR has received funding for travel and lecture fees from Merck Serono and Bayer Schering Pharma, and receives research support from Novartis. LH has received personal compensation for activities with Biogen Idec, Serono and Teva Pharmaceuticals as a Speaker. SL, SC and JH have nothing to disclose. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; Brettschneider J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007638; Cepok S, 2001, BRAIN, V124, P2169, DOI 10.1093/brain/124.11.2169; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Derfuss T, 2001, BRAIN, V124, P1325, DOI 10.1093/brain/124.7.1325; FELGENHAUER K, 1992, CLIN INVESTIGATOR, V70, P28, DOI 10.1007/BF00422934; Jacobi C, 2007, J NEUROIMMUNOL, V187, P139, DOI 10.1016/j.jneuroim.2007.04.002; Jarius S, 2009, J NEUROL SCI, V280, P98, DOI 10.1016/j.jns.2008.08.002; Nociti V, 2010, J NEUROIMMUNOL, V225, P149, DOI 10.1016/j.jneuroim.2010.04.007; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Reiber H, 1998, MULT SCLER, V4, P111, DOI 10.1177/135245859800400304; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Rieckmann P, 2002, NERVENARZT, V73, P556, DOI 10.1007/s00115-002-1328-x; Swanton JK, 2007, LANCET NEUROL, V6, P677, DOI 10.1016/S1474-4422(07)70176-X; Villar LM, 2002, NEUROLOGY, V58, P824, DOI 10.1212/WNL.58.5.824; WALSH MJ, 1986, J EXP MED, V163, P41, DOI 10.1084/jem.163.1.41	16	29	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e28094	10.1371/journal.pone.0028094	http://dx.doi.org/10.1371/journal.pone.0028094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276094	Green Published, Green Submitted, gold			2022-12-27	WOS:000301457200002
J	Schnell, O; Romagna, A; Jaehnert, I; Albrecht, V; Eigenbrod, S; Juerchott, K; Kretzschmar, H; Tonn, JC; Schichor, C				Schnell, Oliver; Romagna, Alexander; Jaehnert, Irene; Albrecht, Valerie; Eigenbrod, Sabina; Juerchott, Kathrin; Kretzschmar, Hans; Tonn, Joerg-Christian; Schichor, Christian			Kruppel-Like Factor 8 (KLF8) Is Expressed in Gliomas of Different WHO Grades and Is Essential for Tumor Cell Proliferation	PLOS ONE			English	Article							FOCAL ADHESION KINASE; KI-67 IMMUNOREACTIVITY; IN-VIVO; TRANSCRIPTION; ASTROCYTOMAS; GENE	Kruppel-like factor 8 (KLF8) has only recently been identified to be involved in tumor cell proliferation and invasion of several different tumor entities like renal cell carcinoma, hepatocellular carcinoma and breast cancer. In the present study, we show for the first time the expression of KLF8 in gliomas of different WHO grades and its functional impact on glioma cell proliferation. In order to get information about KLF8-mRNA regulation qPCR was performed and did not reveal any significant difference in samples (n = 10 each) of non-neoplastic brain (NNB), low-grade gliomas (LGG, WHO degrees II) and glioblastomas (GBM, WHO degrees IV). Immunohistochemistry of tissue samples (n = 7 LGG, 11 AA and 12 GBM) did not show any significant difference in the fraction of KLF8-immunopositive cells of all analyzed cells in LGG (87%), AA (80%) or GBM (89%). Tissue samples from cerebral breast cancer metastasis, meningiomas but also non-neoplastic brain demonstrated comparable relative cell counts as well. Moreover, there was no correlation between KLF8 expression and the expression pattern of the assumed proliferation marker Ki67, which showed high variability between different tumor grade (9% (LGG), 6% (AA) and 15% (GBM) of Ki67-immunopositive cells). Densitometric analysis of Western blotting revealed that the relative amount of KLF8-protein did also not differ between the highly aggressive and proliferative GBM (1.05) compared to LGG (0.93; p<0.05, students t-test). As demonstrated for some other non-glial cancer entities, KLF8-knockdown by shRNA in U87-MG cells confirmed its functional relevance, leading to an almost complete loss of tumor cell proliferation. Selective blocking of KLF8 might represent a novel anti-proliferative treatment strategy for malignant gliomas. Yet, its simultaneous expression in non-proliferating tissues could hamper this approach.	[Schnell, Oliver; Romagna, Alexander; Jaehnert, Irene; Albrecht, Valerie; Tonn, Joerg-Christian; Schichor, Christian] Klinikum Ludwig Maximilians Univ Munchen, Dept Neurosurg, Munich, Germany; [Eigenbrod, Sabina; Kretzschmar, Hans] Univ Munich, Ctr Neuropathol & Pr Res, Munich, Germany; [Juerchott, Kathrin] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	University of Munich; University of Munich; Max Planck Society	Schnell, O (corresponding author), Klinikum Ludwig Maximilians Univ Munchen, Dept Neurosurg, Campus Grosshadern, Munich, Germany.	Oliver.Schnell@med.uni-muenchen.de	Schichor, Christian/D-8635-2014; Tonn, Joerg/AAK-8509-2021		Stiftung Neurochirurgische Forschung of the Deutsche Gesellschaft fur Neurochirurgie (DGNC); bi-national SYSTHER-INREMOS virtual institute; German (BMBF); Slovenian Federal Ministry of Education and Research; Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich (SFB) 824]	Stiftung Neurochirurgische Forschung of the Deutsche Gesellschaft fur Neurochirurgie (DGNC); bi-national SYSTHER-INREMOS virtual institute; German (BMBF)(Federal Ministry of Education & Research (BMBF)); Slovenian Federal Ministry of Education and Research; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by several grants from the Stiftung Neurochirurgische Forschung of the Deutsche Gesellschaft fur Neurochirurgie (DGNC) (O.S.), the bi-national SYSTHER-INREMOS virtual institute, funded by the German (BMBF) and the Slovenian Federal Ministry of Education and Research (I.J., K.J. and C.S.) and the Sonderforschungsbereich (SFB) 824 of the Deutsche Forschungsgemeinschaft (DFG) (V.A. and J.C.T.). The presented work is in partial fulfillment of the requirements for the degree of Dr. med. at the Ludwig-Maximilians-Universitat Munchen (A.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agochiya M, 1999, ONCOGENE, V18, P5646, DOI 10.1038/sj.onc.1202957; Craven RJ, 2003, SURG ONCOL, V12, P39, DOI 10.1016/S0960-7404(03)00004-5; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Fu WJ, 2010, J CANCER RES CLIN, V136, P1255, DOI 10.1007/s00432-010-0776-0; Hsu DW, 1997, J NEUROPATH EXP NEUR, V56, P857, DOI 10.1097/00005072-199708000-00003; Johannessen AL, 2006, PATHOL ONCOL RES, V12, P143, DOI 10.1007/BF02893360; Li JC, 2010, GASTROENTEROLOGY, V139, P2146, DOI 10.1053/j.gastro.2010.08.004; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; McAnuff MA, 2007, J PHARM SCI-US, V96, P2922, DOI 10.1002/jps.20968; Quinones-Hinojosa A, 2005, J NEURO-ONCOL, V74, P19, DOI 10.1007/s11060-004-5758-0; Schnell O, 2008, BRAIN PATHOL, V18, P378, DOI 10.1111/j.1750-3639.2008.00137.x; Torp SH, 2002, PATHOL RES PRACT, V198, P261; Urvalek AM, 2011, AM J TRANSL RES, V3, P121; Urvalek AM, 2010, CELL CYCLE, V9, P601, DOI 10.4161/cc.9.3.10606; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; Wang X, 2011, ONCOGENE, V30, P1901, DOI 10.1038/onc.2010.563; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5; ZHAO JJ, 2006, SCI STKE, pPE52, DOI DOI 10.1126/STKE.3652006PE52	20	31	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30429	10.1371/journal.pone.0030429	http://dx.doi.org/10.1371/journal.pone.0030429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276196	gold, Green Published, Green Submitted			2022-12-27	WOS:000301457200059
J	Gao, W; Sun, WK; Qu, BQ; Cardona, CJ; Powell, K; Wegner, M; Shi, Y; Xing, Z				Gao, Wei; Sun, Wenkui; Qu, Bingqian; Cardona, Carol J.; Powell, Kira; Wegner, Marta; Shi, Yi; Xing, Zheng			Distinct Regulation of Host Responses by ERK and JNK MAP Kinases in Swine Macrophages Infected with Pandemic (H1N1) 2009 Influenza Virus	PLOS ONE			English	Article							A VIRUS; IMMUNE-RESPONSES; UNITED-STATES; RIG-I; ANTIVIRAL RESPONSES; APOPTOTIC RESPONSES; GENE-EXPRESSION; PIGS; RNA; CELLS	Swine influenza is an acute respiratory disease in pigs caused by swine influenza virus (SIV). Highly virulent SIV strains cause mortality of up to 10%. Importantly, pigs have long been considered "mixing vessels'' that generate novel influenza viruses with pandemic potential, a constant threat to public health. Since its emergence in 2009 and subsequent pandemic spread, the pandemic (H1N1) 2009 (H1N1pdm) has been detected in pig farms, creating the risk of generating new reassortants and their possible infection of humans. Pathogenesis in SIV or H1N1pdm-infected pigs remains poorly characterized. Proinflammatory and antiviral cytokine responses are considered correlated with the intensity of clinical signs, and swine macrophages are found to be indispensible in effective clearance of SIV from pig lungs. In this study, we report a unique pattern of cytokine responses in swine macrophages infected with H1N1pdm. The roles of mitogen-activated protein (MAP) kinases in the regulation of the host responses were examined. We found that proinflammatory cytokines IL-6, IL-8, IL-10, and TNF-alpha were significantly induced and their induction was ERK1/2-dependent. IFN-beta and IFN-inducible antiviral Mx and 2959-OAS were sharply induced, but the inductions were effectively abolished when ERK1/2 was inhibited. Induction of CCL5 (RANTES) was completely inhibited by inhibitors of ERK1/2 and JNK1/2, which appeared also to regulate FasL and TNF-alpha, critical for apoptosis in pig macrophages. We found that NF kappa B was activated in H1N1pdm-infected cells, but the activation was suppressed when ERK1/2 was inhibited, indicating there is cross-talk between MAP kinase and NF kappa B responses in pig macrophages. Our data suggest that MAP kinase may activate NF kappa B through the induction of RIG-1, which leads to the induction of IFN-beta in swine macrophages. Understanding host responses and their underlying mechanisms may help identify venues for effective control of SIV and assist in prevention of future influenza pandemics.	[Gao, Wei; Qu, Bingqian; Xing, Zheng] Nanjing Univ, Sch Med, Nanjing, Jiangsu, Peoples R China; [Gao, Wei; Qu, Bingqian; Xing, Zheng] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Gao, Wei; Shi, Yi] Nanjing Univ, Sch Clin Med, Dept Resp Med, Nanjing Gen Hosp Nanjing Mil Command, Nanjing, Jiangsu, Peoples R China; [Sun, Wenkui] Second Mil Med Univ, Dept Resp Med, Nanjing Gen Hosp Nanjing Mil Command, Nanjing, Jiangsu, Peoples R China; [Cardona, Carol J.; Powell, Kira; Wegner, Marta; Xing, Zheng] Univ Minnesota Twin Cities, Coll Vet Med, Dept Vet Biomed Sci, St Paul, MN USA	Nanjing University; Nanjing University; Nanjing General Hospital; Nanjing University; Nanjing General Hospital; Naval Medical University; University of Minnesota System; University of Minnesota Twin Cities	Gao, W (corresponding author), Nanjing Univ, Sch Med, Nanjing, Jiangsu, Peoples R China.	zxing@umn.edu	Xing, Zheng/O-3137-2015; Xing, Zheng/G-8366-2011; Qu, Bingqian/AAD-1728-2020	Xing, Zheng/0000-0002-7288-0268; Xing, Zheng/0000-0002-7288-0268; Qu, Bingqian/0000-0002-7330-2929	National Natural Science Foundation of China [30971450/C0703]; State Key Laboratory of Pharmaceutical Biotechnology of Nanjing University [KF-GW-200902]; Department of Homeland Security National Center for Foreign Animal and Zoonotic Disease Defense [3-V419C33]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Pharmaceutical Biotechnology of Nanjing University; Department of Homeland Security National Center for Foreign Animal and Zoonotic Disease Defense(United States Department of Homeland Security (DHS))	This study was supported by grants from the National Natural Science Foundation of China (grant 30971450/C0703) and the State Key Laboratory of Pharmaceutical Biotechnology of Nanjing University (grant KF-GW-200902). CJC and ZX were also supported in part by a grant from the Department of Homeland Security National Center for Foreign Animal and Zoonotic Disease Defense (3-V419C33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SC, 2009, MOL IMMUNOL, V46, P1744, DOI 10.1016/j.molimm.2009.01.025; Barbe F, 2011, VET J, V187, P48, DOI 10.1016/j.tvjl.2009.12.012; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Calore EE, 2011, PATHOL RES PRACT, V207, P86, DOI 10.1016/j.prp.2010.11.003; CASTRUCCI MR, 1993, VIROLOGY, V193, P503, DOI 10.1006/viro.1993.1155; Charley B, 2006, ANN NY ACAD SCI, V1081, P130, DOI 10.1196/annals.1373.014; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Howden KJ, 2009, CAN VET J, V50, P1153; Khatri M, 2010, J VIROL, V84, P11210, DOI 10.1128/JVI.01211-10; Kim HM, 2008, J VIROL, V82, P4265, DOI 10.1128/JVI.02602-07; Li JL, 2008, ARCH VIROL, V153, P1899, DOI 10.1007/s00705-008-0217-4; Ludwig S, 2001, J BIOL CHEM, V276, P10990, DOI 10.1074/jbc.M009902200; Marozin S, 2002, J GEN VIROL, V83, P735, DOI 10.1099/0022-1317-83-4-735; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Qi X, 2006, ARCH VIROL, V151, P2289, DOI 10.1007/s00705-006-0796-x; Qi X, 2009, VIRUS GENES, V39, P193, DOI 10.1007/s11262-009-0375-9; Richt JA, 2003, J CLIN MICROBIOL, V41, P3198, DOI 10.1128/JCM.41.7.3198-3205.2003; Song MS, 2010, J CLIN MICROBIOL, V48, P3204, DOI 10.1128/JCM.00053-10; Van Reeth K, 2003, VACCINE, V21, P1375, DOI 10.1016/S0264-410X(02)00688-6; Van Reeth K, 2000, VET MICROBIOL, V74, P109, DOI 10.1016/S0378-1135(00)00171-1; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; Vincent AL, 2009, VET MICROBIOL, V137, P51, DOI 10.1016/j.vetmic.2009.01.003; Webby RJ, 2000, J VIROL, V74, P8243, DOI 10.1128/JVI.74.18.8243-8251.2000; WEBSTER RG, 1993, INTERVIROLOGY, V35, P16, DOI 10.1159/000150292; Weingartl HM, 2010, J VIROL, V84, P2245, DOI 10.1128/JVI.02118-09; WHO, 2010, PAND H1N1 2009 UPD 8; Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785; Xing Z, 2008, J GEN VIROL, V89, P1288, DOI 10.1099/vir.0.83362-0; Xing Z, 2011, AM J RESP CELL MOL, V44, P24, DOI 10.1165/rcmb.2009-0120OC; Xing Z, 2010, J GEN VIROL, V91, P343, DOI 10.1099/vir.0.015578-0; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zhang XX, 2000, MICROB PATHOGENESIS, V28, P267, DOI 10.1006/mpat.1999.0349	40	27	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30328	10.1371/journal.pone.0030328	http://dx.doi.org/10.1371/journal.pone.0030328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279582	Green Submitted, Green Published, gold			2022-12-27	WOS:000299771900059
J	Izhak, L; Wildbaum, G; Jung, S; Stein, A; Shaked, Y; Karin, N				Izhak, Liat; Wildbaum, Gizi; Jung, Steffen; Stein, Avi; Shaked, Yuval; Karin, Nathan			Dissecting the Autocrine and Paracrine Roles of the CCR2-CCL2 Axis in Tumor Survival and Angiogenesis	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ENDOTHELIAL PROGENITOR CELLS; PROSTATE-CANCER; BONE-MARROW; DENDRITIC CELLS; BREAST-CANCER; CHEMOKINE RECEPTORS; LUCIFERASE GENE; MYELOID CELLS; MOUSE MODEL	The CCL2 CCR2 axis is likely to contributes to the development and progression of cancer diseases by two major mechanisms; autocrine effect of CCL2 as a survival/growth factor for CCR2+ cancer cells and, the attraction of CCR2+ CX(3)CR1+tumor associated macrophages that in the absence of CCR2 hardly migrate. Thus far no in vivo system has been set up to differentiate the selective contribution of each of these features to cancer development. Here we employed a chimera animal model in which all non-malignant cells are CCR2-/-, but all cancer cells are CCR2+, combined with an adoptive transfer system of bone marrow (BM) CX(3)CR1+ cells from CCR2+ mice harboring a targeted replacement of the CX(3)CR1gene by an enhanced green fluorescent protein (EGFP) reporter gene (cx(3)cr1(gfp)), together with the CD45.1 congene. Using this system we dissected the selective contribution of CX(3)CR1+ CCR2+ cells, which comprise only about 7% of CD11b+ BM cells, to tumor development and angiogenesis. Showing that aside for their direct pro-angiogenic effect they are essential for the recruitment of other CD11b+ cells to the tumor site. We further show that the administration of CCR2-Ig, that selectively and specifically neutralize CCL2, to mice in which CCR2 is expressed only on tumor cells, further suppressed tumor development, implicating for the key role of this chemokine supporting tumor survival in an autocrine manner. This further emphasizes the important role of CCL2 as a target for therapy of cancer diseases.	[Izhak, Liat; Wildbaum, Gizi; Karin, Nathan] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Immunol, Rappaport Inst Med Res, IL-31096 Haifa, Israel; [Shaked, Yuval] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Pharmacol, Rappaport Inst Med Res, IL-31096 Haifa, Israel; [Stein, Avi] Carmel Hosp, Dept Urol, Haifa, Israel; [Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Clalit Health Services; Carmel Medical Center; Weizmann Institute of Science	Izhak, L (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Immunol, Rappaport Inst Med Res, POB 9649, IL-31096 Haifa, Israel.	nkarin@tx.technion.ac.il	Jung, Steffen/K-1409-2012	Jung, Steffen/0000-0003-4290-5716	Israel Cancer Research Fund (ICRF); Israel Cancer Association (ICA); Israel Ministry of Health Chief Scientist; Israel Science Foundation (ISF)	Israel Cancer Research Fund (ICRF); Israel Cancer Association (ICA); Israel Ministry of Health Chief Scientist; Israel Science Foundation (ISF)(Israel Science Foundation)	This study was supported by the Israel Cancer Research Fund (ICRF), the Israel Cancer Association (ICA), the Israel Ministry of Health Chief Scientist and Israel Science Foundation (ISF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JY, 2002, NAT MED, V8, P891, DOI 10.1038/nm743; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Bot I, 2005, BLOOD, V106, P1147, DOI 10.1182/blood-2004-12-4839; BOTTAZZI B, 1992, J IMMUNOL, V148, P1280; del Rio ML, 2008, J IMMUNOL, V181, P6178, DOI 10.4049/jimmunol.181.9.6178; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gazzaniga S, 2007, J INVEST DERMATOL, V127, P2031, DOI 10.1038/sj.jid.5700827; Gingrich JR, 1999, PROSTATE CANCER P D, V2, P70, DOI 10.1038/sj/pcan/4500296; Green J, 2003, KIDNEY INT, V63, P487, DOI 10.1046/j.1523-1755.2003.00773.x; Hefler L, 1999, BRIT J CANCER, V81, P855, DOI 10.1038/sj.bjc.6690776; Hsieh CL, 2005, J MOL ENDOCRINOL, V35, P293, DOI 10.1677/jme.1.01722; Izhak L, 2009, J IMMUNOL, V183, P732, DOI 10.4049/jimmunol.0802746; Izhak L, 2010, J IMMUNOL, V184, P1092, DOI 10.4049/jimmunol.0902725; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim SJ, 2009, AM J PATHOL, V174, P1972, DOI 10.2353/ajpath.2009.080819; Knowles Helen, 2004, Novartis Found Symp, V256, P189; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Loberg RD, 2007, CANCER RES, V67, P9417, DOI 10.1158/0008-5472.CAN-07-1286; Loberg RD, 2006, NEOPLASIA, V8, P578, DOI 10.1593/neo.06280; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mazzucchelli L, 1996, AM J PATHOL, V149, P501; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Ozaki H, 1997, EXP EYE RES, V64, P505, DOI 10.1006/exer.1996.0239; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rollins BJ, 1996, MOL MED TODAY, V2, P198, DOI 10.1016/1357-4310(96)88772-7; Rubio N, 1998, LAB INVEST, V78, P1315; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; Shaked Y, 2006, SCIENCE, V313, P1785, DOI 10.1126/science.1127592; Shojaei F, 2008, DRUG RESIST UPDAT; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	45	38	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e28305	10.1371/journal.pone.0028305	http://dx.doi.org/10.1371/journal.pone.0028305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279523	Green Published, Green Submitted, gold			2022-12-27	WOS:000299771900002
J	Lim, XF; Jia, Q; Khong, WX; Yan, B; Premanand, B; Alonso, S; Chow, VTK; Kwang, J				Lim, Xiao Fang; Jia, Qiang; Khong, Wei Xin; Yan, Benedict; Premanand, Balraj; Alonso, Sylvie; Chow, Vincent T. K.; Kwang, Jimmy			Characterization of an Isotype-Dependent Monoclonal Antibody against Linear Neutralizing Epitope Effective for Prophylaxis of Enterovirus 71 Infection	PLOS ONE			English	Article							MOUTH-DISEASE; ENCEPHALITIS-VIRUS; IMMUNE GLOBULIN; CAPSID PROTEIN; EPIDEMIC; MICE; FOOT; IMMUNOGLOBULIN; VP1; MENINGOENCEPHALITIS	Background: Enterovirus 71 (EV71) is the main causative agent of Hand, Foot and Mouth disease (HFMD) and is associated with severe neurologic complications and mortalities. At present, there is no vaccine or therapeutic available for treatment. Methodology/Principal Finding: In this study, we generated two mAbs, denoted as mAb 51 and 53, both targeting the same linear epitope on VP1 capsid protein, spanning amino acids 215-219. In comparison, mAb 51 belonging to isotype IgM possesses neutralizing activity in vitro, whereas, mAb 53 belonging to isotype IgG1 does not have any neutralizing ability, even towards its homologous strain. When mAb 51 at 10 mg/g of body weight was administered to the 2-week-old AG129 mice one day prior to lethal challenge, 100% in vivo passive protection was observed. In contrast, the isotype control group mice, injected with an irrelevant IgM antibody before the challenge, developed limb paralysis as early as day 6 post-infection. Histological examination demonstrated that mAb 51 was able to protect against pathologic changes such as neuropil vacuolation and neuronal loss in the spinal cord, which were typical in unprotected EV-71 infected mice. BLAST analyses of that epitope revealed that it was highly conserved among all EV71 strains, but not coxsachievirus 16 (CA16). Conclusion: We have defined a linear epitope within the VP1 protein and demonstrated its neutralizing ability to be isotype dependent. The neutralizing property and highly conserved sequence potentiated the application of mAb 51 and 53 for protection against EV71 infection and diagnosis respectively.	[Lim, Xiao Fang; Jia, Qiang; Premanand, Balraj; Kwang, Jimmy] Anim Hlth Biotechnol, Temasek Life Sci Lab, Singapore, Singapore; [Khong, Wei Xin; Alonso, Sylvie; Chow, Vincent T. K.; Kwang, Jimmy] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Khong, Wei Xin; Alonso, Sylvie] Natl Univ Singapore, Yong Loo Lin Sch Med, Immunol Programme, Singapore 117595, Singapore; [Khong, Wei Xin] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Yan, Benedict] Natl Univ Hlth Syst, Dept Pathol, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Lim, XF (corresponding author), Anim Hlth Biotechnol, Temasek Life Sci Lab, Singapore, Singapore.	kwang@tll.org.sg		Chow, Vincent/0000-0003-2634-6213	Temasek Life Sciences Laboratory, Singapore; Temasek Life Sciences Laboratory; Laboratory Animals Centre (National University of Singapore)	Temasek Life Sciences Laboratory, Singapore(National University of Singapore); Temasek Life Sciences Laboratory(National University of Singapore); Laboratory Animals Centre (National University of Singapore)(National University of Singapore)	This project is funded by Temasek Life Sciences Laboratory (http://www.tll.org.sg/), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mr Anbu Kumar Karuppannan and Dr Tanja K. Kiener for their valuable suggestions and Mr Tao Meng for the generation of RG-EV71 viruses. We also thank Temasek Life Sciences Laboratory animal care officers and Laboratory Animals Centre (National University of Singapore) for all their help and support.	Aarthi D, 2004, BIOLOGICALS, V32, P153, DOI 10.1016/j.biologicals.2004.09.001; ABZUG MJ, 1995, CLIN INFECT DIS, V20, P1201, DOI 10.1093/clinids/20.5.1201; ARMSTRONG SJ, 1990, J GEN VIROL, V71, P2313, DOI 10.1099/0022-1317-71-10-2313; BAHNEMANN HG, 1975, ARCH VIROL, V47, P47, DOI 10.1007/BF01315592; Bendig J W, 1996, Commun Dis Rep CDR Rev, V6, pR81; Bible JM, 2008, J CLIN MICROBIOL, V46, P3192, DOI 10.1128/JCM.00628-08; BLOMBERG J, 1974, LANCET, V2, P112; Chang GH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-106; Chang Luan-Yin, 2008, Pediatrics and Neonatology, V49, P103, DOI 10.1016/S1875-9572(08)60023-6; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; DIMMOCK NJ, 1984, J GEN VIROL, V65, P1015, DOI 10.1099/0022-1317-65-6-1015; DWYER JM, 1992, NEW ENGL J MED, V326, P107; FEINSTEIN A, 1971, ANN NY ACAD SCI, V190, P104, DOI 10.1111/j.1749-6632.1971.tb13526.x; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; GELLER TJ, 1995, J NEUROL SCI, V129, P131, DOI 10.1016/0022-510X(94)00261-L; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; HAGIWARA A, 1978, INTERVIROLOGY, V9, P60, DOI 10.1159/000148922; HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218; KENNETT ML, 1974, B WORLD HEALTH ORGAN, V51, P609; KIMURAKURODA J, 1988, J IMMUNOL, V141, P3606; Li C, 2007, CURR MED CHEM, V14, P847, DOI 10.2174/092986707780363032; Li XL, 2009, BIOCHEM BIOPH RES CO, V390, P1126, DOI 10.1016/j.bbrc.2009.09.103; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; MCKINNEY RE, 1987, REV INFECT DIS, V9, P334; Meng T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021757; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531; Salinas-Carmona MC, 2004, INFECT IMMUN, V72, P5597, DOI 10.1128/IAI.72.10.5597-5604.2004; SAMUDA GM, 1987, PEDIATR INFECT DIS J, V6, P206, DOI 10.1097/00006454-198702000-00013; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; SIGOUNAS G, 1994, J CLIN IMMUNOL, V14, P134, DOI 10.1007/BF01541346; Tan CS, 2007, ARCH VIROL, V152, P1069, DOI 10.1007/s00705-007-0941-1; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Wang Li-chun, 2010, Virologica Sinica, V25, P98, DOI 10.1007/s12250-010-3102-8; Wang SM, 2009, EXPERT REV ANTI-INFE, V7, P735, DOI 10.1586/ERI.09.45; Xu FH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011388; Yokoyama Wayne M, 2006, Curr Protoc Immunol, VChapter 2, DOI 10.1002/0471142735.im0205s74; YOKOYAMA WM, 2001, CURR PROTOC IMMUNOL, pCH2	42	43	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29751	10.1371/journal.pone.0029751	http://dx.doi.org/10.1371/journal.pone.0029751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279543	Green Submitted, Green Published, gold			2022-12-27	WOS:000299771900021
J	Wong, G; Howard, K; Chapman, JR; Chadban, S; Cross, N; Tong, A; Webster, AC; Craig, JC				Wong, Germaine; Howard, Kirsten; Chapman, Jeremy R.; Chadban, Steven; Cross, Nicholas; Tong, Allison; Webster, Angela C.; Craig, Jonathan C.			Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; WAITING-LIST; ELDERLY-PATIENTS; ACCESS; RECIPIENTS; UTILITY; GENDER; ALLOCATION; OUTCOMES; EXPAND	Background: Deceased donor kidneys for transplantation are in most countries allocated preferentially to recipients who have limited co-morbidities. Little is known about the incremental health and economic gain from transplanting those with co-morbidities compared to remaining on dialysis. The aim of our study is to estimate the average and incremental survival benefits and health care costs of listing and transplantation compared to dialysis among individuals with varying co-morbidities. Methods: A probabilistic Markov model was constructed, using current outcomes for patients with defined co-morbidities treated with either dialysis or transplantation, to compare the health and economic benefits of listing and transplantation with dialysis. Findings: Using the current waiting time for deceased donor transplantation, transplanting a potential recipient, with or without co-morbidities achieves survival gains of between 6 months and more than three life years compared to remaining on dialysis, with an average incremental cost-effectiveness ratio (ICER) of less than $50,000/LYS, even among those with advanced age. Age at listing and the waiting time for transplantation are the most influential variables within the model. If there were an unlimited supply of organs and no waiting time, transplanting the younger and healthier individuals saves the most number of life years and is cost-saving, whereas transplanting the middle-age to older patients still achieves substantial incremental gains in life expectancy compared to being on dialysis. Conclusions: Our modelled analyses suggest transplanting the younger and healthier individuals with end-stage kidney disease maximises survival gains and saves money. Listing and transplanting those with considerable co-morbidities is also cost-effective and achieves substantial survival gains compared with the dialysis alternative. Preferentially excluding the older and sicker individuals cannot be justified on utilitarian grounds.	[Wong, Germaine; Tong, Allison; Webster, Angela C.; Craig, Jonathan C.] Childrens Hosp, Ctr Kidney Res, Westmead, NSW, Australia; [Wong, Germaine; Howard, Kirsten; Webster, Angela C.; Craig, Jonathan C.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Wong, Germaine; Chapman, Jeremy R.; Webster, Angela C.] Westmead Hosp, Ctr Transplant & Renal Res, Sydney, NSW, Australia; [Chadban, Steven] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia; [Cross, Nicholas] Christchurch Hosp, Dept Nephrol, Christchurch, New Zealand	University of Sydney; University of Sydney; University of Sydney; University of Sydney; Christchurch Hospital New Zealand	Wong, G (corresponding author), Childrens Hosp, Ctr Kidney Res, Westmead, NSW, Australia.	germaine.wong@health.nsw.gov.au	Craig, Jonathan/E-2813-2013; Wong, Germaine/B-2386-2013; Webster, Angela/J-2186-2012	Craig, Jonathan/0000-0002-2548-4035; Webster, Angela/0000-0001-7509-0512; Tong, Allison/0000-0001-8973-9538; Howard, Kirsten/0000-0002-0918-7540; Wong, Germaine/0000-0001-8422-7269	Don and Lorraine Jacquot Fellowship; Screening and Diagnostic Test Evaluation Program (STEP); Health Economics Research, Modelling and Evaluation in Sydney (HERMES)	Don and Lorraine Jacquot Fellowship; Screening and Diagnostic Test Evaluation Program (STEP); Health Economics Research, Modelling and Evaluation in Sydney (HERMES)	GW is the recipient of the Don and Lorraine Jacquot Fellowship, and is also partially funded by the Screening and Diagnostic Test Evaluation Program (STEP) and the Health Economics Research, Modelling and Evaluation in Sydney (HERMES) Capacity Building Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AUSTR GOV AUSTR I, 2007, ARDRG DAT CUB; *AUSTR I HLTH WELF, 2001, AUSTR HOSP STAT; *AUSTR NZ DIAL TRA, 2007, 30 ANN REP AUSTR NZ; *AUSTR NZ ORG DON, 2008, ANZOD REG REP; Australia and New Zealand Dialysis and Transplant Registry (ANZDATA), 2009, SPEC DAT REQ; Australian Government Department of Health, 2010, SCHED PHARM BEN; Australian Government Department of Health, 2010, MED BEN SCHED BOOK; Bloembergen WE, 1996, J AM SOC NEPHROL, V7, P1139; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; Cass A, 2003, ETHNIC HEALTH, V8, P111, DOI 10.1080/13557850303562; DANOVITCH GM, 2005, AM J TRANSPLANT, V5, P1; de Klerk M, 2008, FRONT BIOSCI, V13, P3373; de Klerk Marry, 2008, Clin Transpl, P69; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; EGGERS P, 1992, SEMIN NEPHROL, V12, P284; Ferrari P, 2009, J NEPHROL, V22, P699; Garg PP, 2000, J AM SOC NEPHROL, V11, P958, DOI 10.1681/ASN.V115958; GAYLIN DS, 1993, JAMA-J AM MED ASSOC, V269, P603, DOI 10.1001/jama.269.5.603; Gill JS, 2007, J NEPHROL, V20, P501; Grun RP, 2003, NEPHROL DIAL TRANSPL, V18, P2122, DOI 10.1093/ndt/gfg354; Jassal SV, 2003, J AM SOC NEPHROL, V14, P187, DOI 10.1097/01.ASN.0000042166.70351.57; KARLBERG I, 1995, INT J TECHNOL ASSESS, V11, P611, DOI 10.1017/S026646230000876X; Klassen AC, 2002, AM J PUBLIC HEALTH, V92, P811, DOI 10.2105/AJPH.92.5.811; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; Lim WH, 2010, NEPHROL DIAL TRANSPL, V25, P3082, DOI 10.1093/ndt/gfq127; LYSAGHT MJ, 2002, J AM SOC NEPHROL S40, V13; *NHS BLOOD TRANSPL, 2009, TRANSPL ACT UK; OJO A, 1993, AM J KIDNEY DIS, V22, P835, DOI 10.1016/S0272-6386(12)70343-8; Ojo AO, 2001, J AM SOC NEPHROL, V12, P589, DOI 10.1681/ASN.V123589; Oniscu GC, 2004, NEPHROL DIAL TRANSPL, V19, P945, DOI 10.1093/ndt/gfh022; Organ Donation Taskforce, 2008, ORG TRANSPL REP ORG; Persijn GG, 2002, TRANSPLANTATION, V73, P1536, DOI 10.1097/00007890-200205270-00003; Pilmore H, 2010, TRANSPLANTATION, V89, P851, DOI 10.1097/TP.0b013e3181caeead; Quinn RR, 2007, AM J KIDNEY DIS, V50, P421, DOI 10.1053/j.ajkd.2007.05.019; Raftery J, 2000, BRIT MED J, V320, P1597, DOI 10.1136/bmj.320.7249.1597; Rao PS, 2007, TRANSPLANTATION, V83, P1069, DOI 10.1097/01.tp.0000259621.56861.31; Ravanan R, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3451; Satayathum S, 2005, KIDNEY INT, V68, P330, DOI 10.1111/j.1523-1755.2005.00412.x; Schnitzler MA, 2005, AM J TRANSPLANT, V5, P2289, DOI 10.1111/j.1600-6143.2005.01021.x; Tait BD, 2004, TRANSPLANTATION, V77, P627, DOI 10.1097/01.TP.0000103729.24295.9F; Takahashi K, 2004, AM J TRANSPLANT, V4, P1089, DOI 10.1111/j.1600-6143.2004.00464.x; Tong A, 2010, TRANSPLANTATION, V89, P796, DOI 10.1097/TP.0b013e3181cf1ee1; *TRANSPL SOC AUSTR, 2011, CONS STAT EL CRIT AL; TUTTLENEWHALL JE, 2009, AM J TRANSPLANT, V9, P1; Tyden G, 2003, TRANSPLANTATION, V76, P730, DOI 10.1097/01.TP.0000078622.43689.D4; Villar E, 2004, NEPHROL DIAL TRANSPL, V19, P207, DOI 10.1093/ndt/gfg500; Weber CLC, 2006, AM J TRANSPLANT, V6, P1875, DOI 10.1111/j.1600-6143.2006.01409.x; Wolfe RA, 2009, AM J TRANSPLANT, V9, P1523, DOI 10.1111/j.1600-6143.2009.02708.x; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; WOLFE RA, 2008, AM J TRANSPLANT, V8, P1000	50	123	124	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29591	10.1371/journal.pone.0029591	http://dx.doi.org/10.1371/journal.pone.0029591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279541	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900019
J	Yang, PH; Duan, YQ; Zhang, PR; Li, ZW; Wang, C; Dong, M; Tang, C; Xing, L; Gu, HJ; Zhao, ZP; Liu, XF; Zhang, SG; Wang, XL				Yang, Penghui; Duan, Yueqiang; Zhang, Peirui; Li, Zhiwei; Wang, Cheng; Dong, Mei; Tang, Chong; Xing, Li; Gu, Hongjing; Zhao, Zhongpeng; Liu, Xiufan; Zhang, Shaogeng; Wang, Xiliang			Multiple-Clade H5N1 Influenza Split Vaccine Elicits Broad Cross Protection against Lethal Influenza Virus Challenge in Mice by Intranasal Vaccination	PLOS ONE			English	Article							PANDEMIC INFLUENZA; IMMUNE-RESPONSES; CHINA; HEMAGGLUTININ; EVOLUTION; NUCLEOPROTEIN; INFECTION; ADJUVANT; IMPACT; SAFETY	Background: The increase in recent outbreaks and unpredictable changes of highly pathogenic avian influenza (HPAI) H5N1 in birds and humans highlights the urgent need to develop a cross-protective H5N1 vaccine. We here report our development of a multiple-clade H5N1 influenza vaccine tested for immunogenicity and efficacy to confer cross-protection in an animal model. Methodology/Principal Findings: Mice received two doses of influenza split vaccine with oil-in-water emulsion adjuvant SP01 by intranasal administration separated by two weeks. Single vaccines (3 mu g HA per dose) included rg-A/Vietnam/1203/2004(Clade 1), rg-A/Indonesia/05/2005(Clade 2.1), and rg-A/Anhui/1/2005(Clade 2.3.4). The trivalent vaccine contained 1 mu g HA per dose of each single vaccine. Importantly, complete cross-protection was observed in mice immunized using trivalent vaccine with oil-in-water emulsion adjuvant SP01 that was subsequently challenged with the lethal A/OT/SZ/097/03 influenza strain (Clade 0), whereas only the survival rate was up to 60% in single A/Anhui/1/2005 vaccine group. Conclusion/Significance: Our findings demonstrated that the multiple-clade H5N1 influenza vaccine was able to elicit a cross-protective immune response to heterologous HPAI H5N1 virus, thus giving rise to a broadly cross-reactive vaccine to potential prevention use ahead of the strain-specific pandemic influenza vaccine in the event of an HPAI H5N1 influenza outbreak. Also, the multiple-clade adjuvanted vaccine could be useful in allowing timely initiation of vaccination against unknown pandemic virus.	[Yang, Penghui; Duan, Yueqiang; Dong, Mei; Tang, Chong; Xing, Li; Gu, Hongjing; Zhao, Zhongpeng; Wang, Xiliang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Zhang, Peirui; Li, Zhiwei; Zhang, Shaogeng] 302 Mil Hosp, Dept Hepatobiliary, Beijing, Peoples R China; [Wang, Cheng] Soochow Univ, Coll Med, Suzhou, Peoples R China; [Liu, Xiufan] Yangzhou Univ, Minist Agr, Key Lab Anim Infect Dis, Yangzhou, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Fifth Medical Center of Chinese PLA General Hospital; Soochow University - China; Ministry of Agriculture & Rural Affairs; Yangzhou University	Yang, PH (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	zhangsg302@hotmail.com; xiliangw@126.com		zhongpeng, zhao/0000-0002-9147-6252	National Natural Scientific Foundation [30800977, 30972614]; Beijing Natural Science Foundation [7112105]; National Basic Research Program (973) [2009CB522102]; National Key Technologies RD Program [2006AA02Z450, 2006AA02A204]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Basic Research Program (973)(National Basic Research Program of China); National Key Technologies RD Program(National Key Technology R&D Program)	The study was supported by the National Natural Scientific Foundation (30800977 and 30972614), Beijing Natural Science Foundation (7112105), National Basic Research Program (973) (2009CB522102), and National Key Technologies R&D Program (2006AA02Z450 and 2006AA02A204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Black S, 2010, VACCINE, V28, P7331, DOI 10.1016/j.vaccine.2010.08.075; Bright RA, 2003, VIROLOGY, V308, P270, DOI 10.1016/S0042-6822(03)00008-4; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Ducatez MF, 2011, P NATL ACAD SCI USA, V108, P349, DOI 10.1073/pnas.1012457108; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Fan SF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000409; Forrest HL, 2009, VACCINE, V27, P4187, DOI 10.1016/j.vaccine.2009.04.050; Haynes JR, 2009, VACCINE, V27, P530, DOI 10.1016/j.vaccine.2008.11.011; Huang YH, 2009, J CHIN MED ASSOC, V72, P281, DOI 10.1016/S1726-4901(09)70372-7; Huber VC, 2009, VACCINE, V27, P1192, DOI 10.1016/j.vaccine.2008.12.023; Kayamuro H, 2010, J VIROL, V84, P12703, DOI 10.1128/JVI.01182-10; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; O'Hagan DT, 2007, EXPERT REV VACCINES, V6, P699, DOI 10.1586/14760584.6.5.699; PILLET S, 2011, VACCINE; Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004566; Qiu J, 2009, NATURE, V460, P1066, DOI 10.1038/4601066a; Schultze V, 2008, VACCINE, V26, P3209, DOI 10.1016/j.vaccine.2008.03.093; Stone R, 2009, SCIENCE, V325, P1482, DOI 10.1126/science.325_1482; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; TANG C, 2011, CHINESE SCI IN PRESS; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; WHO, ANT GEN CHAR ZOON IN; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Yamada T, 2008, NATURE, V454, P162, DOI 10.1038/454162a; YANG P, 2008, VET MICROBIOL, V146, P17; Yang PH, 2011, VACCINE, V29, P698, DOI 10.1016/j.vaccine.2010.11.026; Yang PH, 2010, BIOCHEM BIOPH RES CO, V396, P973, DOI 10.1016/j.bbrc.2010.05.035; Yang PH, 2010, CELL MOL IMMUNOL, V7, P116, DOI 10.1038/cmi.2009.116; Zhao ZP, 2009, VACCINE, V27, P5214, DOI 10.1016/j.vaccine.2009.06.075	33	14	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30252	10.1371/journal.pone.0030252	http://dx.doi.org/10.1371/journal.pone.0030252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279575	Green Submitted, Green Published, gold			2022-12-27	WOS:000299771900052
J	Bernacer, J; Prensa, L; Gimenez-Amaya, JM				Bernacer, Javier; Prensa, Lucia; Manuel Gimenez-Amaya, Jose			Distribution of GABAergic Interneurons and Dopaminergic Cells in the Functional Territories of the Human Striatum	PLOS ONE			English	Article							HUMAN BASAL GANGLIA; HUNTINGTONS-DISEASE; CHOLINERGIC INTERNEURONS; MORPHOLOGICAL FEATURES; NIGROSTRIATAL PATHWAY; RECEPTOR SUBUNITS; PRIMATE STRIATUM; GABA(A) RECEPTOR; CAUDATE-NUCLEUS; CORTICAL INPUTS	Background: The afferent projections of the striatum (caudate nucleus and putamen) are segregated in three territories: associative, sensorimotor and limbic. Striatal interneurons are in part responsible for the integration of these different types of information. Among them, GABAergic interneurons are the most abundant, and can be sorted in three populations according to their content in the calcium binding proteins calretinin (CR), parvalbumin (PV) and calbindin (CB). Conversely, striatal dopaminergic cells (whose role as interneurons is still unclear) are scarce. This study aims to analyze the interneuron distribution in the striatal functional territories, as well as their organization regarding to the striosomal compartment. Methodology/Principal Findings: We used immunohistochemical methods to visualize CR, PV, CB and tyrosine hydroxylase (TH) positive striatal neurons. The interneuronal distribution was assessed by stereological methods applied to every striatal functional territory. Considering the four cell groups altogether, their density was higher in the associative (2120 +/- 91 cells/mm(3)) than in the sensorimotor (959 +/- 47 cells/mm(3)) or limbic (633 +/- 119 cells/mm(3)) territories. CB- and TH-immunoreactive (-ir) cells were distributed rather homogeneously in the three striatal territories. However, the density of CR and PV interneurons were more abundant in the associative and sensorimotor striatum, respectively. Regarding to their compartmental organization, CR-ir interneurons were frequently found in the border between compartments in the associative and sensorimotor territories, and CB-ir interneurons abounded at the striosome/matrix border in the sensorimotor domain. Conclusions/Significance: The present study demonstrates that the architecture of the human striatum in terms of its interneuron composition varies in its three functional territories. Furthermore, our data highlight the importance of CR-ir striatal interneurons in the integration of associative information, and the selective role of PV-ir interneurons in the motor territory. On the other hand, the low density of dopaminergic cells casts doubts about their role in the normal human striatum.	[Bernacer, Javier] Univ Navarra Clin, Lab Neuromorfol Func, Pamplona, Spain; [Prensa, Lucia; Manuel Gimenez-Amaya, Jose] Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain	University of Navarra; Autonomous University of Madrid	Bernacer, J (corresponding author), Univ Navarra, Inst Cultura & Soc, E-31080 Pamplona, Spain.	javier.bernacer@gmail.com	Bernacer, Javier/P-5810-2014	Bernacer, Javier/0000-0002-4341-9763; Prensa Sepulveda, Lucia/0000-0003-2217-3271	Ministry of Education and Science [BFI2003-02909]; Fundacion Eugenio Rodriguez Pascual; FPI-CAM; Caja Madrid Foundation	Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fundacion Eugenio Rodriguez Pascual; FPI-CAM; Caja Madrid Foundation	This work was supported by the following grant sponsors: Ministry of Education and Science (BFI2003-02909); Fundacion Eugenio Rodriguez Pascual (to L.P.); FPI-CAM and Caja Madrid Foundation Postdoctoral Fellowship (to J.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alelu-Paz R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003378; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Apicella P, 2002, EUR J NEUROSCI, V16, P2017, DOI 10.1046/j.1460-9568.2002.02262.x; Avendano C, 2005, HISTOCHEM CELL BIOL, P1; Bedard A, 2006, EXP BRAIN RES, V170, P501, DOI 10.1007/s00221-005-0233-5; BENNETT BD, 1993, BRAIN RES, V610, P305, DOI 10.1016/0006-8993(93)91414-N; Bernacer J, 2008, J NEURAL TRANSM, V115, P67, DOI 10.1007/s00702-007-0803-8; Bernacer J, 2005, J COMP NEUROL, V489, P311, DOI 10.1002/cne.20616; Bernacer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001174; Betarbet R, 1997, J NEUROSCI, V17, P6761; BJUGN R, 1993, J COMP NEUROL, V328, P406, DOI 10.1002/cne.903280307; Centonze D, 1999, BRAIN RES REV, V31, P1, DOI 10.1016/S0165-0173(99)00018-1; Cicchetti F, 2000, BRAIN RES REV, V34, P80, DOI 10.1016/S0165-0173(00)00039-4; Cicchetti F, 1998, SYNAPSE, V30, P284, DOI 10.1002/(SICI)1098-2396(199811)30:3<284::AID-SYN6>3.3.CO;2-D; Cossette M, 2005, PARKINSONISM RELAT D, V11, P277, DOI 10.1016/j.parkreldis.2005.02.008; Darmopil S, 2008, EUR J NEUROSCI, V27, P580, DOI 10.1111/j.1460-9568.2008.06040.x; DAWBARN D, 1985, BRAIN RES, V340, P251, DOI 10.1016/0006-8993(85)90921-7; EBLEN F, 1995, J NEUROSCI, V15, P5999; FERRANTE RJ, 1987, J NEUROPATH EXP NEUR, V46, P12, DOI 10.1097/00005072-198701000-00002; FERRANTE RJ, 1991, J NEUROSCI, V11, P3877; Flores-Barrera E, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00015direct, 10.3389/fnsys.2010.00015]; Fudge JL, 2002, NEUROSCIENCE, V110, P257, DOI 10.1016/S0306-4522(01)00546-2; Fujiyama F, 2011, EUR J NEUROSCI, V33, P668, DOI 10.1111/j.1460-9568.2010.07564.x; Grahn JA, 2009, BEHAV BRAIN RES, V199, P53, DOI 10.1016/j.bbr.2008.11.020; GRAVELAND GA, 1985, J COMP NEUROL, V234, P317, DOI 10.1002/cne.902340304; GRAYBIEL AM, 1978, P NATL ACAD SCI USA, V75, P5723, DOI 10.1073/pnas.75.11.5723; GRAYBIEL AM, 1984, NEUROSCIENCE, V13, P1157, DOI 10.1016/0306-4522(84)90293-8; GRAYBIEL AM, 1984, P NATL ACAD SCI-BIOL, V81, P7980, DOI 10.1073/pnas.81.24.7980; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Holt DJ, 1997, J COMP NEUROL, V384, P1, DOI 10.1002/(SICI)1096-9861(19970721)384:1<1::AID-CNE1>3.0.CO;2-5; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Huot P, 2008, J CHEM NEUROANAT, V35, P77, DOI 10.1016/j.jchemneu.2007.06.004; Huot P, 2007, J NEUROCHEM, V101, P1441, DOI 10.1111/j.1471-4159.2006.04430.x; Ibanez-Sandoval O, 2010, J NEUROSCI, V30, P6999, DOI 10.1523/JNEUROSCI.5996-09.2010; Kataoka Y, 2010, J COMP NEUROL, V518, P277, DOI 10.1002/cne.22206; Kawaguchi Y, 1997, NEUROSCI RES, V27, P1, DOI 10.1016/S0168-0102(96)01134-0; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; KIYAMA H, 1990, BRAIN RES, V525, P209, DOI 10.1016/0006-8993(90)90866-A; Lehericy S, 2006, CEREB CORTEX, V16, P149, DOI 10.1093/cercor/bhi089; Levesque M, 2005, P NATL ACAD SCI USA, V102, P11888, DOI 10.1073/pnas.0502710102; Lopez de Maturana R, 2010, CNS NEUROL DISORD DR; Mai J.K., 1997, ATLAS HUMAN BRAIN; Martin R, 2000, J HISTOCHEM CYTOCHEM, V48, P1121, DOI 10.1177/002215540004800809; MARTONE ME, 1994, J CHEM NEUROANAT, V8, P47, DOI 10.1016/0891-0618(94)90035-3; Mayhew TM, 1996, J ANAT, V188, P1; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Pandey M, 2010, J BIOENERG BIOMEMBR, V42, P217, DOI 10.1007/s10863-010-9288-5; PARENT A, 1990, TRENDS NEUROSCI, V13, P254, DOI 10.1016/0166-2236(90)90105-J; Porritt MJ, 2000, LANCET, V356, P44, DOI 10.1016/S0140-6736(00)02437-5; Prensa L, 2001, J NEUROSCI, V21, P7247, DOI 10.1523/JNEUROSCI.21-18-07247.2001; Prensa L, 1999, J COMP NEUROL, V413, P603; Prensa L, 1998, J COMP NEUROL, V390, P552; Prensa L, 2009, J NEURAL TRANSM-SUPP, P49, DOI 10.1007/978-3-211-92660-4_4; Qi Z, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-26; Raghavan R., 1997, ELECT CLIN BRAIN ATL; Ramanathan S, 2002, J NEUROSCI, V22, P8158; Roberts RC, 1996, J COMP NEUROL, V374, P523; Saka E, 2003, BRAIN DEV-JPN, V25, pS15, DOI 10.1016/S0387-7604(03)90002-7; Saka E, 2002, P NATL ACAD SCI USA, V99, P9004, DOI 10.1073/pnas.132212499; Schaltenbrand G., 1977, ATLAS STEREOTAXY HUM; SELDEN N, 1994, NEUROSCIENCE, V60, P621, DOI 10.1016/0306-4522(94)90491-X; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Unal B, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00041; Waldvogel HJ, 1999, J COMP NEUROL, V415, P313, DOI 10.1002/(SICI)1096-9861(19991220)415:3<313::AID-CNE2>3.0.CO;2-7; Waldvogel HJ, 2004, J COMP NEUROL, V470, P339, DOI 10.1002/cne.20005; WREFORD NG, 1995, MICROSC RES TECHNIQ, V32, P423, DOI 10.1002/jemt.1070320505; Wu Y, 2000, BRAIN RES, V863, P182, DOI 10.1016/S0006-8993(00)02135-1	71	47	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30504	10.1371/journal.pone.0030504	http://dx.doi.org/10.1371/journal.pone.0030504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272358	Green Published, Green Submitted, gold			2022-12-27	WOS:000301454400136
J	Cui, YX; Johnson, T; Baumbach, A; Reeves, BC; Rogers, CA; Angelini, GD; Marsden, D; Madeddu, P				Cui, Yu-Xin; Johnson, Tom; Baumbach, Andreas; Reeves, Barnaby C.; Rogers, Chris A.; Angelini, Gianni D.; Marsden, Debbie; Madeddu, Paolo			Stepwise Optimization of the Procedure for Assessment of Circulating Progenitor Cells in Patients with Myocardial Infarction	PLOS ONE			English	Article							PERIPHERAL-BLOOD; FLOW-CYTOMETRY; CD34(+); NEOVASCULARIZATION; COMPLICATIONS; VISUALIZATION; COMPENSATION; MOBILIZATION; LYSE	Background: The number and functional activity of circulating progenitor cells (CPCs) is altered in diabetic patients. Furthermore, reduced CPC count has been shown to independently predict cardiovascular events. Validation of CPCs as a biomarker for cardiovascular risk stratification requires rigorous methodology. Before a standard operation protocol (SOP) can be designed for such a trial, a variety of technical issues have to be addressed fundamentally, which include the appropriate type of red blood cell lysis buffer, FMO or isotype controls to identify rare cell populations from background noise, optimal antibody dilutions and conditions of sample storage. We herein propose improvements in critical steps of CPC isolation, antigenic characterization and determination of functional competence for final application in a prospective investigation of CPCs as a biomarker of outcome following acute myocardial infarction. Methods and Findings: In this validation study, we refined the standard operating procedure (SOP) for flow cytometry characterisation and functional analysis of CPCs from the first 18 patients of the Progenitor Cell Response after Myocardial Infarction Study (ProMIS). ProMIS aims to verify the prognostic value of CPCs in patients with either ST elevation or non-ST elevation myocardial infarction with or without diabetes mellitus, using cardiac magnetic resonance imaging (MRI) for assessment of ventricular function as a primary endpoint. Results indicate crucial steps for SOP implementation, namely timely cell isolation after sampling, use of appropriate lysis buffer to separate blood cell types and minimize the acquisition events during flow cytometry, adoption of proper fluorophore combination and antibody titration for multiple antigenic detection and introduction of counting beads for precise quantification of functional CPC activity in migration assay. Conclusion and Significance: With systematic specification of factors influencing the enumeration of CPC by flow cytometry, the abundance and migration capacity of CPCs can be correctly assessed. Adoption of validated SOP is essential for refined comparison of patients with different comorbidities in the analysis of risk stratification.	[Cui, Yu-Xin; Johnson, Tom; Baumbach, Andreas; Reeves, Barnaby C.; Rogers, Chris A.; Angelini, Gianni D.; Marsden, Debbie; Madeddu, Paolo] Univ Bristol, Bristol Royal Infirm, Bristol Heart Inst, Bristol, Avon, England	Bristol Royal Infirmary; University of Bristol	Cui, YX (corresponding author), Univ Bristol, Bristol Royal Infirm, Bristol Heart Inst, Bristol, Avon, England.	yx.cui@bristol.ac.uk; madeddu@yahoo.com		angelini, gianni/0000-0002-1753-3730; Baumbach, Andreas/0000-0001-7707-2254; Johnson, Thomas/0000-0003-4638-601X	National Institute for Health Research biomedical research unit in cardiovascular medicine, Bristol, UK [2008/SS/BRU]	National Institute for Health Research biomedical research unit in cardiovascular medicine, Bristol, UK	This work was funded by the National Institute for Health Research biomedical research unit in cardiovascular medicine, Bristol, UK (Funding reference: 2008/SS/BRU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JE, 1994, NEW ENGL J MED, V330, P670, DOI 10.1056/NEJM199403103301003; Alvarez-Larran A, 2002, CYTOMETRY, V50, P249, DOI 10.1002/cyto.10129; Barnett D, 1998, BRIT J HAEMATOL, V102, P553; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chen MC, 2009, DIABETIC MED, V26, P134, DOI 10.1111/j.1464-5491.2008.02649.x; Dubois C, 2010, J AM COLL CARDIOL, V55, P2232, DOI 10.1016/j.jacc.2009.10.081; Egan CG, 2008, DIABETOLOGIA, V51, P1296, DOI 10.1007/s00125-008-0939-6; Fadini GP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011488; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Freeman PM, 2009, HEART, V95, P1301, DOI 10.1136/hrt.2008.163915; Gratama JW, 2000, J IMMUNOL METHODS, V239, P13, DOI 10.1016/S0022-1759(00)00154-X; Grundmann F, 2007, CLIN RES CARDIOL, V96, P621, DOI 10.1007/s00392-007-0543-7; Hristov M, 2009, CYTOM PART A, V75A, P848, DOI 10.1002/cyto.a.20772; Jung C, 2009, INT J CARDIOL; Le Bousse-Kerdiles MC., 2004, STANDARDISED PROTOCO; Masouleh BK, 2010, J IMMUNOL METHODS; Menendez P, 1998, CYTOMETRY, V34, P264, DOI 10.1002/(SICI)1097-0320(19981215)34:6<264::AID-CYTO4>3.0.CO;2-P; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Segal MS, 2006, DIABETES, V55, P102, DOI 10.2337/diabetes.55.1.102; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Tung JW, 2004, CLIN IMMUNOL, V110, P277, DOI 10.1016/j.clim.2003.11.016; Valgimigli M, 2004, CIRCULATION, V110, P1209, DOI 10.1161/01.CIR.0000136813.89036.21	22	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30389	10.1371/journal.pone.0030389	http://dx.doi.org/10.1371/journal.pone.0030389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272341	gold, Green Published, Green Submitted			2022-12-27	WOS:000301454400119
J	Secondi, J; Lepetz, V; Thery, M				Secondi, Jean; Lepetz, Virginie; Thery, Marc			Male Attractiveness Is Influenced by UV Wavelengths in a Newt Species but Not in Its Close Relative	PLOS ONE			English	Article							ULTRAVIOLET VISION; MATE-CHOICE; COLOR PATTERNS; SPECTRAL SENSITIVITY; POECILIA-RETICULATA; SEXUAL SELECTION; LIGHT; SIGNALS; COMMUNICATION; REFLECTANCE	Background: Functional communication in the UV range has been reported in Invertebrates and all major groups of Vertebrates but Amphibians. Although perception in this wavelength range has been shown in a few species, UV signalling has not been demonstrated in this group. One reason may be that in lentic freshwater habitats, litter decomposition generates dissolved organic carbon that absorbs UV radiation and thus hinders its use for visual signalling. We tested the effect of male UV characteristics on female sexual preference in two newt species that experience contrasting levels of UV water transmission when breeding. Methodology/Principal Findings: We analysed water spectral characteristics of a sample of breeding ponds in both species. We quantified male ventral coloration and measured male attractiveness under two lighting conditions (UV present, UV absent) using a no-choice female preference design. UV transmission was higher in Lissotriton vulgaris breeding sites. Male UV patterns also differed between experimental males of the two species. We observed a first common peak around 333 nm, higher in L. vulgaris, and a second peak around 397 nm, more frequent and higher in L. helveticus. Male attractiveness was significantly reduced in L. vulgaris when UV was not available but not in L. helveticus. Male attractiveness depended on the hue of the first UV peak in L. vulgaris. Conclusion/Significance: Our study is the first report of functional UV-based communication in Amphibians. Interestingly, male spectral characteristics and female preferences were consistent with the differences in habitat observed between the two species as L. helveticus often breeds in ponds containing more UV blocking compounds. We discuss the three hypotheses proposed so far for UV signalling in animals (enhanced signal detectability, private communication channel, indicator of individual quality).	[Secondi, Jean; Lepetz, Virginie] Univ Angers, Grp Ecol & Conservat Vertebrates, GECCO, Angers, France; [Thery, Marc] Museum Natl Hist Nat, Ctr Natl Rech Sci, UMR 7179, Brunoy, France	Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Secondi, J (corresponding author), Univ Angers, Grp Ecol & Conservat Vertebrates, GECCO, Angers, France.	jean.secondi@univ-angers.fr		Secondi, Jean/0000-0001-8130-1195				ALBERTS AC, 1989, ANIM BEHAV, V38, P129, DOI 10.1016/S0003-3472(89)80072-7; Altshuler DL, 2001, EVOL ECOL RES, V3, P767; Andersson S, 1997, P ROY SOC B-BIOL SCI, V264, P1587, DOI 10.1098/rspb.1997.0221; Andersson S, 1998, P ROY SOC B-BIOL SCI, V265, P445, DOI 10.1098/rspb.1998.0315; Bajer K, 2010, BEHAV ECOL SOCIOBIOL, V64, P2007, DOI 10.1007/s00265-010-1012-2; Bancroft BA, 2008, CONSERV BIOL, V22, P987, DOI 10.1111/j.1523-1739.2008.00966.x; Barta A, 2004, J THEOR BIOL, V226, P429, DOI 10.1016/j.jtbi.2003.09.017; Bennett ATD, 1996, NATURE, V380, P433, DOI 10.1038/380433a0; Bennett ATD, 1997, P NATL ACAD SCI USA, V94, P8618, DOI 10.1073/pnas.94.16.8618; BENNETT ATD, 1994, VISION RES, V34, P1471, DOI 10.1016/0042-6989(94)90149-X; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; Church SC, 1998, NATURWISSENSCHAFTEN, V85, P189, DOI 10.1007/s001140050483; Crump D, 1999, PHOTOCHEM PHOTOBIOL, V70, P893, DOI 10.1562/0031-8655(1999)070<0893:SIIPWI>2.3.CO;2; Cummings ME, 2003, P ROY SOC B-BIOL SCI, V270, P897, DOI 10.1098/rspb.2003.2334; DEUTSCHLANDER ME, 1995, NEUROSCI LETT, V197, P93, DOI 10.1016/0304-3940(95)11905-C; DIETZ M, 1972, NATURWISSENSCHAFTEN, V59, P316, DOI 10.1007/BF00593366; EDRICH W, 1979, J COMP PHYSIOL, V133, P111, DOI 10.1007/BF00657525; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Fuller RC, 2002, P ROY SOC B-BIOL SCI, V269, P1457, DOI 10.1098/rspb.2002.2042; Garcia CM, 2002, BEHAV ECOL SOCIOBIOL, V52, P1, DOI 10.1007/s00265-002-0482-2; Gomez D., 2006, AVICOL PROGRAM ANAL; Gomez D, 2007, AM NAT, V169, pS42, DOI 10.1086/510138; Gomez D, 2009, P ROY SOC B-BIOL SCI, V276, P2351, DOI 10.1098/rspb.2009.0168; GOVARDOVSKII VI, 1974, VISION RES, V14, P1317, DOI 10.1016/0042-6989(74)90003-0; GREEN AJ, 1991, ANIM BEHAV, V41, P367, DOI 10.1016/S0003-3472(05)80489-0; Greenwood VJ, 2002, ANIM BEHAV, V64, P923, DOI 10.1006/anbe.2002.1977; Haerty W, 2007, BEHAVIOUR, V144, P797, DOI 10.1163/156853907781476445; Halliday T.R., 1977, P185; Herberstein ME, 2009, EVOL ECOL, V23, P621, DOI 10.1007/s10682-008-9260-6; HIMSTEDT W, 1979, COPEIA, P40; Honkavaara J, 2002, OIKOS, V98, P505, DOI 10.1034/j.1600-0706.2002.980315.x; Hunt S, 2003, P ROY SOC B-BIOL SCI, V270, pS25, DOI 10.1098/rsbl.2003.0009; Johanet A, 2011, HEREDITY, V106, P962, DOI 10.1038/hdy.2010.144; Johanet A, 2009, CR BIOL, V332, P548, DOI 10.1016/j.crvi.2009.02.004; Kawamura G, 2009, MAR FRESHW BEHAV PHY, V42, P19, DOI 10.1080/10236240802663580; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; LATOUCHE YD, 1979, COMP BIOCHEM PHYS A, V63, P313, DOI 10.1016/0300-9629(79)90165-8; Leal M, 2002, P ROY SOC B-BIOL SCI, V269, P351, DOI 10.1098/rspb.2001.1904; LeBas NR, 2000, P ROY SOC B-BIOL SCI, V267, P445, DOI 10.1098/rspb.2000.1020; Lim MLM, 2008, BEHAV ECOL, V19, P61, DOI 10.1093/beheco/arm100; Losey GS, 1999, J FISH BIOL, V54, P921, DOI 10.1111/j.1095-8649.1999.tb00848.x; Lythgoe J.N., 1979, ECOLOGY VISION; Lyytinen A, 2004, BEHAV ECOL, V15, P982, DOI 10.1093/beheco/arh102; McGregor PK., 1992, PLAYBACK STUDIES ANI; Mougeot F, 2005, J AVIAN BIOL, V36, P203, DOI 10.1111/j.0908-8857.2005.03424.x; PERRY RJ, 1991, J PHYSIOL-LONDON, V433, P561, DOI 10.1113/jphysiol.1991.sp018444; PRZYREMBEL C, 1995, J COMP PHYSIOL A, V176, P575; R Core Team, 2020, R LANG ENV STAT COMP; Ries C, 2008, J ZOOL, V276, P229, DOI 10.1111/j.1469-7998.2008.00456.x; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; Schaefer HM, 2006, BEHAV ECOL, V17, P784, DOI 10.1093/beheco/arl011; Siebeck UE, 2004, ANIM BEHAV, V68, P273, DOI 10.1016/j.anbehav.2003.11.010; Siitari H, 2002, BEHAV ECOL, V13, P737, DOI 10.1093/beheco/13.6.737; Siitari H, 1999, P ROY SOC B-BIOL SCI, V266, P2125, DOI 10.1098/rspb.1999.0897; Smith EJ, 2002, BEHAV ECOL, V13, P11, DOI 10.1093/beheco/13.1.11; Stevens M, 2007, BIOSCIENCE, V57, P501, DOI 10.1641/B570607; Sztatecsny M, 2010, ANIM BEHAV, V79, P779, DOI 10.1016/j.anbehav.2010.01.003; Thorpe RS, 2001, P NATL ACAD SCI USA, V98, P3929, DOI 10.1073/pnas.071576798; TOVEE MJ, 1995, TRENDS ECOL EVOL, V10, P455, DOI 10.1016/S0169-5347(00)89179-X; Uy JAC, 2000, EVOLUTION, V54, P273, DOI 10.1111/j.0014-3820.2000.tb00027.x; VIITALA J, 1995, NATURE, V373, P425, DOI 10.1038/373425a0; Whiting MJ, 2006, ANIM BEHAV, V72, P353, DOI 10.1016/j.anbehav.2005.10.018	64	26	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30391	10.1371/journal.pone.0030391	http://dx.doi.org/10.1371/journal.pone.0030391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272342	Green Published, gold, Green Submitted			2022-12-27	WOS:000301454400120
J	Ye, JQ; Boyle, A; Shih, H; Sievers, RE; Zhang, Y; Prasad, M; Su, H; Zhou, Y; Grossman, W; Bernstein, HS; Yeghiazarians, Y				Ye, Jianqin; Boyle, Andrew; Shih, Henry; Sievers, Richard E.; Zhang, Yan; Prasad, Megha; Su, Hua; Zhou, Yan; Grossman, William; Bernstein, Harold S.; Yeghiazarians, Yerem			Sca-1(+) Cardiosphere-Derived Cells Are Enriched for Isl1-Expressing Cardiac Precursors and Improve Cardiac Function after Myocardial Injury	PLOS ONE			English	Article							STEM-CELLS; PROGENITOR CELLS; HEART; DIFFERENTIATION; CARDIOMYOCYTES; EXPRESSION; INFARCTION; THERAPY; REGENERATION; MULTIPOTENT	Background: Endogenous cardiac progenitor cells are a promising option for cell-therapy for myocardial infarction (MI). However, obtaining adequate numbers of cardiac progenitors after MI remains a challenge. Cardiospheres (CSs) have been proposed to have cardiac regenerative properties; however, their cellular composition and how they may be influenced by the tissue milieu remains unclear. Methodology/Principal Finding: Using "middle aged'' mice as CSs donors, we found that acute MI induced a dramatic increase in the number of CSs in a mouse model of MI, and this increase was attenuated back to baseline over time. We also observed that CSs from post-MI hearts engrafted in ischemic myocardium induced angiogenesis and restored cardiac function. To determine the role of Sca-1(+)CD45(-) cells within CSs, we cloned these from single cell isolates. Expression of Islet-1 (Isl1) in Sca-1(+)CD45(-) cells from CSs was 3-fold higher than in whole CSs. Cloned Sca-1(+)CD45(-) cells had the ability to differentiate into cardiomyocytes, endothelial cells and smooth muscle cells in vitro. We also observed that cloned cells engrafted in ischemic myocardium induced angiogenesis, differentiated into endothelial and smooth muscle cells and improved cardiac function in post-MI hearts. Conclusions/Significance: These studies demonstrate that cloned Sca-1(+)CD45(-) cells derived from CSs from infarcted "middle aged'' hearts are enriched for second heart field (i.e., Isl-1(+)) precursors that give rise to both myocardial and vascular tissues, and may be an appropriate source of progenitor cells for autologous cell-therapy post-MI.	[Ye, Jianqin; Boyle, Andrew; Shih, Henry; Sievers, Richard E.; Zhang, Yan; Prasad, Megha; Grossman, William; Yeghiazarians, Yerem] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA; [Grossman, William; Bernstein, Harold S.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Boyle, Andrew; Bernstein, Harold S.; Yeghiazarians, Yerem] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Bernstein, Harold S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Su, Hua] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Div Cardiol, San Francisco, CA 94143 USA; [Zhou, Yan] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ye, JQ (corresponding author), Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA.	yeghiaza@medicine.ucsf.edu		Boyle, Andrew/0000-0002-3919-5269	Wayne and Gladys Valley Foundation; UCSF; Harold Castle Foundation	Wayne and Gladys Valley Foundation; UCSF; Harold Castle Foundation	This work was supported by the Wayne and Gladys Valley Foundation, the UCSF Cardiac Stem Cell Fund and the Harold Castle Foundation (all to Y.Y. and W.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DC, 2009, STEM CELLS, V27, P1571, DOI 10.1002/stem.72; Barile L, 2007, CARDIAC STEM CELLS I, pS9; Barile L, 2007, PROG CARDIOVASC DIS, V50, P31, DOI 10.1016/j.pcad.2007.03.005; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Boyle AJ, 2006, CIRCULATION, V114, P339, DOI 10.1161/CIRCULATIONAHA.105.590653; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; D'Alessandro DA, 2009, CIRC RES, V105, P1128, DOI 10.1161/CIRCRESAHA.109.207266; Delorme B, 1997, CIRC RES, V81, P423, DOI 10.1161/01.RES.81.3.423; Fischer KM, 2009, CIRCULATION, V120, P2077, DOI 10.1161/CIRCULATIONAHA.109.884403; Genead R, 2010, STEM CELLS DEV, V19, P1601, DOI 10.1089/scd.2009.0483; Ghassemifar MR, 1997, IN VITRO CELL DEV-AN, V33, P622; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Itzhaki-Alfia A, 2009, CIRCULATION, V120, P2559, DOI 10.1161/CIRCULATIONAHA.109.849588; Khattar P, 2011, STEM CELLS DEV, V20, P1043, DOI 10.1089/scd.2010.0374; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229; Springer ML, 2005, AM J PHYSIOL-HEART C, V289, pH1307, DOI 10.1152/ajpheart.00164.2005; Su H, 2002, P NATL ACAD SCI USA, V99, P9480, DOI 10.1073/pnas.132275299; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Tang YL, 2007, BIOCHEM BIOPH RES CO, V359, P877, DOI 10.1016/j.bbrc.2007.05.216; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; Wang XH, 2006, STEM CELLS, V24, P1779, DOI 10.1634/stemcells.2005-0386; Yeghiazarians Y, 2011, CYTOTHERAPY IN PRESS; Yeghiazarians Y, 2009, MOL THER, V17, P1250, DOI 10.1038/mt.2009.85; Zaruba MM, 2010, CIRCULATION, V121, P1992, DOI 10.1161/CIRCULATIONAHA.109.909093; Zhang Y, 2007, AM J PHYSIOL-HEART C, V292, pH1187, DOI 10.1152/ajpheart.00895.2006	36	52	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30329	10.1371/journal.pone.0030329	http://dx.doi.org/10.1371/journal.pone.0030329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272337	Green Published, gold			2022-12-27	WOS:000301454400115
J	Jiang, XL; Yang, JM; Zhang, HB; Zou, HB; Wang, C; Xian, M				Jiang, Xinglin; Yang, Jianming; Zhang, Haibo; Zou, Huibin; Wang, Cong; Xian, Mo			In Vitro Assembly of Multiple DNA Fragments Using Successive Hybridization	PLOS ONE			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; CONSTRUCTION; EXPRESSION; MOLECULES; PATHWAY	Construction of recombinant DNA from multiple fragments is widely required in molecular biology, especially for synthetic biology purposes. Here we describe a new method, successive hybridization assembling (SHA) which can rapidly do this in a single reaction in vitro. In SHA, DNA fragments are prepared to overlap one after another, so after simple denaturation-renaturation treatment they hybridize in a successive manner and thereby assemble into a recombinant molecule. In contrast to traditional methods, SHA eliminates the need for restriction enzymes, DNA ligases and recombinases, and is sequence-independent. We first demonstrated its feasibility by constructing plasmids from 4, 6 and 8 fragments with high efficiencies, and then applied it to constructing a customized vector and two artificial pathways. As SHA is robust, easy to use and can tolerate repeat sequences, we expect it to be a powerful tool in synthetic biology.	[Jiang, Xinglin; Yang, Jianming; Zhang, Haibo; Zou, Huibin; Wang, Cong; Xian, Mo] Chinese Acad Sci, Ctr Biomat, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Jiang, XL (corresponding author), Chinese Acad Sci, Ctr Biomat, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Peoples R China.	xianmo@qibebt.ac.cn	zheng, yonghong/H-3700-2012; Zhang, Haibo/ABB-0042-2022; Zou, Huibin/AAD-6159-2020	Zhang, Haibo/0000-0003-3728-9840; Jiang, Xinglin/0000-0002-4935-8025; Zou, Huibin/0000-0002-0805-3022	National Natural Science Foundation of China [21106170]; Natural Foundation of Shandong Province [Q2006B05]; Chinese Academy of Sciences [KSCX2-EW-G-13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work is supported by the National Natural Science Foundation of China (No. 21106170), the Natural Foundation of Shandong Province (No. Q2006B05) and the Key Project of the Knowledge Innovation of the Chinese Academy of Sciences (No. KSCX2-EW-G-13). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Bongers RS, 2005, APPL ENVIRON MICROB, V71, P8818, DOI 10.1128/AEM.71.12.8818-8824.2005; Ellis T, 2011, INTEGR BIOL-UK, V3, P109, DOI 10.1039/c0ib00070a; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hanai T, 2007, APPL ENVIRON MICROB, V73, P7814, DOI 10.1128/AEM.01140-07; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Nguyen HD, 2005, PLASMID, V54, P241, DOI 10.1016/j.plasmid.2005.05.001; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Titok MA, 2003, PLASMID, V49, P53, DOI 10.1016/S0147-619X(02)00109-9	12	22	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30267	10.1371/journal.pone.0030267	http://dx.doi.org/10.1371/journal.pone.0030267			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291927	gold, Green Published, Green Submitted			2022-12-27	WOS:000301703800011
J	Belda, E; Silva, FJ; Pereto, J; Moya, A				Belda, Eugeni; Silva, Francisco J.; Pereto, Juli; Moya, Andres			Metabolic Networks of Sodalis glossinidius: A Systems Biology Approach to Reductive Evolution	PLOS ONE			English	Article							MINIMAL-GENE-SET; ESCHERICHIA-COLI; GENOME SEQUENCE; SECONDARY ENDOSYMBIONT; MICROBIAL GENOME; SCALE; SYMBIONT; ENZYME; DNA; RECONSTRUCTION	Background: Genome reduction is a common evolutionary process affecting bacterial lineages that establish symbiotic or pathogenic associations with eukaryotic hosts. Such associations yield highly reduced genomes with greatly streamlined metabolic abilities shaped by the type of ecological association with the host. Sodalis glossinidius, the secondary endosymbiont of tsetse flies, represents one of the few complete genomes available of a bacterium at the initial stages of this process. In the present study, genome reduction is studied from a systems biology perspective through the reconstruction and functional analysis of genome-scale metabolic networks of S. glossinidius. Results: The functional profile of ancestral and extant metabolic networks sheds light on the evolutionary events underlying transition to a host-dependent lifestyle. Meanwhile, reductive evolution simulations on the extant metabolic network can predict possible future evolution of S. glossinidius in the context of genome reduction. Finally, knockout simulations in different metabolic systems reveal a gradual decrease in network robustness to different mutational events for bacterial endosymbionts at different stages of the symbiotic association. Conclusions: Stoichiometric analysis reveals few gene inactivation events whose effects on the functionality of S. glossinidius metabolic systems are drastic enough to account for the ecological transition from a free-living to host-dependent lifestyle. The decrease in network robustness across different metabolic systems may be associated with the progressive integration in the more stable environment provided by the insect host. Finally, reductive evolution simulations reveal the strong influence that external conditions exert on the evolvability of metabolic systems.	[Belda, Eugeni; Silva, Francisco J.; Pereto, Juli; Moya, Andres] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolutiva, Valencia, Spain; [Belda, Eugeni; Silva, Francisco J.; Moya, Andres] Univ Valencia, Dept Genet, Valencia, Spain; [Silva, Francisco J.; Moya, Andres] Univ Valencia, Inst Cavanilles, CSISP, Unidad Mixta Invest Genom & Salud, Valencia, Spain; [Pereto, Juli] Univ Valencia, Dept Bioquim & Biol Mol, Valencia, Spain	University of Valencia; University of Valencia; University of Valencia; University of Valencia	Belda, E (corresponding author), CEA Genoscope, Lab Anal Bioinformat Genom & Metab, Evry, France.	andres.moya@uv.es	Moya, Andrés/A-8190-2008; Silva, Francisco/ABF-7144-2021; Belda, Eugeni/ABI-1349-2020; Peretó, Juli/G-5969-2015	Moya, Andrés/0000-0002-2867-1119; Silva, Francisco/0000-0002-6911-6541; Belda, Eugeni/0000-0003-4307-5072; Peretó, Juli/0000-0002-5756-1517	Ministerio de Educacion, Spain; Ministerio de Ciencia y Innovacion (Spain) [BFU2006/06003/BMC, BFU2009-12895-C02-01]	Ministerio de Educacion, Spain; Ministerio de Ciencia y Innovacion (Spain)	EB is a recipient of a FPU fellowship from Ministerio de Educacion, Spain. This work was supported by grants BFU2006/06003/BMC and BFU2009-12895-C02-01 from the Ministerio de Ciencia y Innovacion (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Andersson DI, 1996, P NATL ACAD SCI USA, V93, P906, DOI 10.1073/pnas.93.2.906; Andersson JO, 1999, MOL BIOL EVOL, V16, P1178, DOI 10.1093/oxfordjournals.molbev.a026208; Andersson JO, 2001, MOL BIOL EVOL, V18, P829, DOI 10.1093/oxfordjournals.molbev.a003864; [Anonymous], [No title captured]; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Belda E, 2005, MOL BIOL EVOL, V22, P1456, DOI 10.1093/molbev/msi134; Belda E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-449; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; Boussau B, 2004, P NATL ACAD SCI USA, V101, P9722, DOI 10.1073/pnas.0400975101; Burke GR, 2011, GENOME BIOL EVOL, V3, P195, DOI 10.1093/gbe/evr002; Chen XA, 1999, J MOL EVOL, V48, P49, DOI 10.1007/PL00006444; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; da Silva AM, 2008, COMPUTATIONAL METHOD, P153; Dale C, 2006, APPL ENVIRON MICROB, V72, P2997, DOI 10.1128/AEM.72.4.2997-3004.2006; Dale C, 1999, INT J SYST BACTERIOL, V49, P267, DOI 10.1016/S0020-7519(01)00151-5; Degnan PH, 2005, GENOME RES, V15, P1023, DOI 10.1101/gr.3771305; Edwards JS, 2000, BIOTECHNOL PROGR, V16, P927, DOI 10.1021/bp0000712; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Gabaldon T, 2007, PHILOS T R SOC B, V362, P1751, DOI 10.1098/rstb.2007.2067; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Gil R, 2003, P NATL ACAD SCI USA, V100, P9388, DOI 10.1073/pnas.1533499100; Gomez-Valero L, 2008, MOL ECOL, V17, P4382, DOI 10.1111/j.1365-294X.2008.03912.x; Gomez-Valero L, 2004, MOL BIOL EVOL, V21, P2172, DOI 10.1093/molbev/msh232; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Klasson L, 2004, TRENDS MICROBIOL, V12, P37, DOI 10.1016/j.tim.2003.11.006; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Koonin EV, 2000, ANNU REV GENOM HUM G, V1, P99, DOI 10.1146/annurev.genom.1.1.99; Lee DS, 2009, J BACTERIOL, V191, P4015, DOI 10.1128/JB.01743-08; Lewis NE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.47; March JC, 2002, APPL ENVIRON MICROB, V68, P5620, DOI 10.1128/AEM.68.11.5620-5624.2002; Mira A, 2002, CURR OPIN MICROBIOL, V5, P506, DOI 10.1016/S1369-5274(02)00358-2; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; Moran NA, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-12-research0054; Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Oberhardt MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Pal C, 2006, NATURE, V440, P667, DOI 10.1038/nature04568; Pal C, 2005, BIOINFORMATICS, V21, P222, DOI 10.1093/bioinformatics/bti1136; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Papp B, 2011, NAT REV GENET, V12, P591, DOI 10.1038/nrg3033; Peng L., 2004, Appl Microbiol Biotechnol; Peng LF, 2004, FEMS MICROBIOL LETT, V235, P17, DOI 10.1016/j.femsle.2004.04.003; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; Podani J, 2001, NAT GENET, V29, P54, DOI 10.1038/ng708; Puchalka J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000210; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Rio RVM, 2004, TRENDS MICROBIOL, V12, P325, DOI 10.1016/j.tim.2004.05.001; SATISHCHANDRAN C, 1986, J BACTERIOL, V165, P843, DOI 10.1128/jb.165.3.843-848.1986; Sharples GJ, 2009, TRENDS MICROBIOL, V17, P233, DOI 10.1016/j.tim.2009.03.005; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Silva F.J., 2007, STRUCTURAL APPROACHE, P149; Silva FJ, 2003, TRENDS GENET, V19, P176, DOI 10.1016/S0168-9525(03)00041-6; Silva FJ, 2001, TRENDS GENET, V17, P615, DOI 10.1016/S0168-9525(01)02483-0; Soyer OS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000907; Suthers PF, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.56; Suyama M, 2001, TRENDS GENET, V17, P10, DOI 10.1016/S0168-9525(00)02159-4; Tamames J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-181; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; Thomas GH, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-24; Toh H, 2006, GENOME RES, V16, P149, DOI 10.1101/gr.4106106; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; WELBURN SC, 1987, ANN TROP MED PARASIT, V81, P331, DOI 10.1080/00034983.1987.11812127; Yizhak K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.11; Zhang Y, 2009, SCIENCE, V325, P1544, DOI 10.1126/science.1174671	77	20	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30652	10.1371/journal.pone.0030652	http://dx.doi.org/10.1371/journal.pone.0030652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292008	gold, Green Published, Green Submitted			2022-12-27	WOS:000301639600043
J	Sapra, S; Beavin, LE; Zak, PJ				Sapra, Steve; Beavin, Laura E.; Zak, Paul J.			A Combination of Dopamine Genes Predicts Success by Professional Wall Street Traders	PLOS ONE			English	Article							FINANCIAL RISK-TAKING; TANDEM DUPLICATION POLYMORPHISM; METHYLTRANSFERASE VAL(158)MET GENOTYPE; IMPULSE CONTROL DISORDERS; RECEPTOR GENE; DRD4 GENE; PARKINSON-DISEASE; DECISION-MAKING; ASSOCIATION; BEHAVIOR	What determines success on Wall Street? This study examined if genes affecting dopamine levels of professional traders were associated with their career tenure. Sixty professional Wall Street traders were genotyped and compared to a control group who did not trade stocks. We found that distinct alleles of the dopamine receptor 4 promoter (DRD4P) and catecholamine-O-methyltransferase (COMT) that affect synaptic dopamine were predominant in traders. These alleles are associated with moderate, rather than very high or very low, levels of synaptic dopamine. The activity of these alleles correlated positively with years spent trading stocks on Wall Street. Differences in personality and trading behavior were also correlated with allelic variants. This evidence suggests there may be a genetic basis for the traits that make one a successful trader.	[Sapra, Steve; Beavin, Laura E.; Zak, Paul J.] Claremont Grad Univ, Ctr Neuroecon Studies, Claremont, CA 91711 USA; [Zak, Paul J.] Claremont Grad Univ, Dept Econ, Claremont, CA USA; [Zak, Paul J.] Loma Linda Univ, Med Ctr, Dept Neurol, Loma Linda, CA USA	Claremont Colleges; Claremont Graduate School; Claremont Colleges; Claremont Graduate School; Loma Linda University	Zak, PJ (corresponding author), Claremont Grad Univ, Ctr Neuroecon Studies, Claremont, CA 91711 USA.	paul.zak@cgu.edu						Apicella CL, 2008, EVOL HUM BEHAV, V29, P384, DOI 10.1016/j.evolhumbehav.2008.07.001; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Bajtelsmit VL., 1999, FINANCIAL SERVICES R, V8, P1, DOI [DOI 10.1016/S1057-0810(99)00030-X, 10.1016/S1057-0810(99)00030-X]; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barber BM, 2001, Q J ECON, V116, P261, DOI 10.1162/003355301556400; Barnea A, 2010, J FINANC ECON, V98, P583, DOI 10.1016/j.jfineco.2010.08.001; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Briggs-Myers Isabel, 1995, GIFTS DIFFERING UNDE; Carver CS, 2011, PSYCHOL SCI, V22, P589, DOI 10.1177/0956797611404085; Cesarini D, 2010, J FINANC, V65, P1725, DOI 10.1111/j.1540-6261.2010.01592.x; Coates JM, 2008, P NATL ACAD SCI USA, V105, P6167, DOI 10.1073/pnas.0704025105; Coates JM, 2009, P NATL ACAD SCI USA, V106, P623, DOI 10.1073/pnas.0810907106; Cools R, 2008, NEUROSCIENTIST, V14, P381, DOI 10.1177/1073858408317009; Coval JD, 2005, J FINANC, V60, P1, DOI 10.1111/j.1540-6261.2005.00723.x; Crisan LG, 2009, SOC COGN AFFECT NEUR, V4, P399, DOI 10.1093/scan/nsp019; D'Souza UM, 2004, BIOL PSYCHIAT, V56, P691, DOI 10.1016/j.biopsych.2004.08.008; de Frias CM, 2005, J COGNITIVE NEUROSCI, V17, P1018, DOI 10.1162/0898929054475136; Dreber A, 2009, EVOL HUM BEHAV, V30, P85, DOI 10.1016/j.evolhumbehav.2008.11.001; Durand RB, 2008, J BEHAV FINANC, V9, P193, DOI 10.1080/15427560802341020; Efremidze L, 2011, INTERRUPTIN IN PRESS; Ellis CD, 2002, WINNING LOSERS GAME, P142; Fossella J, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-14; Frydman C, 2011, P ROY SOC B-BIOL SCI, V278, P2053, DOI 10.1098/rspb.2010.2304; Gabaix X, 2006, Q J ECON, V121, P461, DOI 10.1162/qjec.2006.121.2.461; Gjedde A, 2010, P NATL ACAD SCI USA, V107, P3870, DOI 10.1073/pnas.0912319107; Glaser M, 2007, GENEVA RISK INS REV, V32, P1, DOI 10.1007/s10713-007-0003-3; Goldman-Rakic PS, 2000, BRAIN RES REV, V31, P295, DOI 10.1016/S0165-0173(99)00045-4; Golimbet V E, 2007, Neurosci Behav Physiol, V37, P601, DOI 10.1007/s11055-007-0058-8; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; He QH, 2010, NEUROPHARMACOLOGY, V59, P518, DOI 10.1016/j.neuropharm.2010.07.008; Jianakoplos NA, 1998, ECON INQ, V36, P620, DOI 10.1111/j.1465-7295.1998.tb01740.x; Knutson B, 2008, NEUROREPORT, V19, P509, DOI 10.1097/WNR.0b013e3282f85c01; Knutson B, 2007, J NEUROSCI, V27, P8174, DOI 10.1523/JNEUROSCI.1564-07.2007; Kuhnen CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004362; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Lei Feng, 2005, Review of Finance, V9, P305, DOI 10.1007/s10679-005-2262-0; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Lo AW, 2005, AM ECON REV, V95, P352, DOI 10.1257/000282805774670095; Lo AW, 2002, J COGNITIVE NEUROSCI, V14, P323, DOI 10.1162/089892902317361877; McCracken JT, 2000, MOL PSYCHIATR, V5, P531, DOI 10.1038/sj.mp.4000770; MCCRAE RR, 1989, J PERS, V57, P17, DOI 10.1111/j.1467-6494.1989.tb00759.x; Mehra R, 2002, J ECON DYN CONTROL, V26, P869, DOI 10.1016/S0165-1889(01)00035-5; Myers I. B., 1998, MBTI MANUAL GUIDE DE, DOI DOI 10.1080/03075079.2014.977859; Nolan KA, 2004, AM J PSYCHIAT, V161, P359, DOI 10.1176/appi.ajp.161.2.359; Owens M J, 1998, Depress Anxiety, V8 Suppl 1, P5, DOI 10.1002/(SICI)1520-6394(1998)8:1+<5::AID-DA2>3.0.CO;2-I; Paterson AD, 1999, NEUROPSYCHOPHARMACOL, V21, P3, DOI 10.1016/S0893-133X(98)00115-8; Philibert RA, 2008, AM J MED GENET B, V147B, P565, DOI 10.1002/ajmg.b.30778; Pontone G, 2006, NEUROLOGY, V67, P1258, DOI 10.1212/01.wnl.0000238401.76928.45; Riba J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002479; Rivera M, 2009, AM J MED GENET B, V150B, P395, DOI 10.1002/ajmg.b.30829; Rogers G, 2004, AM J MED GENET B, V126B, P95, DOI 10.1002/ajmg.b.20133; Roohi J, 2009, J AUTISM DEV DISORD, V39, P67, DOI 10.1007/s10803-008-0600-8; Ruiz-Sanz JI, 2007, MOL CELL PROBE, V21, P202, DOI 10.1016/j.mcp.2006.12.001; Sapienza P, 2009, P NATL ACAD SCI USA, V106, P15268, DOI 10.1073/pnas.0907352106; Schmack K, 2008, NEUROIMAGE, V42, P1631, DOI 10.1016/j.neuroimage.2008.06.019; Schwager JS, 2008, STOCK MARKET WIZARDS; Schwartz RA, 2009, J TRADING, V4, P46, DOI 10.3905/jot.2009.4.2.046; Seaman MI, 1999, AM J MED GENET, V88, P705, DOI 10.1002/(SICI)1096-8628(19991215)88:6<705::AID-AJMG22>3.0.CO;2-F; Shiller RJ, 2003, J ECON PERSPECT, V17, P83, DOI 10.1257/089533003321164967; SHILLER RJ, 1981, AM ECON REV, V71, P421; STAMFORD JA, 1989, J NEUROCHEM, V52, P1582, DOI 10.1111/j.1471-4159.1989.tb09212.x; Stein MB, 2005, NEUROPSYCHOPHARMACOL, V30, P2092, DOI 10.1038/sj.npp.1300787; Steinberg L, 2010, DEV PSYCHOBIOL, V52, P216, DOI 10.1002/dev.20445; Tadic A, 2003, AM J MED GENET B, V117B, P1, DOI 10.1002/ajmg.b.10013; Taylor WD, 2007, PSYCHIAT RES-NEUROIM, V155, P173, DOI 10.1016/j.pscychresns.2007.01.005; Vandenbergh DJ, 2000, AM J MED GENET, V96, P678, DOI 10.1002/1096-8628(20001009)96:5<678::AID-AJMG15>3.0.CO;2-8; Wahlstrom D, 2010, BRAIN COGNITION, V72, P146, DOI 10.1016/j.bandc.2009.10.013; Weintraub D, 2006, ARCH NEUROL-CHICAGO, V63, P969, DOI 10.1001/archneur.63.7.969; Wyart M, 2007, J ECON BEHAV ORGAN, V63, P1, DOI 10.1016/j.jebo.2004.11.016; Zak PJ, 2004, PHILOS T R SOC B, V359, P1737, DOI 10.1098/rstb.2004.1544; Zhong SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008516	78	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30844	10.1371/journal.pone.0030844	http://dx.doi.org/10.1371/journal.pone.0030844			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292056	Green Submitted, gold, Green Published			2022-12-27	WOS:000301639600060
J	Bilichak, A; Ilnystkyy, Y; Hollunder, J; Kovalchuk, I				Bilichak, Andriy; Ilnystkyy, Yaroslav; Hollunder, Jens; Kovalchuk, Igor			The Progeny of Arabidopsis thaliana Plants Exposed to Salt Exhibit Changes in DNA Methylation, Histone Modifications and Gene Expression	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION; BINDING PROTEINS; GENOME STABILITY; H3 LYSINE-9; STRESS; RECOMBINATION; DEMETHYLATION; ADAPTATION; MEMORY; VIRUS	Plants are able to acclimate to new growth conditions on a relatively short time-scale. Recently, we showed that the progeny of plants exposed to various abiotic stresses exhibited changes in genome stability, methylation patterns and stress tolerance. Here, we performed a more detailed analysis of methylation patterns in the progeny of Arabidopsis thaliana (Arabidopsis) plants exposed to 25 and 75 mM sodium chloride. We found that the majority of gene promoters exhibiting changes in methylation were hypermethylated, and this group was overrepresented by regulators of the chromatin structure. The analysis of DNA methylation at gene bodies showed that hypermethylation in the progeny of stressed plants was primarily due to changes in the 5' and 3' ends as well as in exons rather than introns. All but one hypermethylated gene tested had lower gene expression. The analysis of histone modifications in the promoters and coding sequences showed that hypermethylation and lower gene expression correlated with the enrichment of H3K9me2 and depletion of H3K9ac histones. Thus, our work demonstrated a high degree of correlation between changes in DNA methylation, histone modifications and gene expression in the progeny of salt-stressed plants.	[Bilichak, Andriy; Ilnystkyy, Yaroslav; Kovalchuk, Igor] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada; [Hollunder, Jens] Univ Ghent VIB, Dept Plant Syst Biol, Ghent, Belgium; [Hollunder, Jens] Univ Ghent, Dept Mol Genet, B-9000 Ghent, Belgium	University of Lethbridge; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Bilichak, A (corresponding author), Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada.	igor.kovalchuk@uleth.ca	Hollunder, Jens/G-6588-2016	Hollunder, Jens/0000-0003-3234-6762; Berger, Frederic/0000-0002-3609-8260	Natural Sciences and Engineering Research Council (NSERC) of Canada; Human Frontiers Science Program; Alberta Agriculture Research Institute	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Human Frontiers Science Program(Human Frontier Science Program); Alberta Agriculture Research Institute	This work was supported by a Discovery grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada and by grants from the Human Frontiers Science Program and Alberta Agriculture Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Boyko A, 2010, PLANT SIGNAL BEHAV, V5, P995, DOI [10.4161/psb.5.8.12227, 10.1371/journal.pone.0009514]; Boyko A, 2010, PLANT CELL PHYSIOL, V51, P1066, DOI 10.1093/pcp/pcq048; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Casati P, 2008, PLANT CELL, V20, P827, DOI 10.1105/tpc.107.056457; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Cloix C, 2008, MOL PLANT, V1, P118, DOI 10.1093/mp/ssm012; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Curtin SJ, 2008, FEBS LETT, V582, P2753, DOI 10.1016/j.febslet.2008.07.004; Doyle MR, 2009, PLANT PHYSIOL, V151, P1688, DOI 10.1104/pp.109.145581; Dyachenko OV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P461, DOI 10.1134/S000629790604016X; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Feng SH, 2011, CURR OPIN PLANT BIOL, V14, P179, DOI 10.1016/j.pbi.2010.12.002; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Iizuka M, 2003, CURR OPIN GENET DEV, V13, P154, DOI 10.1016/S0959-437X(03)00020-0; Ilnytskyy Y, 2004, MUTAT RES-GEN TOX EN, V559, P189, DOI 10.1016/j.mrgentox.2004.02.001; Ponferrada-Marin MI, 2010, J BIOL CHEM, V285, P23030, DOI 10.1074/jbc.M110.124578; Ito H, 2011, NATURE, V472, P115, DOI 10.1038/nature09861; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kathiria P, 2010, PLANT PHYSIOL, V153, P1859, DOI 10.1104/pp.110.157263; Kim JM, 2008, PLANT CELL PHYSIOL, V49, P1580, DOI 10.1093/pcp/pcn133; Kovalchuk I, 2004, PLANT PHYSIOL, V135, P357, DOI 10.1104/pp.104.040477; Kovalchuk O, 2003, MUTAT RES-FUND MOL M, V529, P13, DOI 10.1016/S0027-5107(03)00103-9; Lang-Mladek C, 2010, MOL PLANT, V3, P594, DOI 10.1093/mp/ssq014; Lario LD, 2011, J EXP BOT, V62, P2925, DOI 10.1093/jxb/err001; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Mason G, 2008, J VIROL METHODS, V147, P282, DOI 10.1016/j.jviromet.2007.09.015; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Naumann K, 2005, EMBO J, V24, P1418, DOI 10.1038/sj.emboj.7600604; Numa H, 2010, EMBO J, V29, P352, DOI 10.1038/emboj.2009.374; Panella M, 2004, ENVIRON POLLUT, V128, P303, DOI 10.1016/j.envpol.2003.09.003; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Pavet V, 2006, MOL PLANT MICROBE IN, V19, P577, DOI 10.1094/MPMI-19-0577; Pecinka A, 2010, PLANT CELL, V22, P3118, DOI 10.1105/tpc.110.078493; Pecinka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005202; Saleh A, 2008, NAT PROTOC, V3, P1018, DOI 10.1038/nprot.2008.66; Saze H, 2008, SEMIN CELL DEV BIOL, V19, P527, DOI 10.1016/j.semcdb.2008.07.017; Sha AH, 2005, MOL GENET GENOMICS, V273, P484, DOI 10.1007/s00438-005-1148-3; Sridhar VV, 2007, NATURE, V447, P735, DOI 10.1038/nature05864; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; SWOBODA P, 1994, EMBO J, V13, P484, DOI 10.1002/j.1460-2075.1994.tb06283.x; Tam PPC, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-44; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Toedling J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-221; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; Vaillant I, 2007, CURR OPIN PLANT BIOL, V10, P528, DOI 10.1016/j.pbi.2007.06.008; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Wada Y, 2003, J BIOL CHEM, V278, P42386, DOI 10.1074/jbc.M303892200; Yao YL, 2011, MUTAT RES-FUND MOL M, V707, P61, DOI 10.1016/j.mrfmmm.2010.12.013; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhou JL, 2010, PLANT MOL BIOL, V72, P585, DOI 10.1007/s11103-009-9594-7; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	66	125	132	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30515	10.1371/journal.pone.0030515	http://dx.doi.org/10.1371/journal.pone.0030515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291972	Green Published, gold			2022-12-27	WOS:000301570600051
J	Lee, CH; Alpert, BO; Sankaranarayanan, P; Alter, O				Lee, Cheng H.; Alpert, Benjamin O.; Sankaranarayanan, Preethi; Alter, Orly			GSVD Comparison of Patient-Matched Normal and Tumor aCGH Profiles Reveals Global Copy-Number Alterations Predicting Glioblastoma Multiforme Survival	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CIRCULAR BINARY SEGMENTATION; SINGULAR-VALUE DECOMPOSITION; DNA MICROARRAY DATA; GENE-EXPRESSION; INTEGRATIVE ANALYSIS; MOLECULAR SUBTYPES; PANCREATIC-CANCER; REPLICATION; PATTERNS	Despite recent large-scale profiling efforts, the best prognostic predictor of glioblastoma multiforme (GBM) remains the patient's age at diagnosis. We describe a global pattern of tumor-exclusive co-occurring copy-number alterations (CNAs) that is correlated, possibly coordinated with GBM patients' survival and response to chemotherapy. The pattern is revealed by GSVD comparison of patient-matched but probe-independent GBM and normal aCGH datasets from The Cancer Genome Atlas (TCGA). We find that, first, the GSVD, formulated as a framework for comparatively modeling two composite datasets, removes from the pattern copy-number variations (CNVs) that occur in the normal human genome (e. g., female-specific X chromosome amplification) and experimental variations (e. g., in tissue batch, genomic center, hybridization date and scanner), without a-priori knowledge of these variations. Second, the pattern includes most known GBM-associated changes in chromosome numbers and focal CNAs, as well as several previously unreported CNAs in >3% of the patients. These include the biochemically putative drug target, cell cycle-regulated serine/threonine kinase-encoding TLK2, the cyclin E1-encoding CCNE1, and the Rb-binding histone demethylase-encoding KDM5A. Third, the pattern provides a better prognostic predictor than the chromosome numbers or any one focal CNA that it identifies, suggesting that the GBM survival phenotype is an outcome of its global genotype. The pattern is independent of age, and combined with age, makes a better predictor than age alone. GSVD comparison of matched profiles of a larger set of TCGA patients, inclusive of the initial set, confirms the global pattern. GSVD classification of the GBM profiles of an independent set of patients validates the prognostic contribution of the pattern.	[Lee, Cheng H.; Alpert, Benjamin O.; Sankaranarayanan, Preethi; Alter, Orly] Univ Utah, Sci Comp & Imaging SCI Inst, Salt Lake City, UT 84112 USA; [Alpert, Benjamin O.; Sankaranarayanan, Preethi; Alter, Orly] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Alter, Orly] Univ Utah, Dept Human Genet, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Lee, CH (corresponding author), Univ Utah, Sci Comp & Imaging SCI Inst, Salt Lake City, UT 84112 USA.	orly@sci.utah.edu		Alter, Orly/0000-0002-0418-1078; Lee, Cheng/0000-0003-3243-8528	Utah Science Technology and Research initiative; National Human Genome Research Institute [HG-004302]; National Science Foundation [DMS-0847173]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004302] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [0847173] Funding Source: National Science Foundation	Utah Science Technology and Research initiative; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was supported by the Utah Science Technology and Research initiative, National Human Genome Research Institute R01 Grant HG-004302, and National Science Foundation CAREER Award DMS-0847173 (to OA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert BO, 2011, 2 DNA GEN WORLD DAY; Alter O, 2004, P NATL ACAD SCI USA, V101, P16577, DOI 10.1073/pnas.0406767101; Alter O, 2003, P NATL ACAD SCI USA, V100, P3351, DOI 10.1073/pnas.0530258100; Alter O, 2006, P NATL ACAD SCI USA, V103, P16063, DOI 10.1073/pnas.0607650103; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; COX DR, 1972, J R STAT SOC B, V34, P187; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; Etemadmoghadam D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015498; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Golub GH., 2013, MATRIX COMPUTATIONS; Gorlia T, 2008, LANCET ONCOL, V9, P29, DOI 10.1016/S1470-2045(07)70384-4; Hattori Y, 2007, BIOCHEM BIOPH RES CO, V364, P737, DOI 10.1016/j.bbrc.2007.10.041; Heidenblad M, 2005, ONCOGENE, V24, P1794, DOI 10.1038/sj.onc.1208383; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lee CH, 2010, 60 ANN AM SOC HUM GE; Millour Marie, 2006, Cancer Genomics & Proteomics, V3, P89; Mischel PS, 2003, ONCOGENE, V22, P2361, DOI 10.1038/sj.onc.1206344; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Omberg L, 2007, P NATL ACAD SCI USA, V104, P18371, DOI 10.1073/pnas.0709146104; Omberg L, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.70; Pardridge William M, 2005, NeuroRx, V2, P3; Pellegrini Matteo, 2008, BMC Cancer, V8, P264, DOI 10.1186/1471-2407-8-264; Ponnapalli SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028072; Purow B, 2009, NAT REV NEUROL, V5, P419, DOI 10.1038/nrneurol.2009.96; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sillje HHW, 1999, EMBO J, V18, P5691, DOI 10.1093/emboj/18.20.5691; Snijders AM, 2003, ONCOGENE, V22, P4281, DOI 10.1038/sj.onc.1206621; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618; Wiltshire RN, 2000, NEURO-ONCOLOGY, V2, P164, DOI 10.1093/neuonc/2.3.164	42	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30098	10.1371/journal.pone.0030098	http://dx.doi.org/10.1371/journal.pone.0030098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291905	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600015
J	Ma, HB; Chang, WJ; Cui, GB				Ma, Haibo; Chang, Wenjuan; Cui, Guangbai			Ecological Footprint Model Using the Support Vector Machine Technique	PLOS ONE			English	Article							NATIONS	The per capita ecological footprint (EF) is one of the most widely recognized measures of environmental sustainability. It aims to quantify the Earth's biological resources required to support human activity. In this paper, we summarize relevant previous literature, and present five factors that influence per capita EF. These factors are: National gross domestic product (GDP), urbanization (independent of economic development), distribution of income (measured by the Gini coefficient), export dependence (measured by the percentage of exports to total GDP), and service intensity (measured by the percentage of service to total GDP). A new ecological footprint model based on a support vector machine (SVM), which is a machine-learning method based on the structural risk minimization principle from statistical learning theory was conducted to calculate the per capita EF of 24 nations using data from 123 nations. The calculation accuracy was measured by average absolute error and average relative error. They were 0.004883 and 0.351078% respectively. Our results demonstrate that the EF model based on SVM has good calculation performance.	[Ma, Haibo] China Three Gorges Univ, Coll Hydraul & Environm Engn, Yichang, Peoples R China; [Ma, Haibo; Chang, Wenjuan; Cui, Guangbai] Hohai Univ, Coll Hydrol & Water Resources, Nanjing, Jiangsu, Peoples R China	China Three Gorges University; Hohai University	Ma, HB (corresponding author), China Three Gorges Univ, Coll Hydraul & Environm Engn, Yichang, Peoples R China.	mahaibo29@163.com						Barrett J., 2003, LOCAL ENVIRON, V8, P167, DOI DOI 10.1080/1354983032000048488; Binningsbo HM, 2007, POPUL ENVIRON, V28, P337, DOI 10.1007/s11111-007-0053-6; Costanza R, 2000, ECOL ECON, V32, P341; Crompton S., 2002, INT J SUST HIGHER ED, V3, P313, DOI DOI 10.1108/14676370210442355; Jorgenson A.K, 2004, HUMAN ECOLOGY REV, V11, P103; Jorgenson AK, 2006, SOC FORCES, V84, P1779, DOI 10.1353/sof.2006.0050; Jorgenson AK, 2005, SOCIOL PERSPECT, V48, P383, DOI 10.1525/sop.2005.48.3.383; Jorgenson AK, 2003, SOC PROBL, V50, P374, DOI 10.1525/sp.2003.50.3.374; Jorgenson AK, 2007, SOC SCI RES, V36, P834, DOI 10.1016/j.ssresearch.2006.06.003; Li XM, 2010, ECOL INDIC, V10, P241, DOI 10.1016/j.ecolind.2009.05.003; Liu LX, 2011, EXPERT SYST APPL, V38, P116, DOI 10.1016/j.eswa.2010.06.022; McDonald GW, 2004, ECOL ECON, V50, P49, DOI 10.1016/j.ecolecon.2004.02.008; Mostafa MM, 2010, ECOL INDIC, V10, P808, DOI 10.1016/j.ecolind.2010.01.002; Rees W.E., 1996, OUR ECOLOGICAL FOOTP; Rice J, 2007, SOC FORCES, V85, P1369, DOI 10.1353/sof.2007.0054; Wackernagel M, 2000, ECOL ECON, V32, P391; White TJ, 2007, ECOL ECON, V64, P402, DOI 10.1016/j.ecolecon.2007.07.024; *WORLD BANK, 2002, WORLD DEV IND; World Resources Institute (WRI), 2000, WORLD RES 2000 2001; *WWF INT, 2006, LIV PLAN REP	20	3	3	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30396	10.1371/journal.pone.0030396	http://dx.doi.org/10.1371/journal.pone.0030396			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	909NE	22291949	Green Published, gold			2022-12-27	WOS:000301570600039
J	Moiroux, N; Boussari, O; Djenontin, A; Damien, G; Cottrell, G; Henry, MC; Guis, H; Corbel, V				Moiroux, Nicolas; Boussari, Olayide; Djenontin, Armel; Damien, Georgia; Cottrell, Gilles; Henry, Marie-Claire; Guis, Helene; Corbel, Vincent			Dry Season Determinants of Malaria Disease and Net Use in Benin, West Africa	PLOS ONE			English	Article							ANOPHELES-FUNESTUS DIPTERA; TRANSMISSION; CULICIDAE; AREA; RESISTANCE; DYNAMICS; GAMBIAE; BIONOMICS; COVERAGE; CHILDREN	Background: To achieve malaria eradication, control efforts have to be sustained even when the incidence of malaria cases becomes low during the dry season. In this work, malaria incidence and its determinants including bed net use were investigated in children of under 5 years of age in 28 villages in southern Benin during the dry season. Methods and Findings: Mean malaria clinical incidence was measured in children aged 0-5 years by active case detection in 28 villages of the Ouidah-Kpomasse-Tori Bossito sanitary district between November 2007 and March 2008. Using Poisson mixed-effect models, malaria incidence was assessed according to the level of transmission by different vector species, and Long-Lasting Insecticide-treated mosquito Nets (LLIN) use and ownership. Then, a Binomial mixed-effect model was developed to assess whether nighttime temperature (derived from MODIS remote sensing data), biting nuisance and LLIN ownership are good predictors of LLIN use >60%. Results suggested that Anopheles funestus (Incidence Rates Ratio (IRR) = 3.38 [IC95 1.91-6]) rather than An. gambiae s.s. is responsible for malaria transmission. A rate of LLIN use >60% was associated with a lower risk of malaria (IRR = 0.6 [IC95 0.37-0.99]). Low nocturnal temperature and high biting nuisance were good predictors of LLIN use >60%. Conclusions: As recommended by the Malaria Eradication (MalERA) Consultative Group on Modelling, there is a need to understand better the effects of seasonality on malaria morbidity. This study highlights the need to take into account the specificity of malaria epidemiology during the dry-hot season and get a better understanding of the factors that influence malaria incidence and net use. These findings should help National Malaria Control Programmes to implement more effective and sustainable malaria control strategies in Africa.	[Moiroux, Nicolas; Djenontin, Armel; Damien, Georgia; Corbel, Vincent] IRD, MIVEGEC IRD CNRS UM1 224 5290, Cotonou, Benin; [Moiroux, Nicolas; Boussari, Olayide; Djenontin, Armel; Henry, Marie-Claire; Corbel, Vincent] Minist Sante, CREC, Cotonou, Benin; [Cottrell, Gilles] IRD, Mere & Enfant Face Infect Trop UMR216, Cotonou, Benin; [Cottrell, Gilles] Univ Abomey Calavi, ISBA, Cotonou, Benin; [Henry, Marie-Claire] Ambassade France, SCAC, Cotonou, Benin; [Guis, Helene] CIRAD, UMR CMAEE, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Entomological Research Center of Cotonou (CREC); Institut de Recherche pour le Developpement (IRD); University of Abomey Calavi; CIRAD	Moiroux, N (corresponding author), IRD, MIVEGEC IRD CNRS UM1 224 5290, Cotonou, Benin.	vincent.corbel@ird.fr	Corbel, VIncent/G-9576-2016; Moiroux, Nicolas/AFT-2925-2022	Moiroux, Nicolas/0000-0001-6755-6167; Cottrell, Gilles/0000-0002-7964-8963; corbel, vincent/0000-0003-0995-3257; Guis, Helene/0000-0002-0355-0898	French Ministry of Foreign Affairs; Institut de Recherche pour le Developpement (IRD) [2006-22]	French Ministry of Foreign Affairs; Institut de Recherche pour le Developpement (IRD)	This work was supported by the French Ministry of Foreign Affairs and the Institut de Recherche pour le Developpement (IRD)[FSP project REFS No2006-22]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adja AM, 2011, ANN TROP MED PARASIT, V105, P13, DOI 10.1179/136485910X12851868780388; Ahorlu CK, 1997, TROP MED INT HEALTH, V2, P488, DOI 10.1046/j.1365-3156.1997.d01-298.x; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2004, COCHRANE DB SYST REV; Appawu M, 2004, TROP MED INT HEALTH, V9, P164, DOI 10.1046/j.1365-3156.2003.01162.x; Awolola TS, 2002, ANN TROP MED PARASIT, V96, P75, DOI 10.1179/000349802125000538; Bangana ASB, 2009, 5 MIM PAN AFR MAL C; Bates D., 2009, IME4 LINEAR MIXED EF; Binka FN, 1997, TROP MED INT HEALTH, V2, P499, DOI 10.1046/j.1365-3156.1997.d01-299.x; Coetzee M., 2006, Bulletin de la Societe de Pathologie Exotique, V99, P400; Cohuet A, 2004, J MED ENTOMOL, V41, P901, DOI 10.1603/0022-2585-41.5.901; Dabire KR, 2007, J MED ENTOMOL, V44, P990, DOI 10.1603/0022-2585(2007)44[990:AFDCIA]2.0.CO;2; Damien GB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-380; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; Djenontin A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-83; Doannio J.M.C., 2006, Bulletin de la Societe de Pathologie Exotique, V99, P204; Fontenille D, 1997, T ROY SOC TROP MED H, V91, P647, DOI 10.1016/S0035-9203(97)90506-X; Fontenille D, 1997, AM J TROP MED HYG, V56, P247, DOI 10.4269/ajtmh.1997.56.247; Frey C, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-70; GILLIES M. T., 1968, The Anophelinae of Africa south of the Sahara (Ethiopian Zoogeographical Region).; Hay SI, 1998, PARASITOL TODAY, V14, P306, DOI 10.1016/S0169-4758(98)01285-X; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-268; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-19; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; Kweka EJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-59; *MALERA CONS GROUP, 2011, PLOS MED, V0008; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Najera JA, 1998, 981084 WHOMAL, P1; Okoye PN, 2008, T ROY SOC TROP MED H, V102, P591, DOI 10.1016/j.trstmh.2008.02.022; Patz JA, 1998, TROP MED INT HEALTH, V3, P818, DOI 10.1046/j.1365-3156.1998.00309.x; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; THOMSON MC, 1994, T ROY SOC TROP MED H, V88, P638, DOI 10.1016/0035-9203(94)90204-6; Toe LP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-175; United Nations, 2010, MILL DEV GOALS REP 2; Vancutsem C, 2010, REMOTE SENS ENVIRON, V114, P449, DOI 10.1016/j.rse.2009.10.002; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO RBM, 2000, WHOCDSRBM200346	38	27	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30558	10.1371/journal.pone.0030558	http://dx.doi.org/10.1371/journal.pone.0030558			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291987	Green Submitted, Green Published, gold			2022-12-27	WOS:000301570600058
J	Reeb-Sutherland, BC; Levitt, P; Fox, NA				Reeb-Sutherland, Bethany C.; Levitt, Pat; Fox, Nathan A.			The Predictive Nature of Individual Differences in Early Associative Learning and Emerging Social Behavior	PLOS ONE			English	Article							CONTINGENCY DETECTION; EARLY INFANCY; IMITATION; FACE; MECHANISMS; COGNITION; MEMORY; DELAY	Across the first year of life, infants achieve remarkable success in their ability to interact in the social world. The hierarchical nature of circuit and skill development predicts that the emergence of social behaviors may depend upon an infant's early abilities to detect contingencies, particularly socially-relevant associations. Here, we examined whether individual differences in the rate of associative learning at one month of age is an enduring predictor of social, imitative, and discriminative behaviors measured across the human infant's first year. One-month learning rate was predictive of social behaviors at 5, 9, and 12 months of age as well as face-evoked discriminative neural activity at 9 months of age. Learning was not related to general cognitive abilities. These results underscore the importance of early contingency learning and suggest the presence of a basic mechanism underlying the ontogeny of social behaviors.	[Reeb-Sutherland, Bethany C.; Fox, Nathan A.] Univ Maryland, Dept Human Dev, College Pk, MD 20742 USA; [Levitt, Pat] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Levitt, Pat] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA	University System of Maryland; University of Maryland College Park; University of Southern California; University of Southern California	Reeb-Sutherland, BC (corresponding author), Univ Maryland, Dept Human Dev, College Pk, MD 20742 USA.	fox@umd.edu			National Institute of Mental Health [MH 080759]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080759] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was supported by National Institute of Mental Health MH 080759 (PL, NF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr R, 1996, INFANT BEHAV DEV, V19, P159, DOI 10.1016/S0163-6383(96)90015-6; Bolbecker AR, 2009, BIPOLAR DISORD, V11, P19, DOI 10.1111/j.1399-5618.2008.00642.x; Brown SM, 2005, BRAIN COGNITION, V58, P94, DOI 10.1016/j.bandc.2004.09.011; de Haan M, 1999, DEV PSYCHOL, V35, P1113, DOI 10.1037/0012-1649.35.4.1113; deHaan M, 1997, CHILD DEV, V68, P187, DOI 10.2307/1131845; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Domjan M, 2000, BEHAV BRAIN SCI, V23, P235, DOI 10.1017/S0140525X00002430; Fifer WP, 2010, P NATL ACAD SCI USA, V107, P10320, DOI 10.1073/pnas.1005061107; FITZGERALD HE, 1976, PSYCHOL BULL, V83, P353, DOI 10.1037/0033-2909.83.3.353; Freeman JH, 2001, INTEGR PHYS BEH SCI, V36, P15, DOI 10.1007/BF02733945; Goldsmith H. H., 1999, LAB TEMPERAMENT ASSE; Hammock EAD, 2006, HUM DEV, V49, P294, DOI 10.1159/000095581; Herbert JS, 2003, BEHAV NEUROSCI, V117, P1196, DOI 10.1037/0735-7044.117.6.1196; Ivkovich D, 1999, PSYCHOL SCI, V10, P4, DOI 10.1111/1467-9280.00097; LITTLE AH, 1984, J EXP CHILD PSYCHOL, V37, P512, DOI 10.1016/0022-0965(84)90074-2; MELTZOFF AN, 1988, CHILD DEV, V59, P217, DOI 10.2307/1130404; Meltzoff AN, 2003, PHILOS T R SOC B, V358, P491, DOI 10.1098/rstb.2002.1261; Mesman J, 2009, DEV REV, V29, P120, DOI 10.1016/j.dr.2009.02.001; MOORE C, 1994, DEV REV, V14, P349, DOI 10.1006/drev.1994.1014; Mullen E. M, 1995, MULLEN SCALES EARLY; MUNDY P, 1996, EARLY SOCIAL COMMUNI; Papousek M, 2007, INFANT BEHAV DEV, V30, P258, DOI 10.1016/j.infbeh.2007.02.003; Pelphrey K, 2004, MENT RETARD DEV D R, V10, P259, DOI 10.1002/mrdd.20040; Reeb-Sutherland BC, 2011, DEVELOPMENTAL SCI, V14, P1134, DOI 10.1111/j.1467-7687.2011.01062.x; RHEINGOLD HL, 1959, J COMP PHYSIOL PSYCH, V52, P68, DOI 10.1037/h0040067; Richards JE, 2003, DEV SCI, V6; Rochat P, 1999, EARLY SOCIAL COGNITION, P3; Rochat PR, 2001, B MENNINGER CLIN, V65, P347, DOI 10.1521/bumc.65.3.347.19847; ROTHBART MK, 1981, CHILD DEV, V52, P569, DOI 10.1111/j.1467-8624.1981.tb03082.x; ROVEECOLLIER CK, 1982, PSYCHOBIOLOGY HUMAN, P147; Stanton ME, 2000, BEHAV BRAIN RES, V110, P25, DOI 10.1016/S0166-4328(99)00182-5; Tarabulsy GM, 1996, PSYCHOL BULL, V120, P25, DOI 10.1037/0033-2909.120.1.25; TREVARTHEN C., 1979, SPEECH BEGINNINGS HU, P321; TRONICK E, 1978, J AM ACAD CHILD PSY, V17, P1, DOI 10.1016/S0002-7138(09)62273-1; WATSON JS, 1966, MERRILL-PALMER Q BEH, V12, P123; WEINBERG MK, 1994, CHILD DEV, V65, P1503, DOI 10.2307/1131514	36	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30511	10.1371/journal.pone.0030511	http://dx.doi.org/10.1371/journal.pone.0030511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	909NE	22291971	Green Published, gold			2022-12-27	WOS:000301570600050
J	Yan, W; Zhang, W; You, G; Bao, ZS; Wang, YZ; Liu, YW; Kang, CS; You, YP; Wang, L; Jiang, T				Yan, Wei; Zhang, Wei; You, Gan; Bao, Zhaoshi; Wang, Yongzhi; Liu, Yanwei; Kang, Chunsheng; You, Yongping; Wang, Lei; Jiang, Tao			Correlation of IDH1 Mutation with Clinicopathologic Factors and Prognosis in Primary Glioblastoma: A Report of 118 Patients from China	PLOS ONE			English	Article							GLIOMAS; THERAPY; MGMT; TEMOZOLOMIDE; CANCER; PROLIFERATION; METHYLATION; MULTIFORME; INDEX	It has been reported that IDH1 (IDH1R132) mutation was a frequent genomic alteration in grade II and grade III glial tumors but rare in primary glioblastoma (pGBM). To elucidate the frequency of IDH1 mutation and its clinical significance in Chinese patients with pGBM, one hundred eighteen pGBMs were assessed by pyro-sequencing for IDH1 mutation status, and the results were correlated with clinical characteristics and molecular pathological factors. IDH1 mutations were detected in 19/118 pGBM cases (16.1%). Younger age, methylated MGMT promoter, high expression of mutant P53 protein, low expression of Ki-67 or EGFR protein were significantly correlated with IDH1 mutation status. Most notably, we identified pGBM cases with IDH1 mutation were mainly involved in the frontal lobe when compared with those with wild-type IDH1. In addition, Kaplan-Meier survival analysis revealed a highly significant association between IDH1 mutation and a better clinical outcome (p = 0.026 for progression-free survival; p = 0.029 for overall survival). However, in our further multivariable regression analysis, the independent prognostic effect of IDH1 mutation is limited when considering age, preoperative KPS score, extent of resection, TMZ chemotherapy, and Ki-67 protein expression levels, which might narrow its prognostic power in Chinese population in the future.	[Yan, Wei; Zhang, Wei; You, Gan; Bao, Zhaoshi; Wang, Yongzhi; Liu, Yanwei; Wang, Lei; Jiang, Tao] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [You, Yongping] Nanjing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Kang, Chunsheng] Tianjin Neurol Inst, Lab Neurooncol, Tianjin, Peoples R China	Capital Medical University; Nanjing Medical University	Yan, W (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.	wangleitiantan@126.com; taojiang1964@yahoo.com.cn	Kang, Chunsheng/AAM-5979-2021; jiang, tao/GWC-7108-2022; Jiang, Tao/N-8142-2014	Kang, Chunsheng/0000-0002-3255-3369; 	National Key Project of Science and Technology Supporting Programs of China [2007BAI05B08]; National Natural Science Foundation of China [30772238, 30730035]	National Key Project of Science and Technology Supporting Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was Supported by grants from National Key Project of Science and Technology Supporting Programs of China (No. 2007BAI05B08) and National Natural Science Foundation of China (No. 30772238 and 30730035, http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burcombe R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1508; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Fukushima T, 2009, ANTICANCER RES, V29, P4845; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Jin Q, 2011, CHIN MED J, V17, P2584; Kanu OO, 2009, EXPERT OPIN THER TAR, V13, P701, DOI [10.1517/14728220902942348 , 10.1517/14728220902942348]; Labussiere M, 2010, ONCOLOGIST, V15, P196, DOI 10.1634/theoncologist.2009-0218; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Quick A, 2010, REV RECENT CLIN TRIA, V5, P14, DOI 10.2174/157488710790820544; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; SCHERER H. J., 1940, AMER JOUR CANCER, V40, P159; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; von Deimling A, 2011, BRAIN PATHOL, V21, P74, DOI 10.1111/j.1750-3639.2010.00454.x; Wang WG, 2003, CANCER BIOL THER, V2, pS55; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yan W, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-58; Zhang W, 2009, CHINESE MED J-PEKING, V122, P1250, DOI 10.3760/cma.j.issn.0366-6999.2009.11.003	26	98	106	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30339	10.1371/journal.pone.0030339	http://dx.doi.org/10.1371/journal.pone.0030339			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291938	Green Submitted, gold, Green Published			2022-12-27	WOS:000301570600034
J	Allantaz, F; Cheng, DT; Bergauer, T; Ravindran, P; Rossier, MF; Ebeling, M; Badi, L; Reis, B; Bitter, H; D'Asaro, M; Chiappe, A; Sridhar, S; Pacheco, GD; Burczynski, ME; Hochstrasser, D; Vonderscher, J; Matthes, T				Allantaz, Florence; Cheng, Donavan T.; Bergauer, Tobias; Ravindran, Palanikumar; Rossier, Michel F.; Ebeling, Martin; Badi, Laura; Reis, Bernhard; Bitter, Hans; D'Asaro, Matilde; Chiappe, Alberto; Sridhar, Sriram; Pacheco, Gonzalo Duran; Burczynski, Michael E.; Hochstrasser, Denis; Vonderscher, Jacky; Matthes, Thomas			Expression Profiling of Human Immune Cell Subsets Identifies miRNA-mRNA Regulatory Relationships Correlated with Cell Type Specific Expression	PLOS ONE			English	Article							GENE-EXPRESSION; T-CELLS; MICRORNAS; BLOOD; NEUTROPHILS; NAIVE	Blood consists of different cell populations with distinct functions and correspondingly, distinct gene expression profiles. In this study, global miRNA expression profiling was performed across a panel of nine human immune cell subsets (neutrophils, eosinophils, monocytes, B cells, NK cells, CD4 T cells, CD8 T cells, mDCs and pDCs) to identify cell-type specific miRNAs. mRNA expression profiling was performed on the same samples to determine if miRNAs specific to certain cell types down-regulated expression levels of their target genes. Six cell-type specific miRNAs (miR-143; neutrophil specific, miR-125; T cells and neutrophil specific, miR-500; monocyte and pDC specific, miR-150; lymphoid cell specific, miR-652 and miR-223; both myeloid cell specific) were negatively correlated with expression of their predicted target genes. These results were further validated using an independent cohort where similar immune cell subsets were isolated and profiled for both miRNA and mRNA expression. miRNAs which negatively correlated with target gene expression in both cohorts were identified as candidates for miRNA/mRNA regulatory pairs and were used to construct a cell-type specific regulatory network. miRNA/mRNA pairs formed two distinct clusters in the network corresponding to myeloid (nine miRNAs) and lymphoid lineages (two miRNAs). Several myeloid specific miRNAs targeted common genes including ABL2, EIF4A2, EPC1 and INO80D; these common targets were enriched for genes involved in the regulation of gene expression (p<9.0E-7). Those miRNA might therefore have significant further effect on gene expression by repressing the expression of genes involved in transcriptional regulation. The miRNA and mRNA expression profiles reported in this study form a comprehensive transcriptome database of various human blood cells and serve as a valuable resource for elucidating the role of miRNA mediated regulation in the establishment of immune cell identity.	[Allantaz, Florence; Bergauer, Tobias; Ebeling, Martin; Badi, Laura; Reis, Bernhard; Pacheco, Gonzalo Duran] F Hoffmann La Roche Ltd, Pharma Res & Early Dev, Translat Res Sci, Basel, Switzerland; [Cheng, Donavan T.; Ravindran, Palanikumar; Bitter, Hans; Sridhar, Sriram; Burczynski, Michael E.; Vonderscher, Jacky] Roche, Pharma Res & Early Dev, Translat Res Sci, Nutley, NJ USA; [Rossier, Michel F.; D'Asaro, Matilde; Chiappe, Alberto; Hochstrasser, Denis] Univ Hosp Geneva, Dept Genet & Lab Med, Geneva, Switzerland; [Matthes, Thomas] Univ Hosp Geneva, Hematol Serv, Geneva, Switzerland	Roche Holding; Roche Holding; University of Geneva; University of Geneva	Allantaz, F (corresponding author), F Hoffmann La Roche Ltd, Pharma Res & Early Dev, Translat Res Sci, Basel, Switzerland.	florence.frager@hotmail.com; donavan.cheng@roche.com	Rossier, Michel/AAW-2895-2021	Reis, Bernhard/0000-0001-7611-8222	F. Hoffmann-LaRoche Ltd.	F. Hoffmann-LaRoche Ltd.(Hoffmann-La Roche)	This study was supported by F. Hoffmann-LaRoche Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Basso K, 2009, IMMUNITY, V30, P744, DOI 10.1016/j.immuni.2009.03.017; BEAULIEU AD, 1992, J BIOL CHEM, V267, P426; Bezman NA, 2010, J IMMUNOL, V185, P3835, DOI 10.4049/jimmunol.1000980; BRAMEIER M, 2010, NUCL ACIDS RES; Burczynski ME, 2006, PHARMACOGENOMICS, V7, P187, DOI 10.2217/14622416.7.2.187; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; Ehrhardt GRA, 2008, J EXP MED, V205, P1807, DOI 10.1084/jem.20072682; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Griesinger F, 2002, BRIT J HAEMATOL, V119, P454, DOI 10.1046/j.1365-2141.2002.03850.x; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kuipers H, 2010, MOL IMMUNOL; Lindstedt M, 2005, J IMMUNOL, V175, P4839, DOI 10.4049/jimmunol.175.8.4839; Liu SM, 2006, J ALLERGY CLIN IMMUN, V118, P496, DOI 10.1016/j.jaci.2006.04.040; Macaulay IC, 2007, BLOOD, V109, P3260, DOI 10.1182/blood-2006-07-036269; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slezak S, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-39; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-225; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Zhao CQ, 2009, J PROTEOME RES, V8, P4028, DOI 10.1021/pr900364p; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	37	149	159	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29979	10.1371/journal.pone.0029979	http://dx.doi.org/10.1371/journal.pone.0029979			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276136	gold, Green Published, Green Submitted			2022-12-27	WOS:000301568100021
J	Gamber, KM; Huo, LH; Ha, S; Hairston, JE; Greeley, S; Bjorbaek, C				Gamber, Kevin M.; Huo, Lihong; Ha, Sangdeuk; Hairston, Joyce E.; Greeley, Sarah; Bjorbaek, Christian			Over-Expression of Leptin Receptors in Hypothalamic POMC Neurons Increases Susceptibility to Diet-Induced Obesity	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; MESSENGER-RNA EXPRESSION; MICE OVEREXPRESSING LEPTIN; AGOUTI-RELATED PROTEIN; ARCUATE NUCLEUS; IN-VIVO; GLUCOSE-HOMEOSTASIS; LOCOMOTOR-ACTIVITY; GENE-EXPRESSION; MOUSE-BRAIN	Diet-induced obesity (DIO) in rodents is characterized by impaired activation of (s) under bar ignal-(t) under bar ransducer and (a) under bar ctivator of (t) under bar ranscription 3 (STAT3) by leptin receptors (LepRb) within the hypothalamic arcuate nucleus. This signaling defect likely plays an important role in development of DIO. However, the neuro-chemical identity of the leptin-STAT3 resistant arcuate neurons has not been determined and the underlying mechanisms responsible for development of cellular leptin resistance remain unclear. To investigate this, we first measured arcuate gene expression of known key signaling components of the LepRb signaling pathway and tested whether specifically the critical arcuate pro-opiomelanocortin (POMC) neurons are resistant to LepRb-STAT3 signaling in mice given a high-fat-diet (HFD) compared to mice provided a low-fat control diet (LFD). We found that leptin-dependent STAT3 phosphorylation was decreased within POMC neurons of HFD mice. In addition, Leprb mRNA and suppressor of cytokine signaling 3 (Socs3) mRNA were elevated in the arcuate of HFD mice. To investigate whether increased LepRb expression per se in POMC neurons can influence development of DIO and Socs3 expression, we created mice that over-express LepRb selectively in POMC neurons (POMC-LepRb). No differences in body weight, fat mass or food intake were found between LFD POMC-LepRb mice and LFD controls. Surprisingly, body weight, fat mass and caloric intake of HFD POMC-LepRb mice was markedly higher than HFD control mice. In addition, arcuate Socs3 mRNA was increased in HFD POMC-LepRb mice compared to HFD controls. These data show that specifically POMC neurons of DIO mice are resistant to STAT3 activation by leptin, indicating that those cells might play a role in development of DIO. Furthermore, over-expression of LepRb selectively in POMC neurons increases susceptibility to the development of DIO. We propose a model where over-reactivity of the leptin-LepRb signaling system in arcuate neurons may play causal a role in development of diet-induced obesity.	[Gamber, Kevin M.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Gamber, KM (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.	cbjorbae@bidmc.harvard.edu	Bjorbaek, Christian/S-4727-2019	Gamber, Kevin/0000-0002-0694-7639	American Diabetes Association [7-09-BS-17]; The Richard and Susan Smith Family Foundation [7-05-PPG-02]; National Institutes of Health [DK60673, DK65743]; Endocrine Society; Boston Obesity Nutrition Research Center [DK46200]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065743, P30DK046200, R01DK060673] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); The Richard and Susan Smith Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endocrine Society; Boston Obesity Nutrition Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the American Diabetes Association (7-09-BS-17) and The Richard and Susan Smith Family Foundation Pinnacle Program Project (7-05-PPG-02), the National Institutes of Health (DK60673 and DK65743 and ARRA funds), the Endocrine Society (all to C.B.), and by the Boston Obesity Nutrition Research Center (DK46200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Banno R, 2010, J CLIN INVEST, V120, P720, DOI 10.1172/JCI39620; Baskin DG, 2000, REGUL PEPTIDES, V92, P9, DOI 10.1016/S0167-0115(00)00143-9; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Bjorbaek C, 2009, J INVEST MED, V57, P789, DOI 10.2310/JIM.0b013e3181bb0d49; Bouret SG, 2008, CELL METAB, V7, P179, DOI 10.1016/j.cmet.2007.12.001; Bradley RL, 2008, OBESITY, V16, P938, DOI 10.1038/oby.2008.39; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Ernst MB, 2009, J NEUROSCI, V29, P11582, DOI 10.1523/JNEUROSCI.5712-08.2009; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Guo FF, 2004, ENDOCRINOLOGY, V145, P2221, DOI 10.1210/en.2003-1312; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Huang XF, 2004, DIABETES OBES METAB, V6, P35, DOI 10.1111/j.1463-1326.2004.00312.x; Huang XF, 2003, MOL BRAIN RES, V115, P21, DOI 10.1016/S0169-328X(03)00174-8; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; Isobe A, 2006, PLACENTA, V27, P912, DOI 10.1016/j.placenta.2005.10.003; Kievit P, 2006, CELL METAB, V4, P123, DOI 10.1016/j.cmet.2006.06.010; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Knight ZA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011376; Lam NT, 2004, MOL ENDOCRINOL, V18, P1333, DOI 10.1210/me.2002-0193; Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298; Levin BE, 2004, AM J PHYSIOL-REG I, V286, pR143, DOI 10.1152/ajpregu.00393.2003; Lin S, 2000, BRAIN RES, V875, P89, DOI 10.1016/S0006-8993(00)02580-4; Loh K, 2011, CELL METAB, V14, P684, DOI 10.1016/j.cmet.2011.09.011; Low M J, 2004, J Endocrinol Invest, V27, P95; Metlakunta AS, 2008, ENDOCRINOLOGY, V149, P1121, DOI 10.1210/en.2007-1307; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Morton GJ, 2003, ENDOCRINOLOGY, V144, P2016, DOI 10.1210/en.2002-0115; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Ogus S, 2003, ENDOCRINOLOGY, V144, P2865, DOI 10.1210/en.2002-0178; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Picardi PK, 2008, ENDOCRINOLOGY, V149, P3870, DOI 10.1210/en.2007-1506; Qiu J, 2001, ENDOCRINOLOGY, V142, P348, DOI 10.1210/en.142.1.348; Reed AS, 2010, DIABETES, V59, P894, DOI 10.2337/db09-1024; Ricci MR, 2003, AM J PHYSIOL-REG I, V285, pR610, DOI 10.1152/ajpregu.00235.2003; Sahu A, 2002, J NEUROENDOCRINOL, V14, P887, DOI 10.1046/j.1365-2826.2002.00856.x; Satoh N, 1997, NEUROSCI LETT, V224, P149, DOI 10.1016/S0304-3940(97)00163-8; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Starr R, 1998, INT J BIOCHEM CELL B, V30, P1081, DOI 10.1016/S1357-2725(98)00067-3; Velloso LA, 2008, NEUROIMMUNOMODULAT, V15, P189, DOI 10.1159/000153423; Wang S, 2006, J BIOL CHEM, V281, P9439, DOI 10.1074/jbc.M504977200; White CL, 2009, AM J PHYSIOL-ENDOC M, V296, pE291, DOI 10.1152/ajpendo.90513.2008; Wilson BD, 1999, ENDOCRINOLOGY, V140, P2387, DOI 10.1210/en.140.5.2387; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; Zabolotny JM, 2008, J BIOL CHEM, V283, P14230, DOI 10.1074/jbc.M800061200; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X	59	57	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30485	10.1371/journal.pone.0030485	http://dx.doi.org/10.1371/journal.pone.0030485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276206	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100050
J	Huijts, M; Duits, A; Staals, J; van Oostenbrugge, RJ				Huijts, Marjolein; Duits, Annelien; Staals, Julie; van Oostenbrugge, Robert J.			Association of Vitamin B12 Deficiency with Fatigue and Depression after Lacunar Stroke	PLOS ONE			English	Article							SCALE; LIFE	Background: In lacunar stroke patients vitamin B12 deficiency is often found and a relationship with the degree of periventricular white matter lesions (pWMLs) is suggested. Given the known relationships between WMLs and depression and between depression and fatigue after stroke, we studied both depression and fatigue in lacunar stroke patients with and without vitamin B12 deficiency. Methods: In 40 first-ever lacunar stroke patients vitamin B12 levels were determined and self-report questionnaires for fatigue and depression were completed three months after stroke. Results: Lacunar stroke patients with vitamin B12 deficiency (N = 13) reported significantly more fatigue (90.7 versus 59.4; p = .001) and depressive symptoms (6.62 versus 3.89; p < 05) than those without (N = 27). In regression analyses, vitamin B12 deficiency was significantly and independently associated with the presence of severe fatigue and clinically significant depression. Conclusions: Our preliminary results suggest a relationship between vitamin B12 deficiency and increased levels of fatigue and depression in lacunar stroke patients. If these findings could be replicated in a larger and general stroke sample, this would open treatment options and may improve quality of life after stroke.	[Huijts, Marjolein; Staals, Julie; van Oostenbrugge, Robert J.] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands; [Duits, Annelien] Maastricht Univ, Med Ctr, Dept Psychiat & Psychol, Maastricht, Netherlands; [Huijts, Marjolein; Duits, Annelien; van Oostenbrugge, Robert J.] Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Maastricht, Netherlands; [Huijts, Marjolein; Staals, Julie; van Oostenbrugge, Robert J.] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University	Huijts, M (corresponding author), Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands.	M.Huijts@mumc.nl	Duits, Annelien/AFK-9032-2022	Duits, Annelien/0000-0003-0279-1806				Baik HW, 1999, ANNU REV NUTR, V19, P357, DOI 10.1146/annurev.nutr.19.1.357; Bol Y, 2009, J PSYCHOSOM RES, V66, P3, DOI 10.1016/j.jpsychores.2008.05.003; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Carmel Ralph, 2003, Hematology Am Soc Hematol Educ Program, P62; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Naess H, 2006, STROKE, V37, P1232, DOI 10.1161/01.STR.0000217652.42273.02; OBrien J, 1996, BRIT J PSYCHIAT, V168, P477, DOI 10.1192/bjp.168.4.477; Pieters B, 2009, STROKE, V40, P1623, DOI 10.1161/STROKEAHA.108.523431; Snaphaan L, 2011, EUR J NEUROL, V18, P611, DOI 10.1111/j.1468-1331.2010.03217.x; Tang WK, 2011, STROKE, V42, P2443, DOI 10.1161/STROKEAHA.111.614586; Tiemeier H, 2002, AM J PSYCHIAT, V159, P2099, DOI 10.1176/appi.ajp.159.12.2099; Van Zandvoort MJE, 1998, J NEUROL NEUROSUR PS, V65, P697, DOI 10.1136/jnnp.65.5.697; Vercoulen J., 1999, GEDRAGSTHERAPIE, V32, P131; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	14	18	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30519	10.1371/journal.pone.0030519	http://dx.doi.org/10.1371/journal.pone.0030519			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276208	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100052
J	Breiman, RF; Cosmas, L; Njuguna, H; Audi, A; Olack, B; Ochieng, JB; Wamola, N; Bigogo, GM; Awiti, G; Tabu, CW; Burke, H; Williamson, J; Oundo, JO; Mintz, ED; Feikin, DR				Breiman, Robert F.; Cosmas, Leonard; Njuguna, Henry; Audi, Allan; Olack, Beatrice; Ochieng, John B.; Wamola, Newton; Bigogo, Godfrey M.; Awiti, George; Tabu, Collins W.; Burke, Heather; Williamson, John; Oundo, Joseph O.; Mintz, Eric D.; Feikin, Daniel R.			Population-Based Incidence of Typhoid Fever in an Urban Informal Settlement and a Rural Area in Kenya: Implications for Typhoid Vaccine Use in Africa	PLOS ONE			English	Article							SALMONELLA-TYPHI; INVASIVE BACTERIAL; NORTHERN TANZANIA; FUNGAL-INFECTIONS; DISEASE BURDEN; UNITED-STATES; BONE-MARROW; CHILDREN; BACTEREMIA; PAKISTAN	Background: High rates of typhoid fever in children in urban settings in Asia have led to focus on childhood immunization in Asian cities, but not in Africa, where data, mostly from rural areas, have shown low disease incidence. We set out to compare incidence of typhoid fever in a densely populated urban slum and a rural community in Kenya, hypothesizing higher rates in the urban area, given crowding and suboptimal access to safe water, sanitation and hygiene. Methods: During 2007-9, we conducted population-based surveillance in Kibera, an urban informal settlement in Nairobi, and in Lwak, a rural area in western Kenya. Participants had free access to study clinics; field workers visited their homes biweekly to collect information about acute illnesses. In clinic, blood cultures were processed from patients with fever or pneumonia. Crude and adjusted incidence rates were calculated. Results: In the urban site, the overall crude incidence of Salmonella enterica serovar Typhi (S. Typhi) bacteremia was 247 cases per 100,000 person-years of observation (pyo) with highest rates in children 5-9 years old (596 per 100,000 pyo) and 2-4 years old (521 per 100,000 pyo). Crude overall incidence in Lwak was 29 cases per 100,000 pyo with low rates in children 2-4 and 5-9 years old (28 and 18 cases per 100,000 pyo, respectively). Adjusted incidence rates were highest in 2-4 year old urban children (2,243 per 100,000 pyo) which were >15-fold higher than rates in the rural site for the same age group. Nearly 75% of S. Typhi isolates were multi-drug resistant. Conclusions: This systematic urban slum and rural comparison showed dramatically higher typhoid incidence among urban children,10 years old with rates similar to those from Asian urban slums. The findings have potential policy implications for use of typhoid vaccines in increasingly urban Africa.	[Breiman, Robert F.; Cosmas, Leonard; Njuguna, Henry; Audi, Allan; Olack, Beatrice; Ochieng, John B.; Wamola, Newton; Bigogo, Godfrey M.; Awiti, George; Burke, Heather; Williamson, John; Oundo, Joseph O.; Feikin, Daniel R.] US Ctr Dis Control & Prevent, Global Dis Detect Div, Kenya Off, Nairobi, Kenya; [Breiman, Robert F.; Cosmas, Leonard; Njuguna, Henry; Audi, Allan; Olack, Beatrice; Ochieng, John B.; Wamola, Newton; Bigogo, Godfrey M.; Awiti, George; Burke, Heather; Williamson, John; Oundo, Joseph O.; Feikin, Daniel R.] US Ctr Dis Control & Prevent, Global Dis Detect Div, Kenya Off, Kisumu, Kenya; [Cosmas, Leonard; Njuguna, Henry; Audi, Allan; Olack, Beatrice; Ochieng, John B.; Wamola, Newton; Bigogo, Godfrey M.; Awiti, George] Kenya Med Res Inst KEMRI, Nairobi, Kenya; [Cosmas, Leonard; Njuguna, Henry; Audi, Allan; Olack, Beatrice; Ochieng, John B.; Wamola, Newton; Bigogo, Godfrey M.; Awiti, George] Kenya Med Res Inst KEMRI, Kisumu, Kenya; [Tabu, Collins W.] Kenya Minist Publ Hlth & Sanitat, Nairobi, Kenya; [Mintz, Eric D.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA	Kenya Medical Research Institute; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA	Breiman, RF (corresponding author), US Ctr Dis Control & Prevent, Global Dis Detect Div, Kenya Off, Nairobi, Kenya.	rbreiman@ke.cdc.gov	Bigogo, Godfrey/W-3591-2019	Tabu, Collins/0000-0002-0537-1172; Audi, Allan/0000-0003-1683-554X				BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Brooks WA, 2005, EMERG INFECT DIS, V11, P326, DOI 10.3201/eid1102.040422; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; CONDRAN GA, 1978, HUM ECOL, V6, P27, DOI 10.1007/BF00888565; Crump JA, 2003, CLIN INFECT DIS, V37, P75, DOI 10.1086/375602; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2011, TROP MED INT HEALTH, V16, P830, DOI 10.1111/j.1365-3156.2011.02774.x; Crump JA, 2011, CLIN INFECT DIS, V52, P341, DOI 10.1093/cid/ciq103; Cutler D, 2005, DEMOGRAPHY, V42, P1, DOI 10.1353/dem.2005.0002; Ernst R, 1994, IMMIGRANT LIFE NEW Y, P23; ESREY SA, 1985, B WORLD HEALTH ORGAN, V63, P757; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; GILMAN RH, 1975, LANCET, V1, P1211; Graham SM, 2000, T ROY SOC TROP MED H, V94, P310, DOI 10.1016/S0035-9203(00)90337-7; Hasan R, 2008, J INFECT DEV COUNTR, V2, P289; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Jain SK, 2009, CURR OPIN MOL THER, V11, P565; Kenya National Bureau of Statistics ( 2009), 2009, 2009 KEN CENS; KLUGMAN KP, 1987, LANCET, V2, P1165; Krieg NR, 1984, BERGEYS MANUAL SYSTE, P427; LEPAGE P, 1987, LANCET, V1, P1458; Levine MM, 2009, NEW ENGL J MED, V361, P403, DOI 10.1056/NEJMe0905519; Lin FYC, 2001, NEW ENGL J MED, V344, P1263, DOI 10.1056/NEJM200104263441701; Luby SP, 2010, VACCINE, V28, P4903, DOI 10.1016/j.vaccine.2010.05.040; Lutterloh EC, 2012, CLIN INFECT IN PRESS, V55; Mandomando I, 2009, TROP MED INT HEALTH, V14, P1467, DOI 10.1111/j.1365-3156.2009.02399.x; Marks F, 2010, EMERG INFECT DIS, V16, P1796, DOI 10.3201/eid1611.100388; Mweu E, 2008, TROP MED INT HEALTH, V13, P532, DOI 10.1111/j.1365-3156.2008.02031.x; Neil K, 2012, CLIN INFECT IN PRESS, V55; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Patel RB, 2009, NEW ENGL J MED, V361, P741, DOI 10.1056/NEJMp0810878; Rowe B, 1997, CLIN INFECT DIS, V24, pS106, DOI 10.1093/clinids/24.Supplement_1.S106; Siddiqui FJ, 2006, INT J INFECT DIS, V10, P215, DOI 10.1016/j.ijid.2005.03.010; SONG JH, 1993, J CLIN MICROBIOL, V31, P1439, DOI 10.1128/JCM.31.6.1439-1443.1993; Steele D, 2008, J INFECT DEV COUNTR, V2, P250, DOI 10.3855/jidc.217; Sur D, 2009, NEW ENGL J MED, V361, P335, DOI 10.1056/NEJMoa0807521; Tacket CO, 2007, CLIN INFECT DIS, V45, pS20, DOI 10.1086/518135; UN-HABITAT, 2010, STAT AFR CIT 2010 GO, V93; Wain J, 2001, J CLIN MICROBIOL, V39, P1571, DOI 10.1128/JCM.39.4.1571-1576.2001; 2008, RELEVE EPIDEMIOLOGIQ, V83, P49	42	126	126	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29119	10.1371/journal.pone.0029119	http://dx.doi.org/10.1371/journal.pone.0029119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276105	gold, Green Submitted, Green Published			2022-12-27	WOS:000301457200006
J	Clark, JF; Ellis, JK; Bench, J; Khoury, J; Graman, P				Clark, Joseph F.; Ellis, James K.; Bench, Johnny; Khoury, Jane; Graman, Pat			High-Performance Vision Training Improves Batting Statistics for University of Cincinnati Baseball Players	PLOS ONE			English	Article							INFORMATION; BATTERS	Purpose: Baseball requires an incredible amount of visual acuity and eye-hand coordination, especially for the batters. The learning objective of this work is to observe that traditional vision training as part of injury prevention or conditioning can be added to a team's training schedule to improve some performance parameters such as batting and hitting. Methods: All players for the 2010 to 2011 season underwent normal preseason physicals and baseline testing that is standard for the University of Cincinnati Athletics Department. Standard vision training exercises were implemented 6 weeks before the start of the season. Results are reported as compared to the 2009 to 2010 season. Pre season conditioning was followed by a maintenance program during the season of vision training. Results: The University of Cincinnati team batting average increased from 0.251 in 2010 to 0.285 in 2011 and the slugging percentage increased by 0.033. The rest of the Big East's slugging percentage fell over that same time frame 0.082. This produces a difference of 0.115 with 95% confidence interval (0.024, 0.206). As with the batting average, the change for University of Cincinnati is significantly different from the rest of the Big East (p = 0.02). Essentially all batting parameters improved by 10% or more. Similar differences were seen when restricting the analysis to games within the Big East conference. Conclusion: Vision training can combine traditional and technological methodologies to train the athletes' eyes and improve batting. Vision training as part of conditioning or injury prevention can be applied and may improve batting performance in college baseball players. High performance vision training can be instituted in the pre-season and maintained throughout the season to improve batting parameters.	[Clark, Joseph F.] Univ Cincinnati, Dept Neurol, Cincinnati, OH 45221 USA; [Graman, Pat] Univ Cincinnati, Coll Educ Criminal Justice & Human Serv, Cincinnati, OH USA; [Ellis, James K.] Univ Cincinnati, Univ Hlth Serv, Cincinnati, OH USA; [Ellis, James K.] Univ Cincinnati, Dept Athlet, Cincinnati, OH USA; [Clark, Joseph F.; Khoury, Jane] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA; [Bench, Johnny] Stryker Spokesman, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Clark, JF (corresponding author), Univ Cincinnati, Dept Neurol, Cincinnati, OH 45221 USA.	pat.graman@uc.edu	Khoury, Jane/O-2068-2015		National Institutes of Health [EB007954]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB007954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by National Institutes of Health grant EB007954. No additional external funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DELUCIA PR, 1985, PERCEPT MOTOR SKILL, V61, P143, DOI 10.2466/pms.1985.61.1.143; Fleisig GS, 2006, AM J SPORT MED, V34, P423, DOI 10.1177/0363546505280431; GODDARD N, 1994, BRIT MED J, V309, P1684, DOI 10.1136/bmj.309.6970.1684; Gray R, 2009, RES Q EXERCISE SPORT, V80, P491; Helveston EM, 2005, AM J OPHTHALMOL, V140, P903, DOI 10.1016/j.ajo.2005.06.003; Kato T, 2002, PERCEPT MOTOR SKILL, V94, P380, DOI 10.2466/pms.2002.94.2.380; Kirschen DG, 2010, J CATARACT REFR SURG, V36, P396, DOI 10.1016/j.jcrs.2009.09.032; Kirscher D W, 1993, Optom Clin, V3, P171; Laby DM, 1996, AM J OPHTHALMOL, V122, P476, DOI 10.1016/S0002-9394(14)72106-3; Laukkanen Hannu, 2006, Optometry, V77, P508, DOI 10.1016/j.optm.2006.06.008; Reichow AW, 2011, EYE CONTACT LEN 0405; STINE CD, 1982, J AM OPTOM ASSOC, V53, P627; Vesia M, 2008, PERCEPT MOTOR SKILL, V107, P14, DOI 10.2466/PMS.107.1.14-20; Zupan M, 2011, TRAINING CONDITIONIN, V21, P11	14	81	81	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29109	10.1371/journal.pone.0029109	http://dx.doi.org/10.1371/journal.pone.0029109			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276103	Green Submitted, gold, Green Published			2022-12-27	WOS:000301457200005
J	Derrien, T; Estelle, J; Sola, SM; Knowles, DG; Raineri, E; Guigo, R; Ribeca, P				Derrien, Thomas; Estelle, Jordi; Marco Sola, Santiago; Knowles, David G.; Raineri, Emanuele; Guigo, Roderic; Ribeca, Paolo			Fast Computation and Applications of Genome Mappability	PLOS ONE			English	Article							RNA-SEQ; SEGMENTAL DUPLICATIONS; EVOLUTION; ELEMENTS; STRATEGY	We present a fast mapping-based algorithm to compute the mappability of each region of a reference genome up to a specified number of mismatches. Knowing the mappability of a genome is crucial for the interpretation of massively parallel sequencing experiments. We investigate the properties of the mappability of eukaryotic DNA/RNA both as a whole and at the level of the gene family, providing for various organisms tracks which allow the mappability information to be visually explored. In addition, we show that mappability varies greatly between species and gene classes. Finally, we suggest several practical applications where mappability can be used to refine the analysis of high-throughput sequencing data (SNP calling, gene expression quantification and paired-end experiments). This work highlights mappability as an important concept which deserves to be taken into full account, in particular when massively parallel sequencing technologies are employed. The GEM mappability program belongs to the GEM (GEnome Multitool) suite of programs, which can be freely downloaded for any use from its website (http://gemlibrary.sourceforge.net).	[Derrien, Thomas] Univ Rennes 1, Inst Genet & Dev IGDR, Rennes, France; [Estelle, Jordi; Marco Sola, Santiago; Raineri, Emanuele; Ribeca, Paolo] CNAG, Barcelona, Spain; [Knowles, David G.; Guigo, Roderic] Univ Pompeu Fabra, CRG, Barcelona, Spain	Universite de Rennes; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Derrien, T (corresponding author), Univ Rennes 1, Inst Genet & Dev IGDR, Rennes, France.	toma.derrien@gmail.com; paolo.ribeca@gmail.com	Estellé, Jordi/A-7976-2008; Marco-Sola, Santiago/AAB-1471-2020; Raineri, Emanuele/AAX-7874-2020; Guigo, Roderic/D-1303-2010; Derrien, Thomas/ABD-6197-2020	Estellé, Jordi/0000-0002-6241-1732; Marco-Sola, Santiago/0000-0001-7951-3914; Guigo, Roderic/0000-0002-5738-4477; Derrien, Thomas/0000-0002-8211-5789	Spanish Ministerio de Educacion y Ciencia [BIO2006-03380, CONSOLIDER CSD2007-00050]	Spanish Ministerio de Educacion y Ciencia(Spanish Government)	This work has been partially supported by grants BIO2006-03380 (to RG) and CONSOLIDER CSD2007-00050 (to RG and PR) from the Spanish Ministerio de Educacion y Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Burrows M, 1994, ALGORITHM DATA COMPR, V1, P18; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Du J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000432; Faulkner GJ, 2008, GENOMICS, V91, P281, DOI 10.1016/j.ygeno.2007.11.003; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Huda A, 2009, GENE, V436, P12, DOI 10.1016/j.gene.2009.01.013; KAMINKER JS, 2002, GENOME BIOL, V0003; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Lee S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1015; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; OHNO S, 1993, CURR OPIN GENET DEV, V3, P911, DOI 10.1016/0959-437X(93)90013-F; Ohno S, 1987, Haematol Blood Transfus, V31, P511; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pasaniuc B, 2011, J COMPUT BIOL, V18, P459, DOI 10.1089/cmb.2010.0259; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Smit A, 1996, REPEATMASKER OPEN 30; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang J, 2010, BIOINFORMATICS, V26, P2501, DOI 10.1093/bioinformatics/btq460; Whiteford N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni170	35	303	338	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30377	10.1371/journal.pone.0030377	http://dx.doi.org/10.1371/journal.pone.0030377			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276185	Green Published, Green Submitted, gold			2022-12-27	WOS:000301457200055
J	Jovov, B; Araujo-Perez, F; Sigel, CS; Stratford, JK; McCoy, AN; Yeh, JJ; Keku, T				Jovov, Biljana; Araujo-Perez, Felix; Sigel, Carlie S.; Stratford, Jeran K.; McCoy, Amber N.; Yeh, Jen Jen; Keku, Temitope			Differential Gene Expression between African American and European American Colorectal Cancer Patients	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; PROSTATE-CANCER; NORMAL COLON; TUMOR; PROTEIN; PATHWAY; RNA	The incidence and mortality of colorectal cancer (CRC) is higher in African Americans (AAs) than other ethnic groups in the U. S., but reasons for the disparities are unknown. We performed gene expression profiling of sporadic CRCs from AAs vs. European Americans (EAs) to assess the contribution to CRC disparities. We evaluated the gene expression of 43 AA and 43 EA CRC tumors matched by stage and 40 matching normal colorectal tissues using the Agilent human whole genome 4x44K cDNA arrays. Gene and pathway analyses were performed using Significance Analysis of Microarrays (SAM), Ten- fold cross validation, and Ingenuity Pathway Analysis (IPA). SAM revealed that 95 genes were differentially expressed between AA and EA patients at a false discovery rate of <= 5%. Using IPA we determined that most prominent disease and pathway associations of differentially expressed genes were related to inflammation and immune response. Ten- fold cross validation demonstrated that following 10 genes can predict ethnicity with an accuracy of 94%: CRYBB2, PSPH, ADAL, VSIG10L, C17orf81, ANKRD36B, ZNF835, ARHGAP6, TRNT1 and WDR8. Expression of these 10 genes was validated by qRT- PCR in an independent test set of 28 patients (10 AA, 18 EA). Our results are the first to implicate differential gene expression in CRC racial disparities and indicate prominent difference in CRC inflammation between AA and EA patients. Differences in susceptibility to inflammation support the existence of distinct tumor microenvironments in these two patient populations.	[Jovov, Biljana; Araujo-Perez, Felix; McCoy, Amber N.; Keku, Temitope] Univ N Carolina, Dept Med Gastroenterol, Chapel Hill, NC 27515 USA; [Sigel, Carlie S.] Univ N Carolina, Dept Pathol, Chapel Hill, NC USA; [Stratford, Jeran K.; Yeh, Jen Jen] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Yeh, Jen Jen] Univ N Carolina, Dept Surg, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Jovov, B (corresponding author), Univ N Carolina, Dept Med Gastroenterol, Chapel Hill, NC 27515 USA.	bjovov@med.unc.edu		Stratford, Jeran/0000-0003-4305-1468	Gastrointestinal Specialized Program of Research Excellence (GI SPORE) [P50 106991]; University of North Carolina Center for Gastrointestinal Biology and Disease (CGIBD) [P30 DK 34987]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	Gastrointestinal Specialized Program of Research Excellence (GI SPORE); University of North Carolina Center for Gastrointestinal Biology and Disease (CGIBD); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by grant funding for Gastrointestinal Specialized Program of Research Excellence (GI SPORE, P50 106991) and by the University of North Carolina Center for Gastrointestinal Biology and Disease (CGIBD, P30 DK 34987). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander Dominik D., 2007, Cancer Biomarkers, V3, P301; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Ashktorab H, 2003, CLIN CANCER RES, V9, P1112; Brim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020216; Camp JT, 2011, MOL CANCER RES, V9, P3, DOI 10.1158/1541-7786.MCR-10-0372; Choi JS, 2006, LUNG, V184, P355, DOI 10.1007/s00408-006-0009-0; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Devaraj B, 2010, J GASTROINTEST SURG, V14, P1521, DOI 10.1007/s11605-010-1340-6; Dybkaer K, 2004, BIOTECHNIQUES, V37, P470, DOI 10.2144/04373RT03; Eaton AM, 2005, CANCER EPIDEM BIOMAR, V14, P2023, DOI 10.1158/1055-9965.EPI-05-0131; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones BA, 2009, CANCER EPIDEMIOL, V33, P249, DOI 10.1016/j.canep.2009.08.004; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Katkoori VR, 2009, CLIN CANCER RES, V15, P2406, DOI 10.1158/1078-0432.CCR-08-1719; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Kupfer SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026123; Kupfer SS, 2010, GASTROENTEROLOGY, V139, P1677, DOI 10.1053/j.gastro.2010.07.038; Kurashina K, 2008, CANCER SCI, V99, P1835, DOI 10.1111/j.1349-7006.2008.00881.x; Litt M, 1997, HUM MOL GENET, V6, P665, DOI 10.1093/hmg/6.5.665; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Mori R, 2009, PROSTATE, V69, P12, DOI 10.1002/pros.20851; Nagaike T, 2001, J BIOL CHEM, V276, P40041, DOI 10.1074/jbc.M106202200; Notterman DA, 2001, CANCER RES, V61, P3124; Ollberding NJ, 2010, INT J CANC; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Prakash SK, 2000, HUM MOL GENET, V9, P477, DOI 10.1093/hmg/9.4.477; Roff A, 2008, J STEROID BIOCHEM, V112, P47, DOI 10.1016/j.jsbmb.2008.08.009; Round JL, 2007, NAT IMMUNOL, V8, P154, DOI 10.1038/ni1422; Saaf AM, 2007, MOL BIOL CELL, V18, P4245, DOI 10.1091/mbc.E07-04-0309; Secher T, 2010, CANCER RES, V70, P1749, DOI 10.1158/0008-5472.CAN-09-3401; Tan EH, 2010, ANN ONCOL, V21, P217, DOI 10.1093/annonc/mdp520; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vinikoor LC, 2009, NUTR CANCER, V61, P427, DOI 10.1080/01635580802710725; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Westbrook AM, 2010, MUTAT RES-REV MUTAT, V705, P40, DOI 10.1016/j.mrrev.2010.03.001; Williams CD, 2010, CANCER CAUSE CONTROL, V21, P1171, DOI 10.1007/s10552-010-9544-3; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	40	68	68	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30168	10.1371/journal.pone.0030168	http://dx.doi.org/10.1371/journal.pone.0030168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276153	Green Published, gold			2022-12-27	WOS:000301457200037
J	Satoh, R; Tanaka, A; Kita, A; Morita, T; Matsumura, Y; Umeda, N; Takada, M; Hayashi, S; Tani, T; Shinmyozu, K; Sugiura, R				Satoh, Ryosuke; Tanaka, Akitomo; Kita, Ayako; Morita, Takahiro; Matsumura, Yasuhiro; Umeda, Nanae; Takada, Makoto; Hayashi, Sachiko; Tani, Tokio; Shinmyozu, Kaori; Sugiura, Reiko			Role of the RNA-Binding Protein Nrd1 in Stress Granule Formation and Its Implication in the Stress Response in Fission Yeast	PLOS ONE			English	Article							REGULATES CELL INTEGRITY; MESSENGER-RNA; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; SEXUAL-DIFFERENTIATION; KINASE; GENE; TIA-1; ACCUMULATION; TRANSLATION	We have previously identified the RNA recognition motif (RRM)-type RNA-binding protein Nrd1 as an important regulator of the posttranscriptional expression of myosin in fission yeast. Pmk1 MAPK-dependent phosphorylation negatively regulates the RNA-binding activity of Nrd1. Here, we report the role of Nrd1 in stress-induced RNA granules. Nrd1 can localize to poly(A)-binding protein (Pabp)-positive RNA granules in response to various stress stimuli, including heat shock, arsenite treatment, and oxidative stress. Interestingly, compared with the unphosphorylatable Nrd1, Nrd1(DD) (phosphorylation-mimic version of Nrd1) translocates more quickly from the cytoplasm to the stress granules in response to various stimuli; this suggests that the phosphorylation of Nrd1 by MAPK enhances its localization to stress-induced cytoplasmic granules. Nrd1 binds to Cpc2 (fission yeast RACK) in a phosphorylation-dependent manner and deletion of Cpc2 affects the formation of Nrd1-positive granules upon arsenite treatment. Moreover, the depletion of Nrd1 leads to a delay in Pabp-positive RNA granule formation, and overexpression of Nrd1 results in an increased size and number of Pabp-positive granules. Interestingly, Nrd1 deletion induced resistance to sustained stresses and enhanced sensitivity to transient stresses. In conclusion, our results indicate that Nrd1 plays a role in stress-induced granule formation, which affects stress resistance in fission yeast.	[Satoh, Ryosuke; Tanaka, Akitomo; Kita, Ayako; Morita, Takahiro; Matsumura, Yasuhiro; Umeda, Nanae; Takada, Makoto; Sugiura, Reiko] Kinki Univ, Lab Mol Pharmacogen, Sch Pharmaceut Sci, Osaka, Japan; [Satoh, Ryosuke] Japan Soc Promot Sci, Tokyo, Japan; [Hayashi, Sachiko; Tani, Tokio] Kumamoto Univ, Dept Biol Sci, Grad Sch Sci & Technol, Kumamoto, Japan; [Shinmyozu, Kaori] RIKEN Ctr Dev Biol, Prote Support Unit, Hyogo, Japan	Kindai University (Kinki University); Japan Society for the Promotion of Science; Kumamoto University; RIKEN	Satoh, R (corresponding author), Kinki Univ, Lab Mol Pharmacogen, Sch Pharmaceut Sci, Osaka, Japan.	sugiurar@phar.kindai.ac.jp	Hayashi, Sachiko/ABF-8191-2020	Hayashi, Sachiko/0000-0003-4606-9057; Satoh, Ryosuke/0000-0002-7467-0096	Ministry of Education, Culture, Sports, Science and Technology of Japan [20112006]; Academic Frontier Project for Private Universities; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [10J05817] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Academic Frontier Project for Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to R. Sugiura). This work was also supported by a Grant-in-Aid for Scientific Research on Innovative Areas RNA regulation (No. 20112006) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to R. Sugiura). This work was also supported in part by the Academic Frontier Project for Private Universities: matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Azad AK, 1997, MOL BIOL CELL, V8, P825, DOI 10.1091/mbc.8.5.825; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Jeong HT, 2004, BIOSCI BIOTECH BIOCH, V68, P1621, DOI 10.1271/bbb.68.1621; Jeong HT, 2004, GENETICS, V167, P77, DOI 10.1534/genetics.167.1.77; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nilsson D, 2011, RNA, V17, P120, DOI 10.1261/rna.2268111; Nunez A, 2010, J BIOL CHEM, V285, P41366, DOI 10.1074/jbc.M110.173815; Nunez A, 2009, MOL BIOL CELL, V20, P3996, DOI 10.1091/mbc.E09-05-0388; Oowatari Y, 2011, CURR GENET, V57, P191, DOI 10.1007/s00294-011-0335-5; Satoh R, 2009, MOL BIOL CELL, V20, P2473, DOI 10.1091/mbc.E08-09-0893; Sio SO, 2005, J BIOL CHEM, V280, P12231, DOI 10.1074/jbc.M414234200; Takada H, 2007, MOL BIOL CELL, V18, P4794, DOI 10.1091/mbc.E07-03-0282; TANI T, 1995, MOL BIOL CELL, V6, P1515, DOI 10.1091/mbc.6.11.1515; Toda T, 1996, MOL CELL BIOL, V16, P6752; Tsukahara K, 1998, MOL CELL BIOL, V18, P4488, DOI 10.1128/MCB.18.8.4488; Tvegard T, 2007, GENE DEV, V21, P649, DOI 10.1101/gad.421807; Udagawa T, 2008, J BIOL CHEM, V283, P22063, DOI 10.1074/jbc.M710017200; Wen WL, 2010, NUCLEIC ACIDS RES, V38, P6555, DOI 10.1093/nar/gkq555; Yamamoto H, 1999, MOL CELL BIOL, V19, P3829	33	20	23	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29683	10.1371/journal.pone.0029683	http://dx.doi.org/10.1371/journal.pone.0029683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276125	Green Published, gold, Green Submitted			2022-12-27	WOS:000301457200019
J	Benz, C; Clucas, C; Mottram, JC; Hammarton, TC				Benz, Corinna; Clucas, Caroline; Mottram, Jeremy C.; Hammarton, Tansy C.			Cytokinesis in Bloodstream Stage Trypanosoma brucei Requires a Family of Katanins and Spastin	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; CELL-DIVISION; SEVERING ACTIVITY; INDUCIBLE EXPRESSION; TUMOR-SUPPRESSOR; RNA INTERFERENCE; ALPHA-TUBULIN; SPINDLE POLE; P80 KATANIN; LIFE-CYCLE	Microtubule severing enzymes regulate microtubule dynamics in a wide range of organisms and are implicated in important cell cycle processes such as mitotic spindle assembly and disassembly, chromosome movement and cytokinesis. Here we explore the function of several microtubule severing enzyme homologues, the katanins (KAT80, KAT60a, KAT60b and KAT60c), spastin (SPA) and fidgetin (FID) in the bloodstream stage of the African trypanosome parasite, Trypanosoma brucei. The trypanosome cytoskeleton is microtubule based and remains assembled throughout the cell cycle, necessitating its remodelling during cytokinesis. Using RNA interference to deplete individual proteins, we show that the trypanosome katanin and spastin homologues are non-redundant and essential for bloodstream form proliferation. Further, cell cycle analysis revealed that these proteins play essential but discrete roles in cytokinesis. The KAT60 proteins each appear to be important during the early stages of cytokinesis, while downregulation of KAT80 specifically inhibited furrow ingression and SPA depletion prevented completion of abscission. In contrast, RNA interference of FID did not result in any discernible effects. We propose that the stable microtubule cytoskeleton of T. brucei necessitates the coordinated action of a family of katanins and spastin to bring about the cytoskeletal remodelling necessary to complete cell division.	[Benz, Corinna; Clucas, Caroline; Mottram, Jeremy C.; Hammarton, Tansy C.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Glasgow	Benz, C (corresponding author), Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	Tansy.Hammarton@glasgow.ac.uk	Benz, Corinna/AAD-8702-2021; Hammarton, Tansy/A-5632-2011	Benz, Corinna/0000-0003-4367-2758; Hammarton, Tansy/0000-0002-0799-6600; Mottram, Jeremy/0000-0001-5574-3766	Medical Research Council [G120/1001]; New Investigator Research Grant [GO900239]; Research Councils UK; Wellcome Trust [070231, 084546/Z/07/Z]; Medical Research Council [G0700127, G0900239] Funding Source: researchfish; MRC [G0900239, G120/1001, G0700127] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); New Investigator Research Grant; Research Councils UK(UK Research & Innovation (UKRI)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council (via a Career Development Fellowship (ref. G120/1001) and New Investigator Research Grant (ref. GO900239) to TCH), Research Councils UK (Academic Fellowship to TCH) and The Wellcome Trust (Project grant ref. 070231 to JCM and TCH, and Value In People funding ref. 084546/Z/07/Z to TCH for CB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Ahmad FJ, 1999, J CELL BIOL, V145, P305, DOI 10.1083/jcb.145.2.305; Baines A, 2008, PROTIST, V159, P115, DOI 10.1016/j.protis.2007.09.001; BALABAN N, 1992, CELL MOTIL CYTOSKEL, V21, P138, DOI 10.1002/cm.970210207; BALABAN N, 1989, CELL MOTIL CYTOSKEL, V14, P393, DOI 10.1002/cm.970140309; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Benz C, 2007, MOL BIOCHEM PARASIT, V156, P217, DOI 10.1016/j.molbiopara.2007.08.005; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Buster D, 2002, J CELL SCI, V115, P1083; Casanova M, 2009, MOL MICROBIOL, V71, P1353, DOI 10.1111/j.1365-2958.2009.06594.x; Chan KY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001050; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; Detmer E, 1997, EUR J CELL BIOL, V72, P378; Diaz-Valencia JD, 2011, BIOPHYS J, V100, P2440, DOI 10.1016/j.bpj.2011.03.062; Dow MR, 1998, GENETICS, V150, P119; Dymek EE, 2004, EUKARYOT CELL, V3, P870, DOI 10.1128/EC.3.4.870-879.2004; Errico A, 2004, HUM MOL GENET, V13, P2121, DOI 10.1093/hmg/ddh223; Evans KJ, 2005, J CELL BIOL, V168, P599, DOI 10.1083/jcb.200409058; Forsythe GR, 2009, MOL BIOCHEM PARASIT, V164, P131, DOI 10.1016/j.molbiopara.2008.12.008; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Hammarton TC, 2007, CURR OPIN MICROBIOL, V10, P520, DOI 10.1016/j.mib.2007.10.005; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Hammarton TC, 2005, MOL MICROBIOL, V56, P104, DOI 10.1111/j.1365-2958.2005.04542.x; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; HEMPHILL A, 1991, J STRUCT BIOL, V107, P211, DOI 10.1016/1047-8477(91)90046-Y; Hertz-Fowler C, 2001, MOL BIOCHEM PARASIT, V116, P25, DOI 10.1016/S0166-6851(01)00296-1; Karabay A, 2004, J NEUROSCI, V24, P5778, DOI 10.1523/JNEUROSCI.1382-04.2004; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Kohl L, 1998, MOL BIOCHEM PARASIT, V93, P1, DOI 10.1016/S0166-6851(98)00014-0; LaCount DJ, 2000, MOL BIOCHEM PARASIT, V111, P67, DOI 10.1016/S0166-6851(00)00300-5; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; Lee HH, 2009, P NATL ACAD SCI USA, V106, P6363, DOI 10.1073/pnas.0902051106; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003814; Lillico S, 2003, MOL BIOL CELL, V14, P1182, DOI 10.1091/mbc.E02-03-0167; Lu CG, 2007, DEV BIOL, V302, P438, DOI 10.1016/j.ydbio.2006.09.053; Ma JT, 2010, J BIOL CHEM, V285, P15356, DOI 10.1074/jbc.M109.074591; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally FJ, 1998, MOL BIOL CELL, V9, P1847, DOI 10.1091/mbc.9.7.1847; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; McNally KP, 2011, MOL BIOL CELL, V22, P1550, DOI 10.1091/mbc.E10-12-0951; McNally KP, 2002, CELL MOTIL CYTOSKEL, V53, P337, DOI 10.1002/cm.10080; McNally KP, 2000, J CELL SCI, V113, P1623; Meng QT, 2010, PLANT MOL BIOL, V74, P537, DOI 10.1007/s11103-010-9694-4; Monnerat Severine, 2009, BMC Res Notes, V2, P46, DOI 10.1186/1756-0500-2-46; MUNDAY JC, 2010, MOL BIOCHEM PARASIT, pS166; Olego-Fernandez S, 2009, PROTIST, V160, P576, DOI 10.1016/j.protis.2009.05.003; Panteris E, 2011, CYTOSKELETON, V68, P401, DOI 10.1002/cm.20522; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Price HP, 2010, MOL BIOCHEM PARASIT, V173, P123, DOI 10.1016/j.molbiopara.2010.05.016; Qiang L, 2006, J NEUROSCI, V26, P3120, DOI 10.1523/JNEUROSCI.5392-05.2006; Rasi MQ, 2009, MOL BIOL CELL, V20, P379, DOI 10.1091/mbc.E07-10-1007; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; RINDISBACHER L, 1993, MOL BIOCHEM PARASIT, V58, P83, DOI 10.1016/0166-6851(93)90093-D; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Roll-Mecak A, 2005, CURR BIOL, V15, P650, DOI 10.1016/j.cub.2005.02.029; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; SASSE R, 1988, J CELL SCI, V90, P577; Schiel JA, 2011, J CELL SCI, V124, P1411, DOI 10.1242/jcs.081448; SCHNEIDER A, 1987, J CELL BIOL, V104, P431, DOI 10.1083/jcb.104.3.431; SCHNEIDER A, 1988, SCIENCE, V241, P459, DOI 10.1126/science.3393912; Sharma N, 2007, J CELL BIOL, V178, P1065, DOI 10.1083/jcb.200704021; Sharma R, 2008, PROTIST, V159, P137, DOI 10.1016/j.protis.2007.07.004; SHERWIN T, 1989, CELL, V57, P211, DOI 10.1016/0092-8674(89)90959-8; SHERWIN T, 1987, J CELL BIOL, V104, P439, DOI 10.1083/jcb.104.3.439; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Spitznagel D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012282; Srayko M, 2000, GENE DEV, V14, P1072; Sudo H, 2008, HUM MOL GENET, V17, P2524, DOI 10.1093/hmg/ddn153; Sudo H, 2007, FASEB J, V21, P2086, DOI 10.1096/fj.06-7254com; Sudo H, 2010, J NEUROSCI, V30, P7215, DOI 10.1523/JNEUROSCI.0048-10.2010; Toyo-Oka K, 2005, HUM MOL GENET, V14, P3113, DOI 10.1093/hmg/ddi339; Van den Abbeele J, 1999, PARASITOLOGY, V118, P469, DOI 10.1017/S0031182099004217; Vaughan S, 2008, BIOCHEM SOC T, V36, P421, DOI 10.1042/BST0360421; Vedrenne C, 2002, MOL BIOL CELL, V13, P1058, DOI 10.1091/mbc.01-06-0298; Wickstead B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015020; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODS A, 1992, J CELL SCI, V103, P665; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878; Yu WQ, 2005, J NEUROSCI, V25, P5573, DOI 10.1523/JNEUROSCI.0834-05.2005; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011; Zhang D, 2011, NAT CELL BIOL, V13, P361, DOI 10.1038/ncb2206	88	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30367	10.1371/journal.pone.0030367	http://dx.doi.org/10.1371/journal.pone.0030367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279588	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000299771900065
J	Fritz, HM; Bowyer, PW; Bogyo, M; Conrad, PA; Boothroyd, JC				Fritz, Heather M.; Bowyer, Paul W.; Bogyo, Matthew; Conrad, Patricia A.; Boothroyd, John C.			Proteomic Analysis of Fractionated Toxoplasma Oocysts Reveals Clues to Their Environmental Resistance	PLOS ONE			English	Article							PARASITOPHOROUS VACUOLE MEMBRANE; GONDII OOCYSTS; EIMERIA-MAXIMA; WALL FORMATION; APPLE DOMAINS; WATERBORNE TOXOPLASMOSIS; PROTEIN IDENTIFICATIONS; APICOMPLEXAN PARASITES; MASS-SPECTROMETRY; STAGE CONVERSION	Toxoplasma gondii is an obligate intracellular parasite that is unique in its ability to infect a broad range of birds and mammals, including humans, leading to an extremely high worldwide prevalence and distribution. This work focuses on the environmentally resistant oocyst, which is the product of sexual replication in felids and an important source of human infection. Due to the difficulty in producing and working with oocysts, relatively little is known about how this stage is able to resist extreme environmental stresses and how they initiate a new infection, once ingested. To fill this gap, the proteome of the wall and sporocyst/sporozoite fractions of mature, sporulated oocysts were characterized using one-dimensional gel electrophoresis followed by LC-MS/MS on trypsin-digested peptides. A combined total of 1021 non-redundant T. gondii proteins were identified in the sporocyst/sporozoite fraction and 226 were identified in the oocyst wall fraction. Significantly, 172 of the identified proteins have not previously been identified in Toxoplasma proteomic studies. Among these are several of interest for their likely role in conferring environmental resistance including a family of small, tyrosinerich proteins present in the oocyst wall fractions and late embryogenesis abundant domain-containing (LEA) proteins in the cytosolic fractions. The latter are known from other systems to be key to enabling survival against desiccation.	[Fritz, Heather M.; Conrad, Patricia A.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA; [Bowyer, Paul W.; Bogyo, Matthew; Boothroyd, John C.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Bowyer, Paul W.; Bogyo, Matthew] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	University of California System; University of California Davis; Stanford University; Stanford University	Fritz, HM (corresponding author), Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA.	paconrad@ucdavis.edu; john.boothroyd@stanford.edu		Boothroyd, John C./0000-0001-9719-745X; Bogyo, Matthew/0000-0003-3753-4412; /0000-0002-4046-9191	National Institutes of Health (NIH) [AI41014, AI21423, RR07038, R01 AI078947]; EuPathDB.org; National Science Foundation/EID [1065990]; National Center For Research Resources [K01RR031487]; Burroughs Wellcome New Investigator in Pathogenesis Award; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR031487, T32RR007038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041014, R37AI021423, R01AI021423, R01AI078947] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD010917] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EuPathDB.org; National Science Foundation/EID; National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Burroughs Wellcome New Investigator in Pathogenesis Award(Burroughs Wellcome Fund); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grants AI41014, AI21423 and a Eukaryotic Pathogens - Driving Biological Projects grant (EuPathDB.org). Oocyst production was funded by National Science Foundation/EID grant # 1065990. HF was supported by NIH T32 grant # RR07038 and Award Number K01RR031487 from the National Center For Research Resources. PB and MB were supported by NIH Grant R01 AI078947 (to MB) and a Burroughs Wellcome New Investigator in Pathogenesis Award (to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AG USEP, 1999, COMB SEW OV TECHN FA; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; [Anonymous], [No title captured]; Aramini JJ, 1999, EPIDEMIOL INFECT, V122, P305, DOI 10.1017/S0950268899002113; Bahia-Oliveira LMG, 2003, EMERG INFECT DIS, V9, P55; BECKERS CJM, 1994, J CELL BIOL, V127, P947, DOI 10.1083/jcb.127.4.947; Behnke MS, 2011, P NATL ACAD SCI USA, V108, P9631, DOI 10.1073/pnas.1015338108; Belli SI, 2003, GENE, V307, P201, DOI 10.1016/S0378-1119(03)00451-7; Belli SI, 2002, INT J PARASITOL, V32, P1727, DOI 10.1016/S0020-7519(02)00212-6; Belli SI, 2003, EUKARYOT CELL, V2, P456, DOI 10.1128/EC.2.3.456-464.2003; BENENSON MW, 1982, NEW ENGL J MED, V307, P666, DOI 10.1056/NEJM198209093071107; Blumenschein TMA, 2007, EMBO J, V26, P2808, DOI 10.1038/sj.emboj.7601704; Bowie WR, 1997, LANCET, V350, P173, DOI 10.1016/S0140-6736(96)11105-3; Bowyer PW, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001636; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Brown PJ, 2001, FEBS LETT, V497, P31, DOI 10.1016/S0014-5793(01)02424-3; Che FY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000745; Dabritz HA, 2010, ZOONOSES PUBLIC HLTH, V57, P34, DOI 10.1111/j.1863-2378.2009.01273.x; Dabritz HA, 2007, JAVMA-J AM VET MED A, V231, P1676, DOI 10.2460/javma.231.11.1676; de Moura L, 2006, EMERG INFECT DIS, V12, P326, DOI 10.3201/eid1202.041115; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Dubey JP, 1996, J PARASITOL, V82, P438, DOI 10.2307/3284082; DUBEY JP, 1972, J PARASITOL, V58, P1005, DOI 10.2307/3286603; Dumetre A, 2005, J MICROBIOL METH, V61, P209, DOI 10.1016/j.mimet.2004.11.024; Dumetre A, 2003, FEMS MICROBIOL REV, V27, P651, DOI 10.1016/S0168-6445(03)00071-8; Dumetre A, 2008, VET PARASITOL, V153, P209, DOI 10.1016/j.vetpar.2008.02.004; Dybas JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003899; El Hajj H, 2007, PLOS PATHOG, V3, P200, DOI 10.1371/journal.ppat.0030014; El Hajj H, 2007, CELL MICROBIOL, V9, P54, DOI 10.1111/j.1462-5822.2006.00767.x; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Everson WV, 2002, J EUKARYOT MICROBIOL, V49, P344, DOI 10.1111/j.1550-7408.2002.tb00381.x; Ferguson DJP, 2002, INT J PARASITOL, V32, P1399, DOI 10.1016/S0020-7519(02)00129-7; Ferguson DJP, 2004, INT J PARASITOL, V34, P347, DOI 10.1016/j.ijpara.2003.11.024; Friedrich N, 2010, J BIOL CHEM, V285, P2064, DOI 10.1074/jbc.M109.060988; FRITZ H, 2011, J MICROBIOL METHODS; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Hill D, 2011, J PARASITOL, V97, P328, DOI 10.1645/GE-2782.1; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Kim K, 2008, MICROBES INFECT, V10, P978, DOI 10.1016/j.micinf.2008.07.015; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; Kuticic V, 1996, CURR TOP MICROBIOL, V219, P261; Kwok LY, 2004, MOL MICROBIOL, V51, P47, DOI 10.1046/j.1365-2958.2003.03823.x; Lindsay DS, 2009, J PARASITOL, V95, P1019, DOI 10.1645/GE-1919.1; Lindsay DS, 2002, VET PARASITOL, V103, P309, DOI 10.1016/S0304-4017(01)00554-4; Mai K, 2009, MEM I OSWALDO CRUZ, V104, P281, DOI 10.1590/S0074-02762009000200022; Mercier C, 2005, INT J PARASITOL, V35, P829, DOI 10.1016/j.ijpara.2005.03.011; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Pernas L, 2010, INT J PARASITOL, V40, P1367, DOI 10.1016/j.ijpara.2010.07.002; Possenti A, 2010, INT J PARASITOL, V40, P1639, DOI 10.1016/j.ijpara.2010.06.009; Radke JR, 2004, MOL MICROBIOL, V52, P93, DOI 10.1111/j.1365-2958.2003.03967.x; Reese ML, 2009, TRAFFIC, V10, P1458, DOI 10.1111/j.1600-0854.2009.00958.x; REESE ML, 2011, J BIOL CHEM; Reiss M, 2001, J CELL BIOL, V152, P563, DOI 10.1083/jcb.152.3.563; Rejmanek D, 2010, J PARASITOL, V96, P516, DOI 10.1645/GE-2372.1; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; SIBLEY LD, 1995, J CELL SCI, V108, P1669; Sinai AP, 2001, J CELL BIOL, V154, P95, DOI 10.1083/jcb.200101073; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Tilley M, 1997, INFECT IMMUN, V65, P4598, DOI 10.1128/IAI.65.11.4598-4605.1997; Tomavo S, 2001, INT J PARASITOL, V31, P1023, DOI 10.1016/S0020-7519(01)00193-X; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Wainwright KE, 2007, J PARASITOL, V93, P925, DOI 10.1645/GE-1063R.1; Wainwright KE, 2007, APPL ENVIRON MICROB, V73, P5663, DOI 10.1128/AEM.00504-07; Xia D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r116; Zhou XW, 2005, J BIOL CHEM, V280, P34233, DOI 10.1074/jbc.M504160200; [No title captured]; CHEREMISINOFF NHOWAW	70	77	85	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29955	10.1371/journal.pone.0029955	http://dx.doi.org/10.1371/journal.pone.0029955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279555	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000299771900033
J	Mendonca, A; Aristegui, J; Vilas, JC; Montero, MF; Ojeda, A; Espino, M; Martins, A				Mendonca, Ana; Aristegui, Javier; Carlos Vilas, Juan; Fernanda Montero, Maria; Ojeda, Alicia; Espino, Minerva; Martins, Ana			Is There a Seamount Effect on Microbial Community Structure and Biomass? The Case Study of Seine and Sedlo Seamounts (Northeast Atlantic)	PLOS ONE			English	Article							PLANKTON RESPIRATION; FLOW-CYTOMETRY; CELL-VOLUME; PICOPLANKTON; BALANCE; PHYTOPLANKTON; BACTERIA; OCEAN; PHOTOSYNTHESIS; METABOLISM	Seamounts are considered to be "hotspots" of marine life but, their role in oceans primary productivity is still under discussion. We have studied the microbial community structure and biomass of the epipelagic zone (0-150 m) at two northeast Atlantic seamounts (Seine and Sedlo) and compared those with the surrounding ocean. Results from two cruises to Sedlo and three to Seine are presented. Main results show large temporal and spatial microbial community variability on both seamounts. Both Seine and Sedlo heterotrophic community (abundance and biomass) dominate during winter and summer months, representing 75% (Sedlo, July) to 86% (Seine, November) of the total plankton biomass. In Seine, during springtime the contribution to total plankton biomass is similar (47% autotrophic and 53% heterotrophic). Both seamounts present an autotrophic community structure dominated by small cells (nano and picophytoplankton). It is also during spring that a relatively important contribution (26%) of large cells to total autotrophic biomass is found. In some cases, a 'seamount effect" is observed on Seine and Sedlo microbial community structure and biomass. In Seine this is only observed during spring through enhancement of large autotrophic cells at the summit and seamount stations. In Sedlo, and despite the observed low biomasses, some clear peaks of picoplankton at the summit or at stations within the seamount area are also observed during summer. Our results suggest that the dominance of heterotrophs is presumably related to the trapping effect of organic matter by seamounts. Nevertheless, the complex circulation around both seamounts with the presence of different sources of mesoscale variability (e.g. presence of meddies, intrusion of African upwelling water) may have contributed to the different patterns of distribution, abundances and also changes observed in the microbial community.	[Mendonca, Ana; Martins, Ana] Univ Azores, Dept Oceanog & Fisheries, Horta, Portugal; [Aristegui, Javier; Carlos Vilas, Juan; Fernanda Montero, Maria; Espino, Minerva] Univ Las Palmas Gran Canaria, Inst Oceanog & Cambio Global, Gran Canaria, Spain; [Ojeda, Alicia] Inst Canario Ciencias Marinas, Gran Canaria, Spain	Universidade dos Acores; Universidad de Las Palmas de Gran Canaria	Mendonca, A (corresponding author), Univ Azores, Dept Oceanog & Fisheries, Horta, Portugal.	amendonca@uac.pt	da Silva Fernandes Martins, Ana Maria de Pinho Ferreira/X-8053-2019; Arístegui, Javier/D-5833-2013; Martins, Ana/E-3200-2010	da Silva Fernandes Martins, Ana Maria de Pinho Ferreira/0000-0002-4169-8201; Arístegui, Javier/0000-0002-7526-7741; Martins, Ana/0000-0002-4169-8201; Montero, Maria F./0000-0001-8124-8136	OASIS [EVK3-2001-00152]; CIMBA [3.3.44 (46-03-03-FDR-00043)]; ESA/FCT [PDCTE/CTA/49965/2003]; DRCT [DRCT-M2.1.2/F/008/2007]; one Doctoral Fellowship [UAc/DRCT/REF. U&D/MED.M3.1.1/I/003/2005/A]	OASIS; CIMBA; ESA/FCT; DRCT; one Doctoral Fellowship	Funding was obtained through scientific projects: Project OASIS (EVK3-2001-00152); Project CIMBA 3.3.44 (46-03-03-FDR-00043) PRODESA; ESA/FCT project OPALINA (PDCTE/CTA/49965/2003); DRCT project LAMAR (DRCT-M2.1.2/F/008/2007) and one Doctoral Fellowship (UAc/DRCT/REF. U&D/MED.M3.1.1/I/003/2005/A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristegui J, 2005, J MARINE SYST, V54, P65, DOI 10.1016/j.jmarsys.2004.07.004; Aristegui J, 2004, PROG OCEANOGR, V62, P95, DOI 10.1016/j.pocean.2004.07.004; Aristegui J, 2002, AQUAT MICROB ECOL, V29, P199, DOI 10.3354/ame029199; Aristegui J, 2009, DEEP-SEA RES PT II, V56, P2646, DOI 10.1016/j.dsr2.2008.12.025; Baltar F, 2010, ISME J, V4, P975, DOI 10.1038/ismej.2010.33; Baltar F, 2009, PROG OCEANOGR, V83, P180, DOI 10.1016/j.pocean.2009.07.016; Bashmachnikov I, 2009, DEEP-SEA RES PT II, V56, P2593, DOI 10.1016/j.dsr2.2008.12.036; BECKMANN A, 2002, OCEAN DYNAM, V52, P194, DOI DOI 10.1007/S10236-002-0018-3; BLANCHOT J, 1992, J PLANKTON RES, V14, P137, DOI 10.1093/plankt/14.1.137; BONILLAFINDJI O, 2010, BIOGEOSCIENCES DISCU, V7, P2033; BORSHEIM KY, 1987, MAR ECOL PROG SER, V36, P171, DOI 10.3354/meps036171; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P2050, DOI 10.1111/j.1462-2920.2007.01321.x; CAMPBELL L, 1993, DEEP-SEA RES PT I, V40, P2043, DOI 10.1016/0967-0637(93)90044-4; Christiansen B, 2009, DEEP-SEA RES PT II, V56, P2579, DOI 10.1016/j.dsr2.2008.12.021; COMEAU LA, 1995, DEEP-SEA RES PT I, V42, P993, DOI 10.1016/0967-0637(95)00050-G; DOWER J, 1992, DEEP-SEA RES, V39, P1139, DOI 10.1016/0198-0149(92)90061-W; Duarte CM, 2009, LIMNOL OCEANOGR, V54, P1015, DOI 10.4319/lo.2009.54.3.1015; Duarte CM, 1998, SCIENCE, V281, P234, DOI 10.1126/science.281.5374.234; Duarte MC, 2001, LIMNOL OCEANOGR, V46, P425, DOI 10.4319/lo.2001.46.2.0425; FURUYA K, 1995, BIOGEOCHEMICAL PROCE, P255; Garcia-Munoz M, 2004, PROG OCEANOGR, V62, P115, DOI 10.1016/j.pocean.2004.07.005; Gasol JM, 1997, LIMNOL OCEANOGR, V42, P1353, DOI 10.4319/lo.1997.42.6.1353; Gasol JM, 1999, AQUAT MICROB ECOL, V16, P251, DOI 10.3354/ame016251; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; GENIN A, 1985, J MAR RES, V43, P907, DOI 10.1357/002224085788453868; Genin Amatzia, 2007, Fish and Aquatic Resources Series, V12, P85; HAAS LW, 1982, ANN I OCEANOGR PARIS, V58, P261; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Kamiya E, 2007, J OCEANOGR, V63, P101, DOI 10.1007/s10872-007-0008-7; Lebaron P, 2001, APPL ENVIRON MICROB, V67, P1775, DOI 10.1128/AEM.67.4.1775-1782.2001; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Machin F, 2009, DEEP-SEA RES PT II, V56, P2606, DOI 10.1016/j.dsr2.2008.12.038; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Margalef R., 1967, Oceanography and Marine Biology, V5, P257; MARTINS AM, 2007, P SOC PHOTO-OPT INS, V6743; Mendonca A, 2010, J APPL REMOTE SENS, V4, DOI 10.1117/1.3328872; Mohn C, 2009, DEEP-SEA RES PT II, V56, P2582, DOI 10.1016/j.dsr2.2008.12.037; Mourino B, 2001, OCEANOL ACTA, V24, P167, DOI 10.1016/S0399-1784(00)01138-5; Navarro N, 2004, AQUAT MICROB ECOL, V37, P47, DOI 10.3354/ame037047; Odate T, 1998, DEEP-SEA RES PT I, V45, P1595, DOI 10.1016/S0967-0637(98)00031-4; OLSON RJ, 1990, DEEP-SEA RES, V37, P1033, DOI 10.1016/0198-0149(90)90109-9; Parsons T.R., 1984, MANUAL CHEM BIOL MET; Partensky F, 1996, DEEP-SEA RES PT I, V43, P1191, DOI 10.1016/0967-0637(96)00056-8; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Robinson C, 2002, DEEP-SEA RES PT I, V49, P787, DOI 10.1016/S0967-0637(01)00083-8; Serret P, 2001, LIMNOL OCEANOGR, V46, P1642, DOI 10.4319/lo.2001.46.7.1642; SIERACKI ME, 1995, DEEP-SEA RES PT I, V42, P1399, DOI 10.1016/0967-0637(95)00055-B; Smayda T. J., 1965, Bulletin Inter-American Tropical Tuna Commission, V9, P465; Smith EM, 2001, LIMNOL OCEANOGR, V46, P473, DOI 10.4319/lo.2001.46.3.0473; STRATHMANN RR, 1967, LIMNOL OCEANOGR, V12, P411, DOI 10.4319/lo.1967.12.3.0411; TOKAREV YN, 2003, MARINE ECOLOGICAL J, V2, P46; Vaque D, 2001, AQUAT MICROB ECOL, V25, P163, DOI 10.3354/ame025163; VELDHUIS MJW, 1993, NETH J SEA RES, V31, P135, DOI 10.1016/0077-7579(93)90003-B; Vilas JC, 2009, DEEP-SEA RES PT II, V56, P2618, DOI 10.1016/j.dsr2.2008.12.023; WESSEL P, 2007, FISH AQUATIC RESOURC, V12, P3; Wessel P, 2010, OCEANOGRAPHY, V23, P24, DOI 10.5670/oceanog.2010.60; WHITE M, 2007, FISH AQUATIC RESOURC, V12, P65; Williams PJL, 1998, NATURE, V394, P55; Zar J.H., 2010, BIOSTAT ANAL; Zubkov MV, 2000, AQUAT MICROB ECOL, V21, P13, DOI 10.3354/ame021013	60	38	44	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29526	10.1371/journal.pone.0029526	http://dx.doi.org/10.1371/journal.pone.0029526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279538	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900016
J	Zhang, Y; Hu, RM; Wu, HJ; Jiang, WN; Sun, Y; Wang, Y; Song, YN; Jin, T; Zhang, HX; Mao, X; Zhao, ZH; Zhang, ZG				Zhang, Yan; Hu, Ruimin; Wu, Huijuan; Jiang, Weina; Sun, Yu; Wang, Yan; Song, Yanan; Jin, Tong; Zhang, Hongxia; Mao, Xin; Zhao, Zhonghua; Zhang, Zhigang			OTUB1 Overexpression in Mesangial Cells Is a Novel Regulator in the Pathogenesis of Glomerulonephritis through the Decrease of DCN Level	PLOS ONE			English	Article							NF-KAPPA-B; DEUBIQUITINATING ENZYMES; GLOMERULAR EXPRESSION; DECORIN GENE; UBIQUITIN; RAT; PROTEASES; KIDNEY; DOMAIN; RESPONSES	Background: OTUB1 is a member of OTUs (Ovarian-tumor-domain-containing proteases), a deubiquitinating enzymes family (DUBs), which was shown as a proteasome-associated DUB to be involved in the proteins Ub-dependent degradation. It has been reported that OTUB1 was expressed in kidney tissue. But its concrete cellular location and function in the kidney remain unclear. Decorin (DCN) in mesangial cells (MC) is considered to be a potentially important factor for antagonizing glomerulonephritides, and its degradation is mediated by ubiquitination. The aim of this study is to investigate the role of OTUB1 expression in MC and its relationship with DCN during glomerulonephritis. Methodology/Principal Findings: Using quantitative RT-PCR and Western blot, we demonstrated that OTUB1 mRNA and protein were constitutively expressed in cultured rat MC and found to be upregulated by the stimulation of IL-1 beta or ATS. OTUB1 overexpression was detected in the mesangial area of glomeruli in some immunocomplex mediated nephritides such as IgA nephropathy, acute diffuse proliferative glomerulonephritis and lupus nephritis by immunohistochemistry. The immunoprecipitation assay demonstrated that OTUB1 interacted with DCN. The overexpression of OTUB1 enhanced the ubiquitination and degradation of DCN in MC. Conclusion/Significance: These data showed the inflammatory injury could up-regulate OTUB1 expression in MC, which might attribute the promoting effect of OTUB1 on glomerulonephritides to the decrease of DCN level.	[Zhang, Yan; Hu, Ruimin; Wu, Huijuan; Jiang, Weina; Sun, Yu; Wang, Yan; Song, Yanan; Jin, Tong; Zhang, Hongxia; Mao, Xin; Zhao, Zhonghua; Zhang, Zhigang] Fudan Univ, Key Lab Mol Med, Chinese Educ Minist, Dept Pathol,Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University	Zhang, Y (corresponding author), Fudan Univ, Key Lab Mol Med, Chinese Educ Minist, Dept Pathol,Shanghai Med Coll, Shanghai 200433, Peoples R China.	zzg@shmu.edu.cn			National Nature Science Foundation of China [NFSC: 30570859, NFSC: 30900683]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by two grants from the National Nature Science Foundation of China (NFSC: 30570859; NFSC: 30900683). The website is http://www.nsfc.gov.cn/Portal0/default124.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Arguello MD, 2007, CELL HOST MICROBE, V2, P367, DOI 10.1016/j.chom.2007.11.005; BALAKIREV M, 2003, EMBO REPORTS, P517; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; CHENG GP, 1996, J CLIN EXP PATHOL, V12, P241; Costacurta A, 2002, J CLIN LAB ANAL, V16, P178, DOI 10.1002/jcla.10038; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; EDELMANN M, 2009, BIOCHEM J, P379; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; HUANG YZ, 1995, SCIENCE, V270, P1828, DOI 10.1126/science.270.5243.1828; Imai K, 1997, BIOCHEM J, V322, P809, DOI 10.1042/bj3220809; ISAKA Y, 1996, NAT MED, P418; Jeon YJ, 2010, BBA-MOL BASIS DIS, V1802, P485, DOI 10.1016/j.bbadis.2010.02.006; KOMANDER D, 2008, BIOCHEM J, P77; Kuroda M, 2004, CLIN NEPHROL, V61, P7; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Mogyorosi A, 1999, NEPHROL DIAL TRANSPL, V14, P1078, DOI 10.1093/ndt/14.5.1078; Mogyorosi A, 1998, AM J PHYSIOL-RENAL, V275, pF827, DOI 10.1152/ajprenal.1998.275.5.F827; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Reyes-Turcu FE, 2009, CHEM REV, V109, P1495, DOI 10.1021/cr800470j; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; SASS GL, 1995, DEV BIOL, V167, P201, DOI 10.1006/dbio.1995.1017; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Schaefer L, 2001, FASEB J, V15, P559; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; [佟建霞 TONG Jianxia], 2006, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V26, P230; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wang HJ, 2005, EXP MOL PATHOL, V78, P17, DOI 10.1016/j.yexmp.2004.07.006; Williams KJ, 2007, AM J PATHOL, V171, P1441, DOI 10.2353/ajpath.2007.070079; Wu F, 2007, EUR J MED RES, V12, P360; Wu HJ, 2010, J CELL BIOCHEM, V111, P1010, DOI 10.1002/jcb.22789; Xia QW, 2008, FRONT BIOSCI-LANDMRK, V13, P3850; YAMAMOTO T, 1987, KIDNEY INT, V32, P514, DOI 10.1038/ki.1987.240; ZHANG M, 1995, J SHANGHAI MED U, V22, P207	40	4	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29654	10.1371/journal.pone.0029654	http://dx.doi.org/10.1371/journal.pone.0029654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279542	Green Submitted, gold, Green Published			2022-12-27	WOS:000299771900020
J	Perez-Perez, R; Lopez, JA; Garcia-Santos, E; Camafeita, E; Gomez-Serrano, M; Ortega-Delgado, FJ; Ricart, W; Fernandez-Real, JM; Peral, B				Perez-Perez, Rafael; Lopez, Juan A.; Garcia-Santos, Eva; Camafeita, Emilio; Gomez-Serrano, Maria; Ortega-Delgado, Francisco J.; Ricart, Wifredo; Fernandez-Real, Jose M.; Peral, Belen			Uncovering Suitable Reference Proteins for Expression Studies in Human Adipose Tissue with Relevance to Obesity	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TYPE-2 DIABETES-MELLITUS; GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA; INSULIN SENSITIVITY; METABOLIC SYNDROME; DJ-1; PROTEOMICS; DISEASE; MARKERS	Background: Protein expression studies based on the two major intra-abdominal human fat depots, the subcutaneous and the omental fat, can shed light into the mechanisms involved in obesity and its co-morbidities. Here we address, for the first time, the identification and validation of reference proteins for data standardization, which are essential for accurate comparison of protein levels in expression studies based on fat from obese and non-obese individuals. Methodology and Findings: To uncover adipose tissue proteins equally expressed either in omental and subcutaneous fat depots (study 1) or in omental fat from non-obese and obese individuals (study 2), we have reanalyzed our previously published data based on two-dimensional fluorescence difference gel electrophoresis. Twenty-four proteins (12 in study 1 and 12 in study 2) with similar expression levels in all conditions tested were selected and identified by mass spectrometry. Immunoblotting analysis was used to confirm in adipose tissue the expression pattern of the potential reference proteins and three proteins were validated: PARK7, ENOA and FAA. Western Blot analysis was also used to test customary loading control proteins. ENOA, PARK7 and the customary loading control protein Beta-actin showed steady expression profiles in fat from non-obese and obese individuals, whilst FAA maintained steady expression levels across paired omental and subcutaneous fat samples. Conclusions: ENOA, PARK7 and Beta-actin are proper reference standards in obesity studies based on omental fat, whilst FAA is the best loading control for the comparative analysis of omental and subcutaneous adipose tissues either in obese and non-obese subjects. Neither customary loading control proteins GAPDH and TBB5 nor CALX are adequate standards in differential expression studies on adipose tissue. The use of the proposed reference proteins will facilitate the adequate analysis of proteins differentially expressed in the context of obesity, an aim difficult to achieve before this study.	[Perez-Perez, Rafael; Garcia-Santos, Eva; Gomez-Serrano, Maria; Peral, Belen] CSIC, Inst Invest Biomed, Madrid, Spain; [Perez-Perez, Rafael; Garcia-Santos, Eva; Gomez-Serrano, Maria; Peral, Belen] Univ Autonoma Madrid, Madrid, Spain; [Perez-Perez, Rafael; Garcia-Santos, Eva; Gomez-Serrano, Maria; Ortega-Delgado, Francisco J.; Ricart, Wifredo; Fernandez-Real, Jose M.; Peral, Belen] ISCIII, CIBER Fisiopatol Obesidad & Nutr CIBERob, Madrid, Spain; [Lopez, Juan A.; Camafeita, Emilio] CNIC, Unidad Prote, Madrid, Spain; [Ortega-Delgado, Francisco J.; Ricart, Wifredo; Fernandez-Real, Jose M.] Hosp Dr Josep Trueta, Dept Diabet Endocrinol & Nutr, Girona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Universitat de Girona; Girona University Hospital Dr. Josep Trueta	Perez-Perez, R (corresponding author), CSIC, Inst Invest Biomed, Madrid, Spain.	bperal@iib.uam.es	Lopez, Juan Antonio/G-7750-2015; Peral, Belén/F-4562-2015; Gómez-Serrano, María/AAZ-3953-2021; Ortega, Francisco José J/F-3883-2016; Fernández-Real, Jose Manuel/AGH-3599-2022	Lopez, Juan Antonio/0000-0002-9097-6060; Peral, Belén/0000-0003-4984-4020; Gómez-Serrano, María/0000-0002-9669-091X; Ortega, Francisco José J/0000-0003-2111-769X; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Perez-Perez, Rafael/0000-0001-7726-5873; Ricart, Wifredo/0000-0002-3452-9098	MICINN [SAF-2009-10461, SAF-2008-02073]; Fundacion Mutua Madrilena, Spain; Pro CNIC Foundation	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fundacion Mutua Madrilena, Spain; Pro CNIC Foundation	This work was supported by Grants SAF-2009-10461 and SAF-2008-02073 from the MICINN, and from the Fundacion Mutua Madrilena, Spain (BP). The CNIC is supported by MICINN and Pro CNIC Foundation. CIBERobn is an initiative from the Instituto de Salud Carlos III. The funders had no role in study design, data collection nor analysis, decision to publish, or preparation of the manuscript.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Bashan N, 2007, ENDOCRINOLOGY, V148, P2955, DOI 10.1210/en.2006-1369; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Catalan V, 2007, HORM METAB RES, V39, P495, DOI 10.1055/s-2007-982502; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dittmer A, 2006, ELECTROPHORESIS, V27, P2844, DOI 10.1002/elps.200500785; Ferguson RE, 2005, PROTEOMICS, V5, P566, DOI 10.1002/pmic.200400941; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Gabrielsson BG, 2005, OBES RES, V13, P649, DOI 10.1038/oby.2005.72; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; del Pozo CH, 2011, OBES SURG, V21, P633, DOI 10.1007/s11695-010-0246-4; del Pozo CH, 2010, OBESITY, V18, P897, DOI 10.1038/oby.2009.374; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kovsan J, 2011, J CLIN ENDOCR METAB, V96, pE268, DOI 10.1210/jc.2010-1681; Liu SF, 2010, HEPATO-GASTROENTEROL, V57, P1247; MacLaren R, 2008, J LIPID RES, V49, P308, DOI 10.1194/jlr.M700199-JLR200; Mantovani G, 2009, DIABETES, V58, P620, DOI 10.2337/db08-0585; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Mcnally RS, 2011, J BIOL CHEM, V286, P4098, DOI 10.1074/jbc.M110.147371; Peinado JR, 2010, PROTEOMICS, V10, P3356, DOI 10.1002/pmic.201000350; Perez-Perez R, 2012, J PROTEOMICS, V75, P783, DOI 10.1016/j.jprot.2011.09.016; Perez-Perez R, 2009, J PROTEOME RES, V8, P1682, DOI 10.1021/pr800942k; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Prokesch A, 2009, CURR MED CHEM, V16, P2952, DOI 10.2174/092986709788803132; Rai P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018074; Rasche A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-310; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Sun S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-309; TANGUAY RM, 1990, AM J HUM GENET, V47, P308; van Beek EA, 2007, PFLUG ARCH EUR J PHY, V453, P851, DOI 10.1007/s00424-006-0164-4; VANHINSBERGH VWM, 1990, BLOOD, V75, P1490; Vohl MC, 2004, OBES RES, V12, P1217, DOI 10.1038/oby.2004.153; Wu XD, 2001, J CLIN ENDOCR METAB, V86, P5973, DOI 10.1210/jc.86.12.5973; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211	38	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30326	10.1371/journal.pone.0030326	http://dx.doi.org/10.1371/journal.pone.0030326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272336	gold, Green Published, Green Submitted			2022-12-27	WOS:000301454400114
J	Estella, C; Herrer, I; Atkinson, SP; Quinonero, A; Martinez, S; Pellicer, A; Simon, C				Estella, Carlos; Herrer, Isabel; Atkinson, Stuart P.; Quinonero, Alicia; Martinez, Sebastian; Pellicer, Antonio; Simon, Carlos			Inhibition of Histone Deacetylase Activity in Human Endometrial Stromal Cells Promotes Extracellular Matrix Remodelling and Limits Embryo Invasion	PLOS ONE			English	Article							IN-VITRO; TROPHOBLAST INVASION; METALLOPROTEINASE EXPRESSION; PLASMINOGEN-ACTIVATOR; TISSUE INHIBITORS; MENSTRUAL-CYCLE; DECIDUALIZATION; IMPLANTATION; INTERLEUKIN-1-BETA; CANCER	Invasion of the trophoblast into the maternal decidua is regulated by both the trophoectoderm and the endometrial stroma, and entails the action of tissue remodeling enzymes. Trophoblast invasion requires the action of metalloproteinases (MMPs) to degrade extracellular matrix (ECM) proteins and in turn, decidual cells express tissue inhibitors of MMPs (TIMPs). The balance between these promoting and restraining factors is a key event for the successful outcome of pregnancy. Gene expression is post-transcriptionally regulated by histone deacetylases (HDACs) that unpacks condensed chromatin activating gene expression. In this study we analyze the effect of histone acetylation on the expression of tissue remodeling enzymes and activity of human endometrial stromal cells (hESCs) related to trophoblast invasion control. Treatment of hESCs with the HDAC inhibitor trichostatin A (TSA) increased the expression of TIMP-1 and TIMP-3 while decreased MMP-2, MMP-9 and uPA and have an inhibitory effect on trophoblast invasion. Moreover, histone acetylation is detected at the promoters of TIMP-1 and TIMP-3 genes in TSA-treated. In addition, in an in vitro decidualized hESCs model, the increase of TIMP-1 and TIMP-3 expression is associated with histone acetylation at the promoters of these genes. Our results demonstrate that histone acetylation disrupt the balance of ECM modulators provoking a restrain of trophoblast invasion. These findings are important as an epigenetic mechanism that can be used to control trophoblast invasion.	[Estella, Carlos; Herrer, Isabel; Quinonero, Alicia; Martinez, Sebastian; Pellicer, Antonio; Simon, Carlos] Univ Valencia, FIVI, Valencia, Spain; [Estella, Carlos; Herrer, Isabel; Quinonero, Alicia; Martinez, Sebastian; Pellicer, Antonio; Simon, Carlos] Inst Univ IVI INCLIVA, Valencia, Spain; [Atkinson, Stuart P.] Ctr Invest Principe Felipe, Valencia, Spain	University of Valencia; Prince Felipe Research Center	Estella, C (corresponding author), Univ Valencia, FIVI, Valencia, Spain.	carlos.simon@ivi.es	Simon, Carlos/G-2186-2014; MARTINEZ, ANTONIO PELLICER/C-4832-2015; Pellicer, Antonio/AAA-6005-2020; Estella, Carlos/L-2097-2014	Simon, Carlos/0000-0003-0902-9531; Pellicer, Antonio/0000-0002-8254-863X; Estella, Carlos/0000-0003-1551-2327; Atkinson, Stuart P./0000-0002-8218-3730				Anacker J, 2011, MOL HUM REPROD; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Bischof P, 2001, ANN NY ACAD SCI, V943, P157, DOI 10.1111/j.1749-6632.2001.tb03799.x; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Carver J, 2003, HUM REPROD, V18, P283, DOI 10.1093/humrep/deg072; Cockle JV, 2007, REPROD SCI, V14, P629, DOI 10.1177/1933719107304563; Di Nezza LA, 2002, CANCER, V94, P1466, DOI 10.1002/cncr.10355; Ganesan A, 2009, CURR CANCER DRUG TAR, V9, P963, DOI 10.2174/156800909790192428; Garrido-Gomez T, 2010, J CLIN ENDOCRINOL ME; Gellersen B, 2010, HUM REPROD, V25, P862, DOI 10.1093/humrep/dep468; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Graesslin O, 2006, ANN ONCOL, V17, P637, DOI 10.1093/annonc/mdj129; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Grewal S, 2010, BIOL REPROD, V83, P75, DOI 10.1095/biolreprod.109.080630; Hannan NJ, 2010, BIOL REPROD, V82, P235, DOI 10.1095/biolreprod.109.077800; Iwahashi M, 1996, J REPROD FERTIL, V108, P147; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk; Krusche CA, 2007, HUM REPROD, V22, P2956, DOI 10.1093/humrep/dem241; Lala PK, 2003, PLACENTA, V24, P575, DOI 10.1016/S0143-4004(03)00063-8; LIBRACH CL, 1994, J BIOL CHEM, V269, P17125; Lockwood CJ, 2008, BIOL REPROD, V78, P1064, DOI 10.1095/biolreprod.107.063743; Munro SK, 2010, MOL HUM REPROD, V16, P297, DOI 10.1093/molehr/gaq010; Nuttall RK, 1999, BIOL REPROD, V60, P471, DOI 10.1095/biolreprod60.2.471; Osteen KG, 2003, SEMIN REPROD MED, V21, P155; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Paria BC, 2002, SCIENCE, V296, P2185, DOI 10.1126/science.1071601; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; Pulukuri SMK, 2007, J BIOL CHEM, V282, P35594, DOI 10.1074/jbc.M705867200; RODGERS WH, 1994, J CLIN INVEST, V94, P946, DOI 10.1172/JCI117461; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Sakai N, 2003, J BIOL CHEM, V278, P16675, DOI 10.1074/jbc.M211715200; Salamonsen Lois A, 2002, Rev Endocr Metab Disord, V3, P133, DOI 10.1023/A:1015407012559; Schatz F, 1999, SEMIN REPROD ENDOCR, V17, P3, DOI 10.1055/s-2007-1016206; SHIMONOVITZ S, 1994, AM J OBSTET GYNECOL, V171, P832, DOI 10.1016/0002-9378(94)90107-4; SIMON C, 1994, J CLIN ENDOCR METAB, V78, P675, DOI 10.1210/jc.78.3.675; STRICKLAND S, 1992, CELL, V71, P355, DOI 10.1016/0092-8674(92)90503-5; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; TANG BQ, 1993, ENDOCRINOLOGY, V133, P2197, DOI 10.1210/en.133.5.2197; Troeberg Linda, 2004, Curr Protoc Protein Sci, VChapter 21, DOI 10.1002/0471140864.ps2115s33; Uchida H, 2005, ENDOCRINOLOGY, V146, P5365, DOI 10.1210/en.2005-0359; van den Brule F, 2005, CHEM IMMUNOL ALLERGY, V88, P163, DOI 10.1159/000087833; VanLint C, 1996, GENE EXPRESSION, V5, P245; Zhang J, 1997, MOL HUM REPROD, V3, P735, DOI 10.1093/molehr/3.9.735	44	43	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30508	10.1371/journal.pone.0030508	http://dx.doi.org/10.1371/journal.pone.0030508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291969	gold, Green Submitted, Green Published			2022-12-27	WOS:000301703800017
J	Li, LY; Huang, YS; Zhang, LZ; Lin, ZB; Wang, GF				Li, Lingyun; Huang, Yisheng; Zhang, Lizhen; Lin, Zhoubin; Wang, Guofu			Growth, Mechanical, Thermal and Spectral Properties of Cr3+:MgMoO4 Crystal	PLOS ONE			English	Article							ENERGY-LEVELS; SYNCHROTRON-RADIATION; LASER PERFORMANCE; STATE; MGMOO4; LUMINESCENCE; CR-3; CR3+	This paper reports the growth, mechanical, thermal and spectral properties of Cr3+:MgMoO4 crystals. The Cr3+:MgMoO4 crystals with dimensions up to 30 mmx18 mmx14 mm were obtained by TSSG method. The absorption cross-sections of (4)A(2)-> T-4(1) and (4)A(2)-> T-4(2) transitions are 12.94x10(-20) cm(2) at 493 nm and 7.89x10(-20) cm(2) at 705 nm for E//N-g, respectively. The Cr3+: MgMoO4 crystal shows broad band emission extending from 750 nm to 1300 nm with peak at about 705 nm. The emission cross-section with FWHM of 188 nm is 119.88x10(-20) cm(2) at 963 nm for E//N-g. The investigated results showed that the Cr3+:MgMoO4 crystal may be regarded as a potential tunable laser gain medium.	[Li, Lingyun; Huang, Yisheng; Zhang, Lizhen; Lin, Zhoubin; Wang, Guofu] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Optoelect Mat Chem & Phys, Fuzhou 350002, Fujian, Peoples R China; [Li, Lingyun] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, LY (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Optoelect Mat Chem & Phys, Fuzhou 350002, Fujian, Peoples R China.	wgf@ms.fjirsm.ac.cn			National Natural Science Foundation of China [61008060]; National Natural Science Foundation of Fujian Province [2011J01376]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work is supported by the National Natural Science Foundation of China ( No. 61008060) and the National Natural Science Foundation of Fujian Province (No. 2011J01376), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKAKIN VV, 1982, KRISTALLOGRAFIYA+, V27, P38; Cavalli E, 2008, J PHYS CHEM SOLIDS, V69, P29, DOI 10.1016/j.jpcs.2007.07.101; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; FANO U, 1965, PHYS REV, V137, P1364, DOI 10.1103/PhysRev.137.A1364; HUBER G, 1975, J APPL PHYS, V46, P3580, DOI 10.1063/1.322269; KENYON PT, 1982, IEEE J QUANTUM ELECT, V18, P1189, DOI 10.1109/JQE.1982.1071692; KISLIUK P, 1967, PHYS REV, V160, P307, DOI 10.1103/PhysRev.160.307; Kuck S, 2001, APPL PHYS B-LASERS O, V72, P515, DOI 10.1007/s003400100540; LAI ST, 1986, IEEE J QUANTUM ELECT, V22, P1931; Long XF, 2004, CHEM PHYS LETT, V392, P192, DOI 10.1016/j.cplett.2004.05.067; Mikhailik VB, 2006, NUCL INSTRUM METH A, V562, P513, DOI 10.1016/j.nima.2006.03.005; Mikhailik VB, 2005, PHYS STATUS SOLIDI B, V242, pR17, DOI 10.1002/pssb.200409087; PAYNE SA, 1988, IEEE J QUANTUM ELECT, V24, P2243, DOI 10.1109/3.8567; PAYNE SA, 1989, J APPL PHYS, V66, P1051, DOI 10.1063/1.343491; Preifer E, 1990, CRYST RES TECHNOL, V25, P3; Samtleben TA, 2005, OPT LASER ENG, V43, P251, DOI 10.1016/j.optlaseng.2004.02.010; Spasskii DA, 2009, OPT SPECTROSC+, V106, P556, DOI 10.1134/S0030400X09040171; STRUVE B, 1983, APPL PHYS B-PHOTO, V30, P117, DOI 10.1007/BF00695465; Sugano S, MULTIPLETS TRANSITIO; Wang GJ, 2011, MATER RES INNOV, V15, P167, DOI 10.1179/143307511X12998222919191; WANG GF, 1990, J CRYST GROWTH, V100, P447, DOI 10.1016/0022-0248(90)90243-E; Wang GJ, 2008, J LUMIN, V128, P1556, DOI 10.1016/j.jlumin.2008.03.004; Wang GJ, 2010, J ALLOY COMPD, V489, P293, DOI 10.1016/j.jallcom.2009.09.076; Wang GJ, 2009, J LUMIN, V129, P1398, DOI 10.1016/j.jlumin.2009.07.012	24	10	10	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30327	10.1371/journal.pone.0030327	http://dx.doi.org/10.1371/journal.pone.0030327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291935	Green Published, gold, Green Submitted			2022-12-27	WOS:000301639600014
J	Terzian, AS; Bodach, SD; Wiewel, EW; Sepkowitz, K; Bernard, MA; Braunstein, SL; Shepard, CW				Terzian, Arpi S.; Bodach, Sara D.; Wiewel, Ellen W.; Sepkowitz, Kent; Bernard, Marie-Antoinette; Braunstein, Sarah L.; Shepard, Colin W.			Novel Use of Surveillance Data to Detect HIV-Infected Persons with Sustained High Viral Load and Durable Virologic Suppression in New York City	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; PERINATALLY ACQUIRED HIV; DRUG-USERS; PROSPECTIVE COHORT; UNITED-STATES; MEDICAL-CARE; RISK; MEN; TRANSMISSION; SEX	Background: Monitoring of the uptake and efficacy of ART in a population often relies on cross-sectional data, providing limited information that could be used to design specific targeted intervention programs. Using repeated measures of viral load (VL) surveillance data, we aimed to estimate and characterize the proportion of persons living with HIV/AIDS (PLWHA) in New York City (NYC) with sustained high VL (SHVL) and durably suppressed VL (DSVL). Methods/Principal Findings: Retrospective cohort study of all persons reported to the NYC HIV Surveillance Registry who were alive and >= 12 years old by the end of 2005 and who had >= 2 VL tests in 2006 and 2007. SHVL and DSVL were defined as PLWHA with 2 consecutive VLs >= 100,000 copies/mL and PLWHA with all VLs <= 400 copies/mL, respectively. Logistic regression models using generalized estimating equations were used to model the association between SHVL and covariates. There were 56,836 PLWHA, of whom 7% had SHVL and 38% had DSVL. Compared to those without SHVL, persons with SHVL were more likely to be younger, black and have injection drug use (IDU) risk. PLWHA with SHVL were more likely to die by 2007 and be younger by nearly ten years, on average. Conclusions/Significance: Nearly 60% of PLWHA in 2005 had multiple VLs, of whom almost 40% had DSVL, suggesting successful ART uptake. A small proportion had SHVL, representing groups known to have suboptimal engagement in care. This group should be targeted for additional outreach to reduce morbidity and secondary transmission. Measures based on longitudinal analyses of surveillance data in conjunction with cross-sectional measures such as community viral load represent more precise and powerful tools for monitoring ART effectiveness and potential impact on disease transmission than cross-sectional measures alone.	[Terzian, Arpi S.; Bodach, Sara D.; Wiewel, Ellen W.; Bernard, Marie-Antoinette; Braunstein, Sarah L.; Shepard, Colin W.] New York City Dept Hlth & Mental Hyg, New York, NY USA; [Sepkowitz, Kent] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	New York City Department of Health & Mental Hygiene; Memorial Sloan Kettering Cancer Center	Terzian, AS (corresponding author), New York City Dept Hlth & Mental Hyg, New York, NY USA.	aterzian@health.nyc.gov	Wiewel, Ellen/AAN-6338-2020; Terzian, Arpi/AAE-7514-2020	Wiewel, Ellen/0000-0002-5106-0500; 				Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 2007, SUMMARY VITAL STAT 2; [Anonymous], 2010, 52 NYC DEP HLTH MENT; [Anonymous], NAT HIV AIDS STRAT; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Berk ML, 2003, SOC SCI MED, V57, P1091, DOI 10.1016/S0277-9536(02)00487-2; BoHAPaC, 2010, PEDIAT HIV AIDS SURV; BophaphpIoMotN, 2003, MEAS WHAT MATT ALL P; CDC Fact Sheet, CDC FACT SHEET HIV H; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P29; Chadwick EG, 2011, AIDS, V25, P643, DOI 10.1097/QAD.0b013e32834403f6; Christopoulos KA, 2011, CLIN INFECT DIS, V52, pS214, DOI 10.1093/cid/ciq045; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Diamond C, 2000, AM J PUBLIC HEALTH, V90, P115, DOI 10.2105/AJPH.90.1.115; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; Foster C, 2009, AIDS PATIENT CARE ST, V23, P159, DOI 10.1089/apc.2008.0153; Frye Douglas M, 2010, PRED HIGH HIV VIR LO; Hall HI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012756; HIV Prevention Trials Network, TLC PLUS STUD EV FEA; Jenness SM, 2011, SUBST USE MISUSE, V46, P192, DOI 10.3109/10826084.2011.521467; Jenness SM, 2010, AIDS BEHAV, V14, P1353, DOI 10.1007/s10461-010-9769-x; Johnson A. Satcher, 2010, Morbidity and Mortality Weekly Report, V59, P1550; Koenig LJ, 2011, CURR OPIN OBSTET GYN, V23, P321, DOI 10.1097/GCO.0b013e32834a581b; Koenig LJ, J ACQUIR IMMUNE DEFI, V55, P380; Lee LM, 2003, PUBLIC HEALTH REP, V118, P400, DOI 10.1093/phr/118.5.400; Lohse N, 2006, CLIN INFECT DIS, V42, P136, DOI 10.1086/498515; Marhefka SL, AIDS CARE, P1; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Montaner JSG, 2010, JAIDS-J ACQ IMM DEF, V55, pS5, DOI 10.1097/QAI.0b013e3181f9c1f0; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Smit C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001949; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Terzian AS, 2009, J WOMENS HEALTH, V18, P1965, DOI 10.1089/jwh.2008.1090; Torian LV, 2008, ARCH INTERN MED, V168, P1181, DOI 10.1001/archinte.168.11.1181; Torian LV, 2011, AIDS PATIENT CARE ST, V25, P79, DOI 10.1089/apc.2010.0151; Validiserri R, 2011, SAN FRANCISCOS NEW A; Viard JP, 2004, AIDS, V18, P45, DOI 10.1097/00002030-200401020-00005; Wolfe D, 2010, JAIDS-J ACQ IMM DEF, V55, pS56, DOI 10.1097/QAI.0b013e3181f9c0de; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	46	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e29679	10.1371/journal.pone.0029679	http://dx.doi.org/10.1371/journal.pone.0029679			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	910LV	22291892	gold, Green Published, Green Submitted			2022-12-27	WOS:000301639600004
J	Bianchi, V; Gambino, F; Muzio, L; Toniolo, D; Humeau, Y; D'Adamo, P				Bianchi, Veronica; Gambino, Frederic; Muzio, Luca; Toniolo, Daniela; Humeau, Yann; D'Adamo, Patrizia			Forebrain Deletion of alpha GDI in Adult Mice Worsens the Pre-Synaptic Deficit at Cortico-Lateral Amygdala Synaptic Connections	PLOS ONE			English	Article							VESICLE POOLS; PLASTICITY; LTP; MUTATIONS; INDUCTION	The GDI1 gene encodes alpha GDI, which retrieves inactive GDP-bound RAB from membranes to form a cytosolic pool awaiting vesicular release. Mutations in GDI1 are responsible for X-linked Intellectual Disability. Characterization of the Gdi1-null mice has revealed alterations in the total number and distribution of hippocampal and cortical synaptic vesicles, hippocampal short-term synaptic plasticity and specific short-term memory deficits in adult mice, which are possibly caused by alterations of different synaptic vesicle recycling pathways controlled by several RAB GTPases. However, interpretation of these studies is complicated by the complete ablation of Gdi1 in all cells in the brain throughout development. In this study, we generated conditionally gene-targeted mice in which the knockout of Gdi1 is restricted to the forebrain, hippocampus, cortex and amygdala and occurs only during postnatal development. Adult mutant mice reproduce the short-term memory deficit previously reported in Gdi1-null mice. Surprisingly, the delayed ablation of Gdi1 worsens the pre-synaptic phenotype at cortico-amygdala synaptic connections compared to Gdi1-null mice. These results suggest a pivotal role of alpha GDI via specific RAB GTPases acting specifically in forebrain regions at the pre-synaptic sites involved in memory formation.	[Bianchi, Veronica; D'Adamo, Patrizia] Ist Sci San Raffaele, Dulbecco Telethon Inst, Div Neurosci, I-20132 Milan, Italy; [Gambino, Frederic; Humeau, Yann] Univ Strasbourg, UPR3212, CNRS, Strasbourg, France; [Gambino, Frederic] CMU, Dept Neurosci Fondamentales, Geneva, Switzerland; [Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Toniolo, Daniela] CNR, Inst Mol Genet, I-27100 Pavia, Italy; [Humeau, Yann] Univ Bordeaux, CNRS, UMR5297, Inst Interdiciplinaire Neurosci, Bordeaux, France	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Geneva; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Bianchi, V (corresponding author), Ist Sci San Raffaele, Dulbecco Telethon Inst, Div Neurosci, I-20132 Milan, Italy.	p.dadamo@hsr.it	Toniolo, Daniela/AAE-2969-2019; Muzio, Luca/AAB-2308-2022; D'Adamo, Patrizia/AAN-3919-2020	Toniolo, Daniela/0000-0001-9545-6032; Muzio, Luca/0000-0002-1068-865X; D'Adamo, Patrizia/0000-0002-0312-5541; gambino, frederic/0000-0002-2981-5030	Telethon, Italy [TCP04015]; Centre Nationale de la Recherche Scientifique; Agence Nationale de la Recherche [06-003-Neuro-01]; European Neuroscience Institutes Network [LSHM-CT-2005-019063]; Sanofi; Region Aquitaine	Telethon, Italy(Fondazione Telethon); Centre Nationale de la Recherche Scientifique; Agence Nationale de la Recherche(French National Research Agency (ANR)); European Neuroscience Institutes Network(European Commission); Sanofi; Region Aquitaine(Region Nouvelle-Aquitaine)	This work was supported by grants from Telethon, Italy [TCP04015 to PD]; by Centre Nationale de la Recherche Scientifique and the Agence Nationale de la Recherche contract 06-003-Neuro-01 to YH, and by the European Neuroscience Institutes Network (Project Contract N<SUP>o</SUP> LSHM-CT-2005-019063), and Sanofi and the Region Aquitaine to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi V, 2009, HUM MOL GENET, V18, P105, DOI 10.1093/hmg/ddn321; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; D'Adamo P, 2002, HUM MOL GENET, V11, P2567, DOI 10.1093/hmg/11.21.2567; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Fourcaudot E, 2009, NAT NEUROSCI, V12, P1093, DOI 10.1038/nn.2378; Giannandrea M, 2010, AM J HUM GENET, V86, P185, DOI 10.1016/j.ajhg.2010.01.011; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Humeau Y, 2007, J PHYSIOL-LONDON, V583, P983, DOI 10.1113/jphysiol.2007.139899; LEDOUX JE, 1985, ANN NY ACAD SCI, V444, P463, DOI 10.1111/j.1749-6632.1985.tb37611.x; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Pavlos NJ, 2010, J NEUROSCI, V30, P13441, DOI 10.1523/JNEUROSCI.0907-10.2010; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	18	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e29763	10.1371/journal.pone.0029763	http://dx.doi.org/10.1371/journal.pone.0029763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291894	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600006
J	Dierkes, F; Andriopoulos, N; Sucker, C; Kuhr, K; Hollenbeck, M; Hetzel, GR; Burst, V; Teschner, S; Rump, LC; Benzing, T; Grabensee, B; Kurschat, CE				Dierkes, Firuseh; Andriopoulos, Nikolaos; Sucker, Christoph; Kuhr, Kathrin; Hollenbeck, Markus; Hetzel, Gerd R.; Burst, Volker; Teschner, Sven; Rump, Lars C.; Benzing, Thomas; Grabensee, Bernd; Kurschat, Christine E.			Indicators of Acute and Persistent Renal Damage in Adult Thrombotic Microangiopathy	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; C-REACTIVE PROTEIN; VON-WILLEBRAND-FACTOR; THROMBOCYTOPENIC PURPURA; PROGNOSTIC-FACTORS; IMPROVED SURVIVAL; PLASMA-EXCHANGE; PATHOPHYSIOLOGY; DISEASE; RISK	Background: Thrombotic microangiopathies (TMA) in adults such as thrombotic thrombocytopenic purpura (TIP) and hemolytic uremic syndrome (HUS) are life-threatening disorders if untreated. Clinical presentation is highly variable and prognostic factors for clinical course and outcome are not well established. Methods: We performed a retrospective observational study of 62 patients with TMA, 22 males and 40 females aged 16 to 76 years, treated with plasma exchange at one center to identify clinical risk factors for the development of renal insufficiency. Results: On admission, 39 of 62 patients (63%) had acute renal failure (ARF) with 32 patients (52%) requiring dialysis treatment. High systolic arterial pressure (SAP, p = 0.009) or mean arterial pressure (MAP, p = 0.027) on admission was associated with acute renal failure. Patients with SAP>140 mmHg on admission had a sevenfold increased risk of severe kidney disease (OR 7.464, Cl 2.097-26.565). MAP>100 mmHg indicated a fourfold increased risk for acute renal failure (OR 4.261, Cl 1.400-12.972). High SAP, diastolic arterial pressure (DAP), and MAP on admission were also independent risk factors for persistent renal insufficiency with the strongest correlation for high MAP. Moreover, a high C-reactive protein (CRP) level on admission correlated with renal failure in the course of the disease (p = 0.003). At discharge, renal function in 11 of 39 patients (28%) had fully recovered, 14 patients (23%) remained on dialysis, and 14 patients (23%) had non-dialysis-dependent chronic kidney disease. Seven patients (11%) died. We identified an older age as risk factor for death. Conclusions: High blood pressure as well as high CRP serum levels on admission are associated with renal insufficiency in TMA. High blood pressure on admission is also a strong predictor of sustained renal insufficiency. Thus, adult TMA patients with high blood pressure may require special attention to prevent persistent renal failure.	[Dierkes, Firuseh; Hetzel, Gerd R.; Rump, Lars C.; Grabensee, Bernd] Univ Dusseldorf, Dept Nephrol, Fac Med, Dusseldorf, Germany; [Andriopoulos, Nikolaos; Burst, Volker; Teschner, Sven; Benzing, Thomas; Kurschat, Christine E.] Univ Cologne, Dept Med, Div Renal, D-50931 Cologne, Germany; [Andriopoulos, Nikolaos; Burst, Volker; Teschner, Sven; Benzing, Thomas; Kurschat, Christine E.] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; [Sucker, Christoph] Univ Dusseldorf, Med Ctr, Dept Hemostasis & Transfus Med, Dusseldorf, Germany; [Kuhr, Kathrin] Univ Cologne, Inst Med Stat Informat & Epidemiol, D-50931 Cologne, Germany; [Hollenbeck, Markus] Knappschaftskrankenhaus, Dept Nephrol & Rheumatol, Bottrop, Germany; [Benzing, Thomas; Kurschat, Christine E.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany	Heinrich Heine University Dusseldorf; University of Cologne; University of Cologne; Heinrich Heine University Dusseldorf; University of Cologne; University of Cologne	Dierkes, F (corresponding author), Univ Dusseldorf, Dept Nephrol, Fac Med, Dusseldorf, Germany.	christine.kurschat@uk-koeln.de	Benzing, Thomas/X-5476-2019					BELL WR, 1991, NEW ENGL J MED, V325, P398, DOI 10.1056/NEJM199108083250605; Coppo P, 2004, MEDICINE, V83, P233, DOI 10.1097/01.md.0000133622.03370.07; Egan JA, 2004, J CLIN APHERESIS, V19, P165, DOI 10.1002/jca.20017; Frank C, 2011, N ENGL J MED; Hashimoto K, 2005, CANCER-AM CANCER SOC, V103, P1856, DOI 10.1002/cncr.20976; Hollenbeck M, 1998, NEPHROL DIAL TRANSPL, V13, P76, DOI 10.1093/ndt/13.1.76; Iseki K, 1999, NEPHROL DIAL TRANSPL, V14, P1956, DOI 10.1093/ndt/14.8.1956; Kamioka I, 2008, PEDIATR INT, V50, P441, DOI 10.1111/j.1442-200X.2008.02605.x; Kavanagh D, 2011, NEPHRON CLIN PRACT, V118, pC37, DOI 10.1159/000320901; Lapeyraque AL, 2011, NEW ENGL J MED, V364, P2561, DOI 10.1056/NEJMc1100859; Lara PN, 1999, AM J MED, V107, P573, DOI 10.1016/S0002-9343(99)00286-7; Matsumae T, 1996, CLIN NEPHROL, V45, P153; Mayer SA, 2005, MT SINAI J MED, V72, P166; Moake JL, 2004, SEMIN HEMATOL, V41, P4, DOI 10.1053/j.seminhematol.2003.10.003; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Mutluay R, 2010, RENAL FAILURE, V32, P448, DOI 10.3109/08860221003658258; Nakanishi H, 2002, INT J CANCER, V99, P167, DOI 10.1002/ijc.10343; Neveu H, 1996, NEPHROL DIAL TRANSPL, V11, P293, DOI 10.1093/oxfordjournals.ndt.a027256; Noris M, 2005, J AM SOC NEPHROL, V16, P1035, DOI 10.1681/ASN.2004100861; Noris M, 2007, GENEREVIEWS R; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Nurnberger J, 2009, NEW ENGL J MED, V360, P542, DOI 10.1056/NEJMc0808527; Rao M, 2006, SEMIN DIALYSIS, V19, P129, DOI 10.1111/j.1525-139X.2006.00138.x; Remuzzi G, 1998, KIDNEY INT, V53, pS54; Ruggenenti P, 1998, J NEPHROL, V11, P300; Sadler J Evan, 2004, Hematology Am Soc Hematol Educ Program, P407; SCHIEPPATI A, 1992, J AM SOC NEPHROL, V2, P1640; Terrell DR, 2005, J THROMB HAEMOST, V3, P1432, DOI 10.1111/j.1538-7836.2005.01436.x; Tostivint I, 2002, NEPHROL DIAL TRANSPL, V17, P1228, DOI 10.1093/ndt/17.7.1228; Tsai HM, 2003, J AM SOC NEPHROL, V14, P1072, DOI 10.1097/01.ASN.0000060805.04118.4C; Veyradier A, 2001, BLOOD, V98, P1765, DOI 10.1182/blood.V98.6.1765; Wolf G, 2004, NEPHROL DIAL TRANSPL, V19, P1687, DOI 10.1093/ndt/gfh268; Yeun JY, 2000, AM J KIDNEY DIS, V35, P469, DOI 10.1016/S0272-6386(00)70200-9; Zipfel PF, 2010, CURR OPIN NEPHROL HY, V19, P372, DOI 10.1097/MNH.0b013e32833aff4a; Zipfel PF, 2006, SEMIN THROMB HEMOST, V32, P146, DOI 10.1055/s-2006-939770; Zipfel PF, 2011, PEDIAT NEPHROL	36	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30886	10.1371/journal.pone.0030886	http://dx.doi.org/10.1371/journal.pone.0030886			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292070	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600094
J	Huh, Y; Bhatt, R; Jung, D; Shin, HS; Cho, J				Huh, Yeowool; Bhatt, Rushi; Jung, DaeHyun; Shin, Hee-sup; Cho, Jeiwon			Interactive Responses of a Thalamic Neuron to Formalin Induced Lasting Pain in Behaving Mice	PLOS ONE			English	Article							THETA-BURST STIMULATION; DEEP BRAIN-STIMULATION; SOMATOSENSORY BARREL CORTEX; SPINAL-CORD-INJURY; ELECTRICAL-STIMULATION; NUCLEUS SUBMEDIUS; MECHANICAL ALLODYNIA; RECEPTIVE-FIELDS; CA2+ CHANNELS; MOTOR CORTEX	Thalamocortical (TC) neurons are known to relay incoming sensory information to the cortex via firing in tonic or burst mode. However, it is still unclear how respective firing modes of a single thalamic relay neuron contribute to pain perception under consciousness. Some studies report that bursting could increase pain in hyperalgesic conditions while others suggest the contrary. However, since previous studies were done under either neuropathic pain conditions or often under anesthesia, the mechanism of thalamic pain modulation under awake conditions is not well understood. We therefore characterized the thalamic firing patterns of behaving mice in response to nociceptive pain induced by inflammation. Our results demonstrated that nociceptive pain responses were positively correlated with tonic firing and negatively correlated with burst firing of individual TC neurons. Furthermore, burst properties such as intra-burst-interval (IntraBI) also turned out to be reliably correlated with the changes of nociceptive pain responses. In addition, brain stimulation experiments revealed that only bursts with specific bursting patterns could significantly abolish behavioral nociceptive responses. The results indicate that specific patterns of bursting activity in thalamocortical relay neurons play a critical role in controlling long-lasting inflammatory pain in awake and behaving mice.	[Huh, Yeowool; Jung, DaeHyun; Shin, Hee-sup; Cho, Jeiwon] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea; [Huh, Yeowool; Shin, Hee-sup; Cho, Jeiwon] Univ Sci & Technol, Dept Neurosci, Taejon, South Korea; [Bhatt, Rushi] Yahoo Labs, Bangalore, Karnataka, India	Korea Institute of Science & Technology (KIST)	Huh, Y (corresponding author), Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea.	jeiwon@kist.re.kr			Korea Institute of Science and Technology	Korea Institute of Science and Technology(Korea Institute of Science & Technology (KIST))	Intramural funding from Korea Institute of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN P, 1964, ACTA PHYSIOL SCAND, V61, P100, DOI 10.1111/j.1748-1716.1964.tb02946.x; ANDERSEN P, 1973, BRAIN BEHAV EVOLUT, V6, P170, DOI 10.1159/000123705; [Anonymous], 2009, NAT NEUROSCI, V12, P1075, DOI 10.1038/nn0909-1075; Antal A, 2010, RESTOR NEUROL NEUROS, V28, P477, DOI 10.3233/RNN-2010-0555; Arcelli P, 1997, BRAIN RES BULL, V42, P27, DOI 10.1016/S0361-9230(96)00107-4; Beurrier C, 2001, J NEUROPHYSIOL, V85, P1351, DOI 10.1152/jn.2001.85.4.1351; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; BROMBERG MB, 1981, BRAIN RES, V215, P369, DOI 10.1016/0006-8993(81)90519-9; Bruno RM, 2002, J NEUROSCI, V22, P10966; Cheong E, 2011, J NEUROSCI, V31, P1213, DOI 10.1523/JNEUROSCI.3203-10.2011; Cheong EJ, 2008, J NEUROSCI, V28, P13331, DOI 10.1523/JNEUROSCI.3013-08.2008; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998; Destexhe A, 1996, J NEUROPHYSIOL, V76, P2049, DOI 10.1152/jn.1996.76.3.2049; Dostrovsky J O, 2000, Prog Brain Res, V129, P245; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Duncan GH, 1998, J NEUROPHYSIOL, V80, P3326, DOI 10.1152/jn.1998.80.6.3326; EATON SA, 1989, NEUROSCIENCE, V33, P285, DOI 10.1016/0306-4522(89)90208-X; Fanselow EE, 2001, P NATL ACAD SCI USA, V98, P15330, DOI 10.1073/pnas.261273898; Gerke MB, 2003, NEUROSCIENCE, V117, P715, DOI 10.1016/S0306-4522(02)00961-2; GUIDO W, 1995, J NEUROPHYSIOL, V74, P1782, DOI 10.1152/jn.1995.74.4.1782; Hains BC, 2006, J NEUROPHYSIOL, V95, P3343, DOI 10.1152/jn.01009.2005; Halassa MM, 2011, NAT NEUROSCI, V14, P1118, DOI 10.1038/nn.2880; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Henry JL, 1999, PAIN, V82, P57, DOI 10.1016/S0304-3959(99)00033-0; HIGASHI H, 1982, J PHYSIOL-LONDON, V332, P299, DOI 10.1113/jphysiol.1982.sp014414; HIRAYAMA T, 1989, STEREOT FUNCT NEUROS, V52, P120, DOI 10.1159/000099492; HOSOBUCHI Y, 1973, ARCH NEUROL-CHICAGO, V29, P158, DOI 10.1001/archneur.1973.00490270040005; Hu B, 2005, NEUROSCI LETT, V375, P162, DOI 10.1016/j.neulet.2004.11.005; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Ikeda H, 2003, SCIENCE, V299, P1237, DOI 10.1126/science.1080659; Inoue T, 2006, J NEUROPHYSIOL, V96, P1746, DOI 10.1152/jn.00301.2006; JAHNSEN H, 1984, ARCH ITAL BIOL, V122, P73; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Jeanmonod D, 1996, BRAIN, V119, P363, DOI 10.1093/brain/119.2.363; Jones E.G., 2007, THALAMUS, VVolume 1, P575; Jones EG, 1985, THALAMUS, Vxvii; Kim D, 2003, SCIENCE, V302, P117, DOI 10.1126/science.1088886; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Kumar K, 1997, NEUROSURGERY, V40, P736, DOI 10.1097/00006123-199704000-00015; KUPERS RC, 1993, NEUROSCI LETT, V150, P95, DOI 10.1016/0304-3940(93)90116-3; Le Bars D, 2001, PHARMACOL REV, V53, P597; LENZ FA, 1994, J NEUROPHYSIOL, V72, P1570, DOI 10.1152/jn.1994.72.4.1570; LENZ FA, 1989, BRAIN RES, V496, P357, DOI 10.1016/0006-8993(89)91088-3; LENZ FA, 1987, PAIN, V31, P225, DOI 10.1016/0304-3959(87)90038-8; Levy R, 2010, PAIN PHYSICIAN, V13, P157; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; MAFFEI L, 1965, SCIENCE, V149, P563, DOI 10.1126/science.149.3683.563; Masri R, 2009, J NEUROPHYSIOL, V102, P181, DOI 10.1152/jn.00152.2009; MCCORMICK DA, 1990, NEUROSCIENCE, V39, P103, DOI 10.1016/0306-4522(90)90225-S; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; MONTAGNECLAVEL J, 1995, NEUROSCI LETT, V196, P69, DOI 10.1016/0304-3940(95)11847-P; Poreisz C, 2008, NEUROREPORT, V19, P193, DOI 10.1097/WNR.0b013e3282f45498; Radhakrishnan V, 1999, PAIN, V80, P567, DOI 10.1016/S0304-3959(98)00248-6; Ramcharan EJ, 2000, VISUAL NEUROSCI, V17, P55, DOI 10.1017/S0952523800171056; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; STERIADE M, 1990, J NEUROSCI, V10, P2541; STERIADE M, 1995, J NEUROSCI, V15, P623; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; Swadlow HA, 2002, PHILOS T R SOC B, V357, P1717, DOI 10.1098/rstb.2002.1156; Volkmann J, 2002, MOVEMENT DISORD, V17, pS181, DOI 10.1002/mds.10162; WILLIAMS JA, 1994, J NEUROSCI, V14, P5236; YUAN B, 1986, J NEUROSCI, V6, P3611; Zhang S, 1999, NEUROSCIENCE, V92, P867, DOI 10.1016/S0306-4522(99)00062-7; ZHANG YQ, 1995, BRAIN RES, V696, P205, DOI 10.1016/0006-8993(95)00856-L; Zhang YQ, 1996, BRAIN RES, V737, P16, DOI 10.1016/0006-8993(96)00662-2	71	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30699	10.1371/journal.pone.0030699	http://dx.doi.org/10.1371/journal.pone.0030699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292022	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600072
J	Cervello, I; Gil-Sanchis, C; Mas, A; Faus, A; Sanz, J; Moscardo, F; Higueras, G; Sanz, MA; Pellicer, A; Simon, C				Cervello, Irene; Gil-Sanchis, Claudia; Mas, Aymara; Faus, Amparo; Sanz, Jaime; Moscardo, Federico; Higueras, Gema; Angel Sanz, Miguel; Pellicer, Antonio; Simon, Carlos			Bone Marrow-Derived Cells from Male Donors Do Not Contribute to the Endometrial Side Population of the Recipient	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PERIPHERAL-BLOOD; EPITHELIAL-CELLS; STROMAL CELLS; IDENTIFICATION; MARKERS; TRANSPLANTATION; EXPRESSION; RECEPTOR	Accumulated evidence demonstrates the existence of bone marrow-derived cells origin in the endometria of women undergoing bone marrow transplantation (BMT). In these reports, cells of a bone marrow (BM) origin are able to differentiate into endometrial cells, although their contribution to endometrial regeneration is not yet clear. We have previously demonstrated the functional relevance of side population (SP) cells as the endogenous source of somatic stem cells (SSC) in the human endometrium. The present work aims to understand the presence and contribution of bone marrow-derived cells to the endometrium and the endometrial SP population of women who received BMT from male donors. Five female recipients with spontaneous or induced menstruations were selected and their endometrium was examined for the contribution of XY donor-derived cells using fluorescent in situ hybridization (FISH), telomapping and SP method investigation. We confirm the presence of XY donor-derived cells in the recipient endometrium ranging from 1.7% to 2.62%. We also identify 0.45-0.85% of the donor-derived cells in the epithelial compartment displaying CD9 marker, and 1.0-1.83% of the Vimentin-positive XY donor-derived cells in the stromal compartment. Although the percentage of endometrial SP cells decreased, possibly being due to chemotherapy applied to these patients, they were not formed by XY donor-derived cells, donor BM cells were not associated with the stem cell (SC) niches assessed by telomapping technique, and engraftment percentages were very low with no correlation between time from transplant and engraftment efficiency, suggesting random terminal differentiation. In conclusion, XY donor-derived cells of a BM origin may be considered a limited exogenous source of transdifferentiated endometrial cells rather than a cyclic source of BM donor-derived stem cells.	[Cervello, Irene; Gil-Sanchis, Claudia; Mas, Aymara; Faus, Amparo; Simon, Carlos] Fdn IVI Inst Univ IVI Univ Valencia, INCLIVA, Valencia, Spain; [Sanz, Jaime; Moscardo, Federico; Angel Sanz, Miguel] Hosp Univ La Fe, Serv Hematol, Valencia, Spain; [Higueras, Gema; Pellicer, Antonio] Hosp Univ La Fe, Serv Ginecol, Valencia, Spain; [Simon, Carlos] Ctr Invest Principe Felipe, Stem Cell Bank, Valencia, Spain	Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Prince Felipe Research Center	Cervello, I (corresponding author), Fdn IVI Inst Univ IVI Univ Valencia, INCLIVA, Valencia, Spain.	Carlos.Simon@ivi.es	MARTINEZ, ANTONIO PELLICER/C-4832-2015; Sanz, Jaime/K-7141-2019; Mas, Aymara/E-4409-2018; Sanz, Miguel A./F-7485-2018; Pellicer, Antonio/AAA-6005-2020; Simon, Carlos/G-2186-2014	Sanz, Jaime/0000-0001-6934-4619; Sanz, Miguel A./0000-0003-1489-1177; Pellicer, Antonio/0000-0002-8254-863X; Simon, Carlos/0000-0003-0902-9531; Mas, Aymara/0000-0002-5866-6732; Cervello, Irene/0000-0002-7018-4971; Cervello, Irene/0000-0003-4801-5538	SAF; Spanish Ministry of Science and Innovation; Fundacio Gent	SAF; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio Gent	This work has been funded by grants SAF (Plan Nacional de Biomedicina) 2008-02048 supported by the Spanish Ministry of Science and Innovation (PI: C. S.), by Fundacio Gent per Gent 08/09 (PI: C. S.) and by PROMETEO/2008/163 (PI: C. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bratincsak A, 2007, STEM CELLS, V25, P2820, DOI 10.1634/stemcells.2007-0301; Cervello I, 2007, HUM REPROD, V22, P45, DOI 10.1093/humrep/del332; Cervello I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021221; Cervello I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010964; Cervello I, 2009, REPROD SCI, V16, P200, DOI 10.1177/1933719108329955; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Cho NH, 2004, FERTIL STERIL, V81, P403, DOI 10.1016/j.fertnstert.2003.07.015; Dimitrov R, 2008, REPRODUCTION, V135, P551, DOI 10.1530/REP-07-0428; Du HL, 2007, STEM CELLS, V25, P2082, DOI 10.1634/stemcells.2006-0828; Du H, 2009, REPROD SCI, V16, P126, DOI 10.1177/1933719108329956; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Gargett CE, 2007, HUM REPROD UPDATE, V13, P87, DOI 10.1093/humupd/dml045; Gargett Caroline E, 2011, J Hum Reprod Sci, V4, P49; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Herzog EL, 2007, FASEB J, V21, P2592, DOI 10.1096/fj.06-7861com; Ikoma T, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.026; Iohara K, 2008, STEM CELLS, V26, P2408, DOI 10.1634/stemcells.2008-0393; Jung P, 2011, NAT MED         0904; Kato K, 2007, HUM REPROD, V22, P1214, DOI 10.1093/humrep/del514; Korbling M, 2002, NEW ENGL J MED, V346, P738, DOI 10.1056/NEJMoa3461002; Larderet G, 2006, STEM CELLS, V24, P965, DOI 10.1634/stemcells.2005-0196; Martin J, 2008, CYTOTHERAPY, V10, P140, DOI 10.1080/14653240801895296; Maruyama T, 2010, REPRODUCTION, V140, P11, DOI 10.1530/REP-09-0438; Masuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010387; Meng XL, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-57; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Mezey E, 2011, J CELL BIOCH; Mints M, 2008, HUM REPROD, V23, P139, DOI 10.1093/humrep/dem342; Musina RA, 2008, B EXP BIOL MED+, V145, P539, DOI 10.1007/s10517-008-0136-0; Nemeth K, 2011, STEM CELLS DEV; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; Padykula HA, 1991, ANN N Y ACAD SCI, V622, P47, DOI 10.1111/j.1749-6632.1991.tb37849.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Reis FM, 2005, J ASSIST REPROD GEN, V22, P19, DOI 10.1007/s10815-005-0816-x; Salooja N, 2001, LANCET, V358, P271, DOI 10.1016/S0140-6736(01)05482-4; Schuring AN, 2011, FERTIL STERIL, V95, P423, DOI 10.1016/j.fertnstert.2010.08.035; Schwab KE, 2008, HUM REPROD, V23, P934, DOI 10.1093/humrep/den051; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Schwab KE, 2005, FERTIL STERIL, V84, P1124, DOI 10.1016/j.fertnstert.2005.02.056; SIMON C, 1993, J CLIN ENDOCR METAB, V77, P549, DOI 10.1210/jc.77.2.549; Smalley MJ, 2005, J MAMMARY GLAND BIOL, V10, P37, DOI 10.1007/s10911-005-2539-0; Soares SR, 2005, J CLIN ENDOCR METAB, V90, P4399, DOI 10.1210/jc.2004-2252; Taylor HS, 2004, JAMA-J AM MED ASSOC, V292, P81, DOI 10.1001/jama.292.1.81; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Tsuji S, 2008, FERTIL STERIL, V90, P1528, DOI 10.1016/j.fertnstert.2007.08.005; Wolff EF, 2007, REPROD SCI, V14, P524, DOI 10.1177/1933719107306896; Zapata AG, 2009, STEM CELLS HUMAN REP, P177	51	70	78	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30260	10.1371/journal.pone.0030260	http://dx.doi.org/10.1371/journal.pone.0030260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276168	Green Published, gold, Green Submitted			2022-12-27	WOS:000301457200048
J	Doyen, S; Klein, O; Pichon, CL; Cleeremans, A				Doyen, Stephane; Klein, Olivier; Pichon, Cora-Lise; Cleeremans, Axel			Behavioral Priming: It's all in the Mind, but Whose Mind?	PLOS ONE			English	Article							SOCIAL-BEHAVIOR; ACTIVATION; AUTOMATICITY; PERCEPTION; MECHANISMS; ECOLOGY; MODEL	The perspective that behavior is often driven by unconscious determinants has become widespread in social psychology. Bargh, Chen, and Burrows' (1996) famous study, in which participants unwittingly exposed to the stereotype of age walked slower when exiting the laboratory, was instrumental in defining this perspective. Here, we present two experiments aimed at replicating the original study. Despite the use of automated timing methods and a larger sample, our first experiment failed to show priming. Our second experiment was aimed at manipulating the beliefs of the experimenters: Half were led to think that participants would walk slower when primed congruently, and the other half was led to expect the opposite. Strikingly, we obtained a walking speed effect, but only when experimenters believed participants would indeed walk slower. This suggests that both priming and experimenters' expectations are instrumental in explaining the walking speed effect. Further, debriefing was suggestive of awareness of the primes. We conclude that unconscious behavioral priming is real, while real, involves mechanisms different from those typically assumed to cause the effect.	[Doyen, Stephane; Pichon, Cora-Lise; Cleeremans, Axel] Univ Libre Bruxelles, Consciousness Cognit & Computat Grp, Brussels, Belgium; [Doyen, Stephane; Klein, Olivier] Univ Libre Bruxelles, Social Psychol Unit, Brussels, Belgium; [Doyen, Stephane] Univ Cambridge, Social & Dev Psychol Dept, Cambridge, England	Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Cambridge	Doyen, S (corresponding author), Univ Libre Bruxelles, Consciousness Cognit & Computat Grp, Brussels, Belgium.	sdoyen@ulb.ac.be	; Klein, Olivier/F-1954-2011	Lauwereyns, Jan/0000-0003-0551-2550; Klein, Olivier/0000-0003-2737-8049	Wienner-Anspach Fondation; National Fund for Scientific Research (F.N.R.S.-F.R.S.) (Belgium); Universite Libre de Bruxelles; Ministere de la Communaute Francaise - Direction Generale l'Enseignement non obligatoire et de la Recherche scientifique (Belgium) [06/11-342]	Wienner-Anspach Fondation; National Fund for Scientific Research (F.N.R.S.-F.R.S.) (Belgium)(Fonds de la Recherche Scientifique - FNRS); Universite Libre de Bruxelles; Ministere de la Communaute Francaise - Direction Generale l'Enseignement non obligatoire et de la Recherche scientifique (Belgium)	This work was supported by the Wienner-Anspach Fondation, the National Fund for Scientific Research (F.N.R.S.-F.R.S.) (Belgium), and by an institutional grant from the Universite Libre de Bruxelles to Axel Cleeremans by Concerted Research Action 06/11-342 titled "Culturally Modified Or- ganisms: What It Means to Be Human in the Age of Culture," financed by the Ministere de la Communaute Francaise - Direction Generale l'Enseignement non obligatoire et de la Recherche scientifique (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 2003, J PERS SOC PSYCHOL, V84, P18, DOI 10.1037/0022-3514.84.1.18; Aarts H, 2002, BRIT J SOC PSYCHOL, V41, P123, DOI 10.1348/014466602165090; Bargh J. A., 2000, HDB RES METHODS SOCI, P253; Bargh JA, 2006, EUR J SOC PSYCHOL, V36, P147, DOI 10.1002/ejsp.336; Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; Bargh JA, 2001, J PERS SOC PSYCHOL, V81, P1014, DOI 10.1037//0022-3514.81.6.1014; Bickel R, MULTILEVEL ANAL APPL; Cesario J, 2006, J PERS SOC PSYCHOL, V90, P893, DOI 10.1037/0022-3514.90.6.893; Cesario J, 2010, PSYCHOL SCI, V21, P1311, DOI 10.1177/0956797610378685; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Conty L, 2010, COGNITION, V115, P133, DOI 10.1016/j.cognition.2009.12.005; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Gardner WL, 1999, PSYCHOL SCI, V10, P321, DOI 10.1111/1467-9280.00162; Kay AC, 2004, ORGAN BEHAV HUM DEC, V95, P83, DOI 10.1016/j.obhdp.2004.06.003; Lerner JS, 2004, PSYCHOL SCI, V15, P337, DOI 10.1111/j.0956-7976.2004.00679.x; Loersch C, 2011, PERSPECT PSYCHOL SCI, V6, P234, DOI 10.1177/1745691611406921; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; PAGE MM, 1969, J PERS SOC PSYCHOL, V11, P177, DOI 10.1037/h0027025; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Rosenthal R., 1966, EXPT EFFECTS BEHAV R; SRULL TK, 1979, J PERS SOC PSYCHOL, V37, P1660, DOI 10.1037/0022-3514.37.10.1660	25	372	377	2	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29081	10.1371/journal.pone.0029081	http://dx.doi.org/10.1371/journal.pone.0029081			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	885IH	22279526	Green Published, Green Submitted, gold			2022-12-27	WOS:000299771900004
J	O'Brien, LJ; Caron, JB				O'Brien, Lorna J.; Caron, Jean-Bernard			A New Stalked Filter-Feeder from the Middle Cambrian Burgess Shale, British Columbia, Canada	PLOS ONE			English	Article							STEPHEN FORMATION; EVOLUTION; CHINA; PALEOECOLOGY; COMMUNITY; BARNACLE; BIOTA	Burgess Shale-type deposits provide invaluable insights into the early evolution of body plans and the ecological structure of Cambrian communities, but a number of species, continue to defy phylogenetic interpretations. Here we extend this list to include a new soft-bodied animal, Siphusauctum gregarium n. gen. and n. sp., from the Tulip Beds (Campsite Cliff Shale Member, Burgess Shale Formation) of Mount Stephen (Yoho National Park, British Columbia). With 1,133 specimens collected, S. gregarium is clearly the most abundant animal from this locality. This stalked animal (reaching at least 20 cm in length), has a large ovoid calyx connected to a narrow bilayered stem and a small flattened or bulb-like holdfast. The calyx is enclosed by a flexible sheath with six small openings at the base, and a central terminal anus near the top encircled by indistinct openings. A prominent organ, represented by six radially symmetrical segments with comb-like elements, surrounds an internal body cavity with a large stomach, conical median gut and straight intestine. Siphusauctum gregarium was probably an active filter-feeder, with water passing through the calyx openings, capturing food particles with its comb-like elements. It often occurs in large assemblages on single bedding planes suggesting a gregarious lifestyle, with the animal living in high tier clusters. These were probably buried en masse more or less in-situ by rapid mud flow events. Siphusauctum gregarium resembles Dinomischus, another Cambrian enigmatic stalked animal. Principal points of comparison include a long stem with a calyx containing a visceral mass and bract-like elements, and a similar lifestyle albeit occupying different tiering levels. The presence in both animals of a digestive tract with a potential stomach and anus suggest a grade of organization within bilaterians, but relationships with extant phyla are not straightforward. Thus, the broader affinities of S. gregarium remain largely unconstrained.	[O'Brien, Lorna J.; Caron, Jean-Bernard] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [O'Brien, Lorna J.; Caron, Jean-Bernard] Royal Ontario Museum, Palaeobiol Div, Dept Nat Hist, Toronto, ON M5S 2C6, Canada	University of Toronto; Royal Ontario Museum	O'Brien, LJ (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	lornao@rom.on.ca		Caron, Jean-Bernard/0000-0002-1670-5502	University of Toronto (Dept of Ecology and Evolution); JBC Natural Sciences and Engineering Research Council [341944]	University of Toronto (Dept of Ecology and Evolution); JBC Natural Sciences and Engineering Research Council	LJO research is supported by fellowships from the University of Toronto (Dept of Ecology and Evolution) and JBC Natural Sciences and Engineering Research Council Discovery Grant (#341944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtson Stefan, 2000, Palaeontologia Electronica, V3, P1; Boero F, 2007, INTEGR COMP BIOL, V47, P693, DOI 10.1093/icb/icm041; Brasier M, 2004, SCIENCE, V305, P1115, DOI 10.1126/science.1102673; Briggs DEG, 2005, P ROY SOC B-BIOL SCI, V272, P2365, DOI 10.1098/rspb.2005.3224; Briggs DEG, 2005, PALEOBIOLOGY, V31, P94, DOI 10.1666/0094-8373(2005)031[0094:WSSSGA]2.0.CO;2; Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Butterfield NJ, 2007, PALAEONTOLOGY, V50, P537, DOI 10.1111/j.1475-4983.2007.00656.x; Butterfield NJ, 2003, INTEGR COMP BIOL, V43, P166, DOI 10.1093/icb/43.1.166; Butterfield NJ, 2002, PALEOBIOLOGY, V28, P155, DOI 10.1666/0094-8373(2002)028<0155:LGATIO>2.0.CO;2; Caron JB, 2008, PALAEOGEOGR PALAEOCL, V258, P222, DOI 10.1016/j.palaeo.2007.05.023; Caron JB, 2006, NATURE, V442, P159, DOI 10.1038/nature04894; Caron JB, 2010, PLOS ONE, V5, pA189, DOI 10.1371/journal.pone.0009586; Chen J.-y., 1989, Acta Palaeontologica Sinica, V28, P58; Chen J.-y., 1991, P57; Chen JY, 2003, P NATL ACAD SCI USA, V100, P8314, DOI 10.1073/pnas.1431177100; COLLINS D, 1983, SCIENCE, V222, P163, DOI 10.1126/science.222.4620.163; COLLINS D, 1981, J PALEONTOL, V55, P1006; CONWAY MS, 1993, PALAEONTOLOGY, V36, P593; Daley AC, 2009, SCIENCE, V323, P1597, DOI 10.1126/science.1169514; Dornbos SQ, 2005, PALAEOGEOGR PALAEOCL, V220, P47, DOI 10.1016/j.palaeo.2003.11.016; Fletcher TP, 2003, CAN J EARTH SCI, V40, P1823, DOI 10.1139/E03-057; Fletcher TP, 1998, CAN J EARTH SCI, V35, P413, DOI 10.1139/e97-120; Gould S.J, 1989, WONDERFUL LIFE BURGE, P347; Hou GG, 2006, GFF, V128, P47; Hu SX, 2007, PALAEOGEOGR PALAEOCL, V254, P307, DOI 10.1016/j.palaeo.2007.03.044; MORRIS S C, 1977, Palaeontology (Oxford), V20, P833; Morris SC, 1996, PHILOS T ROY SOC B, V351, P279, DOI 10.1098/rstb.1996.0024; MORRIS SC, 1986, PALAEONTOLOGY, V29, P423; Peng J, 2006, ACTA GEOL SIN-ENGL, V80, P498; Rigby J.K., 2004, ROYAL ONTARIO MUSEUM, V1, P1; Shu DG, 2006, SCIENCE, V312, P731, DOI 10.1126/science.1124565; Smith MR, 2010, NATURE, V465, P469, DOI 10.1038/nature09068; Sprinkle J, 2006, CAN J EARTH SCI, V43, P303, DOI 10.1139/E05-107; Walcott Charles Doolittle, 1911, Smithsonian Institution Miscellaneous Collection, V57; Whittington H. B., 1971, Proc. North American Paleontological Convention September 1969, VPart 1, P1170; [No title captured]	36	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29233	10.1371/journal.pone.0029233	http://dx.doi.org/10.1371/journal.pone.0029233			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279532	Green Submitted, Green Published, gold			2022-12-27	WOS:000299771900010
J	Chen, CC; Hung, TH; Wang, YH; Lin, CW; Wang, PY; Lee, CY; Chen, SF				Chen, Chien-Cheng; Hung, Tai-Ho; Wang, Yen-Ho; Lin, Chii-Wann; Wang, Pei-Yi; Lee, Chun-Yen; Chen, Szu-Fu			Wogonin Improves Histological and Functional Outcomes, and Reduces Activation of TLR4/NF-kappa B Signaling after Experimental Traumatic Brain Injury	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; TOLL-LIKE RECEPTORS; SCUTELLARIA-BAICALENSIS GEORGI; FLUORO-JADE-B; GENE-EXPRESSION; INFLAMMATORY CYTOKINES; ENDOTHELIAL-CELLS; FLAVONOID WOGONIN; RAT MODEL; IN-VIVO	Background: Traumatic brain injury (TBI) initiates a neuroinflammatory cascade that contributes to neuronal damage and behavioral impairment. This study was undertaken to investigate the effects of wogonin, a flavonoid with potent antiinflammatory properties, on functional and histological outcomes, brain edema, and toll-like receptor 4 (TLR4)- and nuclear factor kappa B (NF-kappa B)-related signaling pathways in mice following TBI. Methodology/Principal Findings: Mice subjected to controlled cortical impact injury were injected with wogonin (20, 40, or 50 mg.kg(-1)) or vehicle 10 min after injury. Behavioral studies, histology analysis, and measurement of blood-brain barrier (BBB) permeability and brain water content were carried out to assess the effects of wogonin. Levels of TLR4/NF-kappa B-related inflammatory mediators were also examined. Treatment with 40 mg.kg(-1) wogonin significantly improved functional recovery and reduced contusion volumes up to post-injury day 28. Wogonin also significantly reduced neuronal death, BBB permeability, and brain edema beginning at day 1. These changes were associated with a marked reduction in leukocyte infiltration, microglial activation, TLR4 expression, NF-kappa B translocation to nucleus and its DNA binding activity, matrix metalloproteinase-9 activity, and expression of inflammatory mediators, including interleukin-1 beta, interleukin-6, macrophage inflammatory protein-2, and cyclooxygenase-2. Conclusions/Significance: Our results show that post-injury wogonin treatment improved long-term functional and histological outcomes, reduced brain edema, and attenuated the TLR4/NF-kappa B-mediated inflammatory response in mouse TBI. The neuroprotective effects of wogonin may be related to modulation of the TLR4/NF-kappa B signaling pathway.	[Chen, Chien-Cheng; Wang, Pei-Yi; Lee, Chun-Yen; Chen, Szu-Fu] Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chen, Chien-Cheng; Lin, Chii-Wann] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Hung, Tai-Ho] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taipei 10591, Taiwan; [Hung, Tai-Ho] Chang Gung Univ, Coll Med, Taipei, Taiwan; [Wang, Yen-Ho] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Wang, Yen-Ho] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chen, Szu-Fu] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Chen, Szu-Fu] Natl Def Med Ctr, Dept Biophys, Taipei, Taiwan	Cheng Hsin General Hospital; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Defense Medical Center; National Defense Medical Center	Chen, CC (corresponding author), Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	szufuchen@yahoo.com.tw	Hung, Tai-Ho/ABD-1800-2020; Hung, Tai-Ho/C-7584-2011; Lin, Chii-Wann/B-5527-2009; Chen, Szu-Fu/K-5040-2012	Hung, Tai-Ho/0000-0003-2354-7060; Lin, Chii-Wann/0000-0002-8721-3441; 	National Science Council of Taiwan, R.O.C. [98-2314-B-350-001-MY3]; Cheng Hsin General Hospital	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Cheng Hsin General Hospital	This work was supported by the National Science Council of Taiwan, R.O.C. (98-2314-B-350-001-MY3 to S.-F.C.) and the Cheng Hsin General Hospital (C.-C.C., S.-F.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Chang CF, 2011, AM J PATHOL, V178, P1749, DOI 10.1016/j.ajpath.2010.12.023; Chang YL, 2001, MOL PHARMACOL, V60, P507; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chi YS, 2003, BIOCHEM PHARMACOL, V66, P1271, DOI 10.1016/S0006-2952(03)00463-5; Cho J, 2004, BIOL PHARM BULL, V27, P1561, DOI 10.1248/bpb.27.1561; Cho JS, 2004, EUR J PHARMACOL, V485, P105, DOI 10.1016/j.ejphar.2003.11.064; Conti AC, 1998, J NEUROSCI, V18, P5663; Dong XQ, 2011, INFLAMM RES, V60, P533, DOI 10.1007/s00011-010-0300-7; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Downes CE, 2010, BRIT J PHARMACOL, V160, P1872, DOI 10.1111/j.1476-5381.2010.00864.x; Gao ZH, 1999, BBA-GEN SUBJECTS, V1472, P643, DOI 10.1016/S0304-4165(99)00152-X; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Huang GC, 2007, INT IMMUNOPHARMACOL, V7, P1054, DOI 10.1016/j.intimp.2007.04.001; Huang WH, 2006, BIOSCI BIOTECH BIOCH, V70, P2371, DOI 10.1271/bbb.50698; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kim H, 2001, NEUROSCI LETT, V309, P67, DOI 10.1016/S0304-3940(01)02028-6; Lee H, 2003, FASEB J, V17, P1943, DOI 10.1096/fj.03-0057fje; Lee SO, 2006, BIOCHEM BIOPH RES CO, V351, P118, DOI 10.1016/j.bbrc.2006.10.006; Lee YM, 2011, J CARDIOVASC PHARM, V58, P133, DOI 10.1097/FJC.0b013e31821a5078; LIU XF, 1990, MOL PHARMACOL, V37, P911; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Peng J, 2009, J ETHNOPHARMACOL, V124, P257, DOI 10.1016/j.jep.2009.04.031; Piao HZ, 2008, INT IMMUNOPHARMACOL, V8, P1658, DOI 10.1016/j.intimp.2008.07.018; Piao HZ, 2004, ARCH PHARM RES, V27, P930, DOI 10.1007/BF02975846; Qi Q, 2009, PHYTOTHER RES, V23, P417, DOI 10.1002/ptr.2645; Racke MK, 2009, CURR TOP MICROBIOL, V336, P155, DOI 10.1007/978-3-642-00549-7_9; Ransohoff RM, 1998, TRENDS NEUROSCI, V21, P154, DOI 10.1016/S0166-2236(97)01198-3; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shen SC, 2006, NEUROSCIENCE, V140, P477, DOI 10.1016/j.neuroscience.2006.02.028; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Son D, 2004, EUR J PHARMACOL, V493, P99, DOI 10.1016/j.ejphar.2004.04.017; Strauss KI, 2008, BRAIN BEHAV IMMUN, V22, P285, DOI 10.1016/j.bbi.2007.09.011; Tai MC, 2005, CNS DRUG REV, V11, P141; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Wakabayashi I, 2000, EUR J PHARMACOL, V406, P477, DOI 10.1016/S0014-2999(00)00695-6; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	49	60	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30294	10.1371/journal.pone.0030294	http://dx.doi.org/10.1371/journal.pone.0030294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272328	gold, Green Published, Green Submitted			2022-12-27	WOS:000301454400106
J	Lima, M; Navarrete, L; Gonzalez-Andujar, JL				Lima, Mauricio; Navarrete, Luis; Luis Gonzalez-Andujar, Jose			Climate Effects and Feedback Structure Determining Weed Population Dynamics in a Long-Term Experiment	PLOS ONE			English	Article							PAPAVER-RHOEAS; EMERGENCE; MODEL	Pest control is one of the areas in which population dynamic theory has been successfully applied to solve practical problems. However, the links between population dynamic theory and model construction have been less emphasized in the management and control of weed populations. Most management models of weed population dynamics have emphasized the role of the endogenous process, but the role of exogenous variables such as climate have been ignored in the study of weed populations and their management. Here, we use long-term data (22 years) on two annual weed species from a locality in Central Spain to determine the importance of endogenous and exogenous processes (local and large-scale climate factors). Our modeling study determined two different feedback structures and climate effects in the two weed species analyzed. While Descurainia sophia exhibited a second-order feedback and low climate influence, Veronica hederifolia was characterized by a first-order feedback structure and important effects from temperature and rainfall. Our results strongly suggest the importance of theoretical population dynamics in understanding plant population systems. Moreover, the use of this approach, discerning between the effect of exogenous and endogenous factors, can be fundamental to applying weed management practices in agricultural systems and to controlling invasive weedy species. This is a radical change from most approaches currently used to guide weed and invasive weedy species managements.	[Lima, Mauricio] Pontificia Univ Catolica Chile, CASEB, Santiago, Chile; [Navarrete, Luis] Inst Madrileno Invest & Desarrollo Rural Agr & Al, Dept Invest Agr, Alcala De Henares, Spain; [Luis Gonzalez-Andujar, Jose] CSIC, Inst Agr Sostenible, Dept Protecc Cultivos, Cordoba, Spain; [Luis Gonzalez-Andujar, Jose] LINCG CSIC PUC, Lab Int Cambio Global, Santiago, Chile	Pontificia Universidad Catolica de Chile; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Lima, M (corresponding author), Pontificia Univ Catolica Chile, CASEB, Alameda 340, Santiago, Chile.	andujar@cica.es	Lima, Mauricio/F-2722-2013; GONZALEZ-ANDUJAR, JOSE L./G-5671-2013	Lima, Mauricio/0000-0002-3700-2945; GONZALEZ-ANDUJAR, JOSE L./0000-0003-2356-4098	FEDER; Spanish Ministry of Innovation and Science [AGL 2009-7883]	FEDER(European Commission); Spanish Ministry of Innovation and Science(Spanish Government)	This work was supported by the FEDER funds and Spanish Ministry of Innovation and Science Grant AGL 2009-7883 (to JLG-A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; BERREBI A, 1991, AM J HEMATOL, V37, P138, DOI 10.1002/ajh.2830370219; Berryman A., 1999, PRINCIPLES POPULATIO; BERRYMAN AA, 1992, ECOLOGY, V73, P694, DOI 10.2307/1940776; BEST KF, 1977, CAN J PLANT SCI, V57, P499, DOI 10.4141/cjps77-073; FACELLI JM, 1991, BOT REV, V57, P1, DOI 10.1007/BF02858763; Freckleton RP, 2002, J APPL ECOL, V39, P699, DOI 10.1046/j.1365-2664.2002.00748.x; Ginzburg L. R., 2004, ECOLOGICAL ORBITS PL; Ginzburg LR, 2004, TRENDS ECOL EVOL, V19, P121, DOI 10.1016/j.tree.2003.11.004; Gonzalez-Andujar JL, 2006, AM NAT, V168, P318, DOI 10.1086/506915; Gonzalez-Andujar JL, 2000, FUNCT ECOL, V14, P524, DOI 10.1046/j.1365-2435.2000.00423.x; Hernanz JL, 2009, AGR ECOSYST ENVIRON, V133, P114, DOI 10.1016/j.agee.2009.05.009; Holst N, 2007, WEED RES, V47, P1, DOI 10.1111/j.1365-3180.2007.00534.x; Izquierdo J, 2009, WEED SCI, V57, P660, DOI 10.1614/WS-09-043.1; Larcher W, 2000, PLANT BIOSYST, V134, P279, DOI 10.1080/11263500012331350455; MORTIMER AM, 1989, WEED RES, V29, P229, DOI 10.1111/j.1365-3180.1989.tb00907.x; Pardini EA, 2009, ECOL APPL, V19, P387, DOI 10.1890/08-0845.1; Pastor J, 2006, OIKOS, V112, P698, DOI 10.1111/j.0030-1299.2006.14478.x; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; ROBERTS HA, 1978, WEED RES, V18, P41, DOI 10.1111/j.1365-3180.1978.tb01573.x; Royama T., 1992, ANAL POPULATION ECOL; THOMPSON L, 1994, J ECOL, V82, P63, DOI 10.2307/2261386; Torra J, 2008, WEED RES, V48, P136, DOI 10.1111/j.1365-3180.2007.00610.x; Turchin Peter, 2003, Monographs in Population Biology, V35, pi	24	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30569	10.1371/journal.pone.0030569	http://dx.doi.org/10.1371/journal.pone.0030569			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272362	Green Published, Green Submitted, gold			2022-12-27	WOS:000301454400140
J	Jung, RE; Chavez, RS; Flores, RA; Qualls, C; Sibbitt, WL; Roldan, CA				Jung, Rex E.; Chavez, Robert S.; Flores, Ranee A.; Qualls, Clifford; Sibbitt, Wilmer L., Jr.; Roldan, Carlos A.			White Matter Correlates of Neuropsychological Dysfunction in Systemic Lupus Erythematosus	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; SPATIAL STATISTICS; TRACT; RELIABILITY; PREVALENCE; BATTERY; INDEX; BRAIN	Patients diagnosed with Systemic Lupus Erythematosus have similar levels of neuropsychological dysfunction (i. e., 20-50%) as those with Neuropsychiatric Systemic Lupus Erythematosus (NPSLE). We hypothesized a gradient between cognition and white matter integrity, such that strongest brain-behavior relationships would emerge in NPSLE, intermediate in non-NPSLE, and minimal in controls. We studied thirty-one patients (16 non-NPSLE; 15 NPSLE), ranging in age from 18 to 59 years old (100% female), and eighteen age and gender matched healthy controls. DTI examinations were performed on a 1.5T scanner. A broad neuropsychological battery was administered, tapping attention, memory, processing speed, and executive functioning. The Total z-score consisted of the combined sum of all neuropsychological measures. In control subjects, we found no significant FA-Total z-score correlations. NPSLE, non-NPSLE, and control subjects differed significantly in terms of Total z-score (NPSLE = 22.25+/21.77, non-NPSLE = 21.22+/21.03, Controls = 20.10+/2.57; F = 13.2, p,. 001). In non-NPSLE subjects, FA within the right external capsule was significantly correlated with Total z-score. In NPSLE subjects, the largest FA-Total z-score clusters were observed within the left anterior thalamic radiation and right superior longitudinal fasciculus. In subsequent analyses the largest number of significant voxels linked FA with the Processing Speed z-score in NPSLE. The current results reflect objective white matter correlates of neuropsychological dysfunction in both NPSLE and (to a lesser degree) in non-NPSLE. non-NPSLE and NPSLE subjects did not differ significantly in terms of depression, as measured by the GDI; thus, previous hypotheses suggesting moderating effects of depression upon neuropsychological performance do not impact the current FA results.	[Jung, Rex E.] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA; [Jung, Rex E.; Chavez, Robert S.; Flores, Ranee A.] Univ New Mexico, Mind Res Network, Albuquerque, NM 87131 USA; [Qualls, Clifford] Dept Math, Albuquerque, NM USA; [Sibbitt, Wilmer L., Jr.; Roldan, Carlos A.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA	University of New Mexico; Lovelace Respiratory Research Institute; University of New Mexico; University of New Mexico	Jung, RE (corresponding author), Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA.	rex.jung@gmail.com	Chavez, Robert S./ABE-9303-2021; Sibbitt, Wilmer/AAI-7746-2020	Chavez, Robert S./0000-0001-7877-299X; Sibbitt, Wilmer/0000-0001-5872-160X; Breakspear, Michael/0000-0003-4943-3969; Jung, Rex/0000-0003-3718-0597	NIH-NHLBI [R01HL077422-01A3]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077422] Funding Source: NIH RePORTER	NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This manuscript is supported by R01HL077422-01A3 - NIH-NHLBI, to Carlos A. Roldan, M. D. It is also supported by R01HL077422-01A3 - NIH-NHLBI, to Carlos A. Roldan, M. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bosma GPT, 2003, AM J NEURORADIOL, V24, P850; Broca MP, 1861, B SOC ANATOMIQUE PAR; Brooks WM, 1999, J RHEUMATOL, V26, P81; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; CARBOTTE RM, 1986, J NERV MENT DIS, V174, P357, DOI 10.1097/00005053-198606000-00008; Emmer BJ, 2010, ARTHRITIS RHEUM-US, V62, P3716, DOI 10.1002/art.27717; Filley C. M, 2001, BEHAV NEUROLOGY WHIT; Filley CM, 2009, COGN BEHAV NEUROL, V22, P38, DOI 10.1097/WNN.0b013e318190d174; Gladman DD, 1997, ARTHRITIS RHEUM-US, V40, P809, DOI 10.1002/art.1780400506; Hughes M, 2007, ACTA RADIOL, V48, P213, DOI 10.1080/02841850601105825; Jung RE, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-65; Kozora E, 2004, ARTHRIT RHEUM-ARTHR, V51, P810, DOI 10.1002/art.20692; Kozora E, 2006, ARTHRIT RHEUM-ARTHR, V55, P628, DOI 10.1002/art.22101; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Luyendijk J, 2011, ARTHRITIS RHEUM-US, V63, P722, DOI 10.1002/art.30157; Monastero R, 2001, J NEUROL SCI, V184, P33, DOI 10.1016/S0022-510X(00)00492-5; Navarrete, 2000, Curr Treat Options Neurol, V2, P473, DOI 10.1007/s11940-000-0045-7; Sabet A, 1998, STROKE, V29, P2254, DOI 10.1161/01.STR.29.11.2254; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Sibbitt WL, 2010, SEMIN ARTHRITIS RHEU, V40, P32, DOI 10.1016/j.semarthrit.2009.08.005; SIBBITT WL, 1994, AM J NEURORADIOL, V15, P923; Sibbitt WL, 2003, J RHEUMATOL, V30, P1983; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Strauss E, 2006, COMPENDIUM NEUROPSYC; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zhang LJ, 2007, MAGN RESON IMAGING, V25, P399, DOI 10.1016/j.mri.2006.09.037; 1999, ARTHRITIS RHEUM, V42, P599	30	32	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e28373	10.1371/journal.pone.0028373	http://dx.doi.org/10.1371/journal.pone.0028373			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291880	gold, Green Published, Green Submitted			2022-12-27	WOS:000301703800001
J	Makarevitch, I; Thompson, A; Muehlbauer, GJ; Springer, NM				Makarevitch, Irina; Thompson, Addie; Muehlbauer, Gary J.; Springer, Nathan M.			Brd1 Gene in Maize Encodes a Brassinosteroid C-6 Oxidase	PLOS ONE			English	Article							RICE DWARF MUTANT; FUNCTIONAL-ANALYSIS; PLANT DEVELOPMENT; BIOSYNTHESIS; ARABIDOPSIS; CYTOCHROME-P450; MODULATORS; HOMOLOG; ENZYME	The role of brassinosteroids in plant growth and development has been well-characterized in a number of plant species. However, very little is known about the role of brassinosteroids in maize. Map-based cloning of a severe dwarf mutant in maize revealed a nonsense mutation in an ortholog of a brassinosteroid C-6 oxidase, termed brd1, the gene encoding the enzyme that catalyzes the final steps of brassinosteroid synthesis. Homozygous brd1-m1 maize plants have essentially no internode elongation and exhibit no etiolation response when germinated in the dark. These phenotypes could be rescued by exogenous application of brassinolide, confirming the molecular defect in the maize brd1-m1 mutant. The brd1-m1 mutant plants also display alterations in leaf and floral morphology. The meristem is not altered in size but there is evidence for differences in the cellular structure of several tissues. The isolation of a maize mutant defective in brassinosteroid synthesis will provide opportunities for the analysis of the role of brassinosteroids in this important crop system.	[Makarevitch, Irina] Hamline Univ, Dept Biol, St Paul, MN 55104 USA; [Thompson, Addie; Muehlbauer, Gary J.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Springer, Nathan M.] Univ Minnesota, Microbial & Plant Genom Inst, St Paul, MN 55108 USA; [Springer, Nathan M.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA	Mitchell Hamline School of Law; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Makarevitch, I (corresponding author), Hamline Univ, Dept Biol, St Paul, MN 55104 USA.	imakarevitch01@hamline.edu	Springer, Nathan/F-2680-2013	Springer, Nathan/0000-0002-7301-4759; Thompson, Addie/0000-0002-4442-6578	National Science Foundation [IOS-0922095, DBI-0820610]; National Science Foundation (MRI) [0957312]; Hamline Biology Department	National Science Foundation(National Science Foundation (NSF)); National Science Foundation (MRI)(National Science Foundation (NSF)); Hamline Biology Department	This research was supported by a grant from the National Science Foundation to NMS and IM (IOS-0922095), a grant from the National Science Foundation to GJM (DBI-0820610), a grant from the National Science Foundation to IM (MRI #0957312), and the Lund Fund from Hamline Biology Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Bishop GJ, 1999, P NATL ACAD SCI USA, V96, P1761, DOI 10.1073/pnas.96.4.1761; Clouse SD, 2011, PLANT CELL, V23, P1219, DOI 10.1105/tpc.111.084475; Fernandez MGS, 2009, TRENDS PLANT SCI, V14, P454, DOI 10.1016/j.tplants.2009.06.005; Fu Y, 2006, GENETICS, V174, P1671, DOI 10.1534/genetics.106.060376; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Gendron JM, 2007, CURR OPIN PLANT BIOL, V10, P436, DOI 10.1016/j.pbi.2007.08.015; Hartwig T, 2011, P NATL ACAD SCI USA, V108, P19814, DOI 10.1073/pnas.1108359108; Hong Z, 2005, PLANT CELL, V17, P2243, DOI 10.1105/tpc.105.030973; Hong Z, 2003, PLANT CELL, V15, P2900, DOI 10.1105/tpc.014712; Hong Z, 2002, PLANT J, V32, P495, DOI 10.1046/j.1365-313X.2002.01438.x; Jager CE, 2007, PLANT PHYSIOL, V143, P1894, DOI 10.1104/pp.106.093088; Kim YS, 2005, PHYTOCHEMISTRY, V66, P1000, DOI 10.1016/j.phytochem.2005.03.007; Lawit SJ, 2010, PLANT CELL PHYSIOL, V51, P1854, DOI 10.1093/pcp/pcq153; Li JM, 2007, TRENDS PLANT SCI, V12, P37, DOI 10.1016/j.tplants.2006.11.002; Liu SZ, 2010, GENETICS, V184, P19, DOI 10.1534/genetics.109.107557; Liu TS, 2007, PLANT CELL REP, V26, P2091, DOI 10.1007/s00299-007-0418-4; Mori M, 2002, PLANT PHYSIOL, V130, P1152, DOI 10.1104/pp.007179; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Neuffer MG, 1997, MUTANTS MAIZE; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schultz L, 2001, PLANT MOL BIOL, V47, P491, DOI 10.1023/A:1011894812794; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Shimada Y, 2001, PLANT PHYSIOL, V126, P770, DOI 10.1104/pp.126.2.770; Tanabe S, 2005, PLANT CELL, V17, P776, DOI 10.1105/tpc.104.024950; Tao YZ, 2004, PLANT SCI, V167, P743, DOI 10.1016/j.plantsci.2004.05.012; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; WINKLER RG, 1995, PLANT CELL, V7, P1307, DOI 10.1105/tpc.7.8.1307	31	92	105	7	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30798	10.1371/journal.pone.0030798	http://dx.doi.org/10.1371/journal.pone.0030798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292043	Green Published, gold, Green Submitted			2022-12-27	WOS:000301703800031
J	Songok, EM; Luo, M; Liang, B; Mclaren, P; Kaefer, N; Apidi, W; Boucher, G; Kimani, J; Wachihi, C; Sekaly, R; Fowke, K; Ball, BT; Plummer, FA				Songok, Elijah M.; Luo, Ma; Liang, Ben; Mclaren, Paul; Kaefer, Nadine; Apidi, Winnie; Boucher, Genevieve; Kimani, Joshua; Wachihi, Charles; Sekaly, Rafick; Fowke, Keith; Ball, Blake T.; Plummer, Francis A.			Microarray Analysis of HIV Resistant Female Sex Workers Reveal a Gene Expression Signature Pattern Reminiscent of a Lowered Immune Activation State	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DIPEPTIDYL-PEPTIDASE-IV; PERIPHERAL T-CELLS; IN-VITRO; HIV-1-INFECTED INDIVIDUALS; INFECTION; LYMPHOCYTES; MUCOSAL; CD26; CD4	To identify novel biomarkers for HIV-1 resistance, including pathways that may be critical in anti-HIV-1 vaccine design, we carried out a gene expression analysis on blood samples obtained from HIV-1 highly exposed seronegatives (HESN) from a commercial sex worker cohort in Nairobi and compared their profiles to HIV-1 negative controls. Whole blood samples were collected from 43 HIV-1 resistant sex workers and a similar number of controls. Total RNA was extracted and hybridized to the Affymetrix HUG 133 Plus 2.0 micro arrays (Affymetrix, Santa Clara CA). Output data was analysed through ArrayAssist software (Agilent, San Jose CA). More than 2,274 probe sets were differentially expressed in the HESN as compared to the control group (fold change >= 1.3; p value <= 0.0001, FDR <0.05). Unsupervised hierarchical clustering of the differentially expressed genes readily distinguished HESNs from controls. Pathway analysis through the KEGG signaling database revealed a majority of the impacted pathways (13 of 15, 87%) had genes that were significantly down regulated. The most down expressed pathways were glycolysis/gluconeogenesis, pentose phosphate, phosphatidyl inositol, natural killer cell cytotoxicity and T-cell receptor signaling. Ribosomal protein synthesis and tight junction genes were up regulated. We infer that the hallmark of HIV-1 resistance is down regulation of genes in key signaling pathways that HIV-1 depends on for infection.	[Songok, Elijah M.] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Songok, Elijah M.; Luo, Ma; Mclaren, Paul; Kaefer, Nadine; Apidi, Winnie; Kimani, Joshua; Fowke, Keith; Ball, Blake T.; Plummer, Francis A.] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Boucher, Genevieve; Sekaly, Rafick] Univ Montreal, Montreal, PQ, Canada; [Luo, Ma; Liang, Ben; Ball, Blake T.; Plummer, Francis A.] Publ Hlth Agcy Canada, Winnipeg, MB, Canada; [Kimani, Joshua; Wachihi, Charles] Univ Nairobi, Nairobi, Kenya	Kenya Medical Research Institute; Kenya Medical Research Institute; Universite de Montreal; Public Health Agency of Canada; University of Nairobi	Songok, EM (corresponding author), Kenya Govt Med Res Ctr, Nairobi, Kenya.	Esongok@kemri.org	Liang, Binhua/ABN-9806-2022	Songok, Elijah/0000-0001-7790-7063; Fowke, Keith/0000-0001-8227-6649; McLaren, Paul/0000-0001-6019-7018; Boucher, Genevieve/0000-0001-6389-9007; liang, binhua/0000-0002-1108-6407	Bill and Melinda Gates Foundation under Grand Challenges in Global Health (GCGH) initiative; Canada Institutes of Health Research (CIHR)	Bill and Melinda Gates Foundation under Grand Challenges in Global Health (GCGH) initiative; Canada Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded by Bill and Melinda Gates Foundation under Grand Challenges in Global Health (GCGH) initiative and the Canada Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCAMI J, 1995, EMBO J, V14, P1552, DOI 10.1002/j.1460-2075.1995.tb07141.x; An P, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030019; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Ball TB, 2007, AIDS, V21, P1091, DOI 10.1097/QAD.0b013e3280ef6ae1; Begaud E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-35; BENTWICH Z, 1995, IMMUNOL TODAY, V16, P187, DOI 10.1016/0167-5699(95)80119-7; Beyrer C, 1999, J INFECT DIS, V179, P59, DOI 10.1086/314556; Biasin M, 2000, J INFECT DIS, V182, P1365, DOI 10.1086/315873; BLAZQUEZ MV, 1992, J IMMUNOL, V149, P3073; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; Boyton RJ, 2007, CLIN EXP IMMUNOL, V149, P1, DOI 10.1111/j.1365-2249.2007.03424.x; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brown BK, 2007, J VIROL, V81, P2087, DOI 10.1128/JVI.02011-06; Burgener A, 2008, J PROTEOME RES, V7, P4446, DOI 10.1021/pr800406r; Carthagena L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-59; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Chugh P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-11; CLERICI M, 1993, AIDS, V7, P1427, DOI 10.1097/00002030-199311000-00004; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Drucker DJ, 1997, NAT BIOTECHNOL, V15, P673, DOI 10.1038/nbt0797-673; Dudoit S, 2003, BIOTECHNIQUES, P45; Finberg RW, 2007, REV MED VIROL, V17, P35, DOI 10.1002/rmv.525; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Francois F, 2003, J VIROL, V77, P2539, DOI 10.1128/JVI.77.4.2539-2549.2003; Gonzalez E, 2005, SCIENCE, V174, P5655; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; Hildebrandt M, 2001, SCAND J GASTROENTERO, V36, P1067, DOI 10.1080/003655201750422675; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Jennes W, 2006, CLIN EXP IMMUNOL, V143, P435, DOI 10.1111/j.1365-2249.2006.03017.x; Jennes W, 2006, J IMMUNOL, V177, P6588, DOI 10.4049/jimmunol.177.10.6588; Joint United Nations Programme on HIV/AIDS UNAIDS, 2008, REP GLOB AIDS EPID; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kallings LO, 2008, J INTERN MED, V263, P218, DOI 10.1111/j.1365-2796.2007.01910.x; Kaul R, 2001, AIDS, V15, P431, DOI 10.1097/00002030-200102160-00026; Kawata H, 2003, BIOCHEM J, V373, P747, DOI 10.1042/BJ20030171; KELKER HC, 1992, AIDS RES HUM RETROV, V8, P1355, DOI 10.1089/aid.1992.8.1355; Koblavi-Deme S, 2003, AIDS, V17, pS17, DOI 10.1097/00002030-200317003-00003; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9; Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52; Lester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; MacDonald KS, 2000, J INFECT DIS, V181, P1581, DOI 10.1086/315472; Martin MP, 2004, J VIROL, V78, P14053, DOI 10.1128/JVI.78.24.14053-14056.2004; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Modiano JF, 2008, IMMUNOL RES, V41, P137, DOI 10.1007/s12026-008-8017-1; MORIMOTO C, 1994, P NATL ACAD SCI USA, V91, P9960, DOI 10.1073/pnas.91.21.9960; Plummer FA, 1999, IMMUNOL LETT, V66, P27, DOI 10.1016/S0165-2478(98)00182-5; Pratley RE, 2007, CURR MED RES OPIN, V23, P919, DOI 10.1185/030079906X162746; Proost P, 1998, J BIOL CHEM, V273, P7222, DOI 10.1074/jbc.273.13.7222; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rits MAN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003975; ROOS D, 1973, EXP CELL RES, V77, P127, DOI 10.1016/0014-4827(73)90561-2; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; ROWLANDJONES SL, 1993, LANCET, V341, P860, DOI 10.1016/0140-6736(93)93063-7; Saez-Cirion A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-81; SCHUITEMAKER H, 1994, RES IMMUNOL, V145, P588, DOI 10.1016/S0923-2494(05)80038-0; Schweneker M, 2004, BIOCHEM BIOPH RES CO, V325, P751, DOI 10.1016/j.bbrc.2004.10.096; Songok EM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-343; Stover J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003729; Suy A, 2007, J INFECT DIS, V196, P1191, DOI 10.1086/521193; Tran HK, 2006, AIDS RES HUM RETROV, V22, P255, DOI 10.1089/aid.2006.22.255; Ueno M, 2005, DIABETOLOGIA, V48, P506, DOI 10.1007/s00125-004-1662-6; Valcke HS, 2006, AIDS, V20, P1984, DOI 10.1097/01.aids.0000247124.35129.e1; Vanham G, 1993, J ACQ IMMUN DEF SYND, P749; Wainberg MA, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-31; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Wutz A, 2007, CURR OPIN GENET DEV, V17, P387, DOI 10.1016/j.gde.2007.08.001; Xie Z, 2008, P NATL ACAD SCI USA, V105, P10859, DOI 10.1073/pnas.0800647105	72	44	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30048	10.1371/journal.pone.0030048	http://dx.doi.org/10.1371/journal.pone.0030048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291902	gold, Green Published, Green Submitted			2022-12-27	WOS:000301703800007
J	Costechareyre, D; Balmand, S; Condemine, G; Rahbe, Y				Costechareyre, Denis; Balmand, Severine; Condemine, Guy; Rahbe, Yvan			Dickeya dadantii, a Plant Pathogenic Bacterium Producing Cyt-Like Entomotoxins, Causes Septicemia in the Pea Aphid Acyrthosiphon pisum	PLOS ONE			English	Article							ERWINIA APHIDICOLA; EXPRESSION REVEALS; INSECT; POTATO; LOCUS; HOST	Dickeya dadantii (syn. Erwinia chrysanthemi) is a plant pathogenic bacteria that harbours a cluster of four horizontally-transferred, insect-specific toxin genes. It was recently shown to be capable of causing an acute infection in the pea aphid Acyrthosiphon pisum (Insecta: Hemiptera). The infection route of the pathogen, and the role and in vivo expression pattern of these toxins, remain unknown. Using bacterial numeration and immunolocalization, we investigated the kinetics and the pattern of infection of this phytopathogenic bacterium within its insect host. We compared infection by the wild-type strain and by the Cyt toxin-deficient mutant. D. dadantii was found to form dense clusters in many luminal parts of the aphid intestinal tract, including the stomach, from which it invaded internal tissues as early as day 1 post-infection. Septicemia occurred soon after, with the fat body being the main infected tissue, together with numerous early infections of the embryonic chains showing embryonic gut and fat body as the target organs. Generalized septicemia led to insect death when the bacterial load reached about 10(8) cfu. Some individual aphids regularly escaped infection, indicating an effective partial immune response to this bacteria. Cyt-defective mutants killed insects more slowly but were capable of localisation in any type of tissue. Cyt toxin expression appeared to be restricted to the digestive tract where it probably assisted in crossing over the first cell barrier and, thus, accelerating bacterial diffusion into the aphid haemocel. Finally, the presence of bacteria on the surface of leaves hosting infected aphids indicated that the insects could be vectors of the bacteria.	[Costechareyre, Denis; Balmand, Severine; Rahbe, Yvan] INSA Lyon, INRA, UMR203 BF2I, Villeurbanne, France; [Costechareyre, Denis; Condemine, Guy] Univ Lyon 1, UCBL Dept Biol, F-69622 Villeurbanne, France; [Costechareyre, Denis; Balmand, Severine; Condemine, Guy; Rahbe, Yvan] Univ Lyon, Lyon, France; [Costechareyre, Denis; Condemine, Guy] CNRS, MAP UMR5240, Villeurbanne, France	INRAE; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Costechareyre, D (corresponding author), INSA Lyon, INRA, UMR203 BF2I, Villeurbanne, France.	yvan.rahbe@lyon.inra.fr	Rahbe, Yvan/B-9389-2009	Rahbe, Yvan/0000-0002-0074-4443; COSTECHAREYRE, Denis/0000-0002-9258-7421; Condemine, Guy/0000-0002-3256-3815	ANR-Genoplante;  [ANR07GPLA002-Aphicibles]	ANR-Genoplante(French National Research Agency (ANR)); 	This study was funded by an ANR-Genoplante grant to GC, including a post-doctoral fellowship to DC, coordinated by YR (ANR07GPLA002-Aphicibles). The funders had no role in the study design, data collection and analysis, or preparation of the manuscript.	Altincicek B, 2011, DEV COMP IMMUNOL, V35, P1089, DOI 10.1016/j.dci.2011.03.017; Blot N, 2002, J BIOL CHEM, V277, P7936, DOI 10.1074/jbc.M109193200; Broderick NA, 2006, P NATL ACAD SCI USA, V103, P15196, DOI 10.1073/pnas.0604865103; Costechareyre D, 2010, ENVIRON MICROBIOL, V12, P3290, DOI 10.1111/j.1462-2920.2010.02305.x; Delangle A, 2007, J BACTERIOL, V189, P7053, DOI 10.1128/JB.00845-07; Duarte X, 2000, FEMS MICROBIOL LETT, V190, P81, DOI 10.1016/S0378-1097(00)00325-6; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Glasner JD, 2011, J BACTERIOL, V193, P2076, DOI 10.1128/JB.01513-10; Graf J, 2011, MBIO, V2, DOI 10.1128/mBio.00161-11; Grenier AM, 2006, APPL ENVIRON MICROB, V72, P1956, DOI 10.1128/AEM.72.3.1956-1965.2006; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Harada H, 1997, J GEN APPL MICROBIOL, V43, P349, DOI 10.2323/jgam.43.349; Harada H, 1997, J GEN APPL MICROBIOL, V43, P363, DOI 10.2323/jgam.43.363; Helias V, 2008, CAH AGRIC, V17, P349, DOI 10.1684/agr.2008.0216; HugouvieuxCottePattat N, 1996, ANNU REV MICROBIOL, V50, P213, DOI 10.1146/annurev.micro.50.1.213; KLOEPPER JW, 1981, AM POTATO J, V58, P165, DOI 10.1007/BF02854416; Laughton AM, 2011, J INSECT PHYSIOL, V57, P830, DOI 10.1016/j.jinsphys.2011.03.015; Mason KL, 2011, MBIO, V2, DOI 10.1128/mBio.00065-11; Nadarasah G, 2011, FEMS MICROBIOL REV, V35, P555, DOI 10.1111/j.1574-6976.2011.00264.x; Nakabachi A, 2005, P NATL ACAD SCI USA; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; RAHBE Y, 1993, ENTOMOL EXP APPL, V67, P149, DOI 10.1007/BF02386520; Shirasu-Hiza MM, 2007, CELL MICROBIOL, V9, P2775, DOI 10.1111/j.1462-5822.2007.01042.x; Stavrinides J, 2010, ENVIRON MICROBIOL, V12, P147, DOI 10.1111/j.1462-2920.2009.02056.x; Stavrinides J, 2009, APPL ENVIRON MICROB, V75, P2230, DOI 10.1128/AEM.02860-08	25	29	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30702	10.1371/journal.pone.0030702	http://dx.doi.org/10.1371/journal.pone.0030702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292023	gold, Green Published, Green Submitted			2022-12-27	WOS:000301639600048
J	Garcia, K; Gavilan, RG; Hofle, MG; Martinez-Urtaza, J; Espejo, RT				Garcia, Katherine; Gavilan, Ronnie G.; Hoefle, Manfred G.; Martinez-Urtaza, Jaime; Espejo, Romilio T.			Microevolution of Pandemic Vibrio parahaemolyticus Assessed by the Number of Repeat Units in Short Sequence Tandem Repeat Regions	PLOS ONE			English	Article							LOCUS VARIABLE-NUMBER; STEPWISE MUTATION; YERSINIA-PESTIS; DIARRHEA; STRAINS; O3-K6; EVOLUTION; EPIDEMIOLOGY; EMERGENCE; OUTBREAKS	The emergence of the pandemic strain Vibrio parahaemolyticus O3:K6 in 1996 caused a large increase of diarrhea outbreaks related to seafood consumption in Southeast Asia, and later worldwide. Isolates of this strain constitutes a clonal complex, and their effectual differentiation is possible by comparison of their variable number tandem repeats (VNTRs). The differentiation of the isolates by the differences in VNTRs will allow inferring the population dynamics and microevolution of this strain but this requires knowing the rate and mechanism of VNTRs' variation. Our study of mutants obtained after serial cultivation of clones showed that mutation rates of the six VNTRs examined are on the order of 10(-4) mutant per generation and that difference increases by stepwise addition of single mutations. The single stepwise mutation (SSM) was deduced because mutants with 1, 2, 3, or more repeat unit deletions or insertions follow a geometric distribution. Plausible phylogenetic trees are obtained when, according to SSM, the genetic distance between clusters with different number of repeats is assessed by the absolute differences in repeats. Using this approach, mutants originated from different isolates of pandemic V. parahaemolyticus after serial cultivation are clustered with their parental isolates. Additionally, isolates of pandemic V. parahaemolyticus from Southeast Asia, Tokyo, and northern and southern Chile are clustered according their geographical origin. The deepest split in these four populations is observed between the Tokyo and southern Chile populations. We conclude that proper phylogenetic relations and successful tracing of pandemic V. parahaemolyticus requires measuring the differences between isolates by the absolute number of repeats in the VNTRs considered.	[Garcia, Katherine; Espejo, Romilio T.] Univ Chile, INTA, Santiago, Chile; [Gavilan, Ronnie G.; Martinez-Urtaza, Jaime] Univ Santiago de Compostela, Inst Acuicultura, Santiago De Compostela, Spain; [Hoefle, Manfred G.] Helmholtz Ctr Infect Res HZI, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany	Universidad de Chile; Universidade de Santiago de Compostela; Helmholtz Association; Helmholtz-Center for Infection Research	Espejo, RT (corresponding author), Univ Chile, INTA, Santiago, Chile.	romilio.espejo@gmail.com	Martinez-Urtaza, Jaime/ABG-5429-2020; Martinez-Urtaza, Jaime/A-5528-2015; Espejo, Romilio T/J-3183-2015	Martinez-Urtaza, Jaime/0000-0001-6219-0418; Espejo, Romilio T/0000-0003-0495-4576; Gavilan, Ronnie/0000-0003-1437-5607	Fondo Nacional de Ciencia y Tecnologia (FONDECYT), Chile [1070658, 1110425]	Fondo Nacional de Ciencia y Tecnologia (FONDECYT), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Grants # 1070658 and 1110425 from Fondo Nacional de Ciencia y Tecnologia (FONDECYT), Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, BIONUMERICS MANUAL V, P263; Ansede-Bermejo J, 2010, MOL ECOL, V19, P3924, DOI 10.1111/j.1365-294X.2010.04782.x; Calabrese PP, 2001, GENETICS, V159, P839; Chowdhury A, 2004, MICROBIOL IMMUNOL, V48, P319, DOI 10.1111/j.1348-0421.2004.tb03513.x; Chowdhury NR, 2004, J CLIN MICROBIOL, V42, P1280, DOI 10.1128/JCM.42.3.1280-1282.2004; Eisen J. A., 1999, MICROSATELLITES EVOL, P34; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Fuenzalida L, 2006, ENVIRON MICROBIOL, V8, P675, DOI 10.1111/j.1462-2920.2005.00946.x; Fuenzalida L, 2007, INT J FOOD MICROBIOL, V117, P270, DOI 10.1016/j.ijfoodmicro.2007.03.011; Garcia K, 2009, APPL ENVIRON MICROB, V75, P7482, DOI 10.1128/AEM.01662-09; Ghosh R, 2008, FEMS MICROBIOL LETT, V288, P196, DOI 10.1111/j.1574-6968.2008.01352.x; Girard JM, 2004, P NATL ACAD SCI USA, V101, P8408, DOI 10.1073/pnas.0401561101; Goldstein DB, 1999, GENETICS, V151, P797; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Gonzalez-Escalona N, 2005, EMERG INFECT DIS, V11, P129, DOI 10.3201/eid1101.040762; Gonzalez-Escalona N, 2008, J BACTERIOL, V190, P2831, DOI 10.1128/JB.01808-07; Hall BG, 2010, J CLIN MICROBIOL, V48, P1997, DOI 10.1128/JCM.00149-10; Han HH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-570; Harth E, 2009, EMERG INFECT DIS, V15, P163, DOI 10.3201/eid1502.071269; Harth-Chu E, 2009, APPL ENVIRON MICROB, V75, P4079, DOI 10.1128/AEM.02729-08; Iida T, 2006, BIOLOGY OF VIBRIOS, P340; Kimura B, 2008, J MICROBIOL METH, V72, P313, DOI 10.1016/j.mimet.2007.12.014; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Li YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006000; Lindstedt BA, 2005, ELECTROPHORESIS, V26, P2567, DOI 10.1002/elps.200500096; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Matsumoto C, 2000, J CLIN MICROBIOL, V38, P578, DOI 10.1128/JCM.38.2.578-585.2000; Monteil M, 2007, MICROBIOL-SGM, V153, P1141, DOI 10.1099/mic.0.2006/001164-0; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Nasu H, 2000, J CLIN MICROBIOL, V38, P2156; Okuda N, 1997, J CLIN MICROBIOL, V35, P3150, DOI 10.1128/JCM.35.12.3150-3155.1997; Papadopoulos D, 1999, P NATL ACAD SCI USA, V96, P3807, DOI 10.1073/pnas.96.7.3807; Pei YX, 2008, JPN J INFECT DIS, V61, P58; Price EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000725; Rabsch W, 2004, APPL ENVIRON MICROB, V70, P664, DOI 10.1128/AEM.70.2.664-669.2004; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; Sutton A, 2000, J BACTERIOL, V182, P4375, DOI 10.1128/JB.182.16.4375-4379.2000; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van Belkum A, 2007, FEMS IMMUNOL MED MIC, V49, P22, DOI 10.1111/j.1574-695X.2006.00173.x; Vogler AJ, 2007, MUTAT RES-FUND MOL M, V616, P145, DOI 10.1016/j.mrfmmm.2006.11.007; Vogler AJ, 2006, J BACTERIOL, V188, P4253, DOI 10.1128/JB.00001-06; Wong HC, 2000, APPL ENVIRON MICROB, V66, P3981, DOI 10.1128/AEM.66.9.3981-3986.2000	43	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30823	10.1371/journal.pone.0030823	http://dx.doi.org/10.1371/journal.pone.0030823			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292049	Green Submitted, gold, Green Published			2022-12-27	WOS:000301639600057
J	Coupe, B; Grit, I; Hulin, P; Randuineau, G; Parnet, P				Coupe, Berengere; Grit, Isabelle; Hulin, Philippe; Randuineau, Gwenaelle; Parnet, Patricia			Postnatal Growth after Intrauterine Growth Restriction Alters Central Leptin Signal and Energy Homeostasis	PLOS ONE			English	Article							CATCH-UP GROWTH; DIET-INDUCED OBESITY; DEVELOPMENTAL ORIGINS; HYPOTHALAMIC NEURONS; PROTEIN RESTRICTION; ADIPOSE-TISSUE; EXPRESSION; TRANSCRIPTION-3; TRANSDUCER; MECHANISMS	Intrauterine growth restriction (IUGR) is closely linked with metabolic diseases, appetite disorders and obesity at adulthood. Leptin, a major adipokine secreted by adipose tissue, circulates in direct proportion to body fat stores, enters the brain and regulates food intake and energy expenditure. Deficient leptin neuronal signalling favours weight gain by affecting central homeostatic circuitry. The aim of this study was to determine if leptin resistance was programmed by perinatal nutritional environment and to decipher potential cellular mechanisms underneath. We clearly demonstrated that 5 months old IUGR rats develop a decrease of leptin sentivity, characterized by no significant reduction of food intake following an intraperitoneal injection of leptin. Apart from the resistance to leptin injection, results obtained from IUGR rats submitted to rapid catch-up growth differed from those of IUGR rats with no catch-up since we observed, for the first group only, fat accumulation, increased appetite for food rich in fat and increased leptin synthesis. Centrally, the leptin resistant state of both groups was associated with a complex and not always similar changes in leptin receptor signalling steps. Leptin resistance in IUGR rats submitted to rapid catch-up was associated with alteration in AKT and mTOR pathways. Alternatively, in IUGR rats with no catch-up, leptin resistance was associated with low hypothalamic expression of LepRa and LepRb. This study reveals leptin resistance as an early marker of metabolic disorders that appears before any evidence of body weight increase in IUGR rats but whose mechanisms could depend of nutritional environment of the perinatal period.	[Coupe, Berengere; Grit, Isabelle; Randuineau, Gwenaelle; Parnet, Patricia] Univ Nantes Atlantique, UMR Physiol Adaptat Nutr 1280, Nantes, France; [Coupe, Berengere; Grit, Isabelle; Randuineau, Gwenaelle; Parnet, Patricia] Res Ctr Human Nutr Nantes, Nantes, France; [Hulin, Philippe] Univ Nantes, Plate Forme MicroPICell IFR26 Inst Rech Therapeut, Nantes, France	Nantes Universite; Nantes Universite	Coupe, B (corresponding author), Univ Nantes Atlantique, UMR Physiol Adaptat Nutr 1280, Nantes, France.	patricia.parnet@univ-nantes.fr	Parnet, Patricia/AAW-5064-2021; Parnet, Patricia/GOH-1209-2022		INRA; Region Pays de la Loire; La Fondation Louis Bonduelle (France); Agence Nationale de la Recherche (ANR) [PNRA 2005-009]	INRA; Region Pays de la Loire(Region Pays de la Loire); La Fondation Louis Bonduelle (France); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	BC was sponsored by a doctoral fellowship from INRA and Region Pays de la Loire and by a grant from La Fondation Louis Bonduelle (France). This study was supported by a grant from the Agence Nationale de la Recherche (ANR PNRA 2005-009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Alexandre-Gouabau MC, 2011, J PROTEOME RES, V10, P3292, DOI 10.1021/pr2003193; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Bol VV, 2009, AM J PHYSIOL-REG I, V297, pR291, DOI 10.1152/ajpregu.90497.2008; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cota D, 2008, J NEUROSCI, V28, P7202, DOI 10.1523/JNEUROSCI.1389-08.2008; Coupe B, 2010, ENDOCRINOLOGY, V151, P702, DOI 10.1210/en.2009-0893; Coupe B, 2009, AM J PHYSIOL-REG I, V297, pR813, DOI 10.1152/ajpregu.00201.2009; Desai M, 2007, REPROD SCI, V14, P329, DOI 10.1177/1933719107303983; Elmquist JK, 1997, ENDOCRINOLOGY, V138, P839, DOI 10.1210/en.138.2.839; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x; Gong L, 2008, ENDOCRINOLOGY, V149, P3346, DOI 10.1210/en.2007-0945; Grove KL, 2003, PHYSIOL BEHAV, V79, P47, DOI 10.1016/S0031-9384(03)00104-5; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HAMILTON BS, 1995, NAT MED, V1, P953, DOI 10.1038/nm0995-953; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Metlakunta AS, 2008, ENDOCRINOLOGY, V149, P1121, DOI 10.1210/en.2007-1307; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005; Morris D, 2009, AM J PHYSL ENDOCRINO; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; Myers MG, 2004, RECENT PROG HORM RES, V59, P287, DOI 10.1210/rp.59.1.287; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Orozco-Solis R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013537; Paxinos G, 2005, RAT BRAIN STREREOTAX; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Sahu A, 2011, NEUROENDOCRINOLOGY, V93, P201, DOI 10.1159/000326785; Smith SR, 2001, METABOLISM, V50, P425, DOI 10.1053/meta.2001.21693; Xu AW, 2007, ENDOCRINOLOGY, V148, P72, DOI 10.1210/en.2006-1119; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101	37	42	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30616	10.1371/journal.pone.0030616	http://dx.doi.org/10.1371/journal.pone.0030616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291999	gold, Green Published, Green Submitted			2022-12-27	WOS:000301570600064
J	Kalisch, T; Kattenstroth, JC; Kowalewski, R; Tegenthoff, M; Dinse, HR				Kalisch, Tobias; Kattenstroth, Jan-Christoph; Kowalewski, Rebecca; Tegenthoff, Martin; Dinse, Hubert R.			Cognitive and Tactile Factors Affecting Human Haptic Performance in Later Life	PLOS ONE			English	Article							ENTRANCE TEST-SCORES; SPATIAL ACUITY; OLD-AGE; SEX-DIFFERENCES; MENTAL ROTATION; GENDER-DIFFERENCES; COMMON OBJECTS; AGING BRAIN; DISCRIMINATION; STABILITY	Background: Vision and haptics are the key modalities by which humans perceive objects and interact with their environment in a target-oriented manner. Both modalities share higher-order neural resources and the mechanisms required for object exploration. Compared to vision, the understanding of haptic information processing is still rudimentary. Although it is known that haptic performance, similar to many other skills, decreases in old age, the underlying mechanisms are not clear. It is yet to be determined to what extent this decrease is related to the age-related loss of tactile acuity or cognitive capacity. Methodology/Principal Findings: We investigated the haptic performance of 81 older adults by means of a cross-modal object recognition test. Additionally, we assessed the subjects' tactile acuity with an apparatus-based two-point discrimination paradigm, and their cognitive performance by means of the non-verbal Raven-Standard-Progressive matrices test. As expected, there was a significant age-related decline in performance on all 3 tests. With the exception of tactile acuity, this decline was found to be more distinct in female subjects. Correlation analyses revealed a strong relationship between haptic and cognitive performance for all subjects. Tactile performance, on the contrary, was only significantly correlated with male subjects' haptic performance. Conclusions: Haptic object recognition is a demanding task in old age, especially when it comes to the exploration of complex, unfamiliar objects. Our data support a disproportionately higher impact of cognition on haptic performance as compared to the impact of tactile acuity. Our findings are in agreement with studies reporting an increase in co-variation between individual sensory performance and general cognitive functioning in old age.	[Kalisch, Tobias; Tegenthoff, Martin] Ruhr Univ Bochum, Dept Neurol, BG Kliniken Bergmannsheil, Bochum, Germany; [Kalisch, Tobias; Kattenstroth, Jan-Christoph; Kowalewski, Rebecca; Dinse, Hubert R.] Ruhr Univ Bochum, Neural Plast Lab, Inst Neuroinformat, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Kalisch, T (corresponding author), Ruhr Univ Bochum, Dept Neurol, BG Kliniken Bergmannsheil, Univ Str 150, Bochum, Germany.	tobias.kalisch@rub.de	Kalisch, Tobias/AAY-4182-2021	Kalisch, Tobias/0000-0003-4206-4283; dinse, hubert/0000-0001-9024-0451	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [Di 334/19-1, SFB 874, Te 315/4-1]; FoRUM [F637-08]; Allgemeiner Deutscher Tanzlehrerverband (ADTV)	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); FoRUM; Allgemeiner Deutscher Tanzlehrerverband (ADTV)	This research was supported by Grants from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) to HRD (Di 334/19-1, SFB 874) and MT (Te 315/4-1, SFB 874) and a Grant from FoRUM (F637-08) to TK. J-CK is a recipient of a stipend from the Allgemeiner Deutscher Tanzlehrerverband (ADTV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedi A, 2005, EXP BRAIN RES, V166, P559, DOI 10.1007/s00221-005-2396-5; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Amirjani N, 2007, MUSCLE NERVE, V35, P788, DOI 10.1002/mus.20750; [Anonymous], 1998, G FACTOR; Anstey KJ, 1999, PSYCHOL AGING, V14, P605, DOI 10.1037/0882-7974.14.4.605; Anstey KJ, 1997, PSYCHOL AGING, V12, P137, DOI 10.1037/0882-7974.12.1.137; Anstey KJ, 2001, J GERONTOL B-PSYCHOL, V56, pP3, DOI 10.1093/geronb/56.1.P3; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Baltes PB, 1999, BERLIN AGING STUDY A, P552; Besne I, 2002, ARCH DERMATOL, V138, P1445, DOI 10.1001/archderm.138.11.1445; BOUCHE P, 1993, J NEUROL, V240, P263, DOI 10.1007/BF00838158; Brauer SG, 2001, J GERONTOL A-BIOL, V56, pM489, DOI 10.1093/gerona/56.8.M489; Brown LA, 1999, J GERONTOL A-BIOL, V54, pM165, DOI 10.1093/gerona/54.4.M165; BRUCE MF, 1980, J NEUROL NEUROSUR PS, V43, P730, DOI 10.1136/jnnp.43.8.730; CASEY MB, 1995, DEV PSYCHOL, V31, P697, DOI 10.1037/0012-1649.31.4.697; Casey MB, 1997, DEV PSYCHOL, V33, P669, DOI 10.1037/0012-1649.33.4.669; Craddock M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008009; Craddock M, 2009, ATTEN PERCEPT PSYCHO, V71, P910, DOI 10.3758/APP.71.4.910; CRAIK FIM, 1994, CURR DIR PSYCHOL SCI, V3, P155, DOI 10.1111/1467-8721.ep10770653; CUA AB, 1990, ARCH DERMATOL RES, V282, P283, DOI 10.1007/BF00375720; DELLON AL, 1983, J HAND SURG-AM, V8, P865; Desrosiers J, 1999, EXP GERONTOL, V34, P393, DOI 10.1016/S0531-5565(99)00018-2; Dinse H. R., 2009, SAGE ENCY PERCEPTION, P21; Dinse H.R., 2005, ACM T APPL PERCEPT, V2, P71, DOI DOI 10.1145/1060581.1060583; Dinse HR, 2005, ACTA NEUROCHIR SUPPL, V93, P79; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; Dinse HR, 2006, ANN NEUROL, V60, P88, DOI 10.1002/ana.20862; Doubal S, 1998, Sb Lek, V99, P423; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Geiser C, 2008, INTELLIGENCE, V36, P556, DOI 10.1016/j.intell.2007.12.003; Godde B, 2000, J NEUROSCI, V20, P1597; Hsiao SS, 2008, HUMAN HAPTIC PERCEPT, P103; Iwasaki Teruko, 2003, Okajimas Folia Anatomica Japonica, V79, P185, DOI 10.2535/ofaj.79.185; James TW, 2007, CAN J EXP PSYCHOL, V61, P219, DOI 10.1037/cjep2007023; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; JENSEN AR, 1993, ANN NY ACAD SCI, V702, P103, DOI 10.1111/j.1749-6632.1993.tb17244.x; Kalisch T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-58; Kalisch T, 2010, NEURAL PLAST, V2010, DOI 10.1155/2010/690531; Kalisch T, 2008, CLIN INTERV AGING, V3, P673, DOI 10.2147/CIA.S3174; Kalisch T, 2009, CEREB CORTEX, V19, P1530, DOI 10.1093/cercor/bhn190; Kattenstroth JC, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00031; Kattenstroth JC, 2009, FRONTIERS NEUROSCIEN, V3, P100; KLATZKY RL, 1985, PERCEPT PSYCHOPHYS, V37, P299, DOI 10.3758/BF03211351; KLEINMAN JM, 1978, J GERONTOL, V33, P521, DOI 10.1093/geronj/33.4.521; Kucian K, 2005, PSYCHOL SCI, V47, P112; Lacey S, 2010, EUR J NEUROSCI, V31, P1882, DOI 10.1111/j.1460-9568.2010.07204.x; Lacey S, 2010, NEUROIMAGE, V49, P1977, DOI 10.1016/j.neuroimage.2009.10.081; Lawson R, 2009, J EXP PSYCHOL HUMAN, V35, P911, DOI 10.1037/a0015025; Lederman SJ, 2009, ATTEN PERCEPT PSYCHO, V71, P1439, DOI 10.3758/APP.71.7.1439; Lederman SJ, 2004, PERCEPT PSYCHOPHYS, V66, P618, DOI 10.3758/BF03194906; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; LEDERMAN SJ, 1990, COGNITIVE PSYCHOL, V22, P421, DOI 10.1016/0010-0285(90)90009-S; Legge GE, 2008, PERCEPT PSYCHOPHYS, V70, P1471, DOI 10.3758/PP.70.8.1471; Li KZH, 2002, NEUROSCI BIOBEHAV R, V26, P777, DOI 10.1016/S0149-7634(02)00073-8; Li SC, 2004, PSYCHOL SCI, V15, P155, DOI 10.1111/j.0956-7976.2004.01503003.x; Li SC, 1998, INTELLIGENCE, V26, P99, DOI 10.1016/S0160-2896(99)80057-9; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Lindenberger U, 1997, PSYCHOL AGING, V12, P410, DOI 10.1037/0882-7974.12.3.410; Lindenberger U, 2001, PSYCHOL AGING, V16, P196, DOI 10.1037//0882-7974.16.2.196; Miquee A, 2008, NEUROSCIENCE, V152, P29, DOI 10.1016/j.neuroscience.2007.12.021; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Norman JF, 2006, PERCEPTION, V35, P1383, DOI 10.1068/p5504; Norman JF, 2011, ATTEN PERCEPT PSYCHO, V73, P908, DOI 10.3758/s13414-010-0053-y; Park D C, 2001, Dialogues Clin Neurosci, V3, P151; Park D. C., 2000, COGNITIVE AGING PRIM, V11, P3; Peters A, 2002, J NEUROCYTOL, V31, P581, DOI 10.1023/A:1025731309829; PICHORAFULLER MK, 1995, J ACOUST SOC AM, V97, P593, DOI 10.1121/1.412282; Pleger B, 2001, P NATL ACAD SCI USA, V98, P12255, DOI 10.1073/pnas.191176298; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Raven J, 2000, MANUAL RAVENS PRO S3; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Rivner MH, 2001, MUSCLE NERVE, V24, P1134, DOI 10.1002/mus.1124; Roberts JE, 2000, DEV NEUROPSYCHOL, V17, P199, DOI 10.1207/S15326942DN1702_04; Rossini PM, 2007, PROG NEUROBIOL, V83, P375, DOI 10.1016/j.pneurobio.2007.07.010; ROZNOWSKI M, 1993, INTELLIGENCE, V17, P361, DOI 10.1016/0160-2896(93)90005-P; Salthouse TA, 2003, PSYCHOL AGING, V18, P91, DOI 10.1037/0882-7974.18.1.91; Salthouse TA, 1996, J GERONTOL B-PSYCHOL, V51, pP317, DOI 10.1093/geronb/51B.6.P317; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Sathian K, 1997, NEUROLOGY, V49, P168, DOI 10.1212/WNL.49.1.168; Saucier DM, 2002, PERS INDIV DIFFER, V32, P1101, DOI 10.1016/S0191-8869(01)00106-4; Schafer S., 2006, EUR REV AGING PHYS A, V3, P45, DOI DOI 10.1007/S11556-006-0007-5; Schoning S, 2007, NEUROPSYCHOLOGIA, V45, P3203, DOI 10.1016/j.neuropsychologia.2007.06.011; Sowell ER, 2004, NEUROSCIENTIST, V10, P372, DOI 10.1177/1073858404263960; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Speranza F, 2000, PSYCHOL AGING, V15, P253, DOI 10.1037/0882-7974.15.2.253; STEVENS JC, 1995, SOMATOSENS MOT RES, V12, P29, DOI 10.3109/08990229509063140; STEVENS JC, 1992, J GERONTOL, V47, pP35, DOI 10.1093/geronj/47.1.P35; Tremblay F, 2003, SOMATOSENS MOT RES, V20, P127, DOI 10.1080/0899022031000105154; Tremblay F, 2002, SOMATOSENS MOT RES, V19, P101, DOI 10.1080/08990220120113066; Turlejski K, 2002, PROG BRAIN RES, V136, P39; Valerio BCO, 2004, ARQ NEURO-PSIQUIAT, V62, P114, DOI 10.1590/S0004-282X2004000100020; Vega-Bermudez F, 2004, PERCEPT PSYCHOPHYS, V66, P60, DOI 10.3758/BF03194861; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; VERNON PA, 1993, PERS INDIV DIFFER, V14, P413, DOI 10.1016/0191-8869(93)90310-Y; Weiss E, 2003, NEUROSCI LETT, V344, P169, DOI 10.1016/S0304-3940(03)00406-3; WESTER P, 1984, NEUROBIOL AGING, V5, P199, DOI 10.1016/0197-4580(84)90063-0; Whalley LJ, 2004, AGEING RES REV, V3, P369, DOI 10.1016/j.arr.2004.05.001; Wu CW, 2006, ARCH PHYS MED REHAB, V87, P351, DOI 10.1016/j.apmr.2005.11.019; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139	100	37	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30420	10.1371/journal.pone.0030420	http://dx.doi.org/10.1371/journal.pone.0030420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	909NE	22291952	gold, Green Published, Green Submitted			2022-12-27	WOS:000301570600041
J	Kalt, I; Levy, A; Borodianskiy-Shteinberg, T; Sarid, R				Kalt, Inna; Levy, Ayelet; Borodianskiy-Shteinberg, Tatyana; Sarid, Ronit			Nucleolar Localization of GLTSCR2/PICT-1 Is Mediated by Multiple Unique Nucleolar Localization Sequences	PLOS ONE			English	Article							TUMOR-SUPPRESSOR CANDIDATE; NUCLEAR EXPORT; PROTEIN; SIGNALS; NOP53P; PREDICTION	The human glioma tumor suppressor candidate region 2 gene product, GLTSCR2, also called 'protein interacting with carboxyl terminus 1' (PICT-1), has been implicated in the regulation of two major tumor suppressor proteins, PTEN and p53, and reported to bind the membrane-cytoskeleton regulator of cell signaling, Merlin. PICT-1 is a nucleolar protein, conserved among eukaryotes, and its yeast homolog has been functionally associated with ribosomal RNA processing. By means of confocal microscopy of EGFP and myc-tagged PICT-1 fusion proteins, we delineate that the nucleolar localization of PICT-1 is mediated by two independent nucleolar localization sequences (NoLS). Unlike most NoLSs, these NoLSs are relatively long with flexible boundaries and contain arginine and leucine clusters. In addition, we show that PICT-1 exhibits a nucleolar distribution similar to proteins involved in ribosomal RNA processing, yet does not colocalize precisely with either UBF1 or Fibrillarin under normal or stressed conditions. Identification of the precise location of PICT-1 and the signals that mediate its nucleolar localization is an important step towards advancing our understanding of the demonstrated influence of this protein on cell fate and tumorigenesis.	[Kalt, Inna; Levy, Ayelet; Borodianskiy-Shteinberg, Tatyana; Sarid, Ronit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University	Kalt, I (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	saridr@mail.biu.ac.il			Israel Cancer Association; Chief Scientist's Office of the Ministry of Health Israel; Israel Science Foundation [709/10]; NICHD	Israel Cancer Association; Chief Scientist's Office of the Ministry of Health Israel; Israel Science Foundation(Israel Science Foundation); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the Israel Cancer Association (http://www.cancer.org.il/), the Chief Scientist's Office of the Ministry of Health Israel (http://www.health.gov.il/pages/default.asp?PageId = 873&catld=45&maincat=14), and the Israel Science Foundation (Grant No. 709/10)(http://www.isf.org.il/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Yaron Shav-Tal for helpful discussion and Noa Kinor for technical support and advice. Portions of this work will be submitted to Bar Ilan Univeristy, Ramat Gan, Israel, by T. Borodianskiy-Shteinberg in partial fulfillment of the degree of Doctor of Philosophy. The anti-myc developed by Prof. Bishop, J.M. was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242.	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boyne JR, 2006, P NATL ACAD SCI USA, V103, P15190, DOI 10.1073/pnas.0604890103; Bruni R, 1999, J VIROL, V73, P3810, DOI 10.1128/JVI.73.5.3810-3817.1999; Chen HB, 2011, INT J BIOCHEM CELL B, V43, P545, DOI 10.1016/j.biocel.2010.12.011; Corredor AG, 2009, J VIROL, V83, P12842, DOI 10.1128/JVI.01613-09; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Granato DC, 2008, FEBS J, V275, P4164, DOI 10.1111/j.1742-4658.2008.06565.x; Hahn MA, 2007, FEBS LETT, V581, P5070, DOI 10.1016/j.febslet.2007.09.050; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Huang HS, 2005, ARCH BIOCHEM BIOPHYS, V443, P33, DOI 10.1016/j.abb.2005.08.021; Kakuk A, 2008, EXP CELL RES, V314, P2376, DOI 10.1016/j.yexcr.2008.05.006; Kalt I, 2010, J VIROL, V84, P2935, DOI 10.1128/JVI.00757-09; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim JY, 2011, AM J PATHOL, V179, P1257, DOI 10.1016/j.ajpath.2011.05.041; Kim YJ, 2008, J PATHOL, V216, P218, DOI 10.1002/path.2401; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Luo M, 2004, TRAFFIC, V5, P847, DOI 10.1111/j.1600-0854.2004.00227.x; Nemeth A, 2011, TRENDS GENET, V27, P149, DOI 10.1016/j.tig.2011.01.002; Okahara F, 2004, J BIOL CHEM, V279, P45300, DOI 10.1074/jbc.C400377200; Okahara F, 2006, MOL BIOL CELL, V17, P4888, DOI 10.1091/mbc.E06-04-0301; Pederson T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000521; Raska I, 2006, CURR OPIN CELL BIOL, V18, P325, DOI 10.1016/j.ceb.2006.04.008; Sasaki M, 2011, NAT MED, V17, P944, DOI 10.1038/nm.2392; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Smith JS, 2000, GENOMICS, V64, P44, DOI 10.1006/geno.1999.6101; Sydorskyy Y, 2005, BIOCHEM J, V388, P819, DOI 10.1042/BJ20041297; Thomson E, 2005, RNA, V11, P1215, DOI 10.1261/rna.2720205; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Yim JH, 2007, CELL DEATH DIFFER, V14, P1872, DOI 10.1038/sj.cdd.4402204; Yu B, 2005, EXP CELL RES, V311, P218, DOI 10.1016/j.yexcr.2005.08.012; Zhang HY, 2010, BIOCHEM BIOPH RES CO, V391, P651, DOI 10.1016/j.bbrc.2009.11.114	38	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30825	10.1371/journal.pone.0030825	http://dx.doi.org/10.1371/journal.pone.0030825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292050	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600084
J	Nogueira-Silva, C; Piairo, P; Carvalho-Dias, E; Peixoto, FO; Moura, RS; Correia-Pinto, J				Nogueira-Silva, Cristina; Piairo, Paulina; Carvalho-Dias, Emanuel; Peixoto, Francisca O.; Moura, Rute S.; Correia-Pinto, Jorge			Leukemia Inhibitory Factor in Rat Fetal Lung Development: Expression and Functional Studies	PLOS ONE			English	Article							FACTOR LIF; DIFFERENTIATION; RECEPTOR; GROWTH; MORPHOGENESIS; CYTOKINE; IL-6; ANGIOTENSIN; MECHANISMS; SURFACTANT	Background: Leukemia inhibitory factor (LIF) and interleukin-6 (IL-6) are members of the family of the glycoprotein 130 (gp130)-type cytokines. These cytokines share gp130 as a common signal transducer, which explains why they show some functional redundancy. Recently, it was demonstrated that IL-6 promotes fetal lung branching. Additionally, LIF has been implicated in developmental processes of some branching organs. Thus, in this study LIF expression pattern and its effects on fetal rat lung morphogenesis were assessed. Methodology/Principal Findings: LIF and its subunit receptor LIFR alpha expression levels were evaluated by immunohistochemistry and western blot in fetal rat lungs of different gestational ages, ranging from 13.5 to 21.5 days post-conception. Throughout all gestational ages studied, LIF was constitutively expressed in pulmonary epithelium, whereas LIFR alpha was first mainly expressed in the mesenchyme, but after pseudoglandular stage it was also observed in epithelial cells. These results point to a LIF epithelium-mesenchyme cross-talk, which is known to be important for lung branching process. Regarding functional studies, fetal lung explants were cultured with increasing doses of LIF or LIF neutralizing antibodies during 4 days. MAPK, AKT, and STAT3 phosphorylation in the treated lung explants was analyzed. LIF supplementation significantly inhibited lung growth in spite of an increase in p44/42 phosphorylation. On the other hand, LIF inhibition significantly stimulated lung growth via p38 and Akt pathways. Conclusions/Significance: The present study describes that LIF and its subunit receptor LIFR alpha are constitutively expressed during fetal lung development and that they have an inhibitory physiological role on fetal lung branching.	[Nogueira-Silva, Cristina; Piairo, Paulina; Carvalho-Dias, Emanuel; Peixoto, Francisca O.; Moura, Rute S.; Correia-Pinto, Jorge] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Nogueira-Silva, Cristina; Piairo, Paulina; Carvalho-Dias, Emanuel; Peixoto, Francisca O.; Moura, Rute S.; Correia-Pinto, Jorge] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Nogueira-Silva, Cristina] Hosp Braga, Dept Obstet & Gynecol, Braga, Portugal; [Carvalho-Dias, Emanuel] Hosp Sao Joao, Dept Urol, Oporto, Portugal; [Correia-Pinto, Jorge] Hosp Braga, Dept Pediat Surg, Braga, Portugal	Universidade do Minho; Hospital de Braga; Sao Joao Hospital; Hospital de Braga	Nogueira-Silva, C (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	jcp@ecsaude.uminho.pt	Correia-Pinto, Jorge/B-3344-2012; Moura, Rute S/B-4208-2011; Moura, Rute/GYV-3259-2022; Nogueira-Silva, Cristina/T-6998-2018	Correia-Pinto, Jorge/0000-0002-9265-6896; Moura, Rute S/0000-0003-1763-9014; Nogueira-Silva, Cristina/0000-0001-7273-2911; Piairo, Paulina/0000-0003-1905-671X	Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-OBD/108051/2008, SFRH/BPD/15408/2005, UMINHO/BII/172/2009]; Seccao de Neonatologia da Sociedade Portuguesa de Pediatria; Fundação para a Ciência e a Tecnologia [PTDC/SAU-OBD/108051/2008] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Seccao de Neonatologia da Sociedade Portuguesa de Pediatria; Fundação para a Ciência e a Tecnologia	This project was funded by Fundacao para a Ciencia e a Tecnologia (PTDC/SAU-OBD/108051/2008) and by Seccao de Neonatologia da Sociedade Portuguesa de Pediatria (Grant ZERU 2008). RSM was supported by Fundacao para a Ciencia e a Tecnologia (reference SFRH/BPD/15408/2005). FOP was supported by Fundacao para a Ciencia e a Tecnologia (reference UMINHO/BII/172/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE E, 1986, P NATL ACAD SCI USA, V83, P5958, DOI 10.1073/pnas.83.16.5958; Acosta JM, 2001, AM J PHYSIOL-LUNG C, V281, pL250, DOI 10.1152/ajplung.2001.281.1.L250; Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Auernhammer CJ, 2000, ENDOCR REV, V21, P313, DOI 10.1210/er.21.3.313; BARD JBL, 1991, DEVELOPMENT, V113, P193; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; Carbia-Nagashima A, 2004, IUBMB LIFE, V56, P83, DOI 10.1080/15216540410001668064; De Breuck S, 2006, DIABETOLOGIA, V49, P108, DOI 10.1007/s00125-005-0079-1; ESTROV Z, 1995, J INTERF CYTOK RES, V15, P905, DOI 10.1089/jir.1995.15.905; Grant SL, 2001, GROWTH FACTORS, V19, P153, DOI 10.3109/08977190109001083; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Ikegami T, 2000, EUR J OBSTET GYN R B, V93, P97, DOI 10.1016/S0301-2115(00)00247-5; Ikezono T, 1997, BBA-MOL CELL RES, V1355, P121, DOI 10.1016/S0167-4889(96)00122-X; Jorens PG, 1996, CYTOKINE, V8, P873, DOI 10.1006/cyto.1996.9999; Kling DE, 2002, AM J PHYSIOL-LUNG C, V282, pL370, DOI 10.1152/ajplung.00200.2001; Knight D, 1997, BRIT J PHARMACOL, V120, P883, DOI 10.1038/sj.bjp.0700965; Knight D, 2001, PULM PHARMACOL THER, V14, P169, DOI 10.1006/pupt.2001.0282; Knight DA, 1999, AM J RESP CELL MOL, V20, P834, DOI 10.1165/ajrcmb.20.4.3429; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; Kritikou EA, 2003, DEVELOPMENT, V130, P3459, DOI 10.1242/dev.00578; Kurdi M, 2005, MOL CELL BIOCHEM, V269, P95, DOI 10.1007/s11010-005-3085-1; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; McColm JR, 2006, EXP EYE RES, V83, P438, DOI 10.1016/j.exer.2006.01.027; Megeney LA, 1996, DEV GENET, V19, P139, DOI 10.1002/(SICI)1520-6408(1996)19:2<139::AID-DVG5>3.0.CO;2-A; Metcalf D, 2003, STEM CELLS, V21, P5, DOI 10.1634/stemcells.21-1-5; Moreno-Barriuso N, 2006, DEV DYNAM, V235, P2040, DOI 10.1002/dvdy.20842; Moss TJM, 2002, AM J RESP CRIT CARE, V165, P805, DOI 10.1164/ajrccm.165.6.2108053; Nogueira-Silva C, 2006, PEDIATR RES, V60, P530, DOI 10.1203/01.pdr.0000242300.09427.3b; Nogueira-Silva C, 2012, MOL MED, V18, P231, DOI 10.2119/molmed.2011.00210; Park JI, 2005, CYTOKINE, V29, P125, DOI 10.1016/j.cyto.2004.10.005; Park JI, 2003, MOL CELL BIOL, V23, P543, DOI 10.1128/MCB.23.2.543-554.2003; PATTERSON PH, 1992, CIBA F SYMP, V167, P125; Piairo P, 2011, PEPTIDES, V32, P2474, DOI 10.1016/j.peptides.2011.10.010; Pichel JG, 2003, MECH DEVELOP, V120, P349, DOI 10.1016/S0925-4773(02)00449-5; Plisov SY, 2001, DEVELOPMENT, V128, P1045; ROBERTSON M, 1993, DEV GENET, V14, P165, DOI 10.1002/dvg.1020140303; Sariola H, 2002, NEPHROL DIAL TRANSPL, V17, P88, DOI 10.1093/ndt/17.suppl_9.88; Shimoya K, 2000, HUM REPROD, V15, P2234, DOI 10.1093/humrep/15.10.2234; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Stoll M, 2001, REGUL PEPTIDES, V99, P175, DOI 10.1016/S0167-0115(01)00246-4; Wang JM, 2003, J BIOL CHEM, V278, P31226, DOI 10.1074/jbc.M301820200; Warburton D, 2005, PEDIATR RES, V57, p26R, DOI 10.1203/01.PDR.0000159570.01327.ED; WARE CB, 1995, DEVELOPMENT, V121, P1283; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Xiong WN, 2007, J HUAZHONG U SCI-MED, V27, P372, DOI 10.1007/s11596-007-0406-5; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641	47	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30517	10.1371/journal.pone.0030517	http://dx.doi.org/10.1371/journal.pone.0030517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291973	Green Published, gold			2022-12-27	WOS:000301570600052
J	Ito, A; Matsuo, J; Nakamura, S; Yoshida, A; Okude, M; Hayashi, Y; Sakai, H; Yoshida, M; Takahashi, K; Yamaguchi, H				Ito, Atsushi; Matsuo, Junji; Nakamura, Shinji; Yoshida, Asahi; Okude, Miho; Hayashi, Yasuhiro; Sakai, Haruna; Yoshida, Mitsutaka; Takahashi, Kaori; Yamaguchi, Hiroyuki			Amoebal Endosymbiont Protochlamydia Induces Apoptosis to Human Immortal HEp-2 Cells	PLOS ONE			English	Article							INCLUSION MEMBRANE-PROTEINS; CHLAMYDIA-TRACHOMATIS; ORDER CHLAMYDIALES; ACANTHAMOEBAE; PNEUMONIAE; PARACHLAMYDIACEAE; IDENTIFICATION; ACTIVATION; MULTIPLIES; AMEBAS	Protochlamydia, an environmental chlamydia and obligate amoebal endosymbiotic bacterium, evolved to survive within protist hosts, such as Acanthamobae, 700 million years ago. However, these bacteria do not live in vertebrates, including humans. This raises the possibility that interactions between Protochlamydia and human cells could induce a novel cytopathic effect, leading to new insights into host-parasite relationships. Therefore, we studied the effect of Protochlamydia on the survival of human immortal cell line, HEp-2 cells and primary peripheral blood mononuclear cells (PBMC). Using mainly 4',6-diamidino-2-phenylindole staining, fluorescent in situ hybridization, transmission electron microscopy, and also TUNEL and Transwell assays, we demonstrated that the Protochlamydia induced apoptosis in HEp-2 cells. The attachment of viable bacterial cells, but not an increase of bacterial infectious progenies within the cells, was required for the apoptosis. Other chlamydiae [Parachlamydia acanthamoebae and Chlamydia trachomatis (serovars D and L2)] did not induce the same phenomena, indicating that the observed apoptosis may be specific to the Protochlamydia. Furthermore, the bacteria had no effect on the survival of primary PBMCs collected from five volunteers, regardless of activation. We concluded that Protochlamydia induces apoptosis in human-immortal HEp-2 cells and that this endosymbiont could potentially be used as a biological tool for the elucidation of novel host-parasite relationships.	[Ito, Atsushi; Matsuo, Junji; Yoshida, Asahi; Okude, Miho; Hayashi, Yasuhiro; Yamaguchi, Hiroyuki] Hokkaido Univ, Fac Hlth Sci, Dept Med Lab Sci, Sapporo, Hokkaido, Japan; [Nakamura, Shinji; Sakai, Haruna] Juntendo Univ, Grad Sch Med, Div Biomed Imaging Res, Tokyo, Japan; [Yoshida, Mitsutaka; Takahashi, Kaori] Juntendo Univ, Grad Sch Med, Div Ultrastruct Res, Tokyo, Japan	Hokkaido University; Juntendo University; Juntendo University	Ito, A (corresponding author), Hokkaido Univ, Fac Hlth Sci, Dept Med Lab Sci, Sapporo, Hokkaido, Japan.	hiroyuki@med.hokudai.ac.jp	博之, 山口/E-1910-2012; Ito, Atsushi/GWU-9716-2022		KAKENHI; Institute for Fermentation, Osaka, Japan	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Institute for Fermentation, Osaka, Japan(Institute for Fermentation (IFO))	This study was supported in part, by grants-in-aid for scientific research from KAKENHI, and a research grant from the Institute for Fermentation, Osaka, Japan. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedson SP, 1932, BRIT J EXP PATHOL, V13, P461; Birtles RJ, 1997, LANCET, V349, P925, DOI 10.1016/S0140-6736(05)62701-8; Campbell Lee Ann, 2003, Semin Respir Infect, V18, P48, DOI 10.1053/srin.2003.50006; Carabeo RA, 2002, INFECT IMMUN, V70, P3793, DOI 10.1128/IAI.70.7.3793-3803.2002; Casson N, 2008, EMERG INFECT DIS, V14, P168, DOI 10.3201/eid1401.070980; Casson N, 2006, MICROBES INFECT, V8, P1294, DOI 10.1016/j.micinf.2005.12.011; Collingro A, 2005, MICROBIOL-SGM, V151, P301, DOI 10.1099/mic.0.27406-0; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Greub G, 2003, INFECT IMMUN, V71, P5979, DOI 10.1128/IAI.71.10.5979-5985.2003; Greub G, 2003, EMERG INFECT DIS, V9, P755; Haider S, 2010, MOL MICROBIOL, V77, P687, DOI 10.1111/j.1365-2958.2010.07241.x; Heinz E, 2010, PROTEOMICS, V10, P4363, DOI 10.1002/pmic.201000302; Heinz E, 2010, J BACTERIOL, V192, P5093, DOI 10.1128/JB.00605-10; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Heuer D, 2007, INT J MED MICROBIOL, V297, P569, DOI 10.1016/j.ijmm.2007.03.011; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Into T, 2005, CELL MICROBIOL, V7, P1305, DOI 10.1111/j.1462-5822.2005.00558.x; Into T, 2004, CELL MICROBIOL, V6, P187, DOI 10.1046/j.1462-5822.2003.00356.x; Jewett TJ, 2006, P NATL ACAD SCI USA, V103, P15599, DOI 10.1073/pnas.0603044103; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Li ZY, 2008, INFECT IMMUN, V76, P2746, DOI 10.1128/IAI.00010-08; Matsumoto A., 1988, MICROBIOLOGY CHLAMYD, P21; Matsuo J, 2008, APPL ENVIRON MICROB, V74, P6397, DOI 10.1128/AEM.00841-08; Matsuo J, 2010, ENV MICROBIOL REP, V2, P524, DOI 10.1111/j.1758-2229.2009.00094.x; Matsuo J, 2010, MICROBIOL IMMUNOL, V54, P63, DOI 10.1111/j.1348-0421.2009.00182.x; Nakamura S, 2010, ENV MICROBIOL REP, V2, P611, DOI 10.1111/j.1758-2229.2010.00182.x; Ossewaarde JM, 1999, MICROBIOL-SGM, V145, P411, DOI 10.1099/13500872-145-2-411; Rokey DD, 2006, PROTEINS CHLAMYDIAL; Schachter J, 1999, CHLAMYDIA, P139; SCHRAMM N, 1995, INFECT IMMUN, V63, P324, DOI 10.1128/IAI.63.1.324-332.1995; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stratton CW, 2003, MICROBES INFECT, V5, P1249, DOI 10.1016/j.micinf.2003.09.004; Toh H, 2003, DNA RES, V10, P9, DOI 10.1093/dnares/10.1.9; WEISS E, 1989, P NATL ACAD SCI USA, V86, P1674, DOI 10.1073/pnas.86.5.1674; WHO, 2001, GLOB PREV INC CUR ST; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935	38	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30270	10.1371/journal.pone.0030270	http://dx.doi.org/10.1371/journal.pone.0030270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276171	Green Published, gold			2022-12-27	WOS:000301457200051
J	Gibbons, P; van Bommel, L; Gill, AM; Cary, GJ; Driscoll, DA; Bradstock, RA; Knight, E; Moritz, MA; Stephens, SL; Lindenmayer, DB				Gibbons, Philip; van Bommel, Linda; Gill, A. Malcolm; Cary, Geoffrey J.; Driscoll, Don A.; Bradstock, Ross A.; Knight, Emma; Moritz, Max A.; Stephens, Scott L.; Lindenmayer, David B.			Land Management Practices Associated with House Loss in Wildfires	PLOS ONE			English	Article							WILDLAND-URBAN INTERFACE; FIRE MANAGEMENT; FUEL; WEATHER; CLIMATE; HAZARD; MODEL	Losses to life and property from unplanned fires (wildfires) are forecast to increase because of population growth in peri-urban areas and climate change. In response, there have been moves to increase fuel reduction-clearing, prescribed burning, biomass removal and grazing-to afford greater protection to peri-urban communities in fire-prone regions. But how effective are these measures? Severe wildfires in southern Australia in 2009 presented a rare opportunity to address this question empirically. We predicted that modifying several fuels could theoretically reduce house loss by 76%-97%, which would translate to considerably fewer wildfire-related deaths. However, maximum levels of fuel reduction are unlikely to be feasible at every house for logistical and environmental reasons. Significant fuel variables in a logistic regression model we selected to predict house loss were (in order of decreasing effect): (1) the cover of trees and shrubs within 40 m of houses, (2) whether trees and shrubs within 40 m of houses was predominantly remnant or planted, (3) the upwind distance from houses to groups of trees or shrubs, (4) the upwind distance from houses to public forested land (irrespective of whether it was managed for nature conservation or logging), (5) the upwind distance from houses to prescribed burning within 5 years, and (6) the number of buildings or structures within 40 m of houses. All fuel treatments were more effective if undertaken closer to houses. For example, 15% fewer houses were destroyed if prescribed burning occurred at the observed minimum distance from houses (0.5 km) rather than the observed mean distance from houses (8.5 km). Our results imply that a shift in emphasis away from broad-scale fuel-reduction to intensive fuel treatments close to property will more effectively mitigate impacts from wildfires on peri-urban communities.	[Gibbons, Philip; van Bommel, Linda; Gill, A. Malcolm; Cary, Geoffrey J.; Driscoll, Don A.; Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Bradstock, Ross A.] Univ Wollongong, Ctr Environm Risk Management Bushfires, Wollongong, NSW, Australia; [Knight, Emma] Australian Natl Univ, Ctr Math & Its Applicat, Canberra, ACT, Australia; [Moritz, Max A.; Stephens, Scott L.] Univ Calif Berkeley, Ecosyst Sci Div, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Australian National University; University of Wollongong; Australian National University; University of California System; University of California Berkeley	Gibbons, P (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	Philip.Gibbons@anu.edu.au	Driscoll, Don/I-1703-2013; Gibbons, Philip/I-8248-2012; Lindenmayer, David B/P-7183-2017; Cary, Geoffrey J./AAX-1964-2021	Lindenmayer, David B/0000-0002-4766-4088; Knight, Emma/0000-0002-4549-1531; Cary, Geoffrey J./0000-0002-6386-1751; Driscoll, Don/0000-0002-1560-5235	Environmental Decisions Hub of the Australian Government; Australian Research Council Centre of Excellence for Environmental Decisions	Environmental Decisions Hub of the Australian Government; Australian Research Council Centre of Excellence for Environmental Decisions(Australian Research Council)	The authors received financial support from the Environmental Decisions Hub of the Australian Government's National Environmental Research Program and the Australian Research Council Centre of Excellence for Environmental Decisions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt R., 1987, FIRE TECHNOL, V23, P186; Agee JK, 2005, FOREST ECOL MANAG, V211, P83, DOI 10.1016/j.foreco.2005.01.034; [Anonymous], 2010, R LANG ENV STAT COMP; Augustin NH, 1996, J APPL ECOL, V33, P339, DOI 10.2307/2404755; Blanchi R, 2010, INT J WILDLAND FIRE, V19, P914, DOI 10.1071/WF08175; Boer MM, 2009, FOREST ECOL MANAG, V259, P132, DOI 10.1016/j.foreco.2009.10.005; Bradstock RA, 2010, LANDSCAPE ECOL, V25, P607, DOI 10.1007/s10980-009-9443-8; Bradstock RA, 2001, J MEDITERRANEAN ECOL, V2, P179; Bureau of Meteorology (BoM), 2009, MET ASP 7 FEBR 2009; Cary GJ, 2009, INT J WILDLAND FIRE, V18, P147, DOI 10.1071/WF07085; Chen KP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020244; Cohen JD, 2000, J FOREST, V98, P15; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Driscoll DA, 2010, CONSERV LETT, V3, P215, DOI 10.1111/j.1755-263X.2010.00115.x; Fernandes PM, 2003, INT J WILDLAND FIRE, V12, P117, DOI 10.1071/WF02042; Finney MA, 2007, INT J WILDLAND FIRE, V16, P712, DOI 10.1071/WF06064; Gill AM, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034014; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; Haynes K, 2010, ENVIRON SCI POLICY, V13, P185, DOI 10.1016/j.envsci.2010.03.002; Hughes R, 2009, GEOGR RES-AUST, V47, P124, DOI 10.1111/j.1745-5871.2008.00556.x; Keeley JE, 2004, J FOREST, V102, P26; Koo E, 2010, INT J WILDLAND FIRE, V19, P818, DOI 10.1071/WF07119; Liu Y, FOREST ECOLOGY MANAG, V259, P685; Maranghides A, 2011, FIRE TECHNOL, V47, P379, DOI 10.1007/s10694-010-0164-y; Mell WE, 2010, INT J WILDLAND FIRE, V19, P238, DOI 10.1071/WF07131; Moritz MA, 2004, FRONT ECOL ENVIRON, V2, P67, DOI 10.1890/1540-9295(2004)002[0067:TABAOS]2.0.CO;2; NOBLE IR, 1980, AUST J ECOL, V5, P201, DOI 10.1111/j.1442-9993.1980.tb01243.x; Pausas JG, 2004, CLIMATIC CHANGE, V63, P337, DOI 10.1023/B:CLIM.0000018508.94901.9c; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pinol J, 1998, CLIMATIC CHANGE, V38, P345, DOI 10.1023/A:1005316632105; Pyne S, 1996, INTRO WILDLAND FIRE; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Schoennagel T, 2009, P NATL ACAD SCI USA, V106, P10706, DOI 10.1073/pnas.0900991106; Stephens SL, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014010; Stephens SL, BIOSCIENCE IN PRESS; Teague B., 2010, 2009 VICTORIAN BUSHF; Vasquez T, 2011, WEATHERWISE, V62, P20; Venables WN., 2002, MODERN APPL STAT S 4; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; WILSON AAG, 1986, J ENVIRON MANAGE, V23, P259; Wotawa G, 2000, SCIENCE, V288, P324, DOI 10.1126/science.288.5464.324	41	139	141	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29212	10.1371/journal.pone.0029212	http://dx.doi.org/10.1371/journal.pone.0029212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279530	gold, Green Published			2022-12-27	WOS:000299771900008
J	Wang, S; Chen, AJ; Shi, LJ; Zhao, XF; Wang, JX				Wang, Shuai; Chen, An-Jing; Shi, Li-Jie; Zhao, Xiao-Fan; Wang, Jin-Xing			TRBP and eIF6 Homologue in Marsupenaeus japonicus Play Crucial Roles in Antiviral Response	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; RISC-LOADING COMPLEX; BINDING-PROTEIN; IN-VIVO; VIRUS-REPLICATION; MARINE SHRIMP; HIV-1 TAR; DROSOPHILA; DSRNA; IMMUNITY	Plants and invertebrates can suppress viral infection through RNA silencing, mediated by RNA-induced silencing complex (RISC). Trans-activation response RNA-binding protein (TRBP), consisting of three double-stranded RNA-binding domains, is a component of the RISC. In our previous paper, a TRBP homologue in Fenneropenaeus chinensis (Fc-TRBP) was reported to directly bind to eukaryotic initiation factor 6 (Fc-eIF6). In this study, we further characterized the function of TRBP and the involvement of TRBP and eIF6 in antiviral RNA interference (RNAi) pathway of shrimp. The double-stranded RNA binding domains (dsRBDs) B and C of the TRBP from Marsupenaeus japonicus (Mj-TRBP) were found to mediate the interaction of TRBP and eIF6. Gel-shift assays revealed that the N-terminal of Mj-TRBP dsRBD strongly binds to double-stranded RNA (dsRNA) and that the homodimer of the TRBP mediated by the C-terminal dsRBD increases the affinity to dsRNA. RNAi against either Mj-TRBP or Mj-eIF6 impairs the dsRNA-induced sequence-specific RNAi pathway and facilitates the proliferation of white spot syndrome virus (WSSV). These results further proved the important roles of TRBP and eIF6 in the antiviral response of shrimp.	[Wang, Shuai; Chen, An-Jing; Shi, Li-Jie; Zhao, Xiao-Fan; Wang, Jin-Xing] Shandong Univ, Minist Educ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan 250100, Shandong, Peoples R China; [Wang, Shuai] Chinese Acad Sci, Wuhan Inst Virol, Wuchang, Hubei, Peoples R China	Shandong University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Wang, S (corresponding author), Shandong Univ, Minist Educ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan 250100, Shandong, Peoples R China.	jxwang@sdu.edu.cn	Chen, Anjing/GYE-2355-2022; Wang, Jin-Xing/AAU-1514-2021	Wang, Jin-Xing/0000-0003-0283-3930; Zhao, Xiao-Fan/0000-0003-1809-4730	National Natural Science Foundation of China [30972236, 31130056]; Ph.D. program foundation of the Ministry of Education of China [20110131130003]; National High Technology Research and Development Program of China (863 Program) [2007AA09Z425]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. program foundation of the Ministry of Education of China(Ministry of Education, China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (Grant nos. 30972236 and 31130056) and the Ph.D. program foundation of the Ministry of Education of China (Grant no. 20110131130003), and this work was partly supported by the National High Technology Research and Development Program of China (863 Program) (Grant no. 2007AA09Z425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chang KY, 2005, FEBS J, V272, P2109, DOI 10.1111/j.1742-4658.2005.04652.x; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; COSENTINO GP, 1995, P NATL ACAD SCI USA, V92, P9445, DOI 10.1073/pnas.92.21.9445; Daher A, 2009, MOL CELL BIOL, V29, P254, DOI 10.1128/MCB.01030-08; Daniels SM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-38; Daviet L, 2000, EUR J BIOCHEM, V267, P2419, DOI 10.1046/j.1432-1327.2000.01256.x; DE N, METHODS MOL BIOL, V725, P107; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Duarte M, 2000, J BIOMED SCI, V7, P494; Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909; Erard M, 1998, J MOL BIOL, V279, P1085, DOI 10.1006/jmbi.1998.1831; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; GATIGNOL A, 1993, MOL CELL BIOL, V13, P2193, DOI 10.1128/MCB.13.4.2193; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Gupta V, 2003, VIROLOGY, V315, P283, DOI 10.1016/S0042-6822(03)00589-0; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hitti EG, 2004, FEBS LETT, V574, P25, DOI 10.1016/j.febslet.2004.07.080; Laraki G, 2008, RNA BIOL, V5, P92, DOI 10.4161/rna.5.2.6069; Liu HP, 2006, J VIROL, V80, P10365, DOI 10.1128/JVI.01101-06; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Parker GS, 2008, J MOL BIOL, V384, P967, DOI 10.1016/j.jmb.2008.10.002; Parker GS, 2006, RNA, V12, P807, DOI 10.1261/rna.2338706; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Robalino J, 2005, J VIROL, V79, P13561, DOI 10.1128/JVI.79.21.13561-13571.2005; Robalino J, 2007, DEV COMP IMMUNOL, V31, P539, DOI 10.1016/j.dci.2006.08.011; Rossi JJ, 2005, EMBO REP, V6, P927, DOI 10.1038/sj.embor.7400531; Roux MM, 2002, J VIROL, V76, P7140, DOI 10.1128/JVI.76.14.7140-7149.2002; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; SUK K, NUCL ACIDS RES, V39, pE43; Tirasophon W, 2005, BIOCHEM BIOPH RES CO, V334, P102, DOI 10.1016/j.bbrc.2005.06.063; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wang SA, 2009, J IMMUNOL, V182, P5250, DOI 10.4049/jimmunol.0802970; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; YAMASHITA S, PROTEIN SCI, V20, P118; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186	42	29	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30057	10.1371/journal.pone.0030057	http://dx.doi.org/10.1371/journal.pone.0030057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279564	Green Published, Green Submitted, gold			2022-12-27	WOS:000299771900042
J	Hossain, Z; Amyot, L; McGarvey, B; Gruber, M; Jung, J; Hannoufa, A				Hossain, Zakir; Amyot, Lisa; McGarvey, Brian; Gruber, Margaret; Jung, Jinwook; Hannoufa, Abdelali			The Translation Elongation Factor eEF-1B beta 1 Is Involved in Cell Wall Biosynthesis and Plant Development in Arabidopsis thaliana	PLOS ONE			English	Article							CELLULOSE SYNTHASE COMPLEXES; LIGNIN BIOSYNTHESIS; FUNCTIONAL-ANALYSIS; FACTOR 1A; LIGNIFICATION; DEPOSITION; EXPANSION; GENES; CRYSTALLINITY; ORGANIZATION	The eukaryotic translation elongation factor eEF-1B beta 1 (EF1B beta) is a guanine nucleotide exchange factor that plays an important role in translation elongation. In this study, we show that the EF1B beta protein is localized in the plasma membrane and cytoplasm, and that the transcripts should be expressed in most tissue types in seedlings. Sectioning of the inflorescence stem revealed that EF1B beta predominantly localizes to the xylem vessels and in the interfascicular cambium. EF1B beta gene silencing in ef beta caused a dwarf phenotype with 38% and 20% reduction in total lignin and crystalline cellulose, respectively. This loss-of-function mutant also had a lower S/G lignin monomer ratio relative to wild type plants, but no changes were detected in a gain-of-function mutant transformed with the EF1B beta gene. Histochemical analysis showed a reduced vascular apparatus, including smaller xylem vessels in the inflorescence stem of the loss-of-function mutant. Over-expression of EF1B beta in an eli1 mutant background restored a WT phenotype and abolished ectopic lignin deposition as well as cell expansion defects in the mutant. Taken together, these data strongly suggest a role for EF1B beta in plant development and cell wall formation in Arabidopsis.	[Hossain, Zakir; Amyot, Lisa; McGarvey, Brian; Jung, Jinwook; Hannoufa, Abdelali] Agr & Agri Food Canada, London, ON, Canada; [McGarvey, Brian; Hannoufa, Abdelali] Univ Western Ontario, Dept Biol, London, ON, Canada; [Gruber, Margaret] Agr & Agri Food Canada, Saskatoon, SK, Canada	Agriculture & Agri Food Canada; Western University (University of Western Ontario); Agriculture & Agri Food Canada	Hossain, Z (corresponding author), Environm Prote NB Inc, Sackville, NB, Canada.	Abdelali.Hannoufa@agr.gc.ca	Hannoufa, Abdelali/AAP-4593-2021; Hannoufa, Abdelali/GQY-7523-2022	Hannoufa, Abdelali/0000-0003-0064-620X	Agriculture and Agri-Food Canada through the ABIP; Agriculture and Agri-Food Canada through the CBioN Network [159]	Agriculture and Agri-Food Canada through the ABIP; Agriculture and Agri-Food Canada through the CBioN Network	Funding was provided by Agriculture and Agri-Food Canada through the ABIP program and the CBioN Network Project #159 (www.4.agr.gc.ca/AAFC-AAC/display-afficher.do?id = 1289590845916). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Arioli T, 1998, SCIENCE, V279, P717, DOI 10.1126/science.279.5351.717; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Berthet S, 2011, PLANT CELL, V23, P1124, DOI 10.1105/tpc.110.082792; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Brinkmann K, 2002, J CHEM ECOL, V28, P2483, DOI 10.1023/A:1021484002582; Burn JE, 2002, PLANT PHYSIOL, V129, P797, DOI 10.1104/pp.010931; Cano-Delgado A, 2003, PLANT J, V34, P351, DOI 10.1046/j.1365-313X.2003.01729.x; Cano-Delgado AI, 2000, DEVELOPMENT, V127, P3395; Carpita N., 2000, BIOCH MOL BIOL PLANT, P52; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crowell EF, 2009, PLANT CELL, V21, P1141, DOI 10.1105/tpc.108.065334; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Foster CE, 2010, JOVE, V37; Fujita M, 2011, PLANT J, V66, P915, DOI 10.1111/j.1365-313X.2011.04552.x; Furukawa R, 2001, BBA-GEN SUBJECTS, V1527, P130, DOI 10.1016/S0304-4165(01)00157-X; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gu Y, 2010, P NATL ACAD SCI USA, V107, P12866, DOI 10.1073/pnas.1007092107; HAUSER MT, 1995, DEVELOPMENT, V121, P1237; Hematy K, 2007, CURR BIOL, V17, P922, DOI 10.1016/j.cub.2007.05.018; HIRAGA K, 1993, FEBS LETT, V316, P165, DOI 10.1016/0014-5793(93)81208-H; Ito J, 2011, J PROTEOME RES, V10, P1571, DOI 10.1021/pr1009433; LAPIERRE C, 1985, J WOOD CHEM TECHNOL, V5, P277, DOI 10.1080/02773818508085193; Le Sourd F, 2006, BBA-GENE STRUCT EXPR, V1759, P13, DOI 10.1016/j.bbaexp.2006.02.003; Mathews MB, 2000, COLD SPRING HARBOR M, V39, P1; Merrick WC, 2000, COLD SPRING HARBOR M, V39, P89; Mitra SK, 2009, J PROTEOME RES, V8, P2752, DOI 10.1021/pr801044y; Olarewaju Olubunmi, 2004, RNA Biol, V1, P89, DOI 10.4161/rna.1.2.1033; Pagant S, 2002, PLANT CELL, V14, P2001, DOI 10.1105/tpc.002873; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Pittman YR, 2009, J BIOL CHEM, V284, P4739, DOI 10.1074/jbc.M807945200; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reddy MSS, 2005, P NATL ACAD SCI USA, V102, P16573, DOI 10.1073/pnas.0505749102; Rogers LA, 2005, NEW PHYTOL, V168, P123, DOI 10.1111/j.1469-8137.2005.01496.x; Sato S, 2001, PLANT CELL PHYSIOL, V42, P251, DOI 10.1093/pcp/pce045; Scarpella E, 2004, NEW PHYTOL, V164, P209, DOI 10.1111/j.1469-8137.2004.01191.x; Schrick K, 2004, PLANT J, V38, P227, DOI 10.1111/j.1365-313X.2004.02039.x; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Sibout R, 2005, PLANT CELL, V17, P2059, DOI 10.1105/tpc.105.030767; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Sonbol FM, 2009, PLANT MOL BIOL, V70, P283, DOI 10.1007/s11103-009-9473-2; Szyjanowicz PMJ, 2004, PLANT J, V37, P730, DOI 10.1111/j.1365-313X.2003.02000.x; Takahashi J, 2009, PLANT CELL PHYSIOL, V50, P1099, DOI 10.1093/pcp/pcp062; Taylor NG, 2004, CELLULOSE, V11, P329, DOI 10.1023/B:CELL.0000046405.11326.a8; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Taylor NG, 2000, PLANT CELL, V12, P2529, DOI 10.1105/tpc.12.12.2529; Thevenin J, 2011, MOL PLANT, V4, P70, DOI 10.1093/mp/ssq045; Turner SR, 1997, PLANT CELL, V9, P689, DOI 10.1105/tpc.9.5.689; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Vain P, 2011, PLANT J, V66, P929, DOI 10.1111/j.1365-313X.2011.04555.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wightman R, 2008, PLANT J, V54, P794, DOI 10.1111/j.1365-313X.2008.03444.x; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	57	22	22	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30425	10.1371/journal.pone.0030425	http://dx.doi.org/10.1371/journal.pone.0030425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272350	gold, Green Published, Green Submitted			2022-12-27	WOS:000301454400128
J	Boutant, M; Ramos, OHP; Tourrel-Cuzin, C; Movassat, J; Ilias, A; Vallois, D; Planchais, J; Pegorier, JP; Schuit, F; Petit, PX; Bossard, P; Maedler, K; Grapin-Botton, A; Vasseur-Cognet, M				Boutant, Marie; Ramos, Oscar Henrique Pereira; Tourrel-Cuzin, Cecile; Movassat, Jamileh; Ilias, Anissa; Vallois, David; Planchais, Julien; Pegorier, Jean-Paul; Schuit, Frans; Petit, Patrice X.; Bossard, Pascale; Maedler, Kathrin; Grapin-Botton, Anne; Vasseur-Cognet, Mireille			COUP-TFII Controls Mouse Pancreatic beta-Cell Mass through GLP-1-beta-Catenin Signaling Pathways	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; TRANSCRIPTION FACTOR-II; GLUCOSE-HOMEOSTASIS; CHRONIC EXPOSURE; GENE-EXPRESSION; CATENIN; NEOGENESIS; APOPTOSIS; INSULIN; GROWTH	Background: The control of the functional pancreatic beta-cell mass serves the key homeostatic function of releasing the right amount of insulin to keep blood sugar in the normal range. It is not fully understood though how beta-cell mass is determined. Methodology/Principal Findings: Conditional chicken ovalbumin upstream promoter transcription factor II (COUP-TFII)deficient mice were generated and crossed with mice expressing Cre under the control of pancreatic duodenal homeobox 1 (pdx1) gene promoter. Ablation of COUP-TFII in pancreas resulted in glucose intolerance. Beta-cell number was reduced at 1 day and 3 weeks postnatal. Together with a reduced number of insulin-containing cells in the ductal epithelium and normal b-cell proliferation and apoptosis, this suggests decreased beta-cell differentiation in the neonatal period. By testing islets isolated from these mice and cultured beta-cells with loss and gain of COUP-TFII function, we found that COUP-TFII induces the expression of the beta-catenin gene and its target genes such as cyclin D1 and axin 2. Moreover, induction of these genes by glucagon-like peptide 1 (GLP-1) via beta-catenin was impaired in absence of COUP-TFII. The expression of two other target genes of GLP-1 signaling, GLP-1R and PDX-1 was significantly lower in mutant islets compared to control islets, possibly contributing to reduced b-cell mass. Finally, we demonstrated that COUP-TFII expression was activated by the Wnt signaling-associated transcription factor TCF7L2 (T-cell factor 7-like 2) in human islets and rat b-cells providing a feedback loop. Conclusions/Significance: Our findings show that COUP-TFII is a novel component of the GLP-1 signaling cascade that increases beta-cell number during the neonatal period. COUP-TFII is required for GLP-1 activation of the beta-catenin-dependent pathway and its expression is under the control of TCF7L2.	[Boutant, Marie; Ramos, Oscar Henrique Pereira; Tourrel-Cuzin, Cecile; Planchais, Julien; Pegorier, Jean-Paul; Bossard, Pascale; Vasseur-Cognet, Mireille] Cochin Inst, INSERM, Dept Endocrinol Metab & Canc, Paris, France; [Boutant, Marie; Ramos, Oscar Henrique Pereira; Tourrel-Cuzin, Cecile; Planchais, Julien; Pegorier, Jean-Paul; Bossard, Pascale; Vasseur-Cognet, Mireille] CNRS, Paris, France; [Boutant, Marie; Ramos, Oscar Henrique Pereira; Tourrel-Cuzin, Cecile; Planchais, Julien; Pegorier, Jean-Paul; Bossard, Pascale; Vasseur-Cognet, Mireille] Univ Paris 05, Paris, France; [Movassat, Jamileh; Ilias, Anissa] Paris Diderot Univ, Lab Biol & Pathol Endocrine Pancreas, Unit Funct & Adaptat Biol, Paris, France; [Vallois, David] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Schuit, Frans] Dept Mol Cellular Biol, Louvain, Belgium; [Petit, Patrice X.] Cochin Inst, CNRS, Paris, France; [Grapin-Botton, Anne] Ecole Polytech Fed Lausanne, Lausanne, Switzerland; [Maedler, Kathrin] Univ Bremen, Ctr Biomol Interact Bremen, Bremen, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Lausanne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Bremen	Vasseur-Cognet, M (corresponding author), Cochin Inst, INSERM, Dept Endocrinol Metab & Canc, Paris, France.	mireille.vasseur@inserm.fr	Maedler, Kathrin/ABE-3022-2021; Bossard, Pascale/O-6680-2017; Ramos, Oscar HP/E-1862-2013; Petit, Patrice X./A-3692-2009; Vasseur, Mireille/L-6958-2017; Tourrel-Cuzin, Cecile/HDN-8854-2022; Petit, patrice/AAF-6774-2020	Maedler, Kathrin/0000-0002-7436-1197; Ramos, Oscar HP/0000-0002-5788-4500; Petit, Patrice X./0000-0002-5038-9101; Vasseur, Mireille/0000-0001-6963-4114; Grapin-Botton, Anne/0000-0002-1202-5235; Tourrel-Cuzin, Cecile/0000-0002-5368-4018	European Foundation for the Study of Diabetes; programme partner Merk Sharp and Dohme; Ministere de l'Enseignement Superieur et de la Recherche and Association pour la Recherche sur le Cancer; Ile-de-France CODDIM; Agence Nationale pour la Recherche [ANR-05-PCOD-088-01]; K.U.Leuven [GOA/2009/010]; German Research Foundation (DFG); European Research Council (ERC)	European Foundation for the Study of Diabetes; programme partner Merk Sharp and Dohme; Ministere de l'Enseignement Superieur et de la Recherche and Association pour la Recherche sur le Cancer; Ile-de-France CODDIM; Agence Nationale pour la Recherche(French National Research Agency (ANR)); K.U.Leuven(KU Leuven); German Research Foundation (DFG)(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was supported by grants from the European Foundation for the Study of Diabetes and the programme partner Merk Sharp and Dohme 2010. MB is recipient of a doctoral fellowship from the Ministere de l'Enseignement Superieur et de la Recherche and Association pour la Recherche sur le Cancer, OR was recipient of a 12-month post-doctoral fellowship from Ile-de-France CODDIM 2008, CT-C was supported for 12 months by a grant from Agence Nationale pour la Recherche (ANR-05-PCOD-088-01), FS was supported by the K.U.Leuven (GOA/2009/010), KM was supported by the German Research Foundation (DFG) and the European Research Council (ERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Bardoux P, 2005, DIABETES, V54, P1357, DOI 10.2337/diabetes.54.5.1357; Benoit G, 2006, PHARMACOL REV, V58, P798, DOI 10.1124/pr.58.4.10; Buteau J, 1999, DIABETOLOGIA, V42, P856, DOI 10.1007/s001250051238; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen C, 2009, AM J PHYSIOL-GASTR L, V297, pG1126, DOI 10.1152/ajpgi.90586.2008; Cornu M, 2009, DIABETES, V58, P1816, DOI 10.2337/db09-0063; Dessimoz J, 2005, CURR BIOL, V15, P1677, DOI 10.1016/j.cub.2005.08.037; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Duncan S, 2010, BMC BIOINFORMATICS, V11, DOI [10.1186/1471-2105-11-100, 10.1186/1471-2105-11-S4-P10]; Farilla L, 2002, ENDOCRINOLOGY, V143, P4397, DOI 10.1210/en.2002-220405; Figeac F, 2010, AM J PHYSIOL-ENDOC M, V298, pE245, DOI 10.1152/ajpendo.00538.2009; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Heiser PW, 2006, DEVELOPMENT, V133, P2023, DOI 10.1242/dev.02366; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hong JJ, 2009, ANAT REC, V292, P818, DOI 10.1002/ar.20897; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; KAISER N, 1991, ENDOCRINOLOGY, V129, P2067, DOI 10.1210/endo-129-4-2067; Kim BJ, 2009, DEV BIOL, V326, P378, DOI 10.1016/j.ydbio.2008.11.001; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Kwon DY, 2009, J PHARMACOL SCI, V111, P361, DOI 10.1254/jphs.09178FP; Le Bacquer O, 2011, HUM MOL GENET, V20, P1906, DOI 10.1093/hmg/ddr072; Li LP, 2009, CELL METAB, V9, P77, DOI 10.1016/j.cmet.2008.12.002; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Lin FJ, 2011, ENDOCR REV, V32, P404, DOI 10.1210/er.2010-0021; Lin FJ, 2010, J CLIN INVEST, V120, P1694, DOI 10.1172/JCI40101; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Liu ZY, 2008, J BIOL CHEM, V283, P8723, DOI 10.1074/jbc.M706105200; Liu ZY, 2010, ADV EXP MED BIOL, V654, P391, DOI 10.1007/978-90-481-3271-3_17; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Marshak S, 1999, DIABETES, V48, P1230, DOI 10.2337/diabetes.48.6.1230; Murtaugh LC, 2005, DEVELOPMENT, V132, P4663, DOI 10.1242/dev.02063; Nauck MA, 2007, DIABETOLOGIA, V50, P2413, DOI 10.1007/s00125-007-0832-8; Oberholzer J, 2000, TRANSPLANTATION, V69, P1115, DOI 10.1097/00007890-200003270-00016; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Perfetti R, 2000, ENDOCRINOLOGY, V141, P4600, DOI 10.1210/en.141.12.4600; Perilhou A, 2008, MOL CELL BIOL, V28, P6568, DOI 10.1128/MCB.02211-07; Perilhou A, 2008, MOL CELL BIOL, V28, P4588, DOI 10.1128/MCB.01191-07; PETIT PX, 1995, J CELL BIOL, V130, P157, DOI 10.1083/jcb.130.1.157; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Schafer SA, 2007, DIABETOLOGIA, V50, P2443, DOI 10.1007/s00125-007-0753-6; Schulthess FT, 2009, CELL METAB, V9, P125, DOI 10.1016/j.cmet.2009.01.003; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Shu LA, 2009, HUM MOL GENET, V18, P2388, DOI 10.1093/hmg/ddp178; Thorens B, 2004, HORM METAB RES, V36, P766, DOI 10.1055/s-2004-826161; Tourrel C, 2002, DIABETES, V51, P1443, DOI 10.2337/diabetes.51.5.1443; Tourrel C, 2001, DIABETES, V50, P1562, DOI 10.2337/diabetes.50.7.1562; Van Lommel L, 2006, DIABETES, V55, P3214, DOI 10.2337/db06-0774; Welters HJ, 2008, TRENDS ENDOCRIN MET, V19, P349, DOI 10.1016/j.tem.2008.08.004; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Xie X, 2011, P NATL ACAD SCI USA, V108, P14843, DOI 10.1073/pnas.1110236108; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Xu G, 2006, DIABETES RES CLIN PR, V73, P107, DOI 10.1016/j.diabres.2005.11.007; Xu Z, 2008, P NATL ACAD SCI USA, V105, P2421, DOI 10.1073/pnas.0707082105; Zhang P, 2002, MECH DEVELOP, V119, P109, DOI 10.1016/S0925-4773(02)00286-1	60	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30847	10.1371/journal.pone.0030847	http://dx.doi.org/10.1371/journal.pone.0030847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292058	gold, Green Published, Green Submitted			2022-12-27	WOS:000301639600061
J	Farnesi, LC; Brito, JM; Linss, JG; Pelajo-Machado, M; Valle, D; Rezende, GL				Farnesi, Luana C.; Brito, Jose M.; Linss, Jutta G.; Pelajo-Machado, Marcelo; Valle, Denise; Rezende, Gustavo L.			Physiological and Morphological Aspects of Aedes aegypti Developing Larvae: Effects of the Chitin Synthesis Inhibitor Novaluron	PLOS ONE			English	Article							INSECT GROWTH-REGULATORS; CULEX-QUINQUEFASCIATUS; CUTICLE; DIFLUBENZURON; RESISTANCE; DIPTERA; POPULATIONS	Population control of the dengue vector mosquito, Aedes aegypti, is difficult due to many reasons, one being the development of resistance to neurotoxic insecticides employed. The biosynthesis of chitin, a major constituent of insect cuticle, is a novel target for population control. Novaluron is a benzoylphenylurea (BPU) that acts as a chitin synthesis inhibitor, already used against mosquitoes. However, information regarding BPU effects on immature mosquito stages and physiological parameters related with mosquito larval development are scarce. A set of physiological parameters were recorded in control developing larvae and novaluron was administered continuously to Ae. aegypti larvae, since early third instar. Larval instar period duration was recorded from third instar until pupation. Chitin content was measured during third and fourth instars. Fourth instars were processed histochemically at the mesothorax region, stained with hematoxylin and eosin (HE) for assessment of internal tissues, and labeled with WGA-FITC to reveal chitinized structures. In control larvae: i) there is a chitin content increase during both third and fourth instars where late third instars contain more chitin than early fourth instars; ii) thoracic organs and a continuous cuticle, closely associated with the underlying epidermis were observed; iii) chitin was continuously present throughout integument cuticle. Novaluron treatment inhibited adult emergence, induced immature mortality, altered adult sex ratio and caused delay in larval development. Moreover, novaluron: i) significantly affected chitin content during larval development; ii) induced a discontinuous and altered cuticle in some regions while epidermis was often thinner or missing; iii) rendered chitin cuticle presence discontinuous and less evident. In both control and novaluron larvae, chitin was present in the peritrophic matrix. This study showed quantitatively and qualitatively evidences of novaluron effects on Ae. aegypti larval development. To our knowledge, this is the first report describing histological alterations produced by a BPU in immature vector mosquitoes.	[Farnesi, Luana C.; Linss, Jutta G.; Pelajo-Machado, Marcelo; Valle, Denise; Rezende, Gustavo L.] Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil; [Farnesi, Luana C.; Linss, Jutta G.; Valle, Denise] Inst Biol Exercito, Rio De Janeiro, Brazil; [Farnesi, Luana C.; Linss, Jutta G.; Valle, Denise; Rezende, Gustavo L.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil; [Brito, Jose M.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Rezende, Gustavo L.] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Estadual do Norte Fluminense	Farnesi, LC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.	dvalle@ioc.fiocruz.br; grezende@uenf.br	Valle, Denise/F-5069-2013; Rezende, Gustavo Lazzaro/AAV-3456-2021; Machado, Marcelo Pelajo/I-5359-2012; Neurociencia, Inct/I-1011-2013	Rezende, Gustavo Lazzaro/0000-0002-8904-7598; Pelajo Machado, Marcelo/0000-0002-7295-7018	Fundacao Oswaldo Cruz (Fiocruz); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj); Conselho Nacional de Desenvolvimento Cientifico e Tecnoloegico (CNPq)	Fundacao Oswaldo Cruz (Fiocruz); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnoloegico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao Oswaldo Cruz (Fiocruz), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj) and Conselho Nacional de Desenvolvimento Cientifico e Tecnoloegico (CNPq) within the program Pronex - Rede Dengue. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Llinas GA, 2010, MEM I OSWALDO CRUZ, V105, P113, DOI 10.1590/S0074-02762010000100019; [Anonymous], 1992, BIOL MOSQUITOES DEV; Arakane Y, 2004, INSECT BIOCHEM MOLEC, V34, P291, DOI 10.1016/j.ibmb.2003.11.004; Arredondo-Jimenez JI, 2006, MED VET ENTOMOL, V20, P377, DOI 10.1111/j.1365-2915.2006.00656.x; Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892; Batra C. P., 2005, Journal of Vector Borne Diseases, V42, P109; Belinato TA, 2009, MEM I OSWALDO CRUZ, V104, P43, DOI 10.1590/S0074-02762009000100007; CANDY DJ, 1962, J EXP BIOL, V39, P129; Chapman R. F., 1998, INSECT STRUCTURE FUN; CHAVASSE DC, 1997, CHEM METHODS CONTROL; Christophers SR, 1960, YELLOW FEVER MOSQUIT; Cohen E, 1987, ANN REV ENTOMOLOGY, V32; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; Dd Gestao, 2009, 0152009 MIN SAUD SEC; FOURNET F, 1993, J AM MOSQUITO CONTR, V9, P426; Gangishetti U, 2009, EUR J CELL BIOL, V88, P167, DOI 10.1016/j.ejcb.2008.09.002; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; GRAF JF, 1993, PARASITOL TODAY, V9, P471, DOI 10.1016/0169-4758(93)90106-P; Kamal Hany A, 2010, J Egypt Soc Parasitol, V40, P565; LEHMANN PF, 1975, INFECT IMMUN, V12, P987, DOI 10.1128/IAI.12.5.987-992.1975; LIS H, 1973, ANNU REV BIOCHEM, V42, P541, DOI 10.1146/annurev.bi.42.070173.002545; Martins AJ, 2008, PEST MANAG SCI, V64, P676, DOI 10.1002/ps.1547; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; MIAN LS, 1982, RESIDUE REV, V84, P27; Mondal K.A.M.S.H., 2001, Integrated Pest Management Reviews, V5, P255, DOI 10.1023/A:1012901832162; Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467; Moussian B, 2005, J MORPHOL, V264, P117, DOI 10.1002/jmor.10324; Moussian B, 2010, INSECT BIOCHEM MOLEC, V40, P363, DOI 10.1016/j.ibmb.2010.03.003; Mulla MS, 2003, J VECTOR ECOL, V28, P241; Oberlander H, 2000, INSECT GROWTH REGULA, P147; Powers AM, 2010, CLIN LAB MED, V30, P209, DOI 10.1016/j.cll.2009.10.003; Rehimi N, 1999, J APPL ENTOMOL, V123, P437, DOI 10.1046/j.1439-0418.1999.00388.x; REYNOLDS SE, 1987, PESTIC SCI, V20, P131, DOI 10.1002/ps.2780200207; Rezende GL, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-82; Secretaria de Vigilncia em Saude S, 2010, 1092010 SECR VIG SAU; Suman DS, 2010, J MED ENTOMOL, V47, P996, DOI 10.1603/ME09190; VANDAALEN JJ, 1972, NATURWISSENSCHAFTEN, V59, P312, DOI 10.1007/BF00593360; Vasuki V., 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P200; VASUKI V, 1992, MEM I OSWALDO CRUZ, V87, P275, DOI 10.1590/S0074-02761992000200016; White JT, 2010, DEVELOPMENT, V137, P1863, DOI 10.1242/dev.042887; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P165, DOI 10.1016/j.ibmb.2010.02.003; World Health Organization W, 2007, NOV DRINK WAT US VEC; WRIGHT CS, 1984, J MOL BIOL, V178, P91, DOI 10.1016/0022-2836(84)90232-8; Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6; Zhang JZ, 2006, INSECT BIOCHEM MOLEC, V36, P712, DOI 10.1016/j.ibmb.2006.06.002; Zhu KY, 2007, J MED ENTOMOL, V44, P1047, DOI 10.1603/0022-2585(2007)44[1047:CSOEOT]2.0.CO;2	46	63	70	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30363	10.1371/journal.pone.0030363	http://dx.doi.org/10.1371/journal.pone.0030363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291942	gold, Green Submitted, Green Published			2022-12-27	WOS:000301639600017
J	Vijendravarma, RK; Narasimha, S; Kawecki, TJ				Vijendravarma, Roshan K.; Narasimha, Sunitha; Kawecki, Tadeusz J.			Adaptation to Abundant Low Quality Food Improves the Ability to Compete for Limited Rich Food in Drosophila melanogaster	PLOS ONE			English	Article							DEPENDENT NATURAL-SELECTION; FEEDING RATE; PARASITOID RESISTANCE; FASTER DEVELOPMENT; EVOLUTION; ACQUISITION	The rate of food consumption is a major factor affecting success in scramble competition for a limited amount of easy-to-find food. Accordingly, several studies report positive genetic correlations between larval competitive ability and feeding rate in Drosophila; both become enhanced in populations evolving under larval crowding. Here, we report the experimental evolution of enhanced competitive ability in populations of D. melanogaster previously maintained for 84 generations at low density on an extremely poor larval food. In contrast to previous studies, greater competitive ability was not associated with the evolution of higher feeding rate; if anything, the correlation between the two traits across lines tended to be negative. Thus, enhanced competitive ability may be favored by nutritional stress even when competition is not intense, and competitive ability may be decoupled from the rate of food consumption.	[Vijendravarma, Roshan K.; Narasimha, Sunitha; Kawecki, Tadeusz J.] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland	University of Lausanne	Vijendravarma, RK (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.	roshan.vijendravarma@unil.ch	Kawecki, Tadeusz/K-5466-2015; Vijendravarma, Roshan K/E-7746-2018; Vijendravarma, Roshan/E-9985-2013	Kawecki, Tadeusz/0000-0002-9244-1991; Vijendravarma, Roshan K/0000-0002-3274-0682; Vijendravarma, Roshan Kumar/0000-0002-4930-3040	Swiss National Science Foundation (SNF) [31003A-126018]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This study was supported by a grant from the Swiss National Science Foundation (SNF grant# 31003A-126018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON WD, 1979, J ANIM ECOL, V48, P91, DOI 10.2307/4102; Bakker K., 1961, Archives Neerlandaises de Zoologie Leiden, V14, P200; BURNET B, 1977, GENET RES, V30, P149, DOI 10.1017/S0016672300017559; Fellowes MDE, 1999, EVOLUTION, V53, P1302, DOI 10.1111/j.1558-5646.1999.tb04544.x; Joshi A, 1996, EVOL ECOL, V10, P463, DOI 10.1007/BF01237879; JOSHI A, 1988, EVOLUTION, V42, P1090, DOI 10.1111/j.1558-5646.1988.tb02527.x; Joshi A, 2001, J GENET, V80, P63, DOI 10.1007/BF02728332; Kaun KR, 2007, J EXP BIOL, V210, P3547, DOI 10.1242/jeb.006924; Kolss M, 2009, EVOLUTION, V63, P2389, DOI 10.1111/j.1558-5646.2009.00718.x; Kraaijeveld AR, 2001, P ROY SOC B-BIOL SCI, V268, P259, DOI 10.1098/rspb.2000.1354; Mery F, 2003, P ROY SOC B-BIOL SCI, V270, P2465, DOI 10.1098/rspb.2003.2548; MUELLER LD, 1988, P NATL ACAD SCI USA, V85, P4383, DOI 10.1073/pnas.85.12.4383; NUNNEY L, 1990, ECOLOGY, V71, P1904, DOI 10.2307/1937598; Prasad NG, 2001, EVOLUTION, V55, P1363, DOI 10.1111/j.0014-3820.2001.tb00658.x; Rajamani M, 2006, J GENET, V85, P209, DOI 10.1007/BF02935333; Santos M, 1997, EVOLUTION, V51, P420, DOI 10.2307/2411114; SANTOS M, 1992, HEREDITY, V69, P489, DOI 10.1038/hdy.1992.163; SEWELL DF, 1975, BEHAV BIOL, V15, P213, DOI 10.1016/S0091-6773(75)91587-4; Shakarad M, 2005, BIOL LETTERS, V1, P91, DOI 10.1098/2004.0261; Vijendravarma RK, 2011, J EVOLUTION BIOL, V24, P897, DOI 10.1111/j.1420-9101.2010.02225.x; Vijendravarma RK, J EVOLUTION IN PRESS; Vijendravarma RK, 2009, EVOLUTION, V63, P104, DOI 10.1111/j.1558-5646.2008.00516.x; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102	23	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30650	10.1371/journal.pone.0030650	http://dx.doi.org/10.1371/journal.pone.0030650			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292007	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600042
J	Narayanan, A; Paul, LN; Tomar, S; Patil, DN; Kumar, P; Yernool, DA				Narayanan, Anoop; Paul, Lake N.; Tomar, Sakshi; Patil, Dipak N.; Kumar, Pravindra; Yernool, Dinesh A.			Structure-Function Studies of DNA Binding Domain of Response Regulator KdpE Reveals Equal Affinity Interactions at DNA Half-Sites	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SENSOR KINASE KDPD; 2-COMPONENT SIGNAL-TRANSDUCTION; SEDIMENTATION-VELOCITY ANALYSIS; COEFFICIENT DISTRIBUTIONS C(S); ESCHERICHIA-COLI; POSITIVE REGULATOR; TRANSCRIPTION FACTOR; OPERON EXPRESSION; RECEIVER DOMAIN	Expression of KdpFABC, a K+ pump that restores osmotic balance, is controlled by binding of the response regulator KdpE to a specific DNA sequence (kdpFABC(BS)) via the winged helix-turn-helix type DNA binding domain (KdpE(DBD)). Exploration of E. coli KdpE(DBD) and kdpFABC(BS) interaction resulted in the identification of two conserved, AT-rich 6 bp direct repeats that form half-sites. Despite binding to these half-sites, KdpE(DBD) was incapable of promoting gene expression in vivo. Structure-function studies guided by our 2.5 angstrom X-ray structure of KdpE(DBD) revealed the importance of residues R193 and R200 in the alpha-8 DNA recognition helix and T215 in the wing region for DNA binding. Mutation of these residues renders KdpE incapable of inducing expression of the kdpFABC operon. Detailed biophysical analysis of interactions using analytical ultracentrifugation revealed a 2: 1 stoichiometry of protein to DNA with dissociation constants of 200 +/- 100 and 350 +/- 100 nM at half-sites. Inactivation of one half-site does not influence binding at the other, indicating that KdpE(DBD) binds independently to the half-sites with approximately equal affinity and no discernable cooperativity. To our knowledge, these data are the first to describe in quantitative terms the binding at half-sites under equilibrium conditions for a member of the ubiquitous OmpR/PhoB family of proteins.	[Narayanan, Anoop; Yernool, Dinesh A.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Paul, Lake N.] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Tomar, Sakshi; Patil, Dipak N.; Kumar, Pravindra] Indian Inst Technol, Dept Biotechnol, Roorkee, Uttar Pradesh, India	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee	Narayanan, A (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	dyernool@purdue.edu	Patil, Dipak N./X-9567-2019; KUMAR, PRAVINDRA/AAF-2859-2020; Tomar, Sakshi/AAL-6766-2020; Tomar, Sakshi/H-3283-2018	Patil, Dipak N./0000-0003-1112-5557; KUMAR, PRAVINDRA/0000-0003-2128-7736; Tomar, Sakshi/0000-0001-5994-4178; Tomar, Sakshi/0000-0001-5994-4178	Purdue University; CSIR; DST	Purdue University; CSIR(Council of Scientific & Industrial Research (CSIR) - India); DST(Department of Science & Technology (India))	This work was supported by a start-up grant from Purdue University to DAY. ST and DNP were supported by a CSIR fellowship and PK thanks DST for a BOYSCAST fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTENDORF K, 1992, ANN NY ACAD SCI, V671, P228, DOI 10.1111/j.1749-6632.1992.tb43799.x; ASHA H, 1993, J BACTERIOL, V175, P4528, DOI 10.1128/JB.175.14.4528-4537.1993; Baikalov I, 1996, BIOCHEMISTRY-US, V35, P11053, DOI 10.1021/bi960919o; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; Das AK, 2010, J MOL BIOL, V398, P647, DOI 10.1016/j.jmb.2010.03.056; Ellison DW, 2000, J BACTERIOL, V182, P6592, DOI 10.1128/JB.182.23.6592-6597.2000; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; FIEDLER U, 1995, EMBO J, V14, P3696, DOI 10.1002/j.1460-2075.1995.tb00039.x; Friedland N, 2007, BIOCHEMISTRY-US, V46, P6733, DOI 10.1021/bi602546q; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Ghirlando R, 2011, METHODS, V54, P145, DOI 10.1016/j.ymeth.2010.12.005; Heermann R, 2003, J BIOL CHEM, V278, P51277, DOI 10.1074/jbc.M303801200; Heermann R, 2010, FEMS MICROBIOL LETT, V304, P97, DOI 10.1111/j.1574-6968.2010.01906.x; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hizver J, 2001, P NATL ACAD SCI USA, V98, P8490, DOI 10.1073/pnas.151247298; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Janin J, 2007, ACTA CRYSTALLOGR D, V63, P1, DOI 10.1107/S090744490603575X; Kar SR, 2001, BIOCHEMISTRY-US, V40, P13378, DOI 10.1021/bi011289f; Karsten R., 1997, BIF FUTURA, V12, P20; KATO M, 1989, FEBS LETT, V249, P168, DOI 10.1016/0014-5793(89)80617-9; Lacal J, 2008, J MOL BIOL, V384, P1037, DOI 10.1016/j.jmb.2008.10.011; LAIMINS LA, 1981, P NATL ACAD SCI-BIOL, V78, P464, DOI 10.1073/pnas.78.1.464; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Mack TR, 2009, J MOL BIOL, V389, P349, DOI 10.1016/j.jmb.2009.04.014; Makino K, 1996, J MOL BIOL, V259, P15, DOI 10.1006/jmbi.1996.0298; MartinezHackert E, 1997, STRUCTURE, V5, P109, DOI 10.1016/S0969-2126(97)00170-6; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKASHIMA K, 1993, MOL MICROBIOL, V7, P109, DOI 10.1111/j.1365-2958.1993.tb01102.x; Naue N, 2011, NUCLEIC ACIDS RES, V39, P1398, DOI 10.1093/nar/gkq988; NIXON BT, 1986, P NATL ACAD SCI USA, V83, P7850, DOI 10.1073/pnas.83.20.7850; OHWADA T, 1987, ARCH BIOCHEM BIOPHYS, V259, P157, DOI 10.1016/0003-9861(87)90481-4; Pelton JG, 1999, J MOL BIOL, V292, P1095, DOI 10.1006/jmbi.1999.3140; Rhee JE, 2008, J BIOL CHEM, V283, P8664, DOI 10.1074/jbc.M705550200; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; ROSSMANN MG, 1990, ACTA CRYSTALLOGR A, V46, P73, DOI 10.1107/S0108767389009815; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stallkamp I, 1999, ARCH MICROBIOL, V172, P295, DOI 10.1007/s002030050783; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Straume D, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-17; SUGIURA A, 1992, MOL MICROBIOL, V6, P1769, DOI 10.1111/j.1365-2958.1992.tb01349.x; TATE S, 1988, FEBS LETT, V242, P27, DOI 10.1016/0014-5793(88)80978-5; Toro-Roman A, 2005, PROTEIN SCI, V14, P3077, DOI 10.1110/ps.051722805; TSUZUKI M, 1994, J MOL BIOL, V242, P607, DOI 10.1006/jmbi.1994.1610; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; WALDERHAUG MO, 1992, J BACTERIOL, V174, P2152, DOI 10.1128/JB.174.7.2152-2159.1992; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; WOODWARD RS, 1980, J BIOCHEM BIOPH METH, V2, P307, DOI 10.1016/0165-022X(80)90055-X; Yoshida T, 2006, J BIOL CHEM, V281, P17114, DOI 10.1074/jbc.M602112200; ZIMMANN P, 1995, J BIOL CHEM, V270, P28282	61	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30102	10.1371/journal.pone.0030102	http://dx.doi.org/10.1371/journal.pone.0030102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291906	Green Submitted, Green Published, gold			2022-12-27	WOS:000301570600016
J	Sunarto, S; Kelly, MJ; Parakkasi, K; Klenzendorf, S; Septayuda, E; Kurniawan, H				Sunarto, Sunarto; Kelly, Marcella J.; Parakkasi, Karmila; Klenzendorf, Sybille; Septayuda, Eka; Kurniawan, Harry			Tigers Need Cover: Multi-Scale Occupancy Study of the Big Cat in Sumatran Forest and Plantation Landscapes	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; PANTHERA-TIGRIS; CONSERVATION; POPULATION	The critically endangered Sumatran tiger (Panthera tigris sumatrae Pocock, 1929) is generally known as a forest-dependent animal. With large-scale conversion of forests into plantations, however, it is crucial for restoration efforts to understand to what extent tigers use modified habitats. We investigated tiger-habitat relationships at 2 spatial scales: occupancy across the landscape and habitat use within the home range. Across major landcover types in central Sumatra, we conducted systematic detection, non-detection sign surveys in 47, 17x17 km grid cells. Within each cell, we surveyed 40, 1-km transects and recorded tiger detections and habitat variables in 100 m segments totaling 1,857 km surveyed. We found that tigers strongly preferred forest and used plantations of acacia and oilpalm, far less than their availability. Tiger probability of occupancy covaried positively and strongly with altitude, positively with forest area, and negatively with distance-to-forest centroids. At the fine scale, probability of habitat use by tigers across landcover types covaried positively and strongly with understory cover and altitude, and negatively and strongly with human settlement. Within forest areas, tigers strongly preferred sites that are farther from water bodies, higher in altitude, farther from edge, and closer to centroid of large forest block; and strongly preferred sites with thicker understory cover, lower level of disturbance, higher altitude, and steeper slope. These results indicate that to thrive, tigers depend on the existence of large contiguous forest blocks, and that with adjustments in plantation management, tigers could use mosaics of plantations (as additional roaming zones), riparian forests (as corridors) and smaller forest patches (as stepping stones), potentially maintaining a metapopulation structure in fragmented landscapes. This study highlights the importance of a multi-spatial scale analysis and provides crucial information relevant to restoring tigers and other wildlife in forest and plantation landscapes through improvement in habitat extent, quality, and connectivity.	[Sunarto, Sunarto; Kelly, Marcella J.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Sunarto, Sunarto; Parakkasi, Karmila; Septayuda, Eka; Kurniawan, Harry] Worldwide Fund Nat Indonesia, Species Program, Jakarta, Daerah Khusus I, Indonesia; [Klenzendorf, Sybille] World Wildlife Fund, Species Program, Washington, DC 20037 USA	Virginia Polytechnic Institute & State University; World Wildlife Fund	Sunarto, S (corresponding author), Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.	s.sunarto@yahoo.com	Kelly, Marcella/B-4891-2011	Kelly, Marcella/0000-0001-9044-3873	Hurvis Family; Critical Ecosystem Partnership Fund; National Fish and Wildlife Foundation; Save the Tiger Fund; USFWS through WWF; Indonesian Ministry of Forestry and plantation	Hurvis Family; Critical Ecosystem Partnership Fund; National Fish and Wildlife Foundation; Save the Tiger Fund; USFWS through WWF; Indonesian Ministry of Forestry and plantation	The Hurvis Family, Critical Ecosystem Partnership Fund, National Fish and Wildlife Foundation, Save the Tiger Fund, and USFWS Rhino Tiger Conservation Fund provided financial support through WWF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Indonesian Ministry of Forestry and plantation owners/managers for supporting this study. Zulfahmi, Koesdianto, A. Suprianto, F. Panjaitan, E. Tugio, L. Subali, H. Gebog, Nursamsu are some members of the field team who worked vigorously to collect data. Jim Nichols provided guidance in study design and gave many useful inputs in the analysis and during manuscript development. Rob Steinmetz, Matt Linkie, Haryo T. Wibisono provided input in study design. Jim Hines provided tremendous help in understanding, properly developing and running statistical models in the program PRESENCE. Dean Stauffer, Mike Vaughan and Steve Prisley provided input into the study design and earlier document drafts. The fieldwork for this study was fully supported by WWF Indonesia and Networks. Thanks to Riza Sukriana and team for their absolute support for this work. Thanks to A. Budiman, E. Purastuti, K. Yulianto, A. Juli, and Sunandar for the GIS support, to Abeng and team for their support and collaboration; to N. Anam, D. Rufendi, Suhandri, Tarmison, Fina, D. Rahadian, Syamsidar, Samsuardi, S. Maryati, Nursamsu, and Afdhal for their support; to Flying Squad teams, the families of Hermanto and Doni for their great hospitality in hosting the field teams; M. Lewis, B. Pandav, N. Griesshammer, C. William, M. Stuewe, Y. Uryu, B. Long, J. Vertefeuille, E. Dinerstein, and J. Seidensticker for support and advice. R. Sugiyanti, C. Tredick and two anonymous reviewers provided useful comments which improved this paper.	Anderson A., 2006, APPL NATURES DESIGN; Boomgaard P, 2001, FRONTIERS FEAR TIGER, pxii+306; BORNER M, 1978, CARNIVORE, V1, P97; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Buckland S.T., 2001, pi; Burnham K.P., 2003, MODEL SELECTION MULT; Diamond J., 2011, COLLAPSE SOC CHOOSE; DUPONT WD, 2002, STAT MODELING BIOMED; Franklin N, 1999, RIDING TIGER TIGER C, pxx; Gaston KJ, 1996, J ANIM ECOL, V65, P701, DOI 10.2307/5669; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Green R., 1979, SAMPLING DESIGN STAT; GRIFFITHS M, 1993, CONSERV BIOL, V7, P623, DOI 10.1046/j.1523-1739.1993.07030623.x; Griffiths M., 1994, SUMATRAN TIGER REPOR, P93; Guthery FS, 2007, J WILDLIFE MANAGE, V71, P684, DOI 10.2193/2006-285; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hines, 2006, PROGRAM PRESENCE VER; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Holmes D, 2002, TERRESTRIAL ECOREGIO, pxxix+643; Jarvis A, PRACTICAL USE SRTM D; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Karanth K. Ullas, 2002, P39; Karanth KK, 2009, J APPL ECOL, V46, P1189, DOI 10.1111/j.1365-2664.2009.01710.x; Linkie M., 2008, IUCN RED LIST THREAT, V8235; Linkie M, 2008, BIOL CONSERV, V141, P2410, DOI 10.1016/j.biocon.2008.07.002; Linkie M, 2006, J APPL ECOL, V43, P576, DOI 10.1111/j.1365-2664.2006.01153.x; MacKay P, 2008, NONINVASIVE SURVEY M, pviii+385; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie Darryl I., 2004, P149; MacKenzie DI, 2005, J WILDLIFE MANAGE, V69, P849, DOI 10.2193/0022-541X(2005)069[0849:WATIWP]2.0.CO;2; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2387, DOI 10.2307/3071800; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Maurer BA, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P125; Miquelle Dale G., 1999, P71; Morrison ML., 2006, WILDLIFE HABITAT REL; Nichols James D., 2002, P29; Nyhus PJ, 2004, ORYX, V38, P68, DOI 10.1017/S0030605304000110; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; Osborne PE, 2001, J APPL ECOL, V38, P458, DOI 10.1046/j.1365-2664.2001.00604.x; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; Ray JC, 2008, NONINVASIVE SURVEY M, pviii+385; Sanderson E., 2006, SETTING PRIORITIES C; Scott J. M., 2002, PREDICTING SPECIES O; Setiabudi, 2006, ANAL 1990 1995 2000; Setiabudi Budiman A, 2005, ANAL 2000 2004 LAND; Sinclair ARE, 2006, WILDLIFE ECOLOGY CON; Sunarto, 2012, ORYX IN PRESS; Sunarto, 2011, THESIS VIRGINIA TECH, P286; Sunquist ME, 1981, SOCIAL ORG TIGERS; Sunquist Mel, 1999, P5; Thomas L, 2010, USERS GUIDE DISTANCE; URYU Y., 2007, DEFORESTATION FOREST; Uryu Y., 2010, SUMATRAS FORESTS THE; Whitten T, 2000, ECOLOGY INDONESIA SE, pxxxiii+478; Wibisono HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025931; Wibisono HT, 2010, INTEGR ZOOL, V5, P313, DOI 10.1111/j.1749-4877.2010.00219.x; Wibisono HT, 2009, ORYX, V43, P634, DOI 10.1017/S003060530999055X; Wikramanayake ED, 1998, CONSERV BIOL, V12, P865, DOI 10.1046/j.1523-1739.1998.96428.x	59	84	87	1	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30859	10.1371/journal.pone.0030859	http://dx.doi.org/10.1371/journal.pone.0030859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292063	gold, Green Published, Green Submitted			2022-12-27	WOS:000301570600089
J	Tea, I; Le Gall, G; Kuster, A; Guignard, N; Alexandre-Gouabau, MC; Darmaun, D; Robins, RJ				Tea, Illa; Le Gall, Gwenaelle; Kuester, Alice; Guignard, Nadia; Alexandre-Gouabau, Marie-Cecile; Darmaun, Dominique; Robins, Richard J.			H-1-NMR-Based Metabolic Profiling of Maternal and Umbilical Cord Blood Indicates Altered Materno-Foetal Nutrient Exchange in Preterm Infants	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; MAGNETIC-RESONANCE-SPECTROSCOPY; AMINO-ACID-CONCENTRATIONS; PLACENTAL TRANSPORT; PLASMA; GLUTAMINE; LEUCINE; PREGNANCIES; ETHANOL; GLYCINE	Background: Adequate foetal growth is primarily determined by nutrient availability, which is dependent on placental nutrient transport and foetal metabolism. We have used H-1 nuclear magnetic resonance (NMR) spectroscopy to probe the metabolic adaptations associated with premature birth. Methodology: The metabolic profile in H-1 NMR spectra of plasma taken immediately after birth from umbilical vein, umbilical artery and maternal blood were recorded for mothers delivering very-low-birth-weight (VLBW) or normo-ponderal full-term (FT) neonates. Principal Findings: Clear distinctions between maternal and cord plasma of all samples were observed by principal component analysis (PCA). Levels of amino acids, glucose, and albumin-lysyl in cord plasma exceeded those in maternal plasma, whereas lipoproteins (notably low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL) and lipid levels were lower in cord plasma from both VLBW and FT neonates. The metabolic signature of mothers delivering VLBW infants included decreased levels of acetate and increased levels of lipids, pyruvate, glutamine, valine and threonine. Decreased levels of lipoproteins glucose, pyruvate and albumin-lysyl and increased levels of glutamine were characteristic of cord blood (both arterial and venous) from VLBW infants, along with a decrease in levels of several amino acids in arterial cord blood. Conclusion: These results show that, because of its characteristics and simple non-invasive mode of collection, cord plasma is particularly suited for metabolomic analysis even in VLBW infants and provides new insights into the materno-foetal nutrient exchange in preterm infants.	[Tea, Illa; Le Gall, Gwenaelle; Guignard, Nadia; Robins, Richard J.] Univ Nantes, Elucidat Biosynth Isotop Spectrometry Grp, Unit Interdisciplinary Chem, Synth Anal Modelling CEISAM,CNRS,UMR 6230, Nantes, France; [Le Gall, Gwenaelle] Inst Food Res, Norwich, Norfolk, England; [Kuester, Alice; Alexandre-Gouabau, Marie-Cecile; Darmaun, Dominique] CNRH, INRA, UMR Physiol Adaptat Nutr PhAN, Nantes, France; [Kuester, Alice; Alexandre-Gouabau, Marie-Cecile] Univ Nantes, Fac Med, Nantes, France; [Kuester, Alice] CHU Nantes, INSERM, CIC, F-44035 Nantes 01, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Nantes Universite; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; INRAE; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Tea, I (corresponding author), Univ Nantes, Elucidat Biosynth Isotop Spectrometry Grp, Unit Interdisciplinary Chem, Synth Anal Modelling CEISAM,CNRS,UMR 6230, Nantes, France.	illa.tea@univ-nantes.fr	Darmaun, Dominique/X-8453-2018; Le Gall, Gwenaelle/HDL-8283-2022	Darmaun, Dominique/0000-0002-0366-3227; Alexandre-Gouabau, Marie-Cecile/0000-0002-9966-9593; Robins, Richard/0000-0002-5325-8983; Le Gall, Gwenaelle/0000-0002-1379-2196	Hospital of Nantes; Region of the Pays-de-la Loire; "Centre National de la Recherche Scientifique" (CNRS); University of Nantes; Delegation a la Recherche Clinique (DRC CHU de Nantes, France); project "Nutrition Perinatale et Empreinte Metabolique" (NUPEM) (Region of the Pays de la Loire)	Hospital of Nantes; Region of the Pays-de-la Loire; "Centre National de la Recherche Scientifique" (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Nantes; Delegation a la Recherche Clinique (DRC CHU de Nantes, France); project "Nutrition Perinatale et Empreinte Metabolique" (NUPEM) (Region of the Pays de la Loire)	The study was investigator-initiated and funded by the Hospital of Nantes, the Region of the Pays-de-la Loire, the "Centre National de la Recherche Scientifique" (CNRS) and the University of Nantes. This study was supported, in part, by a grant from the Delegation a la Recherche Clinique (DRC CHU de Nantes, France) and by the project "Nutrition Perinatale et Empreinte Metabolique" (NUPEM) (Region of the Pays de la Loire). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AH, 1997, AM J PHYSIOL-ENDOC M, V272, pE892, DOI 10.1152/ajpendo.1997.272.5.E892; Antoshechkin AG, 2002, ANN NY ACAD SCI, V957, P288, DOI 10.1111/j.1749-6632.2002.tb02927.x; Antoshechkin AG, 2001, ALCOHOL ALCOHOLISM, V36, P608, DOI 10.1093/alcalc/36.6.608; AVERNA MR, 1991, BIOL NEONATE, V60, P187, DOI 10.1159/000243407; Battaglia FC, 2001, PLACENTA, V22, P145, DOI 10.1053/plac.2000.0612; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bell J D, 1989, NMR Biomed, V2, P61, DOI 10.1002/nbm.1940020204; BELL JD, 1987, FEBS LETT, V215, P311, DOI 10.1016/0014-5793(87)80168-0; Bon C, 2007, ANN BIOL CLIN-PARIS, V65, P609, DOI 10.1684/abc.2007.0168; Brereton R.G., MULTIVARIATE PATTERN; Camelo JS, 2007, BRAZ J MED BIOL RES, V40, P971, DOI 10.1590/S0100-879X2006005000103; CETIN I, 1990, AM J OBSTET GYNECOL, V162, P253, DOI 10.1016/0002-9378(90)90860-A; Cleal JK, 2008, J NEUROENDOCRINOL, V20, P419, DOI 10.1111/j.1365-2826.2008.01662.x; Darmaun D, 1997, PEDIATR RES, V41, P391, DOI 10.1203/00006450-199703000-00015; DOMENECH M, 1986, PEDIATR RES, V20, P1071, DOI 10.1203/00006450-198611000-00002; Duarte IF, 2007, NMR BIOMED, V20, P401, DOI 10.1002/nbm.1073; DUGDALE AE, 1986, LANCET, V1, P670; Engelke UFH, 2004, CLIN CHEM, V50, P58, DOI 10.1373/clinchem.2003.020214; Galan HL, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.06.054; Graca G, 2009, J PROTEOME RES, V8, P4144, DOI 10.1021/pr900386f; JAIN A, 1995, PEDIATR PULM, V20, P160, DOI 10.1002/ppul.1950200306; Jansson T, 1998, PEDIATR RES, V44, P532, DOI 10.1203/00006450-199810000-00011; Jansson T, 2002, DIABETES, V51, P2214, DOI 10.2337/diabetes.51.7.2214; Kemsley EK, 1996, CHEMOMETR INTELL LAB, V33, P47, DOI 10.1016/0169-7439(95)00090-9; Kuster A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027626; Kuhn KS, 1999, AM J CLIN NUTR, V70, P484; Marconi AM, 1999, PEDIATR RES, V46, P114, DOI 10.1203/00006450-199907000-00019; Marconi AM, 2008, SEMIN PERINATOL, V32, P178, DOI 10.1053/j.semperi.2008.02.007; MCMANUS IR, 1960, SCIENCE, V131, P102, DOI 10.1126/science.131.3393.102; MCMANUS IR, 1966, J BIOL CHEM, V241, P349; MONTELONGO A, 1992, DIABETES, V41, P1651, DOI 10.2337/diabetes.41.12.1651; NAUGHTON DP, 1993, FEBS LETT, V332, P221, DOI 10.1016/0014-5793(93)80636-9; NEARY RH, 1995, CLIN SCI, V88, P311, DOI 10.1042/cs0880311; Nelson DM, 2003, AM J PHYSIOL-CELL PH, V284, pC310, DOI 10.1152/ajpcell.00253.2002; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Paolini CL, 2001, J CLIN ENDOCR METAB, V86, P5427, DOI 10.1210/jc.86.11.5427; Parimi PS, 2004, AM J CLIN NUTR, V79, P402; Prefumo F, 2007, HUM REPROD, V22, P2029, DOI 10.1093/humrep/dem095; Regnault TRH, 2005, PLACENTA, V26, pS52, DOI 10.1016/j.placenta.2005.01.003; Regnault TRH, 2002, ENDOCRINE, V19, P23, DOI 10.1385/ENDO:19:1:23; Rodie VA, 2004, ATHEROSCLEROSIS, V176, P181, DOI 10.1016/j.atherosclerosis.2004.04.026; Rodino-Janeiro BK, 2010, DIABETES-METAB RES, V26, P550, DOI 10.1002/dmrr.1117; Ross JC, 1996, AM J PHYSIOL-ENDOC M, V270, pE491, DOI 10.1152/ajpendo.1996.270.3.E491; Sattar N, 1997, J CLIN ENDOCR METAB, V82, P2483, DOI 10.1210/jc.82.8.2483; Stock Michael K., 1994, P947; Tang HR, 2004, ANAL BIOCHEM, V325, P260, DOI 10.1016/j.ab.2003.10.033; Thibault R, 2008, AM J PHYSIOL-GASTR L, V294, pG548, DOI 10.1152/ajpgi.00461.2007; Torri GM, 1999, CLIN CHIM ACTA, V279, P77, DOI 10.1016/S0009-8981(98)00166-1; Trump S, 2006, MAGN RESON MATER PHY, V19, P305, DOI 10.1007/s10334-006-0058-7; Vadakekut ES, 2011, J AM OSTEOPATH ASSOC, V111, P148; Zheng SN, 2011, METABOLOMICS, V7, P413, DOI 10.1007/s11306-010-0261-4	51	48	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e29947	10.1371/journal.pone.0029947	http://dx.doi.org/10.1371/journal.pone.0029947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291897	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000301570600008
J	Arras, M; Glauser, DL; Jirkof, P; Rettich, A; Schade, B; Cinelli, P; Pinschewer, DD; Ackermann, M				Arras, Margarete; Glauser, Daniel L.; Jirkof, Paulin; Rettich, Andreas; Schade, Benjamin; Cinelli, Paolo; Pinschewer, Daniel D.; Ackermann, Mathias			Multiparameter Telemetry as a Sensitive Screening Method to Detect Vaccine Reactogenicity in Mice	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ADJUVANTS; CHALLENGES; IMPACT; PAIN; US	Refined vaccines and adjuvants are urgently needed to advance immunization against global infectious challenges such as HIV, hepatitis C, tuberculosis and malaria. Large-scale screening efforts are ongoing to identify adjuvants with improved efficacy profiles. Reactogenicity often represents a major hurdle to the clinical use of new substances. Yet, irrespective of its importance, this parameter has remained difficult to screen for, owing to a lack of sensitive small animal models with a capacity for high throughput testing. Here we report that continuous telemetric measurements of heart rate, heart rate variability, body core temperature and locomotor activity in laboratory mice readily unmasked systemic side-effects of vaccination, which went undetected by conventional observational assessment and clinical scoring. Even minor aberrations in homeostasis were readily detected, ranging from sympathetic activation over transient pyrogenic effects to reduced physical activity and apathy. Results in real-time combined with the potential of scalability and partial automation in the industrial context suggest multiparameter telemetry in laboratory mice as a first-line screen for vaccine reactogenicity. This may accelerate vaccine discovery in general and may further the success of vaccines in combating infectious disease and cancer.	[Arras, Margarete; Jirkof, Paulin; Rettich, Andreas; Cinelli, Paolo] Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland; [Arras, Margarete] Univ Zurich Hosp, Div Surg Res, Dept Surg, CH-8091 Zurich, Switzerland; [Glauser, Daniel L.; Ackermann, Mathias] Univ Zurich, Inst Virol, Zurich, Switzerland; [Schade, Benjamin] Univ Zurich, Inst Vet Pathol, Zurich, Switzerland; [Pinschewer, Daniel D.] Univ Geneva, Dept Pathol & Immunol, World Heath Org Collaborating Ctr Neonatal Vaccin, Geneva, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University of Geneva	Arras, M (corresponding author), Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland.	margarete.arras@ltk.uzh.ch		Arras, Margarete/0000-0003-3864-9879; Jirkof, Paulin/0000-0002-7225-2325; Pinschewer, Daniel/0000-0002-1594-3189; Cinelli, Paolo/0000-0002-0163-9055				Abril C, 2004, J VIROL, V78, P3644, DOI 10.1128/JVI.78.7.3644-3653.2004; Arras Margarete, 2007, BMC Vet Res, V3, P16, DOI 10.1186/1746-6148-3-16; Baylor NW, 2002, VACCINE, V20, pS18, DOI 10.1016/S0264-410X(02)00166-4; Camm AJ, 1996, CIRCULATION, V93, P1043; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Cinelli P, 2007, LAB ANIM-UK, V41, P174, DOI 10.1258/002367707780378113; Clements CJ, 2002, VACCINE, V20, pS24, DOI 10.1016/S0264-410X(02)00168-8; Coban C, 2008, HUM VACCINES, V4, P453, DOI 10.4161/hv.4.6.6200; Ebensen T, 2008, HUM VACCINES, V4, P13, DOI 10.4161/hv.4.1.5560; Edelman R, 2002, MOL BIOTECHNOL, V21, P129, DOI 10.1385/MB:21:2:129; Gehrmann J, 2000, AM J PHYSIOL-HEART C, V279, pH733, DOI 10.1152/ajpheart.2000.279.2.H733; Glenn GM, 2007, EXPERT REV VACCINES, V6, P651, DOI 10.1586/14760584.6.5.651; GOURINE VN, 1995, J THERM BIOL, V20, P405, DOI 10.1016/0306-4565(94)00077-V; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x; Mallapragada SK, 2008, INT J PHARMACEUT, V364, P265, DOI 10.1016/j.ijpharm.2008.06.030; Martin SS, 2009, VACCINE, V27, P6814, DOI 10.1016/j.vaccine.2009.09.013; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Perrie Y, 2008, INT J PHARMACEUT, V364, P272, DOI 10.1016/j.ijpharm.2008.04.036; Peterson NC, 2004, CONTEMP TOP LAB ANIM, V43, P74; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Schultze V, 2008, VACCINE, V26, P3209, DOI 10.1016/j.vaccine.2008.03.093; Sgoifo A, 1999, NEUROSCI BIOBEHAV R, V23, P915, DOI 10.1016/S0149-7634(99)00025-1; Singh M, 2006, VACCINE, V24, P1680, DOI 10.1016/j.vaccine.2005.09.046; Spani D, 2003, LAB ANIM-UK, V37, P54, DOI 10.1258/002367703762226692; Stasiak KL, 2003, CONTEMP TOP LAB ANIM, V42, P13; Teeling JL, 2007, BRAIN BEHAV IMMUN, V21, P836, DOI 10.1016/j.bbi.2007.01.012; Thireau J, 2008, EXP PHYSIOL, V93, P83, DOI 10.1113/expphysiol.2007.040733; Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261; Van Sluyters RC, 2004, CONTEMP TOP LAB ANIM, V43, P48; Wilson-Welder JH, 2009, J PHARM SCI-US, V98, P1278, DOI 10.1002/jps.21523	34	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29726	10.1371/journal.pone.0029726	http://dx.doi.org/10.1371/journal.pone.0029726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276127	Green Accepted, Green Published, gold			2022-12-27	WOS:000301457200021
J	Nishi, A; Kawachi, I; Shirai, K; Hirai, H; Jeong, S; Kondo, K				Nishi, Akihiro; Kawachi, Ichiro; Shirai, Kokoro; Hirai, Hiroshi; Jeong, Seungwon; Kondo, Katsunori			Sex/Gender and Socioeconomic Differences in the Predictive Ability of Self-Rated Health for Mortality	PLOS ONE			English	Article							GENDER-DIFFERENCES; SUBSEQUENT MORTALITY; ASSOCIATION	Background: Studies have reported that the predictive ability of self-rated health (SRH) for mortality varies by sex/gender and socioeconomic group. The purpose of this study is to evaluate this relationship in Japan and explore the potential reasons for differences between the groups. Methodology/Principal Findings: The analyses in the study were based on the Aichi Gerontological Evaluation Study's (AGES) 2003 Cohort Study in Chita Peninsula, Japan, which followed the four-year survival status of 14,668 communitydwelling people who were at least 65 years old at the start of the study. We first examined sex/gender and education-level differences in association with fair/poor SRH. We then estimated the sex/gender-and education-specific hazard ratios (HRs) of mortality associated with lower SRH using Cox models. Control variables, including health behaviors (smoking and drinking), symptoms of depression, and chronic co-morbid conditions, were added to sequential regression models. The results showed men and women reported a similar prevalence of lower SRH. However, lower SRH was a stronger predictor of mortality in men (HR = 2.44 [95% confidence interval (CI): 2.14-2.80]) than in women (HR = 1.88 [95% CI: 1.44-2.47]; p for sex/gender interaction = 0.018). The sex/gender difference in the predictive ability of SRH was progressively attenuated with the additional introduction of other co-morbid conditions. The predictive ability among individuals with high school education (HR = 2.39 [95% CI: 1.74-3.30]) was similar to that among individuals with less than a high school education (HR = 2.14 [95% CI: 1.83-2.50]; p for education interaction = 0.549). Conclusions: The sex/gender difference in the predictive ability of SRH for mortality among this elderly Japanese population may be explained by male/female differences in what goes into an individual's assessment of their SRH, with males apparently weighting depressive symptoms more than females.	[Nishi, Akihiro; Kawachi, Ichiro; Shirai, Kokoro] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Nishi, Akihiro] Harvard Univ, Inst Quantitat Social Sci, Boston, MA 02115 USA; [Nishi, Akihiro] Univ Tokyo, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan; [Shirai, Kokoro] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Shirai, Kokoro] Univ Ryukyus, Sch Law & Letters, Dept Human Sci, Okinawa, Japan; [Hirai, Hiroshi] Iwate Univ, Fac Engn, Morioka, Iwate 020, Japan; [Jeong, Seungwon; Kondo, Katsunori] Nihon Fukushi Univ, Ctr Well Being & Soc, Nagoya, Aichi, Japan	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; University of Tokyo; Harvard University; Harvard T.H. Chan School of Public Health; University of the Ryukyus; Iwate University	Nishi, A (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	anishi@hsph.harvard.edu	Kondo, Katsunori/AAI-6373-2020; Swaibu, Ramadhani A/H-3164-2011	Jeong, Seungwon/0000-0003-2919-7508; Nishi, Akihiro/0000-0003-1629-5985	Nihon Fukushi University; Japan Society for the Promotion of Science [14310105, 17730347, 18390200, 19122901]; Ministry of Health, Labour, and Welfare [H22-Choju-Shitei-008]	Nihon Fukushi University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan)	The AGES project is supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (the 21st Century COE Program "Asian COE toward new policy science for social well-being and development" in Nihon Fukushi University, "Academic Frontier" Project, the Japan Society for the Promotion of Science (Grants-in-Aid for Scientific Research: 14310105, 17730347, 18390200, 19122901), and Ministry of Health, Labour, and Welfare (Health Labour Sciences Research Grant: H22-Choju-Shitei-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1984, ILLNESS CULTURE CONT; Benyamini Y, 2000, PSYCHOSOM MED, V62, P354, DOI 10.1097/00006842-200005000-00009; Burstrom B, 2001, J EPIDEMIOL COMMUN H, V55, P836, DOI 10.1136/jech.55.11.836; Deeg DJH, 2003, GERONTOLOGIST, V43, P376, DOI 10.1093/geront/43.3.376; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; DeVellis R., 2003, SCALE DEV THEORY APP; Dowd JB, 2007, INT J EPIDEMIOL, V36, P1214, DOI 10.1093/ije/dym214; Dowd JB, 2010, ANN EPIDEMIOL, V20, P743, DOI 10.1016/j.annepidem.2010.06.007; Huisman M, 2007, INT J EPIDEMIOL, V36, P1207, DOI 10.1093/ije/dym095; Huisman M, 2010, SOC SCI MED, V70, P652, DOI 10.1016/j.socscimed.2009.11.003; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jurges H, 2007, HEALTH ECON, V16, P163, DOI 10.1002/hec.1134; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Khang YH, 2010, J WOMENS HEALTH, V19, P109, DOI 10.1089/jwh.2009.1413; Kondo K., 2010, HLTH INEQUALITIES JA; KORN EL, 1990, AM STAT, V44, P270, DOI 10.2307/2684345; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Lyyra TM, 2009, ARCH GERONTOL GERIAT, V48, P14, DOI 10.1016/j.archger.2007.09.004; McFadden E, 2009, SOC SCI MED, V68, P275, DOI 10.1016/j.socscimed.2008.10.012; Nishi A, 2011, J EPIDEMIOL, V21, P151, DOI 10.2188/jea.JE20100135; Okamoto K, 2008, ARCH GERONTOL GERIAT, V47, P311, DOI 10.1016/j.archger.2007.08.013; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; Schreiner AS, 2003, INT J GERIATR PSYCH, V18, P498, DOI 10.1002/gps.880; Sen A, 2002, BRIT MED J, V324, P860, DOI 10.1136/bmj.324.7342.860; Singh-Manoux A, 2007, INT J EPIDEMIOL, V36, P1222, DOI 10.1093/ije/dym170; Spiers N, 2003, GERONTOLOGIST, V43, P406, DOI 10.1093/geront/43.3.406; Subramanian SV, 2005, J EPIDEMIOL COMMUN H, V59, P664, DOI 10.1136/jech.2004.025742; The World Bank, 2011, GINI IND; WILKINS WE, 1976, SOCIOL EDUC, V49, P175, DOI 10.2307/2112523; Zajacova A, 2011, AM J EPIDEMIOL, V174, P977, DOI 10.1093/aje/kwr204	32	38	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30179	10.1371/journal.pone.0030179	http://dx.doi.org/10.1371/journal.pone.0030179			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	907YS	22276157	Green Published, gold			2022-12-27	WOS:000301457200041
J	Sebastiani, P; Solovieff, N; DeWan, AT; Walsh, KM; Puca, A; Hartley, SW; Melista, E; Andersen, S; Dworkis, DA; Wilk, JB; Myers, RH; Steinberg, MH; Montano, M; Baldwin, CT; Hoh, J; Perls, TT				Sebastiani, Paola; Solovieff, Nadia; DeWan, Andrew T.; Walsh, Kyle M.; Puca, Annibale; Hartley, Stephen W.; Melista, Efthymia; Andersen, Stacy; Dworkis, Daniel A.; Wilk, Jemma B.; Myers, Richard H.; Steinberg, Martin H.; Montano, Monty; Baldwin, Clinton T.; Hoh, Josephine; Perls, Thomas T.			Genetic Signatures of Exceptional Longevity in Humans	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; SUSCEPTIBILITY GENES; IDENTIFIES VARIANTS; STATISTICAL-METHODS; LEIDEN LONGEVITY; RISK; CENTENARIANS; POPULATION; SIBLINGS	Like most complex phenotypes, exceptional longevity is thought to reflect a combined influence of environmental (e. g., lifestyle choices, where we live) and genetic factors. To explore the genetic contribution, we undertook a genome-wide association study of exceptional longevity in 801 centenarians (median age at death 104 years) and 914 genetically matched healthy controls. Using these data, we built a genetic model that includes 281 single nucleotide polymorphisms (SNPs) and discriminated between cases and controls of the discovery set with 89% sensitivity and specificity, and with 58% specificity and 60% sensitivity in an independent cohort of 341 controls and 253 genetically matched nonagenarians and centenarians (median age 100 years). Consistent with the hypothesis that the genetic contribution is largest with the oldest ages, the sensitivity of the model increased in the independent cohort with older and older ages (71% to classify subjects with an age at death >102 and 85% to classify subjects with an age at death >105). For further validation, we applied the model to an additional, unmatched 60 centenarians (median age 107 years) resulting in 78% sensitivity, and 2863 unmatched controls with 61% specificity. The 281 SNPs include the SNP rs2075650 in TOMM40/APOE that reached irrefutable genome wide significance (posterior probability of association = 1) and replicated in the independent cohort. Removal of this SNP from the model reduced the accuracy by only 1%. Further in-silico analysis suggests that 90% of centenarians can be grouped into clusters characterized by different "genetic signatures" of varying predictive values for exceptional longevity. The correlation between 3 signatures and 3 different life spans was replicated in the combined replication sets. The different signatures may help dissect this complex phenotype into sub-phenotypes of exceptional longevity.	[Sebastiani, Paola; Solovieff, Nadia; Hartley, Stephen W.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [DeWan, Andrew T.; Walsh, Kyle M.; Hoh, Josephine] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Div Chron Dis Epidemiol, New Haven, CT 06510 USA; [Puca, Annibale] IRCCS Multimed, Milan, Italy; [Puca, Annibale] CNR, Ist Tecnol Biomed, Segrate, Italy; [Melista, Efthymia] Boston Univ, Sch Med, Ctr Human Genet, Boston, MA 02118 USA; [Andersen, Stacy; Perls, Thomas T.] Boston Univ, Sch Med, Dept Med, Sect Geriatr, Boston, MA 02118 USA; [Andersen, Stacy; Baldwin, Clinton T.; Perls, Thomas T.] Boston Med Ctr, Boston, MA USA; [Wilk, Jemma B.; Myers, Richard H.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Baldwin, Clinton T.] Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA	Boston University; Yale University; IRCCS Multimedica; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Boston University; Boston University; Boston Medical Center; Boston University; Boston University	Sebastiani, P (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.	sebas@bu.edu	Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; Puca, Annibale Alessandro/K-2099-2018	Walsh, Kyle/0000-0002-5879-9981; Steinberg, Martin/0000-0001-8800-8020; sebastiani, paola/0000-0001-6419-1545; Dworkis, Daniel/0000-0003-0706-5117; Perls, Thomas/0000-0002-2492-4334; Montano, Monty/0000-0002-1473-887X; Baldwin, Clinton/0000-0002-3275-9463; DeWan, Andrew/0000-0002-7679-8704; Andersen, Stacy/0000-0002-2442-6386	National Institutes of Health [R01 HL087681, K24 AG025727, R01 AR055115, RO1 AG027216, R01 NS36711-09]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027216, U19AG023122, K24AG025727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants: R01 HL087681 (to MS), K24 AG025727 (to TP), R01 AR055115 (to MM), RO1 AG027216 (to CB), R01 NS36711-09 (to RM). In the study we included 254 subjects enrolled at ELIXIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERT L, 1998, AGE VALIDATION EXTRE; Atmon G, 2005, MECH AGEING DEV, V126, P341, DOI 10.1016/j.mad.2004.08.026; Atzmon G, 2004, J AM GERIATR SOC, V52, P274, DOI 10.1111/j.1532-5415.2004.52068.x; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Baker DJ, 2008, CELL CYCLE, V7, P2795, DOI 10.4161/cc.7.18.6687; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Beekman M, 2010, P NATL ACAD SCI USA, V107, P18046, DOI 10.1073/pnas.1003540107; Bloss CS, 2011, AGEING RES REV, V10, P191, DOI 10.1016/j.arr.2010.07.005; Bonafe M, 2003, J CLIN ENDOCR METAB, V88, P3299, DOI 10.1210/jc.2002-021810; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Deelen J, 2011, AGING CELL; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Evert J, 2003, J GERONTOL A-BIOL, V58, P232; Fraser GE, 2001, ARCH INTERN MED, V161, P1645, DOI 10.1001/archinte.161.13.1645; Goddard ME, 2009, STAT SCI, V24, P517, DOI 10.1214/09-STS306; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Gudmundsson H, 2000, EUR J HUM GENET, V8, P743, DOI 10.1038/sj.ejhg.5200527; Hand DJ, 2009, CH CRC DATA MIN KNOW, P163, DOI 10.1201/9781420089653.ch9; HARMAN D, 1993, DRUG AGING, V3, P60, DOI 10.2165/00002512-199303010-00006; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hekimi S, 2006, NAT GENET, V38, P985, DOI 10.1038/ng1881; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hitt R, 1999, LANCET, V354, P652, DOI 10.1016/S0140-6736(99)01987-X; Holscher C, 2010, NEUROBIOL AGING, V31, P1495, DOI 10.1016/j.neurobiolaging.2008.08.023; Kerber RA, 2001, J GERONTOL A-BIOL, V56, pB130, DOI 10.1093/gerona/56.3.B130; Kooperberg C, 2010, GENET EPIDEMIOL, V34, P643, DOI 10.1002/gepi.20509; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lane RF, 2010, J NEUROSCI, V30, P13110, DOI 10.1523/JNEUROSCI.3872-10.2010; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Lunetta KL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S13; Marroni F, 2009, CIRC-CARDIOVASC GENE, V2, P322, DOI 10.1161/CIRCGENETICS.108.833806; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Meuwissen THE, 2001, GENETICS, V157, P1819; MICHIE D, MACHINE LEARNING NEU; NEBEL A, 2005, SCI AGING KNOWLEDGE, pPE23; Need AC, 2009, HUM MOL GENET, V18, P4650, DOI 10.1093/hmg/ddp413; Okser S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001146; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; PAYNTER NP, JAMA, V303, P631; Perls T, 2000, J AM GERIATR SOC, V48, P1483, DOI 10.1111/jgs.2000.48.11.1483; Perls T, 2007, J GERONTOL A-BIOL, V62, P1028, DOI 10.1093/gerona/62.9.1028; Perls TT, 1998, LANCET, V351, P1560, DOI 10.1016/S0140-6736(05)61126-9; Perls TT, 1999, AGE AGEING, V28, P193, DOI 10.1093/ageing/28.2.193; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rajpathak SN, 2011, J AM GERIATR SOC, V59, P1509, DOI 10.1111/j.1532-5415.2011.03498.x; Ramoni M, 2002, MACH LEARN, V47, P91, DOI 10.1023/A:1013635829250; Ramoni M, 2001, ARTIF INTELL, V125, P209, DOI 10.1016/S0004-3702(00)00085-0; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Sebastiani P, 2005, NAT GENET, V37, P435, DOI 10.1038/ng1533; SEBASTIANI P, 2008, COMPLEX GENETIC MODE, P53; SEBASTIANI P, 2011, FRONTIERS GENETICS, V2; Solovieff N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-108; Song DH, 2007, GASTROENTEROLOGY, V133, P1796, DOI 10.1053/j.gastro.2007.09.005; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Stessman J, 2005, MECH AGEING DEV, V126, P333, DOI 10.1016/j.mad.2004.08.025; Tan QH, 2008, AM J EPIDEMIOL, V168, P890, DOI 10.1093/aje/kwn205; Terry DF, 2008, ARCH INTERN MED, V168, P277, DOI 10.1001/archinternmed.2007.75; Terry DF, 2004, J AM GERIATR SOC, V52, P2074, DOI 10.1111/j.1532-5415.2004.52561.x; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wang JH, 2011, GENOME MED, V3, DOI 10.1186/gm217; Wang L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-147; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Westendorp RGJ, 2009, J AM GERIATR SOC, V57, P1634, DOI 10.1111/j.1532-5415.2009.02381.x; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Willcox BJ, 2006, J GERONTOL A-BIOL, V61, P345, DOI 10.1093/gerona/61.4.345; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Wray NR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000864; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Young RD, 2011, CURR GERONTOL GERIAT, V2010, P1; Yu CE, 2007, GENOMICS, V89, P655, DOI 10.1016/j.ygeno.2007.02.002	91	239	253	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29848	10.1371/journal.pone.0029848	http://dx.doi.org/10.1371/journal.pone.0029848			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279548	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900026
J	Bailes, HJ; Zhuang, LY; Lucas, RJ				Bailes, Helena J.; Zhuang, Ling-Yu; Lucas, Robert J.			Reproducible and Sustained Regulation of G alpha s Signalling Using a Metazoan Opsin as an Optogenetic Tool	PLOS ONE			English	Article							PROTEIN-KINASE-A; CELLULAR CAMP; IN-VIVO; BETA(2)-ADRENERGIC RECEPTOR; ADENYLYL-CYCLASE; COUPLED RECEPTOR; CYCLIC-AMP; RHODOPSIN; CELLS; OSCILLATIONS	Originally developed to regulate neuronal excitability, optogenetics is increasingly also used to control other cellular processes with unprecedented spatiotemporal resolution. Optogenetic modulation of all major G-protein signalling pathways (Gq, Gi and Gs) has been achieved using variants of mammalian rod opsin. We show here that the light response driven by such rod opsin-based tools dissipates under repeated exposure, consistent with the known bleaching characteristics of this photopigment. We continue to show that replacing rod opsin with a bleach resistant opsin from Carybdea rastonii, the box jellyfish, (JellyOp) overcomes this limitation. Visible light induced high amplitude, reversible, and reproducible increases in cAMP in mammalian cells expressing JellyOp. While single flashes produced a brief cAMP spike, repeated stimulation could sustain elevated levels for 10s of minutes. JellyOp was more photosensitive than currently available optogenetic tools, responding to white light at irradiances >= 1 mu W/cm(2). We conclude that JellyOp is a promising new tool for mimicking the activity of Gs-coupled G protein coupled receptors with fine spatiotemporal resolution.	[Bailes, Helena J.; Zhuang, Ling-Yu; Lucas, Robert J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Lucas, RJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	robert.lucas@manchester.ac.uk	; Bailes, Helena/K-5413-2012	Lucas, Robert/0000-0002-1088-8029; Bailes, Helena/0000-0003-3346-0639	Medical Research Council UK [G0801731]; BBSRC; MRC [G0801731] Funding Source: UKRI; Medical Research Council [G0801731] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Milstein Award, Medical Research Council UK to RJL and HJB (G0801731) and a BBSRC doctoral training account. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Brueggemann LI, 2002, J GEN PHYSIOL, V119, P593, DOI 10.1085/jgp.20018495; Bucher D, 2009, J NEUROGENET, V23, P220, DOI 10.1080/01677060802441356; DICKERSON CD, 1995, EXP CELL RES, V216, P46, DOI 10.1006/excr.1995.1006; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Dyachok O, 2006, BIOCHEM SOC T, V34, P498, DOI 10.1042/BST0340498; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Fan F, 2008, ACS CHEM BIOL, V3, P346, DOI 10.1021/cb8000414; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; Gutierrez DV, 2011, J BIOL CHEM, V286, P25848, DOI 10.1074/jbc.M111.253674; HAISENLEDER DJ, 1992, ENDOCRINOLOGY, V131, P3027, DOI 10.1210/en.131.6.3027; Hempel CM, 1996, NATURE, V384, P166, DOI 10.1038/384166a0; IMS HWR, 2000, IMS IND RANK TOP 100; Jastrzebska B, 2010, BIOCHEM J, V428, P1, DOI 10.1042/BJ20100270; Kim JM, 2005, BIOCHEMISTRY-US, V44, P2284, DOI 10.1021/bi048328i; Koyanagi M, 2008, P NATL ACAD SCI USA, V105, P15576, DOI 10.1073/pnas.0806215105; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Ma JX, 1999, FEBS LETT, V452, P199, DOI 10.1016/S0014-5793(99)00606-7; Marin EP, 2000, J BIOL CHEM, V275, P1930, DOI 10.1074/jbc.275.3.1930; Mustafi D, 2009, MOL PHARMACOL, V75, P1, DOI 10.1124/mol.108.051938; Oh E, 2010, J BIOL CHEM, V285, P30825, DOI 10.1074/jbc.M110.147298; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Schoenenberger P, 2011, EXP PHYSIOL, V96, P34, DOI 10.1113/expphysiol.2009.051219; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Schultheis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018766; Seibold A, 2000, MOL PHARMACOL, V58, P1162, DOI 10.1124/mol.58.5.1162; Seifert R, 1998, J BIOL CHEM, V273, P5109, DOI 10.1074/jbc.273.9.5109; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Weissenberger S, 2011, J NEUROCHEM, V116, P616, DOI 10.1111/j.1471-4159.2010.07148.x; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535; Zaccolo M, 2002, CURR OPIN CELL BIOL, V14, P160, DOI 10.1016/S0955-0674(02)00316-2; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140	40	60	60	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30774	10.1371/journal.pone.0030774	http://dx.doi.org/10.1371/journal.pone.0030774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292038	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600055
J	Lamont, EA; Bannantine, JP; Armien, A; Ariyakumar, DS; Sreevatsan, S				Lamont, Elise A.; Bannantine, John P.; Armien, Anibal; Ariyakumar, Don Sanjiv; Sreevatsan, Srinand			Identification and Characterization of a Spore-Like Morphotype in Chronically Starved Mycobacterium avium Subsp Paratuberculosis Cultures	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DIPICOLINIC ACID; CROHNS-DISEASE; TUBERCULOSIS; SPORULATION; PERSISTENCE; INFECTIONS; PRODUCTS; SURVIVAL; VECTORS	Mycobacteria are able to enter into a state of non-replication or dormancy, which may result in their chronic persistence in soil, aquatic environments, and permissive hosts. Stresses such as nutrient deprivation and hypoxia provide environmental cues to enter a persistent state; however, a clear definition of the mechanism that mycobacteria employ to achieve this remains elusive. While the concept of sporulation in mycobacteria is not novel, it continues to spark controversy and challenges our perceptions of a non-replication. We investigated the potential role of sporulation in one-year old broth cultures of Mycobacterium subsp. paratuberculosis (MAP). We show that dormant cultures of MAP contain a mix of vegetative cells and a previously unknown morphotype resembling a spore. These spore-like structures can be enriched for using sporulating media. Furthermore, purified MAP spore forms survive exposure to heat, lysozyme and proteinase K. Heat-treated spores are positive for MAP 16SrRNA and IS900. MAP spores display enhanced infectivity as well as maintain acid-fast characteristics upon germination in a well-established bovine macrophage model. This is the first study to demonstrate a new MAP morphotype possessing spore-like qualities. Data suggest that sporulation may be a viable mechanism by which MAP accomplishes persistence in the host and/or environment. Thus, our current understanding of mycobacterial persistence, pathogenesis, epidemiology and rational drug and vaccine design may need to be reevaluated.	[Lamont, Elise A.; Sreevatsan, Srinand] Univ Minnesota, Dept Vet Biomed Sci, St Paul, MN 55108 USA; [Ariyakumar, Don Sanjiv] Univ Minnesota, Vet Diagnost Lab, St Paul, MN 55108 USA; [Bannantine, John P.] ARS, Natl Anim Dis Ctr, USDA, Ames, IA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA)	Lamont, EA (corresponding author), Univ Minnesota, Dept Vet Biomed Sci, St Paul, MN 55108 USA.	sreev001@umn.edu	Sreevatsan, Srinand/V-6808-2019	Sreevatsan, Srinand/0000-0002-5162-2403; Lamont, Elise/0000-0001-7085-9740; Bannantine, John/0000-0002-5692-7898	USDA-CSREES [2008-55620-18710]	USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by Johne's Disease Integrated Program (USDA-CSREES 2008-55620-18710) awarded to Dr. Sreevatsan. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAHA M, 1956, J BACTERIOL, V72, P34, DOI 10.1128/JB.72.1.34-41.1956; [Anonymous], 2008, Vet Rec, V163, P171; Bentrup KHZ, 2001, TRENDS MICROBIOL, V9, P597, DOI 10.1016/S0966-842X(01)02238-7; Bloom BR, 1999, NAT MED, V5, P872, DOI 10.1038/11309; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; Chacon O, 2004, ANNU REV MICROBIOL, V58, P329, DOI 10.1146/annurev.micro.58.030603.123726; CHIODINI RJ, 1984, DIGEST DIS SCI, V29, P1073, DOI 10.1007/BF01317078; CHIODINI RJ, 1984, J CLIN MICROBIOL, V20, P966, DOI 10.1128/JCM.20.5.966-971.1984; Coussens PM, 2004, INFECT IMMUN, V72, P1409, DOI 10.1128/IAI.72.3.1409-1422.2004; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; DANIEL RA, 1993, J MOL BIOL, V232, P468, DOI 10.1006/jmbi.1993.1403; de Hoon MJL, 2010, CURR BIOL, V20, pR735, DOI 10.1016/j.cub.2010.06.031; Dhand NK, 2009, APPL ENVIRON MICROB, V75, P5581, DOI 10.1128/AEM.00557-09; Di Sabatino A, 2011, INFLAMM BOWEL DIS, V17, P1254, DOI 10.1002/ibd.21461; Donaghy JA, 2004, APPL ENVIRON MICROB, V70, P4899, DOI 10.1128/AEM.70.8.4899-4905.2004; Ehlers S, 2009, INFECTION, V37, P87, DOI 10.1007/s15010-009-8450-7; El-Zaatari FAK, 2001, TRENDS MOL MED, V7, P247, DOI 10.1016/S1471-4914(01)01983-9; Eltholth MM, 2009, J APPL MICROBIOL, V107, P1061, DOI 10.1111/j.1365-2672.2009.04286.x; Filippova S. N., 2005, Mikrobiologiya, V74, P204; Fischer O, 2001, MED VET ENTOMOL, V15, P208, DOI 10.1046/j.1365-2915.2001.00292.x; Fischer OA, 2004, VET MICROBIOL, V102, P247, DOI 10.1016/j.vetmic.2004.06.005; Fischer OA, 2003, VET MICROBIOL, V91, P325, DOI 10.1016/S0378-1135(02)00302-4; Fukutomi Yasuo, 2009, Nihon Hansenbyo Gakkai Zasshi, V78, P7; Garcia D, 2010, INT J FOOD MICROBIOL, V140, P146, DOI 10.1016/j.ijfoodmicro.2010.04.005; Ghosh J, 2009, P NATL ACAD SCI USA, V106, P10781, DOI 10.1073/pnas.0904104106; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Grewal SK, 2006, APPL ENVIRON MICROB, V72, P565, DOI 10.1128/AEM.72.1.565-574.2006; Gumber S, 2009, VET MICROBIOL, V133, P344, DOI 10.1016/j.vetmic.2008.07.021; Hamilton HK, 2008, INT J DERMATOL, V47, P545, DOI 10.1111/j.1365-4632.2008.03722.x; Hesketh A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r161; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; JANSSEN FW, 1958, SCIENCE, V127, P26, DOI 10.1126/science.127.3288.26; KANETSUNA F, 1964, Int J Lepr, V32, P185; Lamont EA, 2010, MICROB PATHOGENESIS, V48, P143, DOI 10.1016/j.micpath.2010.02.002; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Orme IM, 2001, INT J TUBERC LUNG D, V5, P589; Orsburn BC, 2010, MOL MICROBIOL, V75, P178, DOI 10.1111/j.1365-2958.2009.06975.x; Pickup RW, 2006, APPL ENVIRON MICROB, V72, P4067, DOI 10.1128/AEM.02490-05; Pribylova R, 2011, CURR MICROBIOL, V62, P1405, DOI 10.1007/s00284-011-9875-7; Raizman EA, 2005, CAN J VET RES, V69, P32; RAMAKRISHNAN L, 1994, INFECT IMMUN, V62, P3222, DOI 10.1128/IAI.62.8.3222-3229.1994; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; ROBINOW CF, 1953, J BACTERIOL, V65, P378, DOI 10.1128/JB.65.4.378-382.1953; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Sechi LA, 2004, MICROBIOLOGICA, V27, P75; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Shankar H, 2010, INT J INFECT DIS, V14, pE121, DOI 10.1016/j.ijid.2009.03.031; Singh SV, 2009, INT J INFECT DIS, V13, pE221, DOI 10.1016/j.ijid.2008.11.022; SOLARI AA, 1968, APPL MICROBIOL, V16, P792, DOI 10.1128/AEM.16.5.792-.1968; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; STASTNA J, 1992, FOLIA MICROBIOL, V37, P111, DOI 10.1007/BF02836614; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TANAKA K, 1991, GUT, V32, P43, DOI 10.1136/gut.32.1.43; Traag BA, 2010, P NATL ACAD SCI USA, V107, P878, DOI 10.1073/pnas.0911299107; Van Brandt L, 2011, J APPL MICROBIOL, V110, P1252, DOI 10.1111/j.1365-2672.2011.04979.x; van Schaik W, 2007, MICROBIOL-SGM, V153, P4234, DOI 10.1099/mic.0.2007/010355-0; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Wang MY, 2007, APPL MICROBIOL BIOT, V77, P645, DOI 10.1007/s00253-007-1196-1; Wekesa VW, 2010, J INVERTEBR PATHOL, V103, P36, DOI 10.1016/j.jip.2009.10.003; Whittington RJ, 2004, APPL ENVIRON MICROB, V70, P2989, DOI 10.1128/AEM.70.5.2989-3004.2004; Yang WW, 2009, J APPL MICROBIOL, V106, P27, DOI 10.1111/j.1365-2672.2008.03931.x	62	65	66	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30648	10.1371/journal.pone.0030648	http://dx.doi.org/10.1371/journal.pone.0030648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292005	Green Published, gold, Green Submitted			2022-12-27	WOS:000301639600040
J	Wang, Y; Hu, HH; Pang, H; Zhou, XY; Yu, LS; Wang, LL; Liu, CE; Guo, KN; Zhao, C; Liu, Q; Zeng, BH; Tang, H; Shang, HT; Zeng, S; Wei, H				Wang, Yong; Hu, Hai-Hong; Pang, Hao; Zhou, Xiao-Yang; Yu, Lu-Shan; Wang, Lu-Lu; Liu, Cang'e; Guo, Ke-Nan; Zhao, Cong; Liu, Qin; Zeng, Ben-Hua; Tang, Huan; Shang, Hai-Tao; Zeng, Su; Wei, Hong			Lentiviral Transgenic MicroRNA-Based shRNA Suppressed Mouse Cytochromosome P450 3A (CYP3A) Expression in a Dose-Dependent and Inheritable Manner	PLOS ONE			English	Article							GEL-ELECTROPHORESIS; RNA INTERFERENCE; HUMANIZED MOUSE; STEM-CELLS; LIVER; DOCETAXEL; MODEL; MICE; RAT; RESTRICTION	Cytochomosome P450 enzymes (CYP) are heme-containing monooxygenases responsible for oxidative metabolism of many exogenous and endogenous compounds including drugs. The species difference of CYP limits the extent to which data obtained from animals can be translated to humans in pharmacodynamics or pharmacokinetics studies. Transgenic expression of human CYP in animals lacking or with largely reduced endogenous CYP counterparts is recognized as an ideal strategy to correct CYP species difference. CYP3A is the most abundant CYP subfamily both in human and mammals. In this study, we designed a microRNA-based shRNA (miR-shRNA) simultaneously targeting four members of mouse CYP3A subfamily (CYP3A11, CYP3A16, CYP3A41 and CYP3A44), and transgenic mice expressing the designed miR-shRNA were generated by lentiviral transgenesis. Results showed that the CYP3A expression level in transgenic mice was markedly reduced compared to that in wild type or unrelated miR-shRNA transgenic mice, and was inversely correlated to the miR-shRNA expression level. The CYP3A expression levels in transgenic offspring of different generations were also remarkably lower compared to those of controls, and moreover the inhibition rate of CYP3A expression remained comparable over generations. The ratio of the targeted CYP3A transcriptional levels was comparable between knockdown and control mice of the same gender as detected by RT-PCR DGGE analysis. These data suggested that transgenic miR-shRNA suppressed CYP3A expression in a dose-dependent and inheritable manner, and transcriptional levels of the targeted CYP3As were suppressed to a similar extent. The observed knockdown efficacy was further confirmed by enzymatic activity analysis, and data showed that CYP3A activities in transgenic mice were markedly reduced compared to those in wild-type or unrelated miR-shRNA transgenic controls (1.11 +/- 0.71 vs 5.85 +/- 1.74, 5.9 +/- 2.4; P<0.01). This work laid down a foundation to further knock down the remaining murine CYP3As or CYPs of other subfamilies, and a basis to generate CYP knockdown animals of other species.	[Wang, Yong; Pang, Hao; Zhou, Xiao-Yang; Wang, Lu-Lu; Liu, Cang'e; Guo, Ke-Nan; Liu, Qin; Zeng, Ben-Hua; Tang, Huan; Shang, Hai-Tao; Wei, Hong] Third Mil Med Univ, Coll Basic Med Sci, Dept Lab Anim Sci, Chongqing, Peoples R China; [Hu, Hai-Hong; Yu, Lu-Shan; Zeng, Su] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Cong] Southwest Univ, Sch Anim Sci & Technol, Chongqing, Peoples R China	Army Medical University; Zhejiang University; Southwest University - China	Wang, Y (corresponding author), Third Mil Med Univ, Coll Basic Med Sci, Dept Lab Anim Sci, Chongqing, Peoples R China.	zengsu@zju.edu.cn; weihong63528@163.com	Shang, Haitao/P-5507-2018; Pang, Hao/H-1319-2012		Natural Science Foundation of China [30700076, 81173126]; Chongqing Natural Science Foundation (CSTC) [2009BB5318]; Third Military Medical university (Chongqing, China) [2009XQN09]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Foundation (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Third Military Medical university (Chongqing, China)	This work was supported by grants from Natural Science Foundation of China (30700076 and 81173126), Chongqing Natural Science Foundation (CSTC, 2009BB5318) and Youth Innovation Fund of Third Military Medical university (Chongqing, China)(2009XQN09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTERMAN M, 1993, AGE, V16, P1, DOI 10.1007/BF02436124; Bjork BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014375; Bogaards JJP, 2000, XENOBIOTICA, V30, P1131, DOI 10.1080/00498250010021684; Bruno R, 1998, J CLIN ONCOL, V16, P187, DOI 10.1200/JCO.1998.16.1.187; Corchero J, 2001, MOL PHARMACOL, V60, P1260, DOI 10.1124/mol.60.6.1260; Daly AK, 2006, CLIN PHARMACOKINET, V45, P13, DOI 10.2165/00003088-200645010-00002; Dann CT, 2006, P NATL ACAD SCI USA, V103, P11246, DOI 10.1073/pnas.0604657103; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P340, DOI 10.1128/AEM.62.2.340-346.1996; FISCHER SG, 1979, CELL, V16, P191, DOI 10.1016/0092-8674(79)90200-9; Galeva N, 2002, PROTEOMICS, V2, P713, DOI 10.1002/1615-9861(200206)2:6<713::AID-PROT713>3.0.CO;2-M; Gonzalez FJ, 2003, ARCH BIOCHEM BIOPHYS, V409, P153, DOI 10.1016/S0003-9861(02)00364-8; Guengerich FP, 1997, CHEM-BIOL INTERACT, V106, P161, DOI 10.1016/S0009-2797(97)00068-9; Hasuwa H, 2002, FEBS LETT, V532, P227, DOI 10.1016/S0014-5793(02)03680-3; Hirth J, 2000, CLIN CANCER RES, V6, P1255; Hofmann A, 2006, MOL THER, V13, P59, DOI 10.1016/j.ymthe.2005.07.685; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marre F, 1996, CANCER RES, V56, P1296; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Peng SH, 2006, P NATL ACAD SCI USA, V103, P2252, DOI 10.1073/pnas.0511034103; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sakuma T, 2002, ARCH BIOCHEM BIOPHYS, V404, P234, DOI 10.1016/S0003-9861(02)00329-6; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Van Herwaarden AE, 2005, DRUG METAB DISPOS, V33, P892, DOI 10.1124/dmd.105.004721; van Herwaarden AE, 2007, J CLIN INVEST, V117, P3583, DOI 10.1172/JCI33435; Wang Y, 2010, TRANSGENIC RES, V19, P775, DOI 10.1007/s11248-009-9355-z; Whitelaw CBA, 2004, FEBS LETT, V571, P233, DOI 10.1016/j.febslet.2004.06.076; Yanagimoto T, 1997, ARCH BIOCHEM BIOPHYS, V340, P215, DOI 10.1006/abbi.1997.9900; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Yu AM, 2004, DRUG METAB REV, V36, P243, DOI 10.1081/DMR-120034000; Yu LS, 2008, J PHARM PHARMACOL, V60, P1601, DOI [10.1211/jpp/60.11.0005, 10.1111/j.2042-7158.2008.tb02172.x]; Zhou HX, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni061; Zuber R, 2002, J CELL MOL MED, V6, P189, DOI 10.1111/j.1582-4934.2002.tb00186.x	41	8	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30560	10.1371/journal.pone.0030560	http://dx.doi.org/10.1371/journal.pone.0030560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291988	Green Published, gold, Green Submitted			2022-12-27	WOS:000301639600033
J	Ponnuswamy, P; Schrottle, A; Ostermeier, E; Gruner, S; Huang, PL; Ertl, G; Hoffmann, U; Nieswandt, B; Kuhlencordt, PJ				Ponnuswamy, Padmapriya; Schroettle, Angelika; Ostermeier, Eva; Gruener, Sabine; Huang, Paul L.; Ertl, Georg; Hoffmann, Ulrich; Nieswandt, Bernhard; Kuhlencordt, Peter J.			eNOS Protects from Atherosclerosis Despite Relevant Superoxide Production by the Enzyme in apoE(-/-) Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIAL CELL-INTERACTIONS; DOUBLE-KNOCKOUT MICE; APOLIPOPROTEIN-E; DEFICIENT MICE; IN-VIVO; ACCELERATED ATHEROSCLEROSIS; LEUKOCYTE ADHESION; PLATELET-ADHESION; LESION FORMATION	Background: All three nitric oxide synthase (NOS) isoforms are expressed in atherosclerotic plaques. NOS enzymes in general catalyse NO production. However, under conditions of substrate and cofactor deficiency, the enzyme directly catalyse superoxide formation. Considering this alternative chemistry, the effects of NOS on key events in spontaneous hyperlipidemia driven atherosclerosis have not been investigated yet. Here, we evaluate how endothelial nitric oxide synthase (eNOS) modulates leukocyte/endothelial-(L/E) and platelet/endothelial-(P/E) interactions in atherosclerosis and the production of nitric oxide (NO) and superoxide by the enzyme. Principal Findings: Intravital microscopy (IVM) of carotid arteries revealed significantly increased L/E-interactions in apolipoproteinE/eNOS double knockout mice (apoE(-/-)/eNOS(-/-)), while P/E-interactions did not differ, compared to apoE(-/-). eNOS deficiency increased macrophage infiltration in carotid arteries and vascular cell adhesion molecule-1 (VCAM-1) expression, both in endothelial and smooth muscle cells. Despite the expression of other NOS isoforms (inducible NOS, iNOS and neuronal NOS, nNOS) in plaques, Electron Spin Resonance (ESR) measurements of NO showed significant contribution of eNOS to total circulating and vascular wall NO production. Pharmacological inhibition and genetic deletion of eNOS reduced vascular superoxide production, indicating uncoupling of the enzyme in apoE(-/-) vessels. Conclusion: Overt plaque formation, increased vascular inflammation and L/E-interactions are associated with significant reduction of superoxide production in apoE(-/-)/eNOS(-/-) vessels. Therefore, lack of eNOS does not cause an automatic increase in oxidative stress. Uncoupling of eNOS occurs in apoE(-/-) atherosclerosis but does not negate the enzyme's strong protective effects.	[Ponnuswamy, Padmapriya; Schroettle, Angelika; Ostermeier, Eva; Ertl, Georg; Kuhlencordt, Peter J.] Univ Wurzburg, Med Klin 1, Herz Kreislaufzentrum, Wurzburg, Germany; [Gruener, Sabine; Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Zentrum Expt Biomed, DFG Res Ctr Expt Biomed, Wurzburg, Germany; [Huang, Paul L.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Huang, Paul L.] Harvard Univ, Sch Med, Boston, MA USA; [Schroettle, Angelika; Hoffmann, Ulrich; Kuhlencordt, Peter J.] Univ Munich, Med Poliklin, Div Vasc Med, D-8000 Munich, Germany	University of Wurzburg; German Research Foundation (DFG); University of Wurzburg; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Munich	Ponnuswamy, P (corresponding author), INSERM, Paris Cardiovasc Res Ctr, U970, Paris, France.	peter.kuhlencordt@med.uni-muenchen.de	Hoffmann, Ulrich/AAF-9798-2020	Huang, Paul/0000-0002-5436-8658	Deutsche-Forschungsgemeinschaft [KU-1206(1), KU1206(2)]; Interdisziplinares Zentrum fur Klinische Forschung, Wurzburg [E-30F]	Deutsche-Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisziplinares Zentrum fur Klinische Forschung, Wurzburg	This work was supported by grants from the Deutsche-Forschungsgemeinschaft [KU-1206(1) and KU1206(2)] and the Interdisziplinares Zentrum fur Klinische Forschung, Wurzburg [E-30F] to PJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht EWJA, 2003, J PATHOL, V199, P8, DOI 10.1002/path.1250; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; Cerwinka WH, 2002, AM J PHYSIOL-HEART C, V282, pH1111, DOI 10.1152/ajpheart.00391.2001; Chen JQ, 2001, CIRCULATION, V104, P2391, DOI 10.1161/hc4501.099729; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Detmers PA, 2000, J IMMUNOL, V165, P3430, DOI 10.4049/jimmunol.165.6.3430; Dikalov S, 2005, METHOD ENZYMOL, V396, P597, DOI 10.1016/S0076-6879(05)96052-7; Dikalova A, 2005, CIRCULATION, V112, P2668, DOI 10.1161/CIRCULATIONAHA.105.538934; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; GAUTHIER TW, 1994, AM J PHYSIOL-GASTR L, V267, pG562, DOI 10.1152/ajpgi.1994.267.4.G562; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Hall DM, 1996, METHOD ENZYMOL, V268, P188; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Kleschyov AL, 2000, BIOCHEM BIOPH RES CO, V275, P672, DOI 10.1006/bbrc.2000.3361; Knowles JW, 2000, J CLIN INVEST, V105, P451, DOI 10.1172/JCI8376; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Kuhlencordt PJ, 2006, ARTERIOSCL THROM VAS, V26, P1539, DOI 10.1161/01.ATV.0000223143.88128.19; Kuhlencordt PJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1195, DOI 10.1152/ajpcell.00546.2002; Kuhlencordt PJ, 2001, CIRCULATION, V103, P3099, DOI 10.1161/01.CIR.103.25.3099; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Lefer DJ, 1999, AM J PHYSIOL-HEART C, V276, pH1943, DOI 10.1152/ajpheart.1999.276.6.H1943; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Massberg S, 2005, CIRCULATION, V112, P1180, DOI 10.1161/CIRCULATIONAHA.105.539221; Massberg S, 1998, RES EXP MED, V198, P23, DOI 10.1007/s004330050086; Michelson AD, 1996, AM J PHYSIOL-HEART C, V270, pH1640, DOI 10.1152/ajpheart.1996.270.5.H1640; OHARA Y, 1993, J CLIN INVEST, V91, P2546, DOI 10.1172/JCI116491; Ozaki M, 2002, J CLIN INVEST, V110, P331, DOI 10.1172/JCI200215215; Ponnuswamy P, 2009, AM J PATHOL, V174, P2400, DOI 10.2353/ajpath.2009.080730; POU S, 1992, J BIOL CHEM, V267, P24173; Rabelink TJ, 2006, ARTERIOSCL THROM VAS, V26, P267, DOI 10.1161/01.ATV.0000196554.85799.77; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sanz MJ, 2001, BRIT J PHARMACOL, V134, P305, DOI 10.1038/sj.bjp.0704234; Schafer A, 2008, BRIT J PHARMACOL, V153, P886, DOI 10.1038/sj.bjp.0707459; Sorescu D, 2002, CIRCULATION, V105, P1429, DOI 10.1161/01.CIR.0000012917.74432.66; STAMLER J, 1989, CIRC RES, V65, P789, DOI 10.1161/01.RES.65.3.789; Theilmeier G, 2002, BLOOD, V99, P4486, DOI 10.1182/blood.V99.12.4486; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; WHITE CR, 1994, P NATL ACAD SCI USA, V91, P1044, DOI 10.1073/pnas.91.3.1044; Wilcox JN, 1997, ARTERIOSCL THROM VAS, V17, P2479, DOI 10.1161/01.ATV.17.11.2479; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Xia Y, 1998, J BIOL CHEM, V273, P22635, DOI 10.1074/jbc.273.35.22635	45	69	75	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30193	10.1371/journal.pone.0030193	http://dx.doi.org/10.1371/journal.pone.0030193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291917	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600023
J	Hong, MH; Chou, YC; Wu, YC; Tsai, KN; Hu, CP; Jeng, KS; Chen, ML; Chang, CM				Hong, Ming-Hsiang; Chou, Yu-Chi; Wu, Yi-Chieh; Tsai, Kuen-Nan; Hu, Cheng-po; Jeng, King-Song; Chen, Mong-Liang; Chang, Chungming			Transforming Growth Factor-beta 1 Suppresses Hepatitis B Virus Replication by the Reduction of Hepatocyte Nuclear Factor-4 alpha Expression	PLOS ONE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; DIFFERENTIAL REGULATION; VIRAL CLEARANCE; FACTOR 4-ALPHA; TGF-BETA; PRE-C	Several studies have demonstrated that cytokine-mediated noncytopathic suppression of hepatitis B virus (HBV) replication may provide an alternative therapeutic strategy for the treatment of chronic hepatitis B infection. In our previous study, we showed that transforming growth factor-beta1 (TGF-beta 1) could effectively suppress HBV replication at physiological concentrations. Here, we provide more evidence that TGF-beta 1 specifically diminishes HBV core promoter activity, which subsequently results in a reduction in the level of viral pregenomic RNA (pgRNA), core protein (HBc), nucleocapsid, and consequently suppresses HBV replication. The hepatocyte nuclear factor 4alpha (HNF-4 alpha) binding element(s) within the HBV core promoter region was characterized to be responsive for the inhibitory effect of TGF-beta 1 on HBV regulation. Furthermore, we found that TGF-beta 1 treatment significantly repressed HNF-4 alpha expression at both mRNA and protein levels. We demonstrated that RNAi-mediated depletion of HNF-4 alpha was sufficient to reduce HBc synthesis as TGF-beta 1 did. Prevention of HNF-4 alpha degradation by treating with proteasome inhibitor MG132 also prevented the inhibitory effect of TGF-beta 1. Finally, we confirmed that HBV replication could be rescued by ectopic expression of HNF-4 alpha in TGF-beta 1-treated cells. Our data clarify the mechanism by which TGF-beta 1 suppresses HBV replication, primarily through modulating the expression of HNF-4a gene.	[Hong, Ming-Hsiang; Chang, Chungming] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Hong, Ming-Hsiang; Wu, Yi-Chieh; Tsai, Kuen-Nan; Chang, Chungming] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan; [Chou, Yu-Chi; Jeng, King-Song] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Tsai, Kuen-Nan] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Hu, Cheng-po] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Chen, Mong-Liang] China Med Univ & Hosp, Ctr Mol Med, Taichung, Taiwan	National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; National Tsing Hua University; Tunghai University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Hong, MH (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	tonychang@nhri.org.tw	Tsai, Kuen-Nan/G-4606-2019; Chang, Chung-Ming/E-3945-2010		National Health Research Institutes (NHRI), Taiwan (ROC) [MG-098-PP-08, MG-099-PP-07]	National Health Research Institutes (NHRI), Taiwan (ROC)(National Health Research Institutes - Taiwan)	This work was supported by research grants (MG-098-PP-08 and MG-099-PP-07) from the National Health Research Institutes (NHRI), Taiwan (ROC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpolat N, 2005, WORLD J GASTROENTERO, V11, P3260, DOI 10.3748/wjg.v11.i21.3260; Biermer M, 2003, J VIROL, V77, P4033, DOI 10.1128/JVI.77.7.4033-4042.2003; Billerbeck E, 2007, WORLD J GASTROENTERO, V13, P4858, DOI 10.3748/wjg.v13.i36.4858; BISSELL DM, 1995, J CLIN INVEST, V96, P447, DOI 10.1172/JCI118055; Bock CT, 2000, J VIROL, V74, P2193, DOI 10.1128/JVI.74.5.2193-2202.2000; Borlak J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004662; CALVERT J, 1994, J VIROL, V68, P2084, DOI 10.1128/JVI.68.4.2084-2090.1994; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen ML, 2010, WORLD J GASTROENTERO, V16, P5092, DOI 10.3748/wjg.v16.i40.5092; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cheng YC, 2009, J NEUROCHEM, V110, P947, DOI 10.1111/j.1471-4159.2009.06186.x; Chou YC, 2005, J VIROL, V79, P1813, DOI 10.1128/JVI.79.3.1813-1823.2005; Chou YC, 2007, HEPATOLOGY, V46, P672, DOI 10.1002/hep.21726; Cicchini C, 2006, J CELL PHYSIOL, V209, P230, DOI 10.1002/jcp.20730; de Lucas S, 2004, BIOCHEM BIOPH RES CO, V321, P688, DOI 10.1016/j.bbrc.2004.07.025; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; GALIBERT F, 1979, NATURE, V281, P646, DOI 10.1038/281646a0; GARCIA AD, 1993, J VIROL, V67, P3940, DOI 10.1128/JVI.67.7.3940-3950.1993; Guidotti LG, 2002, J VIROL, V76, P2617, DOI 10.1128/JVI.76.6.2617-2621.2002; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Ishikawa F, 2008, EXP CELL RES, V314, P2131, DOI 10.1016/j.yexcr.2008.03.013; KAKUMU S, 1993, LIVER, V13, P62; Kimura K, 2002, J VIROL, V76, P10702, DOI 10.1128/JVI.76.21.10702-10707.2002; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; Kuo TM, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-41; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; LeJossic C, 1996, EUR J BIOCHEM, V238, P400, DOI 10.1111/j.1432-1033.1996.0400z.x; Li J, 1999, J VIROL, V73, P1239, DOI 10.1128/JVI.73.2.1239-1244.1999; Li J, 2001, J VIROL, V75, P8400, DOI 10.1128/JVI.75.18.8400-8406.2001; Li JX, 2000, GENE DEV, V14, P464; Li S, 2008, J VIROL, V82, P21, DOI 10.1128/JVI.01768-07; Lin SJ, 2003, J IMMUNOL, V171, P4708, DOI 10.4049/jimmunol.171.9.4708; Martin-Vilchez S, 2008, HEPATOLOGY, V47, P1872, DOI 10.1002/hep.22265; McClary H, 2000, J VIROL, V74, P2255, DOI 10.1128/JVI.74.5.2255-2264.2000; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Mizuguchi T, 1998, J CELL PHYSIOL, V174, P273, DOI 10.1002/(SICI)1097-4652(199803)174:3<273::AID-JCP1>3.3.CO;2-1; Moolla N, 2002, J VIRAL HEPATITIS, V9, P323, DOI 10.1046/j.1365-2893.2002.00381.x; Murawaki Y, 1998, J GASTROEN HEPATOL, V13, P680, DOI 10.1111/j.1440-1746.1998.tb00713.x; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Quasdorff M, 2010, J VIRAL HEPATITIS, V17, P527, DOI 10.1111/j.1365-2893.2010.01315.x; RANEY AK, 1995, J VIROL, V69, P3265, DOI 10.1128/JVI.69.6.3265-3272.1995; Raney AK, 1997, J VIROL, V71, P1058, DOI 10.1128/JVI.71.2.1058-1071.1997; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Romero R, 1996, HEPATOLOGY, V23, P17, DOI 10.1053/jhep.1996.v23.pm0008550037; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; SHIRAI Y, 1994, CANCER, V73, P2275, DOI 10.1002/1097-0142(19940501)73:9<2275::AID-CNCR2820730907>3.0.CO;2-T; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Takagi S, 2010, J BIOL CHEM, V285, P4415, DOI 10.1074/jbc.M109.085431; Tang H, 2001, P NATL ACAD SCI USA, V98, P1841, DOI 10.1073/pnas.041479698; Tang H, 2001, DRUG NEWS PERSPECT, V14, P325; Tseng Ya Ping, 2010, Front Biosci (Elite Ed), V2, P1538; Wang B, 2001, HEPATOLOGY, V34, P979, DOI 10.1053/jhep.2001.28885; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; YAGINUMA K, 1989, J VIROL, V63, P2914, DOI 10.1128/JVI.63.7.2914-2920.1989; Yang GL, 2007, INT IMMUNOL, V19, P133, DOI 10.1093/intimm/dxl130; Ying CX, 2007, P NATL ACAD SCI USA, V104, P8526, DOI 10.1073/pnas.0609883104; Yu XM, 2003, J VIROL, V77, P2489, DOI 10.1128/JVI.77.4.2489-2499.2003; Yu XM, 1997, J VIROL, V71, P9366, DOI 10.1128/JVI.71.12.9366-9374.1997; Yu XM, 1996, J VIROL, V70, P8719, DOI 10.1128/JVI.70.12.8719-8726.1996; Yu XM, 2001, J VIROL, V75, P11354, DOI 10.1128/JVI.75.23.11354-11364.2001; YUH CH, 1992, J VIROL, V66, P4073, DOI 10.1128/JVI.66.7.4073-4084.1992; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634; Zheng YY, 2004, J VIROL, V78, P6908, DOI 10.1128/JVI.78.13.6908-6914.2004	67	45	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30360	10.1371/journal.pone.0030360	http://dx.doi.org/10.1371/journal.pone.0030360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276183	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100038
J	Mulligan, KX; Morris, RT; Otero, YF; Wasserman, DH; McGuinness, OP				Mulligan, Kimberly X.; Morris, R. Tyler; Otero, Yolanda F.; Wasserman, David H.; McGuinness, Owen P.			Disassociation of Muscle Insulin Signaling and Insulin-Stimulated Glucose Uptake during Endotoxemia	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; UPTAKE IN-VIVO; SKELETAL-MUSCLE; BLOOD-FLOW; INDIVIDUAL TISSUES; TNF-ALPHA; RESISTANCE; SEPSIS; METABOLISM	Lipopolysaccharide (LPS) elicits a strong immune response, which leads to the release of inflammatory cytokines. Increased cytokine production has been shown to impair insulin-mediated glucose disposal. LPS can alter other factors, such as muscle blood flow and insulin signaling in the myocyte, that can influence glucose disposal. We hypothesize that LPS induced impairments in cardiovascular function contribute to the associated impairments in insulin action in vivo. Male wild-type C57BL/6J mice had a catheter implanted in the jugular vein for infusions and the carotid artery for sampling 5 days prior to the hyperinsulinemic-euglycemic clamp. Mice were treated with vehicle, low-(1 ug/gBW) or high-dose (10 ug/gBW) LPS 4 hours prior to the clamp. Muscle glucose uptake (MGU) was assessed using [2(-14)C] deoxyglucose. While both low-and high-dose LPS inhibited insulin-stimulated MGU compared to vehicle-treated mice, the impairment was more significant with the high-dose treatment (similar to 25% in soleus and similar to 70% in both gastrocnemius and vastus lateralis). Interestingly, insulin signaling through the PI3-kinase pathway in the muscle was not affected by this treatment suggesting that the decrease in MGU is not directly due to impairments in muscle insulin action. Echocardiography demonstrated that high-dose LPS treatment significantly decreased stroke volume (similar to 30%), heart rate (similar to 35%), and cardiac output (similar to 50%). These observations were not seen with vehicle or low-dose LPS treatment. High-dose LPS treatment also significantly decreased muscle blood flow (similar to 70%) and whole body oxygen consumption (similar to 50%). Thus, in vivo acute endotoxemia does not impair insulin signaling through the PI3-kinase pathway in skeletal muscle and decreased tissue blood flow likely plays a central role in the impairment of glucose uptake in the muscle.	[Mulligan, Kimberly X.; Morris, R. Tyler; Otero, Yolanda F.; Wasserman, David H.; McGuinness, Owen P.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med Nashville, Nashville, TN 37203 USA	Vanderbilt University	Mulligan, KX (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med Nashville, Nashville, TN 37203 USA.	owen.mcguinness@vanderbilt.edu			National Institutes of Health [DK43748, DK78188]; Vanderbilt Diabetes and Research and Training Center [DK20593]; Vanderbilt Mouse Metabolic Phenotyping Center [DK59637]; Molecular Endocrinology Training Grant [T32-DK-07563]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078188, T32DK007563, P30DK020593, R56DK043748, P60DK020593, R01DK043748, R29DK043748, U24DK059637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Diabetes and Research and Training Center; Vanderbilt Mouse Metabolic Phenotyping Center; Molecular Endocrinology Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants (DK43748, DK78188; PI: Owen McGuinness), Vanderbilt Diabetes and Research and Training Center (DK20593) and Vanderbilt Mouse Metabolic Phenotyping Center (DK59637). Kimberly Mulligan was supported by the Molecular Endocrinology Training Grant T32-DK-07563. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; BARON AD, 1994, AM J PHYSIOL, V266, pE248, DOI 10.1152/ajpendo.1994.266.2.E248; BARON AD, 1994, AM J PHYSIOL, V267, pE187, DOI 10.1152/ajpendo.1994.267.2.E187; Baron AD, 1996, AM J PHYSIOL-ENDOC M, V271, pE1067, DOI 10.1152/ajpendo.1996.271.6.E1067; Bedard S, 1997, BIOCHEM J, V325, P487, DOI 10.1042/bj3250487; BONE RC, 1992, CRIT CARE MED, V20, P724, DOI 10.1097/00003246-199206000-00002; Carvalho-Filho MA, 2006, AM J PHYSIOL-ENDOC M, V291, pE476, DOI 10.1152/ajpendo.00422.2005; Clark MG, 2003, AM J PHYSIOL-ENDOC M, V284, pE241, DOI 10.1152/ajpendo.00408.2002; de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200; Del Aguila LF, 1999, AM J PHYSIOL-ENDOC M, V276, pE849, DOI 10.1152/ajpendo.1999.276.5.E849; DOUEN AG, 1990, J BIOL CHEM, V265, P13427; Ellis CG, 2002, AM J PHYSIOL-HEART C, V282, pH156, DOI 10.1152/ajpheart.2002.282.1.H156; Eringa EC, 2006, ARTERIOSCL THROM VAS, V26, P274, DOI 10.1161/01.ATV.0000198248.19391.3e; Fan J, 1996, SHOCK, V6, P164, DOI 10.1097/00024382-199609010-00002; Frost RA, 2002, AM J PHYSIOL-REG I, V283, pR698, DOI 10.1152/ajpregu.00039.2002; Hallemeesch MM, 2003, AM J PHYSIOL-ENDOC M, V285, pE871, DOI 10.1152/ajpendo.00004.2002; KRAEGEN EW, 1985, AM J PHYSIOL, V248, pE353; LAM C, 1994, J CLIN INVEST, V94, P2077, DOI 10.1172/JCI117562; LANG CH, 1989, CIRC SHOCK, V28, P165; LANG CH, 1990, METABOLISM, V39, P1096, DOI 10.1016/0026-0495(90)90172-9; LING PR, 1994, METABOLISM, V43, P279, DOI 10.1016/0026-0495(94)90093-0; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MARTIN IK, 1995, AM J PHYSIOL-ENDOC M, V269, pE583, DOI 10.1152/ajpendo.1995.269.3.E583; Niswender KD, 1997, J BIOL CHEM, V272, P22570, DOI 10.1074/jbc.272.36.22570; Orellana RA, 2008, PEDIATR RES, V64, P505, DOI 10.1203/PDR.0b013e318183fd4c; Park HK, 2011, DIABETES, V60, P775, DOI 10.2337/db10-1416; Petersen HA, 2003, AM J PHYSIOL-ENDOC M, V284, pE541, DOI 10.1152/ajpendo.00323.2002; Pilon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015912; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; REN JM, 1994, J BIOL CHEM, V269, P14396; Rottman JN, 2007, ECHOCARDIOGR-J CARD, V24, P83, DOI 10.1111/j.1540-8175.2006.00356.x; SCHULTZ TA, 1977, AM J PHYSIOL, V233, pE514, DOI 10.1152/ajpendo.1977.233.6.E514; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Tweedell A, 2011, METABOLISM, V60, P92, DOI 10.1016/j.metabol.2009.12.022; van der Crabben SN, 2009, J CLIN ENDOCR METAB, V94, P463, DOI 10.1210/jc.2008-0761; Vincent MA, 2004, DIABETES, V53, P1418, DOI 10.2337/diabetes.53.6.1418; Wasserman DH, 2011, J EXP BIOL, V214, P254, DOI 10.1242/jeb.048041; Youd JM, 2000, DIABETES, V49, P1904, DOI 10.2337/diabetes.49.11.1904	38	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30160	10.1371/journal.pone.0030160	http://dx.doi.org/10.1371/journal.pone.0030160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276152	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100025
J	Varma, NRS; Janic, B; Iskander, ASM; Shankar, A; Bhuiyan, MPI; Soltanian-Zadeh, H; Jiang, Q; Barton, K; Ali, MM; Arbab, AS				Varma, Nadimpalli Ravi S.; Janic, Branislava; Iskander, A. S. M.; Shankar, Adarsh; Bhuiyan, Mohammed P. I.; Soltanian-Zadeh, Hamid; Jiang, Quan; Barton, Kenneth; Ali, Meser M.; Arbab, Ali S.			Endothelial Progenitor Cells (EPCs) as Gene Carrier System for Rat Model of Human Glioma	PLOS ONE			English	Article							STEM-CELLS; IN-VITRO; THERAPY; EXPRESSION; GROWTH; TUMOR; MIGRATION; DELIVERY; SUICIDE; DIFFERENTIATION	Background: Due to their unique property to migrate to pathological lesions, stem cells are used as a delivery vehicle for therapeutic genes to tumors, especially for glioma. It is critically important to track the movement, localization, engraftment efficiency and functional capability or expression of transgenes of selected cell populations following transplantation. The purposes of this study were to investigate whether 1) intravenously administered, genetically transformed cord blood derived EPCs can carry human sodium iodide symporter (hNIS) to the sites of tumors in rat orthotopic model of human glioma and express transgene products, and 2) whether accumulation of these administered EPCs can be tracked by different in vivo imaging modalities. Methods and Results: Collected EPCs were cultured and transduced to carry hNIS. Cellular viability, differential capacity and Tc-99m uptake were determined. Five to ten million EPCs were intravenously administered and Tc-99-SPECT images were acquired on day 8, to determine the accumulation of EPCs and expression of transgenes (increase activity of Tc-99m) in the tumors. Immunohistochemistry was performed to determine endothelial cell markers and hNIS positive cells in the tumors. Transduced EPCs were also magnetically labeled and accumulation of cells was confirmed by MRI and histochemistry. SPECT analysis showed increased activity of Tc-99m in the tumors that received transduced EPCs, indicative of the expression of transgene (hNIS). Activity of Tc-99m in the tumors was also dependent on the number of administered transduced EPCs. MRI showed the accumulation of magnetically labeled EPCs. Immunohistochemical analysis showed iron and hNIS positive and, human CD31 and vWF positive cells in the tumors. Conclusion: EPC was able to carry and express hNIS in glioma following IV administration. SPECT detected migration of EPCs and expression of the hNIS gene. EPCs can be used as gene carrier/delivery system for glioma therapy as well as imaging probes.	[Varma, Nadimpalli Ravi S.; Janic, Branislava; Iskander, A. S. M.; Shankar, Adarsh; Bhuiyan, Mohammed P. I.; Soltanian-Zadeh, Hamid; Jiang, Quan; Barton, Kenneth; Ali, Meser M.; Arbab, Ali S.] Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Varma, NRS (corresponding author), Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA.	saali@rad.hfh.edu	Arbab, Ali/AAS-1933-2020; Soltanian-Zadeh, Hamid/K-2903-2016; Soltanian-Zadeh, Hamid/AAD-7027-2022	Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Bhuiyan, Mohammed/0000-0003-1116-0280	NIH [1R21CA129801, R01CA122031, R21NS066143, K25CA129173]; American Heart Association [SDG2230011]; NATIONAL CANCER INSTITUTE [K25CA129173, R01CA122031, R21CA129801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064134, R01NS048349, R21NS066143] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work is supported by NIH grants 1R21CA129801 (to ASA), R01CA122031 (to ASA), R21NS066143 (to MMA), K25CA129173 (to MMA) and American Heart Association grant SDG2230011 (to BJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2006, NEURO-ONCOLOGY, V8, P119, DOI 10.1215/15228517-2005-012; Anderson SA, 2005, BLOOD, V105, P420, DOI 10.1182/blood-2004-06-2222; Arbab AS, 2008, FASEB J, V22, P3234, DOI 10.1096/fj.07-105676; Arbab AS, 2006, STEM CELLS, V24, P671, DOI 10.1634/stemcells.2005-0017; Arbab AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009365; Arbab AS, 2009, CURR MED IMAGING, V5, P19, DOI 10.2174/157340509787354697; Arbab AS, 2005, NMR BIOMED, V18, P553, DOI 10.1002/nbm.991; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Barton KN, 2004, MOL THER, V9, P625, DOI 10.1016/j.ymthe.2004.01.011; Brown AB, 2003, HUM GENE THER, V14, P1777, DOI 10.1089/104303403322611782; Buursma AR, 2006, NUCL MED COMMUN, V27, P25, DOI 10.1097/01.mnm.0000186609.12895.20; Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONAHA.105.588954; Cao F, 2007, CLONING STEM CELLS, V9, P107, DOI 10.1089/clo.2006.0E16; Chang GY, 2007, J MOL CELL CARDIOL, V43, P18, DOI 10.1016/j.yjmcc.2007.03.809; Chen L, 1997, CANCER RES, V57, P4830; Chen LB, 2006, NUCL MED BIOL, V33, P575, DOI 10.1016/j.nucmedbio.2006.01.011; Cohen B, 2005, NEOPLASIA, V7, P109, DOI 10.1593/neo.04436; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; Dickson PV, 2007, J PEDIATR SURG, V42, P48, DOI 10.1016/j.jpedsurg.2006.09.050; El Hallani S, 2010, BRAIN, V133, P973, DOI 10.1093/brain/awq044; Finney MR, 2010, CYTOTHERAPY, V12, P67, DOI 10.3109/14653240903300658; Janic B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005873; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Komita H, 2009, CANCER GENE THER, V16, P883, DOI 10.1038/cgt.2009.33; Kuriyama S, 1999, INT J CANCER, V81, P592, DOI 10.1002/(SICI)1097-0215(19990517)81:4<592::AID-IJC15>3.0.CO;2-I; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Oba M, 2010, MOL PHARMACEUT, V7, P501, DOI 10.1021/mp9002317; Patenaude A, 2010, MICROVASC RES, V79, P217, DOI 10.1016/j.mvr.2010.01.007; Rad AM, 2007, BIOTECHNIQUES, V43, P627, DOI 10.2144/000112599; Rad AM, 2007, J MAGN RESON IMAGING, V26, P366, DOI 10.1002/jmri.20978; Rogulski KR, 1997, HUM GENE THER, V8, P73, DOI 10.1089/hum.1997.8.1-73; Schichor C, 2006, EXP NEUROL, V199, P301, DOI 10.1016/j.expneurol.2005.11.027; Shichinohe H, 2004, BRAIN RES PROTOC, V13, P166, DOI 10.1016/j.brainresprot.2004.04.004; Shichinohe H, 2007, BRAIN RES; Sivanandam VG, 2008, J GENE MED, V10, P1083, DOI 10.1002/jgm.1244; Smanik PA, 1996, BIOCHEM BIOPH RES CO, V226, P339, DOI 10.1006/bbrc.1996.1358; Tatsumi T, 2003, CANCER RES, V63, P6378; Terrovitis JV, 2010, CIRC RES, V106, P479, DOI 10.1161/CIRCRESAHA.109.208991; Tjuvajev JG, 2002, J NUCL MED, V43, P1072; Varma NRS, 2011, J STEM CELLS REGEN, V7, P41; Yaghoubi SS, 2005, CANCER GENE THER, V12, P329, DOI 10.1038/sj.cgt.7700795; Yu L, 2010, CANCER RES, V70, P1334, DOI 10.1158/0008-5472.CAN-09-2795	43	23	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30310	10.1371/journal.pone.0030310	http://dx.doi.org/10.1371/journal.pone.0030310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276177	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100033
J	Wang, KQ; Hampson, P; Hazeldine, J; Krystof, V; Strnad, M; Pechan, P; Lord, JM				Wang, Keqing; Hampson, Peter; Hazeldine, Jon; Krystof, Vladimir; Strnad, Miroslav; Pechan, Paul; Lord, Janet M.			Cyclin-Dependent Kinase 9 Activity Regulates Neutrophil Spontaneous Apoptosis	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; DOWN-REGULATION; LEUKOCYTE APOPTOSIS; MCL-1 EXPRESSION; LIFE-SPAN; IN-VIVO; INHIBITION; CELLS; INFLAMMATION; DEATH	Neutrophils are the most abundant leukocyte and play a central role in the immune defense against rapidly dividing bacteria. However, they are also the shortest lived cell in the blood with a lifespan in the circulation of 5.4 days. The mechanisms underlying their short lifespan and spontaneous entry into apoptosis are poorly understood. Recently, the broad range cyclin-dependent kinase (CDK) inhibitor R-roscovitine was shown to increase neutrophil apoptosis, implicating CDKs in the regulation of neutrophil lifespan. To determine which CDKs were involved in regulating neutrophil lifespan we first examined CDK expression in human neutrophils and found that only three CDKs: CDK5, CDK7 and CDK9 were expressed in these cells. The use of CDK inhibitors with differing selectivity towards the various CDKs suggested that CDK9 activity regulates neutrophil lifespan. Furthermore CDK9 activity and the expression of its activating partner cyclin T1 both declined as neutrophils aged and entered apoptosis spontaneously. CDK9 is a component of the P-TEFb complex involved in transcriptional regulation and its inhibition will preferentially affect proteins with short half-lives. Treatment of neutrophils with flavopiridol, a potent CDK9 inhibitor, increased apoptosis and caused a rapid decline in the level of the anti-apoptotic protein Mcl-1, whilst Bcl2A was unaffected. We propose that CDK9 activity is a key regulator of neutrophil lifespan, preventing apoptosis by maintaining levels of short lived anti-apoptotic proteins such as Mcl-1. Furthermore, as inappropriate inhibition of neutrophil apoptosis contributes to chronic inflammatory diseases such as Rheumatoid Arthritis, CDK9 represents a novel therapeutic target in such diseases.	[Wang, Keqing; Hampson, Peter; Hazeldine, Jon; Lord, Janet M.] Univ Birmingham, Inst Biomed Res, Sch Med, MRC Ctr Immune Regulat, Birmingham, W Midlands, England; [Krystof, Vladimir; Strnad, Miroslav] Inst Expt Bot ASCR, Lab Growth Regulators, Olomouc, Czech Republic; [Krystof, Vladimir; Strnad, Miroslav] Palacky Univ, CR-77147 Olomouc, Czech Republic; [Pechan, Paul] C3Bio Ltd, Munich, Germany	University of Birmingham; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc	Wang, KQ (corresponding author), Univ Birmingham, Inst Biomed Res, Sch Med, MRC Ctr Immune Regulat, Birmingham, W Midlands, England.	J.M.Lord@bham.ac.uk	Krystof, Vladimir/B-9499-2009; Hazeldine, Jon/T-5725-2019; Strnad, Miroslav/H-1858-2014	Krystof, Vladimir/0000-0001-5838-2118; Strnad, Miroslav/0000-0002-2806-794X; Lord, Janet/0000-0003-1030-6786; Wang, Keqing/0000-0001-6239-6344	European commission [LSHB-CT-2004-503467]; Czech Ministry of Education [MSM6198959216]; Czech Grant Agency [301/08/1649, 204/08/0511]	European commission(European CommissionEuropean Commission Joint Research Centre); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Czech Grant Agency(Grant Agency of the Czech Republic)	This work was supported by funding from the European commission (LSHB-CT-2004-503467), the Czech Ministry of Education (MSM6198959216) and the Czech Grant Agency (301/08/1649 and 204/08/0511). JH is supported by a PhD studentship from the Biotechnology and Biological Sciences Research Council UK, and JML is a holder of an Arthritis Research UK programme grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFORD SC, 1992, J BIOL CHEM, V267, P21612; Aldridge AJ, 2002, EUR J SURG, V168, P204, DOI 10.1080/11024150260102807; Arris CE, 2000, J MED CHEM, V43, P2797, DOI 10.1021/jm990628o; BRACH MA, 1992, BLOOD, V80, P2920; Carvajal RD, 2009, PANCREATOLOGY, V9, P404, DOI 10.1159/000187135; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; Garriga J, 2003, MOL CELL BIOL, V23, P5165, DOI 10.1128/MCB.23.15.5165-5173.2003; Gojo I, 2002, CLIN CANCER RES, V8, P3527; Johnson N, 2010, BRIT J CANCER, V102, P342, DOI 10.1038/sj.bjc.6605479; Klausen P, 2004, J LEUKOCYTE BIOL, V75, P569, DOI 10.1189/jlb.1003474; Leitch AE, 2010, EUR J IMMUNOL, V40, P1127, DOI 10.1002/eji.200939664; Leuenroth SJ, 2000, J LEUKOCYTE BIOL, V68, P158; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; Nasreen N, 2003, J CLIN IMMUNOL, V23, P1, DOI 10.1023/A:1021958529763; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Raza K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2009; Robak T, 2009, DRUGS, V69, P2415, DOI 10.2165/11319270-000000000-00000; Rosales JL, 2004, J BIOL CHEM, V279, P53932, DOI 10.1074/jbc.M408467200; Rosato RR, 2007, MOL CANCER THER, V6, P692, DOI 10.1158/1535-7163.MCT-06-0562; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Scheel-Toellner D, 2004, BLOOD, V104, P2557, DOI 10.1182/blood-2004-01-0191; Scheel-Toellner D, 2002, EUR J IMMUNOL, V32, P486, DOI 10.1002/1521-4141(200202)32:2<486::AID-IMMU486>3.0.CO;2-U; Sekine C, 2008, J IMMUNOL, V180, P1954, DOI 10.4049/jimmunol.180.3.1954; Sroka IM, 2010, MOL PHARMACOL, V77, P255, DOI 10.1124/mol.109.060327; Wang KQ, 2003, J IMMUNOL, V171, P1035, DOI 10.4049/jimmunol.171.2.1035; Wang S, 2008, TRENDS PHARMACOL SCI, V29, P302, DOI 10.1016/j.tips.2008.03.003; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045	30	38	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30128	10.1371/journal.pone.0030128	http://dx.doi.org/10.1371/journal.pone.0030128			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276149	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000301457200034
J	Calias, P; Papisov, M; Pan, J; Savioli, N; Belov, V; Huang, Y; Lotterhand, J; Alessandrini, M; Liu, N; Fischman, AJ; Powell, JL; Heartlein, MW				Calias, Pericles; Papisov, Mikhail; Pan, Jing; Savioli, Nancy; Belov, Vasily; Huang, Yan; Lotterhand, Jason; Alessandrini, Mary; Liu, Nan; Fischman, Alan J.; Powell, Jan L.; Heartlein, Michael W.			CNS Penetration of Intrathecal-Lumbar Idursulfase in the Monkey, Dog and Mouse: Implications for Neurological Outcomes of Lysosomal Storage Disorder	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ENZYME REPLACEMENT THERAPY; II HUNTER-SYNDROME; GROWTH FACTOR-II/MANNOSE-6-PHOSPHATE RECEPTOR; ADENOASSOCIATED VIRUS VECTOR; CENTRAL-NERVOUS-SYSTEM; MUCOPOLYSACCHARIDOSIS-II; CEREBROSPINAL-FLUID; TRANSFERRIN RECEPTOR; MONOCLONAL-ANTIBODY	A major challenge for the treatment of many central nervous system (CNS) disorders is the lack of convenient and effective methods for delivering biological agents to the brain. Mucopolysaccharidosis II (Hunter syndrome) is a rare inherited lysosomal storage disorder resulting from a deficiency of iduronate-2-sulfatase (I2S). I2S is a large, highly glycosylated enzyme. Intravenous administration is not likely to be an effective therapy for disease-related neurological outcomes that require enzyme access to the brain cells, in particular neurons and oligodendrocytes. We demonstrate that intracerebroventricular and lumbar intrathecal administration of recombinant I2S in dogs and nonhuman primates resulted in widespread enzyme distribution in the brain parenchyma, including remarkable deposition in the lysosomes of both neurons and oligodendrocytes. Lumbar intrathecal administration also resulted in enzyme delivery to the spinal cord, whereas little enzyme was detected there after intraventricular administration. Mucopolysaccharidosis II model is available in mice. Lumbar administration of recombinant I2S to enzyme deficient animals reduced the storage of glycosaminoglycans in both superficial and deep brain tissues, with concurrent morphological improvements. The observed patterns of enzyme transport from cerebrospinal fluid to the CNS tissues and the resultant biological activity (a) warrant further investigation of intrathecal delivery of I2S via lumbar catheter as an experimental treatment for the neurological symptoms of Hunter syndrome and (b) may have broader implications for CNS treatment with biopharmaceuticals.	[Calias, Pericles; Pan, Jing; Savioli, Nancy; Huang, Yan; Lotterhand, Jason; Alessandrini, Mary; Liu, Nan; Powell, Jan L.; Heartlein, Michael W.] Shire Human Genet Therapies Inc, Lexington, MA USA; [Papisov, Mikhail; Belov, Vasily] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Papisov, Mikhail; Belov, Vasily; Fischman, Alan J.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Papisov, Mikhail; Belov, Vasily; Fischman, Alan J.] Shriners Burns Hosp, Dept Nucl Med, Boston, MA USA	Shire Pharmaceuticals Limited; Harvard University; Massachusetts General Hospital; Harvard University	Calias, P (corresponding author), Shire Human Genet Therapies Inc, Lexington, MA USA.	pcalias@shire.com	Belov, Vasily/AAC-9251-2020	Belov, Vasily/0000-0002-3185-2412; Papisov, Mikhail/0000-0003-4716-2122	Shire Human Genetic Therapies, Inc.	Shire Human Genetic Therapies, Inc.	This study was sponsored by Shire Human Genetic Therapies, Inc. The funders participated in the study design and conduct, data collection and analysis, decision to publish and preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Ballantyne JC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005178; Barbu E, 2009, EXPERT OPIN DRUG DEL, V6, P553, DOI [10.1517/17425240902939143 , 10.1517/17425240902939143]; Begley DJ, 2008, CURR PHARM DESIGN, V14, P1566, DOI 10.2174/138161208784705504; Belverud S, 2008, NEUROTHERAPEUTICS, V5, P114, DOI 10.1016/j.nurt.2007.10.070; Boado RJ, 2010, J DRUG TARGET, V18, P205, DOI 10.3109/10611860903353362; Boado RJ, 2010, MOL PHARMACEUT, V7, P237, DOI 10.1021/mp900235k; Boado RJ, 2009, J BIOTECHNOL, V144, P135, DOI 10.1016/j.jbiotec.2009.08.019; Boado RJ, 2009, BIOTECHNOL BIOENG, V102, P1251, DOI 10.1002/bit.22135; Brown PD, 2004, NEUROSCIENCE, V129, P957, DOI 10.1016/j.neuroscience.2004.07.003; Cearley CN, 2007, J NEUROSCI, V27, P9928, DOI 10.1523/JNEUROSCI.2185-07.2007; Chen FT, 2006, MOL GENET METAB, V87, P349, DOI 10.1016/j.ymgme.2005.11.017; Coloma MJ, 2000, PHARMACEUT RES, V17, P266, DOI 10.1023/A:1007592720793; Consiglio A, 2001, NAT MED, V7, P310, DOI 10.1038/85454; Davidson BL, 2003, NAT REV NEUROSCI, V4, P353, DOI 10.1038/nrn1104; Defrise M, 1997, IEEE T MED IMAGING, V16, P145, DOI 10.1109/42.563660; DICHIRO G, 1976, NEUROLOGY, V26, P1; Felice BR, 2011, TOXICOL PATHOL, V39, P879, DOI 10.1177/0192623311409595; FENSTERMACHER J, 1988, ANN NY ACAD SCI, V531, P29, DOI 10.1111/j.1749-6632.1988.tb51416.x; Garcia AR, 2007, J INHERIT METAB DIS, V30, P924, DOI 10.1007/s10545-007-0641-8; Ghafoor VL, 2007, AM J HEALTH-SYST PH, V64, P2447, DOI 10.2146/ajhp060204; GhersiEgea JF, 1996, NEUROSCIENCE, V75, P1271, DOI 10.1016/0306-4522(96)00281-3; Gooch JL, 2003, PEDIATR NEUROSURG, V39, P1, DOI 10.1159/000070870; Guffon N, 2009, J PEDIATR-US, V154, P733, DOI 10.1016/j.jpeds.2008.11.041; Hamano K, 2008, ACTA NEUROPATHOL, V115, P547, DOI 10.1007/s00401-007-0325-3; Hawkes C, 2002, EUR J NEUROSCI, V15, P33, DOI 10.1046/j.0953-816x.2001.01864.x; Hematti P, 2004, PLOS BIOL, V2, P2183, DOI 10.1371/journal.pbio.0020423; Hemsley KM, 2009, INT J CLIN PHARM TH, V47, pS118; Hsieh JC, 2006, NEUROSURG FOCUS, V21, P1; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; Kakkis E, 2004, MOL GENET METAB, V83, P163, DOI 10.1016/j.ymgme.2004.07.003; Kakkis ED, 2002, EXPERT OPIN INV DRUG, V11, P675, DOI 10.1517/13543784.11.5.675; Kar S, 2006, NEUROBIOL AGING, V27, P199, DOI 10.1016/j.neurobiolaging.2005.03.005; Kerr JZ, 2001, CRIT REV ONCOL HEMAT, V37, P227, DOI 10.1016/S1040-8428(00)00115-3; Laterra J., 2000, PRINCIPLES NEURAL SC, P1288; Lattanzi A, 2010, HUM MOL GENET, V19, P2208, DOI 10.1093/hmg/ddq099; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Luca T, 2005, MOL THER, V12, P669, DOI 10.1016/j.ymthe.2005.06.438; Martin R, 2008, PEDIATRICS, V121, pE377, DOI 10.1542/peds.2007-1350; Matheus MG, 2004, NEURORADIOLOGY, V46, P666, DOI 10.1007/s00234-004-1215-1; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Muenzer J, 2006, GENET MED, V8, P465, DOI 10.1097/01.gim.0000232477.37660.fb; Nakai H, 2003, NAT GENET, V34, P297, DOI 10.1038/ng1179; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Papisov M, 2010, J NUCL MED, V51; Pardridge William M, 2003, Mol Interv, V3, P90, DOI 10.1124/mi.3.2.90; Passini MA, 2002, J NEUROSCI, V22, P6437; Patel NK, 2007, ACTA NEUROCHIR SUPPL, V97, P135; Proescholdt MG, 2000, NEUROSCIENCE, V95, P577; Qi JY, 1998, PHYS MED BIOL, V43, P1001, DOI 10.1088/0031-9155/43/4/027; Rennels M L, 1990, Adv Neurol, V52, P431; RENNELS ML, 1985, BRAIN RES, V326, P47, DOI 10.1016/0006-8993(85)91383-6; RIESELBACH RE, 1962, NEW ENGL J MED, V267, P1273, DOI 10.1056/NEJM196212202672502; Segal MB, 2005, BLOOD-CEREBROSPINAL FLUID BARRIER, P83, DOI 10.1201/9781420023404.sec2; Shihabuddin LS, 2010, NEUROPHARMACOLOGY, V58, P845, DOI 10.1016/j.neuropharm.2009.12.015; *SHIR HUM GEN THER, 2010, EL PACK INS; Soderquist RG, 2010, EXPERT OPIN DRUG DEL, V7, P285, DOI 10.1517/17425240903540205; Tsai SY, 2007, EXP BRAIN RES, V182, P261, DOI 10.1007/s00221-007-1067-0; Vedolin L, 2007, AM J NEURORADIOL, V28, P1029, DOI 10.3174/ajnr.A0510; Vite CH, 2003, GENE THER, V10, P1874, DOI 10.1038/sj.gt.3302087; Voznyi YV, 2001, J INHERIT METAB DIS, V24, P675, DOI 10.1023/A:1012763026526; Woods NB, 2003, BLOOD, V101, P1284, DOI 10.1182/blood-2002-07-2238; Wu X, 2004, CELL MOL LIFE SCI, V61, P2588, DOI 10.1007/s00018-004-4206-9; Zhang Y, 2002, J GENE MED, V4, P183, DOI 10.1002/jgm.255	64	94	98	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30341	10.1371/journal.pone.0030341	http://dx.doi.org/10.1371/journal.pone.0030341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279584	Green Submitted, gold, Green Published			2022-12-27	WOS:000299771900061
J	Kim, SS; Chung, Y; Perry, MJ; Kawachi, I; Subramanian, SV				Kim, Seung-Sup; Chung, Yeonseung; Perry, Melissa J.; Kawachi, Ichiro; Subramanian, S. V.			Association between Interpersonal Trust, Reciprocity, and Depression in South Korea: A Prospective Analysis	PLOS ONE			English	Article							FINNISH PUBLIC-SECTOR; SELF-RATED HEALTH; MULTILEVEL ANALYSIS; CES-D; INCOME INEQUALITY; MENTAL-HEALTH; UNITED-STATES; RURAL CHINA; SYMPTOMS; SMOKING	Background: A growing body of empirical evidence indicates that low-level social capital is related to poor mental health outcomes. However, the prospective association between social capital and depression remains unclear, and no published studies have investigated the association with longitudinal data in East-Asian countries. Methods: We analyzed data from the ongoing Korean Welfare Panel Study to prospectively investigate association between social capital and depression. Social capital was measured at the individual level by two items specific to interpersonal trust and reciprocity. Depression was annually assessed as a dichotomous variable using the Center for Epidemiologic Studies Depression Scale. After excluding participants who had depression in 2006, logistic regression models were applied to estimate the association between each social capital indicator and new-onset depression developed in 2007 or long-term depression in both 2007 and 2008. We also examined the association in a subpopulation restricted to healthy participants after excluding individuals with any pre-existing disability, chronic disease, or poor self-rated health condition. Results: Compared to the high interpersonal trust group, the odds ratios of developing new-onset and long-term depression among the low interpersonal trust group were 1.22 (95% CI: 1.08 similar to 1.38) and 1.23 (95% CI: 1.03 similar to 1.50), respectively, and increased to 1.32 (95% CI: 1.10 similar to 1.57) and 1.47 (95% CI: 1.05 similar to 2.08) in the subpopulation analyses restricted to healthy individuals. Although the low and intermediate reciprocity group also had significantly higher odds of developing new-onset depression compared to the high reciprocity group, the effects were attenuated and statistically non-significant in the subpopulation analyses. Conclusion: Low interpersonal trust appears to be an independent risk factor for new-onset and long-term depression in South Korea.	[Kim, Seung-Sup; Perry, Melissa J.] George Washington Univ, Dept Environm & Occupat Hlth, Sch Publ Hlth & Hlth Serv, Washington, DC USA; [Chung, Yeonseung] Korea Adv Inst Sci & Technol, Dept Math Sci, Taejon 305701, South Korea; [Kawachi, Ichiro; Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	George Washington University; Korea Advanced Institute of Science & Technology (KAIST); Harvard University; Harvard T.H. Chan School of Public Health	Kim, SS (corresponding author), George Washington Univ, Dept Environm & Occupat Hlth, Sch Publ Hlth & Hlth Serv, Washington, DC USA.	sskim@gwu.edu	Chung, Yeonseung/C-1844-2011					Aida J, 2009, SOC SCI MED, V69, P512, DOI 10.1016/j.socscimed.2009.06.003; Almedom AM, 2005, SOC SCI MED, V61, P943, DOI 10.1016/j.socscimed.2004.12.025; ANDA RF, 1990, JAMA-J AM MED ASSOC, V264, P1541, DOI 10.1001/jama.264.12.1541; BEAUDOIN CE, 2010, SOC SCI MED; Boey KW, 1999, INT J GERIATR PSYCH, V14, P608, DOI 10.1002/(SICI)1099-1166(199908)14:8<608::AID-GPS991>3.0.CO;2-Z; Brummett BH, 2000, J BEHAV MED, V23, P95, DOI 10.1023/A:1005424405056; Cheung CK, 1998, J PSYCHOL, V132, P169, DOI 10.1080/00223989809599157; Cho MJ, 1998, J NERV MENT DIS, V186, P304, DOI 10.1097/00005053-199805000-00007; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; Fitzpatrick KA, 2005, AM J ORTHOPSYCHIAT, V75, P262, DOI 10.1037/0002-9432.75.2.262; Fujisawa Y, 2009, SOC SCI MED, V69, P500, DOI 10.1016/j.socscimed.2009.05.046; Fujiwara T, 2008, J EPIDEMIOL COMMUN H, V62, P627, DOI 10.1136/jech.2007.064261; GIORDANO GN, 2010, EUR J PUBLIC HLTH; HURTADO D, 2010, SOC SCI MED; Jang SN, 2009, J GERONTOL B-PSYCHOL, V64, P677, DOI 10.1093/geronb/gbp014; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kelly BD, 2009, SOC PSYCH PSYCH EPID, V44, P971, DOI 10.1007/s00127-009-0018-4; Kim D, 2006, J EPIDEMIOL COMMUN H, V60, P116, DOI 10.1136/jech.2005.038281; Kim E, 2005, ANN EPIDEMIOL, V15, P145, DOI 10.1016/j.annepidem.2004.05.004; Kim HC, 2009, INT ARCH OCC ENV HEA, V82, P715, DOI 10.1007/s00420-008-0365-6; Kim IH, 2008, AM J IND MED, V51, P748, DOI 10.1002/ajim.20626; Kim JY, 2005, INT POLIT SCI REV, V26, P193, DOI 10.1177/0192512105050381; Kim MH, 2008, SOC SCI MED, V67, P1982, DOI 10.1016/j.socscimed.2008.09.051; Kouvonen A, 2008, ADDICTION, V103, P1857, DOI 10.1111/j.1360-0443.2008.02315.x; Kouvonen A, 2008, AM J EPIDEMIOL, V167, P1143, DOI 10.1093/aje/kwn067; Lee A., 2007, ASIAN AFFAIRS AM REV, V34, P101, DOI DOI 10.3200/AAFS.34.2.101-118; Lindstrom M, 2003, PREV MED, V36, P177, DOI 10.1016/S0091-7435(02)00049-X; Lofors J, 2007, SOC SCI MED, V64, P21, DOI 10.1016/j.socscimed.2006.08.024; Mackinnon A, 1998, J GERONTOL B-PSYCHOL, V53, pP343, DOI 10.1093/geronb/53B.6.P343; McKenzie K, 2002, BRIT J PSYCHIAT, V181, P280, DOI 10.1192/bjp.181.4.280; OKSANEN T, 2010, J EPIDEMIOL COMMUNIT; Oksanen T, 2008, SOC SCI MED, V66, P637, DOI 10.1016/j.socscimed.2007.10.013; PARK CM, 2005, JAPANESE J POLITICAL, V6, P63, DOI DOI 10.1017/S1468109905001726; Patton GC, 1998, AM J PUBLIC HEALTH, V88, P1518, DOI 10.2105/AJPH.88.10.1518; Patton GC, 1996, AM J PUBLIC HEALTH, V86, P225, DOI 10.2105/AJPH.86.2.225; Phongsavan P, 2006, SOC SCI MED, V63, P2546, DOI 10.1016/j.socscimed.2006.06.021; Pollack CE, 2004, HEALTH PLACE, V10, P383, DOI 10.1016/j.healthplace.2004.08.008; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Saluja G, 2003, ARCH PEDIAT ADOL MED, V157, P681, DOI 10.1001/archpedi.157.7.681; Siahpush M, 2006, SOC SCI MED, V63, P2801, DOI 10.1016/j.socscimed.2006.07.015; Stewart JC, 2010, ANN BEHAV MED, V39, P258, DOI 10.1007/s12160-010-9185-5; Suzuki E, 2010, SOC SCI MED, V70, P1367, DOI 10.1016/j.socscimed.2010.01.014; Takeshita J, 2002, AM J PSYCHIAT, V159, P1127, DOI 10.1176/appi.ajp.159.7.1127; Torche F, 2011, EUR J SOC THEORY, V14, P181, DOI 10.1177/1368431011403461; *U SWRIOSN AFF KIO, 2008, US GUID KOR WELF PAN; Wang HM, 2009, SOC SCI MED, V68, P133, DOI 10.1016/j.socscimed.2008.09.038; Yamaoka K, 2008, SOC SCI MED, V66, P885, DOI 10.1016/j.socscimed.2007.10.024; Yip W, 2007, SOC SCI MED, V64, P35, DOI 10.1016/j.socscimed.2006.08.027	49	25	26	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30602	10.1371/journal.pone.0030602	http://dx.doi.org/10.1371/journal.pone.0030602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	885IH	22279597	Green Published, gold			2022-12-27	WOS:000299771900074
J	Xiang, TX; Li, LL; Yin, XD; Yuan, CF; Tan, C; Su, XW; Xiong, L; Putti, TC; Oberst, M; Kelly, K; Ren, GS; Tao, Q				Xiang, Tingxiu; Li, Lili; Yin, Xuedong; Yuan, Chenfu; Tan, Cui; Su, Xianwei; Xiong, Lei; Putti, Thomas C.; Oberst, Michael; Kelly, Kathleen; Ren, Guosheng; Tao, Qian			The Ubiquitin Peptidase UCHL1 Induces G0/G1 Cell Cycle Arrest and Apoptosis Through Stabilizing p53 and Is Frequently Silenced in Breast Cancer	PLOS ONE			English	Article							CANDIDATE TUMOR-SUPPRESSOR; TERMINAL HYDROLASE L1; DNA METHYLATION; PROMOTER METHYLATION; MULTIPLE CARCINOMAS; PROTEASOME PATHWAY; GENE; ESOPHAGEAL; DISEASE; NASOPHARYNGEAL	Background: Breast cancer (BrCa) is a complex disease driven by aberrant gene alterations and environmental factors. Recent studies reveal that abnormal epigenetic gene regulation also plays an important role in its pathogenesis. Ubiquitin carboxyl-terminal esterase L1 (UCHL1) is a tumor suppressor silenced by promoter methylation in multiple cancers, but its role and alterations in breast tumorigenesis remain unclear. Methodology/Principal Findings: We found that UCHL1 was frequently downregulated or silenced in breast cancer cell lines and tumor tissues, but readily expressed in normal breast tissues and mammary epithelial cells. Promoter methylation of UCHL1 was detected in 9 of 10 breast cancer cell lines (90%) and 53 of 66 (80%) primary tumors, but rarely in normal breast tissues, which was statistically correlated with advanced clinical stage and progesterone receptor status. Pharmacologic demethylation reactivated UCHL1 expression along with concomitant promoter demethylation. Ectopic expression of UCHL1 significantly suppressed the colony formation and proliferation of breast tumor cells, through inducing G0/G1 cell cycle arrest and apoptosis. Subcellular localization study showed that UCHL1 increased cytoplasmic abundance of p53. We further found that UCHL1 induced p53 accumulation and reduced MDM2 protein level, and subsequently upregulated the expression of p21, as well as cleavage of caspase3 and PARP, but not in catalytic mutant UCHL1 C90S-expressed cells. Conclusions/Significance: UCHL1 exerts its tumor suppressive functions by inducing G0/G1cell cycle arrest and apoptosis in breast tumorigenesis, requiring its deubiquitinase activity. Its frequent silencing by promoter CpG methylation may serve as a potential tumor marker for breast cancer.	[Xiang, Tingxiu; Yin, Xuedong; Yuan, Chenfu; Tan, Cui; Ren, Guosheng; Tao, Qian] Chongqing Med Univ, Affiliated Hosp 1, Mol Oncol & Epigenet Lab, Chongqing, Peoples R China; [Li, Lili; Su, Xianwei; Xiong, Lei; Tao, Qian] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Li Ka Shing Inst Hlth Sci,Canc Epigenet Lab, Dept Clin Oncol,Sir YK Pao Ctr Canc, Hong Kong, Hong Kong, Peoples R China; [Putti, Thomas C.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 117595, Singapore; [Oberst, Michael; Kelly, Kathleen] NCI, Signal Transduct Sect, NIH, Bethesda, MD 20892 USA	Chongqing Medical University; Chinese University of Hong Kong; National University of Singapore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ren, GS (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Mol Oncol & Epigenet Lab, Chongqing, Peoples R China.	rgs726@163.com; qtao@clo.cuhk.edu.hk	Li, Lili/Q-5750-2018; Tao, Qian/T-4743-2018	Li, Lili/0000-0002-0292-5889; Tao, Qian/0000-0001-5383-4808	Chongqing Health Bureau; National Natural Science Foundation of China [31171243, 81072148, 81172582]; Shenzhen Science Fund for Distinguished Young Scholars [JC201005270328A]; NATIONAL CANCER INSTITUTE [ZIABC010607] Funding Source: NIH RePORTER	Chongqing Health Bureau; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Chongqing Health Bureau grant, National Natural Science Foundation of China (#31171243, 81072148 and 81172582) and Shenzhen Science Fund for Distinguished Young Scholars (#JC201005270328A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brait M, 2008, CANCER EPIDEM BIOMAR, V17, P2786, DOI 10.1158/1055-9965.EPI-08-0192; Brooks J, 2009, CANCER CAUSE CONTROL, V20, P1539, DOI 10.1007/s10552-009-9415-y; Cheng YD, 2010, CANCER RES, V70, P6516, DOI 10.1158/0008-5472.CAN-09-4566; Cui Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002990; Dehan P, 2009, EXPERT REV MOL DIAGN, V9, P651, DOI 10.1586/ERM.09.53; EDWARDS YH, 1991, ANN HUM GENET, V55, P273, DOI 10.1111/j.1469-1809.1991.tb00853.x; Fujikane T, 2010, BREAST CANCER RES TR, V122, P699, DOI 10.1007/s10549-009-0600-1; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hu XT, 2009, ONCOGENE, V28, P2466, DOI 10.1038/onc.2009.92; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kuperwasser C, 2000, CANCER RES, V60, P2723; Li LL, 2010, CLIN CANCER RES, V16, P2949, DOI 10.1158/1078-0432.CCR-09-3178; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Loyo M, 2011, INT J CANCER, V128, P1393, DOI 10.1002/ijc.25443; Mandelker DL, 2005, CANCER RES, V65, P4963, DOI 10.1158/0008-5472.CAN-04-3923; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Miasari M, 2008, CURR CANCER DRUG TAR, V8, P118; Miyoshi Y, 2006, CANCER SCI, V97, P523, DOI 10.1111/j.1349-7006.2006.00202.x; Mizukami H, 2008, ANTICANCER RES, V28, P2697; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Oka D, 2009, CANCER-AM CANCER SOC, V115, P3412, DOI 10.1002/cncr.24394; Okochi-Takada E, 2006, INT J CANCER, V119, P1338, DOI 10.1002/ijc.22025; Orlowski RZ, 2003, BREAST CANCER RES, V5, P1, DOI 10.1186/bcr460; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Parrella P, 2010, BREAST CARE, V5, P66, DOI 10.1159/000309138; Qiu GH, 2004, ONCOGENE, V23, P4793, DOI 10.1038/sj.onc.1207632; Seliger B, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-90; Seng TJ, 2007, ONCOGENE, V26, P934, DOI 10.1038/sj.onc.1209839; Shivapurkar N, 2010, CURR MOL MED, V10, P123, DOI 10.2174/156652410790963303; Tao Q, 1999, AM J PATHOL, V155, P619, DOI 10.1016/S0002-9440(10)65157-7; Tao Q, 2002, HUM MOL GENET, V11, P2091, DOI 10.1093/hmg/11.18.2091; Wang WJ, 2008, INT J ONCOL, V33, P1037, DOI 10.3892/ijo_00000092; Wang Y, 2009, CANCER RES, V69, P5194, DOI 10.1158/0008-5472.CAN-08-3694; Xavier LL, 2005, BRAIN RES PROTOC, V16, P58, DOI 10.1016/j.brainresprot.2005.10.002; Xiang TX, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12726; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Yu J, 2008, HEPATOLOGY, V48, P508, DOI 10.1002/hep.22343; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032	39	103	113	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29783	10.1371/journal.pone.0029783	http://dx.doi.org/10.1371/journal.pone.0029783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279545	Green Published, Green Submitted, gold			2022-12-27	WOS:000299771900023
J	Xue, HP; Liu, JJ; Lin, B; Wang, Z; Sun, JH; Huang, G				Xue, Huiping; Liu, Jianjun; Lin, Bing; Wang, Zheng; Sun, Jianhua; Huang, Gang			A Meta-Analysis of Interleukin-8-251 Promoter Polymorphism Associated with Gastric Cancer Risk	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HELICOBACTER-PYLORI INFECTION; GENETIC POLYMORPHISMS; CHINESE POPULATION; ADENOCARCINOMA; CARDIA; SUSCEPTIBILITY; ANGIOGENESIS; DISEASES; STOMACH	Background: Potential functional allele A/T single nucleotide polymorphism (SNP) of Interleukin 8 (IL-8) promoter -251has been implicated in gastric cancer risk. Methods: We aimed to explore the role of A/T SNP of IL-8 -251 in the susceptibility to gastric cancer through a systematic review and meta-analysis. Each initially included article was scored for quality appraisal. Desirable data were extracted and registered into databases. Eighteen studies were ultimately eligible for the meta-analysis of IL-8 -251 A/T SNP. We adopted the most probably appropriate genetic model (codominant model). Potential sources of heterogeneity were sought out via stratification and sensitivity analyses, and publication biases were estimated. Results: Between IL-8 -251 AA genotype with gastric cancer risk, statistically significant association could be noted with overall gastric cancer, evidently noted in Asians, witnessed in high quality subgroup, and apparently noted in intestinal-type gastric cancer. Conclusions: Our meta-analysis indicates that IL-8 -251 AA genotype is associated with the overall risk of developing gastric cancer and may seem to be more susceptible to overall gastric cancer in Asian populations. IL-8 -251 AA genotype is more associated with the intestinal-type gastric cancer. IL-8 -251 AA genotype is not associated with Helicobacter Pylori infection status in our meta-analysis. Impact: The analyses suggest that IL-8 -251 AA genotype may be an important biomarker of gastric cancer susceptibility for Asians, especially for Chinese Han population, the assumption that needs to be further confirmed in future well-designed studies in China.	[Xue, Huiping] Shanghai Jiao Tong Univ, Div Gastroenterol & Hepatol, Renji Hosp,Minist Hlth, Sch Med,Shanghai Inst Digest Dis,Key Lab Gastroen, Shanghai 200030, Peoples R China; [Liu, Jianjun; Huang, Gang] Shanghai Jiao Tong Univ, Dept Nucl Med, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China; [Lin, Bing] Fundan Univ, Div Nutr, Zhongshan Hosp, Sch Med, Shanghai, Peoples R China; [Wang, Zheng; Sun, Jianhua] Renji Hosp, Dept Gen Surg, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University	Xue, HP (corresponding author), Shanghai Jiao Tong Univ, Div Gastroenterol & Hepatol, Renji Hosp,Minist Hlth, Sch Med,Shanghai Inst Digest Dis,Key Lab Gastroen, Shanghai 200030, Peoples R China.	xue_huiping@126.com; huanggang_sjumed@163.com			National Natural Science Foundation of China [30830038, 30970842, 81071180]; "973" Project [2012CB932604]; Science and Technology Commission of Shanghai Municipality [10JC1410000, 08JC1415000, 08410702000]; Shanghai Leading Academic Discipline Project [S30203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973" Project(National Basic Research Program of China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the National Natural Science Foundation of China (grants 30830038, 30970842, and 81071180); "973" Project (2012CB932604); the Key Project of Science and Technology Commission of Shanghai Municipality (grants 10JC1410000, 08JC1415000, and 08410702000) and the Shanghai Leading Academic Discipline Project (grant S30203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; BENBARUCH A, 1995, J BIOL CHEM, V270, P11703, DOI 10.1074/jbc.270.20.11703; Camargo MC, 2006, CANCER EPIDEM BIOMAR, V15, P1674, DOI 10.1158/1055-9965.EPI-06-0189; Canedo P, 2008, EUR J CANCER PREV, V17, P28, DOI 10.1097/CEJ.0b013e32809b4d0f; CRABTREE JE, 1995, J CLIN PATHOL, V48, P41, DOI 10.1136/jcp.48.1.41; Crusius JBA, 2008, ANN ONCOL, V19, P1894, DOI 10.1093/annonc/mdn400; Gao LB, 2010, EUR J CANCER, V46, P1333, DOI 10.1016/j.ejca.2010.03.011; Garza-Gonzalez E, 2005, INT J CANCER, V114, P237, DOI 10.1002/ijc.20718; Garza-Gonzalez E, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-70; HEIDL G, 1993, J CANCER RES CLIN, V120, P95, DOI 10.1007/BF01200731; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; Hwang IR, 2002, GASTROENTEROLOGY, V123, P1793, DOI 10.1053/gast.2002.37043; Ju D, 2010, MED ONCOL       1230; Kamali-Sarvestani E, 2006, WORLD J GASTROENTERO, V12, P5205; Kamangar F, 2006, CANCER CAUSE CONTROL, V17, P117, DOI 10.1007/s10552-005-0439-7; Kang JM, 2009, J CLIN GASTROENTEROL, V43, P420, DOI 10.1097/MCG.0b013e318178d1d3; Kido S, 2001, EUR J CANCER, V37, P1482, DOI 10.1016/S0959-8049(01)00147-2; Kim MA, 2005, CANCER-AM CANCER SOC, V103, P1439, DOI 10.1002/cncr.20966; Kitadai Y, 1999, BRIT J CANCER, V81, P647, DOI 10.1038/sj.bjc.6690742; Ko KP, 2009, J NUTR, V139, P1008, DOI 10.3945/jn.108.101865; Lee WP, 2005, CLIN CANCER RES, V11, P6431, DOI 10.1158/1078-0432.CCR-05-0942; Liu L, 2010, CYTOKINE, V50, P328, DOI 10.1016/j.cyto.2010.03.008; Lu WL, 2005, CARCINOGENESIS, V26, P631, DOI 10.1093/carcin/bgh349; Lu Yan, 2007, Zhonghua Yufang Yixue Zazhi, V41, P39; Matsuo Y, 2009, INT J CANCER, V124, P853, DOI 10.1002/ijc.24040; Minelli C, 2008, INT J EPIDEMIOL, V37, P136, DOI 10.1093/ije/dym234; Ning Y, 2010, INT J CANC      0720; Ohyauchi M, 2005, GUT, V54, P330, DOI 10.1136/gut.2003.033050; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Saito H, 2006, WORLD J SURG, V30, P1864, DOI 10.1007/s00268-005-0582-z; Savage SA, 2006, CANCER EPIDEM BIOMAR, V15, P589, DOI 10.1158/1055-9965.EPI-05-0887; Savage SA, 2004, CANCER EPIDEM BIOMAR, V13, P2251; Shirai K, 2006, J GASTROEN HEPATOL, V21, P1129, DOI 10.1111/j.1440-1746.2006.04443.x; Song B, 2010, J INTERF CYTOK RES, V30, P9, DOI 10.1089/jir.2009.0007; Song B, 2009, COMP FUNCT GENOM, P1, DOI 10.1155/2009/212345; Song JH, 2010, CYTOKINE, V51, P158, DOI 10.1016/j.cyto.2010.05.001; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Taguchi A, 2005, CANCER EPIDEM BIOMAR, V14, P2487, DOI 10.1158/1055-9965.EPI-05-0326; Taub D D, 1994, Ther Immunol, V1, P229; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Wang J, 2010, DIGEST DIS SCI, V55, P1818, DOI 10.1007/s10620-009-0978-y; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang N, 2011, MOL BIOL REP    0617; Xue HP, 2011, AM J EPIDEMIOL, V173, P363, DOI 10.1093/aje/kwq378; Xue HP, 2010, J GASTROEN HEPATOL, V25, P1604, DOI 10.1111/j.1440-1746.2010.06428.x; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Ye BD, 2009, J CLIN GASTROENTEROL, V43, P233, DOI 10.1097/MCG.0b013e3181646701; Yoshimura N, 2002, J GASTROEN HEPATOL, V17, P1153, DOI 10.1046/j.1440-1746.2002.02880.x; [曾志荣 Zeng Zhirong], 2005, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V26, P537; Zhang LW, 2010, MOL BIOL REP, V37, P3983, DOI 10.1007/s11033-010-0057-7	51	51	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e28083	10.1371/journal.pone.0028083	http://dx.doi.org/10.1371/journal.pone.0028083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279522	Green Published, gold			2022-12-27	WOS:000299771900001
J	Guo, J; Jin, MJ; Zhang, MW; Chen, K				Guo, Jing; Jin, Mingjuan; Zhang, Mingwu; Chen, Kun			A Genetic Variant in miR-196a2 Increased Digestive System Cancer Risks: A Meta-Analysis of 15 Case-Control Studies	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; NORTH INDIAN POPULATION; PUBLICATION BIAS; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; MICRORNA GENES; GASTRIC-CANCER; BREAST-CANCER; PRE-MICRORNAS; SUSCEPTIBILITY	Background: MicroRNAs (miRNAs) negatively regulate the gene expression and act as tumor suppressors or oncogenes in oncogenesis. The association between single nucleotide polymorphism (SNP) in miR-196a2 rs11614913 and the susceptibility of digestive system cancers was inconsistent in previous studies. Methodology/Principal Findings: An updated meta-analysis based on 15 independent case-control studies consisting of 4999 cancer patients and 7606 controls was performed to address this association. It was found that miR-196a2 polymorphism significantly elevated the risks of digestive system cancers (CT vs. TT, OR=1.25, 95% CI=1.07-1.45; CC vs. TT, OR=1.38, 95% CI=1.13-1.67; CC/CT vs. TT, OR=1.29, 95% CI=1.10-1.50; CC vs. CT/TT, OR=1.14, 95% CI=1.01-1.30; C vs. T, OR=1.15, 95% CI=1.05-1.26). We also found that variant in miR-196a2 increased the susceptibility of colorectal cancer (CRC) (CT vs. TT, OR=1.23, 95% CI=1.04-1.44; CC vs. TT, OR=1.32, 95% CI=1.08-1.61; CC/CT vs. TT, OR=1.25, 95% CI=1.07-1.46; C vs. T, OR=1.15, 95% CI=1.05-1.28), while the association in recessive model (CC vs. CT/TT, OR=1.16, 95% CI=0.98-1.38) showed a marginal significance. Additionally, significant association between miR-196a2 polymorphism and increased risk of hepatocellular cancer (HCC) was detected. By stratifying tumors on the basis of site of origin, source of controls, ethnicity and allele frequency in controls, elevated cancer risks were observed. Conclusion/Significance: Our findings suggest the significant association between miR-196a2 polymorphism and increased susceptibility of digestive system cancers, especially of CRC, HCC and Asians. Besides, C allele may contribute to increased digestive cancer risks.	[Guo, Jing; Jin, Mingjuan; Zhang, Mingwu; Chen, Kun] Zhejiang Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Guo, J (corresponding author), Zhejiang Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hangzhou 310003, Zhejiang, Peoples R China.	ck@zju.edu.cn		Guo, Jing/0000-0002-2177-6970	National Natural Science Foundation of China [81072356]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81072356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiz H, 2011, J VIRAL HEPATITIS, V18, pE399, DOI 10.1111/j.1365-2893.2010.01414.x; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Camargo MC, 2006, CANCER EPIDEM BIOMAR, V15, P1674, DOI 10.1158/1055-9965.EPI-06-0189; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Chen H, 2011, INTERN MED J; Chen KX, 2008, CARCINOGENESIS, V29, P1306, DOI 10.1093/carcin/bgn116; Christensen BC, 2010, CLIN CANCER RES, V16, P3713, DOI 10.1158/1078-0432.CCR-10-0657; Chu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018108; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dick DM, 2011, ANNU REV CLIN PSYCHO, V7, P383, DOI 10.1146/annurev-clinpsy-032210-104518; Dou TH, 2010, J CANCER RES CLIN, V136, P1853, DOI 10.1007/s00432-010-0844-5; Gao LB, 2011, BREAST CANCER RES TR, V125, P827, DOI 10.1007/s10549-010-0995-8; Gao LB, 2011, BREAST CANCER RES TR, V125, P571, DOI 10.1007/s10549-010-0993-x; Gao LB, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-117; George GP, 2011, MOL BIOL REP, V38, P1609, DOI 10.1007/s11033-010-0270-4; Hayashino Y, 2005, J EPIDEMIOL, V15, P235, DOI 10.2188/jea.15.235; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hong Young-Seoub, 2011, J Prev Med Public Health, V44, P125, DOI 10.3961/jpmph.2011.44.3.125; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Li XD, 2010, PATHOLOGY, V42, P669, DOI 10.3109/00313025.2010.522175; Liu ZS, 2010, CANCER-AM CANCER SOC, V116, P4753, DOI 10.1002/cncr.25323; MANTEL N, 1959, J NATL CANCER I, V22, P719; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; Peng S, 2010, DIGEST DIS SCI, V55, P2288, DOI 10.1007/s10620-009-1007-x; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Qi P, 2010, HUM IMMUNOL, V71, P621, DOI 10.1016/j.humimm.2010.02.017; Srivastava K, 2010, J HUM GENET, V55, P495, DOI 10.1038/jhg.2010.54; Tapia T, 2008, BREAST CANCER RES TR, V107, P281, DOI 10.1007/s10549-007-9544-5; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Tian T, 2010, INT J MOL EPIDEMIOL, V1, P358; Wallace TA, 2011, CARCINOGENESIS, V32, P1107, DOI 10.1093/carcin/bgr066; Wang F, 2011, MOL BIOL REP; Wang K, 2010, BIOMARKERS, V15, P614, DOI 10.3109/1354750X.2010.505299; Xu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020471; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zhan JF, 2011, ARCH MED RES, V42, P144, DOI 10.1016/j.arcmed.2011.04.001; Zhu L, 2011, DNA CELL BIOL	44	86	88	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30585	10.1371/journal.pone.0030585	http://dx.doi.org/10.1371/journal.pone.0030585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291993	Green Submitted, Green Published, gold			2022-12-27	WOS:000301639600034
J	Kravchenko, J; Akushevich, I; Sudenga, SL; Wilson, CM; Levitan, EB; Shrestha, S				Kravchenko, Julia; Akushevich, Igor; Sudenga, Staci L.; Wilson, Craig M.; Levitan, Emily B.; Shrestha, Sadeep			Transitional Probability-Based Model for HPV Clearance in HIV-1-Positive Adolescent Females	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; HUMAN-IMMUNODEFICIENCY-VIRUS; SQUAMOUS INTRAEPITHELIAL LESIONS; RISK HUMAN-PAPILLOMAVIRUS; CHLAMYDIA-TRACHOMATIS INFECTION; GENITAL HUMAN-PAPILLOMAVIRUS; CERVICAL-CANCER; CLINICAL MANIFESTATIONS; SEROPOSITIVE WOMEN; NATURAL-HISTORY	Background: HIV-1-positive patients clear the human papillomavirus (HPV) infection less frequently than HIV-1-negative. Datasets for estimating HPV clearance probability often have irregular measurements of HPV status and risk factors. A new transitional probability-based model for estimation of probability of HPV clearance was developed to fully incorporate information on HIV-1-related clinical data, such as CD4 counts, HIV-1 viral load (VL), highly active antiretroviral therapy (HAART), and risk factors (measured quarterly), and HPV infection status (measured at 6-month intervals). Methodology and Findings: Data from 266 HIV-1-positive and 134 at-risk HIV-1-negative adolescent females from the Reaching for Excellence in Adolescent Care and Health (REACH) cohort were used in this study. First, the associations were evaluated using the Cox proportional hazard model, and the variables that demonstrated significant effects on HPV clearance were included in transitional probability models. The new model established the efficacy of CD4 cell counts as a main clearance predictor for all type-specific HPV phylogenetic groups. The 3-month probability of HPV clearance in HIV-1-infected patients significantly increased with increasing CD4 counts for HPV16/16-like (p<0.001), HPV18/18-like (p<0.001), HPV56/56-like (p=0.05), and low-risk HPV (p<0.001) phylogenetic groups, with the lowest probability found for HPV16/16like infections (21.60 +/- 1.81% at CD4 level 200 cells/mm(3), p<0.05; and 28.03 +/- 1.47% at CD4 level 500 cells/mm(3)). HIV-1 VL was a significant predictor for clearance of low-risk HPV infections (p<0.05). HAART (with protease inhibitor) was significant predictor of probability of HPV16 clearance (p<0.05). HPV16/16-like and HPV18/18-like groups showed heterogeneity (p<0.05) in terms of how CD4 counts, HIV VL, and HAART affected probability of clearance of each HPV infection. Conclusions: This new model predicts the 3-month probability of HPV infection clearance based on CD4 cell counts and other HIV-1-related clinical measurements.	[Kravchenko, Julia] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC 27710 USA; [Akushevich, Igor] Duke Univ, Ctr Populat Hlth & Aging, Durham, NC USA; [Sudenga, Staci L.; Wilson, Craig M.; Levitan, Emily B.; Shrestha, Sadeep] Univ Alabama, Dept Epidemiol, Birmingham, AL USA	Duke University; Duke University; University of Alabama System; University of Alabama Birmingham	Kravchenko, J (corresponding author), Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC 27710 USA.	julia.krauchanka@duke.edu; sshrestha@uab.edu	Sudenga, Staci/A-7726-2015; Sudenga, Staci/O-1545-2019	Sudenga, Staci/0000-0001-7305-8738; Levitan, Emily/0000-0002-5429-3852; Wilson, Craig/0000-0001-6869-1053	SPORE in Cervical Cancer [5P50CA098252-05]; Agency for Healthcare Research and Quality [K12HS019465]; Cancer Prevention and Control Training Program [5R25CA047888]; National Institute of Child Health and Human Development [U01-HD32830]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS019465] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD032830] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R25CA047888, P50CA098252] Funding Source: NIH RePORTER	SPORE in Cervical Cancer; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Cancer Prevention and Control Training Program; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a career developmental award (SS) from the SPORE in Cervical Cancer (5P50CA098252-05). EBL was supported by the Agency for Healthcare Research and Quality (K12HS019465). SLS was supported by the Cancer Prevention and Control Training Program (5R25CA047888). The REACH study was supported by the National Institute of Child Health and Human Development (U01-HD32830). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahdieh L, 2000, AM J EPIDEMIOL, V151, P1148, DOI 10.1093/oxfordjournals.aje.a010165; Ahdieh L, 2001, J INFECT DIS, V184, P682, DOI 10.1086/323081; BONNEY GE, 1987, BIOMETRICS, V43, P951, DOI 10.2307/2531548; CLARK RA, 1993, CLIN INFECT DIS, V17, P165, DOI 10.1093/clinids/17.2.165; Crowley-Nowick PA, 2000, J INFECT DIS, V181, P939, DOI 10.1086/315311; Denny L, 2008, OBSTET GYNECOL, V111, P1380, DOI 10.1097/AOG.0b013e3181743327; FENNEMA JSA, 1995, AIDS, V9, P1071, DOI 10.1097/00002030-199509000-00014; Franco EL, 1999, J INFECT DIS, V180, P1415, DOI 10.1086/315086; Hampson L, 2006, ANTIVIR THER, V11, P813; Harris TG, 2005, JAMA-J AM MED ASSOC, V293, P1471, DOI 10.1001/jama.293.12.1471; HO GYF, 1995, JNCI-J NATL CANCER I, V87, P1365, DOI 10.1093/jnci/87.18.1365; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Johansson M, 1997, SCAND J IMMUNOL, V46, P546, DOI 10.1046/j.1365-3083.1997.d01-167.x; Khanna Niharika, 2002, J Low Genit Tract Dis, V6, P111, DOI 10.1097/00128360-200204000-00007; Kjaer SK, 2016, BMJ-BRIT MED J, V353, DOI [10.1136/bmj.325.7364.572, 10.1136/bmj.i2820]; Kong XR, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-40; Koshiol JE, 2006, INT J CANCER, V119, P1623, DOI 10.1002/ijc.22015; Koskela P, 2000, INT J CANCER, V85, P35, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;35::AID-IJC6&gt;3.0.CO;2-A; Kotloff KL, 1998, SEX TRANSM DIS, V25, P243, DOI 10.1097/00007435-199805000-00005; Kulmala SMA, 2007, CANCER EPIDEM BIOMAR, V16, P17, DOI 10.1158/1055-9965.EPI-06-0649; Lehtinen M, 2001, J CLIN VIROL, V22, P117, DOI 10.1016/S1386-6532(01)00172-X; Lillo FB, 2001, J INFECT DIS, V184, P547, DOI 10.1086/322856; Lorincz AT, 2002, LANCET, V360, P228, DOI 10.1016/S0140-6736(02)09463-1; Molano M, 2003, AM J EPIDEMIOL, V158, P486, DOI 10.1093/aje/kwg171; Moscicki AB, 2004, J INFECT DIS, V190, P37, DOI 10.1086/421467; Moscicki AB, 2004, J INFECT DIS, V190, P1413, DOI 10.1086/424466; Moscicki AB, 2000, ARCH PEDIAT ADOL MED, V154, P127, DOI 10.1001/archpedi.154.2.127; Murphy DA, 2001, AIDS CARE, V13, P27, DOI 10.1080/09540120020018161; Nakagawa M, 1997, J INFECT DIS, V175, P927, DOI 10.1086/513992; Nobbenhuis MAE, 2001, LANCET, V358, P1782, DOI 10.1016/S0140-6736(01)06809-X; Rogers AS, 1998, J ADOLESCENT HEALTH, V22, P300, DOI 10.1016/S1054-139X(97)00279-6; Rosenblatt A, 2009, HUMAN PAPILLOMAVIRUS: A PRACTICAL GUIDE FOR UROLOGISTS, P163, DOI 10.1007/978-3-540-70974-9_9; Rowhani-Rahbar A, 2007, J INFECT DIS, V196, P887, DOI 10.1086/520883; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Schiffman Mark H, 2003, J Natl Cancer Inst, V95, pE2; Shrestha S., 2007, CANCER EPIDEM BIOMAR, V16, P1; Shrestha S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-295; Silverberg MJ, 2006, CLIN VACCINE IMMUNOL, V13, P511, DOI 10.1128/CVI.13.4.511-519.2006; Sobhani I, 2004, AIDS, V18, P1561, DOI 10.1097/01.aids.0000131335.15301.dd; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P1062, DOI 10.1093/jnci/95.14.1062; SU H, 1995, INFECT IMMUN, V63, P3302, DOI 10.1128/IAI.63.9.3302-3308.1995; Sun XW, 1997, NEW ENGL J MED, V337, P1343, DOI 10.1056/NEJM199711063371903; SUN XW, 1995, OBSTET GYNECOL, V85, P680, DOI 10.1016/0029-7844(95)00025-M; Taubman SL, 2009, INT J EPIDEMIOL, V38, P1599, DOI 10.1093/ije/dyp192; VANRANST M, 1992, J GEN VIROL, V73, P2653, DOI 10.1099/0022-1317-73-10-2653; VERMUND SH, 1991, AM J OBSTET GYNECOL, V165, P392, DOI 10.1016/0002-9378(91)90101-V; WILLIAMS DA, 1975, BIOMETRICS, V31, P949, DOI 10.2307/2529820; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Xue X, CANC EPIDEMIOL BIOMA, V19, P159; Yashin AI, 1997, STAT SCI, V12, P20; Yashin AI, 2007, MATH BIOSCI, V208, P538, DOI 10.1016/j.mbs.2006.11.006; [No title captured], DOI DOI 10.1080/08898480590932296	53	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30736	10.1371/journal.pone.0030736	http://dx.doi.org/10.1371/journal.pone.0030736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292027	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600051
J	Riparbelli, MG; Giordano, R; Ueyama, M; Callaini, G				Riparbelli, Maria Giovanna; Giordano, Rosanna; Ueyama, Morio; Callaini, Giuliano			Wolbachia-Mediated Male Killing Is Associated with Defective Chromatin Remodeling	PLOS ONE			English	Article							SEX-RATIO CONDITION; CYTOPLASMIC INCOMPATIBILITY; DROSOPHILA-INNUBILA; BACTERIAL DENSITY; FREE CENTROSOMES; MEIOTIC SPINDLE; HOST; EXPRESSION; INFECTION; FERTILIZATION	Male killing, induced by different bacterial taxa of maternally inherited microorganisms, resulting in highly distorted female-biased sex-ratios, is a common phenomenon among arthropods. Some strains of the endosymbiont bacteria Wolbachia have been shown to induce this phenotype in particular insect hosts. High altitude populations of Drosophila bifasciata infected with Wolbachia show selective male killing during embryonic development. However, since this was first reported, circa 60 years ago, the interaction between Wolbachia and its host has remained unclear. Herein we show that D. bifasciata male embryos display defective chromatin remodeling, improper chromatid segregation and chromosome bridging, as well as abnormal mitotic spindles and gradual loss of their centrosomes. These defects occur at different times in the early development of male embryos leading to death during early nuclear division cycles or large defective areas of the cellular blastoderm, culminating in abnormal embryos that die before eclosion. We propose that Wolbachia affects the development of male embryos by specifically targeting male chromatin remodeling and thus disturbing mitotic spindle assembly and chromosome behavior. These are the first observations that demonstrate fundamental aspects of the cytological mechanism of male killing and represent a solid base for further molecular studies of this phenomenon.	[Riparbelli, Maria Giovanna; Callaini, Giuliano] Univ Siena, Dept Evolutionary Biol, I-53100 Siena, Italy; [Giordano, Rosanna] Univ Illinois, Illinois Nat Hist Survey, Inst Nat Resource Sustainabil, Champaign, IL USA; [Ueyama, Morio] Soka Univ, Cell Biol Lab, Dept Bioinformat, Hachioji, Tokyo, Japan	University of Siena; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; Soka University	Riparbelli, MG (corresponding author), Univ Siena, Dept Evolutionary Biol, Via Laterina 8, I-53100 Siena, Italy.	Callaini@unisi.it	Callaini, Giuliano/T-6353-2018	Callaini, Giuliano/0000-0003-2252-0309; Giordano, Rosanna/0000-0002-6175-2981; Ueyama, Morio/0000-0002-2950-7361				Belmont AS, 2006, CURR OPIN CELL BIOL, V18, P632, DOI 10.1016/j.ceb.2006.09.007; Bentley JK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-9; BOPP D, 1991, GENE DEV, V5, P96; Bourtzis K, 2003, CONT T ENT, P217; BOYLE L, 1993, SCIENCE, V260, P1796, DOI 10.1126/science.8511587; BREEUWER JAJ, 1993, GENETICS, V135, P565; BRESSAC C, 1993, J INVERTEBR PATHOL, V61, P226, DOI 10.1006/jipa.1993.1044; Callaini G, 1997, J CELL SCI, V110, P271; Callaini G, 1996, DEV BIOL, V176, P199, DOI 10.1006/dbio.1996.0127; CALLAINI G, 1994, J CELL SCI, V107, P673; Charlat S, 2007, BIOL LETTERS, V3, P154, DOI 10.1098/rsbl.2006.0584; Clancy DJ, 1998, ENTOMOL EXP APPL, V86, P13, DOI 10.1023/A:1003043814761; COUNCE SJ, 1962, J EXP ZOOL, V151, P17, DOI 10.1002/jez.1401510103; Debec A, 1996, J CELL BIOL, V134, P103, DOI 10.1083/jcb.134.1.103; Dyer KA, 2005, EVOLUTION, V59, P838, DOI 10.1111/j.0014-3820.2005.tb01757.x; Dyer KA, 2004, GENETICS, V168, P1443, DOI 10.1534/genetics.104.027854; Endow SA, 1998, J CELL SCI, V111, P2487; Ferree PM, 2008, CURR BIOL, V18, P1409, DOI 10.1016/j.cub.2008.07.093; Ferree PM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000234; Fialho RF, 2000, P ROY SOC B-BIOL SCI, V267, P1469, DOI 10.1098/rspb.2000.1166; GONZALEZ C, 1990, J CELL SCI, V96, P605; Harris HL, 2003, BIOCHEM CELL BIOL, V81, P229, DOI [10.1139/o03-053, 10.1139/O03-053]; Hurst CDD, 1997, INFLUENTIAL PASSENGERS, P125; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Hurst GDD, 2000, GENETICS, V156, P699; IKEDA H, 1970, GENETICS, V65, P311; Ivanovska I, 2006, CELL CYCLE, V5, P2064, DOI 10.4161/cc.5.18.3253; Jaenike J, 2007, EVOLUTION, V61, P2244, DOI 10.1111/j.1558-5646.2007.00180.x; Jiggins FM, 2001, HEREDITY, V86, P161, DOI 10.1046/j.1365-2540.2001.00804.x; Kageyama D, 2009, HEREDITY, V102, P475, DOI 10.1038/hdy.2009.14; Kageyama D, 2007, NATURWISSENSCHAFTEN, V94, P333, DOI 10.1007/s00114-006-0195-x; KOSE H, 1995, MECH DEVELOP, V51, P275, DOI 10.1016/0925-4773(95)00372-X; KURODA Y, 1992, ZOOL SCI, V9, P283; Landmann F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000343; Lassy CW, 1996, MECH DEVELOP, V57, P47, DOI 10.1016/0925-4773(96)00527-8; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; MAGNI GE, 1953, NATURE, V172, P81, DOI 10.1038/172081a0; Montenegro H, 2005, INSECT MOL BIOL, V14, P281, DOI 10.1111/j.1365-2583.2005.00558.x; Oakley BR, 2000, CURR TOP DEV BIOL, V49, P27; ONeill SL, 1997, INFLUENTIAL PASSENGE; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; RAFF JW, 1988, J CELL BIOL, V107, P2009, DOI 10.1083/jcb.107.6.2009; Riparbelli MG, 2010, CYTOSKELETON, V67, P251, DOI 10.1002/cm.20440; Riparbelli MG, 1996, J CELL SCI, V109, P911; Riparbelli MG, 1997, MECH DEVELOP, V65, P135, DOI 10.1016/S0925-4773(97)00066-X; Riparbelli MG, 2005, J CELL SCI, V118, P2827, DOI 10.1242/jcs.02413; SAKAGUCHI B, 1963, GENETICS, V48, P841; Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354; Sinkins SP, 1995, EXP PARASITOL, V81, P284, DOI 10.1006/expr.1995.1119; Stevens L, 2001, ANNU REV ECOL SYST, V32, P519, DOI 10.1146/annurev.ecolsys.32.081501.114132; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Sugimoto TN, 2010, INSECT BIOCHEM MOLEC, V40, P847, DOI 10.1016/j.ibmb.2010.08.004; Tortosa P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009700; Tram U, 2003, MICROBES INFECT, V5, P999, DOI 10.1016/S1286-4579(03)00192-8; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; TSUCHIYAMA S, 1978, GENETICS, V89, P711; TSUYICHIYAOMURA S, 1985, ZOOL SCI, V5, P373; Vaizel-Ohayon D, 1999, CURR BIOL, V9, P889, DOI 10.1016/S0960-9822(99)80393-5; Veneti Z, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-52; Veneti Z, 2005, SCIENCE, V307, P1461, DOI 10.1126/science.1107182; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wilson PG, 1998, DEV BIOL, V199, P273, DOI 10.1006/dbio.1998.8900; Woodcock CL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000596; YASUDA GK, 1991, DEVELOPMENT, V111, P379; Zeh DW, 2005, HEREDITY, V95, P41, DOI 10.1038/sj.hdy.6800666; Zhang G, 2009, J CELL SCI, V122, P535, DOI 10.1242/jcs.040352; Zhang J, 2007, MOL BIOL CELL, V18, P4037, DOI 10.1091/mbc.E07-05-0474	67	31	37	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30045	10.1371/journal.pone.0030045	http://dx.doi.org/10.1371/journal.pone.0030045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291901	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600012
J	Wang, YH; Williamson, KE; Kelly, PJ; James, JA; Hamilton, PW				Wang, Yinhai; Williamson, Kate E.; Kelly, Paul J.; James, Jacqueline A.; Hamilton, Peter W.			SurfaceSlide: A Multitouch Digital Pathology Platform	PLOS ONE			English	Article							MORPHOLOGY; DIAGNOSIS; SYSTEMS; SLIDES	Background: Digital pathology provides a digital environment for the management and interpretation of pathological images and associated data. It is becoming increasing popular to use modern computer based tools and applications in pathological education, tissue based research and clinical diagnosis. Uptake of this new technology is stymied by its single user orientation and its prerequisite and cumbersome combination of mouse and keyboard for navigation and annotation. Methodology: In this study we developed SurfaceSlide, a dedicated viewing platform which enables the navigation and annotation of gigapixel digitised pathological images using fingertip touch. SurfaceSlide was developed using the Microsoft Surface, a 30 inch multitouch tabletop computing platform. SurfaceSlide users can perform direct panning and zooming operations on digitised slide images. These images are downloaded onto the Microsoft Surface platform from a remote server on-demand. Users can also draw annotations and key in texts using an on-screen virtual keyboard. We also developed a smart caching protocol which caches the surrounding regions of a field of view in multi-resolutions thus providing a smooth and vivid user experience and reducing the delay for image downloading from the internet. We compared the usability of SurfaceSlide against Aperio ImageScope and PathXL online viewer. Conclusion: SurfaceSlide is intuitive, fast and easy to use. SurfaceSlide represents the most direct, effective and intimate human-digital slide interaction experience. It is expected that SurfaceSlide will significantly enhance digital pathology tools and applications in education and clinical practice.	[Wang, Yinhai; Williamson, Kate E.; James, Jacqueline A.; Hamilton, Peter W.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Kelly, Paul J.] Royal Victoria Hosp, Dept Pathol, Belfast, Antrim, North Ireland	Queens University Belfast	Wang, YH (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	y.wang@qub.ac.uk			Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative; Pathological Society of Great Britain and Ireland [OS 2009 06 03]	Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative; Pathological Society of Great Britain and Ireland	This work was supported by the Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative. The purchase of Microsoft Surface was partially funded by the Pathological Society of Great Britain and Ireland under the Pathological Society Open Scheme: OS 2009 06 03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akif Burak T, 2010, UNSUPERVISED TISSUE, P2516; [Anonymous], 2006, DIG SLID 3 PART DAT; [Anonymous], 2009, MICR SURF TRAIN COUR; Armbrust M., 2009, UCBEECS200928; Banister BA, 2002, IEEE SIGNAL PROC LET, V9, P117, DOI 10.1109/97.1001646; Burthem J, 2005, BRIT J HAEMATOL, V130, P293, DOI 10.1111/j.1365-2141.2005.05597.x; Buxton B., 2009, MULTITOUCH SYSTEMS I; Buyya R, 2009, FUTURE GENER COMP SY, V25, P599, DOI 10.1016/j.future.2008.12.001; Chen WJ, 2004, IEEE T INF TECHNOL B, V8, P89, DOI 10.1109/TITB.2004.828891; Cho Y, 2007, IEEE T IMAGE PROCESS, V16, P2005, DOI 10.1109/TIP.2007.901247; Diamond J, 2004, HUM PATHOL, V35, P1121, DOI 10.1016/j.humpath.2004.05.010; Diaz G, 2012, MICROSC RES TECHNIQ, V75, P343, DOI 10.1002/jemt.21063; Elezovic S, 2008, MULTITOUCH USER INTE, P3; Ficsor L, 2005, AUTOMATED HISTOLOGIC, P43; Fitzmaurice G.W., 1995, P SIGCHI C HUM FACT; Rojo MG, 2006, INT J SURG PATHOL, V14, P285, DOI 10.1177/1066896906292274; He L, 2011, MULTIPHASE LEVEL SET, P32; Helin H, 2005, HUM PATHOL, V36, P381, DOI 10.1016/j.humpath.2005.01.020; Jefferson YH, 2005, P 18 ANN ACM S US IN; Kumar RK, 2004, J PATHOL, V204, P613, DOI 10.1002/path.1658; Kwan-Liu M, 2000, P 2000 ACM IEEE C SU; Lee S., 1985, ACM SIGCHI B, V16, P21, DOI DOI 10.1145/317456.317461; Lundin M, 2004, J CLIN PATHOL, V57, P1288, DOI 10.1136/jcp.2004.018739; Montironi R, 2009, CANCER-AM CANCER SOC, V115, P3068, DOI 10.1002/cncr.24345; Peltonen P, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1285; Pierre W, 1993, COMMUN ACM, V36, P87; Rooney C, 2008, NEW METHOD INTERACTI; Soenksen D, 2006, PATH VIS AP DIG PATH; Toshifumi A, 1995, INTERACTIVEDESK COMP; Treanor D, 2009, HISTOPATHOLOGY, V55, P294, DOI 10.1111/j.1365-2559.2009.03389.x; Wang YH, 2007, P ANN INT IEEE EMBS, P775, DOI 10.1109/IEMBS.2007.4352405; Wang YH, 2010, ANAL CELL PATHOL, V33, P271, DOI [10.1155/2010/918306, 10.3233/ACP-CLO-2010-0551]; Wang YH, 2009, IEEE J-STSP, V3, P112, DOI 10.1109/JSTSP.2008.2011157; Wilbur DC, 2009, ARCH PATHOL LAB MED, V133, P1949, DOI 10.1043/1543-2165-133.12.1949	34	9	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30783	10.1371/journal.pone.0030783	http://dx.doi.org/10.1371/journal.pone.0030783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292040	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600078
J	Cornelis, H; Rodriguez, AL; Coop, AD; Bower, JM				Cornelis, Hugo; Rodriguez, Armando L.; Coop, Allan D.; Bower, James M.			Python as a Federation Tool for GENESIS 3.0	PLOS ONE			English	Article							CEREBELLAR PURKINJE-CELL; ACTIVE MEMBRANE MODEL; DYNAMIC CLAMP; SIMULATION; NEUROSPACES; NETWORKS	The GENESIS simulation platform was one of the first broad-scale modeling systems in computational biology to encourage modelers to develop and share model features and components. Supported by a large developer community, it participated in innovative simulator technologies such as benchmarking, parallelization, and declarative model specification and was the first neural simulator to define bindings for the Python scripting language. An important feature of the latest version of GENESIS is that it decomposes into self-contained software components complying with the Computational Biology Initiative federated software architecture. This architecture allows separate scripting bindings to be defined for different necessary components of the simulator, e. g., the mathematical solvers and graphical user interface. Python is a scripting language that provides rich sets of freely available open source libraries. With clean dynamic object-oriented designs, they produce highly readable code and are widely employed in specialized areas of software component integration. We employ a simplified wrapper and interface generator to examine an application programming interface and make it available to a given scripting language. This allows independent software components to be 'glued' together and connected to external libraries and applications from user-defined Python or Perl scripts. We illustrate our approach with three examples of Python scripting. (1) Generate and run a simple single-compartment model neuron connected to a stand-alone mathematical solver. (2) Interface a mathematical solver with GENESIS 3.0 to explore a neuron morphology from either an interactive command-line or graphical user interface. (3) Apply scripting bindings to connect the GENESIS 3.0 simulator to external graphical libraries and an open source three dimensional content creation suite that supports visualization of models based on electron microscopy and their conversion to computational models. Employed in this way, the stand-alone software components of the GENESIS 3.0 simulator provide a framework for progressive federated software development in computational neuroscience.	[Cornelis, Hugo] Univ Texas Hlth Sci Ctr San Antonio, Cornelis H Res Imaging Inst, San Antonio, TX 78229 USA; [Rodriguez, Armando L.] Univ Texas Hlth Sci Ctr San Antonio, Rodriguez AL Res Imaging Inst, San Antonio, TX 78229 USA; [Coop, Allan D.] Univ Texas Hlth Sci Ctr San Antonio, Coop AD Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Bower, James M.] Univ Texas Hlth Sci Ctr San Antonio, Bower JM Res Imaging Inst, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Cornelis, H (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Cornelis H Res Imaging Inst, San Antonio, TX 78229 USA.	Hugo.Cornelis@gmail.com			K.U.Leuven, Belgium, EU [CREA/07/027]; National Institutes of Health [3 R01 NS049288-06S1, 5R01NS049288-07, 5R01NS049288-06, 3R01NS049288-06S1, 2R01NS049288-05, 5R01NS049288-04, 5R01N S049288-03]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049288] Funding Source: NIH RePORTER	K.U.Leuven, Belgium, EU; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Creative Research Actions (CREA) Financing program (CREA/07/027) of the K.U.Leuven, Belgium, EU (www.kuleuven.be) to Dr. Marc Van Hulle. National Institutes of Health grant 3 R01 NS049288-06S1, 5R01NS049288-07, 5R01NS049288-06, 3R01NS049288-06S1, 2R01NS049288-05, 5R01NS049288-04, 5R01N S049288-03 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; Bettencourt JC, 2008, J NEUROSCI METH, V169, P282, DOI 10.1016/j.jneumeth.2007.10.009; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Blackwell KT, 2000, J COMPUT NEUROSCI, V9, P149, DOI 10.1023/A:1008919924579; Bower JM, 1998, BOOK GENESIS EXPLORI; Brooks F, 1995, MYTHICAL MAN MONTH E, P5; Cornelis H, 2004, NEUROCOMPUTING, V58, P1079, DOI 10.1016/j.neucom.2004.01.169; Cornelis H, 2003, NEUROCOMPUTING, V52-4, P227, DOI [10.1016/S0925-2312(02)00750-6, 10.1016/SO925-2312(02)00750-6]; Cornelis H, 2007, BMC NEUROSCI, V8, pP3; Cornelis H, 2010, BMC NEUROSCIENCE S1, V11, pP68; Cornelis H, 2011, PLOS COMPUTATIONAL B, V7; Crook S, 2007, NEUROINFORMATICS, V5, P96, DOI 10.1007/s12021-007-0003-6; Davison Andrew P, 2008, Front Neuroinform, V2, P11, DOI 10.3389/neuro.11.011.2008; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P401, DOI 10.1152/jn.1994.71.1.401; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P375, DOI 10.1152/jn.1994.71.1.375; Diesmann M, 2001, FORSCHUNG WISSCHENSC, V58, P43; Djurfeldt M, 2010, NEUROINFORMATICS, V8, P43, DOI 10.1007/s12021-010-9064-z; Dorval AD, 2001, ANN BIOMED ENG, V29, P897, DOI 10.1114/1.1408929; EPPLER J, 2008, FRONTIERS NEUROINFOR, V2; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Gleeson P, 2007, NEURON, V54, P219, DOI 10.1016/j.neuron.2007.03.025; Gleeson P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000815; Goddard NH, 2001, PHILOS T R SOC B, V356, P1; Goodman D. F., 2008, FRONTIERS NEUROINFOR, V2; Gortechnikov A, 2010, BMC NEUROSCIENCE S1, V11, pP71; Gunay C, 2008, J NEUROSCI, V28, P7476, DOI 10.1523/JNEUROSCI.4198-07.2008; Hines M, 1993, NEURAL SYSTEMS ANAL, P127, DOI DOI 10.1007/978-1-4615-3560-711; Hines ML, 2009, FRONTIERS NEUROINFOR, V3; King JG, 2009, FRONTIERS NEUROINFOR; Lu H, 2009, J COMP NEUROL, V514, P583, DOI 10.1002/cne.22041; Martelli A, 2006, PYTHON NUTSHELL OREI; Nordlie E, 2009, FRONT NEUROINFORM, V3, P39; O'Hara R, 1988, MODERN PROGRAMMING U; Ousterhout J. K., 1994, TCL TK TOOLKIT; Ousterhout JK, 1998, COMPUTER, V31, P23, DOI 10.1109/2.660187; Pecevski D, 2009, PCSIM PARALLEL SIMUL, DOI [10.3389/neuro.11.011.2009, DOI 10.3389/NEURO.11.011.2009]; Ray Subhasis, 2008, Front Neuroinform, V2, P6, DOI 10.3389/neuro.11.006.2008; Raymond ES, 2001, CATHEDRAL BAZAAR OR; Wall L, 2000, PERL PROGRAMMERS REF; Wils S, 2009, FRONTIERS NEUROINFOR, V3	40	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29018	10.1371/journal.pone.0029018	http://dx.doi.org/10.1371/journal.pone.0029018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276101	Green Submitted, Green Published, gold			2022-12-27	WOS:000301568100007
J	Lee, J; Jiffar, T; Kupferman, ME				Lee, Junegoo; Jiffar, Tilahun; Kupferman, Michael E.			A Novel Role for BDNF-TrkB in the Regulation of Chemotherapy Resistance in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							NEUROTROPHIC RECEPTOR TRKB; BLADDER-CANCER; MDR1; EXPRESSION; ANOIKIS; NEUROBLASTOMA; GENE; TRANSCRIPTION; METHYLATION; METASTASIS	Mechanisms of resistance for HNSCC to cisplatin (CDDP), the foundational chemotherapeutic agent in the treatment of this disease, remain poorly understood. We previously demonstrated that cisplatin resistance (CR) can be overcome by targeting Trk receptor. In the current study, we explored the potential mechanistic role of the BDNF-TrkB signaling system in the development of CDDP resistance in HNSCC. Utilizing an in vitro system of acquired CR, we confirmed a substantial up-regulation of both BDNF and TrkB at the protein and mRNA levels in CR cells, suggesting an autocrine pathway dysregulation in this system. Exogenous BDNF stimulation led to an enhanced expression of the drug-resistance and antiapoptotic proteins MDR1 and XiAP, respectively, in a dose-dependently manner, demonstrating a key role for BDNF-TrkB signaling in modulating the response to cytotoxic agents. In addition, modulation of TrkB expression induced an enhanced sensitivity of cells to CDDP in HNSCC. Moreover, genetic suppression of TrkB resulted in changes in expression of Bim, XiAP, and MDR1 contributing to HNSCC survival. To elucidate intracellular signaling pathways responsible for mechanisms underlying BDNF/TrkB induced CDDP-resistance, we analyzed expression levels of these molecules following inhibition of Akt. Inhibition of Akt eliminated BDNF effect on MDR1 and Bim expression in OSC-19P cells as well as modulated expressions of MDR1, Bim, and XiAP in OSC-19CR cells. These results suggest BDNF/TrkB system plays critical roles in CDDP-resistance development by utilizing Akt-dependent signaling pathways.	[Lee, Junegoo; Jiffar, Tilahun; Kupferman, Michael E.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Lee, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA.	mekupfer@mdanderson.org			NIH [K08-DE019185]; Joint American-College of Surgeons - Triological Society; MD Anderson Cancer Center; Sheila Newar Cancer Research Foundation; National Institutes of Health through M.D. Anderson's Cancer Center [CA016672]; Characterized Cell Line core, NCI [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE019185] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joint American-College of Surgeons - Triological Society; MD Anderson Cancer Center; Sheila Newar Cancer Research Foundation; National Institutes of Health through M.D. Anderson's Cancer Center; Characterized Cell Line core, NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is supported by the following funding sources: NIH Grant K08-DE019185 (MEK), Joint American-College of Surgeons - Triological Society Grant (MEK), MD Anderson Cancer Center Physician-Scientist Program (MEK) and Sheila Newar Cancer Research Foundation. This research is also supported in part by the National Institutes of Health through M.D. Anderson's Cancer Center Support Grant CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; STR DNA fingerprinting was done by the Cancer Center Support grant funded Characterized Cell Line core, NCI # CA16672.	Allen KE, 2010, MOL CANCER THER, V9, P3126, DOI 10.1158/1535-7163.MCT-10-0397; Almeida S, 2009, NEUROBIOL DIS, V35, P448, DOI 10.1016/j.nbd.2009.06.006; Baker EK, 2005, ONCOGENE, V24, P8061, DOI 10.1038/sj.onc.1208955; Boisvert-Adamo K, 2008, ONCOGENE, V27, P3301, DOI 10.1038/sj.onc.1211003; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Coley HM, 2009, EJC SUPPL, V7, P3, DOI 10.1016/S1359-6349(09)70003-5; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Coppin CML, 1996, J CLIN ONCOL, V14, P2901, DOI 10.1200/JCO.1996.14.11.2901; Desmet CJ, 2006, CELL MOL LIFE SCI, V63, P755, DOI 10.1007/s00018-005-5490-8; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Eicher C, 2011, INT J ONCOL, V38, P447, DOI 10.3892/ijo.2010.860; Geiger TR, 2005, CANCER RES, V65, P7033, DOI 10.1158/0008-5472.CAN-05-0709; Han LH, 2007, MED HYPOTHESES, V68, P407, DOI 10.1016/j.mehy.2006.05.038; Ho R, 2002, CANCER RES, V62, P6462; Hoffmann AC, 2010, NEOPLASIA, V12, P628, DOI 10.1593/neo.10402; Holcik M, 2001, NAT REV MOL CELL BIO, V2, P550, DOI 10.1038/35080103; Huang YZ, 2010, J BIOL CHEM, V285, P8207, DOI 10.1074/jbc.M109.091041; Huo HR, 2010, CANCER RES, V70, P8726, DOI 10.1158/0008-5472.CAN-10-0755; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiffar T, 2011, ONCOGENE; Kantharidis P, 1997, CLIN CANCER RES, V3, P2025; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Kupferman ME, 2010, ONCOGENE, V29, P2047, DOI 10.1038/onc.2009.486; Kupferman Michael E, 2009, J Exp Ther Oncol, V8, P117; Lai PC, 2010, ONCOL REP, V24, P1265, DOI 10.3892/or_00000981; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Li Z, 2007, MOL CANCER THER, V6, P3113, DOI 10.1158/1535-7163.MCT-07-0133; Li ZJ, 2007, EXPERT OPIN THER TAR, V11, P1611, DOI 10.1517/14728222.11.12.1611; Middlemas DS, 1999, J NEURO-ONCOL, V45, P27, DOI 10.1023/A:1006342423175; Nemati F, 2010, ANTI-CANCER DRUG, V21, P25, DOI 10.1097/CAD.0b013e3283300a29; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Pearse RN, 2005, BLOOD, V105, P4429, DOI 10.1182/blood-2004-08-3096; Poplawski T., 2008, Experimental Oncology, V30, P112; Schmelzle T, 2007, P NATL ACAD SCI USA, V104, P3787, DOI 10.1073/pnas.0700115104; Schulte JH, 2005, ONCOGENE, V24, P165, DOI 10.1038/sj.onc.1208000; Sengupta S, 2011, ONCOGENE, V30, P482, DOI 10.1038/onc.2010.435; Sharma G, 2010, CLIN BIOCHEM, V43, P373, DOI 10.1016/j.clinbiochem.2009.10.009; Stewart DJ, 2007, CRIT REV ONCOL HEMAT, V63, P12, DOI 10.1016/j.critrevonc.2007.02.001; Weinreb O, 2006, J NEURAL TRANSM-SUPP, P457; Yague E, 2003, J BIOL CHEM, V278, P10344, DOI 10.1074/jbc.M211093200; Yilmaz T, 2010, CANC BIOL THER, P10; Zhu NX, 2008, MOL CANCER THER, V7, P1101, DOI 10.1158/1535-7163.MCT-08-0179	43	39	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30246	10.1371/journal.pone.0030246	http://dx.doi.org/10.1371/journal.pone.0030246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276165	Green Published, gold, Green Submitted			2022-12-27	WOS:000301568100028
J	Zhang, T; Wu, ZQ; Du, J; Hu, YF; Liu, LG; Yang, F; Jin, Q				Zhang, Ting; Wu, Zhiqiang; Du, Jiang; Hu, Yongfeng; Liu, Liguo; Yang, Fan; Jin, Qi			Anti- Japanese-Encephalitis-Viral Effects of Kaempferol and Daidzin and Their RNA-Binding Characteristics	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; B-VIRUS ACTIVITIES; IN-VITRO; SOY ISOFLAVONES; ALKALOIDS BERBERINE; BIOAVAILABILITY; FLAVIVIRUSES; FLAVONOIDS; PALMATINE; EXTRACTS	New therapeutic tools and molecular targets are needed for treatment of Japanese encephalitis virus (JEV) infections. JEV requires an alpha-1 translational frameshift to synthesize the NS1' protein required for viral neuroinvasiveness. Several flavonoids have been shown to possess antiviral activity in vitro against a wide spectrum of viruses. To date, the antiviral activities of flavonol kaempferol (Kae) and isoflavonoid daidzin (Dai) against JEV have not been described. Methodology/Principal Findings: The 50% cytotoxic concentration (CC50) and 50% effective concentration (EC50) against JEV were investigated in BHK21 cells by MTS reduction. Activity against viral genomic RNA and proteins was measured by real-time RT-PCR and western blotting. The frameshift site RNA-binding characterization was also determined by electrospray ionization mass spectrometry, isothermal titration calorimetry and autodocking analysis. EC50 values of Kae and Dai were 12.6 and 25.9 mu M against JEV in cells pretreated before infection, whereas in cells infected before treatment, EC50 was 21.5 and 40.4 mu M, respectively. Kae exhibited more potent activity against JEV and RNA binding in cells following internalization through direct inhibition of viral replication and protein expression, indicating that its antiviral activity was principally due to direct virucidal effects. The JEV frameshift site RNA (fsRNA) was selected as a target for assaying Kae and Dai. ITC of fsRNA revealed an apparent K-b value for Kae that was nine fold stronger than that for Dai. This binding was confirmed and localized to the RNA using ESI-MS and autodock analysis. Kae could form non-covalent complexes with fsRNA more easily than Dai could. Conclusions/Significance: Kae demonstrates more potent antiviral activity against JEV than does Dai. The mode of action of Kae as an anti-JEV agent seems to be related to its ability to inactivate virus by binding with JEV fsRNA.	[Zhang, Ting] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhang, T (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China.	ymf129@163.com; jinqi36@yahoo.com.cn	Zhang, Ting/S-8215-2019; wu, zhi/GXH-3041-2022		Ministry of Science and Technology of China [2011CB504902]; National Science and Technology Key Projects on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment'' [2009ZX10004-102]; Institute of Pathogen Biology, Chinese Academy of Medical Sciences [2009IPB112]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science and Technology Key Projects on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment''; Institute of Pathogen Biology, Chinese Academy of Medical Sciences	The work was supported by the National Basic Research Program (Grant No. 2011CB504902) from the Ministry of Science and Technology of China, National Science and Technology Key Projects on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment'' (2009ZX10004-102), and an intramural grant from the Institute of Pathogen Biology, Chinese Academy of Medical Sciences (2009IPB112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOROS M, 1992, J NAT PROD, V55, P1732, DOI 10.1021/np50090a003; Andres A, 2009, J NUTR BIOCHEM, V20, P563, DOI 10.1016/j.jnutbio.2009.04.004; Brown L, 2008, J ETHNOPHARMACOL, V119, P588, DOI 10.1016/j.jep.2008.06.028; Cassidy A, 2006, J AOAC INT, V89, P1182; Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14; Giri P, 2008, MOL BIOSYST, V4, P341, DOI 10.1039/b716356h; Greiner LL, 2001, J ANIM SCI, V79, P3113; Hemsath L, 2005, METHODS, V37, P173, DOI 10.1016/j.ymeth.2005.05.014; Hendrich AB, 2006, ACTA PHARMACOL SIN, V27, P27, DOI 10.1111/j.1745-7254.2006.00238.x; HENION J, 1993, THER DRUG MONIT, V15, P563, DOI 10.1097/00007691-199312000-00020; Hills SL, 2009, EMERG INFECT DIS, V15, P1333, DOI 10.3201/eid1508.090149; Holt PA, 2008, J CHEM INF MODEL, V48, P1602, DOI 10.1021/ci800063v; Islam M, 2007, BIOPHYS CHEM, V125, P508, DOI 10.1016/j.bpc.2006.11.001; Islam MM, 2009, DNA CELL BIOL, V28, P637, DOI 10.1089/dna.2009.0930; Islam MM, 2009, J PHYS CHEM B, V113, P1210, DOI 10.1021/jp806597w; Jeong HJ, 2009, BIOORGAN MED CHEM, V17, P6816, DOI 10.1016/j.bmc.2009.08.036; Kanakis CD, 2007, CELL BIOCHEM BIOPHYS, V49, P29, DOI 10.1007/s12013-007-0037-2; Kempen EC, 2000, ANAL CHEM, V72, P5411, DOI 10.1021/ac000540e; Kubo Y, 2003, ARCH VIROL, V148, P1899, DOI 10.1007/s00705-003-0164-z; Levesque D, 2007, BIOCHEM J, V403, P129, DOI 10.1042/BJ20061216; Li JY, 2008, BIOL PHARM BULL, V31, P743, DOI 10.1248/bpb.31.743; Li JY, 2008, ANTIVIR RES, V79, P114, DOI 10.1016/j.antiviral.2008.03.001; Liu AL, 2008, BIOORGAN MED CHEM, V16, P7141, DOI 10.1016/j.bmc.2008.06.049; Liu Y, 2010, METHODS MOL BIOL, V613, P1, DOI 10.1007/978-1-60327-418-0_1; Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0; Marcheschi RJ, 2009, ACS CHEM BIOL, V4, P844, DOI 10.1021/cb900167m; Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09; Morris JR, 1998, J ANIM SCI, V76, P2759; Nafisi S, 2009, J PHOTOCH PHOTOBIO B, V94, P1, DOI 10.1016/j.jphotobiol.2008.08.001; Nielsen ILF, 2007, NUTR CANCER, V57, P1, DOI 10.1080/01635580701267677; Orhan DD, 2009, MICROBIOL RES; Penn SG, 1997, J AM SOC MASS SPECTR, V8, P244, DOI 10.1016/S1044-0305(96)00242-5; Robin V, 2001, ANTIVIR CHEM CHEMOTH, V12, P283, DOI 10.1177/095632020101200503; Rosu F, 2003, BIOCHEMISTRY-US, V42, P10361, DOI 10.1021/bi034531m; Rosu F, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf081; Rosu F, 2008, BIOCHIMIE, V90, P1074, DOI 10.1016/j.biochi.2008.01.005; Salvati AL, 2004, ANTIMICROB AGENTS CH, V48, P2233, DOI 10.1128/AAC.48.6.2233-2243.2004; Saxena SK, 2009, J INFECT DEV COUNTR, V3, P517, DOI 10.3855/jidc.470; Tarahovsky YS, 2008, PLANT SIGNAL BEHAV, V3, P609, DOI 10.4161/psb.3.8.6359; van den Hurk AF, 2008, EMERG INFECT DIS, V14, P1736, DOI 10.3201/eid1411.071368; van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510; Van Dyke MW, 2010, METHODS MOL BIOL, V613, P193, DOI 10.1007/978-1-60327-418-0_12; Verge S, 2002, TETRAHEDRON LETT, V43, P2363, DOI 10.1016/S0040-4039(02)00255-1; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wright B, 2010, BRIT J PHARMACOL, V159, P1312, DOI 10.1111/j.1476-5381.2009.00632.x	45	39	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30259	10.1371/journal.pone.0030259	http://dx.doi.org/10.1371/journal.pone.0030259			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276167	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100029
J	Kolmeder, CA; de Been, M; Nikkila, J; Ritamo, I; Matto, J; Valmu, L; Salojarvi, J; Palva, A; Salonen, A; de Vos, WM				Kolmeder, Carolin A.; de Been, Mark; Nikkila, Janne; Ritamo, Ilja; Matto, Jaana; Valmu, Leena; Salojarvi, Jarkko; Palva, Airi; Salonen, Anne; de Vos, Willem M.			Comparative Metaproteomics and Diversity Analysis of Human Intestinal Microbiota Testifies for Its Temporal Stability and Expression of Core Functions	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; HUMAN FECAL MICROBIOTA; MICROARRAY ANALYSIS; GUT; PROTEINS; BUTYRATE; BACTERIA; CELL; PATHWAYS; CATALOG	The human intestinal tract is colonized by microbial communities that show a subject-specific composition and a high-level temporal stability in healthy adults. To determine whether this is reflected at the functional level, we compared the faecal metaproteomes of healthy subjects over time using a novel high-throughput approach based on denaturing polyacrylamide gel electrophoresis and liquid chromatography-tandem mass spectrometry. The developed robust metaproteomics workflow and identification pipeline was used to study the composition and temporal stability of the intestinal metaproteome using faecal samples collected from 3 healthy subjects over a period of six to twelve months. The same samples were also subjected to DNA extraction and analysed for their microbial composition and diversity using the Human Intestinal Tract Chip, a validated phylogenetic microarray. Using metagenome and single genome sequence data out of the thousands of mass spectra generated per sample, approximately 1,000 peptides per sample were identified. Our results indicate that the faecal metaproteome is subject-specific and stable during a one-year period. A stable common core of approximately 1,000 proteins could be recognized in each of the subjects, indicating a common functional core that is mainly involved in carbohydrate transport and degradation. Additionally, a variety of surface proteins could be identified, including potential microbes-host interacting components such as flagellins and pili. Altogether, we observed a highly comparable subject-specific clustering of the metaproteomic and phylogenetic profiles, indicating that the distinct microbial activity is reflected by the individual composition.	[Kolmeder, Carolin A.; de Been, Mark; Nikkila, Janne; Salojarvi, Jarkko; Palva, Airi; Salonen, Anne; de Vos, Willem M.] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Nikkila, Janne; Ritamo, Ilja; Matto, Jaana; Valmu, Leena] Finnish Red Cross Blood Serv, Helsinki, Finland; [de Vos, Willem M.] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands	University of Helsinki; Wageningen University & Research	Kolmeder, CA (corresponding author), Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.	carolin.kolmeder@helsinki.fi	Salonen, Anne/AAW-1858-2020; Salojärvi, Jarkko/E-9103-2016	Salonen, Anne/0000-0002-6960-7447; Salojärvi, Jarkko/0000-0002-4096-6278; Ritamo, Ilja/0000-0002-7655-884X	Finnish Funding Agency for Technology and Innovation (TEKES) [40274/06]	Finnish Funding Agency for Technology and Innovation (TEKES)(Finnish Funding Agency for Technology & Innovation (TEKES))	This work was funded by the Finnish Funding Agency for Technology and Innovation (TEKES - www.tekes.fi; grant number 40274/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Bastida F, 2009, EUR J SOIL SCI, V60, P845, DOI 10.1111/j.1365-2389.2009.01184.x; Ben-Amor K, 2005, APPL ENVIRON MICROB, V71, P4679, DOI 10.1128/AEM.71.8.4679-4689.2005; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Booijink CCGM, 2010, ENVIRON MICROBIOL, V12, P3213, DOI 10.1111/j.1462-2920.2010.02294.x; Booijink CCGM, 2010, APPL ENVIRON MICROB, V76, P5533, DOI 10.1128/AEM.00502-10; Bottacini F, 2010, MICROBIOL-SGM, V156, P3243, DOI 10.1099/mic.0.039545-0; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; De La Cochetiere MF, 2005, J CLIN MICROBIOL, V43, P5588, DOI 10.1128/JCM.43.11.5588-5592.2005; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Duncan SH, 2004, APPL ENVIRON MICROB, V70, P5810, DOI 10.1128/AEM.70.10.5810-5817.2004; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ellrott K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000798; Faraway J.J., 2002, PRACTICAL REGRESSION, V168; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Karlsson FH, 2011, MICROB ECOL, V61, P473, DOI 10.1007/s00248-010-9796-1; KENGEN SWM, 1994, ARCH MICROBIOL, V161, P168, DOI 10.1007/BF00276479; Klaassens ES, 2007, APPL ENVIRON MICROB, V73, P1388, DOI 10.1128/AEM.01921-06; Klaassens ES, 2009, APPL ENVIRON MICROB, V75, P2668, DOI 10.1128/AEM.02492-08; Konstantinov SR, 2008, P NATL ACAD SCI USA, V105, P19474, DOI 10.1073/pnas.0810305105; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lacerda Carla M. R., 2009, Briefings in Functional Genomics & Proteomics, V8, P75, DOI 10.1093/bfgp/elp005; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Louis P, 2010, ENVIRON MICROBIOL, V12, P304, DOI 10.1111/j.1462-2920.2009.02066.x; Magdeldin S, 2010, J PROTEOME RES, V9, P6635, DOI 10.1021/pr100789v; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2007, THESIS WAGENINGEN U; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Redon E, 2005, J BIOL CHEM, V280, P36380, DOI 10.1074/jbc.M506006200; Rooijers K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-6; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schoepfer AM, 2008, NEUROGASTROENT MOTIL, V20, P1110, DOI 10.1111/j.1365-2982.2008.01166.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Tannock GW, 2004, APPL ENVIRON MICROB, V70, P2129, DOI 10.1128/AEM.70.4.2129-2136.2004; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Taverna DM, 2002, PROTEINS, V46, P105, DOI 10.1002/prot.10016; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Passel MWJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016876; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Vijay-Kumar M, 2008, SEMIN IMMUNOPATHOL, V30, P11, DOI 10.1007/s00281-007-0100-5; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	57	142	147	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29913	10.1371/journal.pone.0029913	http://dx.doi.org/10.1371/journal.pone.0029913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279554	Green Submitted, Green Published, gold			2022-12-27	WOS:000299771900032
J	Monach, PA; Kumpers, P; Lukasz, A; Tomasson, G; Specks, U; Stone, JH; Cuthbertson, D; Krischer, J; Carette, S; Ding, LN; Hoffman, GS; Ikle, D; Kallenberg, CGM; Khalidi, NA; Langford, CA; Seo, P; St Clair, EW; Spiera, R; Tchao, N; Ytterberg, SR; Haubitz, M; Merkel, PA				Monach, Paul A.; Kuempers, Philipp; Lukasz, Alexander; Tomasson, Gunnar; Specks, Ulrich; Stone, John H.; Cuthbertson, David; Krischer, Jeffrey; Carette, Simon; Ding, Linna; Hoffman, Gary S.; Ikle, David; Kallenberg, Cees G. M.; Khalidi, Nader A.; Langford, Carol A.; Seo, Philip; St Clair, E. William; Spiera, Robert; Tchao, Nadia; Ytterberg, Steven R.; Haubitz, Marion; Merkel, Peter A.			Circulating Angiopoietin-2 as a Biomarker in ANCA-Associated Vasculitis	PLOS ONE			English	Article							SOLUBLE ADHESION MOLECULES; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; TIE-2 LIGAND ANGIOPOIETIN-2; CRITICALLY-ILL PATIENTS; C-REACTIVE PROTEIN; WEGENERS-GRANULOMATOSIS; E-SELECTIN; FOLLOW-UP; SYSTEMIC VASCULITIS; DISEASE-ACTIVITY	The endothelial-specific Angiopoietin-Tie2 ligand-receptor system is an important regulator of endothelial activation. Binding of angiopoietin-2 (Ang-2) to Tie2 receptor renders the endothelial barrier responsive to pro-inflammatory cytokines. We previously showed that circulating Ang-2 correlated with disease severity in a small cohort of critically ill patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis. The current study reassessed Ang-2 as a biomarker of disease activity and relapse in AAV. Circulating Ang-2 was measured in 162 patients with severe AAV (BVAS/WG >= 3, with or without glomerulonephritis) in a clinical trial. Ang-2 levels during active AAV were compared to levels in the same patients during remission (BVAS/WG = 0). Levels in clinical subsets of AAV were compared, and association with future disease course was assessed. Ang-2 levels were elevated in severe disease (median 3.0 ng/ml, interquartile range 1.9-4.4) compared to healthy controls (1.2, 0.9-1.5). However, they did not reliably decline with successful treatment (median 2.6 ng/ml, interquartile range 1.9-3.8, median change -0.1). Ang-2 correlated weakly with BVAS/WG score (r = 0.17), moderately with markers of systemic inflammation (r = 0.25-0.41), and inversely with renal function (r = -0.36). Levels were higher in patients with glomerulonephritis, but levels adjusted for renal dysfunction were no different in patients with or without glomerulonephritis. Levels were higher in patients with newly diagnosed AAV and lower in patients in whom treatment had recently been started. Ang-2 levels during active disease did not predict response to treatment, and Ang-2 levels in remission did not predict time to flare. Thus, Ang-2 appears to have limited practical value in AAV as a biomarker of disease activity at time of measurement or for predicting future activity.	[Monach, Paul A.; Tomasson, Gunnar; Merkel, Peter A.] Boston Univ, Rheumatol Sect, Dept Med, Sch Med,Vasculitis Ctr, Boston, MA 02215 USA; [Kuempers, Philipp; Lukasz, Alexander; Haubitz, Marion] Hannover Med Sch, Dept Hypertens & Nephrol, D-3000 Hannover, Germany; [Kuempers, Philipp] Univ Hosp Munster, Div Gen Internal Med Nephrol & Rheumatol, Dept Med, Munster, Germany; [Specks, Ulrich] Mayo Clin Coll Med, Div Pulm & Crit Care Med, Rochester, MN USA; [Stone, John H.] Massachusetts Gen Hosp, Rheumatol Unit, Boston, MA 02114 USA; [Cuthbertson, David; Krischer, Jeffrey] Univ S Florida, Coll Med, Dept Pediat, Tampa, FL 33612 USA; [Carette, Simon] Univ Toronto, Div Rheumatol, Toronto, ON, Canada; [Ding, Linna] NIAID, Bethesda, MD 20892 USA; [Hoffman, Gary S.; Langford, Carol A.] Cleveland Clin, Ctr Vasculitis Care & Res, Cleveland, OH 44106 USA; [Ikle, David] Rho, Fed Syst Div, Chapel Hill, NC USA; [Kallenberg, Cees G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Khalidi, Nader A.] McMaster Univ, Div Rheumatol, Hamilton, ON, Canada; [Seo, Philip] Johns Hopkins Univ, Div Rheumatol, Baltimore, MD USA; [St Clair, E. William] Duke Univ, Div Rheumatol & Immunol, Durham, NC USA; [Spiera, Robert] Hosp Special Surg, Div Rheumatol, New York, NY 10021 USA; [Tchao, Nadia] Immune Tolerance Network, San Francisco, CA USA; [Ytterberg, Steven R.] Mayo Clin Coll Med, Div Rheumatol, Rochester, MN USA	Boston University; Hannover Medical School; University of Munster; Mayo Clinic; Harvard University; Massachusetts General Hospital; State University System of Florida; University of South Florida; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cleveland Clinic Foundation; Rho; University of Groningen; McMaster University; Johns Hopkins University; Duke University; Immune Tolerance Network; Mayo Clinic	Monach, PA (corresponding author), Boston Univ, Rheumatol Sect, Dept Med, Sch Med,Vasculitis Ctr, Boston, MA 02215 USA.	pmonach@bu.edu	Spiera, Robert/W-7479-2019; Cuthbertson, David/AAC-7703-2019; Ikle, David/AAK-7541-2020; Krischer, Jeffrey P/I-5004-2012	Ikle, David/0000-0003-0091-5246; Monach, Paul/0000-0003-4937-0515; Seo, Philip/0000-0003-3435-6737	National Institute of Arthritis and Musculoskeletal and Skin Diseases [U54AR057319, RC1 AR058303, P60 AR047785]; National Center for Research Resources [U54 RR019497]; National Institute of Neurological Disorders and Stroke [NS064808]; Office of Rare Diseases Research; NIH [N01 AI15416, M01 RR00533, K24 AR02224]; National Institute of Allergy and Infectious Diseases; Juvenile Diabetes Research Foundation; National Center for Research Resources (NCRR) [RR024150-01, RR025005, K24 AR049185, K23 AR052820]; Boston University [RR 025771]; Arthritis Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025771, M01RR000533, UL1RR024150, UL1RR025005, U54RR019497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI015416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR002224, K24AR049185, RC1AR058303, U54AR057319, P60AR047785, K23AR052820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS064808] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Office of Rare Diseases Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Boston University; Arthritis Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was sponsored by the Vasculitis Clinical Research Consortium which has received support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54AR057319, RC1 AR058303, and P60 AR047785), the National Center for Research Resources (U54 RR019497), the National Institute of Neurological Disorders and Stroke (NS064808), and the Office of Rare Diseases Research. The Rituximab in ANCA-Associated Vasculitis (RAVE) trial was performed with the support of the Immune Tolerance Network (NIH Contract #N01 AI15416), an international clinical research consortium supported by the National Institute of Allergy and Infectious Diseases and the Juvenile Diabetes Research Foundation. Genentech and Biogen Idec provided the study medications and partial funding of the clinical trial. For this ancillary study, Genentech had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. At the Mayo Clinic and Foundation, the trial was supported by a Clinical and Translational Science Award from the National Center for Research Resources (NCRR) (RR024150-01); at Johns Hopkins University, by grants from the NCRR (RR025005) and career development awards (K24 AR049185 to Dr. Stone, and K23 AR052820 to Dr. Seo); and at Boston University, by a Clinical and Translational Science Award (RR 025771), grants from the National Institutes of Health (M01 RR00533) and a career development award (K24 AR02224 to Dr. Merkel). Dr. Monach was also supported by an Arthritis Investigator Award from the Arthritis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara J, 2001, NEPHROL DIAL TRANSPL, V16, P276, DOI 10.1093/ndt/16.2.276; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boehme MWJ, 1996, AM J MED, V101, P387, DOI 10.1016/S0002-9343(96)00230-6; Boomsma MM, 2000, ARTHRITIS RHEUM-US, V43, P2025, DOI 10.1002/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; David S, 2010, NEPHROL DIAL TRANSPL, V25, P2571, DOI 10.1093/ndt/gfq060; David S, 2009, J HYPERTENS, V27, P1641, DOI 10.1097/HJH.0b013e32832be575; Davis JS, 2010, CRIT CARE, V14, DOI 10.1186/cc9020; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Erdbruegger U, 2008, RHEUMATOLOGY, V47, P1820, DOI 10.1093/rheumatology/ken373; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2003, J BIOL CHEM, V278, P1721, DOI 10.1074/jbc.M208550200; Finkielman JD, 2007, ANN INTERN MED, V147, P611, DOI 10.7326/0003-4819-147-9-200711060-00005; Girard T, 2001, RHEUMATOLOGY, V40, P147, DOI 10.1093/rheumatology/40.2.147; Hergesell O, 1996, THROMB HAEMOSTASIS, V75, P892; HIND CRK, 1984, CLIN NEPHROL, V21, P341; Kalsch AI, 2010, J RHEUMATOL, V37, P2319, DOI 10.3899/jrheum.100302; KERR GS, 1993, ARTHRITIS RHEUM, V36, P365, DOI 10.1002/art.1780360312; Kumpers P, 2009, ANN RHEUM DIS, V68, P1638, DOI 10.1136/ard.2008.094664; Kumpers P, 2008, CRIT CARE, V12, DOI 10.1186/cc7130; KUMPERS P, 2009, NEPHROL DIAL TRANSPL; Kyndt X, 1999, AM J MED, V106, P527, DOI 10.1016/S0002-9343(99)00064-9; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lukasz A, 2008, CRIT CARE, V12, DOI 10.1186/cc6966; Monach PA, 2011, ARTHRITIS RHEUM-US, V63, P3988, DOI 10.1002/art.30615; MROWKA C, 1994, CLIN INVESTIGATOR, V72, P762; Ohta N, 2001, AURIS NASUS LARYNX, V28, P311, DOI 10.1016/S0385-8146(01)00097-9; Olle EW, 2007, PROTEOM CLIN APPL, V1, P1212, DOI 10.1002/prca.200600906; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Scharpfenecker M, 2005, J CELL SCI, V118, P771, DOI 10.1242/jcs.01653; Schneeweis C, 2010, CLIN EXP RHEUMATOL, V28, pS62; Sproson EL, 2007, RHINOLOGY, V45, P63; STEGEMAN CA, 1994, ARTHRITIS RHEUM, V37, P1228, DOI 10.1002/art.1780370818; Stone JH, 2001, ARTHRITIS RHEUM, V44, P912, DOI 10.1002/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; van der Heijden M, 2008, THORAX, V63, P903, DOI 10.1136/thx.2007.087387; Whitcomb DC, 2010, AM J GASTROENTEROL, V105, P2287, DOI 10.1038/ajg.2010.183; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567	41	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30197	10.1371/journal.pone.0030197	http://dx.doi.org/10.1371/journal.pone.0030197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279570	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900048
J	Sakoulas, G; Nam, SJ; Loesgen, S; Fenical, W; Jensen, PR; Nizet, V; Hensler, M				Sakoulas, George; Nam, Sang-Jip; Loesgen, Sandra; Fenical, William; Jensen, Paul R.; Nizet, Victor; Hensler, Mary			Novel Bacterial Metabolite Merochlorin A Demonstrates in vitro Activity against Multi-Drug Resistant Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							LINEZOLID RESISTANCE; GENE; NONSUSCEPTIBILITY; ISOLATE	Background: We evaluated the in vitro activity of a merochlorin A, a novel compound with a unique carbon skeleton, against a spectrum of clinically relevant bacterial pathogens and against previously characterized clinical and laboratory Staphylococcus aureus isolates with resistance to numerous antibiotics. Methods: Merochlorin A was isolated and purified from a marine-derived actinomycete strain CNH189. Susceptibility testing for merochlorin A was performed against previously characterized human pathogens using broth microdilution and agar dilution methods. Cytotoxicity was assayed in tissue culture assays at 24 and 72 hours against human HeLa and mouse sarcoma L929 cell lines. Results: The structure of as new antibiotic, merochlorin A, was assigned by comprehensive spectroscopic analysis. Merochlorin A demonstrated in vitro activity against Gram-positive bacteria, including Clostridium dificile, but not against Gram negative bacteria. In S. aureus, susceptibility was not affected by ribosomal mutations conferring linezolid resistance, mutations in dlt or mprF conferring resistance to daptomycin, accessory gene regulator knockout mutations, or the development of the vancomycin-intermediate resistant phenotype. Merochlorin A demonstrated rapid bactericidal activity against MRSA. Activity was lost in the presence of 20% serum. Conclusions: The unique meroterpenoid, merochlorin A demonstrated excellent in vitro activity against S. aureus and C. dificile and did not show cross-resistance to contemporary antibiotics against Gram positive organisms. The activity was, however, markedly reduced in 20% human serum. Future directions for this compound may include evaluation for topical use, coating biomedical devices, or the pursuit of chemically modified derivatives of this compound that retain activity in the presence of serum.	[Sakoulas, George; Nizet, Victor; Hensler, Mary] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Nam, Sang-Jip; Loesgen, Sandra; Fenical, William; Jensen, Paul R.] Univ Calif San Diego, Ctr Marine Biotechnol & Biomed, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Fenical, William; Nizet, Victor; Hensler, Mary] Univ Calif San Diego, Sch Pharm & Pharmaceut Sci, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego	Sakoulas, G (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA.	gsakoulas@ucsd.edu	Nizet, Victor/AAF-3190-2019	jensen, paul/0000-0003-2349-1888; Nizet, Victor/0000-0003-3847-0422; Fenical, William/0000-0002-8955-1735	National Institutes of Health [RO1-GM08555]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by National Institutes of Health Grant RO1-GM08555. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*CDCP, 2002, MMWR-MORBID MORTAL W, V51, P902; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P565; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P813; Coates T, 2009, J ANTIMICROB CHEMOTH, V64, P9, DOI 10.1093/jac/dkp159; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Craig W, 1996, ANTIBIOTICS LAB MED, P296; Jarvis WR, 2007, AM J INFECT CONTROL, V35, P631, DOI 10.1016/j.ajic.2007.10.009; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Meka VG, 2004, J INFECT DIS, V190, P311, DOI 10.1086/421471; Sakoulas G, 2003, J INFECT DIS, V187, P929, DOI 10.1086/368128; Sakoulas G, 2003, J ANTIMICROB CHEMOTH, V51, P1039, DOI 10.1093/jac/dkg194; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; Sakoulas G, 2008, CLIN INFECT DIS, V46, pS360, DOI 10.1086/533592; Sakoulas G, 2008, J CLIN MICROBIOL, V46, P220, DOI 10.1128/JCM.00660-07; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Tsiodras S, 2001, LANCET, V358, P207, DOI 10.1016/S0140-6736(01)05410-1; Yang SJ, 2009, J INFECT DIS, V200, P1916, DOI 10.1086/648473; Zurenko GE, 1996, ANTIMICROB AGENTS CH, V40, P839, DOI 10.1128/AAC.40.4.839	19	56	56	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29439	10.1371/journal.pone.0029439	http://dx.doi.org/10.1371/journal.pone.0029439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279537	Green Submitted, Green Published, gold			2022-12-27	WOS:000299771900015
J	Sorani, MD				Sorani, Marco D.			Informatics Technology Mimics Ecology: Dense, Mutualistic Collaboration Networks Are Associated with Higher Publication Rates	PLOS ONE			English	Article							INNOVATION; DIFFUSION; CAPACITY; ADOPTION; CARE	Information technology (IT) adoption enables biomedical research. Publications are an accepted measure of research output, and network models can describe the collaborative nature of publication. In particular, ecological networks can serve as analogies for publication and technology adoption. We constructed network models of adoption of bioinformatics programming languages and health IT (HIT) from the literature. We selected seven programming languages and four types of HIT. We performed PubMed searches to identify publications since 2001. We calculated summary statistics and analyzed spatiotemporal relationships. Then, we assessed ecological models of specialization, cooperativity, competition, evolution, biodiversity, and stability associated with publications. Adoption of HIT has been variable, while scripting languages have experienced rapid adoption. Hospital systems had the largest HIT research corpus, while Perl had the largest language corpus. Scripting languages represented the largest connected network components. The relationship between edges and nodes was linear, though Bioconductor had more edges than expected and Perl had fewer. Spatiotemporal relationships were weak. Most languages shared a bioinformatics specialization and appeared mutualistic or competitive. HIT specializations varied. Specialization was highest for Bioconductor and radiology systems. Specialization and cooperativity were positively correlated among languages but negatively correlated among HIT. Rates of language evolution were similar. Biodiversity among languages grew in the first half of the decade and stabilized, while diversity among HIT was variable but flat. Compared with publications in 2001, correlation with publications one year later was positive while correlation after ten years was weak and negative. Adoption of new technologies can be unpredictable. Spatiotemporal relationships facilitate adoption but are not sufficient. As with ecosystems, dense, mutualistic, specialized co-habitation is associated with faster growth. There are rapidly changing trends in external technological and macroeconomic influences. We propose that a better understanding of how technologies are adopted can facilitate their development.	Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sorani, MD (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	soranim@pharmacy.ucsf.edu						Agyeman P, 2009, VACCINE, V27, P4771, DOI 10.1016/j.vaccine.2009.05.097; Armstrong K, 2003, GENET MED, V5, P92, DOI 10.1097/01.GIM.0000056829.76915.2A; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; BECHHOFER SK, 2005, PAC S BIOCOMPUT, V7990; Berlin A, 2006, J BIOMED INFORM, V39, P656, DOI 10.1016/j.jbi.2005.12.003; Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; BORNER K, 2011, SCIENTOMETR IN PRESS; Chen CM, 2004, P NATL ACAD SCI USA, V101, P5303, DOI 10.1073/pnas.0307513100; COLEMAN J, 1957, SOCIOMETRY, V20, P253, DOI 10.2307/2785979; Dixon DR, 1999, INT J MED INFORM, V56, P117, DOI 10.1016/S1386-5056(99)00037-4; Douglas SM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r80; Dudley JT, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000589; Eveleigh ES, 2007, P NATL ACAD SCI USA, V104, P16976, DOI 10.1073/pnas.0704301104; Freilich S, 2010, NUCLEIC ACIDS RES, V38, P3857, DOI 10.1093/nar/gkq118; Freilich S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r61; Gonzalez-Alcaide G, 2010, ARCH BRONCONEUMOL, V46, P78, DOI 10.1016/j.arbres.2009.10.014; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Greenberg Steven A, 2009, BMJ, V339, pb2680, DOI 10.1136/bmj.b2680; Greenhalgh T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1786; HATORA M, 2010, STATE COMPUTER BOOK; Haux R, 2010, INT J MED INFORM, V79, P599, DOI 10.1016/j.ijmedinf.2010.06.003; Iansiti M, 2004, HARVARD BUS REV, V82, P68; Institute of Medicine, 2001, CROSSING QUALITY CHA; Johnson KB, 2004, INT J MED INFORM, V73, P665, DOI 10.1016/j.ijmedinf.2004.05.009; Kaluzny A D, 1974, Health Serv Res, V9, P101; Kilicoglu H, 2009, J AM MED INFORM ASSN, V16, P25, DOI 10.1197/jamia.M2996; Koboldt DC, 2010, BRIEF BIOINFORM, V11, P484, DOI 10.1093/bib/bbq016; KOHANE IS, 2002, P AMIA ANN S, pR8; Kowalczyk Nina, 2009, Radiol Manage, V31, P18; Kwan SW, 2010, RADIOLOGY, V256, P751, DOI 10.1148/radiol.10092130; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liu Q, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006594.pub2; McKibbon K Ann, 2002, Proc AMIA Symp, P514; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Morel CM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000501; Neutel AM, 2007, NATURE, V449, P599, DOI 10.1038/nature06154; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; PETERSON D, 2009, INPUT; Peterson LT, 2011, J MED SYST, V35, P151, DOI 10.1007/s10916-009-9352-z; Shea S, 1996, J AM MED INFORM ASSN, V3, P399, DOI 10.1136/jamia.1996.97084513; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3; Vann JCJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003941.pub2; Verella J Tipan, 2009, J Diabetes Sci Technol, V3, P353; Vest JR, 2010, INT J MED INFORM, V79, P797, DOI 10.1016/j.ijmedinf.2010.09.003; WARNER HR, 1972, COMPUT BIOMED RES, V5, P65, DOI 10.1016/0010-4809(72)90007-9; Weinstein RS, 2009, HUM PATHOL, V40, P1057, DOI 10.1016/j.humpath.2009.04.006; Yousefi-Nooraie Reza, 2008, Health Res Policy Syst, V6, P9, DOI 10.1186/1478-4505-6-9; Zheng K, 2005, INT J MED INFORM, V74, P535, DOI 10.1016/j.ijmedinf.2005.03.007; OREILLY NEWS COMMENT; COMPUTER LANGUAGES H; 2011, SCIENCE, V331, P516	55	1	1	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30463	10.1371/journal.pone.0030463	http://dx.doi.org/10.1371/journal.pone.0030463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	885IH	22279593	Green Published, Green Submitted, gold			2022-12-27	WOS:000299771900070
J	Hsiao, M; Morris, SK; Bassani, DG; Montgomery, AL; Thakur, JS; Jha, P				Hsiao, Marvin; Morris, Shaun K.; Bassani, Diego G.; Montgomery, Ann L.; Thakur, J. S.; Jha, Prabhat			Factors Associated with Physician Agreement on Verbal Autopsy of over 11500 Injury Deaths in India	PLOS ONE			English	Article							ADULT DEATHS; VALIDATION	Introduction: Worldwide, injuries account for 9.8% of all deaths. The majority of these deaths occur in low-and middle-income countries where vital registration systems are often inadequate. Verbal autopsy (VA) is a tool used to ascertain cause of death in such settings. Validation studies for VA using hospital diagnosed causes of death as comparisons have shown that injury deaths can be reliably diagnosed by VA. However, no study has assessed the factors that may affect physicians' abilities to code specific causes of injury death using VA. Method/Principal Findings: This study used data from over 11 500 verbal autopsies of injury deaths from the Million Death Study (MDS) in which 6.3 million people in India were monitored from 2001-2003 for vital events. Deaths that occurred in the MDS were coded by two independent physicians. This study focused on whether physician agreement on the classification of injury deaths was affected by characteristics of the deceased and respondent. Agreement was analyzed using three primary methods: 1) kappa statistic; 2) sensitivity and specificity analysis using the final VA diagnosed category of injury death as gold standard; and 3) multivariate logistic regression using a conceptual hierarchical model. The overall agreement for all injury deaths was 77.9% with a kappa of 0.74 (99% CI 0.74-0.75). Deaths in the injury categories of "transport'', "falls'', "drowning'' and "other unintentional injury'' occurring outside the home were associated with greater physician agreement than those occurring at home. In contrast, self-inflicted injury deaths that occurred outside the home were associated with lower physician agreement. Conclusions/Significance: With few exceptions, most characteristics of the deceased and the respondent did not influence physician agreement on the classification of injury deaths. Physician training and continued adaptation of the VA tool should focus on the reasons these factors influenced physician agreement.	[Hsiao, Marvin; Morris, Shaun K.; Bassani, Diego G.; Montgomery, Ann L.; Thakur, J. S.; Jha, Prabhat] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada; [Hsiao, Marvin] Univ Toronto, St Michaels Hosp, Dept Surg, Toronto, ON M5B 1W8, Canada; [Morris, Shaun K.] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Infect Dis, Toronto, ON M5B 1W8, Canada; [Bassani, Diego G.; Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5B 1W8, Canada; [Bassani, Diego G.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Thakur, J. S.] Post Grad Inst Med Educ & Res PGIMER, Dept Community Med, Chandigarh, India	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Hsiao, M (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada.	marvin.my.hsiao@gmail.com	Bassani, Diego/G-2827-2015	Bassani, Diego/0000-0001-6704-3820; Jha, Prabhat/0000-0001-7067-8341				[Anonymous], SCAND J PUBLIC HLT S; Byass P, 2006, SCAND J PUBLIC HEALT, V34, P26, DOI 10.1080/14034940510032202; Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x; Gajalakshmi V, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-47; Gajalakshmi V, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-7; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; Khademi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011183; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Morris SK, 2010, PLOS ONE, V5, pA170, DOI 10.1371/journal.pone.0009583; Murray CJL, 2007, PLOS MED, V4, P1739, DOI 10.1371/journal.pmed.0040327; Quigley MA, 1999, INT J EPIDEMIOL, V28, P1081, DOI 10.1093/ije/28.6.1081; Reichenheim ME, 2004, STATA J, V4, P421, DOI 10.1177/1536867X0400400404; Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x; Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003; StataCorp L, 2007, STAT DAT AN STAT SOF; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn; Yang GH, 2006, INT J EPIDEMIOL, V35, P741, DOI 10.1093/ije/dyi181	20	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30336	10.1371/journal.pone.0030336	http://dx.doi.org/10.1371/journal.pone.0030336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272338	gold, Green Published			2022-12-27	WOS:000301454400116
J	Kubinyi, E; Vas, J; Hejjas, K; Ronai, Z; Bruder, I; Turcsan, B; Sasvari-Szekely, M; Miklosi, A				Kubinyi, Eniko; Vas, Judit; Hejjas, Krisztina; Ronai, Zsolt; Bruder, Ildiko; Turcsan, Borbala; Sasvari-Szekely, Maria; Miklosi, Adam			Polymorphism in the Tyrosine Hydroxylase (TH) Gene Is Associated with Activity-Impulsivity in German Shepherd Dogs	PLOS ONE			English	Article							DOPAMINE-D4 RECEPTOR GENE; REPEAT POLYMORPHISM; PERSONALITY-TRAITS; CANIS-FAMILIARIS; BEHAVIOR TEST; MODEL; ATTENTION; SEARCH; TEMPERAMENT; VALIDATION	We investigated the association between repeat polymorphism in intron 4 of the tyrosine hydroxylase (TH) gene and two personality traits, activity-impulsivity and inattention, in German Shepherd Dogs. The behaviour of 104 dogs was characterized by two instruments: (1) the previously validated Dog-Attention Deficit Hyperactivity Disorder Rating Scale (Dog-ADHD RS) filled in by the dog owners and (2) the newly developed Activity-impulsivity Behavioural Scale (AIBS) containing four subtests, scored by the experimenters. Internal consistency, inter-observer reliability, test-retest reliability and convergent validity were demonstrated for AIBS. Dogs possessing at least one short allele were proved to be more active-impulsive by both instruments, compared to dogs carrying two copies of the long allele (activity-impulsivity scale of Dog-ADHD RS: p = 0.007; AIBS: p = 0.023). The results have some potential to support human studies; however, further research should reveal the molecular function of the TH gene variants, and look for the effect in more breeds.	[Kubinyi, Eniko; Vas, Judit; Bruder, Ildiko; Turcsan, Borbala; Miklosi, Adam] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Hejjas, Krisztina; Ronai, Zsolt; Sasvari-Szekely, Maria] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary	Eotvos Lorand University; Semmelweis University	Kubinyi, E (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.	kubinyie@gmail.com	Kubinyi, Eniko/B-5824-2013; Turcsán, Borbála/I-7983-2018; Ronai, Zsolt/A-2473-2008; Vas, Judit/GRJ-7640-2022; Miklosi, Adam/N-5147-2017	Kubinyi, Eniko/0000-0002-4468-9845; Turcsán, Borbála/0000-0002-0197-5243; Ronai, Zsolt/0000-0002-0909-7932; Miklosi, Adam/0000-0003-4831-8985	EU [FP7 ICT-215554 LIREC]; Hungarian Scientific Research Fund [K 84036]; Bolyai Foundation of the Hungarian Academy of Sciences	EU(European Commission); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Foundation of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the EU FP7 ICT-215554 LIREC, the Hungarian Scientific Research Fund (K 84036) and the Bolyai Foundation of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JN, 2007, PSYCHIAT GENET, V17, P23, DOI 10.1097/YPG.0b013e32801140f2; Chase K, 2009, J HERED, P1; Diederich C, 2006, APPL ANIM BEHAV SCI, V97, P51, DOI 10.1016/j.applanim.2005.11.018; DuPaul G. J., 1998, ADHD RATING SCALE 4; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2003, J PERS SOC PSYCHOL, V85, P1161, DOI 10.1037/0022-3514.85.6.1161; Hejjas K, 2007, ANIM GENET, V38, P629, DOI 10.1111/j.1365-2052.2007.01657.x; Hejjas K, 2009, GENES BRAIN BEHAV, V8, P330, DOI 10.1111/j.1601-183X.2008.00475.x; Hejjas K, 2007, MAMM GENOME, V18, P871, DOI 10.1007/s00335-007-9070-0; Hennessy MB, 2001, APPL ANIM BEHAV SCI, V73, P217, DOI 10.1016/S0168-1591(01)00139-3; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Jones P, 2008, GENETICS, V179, P1033, DOI 10.1534/genetics.108.087866; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Konno A, 2011, BIOL LETT; Korsten P, 2010, MOL ECOL, V19, P832, DOI 10.1111/j.1365-294X.2009.04518.x; Kwan VSY, 2008, SOC COGNITION, V26, P129, DOI 10.1521/soco.2008.26.2.129; Lit L, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-1; Maejima M, 2007, APPL ANIM BEHAV SCI, V107, P287, DOI 10.1016/j.applanim.2006.10.005; Momozawa Y, 2005, MAMM GENOME, V16, P538, DOI 10.1007/s00335-005-0021-3; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Ostrander EA, 2000, TRENDS GENET, V16, P117, DOI 10.1016/S0168-9525(99)01958-7; Overall KL, 2000, PROG NEURO-PSYCHOPH, V24, P727, DOI 10.1016/S0278-5846(00)00104-4; Parker HG, 2010, ANNU REV GENET, V44, P309, DOI 10.1146/annurev-genet-102808-115200; Persson ML, 1997, PSYCHIAT RES, V72, P73, DOI 10.1016/S0165-1781(97)00068-1; Persson ML, 2000, PSYCHIAT RES, V95, P1, DOI 10.1016/S0165-1781(00)00160-8; Pongracz P, 2005, J COMP PSYCHOL, V119, P136, DOI 10.1037/0735-7036.119.2.136; Rooney NJ, 2007, APPL ANIM BEHAV SCI, V103, P90, DOI 10.1016/j.applanim.2006.03.016; Ruefenacht S, 2002, APPL ANIM BEHAV SCI, V79, P113, DOI 10.1016/S0168-1591(02)00134-X; Schwandt ML, 2010, BIOL PSYCHIAT, V67, P323, DOI 10.1016/j.biopsych.2009.10.016; Serretti A, 1998, AM J MED GENET, V81, P127, DOI 10.1002/(SICI)1096-8628(19980328)81:2<127::AID-AJMG1>3.3.CO;2-X; Sharma P, 1998, HYPERTENSION, V32, P676, DOI 10.1161/01.HYP.32.4.676; Slabbert JM, 1999, APPL ANIM BEHAV SCI, V64, P269, DOI 10.1016/S0168-1591(99)00038-6; Spady TC, 2008, AM J HUM GENET, V82, P10, DOI 10.1016/j.ajhg.2007.12.001; Sutter NB, 2004, NAT REV GENET, V5, P900, DOI 10.1038/nrg1492; Takeuchi Y, 2005, J VET MED SCI, V67, P861, DOI 10.1292/jvms.67.861; Tami G, 2009, APPL ANIM BEHAV SCI, V120, P159, DOI 10.1016/j.applanim.2009.06.009; Tochigi M, 2006, NEUROSCI RES, V54, P180, DOI 10.1016/j.neures.2005.11.003; Topal J, 2009, ADV STUD BEHAV, V39, P71, DOI 10.1016/S0065-3454(09)39003-8; Vas J, 2007, APPL ANIM BEHAV SCI, V103, P105, DOI 10.1016/j.applanim.2006.03.017; Wan M, 2009, APPL ANIM BEHAV SCI, V121, P206, DOI 10.1016/j.applanim.2009.09.015; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wilsson E, 1997, APPL ANIM BEHAV SCI, V53, P279, DOI 10.1016/S0168-1591(96)01174-4	43	43	43	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30271	10.1371/journal.pone.0030271	http://dx.doi.org/10.1371/journal.pone.0030271			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272320	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000301454400098
J	Frazer, LC; Darville, T; Chandra-Kuntal, K; Andrews, CW; Zurenski, M; Mintus, M; AbdelRahman, YM; Belland, RJ; Ingalls, RR; O'Connell, CM				Frazer, Lauren C.; Darville, Toni; Chandra-Kuntal, Kumar; Andrews, Charles W., Jr.; Zurenski, Matthew; Mintus, Margaret; AbdelRahman, Yasser M.; Belland, Robert J.; Ingalls, Robin R.; O'Connell, Catherine M.			Plasmid-Cured Chlamydia caviae Activates TLR2-Dependent Signaling and Retains Virulence in the Guinea Pig Model of Genital Tract Infection	PLOS ONE			English	Article							GENOME SEQUENCE; TRACHOMATIS; METABOLISM; REGULATOR; DIVERSITY; PATHOLOGY; STRAINS; BIOVAR; GENES	Loss of the conserved "cryptic" plasmid from C. trachomatis and C. muridarum is pleiotropic, resulting in reduced innate inflammatory activation via TLR2, glycogen accumulation and infectivity. The more genetically distant C. caviae GPIC is a natural pathogen of guinea pigs and induces upper genital tract pathology when inoculated intravaginally, modeling human disease. To examine the contribution of pCpGP1 to C. caviae pathogenesis, a cured derivative of GPIC, strain CC13, was derived and evaluated in vitro and in vivo. Transcriptional profiling of CC13 revealed only partial conservation of previously identified plasmid-responsive chromosomal loci (PRCL) in C. caviae. However, 2-deoxyglucose (2DG) treatment of GPIC and CC13 resulted in reduced transcription of all identified PRCL, including glgA, indicating the presence of a plasmid-independent glucose response in this species. In contrast to plasmid-cured C. muridarum and C. trachomatis, plasmid-cured C. caviae strain CC13 signaled via TLR2 in vitro and elicited cytokine production in vivo similar to wild-type C. caviae. Furthermore, inflammatory pathology induced by infection of guinea pigs with CC13 was similar to that induced by GPIC, although we observed more rapid resolution of CC13 infection in estrogen-treated guinea pigs. These data indicate that either the plasmid is not involved in expression or regulation of virulence in C. caviae or that redundant effectors prevent these phenotypic changes from being observed in C. caviae plasmid-cured strains.	[Frazer, Lauren C.; Darville, Toni; Chandra-Kuntal, Kumar; Zurenski, Matthew; Mintus, Margaret; O'Connell, Catherine M.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA; [Andrews, Charles W., Jr.] Milstead Pathol Grp, Conyers, GA USA; [AbdelRahman, Yasser M.; Belland, Robert J.] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN USA; [AbdelRahman, Yasser M.] Cairo Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt; [Ingalls, Robin R.] Boston Univ, Sch Med, Dept Med, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Tennessee System; University of Tennessee Health Science Center; Egyptian Knowledge Bank (EKB); Cairo University; Boston University	O'Connell, CM (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA.	oconnellcm@upmc.edu	Andrews Jr, Charles/ABE-9558-2021	Ingalls, Robin/0000-0003-2197-7198; Frazer, Lauren/0000-0003-2366-7409; O'Connell, Catherine/0000-0002-8229-684X	Hartwell Foundation; National Institutes of Health [R21 AI083657, R01 AI070693, R01 AI064749]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064749, R21AI083657, R01AI070693] Funding Source: NIH RePORTER	Hartwell Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Hartwell Foundation (http://www.thehartwellfoundation.org/) to TD, National Institutes of Health via grants R21 AI083657 to COC, R01 AI070693 to RB, and R01 AI064749 to RI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma Y, 2006, DNA RES, V13, P15, DOI 10.1093/dnares/dsi027; Batteiger BE, 1990, IMMUNIZATION GUINEA, P2650; Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; COMANDUCCI M, 1988, MOL MICROBIOL, V2, P531, DOI 10.1111/j.1365-2958.1988.tb00060.x; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; Darville T, 1997, INFECT IMMUN, V65, P3065, DOI 10.1128/IAI.65.8.3065-3073.1997; FAN VSC, 1970, J BACTERIOL, V104, P608, DOI 10.1128/JB.104.1.608-609.1970; GORDON FB, 1972, ANTIMICROB AGENTS CH, V2, P242, DOI 10.1128/AAC.2.3.242; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Harley R, 2010, VET MICROBIOL, V146, P172, DOI 10.1016/j.vetmic.2010.05.005; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; INGALLS RR, 1995, INFECT IMMUN, V63, P3125, DOI 10.1128/IAI.63.8.3125-3130.1995; Jorgensen I, 2008, INFECT IMMUN, V76, P3940, DOI 10.1128/IAI.00632-08; Kelly KA, 1996, INFECT IMMUN, V64, P4976, DOI 10.1128/IAI.64.12.4976-4983.1996; Klinkert B, 2009, CELL MOL LIFE SCI, V66, P2661, DOI 10.1007/s00018-009-0041-3; Kobayashi Y, 2006, J OBSTET GYNAECOL RE, V32, P280, DOI 10.1111/j.1447-0756.2006.00399.x; Koo IC, 2006, P NATL ACAD SCI USA, V103, P750, DOI 10.1073/pnas.0509690103; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucchetti-Miganeh C, 2008, MICROBIOL-SGM, V154, P16, DOI 10.1099/mic.0.2007/012286-0; Matsumoto A, 1998, J CLIN MICROBIOL, V36, P3013, DOI 10.1128/JCM.36.10.3013-3019.1998; MCCLENAGHAN M, 1988, J GEN MICROBIOL, V134, P559; Mitchell CM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-442; O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027; O'Connell CM, 2006, MICROBIOL-SGM, V152, P1601, DOI 10.1099/mic.0.28658-0; O'Connell CM, 2011, INFECT IMMUN, V79, P1044, DOI 10.1128/IAI.01118-10; O'Connell CM, 2006, J BIOL CHEM, V281, P1652, DOI 10.1074/jbc.M510182200; Ojcius DM, 1998, J BIOL CHEM, V273, P7052, DOI 10.1074/jbc.273.12.7052; PASLEY JN, 1985, SEX TRANSM DIS, V12, P8, DOI 10.1097/00007435-198501000-00003; Paterson TL, 1996, SEX TRANSM DIS, V23, P145, DOI 10.1097/00007435-199603000-00010; Prantner D, 2009, INFECT IMMUN, V77, P5334, DOI 10.1128/IAI.00883-09; Rank RG, 2003, INFECT IMMUN, V71, P6148, DOI 10.1128/IAI.71.11.6148-6154.2003; RANK RG, 1992, AM J PATHOL, V140, P927; Rank RG, 1982, CHLAMYDIAL INFECTION, P391; Rank RG, 1990, ASCENDING GENITAL TR, P249; Read TD, 2003, NUCLEIC ACIDS RES, V31, P2134, DOI 10.1093/nar/gkg321; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Rockey DD, 1996, INFECT IMMUN, V64, P4269, DOI 10.1128/IAI.64.10.4269-4278.1996; Russell M, 2011, INFECT IMMUN, V79, P98, DOI 10.1128/IAI.01105-10; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Stephens RS, 2009, FEMS IMMUNOL MED MIC, V55, P115, DOI 10.1111/j.1574-695X.2008.00516.x; Sturdevant GL, 2010, INFECT IMMUN, V78, P3660, DOI 10.1128/IAI.00386-10; Thomas NS, 1997, MICROBIOL-SGM, V143, P1847, DOI 10.1099/00221287-143-6-1847; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108	46	26	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30747	10.1371/journal.pone.0030747	http://dx.doi.org/10.1371/journal.pone.0030747			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292031	Green Submitted, gold, Green Published			2022-12-27	WOS:000301639600052
J	Jahan, I; Pan, N; Kersigo, J; Calisto, LE; Morris, KA; Kopecky, B; Duncan, JS; Beisel, KW; Fritzsch, B				Jahan, Israt; Pan, Ning; Kersigo, Jennifer; Calisto, Lilian E.; Morris, Ken A.; Kopecky, Benjamin; Duncan, Jeremy S.; Beisel, Kirk W.; Fritzsch, Bernd			Expression of Neurog1 Instead of Atoh1 Can Partially Rescue Organ of Corti Cell Survival	PLOS ONE			English	Article							MAMMALIAN INNER-EAR; SPIRAL GANGLION NEURONS; GENE REGULATORY NETWORK; OUTER HAIR-CELLS; NULL MICE; SENSORY EPITHELIA; TRANSCRIPTION FACTORS; PRONEURAL GENES; MOLECULAR-BASIS; NERVOUS-SYSTEM	In the mammalian inner ear neurosensory cell fate depends on three closely related transcription factors, Atoh1 for hair cells and Neurog1 and Neurod1 for neurons. We have previously shown that neuronal cell fate can be altered towards hair cell fate by eliminating Neurod1 mediated repression of Atoh1 expression in neurons. To test whether a similar plasticity is present in hair cell fate commitment, we have generated a knockin (KI) mouse line (Atoh1(KINeurog1)) in which Atoh1 is replaced by Neurog1. Expression of Neurog1 under Atoh1 promoter control alters the cellular gene expression pattern, differentiation and survival of hair cell precursors in both heterozygous (Atoh1(+/KINeurog1)) and homozygous (Atoh1(KINeurog1/KINeurog1)) KI mice. Homozygous KI mice develop patches of organ of Corti precursor cells that express Neurog1, Neurod1, several prosensory genes and neurotrophins. In addition, these patches of cells receive afferent and efferent processes. Some cells among these patches form multiple microvilli but no stereocilia. Importantly, Neurog1 expressing mutants differ from Atoh1 null mutants, as they have intermittent formation of organ of Corti-like patches, opposed to a complete 'flat epithelium' in the absence of Atoh1. In heterozygous KI mice co-expression of Atoh1 and Neurog1 results in change in fate and patterning of some hair cells and supporting cells in addition to the abnormal hair cell polarity in the later stages of development. This differs from haploinsufficiency of Atoh1 (Pax2cre; Atoh1(f/+)), indicating the effect of Neurog1 expression in developing hair cells. Our data suggest that Atoh1(KINeurog1) can provide some degree of functional support for survival of organ of Corti cells. In contrast to the previously demonstrated fate plasticity of neurons to differentiate as hair cells, hair cell precursors can be maintained for a limited time by Neurog1 but do not transdifferentiate as neurons.	[Jahan, Israt; Pan, Ning; Kersigo, Jennifer; Kopecky, Benjamin; Duncan, Jeremy S.; Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Calisto, Lilian E.; Morris, Ken A.; Beisel, Kirk W.] Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA	University of Iowa; Creighton University	Fritzsch, B (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	bernd-fritzsch@uiowa.edu	Duncan, Jeremy/E-8176-2013; Duncan, Jeremy/K-7230-2013	Fritzsch, Bernd/0000-0002-4882-8398; Duncan, Jeremy/0000-0002-5555-3273	National Institute on Deafness and Other Communication Disorders (NIDCD) [R01 DC 005590, R01 S1 DC 005590]; Office of the Vice President for Research (OVPR), University of Iowa College of Liberal Arts and Sciences (CLAS); P30 core grant [DC 010362]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC010362, R01DC005590] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Office of the Vice President for Research (OVPR), University of Iowa College of Liberal Arts and Sciences (CLAS); P30 core grant; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institute on Deafness and Other Communication Disorders (NIDCD) (R01 DC 005590 to BF; R01 S1 DC 005590). The authors thank the Office of the Vice President for Research (OVPR), University of Iowa College of Liberal Arts and Sciences (CLAS), and the P30 core grant for support (DC 010362). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod JD, 2009, SEMIN CELL DEV BIOL, V20, P964, DOI 10.1016/j.semcdb.2009.08.001; Basch ML, 2011, J NEUROSCI, V31, P8046, DOI 10.1523/JNEUROSCI.6671-10.2011; Bayly R, 2011, NAT REV GENET, V12, P385, DOI 10.1038/nrg2956; BEISEL KW, 1989, NUCLEIC ACIDS RES, V17, P10519, DOI 10.1093/nar/17.24.10519; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Cajal SR, 1919, TRAB LAB INVEST BIOL, V17, P1; Chen P, 2002, DEVELOPMENT, V129, P2495; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Duncan JS, 2011, INT J DEV BIOL, V55, P297, DOI 10.1387/ijdb.103178jd; Eberl DF, 2007, INT J DEV BIOL, V51, P679, DOI 10.1387/ijdb.072364de; Farinas I, 2001, J NEUROSCI, V21, P6170, DOI 10.1523/JNEUROSCI.21-16-06170.2001; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Flora A, 2007, P NATL ACAD SCI USA, V104, P15382, DOI 10.1073/pnas.0707456104; Flora A, 2009, SCIENCE, V326, P1424, DOI 10.1126/science.1181453; Fritzsch B, 2005, DEV DYNAM, V233, P570, DOI 10.1002/dvdy.20370; Fritzsch B, 2007, INT J DEV BIOL, V51, P663, DOI 10.1387/ijdb.072367bf; Fritzsch B, 2011, HEARING RES, V276, P16, DOI 10.1016/j.heares.2011.01.007; Fritzsch B, 2010, CELL MOL LIFE SCI, V67, P3089, DOI 10.1007/s00018-010-0403-x; Fritzsch B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009377; Gemel J, 1999, J BIOL CHEM, V274, P6020, DOI 10.1074/jbc.274.9.6020; Geoffroy CG, 2009, STEM CELLS, V27, P847, DOI 10.1002/stem.17; Gohlke JM, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-15; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379; Helms AW, 2000, DEVELOPMENT, V127, P1185; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Izumikawa M, 2008, HEARING RES, V240, P52, DOI 10.1016/j.heares.2008.02.007; Jahan I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011661; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Kim WY, 2001, DEVELOPMENT, V128, P417; Klisch TJ, 2011, P NATL ACAD SCI USA, V108, P3288, DOI 10.1073/pnas.1100230108; Kuhn S, 2011, P NATL ACAD SCI USA, V108, P2355, DOI 10.1073/pnas.1016646108; Ma QF, 2000, JARO-J ASSOC RES OTO, V1, P129, DOI 10.1007/s101620010017; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Mao CA, 2008, DEVELOPMENT, V135, P3379, DOI 10.1242/dev.024612; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; McDevitt MA, 1997, P NATL ACAD SCI USA, V94, P6781, DOI 10.1073/pnas.94.13.6781; Mcnay DEG, 2006, MOL ENDOCRINOL, V20, P1623, DOI 10.1210/me.2005-0518; Morsli H, 1998, J NEUROSCI, V18, P3327; Mu XQ, 2005, DEV BIOL, V280, P467, DOI 10.1016/j.ydbio.2005.01.028; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakada Y, 2004, DEVELOPMENT, V131, P1319, DOI 10.1242/dev.01008; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; Ohyama T, 2010, J NEUROSCI, V30, P15044, DOI 10.1523/JNEUROSCI.3547-10.2010; Pan N, 2011, HEARING RES, V275, P66, DOI 10.1016/j.heares.2010.12.002; Pan W, 2010, P NATL ACAD SCI USA, V107, P15798, DOI 10.1073/pnas.1003089107; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Pauley S, 2008, PANMINERVA MED, V50, P41; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Powell LM, 2008, CURR OPIN GENET DEV, V18, P411, DOI 10.1016/j.gde.2008.07.012; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Raft S, 2007, DEVELOPMENT, V134, P4405, DOI 10.1242/dev.009118; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Shibata SB, 2010, EXP NEUROL, V223, P464, DOI 10.1016/j.expneurol.2010.01.011; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Soriano P, 1997, DEVELOPMENT, V124, P2691; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Wang Q, 2011, J NEUROSCI, V31, P7938, DOI 10.1523/JNEUROSCI.1434-10.2011; Wang VY, 2002, CURR BIOL, V12, P1611, DOI 10.1016/S0960-9822(02)01144-2; Weston MD, 2011, DEV DYNAM, V240, P808, DOI 10.1002/dvdy.22591; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Willardsen MI, 2009, DEV BIOL, V326, P471, DOI 10.1016/j.ydbio.2008.10.046; Yamamoto N, 2011, DEV BIOL, V353, P367, DOI 10.1016/j.ydbio.2011.03.016; Yang T, 2011, HEARING RES, V278, P21, DOI 10.1016/j.heares.2011.03.002; Zine A, 2001, J NEUROSCI, V21, P4712, DOI 10.1523/JNEUROSCI.21-13-04712.2001	74	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30853	10.1371/journal.pone.0030853	http://dx.doi.org/10.1371/journal.pone.0030853			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292060	gold, Green Published, Green Submitted			2022-12-27	WOS:000301639600062
J	Lowry, DB; Sheng, CC; Zhu, ZR; Juenger, TE; Lahner, B; Salt, DE; Willis, JH				Lowry, David B.; Sheng, Calvin C.; Zhu, Zhirui; Juenger, Thomas E.; Lahner, Brett; Salt, David E.; Willis, John H.			Mapping of Ionomic Traits in Mimulus guttatus Reveals Mo and Cd QTLs That Colocalize with MOT1 Homologues	PLOS ONE			English	Article							AFFINITY MOLYBDATE TRANSPORTER; REPRODUCTIVE ISOLATION; ARABIDOPSIS-THALIANA; COPPER TOLERANCE; LOCAL ADAPTATION; CLIMATE-CHANGE; FOOD SECURITY; MOLYBDENUM; IRON; HYPERACCUMULATION	Natural variation in the regulation of the accumulation of mineral nutrients and trace elements in plant tissues is crucial to plant metabolism, development, and survival across different habitats. Studies of the genetic basis of natural variation in nutrient metabolism have been facilitated by the development of ionomics. Ionomics is a functional genomic approach for the identification of the genes and gene networks that regulate the elemental composition, or ionome, of an organism. In this study, we evaluated the genetic basis of divergence in elemental composition between an inland annual and a coastal perennial accession of Mimulus guttatus using a recombinant inbred line (RIL) mapping population. Out of 20 elements evaluated, Mo and Cd were the most divergent in accumulation between the two accessions and were highly genetically correlated in the RILs across two replicated experiments. We discovered two major quantitative trait loci (QTL) for Mo accumulation, the largest of which consistently colocalized with a QTL for Cd accumulation. Interestingly, both Mo QTLs also colocalized with the two M. guttatus homologues of MOT1, the only known plant transporter to be involved in natural variation in molybdate uptake.	[Lowry, David B.; Willis, John H.] Duke Univ, Med Ctr, Univ Program Genet & Genom, Durham, NC 27710 USA; [Lowry, David B.; Sheng, Calvin C.; Zhu, Zhirui; Willis, John H.] Duke Univ, Dept Biol, Durham, NC USA; [Juenger, Thomas E.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Juenger, Thomas E.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Lahner, Brett; Salt, David E.] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Salt, David E.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland	Duke University; Duke University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Aberdeen	Lowry, DB (corresponding author), Duke Univ, Med Ctr, Univ Program Genet & Genom, Durham, NC 27710 USA.	davidbryantlowry@gmail.com			National Science Foundation, through a FIBR [EF-0328636]; Environmental Genomics [EF-0723814]; Doctoral Dissertation Improvement Grant [DEB-0710094]; National Institute of Health; Duke University	National Science Foundation, through a FIBR(National Science Foundation (NSF)); Environmental Genomics; Doctoral Dissertation Improvement Grant; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University	Funding was provided by the National Science Foundation, through a FIBR grant (EF-0328636), an Environmental Genomics Grant (EF-0723814), and a Doctoral Dissertation Improvement Grant (DEB-0710094). Funding was also provided by a National Institute of Health Graduate Student Fellowship and a Duke University Travel Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONOVICS J, 1970, HEREDITY, V25, P349, DOI 10.1038/hdy.1970.36; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Baxter I, 2007, PLANT PHYSIOL, V143, P600, DOI 10.1104/pp.106.092528; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Baxter I, 2009, CURR OPIN PLANT BIOL, V12, P381, DOI 10.1016/j.pbi.2009.05.002; Bernard DG, 2009, PLANT PHYSIOL, V151, P590, DOI 10.1104/pp.109.143651; BITTNER F, 2010, PLANT CELL MONOGR, V17, P119, DOI DOI 10.1007/978-3-642-10613-2_6; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Buescher E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011081; Chao DY, 2011, PLANT CELL, V23, P1061, DOI 10.1105/tpc.110.079095; Fitzpatrick KL, 2008, FEBS LETT, V582, P1508, DOI 10.1016/j.febslet.2008.03.045; Gardner M, 2000, BIOL J LINN SOC, V69, P443, DOI 10.1111/j.1095-8312.2000.tb01218.x; Gasber A, 2011, PLANT BIOLOGY, V13, P710, DOI 10.1111/j.1438-8677.2011.00448.x; Gupta UC, 1997, MOLYBDENUM AGR; Hall MC, 2010, MOL ECOL, V19, P2739, DOI 10.1111/j.1365-294X.2010.04680.x; Hall MC, 2006, GENETICS, V172, P1829, DOI 10.1534/genetics.105.051227; Hall MC, 2006, EVOLUTION, V60, P2466, DOI 10.1554/05-688.1; Harrison S, 2011, SERPENTINE: THE EVOLUTION AND ECOLOGY OF A MODEL SYSTEM, P1, DOI 10.1525/california/9780520268357.001.0001; HEWITT E. J., 1956, SOIL SCI, V81, P159, DOI 10.1097/00010694-195603000-00002; Ide Y, 2011, J EXP BOT, V62, P1483, DOI 10.1093/jxb/erq345; Ingram JSI, 2008, AGR ECOSYST ENVIRON, V126, P4, DOI 10.1016/j.agee.2008.01.009; Jiang RF, 2005, NEW PHYTOL, V167, P805, DOI 10.1111/j.1469-8137.2005.01452.x; Kaiser BN, 2005, ANN BOT-LONDON, V96, P745, DOI 10.1093/aob/mci226; Kay KM, 2011, SERPENTINE: THE EVOLUTION AND ECOLOGY OF A MODEL SYSTEM, P71; Kobayashi Y, 2008, PLANT PHYSIOL, V148, P969, DOI 10.1104/pp.108.119933; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Loudet O, 2007, NAT GENET, V39, P896, DOI 10.1038/ng2050; Lowry DB, 2008, EVOLUTION, V62, P2196, DOI 10.1111/j.1558-5646.2008.00457.x; Lowry DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000500; Lowry DB, 2010, BIOL LETTERS, V6, P502, DOI 10.1098/rsbl.2009.0969; Lowry DB, 2009, NEW PHYTOL, V183, P776, DOI 10.1111/j.1469-8137.2009.02901.x; MACNAIR MR, 1983, HEREDITY, V50, P295, DOI 10.1038/hdy.1983.31; Mendel RR, 2011, COORDIN CHEM REV, V255, P1145, DOI 10.1016/j.ccr.2011.01.054; Morrissey J, 2009, PLANT CELL, V21, P3326, DOI 10.1105/tpc.109.069401; Poschenrieder C, 2006, TRENDS PLANT SCI, V11, P288, DOI 10.1016/j.tplants.2006.04.007; Prinzenberg AE, 2010, PLANT PHYSIOL, V154, P1361, DOI 10.1104/pp.110.161398; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Sanita di Toppi L, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Tejada-Jimenez M, 2007, P NATL ACAD SCI USA, V104, P20126, DOI 10.1073/pnas.0704646104; Tejada-Jimenez M, 2011, P NATL ACAD SCI USA, V108, P6420, DOI 10.1073/pnas.1100700108; Tian H, 2010, PLANT CELL, V22, P3963, DOI 10.1105/tpc.110.080010; Tomatsu H, 2007, P NATL ACAD SCI USA, V104, P18807, DOI 10.1073/pnas.0706373104; Verbruggen N, 2009, NEW PHYTOL, V181, P759, DOI 10.1111/j.1469-8137.2008.02748.x; Verbruggen N, 2009, CURR OPIN PLANT BIOL, V12, P364, DOI 10.1016/j.pbi.2009.05.001; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Wu CA, 2010, OECOLOGIA, V162, P23, DOI 10.1007/s00442-009-1448-0	47	15	16	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30730	10.1371/journal.pone.0030730	http://dx.doi.org/10.1371/journal.pone.0030730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292026	gold, Green Published, Green Submitted			2022-12-27	WOS:000301639600050
J	Tao, J; Chen, M; Zong, SX; Luo, YQ				Tao, Jing; Chen, Min; Zong, Shi-Xiang; Luo, You-Qing			Genetic Structure in the Seabuckthorn Carpenter Moth (Holcocerus hippophaecolus) in China: The Role of Outbreak Events, Geographical and Host Factors	PLOS ONE			English	Article							POPULATIONS; PATTERNS; INSECTS; SYSTEMS; DIFFERENTIATION; HETEROZYGOSITY; ORTHOPTERA; AFLP; SIZE	Understanding factors responsible for structuring genetic diversity is of fundamental importance in evolutionary biology. The seabuckthorn carpenter moth (Holcocerus hippophaecolus Hua) is a native species throughout the north of China and is considered the main threat to seabuckthorn, Hippophae rhamnoides L. We assessed the influence of outbreaks, environmental factors and host species in shaping the genetic variation and structure of H. hippophaecolus by using Amplified Fragment Length Polymorphism (AFLP) markers. We rejected the hypothesis that outbreak-associated genetic divergence exist, as evidenced by genetic clusters containing a combination of populations from historical outbreak areas, as well as non-outbreak areas. Although a small number of markers (4 of 933 loci) were identified as candidates under selection in response to population densities. H. hippophaecolus also did not follow an isolation-by-distance pattern. We rejected the hypothesis that outbreak and drought events were driving the genetic structure of H. hippophaecolus. Rather, the genetic structure appears to be influenced by various confounding bio-geographical factors. There were detectable genetic differences between H. hippophaecolus occupying different host trees from within the same geographic location. Host-associated genetic divergence should be confirmed by further investigation.	[Tao, Jing; Chen, Min; Zong, Shi-Xiang; Luo, You-Qing] Beijing Forestry Univ, Beijing, Peoples R China; [Tao, Jing; Chen, Min; Zong, Shi-Xiang; Luo, You-Qing] Beijing Forestry Univ, Silviculture & Conservat Minist Educ, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Luo, YQ (corresponding author), Beijing Forestry Univ, Beijing, Peoples R China.	youqingluo@126.com			National Nature Science Fund [30730075]; Fundamental Research Funds for the Central Universities [YX2011-18]	National Nature Science Fund(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Nature Science Fund (project NO 30730075 and Fundamental Research Funds for the Central Universities (project NO YX2011-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antao T, 2011, BIOINFORMATICS, V27, P1717, DOI 10.1093/bioinformatics/btr253; Arnaud JF, 2003, LANDSCAPE ECOL, V18, P333, DOI 10.1023/A:1024409116214; Bailey NW, 2005, HEREDITY, V95, P166, DOI 10.1038/sj.hdy.6800704; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernays EA, 1994, HOST PLANT SELECTION; BERRYMAN AA, 1978, RES POPUL ECOL, V19, P181, DOI 10.1007/BF02518826; Chapuis MP, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-37; Chapuis MP, 2009, MOL ECOL, V18, P792, DOI 10.1111/j.1365-294X.2008.04072.x; Chen Min, 2008, Journal of Beijing Forestry University, V30, P116; Chitty D, 1971, NATRUAL REGULATION A; Cognato AI, 2003, ENVIRON ENTOMOL, V32, P1262, DOI 10.1603/0046-225X-32.5.1262; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Feder JL, 2003, P NATL ACAD SCI USA, V100, P10314, DOI 10.1073/pnas.1730757100; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Funk DJ, 2002, GENETICA, V116, P251, DOI 10.1023/A:1021236510453; GAINES MS, 1978, EVOLUTION, V32, P723, DOI 10.1111/j.1558-5646.1978.tb04626.x; Grapputo A, 2005, MOL ECOL, V14, P4207, DOI 10.1111/j.1365-294X.2005.02740.x; Hua BZ, 1990, CHINESE COSSIDAE, P56; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Kennedy GG, 2000, ANNU REV ENTOMOL, V45, P467, DOI 10.1146/annurev.ento.45.1.467; Louy D, 2007, CONSERV GENET, V8, P671, DOI 10.1007/s10592-006-9213-y; Luo Y., 2003, FOR PEST DIS, V5, P25; Maron JL, 2001, OECOLOGIA, V126, P595, DOI 10.1007/s004420000558; Martinat P.J., 1987, P241; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; Miller MP, 1997, TOOLS POPULATION GEN; Mock KE, 2007, MOL ECOL, V16, P553, DOI 10.1111/j.1365-294X.2006.03158.x; Mopper S, 1996, TRENDS ECOL EVOL, V11, P235, DOI 10.1016/0169-5347(96)10036-7; MOTRO U, 1982, EVOLUTION, V36, P1059, DOI 10.1111/j.1558-5646.1982.tb05474.x; Myers JH, 1988, CAN GEN HYPOTHESIS E, P179; NEI M, 1974, GENETICS, V76, P379; Peterson MA, 1998, GENETIC STRUCTURE LO, P236; Price PW, 1987, INSECT OUTBREAKS, P208; Rossiter M.C., 1992, P13; Salvato P, 2002, MOL ECOL, V11, P2435, DOI 10.1046/j.1365-294X.2002.01631.x; Sander AC, 2006, BASIC APPL ECOL, V7, P555, DOI 10.1016/j.baae.2006.01.001; Schneider S., 2000, ARLEQUIN VERSION 20; Simchuk AP, 1999, FOREST ECOL MANAG, V113, P35, DOI 10.1016/S0378-1127(98)00340-5; SOLBRECK C, 1991, OIKOS, V60, P343, DOI 10.2307/3545077; STEWART WDP, 1967, PLANT SOIL, V26, P348, DOI 10.1007/BF01880184; Sword GA, 2005, MOL ECOL, V14, P2197, DOI 10.1111/j.1365-294X.2005.02546.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WALLNER WE, 1987, ANNU REV ENTOMOL, V32, P317, DOI 10.1146/annurev.en.32.010187.001533; Walsh PJ, 1990, POPULATION DYNAMICS, P242; Wang DS, 2007, SCI TECH INFORM DEV, V17, P170; Wang Zhi-zheng, 2010, Journal of Beijing Forestry University, V32, P130; WHITE TCR, 1984, OECOLOGIA, V63, P90, DOI 10.1007/BF00379790; You Y, 2000, SHAANXI FOREST SCI T, V4, P1; Zhang De-Xing, 1998, P5; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x; Zhou ZhangYi, 2007, Journal of Beijing Forestry University, V29, P50; Zhou ZY, 2002, HIPPOPHAE, V15, P7; Zong Shi-xiang, 2006, Zhongguo Senlin Bingchong, V25, P7; Zong SX, 2006, SCI SILVAE SINICAE, V41, P79	58	4	6	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30544	10.1371/journal.pone.0030544	http://dx.doi.org/10.1371/journal.pone.0030544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291983	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600031
J	Zhou, R; Li, XQ; Hu, GK; Gong, AY; Drescher, KM; Chen, XM				Zhou, Rui; Li, Xiaoqing; Hu, Guoku; Gong, Ai-Yu; Drescher, Kristen M.; Chen, Xian-Ming			miR-16 Targets Transcriptional Corepressor SMRT and Modulates NF-kappaB-Regulated Transactivation of Interleukin-8 Gene	PLOS ONE			English	Article							MICRORNA; EXPRESSION; COMPLEX; ALPHA; INVOLVEMENT; BIOGENESIS; ACTIVATION; MECHANISMS; PROTEIN	The signaling pathways associated with the Toll-like receptors (TLRs) and nuclear factor-kappaB (NF-kappa B) are essential to proinflammatory cytokine and chemokine expression, as well as initiating innate epithelial immune responses. The TLR/NF-kappa B signaling pathways must be stringently controlled through an intricate network of positive and negative regulatory elements. MicroRNAs (miRNAs) are non-coding small RNAs that regulate the stability and/or translation of protein-coding mRNAs. Herein we report that miR-16 promotes NF-kappa B-regulated transactivation of the IL-8 gene by suppression of the silencing mediator for retinoid and thyroid hormone receptor (SMRT). LPS stimulation activated miR-16 gene transcription in human monocytes (U937) and biliary epithelial cells (H69) through MAPK-dependent mechanisms. Transfection of cells with the miR-16 precursor promoted LPS-induced production of IL-8, IL-6, and IL-1 alpha, without a significant effect on their RNA stability. Instead, an increase in NF-kappa B-regulated transactivation of the IL-8 gene was confirmed in cells following transfection of miR-16 precursor. Importantly, miR-16 targeted the 3'-untranslated region of SMRT and caused translational suppression of SMRT. LPS decreased SMRT expression via upregulation of miR-16. Moreover, functional manipulation of SMRT altered NF-kappa B-regulated transactivation of LPS-induced IL-8 expression. These data suggest that miR-16 targets SMRT and modulates NF-kappa B-regulated transactivation of the IL-8 gene.	[Zhou, Rui; Hu, Guoku; Gong, Ai-Yu; Drescher, Kristen M.; Chen, Xian-Ming] Creighton Univ, Med Ctr, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA; [Li, Xiaoqing] Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Sch, Wuhan, Hubei, Peoples R China	Creighton University; Huazhong University of Science & Technology	Chen, XM (corresponding author), Creighton Univ, Med Ctr, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA.	xianmingchen@creighton.edu	hu, gengkai/E-5737-2010		National Institutes of Health [AI071321, AI095532]; Nebraska Tobacco Settlement Biomedical Research Program [LB692, LB595]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095532, R01AI071321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Tobacco Settlement Biomedical Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI071321, AI095532 and by the Nebraska Tobacco Settlement Biomedical Research Program (LB692 and LB595) (to XMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Angrisano T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-172; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bayarsaihan D, 2011, J DENT RES, V90, P9, DOI 10.1177/0022034510378683; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chen XM, 2008, IMMUNOL CELL BIOL, V86, P497, DOI 10.1038/icb.2008.37; Clark A, 2009, FRONT BIOSCI-LANDMRK, V14, P847, DOI 10.2741/3282; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Gong AY, 2010, J INFECT DIS, V201, P160, DOI 10.1086/648589; Guenther MG, 2000, GENE DEV, V14, P1048; Guglielmelli P, 2011, BLOOD, V117, P6923, DOI 10.1182/blood-2010-09-306506; Hamon MA, 2008, CELL HOST MICROBE, V4, P100, DOI 10.1016/j.chom.2008.07.009; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu GK, 2009, J IMMUNOL, V183, P1617, DOI 10.4049/jimmunol.0804362; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Kobayashi KS, 2004, J LEUKOCYTE BIOL, V75, P428, DOI 10.1189/jlb.0703321; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Liu J, 2009, INT REV IMMUNOL, V28, P139, DOI 10.1080/08830180902943058; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Shin VY, 2011, CARCINOGENESIS, V32, P240, DOI 10.1093/carcin/bgq240; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Viswanathan VK, 2000, CURR OPIN GASTROEN, V16, P546, DOI 10.1097/00001574-200011000-00015; Wang X, 2011, J BIOL CHEM, V285, P23241; Zhou R, 2011, CELL MOL IMMUNOL, V8, P371, DOI 10.1038/cmi.2011.19; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	38	48	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30772	10.1371/journal.pone.0030772	http://dx.doi.org/10.1371/journal.pone.0030772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292036	gold, Green Submitted, Green Published			2022-12-27	WOS:000301639600053
J	Aburto, MR; Magarinos, M; Leon, Y; Varela-Nieto, I; Sanchez-Calderon, H				Aburto, Maria R.; Magarinos, Marta; Leon, Yolanda; Varela-Nieto, Isabel; Sanchez-Calderon, Hortensia			AKT Signaling Mediates IGF-I Survival Actions on Otic Neural Progenitors	PLOS ONE			English	Article							GROWTH-FACTOR-I; DEVELOPING INNER-EAR; PROGRAMMED CELL-DEATH; CHICK-EMBRYO; NEUROTROPHIC FACTOR; HEARING-LOSS; INSULIN; EXPRESSION; DIFFERENTIATION; PROLIFERATION	Background: Otic neurons and sensory cells derive from common progenitors whose transition into mature cells requires the coordination of cell survival, proliferation and differentiation programmes. Neurotrophic support and survival of postmitotic otic neurons have been intensively studied, but the bases underlying the regulation of programmed cell death in immature proliferative otic neuroblasts remains poorly understood. The protein kinase AKT acts as a node, playing a critical role in controlling cell survival and cell cycle progression. AKT is activated by trophic factors, including insulin-like growth factor I (IGF-I), through the generation of the lipidic second messenger phosphatidylinositol 3-phosphate by phosphatidylinositol 3-kinase (PI3K). Here we have investigated the role of IGF-dependent activation of the PI3K-AKT pathway in maintenance of otic neuroblasts. Methodology/Principal Findings: By using a combination of organotypic cultures of chicken (Gallus gallus) otic vesicles and acoustic-vestibular ganglia, Western blotting, immunohistochemistry and in situ hybridization, we show that IGF-I-activation of AKT protects neural progenitors from programmed cell death. IGF-I maintains otic neuroblasts in an undifferentiated and proliferative state, which is characterised by the upregulation of the forkhead box M1 (FoxM1) transcription factor. By contrast, our results indicate that post-mitotic p27(Kip)-positive neurons become IGF-I independent as they extend their neuronal processes. Neurons gradually reduce their expression of the Igf1r, while they increase that of the neurotrophin receptor, TrkC. Conclusions/Significance: Proliferative otic neuroblasts are dependent on the activation of the PI3K-AKT pathway by IGF-I for survival during the otic neuronal progenitor phase of early inner ear development.	[Aburto, Maria R.; Magarinos, Marta; Leon, Yolanda; Varela-Nieto, Isabel; Sanchez-Calderon, Hortensia] CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Magarinos, Marta; Leon, Yolanda] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Aburto, Maria R.; Magarinos, Marta; Varela-Nieto, Isabel; Sanchez-Calderon, Hortensia] ISCIII, CIBERER, Unit 761, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Aburto, MR (corresponding author), CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain.	ivarela@iib.uam.es	Varela-Nieto, Isabel/G-5289-2015; SÁNCHEZ, MARTA MAGARIÑOS/ABG-7748-2020; Rodriguez Aburto, Maria/ABG-7492-2021; Leon, Yolanda/ABG-6797-2020	Varela-Nieto, Isabel/0000-0003-3077-0500; SÁNCHEZ, MARTA MAGARIÑOS/0000-0003-4592-9377; Leon Alvarez, Yolanda/0000-0002-4536-8373; de las Heras, Ana Isabel/0000-0002-4446-7417	Ministerio de Ciencia e Innovacion [SAF2008-00470]; Fundacion Mutua Madrilena	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III)	This work was supported by the "Ministerio de Ciencia e Innovacion" (SAF2008-00470; http://www.micinn.es/) and the "Fundacion Mutua Madrilena" (http://www.fundacionmutua.es/) to IVN. The funders had no role in the study design, data collection and analysis, decision to publish or the preparation of the manuscript.	Aberg MAI, 2003, MOL CELL NEUROSCI, V24, P23, DOI 10.1016/S1044-7431(03)00082-4; Aberg MAI, 2000, J NEUROSCI, V20, P2896; Arsenijevic Y, 2001, J NEUROSCI, V21, P7194, DOI 10.1523/JNEUROSCI.21-18-07194.2001; AVILA MA, 1993, DEV BIOL, V159, P266, DOI 10.1006/dbio.1993.1239; Becker E, 1998, J NEUROSCI, V18, P7903; Bissonnette JP, 1996, J COMP NEUROL, V368, P620, DOI 10.1002/(SICI)1096-9861(19960513)368:4<620::AID-CNE12>3.0.CO;2-L; Camarero G, 2003, DEV BIOL, V262, P242, DOI 10.1016/S0012-1606(03)00387-7; Camarero G, 2001, J NEUROSCI, V21, P7630, DOI 10.1523/JNEUROSCI.21-19-07630.2001; Cediel R, 2006, EUR J NEUROSCI, V23, P587, DOI 10.1111/j.1460-9568.2005.04584.x; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Davies D, 2007, J COMP NEUROL, V502, P673, DOI 10.1002/cne.21302; De Zio D, 2005, SEMIN CELL DEV BIOL, V16, P281, DOI 10.1016/j.semcdb.2004.12.003; DICICCOBLOOM E, 1988, P NATL ACAD SCI USA, V85, P4066, DOI 10.1073/pnas.85.11.4066; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Fekete DM, 2007, INT J DEV BIOL, V51, P549, DOI 10.1387/ijdb.072341df; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Frago LM, 2003, J CELL SCI, V116, P475, DOI 10.1242/jcs.00223; Frago LM, 1998, J CELL SCI, V111, P549; Fritzsch B, 2004, PROG BRAIN RES, V146, P265, DOI 10.1016/S0079-6123(03)46017-2; Fritzsch B, 1999, CELL TISSUE RES, V295, P369, DOI 10.1007/s004410051244; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Hajduch E, 2001, FEBS LETT, V492, P199, DOI 10.1016/S0014-5793(01)02242-6; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HEMOND SG, 1991, ANAT EMBRYOL, V184, P1, DOI 10.1007/BF01744256; HERNANDEZSANCHEZ C, 1995, P NATL ACAD SCI USA, V92, P9834, DOI 10.1073/pnas.92.21.9834; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Hodge RD, 2004, J NEUROSCI, V24, P10201, DOI 10.1523/JNEUROSCI.3246-04.2004; Husseman J, 2009, ADV OTO-RHINO-LARYNG, V66, P37, DOI 10.1159/000218206; Karis A, 2001, J COMP NEUROL, V429, P615, DOI 10.1002/1096-9861(20010122)429:4<615::AID-CNE8>3.0.CO;2-F; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Korver W, 1998, CURR BIOL, V8, P1327, DOI 10.1016/S0960-9822(07)00563-5; Lang HN, 2000, J COMP NEUROL, V417, P205, DOI 10.1002/(SICI)1096-9861(20000207)417:2<205::AID-CNE6>3.0.CO;2-Y; Lein Y, 1998, J COMP NEUROL, V398, P323, DOI 10.1002/(SICI)1096-9861(19980831)398:3<323::AID-CNE2>3.0.CO;2-1; Leon Y, 2004, APOPTOSIS, V9, P255, DOI 10.1023/B:APPT.0000025802.07676.a5; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Li HW, 2004, J COMP NEUROL, V477, P1, DOI 10.1002/cne.20190; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Magarinos M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014435; Mairet-Coello G, 2009, J NEUROSCI, V29, P775, DOI 10.1523/JNEUROSCI.1700-08.2009; Milo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007144; Neves J, 2007, J COMP NEUROL, V503, P487, DOI 10.1002/cne.21299; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Pirvola U, 1997, J NEUROBIOL, V33, P1019, DOI 10.1002/(SICI)1097-4695(199712)33:7<1019::AID-NEU11>3.0.CO;2-A; Puligilla C, 2010, J NEUROSCI, V30, P714, DOI 10.1523/JNEUROSCI.3852-09.2010; RATHJEN FG, 1987, CELL, V51, P841, DOI 10.1016/0092-8674(87)90107-3; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Riquelme R, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00027; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Sanchez-Calderon H, 2004, GENE EXPR PATTERNS, V4, P659, DOI 10.1016/j.modgep.2004.04.008; Sanchez-Calderon H, 2007, INT J DEV BIOL, V51, P557, DOI 10.1387/ijdb.072373hs; Sanchez-Calderon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008699; Sinor AD, 2004, J NEUROSCI, V24, P8531, DOI 10.1523/JNEUROSCI.1470-04.2004; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Varela-Nieto I, 2003, MOL NEUROBIOL, V28, P23, DOI 10.1385/MN:28:1:23; Varela-Nieto I, 2007, CURR PHARM DESIGN, V13, P687, DOI 10.2174/138161207780249164; Walenkamp MJE, 2007, EUR J ENDOCRINOL, V156, P155, DOI 10.1530/eje.1.02327; WIKSTROM SO, 1987, ACTA OTO-LARYNGOL, V104, P166, DOI 10.3109/00016488709109063; Ye P, 2006, J NEUROSCI RES, V83, P1, DOI 10.1002/jnr.20688	63	50	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30790	10.1371/journal.pone.0030790	http://dx.doi.org/10.1371/journal.pone.0030790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292041	gold, Green Published, Green Submitted			2022-12-27	WOS:000301570600079
J	Ito, M; Johansson, J; Stromberg, R; Nilsson, L				Ito, Mika; Johansson, Jan; Stromberg, Roger; Nilsson, Lennart			Effects of Ligands on Unfolding of the Amyloid beta-Peptide Central Helix: Mechanistic Insights from Molecular Dynamics Simulations	PLOS ONE			English	Article							FIBRIL-FORMING PROTEINS; ALZHEIMERS-DISEASE; FORCE-FIELDS; A-BETA(1-42); WATER; HYPOTHESIS; BACKBONE; PROGRAM; CHARMM; NMR	Polymerization of the amyloid beta-peptide (A beta), a process which requires that the helical structure of A beta unfolds beforehand, is suspected to cause neurodegeneration in Alzheimer's disease. According to recent experimental studies, stabilization of the A beta central helix counteracts A beta polymerization into toxic assemblies. The effects of two ligands (Dec-DETA and Pep1b), which were designed to bind to and stabilize the A beta central helix, on unfolding of the A beta central helix were investigated by molecular dynamics simulations. It was quantitatively demonstrated that the stability of the A beta central helix is increased by both ligands, and more effectively by Pep1b than by Dec-DETA. In addition, it was shown that Dec-DETA forms parallel conformations with beta-strand-like A beta, whereas Pep1b does not and instead tends to bend unwound A beta. The molecular dynamics results correlate well with previous experiments for these ligands, which suggest that the simulation method should be useful in predicting the effectiveness of novel ligands in stabilizing the A beta central helix. Detailed A beta structural changes upon loss of helicity in the presence of the ligands are also revealed, which gives further insight into which ligand may lead to which path subsequent to unwinding of the A beta central helix.	[Ito, Mika; Stromberg, Roger; Nilsson, Lennart] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Johansson, Jan] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Huddinge, Sweden; [Johansson, Jan] Karolinska Inst, Alzheimer Dis Res Ctr KI ADRC, Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Ito, M (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.	Lennart.Nilsson@ki.se	Stromberg, Roger/C-2960-2013; Nilsson, Lennart/B-7208-2009	Nilsson, Lennart/0000-0002-5067-6397; Johansson, Jan/0000-0002-8719-4703	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council (http://www.vr.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INS 2 VERS 2000; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; DELOOF H, 1992, J AM CHEM SOC, V114, P4028, DOI 10.1021/ja00037a002; ELOFSSON A, 1993, J MOL BIOL, V233, P766, DOI 10.1006/jmbi.1993.1551; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ito M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017587; Jarvet J, 2007, J BIOMOL NMR, V39, P63, DOI 10.1007/s10858-007-9176-4; Johansson J, 2010, BIOCHEM BIOPH RES CO, V402, P515, DOI 10.1016/j.bbrc.2010.10.062; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mason JM, 2003, CURR OPIN STRUC BIOL, V13, P526, DOI 10.1016/S0959-440X(03)00100-3; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Nilsson L, 2009, J COMPUT CHEM, V30, P1490, DOI 10.1002/jcc.21169; Nordling E, 2008, J COMPUT AID MOL DES, V22, P53, DOI 10.1007/s10822-007-9155-6; Paivio A, 2004, PROTEIN SCI, V13, P1251, DOI 10.1110/ps.03442404; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shen L, 2008, J PHYS CHEM B, V112, P3164, DOI 10.1021/jp7108237; STEINBACH PJ, 1994, J COMPUT CHEM, V15, P667, DOI 10.1002/jcc.540150702; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1997, J BIOL CHEM, V272, P12601, DOI 10.1074/jbc.272.19.12601; Triguero L, 2008, J PHYS CHEM B, V112, P7123, DOI 10.1021/jp801168v; Triguero L, 2008, J PHYS CHEM B, V112, P2159, DOI 10.1021/jp0771872; Watanabe K, 2002, BIOCHEM BIOPH RES CO, V290, P121, DOI 10.1006/bbrc.2001.6191; Watanabe K, 2001, J PEPT RES, V58, P342, DOI 10.1034/j.1399-3011.2001.00920.x; Zhang S, 2000, J STRUCT BIOL, V130, P130, DOI 10.1006/jsbi.2000.4288	40	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30510	10.1371/journal.pone.0030510	http://dx.doi.org/10.1371/journal.pone.0030510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291970	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600049
J	Popa-Lisseanu, AG; Sorgel, K; Luckner, A; Wassenaar, LI; Ibanez, C; Kramer-Schadt, S; Ciechanowski, M; Gorfol, T; Niermann, I; Beuneux, G; Myslajek, RW; Juste, J; Fonderflick, J; Kelm, DH; Voigt, CC				Popa-Lisseanu, Ana G.; Soergel, Karin; Luckner, Anja; Wassenaar, Leonard I.; Ibanez, Carlos; Kramer-Schadt, Stephanie; Ciechanowski, Mateusz; Goerfoel, Tamas; Niermann, Ivo; Beuneux, Gregory; Myslajek, Robert W.; Juste, Javier; Fonderflick, Jocelyn; Kelm, Detlev H.; Voigt, Christian C.			A Triple-Isotope Approach to Predict the Breeding Origins of European Bats	PLOS ONE			English	Article							STABLE-ISOTOPES; DELTA-D; MIGRATORY CONNECTIVITY; MONARCH BUTTERFLIES; NATAL ORIGINS; LESSER SCAUP; HYDROGEN; RATIOS; CHIROPTERA; DELINEATE	Despite a commitment by the European Union to protect its migratory bat populations, conservation efforts are hindered by a poor understanding of bat migratory strategies and connectivity between breeding and wintering grounds. Traditional methods like mark-recapture are ineffective to study broad-scale bat migratory patterns. Stable hydrogen isotopes (delta D) have been proven useful in establishing spatial migratory connectivity of animal populations. Before applying this tool, the method was calibrated using bat samples of known origin. Here we established the potential of delta D as a robust geographical tracer of breeding origins of European bats by measuring delta D in hair of five sedentary bat species from 45 locations throughout Europe. The delta D of bat hair strongly correlated with well-established spatial isotopic patterns in mean annual precipitation in Europe, and therefore was highly correlated with latitude. We calculated a linear mixed-effects model, with species as random effect, linking delta D of bat hair to precipitation delta D of the areas of hair growth. This model can be used to predict breeding origins of European migrating bats. We used delta C-13 and delta N-15 to discriminate among potential origins of bats, and found that these isotopes can be used as variables to further refine origin predictions. A triple-isotope approach could thereby pinpoint populations or subpopulations that have distinct origins. Our results further corroborated stable isotope analysis as a powerful method to delineate animal migrations in Europe.	[Popa-Lisseanu, Ana G.; Soergel, Karin; Luckner, Anja; Kramer-Schadt, Stephanie; Voigt, Christian C.] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Wassenaar, Leonard I.] Environm Canada, Saskatoon, SK, Canada; [Ibanez, Carlos; Juste, Javier] CSIC, Estn Biol Donana, Seville, Spain; [Ciechanowski, Mateusz] Univ Gdansk, Dept Vertebrate Ecol & Zool, PL-80952 Gdansk, Poland; [Goerfoel, Tamas] Szent Istvan Univ, Inst Biol, Fac Vet Sci, Budapest, Hungary; [Goerfoel, Tamas] Nat Conservat Fdn Tolna Cty, Szekszard, Hungary; [Niermann, Ivo] Leibniz Univ Hannover, Inst Umweltplanung, Hannover, Germany; [Beuneux, Gregory] Grp Chiropteres Corse, Corte, Corsica, France; [Myslajek, Robert W.] Assoc Nat Wolf, Lipowa, Poland; [Fonderflick, Jocelyn] Montpellier SupAgro, Dept Biol & Ecol, Montpellier, France; [Fonderflick, Jocelyn] Ctr Ecol Fonct & Evolut, Montpellier, France; [Kelm, Detlev H.] Univ Berlin, Dept Biol, Berlin, Germany	Leibniz Institut fur Zoo und Wildtierforschung; Environment & Climate Change Canada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Fahrenheit Universities; University of Gdansk; Hungarian University of Agriculture & Life Sciences; Leibniz University Hannover; Institut Agro; Montpellier SupAgro; Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Popa-Lisseanu, AG (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	anapopa@izw-berlin.de	Görföl, Tamás/F-7688-2010; Wassenaar, Leonard/AAY-7081-2020; Mysłajek, Robert W./AAD-9569-2022; Juste, Javier/B-9253-2013; Ibanez, Carlos/H-7577-2015; Kramer-Schadt, Stephanie/A-8778-2013; Myslajek, Robert/K-8248-2015	Görföl, Tamás/0000-0002-1910-4024; Wassenaar, Leonard/0000-0001-5532-0771; Juste, Javier/0000-0003-1383-8462; Ibanez, Carlos/0000-0003-1181-7641; Kramer-Schadt, Stephanie/0000-0002-9269-4446; Myslajek, Robert/0000-0001-9619-2868	Alexander von Humboldt Foundation	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	Financial support was provided by the Alexander von Humboldt Foundation with a post-doctoral fellowship for A. G. Popa-Lisseanu. Funder's website: http://www.humboldt-foundation.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birchall J, 2005, J ANIM ECOL, V74, P877, DOI 10.1111/j.1365-2656.2005.00979.x; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Bowen GJ, 2010, GRIDDED MAPS ISOTOPI; Britzke ER, 2009, J MAMMAL, V90, P743, DOI 10.1644/08-MAMM-A-211R2.1; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Chamberlain CP, 2000, P ROY SOC B-BIOL SCI, V267, P43, DOI 10.1098/rspb.2000.0964; Clark RG, 2006, CAN J ZOOL, V84, P1395, DOI 10.1139/Z06-135; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; Cryan PM, 2004, J MAMMAL, V85, P995, DOI 10.1644/BRG-202; Dietz C., 2007, HDB FLEDERMAUSE EURO; Dietz C, 2006, ACTA CHIROPTEROL, V8, P523, DOI 10.3161/1733-5329(2006)8[523:EOFBOH]2.0.CO;2; Ehleringer JR, 2008, P NATL ACAD SCI USA, V105, P2788, DOI 10.1073/pnas.0712228105; Eisentraut M., 1943, Zoologischer Anzeiger Leipzig, V148, P20; Ellison L., 2008, 20081363 US GEOL SUR, P1, DOI DOI 10.3996/082012-JFWM-065/SUPPLFILE/10.3996_082012-JFWM-065.S2.PDF?C0DE=UFWS-SITE; Erzberger A, ACTA CHIROP IN PRESS; Fraser KC, 2010, BIOTROPICA, V42, P512, DOI 10.1111/j.1744-7429.2009.00608.x; Gotelli NJ, 2013, ECOSIMR 1 00; Hebert CE, 2005, WILDLIFE SOC B, V33, P92, DOI 10.2193/0091-7648(2005)33[92:FSIIWN]2.0.CO;2; Hobson KA, 2005, DIVERS DISTRIB, V11, P157, DOI 10.1111/j.1366-9516.2005.00149.x; Hobson KA, 2004, OECOLOGIA, V141, P477, DOI 10.1007/s00442-004-1671-7; Hobson KA, 1999, OECOLOGIA, V120, P397, DOI 10.1007/s004420050872; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hobson KA, 2008, TERR ECOL SER, V2, P45, DOI 10.1016/S1936-7961(07)00003-6; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; Hobson KA, 2009, J APPL ECOL, V46, P572, DOI 10.1111/j.1365-2664.2009.01651.x; Holland RA, 2009, J MAMMAL, V90, P1324, DOI 10.1644/09-MAMM-S-086R2.1; Hutterer R., 2005, BAT MIGRATIONS EUROP; Ibanez C, 2006, ACTA CHIROPTEROL, V8, P277, DOI 10.3161/1733-5329(2006)8[277:TICTCD]2.0.CO;2; Ibanez C, 2009, J MAMMAL, V90, P235, DOI 10.1644/08-MAMM-A-037.1; Juste J, 2009, HEREDITY, V103, P178, DOI 10.1038/hdy.2009.47; Kelly JF, 2002, OECOLOGIA, V130, P216, DOI 10.1007/s004420100789; Liu XZ, 2010, RAPID COMMUN MASS SP, V24, P3063, DOI 10.1002/rcm.4735; Pain DJ, 2004, OECOLOGIA, V138, P168, DOI 10.1007/s00442-003-1416-z; Perez GE, 2007, DIVERS DISTRIB, V13, P166, DOI 10.1111/j.1472-4642.2006.00306.x; Perez-Jorda JL, 1994, THESIS U SEVILLE; Popa-Lisseanu AG, 2009, J MAMMAL, V90, P1283, DOI 10.1644/09-MAMM-S-130R2.1; R Core Team, 2020, R LANG ENV STAT COMP; Reichlin TS, 2010, DIVERS DISTRIB, V16, P643, DOI 10.1111/j.1472-4642.2010.00664.x; Suits NS, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002141; Tiunov MP, 2007, ACTA CHIROPTEROL, V9, P538, DOI 10.3161/1733-5329(2007)9[538:SMIMPC]2.0.CO;2; Verbeke G., 2000, SPRINGER SERIES STAT; Wassenaar LI, 2008, TERR ECOL SER, V2, P21, DOI 10.1016/S1936-7961(07)00002-4; Wassenaar LI, 2000, ECOL APPL, V10, P911, DOI 10.1890/1051-0761(2000)010[0911:SCAHIR]2.0.CO;2; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wassenaar LI, 1998, P NATL ACAD SCI USA, V95, P15436, DOI 10.1073/pnas.95.26.15436; Wassenaar LI, 2001, ENVIRON SCI TECHNOL, V35, P1845, DOI 10.1021/es0010204; Wassenaar LI, 2000, ENVIRON SCI TECHNOL, V34, P2354, DOI 10.1021/es990804i; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Zuur Alain F., 2009, P1	51	47	47	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30388	10.1371/journal.pone.0030388	http://dx.doi.org/10.1371/journal.pone.0030388			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291947	Green Published, gold			2022-12-27	WOS:000301570600037
J	Zedek, F; Bures, P				Zedek, Frantisek; Bures, Petr			Evidence for Centromere Drive in the Holocentric Chromosomes of Caenorhabditis	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; ALIGNMENT; ORGANIZATION; SATELLITE; SEQUENCE	In monocentric organisms with asymmetric meiosis, the kinetochore proteins, such as CENH3 and CENP-C, evolve adaptively to counterbalance the deleterious effects of centromere drive, which is caused by the expansion of centromeric satellite repeats. The selection regimes that act on CENH3 and CENP-C genes have not been analyzed in organisms with holocentric chromosomes, although holocentrism is speculated to have evolved to suppress centromere drive. We tested both CENH3 and CENP-C for positive selection in several species of the holocentric genus Caenorhabditis using the maximum likelihood approach and sliding-window analysis. Although CENP-C did not show any signs of positive selection, positive selection has been detected in the case of CENH3. These results support the hypothesis that centromere drive occurs in Nematoda, at least in the telokinetic meiosis of Caenorhabditis.	[Zedek, Frantisek; Bures, Petr] Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic	Masaryk University Brno	Zedek, F (corresponding author), Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic.	fzedek@gmail.com	Zedek, Frantisek/AAD-8132-2019	Zedek, Frantisek/0000-0003-1593-1775; Bures, Petr/0000-0002-0146-956X	Czech Science Foundation [GACR 206/09/1405]; Ministry of Education, Youth and Sports of the Czech Republic [LC06073, MSM0021622416]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This study was supported by the Czech Science Foundation (project GACR 206/09/1405) and the Ministry of Education, Youth and Sports of the Czech Republic (projects LC06073 and MSM0021622416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG., 1997, CHROMOSOME ORG MITOS; Baker RE, 2006, GENETICS, V174, P1481, DOI 10.1534/genetics.106.062794; Chan RC, 2004, J CELL BIOL, V167, P613, DOI 10.1083/jcb.200408061; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; Dawe RK, 2006, TRENDS BIOCHEM SCI, V31, P662, DOI 10.1016/j.tibs.2006.10.004; Dernburg AF, 2001, J CELL BIOL, V153, pF33, DOI 10.1083/jcb.153.6.F33; Dumont J, 2010, NAT CELL BIOL, V12, P894, DOI 10.1038/ncb2093; Fishman L, 2008, SCIENCE, V322, P1559, DOI 10.1126/science.1161406; GODAY C, 1989, CHROMOSOMA, V98, P160, DOI 10.1007/BF00329679; Haizel T, 2005, CYTOGENET GENOME RES, V109, P134, DOI 10.1159/000082392; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Jiang JM, 2003, TRENDS PLANT SCI, V8, P570, DOI 10.1016/j.tplants.2003.10.011; Kiontke K, 2004, P NATL ACAD SCI USA, V101, P9003, DOI 10.1073/pnas.0403094101; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Malik HS, 2002, P NATL ACAD SCI USA, V99, P1449, DOI 10.1073/pnas.032664299; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Monen J, 2005, NAT CELL BIOL, V7, P1248, DOI 10.1038/ncb1331; Niedermaier J, 2000, CHROMOSOMA, V109, P439, DOI 10.1007/s004120000104; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Rutkowska J, 2008, PHILOS T R SOC B, V363, P1675, DOI 10.1098/rstb.2007.0006; Shakes DC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000611; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Sullivan Beth A., 2009, P45, DOI 10.1007/978-0-387-69076-6_3; Surzycki SA, 2000, P NATL ACAD SCI USA, V97, P245, DOI 10.1073/pnas.97.1.245; Talbert Paul B., 2009, P193, DOI 10.1007/978-0-387-69076-6_7; TALBERT PB, 2004, J BIOL LONDON, V3, pNIL1; Tamura K, 2011, MOL BIOL EVOLUTION; Vermaak D, 2002, MOL CELL BIOL, V22, P7553, DOI 10.1128/MCB.22.21.7553-7561.2002; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	34	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30496	10.1371/journal.pone.0030496	http://dx.doi.org/10.1371/journal.pone.0030496			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291967	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600047
J	Zhang, RY; Hummelgard, M; Olin, H				Zhang, Renyun; Hummelgard, Magnus; Olin, Hakan			Simple Fabrication of Gold Nanobelts and Patterns	PLOS ONE			English	Article							SURFACE; FILMS; NANOWIRES; GROWTH; MORPHOLOGY; SENSOR	Gold nanobelts are of interest in several areas; however, there are only few methods available to produce these belts. We report here on a simple evaporation induced self-assembly (EISA) method to produce porous gold nanobelts with dimensions that scale across nanometer (thickness similar to 80 nm) and micrometer (width similar to 20 mu m), to decimeter (length similar to 0.15 m). The gold nanobelts are well packed on the beaker wall and can be easily made to float on the surface of the solution for depositing onto other substrates. Microscopy showed that gold nanobelts had a different structure on the two sides of the belt; the density of gold nanowires on one side was greater than on the other side. Electrical measurements showed that these nanobelts were sensitive to compressive or tensile forces, indicating a potential use as a strain sensor. The patterned nanobelts were further used as a template to grow ZnO nanowires for potential use in applications such as piezo-electronics.	[Zhang, Renyun; Hummelgard, Magnus; Olin, Hakan] Mid Sweden Univ, Dept Nat Sci Engn & Math, Sundsvall, Sweden	Mid-Sweden University	Zhang, RY (corresponding author), Mid Sweden Univ, Dept Nat Sci Engn & Math, Sundsvall, Sweden.	renyun.zhang@miun.se	Olin, Håkan/A-8175-2008; Zhang, Renyun/C-6617-2009	Olin, Håkan/0000-0001-7329-3359; Zhang, Renyun/0000-0003-2873-7875; Hummelgard, Magnus/0000-0001-9137-3440	Sundsvall Community; European Regional Development Fund through the project Energywise [00159526]	Sundsvall Community; European Regional Development Fund through the project Energywise	The project was supported by the Sundsvall Community through a fellowship for RYZ, and also part-financed by the European Regional Development Fund through the project Energywise (00159526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI E, 1995, LANGMUIR, V11, P1057, DOI 10.1021/la00004a003; Chen Y, 2008, NANO LETT, V8, P737, DOI 10.1021/nl0725852; Chen Y, 2009, J MATER CHEM, V19, P924, DOI 10.1039/b816897k; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Doerk GS, 2008, J MATER CHEM, V18, P5376, DOI 10.1039/b811535d; Eustis S, 2009, J PHYS CHEM C, V113, P2277, DOI 10.1021/jp808129j; Ferralis N, 2007, J PHYS CHEM C, V111, P7508, DOI 10.1021/jp071105s; Kang IP, 2006, SMART MATER STRUCT, V15, P737, DOI 10.1088/0964-1726/15/3/009; Kondo Y, 2000, SCIENCE, V289, P606, DOI 10.1126/science.289.5479.606; Kondo Y, 1999, PHYS REV LETT, V82, P751, DOI 10.1103/PhysRevLett.82.751; Li LS, 2010, LANGMUIR, V26, P12330, DOI 10.1021/la1015737; Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120; Paulose M, 2003, J NANOSCI NANOTECHNO, V3, P341, DOI 10.1166/jnn.2003.209; Shmuylovich L, 2002, LANGMUIR, V18, P3441, DOI 10.1021/la011484v; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Tessier PM, 2000, J AM CHEM SOC, V122, P9554, DOI 10.1021/ja0022831; Wang XD, 2006, NANO LETT, V6, P2768, DOI 10.1021/nl061802g; Wang ZL, 2010, NANO TODAY, V5, P540, DOI 10.1016/j.nantod.2010.10.008; Zhang JH, 2007, ADV FUNCT MATER, V17, P1558, DOI 10.1002/adfm.200600727; Zhang JL, 2006, ANGEW CHEM INT EDIT, V45, P1116, DOI 10.1002/anie.200503762; Zhang RY, 2010, PHYSICA B, V405, P4517, DOI 10.1016/j.physb.2010.08.029; Zhang RY, 2009, J COLLOID INTERF SCI, V340, P58, DOI 10.1016/j.jcis.2009.08.006; Zhao N, 2008, LANGMUIR, V24, P991, DOI 10.1021/la702848x	23	6	6	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30469	10.1371/journal.pone.0030469	http://dx.doi.org/10.1371/journal.pone.0030469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291962	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600045
J	Belton, A; Gabrovsky, A; Bae, YK; Reeves, R; Iacobuzio-Donahue, C; Huso, DL; Resar, LMS				Belton, Amy; Gabrovsky, Alexander; Bae, Young Kyung; Reeves, Ray; Iacobuzio-Donahue, Christine; Huso, David L.; Resar, Linda M. S.			HMGA1 Induces Intestinal Polyposis in Transgenic Mice and Drives Tumor Progression and Stem Cell Properties in Colon Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION; MESENCHYMAL TRANSITION; TRANSFORMATION; LOCALIZATION; PROTEINS; SEQUENCE; GROWTH; AKNA; I/Y	Background: Although metastatic colon cancer is a leading cause of cancer death worldwide, the molecular mechanisms that enable colon cancer cells to metastasize remain unclear. Emerging evidence suggests that metastatic cells develop by usurping transcriptional networks from embryonic stem (ES) cells to facilitate an epithelial-mesenchymal transition (EMT), invasion, and metastatic progression. Previous studies identified HMGA1 as a key transcription factor enriched in ES cells, colon cancer, and other aggressive tumors, although its role in these settings is poorly understood. Methods/Principal Findings: To determine how HMGA1 functions in metastatic colon cancer, we manipulated HMGA1 expression in transgenic mice and colon cancer cells. We discovered that HMGA1 drives proliferative changes, aberrant crypt formation, and intestinal polyposis in transgenic mice. In colon cancer cell lines from poorly differentiated, metastatic tumors, knock-down of HMGA1 blocks anchorage-independent cell growth, migration, invasion, xenograft tumorigenesis and three-dimensional colonosphere formation. Inhibiting HMGA1 expression blocks tumorigenesis at limiting dilutions, consistent with depletion of tumor-initiator cells in the knock-down cells. Knock-down of HMGA1 also inhibits metastatic progression to the liver in vivo. In metastatic colon cancer cells, HMGA1 induces expression of Twist1, a gene involved in embryogenesis, EMT, and tumor progression, while HMGA1 represses E-cadherin, a gene that is down-regulated during EMT and metastatic progression. In addition, HMGA1 is among the most enriched genes in colon cancer compared to normal mucosa. Conclusions: Our findings demonstrate for the first time that HMGA1 drives proliferative changes and polyp formation in the intestines of transgenic mice and induces metastatic progression and stem-like properties in colon cancer cells. These findings indicate that HMGA1 is a key regulator, both in metastatic progression and in the maintenance of a stem-like state. Our results also suggest that HMGA1 or downstream pathways could be rational therapeutic targets in metastatic, poorly differentiated colon cancer.	[Belton, Amy; Gabrovsky, Alexander; Resar, Linda M. S.] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA; [Bae, Young Kyung] Yeungnam Univ, Coll Med, Dept Pathol, Taegu, South Korea; [Reeves, Ray] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Iacobuzio-Donahue, Christine; Huso, David L.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Iacobuzio-Donahue, Christine; Huso, David L.; Resar, Linda M. S.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Huso, David L.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Resar, Linda M. S.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Yeungnam University; Washington State University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Belton, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA.	lresar@jhmi.edu	Iacobuzio-Donahue, Christine/ABF-1295-2020	Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Gabrovsky, Alexander/0000-0002-5057-4358; Bae, Young Kyung/0000-0002-6689-9413	National Institutes of Health (NIH) [RO1CA092339, R21CA2149550, NIH T32HL007525]; Maryland Stem Cell Research Fund; NATIONAL CANCER INSTITUTE [R01CA092339] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007525] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding came from The National Institutes of Health (NIH) RO1CA092339 and R21CA2149550 to L. Resar, NIH T32HL007525 to A. Belton, and the Maryland Stem Cell Research Fund to L. Resar and A. Belton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Botchkina Inna L., 2009, Cancer Genomics & Proteomics, V6, P19; Chiappetta G, 1996, ONCOGENE, V13, P2439; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Dhar A, 2004, ONCOGENE, V23, P4466, DOI 10.1038/sj.onc.1207581; Di Cello F, 2008, MOL CANCER THER, V7, P2090, DOI 10.1158/1535-7163.MCT-07-2282; Di Cello F, 2008, MOL CANCER RES, V6, P743, DOI 10.1158/1541-7786.MCR-07-0095; Dolde CE, 2002, BREAST CANCER RES TR, V71, P181, DOI 10.1023/A:1014444114804; Ericson K, 2010, P NATL ACAD SCI USA, V107, P2598, DOI 10.1073/pnas.0914018107; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fedele M, 2005, ONCOGENE, V24, P3427, DOI 10.1038/sj.onc.1208501; FRIEDMANN M, 1993, NUCLEIC ACIDS RES, V21, P4259, DOI 10.1093/nar/21.18.4259; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Hillion J, 2009, MOL CANCER RES, V7, P1803, DOI 10.1158/1541-7786.MCR-08-0336; Hillion J, 2008, CANCER RES, V68, P10121, DOI 10.1158/0008-5472.CAN-08-2121; Hock R, 2007, TRENDS CELL BIOL, V28, P7394; Hommura F, 2004, MOL CANCER RES, V2, P305; Hristov A, 2010, MODERN PATHOL, V22, P43; Hristov AC, 2009, MODERN PATHOL, V22, P43, DOI 10.1038/modpathol.2008.140; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; JOHNSON KR, 1992, GENOMICS, V12, P503, DOI 10.1016/0888-7543(92)90441-T; JOHNSON KR, 1988, J BIOL CHEM, V263, P18338; Karp JE, 2011, BLOOD, V117, P3302, DOI 10.1182/blood-2010-09-310862; Kim DH, 1999, INT J CANCER, V84, P376, DOI 10.1002/(SICI)1097-0215(19990820)84:4<376::AID-IJC8>3.0.CO;2-N; Liau SS, 2006, CANCER RES, V66, P11613, DOI 10.1158/0008-5472.CAN-06-1460; Ma WB, 2011, CELL RES, V21, P1564, DOI 10.1038/cr.2011.84; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Moliterno AR, 2011, CELL RES, V21, P1528, DOI 10.1038/cr.2011.96; Nelson DM, 2011, LEUK LYMPHOMA; Pedulla ML, 2001, GENE, V271, P51, DOI 10.1016/S0378-1119(01)00500-5; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Reeves R, 2001, MOL CELL BIOL, V21, P575, DOI 10.1128/MCB.21.2.575-594.2001; Resar LM, 2011, BLOOD, V117, P5788, DOI 10.1182/blood-2011-04-346668; Resar LMS, 2010, CANCER RES, V70, P436, DOI 10.1158/0008-5472.CAN-09-1212; Schuldenfrei A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-549; Shah S, 2011, HISTOL HIST IN PRESS; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Takaha N, 2004, PROSTATE, V60, P160, DOI 10.1002/pros.20049; Tesfaye A, 2007, HIGH MOBILITY GROUP, V9, P3998; Wood LJ, 2000, MOL CELL BIOL, V20, P5490, DOI 10.1128/MCB.20.15.5490-5502.2000; Wood LJ, 2000, CANCER RES, V60, P4256; Xu Y, 2004, CANCER RES, V64, P3371, DOI 10.1158/0008-5472.CAN-04-0044; Zhou GL, 2001, P NATL ACAD SCI USA, V98, P13966, DOI 10.1073/pnas.241526198	43	87	94	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30034	10.1371/journal.pone.0030034	http://dx.doi.org/10.1371/journal.pone.0030034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276142	Green Published, gold, Green Submitted			2022-12-27	WOS:000301568100022
J	Riuzzi, F; Sorci, G; Beccafico, S; Donato, R				Riuzzi, Francesca; Sorci, Guglielmo; Beccafico, Sara; Donato, Rosario			S100B Engages RAGE or bFGF/FGFR1 in Myoblasts Depending on Its Own Concentration and Myoblast Density. Implications for Muscle Regeneration	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; SKELETAL-MUSCLE; MYOGENIC DIFFERENTIATION; P38-ALPHA/BETA MAPK; MYOTUBE FORMATION; M-CADHERIN; P38 MAPK; RECEPTOR; PROTEIN; PROLIFERATION	In high-density myoblast cultures S100B enhances basic fibroblast growth factor (bFGF) receptor 1 (FGFR1) signaling via binding to bFGF and blocks its canonical receptor, receptor for advanced glycation end-products (RAGE), thereby stimulating proliferation and inhibiting differentiation. Here we show that upon skeletal muscle injury S100B is released from myofibers with maximum release at day 1 post-injury in coincidence with satellite cell activation and the beginning of the myoblast proliferation phase, and declining release thereafter in coincidence with reduced myoblast proliferation and enhanced differentiation. By contrast, levels of released bFGF are remarkably low at day 1 post-injury, peak around day 5 and decline thereafter. We also show that in low-density myoblast cultures S100B binds RAGE, but not bFGF/FGFR1 thereby simultaneously stimulating proliferation via ERK1/2 and activating the myogenic program via p38 MAPK. Clearance of S100B after a 24-h treatment of low-density myoblasts results in enhanced myotube formation compared with controls as a result of increased cell numbers and activated myogenic program, whereas chronic treatment with S100B results in stimulation of proliferation and inhibition of differentiation due to a switch of the initial low-density culture to a high-density culture. However, at relatively high doses, S100B stimulates the mitogenic bFGF/FGFR1 signaling in low-density myoblasts, provided bFGF is present. We propose that S100B is a danger signal released from injured muscles that participates in skeletal muscle regeneration by activating the promyogenic RAGE or the mitogenic bFGF/FGFR1 depending on its own concentration, the absence or presence of bFGF, and myoblast density.	[Riuzzi, Francesca] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; Univ Perugia, Ist Interuniv Miol, I-06100 Perugia, Italy	University of Perugia; University of Perugia	Riuzzi, F (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy.	donato@unipg.it	Donato, Rosario/I-3943-2019	Sorci, Guglielmo/0000-0002-1973-9679; Riuzzi, Francesca/0000-0001-7908-3379	Ministero dell'Universita e della Ricerca [2004054293, 2007LNKSYS, 2007AWZTHH_004, 2009WBFZYM_002]; Association Francaise contre les Myopathies [12992]; Associazione Italiana per la Ricerca sul Cancro [Associazione Italiana per la Ricerca sul Cancro (Project 6021]; Fondazione Cassa di Risparmio di Perugia [2007.0218.020, 2009.020.0021]; POR UMBRIA FSE	Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia); POR UMBRIA FSE	This work was supported by Ministero dell'Universita e della Ricerca (PRIN 2004054293, 2007LNKSYS, 2007AWZTHH_004 and 2009WBFZYM_002), Association Francaise contre les Myopathies (Project 12992), Associazione Italiana per la Ricerca sul Cancro (Project 6021) and Fondazione Cassa di Risparmio di Perugia (2007.0218.020 and 2009.020.0021) funds. SB is a recipient of a fellowship from POR UMBRIA FSE 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcuri C, 2002, NEUROSCIENCE, V109, P371, DOI 10.1016/S0306-4522(01)00330-X; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bianchi R, 2011, J BIOL CHEM, V286, P7214, DOI 10.1074/jbc.M110.169342; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; CALDWELL CJ, 1990, NEUROPATH APPL NEURO, V16, P225, DOI 10.1111/j.1365-2990.1990.tb01159.x; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Charrasse S, 2007, MOL BIOL CELL, V18, P1734, DOI 10.1091/mbc.E06-08-0766; CHEN G, 1992, J CELL PHYSIOL, V153, P563, DOI 10.1002/jcp.1041530318; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; de Angelis L, 2005, DEV BIOL, V283, P171, DOI 10.1016/j.ydbio.2005.04.009; De Mori R, 2007, ARTERIOSCL THROM VAS, V27, P2377, DOI 10.1161/ATVBAHA.107.153429; DONATO R, 1988, J BIOL CHEM, V263, P106; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Galbiati F, 1999, J BIOL CHEM, V274, P30315, DOI 10.1074/jbc.274.42.30315; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Lovett FA, 2006, J CELL SCI, V119, P4828, DOI 10.1242/jcs.03278; Ma WC, 2007, INVEST OPHTH VIS SCI, V48, P1355, DOI 10.1167/iovs.06-0738; Neville C, 1997, METHOD CELL BIOL, V52, P85, DOI 10.1016/S0091-679X(08)60375-1; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Rauvala H, 2007, CURR MOL MED, V7, P725, DOI 10.2174/156652407783220750; Riuzzi F, 2006, J CELL PHYSIOL, V207, P461, DOI 10.1002/jcp.20580; Riuzzi F, 2006, J BIOL CHEM, V281, P8242, DOI 10.1074/jbc.M509436200; Riuzzi F, 2011, J CELL SCI IN PRESS; Riuzzi F, 2007, AM J PATHOL, V171, P947, DOI 10.2353/ajpath.2007.070049; Riuzzi F, 2011, J CELL SCI, V124, P2389, DOI 10.1242/jcs.084491; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sorci G, 2004, MOL CELL BIOL, V24, P4880, DOI 10.1128/MCB.24.11.4880-4894.2004; Sorci G, 2003, MOL CELL BIOL, V23, P4870, DOI 10.1128/MCB.23.14.4870-4881.2003; Steiner J, 2011, BRAIN BEHAV IMMUN, V25, P1233, DOI 10.1016/j.bbi.2011.03.015; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Tubaro C, 2010, J CELL PHYSIOL, V223, P270, DOI 10.1002/jcp.22035; Winter B, 2000, J CELL SCI, V113, P4211; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; ZESCHNIGK M, 1995, J CELL SCI, V108, P2973	47	34	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e28700	10.1371/journal.pone.0028700	http://dx.doi.org/10.1371/journal.pone.0028700			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276098	gold, Green Submitted, Green Published			2022-12-27	WOS:000301568100004
J	Liang, Y; Gong, YH; Wen, XP; Guan, CP; Li, MC; Yin, P; Wang, ZQ				Liang, Yuan; Gong, Yan-Hong; Wen, Xiao-Piao; Guan, Chao-Ping; Li, Ming-Chuan; Yin, Ping; Wang, Zhi-Qing			Social Determinants of Health and Depression: A Preliminary Investigation from Rural China	PLOS ONE			English	Article							MENTAL-HEALTH; RISK-FACTORS; REPRESENTATIVE SAMPLE; PRIMARY-CARE; ILLNESS; EQUITY; NEED; EXPERIENCE; CHALLENGE; ATTITUDES	Background: In the last several years, research related to social determinants of health (SDH) has begun to resonate in the medical, behavioral, social and political sciences arena. The aim of the present study was to explore the relationship between SDH and depression, and to provide new evidences and clues for depression control and prevention. Methodology/Principal Findings: This research was a cross-sectional survey executed door to door from October 2006 to April 2008, with a sample of 3,738 individuals aged 18 and older in rural China. The three variables of SDH were socioeconomic status (years of schooling and self-reported economic status of family), social cohesion and negative life events. Demographic variables and self-perceived physical health were taken as potential confounders. The cross-table analysis showed that variations in levels of depression were associated with variations in SDH, and logistic regression analysis confirmed the association even after adjusting for potential confounding variables. Conclusions: Although there were some limitations, the current study provides initial evidence of the importance of SDH in depression. Findings indicate that social inequity and the role of policy action emphasized by SDH should be considered high priorities when addressing the issue of depression. In addition, cell-to-society and pill-to-policy approaches should be encouraged in the future.	[Liang, Yuan; Gong, Yan-Hong; Wen, Xiao-Piao; Guan, Chao-Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Social Med & Hlth Management, Wuhan 430074, Peoples R China; [Li, Ming-Chuan; Yin, Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Wang, Zhi-Qing] Beijing Hui Long Guan Hosp, World Hlth Org, Suicide Res & Training Ctr, Dept Clin Epidemiol, Beijing, Peoples R China; [Wang, Zhi-Qing] Beijing Hui Long Guan Hosp, Beijing Suicide Res & Prevent Ctr, Beijing, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; World Health Organization	Liang, Y (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Social Med & Hlth Management, Wuhan 430074, Peoples R China.	ping_y2000@163.com	龚, 言红/N-8912-2013		China Medical Board of New York, CMB [05-813]	China Medical Board of New York, CMB	This study was supported by grants from China Medical Board of New York, CMB (No 05-813). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson D., 1998, INDEPENDENT INQUIRY; Alonso Y, 2004, PATIENT EDUC COUNS, V53, P239, DOI 10.1016/S0738-3991(03)00146-0; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; ATKINSON DR, 1989, J COUNS PSYCHOL, V36, P209, DOI 10.1037/0022-0167.36.2.209; Baum FE, 2009, AM J PUBLIC HEALTH, V99, P1967, DOI 10.2105/AJPH.2008.154856; Beck AT, 1996, PSYCHOL ASSESS; Beydoun MA, 2010, J AFFECT DISORDERS, V123, P52, DOI 10.1016/j.jad.2009.09.021; Boyce CA, 2011, AM J PREV MED, V40, pS86, DOI 10.1016/j.amepre.2010.10.006; Braveman PA, 2011, AM J PREV MED, V40, pS4, DOI 10.1016/j.amepre.2010.10.002; Chen Hongtu, 2005, J Immigr Health, V7, P109, DOI 10.1007/s10903-005-2644-6; CHEUNG FM, 1982, COMPR PSYCHIAT, V23, P252, DOI 10.1016/0010-440X(82)90073-6; Department of Health Social Security, 1980, WORK GROUP IN HLTH I; Emerson E, 2011, PUBLIC HEALTH, V125, P145, DOI 10.1016/j.puhe.2010.11.003; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Fung KMT, 2007, INT J SOC PSYCHIATR, V53, P408, DOI 10.1177/0020764007078342; Gadit AAM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000209; Garland EL, 2009, HEALTH SOC WORK, V34, P191, DOI 10.1093/hsw/34.3.191; [桂立辉 Gui Lihui], 2010, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V18, P206; Heun R, 2005, EUR PSYCHIAT, V20, P199, DOI 10.1016/j.eurpsy.2004.09.036; Hiatt RA, 2008, AM J PREV MED, V35, pS141, DOI 10.1016/j.amepre.2008.05.006; Inoue A, 2010, SOC SCI MED, V71, P173, DOI 10.1016/j.socscimed.2010.02.047; IPBES (Intergovernmental Panel on Biodiversity and Ecosystems), 2021, POLICY DISCUSSION PA; Johnson S, 2008, LANCET, V372, P1690, DOI 10.1016/S0140-6736(08)61694-3; Karasz A, 2005, SOC SCI MED, V60, P1625, DOI 10.1016/j.socscimed.2004.08.011; Karasz A, 2008, TRANSCULT PSYCHIATRY, V45, P415, DOI 10.1177/1363461508094674; Kleinman A., 1988, SOCIAL ORIGINS DISTR; Koster A, 2006, J PSYCHOSOM RES, V61, P619, DOI 10.1016/j.jpsychores.2006.05.009; Lauder W, 2007, J PSYCHIATR MENT HLT, V14, P661, DOI 10.1111/j.1365-2850.2007.01156.x; Liu S, 2011, PUBLIC HEALTH, V125, P669, DOI 10.1016/j.puhe.2011.08.004; Liu YL, 1999, SOC SCI MED, V49, P1349, DOI 10.1016/S0277-9536(99)00207-5; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; McKenzie K, 2002, BRIT J PSYCHIAT, V181, P280, DOI 10.1192/bjp.181.4.280; Miller W, HLTH CARE NEW DIRECT; Myer L, 2008, SOC SCI MED, V66, P1828, DOI 10.1016/j.socscimed.2008.01.025; Oldenburg B, 2000, MED J AUSTRALIA, V172, P489, DOI 10.5694/j.1326-5377.2000.tb124074.x; Osborn DPJ, 2003, INT J GERIATR PSYCH, V18, P623, DOI 10.1002/gps.896; Phillips M.R., 2004, CHIN J NERV MENT DIS, V30, P1; Phillips MR, 2002, LANCET, V360, P1728, DOI 10.1016/S0140-6736(02)11681-3; Raphael D, 2008, HEALTH POLICY, V88, P222, DOI 10.1016/j.healthpol.2008.03.015; Sacker A, 2009, PSYCHOSOM MED, V71, P763, DOI 10.1097/PSY.0b013e3181b1e45e; Salokangas RKR, 1998, J AFFECT DISORDERS, V48, P171, DOI 10.1016/S0165-0327(97)00171-7; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD; Siegrist J, 2008, INT J PUBLIC HEALTH, V53, P277, DOI 10.1007/s00038-008-8139-1; Smedley BD, 2000, PROMOTING HLTH INTER; Stewart DE, 2007, J PSYCHOSOM RES, V63, P223, DOI 10.1016/j.jpsychores.2007.07.002; Tarlov AR., 1996, HLTH SOCIAL ORG HLTH; Tsang HWH, 2003, J COMMUNITY PSYCHOL, V31, P383, DOI 10.1002/jcop.10055; Xanthos C, 2010, J MENS HEALTH, V7, P11, DOI 10.1016/j.jomh.2009.12.002; Yeung A, 2004, J NERV MENT DIS, V192, P324, DOI 10.1097/01.nmd.0000120892.96624.00	49	25	25	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30553	10.1371/journal.pone.0030553	http://dx.doi.org/10.1371/journal.pone.0030553			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	907YS	22276213	gold, Green Published, Green Submitted			2022-12-27	WOS:000301457200067
J	Rahman, MN; Vlahakis, JZ; Vukomanovic, D; Lee, W; Szarek, WA; Nakatsu, K; Jia, ZC				Rahman, Mona N.; Vlahakis, Jason Z.; Vukomanovic, Dragic; Lee, Wallace; Szarek, Walter A.; Nakatsu, Kanji; Jia, Zongchao			A Novel, "Double-Clamp'' Binding Mode for Human Heme Oxygenase-1 Inhibition	PLOS ONE			English	Article							IMIDAZOLE-DIOXOLANE COMPOUNDS; RAY CRYSTAL-STRUCTURE; THIOL/DISULFIDE REDOX SWITCH; NITRIC-OXIDE SYNTHASE; REGULATORY MOTIFS; MONOXIDE; METALLOPORPHYRINS; ANTIOXIDANT; EXPRESSION; COMPLEX	The development of heme oxygenase (HO) inhibitors is critical in dissecting and understanding the HO system and for potential therapeutic applications. We have established a program to design and optimize HO inhibitors using structure-activity relationships in conjunction with X-ray crystallographic analyses. One of our previous complex crystal structures revealed a putative secondary hydrophobic binding pocket which could be exploited for a new design strategy by introducing a functional group that would fit into this potential site. To test this hypothesis and gain further insights into the structural basis of inhibitor binding, we have synthesized and characterized 1-(1H-imidazol-1-yl)-4,4-diphenyl-2-butanone (QC-308). Using a carbon monoxide (CO) formation assay on rat spleen microsomes, the compound was found to be similar to 15 times more potent (IC50 = 0.27 +/- 0.07 mu M) than its monophenyl analogue, which is already a potent compound in its own right (QC-65; IC50 = 4.0 +/- 1.8 mu M). The crystal structure of hHO-1 with QC-308 revealed that the second phenyl group in the western region of the compound is indeed accommodated by a definitive secondary proximal hydrophobic pocket. Thus, the two phenyl moieties are each stabilized by distinct hydrophobic pockets. This "double-clamp'' binding offers additional inhibitor stabilization and provides a new route for improvement of human heme oxygenase inhibitors.	[Rahman, Mona N.; Vukomanovic, Dragic; Lee, Wallace; Nakatsu, Kanji; Jia, Zongchao] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Vlahakis, Jason Z.; Szarek, Walter A.] Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Rahman, MN (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	jia@queensu.ca	Rahman, Mona/GRF-6475-2022	Rahman, Mona Naeema/0000-0002-9782-0173	Canadian Institute of Health Research [CIHR MOP-64305, CIHR MOP-77810]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institute of Health Research (http://www.cihr-irsc.gc.ca, CIHR MOP-64305, CIHR MOP-77810). Dr. Zongchao Jia is a Killam Research Fellow and holds a Canada Research Chair in Structural Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton SD, 1999, DRUG METAB DISPOS, V27, P1214; Asad SF, 2001, CHEM-BIOL INTERACT, V137, P59, DOI 10.1016/S0009-2797(01)00209-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; Bianchetti CM, 2007, J BIOL CHEM, V282, P37624, DOI 10.1074/jbc.M707396200; COOK MN, 1995, CAN J PHYSIOL PHARM, V73, P515, DOI 10.1139/y95-065; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denagel D. C., 1998, Society for Neuroscience Abstracts, V24, P2058; Di Francesco L, 2009, CIRC RES, V104, P506, DOI 10.1161/CIRCRESAHA.108.191114; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farrera J A, 1994, Bioorg Med Chem, V2, P181, DOI 10.1016/S0968-0896(00)82013-1; Gardner JD, 2010, J BIOL INORG CHEM, V15, P1117, DOI 10.1007/s00775-010-0672-8; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Grundemar L, 1997, TRENDS PHARMACOL SCI, V18, P193, DOI 10.1016/S0165-6147(97)90622-2; Hayashi S, 2004, GENE, V336, P241, DOI 10.1016/j.gene.2004.04.002; Huang TJ, 2001, ANTIOXID REDOX SIGN, V3, P685, DOI 10.1089/15230860152543023; Huber WJ, 2007, BIOCHEMISTRY-US, V46, P12212, DOI 10.1021/bi701496z; Huber WJ, 2009, DRUG METAB DISPOS, V37, P857, DOI 10.1124/dmd.108.025023; Huber WJ, 2009, BIOCHEMISTRY-US, V48, P190, DOI 10.1021/bi801912z; Hum M, 2010, J PHARMACOL EXP THER, V334, P981, DOI 10.1124/jpet.110.168492; Imuta N, 2007, ANTIOXID REDOX SIGN, V9, P543, DOI 10.1089/ars.2006.1519; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kinobe RT, 2006, BRIT J PHARMACOL, V147, P307, DOI 10.1038/sj.bjp.0706555; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lad L, 2003, J BIOL CHEM, V278, P7834, DOI 10.1074/jbc.M211450200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee TS, 2003, J BIOL CHEM, V278, P19325, DOI 10.1074/jbc.M300498200; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; LUO DS, 1994, EUR J PHARM-MOLEC PH, V267, P263, DOI 10.1016/0922-4106(94)90149-X; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Maines MD, 1996, UROLOGY, V47, P727, DOI 10.1016/S0090-4295(96)00010-6; McCoubrey WK, 1997, J BIOL CHEM, V272, P12568, DOI 10.1074/jbc.272.19.12568; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEFFERT MK, 1994, NEURON, V13, P1225, DOI 10.1016/0896-6273(94)90060-4; Minetti M, 1998, ARCH BIOCHEM BIOPHYS, V352, P165, DOI 10.1006/abbi.1998.0584; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nowis D, 2006, ONCOGENE, V25, P3365, DOI 10.1038/sj.onc.1209378; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Rahman MN, 2008, J MED CHEM, V51, P5943, DOI 10.1021/jm800505m; Rahman MN, 2010, J INORG BIOCHEM, V104, P324, DOI 10.1016/j.jinorgbio.2009.10.011; Rahman MN, 2009, J MED CHEM, V52, P4946, DOI 10.1021/jm900434f; Roman G, 2007, BIOORGAN MED CHEM, V15, P3225, DOI 10.1016/j.bmc.2007.02.034; Roman G, 2010, CHEM BIOL DRUG DES, V75, P68, DOI 10.1111/j.1747-0285.2009.00909.x; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schuller DJ, 1998, PROTEIN SCI, V7, P1836, DOI 10.1002/pro.5560070820; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sugishima M, 2007, BIOCHEMISTRY-US, V46, P1860, DOI 10.1021/bi062264p; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Vlahakis JZ, 2006, J MED CHEM, V49, P4437, DOI 10.1021/jm0511435; Vlahakis JZ, 2011, J PHARMACOL TOX MET, V63, P79, DOI 10.1016/j.vascn.2010.05.015; Vlahakis JZ, 2009, BIOORGAN MED CHEM, V17, P2461, DOI 10.1016/j.bmc.2009.01.078; Vlahakis JZ, 2005, BIOORG MED CHEM LETT, V15, P1457, DOI 10.1016/j.bmcl.2004.12.075; VREMAN HJ, 1988, ANAL BIOCHEM, V168, P31, DOI 10.1016/0003-2697(88)90006-1; Vreman HJ, 2002, CARBON MONOXIDE CARD; Vukomanovic D, 2010, CAN J PHYSIOL PHARM, V88, P480, DOI [10.1139/Y10-004, 10.1139/y10-004]; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; Yi L, 2009, J BIOL CHEM, V284, P20556, DOI 10.1074/jbc.M109.015651	60	21	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29514	10.1371/journal.pone.0029514	http://dx.doi.org/10.1371/journal.pone.0029514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276118	Green Published, gold, Green Submitted			2022-12-27	WOS:000301457200016
J	Verdoodt, F; Willems, M; Mouton, S; De Mulder, K; Bert, W; Houthoofd, W; Smith, J; Ladurner, P				Verdoodt, Freija; Willems, Maxime; Mouton, Stijn; De Mulder, Katrien; Bert, Wim; Houthoofd, Wouter; Smith, Julian, III; Ladurner, Peter			Stem Cells Propagate Their DNA by Random Segregation in the Flatworm Macrostomum lignano	PLOS ONE			English	Article							LABEL-RETAINING CELLS; IMMORTAL STRAND HYPOTHESIS; SELF-RENEWAL; SELECTIVE SEGREGATION; REGENERATION; PROLIFERATION; PLANARIAN; QUIESCENT; NICHES; CYCLE	Adult stem cells are proposed to have acquired special features to prevent an accumulation of DNA-replication errors. Two such mechanisms, frequently suggested to serve this goal are cellular quiescence, and non-random segregation of DNA strands during stem cell division, a theory designated as the immortal strand hypothesis. To date, it has been difficult to test the in vivo relevance of both mechanisms in stem cell systems. It has been shown that in the flatworm Macrostomum lignano pluripotent stem cells (neoblasts) are present in adult animals. We sought to address by which means M. lignano neoblasts protect themselves against the accumulation of genomic errors, by studying the exact mode of DNA-segregation during their division. In this study, we demonstrated four lines of in vivo evidence in favor of cellular quiescence. Firstly, performing BrdU pulse-chase experiments, we localized ` Label-Retaining Cells' (LRCs). Secondly, EDU pulse-chase combined with Vasa labeling demonstrated the presence of neoblasts among the LRCs, while the majority of LRCs were differentiated cells. We showed that stem cells lose their label at a slow rate, indicating cellular quiescence. Thirdly, CldU/ IdU2 double labeling studies confirmed that label-retaining stem cells showed low proliferative activity. Finally, the use of the actin inhibitor, cytochalasin D, unequivocally demonstrated random segregation of DNA-strands in LRCs. Altogether, our data unambiguously demonstrated that the majority of neoblasts in M. lignano distribute their DNA randomly during cell division, and that label-retention is a direct result of cellular quiescence, rather than a sign of co-segregation of labeled strands.	[Verdoodt, Freija; Bert, Wim; Houthoofd, Wouter] Univ Ghent, Dept Biol, Nematol Unit, B-9000 Ghent, Belgium; [Willems, Maxime] Univ Ghent, Dept Pharmaceut, Lab Pharmaceut Technol, B-9000 Ghent, Belgium; [Mouton, Stijn] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Mouton, Stijn] Univ Med Ctr Utrecht, Utrecht, Netherlands; [De Mulder, Katrien] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium; [Smith, Julian, III] Winthrop Univ, Dept Biol, Rock Hill, SC 29733 USA; [Ladurner, Peter] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; [Ladurner, Peter] Univ Innsbruck, CMBI, A-6020 Innsbruck, Austria	Ghent University; Ghent University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Ghent University; University of Innsbruck; University of Innsbruck	Verdoodt, F (corresponding author), Univ Ghent, Dept Biol, Nematol Unit, B-9000 Ghent, Belgium.	peter.ladurner@uibk.ac.at	Bert, Wim/D-4511-2013	Bert, Wim/0000-0002-5864-412X; Verdoodt, Freija/0000-0002-8243-697X; Ladurner, Peter/0000-0002-0323-9266; Mouton, Stijn/0000-0002-1123-6268	(Institute for the Promotion of Innovation through Science and Technology in Flanders, IWTVlaanderen); FWF (Austria) [18099]	(Institute for the Promotion of Innovation through Science and Technology in Flanders, IWTVlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); FWF (Austria)(Austrian Science Fund (FWF))	This work was supported by an IWT doctoral grant (Institute for the Promotion of Innovation through Science and Technology in Flanders, IWTVlaanderen) to FV, MW and SM, and by FWF grant 18099 to PL (Austria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Agata K, 2003, CURR OPIN GENET DEV, V13, P492, DOI 10.1016/j.gde.2003.08.009; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alison MR, 2009, J PATHOL, V217, P144, DOI 10.1002/path.2498; Alvarado AS, 2004, PHILOS T R SOC B, V359, P759, DOI 10.1098/rstb.2004.1465; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Armakolas A, 2006, SCIENCE, V311, P1146, DOI 10.1126/science.1120519; BAGUNA J, 1981, NATURE, V290, P14, DOI 10.1038/290014b0; BAGUNA J, 1981, HYDROBIOLOGIA, V84, P181, DOI 10.1007/BF00026179; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Bode A, 2006, CELL TISSUE RES, V325, P577, DOI 10.1007/s00441-006-0196-2; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Cairns J, 2006, GENETICS, V174, P1069, DOI 10.1534/genetics.104.66886; Clayton JE, 2008, DEV BIOL, V313, P603, DOI 10.1016/j.ydbio.2007.10.051; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; De Mulder K, 2010, CELL TISSUE RES, V339, P527, DOI 10.1007/s00441-009-0915-6; De Mulder K, 2009, DEV BIOL, V334, P198, DOI 10.1016/j.ydbio.2009.07.019; DUBOIS F, 1948, CR SOC BIOL, V142, P699; Egger B, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-41; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Handberg-Thorsager M, 2008, FRONT BIOSCI-LANDMRK, V13, P6374, DOI 10.2741/3160; Joseph NM, 2005, DEV CELL, V9, P173, DOI 10.1016/j.devcel.2005.07.001; Karpowicz P, 2005, J CELL BIOL, V170, P721, DOI 10.1083/jcb.200502073; Karpowicz P, 2009, EUR J CELL BIOL, V88, P397, DOI 10.1016/j.ejcb.2009.03.001; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; KUROKI T, 1989, JPN J CANCER RES, V80, P637, DOI 10.1111/j.1349-7006.1989.tb01690.x; Ladurner P, 2000, DEV BIOL, V226, P231, DOI 10.1006/dbio.2000.9867; Ladurner Peter, 2008, P75, DOI 10.1007/978-1-4020-8274-0_5; LANGE CS, 1968, EXP GERONTOL, V3, P219, DOI 10.1016/0531-5565(68)90005-3; LANGE CS, 1968, INT J RADIAT BIOL RE, V14, P373, DOI 10.1080/09553006814551221; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Mouton S, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-15; Mouton S, 2009, EXP GERONTOL, V44, P243, DOI 10.1016/j.exger.2008.11.007; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Nimeth KT, 2004, DEV DYNAM, V230, P91, DOI 10.1002/dvdy.20035; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pfister D, 2008, DEV BIOL, V319, P146, DOI 10.1016/j.ydbio.2008.02.045; Pfister D, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-9; Potten CS, 2002, J CELL SCI, V115, P2381; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Rieger R, 1988, FORTSCHR ZOOL, V36, P525; Rossi L, 2008, CELL MOL LIFE SCI, V65, P16, DOI 10.1007/s00018-007-7426-y; Scharer L, 2007, ANIM BIOL, V57, P121, DOI 10.1163/157075607780377992; Scharer L, 2004, BEHAV ECOL SOCIOBIOL, V56, P420, DOI 10.1007/s00265-004-0802-9; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; Sotiropoulou PA, 2008, STEM CELLS, V26, P2964, DOI 10.1634/stemcells.2008-0634; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; STEPH.F, 1961, J EMBRYOL EXP MORPH, V9, P642; Tannenbaum E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041914; Tsai RYL, 2002, DEV CELL, V2, P707, DOI 10.1016/S1534-5807(02)00195-8; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; WEI ZG, 1995, INVEST OPHTH VIS SCI, V36, P236; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680	66	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30227	10.1371/journal.pone.0030227	http://dx.doi.org/10.1371/journal.pone.0030227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276162	Green Published, Green Submitted, gold			2022-12-27	WOS:000301457200045
J	Hilbert, A; de Zwaan, M; Braehler, E				Hilbert, Anja; de Zwaan, Martina; Braehler, Elmar			How Frequent Are Eating Disturbances in the Population? Norms of the Eating Disorder Examination-Questionnaire	PLOS ONE			English	Article							SELF-REPORT; EDE-Q; PSYCHOMETRIC PROPERTIES; GENERAL-POPULATION; YOUNG-WOMEN; PREVALENCE; COMMUNITY; INTERVIEW; COMORBIDITY; GENDER	Objective: The Eating Disorder Examination-Questionnaire (EDE-Q) is a self-report instrument assessing the specific psychopathology and key behaviors of eating disorders. This study sought to determine the prevalence of eating disturbances, and to provide psychometric properties and norms of the EDE-Q, in a representative German population sample. Methods: A total of 2520 individuals (1166 men, 1354 women) were assessed with the EDE-Q. Results: Eating disorder psychopathology was higher and most key behaviors were more prevalent in women than in men. Psychopathology declined with age >= 65 in both sexes, and showed a peak at age 55-64 in men. Overall, 5.9% of the women and 1.5% of the men revealed eating disturbances. The prevalence of eating disturbances decreased with age in women and was significantly higher in obese than in normal-weight individuals. Psychometric analyses showed favorable item characteristics. Internal consistencies of EDE-Q composite scores were >= 80 for women and >= 70 for men. The factor structure of the EDE-Q was partially reproduced. Sex- and age-specific population norms are reported. Discussion: This study provides population norms of the EDE-Q for both sexes and across the age range, demonstrates demographic variations in symptomatology, and reveals satisfactory psychometric properties. Further research is warranted on eating disturbances in older adults.	[Hilbert, Anja] Univ Leipzig, Integrated Res & Treatment Ctr AdiposityDis, Dept Med Psychol & Med Sociol, Med Ctr, Leipzig, Germany; [de Zwaan, Martina] Hannover Med Sch, Clin Psychosomat, D-3000 Hannover, Germany; [de Zwaan, Martina] Hannover Med Sch, Clin Psychotherapy, D-3000 Hannover, Germany	Leipzig University; Hannover Medical School; Hannover Medical School	Hilbert, A (corresponding author), Univ Leipzig, Integrated Res & Treatment Ctr AdiposityDis, Dept Med Psychol & Med Sociol, Med Ctr, Leipzig, Germany.	anja.hilbert@medizin.uni-leipzig.de	Braehler, Elmar/C-6535-2009	Braehler, Elmar/0000-0002-2648-2728	Department of Medical Psychology and Medical Sociology, University of Leipzig Medical Center; Integrated Research and Treatment Center Adiposity Diseases [ADI K7-6c]	Department of Medical Psychology and Medical Sociology, University of Leipzig Medical Center; Integrated Research and Treatment Center Adiposity Diseases	This research was supported by internal funds from the Department of Medical Psychology and Medical Sociology, University of Leipzig Medical Center and by the Integrated Research and Treatment Center Adiposity Diseases grant ADI K7-6c. The external funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KL, 2011, EAT BEHAV, V12, P143, DOI 10.1016/j.eatbeh.2011.01.005; Byers AL, 2010, ARCH GEN PSYCHIAT, V67, P489, DOI 10.1001/archgenpsychiatry.2010.35; Celio AA, 2004, INT J EAT DISORDER, V36, P434, DOI 10.1002/eat.20057; Cohen J.E., 1988, STAT POWER ANAL BEHA; Darby A, 2007, INT J OBESITY, V31, P876, DOI 10.1038/sj.ijo.0803501; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Fairburn CG., 2008, COGNITIVE BEHAV THER, P309; Fairburn Christopher G., 1993, P317; Favaro A, 2003, PSYCHOSOM MED, V65, P701, DOI 10.1097/01.PSY.0000073871.67679.D8; Gadalla T, 2008, ARCH WOMEN MENT HLTH, V11, P357, DOI 10.1007/s00737-008-0031-8; Grilo CM, 2005, BIOL PSYCHIAT, V57, P301, DOI 10.1016/j.biopsych.2004.11.002; Grilo CM, 2001, J CONSULT CLIN PSYCH, V69, P317, DOI 10.1037//0022-006X.69.2.317; Hay P, 1998, INT J EAT DISORDER, V23, P371, DOI 10.1002/(SICI)1098-108X(199805)23:4&lt;371::AID-EAT4&gt;3.0.CO;2-F; Hay PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001541; Hilbert A, 2007, DIAGNOSTICA, V53, P144, DOI 10.1026/0012-1924.53.3.144; Hoek HW, 2003, INT J EAT DISORDER, V34, P383, DOI 10.1002/eat.10222; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Jacobi F, 2004, PSYCHOL MED, V34, P597, DOI 10.1017/S0033291703001399; Jenkins PE, 2011, CLIN PSYCHOL REV, V31, P113, DOI 10.1016/j.cpr.2010.08.003; Lavender JM, 2010, EAT BEHAV, V11, P119, DOI 10.1016/j.eatbeh.2009.09.005; Luce KH, 1999, INT J EAT DISORDER, V25, P349, DOI 10.1002/(SICI)1098-108X(199904)25:3&lt;349::AID-EAT15&gt;3.0.CO;2-M; Luce KH, 2008, INT J EAT DISORDER, V41, P273, DOI 10.1002/eat.20504; Mangweth-Matzek B, 2006, INT J EAT DISORDER, V39, P583, DOI 10.1002/eat.20327; McCabe MP, 2004, J PSYCHOSOM RES, V56, P675, DOI 10.1016/S0022-3999(03)00129-6; Mensink G B M, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P1348, DOI 10.1007/s00103-005-1163-x; Mond JM, 2007, EUR EAT DISORD REV, V15, P403, DOI 10.1002/erv.792; Mond JM, 2004, BEHAV RES THER, V42, P551, DOI 10.1016/S0005-7967(03)00161-X; Mond JM, 2004, INT J EAT DISORDER, V36, P195, DOI 10.1002/eat.20017; Mond JM, 2006, BEHAV RES THER, V44, P53, DOI 10.1016/j.brat.2004.12.003; Peterson CB, 2007, INT J EAT DISORDER, V40, P386, DOI 10.1002/eat.20373; Preti A, 2009, J PSYCHIATR RES, V43, P1125, DOI 10.1016/j.jpsychires.2009.04.003; Reagan P, 2005, INT J EAT DISORDER, V38, P252, DOI 10.1002/eat.20177; Reas DL, 2006, BEHAV RES THER, V44, P43, DOI 10.1016/j.brat.2005.01.004; Sepulveda AR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-102; Striegel-Moore RH, 2009, INT J EAT DISORDER, V42, P471, DOI 10.1002/eat.20625; Sysko R, 2005, INT J EAT DISORDER, V37, P100, DOI 10.1002/eat.20078; Tasca GA, 2009, HDB ASSESSMENT METHO, P347; Taylor CB, 2006, ARCH GEN PSYCHIAT, V63, P881, DOI 10.1001/archpsyc.63.8.881; Treasure J, 2010, LANCET, V375, P583, DOI 10.1016/S0140-6736(09)61748-7; Wolitzky-Taylor KB, 2010, DEPRESS ANXIETY, V27, P190, DOI 10.1002/da.20653; Wolitzky-Taylor KB, 2010, NAT NUTR SURV, V227, P190; Wolk SL, 2005, INT J EAT DISORDER, V37, P92, DOI 10.1002/eat.20076; Zachrisson HD, 2008, INT J EAT DISORDER, V41, P673, DOI 10.1002/eat.20565	43	161	162	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29125	10.1371/journal.pone.0029125	http://dx.doi.org/10.1371/journal.pone.0029125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	885IH	22279527	Green Submitted, Green Published, gold			2022-12-27	WOS:000299771900005
J	Nacher, JC; Schwartz, JM				Nacher, Jose C.; Schwartz, Jean-Marc			Modularity in Protein Complex and Drug Interactions Reveals New Polypharmacological Properties	PLOS ONE			English	Article							COMMUNITY STRUCTURE; NETWORK MOTIFS; TARGETS; DEFICIENCY; ALZHEIMERS; PREDICTION; FEATURES; BIOLOGY; YEAST	Recent studies have highlighted the importance of interconnectivity in a large range of molecular and human disease-related systems. Network medicine has emerged as a new paradigm to deal with complex diseases. Connections between protein complexes and key diseases have been suggested for decades. However, it was not until recently that protein complexes were identified and classified in sufficient amounts to carry out a large-scale analysis of the human protein complex system. We here present the first systematic and comprehensive set of relationships between protein complexes and associated drugs and analyzed their topological features. The network structure is characterized by a high modularity, both in the bipartite graph and in its projections, indicating that its topology is highly distinct from a random network and that it contains a rich and heterogeneous internal modular structure. To unravel the relationships between modules of protein complexes, drugs and diseases, we investigated in depth the origins of this modular structure in examples of particular diseases. This analysis unveils new associations between diseases and protein complexes and highlights the potential role of polypharmacological drugs, which target multiple cellular functions to combat complex diseases driven by gain-of-function mutations.	[Nacher, Jose C.] Future Univ Hakodate, Dept Complex & Intelligent Syst, Hakodate, Hokkaido, Japan; [Schwartz, Jean-Marc] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England	Future University Hakodate; University of Manchester	Nacher, JC (corresponding author), Future Univ Hakodate, Dept Complex & Intelligent Syst, Hakodate, Hokkaido, Japan.	nacher@fun.ac.jp	Schwartz, Jean-Marc/AAS-8274-2020	Schwartz, Jean-Marc/0000-0002-6472-0184	MEXT Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [23700352] Funding Source: KAKEN	MEXT Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by a Grant-in-Aid for Scientific Research from MEXT Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Arenas A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.114102; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bergmans BA, 2010, LANCET NEUROL, V9, P215, DOI 10.1016/S1474-4422(09)70332-1; Beyer A, 2005, BIOINFORMATICS, V21, P1610, DOI 10.1093/bioinformatics/bti223; Bulgakova NA, 2009, J CELL SCI, V122, P2587, DOI 10.1242/jcs.023648; CHIGNELL CF, 1969, MOL PHARMACOL, V5, P244; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Diao YB, 2007, J THEOR BIOL, V247, P608, DOI 10.1016/j.jtbi.2007.04.007; Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058; Endy D, 2001, NATURE, V409, P391, DOI 10.1038/35053181; Farkas IJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001950; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fraser HB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r252; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guillaume JL, 2006, PHYSICA A, V371, P795, DOI 10.1016/j.physa.2006.04.047; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Halperin I, 2009, NEUROTHERAPEUTICS, V6, P128, DOI 10.1016/j.nurt.2008.10.033; Hannum G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000782; Hlavacek WS, 2003, BIOTECHNOL BIOENG, V84, P783, DOI 10.1002/bit.10842; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Kovacs IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012528; Laudon H, 2007, PHYSIOL BEHAV, V92, P115, DOI 10.1016/j.physbeh.2007.05.037; Lee SH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-126; Ma'ayan A, 2007, MT SINAI J MED, V74, P27, DOI 10.1002/msj.20002; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107; Nacher Jose C., 2008, BMC Pharmacology, V8, P5, DOI 10.1186/1471-2210-8-5; Newman M. E. J., 2004, PHYS REV, V69; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Park K, 2008, PROTEINS, V71, P960, DOI 10.1002/prot.21780; Pereira-Leal JB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r51; Rodriguez-Soca Y, 2010, J PROTEOME RES, V9, P1182, DOI 10.1021/pr900827b; Rubin GM, 2001, NATURE, V409, P820, DOI 10.1038/35057277; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Spiro Zoltan, 2008, J Biol, V7, P20, DOI 10.1186/jbiol81; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Van der Schyf CJ, 2006, J NEUROCHEM, V99, P1033, DOI 10.1111/j.1471-4159.2006.04141.x; Van Laarhoven Peter JM, 1987, SIMULATED ANNEALING, P7, DOI [DOI 10.1007/978-94-015-7744-1, DOI 10.1007/978-94-015-7744-1_2]; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Veselovsky AV, 2007, CURR COMPUT-AID DRUG, V3, P51, DOI 10.2174/157340907780058754; Wang CQ, 2011, J DRUG TARGET, V19, P354, DOI 10.3109/1061186X.2010.504261; Wang XJ, 2011, BRIEF FUNCT GENOMICS, V10, P280, DOI 10.1093/bfgp/elr024; Wegener E., 2008, V186, P237, DOI 10.1007/978-3-540-72843-6_10; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338	58	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30028	10.1371/journal.pone.0030028	http://dx.doi.org/10.1371/journal.pone.0030028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279562	gold, Green Published, Green Submitted			2022-12-27	WOS:000299771900040
J	Radicchi, F; Baronchelli, A; Amaral, LAN				Radicchi, Filippo; Baronchelli, Andrea; Amaral, Luis A. N.			Rationality, Irrationality and Escalating Behavior in Lowest Unique Bid Auctions	PLOS ONE			English	Article							ELECTRONIC MARKETPLACES; PREFERENCE REVERSAL; RANDOM SEARCHES; SCALING LAWS; LEVY FLIGHTS; PATTERNS; INTERNET; CONTEXT	Information technology has revolutionized the traditional structure of markets. The removal of geographical and time constraints has fostered the growth of online auction markets, which now include millions of economic agents worldwide and annual transaction volumes in the billions of dollars. Here, we analyze bid histories of a little studied type of online auctions - lowest unique bid auctions. Similarly to what has been reported for foraging animals searching for scarce food, we find that agents adopt Levy flight search strategies in their exploration of "bid space". The Levy regime, which is characterized by a power-law decaying probability distribution of step lengths, holds over nearly three orders of magnitude. We develop a quantitative model for lowest unique bid online auctions that reveals that agents use nearly optimal bidding strategies. However, agents participating in these auctions do not optimize their financial gain. Indeed, as long as there are many auction participants, a rational profit optimizing agent would choose not to participate in these auction markets.	[Radicchi, Filippo; Amaral, Luis A. N.] Northwestern Univ, Howard Hughes Med Inst HHMI, Evanston, IL 60208 USA; [Radicchi, Filippo; Amaral, Luis A. N.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Radicchi, Filippo] Univ Rovira & Virgili, Dept Engn Quim, Tarragona, Catalunya, Spain; [Baronchelli, Andrea] Univ Politecn Cataluna, Dept Fis & Engn Nucl, Barcelona, Spain; [Amaral, Luis A. N.] Northwestern Univ, NW Inst Complex Syst NICO, Evanston, IL USA	Howard Hughes Medical Institute; Northwestern University; Northwestern University; Universitat Rovira i Virgili; Universitat Politecnica de Catalunya; Northwestern University	Radicchi, F (corresponding author), Northwestern Univ, Howard Hughes Med Inst HHMI, Evanston, IL 60208 USA.	amaral@northwestern.edu	Amaral, LAN/A-4980-2008; Baronchelli, Andrea/F-9550-2016; Amaral, Luis N./C-5485-2009; Radicchi, Filippo/B-4407-2009	Amaral, LAN/0000-0002-3762-789X; Baronchelli, Andrea/0000-0002-0255-0829; Radicchi, Filippo/0000-0002-8352-1287	National Science Foundation (NSF)	National Science Foundation (NSF)(National Science Foundation (NSF))	Funding from National Science Foundation (NSF) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augenblick N., 2009, CONSUMER PRODU UNPUB; Bakos Y, 1998, COMMUN ACM, V41, P35, DOI 10.1145/280324.280330; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Basar T., 1995, DYNAMIC NONCOOPERATI, V2nd ed.; Bazerman MH, 1992, NEGOTIATING RATIONAL; Berkolaiko G, 1997, PHYS REV E, V55, P1395, DOI 10.1103/PhysRevE.55.1395; Bertrand S, 2005, ICES J MAR SCI, V62, P477, DOI 10.1016/j.icesjms.2004.12.002; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; BYERS JW, 2010, 10010592 ARXIV; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; GRETHER DM, 1979, AM ECON REV, V69, P623; Grieger M, 2003, EUR J OPER RES, V144, P280, DOI 10.1016/S0377-2217(02)00394-6; HINNOSAAR T, 2010, PENNY AUCTIONS UNPUB; HUGHES DH, 1981, P NATL ACAD SCI USA, V78, P3287; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; KRISHNA V., 2002, AUCTION THEORY; Lucking-Reiley D, 2000, J IND ECON, V48, P227; Lucking-Reiley D, 2007, J IND ECON, V55, P223, DOI 10.1111/j.1467-6451.2007.00309.x; MALONE TW, 1987, COMMUN ACM, V30, P484, DOI 10.1145/214762.214766; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; MCAFEE RP, 1987, ECON LETT, V23, P343, DOI 10.1016/0165-1765(87)90142-X; MEYERSON R, 1981, MATH OPER RES, V6, P58; MILGROM PR, 1982, ECONOMETRICA, V50, P1089, DOI 10.2307/1911865; MITTAL S, 2010, EQUILIBRIUM A UNPUB; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; PLATT BC, 2010, PAY TO BID AUC UNPUB; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; RAPOPORT A, 1970, N PERSON GAME THEORY; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; SHLESINGER MF, 1993, NATURE, V363, P31, DOI 10.1038/363031a0; SHUBIK M, 1971, J CONFLICT RESOLUT, V15, P109, DOI 10.1177/002200277101500111; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; STAW BM, 1989, SCIENCE, V246, P216, DOI 10.1126/science.246.4927.216; STAW BM, 1976, ORGAN BEHAV HUM PERF, V16, P27, DOI 10.1016/0030-5073(76)90005-2; TVERSKY A, 1990, AM ECON REV, V80, P204; van Heck E, 1998, COMMUN ACM, V41, P99, DOI 10.1145/278476.278495; Viswanathan GM, 2008, PHYS LIFE REV, V5, P133, DOI 10.1016/j.plrev.2008.03.002; Viswanathan GM, 2010, NATURE, V465, P1018, DOI 10.1038/4651018a; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Wald C, 2008, SCIENCE, V322, P1624, DOI 10.1126/science.322.5908.1624	41	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29910	10.1371/journal.pone.0029910	http://dx.doi.org/10.1371/journal.pone.0029910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	885IH	22279553	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000299771900031
J	Claisse, JT; Pondella, DJ; Williams, JP; Sadd, J				Claisse, Jeremy T.; Pondella, Daniel J., II; Williams, Jonathan P.; Sadd, James			Using GIS Mapping of the Extent of Nearshore Rocky Reefs to Estimate the Abundance and Reproductive Output of Important Fishery Species	PLOS ONE			English	Article							SEMICOSSYPHUS-PULCHER LABRIDAE; ADULT CALIFORNIA SHEEPHEAD; MARINE RESERVES; KELP BASS; PARALABRAX-CLATHRATUS; HABITAT UTILIZATION; MOVEMENT PATTERNS; TEMPORAL PATTERNS; LIFE-HISTORIES; MATERNAL AGE	Kelp Bass (Paralabrax clathratus) and California Sheephead (Semicossyphus pulcher) are economically and ecologically valuable rocky reef fishes in southern California, making them likely indicator species for evaluating resource management actions. Multiple spatial datasets, aerial and satellite photography, underwater observations and expert judgment were used to produce a comprehensive map of nearshore natural rocky reef habitat for the Santa Monica Bay region (California, USA). It was then used to examine the relative contribution of individual reefs to a regional estimate of abundance and reproductive potential of the focal species. For the reefs surveyed for fishes (i.e. 18 out of the 22 in the region, comprising 82% the natural rocky reef habitat <30 m depth, with a total area of 1850 ha), total abundance and annual egg production of California Sheephead were 451 thousand fish (95% CI: 369 to 533 thousand) and 203 billion eggs (95% CI: 135 to 272 billion). For Kelp Bass, estimates were 805 thousand fish (95% CI: 669 to 941thousand) and 512 billion eggs (95% CI: 414 to 610 billion). Size structure and reef area were key factors in reef-specific contributions to the regional egg production. The size structures of both species illustrated impacts from fishing, and results demonstrate the potential that relatively small increases in the proportion of large females on larger reefs could have on regional egg production. For California Sheephead, a substantial proportion of the regional egg production estimate (>30%) was produced from a relatively small proportion of the regional reef area (c. 10%). Natural nearshore rocky reefs make up only 11% of the area in the newly designated MPAs in this region, but results provide some optimism that regional fisheries could benefit through an increase in overall reproductive output, if adequate increases in size structure of targeted species are realized.	[Claisse, Jeremy T.; Pondella, Daniel J., II; Williams, Jonathan P.] Occidental Coll, Dept Biol, Vantuna Res Grp, Los Angeles, CA 90041 USA; [Sadd, James] Occidental Coll, Dept Geol, Los Angeles, CA 90041 USA	Occidental College; Occidental College	Claisse, JT (corresponding author), Occidental Coll, Dept Biol, Vantuna Res Grp, Los Angeles, CA 90041 USA.	claisse@oxy.edu	Williams, Jonathan/AAX-3534-2020	Williams, Jonathan/0000-0002-4829-2474	Santa Monica Bay Restoration Commission; Southern California Coastal Water Research Project; Montrose Settlements Restoration Program; Sanitation Districts of Los Angeles County; Port of Los Angeles; Chevron Products Company	Santa Monica Bay Restoration Commission; Southern California Coastal Water Research Project; Montrose Settlements Restoration Program; Sanitation Districts of Los Angeles County; Port of Los Angeles; Chevron Products Company	Funding for this study was provided by the Santa Monica Bay Restoration Commission (http://www.santamonicabay.org), the Southern California Coastal Water Research Project (http://www.sccwrp.org), Montrose Settlements Restoration Program (www.montroserestoration.gov/), Sanitation Districts of Los Angeles County (www.lacsd.org), Port of Los Angeles (www.portoflosangeles.org) and Chevron Products Company (www.chevronelsegundo.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airame S, 2008, CHANNEL ISLANDS MARI; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Allen LG, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P1; Alonzo SH, 2004, STATUS CALIFORNIA SH; Anderson MJ, 2004, J EXP MAR BIOL ECOL, V305, P191, DOI 10.1016/j.jembe.2003.12.011; ANDERSON TW, 1989, B MAR SCI, V44, P681; [Anonymous], CDFG AB REC MAN PLAN; Barnett AM, 1991, PRODUCTION VALUATION; Berkeley SA, 2004, ECOLOGY, V85, P1258, DOI 10.1890/03-0706; Bight' 08_Rocky_Reef_Committee, 2008, SO CAL BIGHT 2008 RE; Burnham K. P., 2002, MODEL SELECTION MULT, P484; Carr JP, 2009, BIOL CONSERV, V142, P477, DOI 10.1016/j.biocon.2008.10.004; Caselle JE, 2011, CAN J FISH AQUAT SCI, V68, P288, DOI 10.1139/F10-140; Cavanaugh KC, 2010, MAR ECOL PROG SER, V403, P13, DOI 10.3354/meps08467; Costello C, 2010, P NATL ACAD SCI USA, V107, P18294, DOI 10.1073/pnas.0908057107; COWEN RK, 1985, J MAR RES, V43, P719, DOI 10.1357/002224085788440376; COWEN RK, 1990, COPEIA, P787; Curley BG, 2002, MAR FRESHWATER RES, V53, P1197, DOI 10.1071/MF01199; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; DEMARTINI EE, 1994, B MAR SCI, V55, P484; Dojiri M, 2003, MAR ENVIRON RES, V56, P1, DOI 10.1016/S0141-1136(03)00003-5; Domeier ML, 2001, CALIFORNIAS MARINE L, P209; Erisman BE, 2006, J FISH BIOL, V68, P157, DOI 10.1111/j.0022-1112.2006.00886.x; Erisman BE, 2011, CAN J FISH AQUAT SCI, V68, P1705, DOI 10.1139/F2011-090; Feder HM, 1974, CALIF DEPT FISH GAME, V160, P144; Findlay AM, 2002, MAR ECOL PROG SER, V238, P237, DOI 10.3354/meps238237; Ford T., 2010, URBAN COAST, V2, P43; Foster MS, 2010, J EXP MAR BIOL ECOL, V393, P59, DOI 10.1016/j.jembe.2010.07.002; Froeschke John T., 2006, Bulletin Southern California Academy of Sciences, V105, P128, DOI 10.3160/0038-3872(2006)105[128:TFAIAO]2.0.CO;2; Graham MH, 2004, ECOSYSTEMS, V7, P341, DOI 10.1007/s10021-003-0245-6; Graham MH, 2003, TRENDS ECOL EVOL, V18, P33, DOI 10.1016/S0169-5347(02)00006-X; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Hamilton SL, 2007, ECOL APPL, V17, P2268, DOI 10.1890/06-1930.1; Hamilton SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024580; Hamilton SL, 2010, P NATL ACAD SCI USA, V107, P18272, DOI 10.1073/pnas.0908091107; Hapke C, 20061251 US GEOL SUR; HOLBROOK SJ, 1990, AUST J ECOL, V15, P489, DOI 10.1111/j.1442-9993.1990.tb01473.x; HOLBROOK SJ, 1994, AM ZOOL, V34, P463; Kellner JB, 2005, BIOGEOGRAPHIC ASSESS, P89; Lewis R.D., 1989, GUIDE ARTIFICIAL REE; Lizaso JLS, 2000, ENVIRON CONSERV, V27, P144, DOI 10.1017/S0376892900000187; Loke-Smith K, 2011, THESIS CALIFORNIA ST; Lorenzen K, 2002, P ROY SOC B-BIOL SCI, V269, P49, DOI 10.1098/rspb.2001.1853; Love MS, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P567; Love MS, 1996, FISH B-NOAA, V94, P472; Love RM, 1991, PROBABLY MORE YOU WA, P381; Lowe CG, 2003, MAR ECOL PROG SER, V256, P205, DOI 10.3354/meps256205; MCCORMICK MI, 1987, MAR BIOL, V96, P469, DOI 10.1007/BF00397964; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; ODA DL, 1993, CAL COOP OCEAN FISH, V34, P122; Paddack MJ, 2000, ECOL APPL, V10, P855, DOI 10.2307/2641050; PATTON ML, 1985, B MAR SCI, V37, P279; Pelc RA, 2010, P NATL ACAD SCI USA, V107, P18266, DOI 10.1073/pnas.0907368107; Pondella D.J., 2009, URBAN COAST, V1, P33; Pondella DJ, 2008, MAR BIOL, V154, P307, DOI 10.1007/s00227-008-0924-0; Pondella DJ, 2002, ICES J MAR SCI, V59, pS88, DOI 10.1006/jmsc.2002.1219; PONDELLA DJ, 1994, B MAR SCI, V55, P1216; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Schiff K, 2003, MAR ENVIRON RES, V56, P225, DOI 10.1016/S0141-1136(02)00332-X; Schroeder DM, 2002, CAL COOP OCEAN FISH, V43, P182; Smith SG, 2011, FISHERIES RES; Steele MA, 2002, MAR ECOL PROG SER, V235, P195, DOI 10.3354/meps235195; Stephens J.S., 2001, CALIFORNIAS MARINE L, P155; STEPHENS JS, 1994, B MAR SCI, V55, P1224; Sundberg Michael A., 2009, Bulletin Southern California Academy of Sciences, V108, P16, DOI 10.3160/0038-3872-108.1.16; Taylor BM, 2010, MAR ECOL PROG SER, V411, P243, DOI 10.3354/meps08672; Tetreault I, 2007, ECOL APPL, V17, P2251, DOI 10.1890/06-0161.1; Topping DT, 2006, MAR ECOL PROG SER, V326, P257, DOI 10.3354/meps326257; Topping DT, 2005, MAR BIOL, V147, P301, DOI 10.1007/s00227-005-1573-1; Venables WN., 2002, MODERN APPL STAT S 4; Watson JR, 2010, MAR ECOL PROG SER, V401, P31, DOI 10.3354/meps08376; White JW, 2008, ECOLOGY, V89, P1323, DOI 10.1890/07-0840.1	73	8	11	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30290	10.1371/journal.pone.0030290	http://dx.doi.org/10.1371/journal.pone.0030290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272326	Green Published, gold, Green Submitted			2022-12-27	WOS:000301454400104
J	Ma, PF; Guo, ZH; Li, DZ				Ma, Peng-Fei; Guo, Zhen-Hua; Li, De-Zhu			Rapid Sequencing of the Bamboo Mitochondrial Genome Using Illumina Technology and Parallel Episodic Evolution of Organelle Genomes in Grasses	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; PLANT MITOCHONDRIAL; PHYLOGENETIC ANALYSIS; ANGIOSPERM PHYLOGENY; CHLOROPLAST GENOMES; SUBSTITUTION RATES; LEVEL CHARACTERS; SCALE DATA; DNA; GENES	Background: Compared to their counterparts in animals, the mitochondrial (mt) genomes of angiosperms exhibit a number of unique features. However, unravelling their evolution is hindered by the few completed genomes, of which are essentially Sanger sequenced. While next-generation sequencing technologies have revolutionized chloroplast genome sequencing, they are just beginning to be applied to angiosperm mt genomes. Chloroplast genomes of grasses (Poaceae) have undergone episodic evolution and the evolutionary rate was suggested to be correlated between chloroplast and mt genomes in Poaceae. It is interesting to investigate whether correlated rate change also occurred in grass mt genomes as expected under lineage effects. A time-calibrated phylogenetic tree is needed to examine rate change. Methodology/Principal Findings: We determined a largely completed mt genome from a bamboo, Ferrocalamus rimosivaginus (Poaceae), through Illumina sequencing of total DNA. With combination of de novo and reference-guided assembly, 39.5-fold coverage Illumina reads were finally assembled into scaffolds totalling 432,839 bp. The assembled genome contains nearly the same genes as the completed mt genomes in Poaceae. For examining evolutionary rate in grass mt genomes, we reconstructed a phylogenetic tree including 22 taxa based on 31 mt genes. The topology of the well-resolved tree was almost identical to that inferred from chloroplast genome with only minor difference. The inconsistency possibly derived from long branch attraction in mtDNA tree. By calculating absolute substitution rates, we found significant rate change (similar to 4-fold) in mt genome before and after the diversification of Poaceae both in synonymous and nonsynonymous terms. Furthermore, the rate change was correlated with that of chloroplast genomes in grasses. Conclusions/Significance: Our result demonstrates that it is a rapid and efficient approach to obtain angiosperm mt genome sequences using Illumina sequencing technology. The parallel episodic evolution of mt and chloroplast genomes in grasses is consistent with lineage effects.	[Ma, Peng-Fei; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Ma, Peng-Fei; Guo, Zhen-Hua; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Plant Germplasm & Genom Ctr, Kunming, Yunnan, Peoples R China; [Ma, Peng-Fei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ma, PF (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China.	guozhenhua@mail.kib.ac.cn; dzl@mail.kib.ac.cn	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X	National Natural Science Foundation of China [31170204]; Chinese Academy of Sciences [KSCX-YW-N-029, KSCX2-YW-N-067]; Yunnan Provincial Government through an innovation team	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Yunnan Provincial Government through an innovation team	This project is supported by National Natural Science Foundation of China (no. 31170204), the Chinese Academy of Sciences under the knowledge innovation program (grants KSCX-YW-N-029 and KSCX2-YW-N-067), and Yunnan Provincial Government through an innovation team program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Atherton RA, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-22; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Boore JL, 2008, PHILOS T R SOC B, V363, P1445, DOI 10.1098/rstb.2007.2234; Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; Bouchenak-Khelladi Y, 2010, BOT J LINN SOC, V162, P543, DOI 10.1111/j.1095-8339.2010.01041.x; Bowe LM, 1996, MOL BIOL EVOL, V13, P1159, DOI 10.1093/oxfordjournals.molbev.a025680; Chaw SM, 2008, MOL BIOL EVOL, V25, P603, DOI 10.1093/molbev/msn009; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Davila JI, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-64; EyreWalker A, 1997, MOL BIOL EVOL, V14, P455, DOI 10.1093/oxfordjournals.molbev.a025781; Fujii S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-209; GAUT BS, 1992, J MOL EVOL, V35, P292, DOI 10.1007/BF00161167; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; HSU CL, 1989, PLANT MOL BIOL, V13, P467, DOI 10.1007/BF00015558; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; KELLOGG EA, 1993, SYST BIOL, V42, P415, DOI 10.2307/2992482; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; Kubo T, 2008, MITOCHONDRION, V8, P5, DOI 10.1016/j.mito.2007.10.006; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lockhart P, 2006, MOL BIOL EVOL, V23, P40, DOI 10.1093/molbev/msj005; Lu MZ, 1998, PLANT MOL BIOL, V37, P225, DOI 10.1023/A:1005972513322; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Mower JP, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-265; Mower JP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-135; Neafsey Daniel E, 2011, Genome Biol, V12, P303, DOI 10.1186/gb-2011-12-3-303; Nock CJ, 2011, PLANT BIOTECHNOL J, V9, P328, DOI 10.1111/j.1467-7652.2010.00558.x; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Ogihara Y, 2005, NUCLEIC ACIDS RES, V33, P6235, DOI 10.1093/nar/gki925; Ong HC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-55; Palmer JD, 2000, P NATL ACAD SCI USA, V97, P6960, DOI 10.1073/pnas.97.13.6960; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Parkinson CL, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-73; Picardi E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S14; Piperno DR, 2005, SCIENCE, V310, P1126, DOI 10.1126/science.1121020; Qiu YL, 2006, TAXON, V55, P837, DOI 10.2307/25065680; Qiu YL, 2010, J SYST EVOL, V48, P391, DOI 10.1111/j.1759-6831.2010.00097.x; Rodriguez-Moreno L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-424; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Sloan DB, 2008, MOL BIOL EVOL, V25, P243, DOI 10.1093/molbev/msm266; Sloan DB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-274; Sloan DB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-260; Soltis DE, 2004, TRENDS PLANT SCI, V9, P477, DOI 10.1016/j.tplants.2004.08.008; Soria-Hernanz DF, 2008, MOL BIOL EVOL, V25, P1282, DOI 10.1093/molbev/msn074; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Wolf PG, 2011, PLANT MOL BIOL, V76, P251, DOI 10.1007/s11103-010-9706-4; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu CS, 2011, GENOME BIOL EVOL; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang WP, 2000, MOL PHYLOGENET EVOL, V15, P135, DOI 10.1006/mpev.1999.0729; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]; Zhong BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005297; [No title captured]	71	25	27	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30297	10.1371/journal.pone.0030297	http://dx.doi.org/10.1371/journal.pone.0030297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272330	gold, Green Submitted, Green Published			2022-12-27	WOS:000301454400108
J	Chien, YW; Levin, BR; Klugman, KP				Chien, Yu-Wen; Levin, Bruce R.; Klugman, Keith P.			The Anticipated Severity of a "1918-Like" Influenza Pandemic in Contemporary Populations: The Contribution of Antibacterial Interventions	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; PNEUMOCOCCAL BACTEREMIA; STAPHYLOCOCCUS-AUREUS; BACTERIAL PNEUMONIA; IMMUNE-RESPONSE; HOST IMMUNE; EPIDEMIOLOGY; CHILDREN	Recent studies have shown that most of deaths in the 1918 influenza pandemic were caused by secondary bacterial infections, primarily pneumococcal pneumonia. Given the availability of antibiotics and pneumococcal vaccination, how will contemporary populations fare when they are next confronted with pandemic influenza due to a virus with the transmissibility and virulence of that of 1918? To address this question we use a mathematical model and computer simulations. Our model considers the epidemiology of both the influenza virus and pneumonia-causing bacteria and allows for co-infection by these two agents as well as antibiotic treatment, prophylaxis and pneumococcal vaccination. For our simulations we use influenza transmission and virulence parameters estimated from 1918 pandemic data. We explore the anticipated rates of secondary pneumococcal pneumonia and death in populations with different prevalence of pneumococcal carriage and contributions of antibiotic prophylaxis, treatment, and vaccination to these rates. Our analysis predicts that in countries with lower prevalence of pneumococcal carriage and access to antibiotics and pneumococcal conjugate vaccines, there would substantially fewer deaths due to pneumonia in contemporary populations confronted with a 1918-like virus than that observed in the 1918. Our results also predict that if the pneumococcal carriage prevalence is less than 40%, the positive effects of antibiotic prophylaxis and treatment would be manifest primarily at of level of individuals. These antibiotic interventions would have little effect on the incidence of pneumonia in the population at large. We conclude with the recommendation that pandemic preparedness plans should consider co-infection with and the prevalence of carriage of pneumococci and other bacteria responsible for pneumonia. While antibiotics and vaccines will certainly reduce the rate of individual mortality, the factor contributing most to the relatively lower anticipated lethality of a pandemic with a 1918-like influenza virus in contemporary population is the lower prevalence of pneumococcal carriage.	[Chien, Yu-Wen] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Levin, Bruce R.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Klugman, Keith P.] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University; Emory University; Rollins School Public Health	Chien, YW (corresponding author), Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	yuwen32@gmail.com			Pfizer Vaccines; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM091875] Funding Source: NIH RePORTER	Pfizer Vaccines; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	KPK has received research funding unrelated to the current paper from Pfizer Vaccines and has consulted for Pfizer Vaccines, Merck, GSK and Sanofi-Aventis. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials. YC and BRL report no conflict of interest.	Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; [Anonymous], 1958, BMJ-BRIT MED J, V1, P908; AUSTRIAN R, 1964, ANN INTERN MED, V60, P759, DOI 10.7326/0003-4819-60-5-759; Bassetti S, 2005, INFECT CONT HOSP EP, V26, P196, DOI 10.1086/502526; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; BRIMBLECOMBE FSW, 1958, BRIT MED J, V1, P119, DOI 10.1136/bmj.1.5063.119; Brundage JF, 2006, LANCET INFECT DIS, V6, P303, DOI 10.1016/S1473-3099(06)70466-2; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Brundage JF, 2007, J INFECT DIS, V196, P1717, DOI 10.1086/522355; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chen CJ, 2007, DIAGN MICR INFEC DIS, V59, P265, DOI 10.1016/j.diagmicrobio.2007.05.012; Chien YW, 2010, J INFECT DIS, V202, P1639, DOI 10.1086/657144; Chien YW, 2009, NEW ENGL J MED, V361, P2582, DOI 10.1056/NEJMc0908216; Domenech A, 2011, J ANTIMICROB CHEMOTH, V66, P487, DOI 10.1093/jac/dkq480; EICHENWALD HF, 1960, AM J DIS CHILD, V100, P161, DOI 10.1001/archpedi.1960.04020040163003; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FINLAND M, 1972, CLIN PHARMACOL THER, V13, P469; Frost WH, 1919, J AMER MED ASSOC, V73, P313, DOI 10.1001/jama.1919.02610310007003; GWALTNEY JM, 1975, J INFECT DIS, V132, P62, DOI 10.1093/infdis/132.1.62; HERS JFP, 1958, LANCET, V2, P1141; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Hogberg L, 2007, J CLIN MICROBIOL, V45, P948, DOI 10.1128/JCM.01913-06; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Kash JC, 2004, J VIROL, V78, P9499, DOI 10.1128/JVI.78.17.9499-9511.2004; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Klugman KP, 2009, VACCINE, V27, pC9, DOI 10.1016/j.vaccine.2009.06.007; Klugman KP, 2009, EMERG INFECT DIS, V15, P346, DOI 10.3201/eid1502.081208; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; LEVINS R, 1966, AM SCI, V54, P421; Lynch JP, 2009, SEMIN RESP CRIT CARE, V30, P189, DOI 10.1055/s-0029-1202938; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; McCullers JA, 2010, J INFECT DIS, V202, P1287, DOI 10.1086/656333; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Miller MA, 2008, J INFECT DIS, V198, P305, DOI 10.1086/589716; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Moore MR, 2004, J INFECT DIS, V190, P2031, DOI 10.1086/425422; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Olson DR, 2005, P NATL ACAD SCI USA, V102, P11059, DOI 10.1073/pnas.0408290102; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Peltola VT, 2004, PEDIATR INFECT DIS J, V23, pS87, DOI 10.1097/01.inf.0000108197.81270.35; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Porath A, 1997, J INFECTION, V34, P41, DOI 10.1016/S0163-4453(97)80008-4; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Rosen FS, 2007, ENT-EAR NOSE THROAT, V86, P38, DOI 10.1177/014556130708600116; Rubin JL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-14; Schrag SJ, 2001, JAMA-J AM MED ASSOC, V286, P49, DOI 10.1001/jama.286.1.49; Sherertz RJ, 1996, ANN INTERN MED, V124, P539, DOI 10.7326/0003-4819-124-6-199603150-00001; Shinde V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014809; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103; Simonsen L, 2011, MBIO, V2, DOI 10.1128/mBio.00309-10; Stillman EG, 1917, J EXP MED, V26, P513, DOI 10.1084/jem.26.4.513; Stillman EG, 1916, J EXP MED, V24, P651, DOI 10.1084/jem.24.6.651; Sydenstricker VPW, 1917, B JOHNS HOPKINS HOSP, V28, P312; Syrjanen RK, 2001, J INFECT DIS, V184, P451, DOI 10.1086/322048; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Yu VL, 2003, CLIN INFECT DIS, V37, P230, DOI 10.1086/377534	61	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e29219	10.1371/journal.pone.0029219	http://dx.doi.org/10.1371/journal.pone.0029219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291887	Green Submitted, Green Published, gold			2022-12-27	WOS:000301570600003
J	Huang, W; Nadeem, A; Zhang, B; Babar, M; Soller, M; Khatib, H				Huang, Wen; Nadeem, Asif; Zhang, Bao; Babar, Masroor; Soller, Morris; Khatib, Hasan			Characterization and Comparison of the Leukocyte Transcriptomes of Three Cattle Breeds	PLOS ONE			English	Article							RNA-SEQ; BOOPHILUS-MICROPLUS; GENE-EXPRESSION; ZEBU CATTLE; BOS-INDICUS; HEAT-SHOCK; EVOLUTION; GENOME; RESISTANCE; PRIMATES	In this study, mRNA-Seq was used to characterize and compare the leukocyte transcriptomes from two taurine breeds (Holstein and Jersey), and one indicine breed (Cholistani). At the genomic level, we identified breed-specific base changes in protein coding regions. Among 7,793,425 coding bases, only 165 differed between Holstein and Jersey, and 3,383 (0.04%) differed between Holstein and Cholistani, 817 (25%) of which resulted in amino acid changes in 627 genes. At the transcriptional level, we assembled transcripts and estimated their abundances including those from more than 3,000 unannotated intergeneic regions. Differential gene expression analysis showed a high similarity between Holstein and Jersey, and a much greater difference between the taurine breeds and the indicine breed. We identified gene ontology pathways that were systematically altered, including the electron transport chain and immune response pathways that may contribute to different levels of heat tolerance and disease resistance in taurine and indicine breeds. At the post-transcriptional level, sequencing mRNA allowed us to identify a number of genes undergoing differential alternative splicing among different breeds. This study provided a high-resolution survey of the variation between bovine transcriptomes at different levels and may provide important biological insights into the phenotypic differentiation among cattle breeds.	[Huang, Wen] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA; [Nadeem, Asif; Babar, Masroor] Univ Vet & Anim Sci, Inst Biochem & Biotechnol, Lahore, Pakistan; [Zhang, Bao] NW A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Soller, Morris] Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel; [Khatib, Hasan] Univ Wisconsin, Dept Anim Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Veterinary & Animal Science - Pakistan; Northwest A&F University - China; Hebrew University of Jerusalem; University of Wisconsin System; University of Wisconsin Madison	Huang, W (corresponding author), Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA.	hkhatib@wisc.edu	Babar, Masroor Ellahi/AAC-8150-2021; nadeem, asif/D-7804-2015; Huang, Wen/B-5005-2011; Khatib, Hasan/AAA-2693-2021	nadeem, asif/0000-0002-6777-2801; Huang, Wen/0000-0001-6788-8364	United States Department of Agriculture (USDA) from the University of Wisconsin-Madison [WIS-142-PRJ16JH]	United States Department of Agriculture (USDA) from the University of Wisconsin-Madison	This study was supported by a United States Department of Agriculture (USDA) Hatch grant No. WIS-142-PRJ16JH from the University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Farooq U, 2010, PAK VET J, V30, P126; Fries R, 1999, GENETICS CATTLE; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hansen PJ, 2004, ANIM REPROD SCI, V82-3, P349, DOI 10.1016/j.anireprosci.2004.04.011; Hwang SO, 2008, J BIOL CHEM, V283, P13063, DOI 10.1074/jbc.M709656200; KAMWANJA LA, 1994, J ANIM SCI, V72, P438, DOI 10.2527/1994.722438x; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lin L, 2010, HUM MOL GENET, V19, P2958, DOI 10.1093/hmg/ddq201; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacHugh DE, 1997, GENETICS, V146, P1071; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Passador-Gurgel G, 2007, NAT GENET, V39, P264, DOI 10.1038/ng1944; Piper EK, 2009, CLIN VACCINE IMMUNOL, V16, P1074, DOI 10.1128/CVI.00157-09; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; UTECH KBW, 1978, AUST J AGR RES, V29, P885, DOI 10.1071/AR9780885; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Xia CZ, 2001, P NATL ACAD SCI USA, V98, P6174, DOI 10.1073/pnas.101137298; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	27	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30244	10.1371/journal.pone.0030244	http://dx.doi.org/10.1371/journal.pone.0030244			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291923	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600028
J	Martinho, O; Granja, S; Jaraquemada, T; Caeiro, C; Miranda-Goncalves, V; Honavar, M; Costa, P; Damasceno, M; Rosner, MR; Lopes, JM; Reis, RM				Martinho, Olga; Granja, Sara; Jaraquemada, Teresa; Caeiro, Claudia; Miranda-Goncalves, Vera; Honavar, Mrinalini; Costa, Paulo; Damasceno, Margarida; Rosner, Marsha R.; Lopes, Jose M.; Reis, Rui M.			Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas	PLOS ONE			English	Article							KINASE INHIBITOR PROTEIN; COLORECTAL-CANCER; METASTASIS; EXPRESSION; PROSTATE; RAF-1; CELLS; SNAIL; SUPPRESSION; REDUCTION	Malignant gliomas are highly infiltrative and invasive tumors, which precludes the few treatment options available. Therefore, there is an urgent need to elucidate the molecular mechanisms underlying gliomas aggressive phenotype and poor prognosis. The Raf Kinase Inhibitory protein (RKIP), besides regulating important intracellular signaling cascades, was described to be associated with progression, metastasis and prognosis in several human neoplasms. Its role in the prognosis and tumourigenesis of gliomas remains unclear. In the present study, we found that RKIP protein is absent in a low frequency (10%, 20/193) of glioma tumors. Nevertheless, the absence of RKIP expression was an independent prognostic marker in glioma. Additionally, by in vitro downregulation of RKIP, we found that RKIP inhibition induces a higher viability and migration of the cells, having no effect on cellular proliferation and angiogenesis, as assessed by in vivo CAM assay. In conclusion, this is the largest series studied so far evaluating the expression levels of this important cancer suppressor protein in glioma tumors. Our results suggest that in a subset of tumors, the absence of RKIP associates with highly malignant behavior and poor survival of patients, which may be a useful biomarker for tailored treatment of glioma patients.	[Martinho, Olga; Granja, Sara; Miranda-Goncalves, Vera; Reis, Rui M.] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst, Braga, Portugal; [Martinho, Olga; Granja, Sara; Miranda-Goncalves, Vera; Reis, Rui M.] 3Bs PT Govt Associate Lab, Life & Hlth Sci Res Inst, Braga, Portugal; [Jaraquemada, Teresa; Caeiro, Claudia; Damasceno, Margarida] Hosp Sao Joao, Dept Oncol, Oporto, Portugal; [Honavar, Mrinalini] Hosp Pedro Hispano, Dept Pathol, Matosinhos, Portugal; [Costa, Paulo] Inst CUF, Oporto, Portugal; [Rosner, Marsha R.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Lopes, Jose M.] Hosp Sao Joao, Dept Pathol, Oporto, Portugal; [Lopes, Jose M.] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Lopes, Jose M.] Univ Porto, IPATIMUP, P-4100 Oporto, Portugal; [Reis, Rui M.] Barretos Canc Hosp, Mol Oncol Res Ctr, Sao Paulo, Brazil	Universidade do Minho; Sao Joao Hospital; University of Chicago; Sao Joao Hospital; Universidade do Porto; Universidade do Porto; Hospital de Cancer de Barretos	Martinho, O (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst, Braga, Portugal.	rreis@ecsaude.uminho.pt	Reis, Rui M/C-2859-2009; Lopes, José Manuel Manuel/J-7428-2013; Reis, Rui Manuel/B-1744-2018; Granja, Sara/AAE-7136-2021; Reis, Rui Manuel/AAD-6470-2020; Martinho, Olga/B-9695-2009; Sara, Granja C/T-6442-2018	Reis, Rui M/0000-0002-9639-7940; Lopes, José Manuel Manuel/0000-0001-8597-3474; Reis, Rui Manuel/0000-0002-9639-7940; Granja, Sara/0000-0001-8717-6751; Reis, Rui Manuel/0000-0002-9639-7940; Martinho, Olga/0000-0002-3221-0403; Sara, Granja C/0000-0001-8717-6751; Miranda-Goncalves, Vera/0000-0002-4231-5532	Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/SAU-TOX/114549/2009]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-TOX/114549/2009] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This study was partially funded by the Fundacao para a Ciencia e Tecnologia, Portugal (PTDC/SAU-TOX/114549/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akaishi J, 2006, ANTICANCER RES, V26, P4437; Al-Mulla F, 2006, J CLIN ONCOL, V24, P5672, DOI 10.1200/JCO.2006.07.5499; al-Mulla F, 2011, MOL BIOSYST, V7, P928, DOI 10.1039/c0mb00208a; Al-Mulla F, 2011, CANCER RES, V71, P1334, DOI 10.1158/0008-5472.CAN-10-3102; Baritaki S, 2009, ONCOGENE, V28, P3573, DOI 10.1038/onc.2009.214; Baritaki S, 2010, CRIT REV IMMUNOL, V30, P31, DOI 10.1615/CritRevImmunol.v30.i1.20; Beach S, 2008, ONCOGENE, V27, P2243, DOI 10.1038/sj.onc.1210860; Bement WM, 2005, CHEM BIOL, V12, P953, DOI 10.1016/j.chembiol.2005.08.012; Chatterjee D, 2004, J BIOL CHEM, V279, P17515, DOI 10.1074/jbc.M313816200; Chatterjee D, 2008, CLIN CANCER RES, V14, P2994, DOI 10.1158/1078-0432.CCR-07-4496; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Fu Z, 2006, PROSTATE, V66, P248, DOI 10.1002/pros.20319; Gimenez M, 2010, PROTEOMICS, V10, P2812, DOI 10.1002/pmic.200900722; Hagan S, 2005, CLIN CANCER RES, V11, P7392, DOI 10.1158/1078-0432.CCR-05-0283; Hagedorn M, 2005, P NATL ACAD SCI USA, V102, P1643, DOI 10.1073/pnas.0408622102; Hellmann J, 2010, DEV NEUROSCI-BASEL, V32, P33, DOI 10.1159/000236595; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Keller ET, 2004, CANCER LETT, V207, P131, DOI 10.1016/j.canlet.2004.02.006; Keller ET, 2004, ANTI-CANCER DRUG, V15, P663, DOI 10.1097/01.cad.0000136877.89057.b9; Keller ET, 2004, BIOCHEM PHARMACOL, V68, P1049, DOI 10.1016/j.bcp.2004.04.024; Keller ET, 2005, J CELL BIOCHEM, V94, P273, DOI 10.1002/jcb.20169; Kim HS, 2010, PATHOLOGY, V42, P655, DOI 10.3109/00313025.2010.522172; Klysik J, 2008, CELL SIGNAL, V20, P1, DOI 10.1016/j.cellsig.2007.07.003; Li HZ, 2009, MOL CANCER RES, V7, P832, DOI 10.1158/1541-7786.MCR-08-0403; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Maresch J, 2011, CANCER-AM CANCER SOC, V117, P2499, DOI 10.1002/cncr.25799; Martinho O, 2011, J CLIN PATHOL, DOI [10.1136/jclin-path-2011-200358, DOI 10.1136/JCLIN-PATH-2011-200358]; Martinho O, 2009, VIRCHOWS ARCH, V455, P277, DOI 10.1007/s00428-009-0821-z; Riemenschneider MJ, 2010, ACTA NEUROPATHOL, V120, P567, DOI 10.1007/s00401-010-0736-4; Schuierer MM, 2004, CANCER RES, V64, P5186, DOI 10.1158/0008-5472.CAN-03-3861; Shemon AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006028; Tabatabai G, 2010, ACTA NEUROPATHOL, V120, P585, DOI 10.1007/s00401-010-0750-6; Trakul N, 2005, J BIOL CHEM, V280, P24931, DOI 10.1074/jbc.M413929200; von Deimling A, 2011, BRAIN PATHOL, V21, P74, DOI 10.1111/j.1750-3639.2010.00454.x; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Woods KM, 2008, INT J RADIAT ONCOL, V72, P153, DOI 10.1016/j.ijrobp.2008.04.072; Wu K, 2009, CRIT REV IMMUNOL, V29, P241, DOI 10.1615/CritRevImmunol.v29.i3.40; Xu YF, 2010, J HEPATOL, V53, P872, DOI 10.1016/j.jhep.2010.05.019; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Zhang LZ, 2004, SURGERY, V136, P708, DOI 10.1016/j.surg.2003.12.013; Zlobec I, 2008, CLIN CANCER RES, V14, P143, DOI 10.1158/1078-0432.CCR-07-1380	47	43	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30769	10.1371/journal.pone.0030769	http://dx.doi.org/10.1371/journal.pone.0030769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292035	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600076
J	Stilp, CE; Kluender, KR				Stilp, Christian E.; Kluender, Keith R.			Efficient Coding and Statistically Optimal Weighting of Covariance among Acoustic Attributes in Novel Sounds	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; VISUAL-ADAPTATION; INFORMATION; TIME; INTEGRATION; CUES; REPRESENTATIONS; COMBINATION; PERCEPTION; TEXTURE	To the extent that sensorineural systems are efficient, redundancy should be extracted to optimize transmission of information, but perceptual evidence for this has been limited. Stilp and colleagues recently reported efficient coding of robust correlation (r = .97) among complex acoustic attribute (attack/decay, spectral shape) in novel sounds. Discrimination of sounds orthogonal to the correlation was initially inferior but later comparable to that of sounds obeying the correlation. These effects were attenuated for less-correlated stimuli (r = .54) for reasons that are unclear. Here, statistical properties of correlation among acoustic attributes essential for perceptual organization are investigated. Overall, simple strength of the principal correlation is inadequate to predict listener performance. Initial superiority of discrimination for statistically consistent sound pairs was relatively insensitive to decreased physical acoustic/psychoacoustic range of evidence supporting the correlation, and to more frequent presentations of the same orthogonal test pairs. However, increased range supporting an orthogonal dimension has substantial effects upon perceptual organization Connectionist simulations and Eigenvalues from closed-form calculations of principal components analysis (PCA) reveal that perceptual organization is near-optimally weighted to shared versus unshared covariance in experienced sound distributions Implications of reduced perceptual dimensionality for speech perception and plausible neural substrates are discussed.	[Stilp, Christian E.; Kluender, Keith R.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Stilp, CE (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	christian.stilp@gmail.com			National Institute on Deafness and Other Communication Disorders at the National Institutes of Health [DC 009532, DC 004072]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004072, F31DC009532] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	CS was funded by DC 009532, and KK was funded by DC 004072, both through the National Institute on Deafness and Other Communication Disorders at the National Institutes of Health (http://www.nidcd.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Anderson JL, 2003, LANG SPEECH, V46, P155, DOI 10.1177/00238309030460020601; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barbour DL, 2003, SCIENCE, V299, P1073, DOI 10.1126/science.1080425; Barlow H. B, 1961, SENS COMMUN, P53; Barlow H.B., 1959, P NPL S MECH THOUGHT; Barlow HB, 1989, COMPUTING NEURON, P54; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Bendor D, 2006, CURR OPIN NEUROBIOL, V16, P391, DOI 10.1016/j.conb.2006.07.001; Caclin A, 2006, J COGNITIVE NEUROSCI, V18, P1959, DOI 10.1162/jocn.2006.18.12.1959; Chapin JK, 1999, J NEUROSCI METH, V94, P121, DOI 10.1016/S0165-0270(99)00130-2; Chechik G, 2002, ADV NEURAL INFORM PR, V14, P27; Chechik G, 2006, NEURON, V51, P359, DOI 10.1016/j.neuron.2006.06.030; Clifford CWG, 2007, VISION RES, V47, P3125, DOI 10.1016/j.visres.2007.08.023; Clifford CWG, 2000, P ROY SOC B-BIOL SCI, V267, P1705, DOI 10.1098/rspb.2000.1198; Cristia A, 2011, J PHONETICS, V39, P388, DOI 10.1016/j.wocn.2011.02.004; DELATTRE PC, 1955, J ACOUST SOC AM, V27, P769, DOI 10.1121/1.1908024; Durgin FH, 1996, PERCEPT PSYCHOPHYS, V58, P207, DOI 10.3758/BF03211876; Ernst MO, 2007, J VISION, V7, DOI 10.1167/7.5.7; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Faisal AA, 2009, J NEUROPHYSIOL, V101, P1901, DOI 10.1152/jn.90974.2008; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; Girshick AR, 2009, J VISION, V9, DOI 10.1167/9.9.8; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; Hebb Donald O., 1949, ORG BEHAV; Helbig HB, 2007, EXP BRAIN RES, V179, P595, DOI 10.1007/s00221-006-0814-y; Hillis JM, 2004, J VISION, V4, P967, DOI 10.1167/4.12.1; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Holt LL, 2006, J ACOUST SOC AM, V119, P3059, DOI 10.1121/1.2188377; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kersten D, 2003, CURR OPIN NEUROBIOL, V13, P150, DOI 10.1016/S0959-4388(03)00042-4; Kluender K. R., 2008, SENSES COMPREHENSIVE, P829, DOI DOI 10.1016/B978-012370880-9.00067-0; Kluender KR, 1998, J ACOUST SOC AM, V104, P3568, DOI 10.1121/1.423939; Kluender KR, 1999, J ACOUST SOC AM, V105, P503, DOI 10.1121/1.424587; KLUENDER KR, 2006, HDB PSYCHOLINGUISTIC, P153, DOI DOI 10.1016/B978-012369374-7/50007-9; Kluender KR, VOWEL INHERENT SPECT; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Lisker L, 1978, SR54 HASK LAB STAT R, P127; Lu T, 2000, J NEUROPHYSIOL, V84, P236, DOI 10.1152/jn.2000.84.1.236; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; Maye J, 2008, DEVELOPMENTAL SCI, V11, P122, DOI 10.1111/j.1467-7687.2007.00653.x; MCCOLLOUGH C, 1965, SCIENCE, V149, P1115, DOI 10.1126/science.149.3688.1115; McMurray B, 2009, DEVELOPMENTAL SCI, V12, P369, DOI 10.1111/j.1467-7687.2009.00822.x; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Nelken I, 2003, BIOL CYBERN, V89, P397, DOI 10.1007/s00422-003-0445-3; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; Opolko F., 1989, MCGILL U MASTER SAMP; PATTERSON RD, 1982, J ACOUST SOC AM, V72, P1788, DOI 10.1121/1.388652; REPP BH, 1982, PSYCHOL BULL, V92, P81, DOI 10.1037/0033-2909.92.1.81; SANGER TD, 1989, NEURAL NETWORKS, V2, P459, DOI 10.1016/0893-6080(89)90044-0; Schwartz O, 2007, NAT REV NEUROSCI, V8, P522, DOI 10.1038/nrn2155; SEJNOWSKI IJ, 1977, J THEOR BIOL, V69, P385, DOI 10.1016/0022-5193(77)90146-1; SEJNOWSKI TJ, 1977, J MATH BIOL, V4, P303, DOI 10.1007/BF00275079; Simoncelli EP, 2003, CURR OPIN NEUROBIOL, V13, P144, DOI 10.1016/S0959-4388(03)00047-3; STANTON PK, 1989, NATURE, V339, P215, DOI 10.1038/339215a0; Stilp CE, 2011, J ACOUST SOC AM, V130, pEL352, DOI 10.1121/1.3647264; Stilp CE, 2010, P NATL ACAD SCI USA, V107, P21914, DOI 10.1073/pnas.1009020107; Stilp CE, 2010, P NATL ACAD SCI USA, V107, P12387, DOI 10.1073/pnas.0913625107; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Sullivan SC, 2010, J ACOUST SOC AM, V128, P2455; Sussman HM, 1998, BEHAV BRAIN SCI, V21, P241, DOI 10.1017/S0140525X98001174; SUSSMAN HM, 1991, J ACOUST SOC AM, V90, P1309, DOI 10.1121/1.401923; Toscano JC, 2010, COGNITIVE SCI, V34, P434, DOI 10.1111/j.1551-6709.2009.01077.x; Turnham EJA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001112; Vinje WE, 2002, J NEUROSCI, V22, P2904, DOI 10.1523/JNEUROSCI.22-07-02904.2002; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wang XQ, 2007, HEARING RES, V229, P81, DOI 10.1016/j.heares.2007.01.019; Xu J-M, ACM T EMBED COMP SYS	77	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30845	10.1371/journal.pone.0030845	http://dx.doi.org/10.1371/journal.pone.0030845			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	909NE	22292057	Green Published, gold			2022-12-27	WOS:000301570600086
J	Bastea, LI; Doppler, H; Balogun, B; Storz, P				Bastea, Ligia I.; Doeppler, Heike; Balogun, Bolanle; Storz, Peter			Protein Kinase D1 Maintains the Epithelial Phenotype by Inducing a DNA-Bound, Inactive SNAI1 Transcriptional Repressor Complex	PLOS ONE			English	Article							BREAST-CARCINOMA PROGRESSION; NF-KAPPA-B; E-CADHERIN; MESENCHYMAL TRANSITION; TUMOR PROGRESSION; PROMOTES METASTASIS; MEDIATED ACTIVATION; 14-3-3 BINDING; PHOSPHORYLATION; EXPRESSION	Background: Protein Kinase D1 is downregulated in its expression in invasive ductal carcinoma of the breast and in invasive breast cancer cells, but its functions in normal breast epithelial cells is largely unknown. The epithelial phenotype is maintained by cell-cell junctions formed by E-cadherin. In cancer cells loss of E-cadherin expression contributes to an invasive phenotype. This can be mediated by SNAI1, a transcriptional repressor for E-cadherin that contributes to epithelial-to-mesenchymal transition (EMT). Methodology/Principal Findings: Here we show that PKD1 in normal murine mammary gland (NMuMG) epithelial cells is constitutively-active in its basal state and prevents a transition to a mesenchymal phenotype. Investigation of the involved mechanism suggested that PKD1 regulates the expression of E-cadherin at the promoter level through direct phosphorylation of the transcriptional repressor SNAI1. PKD1-mediated phosphorylation of SNAI1 occurs in the nucleus and generates a nuclear, inactive DNA/SNAI1 complex that shows decreased interaction with its co-repressor Ajuba. Analysis of human tissue samples with a newly-generated phosphospecific antibody for PKD1-phosphorylated SNAI1 showed that regulation of SNAI1 through PKD1 occurs in vivo in normal breast ductal tissue and is decreased or lost in invasive ductal carcinoma. Conclusions/Significance: Our data describe a mechanism of how PKD1 maintains the breast epithelial phenotype. Moreover, they suggest, that the analysis of breast tissue for PKD-mediated phosphorylation of SNAI1 using our novel phosphoS11-SNAI1-specific antibody may allow predicting the invasive potential of breast cancer cells.	[Bastea, Ligia I.; Doeppler, Heike; Balogun, Bolanle; Storz, Peter] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Bastea, LI (corresponding author), Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA.	storz.peter@mayo.edu			Florida Department of Health [10BG11]; Mayo Clinic Breast Cancer SPORE [CA116201-03DR4]; NIH [GM086438, CA140182]; NATIONAL CANCER INSTITUTE [R01CA140182, P50CA116201] Funding Source: NIH RePORTER	Florida Department of Health; Mayo Clinic Breast Cancer SPORE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Bankhead-Coley grant (10BG11) from the Florida Department of Health, the Mayo Clinic Breast Cancer SPORE (CA116201-03DR4) and NIH grants GM086438 and CA140182 (all to PS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyanathan K, 2007, CANCER RES, V67, P9097, DOI 10.1158/0008-5472.CAN-07-2987; Barisic S, 2011, EMBO REP, V12, P527, DOI 10.1038/embor.2011.53; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cheng CW, 2001, ONCOGENE, V20, P3814, DOI 10.1038/sj.onc.1204505; Come C, 2004, J MAMMARY GLAND BIOL, V9, P183, DOI 10.1023/B:JOMG.0000037161.91969.de; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Cowell CF, 2009, J CELL BIOCHEM, V106, P714, DOI 10.1002/jcb.22067; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Du C, 2010, CANCER RES, V70, P7810, DOI 10.1158/0008-5472.CAN-09-4481; Du C, 2009, CANCER RES, V69, P1117, DOI 10.1158/0008-5472.CAN-07-6270; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hou ZY, 2008, MOL CELL BIOL, V28, P3198, DOI 10.1128/MCB.01435-07; Hou ZY, 2010, CANCER RES, V70, P4385, DOI 10.1158/0008-5472.CAN-10-0070; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Jaggi M, 2005, CANCER RES, V65, P483; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Kim M, 2008, CARCINOGENESIS, V29, P629, DOI 10.1093/carcin/bgm291; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peinado H, 2005, CELL CYCLE, V4, P1749, DOI 10.4161/cc.4.12.2224; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2004, J CELL SCI, V117, P2827, DOI 10.1242/jcs.01145; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peiro S, 2006, NUCLEIC ACIDS RES, V34, P2077, DOI 10.1093/nar/gkl141; Radisky DC, 2008, CELL STEM CELL, V2, P511, DOI 10.1016/j.stem.2008.05.007; MacPherson MR, 2010, MOL BIOL CELL, V21, P244, DOI 10.1091/mbc.E09-06-0504; Seki K, 2003, J BIOL CHEM, V278, P41862, DOI 10.1074/jbc.M308336200; Song J, 2006, AM J PHYSL CELL PHYS; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; Waldron RT, 2004, J BIOL CHEM, V279, P27482, DOI 10.1074/jbc.M402875200; Watkins JL, 2008, P NATL ACAD SCI USA, V105, P18378, DOI 10.1073/pnas.0809661105; Yin T, 2007, J SURG RES, V141, P196, DOI 10.1016/j.jss.2006.09.027; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	48	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30459	10.1371/journal.pone.0030459	http://dx.doi.org/10.1371/journal.pone.0030459			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276203	gold, Green Submitted, Green Published			2022-12-27	WOS:000301568100048
J	Li, FCH; Yen, JC; Chan, SHH; Chang, AYW				Li, Faith C. H.; Yen, Jiin-Cherng; Chan, Samuel H. H.; Chang, Alice Y. W.			Bioenergetics Failure and Oxidative Stress in Brain Stem Mediates Cardiovascular Collapse Associated with Fatal Methamphetamine Intoxication	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; SYSTEMIC ARTERIAL-PRESSURE; MITOCHONDRIAL RESPIRATORY-CHAIN; ENDOPLASMIC-RETICULUM STRESS; ACUTE MEVINPHOS INTOXICATION; INTENSIVE-CARE UNIT; NECROTIC CELL-DEATH; HEART-RATE SIGNALS; PROLIFE ROLE; VASOMOTOR COMPONENT	Background: Whereas sudden death, most often associated with cardiovascular collapse, occurs in abusers of the psychostimulant methamphetamine (METH), the underlying mechanism is much less understood. The demonstration that successful resuscitation of an arrested heart depends on maintained functionality of the rostral ventrolateral medulla (RVLM), which is responsible for the maintenance of stable blood pressure, suggests that failure of brain stem cardiovascular regulation, rather than the heart, holds the key to cardiovascular collapse. We tested the hypothesis that cessation of brain stem cardiovascular regulation because of a loss of functionality in RVLM mediated by bioenergetics failure and oxidative stress underlies the cardiovascular collapse elicited by lethal doses of METH. Methodology/Principal Findings: Survival rate, cardiovascular responses and biochemical or morphological changes in RVLM induced by intravenous administration of METH in Sprague-Dawley rats were investigated. High doses of METH induced significant mortality within 20 min that paralleled concomitant the collapse of arterial pressure or heart rate and loss of functionality in RVLM. There were concurrent increases in the concentration of METH in serum and ventrolateral medulla, along with tissue anoxia, cessation of microvascular perfusion and necrotic cell death in RVLM. Furthermore, mitochondrial respiratory chain enzyme activity or electron transport capacity and ATP production in RVLM were reduced, and mitochondria-derived superoxide anion level was augmented. All those detrimental physiological and biochemical events were reversed on microinjection into RVLM of a mobile electron carrier in the mitochondrial respiratory chain, coenzyme Q10; a mitochondria-targeted antioxidant and superoxide anion scavenger, Mito-TEMPO; or an oxidative stress-induced necrotic cell death inhibitor, IM-54. Conclusion: We conclude that sustained anoxia and cessation of local blood flow that leads to bioenergetics failure and oxidative stress because of mitochondrial dysfunction, leading to acute necrotic cell death in RVLM underpins cardiovascular collapse elicited by lethal doses of METH.	[Li, Faith C. H.; Yen, Jiin-Cherng] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Li, Faith C. H.; Chan, Samuel H. H.; Chang, Alice Y. W.] Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Kaohsiung, Taiwan	National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital	Li, FCH (corresponding author), Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan.	cgmf.kmc@gmail.com			Chang Gung Medical Foundation; Chang Gung Memorial Hospital, Taiwan, Republic of China [CMRPG891071]	Chang Gung Medical Foundation; Chang Gung Memorial Hospital, Taiwan, Republic of China(Chang Gung Memorial Hospital)	This work was supported by the Chang Gung Medical Foundation and the Chang Gung Memorial Hospital, Taiwan, Republic of China (Grant number CMRPG891071 to A.Y.W.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago Mihoko, 2006, Legal Medicine, V8, P235, DOI 10.1016/j.legalmed.2006.03.002; Bachmann RF, 2009, INT J NEUROPSYCHOPH, V12, P805, DOI 10.1017/S1461145708009802; Bowyer JF, 2006, SYNAPSE, V60, P521, DOI 10.1002/syn.20324; Brown JM, 2005, J NEUROCHEM, V95, P429, DOI 10.1111/j.1471-4159.2005.03379.x; Cevik IU, 2003, CELL DEATH DIFFER, V10, P928, DOI 10.1038/sj.cdd.4401250; Chan JYH, 2006, NEUROPHARMACOLOGY, V51, P1109, DOI 10.1016/j.neuropharm.2006.06.024; Chan JYH, 2007, J BIOL CHEM, V282, P4585, DOI 10.1074/jbc.M603394200; Chan JYH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017375; Chan JYH, 2005, PROG NEUROBIOL, V77, P396, DOI 10.1016/j.pneurobio.2005.11.004; CHAN P, 1994, J TOXICOL-CLIN TOXIC, V32, P147, DOI 10.3109/15563659409000444; Chan SHH, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-17; Chan SHH, 2005, CIRC RES, V97, P772, DOI 10.1161/01.RES.0000185804.79157.C0; Chan SHH, 2011, BRIT J PHAR IN PRESS; Chang AYW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007744; Chang AYW, 2009, SHOCK, V32, P651, DOI 10.1097/SHK.0b013e3181a71027; Choi J, 1997, ARCH PHARM RES, V20, P46, DOI 10.1007/BF02974041; Clarke P, 2009, FEBS J, V276, P6049, DOI 10.1111/j.1742-4658.2009.07328.x; CODY JT, 1992, J CHROMATOGR-BIOMED, V580, P77, DOI 10.1016/0378-4347(92)80529-Y; Dai KY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-72; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Dodo K, 2005, BIOORG MED CHEM LETT, V15, P3114, DOI 10.1016/j.bmcl.2005.04.016; ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3; FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879; Inoue Hiromasa, 2006, Legal Medicine, V8, P150, DOI 10.1016/j.legalmed.2005.12.004; Johnson BA, 2005, INT J NEUROPSYCHOPH, V8, P203, DOI 10.1017/S1461145704005036; Kadara H, 2007, CANCER BIOL THER, V6, P705, DOI 10.4161/cbt.6.5.3963; Karila L, 2010, BRIT J CLIN PHARMACO, V69, P578, DOI 10.1111/j.1365-2125.2010.03639.x; KATSUMATA S, 1993, FORENSIC SCI INT, V62, P209, DOI 10.1016/0379-0738(93)90209-S; Kaye S, 2008, ADDICTION, V103, P1353, DOI 10.1111/j.1360-0443.2008.02231.x; Kerrigan S, 2001, CLIN CHEM, V47, P540; Kiyatkin EA, 2007, EUR J NEUROSCI, V26, P1242, DOI 10.1111/j.1460-9568.2007.05741.x; Kiyatkin EA, 2009, INT REV NEUROBIOL, V88, P65, DOI 10.1016/S0074-7742(09)88004-5; KOJIMA T, 1984, FORENSIC SCI INT, V24, P87, DOI 10.1016/0379-0738(84)90156-7; Kuo TBJ, 1997, AM J PHYSIOL-HEART C, V272, pH485, DOI 10.1152/ajpheart.1997.272.1.H485; Kuo TBJ, 1997, AM J PHYSIOL-HEART C, V273, pH1291, DOI 10.1152/ajpheart.1997.273.3.H1291; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Li FCH, 2005, ANN NY ACAD SCI, V1042, P195, DOI 10.1196/annals.1338.048; Li PL, 2001, CIRCULATION, V103, P2114; Liang HL, 2010, FREE RADICAL BIO MED, V49, P1550, DOI 10.1016/j.freeradbiomed.2010.08.018; Liu HH, 2011, J CELL BIOCHEM, V112, P3695, DOI 10.1002/jcb.23303; Lu CC, 2010, MOL NUTR FOOD RES, V54, P967, DOI 10.1002/mnfr.200900265; Matthews RT, 1998, P NATL ACAD SCI USA, V95, P8892, DOI 10.1073/pnas.95.15.8892; Maxwell JC, 2008, DRUG ALCOHOL REV, V27, P229, DOI 10.1080/09595230801919460; Miyashita Tomoko, 2007, J Forensic Leg Med, V14, P444, DOI 10.1016/j.jflm.2007.01.006; Nadanaciva S, 2007, TOXICOL IN VITRO, V21, P902, DOI 10.1016/j.tiv.2007.01.011; Naganska E, 2001, FOLIA NEUROPATHOL, V39, P129; PALLIS C, 1983, BRIT MED J, V286, P39, DOI 10.1136/bmj.286.6358.39; Saito T, 1996, J Clin Forensic Med, V3, P183, DOI 10.1016/S1353-1131(96)90025-5; Sharma HS, 2009, J CHEM NEUROANAT, V37, P18, DOI 10.1016/j.jchemneu.2008.08.002; Shaw KP, 1999, J FORENSIC SCI, V44, P27; Shibata S, 1991, Neurol Med Chir (Tokyo), V31, P49, DOI 10.2176/nmc.31.49; Sodeoka M, 2010, CHEM REC, V10, P308, DOI 10.1002/tcr.201000031; SPYER KM, 1994, J PHYSIOL-LONDON, V474, P1; Takekawa K, 2007, J FORENSIC SCI, V52, P1219, DOI 10.1111/j.1556-4029.2007.00518.x; Tian CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005546; Tyagi N, 2010, J RECEPT SIG TRANSD, V30, P78, DOI 10.3109/10799891003614808; Varner KJ, 2002, J PHARMACOL EXP THER, V301, P152, DOI 10.1124/jpet.301.1.152; VITALE M, 1993, HISTOCHEMISTRY, V100, P223, DOI 10.1007/BF00269095; Wu CW, 2007, TOXICOL APPL PHARM, V220, P243, DOI 10.1016/j.taap.2007.01.011; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Yang CH, 1995, J PHARMACOL EXP THER, V275, P1568; Yen DHT, 2005, SHOCK, V23, P353, DOI 10.1097/01.shk.0000156673.44063.e8; Yen DHT, 2004, SHOCK, V21, P358, DOI 10.1097/00024382-200404000-00011; Yen DHT, 2000, CRIT CARE MED, V28, P2805, DOI 10.1097/00003246-200008000-00021; Yien HW, 1997, CRIT CARE MED, V25, P258, DOI 10.1097/00003246-199702000-00011	65	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30589	10.1371/journal.pone.0030589	http://dx.doi.org/10.1371/journal.pone.0030589			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276218	gold, Green Published, Green Submitted			2022-12-27	WOS:000301457200068
J	O'Brien, AM; Hanson, BM; Farina, SA; Wu, JY; Simmering, JE; Wardyn, SE; Forshey, BM; Kulick, ME; Wallinga, DB; Smith, TC				O'Brien, Ashley M.; Hanson, Blake M.; Farina, Sarah A.; Wu, James Y.; Simmering, Jacob E.; Wardyn, Shylo E.; Forshey, Brett M.; Kulick, Marie E.; Wallinga, David B.; Smith, Tara C.			MRSA in Conventional and Alternative Retail Pork Products	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; UNITED-STATES; EMERGENCY-DEPARTMENT; PORCINE ORIGIN; MEAT-PRODUCTS; ANIMAL ORIGIN; INFECTIONS; PREVALENCE; ST398	In order to examine the prevalence of Staphylococcus aureus on retail pork, three hundred ninety-five pork samples were collected from a total of 36 stores in Iowa, Minnesota, and New Jersey. S. aureus was isolated from 256 samples (64.8%, 95% confidence interval [CI] 59.9%-69.5%). S. aureus was isolated from 67.3% (202/300) of conventional pork samples and from 56.8% (54/95) of alternative pork samples (labeled `` raised without antibiotics'' or `` raised without antibiotic growth promotants''). Two hundred and thirty samples (58.2%, 95% CI 53.2%-63.1%) were found to carry methicillin-sensitive S. aureus (MSSA). MSSA was isolated from 61.0% (183/300) of conventional samples and from 49.5% (47/95) of alternative samples. Twenty-six pork samples (6.6%, 95% CI 4.3%-9.5%) carried methicillin-resistant S. aureus (MRSA). No statistically significant differences were observed for the prevalence of S. aureus in general, or MSSA or MRSA specifically, when comparing pork products from conventionally raised swine and swine raised without antibiotics, a finding that contrasts with a prior study from the Netherlands examining both conventional and "biologic" meat products. In our study spa types associated with "livestock-associated" ST398 (t034, t011) were found in 26.9% of the MRSA isolates, while 46.2% were spa types t002 and t008-common human types of MRSA that also have been found in live swine. The study represents the largest sampling of raw meat products for MRSA contamination to date in the U. S. MRSA prevalence on pork products was higher than in previous U. S.-conducted studies, although similar to that in Canadian studies.	[O'Brien, Ashley M.; Hanson, Blake M.; Farina, Sarah A.; Wu, James Y.; Simmering, Jacob E.; Wardyn, Shylo E.; Smith, Tara C.] Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Iowa City, IA 52242 USA; [O'Brien, Ashley M.; Hanson, Blake M.; Farina, Sarah A.; Wu, James Y.; Simmering, Jacob E.; Wardyn, Shylo E.; Forshey, Brett M.; Smith, Tara C.] Ctr Emerging Infect Dis, Coralville, IA USA; [Forshey, Brett M.] Univ Iowa, Dept Biostat, Coll Publ Hlth, Iowa City, IA USA; [Kulick, Marie E.; Wallinga, David B.] Inst Agr & Trade Policy, Minneapolis, MN USA	University of Iowa; University of Iowa	Smith, TC (corresponding author), Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Iowa City, IA 52242 USA.	tara-smith@uiowa.edu	Hanson, Blake/AAL-8522-2021	Hanson, Blake/0000-0003-2949-7818; Simmering, Jacob/0000-0001-9172-0983; Smith, Tara C./0000-0003-3747-1116	Claneil Foundation	Claneil Foundation	This study was funded, in part, with support from the Claneil Foundation. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosgelmez-Tinaz G, 2006, EUR J CLIN MICROBIOL, V25, P410, DOI 10.1007/s10096-006-0153-8; Chan PA, 2008, J FOOD AGRIC ENVIRON, V6, P71; Clinical and Laboratory Standard Institute (CBI), 2009, PERF STAND ANT SUS S; [CLSI Institute CaLS], 2006, M07A7 CLSI I CALS; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; de Jonge R, 2010, EUROSURVEILLANCE, V15, P17; Declercq P, 2008, INFECTION, V36, P590, DOI 10.1007/s15010-007-7029-4; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Frazee BW, 2005, ANN EMERG MED, V45, P311, DOI 10.1016/j.annemergmed.2004.10.011; Golding GR, 2010, EMERG INFECT DIS, V16, P587, DOI 10.3201/eid1604.091435; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Hanson B M, 2011, J Infect Public Health, V4, P169, DOI 10.1016/j.jiph.2011.06.001; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Larson KRL, 2011, APPL ENVIRON MICROB, V77, P696, DOI 10.1128/AEM.01128-10; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Lozano C, 2011, EMERG INFECT DIS, V17, P138, DOI 10.3201/eid1701.100307; Lozano C, 2009, J ANTIMICROB CHEMOTH, V64, P1325, DOI 10.1093/jac/dkp378; Maree CL, 2007, EMERG INFECT DIS, V13, P236, DOI 10.3201/eid1302.060781; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Mulders MN, 2010, EPIDEMIOL INFECT, P1; Noskin GA, 2005, ARCH INTERN MED, V165, P1756, DOI 10.1001/archinte.165.15.1756; Pu S, 2008, APPL ENV MICROBIOL; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Sunde M, 2011, J VET DIAGN INVEST, V23, P348, DOI 10.1177/104063871102300226; Van Cleef BA, 2010, EPIDEMIOL INFECT, P1; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van der Mee-Marquet N, 2011, CLIN INFECT DIS, V52, P152, DOI 10.1093/cid/ciq053; Van Hoecke H, 2009, LARYNGOSCOPE, V119, P137, DOI 10.1002/lary.20030; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Van Loo IHM, 2007, EMERG INFECT DIS, V13, P1753, DOI 10.3201/eid1311.070358; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Waters AE, 2011, CLIN INFECT DIS, V52, P1227, DOI 10.1093/cid/cir181; Weese JS, 2010, LETT APPL MICROBIOL, V51, P338, DOI 10.1111/j.1472-765X.2010.02901.x; Weese JS, 2010, CAN VET J, V51, P749; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026	40	99	99	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30092	10.1371/journal.pone.0030092	http://dx.doi.org/10.1371/journal.pone.0030092			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276147	Green Published, Green Submitted, gold			2022-12-27	WOS:000301457200032
J	Dada, L; Gonzalez, AR; Urich, D; Soberanes, S; Manghi, TS; Chiarella, SE; Chandel, NS; Budinger, GRS; Mutlu, GM				Dada, Laura; Gonzalez, Angel R.; Urich, Daniela; Soberanes, Saul; Manghi, Tomas S.; Chiarella, Sergio E.; Chandel, Navdeep S.; Budinger, G. R. Scott; Mutlu, Goekhan M.			Alcohol Worsens Acute Lung Injury by Inhibiting Alveolar Sodium Transport through the Adenosine A1 Receptor	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RESPIRATORY-DISTRESS-SYNDROME; FLUID CLEARANCE; NA,K-ATPASE ENDOCYTOSIS; EXTRACELLULAR ADENOSINE; ETHANOL INGESTION; EPITHELIAL-CELLS; PULMONARY-EDEMA; ABUSE; GLUTATHIONE	Objective: Alcohol intake increases the risk of acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS) and is associated with poor outcomes in patients who develop these syndromes. No specific therapies are currently available to treat or decrease the risk of ARDS in patients with alcoholism. We have recently shown increased levels of lung adenosine inhibit alveolar fluid clearance, an important predictor of outcome in patients with ARDS. We hypothesized that alcohol might worsen lung injury by increasing lung adenosine levels, resulting in impaired active Na+ transport in the lung. Methods: We treated wild-type mice with alcohol administered i.p. to achieve blood alcohol levels associated with moderate to severe intoxication and measured the rate of alveolar fluid clearance and Na,K-ATPase expression in peripheral lung tissue and assessed the effect of alcohol on survival during exposure to hyperoxia. We used primary rat alveolar type II cells to investigate the mechanisms by which alcohol regulates alveolar Na+ transport. Results: Exposure to alcohol reduced alveolar fluid clearance, downregulated Na,K-ATPase in the lung tissue and worsened hyperoxia-induced lung injury. Alcohol caused an increase in BAL fluid adenosine levels. A similar increase in lung adenosine levels was observed after exposure to hyperoxia. In primary rat alveolar type II cells alcohol and adenosine decreased the abundance of the Na,K-ATPase at the basolateral membrane via a mechanism that required activation of the AMPK. Conclusions: Alcohol decreases alveolar fluid clearance and impairs survival from acute lung injury. Alcohol induced increases in lung adenosine levels may be responsible for reduction in alveolar fluid clearance and associated worsening of lung injury.	[Dada, Laura; Gonzalez, Angel R.; Urich, Daniela; Soberanes, Saul; Manghi, Tomas S.; Chiarella, Sergio E.; Chandel, Navdeep S.; Budinger, G. R. Scott; Mutlu, Goekhan M.] Northwestern Univ, Dept Med, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Dada, L (corresponding author), Northwestern Univ, Dept Med, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA.	g-mutlu@northwestern.edu	Mutlu, Gokhan/HIR-2545-2022	Chiarella, Sergio/0000-0002-0445-4929	National Institutes of Health [ES015024, ES013995, P01HL071643]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015024, R01ES013995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Grant Support: National Institutes of Health ES015024 (GMM), ES013995 (GRSB), and P01HL071643 (LD, GMM, NSC and GRSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELL M, 1994, NEW ENGL J MED, V331, P537, DOI 10.1056/NEJM199408253310810; Azzam ZS, 2002, CIRCULATION, V105, P497, DOI 10.1161/hc0402.102848; Bellmeyer A, 2007, AM J RESP CRIT CARE, V175, P587, DOI 10.1164/rccm.200603-312OC; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Brown LAS, 2001, ALCOHOL CLIN EXP RES, V25, P1078, DOI 10.1111/j.1530-0277.2001.tb02320.x; Budinger GRS, 2005, J CLIN INVEST, V115, P828, DOI 10.1172/JCI200524681; Budinger GRS, 1996, AM J PHYSIOL-LUNG C, V270, pL44, DOI 10.1152/ajplung.1996.270.1.L44; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P866; Dada LA, 2003, J CLIN INVEST, V111, P1057, DOI 10.1172/JCI200316826; Dada LA, 2007, CELL SIGNAL, V19, P1893, DOI 10.1016/j.cellsig.2007.04.013; Dohrman DP, 1997, ALCOHOL HEALTH RES W, V21, P136; Dumasius V, 2002, CHEST, V121, p33S, DOI 10.1378/chest.121.3_suppl.33S; Dumasius V, 2001, CIRC RES, V89, P907, DOI 10.1161/hh2201.100204; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eckle T, 2009, PHYSIOLOGY, V24, P298, DOI 10.1152/physiol.00022.2009; Factor P, 1998, J CLIN INVEST, V102, P1421, DOI 10.1172/JCI3214; Factor P, 2007, P NATL ACAD SCI USA, V104, P4083, DOI 10.1073/pnas.0601117104; GENTRY RT, 1983, PHYSIOL BEHAV, V31, P529, DOI 10.1016/0031-9384(83)90077-X; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Guidot DM, 2000, ALCOHOL CLIN EXP RES, V24, P1070, DOI 10.1097/00000374-200007000-00019; Guidot DM, 2005, J INVEST MED, V53, P235, DOI 10.2310/6650.2005.53506; Guidot DM, 2000, AM J PHYSIOL-LUNG C, V279, pL127, DOI 10.1152/ajplung.2000.279.1.L127; Gusarova GA, 2009, MOL CELL BIOL, V29, P3455, DOI 10.1128/MCB.00054-09; Hallows KR, 2003, AM J PHYSIOL-CELL PH, V284, pC1297, DOI 10.1152/ajpcell.00227.2002; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Huszar E, 1996, CHROMATOGRAPHIA, V42, P318, DOI 10.1007/BF02290317; Joshi PC, 2007, AM J PHYSIOL-LUNG C, V292, pL813, DOI 10.1152/ajplung.00348.2006; Kongsuphol P, 2009, J BIOL CHEM, V284, P5645, DOI 10.1074/jbc.M806780200; KRAUSS SW, 1993, MOL PHARMACOL, V44, P1021; Lecuona E, 2009, J CELL SCI, V122, P3915, DOI 10.1242/jcs.046953; Li J, 2011, EUR J PHARMACOL, V654, P295, DOI 10.1016/j.ejphar.2010.12.040; Moss M, 2003, CRIT CARE MED, V31, P869, DOI 10.1097/01.CCM.0000055389.64497.11; Moss M, 1996, JAMA-J AM MED ASSOC, V275, P50, DOI 10.1001/jama.275.1.50; Mutlu G, 2005, CIRC RES, V96, P999, DOI 10.1161/01.RES.0000164554.21993.AC; Mutlu GM, 2005, AM J PHYSIOL-LUNG C, V289, pL685, DOI 10.1152/ajplung.00247.2005; Mutlu GM, 2004, AM J RESP CRIT CARE, V170, P1270, DOI 10.1164/rccm.200404-470CP; Mutlu GM, 2004, CRIT CARE MED, V32, P1607, DOI 10.1097/01.CCM.0000130825.84691.E2; Mutlu GM, 2004, CIRC RES, V94, P1091, DOI 10.1161/01.RES.0000125623.56442.20; Mutlu GM, 2008, AM J RESP CELL MOL, V38, P127, DOI 10.1165/rcmb.2007-0198TR; NAGY LE, 1989, MOL PHARMACOL, V36, P744; NAGY LE, 1990, J BIOL CHEM, V265, P1946; Neely CF, 1997, AM J PHYSIOL-LUNG C, V272, pL353, DOI 10.1152/ajplung.1997.272.2.L353; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-1302OC; Ridge KM, 2003, CIRC RES, V92, P453, DOI 10.1161/01.RES.0000059414.10360.F2; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Soberanes S, 2009, J BIOL CHEM, V284, P2176, DOI 10.1074/jbc.M808844200; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Vizi E, 2002, J ALLERGY CLIN IMMUN, V109, P446, DOI 10.1067/mai.2002.121955; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Welch LC, 2010, FEBS LETT, V584, P3985, DOI 10.1016/j.febslet.2010.08.002; Wolk KE, 2008, AM J RESP CRIT CARE, V178, P969, DOI 10.1164/rccm.200803-455OC	58	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30448	10.1371/journal.pone.0030448	http://dx.doi.org/10.1371/journal.pone.0030448			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272351	Green Published, Green Submitted, gold			2022-12-27	WOS:000301454400129
J	Diepold, K; Bomans, K; Wiedmann, M; Zimmermann, B; Petzold, A; Schlothauer, T; Mueller, R; Moritz, B; Stracke, JO; Molhoj, M; Reusch, D; Bulau, P				Diepold, Katharina; Bomans, Katrin; Wiedmann, Michael; Zimmermann, Boris; Petzold, Andreas; Schlothauer, Tilman; Mueller, Robert; Moritz, Bernd; Stracke, Jan Olaf; Molhoj, Michael; Reusch, Dietmar; Bulau, Patrick			Simultaneous Assessment of Asp Isomerization and Asn Deamidation in Recombinant Antibodies by LC-MS following Incubation at Elevated Temperatures	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; MASS-SPECTROMETRY; ASPARTATE ISOMERIZATION; ASPARAGINE DEAMIDATION; IDENTIFICATION; SUCCINIMIDE; PROTEINS; SITES; HETEROGENEITY; QUANTIFICATION	The degradation of proteins by asparagine deamidation and aspartate isomerization is one of several chemical degradation pathways for recombinant antibodies. In this study, we have identified two solvent accessible degradation sites (light chain aspartate-56 and heavy chain aspartate-99/101) in the complementary-determining regions of a recombinant IgG1 antibody susceptible to isomerization under elevated temperature conditions. For both hot-spots, the degree of isomerization was found to be significantly higher than the deamidation of asparagine-(387, 392, 393) in the conserved CH3 region, which has been identified as being solvent accessible and sensitive to chemical degradation in previous studies. In order to reduce the time for simultaneous identification and functional evaluation of potential asparagine deamidation and aspartate isomerization sites, a test system employing accelerated temperature conditions and proteolytic peptide mapping combined with quantitative UPLC-MS was developed. This method occupies the formulation buffer system histidine/HCl (20 mM; pH 6.0) for denaturation/reduction/digestion and eliminates the alkylation step. The achieved degree of asparagine deamidation and aspartate isomerization was adequate to identify the functional consequence by binding studies. In summary, the here presented approach greatly facilitates the evaluation of fermentation, purification, formulation, and storage conditions on antibody asparagine deamidation and aspartate isomerization by monitoring susceptible marker peptides located in the complementary-determining regions of recombinant antibodies.	[Diepold, Katharina; Bomans, Katrin; Wiedmann, Michael; Petzold, Andreas; Schlothauer, Tilman; Stracke, Jan Olaf; Molhoj, Michael; Reusch, Dietmar; Bulau, Patrick] Roche Diagnost GmbH, Pharma Res & Dev Penzberg, Penzberg, Germany; [Zimmermann, Boris] Roche Diagnost GmbH, Pharma Biotech Penzberg, Penzberg, Germany; [Mueller, Robert] F Hoffmann La Roche & Co Ltd, Late Stage Pharmaceut & Proc Dev, CH-4002 Basel, Switzerland; [Moritz, Bernd] F Hoffmann La Roche & Co Ltd, Analyt Res & Dev, Basel, Switzerland	Roche Holding; Roche Holding; Roche Holding; Roche Holding	Diepold, K (corresponding author), Roche Diagnost GmbH, Pharma Res & Dev Penzberg, Penzberg, Germany.	patrick.bulau@roche.com		Bulau, Patrick/0000-0002-7121-2954				Cacia J, 1996, BIOCHEMISTRY-US, V35, P1897, DOI 10.1021/bi951526c; CARR SA, 1991, ANAL CHEM, V63, P2802, DOI 10.1021/ac00024a003; Chelius D, 2005, ANAL CHEM, V77, P6004, DOI 10.1021/ac050672d; Chu GC, 2007, PHARM RES-DORDR, V24, P1145, DOI 10.1007/s11095-007-9241-4; Cournoyer JJ, 2005, PROTEIN SCI, V14, P452, DOI 10.1110/ps.041062905; FLATMARK T, 1968, J BIOL CHEM, V243, P1623; HARDING JJ, 1989, MECH AGEING DEV, V50, P7, DOI 10.1016/0047-6374(89)90054-7; Harris RJ, 2005, DEV BIOLOGICALS, V122, P117; Harris RJ, 2001, J CHROMATOGR B, V752, P233, DOI 10.1016/S0378-4347(00)00548-X; Hensel M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017708; Huang HZ, 2009, ANAL CHEM, V81, P1686, DOI 10.1021/ac802708s; Huang LH, 2005, ANAL CHEM, V77, P1432, DOI 10.1021/ac0494174; KROON DJ, 1992, PHARMACEUT RES, V9, P1386, DOI 10.1023/A:1015894409623; KWONG MY, 1994, PROTEIN SCI, V3, P147; LOWENSON J, 1988, BLOOD CELLS, V14, P103; OTA IM, 1987, J BIOL CHEM, V262, P8522; PABORJI M, 1994, PHARMACEUT RES, V11, P764, DOI 10.1023/A:1018948901599; POTTER SM, 1993, PROTEIN SCI, V2, P1648, DOI 10.1002/pro.5560021011; Robinson NE, 2006, RAPID COMMUN MASS SP, V20, P3535, DOI 10.1002/rcm.2767; Schmid DG, 2001, ANAL CHEM, V73, P6008, DOI 10.1021/ac0104274; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; TESHIMA G, 1991, J BIOL CHEM, V266, P13544; Timm V, 2010, J CHROMATOGR B, V878, P777, DOI 10.1016/j.jchromb.2010.01.036; Vlasak J, 2008, CURR PHARM BIOTECHNO, V9, P468, DOI 10.2174/138920108786786402; Wakankar AA, 2006, J PHARM SCI-US, V95, P2321, DOI 10.1002/jps.20740; Xiao G, 2007, ANAL CHEM, V79, P2714, DOI 10.1021/ac0617870; Yan BX, 2009, J PHARM SCI-US, V98, P3509, DOI 10.1002/jps.21655; Yang HQ, 2010, ELECTROPHORESIS, V31, P1764, DOI 10.1002/elps.201000027; Yu XC, 2011, ANAL CHEM, V83, P5912, DOI 10.1021/ac200750u; Zabrouskov V, 2006, BIOCHEMISTRY-US, V45, P987, DOI 10.1021/bi0517584; Zhang J, 2011, ANAL BIOCHEM, V410, P234, DOI 10.1016/j.ab.2010.11.040	31	85	90	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30295	10.1371/journal.pone.0030295	http://dx.doi.org/10.1371/journal.pone.0030295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272329	gold, Green Submitted, Green Published			2022-12-27	WOS:000301454400107
J	Fratta Pasini, A; Albiero, A; Stranieri, C; Cominacini, M; Pasini, A; Mozzini, C; Vallerio, P; Cominacini, L; Garbin, U				Fratta Pasini, Anna; Albiero, Anna; Stranieri, Chiara; Cominacini, Mattia; Pasini, Andrea; Mozzini, Chiara; Vallerio, Paola; Cominacini, Luciano; Garbin, Ulisse			Serum Oxidative Stress-Induced Repression of Nrf2 and GSH Depletion: A Mechanism Potentially Involved in Endothelial Dysfunction of Young Smokers	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; NITRIC-OXIDE BIOSYNTHESIS; FLOW-MEDIATED DILATATION; ARTERIES IN-VIVO; OXIDIZED PHOSPHOLIPIDS; CIGARETTE-SMOKING; BRACHIAL-ARTERY; DEPENDENT DILATION; HEME OXYGENASE-1; HEALTHY SMOKERS	Background: Although oxidative stress plays a major role in endothelial dysfunction (ED), the role of glutathione (GSH), of nuclear erythroid-related factor 2 (Nrf2) and of related antioxidant genes (ARE) are yet unknown. In this study we combined an in vivo with an in vitro model to assess whether cigarette smoking affects flow-mediated vasodilation (FMD), GSH concentrations and the Nrf2/ARE pathway in human umbilical vein endothelial cells (HUVECs). Methods and Results: 52 healthy subjects (26 non-smokers and 26 heavy smokers) were enrolled in this study. In smokers we demonstrated increased oxidative stress, i.e., reduced concentrations of GSH and increased concentrations of oxidation products of the phospholipid 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (oxPAPC) in serum and in peripheral blood mononuclear cells (PBMC), used as in vivo surrogates of endothelial cells. Moreover we showed impairment of FMD in smokers and a positive correlation with the concentration of GSH in PBMC of all subjects. In HUVECs exposed to smokers' serum but not to non-smokers' serum we found that oxidative stress increased, whereas nitric oxide and GSH concentrations decreased; interestingly the expression of Nrf2, of heme oxygenase-1 (HO-1) and of glutamate-cysteine ligase catalytic (GCLC) subunit, the rate-limiting step of synthesis of GSH, was decreased. To test the hypothesis that the increased oxidative stress in smokers may have a causal role in the repression of Nrf2/ARE pathway, we exposed HUVECs to increasing concentrations of oxPAPC and found that at the highest concentration (similar to that found in smokers' serum) the expression of Nrf2/ARE pathway was reduced. The knockdown of Nrf2 was associated to a significant reduction of HO-1 and GCLC expression induced by oxPAPC in ECs. Conclusions: In young smokers with ED a novel further consequence of increased oxidative stress is a repression of Nrf2/ARE pathway leading to GSH depletion.	[Fratta Pasini, Anna; Albiero, Anna; Stranieri, Chiara; Cominacini, Mattia; Pasini, Andrea; Mozzini, Chiara; Vallerio, Paola; Cominacini, Luciano; Garbin, Ulisse] Univ Verona, Dept Med, Sect Internal Med D, I-37100 Verona, Italy	University of Verona	Fratta Pasini, A (corresponding author), Univ Verona, Dept Med, Sect Internal Med D, I-37100 Verona, Italy.	anna.frattapasini@univr.it	cominacini, luciano/B-2775-2011; Stranieri, Chiara/GWV-1749-2022; mozzini, chiara/AAW-3028-2021		Fondazione Cariverona, Verona, Italy; Ministry of University and Scientific Research of Italy	Fondazione Cariverona, Verona, Italy(Fondazione Cariverona); Ministry of University and Scientific Research of Italy(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by Fondazione Cariverona, Verona, Italy; by grants from the Ministry of University and Scientific Research of Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barua RS, 2003, CIRCULATION, V107, P2342, DOI 10.1161/01.CIR.0000066691.52789.BE; Barua RS, 2001, CIRCULATION, V104, P1905, DOI 10.1161/hc4101.097525; Benowitz NL, 2003, PROG CARDIOVASC DIS, V46, P91, DOI 10.1016/S0033-0620(03)00087-2; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Boutten A, 2010, EXPERT OPIN THER TAR, V14, P329, DOI 10.1517/14728221003629750; CELERMAJER DS, 1993, CIRCULATION, V88, P2149, DOI 10.1161/01.CIR.88.5.2149; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P1468, DOI 10.1016/0735-1097(94)90141-4; Chen L, 1997, AM J PHYSIOL, V42, P1854; Cominacini L, 2005, J AM COLL CARDIOL, V46, P799, DOI 10.1016/j.jacc.2005.05.063; Cominacini L, 1998, J HYPERTENS, V16, P1913, DOI 10.1097/00004872-199816121-00010; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Cortese-Krott MM, 2009, AM J PHYSIOL-CELL PH, V296, pC811, DOI 10.1152/ajpcell.00643.2008; Csiszar A, 2009, FRONT BIOSCI-LANDMRK, V14, P3128, DOI 10.2741/3440; Deanfield J, 2005, J HYPERTENS, V23, P7, DOI 10.1097/00004872-200501000-00004; Dulak J, 2008, CURR OPIN LIPIDOL, V19, P505, DOI 10.1097/MOL.0b013e32830d81e9; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Fennessy FM, 2003, CIRCULATION, V107, P410, DOI 10.1161/01.CIR.0000046447.72402.47; Fratta Pasini A, 2007, ARTERIOSCL THROM VAS, V27, P1991, DOI 10.1161/ATVBAHA.107.142695; Fruhwirth GO, 2007, BBA-MOL BASIS DIS, V1772, P718, DOI 10.1016/j.bbadis.2007.04.009; Garbin U, 2007, PHARMACOL RES, V56, P515, DOI 10.1016/j.phrs.2007.09.015; Garbin U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008225; Gemignani V, 2008, ULTRASOUND MED BIOL, V34, P385, DOI 10.1016/j.ultrasmedbio.2007.08.006; Goven D, 2009, FEBS LETT, V583, P3508, DOI 10.1016/j.febslet.2009.10.010; Gruber F, 2007, J BIOL CHEM, V282, P16934, DOI 10.1074/jbc.M702523200; HASHIMOTO M, 1995, CIRCULATION, V92, P3431, DOI 10.1161/01.CIR.92.12.3431; JOANNIDES R, 1995, CIRCULATION, V91, P1314, DOI 10.1161/01.CIR.91.5.1314; Jyrkkanen HK, 2008, CIRC RES, V103, pE1, DOI 10.1161/CIRCRESAHA.108.176883; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Moriarty SE, 2003, FREE RADICAL BIO MED, V35, P1582, DOI 10.1016/j.freeradbiomed.2003.09.006; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nguyen H, 2001, TOXICOLOGY, V160, P207, DOI 10.1016/S0300-483X(00)00450-9; OBRIEN MC, 1995, CYTOMETRY, V19, P243, DOI 10.1002/cyto.990190308; Pae HO, 2010, NITRIC OXIDE-BIOL CH, V23, P251, DOI 10.1016/j.niox.2010.08.002; Park EM, 1998, FREE RADICAL BIO MED, V25, P79, DOI 10.1016/S0891-5849(98)00041-0; Pasini Anna Fratta, 2005, Journal of Hypertension, V23, P589, DOI 10.1097/01.hjh.0000160216.86597.ff; Rahman I, 1999, AM J PHYSIOL-LUNG C, V277, pL1067, DOI 10.1152/ajplung.1999.277.6.L1067; Raij L, 2001, J HYPERTENS, V19, P891, DOI 10.1097/00004872-200105000-00009; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Siepi D, 2002, ANN NUTR METAB, V46, P32, DOI 10.1159/000046750; Stamler JS, 1996, NUTR REV, V54, P1; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Suzuki M, 2008, AM J RESP CELL MOL, V39, P673, DOI 10.1165/rcmb.2007-0424OC; Tanriverdi H, 2006, CIRC J, V70, P593, DOI 10.1253/circj.70.593; UBBINK JB, 1991, J CHROMATOGR-BIOMED, V565, P441, DOI 10.1016/0378-4347(91)80407-4; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Yufu K, 2007, HYPERTENS RES, V30, P607, DOI 10.1291/hypres.30.607; ZANG LY, 1995, FREE RADICAL BIO MED, V19, P161, DOI 10.1016/0891-5849(94)00236-D	49	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30291	10.1371/journal.pone.0030291	http://dx.doi.org/10.1371/journal.pone.0030291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272327	Green Published, gold			2022-12-27	WOS:000301454400105
J	Butler, MO; Imataki, O; Yamashita, Y; Tanaka, M; Ansen, S; Berezovskaya, A; Metzler, G; Milstein, MI; Mooney, MM; Murray, AP; Mano, H; Nadler, LM; Hirano, N				Butler, Marcus O.; Imataki, Osamu; Yamashita, Yoshihiro; Tanaka, Makito; Ansen, Sascha; Berezovskaya, Alla; Metzler, Genita; Milstein, Matthew I.; Mooney, Mary M.; Murray, Andrew P.; Mano, Hiroyuki; Nadler, Lee M.; Hirano, Naoto			Ex Vivo Expansion of Human CD8(+) T Cells Using Autologous CD4(+) T Cell Help	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; ANTIGEN-PRESENTING CELLS; CUTTING EDGE; ADOPTIVE IMMUNOTHERAPY; METASTATIC MELANOMA; CANCER REGRESSION; TRANSFER THERAPY; CD27 EXPRESSION; PHASE-I; IMMUNITY	Background: Using in vivo mouse models, the mechanisms of CD4(+) T cell help have been intensively investigated. However, a mechanistic analysis of human CD4(+) T cell help is largely lacking. Our goal was to elucidate the mechanisms of human CD4(+) T cell help of CD8(+) T cell proliferation using a novel in vitro model. Methods/Principal Findings: We developed a genetically engineered novel human cell-based artificial APC, aAPC/mOKT3, which expresses a membranous form of the anti-CD3 monoclonal antibody OKT3 as well as other immune accessory molecules. Without requiring the addition of allogeneic feeder cells, aAPC/mOKT3 enabled the expansion of both peripheral and tumor-infiltrating T cells, regardless of HLA-restriction. Stimulation with aAPC/mOKT3 did not expand Foxp3(+) regulatory T cells, and expanded tumor infiltrating lymphocytes predominantly secreted Th1-type cytokines, interferonthis aAPC-based system, the presence of autologous CD4(+) T cells was associated with significantly improved CD8(+) T cell expansion in vitro. The CD4(+) T cell derived cytokines IL-2 and IL-21 were necessary but not sufficient for this effect. However, CD4(+) T cell help of CD8(+) T cell proliferation was partially recapitulated by both adding IL-2/IL-21 and by upregulation of IL21 receptor on CD8(+) T cells. Conclusions: We have developed an in vitro model that advances our understanding of the immunobiology of human CD4(+) T cell help of CD8(+) T cells. Our data suggests that human CD4(+) T cell help can be leveraged to expand CD8(+) T cells in vitro.	[Butler, Marcus O.; Imataki, Osamu; Tanaka, Makito; Ansen, Sascha; Berezovskaya, Alla; Metzler, Genita; Milstein, Matthew I.; Mooney, Mary M.; Murray, Andrew P.; Nadler, Lee M.; Hirano, Naoto] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Butler, Marcus O.; Imataki, Osamu; Tanaka, Makito; Ansen, Sascha; Nadler, Lee M.; Hirano, Naoto] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Butler, Marcus O.; Imataki, Osamu; Tanaka, Makito; Ansen, Sascha; Nadler, Lee M.; Hirano, Naoto] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Yamashita, Yoshihiro; Mano, Hiroyuki] Jichi Med Univ, Div Funct Genom, Shimotsuke, Tochigi, Japan; [Mano, Hiroyuki] Univ Tokyo, Dept Med Genom, Tokyo, Japan; [Hirano, Naoto] Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Immune Therapy Program, Toronto, ON M4X 1K9, Canada; [Hirano, Naoto] Univ Toronto, Dept Immunol, Toronto, ON, Canada	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Jichi Medical University; University of Tokyo; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Butler, MO (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	nhirano@uhnres.utoronto.ca		Murray, Andrew/0000-0003-3657-4738; Butler, Marcus/0000-0002-9840-7057	Madeleine Franchi Ovarian Research Fund; Dunkin Donuts Rising Stars Awards; Cancer Research Institute; NIH [K22 CA129240, R01 CA148673]; American Society of Hematology; NATIONAL CANCER INSTITUTE [K22CA129240, R01CA148673] Funding Source: NIH RePORTER	Madeleine Franchi Ovarian Research Fund; Dunkin Donuts Rising Stars Awards; Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Madeleine Franchi Ovarian Research Fund (MOB), Dunkin Donuts Rising Stars Awards (MOB and NH), a grant from the Cancer Research Institute (LMN), NIH grant K22 CA129240 (NH), NIH grant R01 CA148673 (NH), and the American Society of Hematology Scholar Award (NH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AK, 2008, SCAND J IMMUNOL, V68, P103, DOI 10.1111/j.1365-3083.2008.02118.x; Bachmann MF, 2007, EUR J IMMUNOL, V37, P1502, DOI 10.1002/eji.200637023; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Berger C, 2009, CURR OPIN IMMUNOL, V21, P224, DOI 10.1016/j.coi.2009.02.010; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bollard CM, 2007, BLOOD, V110, P2838, DOI 10.1182/blood-2007-05-091280; Butler M, 2009, BLOOD, V114, P782; Butler MO, 2007, CLIN CANCER RES, V13, P1857, DOI 10.1158/1078-0432.CCR-06-1905; Butler MO, 2010, INT IMMUNOL, V22, P863, DOI 10.1093/intimm/dxq440; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; de Totero D, 2006, BLOOD, V107, P3708, DOI 10.1182/blood-2005-09-3535; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2003, J IMMUNOTHER, V26, P332, DOI 10.1097/00002371-200307000-00005; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Haque T, 2007, BLOOD, V110, P1123, DOI 10.1182/blood-2006-12-063008; Hirano N, 2006, BLOOD, V107, P1528, DOI 10.1182/blood-2005-05-2073; Huang JP, 2006, J IMMUNOL, V176, P7726, DOI 10.4049/jimmunol.176.12.7726; Huang JP, 2005, J IMMUNOTHER, V28, P258, DOI 10.1097/01.cji.0000158855.92792.7a; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Klebanoff CA, 2005, TRENDS IMMUNOL, V26, P111, DOI 10.1016/j.it.2004.12.003; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kusuda T, 2005, ONCOL REP, V13, P1153; Lamers C. H. J., 2006, J CLIN ONCOL, V24, pE20, DOI [10.1200/JCO.2006.05.9964, DOI 10.1200/JCO.2006.05.9964]; Lee BO, 2003, J EXP MED, V198, P1759, DOI 10.1084/jem.20031440; Levine BL, 1997, J IMMUNOL, V159, P5921; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Mackensen A, 2006, J CLIN ONCOL, V24, P5060, DOI 10.1200/JCO.2006.07.1100; Mantovani A, 2008, LANCET, V371, P771, DOI 10.1016/S0140-6736(08)60241-X; Marth C, 2004, AM J OBSTET GYNECOL, V191, P1598, DOI 10.1016/j.ajog.2004.05.007; Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143; Mihm MC, 1996, LAB INVEST, V74, P43; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Numbenjapon T, 2006, LEUKEMIA, V20, P1889, DOI 10.1038/sj.leu.2404329; Ochsenbein AF, 2004, J EXP MED, V200, P1407, DOI 10.1084/jem.20040717; Oh S, 2008, P NATL ACAD SCI USA, V105, P5201, DOI 10.1073/pnas.0801003105; Parmiani G, 2007, J IMMUNOL, V178, P1975, DOI 10.4049/jimmunol.178.4.1975; Peggs KS, 2003, LANCET, V362, P1375, DOI 10.1016/S0140-6736(03)14634-X; Pellegrini M, 2010, TRENDS PHARMACOL SCI, V31, P356, DOI 10.1016/j.tips.2010.05.003; Powell DJ, 2005, BLOOD, V105, P241, DOI 10.1182/blood-2004-06-2482; Prazma CM, 2007, J IMMUNOL, V179, P4550, DOI 10.4049/jimmunol.179.7.4550; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Robbins PF, 2004, J IMMUNOL, V173, P7125, DOI 10.4049/jimmunol.173.12.7125; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Shimizu J, 1999, J IMMUNOL, V163, P5211; Soiffer R, 1998, P NATL ACAD SCI USA, V95, P13141, DOI 10.1073/pnas.95.22.13141; Suhoski MM, 2007, MOL THER, V15, P981, DOI 10.1038/mt.sj.6300134; Sun JC, 2004, J IMMUNOL, V172, P3385, DOI 10.4049/jimmunol.172.6.3385; Till BG, 2008, BLOOD, V112, P2261, DOI 10.1182/blood-2007-12-128843; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Wilke CM, 2010, INT J CANCER, V127, P748, DOI 10.1002/ijc.25464; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wilson EB, 2008, J IMMUNOL, V181, P7445, DOI 10.4049/jimmunol.181.11.7445; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhou JH, 2005, J IMMUNOL, V175, P7046, DOI 10.4049/jimmunol.175.10.7046; Zhou JH, 2005, J IMMUNOTHER, V28, P53, DOI 10.1097/00002371-200501000-00007	71	40	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e30229	10.1371/journal.pone.0030229	http://dx.doi.org/10.1371/journal.pone.0030229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22279573	Green Published, Green Submitted, gold			2022-12-27	WOS:000301357100047
J	Houot, B; Fraichard, S; Greenspan, RJ; Ferveur, JF				Houot, Benjamin; Fraichard, Stephane; Greenspan, Ralph J.; Ferveur, Jean-Francois			Genes Involved in Sex Pheromone Discrimination in Drosophila melanogaster and Their Background-Dependent Effect	PLOS ONE			English	Article							CUTICULAR HYDROCARBONS; BEHAVIOR; MALES; EXPRESSION; COURTSHIP; MUTATION; PROTEIN; TASTE; LOCI; PCR	Mate choice is based on the comparison of he sensory quality of potential mating partners, and sex pheromones play an important role in this process. In Drosophila melanogaster, contact pheromones differ between male and female in the content and in their effects on male courtship, both inhibitory and stimulatory. To investigate the genetic basis of x pheromone discrimination, we experimentally selected males showing either a higher or lower ability to discriminate sex pheromones over 20 generations. This experimental selection was carried out in parallel on two different genetic backgrounds: wild-type and desat1 mutant, in which parental males showed high and low sex pheromone discrimination ability respectively. Male perception of male and female pheromones was separately affected during the process of election. A comparison of transcriptomic activity between high and low discrimination lines revealed genes not only that varied according to the starting genetic background, but varied reciprocally. Mutants in two of these genes, Shaker and quick-to-court, were capable of producing similar effects on discrimination on their own in some instances mimicking the selected lines, in others not. This suggests that discrimination of sex pheromones depends on genes whose activity is sensitive to genetic context and provides a rare, genetically defined example of the phenomenon known as "allele flips", in which interactions have reciprocal effects on different genetic backgrounds	[Houot, Benjamin; Fraichard, Stephane; Ferveur, Jean-Francois] Univ Bourgogne, Ctr Sci Gout & Alimentat, Ctr Natl Rech Sci, UMR6265, Dijon, France; [Greenspan, Ralph J.] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; University of California System; University of California San Diego	Houot, B (corresponding author), W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA.	jean-francois.ferveur@u-bourgogne.fr	Fraichard, Stephane/R-1930-2019		Le Centre National de la Recherche Scientifique; Burgundy Regional Council; ANR (INSAVEL); National Science Foundation [IOS-0840717]	Le Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Burgundy Regional Council(Region Bourgogne-Franche-Comte); ANR (INSAVEL)(French National Research Agency (ANR)); National Science Foundation(National Science Foundation (NSF))	This work was supported by Le Centre National de la Recherche Scientifique, the Burgundy Regional Council, the ANR (INSAVEL) to J-FF, and a National Science Foundation grant IOS-0840717 to RJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALAKRISHNAN R, 1991, J EXP BIOL, V157, P161; Bogart K., 2006, 200610 CGB; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; Broughton SJ, 2004, CURR BIOL, V14, pR290, DOI 10.1016/j.cub.2004.03.037; Clarke GM, 2010, GENET EPIDEMIOL, V34, P266, DOI 10.1002/gepi.20458; Cowan T.M., 1984, Journal of Neurogenetics, V1, P333, DOI 10.3109/01677068409107095; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Eder W, 2005, J ALLERGY CLIN IMMUN, V116, P601, DOI 10.1016/j.jaci.2005.05.003; Everaerts C, 2010, ANIM BEHAV, V79, P1135, DOI 10.1016/j.anbehav.2010.02.013; Ferveur J F, 1998, J Neurogenet, V12, P205; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; FERVEUR JF, 1995, SCIENCE, V267, P902, DOI 10.1126/science.7846534; Ferveur JF, 1997, BIOESSAYS, V19, P353, DOI 10.1002/bies.950190413; Gaines P, 2000, GENETICS, V154, P1627; Greenspan RJ, 2009, COLD SH Q B, V74, P131, DOI 10.1101/sqb.2009.74.029; Greenspan R.J., 2004, FLY PUSHING THEORY P; Greenspan RJ, 2004, ANNU REV NEUROSCI, V27, P79, DOI 10.1146/annurev.neuro.27.070203.144323; Greenspan RJ, 2003, J NEUROGENET, V17, P241, DOI 10.1080/01677060390265648; Houot B, 2010, GENETICS, V185, P1297, DOI 10.1534/genetics.110.117226; Koganezawa M, 2010, CURR BIOL, V20, P1, DOI 10.1016/j.cub.2009.11.038; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Lacaille F, 2009, BEHAV GENET, V39, P554, DOI 10.1007/s10519-009-9286-8; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Mackay TFC, 2005, P NATL ACAD SCI USA, V102, P6622, DOI 10.1073/pnas.0501986102; Marcillac F, 2005, GENETICS, V171, P1617, DOI 10.1534/genetics.104.033159; Marcillac F, 2005, P ROY SOC B-BIOL SCI, V272, P303, DOI 10.1098/rspb.2004.2971; McMahon C, 2002, GENET RES, V79, P149, DOI 10.1017/S0016672301005535; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Park SK, 2006, CURR BIOL, V16, P1154, DOI 10.1016/j.cub.2006.04.028; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polaczyk PJ, 1998, DEV GENES EVOL, V207, P462, DOI 10.1007/s004270050137; STERNBERG PW, 1984, ANNU REV GENET, V18, P489, DOI 10.1146/annurev.ge.18.120184.002421; Sureau G, 1999, GENET RES, V74, P129, DOI 10.1017/S0016672399003936; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; van Swinderen B, 2005, GENETICS, V169, P2151, DOI 10.1534/genetics.104.032631; Vieira C, 2000, GENETICS, V154, P213; Vosshall LB, 2008, NEURON, V59, P685, DOI 10.1016/j.neuron.2008.08.014; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang LM, 2011, NAT NEUROSCI, V14, P757, DOI 10.1038/nn.2800	43	9	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30799	10.1371/journal.pone.0030799	http://dx.doi.org/10.1371/journal.pone.0030799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292044	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600081
J	Mathieu, M; Cotta-Grand, N; Daudelin, JF; Boulet, S; Lapointe, R; Labrecque, N				Mathieu, Melissa; Cotta-Grand, Natacha; Daudelin, Jean-Francois; Boulet, Salix; Lapointe, Rejean; Labrecque, Nathalie			CD40-Activated B Cells Can Efficiently Prime Antigen-Specific Naive CD8(+) T Cells to Generate Effector but Not Memory T cells	PLOS ONE			English	Article							IFN-GAMMA; PRESENTING CELLS; DENDRITIC CELLS; IN-VIVO; TRANSCRIPTION FACTOR; RECEPTOR EXPRESSION; TUMOR-DEVELOPMENT; INTERFERON-GAMMA; PROTEIN ANTIGENS; CUTTING EDGE	Background: The identification of the signals that should be provided by antigen-presenting cells (APCs) to induce a CD8(+) T cell response in vivo is essential to improve vaccination strategies using antigen-loaded APCs. Although dendritic cells have been extensively studied, the ability of other APC types, such as B cells, to induce a CD8(+) T cell response have not been thoroughly evaluated. Methodology/Principal Findings: In this manuscript, we have characterized the ability of CD40-activated B cells, stimulated or not with Toll-like receptor (TLR) agonists (CpG or lipopolysaccharide) to induce the response of mouse naive CD8(+) T cells in vivo. Our results show that CD40-activated B cells can directly present antigen to naive CD8(+) T cells to induce the generation of potent effectors able to secrete cytokines, kill target cells and control a Listeria monocytogenes infection. However, CD40-activated B cell immunization did not lead to the proper formation of CD8(+) memory T cells and further maturation of CD40-activated B cells with TLR agonists did not promote the development of CD8(+) memory T cells. Our results also suggest that inefficient generation of CD8(+) memory T cells with CD40-activated B cell immunization is a consequence of reduced Bcl-6 expression by effectors and enhanced contraction of the CD8(+) T cell response. Conclusions: Understanding why CD40-activated B cell immunization is defective for the generation of memory T cells and gaining new insights about signals that should be provided by APCs are key steps before translating the use of CD40-B cell for therapeutic vaccination.	[Mathieu, Melissa; Cotta-Grand, Natacha; Daudelin, Jean-Francois; Boulet, Salix; Labrecque, Nathalie] Maisonneuve Rosemont Hosp Res Ctr, Montreal, PQ, Canada; [Mathieu, Melissa; Cotta-Grand, Natacha; Boulet, Salix; Labrecque, Nathalie] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Lapointe, Rejean] Ctr Hosp Univ Montreal Hop Notre Dame Res Ctr CRC, Montreal, PQ, Canada; [Lapointe, Rejean; Labrecque, Nathalie] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Mathieu, M (corresponding author), Maisonneuve Rosemont Hosp Res Ctr, Montreal, PQ, Canada.	nathalie.labrecque@umontreal.ca			Canadian Institutes of Health Research (CIHR) [MOP-77545, MOP-115139]; Fonds de la recherche en sante du Quebec (FRSQ); Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants (MOP-77545 and MOP-115139) from the Canadian Institutes of Health Research (CIHR), www.cihr-irsc.gc.ca. NL holds a Senior Scholarship from the Fonds de la recherche en sante du Quebec (FRSQ). MM is supported by a studentship from the Natural Sciences and Engineering Research Council of Canada and has received a scholarship from the FRSQ to learn the Listeria infection model. SB is supported by a CIHR post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi T, 2008, IMMUNOLOGY, V124, P129, DOI 10.1111/j.1365-2567.2007.02749.x; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Bahjat KS, 2006, INFECT IMMUN, V74, P6387, DOI 10.1128/IAI.01088-06; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; BARTH RJ, 1991, J EXP MED, V173, P647, DOI 10.1084/jem.173.3.647; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Blankenstein T, 2003, CURR OPIN IMMUNOL, V15, P148, DOI 10.1016/S0952-7915(03)00007-4; Coles RM, 2002, J IMMUNOL, V168, P834, DOI 10.4049/jimmunol.168.2.834; Coughlin CM, 2004, BLOOD, V103, P2046, DOI 10.1182/blood-2003-07-2379; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; EYNON EE, 1992, J EXP MED, V175, P131, DOI 10.1084/jem.175.1.131; FUCHS EJ, 1992, SCIENCE, V258, P1156, DOI 10.1126/science.1439825; GILBERT KM, 1994, J EXP MED, V179, P249, DOI 10.1084/jem.179.1.249; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ichii H, 2004, J IMMUNOL, V173, P883, DOI 10.4049/jimmunol.173.2.883; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kershaw MH, 2001, CANCER RES, V61, P7920; Kondo E, 2009, CLIN EXP IMMUNOL, V155, P249, DOI 10.1111/j.1365-2249.2008.03820.x; Lacombe MH, 2005, J IMMUNOL, V175, P4400, DOI 10.4049/jimmunol.175.7.4400; Lapointe R, 2003, CANCER RES, V63, P2836; LASSILA O, 1988, NATURE, V334, P253, DOI 10.1038/334253a0; Leignadier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013740; Livingstone AM, 1999, EUR J IMMUNOL, V29, P2826, DOI 10.1002/(SICI)1521-4141(199909)29:09<2826::AID-IMMU2826>3.0.CO;2-M; Lopez JA, 2003, J IMMUNOL METHODS, V274, P47, DOI 10.1016/S0022-1759(02)00429-5; Loyer V, 1999, J IMMUNOL, V163, P6462; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Meunier MC, 2005, NAT MED, V11, P1222, DOI 10.1038/nm1311; Ostiguy V, 2007, J LEUKOCYTE BIOL, V82, P645, DOI 10.1189/jlb.0806494; Parekh VV, 2003, J IMMUNOL, V170, P5897, DOI 10.4049/jimmunol.170.12.5897; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Prevost-Blondel A, 2000, EUR J IMMUNOL, V30, P2507, DOI 10.1002/1521-4141(200009)30:9<2507::AID-IMMU2507>3.0.CO;2-V; Qin ZH, 2000, IMMUNITY, V12, P677, DOI 10.1016/S1074-7613(00)80218-6; Qin ZH, 2003, CANCER RES, V63, P4095; Raimondi G, 2006, J IMMUNOL, V176, P4021, DOI 10.4049/jimmunol.176.7.4021; Raimondi G, 2006, J IMMUNOL, V176, P4012, DOI 10.4049/jimmunol.176.7.4012; RONCHESE F, 1993, J EXP MED, V177, P679, DOI 10.1084/jem.177.3.679; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Schultze JL, 1997, J CLIN INVEST, V100, P2757, DOI 10.1172/JCI119822; SCHULZE DH, 1983, P NATL ACAD SCI-BIOL, V80, P2007, DOI 10.1073/pnas.80.7.2007; Seki N, 2002, J IMMUNOL, V168, P3484, DOI 10.4049/jimmunol.168.7.3484; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shen S., 2007, Experimental Oncology, V29, P137; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; TUTTLE TM, 1993, CANCER RES, V53, P833; Vanden Bush Tony J, 2009, J Immunol, V183, P4833, DOI 10.4049/jimmunol.0900968; von Bergwelt-Baildon M, 2006, BLOOD, V107, P2786, DOI 10.1182/blood-2004-01-0113; von Bergwelt-Baildon MS, 2002, BLOOD, V99, P3319, DOI 10.1182/blood.V99.9.3319	54	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30139	10.1371/journal.pone.0030139	http://dx.doi.org/10.1371/journal.pone.0030139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291907	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600017
J	Messaoudi, S; Di Zhang, A; Griol-Charhbili, V; Escoubet, B; Sadoshima, J; Farman, N; Jaisser, F				Messaoudi, Smail; Di Zhang, An; Griol-Charhbili, Violaine; Escoubet, Brigitte; Sadoshima, Junichi; Farman, Nicolette; Jaisser, Frederic			The Epidermal Growth Factor Receptor Is Involved in Angiotensin II But Not Aldosterone/Salt-Induced Cardiac Remodelling	PLOS ONE			English	Article							HUMAN MINERALOCORTICOID RECEPTOR; SMOOTH-MUSCLE-CELLS; EXPRESSION; TRANSACTIVATION; DYSFUNCTION; FIBROSIS; PATHWAY; LACKING; SYSTEM; HEART	Experimental and clinical studies have shown that aldosterone/mineralocorticoid receptor (MR) activation has deleterious effects in the cardiovascular system; however, the signalling pathways involved in the pathophysiological effects of aldosterone/MR in vivo are not fully understood. Several in vitro studies suggest that Epidermal Growth Factor Receptor (EGFR) plays a role in the cardiovascular effects of aldosterone. This hypothesis remains to be demonstrated in vivo. To investigate this question, we analyzed the molecular and functional consequences of aldosterone exposure in a transgenic mouse model with constitutive cardiomyocyte-specific overexpression of a mutant EGFR acting as a dominant negative protein (DN-EGFR). As previously reported, Angiotensin II-mediated cardiac remodelling was prevented in DN-EGFR mice. However, when chronic MR activation was induced by aldosterone-salt-uninephrectomy, cardiac hypertrophy was similar between control littermates and DN-EGFR. In the same way, mRNA expression of markers of cardiac remodelling such as ANF, BNF or beta-Myosin Heavy Chain as well as Collagen 1a and 3a was similarly induced in DN-EGFR mice and their CT littermates. Our findings confirm the role of EGFR in AngII mediated cardiac hypertrophy, and highlight that EGFR is not involved in vivo in the damaging effects of aldosterone on cardiac function and remodelling.	[Messaoudi, Smail; Di Zhang, An; Griol-Charhbili, Violaine; Escoubet, Brigitte; Farman, Nicolette; Jaisser, Frederic] Ctr Rech Cordeliers, INSERM, U872, Paris, France; [Messaoudi, Smail; Di Zhang, An; Griol-Charhbili, Violaine; Farman, Nicolette; Jaisser, Frederic] Univ Paris 06, Paris, France; [Escoubet, Brigitte] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, F-75877 Paris, France; [Escoubet, Brigitte] Univ Paris 07, Paris, France; [Sadoshima, Junichi] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, Newark, NJ 07103 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Rutgers State University New Brunswick; Rutgers State University Medical Center	Messaoudi, S (corresponding author), Ctr Rech Cordeliers, INSERM, U872, Paris, France.	frederic.jaisser@crc.jussieu.fr	Jaisser, Frederic/P-4287-2017	Jaisser, Frederic/0000-0001-9051-1901; Sadoshima, Junichi/0000-0003-3724-4132	INSERM (Institut National pour la Sante et Recherche Medicale); Agence Nationale pour la Recherche [ANR005-PCOD005]; CRIT (Centre de Recherche Industrielle et Technique); Region ile de France (CODDIM-Cardiovasculaire Obesite Diabete, Domaine d'Interet Majeur); Societe Francaise d'Hypertension Arterielle/MSD	INSERM (Institut National pour la Sante et Recherche Medicale); Agence Nationale pour la Recherche(French National Research Agency (ANR)); CRIT (Centre de Recherche Industrielle et Technique); Region ile de France (CODDIM-Cardiovasculaire Obesite Diabete, Domaine d'Interet Majeur)(Region Ile-de-France); Societe Francaise d'Hypertension Arterielle/MSD	This work was supported by grants from INSERM (Institut National pour la Sante et Recherche Medicale), the Agence Nationale pour la Recherche (ANR005-PCOD005), and the CRIT (Centre de Recherche Industrielle et Technique). SM received a Region ile de France (CODDIM-Cardiovasculaire Obesite Diabete, Domaine d'Interet Majeur) grant; ADZ received a Societe Francaise d'Hypertension Arterielle/MSD research grant; VG-C held a Lefoulon-Delalande fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick CJ, 2008, TOXICOL APPL PHARM, V228, P315, DOI 10.1016/j.taap.2007.12.012; de Azambuja E, 2009, TARGET ONCOL, V4, P77, DOI 10.1007/s11523-009-0112-2; Di Zhang A, 2008, HYPERTENSION, V52, P1060, DOI 10.1161/HYPERTENSIONAHA.108.117531; Florian JA, 2001, AM J PHYSIOL-REG I, V281, pR878, DOI 10.1152/ajpregu.2001.281.3.R878; Funder JW, 2007, AM J CARDIOVASC DRUG, V7, P151, DOI 10.2165/00129784-200707030-00001; Gekle M, 2001, PFLUG ARCH EUR J PHY, V441, P781, DOI 10.1007/s004240000507; Gekle M, 2009, PFLUG ARCH EUR J PHY, V458, P231, DOI 10.1007/s00424-008-0616-0; Griol-Charhbili V, 2011, HYPERTENSION, V57, P238, DOI 10.1161/HYPERTENSIONAHA.110.153619; Grossmann C, 2005, MOL ENDOCRINOL, V19, P1697, DOI 10.1210/me.2004-0469; Grossmann C, 2004, AM J PHYSIOL-RENAL, V286, pF1226, DOI 10.1152/ajprenal.00378.2003; Grossmann C, 2007, AM J PHYSIOL-ENDOC M, V292, pE1790, DOI 10.1152/ajpendo.00708.2006; Iglarz M, 2004, AM J HYPERTENS, V17, P597, DOI 10.1016/j.amjhyper.2004.04.005; Krug AW, 2003, J BIOL CHEM, V278, P43060, DOI 10.1074/jbc.M308134200; Mazak I, 2004, CIRCULATION, V109, P2792, DOI 10.1161/01.CIR.0000131860.80444.AB; McEneaney V, 2007, J STEROID BIOCHEM, V107, P180, DOI 10.1016/j.jsbmb.2007.03.043; Min LJ, 2005, CIRC RES, V97, P434, DOI 10.1161/01.RES.0000180753.63183.95; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; ROBERT V, 1994, HYPERTENSION, V24, P30, DOI 10.1161/01.HYP.24.1.30; Robert V, 1999, HYPERTENSION, V33, P981, DOI 10.1161/01.HYP.33.4.981; Rocha R, 2002, AM J PHYSIOL-HEART C, V283, pH1802, DOI 10.1152/ajpheart.01096.2001; Schreier B, 2011, HYPERTENS RES, V34, P623, DOI 10.1038/hr.2011.16; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Sugiyama T, 2005, ENDOCRINOLOGY, V146, P3900, DOI 10.1210/en.2004-1674; Zahorowska B, 2009, J CANCER RES CLIN, V135, P1137, DOI 10.1007/s00432-009-0622-4; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zhai PY, 2006, CIRC RES, V99, P528, DOI 10.1161/01.RES.0000240147.49390.61	27	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30156	10.1371/journal.pone.0030156	http://dx.doi.org/10.1371/journal.pone.0030156			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291909	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600019
J	Chan, KH; Li, T; Wong, CO; Wong, KB				Chan, Kwok-Ho; Li, Ting; Wong, Ching-On; Wong, Kam-Bo			Structural Basis for GTP-Dependent Dimerization of Hydrogenase Maturation Factor HypB	PLOS ONE			English	Article							ESCHERICHIA-COLI; ACTIVE-SITE; HELICOBACTER-PYLORI; METAL-BINDING; BRADYRHIZOBIUM-JAPONICUM; ACCESSORY PROTEINS; RALSTONIA-EUTROPHA; NICKEL; CYANIDE; UREASE	Maturation of [NiFe]-hydrogenase requires the insertion of iron, cyanide and carbon monoxide, followed by nickel, to the catalytic core of the enzyme. Hydrogenase maturation factor HypB is a metal-binding GTPase that is essential for the nickel delivery to the hydrogenase. Here we report the crystal structure of Archeoglobus fulgidus HypB (AfHypB) in apo-form. We showed that AfHypB recognizes guanine nucleotide using Asp-194 on the G5 loop despite having a non-canonical NKxA G4-motif. Structural comparison with the GTP gamma S-bound Methanocaldococcus jannaschii HypB identifies conformational changes in the switch I region, which bring an invariant Asp-72 to form an intermolecular salt-bridge with another invariant residue Lys-148 upon GTP binding. Substitution of K148A abolished GTP-dependent dimerization of AfHypB, but had no significant effect on the guanine nucleotide binding and on the intrinsic GTPase activity. In vivo complementation study in Escherichia coli showed that the invariant lysine residue is required for in vivo maturation of hydrogenase. Taken together, our results suggest that GTP-dependent dimerization of HypB is essential for hydrogenase maturation. It is likely that a nickel ion is loaded to an extra metal binding site at the dimeric interface of GTP-bound HypB and transferred to the hydrogenase upon GTP hydrolysis.	[Chan, Kwok-Ho; Li, Ting; Wong, Ching-On; Wong, Kam-Bo] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Chan, KH (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China.	kbwong@cuhk.edu.hk	Wong, Kam-Bo/G-4258-2013; Wong, Kam-Bo/AAU-9364-2021	Wong, Kam-Bo/0000-0002-6984-5373; Wong, Kam-Bo/0000-0002-6984-5373; Chan, Kwok Ho/0000-0002-6693-2682; Wong, Ching On/0000-0002-8602-2125	Research Grants Council of Hong Kong [CUHK4610/06M]; University Grants Committee of Hong Kong [SEG CUHK08]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); University Grants Committee of Hong Kong	This work is supported by a General Research Fund from Research Grants Council of Hong Kong (Project code: CUHK4610/06M) and the equipment used is supported in part by an One-Off Special Equipment Grant from University Grants Committee of Hong Kong (Project code: SEG CUHK08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian Mohammad Reza, 2002, Methods Mol Biol, V189, P45; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BALLANTINE SP, 1985, J BACTERIOL, V163, P454, DOI 10.1128/JB.163.2.454-459.1985; Blokesch M, 2002, BIOCHEM SOC T, V30, P674, DOI 10.1042/BST0300674; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Cai F, 2011, J BIOL INORG CHEM, V16, P857, DOI 10.1007/s00775-011-0782-y; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Dias AV, 2008, BIOCHEMISTRY-US, V47, P11981, DOI 10.1021/bi801337x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Forzi L, 2007, FEBS LETT, V581, P3317, DOI 10.1016/j.febslet.2007.06.028; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; FU CL, 1995, P NATL ACAD SCI USA, V92, P2333, DOI 10.1073/pnas.92.6.2333; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Gawronski JD, 2004, ANAL BIOCHEM, V327, P114, DOI 10.1016/j.ab.2003.12.024; Hoffmann D, 2006, FEBS J, V273, P4516, DOI 10.1111/j.1742-4658.2006.05460.x; Hube M, 2002, J BACTERIOL, V184, P3879, DOI 10.1128/JB.184.14.3879-3885.2002; JACOBI A, 1992, ARCH MICROBIOL, V158, P444; Leach MR, 2005, BIOCHEMISTRY-US, V44, P12229, DOI 10.1021/bi050993j; Lenz O, 2007, FEBS LETT, V581, P3322, DOI 10.1016/j.febslet.2007.06.027; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Loscher S, 2005, FEBS LETT, V579, P4287, DOI 10.1016/j.febslet.2005.06.063; MAIER T, 1993, J BACTERIOL, V175, P630, DOI 10.1128/JB.175.3.630-635.1993; MAIER T, 1995, EUR J BIOCHEM, V230, P133, DOI 10.1111/j.1432-1033.1995.tb20543.x; Mehta N, 2003, J BACTERIOL, V185, P726, DOI 10.1128/JB.185.3.726-734.2003; Mehta N, 2003, MICROB PATHOGENESIS, V35, P229, DOI 10.1016/S0882-4010(03)00151-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olson JW, 1997, MOL MICROBIOL, V24, P119, DOI 10.1046/j.1365-2958.1997.3251690.x; Olson JW, 2001, MOL MICROBIOL, V39, P176, DOI 10.1046/j.1365-2958.2001.02244.x; Olson JW, 2000, J BACTERIOL, V182, P1702, DOI 10.1128/JB.182.6.1702-1705.2000; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Paschos A, 2001, FEBS LETT, V488, P9, DOI 10.1016/S0014-5793(00)02408-X; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; REY L, 1994, J BACTERIOL, V176, P6066, DOI 10.1128/jb.176.19.6066-6073.1994; Roseboom W, 2005, FEBS LETT, V579, P469, DOI 10.1016/j.febslet.2004.12.013; Sydor AM, 2011, J BACTERIOL, V193, P1359, DOI 10.1128/JB.01333-10; Theodoratou E, 2005, BIOCHEM SOC T, V33, P108, DOI 10.1042/BST0330108; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Watanabe S, 2009, J MOL BIOL, V394, P448, DOI 10.1016/j.jmb.2009.09.030; WAUGH R, 1986, BIOCHIMIE, V68, P157, DOI 10.1016/S0300-9084(86)81080-X; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2005, FEBS LETT, V579, P4292, DOI 10.1016/j.febslet.2005.06.064; Xia W, 2009, J AM CHEM SOC, V131, P10031, DOI 10.1021/ja900543y; Zambelli B, 2005, J BIOL CHEM, V280, P4684, DOI 10.1074/jbc.M408483200; Zhang JW, 2005, J BIOL CHEM, V280, P4360, DOI 10.1074/jbc.M411799200	49	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30547	10.1371/journal.pone.0030547	http://dx.doi.org/10.1371/journal.pone.0030547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276211	gold, Green Published, Green Submitted			2022-12-27	WOS:000301568100055
J	Geniole, SN; Keyes, AE; Mondloch, CJ; Carre, JM; McCormick, CM				Geniole, Shawn N.; Keyes, Amanda E.; Mondloch, Catherine J.; Carre, Justin M.; McCormick, Cheryl M.			Facing Aggression: Cues Differ for Female versus Male Faces	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; ATTRACTIVENESS; DOMINANCE; SIGNAL; TESTOSTERONE; MASCULINITY; EXPRESSIONS; EVOLUTION; JUDGMENTS; SYMMETRY	The facial width-to-height ratio (face ratio), is a sexually dimorphic metric associated with actual aggression in men and with observers' judgements of aggression in male faces. Here, we sought to determine if observers' judgements of aggression were associated with the face ratio in female faces. In three studies, participants rated photographs of female and male faces on aggression, femininity, masculinity, attractiveness, and nurturing. In Studies 1 and 2, for female and male faces, judgements of aggression were associated with the face ratio even when other cues in the face related to masculinity were controlled statistically. Nevertheless, correlations between the face ratio and judgements of aggression were smaller for female than for male faces (F-1,F-36 = 7.43, p = 0.01). In Study 1, there was no significant relationship between judgements of femininity and of aggression in female faces. In Study 2, the association between judgements of masculinity and aggression was weaker in female faces than for male faces in Study 1. The weaker association in female faces may be because aggression and masculinity are stereotypically male traits. Thus, in Study 3, observers rated faces on nurturing (a stereotypically female trait) and on femininity. Judgements of nurturing were associated with femininity (positively) and masculinity (negatively) ratings in both female and male faces. In summary, the perception of aggression differs in female versus male faces. The sex difference was not simply because aggression is a gendered construct; the relationships between masculinity/femininity and nurturing were similar for male and female faces even though nurturing is also a gendered construct. Masculinity and femininity ratings are not associated with aggression ratings nor with the face ratio for female faces. In contrast, all four variables are highly inter-correlated in male faces, likely because these cues in male faces serve as "honest signals''.	[Geniole, Shawn N.; Keyes, Amanda E.; Mondloch, Catherine J.; McCormick, Cheryl M.] Brock Univ, Dept Psychol, St Catharines, ON L2S 3A1, Canada; [Mondloch, Catherine J.; McCormick, Cheryl M.] Brock Univ, Ctr Neurosci, St Catharines, ON L2S 3A1, Canada; [Carre, Justin M.] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA	Brock University; Brock University; Wayne State University	Geniole, SN (corresponding author), Brock Univ, Dept Psychol, St Catharines, ON L2S 3A1, Canada.	cmccormick@brocku.ca	McCormick, Cheryl M/D-9678-2011		Social Sciences and Humanities Research Council of Canada [210-2009-0487]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was supported by the Social Sciences and Humanities Research Council of Canada grant Number 210-2009-0487 to Dr. McCormick. www.sshrc-crsh.gc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Archer J, 2010, BRIT J SOC PSYCHOL, V49, P525, DOI 10.1348/014466609X471525; Becker DV, 2007, J PERS SOC PSYCHOL, V92, P179, DOI 10.1037/0022-3514.92.2.179; Boothroyd LG, 2007, PERS INDIV DIFFER, V43, P1161, DOI 10.1016/j.paid.2007.03.008; Burton LA, 2007, SOC BEHAV PERSONAL, V35, P41, DOI 10.2224/sbp.2007.35.1.41; Carre JM, 2010, PERCEPTION, V39, P356, DOI 10.1068/p6543; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Cherek DR, 1996, AGGRESSIVE BEHAV, V22, P27, DOI 10.1002/(SICI)1098-2337(1996)22:1<27::AID-AB3>3.0.CO;2-R; Danel D, 2007, J COMP PSYCHOL, V121, P221, DOI 10.1037/0735-7036.121.2.221; EKMAN P, 1987, J PERS SOC PSYCHOL, V53, P712, DOI 10.1037/0022-3514.53.4.712; Ekman P., 2007, EMOTIONS REVEALED RE; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Fridlund BA, 1994, HUMAN FACIAL EXPRESS; Gangestad SW, 2003, EVOL HUM BEHAV, V24, P231, DOI 10.1016/S1090-5138(03)00017-5; Haselhuhn MP, 2012, P ROY SOC B-BIOL SCI, V279, P571, DOI 10.1098/rspb.2011.1193; Hess U, 2009, J VISION, V9, DOI 10.1167/9.12.19; Johnston VS, 2001, EVOL HUM BEHAV, V22, P251, DOI 10.1016/S1090-5138(01)00066-6; Jones BC, 2010, P ROY SOC B-BIOL SCI, V277, P617, DOI 10.1098/rspb.2009.1575; Koehler N, 2004, P ROY SOC B-BIOL SCI, V271, pS233, DOI 10.1098/rsbl.2003.0146; Kramer RSS, 2011, EVOL HUM BEHAV, V32, P179, DOI 10.1016/j.evolhumbehav.2010.10.005; Laidre ME, 2008, BEHAV ECOL SOCIOBIOL, V62, P1207, DOI 10.1007/s00265-007-0539-3; Maestripieri D, 2002, HUM NATURE-INT BIOS, V13, P327, DOI 10.1007/s12110-002-1018-1; Main JC, 2009, PERCEPTION, V38, P1275, DOI 10.1068/p6347; Marsh AA, 2005, EMOTION, V5, P119, DOI 10.1037/1528-3542.5.1.119; MAZUR A, 1994, ETHOL SOCIOBIOL, V15, P87, DOI 10.1016/0162-3095(94)90019-1; MCARTHUR LZ, 1983, PSYCHOL REV, V90, P215, DOI 10.1037/0033-295X.90.3.215; Montepare JM, 2003, J NONVERBAL BEHAV, V27, P237, DOI 10.1023/A:1027332800296; Moretz JA, 2006, AM NAT, V168, P336, DOI 10.1086/506920; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Quist MC, 2011, PERS INDIV DIFFER, V50, P1089, DOI 10.1016/j.paid.2011.01.032; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Rhodes G, 2000, BRIT J PSYCHOL, V91, P125, DOI 10.1348/000712600161718; Roney JR, 2006, P ROY SOC B-BIOL SCI, V273, P2169, DOI 10.1098/rspb.2006.3569; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Short LA, EVOL HUM BE IN PRESS; Stillman TF, 2010, EVOL HUM BEHAV, V31, P298, DOI 10.1016/j.evolhumbehav.2009.12.001; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Tibbetts EA, 2008, BIOL LETTERS, V4, P237, DOI 10.1098/rsbl.2008.0048; Verdonck A, 1999, EUR J ORTHODONT, V21, P137, DOI 10.1093/ejo/21.2.137; Verplaetse J, 2007, EVOL HUM BEHAV, V28, P260, DOI 10.1016/j.evolhumbehav.2007.04.006; Watkins CD, 2010, PERS INDIV DIFFER, V49, P967, DOI 10.1016/j.paid.2010.08.006; Weston EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000710; Zebrowitz LA, 2008, SOC PERSONAL PSYCHOL, V2, P1497, DOI 10.1111/j.1751-9004.2008.00109.x	48	41	44	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30366	10.1371/journal.pone.0030366	http://dx.doi.org/10.1371/journal.pone.0030366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	909MH	22276184	Green Submitted, Green Published, gold			2022-12-27	WOS:000301568100039
J	Briand, E; Bormans, M; Quiblier, C; Salencon, MJ; Humbert, JF				Briand, Enora; Bormans, Myriam; Quiblier, Catherine; Salencon, Marie-Jose; Humbert, Jean-Francois			Evidence of the Cost of the Production of Microcystins by Microcystis aeruginosa under Differing Light and Nitrate Environmental Conditions	PLOS ONE			English	Article							TOXIC CYANOBACTERIUM; PLANKTOTHRIX-RUBESCENS; SPATIOTEMPORAL CHANGES; GENETIC DIVERSITY; NONTOXIC STRAINS; GROWTH-RATE; COMPETITION; COOPERATION; QUANTIFICATION; POPULATIONS	The cyanobacterium Microcystis aeruginosa is known to proliferate in freshwater ecosystems and to produce microcystins. It is now well established that much of the variability of bloom toxicity is due to differences in the relative proportions of microcystin-producing and non-microcystin-producing cells in cyanobacterial populations. In an attempt to elucidate changes in their relative proportions during cyanobacterial blooms, we compared the fitness of the microcystin-producing M. aeruginosa PCC 7806 strain (WT) to that of its non-microcystin-producing mutant (MT). We investigated the effects of two light intensities and of limiting and non-limiting nitrate concentrations on the growth of these strains in monoculture and co-culture experiments. We also monitored various physiological parameters, and microcystin production by the WT strain. In monoculture experiments, no significant difference was found between the growth rates or physiological characteristics of the two strains during the exponential growth phase. In contrast, the MT strain was found to dominate the WT strain in co-culture experiments under favorable growth conditions. Moreover, we also found an increase in the growth rate of the MT strain and in the cellular MC content of the WT strain. Our findings suggest that differences in the fitness of these two strains under optimum growth conditions were attributable to the cost to microcystin-producing cells of producing microcystins, and to the putative existence of cooperation processes involving direct interactions between these strains.	[Briand, Enora; Bormans, Myriam] Univ Rennes, Rennes, France; [Briand, Enora; Quiblier, Catherine] Museum Natl Hist Nat, F-75231 Paris, France; [Quiblier, Catherine] Univ Paris Diderot, Paris, France; [Salencon, Marie-Jose] Environm Def Fund Rand, Dept LNHE, Chatou, France; [Humbert, Jean-Francois] French Natl Inst Agr Res, UMR Biogeochim & Ecol Milleux Continent BIOEMCO, Paris, France	Universite de Rennes; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Sorbonne Universite	Briand, E (corresponding author), Univ Rennes, Rennes, France.	humbert@biologie.ens.fr	Briand, Enora/AAS-8520-2020; Briand, Enora/P-6074-2016	Briand, Enora/0000-0001-8996-0072; Bormans, Myriam/0000-0002-4755-6327; Humbert, Jean-Francois/0000-0002-1519-5651	Electricite de France Research & Development (EDF R D); Alpha Natural Resources (ANR)	Electricite de France Research & Development (EDF R D); Alpha Natural Resources (ANR)(French National Research Agency (ANR))	This work was conducted in the framework of a research program with Electricite de France Research & Development (EDF R& D). This work was also funded by the Alpha Natural Resources (ANR) Research Program SEST 2007 (project MATRICS). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; This research was partly funded by Electricite de France Research&Development (EDF R&D). Marie-Jose Salencon is employed by Electricite de France Research&Development (EDF R&D). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. All other authors have declared that no competing interests exist.	Alexova R, 2011, ENVIRON MICROBIOL, V13, P1064, DOI 10.1111/j.1462-2920.2010.02412.x; Baxa DV, 2010, HARMFUL ALGAE, V9, P342, DOI 10.1016/j.hal.2010.01.001; BOTES DP, 1985, J CHEM SOC PERK T 1, P2747, DOI 10.1039/p19850002747; Briand E, 2008, ENVIRON MICROBIOL, V10, P3337, DOI 10.1111/j.1462-2920.2008.01730.x; Briand E, 2008, APPL ENVIRON MICROB, V74, P3839, DOI 10.1128/AEM.02343-07; Briand E, 2009, ISME J, V3, P419, DOI 10.1038/ismej.2008.121; Briand JF, 2005, MICROB ECOL, V50, P418, DOI 10.1007/s00248-005-0186-z; Briand JF, 2003, VET RES, V34, P361, DOI 10.1051/vetres:2003019; Buckling A, 2007, FEMS MICROBIOL ECOL, V62, P135, DOI 10.1111/j.1574-6941.2007.00388.x; Davis TW, 2010, AQUAT MICROB ECOL, V61, P149, DOI 10.3354/ame01445; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Dittmann E, 2001, MICROBIOL-SGM, V147, P3113, DOI 10.1099/00221287-147-11-3113; Dittmann E, 1997, MOL MICROBIOL, V26, P779, DOI 10.1046/j.1365-2958.1997.6131982.x; Downing TG, 2005, MICROB ECOL, V49, P468, DOI 10.1007/s00248-004-0054-2; Foster KR, 2007, TRENDS GENET, V23, P74, DOI 10.1016/j.tig.2006.12.003; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Ha JH, 2009, ENVIRON SCI TECHNOL, V43, P812, DOI 10.1021/es801265f; Hesse K, 2001, FEMS MICROBIOL ECOL, V37, P39, DOI 10.1111/j.1574-6941.2001.tb00851.x; HUISMAN J, 1994, ECOLOGY, V75, P507, DOI 10.2307/1939554; Kaebernick M, 2002, APPL ENVIRON MICROB, V68, P449, DOI 10.1128/AEM.68.2.449-455.2002; Kardinaal WEA, 2007, APPL ENVIRON MICROB, V73, P2939, DOI 10.1128/AEM.02892-06; Kardinaal WEA, 2005, AQUAT ECOL SER, V3, P41; Kehr JC, 2006, MOL MICROBIOL, V59, P893, DOI 10.1111/j.1365-2958.2005.05001.x; Keiblinger KM, 2010, FEMS MICROBIOL ECOL, V73, P430, DOI 10.1111/j.1574-6941.2010.00912.x; KUIPERGOODMAN T, 1999, TOXIC CYANOBACTERIA, P41; Kurmayer R, 2003, APPL ENVIRON MICROB, V69, P6723, DOI 10.1128/AEM.69.11.6723-6730.2003; Long BM, 2001, APPL ENVIRON MICROB, V67, P278, DOI 10.1128/AEM.67.1.278-283.2001; Makino W, 2003, FUNCT ECOL, V17, P121, DOI 10.1046/j.1365-2435.2003.00712.x; Manganelli M, 2010, WATER RES, V44, P1297, DOI 10.1016/j.watres.2009.10.045; Orr PT, 1998, LIMNOL OCEANOGR, V43, P1604, DOI 10.4319/lo.1998.43.7.1604; Renaud SL, 2011, APPL ENVIRON MICROB, V77, P7016, DOI 10.1128/AEM.05246-11; Rinta-Kanto JM, 2009, HARMFUL ALGAE, V8, P665, DOI 10.1016/j.hal.2008.12.004; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Sabart M, 2010, APPL ENVIRON MICROB, V76, P4750, DOI 10.1128/AEM.02531-09; Sabart M, 2009, ENV MICROBIOL REP, V1, P263, DOI 10.1111/j.1758-2229.2009.00042.x; Schatz D, 2007, ENVIRON MICROBIOL, V9, P965, DOI 10.1111/j.1462-2920.2006.01218.x; Schreiber U., 1998, P320; Sevilla E, 2008, ENVIRON MICROBIOL, V10, P2476, DOI 10.1111/j.1462-2920.2008.01663.x; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; UTKILEN H, 1995, APPL ENVIRON MICROB, V61, P797, DOI 10.1128/AEM.61.2.797-800.1995; Van de Waal DB, 2011, ISME J, V5, P1438, DOI 10.1038/ismej.2011.28; Van de Waal DB, 2010, FEMS MICROBIOL ECOL, V74, P430, DOI 10.1111/j.1574-6941.2010.00958.x; Van de Waal DB, 2009, ECOL LETT, V12, P1326, DOI 10.1111/j.1461-0248.2009.01383.x; Yoshida M, 2007, FEMS MICROBIOL LETT, V266, P49, DOI 10.1111/j.1574-6968.2006.00496.x; Zilliges Y, 2008, J BACTERIOL, V190, P2871, DOI 10.1128/JB.01867-07; Zilliges Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017615	47	70	73	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29981	10.1371/journal.pone.0029981	http://dx.doi.org/10.1371/journal.pone.0029981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276137	Green Published, gold			2022-12-27	WOS:000301457200025
J	Mikitova, V; Levine, TP				Mikitova, Veronika; Levine, Timothy P.			Analysis of the Key Elements of FFAT-Like Motifs Identifies New Proteins That Potentially Bind VAP on the ER, Including Two AKAPs and FAPP2	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; PLASMA-MEMBRANE; STRUCTURAL BASIS; FIBROUS SHEATH; LIPID TRANSFER; REQUIRES; LOCALIZATION; TRAFFICKING; COMPLEX	Background: Two phenylalanines (FF) in an acidic tract (FFAT)-motifs were originally described as having seven elements: an acidic flanking region followed by 6 residues (EFFDA-E). Such motifs are found in several lipid transfer protein (LTP) families, and they interact with a protein on the cytosolic face of the ER called vesicle-associated membrane protein-associated protein (VAP). Mutation of which causes ER stress and motor neuron disease, making it important to determine which proteins bind VAP. Among other proteins that bind VAP, some contain FFAT-like motifs that are missing one or more of the seven elements. Defining how much variation is tolerated in FFAT-like motifs is a preliminary step prior to the identification of the full range of VAP interactors. Results: We used a quantifiable in vivo system that measured ER targeting in a reporter yeast strain that over-expressed VAP to study the effect of substituting different elements of FFAT-like motifs in turn. By defining FFAT-like motifs more widely than before, we found them in novel proteins the functions of which had not previously been directly linked to the ER, including: two PKA anchoring proteins, AKAP220 and AKAP110; a family of plant LTPs; and the glycolipid LTP phosphatidylinositol-four-phosphate adaptor-protein-2 (FAPP-2). Conclusion: All of the seven essential elements of a FFAT motif tolerate variation, and weak targeting to the ER via VAP is still detected if two elements are substituted. In addition to the strong FFAT motifs already known, there are additional proteins with weaker FFAT-like motifs, which might be functionally important VAP interactors.	[Mikitova, Veronika; Levine, Timothy P.] UCL, Inst Ophthalmol, Dept Cell Biol, London, England	University of London; University College London	Mikitova, V (corresponding author), Inst Fdn Caubet Cimera, Bunyola, Spain.	tim.levine@ucl.ac.uk		Levine, Timothy/0000-0002-7231-0775	Wellcome Trust, UK [082119/Z/07/Z]	Wellcome Trust, UK(Wellcome Trust)	The work was funded entirely by the Wellcome Trust, UK, grant number 082119/Z/07/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airenne TT, 2006, J MOL BIOL, V355, P224, DOI 10.1016/j.jmb.2005.10.031; Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Bajpai M, 2006, BIOL REPROD, V74, P109, DOI 10.1095/biolreprod.105.043588; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Bui M, 2010, J BIOL CHEM, V285, P31590, DOI 10.1074/jbc.M110.101584; Cao XW, 2009, P NATL ACAD SCI USA, V106, P21121, DOI 10.1073/pnas.0911789106; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; De Vos KJ, 2011, HUM MOL GENET; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; Foster LJ, 2000, TRAFFIC, V1, P512, DOI 10.1034/j.1600-0854.2000.010609.x; Fujita A, 2000, J CELL SCI, V113, P103; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; Furuita K, 2010, J BIOL CHEM, V285, P12961, DOI 10.1074/jbc.M109.082602; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gkogkas C, 2008, HUM MOL GENET, V17, P1517, DOI 10.1093/hmg/ddn040; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Haaf A, 1998, J MOL BIOL, V284, P1611, DOI 10.1006/jmbi.1998.2291; Halter D, 2007, JCB CURRENT; HICKE L, 1989, EMBO J, V8, P1677, DOI 10.1002/j.1460-2075.1989.tb03559.x; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kim S, 2010, J BIOL CHEM, V285, P13839, DOI 10.1074/jbc.M109.097345; Kodama M, 2010, MOL CELL BIOL, V30, P1620, DOI 10.1128/MCB.00810-09; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Langeberg LK, 2005, J CELL SCI, V118, P3217, DOI 10.1242/jcs.02416; Langou K, 2010, J NEUROCHEM, V114, P795, DOI 10.1111/j.1471-4159.2010.06806.x; Lapierre LA, 1999, J CELL SCI, V112, P3723; Lehto M, 2005, EXP CELL RES, V310, P445, DOI 10.1016/j.yexcr.2005.08.003; Lehto M, 2003, BBA-MOL CELL BIOL L, V1631, P1, DOI 10.1016/S1388-1981(02)00364-5; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Lewis MJ, 1997, EMBO J, V16, P3017, DOI 10.1093/emboj/16.11.3017; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mammoto A, 2000, J BIOL CHEM, V275, P13167, DOI 10.1074/jbc.C000096200; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MILLER JD, 1995, J CELL BIOL, V128, P273, DOI 10.1083/jcb.128.3.273; Mitne-Neto M, 2011, HUM MOL GENET, V20, P3642, DOI 10.1093/hmg/ddr284; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Petersen NHT, 2008, FEBS J, V275, P4378, DOI 10.1111/j.1742-4658.2008.06584.x; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; Reinton N, 2000, DEV BIOL, V223, P194, DOI 10.1006/dbio.2000.9725; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Saita S, 2009, J BIOL CHEM, V284, P13766, DOI 10.1074/jbc.M807938200; Saito S, 2008, J BIOL CHEM, V283, P6584, DOI 10.1074/jbc.M707691200; Saravanan RS, 2009, PLANT J, V58, P817, DOI 10.1111/j.1365-313X.2009.03815.x; Schrick K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r41; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Sengupta S, 2010, BBA-MOL CELL RES, V1803, P796, DOI 10.1016/j.bbamcr.2010.03.017; Shi JH, 2010, BIOCHEMISTRY-US, V49, P3887, DOI 10.1021/bi902057a; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sroubek J, 2011, J BIOL CHEM, V286, P21927, DOI 10.1074/jbc.M110.201699; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Tuuf J, 2007, BBA-MOL CELL BIOL L, V1771, P1353, DOI 10.1016/j.bbalip.2007.09.001; Tuuf J, 2009, BIOCHEM BIOPH RES CO, V388, P395, DOI 10.1016/j.bbrc.2009.08.023; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012; Walker AK, 2011, IUBMB LIFE; West G, 2004, ACTA CRYSTALLOGR D, V60, P703, DOI 10.1107/S090744490400109X; Wyles JP, 2004, EXP CELL RES, V297, P533, DOI 10.1016/j.yexcr.2004.03.052; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Zaccolo M, 2002, CURR OPIN CELL BIOL, V14, P160, DOI 10.1016/S0955-0674(02)00316-2; Zeng JB, 1999, P NATL ACAD SCI USA, V96, P2840, DOI 10.1073/pnas.96.6.2840	80	60	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30455	10.1371/journal.pone.0030455	http://dx.doi.org/10.1371/journal.pone.0030455			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276202	gold, Green Published, Green Submitted			2022-12-27	WOS:000301457200064
J	Yokoi, T; Seko, Y; Yokoi, T; Makino, H; Hatou, S; Yamada, M; Kiyono, T; Umezawa, A; Nishina, H; Azuma, N				Yokoi, Tadashi; Seko, Yuko; Yokoi, Tae; Makino, Hatsune; Hatou, Shin; Yamada, Masakazu; Kiyono, Tohru; Umezawa, Akihiro; Nishina, Hiroshi; Azuma, Noriyuki			Establishment of Functioning Human Corneal Endothelial Cell Line with High Growth Potential	PLOS ONE			English	Article							SURFACE EPITHELIAL-CELLS; OLDER DONORS; IN-VITRO; YOUNG; KERATOPLASTY; PROTEIN; TRANSPLANTATION; PROLIFERATION; RETROVIRUSES; EXPRESSION	Hexagonal-shaped human corneal endothelial cells (HCEC) form a monolayer by adhering tightly through their intercellular adhesion molecules. Located at the posterior corneal surface, they maintain corneal translucency by dehydrating the corneal stroma, mainly through the Na+- and K+-dependent ATPase (Na+/K+-ATPase). Because HCEC proliferative activity is low in vivo, once HCEC are damaged and their numbers decrease, the cornea begins to show opacity due to overhydration, resulting in loss of vision. HCEC cell cycle arrest occurs at the G1 phase and is partly regulated by cyclin-dependent kinase inhibitors (CKIs) in the Rb pathway (p16-CDK4/CyclinD1-pRb). In this study, we tried to activate proliferation of HCEC by inhibiting CKIs. Retroviral transduction was used to generate two new HCEC lines: transduced human corneal endothelial cell by human papillomavirus type E6/E7 (THCEC (E6/E7)) and transduced human corneal endothelial cell by Cdk4R24C/CyclinD1 (THCEH (Cyclin)). Reverse transcriptase polymerase chain reaction analysis of gene expression revealed little difference between THCEC (E6/E7), THCEH (Cyclin) and non-transduced HCEC, but cell cycle-related genes were up-regulated in THCEC (E6/E7) and THCEH (Cyclin). THCEH (Cyclin) expressed intercellular molecules including ZO-1 and N-cadherin and showed similar Na+/K+-ATPase pump function to HCEC, which was not demonstrated in THCEC (E6/E7). This study shows that HCEC cell cycle activation can be achieved by inhibiting CKIs even while maintaining critical pump function and morphology.	[Yokoi, Tadashi; Seko, Yuko; Yokoi, Tae; Azuma, Noriyuki] Natl Ctr Child Hlth & Dev, Dept Ophthalomol, Tokyo, Japan; [Yokoi, Tadashi; Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Bunkyo Ku, Tokyo, Japan; [Makino, Hatsune; Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan; [Hatou, Shin] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Yamada, Masakazu] Natl Tokyo Med Ctr, Div Vis Res, Natl Inst Sensory Organs, Tokyo, Japan; [Kiyono, Tohru] Natl Canc Ctr, Div Virol, Tokyo, Japan; [Seko, Yuko] Natl Rehabil Ctr Persons Disabil, Sensory Funct Sect, Res Inst, Tokyo, Japan	National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU); National Center for Child Health & Development - Japan; Keio University; National Cancer Center - Japan	Yokoi, T (corresponding author), Natl Ctr Child Hlth & Dev, Dept Ophthalomol, Tokyo, Japan.	azuma-n@ncchd.go.jp		Hatou, Shin/0000-0001-9273-5909	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [18390473]; Grants-in-Aid for Scientific Research [22390327, 24659770] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant (# 18390473) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMIS AP, 1993, SURV OPHTHALMOL, V38, P149, DOI 10.1016/0039-6257(93)90099-S; BARFORT P, 1974, EXP EYE RES, V19, P11, DOI 10.1016/0014-4835(74)90067-0; BOURNE WM, 1994, OPHTHALMOLOGY, V101, P1014; Bourne WM, 1997, INVEST OPHTH VIS SCI, V38, P779; Coster DJ, 2005, AM J OPHTHALMOL, V140, P1112, DOI 10.1016/j.ajo.2005.07.024; Enomoto K, 2006, INVEST OPHTH VIS SCI, V47, P4330, DOI 10.1167/iovs.05-1581; Fan TJ, 2011, MOL VIS, V17, P469; Fan TJ, 2009, MOL VIS, V15, P1070; Gagnon MM, 1997, CORNEA, V16, P314; Haga K, 2007, CANCER SCI, V98, P147, DOI 10.1111/j.1349-7006.2006.00373.x; Hashemian Mohammad Nasser, 2006, BMC Ophthalmol, V6, P9; Hatou S, 2009, CURR EYE RES, V34, P347, DOI 10.1080/02713680902829624; Ishino Y, 2008, MOL VIS, V14, P61; Kikuchi M, 2006, INVEST OPHTH VIS SCI, V47, P4803, DOI 10.1167/iovs.06-0521; Kim Hyun-Ju, 2006, Korean J Ophthalmol, V20, P47; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; LAING RA, 1976, EXP EYE RES, V22, P587, DOI 10.1016/0014-4835(76)90003-8; LANDSHMAN N, 1988, INVEST OPHTH VIS SCI, V29, P1100; Li W, 2007, INVEST OPHTH VIS SCI, V48, P614, DOI 10.1167/iovs.06-1126; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Narisawa-Saito M, 2008, CANCER RES, V68, P5699, DOI 10.1158/0008-5472.CAN-07-6862; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nitta M, 2001, GYNECOL ONCOL, V81, P10, DOI 10.1006/gyno.2000.6084; Padilla MDB, 2004, CORNEA, V23, P129, DOI 10.1097/00003226-200403000-00005; Price FW, 2005, J REFRACT SURG, V21, P339; Rane SG, 2002, MOL CELL BIOL, V22, P644, DOI 10.1128/MCB.22.2.644-656.2002; ROBINSON HL, 1982, REV INFECT DIS, V4, P1015; Sasaki R, 2009, CARCINOGENESIS, V30, P423, DOI 10.1093/carcin/bgp007; SCHULTZ RO, 1984, AM J OPHTHALMOL, V98, P401, DOI 10.1016/0002-9394(84)90120-X; Sekiguchi T, 1998, ONCOGENE, V16, P369, DOI 10.1038/sj.onc.1201539; Senoo T, 2000, INVEST OPHTH VIS SCI, V41, P660; Shiraishi A, 2007, CORNEA, V26, pS55, DOI 10.1097/ICO.0b013e31812f6b67; SLINGSBY JG, 1981, ARCH OPHTHALMOL-CHIC, V99, P1041; Terry MA, 2001, CORNEA, V20, P239, DOI 10.1097/00003226-200104000-00001; TSAO SW, 1995, EXP CELL RES, V218, P499, DOI 10.1006/excr.1995.1184; Valtink M, 2008, CELLS TISSUES ORGANS, V187, P286, DOI 10.1159/000113406; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814; Zhu C, 2008, MOL VIS, V14, P1805; Zhu YT, 2008, INVEST OPHTH VIS SCI, V49, P3879, DOI 10.1167/iovs.08-1693	41	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29677	10.1371/journal.pone.0029677	http://dx.doi.org/10.1371/journal.pone.0029677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276123	gold, Green Submitted, Green Published			2022-12-27	WOS:000301457200018
J	Bjorkqvist, M; Ohlsson, M; Minthon, L; Hansson, O				Bjorkqvist, Maria; Ohlsson, Mattias; Minthon, Lennart; Hansson, Oskar			Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's Disease	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; CSF BIOMARKERS; WORK GROUP; DIAGNOSIS; DEMENTIA; SIGNATURE	There is an urgent need for biomarkers in plasma to identify Alzheimer's disease (AD). It has previously been shown that a signature of 18 plasma proteins can identify AD during pre-dementia and dementia stages (Ray et al, Nature Medicine, 2007). We quantified the same 18 proteins in plasma from 174 controls, 142 patients with AD, and 88 patients with other dementias. Only three of these proteins (EGF, PDG-BB and MIP-1 delta) differed significantly in plasma between controls and AD. The 18 proteins could classify patients with AD from controls with low diagnostic precision (area under the ROC curve was 63%). Moreover, they could not distinguish AD from other dementias. In conclusion, independent validation of results is important in explorative biomarker studies.	[Bjorkqvist, Maria] Lund Univ, Brain Dis Biomarker Unit, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden; [Minthon, Lennart] Lund Univ, Clin Memory Res Unit, Dept Clin Sci Malmo, Malmo, Sweden; [Minthon, Lennart; Hansson, Oskar] Skane Univ Hosp, Neuropsychiat Clin, Malmo, Sweden	Lund University; Lund University; Lund University; Skane University Hospital	Bjorkqvist, M (corresponding author), Lund Univ, Brain Dis Biomarker Unit, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden.	maria.bjorkqvist@med.lu.se	Ohlsson, Mattias/G-5790-2011; Hansson, Oskar/A-7134-2013	Hansson, Oskar/0000-0001-8467-7286; Ohlsson, Mattias/0000-0003-1145-4297; Bjorkqvist, Maria/0000-0001-8550-0431	Swedish Research Council; Swedish Brain Power; Skane County Counsil; Lund University; Torsten and Ragnar Soderberg Foundation; BenteRexed foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Power; Skane County Counsil; Lund University; Torsten and Ragnar Soderberg Foundation; BenteRexed foundation	This work was supported by the Swedish Research Council, the Swedish Brain Power, the Regional Agreement on Medical Training and Clinical Research (ALF) between Skane County Counsil and Lund University and the Torsten and Ragnar Soderberg Foundation. MB is supported by BenteRexed foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association AP, 1987, DIAGN STAT MAN MENT; Bishop C.M., 1995, NEURAL NETWORKS PATT; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; de Paula MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017481; Erkinjuntti T, 2000, J NEURAL TRANSM-SUPP, P23; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; HOSMER DW, 1989, APPL LOGISTIC REGRES; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Knudsen LS, 2008, BIOMARKERS, V13, P59, DOI 10.1080/13547500701615017; Marksteiner J, 2011, NEUROBIOL AGING, V32, P539, DOI 10.1016/j.neurobiolaging.2009.03.011; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; McKeith IG, 1999, NEUROLOGY, V53, P902, DOI 10.1212/WNL.53.5.902; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Soares HD, 2009, ANN NY ACAD SCI, V1180, P56, DOI 10.1111/j.1749-6632.2009.05066.x; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299	26	84	87	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29868	10.1371/journal.pone.0029868	http://dx.doi.org/10.1371/journal.pone.0029868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279551	gold, Green Published			2022-12-27	WOS:000299771900029
J	Denman, CJ; Senyukov, VV; Somanchi, SS; Phatarpekar, PV; Kopp, LM; Johnson, JL; Singh, H; Hurton, L; Maiti, SN; Huls, MH; Champlin, RE; Cooper, LJN; Lee, DA				Denman, Cecele J.; Senyukov, Vladimir V.; Somanchi, Srinivas S.; Phatarpekar, Prasad V.; Kopp, Lisa M.; Johnson, Jennifer L.; Singh, Harjeet; Hurton, Lenka; Maiti, Sourindra N.; Huls, M. Helen; Champlin, Richard E.; Cooper, Laurence J. N.; Lee, Dean A.			Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells	PLOS ONE			English	Article							CELLULAR CYTOTOXICITY ADCC; IN-VITRO EXPANSION; CD8(+) T-CELLS; MOUSE NK CELLS; PERIPHERAL-BLOOD; ADOPTIVE TRANSFER; CLINICAL-GRADE; MONOCLONAL-ANTIBODY; GAMMA PRODUCTION; SCALE EXPANSION	NK cells have therapeutic potential for a wide variety of human malignancies. However, because NK cells expand poorly in vitro, have limited life spans in vivo, and represent a small fraction of peripheral white blood cells, obtaining sufficient cell numbers is the major obstacle for NK-cell immunotherapy. Genetically-engineered artificial antigen-presenting cells (aAPCs) expressing membrane-bound IL-15 (mbIL15) have been used to propagate clinical-grade NK cells for human trials of adoptive immunotherapy, but ex vivo proliferation has been limited by telomere shortening. We developed K562-based aAPCs with membrane-bound IL-21 (mbIL21) and assessed their ability to support human NK-cell proliferation. In contrast to mbIL15, mbIL21-expressing aAPCs promoted log-phase NK cell expansion without evidence of senescence for up to 6 weeks of culture. By day 21, parallel expansion of NK cells from 22 donors demonstrated a mean 47,967-fold expansion (median 31,747) when co-cultured with aAPCs expressing mbIL21 compared to 825-fold expansion (median 325) with mbIL15. Despite the significant increase in proliferation, mbIL21-expanded NK cells also showed a significant increase in telomere length compared to freshly obtained NK cells, suggesting a possible mechanism for their sustained proliferation. NK cells expanded with mbIL21 were similar in phenotype and cytotoxicity to those expanded with mbIL15, with retained donor KIR repertoires and high expression of NCRs, CD16, and NKG2D, but had superior cytokine secretion. The mbIL21-expanded NK cells showed increased transcription of the activating receptor CD160, but otherwise had remarkably similar mRNA expression profiles of the 96 genes assessed. mbIL21-expanded NK cells had significant cytotoxicity against all tumor cell lines tested, retained responsiveness to inhibitory KIR ligands, and demonstrated enhanced killing via antibody-dependent cell cytotoxicity. Thus, aAPCs expressing mbIL21 promote improved proliferation of human NK cells with longer telomeres and less senescence, supporting their clinical use in propagating NK cells for adoptive immunotherapy.	[Denman, Cecele J.; Senyukov, Vladimir V.; Somanchi, Srinivas S.; Phatarpekar, Prasad V.; Kopp, Lisa M.; Johnson, Jennifer L.; Singh, Harjeet; Hurton, Lenka; Maiti, Sourindra N.; Huls, M. Helen; Cooper, Laurence J. N.; Lee, Dean A.] Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA; [Phatarpekar, Prasad V.; Hurton, Lenka; Cooper, Laurence J. N.; Lee, Dean A.] Univ Texas Houston, Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX USA; [Champlin, Richard E.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Denman, CJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA.	dale@mdanderson.org	Somanchi, Srinivas S/D-5995-2013; Lee, Dean Anthony/AAK-8443-2021	Lee, Dean Anthony/0000-0001-6693-5392; Kopp, Lisa/0000-0002-3412-4189; Hurton, Lenka/0000-0001-5670-5155	NIH [R21CA114251]; University of Texas MD Anderson Cancer Center; St. Baldrick's Foundation; Mike Doiron Legends of Friendswood; NCI Cancer Center [CA 16672]; NATIONAL CANCER INSTITUTE [R01CA141303, R21CA114251, P30CA016672, P01CA049639] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas MD Anderson Cancer Center; St. Baldrick's Foundation; Mike Doiron Legends of Friendswood; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this work was provided by NIH grant R21CA114251, the University of Texas MD Anderson Cancer Center Physician Scientist Program, the Johnson Fund, the St. Baldrick's Foundation (http://www.stbaldricks.org/), the Mike Doiron Legends of Friendswood, and NCI Cancer Center Support (Core) Grant CA 16672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu N, 2007, CANCER LETT, V256, P196, DOI 10.1016/j.canlet.2007.06.001; Alici E, 2008, BLOOD, V111, P3155, DOI 10.1182/blood-2007-09-110312; Ansen S, 2008, CLIN CANCER RES, V14, P6125, DOI 10.1158/1078-0432.CCR-08-1146; Bachanova V, 2010, CANCER IMMUNOL IMMUN, V59, P1739, DOI 10.1007/s00262-010-0896-z; Baerlocher GM, 2006, NAT PROTOC, V1, P2365, DOI 10.1038/nprot.2006.263; Barakonyi A, 2004, J IMMUNOL, V173, P5349, DOI 10.4049/jimmunol.173.9.5349; Barao I, 2003, BIOL BLOOD MARROW TR, V9, P727, DOI 10.1016/j.bbmt.2003.09.002; Barkholt L, 2009, IMMUNOTHERAPY, V1, P753, DOI 10.2217/IMT.09.47; Berg M, 2010, CYTOTHERAPY, V12, P969, DOI 10.3109/14653249.2010.536216; Berg M, 2009, CYTOTHERAPY, V11, P341, DOI 10.1080/14653240902807034; Boissel L, 2008, BIOL BLOOD MARROW TR, V14, P1031, DOI 10.1016/j.bbmt.2008.06.016; Bonanno G, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-46; Brady J, 2010, J IMMUNOL, V185, P6679, DOI 10.4049/jimmunol.0903354; Brandt K, 2007, CYTOKINE GROWTH F R, V18, P223, DOI 10.1016/j.cytogfr.2007.04.003; Buddingh EP, 2011, CANCER IMMUNOL IMMUN, V60, P575, DOI 10.1007/s00262-010-0965-3; Burgess SJ, 2006, J IMMUNOL, V176, P1490, DOI 10.4049/jimmunol.176.3.1490; Carlens S, 2001, HUM IMMUNOL, V62, P1092, DOI 10.1016/S0198-8859(01)00313-5; Cassard L, 2008, INT J CANCER, V123, P2832, DOI 10.1002/ijc.23870; Castriconi R, 2003, P NATL ACAD SCI USA, V100, P4120, DOI 10.1073/pnas.0730640100; Cho D, 2010, CLIN CANCER RES, V16, P3901, DOI 10.1158/1078-0432.CCR-10-0735; Cho D, 2009, KOREAN J LAB MED, V29, P89, DOI 10.3343/kjlm.2009.29.2.89; Cholujova D, 2008, IMMUNOBIOLOGY, V213, P629, DOI 10.1016/j.imbio.2008.02.006; Clausen J, 2004, BIOL BLOOD MARROW TR, V10, P691, DOI 10.1016/j.bbmt.2004.06.009; Clausen J, 2003, IMMUNOBIOLOGY, V207, P85, DOI 10.1078/0171-2985-00219; Clausen J, 2001, J HEMATOTH STEM CELL, V10, P513, DOI 10.1089/15258160152509127; Clemenceau B, 2006, J IMMUNOTHER, V29, P53; Clemenceau B, 2006, BLOOD, V107, P4669, DOI 10.1182/blood-2005-09-3775; Davies JK, 2010, CANCER RES, V70, P3915, DOI 10.1158/0008-5472.CAN-09-3845; de Rham C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2336; Decot V, 2010, EXP HEMATOL, V38, P351, DOI 10.1016/j.exphem.2010.02.006; Farag SS, 2002, BLOOD, V100, P1935, DOI 10.1182/blood-2002-02-0350; Fujisaki H, 2009, CANCER RES, V69, P4010, DOI 10.1158/0008-5472.CAN-08-3712; Fujisaki H, 2009, BRIT J HAEMATOL, V145, P606, DOI 10.1111/j.1365-2141.2009.07667.x; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Geller MA, 2011, CYTOTHERAPY, V13, P98, DOI 10.3109/14653249.2010.515582; Giustiniani J, 2007, J IMMUNOL, V178, P1293, DOI 10.4049/jimmunol.178.3.1293; Giustiniani J, 2009, J IMMUNOL, V182, P63, DOI 10.4049/jimmunol.182.1.63; Gong W, 2010, TISSUE ANTIGENS; HERBERMAN RB, 1981, SCIENCE, V214, P24, DOI 10.1126/science.7025208; Hurton LV, 2010, LEUKEMIA, V24, P1059, DOI 10.1038/leu.2010.19; Iliopoulou EG, 2010, CANCER IMMUNOL IMMUN, V59, P1781, DOI 10.1007/s00262-010-0904-3; Jung ST, 2011, CURR OPIN BIOTECHNOL; Kasaian MT, 2002, IMMUNITY, V16, P559, DOI 10.1016/S1074-7613(02)00295-9; Klingemann HG, 2004, CYTOTHERAPY, V6, P15, DOI 10.1080/14653240310004548; Koehl U, 2005, KLIN PADIATR, V217, P345, DOI 10.1055/s-2005-872520; Koehl U, 2004, BLOOD CELL MOL DIS, V33, P261, DOI 10.1016/j.bcmd.2004.08.013; Konnikova L, 2005, CANCER RES, V65, P6516, DOI 10.1158/0008-5472.CAN-05-0924; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Le Bouteiller P, 2002, P NATL ACAD SCI USA, V99, P16963, DOI 10.1073/pnas.012681099; LICHTENFELS R, 1994, J IMMUNOL METHODS, V172, P227, DOI 10.1016/0022-1759(94)90110-4; Lu HZ, 2011, HUM IMMUNOL, V72, P538, DOI 10.1016/j.humimm.2011.03.022; Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143; Meyer-Monard S, 2009, TRANSFUSION, V49, P362, DOI 10.1111/j.1537-2995.2008.01969.x; Miller JS, 2009, CYTOTHERAPY, V11, P259, DOI 10.1080/14653240902888000; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Minamiguchi H, 2005, BIOL BLOOD MARROW TR, V11, P487, DOI 10.1016/j.bbmt.2005.04.003; Nitta E, 2011, BLOOD, V117, P4169, DOI 10.1182/blood-2010-08-297390; Numbenjapon T, 2006, LEUKEMIA, V20, P1889, DOI 10.1038/sj.leu.2404329; Parham P, 2003, NAT REV IMMUNOL, V3, P108, DOI 10.1038/nri999; Parkhurst MR, 2011, CLIN CANCER RES, V17, P6287, DOI 10.1158/1078-0432.CCR-11-1347; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Perez SA, 2006, INT IMMUNOL, V18, P49, DOI 10.1093/intimm/dxh348; PERUSSIA B, 1987, NAT IMMUN CELL GROW, V6, P171; Pittari G, 2010, BONE MARROW TRANSPL, V45, P862, DOI 10.1038/bmt.2009.265; Portevin D, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-82; Reim F, 2009, CANCER RES, V69, P8058, DOI 10.1158/0008-5472.CAN-09-0834; ROBERTSON MJ, 1990, BLOOD, V76, P2421; Roda JM, 2006, J IMMUNOL, V177, P120, DOI 10.4049/jimmunol.177.1.120; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Rose MJJ, 2009, J IMMUNOL, V183, P4502, DOI 10.4049/jimmunol.0803323; Rubnitz JE, 2010, J CLIN ONCOL, V28, P955, DOI 10.1200/JCO.2009.24.4590; Satwani P, 2011, CYTOTHERAPY; Shi J, 2008, BRIT J HAEMATOL, V143, P641, DOI 10.1111/j.1365-2141.2008.07340.x; Siegler U, 2010, CYTOTHERAPY, V12, P750, DOI 10.3109/14653241003786155; Singh H, 2011, CANC RES; Singh H, 2008, CANCER RES, V68, P2961, DOI 10.1158/0008-5472.CAN-07-5600; Sivori S, 2003, EUR J IMMUNOL, V33, P3439, DOI 10.1002/eji.200324533; Skak K, 2008, IMMUNOLOGY, V123, P575, DOI 10.1111/j.1365-2567.2007.02730.x; Somanchi SS, 2011, J VIS EXP; Sondergaard H, 2009, J IMMUNOL, V183, P7326, DOI 10.4049/jimmunol.0902697; Spanholtz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009221; Strengell M, 2003, J IMMUNOL, V170, P5464, DOI 10.4049/jimmunol.170.11.5464; Suhoski MM, 2007, MOL THER, V15, P981, DOI 10.1038/mt.sj.6300134; Sutlu T, 2009, J INTERN MED, V266, P154, DOI 10.1111/j.1365-2796.2009.02121.x; Sutlu T, 2011, CYTOTHERAPY; Sutlu T, 2010, CYTOTHERAPY, V12, P1044, DOI 10.3109/14653249.2010.504770; Takaki R, 2005, J IMMUNOL, V175, P2167, DOI 10.4049/jimmunol.175.4.2167; Tokuyama H, 2008, INT J CANCER, V122, P2526, DOI 10.1002/ijc.23365; Tomala J, 2009, J IMMUNOL, V183, P4904, DOI 10.4049/jimmunol.0900284; Toomey JA, 2003, J LEUKOCYTE BIOL, V74, P233, DOI 10.1189/jlb.0303097; Torelli GF, 2002, BRIT J HAEMATOL, V116, P299, DOI 10.1046/j.1365-2141.2002.03277.x; Torelli GF, 2005, HAEMATOLOGICA, V90, P785; Tran KQ, 2008, J IMMUNOTHER, V31, P742, DOI 10.1097/CJI.0b013e31818403d5; Vitale M, 2004, EUR J IMMUNOL, V34, P1715, DOI 10.1002/eji.200425100; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Warren HS, 2003, J IMMUNOL METHODS, V280, P135, DOI 10.1016/S0022-1759(03)00106-6; Wendt K, 2007, IMMUNOLOGY, V122, P486, DOI 10.1111/j.1365-2567.2007.02675.x; Wu ZF, 2010, J MOL CELL BIOL, V2, P217, DOI 10.1093/jmcb/mjq012; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973; Zhang H, 2011, J IMMUNOTHER, V34, P187, DOI 10.1097/CJI.0b013e31820d2a21	100	355	394	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30264	10.1371/journal.pone.0030264	http://dx.doi.org/10.1371/journal.pone.0030264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279576	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900053
J	Kuchenbuch, A; Paraskevopoulos, E; Herholz, SC; Pantev, C				Kuchenbuch, Anja; Paraskevopoulos, Evangelos; Herholz, Sibylle C.; Pantev, Christo			Electromagnetic Correlates of Musical Expertise in Processing of Tone Patterns	PLOS ONE			English	Article							MISMATCH NEGATIVITY MMN; AUDITORY-CORTEX; COMPARING MUSICIANS; CORTICAL PLASTICITY; SEQUENTIAL SOUNDS; HUMAN BRAIN; MINDS EAR; IMAGERY; NONMUSICIANS; ATTENTION	Using magnetoencephalography (MEG), we investigated the influence of long term musical training on the processing of partly imagined tone patterns (imagery condition) compared to the same perceived patterns (perceptual condition). The magnetic counterpart of the mismatch negativity (MMNm) was recorded and compared between musicians and non-musicians in order to assess the effect of musical training on the detection of deviants to tone patterns. The results indicated a clear MMNm in the perceptual condition as well as in a simple pitch oddball (control) condition in both groups. However, there was no significant mismatch response in either group in the imagery condition despite above chance behavioral performance in the task of detecting deviant tones. The latency and the laterality of the MMNm in the perceptual condition differed significantly between groups, with an earlier MMNm in musicians, especially in the left hemisphere. In contrast the MMNm amplitudes did not differ significantly between groups. The behavioral results revealed a clear effect of long-term musical training in both experimental conditions. The obtained results represent new evidence that the processing of tone patterns is faster and more strongly lateralized in musically trained subjects, which is consistent with other findings in different paradigms of enhanced auditory neural system functioning due to long-term musical training.	[Kuchenbuch, Anja; Paraskevopoulos, Evangelos; Pantev, Christo] Univ Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Herholz, Sibylle C.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	University of Munster; McGill University	Kuchenbuch, A (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany.	pantev@uni-muenster.de		Paraskevopoulos, Evangelos/0000-0003-4063-4182	Deutsche Forschungsgemeinschaft [PA392/12-2, HE6067-1/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft [PA392/12-2 and HE6067-1/1]. URL:http://www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAIN C, 1994, NEUROREPORT, V6, P140, DOI 10.1097/00001756-199412300-00036; Aleman A, 2000, NEUROPSYCHOLOGIA, V38, P1664, DOI 10.1016/S0028-3932(00)00079-8; Boh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021458; Brattico E, 2001, MUSIC PERCEPT, V19, P199, DOI 10.1525/mp.2001.19.2.199; CSEPE V, 1992, ELECTROEN CLIN NEURO, V84, P538, DOI 10.1016/0168-5597(92)90043-B; Darvas F, 2005, NEUROIMAGE, V25, P355, DOI 10.1016/j.neuroimage.2004.09.045; Di Nocera F, 2000, BEHAV RES METH INS C, V32, P111, DOI 10.3758/BF03200793; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; Fujioka T, 2005, J COGNITIVE NEUROSCI, V17, P1578, DOI 10.1162/089892905774597263; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Halpern AR, 2004, NEUROPSYCHOLOGIA, V42, P1281, DOI 10.1016/j.neuropsychologia.2003.12.017; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; HERHOLZ SG, 2011, EUROPEAN J IN PRESS; Herholz SC, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-42; Herholz SC, 2008, EUR J NEUROSCI, V28, P2352, DOI 10.1111/j.1460-9568.2008.06515.x; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Jancke L, 2009, RESTOR NEUROL NEUROS, V27, P521, DOI 10.3233/RNN-2009-0519; Jancke Lutz, 2009, F1000 Biol Rep, V1, P78, DOI 10.3410/B1-78; Koelsch S, 1999, NEUROREPORT, V10, P1309, DOI 10.1097/00001756-199904260-00029; Kraemer DJM, 2005, NATURE, V434, P158, DOI 10.1038/434158a; Kujala A, 2003, NEUROREPORT, V14, P1683, DOI 10.1097/00001756-200309150-00005; Kujala T, 2001, P NATL ACAD SCI USA, V98, P10509, DOI 10.1073/pnas.181589198; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; LAPPE C, 2011, PLOS ONE IN PRESS; Lappe C, 2008, J NEUROSCI, V28, P9632, DOI 10.1523/JNEUROSCI.2254-08.2008; Lopez L, 2003, ANN NY ACAD SCI, V999, P124, DOI 10.1196/annals.1284.013; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; Naatanen R, 2004, CLIN NEUROPHYSIOL, V115, P140, DOI 10.1016/j.clinph.2003.04.001; Nikjeh DA, 2009, EAR HEARING, V30, P432, DOI 10.1097/AUD.0b013e3181a61bf2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paavilainen P, 2001, PSYCHOPHYSIOLOGY, V38, P359, DOI 10.1017/S0048577201000920; Paavilainen P, 2007, NEUROREPORT, V18, P159, DOI 10.1097/WNR.0b013e328010e2ac; Pantev C, 2009, ANN NY ACAD SCI, V1169, P143, DOI 10.1111/j.1749-6632.2009.04588.x; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; SAARINEN J, 1992, NEUROREPORT, V3, P1149, DOI 10.1097/00001756-199212000-00030; Schlaug G, 2001, ANN NY ACAD SCI, V930, P281, DOI 10.1111/j.1749-6632.2001.tb05739.x; Schurmann M, 2002, NEUROIMAGE, V16, P434, DOI 10.1006/nimg.2002.1098; Sculthorpe LD, 2008, BRAIN RES, V1234, P78, DOI 10.1016/j.brainres.2008.07.031; Sculthorpe LD, 2009, BRAIN RES, V1290, P52, DOI 10.1016/j.brainres.2009.06.013; SCULTHORPE LD, 2011, CLIN NEUROPHYSIOLOGY; Shahin AJ, 2007, CLIN NEUROPHYSIOL, V118, P209, DOI 10.1016/j.clinph.2006.09.019; Sussman E, 2003, PSYCHOPHYSIOLOGY, V40, P430, DOI 10.1111/1469-8986.00045; Sussman E, 2002, COGNITIVE BRAIN RES, V13, P393, DOI 10.1016/S0926-6410(01)00131-8; Sussman ES, 2007, J PSYCHOPHYSIOL, V21, P164, DOI 10.1027/0269-8803.21.34.164; Sussman ES, 2005, NEUROREPORT, V16, P1519, DOI 10.1097/01.wnr.0000177002.35193.4c; Tervaniemi M, 2003, BRAIN RES REV, V43, P231, DOI 10.1016/j.brainresrev.2003.08.004; TERVANIEMI M, 1994, NEUROREPORT, V5, P844, DOI 10.1097/00001756-199403000-00027; Tervaniemi M, 2001, LEARN MEMORY, V8, P295, DOI 10.1101/lm.39501; Tervaniemi M, 2005, EXP BRAIN RES, V161, P1, DOI 10.1007/s00221-004-2044-5; Tervaniemi M, 2006, NEUROREPORT, V17, P1225, DOI 10.1097/01.wnr.0000230510.55596.8b; TESCHE CD, 1995, ELECTROEN CLIN NEURO, V95, P189, DOI 10.1016/0013-4694(95)00064-6; van Zuijen TL, 2005, COGNITIVE BRAIN RES, V23, P270, DOI 10.1016/j.cogbrainres.2004.10.007; van Zuijen TL, 2004, J COGNITIVE NEUROSCI, V16, P331, DOI 10.1162/089892904322984607; Vuust P, 2005, NEUROIMAGE, V24, P560, DOI 10.1016/j.neuroimage.2004.08.039; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; Yoo SS, 2001, NEUROREPORT, V12, P3045, DOI 10.1097/00001756-200110080-00013; Zatorre RJ, 2005, NEURON, V47, P9, DOI 10.1016/j.neuron.2005.06.013; Zatorre RJ, 1996, J COGNITIVE NEUROSCI, V8, P29, DOI 10.1162/jocn.1996.8.1.29; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; ZATORRE RJ, 2005, NATURE, V434	63	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30171	10.1371/journal.pone.0030171	http://dx.doi.org/10.1371/journal.pone.0030171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279568	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900046
J	Lehmann, T; Hess, M; Melzer, RR				Lehmann, Tobias; Hess, Martin; Melzer, Roland R.			Wiring a Periscope - Ocelli, Retinula Axons, Visual Neuropils and the Ancestrality of Sea Spiders	PLOS ONE			English	Article							CRAB LIMULUS-POLYPHEMUS; ARTHROPOD PHYLOGENY; CUPIENNIUS-SALEI; ONE BRAIN; EYES; EVOLUTION; ORGANIZATION; MORPHOLOGY; SYSTEMS; NEUROANATOMY	The Pycnogonida or sea spiders are cryptic, eight-legged arthropods with four median ocelli in a 'periscope' or eye tubercle. In older attempts at reconstructing phylogeny they were Arthropoda incertae sedis, but recent molecular trees placed them as the sister group either to all other euchelicerates or even to all euarthropods. Thus, pycnogonids are among the oldest extant arthropods and hold a key position for the understanding of arthropod evolution. This has stimulated studies of new sets of characters conductive to cladistic analyses, e. g. of the chelifores and of the hox gene expression pattern. In contrast knowledge of the architecture of the visual system is cursory. A few studies have analysed the ocelli and the uncommon "pseudoinverted'' retinula cells. Moreover, analyses of visual neuropils are still at the stage of Hanstrom's early comprehensive works. We have therefore used various techniques to analyse the visual fibre pathways and the structure of their interrelated neuropils in several species. We found that pycnogonid ocelli are innervated to first and second visual neuropils in close vicinity to an unpaired midline neuropil, i.e. possibly the arcuate body, in a way very similar to ancestral euarthropods like Euperipatoides rowelli (Onychophora) and Limulus polyphemus (Xiphosura). This supports the ancestrality of pycnogonids and sheds light on what eyes in the pycnogonid ground plan might have 'looked' like. Recently it was suggested that arthropod eyes originated from simple ocelli similar to larval eyes. Hence, pycnogonid eyes would be one of the early offshoots among the wealth of more sophisticated arthropod eyes.	[Lehmann, Tobias; Melzer, Roland R.] Bavarian State Collect Zool, Munich, Germany; [Lehmann, Tobias; Hess, Martin] Univ Munich, Dept Biol 1, Planegg Martinsried, Germany	University of Munich	Lehmann, T (corresponding author), Bavarian State Collect Zool, Munich, Germany.	lehmann@zsm.mwn.de			Graduiertenstipendium (BayEFG) from the Universitat Bayern e.V.; Deutsche Forschungsgemeinschaft (DFG) [Me 2683/6-1]	Graduiertenstipendium (BayEFG) from the Universitat Bayern e.V.; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by a Graduiertenstipendium (BayEFG) from the Universitat Bayern e.V. to T. Lehmann, and by the Deutsche Forschungsgemeinschaft (DFG Me 2683/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN JS, 1980, NEUROANATOMICAL TECH; Brenneis G, 2008, EVOL DEV, V10, P717, DOI 10.1111/j.1525-142X.2008.00285.x; CALMAN BG, 1991, J COMP NEUROL, V313, P553, DOI 10.1002/cne.903130402; CHAMBERLAIN SC, 1980, J COMP NEUROL, V192, P387, DOI 10.1002/cne.901920212; COLONNIER M, 1964, J ANAT, V98, P327; Dohle W, 2001, ANN SOC ENTOMOL FR, V37, P85; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; GOODMAN LJ, 1975, CELL TISSUE RES, V157, P467; Hanstrom B, 1928, VERGLEICHENDE ANATOM; Harzsch S, 2006, DEV DYNAM, V235, P2641, DOI 10.1002/dvdy.20866; Helfer H, 1935, BRONNS KLASSEN ORDNU, V5, P1; Hess M, 1996, HELGOLANDER MEERESUN, V50, P25, DOI 10.1007/BF02367135; Homberg U, 2008, ARTHROPOD STRUCT DEV, V37, P347, DOI 10.1016/j.asd.2008.01.008; HUDSPETH AJ, 1977, J PHYSIOL-LONDON, V272, P1; Jager M, 2006, NATURE, V441, P506, DOI 10.1038/nature04591; Jarvis J.H., 1973, Marine Behav Physiol, V2, P1; JARVIS JH, 1979, MAR BEHAV PHYSIOL, V6, P307, DOI 10.1080/10236247909378576; Manuel M, 2006, DEV GENES EVOL, V216, P481, DOI 10.1007/s00427-006-0095-2; Maxmen A, 2005, NATURE, V437, P1144, DOI 10.1038/nature03984; Mayer G, 2006, ARTHROPOD STRUCT DEV, V35, P231, DOI 10.1016/j.asd.2006.06.003; Melzer RR, 2009, J MORPHOL, V270, P1524, DOI 10.1002/jmor.10779; Melzer RR, 1997, NATURWISSENSCHAFTEN, V84, P542, DOI 10.1007/s001140050442; Paulus H.F., 1979, P299; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; Richter S, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-29; Siveter DJ, 2004, NATURE, V431, P978, DOI 10.1038/nature02928; Sokolow I, 1911, Z WISS ZOOL ABT A, V98, P339; Strausfeld NJ, 2006, ARTHROPOD STRUCT DEV, V35, P169, DOI 10.1016/j.asd.2006.06.002; Strausfeld NJ, 2006, P ROY SOC B-BIOL SCI, V273, P1857, DOI 10.1098/rspb.2006.3536; STRAUSFELD NJ, 1993, J COMP NEUROL, V328, P63, DOI 10.1002/cne.903280105; STRAUSFELD NJ, 1993, J COMP NEUROL, V328, P43, DOI 10.1002/cne.903280104; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; WIGGLESWORTH VB, 1957, PROC R SOC SER B-BIO, V147, P185, DOI 10.1098/rspb.1957.0043; WINTER G, 1980, Z ZOOL SYST EVOL, V18, P27	35	22	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30474	10.1371/journal.pone.0030474	http://dx.doi.org/10.1371/journal.pone.0030474			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279594	gold, Green Published, Green Submitted			2022-12-27	WOS:000299771900071
J	Ubuka, T; Mukai, M; Wolfe, J; Beverly, R; Clegg, S; Wang, A; Hsia, S; Li, M; Krause, JS; Mizuno, T; Fukuda, Y; Tsutsui, K; Bentley, GE; Wingfield, JC				Ubuka, Takayoshi; Mukai, Motoko; Wolfe, Jordan; Beverly, Ryan; Clegg, Sarah; Wang, Ariel; Hsia, Serena; Li, Molly; Krause, Jesse S.; Mizuno, Takanobu; Fukuda, Yujiro; Tsutsui, Kazuyoshi; Bentley, George E.; Wingfield, John C.			RNA Interference of Gonadotropin-Inhibitory Hormone Gene Induces Arousal in Songbirds	PLOS ONE			English	Article							QUAIL COTURNIX-JAPONICA; LUTEINIZING-HORMONE; CDNA CLONING; IDENTIFICATION; BEHAVIOR; RECEPTOR; BRAIN; SONG; HYPOTHALAMUS; EXPRESSION	Gonadotropin-inhibitory hormone (GnIH) was originally identified in quail as a hypothalamic neuropeptide inhibitor of pituitary gonadotropin synthesis and release. However, GnIH neuronal fibers do not only terminate in the median eminence to control anterior pituitary function but also extend widely in the brain, suggesting it has multiple roles in the regulation of behavior. To identify the role of GnIH neurons in the regulation of behavior, we investigated the effect of RNA interference (RNAi) of the GnIH gene on the behavior of white-crowned sparrows, a highly social songbird species. Administration of small interfering RNA against GnIH precursor mRNA into the third ventricle of male and female birds reduced resting time, spontaneous production of complex vocalizations, and stimulated brief agonistic vocalizations. GnIH RNAi further enhanced song production of short duration in male birds when they were challenged by playbacks of novel male songs. These behaviors resembled those of breeding birds during territorial defense. The overall results suggest that GnIH gene silencing induces arousal. In addition, the activities of male and female birds were negatively correlated with GnIH mRNA expression in the paraventricular nucleus. Density of GnIH neuronal fibers in the ventral tegmental area was decreased by GnIH RNAi treatment in female birds, and the number of gonadotropin-releasing hormone neurons that received close appositions of GnIH neuronal fiber terminals was negatively correlated with the activity of male birds. In summary, GnIH may decrease arousal level resulting in the inhibition of specific motivated behavior such as in reproductive contexts.	[Ubuka, Takayoshi; Wolfe, Jordan; Beverly, Ryan; Clegg, Sarah; Wang, Ariel; Hsia, Serena; Li, Molly; Bentley, George E.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Ubuka, Takayoshi; Wolfe, Jordan; Beverly, Ryan; Clegg, Sarah; Wang, Ariel; Hsia, Serena; Li, Molly; Bentley, George E.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Mukai, Motoko; Krause, Jesse S.; Wingfield, John C.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Ubuka, Takayoshi; Mizuno, Takanobu; Fukuda, Yujiro; Tsutsui, Kazuyoshi] Waseda Univ, Dept Biol, Shinjuku Ku, Tokyo, Japan; [Mukai, Motoko] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Davis; Waseda University; Cornell University	Ubuka, T (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	t.ubuka@aoni.waseda.jp	Mukai, Motoko/L-9910-2014	Mukai, Motoko/0000-0002-5695-3826; Ubuka, Takayoshi/0000-0002-4731-8118; Krause, Jesse/0000-0001-8678-4309	USA National Science Foundation [IOS-0750540]; Endowed Chair in Physiology, University of California Davis; Ministry of Education, Science and Culture, Japan [18107002, 22132004, 22227002]; Grants-in-Aid for Scientific Research [22227002] Funding Source: KAKEN	USA National Science Foundation(National Science Foundation (NSF)); Endowed Chair in Physiology, University of California Davis(University of California System); Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	J.C.W. acknowledges support IOS-0750540 from the USA National Science Foundation and the Endowed Chair in Physiology, University of California Davis. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan (18107002, 22132004 and 22227002 to K. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appeltants D, 2000, J CHEM NEUROANAT, V18, P117, DOI 10.1016/S0891-0618(99)00054-X; Bentley GE, 2006, HORM BEHAV, V49, P550, DOI 10.1016/j.yhbeh.2005.12.005; Bentley GE, 2003, J NEUROENDOCRINOL, V15, P794, DOI 10.1046/j.1365-2826.2003.01062.x; BURGUS R, 1972, P NATL ACAD SCI USA, V69, P278, DOI 10.1073/pnas.69.1.278; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chilton G., 1995, WHITE CROWNED SPARRO; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Dorn G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh044; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; HILL BG, 1985, CONDOR, V87, P327, DOI 10.2307/1367211; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; Hoyer D, 2006, J RECEPT SIG TRANSD, V26, P527, DOI 10.1080/10799890600929663; Johnson MA, 2007, HORM BEHAV, V51, P171, DOI 10.1016/j.yhbeh.2006.09.009; KING JA, 1982, J BIOL CHEM, V257, P722; Krebs MD, 2011, CHEM-EUR J, V17, P3054, DOI 10.1002/chem.201003144; Kriegsfeld LJ, 2006, P NATL ACAD SCI USA, V103, P2410, DOI 10.1073/pnas.0511003103; LEWIS JW, 1981, J COMP NEUROL, V196, P347, DOI 10.1002/cne.901960212; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Makimura H, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-18; Maney DL, 1997, HORM BEHAV, V32, P11, DOI 10.1006/hbeh.1997.1399; MATSUO H, 1971, BIOCHEM BIOPH RES CO, V43, P1334, DOI 10.1016/S0006-291X(71)80019-0; MIYAMOTO K, 1982, BIOCHEM BIOPH RES CO, V107, P820, DOI 10.1016/0006-291X(82)90596-4; MIYAMOTO K, 1984, P NATL ACAD SCI-BIOL, V81, P3874, DOI 10.1073/pnas.81.12.3874; MOSS RL, 1973, SCIENCE, V181, P177, DOI 10.1126/science.181.4095.177; Nelson DA, 2011, BEHAV ECOL SOCIOBIOL, V65, P1103, DOI 10.1007/s00265-010-1120-z; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Osugi T, 2004, J ENDOCRINOL, V182, P33, DOI 10.1677/joe.0.1820033; Pfaff D. W., 2006, BRAIN AROUSAL INFORM; Pfaff D, 2008, ANN NY ACAD SCI, V1129, P11, DOI 10.1196/annals.1417.019; PFAFF DW, 1973, SCIENCE, V182, P1148, DOI 10.1126/science.182.4117.1148; Qi Y, 2009, J NEUROENDOCRINOL, V21, P690, DOI 10.1111/j.1365-2826.2009.01886.x; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; SPITLERNABORS KJ, 1983, CONDOR, V85, P491, DOI 10.2307/1367993; Stevenson TJ, 2009, ENDOCRINOLOGY, V150, P1826, DOI 10.1210/en.2008-1435; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; Thakker DR, 2005, MOL PSYCHIATR, V10, P782, DOI 10.1038/sj.mp.4001687; Thakker DR, 2004, P NATL ACAD SCI USA, V101, P17270, DOI 10.1073/pnas.0406214101; Tobari Y, 2010, PEPTIDES, V31, P816, DOI 10.1016/j.peptides.2010.01.015; Tsutsui K, 2000, BIOCHEM BIOPH RES CO, V275, P661, DOI 10.1006/bbrc.2000.3350; Ubuka T, 2005, P NATL ACAD SCI USA, V102, P3052, DOI 10.1073/pnas.0403840102; Ubuka T, 2006, ENDOCRINOLOGY, V147, P1187, DOI 10.1210/en.2005-1178; Ubuka T, 2003, J ENDOCRINOL, V178, P311, DOI 10.1677/joe.0.1780311; Ubuka T., 2010, HORMONES REPROD VERT, V4, P1; Ubuka T, 2008, INTEGR COMP BIOL, V48, P560, DOI 10.1093/icb/icn019; Ubuka T, 2008, ENDOCRINOLOGY, V149, P4229; Ubuka T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008400; Ubuka T, 2009, J COMP NEUROL, V517, P841, DOI 10.1002/cne.22191; Ubuka T, 2009, J ENDOCRINOL, V201, P81, DOI 10.1677/JOE-08-0508; Ubuka T, 2009, GEN COMP ENDOCR, V162, P301, DOI 10.1016/j.ygcen.2009.04.001; Ukena K, 2003, CELL TISSUE RES, V312, P73, DOI 10.1007/s00441-003-0700-x; Weil ZM, 2010, P NATL ACAD SCI USA, V107, P2265, DOI 10.1073/pnas.0914014107; WINGFIELD JC, 1991, J ZOOL, V225, P43, DOI 10.1111/j.1469-7998.1991.tb03800.x; WINGFIELD JC, 1975, STEROIDS, V26, P311, DOI 10.1016/0039-128X(75)90077-X; Yin H, 2005, J ENDOCRINOL, V184, P257, DOI 10.1677/joe.1.05926	56	58	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30202	10.1371/journal.pone.0030202	http://dx.doi.org/10.1371/journal.pone.0030202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279571	gold, Green Published, Green Submitted			2022-12-27	WOS:000299771900049
J	Ungermannova, D; Parker, SJ; Nasveschuk, CG; Wang, W; Quade, B; Zhan, G; Kuchta, RD; Phillips, AJ; Liu, XD				Ungermannova, Dana; Parker, Seth J.; Nasveschuk, Christopher G.; Wang, Wei; Quade, Bettina; Zhan, Gan; Kuchta, Robert D.; Phillips, Andrew J.; Liu, Xuedong			Largazole and Its Derivatives Selectively Inhibit Ubiquitin Activating Enzyme (E1)	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; MULTICATALYTIC PROTEINASE COMPLEX; BIOLOGICAL EVALUATION; CANCER-THERAPY; PROTEASOME; ANALOGS; SYSTEM; CONJUGATION; CULLIN; NEDD8	Protein ubiquitination plays an important role in the regulation of almost every aspect of eukaryotic cellular function; therefore, its destabilization is often observed in most human diseases and cancers. Consequently, developing inhibitors of the ubiquitination system for the treatment of cancer has been a recent area of interest. Currently, only a few classes of compounds have been discovered to inhibit the ubiquitin-activating enzyme (E1) and only one class is relatively selective in E1 inhibition in cells. We now report that Largazole and its ester and ketone analogs selectively inhibit ubiquitin conjugation to p27(Kip1) and TRF1 in vitro. The inhibitory activity of these small molecules on ubiquitin conjugation has been traced to their inhibition of the ubiquitin E1 enzyme. To further dissect the mechanism of E1 inhibition, we analyzed the effects of these inhibitors on each of the two steps of E1 activation. We show that Largazole and its derivatives specifically inhibit the adenylation step of the E1 reaction while having no effect on thioester bond formation between ubiquitin and E1. E1 inhibition appears to be specific to human E1 as Largazole ketone fails to inhibit the activation of Uba1p, a homolog of E1 in Schizosaccharomyces pombe. Moreover, Largazole analogs do not significantly inhibit SUMO E1. Thus, Largazole and select analogs are a novel class of ubiquitin E1 inhibitors and valuable tools for studying ubiquitination in vitro. This class of compounds could be further developed and potentially be a useful tool in cells.	[Ungermannova, Dana; Parker, Seth J.; Nasveschuk, Christopher G.; Wang, Wei; Quade, Bettina; Zhan, Gan; Kuchta, Robert D.; Liu, Xuedong] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Phillips, Andrew J.] Yale Univ, Dept Chem, New Haven, CT USA	University of Colorado System; University of Colorado Boulder; Yale University	Ungermannova, D (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	Xuedong.Liu@Colorado.edu		LIU, XUEDONG/0000-0001-7209-4964; Parker, Seth/0000-0001-7971-8848	National Institutes of Health [CA107089]; United States Army [W81XWH-10-1-0989]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army(United States Department of DefenseUnited States Army)	This work was supported by a grant from the National Institutes of Health (CA107089) to XL and United States Army grants no. W81XWH-10-1-0989 to XL and AJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowers A, 2008, J AM CHEM SOC, V130, P11219, DOI 10.1021/ja8033763; Bowers AA, 2009, ORG LETT, V11, P1301, DOI 10.1021/ol900078k; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Chen F, 2009, CHEMMEDCHEM, V4, P1269, DOI 10.1002/cmdc.200900125; Chiba T, 2004, CURR PROTEIN PEPT SC, V5, P177, DOI 10.2174/1389203043379783; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Eldridge AG, 2010, CELL DEATH DIFFER, V17, P4, DOI 10.1038/cdd.2009.82; Garber K, 2005, J NATL CANCER I, V97, P166, DOI 10.1093/jnci/97.3.166; Ghosh AK, 2008, ORG LETT, V10, P3907, DOI 10.1021/ol8014623; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; HERSHKO A, 1979, P NATL ACAD SCI USA, V76, P3107, DOI 10.1073/pnas.76.7.3107; HERSHKO A, 1982, ANNU REV BIOCHEM, V51, P335, DOI 10.1146/annurev.bi.51.070182.002003; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; ImajohOhmi S, 1995, BIOCHEM BIOPH RES CO, V217, P1070, DOI 10.1006/bbrc.1995.2878; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Knuesel M, 2005, MOL CELL PROTEOMICS, V4, P1626, DOI 10.1074/mcp.T500011-MCP200; Lu XQ, 2010, J AM CHEM SOC, V132, P1748, DOI 10.1021/ja9088549; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Nasveschuk CG, 2008, ORG LETT, V10, P3595, DOI 10.1021/ol8013478; Newkirk TL, 2009, NAT PROD REP, V26, P1293, DOI 10.1039/b817886k; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Seiser T, 2008, ANGEW CHEM INT EDIT, V47, P6483, DOI 10.1002/anie.200802043; Sekizawa R, 2002, J NAT PROD, V65, P1491, DOI 10.1021/np020098q; Shinohara K, 1996, BIOCHEM J, V317, P385, DOI 10.1042/bj3170385; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Souto JA, 2010, J MED CHEM, V53, P4654, DOI 10.1021/jm100244y; Taori K, 2008, J AM CHEM SOC, V130, P1806, DOI 10.1021/ja7110064; Tsukamoto S, 2005, BIOORG MED CHEM LETT, V15, P191, DOI 10.1016/j.bmcl.2004.10.012; Ungermannova D, 2005, J BIOL CHEM, V280, P30301, DOI 10.1074/jbc.M411103200; VINITSKY A, 1992, BIOCHEMISTRY-US, V31, P9421, DOI 10.1021/bi00154a014; VINITSKY A, 1994, J BIOL CHEM, V269, P29860; Wang B, 2011, J ORG CHEM; Wang W, 2004, J BIOL CHEM, V279, P51362, DOI 10.1074/jbc.M405944200; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Ying YC, 2008, ORG LETT, V10, P4021, DOI 10.1021/ol801532s; Ying YC, 2008, J AM CHEM SOC, V130, P8455, DOI 10.1021/ja8013727; Zeng X, 2010, ORG LETT, V12, P1368, DOI 10.1021/ol100308a; Zeng ZX, 2010, DEV CELL, V18, P214, DOI 10.1016/j.devcel.2010.01.007	46	56	56	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29208	10.1371/journal.pone.0029208	http://dx.doi.org/10.1371/journal.pone.0029208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279528	gold, Green Submitted, Green Published			2022-12-27	WOS:000299771900006
J	Aratake, S; Tomura, T; Saitoh, S; Yokokura, R; Kawanishi, Y; Shinjo, R; Reimer, JD; Tanaka, J; Maekawa, H				Aratake, Satoe; Tomura, Tomohiko; Saitoh, Seikoh; Yokokura, Ryouma; Kawanishi, Yuichi; Shinjo, Ryuichi; Reimer, James Davis; Tanaka, Junichi; Maekawa, Hideaki			Soft Coral Sarcophyton (Cnidaria: Anthozoa: Octocorallia) Species Diversity and Chemotypes	PLOS ONE			English	Article							COMPLEMENTARY SECONDARY METABOLITES; GREAT-BARRIER-REEF; SCLERACTINIAN CORAL; MARINE TERPENES; ALCYONACEA; COELENTERATA; VARIABILITY; DITERPENES; COMMUNITY	Research on the soft coral genus Sarcophyton extends over a wide range of fields, including marine natural products and the isolation of a number of cembranoid diterpenes. However, it is still unknown how soft corals produce this diverse array of metabolites, and the relationship between soft coral diversity and cembranoid diterpene production is not clear. In order to understand this relationship, we examined Sarcophyton specimens from Okinawa, Japan, by utilizing three methods: morphological examination of sclerites, chemotype identification, and phylogenetic examination of both Sarcophyton (utilizing mitochondrial protein-coding genes MutS homolog: msh1) and their endosymbiotic Symbiodinium spp. (utilizing nuclear internal transcribed spacer of ribosomal DNA: ITS-rDNA). Chemotypes, molecular phylogenetic clades, and sclerites of Sarcophyton trocheliophorum specimens formed a clear and distinct group, but the relationships between chemotypes, molecular phylogenetic clade types and sclerites of the most common species, Sarcophyton glaucum, was not clear. S. glaucum was divided into four clades. A characteristic chemotype was observed within one phylogenetic clade of S. glaucum. Identities of symbiotic algae Symbiodinium spp. had no apparent relation to chemotypes of Sarcophyton spp. This study demonstrates that the complex results observed for S. glaucum are due to the incomplete and complex taxonomy of this species group. Our novel method of identification should help contribute to classification and taxonomic reassessment of this diverse soft coral genus.	[Aratake, Satoe; Tomura, Tomohiko] Univ Ryukyus, Grad Sch Sci & Engn, Nishihara, Okinawa 90301, Japan; [Saitoh, Seikoh; Kawanishi, Yuichi; Maekawa, Hideaki] Univ Ryukyus, Trop Biosphere Res Ctr, Ctr Mol Biosci, Nishihara, Okinawa 90301, Japan; [Yokokura, Ryouma; Tanaka, Junichi] Univ Ryukyus, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 90301, Japan; [Shinjo, Ryuichi] Univ Ryukyus, Dept Phys & Earth Sci, Nishihara, Okinawa 90301, Japan; [Reimer, James Davis] Univ Ryukyus, TRO SIS, Rising Star Program, Nishihara, Okinawa 90301, Japan	University of the Ryukyus; University of the Ryukyus; University of the Ryukyus; University of the Ryukyus; University of the Ryukyus	Aratake, S (corresponding author), Univ Ryukyus, Grad Sch Sci & Engn, Nishihara, Okinawa 90301, Japan.	hidemae@comb.u-ryukyu.ac.jp	Reimer, James Davis/AAP-1331-2020	Tanaka, Junichi/0000-0002-8672-7379	Ministry of Education, Culture, Sports, Science and Technology Japan; Grants-in-Aid for Scientific Research [21540496] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The project of "Research of insertion mechanism into the genome of movable gene with its transporter and development of the general gene introduction system'' was supported by Ministry of Education, Culture, Sports, Science and Technology Japan. International Research Hub Project for Climate Change and Coral Reef/Island Dynamics, University of the Ryukyus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSLADE P, 1991, Beagle, V8, P189; Alderslade Philip, 1993, Precious Corals & Octocoral Research, V1, P20; Benayahu Y, 2004, ZOOL STUD, V43, P537; Benayahu Y., 2009, Zoologische Mededelingen (Leiden), V83, P863; Blunt JW, 2004, NAT PROD REP, V21, P1, DOI 10.1039/b305250h; Chanmethakul T, 2010, ZOOL STUD, V49, P72; COLL JC, 1982, J EXP MAR BIOL ECOL, V60, P293, DOI 10.1016/0022-0981(82)90166-6; DINESEN Z D, 1983, Coral Reefs, V1, P229, DOI 10.1007/BF00304420; Fabricius KE, 1997, CORAL REEFS, V16, P159, DOI 10.1007/s003380050070; Fleury B, 2006, MAR ECOL-EVOL PERSP, V27, P204, DOI 10.1111/j.1439-0485.2006.00106.x; Fleury BG, 2004, J EXP MAR BIOL ECOL, V303, P115, DOI 10.1016/j.jembe.2003.11.006; FUJIKI H, 1989, J CANCER RES CLIN, V115, P25, DOI 10.1007/BF00391595; Fukatsu T, 2007, J NAT PROD, V70, P407, DOI 10.1021/np060596p; Griffith JK, 1997, MAR FRESHWATER RES, V48, P129, DOI 10.1071/MF96086; Gross Harald, 2006, Phytochemistry Reviews, V5, P115, DOI 10.1007/s11101-005-5464-3; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hegazy MEF, 2011, MAR DRUGS, V9, P1243, DOI 10.3390/md9071243; Hunter Cynthia L., 1997, P1599; Kita M, 2010, CHEM REC, V10, P57, DOI 10.1002/tcr.200900007; KOBAYASHI M, 1988, CHEM PHARM BULL, V36, P2331; KOBAYASHI M, 1990, CHEM PHARM BULL, V38, P815; KOBAYASHI M, 1979, CHEM PHARM BULL, V27, P2382; Koh M, 2000, BIOSCI BIOTECH BIOCH, V64, P858, DOI 10.1271/bbb.64.858; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Li C, 1984, NANHAI STUD MAR SINI, V6, P103; Ma AY, 2008, J NAT PROD, V71, P1152, DOI 10.1021/np800003w; MAIDA M, 1993, J CHEM ECOL, V19, P2285, DOI 10.1007/BF00979664; Maida M, 2001, MAR ECOL-P S Z N I, V22, P397, DOI 10.1046/j.1439-0485.2001.01709.x; McFadden CS, 2006, INVERTEBR BIOL, V125, P288, DOI 10.1111/j.1744-7410.2006.00070.x; McFadden CS, 2010, INTEGR COMP BIOL, V50, P389, DOI 10.1093/icb/icq056; PASS MA, 1989, COMP BIOCHEM PHYS C, V94, P677, DOI 10.1016/0742-8413(89)90131-X; Pawlowski J, 2001, J EUKARYOT MICROBIOL, V48, P368, DOI 10.1111/j.1550-7408.2001.tb00326.x; RIEGL B, 1995, B MAR SCI, V56, P676; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROWAN R, 1992, P NATL ACAD SCI USA, V89, P3639, DOI 10.1073/pnas.89.8.3639; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sammarco P.W., 1983, Coral Reefs, V1, P173, DOI 10.1007/BF00571194; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka J, 2005, GALAXEA, V7, P1; TURSCH B, 1982, MAR BIOL, V68, P321, DOI 10.1007/BF00409597; VERSEVELDT J., 1982, ZOOL VERH-LEIDEN, V192, P1; Verseveldt J, 1983, ZOOL VERHANDEL LEIDE, V208, P3; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	45	39	40	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30410	10.1371/journal.pone.0030410	http://dx.doi.org/10.1371/journal.pone.0030410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272344	gold, Green Submitted, Green Published			2022-12-27	WOS:000301454400122
J	Baxter, EM; Jarvis, S; Palarea-Albaladejo, J; Edwards, SA				Baxter, Emma M.; Jarvis, Susan; Palarea-Albaladejo, Javier; Edwards, Sandra A.			The Weaker Sex? The Propensity for Male-Biased Piglet Mortality	PLOS ONE			English	Article							MATERNAL INVESTMENT; DOMESTIC PIGS; NEONATAL PIG; WEIGHT-GAIN; TRADE-OFF; RATIO; BEHAVIOR; BIRTH; ALLOCATION; CONFLICT	For the most part solutions to farm animal welfare issues, such as piglet mortality, are likely to lie within the scientific disciplines of environmental design and genetic selection, however understanding the ecological basis of some of the complex dynamics observed between parent and offspring could make a valuable contribution. One interesting, and often discussed, aspect of mortality is the propensity for it to be sex-biased. This study investigated whether known physiological and behavioural indicators of piglet survival differed between the sexes and whether life history strategies (often reported in wild or feral populations) relating to parental investment were being displayed in a domestic population of pigs. Sex ratio (proportion of males (males/males+females)) at birth was 0.54 and sex allocation (maternal investment measured as piglet birth weight/litter weight) was statistically significantly male-biased at 0.55 (t(35) = 2.51 P = 0.017), suggesting that sows invested more in sons than daughters during gestation. Despite this investment in birth weight, a known survival indicator, total pre-weaning male mortality was statistically significantly higher than female mortality (12% vs. 7% respectively z = 2.06 P = 0.040). Males tended to suffer from crushing by the sow more than females and statistically significantly more males died from disease-related causes. Although males were born on average heavier, with higher body mass index and ponderal index, these differences were not sustained. In addition male piglets showed impaired thermoregulation compared to females. These results suggest male-biased mortality exists despite greater initial maternal investment, and therefore reflects the greater susceptibility of this sex to causal mortality factors. Life history strategies are being displayed by a domestic population of pigs with sows in this study displaying a form of parental optimism by allocating greater resources at birth to males and providing an over-supply of this more vulnerable sex in expectation of sex-biased mortality.	[Baxter, Emma M.] Scottish Agr Coll, Edinburgh, Midlothian, Scotland; [Jarvis, Susan] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Palarea-Albaladejo, Javier] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland; [Edwards, Sandra A.] Newcastle Univ, Sch Agr Food & Rural Dev, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Scottish Agricultural College; University of Edinburgh; James Hutton Institute; Newcastle University - UK	Baxter, EM (corresponding author), Scottish Agr Coll, Edinburgh, Midlothian, Scotland.	Emma.Baxter@sac.ac.uk	Palarea-Albaladejo, Javier/J-5591-2013	Palarea-Albaladejo, Javier/0000-0003-0162-669X; Edwards, Sandra/0000-0002-8890-0112; Baxter, Emma/0000-0003-3370-7371	Scottish Government [WP2.4]; Scottish Government Rural and Environment Science and Analytical Services	Scottish Government; Scottish Government Rural and Environment Science and Analytical Services	This work was supported by the Scottish Government under WP2.4 and the Scottish Government Rural and Environment Science and Analytical Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGERS B, 1991, CAN J ANIM SCI, V71, P51, DOI 10.4141/cjas91-006; ALGERS B, 1985, APPL ANIM BEHAV SCI, V14, P49, DOI 10.1016/0168-1591(85)90037-1; Andersen IL, 2006, APPL ANIM BEHAV SCI, V97, P85, DOI 10.1016/j.applanim.2005.11.020; Bandrick M, 2011, Vet Rec, V168, P100, DOI 10.1136/vr.c6163; Baxter EM, 2008, THERIOGENOLOGY, V69, P773, DOI 10.1016/j.theriogenology.2007.12.007; Baxter EM, 2009, LIVEST SCI, V124, P266, DOI 10.1016/j.livsci.2009.02.008; CASTREN H, 1991, LIVEST PROD SCI, V28, P321, DOI 10.1016/0301-6226(91)90013-G; CHEN ZY, 1993, J ANIM SCI, V71, P1895, DOI 10.2527/1993.7171895x; Clutton-Brock T.H., 1994, P347; CLUTTONBROCK TH, 1986, Q REV BIOL, V61, P339, DOI 10.1086/415033; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; Darwin C., 1871, P423; DEPASSILLE AMB, 1988, CAN J ANIM SCI, V68, P325, DOI 10.4141/cjas88-037; Fernandez-Llario P, 1999, ANIM BEHAV, V58, P1079, DOI 10.1006/anbe.1999.1234; Forbes LS, 1998, J THEOR BIOL, V192, P3, DOI 10.1006/jtbi.1997.0596; FRANK SA, 1990, ANNU REV ECOL SYST, V21, P13, DOI 10.1146/annurev.es.21.110190.000305; FRASER D, 1995, APPL ANIM BEHAV SCI, V44, P139, DOI 10.1016/0168-1591(95)00610-5; Fraser D, 1990, J Reprod Fertil Suppl, V40, P355; Gaskins H. R., 1995, P39; Gustafsson M, 1999, APPL ANIM BEHAV SCI, V62, P305, DOI 10.1016/S0168-1591(98)00236-6; Held S, 2005, ANIM COGN, V8, P114, DOI 10.1007/s10071-004-0242-y; Herpin P., 1995, P57; Herpin P, 2001, J ANIM SCI, V79, P5; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; HOLLAND RE, 1990, CLIN MICROBIOL REV, V3, P345, DOI 10.1128/CMR.3.4.345-375.1990; HORRELL I, 1992, APPL ANIM BEHAV SCI, V33, P319, DOI 10.1016/S0168-1591(05)80069-3; James WH, 1998, ANIM BEHAV, V55, P767, DOI 10.1006/anbe.1997.0676; JENSEN P, 1986, APPL ANIM BEHAV SCI, V16, P131, DOI 10.1016/0168-1591(86)90105-X; Kalmbach E, 2005, BEHAV ECOL, V16, P442, DOI 10.1093/beheco/ari018; KLAVER J, 1981, J ANIM SCI, V52, P1091, DOI 10.2527/jas1981.5251091x; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; Krackow S, 1997, PHYSIOL BEHAV, V63, P81, DOI 10.1016/S0031-9384(97)00393-4; LEDIVIDICH J, 1991, BIOL NEONATE, V59, P268, DOI 10.1159/000243360; Marchant JN, 2001, ANIM SCI, V72, P19, DOI 10.1017/S135772980005551X; *MEAT LIV COMM, 2006, PIG YB 2006; Meikle DB, 1997, ANIM BEHAV, V53, P428, DOI 10.1006/anbe.1996.0376; Meikle DB, 1998, ANIM BEHAV, V55, P770, DOI 10.1006/anbe.1997.0677; MEIKLE DB, 1993, ANIM BEHAV, V46, P79, DOI 10.1006/anbe.1993.1163; Mendl M, 1998, ANIM BEHAV, V55, P773, DOI 10.1006/anbe.1997.0678; Mendl M, 1997, ANIM BEHAV, V53, P432, DOI 10.1006/anbe.1996.0380; MENDL M, 1995, ANIM BEHAV, V50, P1361, DOI 10.1016/0003-3472(95)80051-4; MOCK DW, 1995, TRENDS ECOL EVOL, V10, P130, DOI 10.1016/S0169-5347(00)89014-X; Mock DW, 1998, ANIM BEHAV, V56, P1, DOI 10.1006/anbe.1998.0842; Moses RA, 1998, ANIM BEHAV, V55, P563, DOI 10.1006/anbe.1997.0643; MOUNT LE, 1966, BRIT MED BULL, V22, P84, DOI 10.1093/oxfordjournals.bmb.a070444; Muirhead MR., 1997, MANAGING PIG HLTH TR; Nishida S., 1977, Japanese Journal of Animal Reproduction, V23, P55; Ono KA, 1996, BEHAV ECOL SOCIOBIOL, V38, P31, DOI 10.1007/s002650050214; Pope WF, 1994, EMBRYONIC MORTALITY, P53; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Puppe B, 2007, APPL ANIM BEHAV SCI, V105, P75, DOI 10.1016/j.applanim.2006.05.016; Reynolds John D., 1994, P53; Rutkowska J, 2011, P ROY SOC B-BIOL SCI, V278, P2962, DOI 10.1098/rspb.2010.2654; Salmon H, 2009, DEV COMP IMMUNOL, V33, P384, DOI 10.1016/j.dci.2008.07.007; SPINKA M, 1995, APPL ANIM BEHAV SCI, V43, P197, DOI 10.1016/0168-1591(95)00560-F; Stearns S.C., 1992, pi; STOLBA A, 1980, APPL ANIM ETHOL, V6, P382, DOI 10.1016/0304-3762(80)90140-6; STOLBA A, 1981, APPL ANIM ETHOL, V7, P388, DOI 10.1016/0304-3762(81)90072-9; TRILLMICH F, 1986, BEHAV ECOL SOCIOBIOL, V19, P157; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Tuchscherer M, 2000, THERIOGENOLOGY, V54, P371, DOI 10.1016/S0093-691X(00)00355-1; Weary DM, 1996, ANIM BEHAV, V51, P619, DOI 10.1006/anbe.1996.0066; Wells JCK, 2003, Q REV BIOL, V78, P169, DOI 10.1086/374952; WESTROM BR, 1985, BIOL NEONATE, V47, P359, DOI 10.1159/000242140; WILLIAMS GC, 1979, PROC R SOC SER B-BIO, V205, P567, DOI 10.1098/rspb.1979.0085	65	60	60	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30318	10.1371/journal.pone.0030318	http://dx.doi.org/10.1371/journal.pone.0030318			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272334	Green Submitted, gold, Green Published			2022-12-27	WOS:000301454400112
J	Wei, N; Liu, SS; Chan, KKL; Ngan, HYS				Wei, Na; Liu, Stephanie S.; Chan, Karen K. L.; Ngan, Hextan Y. S.			Tumour Suppressive Function and Modulation of Programmed Cell Death 4 (PDCD4) in Ovarian Cancer	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; INITIATION-FACTOR 4A; EUKARYOTIC TRANSLATION; EXPRESSION; PROTEIN; TRANSFORMATION; GENE; APOPTOSIS; BINDING; PROGRAMMED-CELL-DEATH-4	Background: Programmed cell death 4 (PDCD4), originally identified as the neoplastic transformation inhibitor, was attenuated in various cancer types. Our previous study demonstrated a continuous down-regulation of PDCD4 expression in the sequence of normal-borderline-malignant ovarian tissue samples and a significant correlation of PDCD4 expression with disease-free survival. The objective of the current study was to further investigate the function and modulation of PDCD4 in ovarian cancer cells. Principal Findings: We demonstrated that ectopic PDCD4 expression significantly inhibited cell proliferation by inducing cell cycle arrest at G(1) stage and up-regulation of cell cycle inhibitors of p27 and p21. Cell migration and invasion were also inhibited by PDCD4. PDCD4 over-expressing cells exhibited elevated phosphatase and tensin homolog (PTEN) and inhibited protein kinase B (p-Akt). In addition, the expression of PDCD4 was up-regulated and it was exported to the cytoplasm upon serum withdrawal treatment, but it was rapidly depleted via proteasomal degradation upon serum re-administration. Treatment of a phosphoinositide 3-kinase (PI3K) inhibitor prevented the degradation of PDCD4, indicating the involvement of PI3K-Akt pathway in the modulation of PDCD4. Conclusion: PDCD4 may play a critical function in arresting cell cycle progression at key checkpoint, thus inhibiting cell proliferation, as well as suppressing tumour metastasis. The PI3K-Akt pathway was implied to be involved in the regulation of PDCD4 degradation in ovarian cancer cells. In response to the stress condition, endogenous PDCD4 was able to shuttle between cell compartments to perform its diverted functions.	[Wei, Na; Liu, Stephanie S.; Chan, Karen K. L.; Ngan, Hextan Y. S.] Univ Hong Kong, Queen Mary Hosp, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Wei, N (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China.	gyonc@hku.hk	Chan, Karen/E-4041-2015	Chan, Karen/0000-0001-9947-4713; Ngan, Hextan Y S/0000-0003-3945-159X	University of Hong Kong	University of Hong Kong(University of Hong Kong)	This study was supported by an internal grant from the University of Hong Kong Seed Funding Programme for Basic Research [to K.K.L.C.], and by a donation from the Wong Check She Charitable Foundation [to H.Y.S.N.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonja O, 2004, ONCOGENE, V23, P8135, DOI 10.1038/sj.onc.1207983; Bitomsky N, 2008, ONCOGENE, V27, P4820, DOI 10.1038/onc.2008.115; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Bohm M, 2003, ONCOGENE, V22, P4905, DOI 10.1038/sj.onc.1206710; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Goke R, 2004, ANN NY ACAD SCI, V1014, P220, DOI 10.1196/annals.1294.024; Goke R, 2004, AM J PHYSIOL-CELL PH, V287, pC1541, DOI 10.1152/ajpcell.00025.2004; Hwang SK, 2007, GENE THER, V14, P1353, DOI 10.1038/sj.gt.3302983; Hwang SK, 2010, J AEROSOL MED PULM D; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jansen AP, 2004, MOL CANCER THER, V3, P103; Jiang Y, 2010, BIOMED PHARMACOTHER; Lankat-Buttgereit B, 2008, APOPTOSIS, V13, P157, DOI 10.1007/s10495-007-0153-x; Lee S, 2006, ONCOL REP, V16, P747; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Mudduluru G, 2007, CANCER-AM CANCER SOC, V110, P1697, DOI 10.1002/cncr.22983; Onishi Y, 1998, GENE, V215, P453, DOI 10.1016/S0378-1119(98)00313-8; Ozpolat B, 2007, MOL CANCER RES, V5, P95, DOI 10.1158/1541-7786.MCR-06-0125; Ramdas L, 2009, HEAD NECK-J SCI SPEC, V31, P642, DOI 10.1002/hed.21017; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; Shiota M, 2009, CANCER RES, V69, P3148, DOI 10.1158/0008-5472.CAN-08-2334; Singh P, 2009, ONCOGENE, V28, P3758, DOI 10.1038/onc.2009.239; Wei N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-70; Wei ZT, 2009, CANCER SCI, V100, P1408, DOI 10.1111/j.1349-7006.2009.01210.x; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Zakowicz H, 2005, RNA, V11, P261, DOI 10.1261/rna.7191905; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634; Zhang SH, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-71	34	45	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30311	10.1371/journal.pone.0030311	http://dx.doi.org/10.1371/journal.pone.0030311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272332	Green Published, gold, Green Submitted			2022-12-27	WOS:000301454400110
J	Wu, MT; Chatterji, S; Eisen, JA				Wu, Martin; Chatterji, Sourav; Eisen, Jonathan A.			Accounting For Alignment Uncertainty in Phylogenomics	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; TREE; SELECTION; IMPROVEMENT; ACCURACY; PROTEIN; BLOCKS	Uncertainty in multiple sequence alignments has a large impact on phylogenetic analyses. Little has been done to evaluate the quality of individual positions in protein sequence alignments, which directly impact the accuracy of phylogenetic trees. Here we describe ZORRO, a probabilistic masking program that accounts for alignment uncertainty by assigning confidence scores to each alignment position. Using the BALIBASE database and in simulation studies, we demonstrate that masking by ZORRO significantly reduces the alignment uncertainty and improves the tree accuracy.	[Wu, Martin] Univ Virginia, Dept Biol, Charlottesville, VA 22901 USA; [Chatterji, Sourav; Eisen, Jonathan A.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	University of Virginia; University of California System; University of California Davis; University of California System; University of California Davis	Wu, MT (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22901 USA.	mw4yv@virginia.edu	Eisen, Jonathan A./H-2706-2019	Eisen, Jonathan A./0000-0002-0159-2197; Wu, Martin/0000-0003-3093-4077	Gordon and Betty Moore Foundation [1660]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This was supported by Grant 1660 from the Gordon and Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803; Bucka-Lassen K, 1999, BIOINFORMATICS, V15, P122, DOI 10.1093/bioinformatics/15.2.122; Cammarano P, 1999, J MOL EVOL, V49, P524, DOI 10.1007/PL00006574; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Dessimoz C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r37; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Drummond A, 2001, BIOINFORMATICS, V17, P662, DOI 10.1093/bioinformatics/17.7.662; Durbin R, 1998, BIOL SEQUENCE ANAL P, p[xi, 356]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2006, CURR OPIN STRUC BIOL, V16, P368, DOI 10.1016/j.sbi.2006.04.004; FELSENSTEIN J, 1973, AM J HUM GENET, V25, P471; Grundy WN, 1999, J EXP ZOOL, V285, P128, DOI 10.1002/(SICI)1097-010X(19990815)285:2<128::AID-JEZ5>3.0.CO;2-C; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall BG, 2005, MOL BIOL EVOL, V22, P792, DOI 10.1093/molbev/msi066; Hartmann S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-95; Hwang UW, 1998, MOL PHYLOGENET EVOL, V9, P470, DOI 10.1006/mpev.1998.0518; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KJER KM, 1995, MOL PHYLOGENET EVOL, V4, P314, DOI 10.1006/mpev.1995.1028; Kuck P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-10; LAKE JA, 1991, MOL BIOL EVOL, V8, P378; Landan G, 2007, MOL BIOL EVOL, V24, P1380, DOI 10.1093/molbev/msm060; Lassmann T, 2005, NUCLEIC ACIDS RES, V33, P7120, DOI 10.1093/nar/gki1020; Lassmann T, 2002, FEBS LETT, V529, P126, DOI 10.1016/S0014-5793(02)03189-7; Lee MSY, 2001, TRENDS ECOL EVOL, V16, P681, DOI 10.1016/S0169-5347(01)02313-8; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Loytynoja A, 2001, BIOINFORMATICS, V17, P573, DOI 10.1093/bioinformatics/17.6.573; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Morrison DA, 1997, MOL BIOL EVOL, V14, P428, DOI 10.1093/oxfordjournals.molbev.a025779; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ogden TH, 2006, SYST BIOL, V55, P314, DOI 10.1080/10635150500541730; Pei JM, 2006, NUCLEIC ACIDS RES, V34, P4364, DOI 10.1093/nar/gkl514; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Redelings BD, 2005, SYST BIOL, V54, P401, DOI 10.1080/10635150590947041; Rosenberg MS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-102; Roshan U, 2006, BIOINFORMATICS, V22, P2715, DOI 10.1093/bioinformatics/btl472; Schwartz AS, 2007, BIOINFORMATICS, V23, pE24, DOI 10.1093/bioinformatics/btl311; Schwartz AS, 2006, ARXIVQBIOQM0510052; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; States DJ, 1991, SEQUENCE ANAL PRIMER, P89; Stoye J, 1998, BIOINFORMATICS, V14, P157, DOI 10.1093/bioinformatics/14.2.157; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; Van Walle I, 2005, BIOINFORMATICS, V21, P1267, DOI 10.1093/bioinformatics/bth493; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151	52	135	136	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30288	10.1371/journal.pone.0030288	http://dx.doi.org/10.1371/journal.pone.0030288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272325	Green Published, gold, Green Submitted			2022-12-27	WOS:000301454400103
J	Taton, A; Lis, E; Adin, DM; Dong, G; Cookson, S; Kay, SA; Golden, SS; Golden, JW				Taton, Arnaud; Lis, Ewa; Adin, Dawn M.; Dong, Guogang; Cookson, Scott; Kay, Steve A.; Golden, Susan S.; Golden, James W.			Gene Transfer in Leptolyngbya sp Strain BL0902, a Cyanobacterium Suitable for Production of Biomass and Bioproducts	PLOS ONE			English	Article							ESCHERICHIA-COLI; DRY VALLEYS; SEQUENCE; DIVERSITY; TRANSFORMATION; BIOSYNTHESIS; CONSTRUCTION; PHYLOGENIES; EVOLUTION; COMPLEX	Current cyanobacterial model organisms were not selected for their growth traits or potential for the production of renewable biomass, biofuels, or other products. The cyanobacterium strain BL0902 emerged from a search for strains with superior growth traits. Morphology and 16S rRNA sequence placed strain BL0902 in the genus Leptolyngbya. Leptolyngbya sp. strain BL0902 (hereafter Leptolyngbya BL0902) showed robust growth at temperatures from 22 degrees C to 40 degrees C and tolerated up to 0.5 M NaCl, 32 mM urea, high pH, and high solar irradiance. Its growth rate under outdoor conditions rivaled Arthrospira ("pirulina" strains. Leptolyngbya BL0902 accumulated higher lipid content and a higher proportion of monounsaturated fatty acids than Arthrospira strains. In addition to these desirable qualities, Leptolyngbya BL0902 is amenable to genetic engineering that is reliable, efficient, and stable. We demonstrated conjugal transfer from Escherichia coli of a plasmid based on RSF1010 and expression of spectinomycin/streptomycin resistance and yemGFP reporter transgenes. Conjugation efficiency was investigated in biparental and triparental matings with and without a "elper" plasmid that carries DNA methyltransferase genes, and with two different conjugal plasmids. We also showed that Leptolyngbya BL0902 is amenable to transposon mutagenesis with a Tn5 derivative. To facilitate genetic manipulation of Leptolyngbya BL0902, a conjugal plasmid vector was engineered to carry a trc promoter upstream of a Gateway recombination cassette. These growth properties and genetic tools position Leptolyngbya BL0902 as a model cyanobacterial production strain.	[Taton, Arnaud; Lis, Ewa; Adin, Dawn M.; Dong, Guogang; Cookson, Scott; Kay, Steve A.; Golden, Susan S.; Golden, James W.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Golden, JW (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	jwgolden@ucsd.edu	Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878; Lis, Ewa/0000-0002-0345-7933; Adin, Dawn/0000-0002-7341-3952; Golden, James/0000-0001-5463-3207	Biolight Harvesting, Inc.; University of California	Biolight Harvesting, Inc.; University of California(University of California System)	This work was supported by Biolight Harvesting, Inc., of which SAK, SSG, and JWG were founders, and by University of California San Diego research funds to SSG and JWG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAGNOSTIDIS K, 1988, Archiv fuer Hydrobiologie Supplement, V80, P327; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; Bahassi EM, 1999, J BIOL CHEM, V274, P10936, DOI 10.1074/jbc.274.16.10936; Billi D, 2001, J BACTERIOL, V183, P2298, DOI 10.1128/JB.183.7.2298-2305.2001; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Castenholz RW, 2001, BERGEYS MANUAL SYSTE, P544; Castiglioni B, 2004, APPL ENVIRON MICROB, V70, P7161, DOI 10.1128/AEM.70.12.7161-7172.2004; Clerico Eugenia M, 2007, Methods Mol Biol, V362, P155; COHEN MF, 1994, MICROBIOL-SGM, V140, P3233, DOI 10.1099/13500872-140-12-3233; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Deng MD, 1999, APPL ENVIRON MICROB, V65, P523; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; ElhaI J, 1997, J BACTERIOL, V179, P1998, DOI 10.1128/jb.179.6.1998-2005.1997; ELHAI J, 1994, J APPL PHYCOL, V6, P177, DOI 10.1007/BF02186071; Elhai J, 1988, METHOD ENZYMOL, V168, P747; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; Flores Enrique, 2008, P45; Frazao B, 2010, MAR DRUGS, V8, P1908, DOI 10.3390/md8061908; Gao Q, 2011, NAT REV MICROBIOL, V9, P791, DOI 10.1038/nrmicro2649; Gordon D, 2003, CURR PROTOC BIOINFOR, V2; Gorelova O.A., 2009, MOSC U BIOL SCI B, V64, P16, DOI [10.3103/S0096392509010040, DOI 10.3103/S0096392509010040]; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heidorn T, 2011, METHOD ENZYMOL, V497, P539, DOI 10.1016/B978-0-12-385075-1.00024-X; Herrero A., 2008, CYANOBACTERIA MOL BI; Huang G, 2005, J BACTERIOL, V187, P1114, DOI 10.1128/JB.187.3.1114-1123.2005; Ishida T, 1997, J GEN APPL MICROBIOL, V43, P237, DOI 10.2323/jgam.43.237; Janse I, 2005, ENVIRON MICROBIOL, V7, P1514, DOI 10.1111/j.1462-2920.2005.00858.x; Kawata Y, 2004, MAR BIOTECHNOL, V6, P355, DOI 10.1007/s10126-003-0037-1; Kehoe DM, 2010, P NATL ACAD SCI USA, V107, P9029, DOI 10.1073/pnas.1004510107; Koksharova OA, 2002, J BACTERIOL, V184, P5524, DOI 10.1128/JB.184.19.5524-5528.2002; Koksharova OA, 2002, APPL MICROBIOL BIOT, V58, P123, DOI 10.1007/s00253-001-0864-9; Komarek J., 2005, CYANOPROKARYOTA; Kumar K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000315; LI RX, 1993, P NATL ACAD SCI USA, V90, P11678, DOI 10.1073/pnas.90.24.11678; Li ZK, 2007, PHYCOLOGIA, V46, P396, DOI 10.2216/06-89.1; Liu DA, 2002, J BACTERIOL, V184, P6873, DOI 10.1128/JB.184.24.6873-6881.2002; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marquardt J, 2007, ARCH MICROBIOL, V187, P397, DOI 10.1007/s00203-006-0204-7; Mendez-Perez D, 2011, APPL ENVIRON MICROB, V77, P4264, DOI 10.1128/AEM.00467-11; Mur L., 1999, TOXIC CYANOBACTERIA, P15; Mutsuda M, 2003, J BIOL CHEM, V278, P19102, DOI 10.1074/jbc.M213255200; NAKAMURA K, 1979, CELL, V18, P1109, DOI 10.1016/0092-8674(79)90224-1; OROSZ A, 1991, EUR J BIOCHEM, V201, P653, DOI 10.1111/j.1432-1033.1991.tb16326.x; Osanai T, 2007, PHOTOCH PHOTOBIO SCI, V6, P508, DOI 10.1039/b616219n; Pacrl HW, 2000, ECOLOGY CYANOBACTERI, P121; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Roessler PG, 2009, US patent, Patent No. 20090298143; Sato N, 2009, ADV PHOTOSYNTH RESP, V30, P157; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sheng J, 2011, BIORESOURCE TECHNOL, V102, P1697, DOI 10.1016/j.biortech.2010.08.007; SHESTAKOV SV, 1970, MOL GEN GENET, V107, P372, DOI 10.1007/BF00441199; Siegesmund MA, 2008, J PHYCOL, V44, P1572, DOI 10.1111/j.1529-8817.2008.00604.x; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Taton A, 2003, APPL ENVIRON MICROB, V69, P5157, DOI 10.1128/AEM.69.9.5157-5169.2003; Taton A, 2006, J PHYCOL, V42, P1257, DOI 10.1111/j.1529-8817.2006.00278.x; Taton A, 2006, FEMS MICROBIOL ECOL, V57, P272, DOI 10.1111/j.1574-6941.2006.00110.x; THOMAS CM, 1987, ANNU REV MICROBIOL, V41, P77, DOI 10.1146/annurev.mi.41.100187.000453; Toyomizu M, 2001, J APPL PHYCOL, V13, P209, DOI 10.1023/A:1011182613761; TSINOREMAS NF, 1994, J BACTERIOL, V176, P6764, DOI 10.1128/JB.176.21.6764-6768.1994; WADA H, 1992, PLANT CELL PHYSIOL, V33, P535; WILSON KJ, 1995, MICROBIOL-SGM, V141, P1691, DOI 10.1099/13500872-141-7-1691; WOLK CP, 1984, P NATL ACAD SCI-BIOL, V81, P1561, DOI 10.1073/pnas.81.5.1561; Wood SA, 2008, ISME J, V2, P308, DOI 10.1038/ismej.2007.104; Wu XQ, 2007, MOL MICROBIOL, V64, P782, DOI 10.1111/j.1365-2958.2007.05698.x; Yoon HS, 1998, SCIENCE, V282, P935, DOI 10.1126/science.282.5390.935; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	72	50	51	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30901	10.1371/journal.pone.0030901	http://dx.doi.org/10.1371/journal.pone.0030901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292073	Green Published, gold, Green Submitted			2022-12-27	WOS:000301639600066
J	Vodovar, N; Bronkhorst, AW; van Cleef, KWR; Miesen, P; Blanc, H; van Rij, RP; Saleh, MC				Vodovar, Nicolas; Bronkhorst, Alfred W.; van Cleef, Koen W. R.; Miesen, Pascal; Blanc, Herve; van Rij, Ronald P.; Saleh, Maria-Carla			Arbovirus-Derived piRNAs Exhibit a Ping-Pong Signature in Mosquito Cells	PLOS ONE			English	Article							RNA INTERFERENCE; ANTIVIRAL IMMUNITY; AEDES-AEGYPTI; VIRUS; DENGUE; ALPHAVIRUS; EXPRESSION; SEQUENCE; DEFENSE	The siRNA pathway is an essential antiviral mechanism in insects. Whether other RNA interference pathways are involved in antiviral defense remains unclear. Here, we report in cells derived from the two main vectors for arboviruses, Aedes albopictus and Aedes aegypti, the production of viral small RNAs that exhibit the hallmarks of ping-pong derived piwi-associated RNAs (piRNAs) after infection with positive or negative sense RNA viruses. Furthermore, these cells produce endogenous piRNAs that mapped to transposable elements. Our results show that these mosquito cells can initiate de novo piRNA production and recapitulate the ping-pong dependent piRNA pathway upon viral infection. The mechanism of viral-piRNA production is discussed.	[Bronkhorst, Alfred W.; van Cleef, Koen W. R.; Miesen, Pascal; van Rij, Ronald P.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Med Microbiol, Nijmegen, Netherlands; [Vodovar, Nicolas; Blanc, Herve; Saleh, Maria-Carla] Inst Pasteur, Viruses & RNA Interference Grp, Paris, France; [Vodovar, Nicolas; Blanc, Herve; Saleh, Maria-Carla] CNRS, URA 3015, Paris, France	Radboud University Nijmegen; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	van Rij, RP (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Med Microbiol, Nijmegen, Netherlands.	r.vanrij@ncmls.ru.nl; carla.saleh@pasteur.fr	Miesen, Pascal/Q-2112-2015; Van Rij, Ronald/I-7073-2012; Vodovar, Nicolas/S-2947-2019; Saleh, Maria-Carla/ABC-2527-2021	Miesen, Pascal/0000-0002-6378-0871; Van Rij, Ronald/0000-0003-0221-4689; Saleh, Maria-Carla/0000-0001-8593-4117; Vodovar, Nicolas/0000-0001-8087-387X	French Agence Nationale de la Recherche [ANR-09-394JCJC-0045-01]; European Research Council [FP7/2007-2013 ERC 242703]; Netherlands Organization for Scientific Research [864.08.003]; Netherlands Genomics Initiative [93519018]	French Agence Nationale de la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative	This work was financially supported by the French Agence Nationale de la Recherche (ANR-09-394JCJC-0045-01) and the European Research Council (FP7/2007-2013 ERC 242703) to M.C.S., and a VIDI fellowship from the Netherlands Organization for Scientific Research (project number 864.08.003) and Horizon Breakthrough fellowship from the Netherlands Genomics Initiative (project number 93519018) to RPvR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borucki MK, 2002, MICROBES INFECT, V4, P341, DOI 10.1016/S1286-4579(02)01547-2; Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47; Campbell CL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-425; CONDREAY LD, 1986, J VIROL, V58, P81, DOI 10.1128/JVI.58.1.81-86.1986; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Gausson V, 2011, METHODS MOL BIOL, V721, P107, DOI 10.1007/978-1-61779-037-9_6; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Haley B, 2003, METHODS, V30, P330, DOI 10.1016/S1046-2023(03)00052-5; Hanley KA, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P351, DOI 10.1016/B978-0-12-374153-0.00016-3; Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Kawaoka S, 2009, RNA, V15, P1258, DOI 10.1261/rna.1452209; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; PELEG J, 1968, VIROLOGY, V35, P617, DOI 10.1016/0042-6822(68)90293-6; ROSSIER C, 1988, VIROLOGY, V165, P539, DOI 10.1016/0042-6822(88)90598-3; Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848; Singh KPR, 1967, CURR SCI, V36, P56; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Siu RWC, 2011, J VIROL, V85, P2907, DOI 10.1128/JVI.02052-10; van Cleef KWR, 2011, METHODS MOL BIOL, V721, P201, DOI 10.1007/978-1-61779-037-9_12; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vodovar N, 2011, J VIROL; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Yan Z, 2011, NUCLEIC ACIDS RES, V39, P6596, DOI 10.1093/nar/gkr298; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x	36	147	150	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30861	10.1371/journal.pone.0030861	http://dx.doi.org/10.1371/journal.pone.0030861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292064	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600063
J	George, SL; Varmaz, D; Tavis, JE; Chowdhury, A				George, Sarah L.; Varmaz, Dino; Tavis, John E.; Chowdhury, Adnan			The GB Virus C (GBV-C) NS3 Serine Protease Inhibits HIV-1 Replication in a CD4+T Lymphocyte Cell Line without Decreasing HIV Receptor Expression	PLOS ONE			English	Article							HEPATITIS-G VIRUS; ENVELOPE PROTEIN; T-LYMPHOCYTE; INFECTION; COINFECTION; PROGRESSION; CLEAVAGE; TYPE-1; RNA; PHOSPHOPROTEIN	Introduction: Persistent infection with GBV-C (GB Virus C), a non-pathogenic virus related to hepatitis C virus (HCV), prolongs survival in HIV infection. Two GBV-C proteins, NS5A and E2, have been shown previously to inhibit HIV replication in vitro. We investigated whether the GBV-C NS3 serine protease affects HIV replication. Results: GBV-C NS3 protease expressed in a human CD4+ T lymphocyte cell line significantly inhibited HIV replication. Addition of NS4A or NS4A/4B coding sequence to GBV-C NS3 increased the effect on HIV replication. Inhibition of HIV replication was dose-dependent and was not mediated by increased cell toxicity. Mutation of the NS3 catalytic serine to alanine resulted in loss of both HIV inhibition and protease activity. GBV-C NS3 expression did not measurably decrease CD4 or CXCR4 expression. Conclusion: GBV-C NS3 serine protease significantly inhibited HIV replication without decreasing HIV receptor expression. The requirement for an intact catalytic serine at the active site indicates that inhibition was mediated by proteolytic cleavage of an unidentified target(s).	[George, Sarah L.; Varmaz, Dino] St Louis Univ, Dept Internal Med, Div Infect Dis, St Louis, MO 63103 USA; [George, Sarah L.; Varmaz, Dino] St Louis Univ, St Louis Vet Affairs Med Ctr, Res Serv, St Louis, MO 63103 USA; [George, Sarah L.; Tavis, John E.; Chowdhury, Adnan] St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA	Saint Louis University; Saint Louis University; Saint Louis University	George, SL (corresponding author), St Louis Univ, Dept Internal Med, Div Infect Dis, St Louis, MO 63103 USA.	georgesl@slu.edu		George, Sarah/0000-0002-9699-1042	Veteran's Administration Merit Review Research Grant; St. Louis University Department of Internal Medicine Seed	Veteran's Administration Merit Review Research Grant; St. Louis University Department of Internal Medicine Seed	The work was supported in part by a Veteran's Administration Merit Review Research Grant (SG) and a St. Louis University Department of Internal Medicine Seed Grant (SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Belyaev AS, 1998, J VIROL, V72, P868, DOI 10.1128/JVI.72.1.868-872.1998; Benureau Y, 2010, VIROLOGY, V406, P228, DOI 10.1016/j.virol.2010.07.014; Beran RKF, 2009, J VIROL, V83, P3268, DOI 10.1128/JVI.01849-08; CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; George Sarah L, 2005, Curr Gastroenterol Rep, V7, P54, DOI 10.1007/s11894-005-0067-0; George Sarah L., 2002, Curr Infect Dis Rep, V4, P550, DOI 10.1007/s11908-002-0044-9; George SL, 2006, J INFECT DIS, V193, P451, DOI 10.1086/499435; George SL, 2003, VIROLOGY, V316, P191, DOI 10.1016/S0042-6822(03)00585-3; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; Heringlake S, 1998, J INFECT DIS, V177, P1723, DOI 10.1086/517431; Herrera E, 2010, J MED CHEM, V53, P6054, DOI 10.1021/jm100452c; Johnson CL, 2007, J BIOL CHEM, V282, P10792, DOI 10.1074/jbc.M610361200; Jung S, 2005, AIDS, V19, P1267, DOI 10.1097/01.aids.0000180097.50393.df; Jung S, 2007, AIDS, V21, P645, DOI 10.1097/QAD.0b013e32803277c7; Koedel Y, 2011, J VIROL, V85, P7037, DOI 10.1128/JVI.02366-10; Kuang WF, 2004, BIOCHEM BIOPH RES CO, V317, P211, DOI 10.1016/j.bbrc.2004.03.032; Lam AMI, 2003, J BIOL CHEM, V278, P44514, DOI 10.1074/jbc.M306444200; Leary TP, 1996, J MED VIROL, V48, P60, DOI 10.1002/(SICI)1096-9071(199601)48:1&lt;60::AID-JMV10&gt;3.0.CO;2-A; Lee YJ, 2001, BIOCHEM BIOPH RES CO, V286, P171, DOI 10.1006/bbrc.2001.5354; Lefrere JJ, 1999, J INFECT DIS, V179, P783, DOI 10.1086/314671; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; Maidana-Giret MT, 2009, AIDS, V23, P2277, DOI 10.1097/QAD.0b013e32832d7a11; Mohr EL, 2010, J IMMUNOL, V185, P4496, DOI 10.4049/jimmunol.1001980; Mohr EL, 2009, J VIRAL HEPATITIS, V16, P757, DOI 10.1111/j.1365-2893.2009.01194.x; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Nunnari G, 2003, ANN INTERN MED, V139, P26, DOI 10.7326/0003-4819-139-1-200307010-00009; Paul D, 2011, J VIROL, V85, P6963, DOI 10.1128/JVI.00502-11; Qing C, 2007, J GEN VIROL, V88, P3341; Raney KD, 2010, J BIOL CHEM, V285, P22725, DOI 10.1074/jbc.R110.125294; Rodriguez B, 2003, J INFECT DIS, V187, P504, DOI 10.1086/368206; Sklan EH, 2006, HEPATITIS C VIRUSES, P245; Souza IE, 2006, HIV MED, V7, P25, DOI 10.1111/j.1468-1293.2005.00339.x; Srinivas RV, 1996, VIRUS RES, V45, P87, DOI 10.1016/S0168-1702(96)01361-5; Supapol WB, 2008, J INFECT DIS, V197, P1369, DOI 10.1086/587488; Takano Y, 2007, BBA-MOL BASIS DIS, V1772, P549, DOI 10.1016/j.bbadis.2007.01.010; Taremi SS, 1998, PROTEIN SCI, V7, P2143, DOI 10.1002/pro.5560071011; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; Toyoda H, 1998, J ACQ IMMUN DEF SYND, V17, P209, DOI 10.1097/00042560-199803010-00004; Williams CM, 2003, NEW ENGL J MED, V350, P981; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Xiang JH, 2004, LANCET, V363, P2040, DOI 10.1016/S0140-6736(04)16453-2; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Xiang JH, 2006, P NATL ACAD SCI USA, V103, P15570, DOI 10.1073/pnas.0604728103; Xiang J, 2009, J IMMUNOL, V183, P7860, DOI 10.4049/jimmunol.0902276; Xiang JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002580; Yeo AET, 2000, ANN INTERN MED, V132, P959, DOI 10.7326/0003-4819-132-12-200006200-00006; Zhang W, 2006, HIV MED, V7, P173, DOI 10.1111/j.1468-1293.2006.00366.x	52	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30653	10.1371/journal.pone.0030653	http://dx.doi.org/10.1371/journal.pone.0030653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292009	gold, Green Published, Green Submitted			2022-12-27	WOS:000301570600067
J	Oliveira, L; Madureira, P; Andrade, EB; Bouaboud, A; Morello, E; Ferreira, P; Poyart, C; Trieu-Cuot, P; Dramsi, S				Oliveira, Liliana; Madureira, Pedro; Andrade, Elva Bonifacio; Bouaboud, Abdelouhab; Morello, Eric; Ferreira, Paula; Poyart, Claire; Trieu-Cuot, Patrick; Dramsi, Shaynoor			Group B Streptococcus GAPDH Is Released upon Cell Lysis, Associates with Bacterial Surface, and Induces Apoptosis in Murine Macrophages	PLOS ONE			English	Article							GROUP-A STREPTOCOCCI; FIBRONECTIN-BINDING PROTEIN; HUMAN PHARYNGEAL CELL; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; SUPEROXIDE-DISMUTASE; ACID BIOSYNTHESIS; HUMAN PLASMINOGEN; ALPHA-ENOLASE; VIRULENCE; GENE	Glyceraldehyde 3-phosphate dehydrogenases (GAPDH) are cytoplasmic glycolytic enzymes that, despite lacking identifiable secretion signals, have been detected at the surface of several prokaryotic and eukaryotic organisms where they exhibit non-glycolytic functions including adhesion to host components. Group B Streptococcus (GBS) is a human commensal bacterium that has the capacity to cause life-threatening meningitis and septicemia in newborns. Electron microscopy and fluorescence-activated cell sorter (FACS) analysis demonstrated the surface localization of GAPDH in GBS. By addressing the question of GAPDH export to the cell surface of GBS strain NEM316 and isogenic mutant derivatives of our collection, we found that impaired GAPDH presence in the surface and supernatant of GBS was associated with a lower level of bacterial lysis. We also found that following GBS lysis, GAPDH can associate to the surface of many living bacteria. Finally, we provide evidence for a novel function of the secreted GAPDH as an inducer of apoptosis of murine macrophages.	[Oliveira, Liliana; Madureira, Pedro; Andrade, Elva Bonifacio; Ferreira, Paula] Univ Porto, ICBAS, P-4100 Oporto, Portugal; [Oliveira, Liliana; Madureira, Pedro; Andrade, Elva Bonifacio; Ferreira, Paula] IBMC, Oporto, Portugal; [Oliveira, Liliana; Bouaboud, Abdelouhab; Poyart, Claire] Univ Paris 05, Inst Cochin, Fac Med, Ctr Natl Rech Sci,UMR 8104, Paris, France; [Oliveira, Liliana; Bouaboud, Abdelouhab; Poyart, Claire] Inst Natl Sante & Rech Med, U1016, Paris, France; [Morello, Eric; Trieu-Cuot, Patrick; Dramsi, Shaynoor] Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, CNRS, URA 2172, Paris, France	Universidade do Porto; Universidade do Porto; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Oliveira, L (corresponding author), Univ Porto, ICBAS, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	shaynoor.dramsi@pasteur.fr	POYART, Claire/P-4225-2017; Oliveira, Liliana/K-5859-2013; Andrade, Elva Bonifácio/K-3096-2013; Madureira, Pedro/D-2174-2013; Ferreira, Paula/J-6149-2013; Oliveira, Liliana/AAX-9115-2021; MORELLO, Eric/P-8087-2016	POYART, Claire/0000-0003-2158-6293; Oliveira, Liliana/0000-0001-5222-7600; Andrade, Elva Bonifácio/0000-0002-1941-580X; Madureira, Pedro/0000-0003-4078-800X; Ferreira, Paula/0000-0001-8639-9224; Oliveira, Liliana/0000-0001-5222-7600; MORELLO, Eric/0000-0002-2009-4919; TRIEU-CUOT, Patrick/0000-0002-2768-9587	Fondation pour La Recherche Medicale; Agence Nationale de la Recherche [ERA-NET PathoGenoMics ANR-06-PATHO-001-01]; SUDOE [SOE1/P1/E014]; FCT [SFRH/BD/38121/2007]	Fondation pour La Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); SUDOE; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by grants from the Fondation pour La Recherche Medicale (to C. P), from the Agence Nationale de la Recherche "ERA-NET PathoGenoMics ANR-06-PATHO-001-01" (to P. T.-C.) and from SUDOE-FEDER IMMUNONET SOE1/P1/E014 (to P. F.). L. Oliveira was supported by PhD FCT fellowship SFRH/BD/38121/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambaud C, 2006, J BIOL CHEM, V281, P31812, DOI 10.1074/jbc.M606249200; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Courtney HS, 1996, INFECT IMMUN, V64, P2415, DOI 10.1128/IAI.64.7.2415-2419.1996; D'Costa SS, 2000, METHODS, V21, P165, DOI 10.1006/meth.2000.0988; Da Costa AF, INT J MOL MED, V27, P739; Dramsi S, 2004, MOL MICROBIOL, V53, P639, DOI 10.1111/j.1365-2958.2004.04138.x; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Edwards MS, 2005, GROUP B STREPTOCOCCA, P1091; Egea L, 2007, INT J BIOCHEM CELL B, V39, P1190, DOI 10.1016/j.biocel.2007.03.008; Fettucciari K, 2000, J IMMUNOL, V165, P3923, DOI 10.4049/jimmunol.165.7.3923; Fettucciari K, 2006, J IMMUNOL, V176, P7542, DOI 10.4049/jimmunol.176.12.7542; Forquin MP, 2007, INFECT IMMUN, V75, P2063, DOI 10.1128/IAI.01565-06; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Hughes MJG, 2002, INFECT IMMUN, V70, P1254, DOI 10.1128/IAI.70.3.1254-1259.2002; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Jin H, 2005, J MOL BIOL, V350, P27, DOI 10.1016/j.jmb.2005.04.063; Lehnardt S, 2007, J IMMUNOL, V179, P6134, DOI 10.4049/jimmunol.179.9.6134; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; Machata S, 2005, J BACTERIOL, V187, P8385, DOI 10.1128/JB.187.24.8385-8394.2005; Madureira P, 2007, J IMMUNOL, V178, P1379, DOI 10.4049/jimmunol.178.3.1379; Madureira P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002363; Magalhaes V, 2007, MICROBES INFECT, V9, P1276, DOI 10.1016/j.micinf.2007.06.001; Mistou MY, 2009, J BACTERIOL, V191, P4195, DOI 10.1128/JB.01673-08; Nau R, 2002, CLIN MICROBIOL REV, V15, P95, DOI 10.1128/CMR.15.1.95-110.2002; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; Pancholi V, 1997, J EXP MED, V186, P1633, DOI 10.1084/jem.186.10.1633; PANCHOLI V, 1993, P NATL ACAD SCI USA, V90, P8154, DOI 10.1073/pnas.90.17.8154; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Pasztor L, 2010, J BIOL CHEM, V285, P36794, DOI 10.1074/jbc.M110.167312; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Plummer C, 2005, BRIT J HAEMATOL, V129, P101, DOI 10.1111/j.1365-2141.2005.05421.x; PODBIELSKI A, 1994, MED MICROBIOL IMMUN, V183, P239, DOI 10.1007/BF00198458; Poyart C, 2001, INFECT IMMUN, V69, P5098, DOI 10.1128/IAI.69.8.5098-5106.2001; Poyart C, 2001, J BACTERIOL, V183, P6324, DOI 10.1128/JB.183.21.6324-6334.2001; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Seifert KN, 2003, CAN J MICROBIOL, V49, P350, DOI 10.1139/W03-042; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Suvorov AN, 1997, INFECT IMMUN, V65, P191, DOI 10.1128/IAI.65.1.191-196.1997; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; Ulett GC, 2005, J INFECT DIS, V191, P1761, DOI 10.1086/429693; Ulett GC, 2005, J IMMUNOL, V175, P2555, DOI 10.4049/jimmunol.175.4.2555; Ulett GC, 2003, J INFECT DIS, V188, P1049, DOI 10.1086/378202; Winram SB, 1996, MICROBIOL-SGM, V142, P2311, DOI 10.1099/13500872-142-8-2311; Yamamoto Y, 2006, MOL MICROBIOL, V62, P772, DOI 10.1111/j.1365-2958.2006.05406.x	50	62	65	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e29963	10.1371/journal.pone.0029963	http://dx.doi.org/10.1371/journal.pone.0029963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291899	Green Published, gold			2022-12-27	WOS:000301570600010
J	van Mourik, S; Kaufmann, K; van Dijk, ADJ; Angenent, GC; Merks, RMH; Molenaar, J				van Mourik, Simon; Kaufmann, Kerstin; van Dijk, Aalt D. J.; Angenent, Gerco C.; Merks, Roeland M. H.; Molenaar, Jaap			Simulation of Organ Patterning on the Floral Meristem Using a Polar Auxin Transport Model	PLOS ONE			English	Article							FLOWER DEVELOPMENT; ARABIDOPSIS; CANALIZATION; PHYLLOTAXIS; INITIATION; EFFLUX; LEAF	An intriguing phenomenon in plant development is the timing and positioning of lateral organ initiation, which is a fundamental aspect of plant architecture. Although important progress has been made in elucidating the role of auxin transport in the vegetative shoot to explain the phyllotaxis of leaf formation in a spiral fashion, a model study of the role of auxin transport in whorled organ patterning in the expanding floral meristem is not available yet. We present an initial simulation approach to study the mechanisms that are expected to play an important role. Starting point is a confocal imaging study of Arabidopsis floral meristems at consecutive time points during flower development. These images reveal auxin accumulation patterns at the positions of the organs, which strongly suggests that the role of auxin in the floral meristem is similar to the role it plays in the shoot apical meristem. This is the basis for a simulation study of auxin transport through a growing floral meristem, which may answer the question whether auxin transport can in itself be responsible for the typical whorled floral pattern. We combined a cellular growth model for the meristem with a polar auxin transport model. The model predicts that sepals are initiated by auxin maxima arising early during meristem outgrowth. These form a pre-pattern relative to which a series of smaller auxin maxima are positioned, which partially overlap with the anlagen of petals, stamens, and carpels. We adjusted the model parameters corresponding to properties of floral mutants and found that the model predictions agree with the observed mutant patterns. The predicted timing of the primordia outgrowth and the timing and positioning of the sepal primordia show remarkable similarities with a developing flower in nature.	[van Mourik, Simon; van Dijk, Aalt D. J.; Molenaar, Jaap] Univ Wageningen & Res Ctr, Plant Sci Grp, Wageningen, Netherlands; [Kaufmann, Kerstin] Univ Wageningen & Res Ctr, Mol Biol Lab, Wageningen, Netherlands; [Merks, Roeland M. H.] Ctr Wiskunde & Informat, Amsterdam, Netherlands; [Angenent, Gerco C.] Ctr BioSyst Genom, Wageningen, Netherlands; [Merks, Roeland M. H.] Netherlands Inst Syst Biol, Amsterdam, Netherlands; [van Mourik, Simon; van Dijk, Aalt D. J.; Angenent, Gerco C.; Merks, Roeland M. H.; Molenaar, Jaap] Netherlands Consortium Syst Biol, Amsterdam, Netherlands	Wageningen University & Research; Wageningen University & Research; Centre for BioSystems Genomics	van Mourik, S (corresponding author), Univ Wageningen & Res Ctr, Plant Sci Grp, Wageningen, Netherlands.	simon.vanmourik@wur.nl	Kaufmann, Kerstin/GXF-3402-2022; Merks, Roeland/A-2249-2008; Angenent, Gerco C./A-5993-2011; Kaufmann, Kerstin/A-2662-2012; van Mourik, Simon/D-9006-2013	Kaufmann, Kerstin/0000-0001-7960-6256; Merks, Roeland/0000-0002-6152-687X; Kaufmann, Kerstin/0000-0001-7960-6256; van Dijk, Aalt-Jan/0000-0002-8872-5123	Netherlands Consortium for Systems Biology (NCSB), Netherlands Genomics Initiative / Netherlands Organisation for Scientific Research; European Community [230974]; Netherlands Organization for Scientific Research (NWO, NWO-VENI) [863.08.027]	Netherlands Consortium for Systems Biology (NCSB), Netherlands Genomics Initiative / Netherlands Organisation for Scientific Research; European Community(European Commission); Netherlands Organization for Scientific Research (NWO, NWO-VENI)(Netherlands Organization for Scientific Research (NWO))	This work was cofinanced by the Netherlands Consortium for Systems Biology (NCSB) which is part of the Netherlands Genomics Initiative / Netherlands Organisation for Scientific Research. The research leading to these results has received funding from the European Community's Seventh Framework Programme under grant agreement n<SUP>o</SUP> 230974, and the Netherlands Organization for Scientific Research (NWO, NWO-VENI Grant 863.08.027 to AvD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloni R, 2006, PLANTA, V223, P315, DOI 10.1007/s00425-005-0088-9; Bayer EM, 2009, GENE DEV, V23, P373, DOI 10.1101/gad.497009; Benjamins R, 2001, DEVELOPMENT, V128, P4057; BENNETT SRM, 1995, PLANT J, V8, P505, DOI 10.1046/j.1365-313X.1995.8040505.x; Cheng YF, 2007, J INTEGR PLANT BIOL, V49, P99, DOI 10.1111/j.1744-7909.2006.00412.x; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; CRONE W, 1993, AM J BOT, V80, P1419, DOI 10.2307/2445671; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; GOLDSMITH MHM, 1981, P NATL ACAD SCI-BIOL, V78, P976, DOI 10.1073/pnas.78.2.976; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kaufmann K, 2010, SCIENCE, V328, P85, DOI 10.1126/science.1185244; Kaufmann K, 2009, PLOS BIOL, V7, P854, DOI 10.1371/journal.pbio.1000090; Kramer EM, 2006, TRENDS PLANT SCI, V11, P382, DOI 10.1016/j.tplants.2006.06.002; Kramer EM, 2009, TRENDS PLANT SCI, V14, P242, DOI 10.1016/j.tplants.2009.02.005; Merks RMH, 2007, TRENDS PLANT SCI, V12, P384, DOI 10.1016/j.tplants.2007.08.004; Merks RMH, 2011, PLANT PHYSIOL, V155, P656, DOI 10.1104/pp.110.167619; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; MITCHISON GJ, 1980, PROC R SOC SER B-BIO, V209, P489, DOI 10.1098/rspb.1980.0109; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Rolland-Lagan AG, 2005, PLANT J, V44, P854, DOI 10.1111/j.1365-313X.2005.02581.x; Smith RS, 2006, CAN J BOT, V84, P1635, DOI 10.1139/B06-133; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Stoma S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000207; Tobena-Santamaria R, 2002, GENE DEV, V16, P753, DOI 10.1101/gad.219502; Urbanus SL, 2010, PLANT J; Wabnik K, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.103; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083	33	33	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e28762	10.1371/journal.pone.0028762	http://dx.doi.org/10.1371/journal.pone.0028762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291882	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600001
J	Hauberg-Lotte, L; Klingenberg, H; Scharf, C; Bohm, M; Plessl, J; Friedrich, F; Volker, U; Becker, A; Reinhold-Hurek, B				Hauberg-Lotte, Lena; Klingenberg, Hannah; Scharf, Christian; Boehm, Melanie; Plessl, Joerg; Friedrich, Frauke; Voelker, Uwe; Becker, Anke; Reinhold-Hurek, Barbara			Environmental Factors Affecting the Expression of pilAB as Well as the Proteome and Transcriptome of the Grass Endophyte Azoarcus sp Strain BH72	PLOS ONE			English	Article							QUORUM-SENSING SYSTEMS; TO-CELL COMMUNICATION; TIME RT-PCR; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; BURKHOLDERIA-CENOCEPACIA; MICROARRAY ANALYSIS; TWITCHING MOTILITY; GENE-EXPRESSION; RICE ROOTS	Background: Bacterial communication is involved in regulation of cellular mechanisms such as metabolic processes, microbe-host interactions or biofilm formation. In the nitrogen-fixing model endophyte of grasses Azoarcus sp. strain BH72, known cell-cell signaling systems have not been identified; however, the pilA gene encoding the structural protein of type IV pili that are essential for plant colonization appears to be regulated in a population density-dependent manner. Methodology/Principal Findings: Our data suggest that pilAB expression is affected by population density, independent of autoinducers typical for Gram-negative bacteria, likely depending on unknown secreted molecule(s) that can be produced by different bacterial species. We used transcriptomic and proteomic approaches to identify target genes and proteins differentially regulated in conditioned supernatants in comparison to standard growth conditions. Around 8% of the 3992 protein-coding genes of Azoarcus sp. and 18% of the detected proteins were differentially regulated. Regulatory proteins and transcription factors among the regulated proteins indicated a complex hierarchy. Differentially regulated genes and proteins were involved in processes such as type IV pili formation and regulation, metal and nutrient transport, energy metabolism, and unknown functions mediated by hypothetical proteins. Four of the newly discovered target genes were further analyzed and in general they showed regulation patterns similar to pilAB. The expression of one of them was shown to be induced in plant roots. Conclusion/Significance: This study is the first global approach to initiate characterization of cell density-dependent gene regulation mediated by soluble molecule(s) in the model endophyte Azoarcus sp. strain BH72. Our data suggest that the putative signaling molecule(s) are also produced by other Proteobacteria and might thus be used for interspecies communication. This study provides the foundation for the development of robust reporter systems for Azoarcus sp. to analyze mechanisms and molecules involved in the population-dependent gene expression in this endophyte in future.	[Hauberg-Lotte, Lena; Klingenberg, Hannah; Boehm, Melanie; Plessl, Joerg; Friedrich, Frauke; Reinhold-Hurek, Barbara] Univ Bremen, Ctr Biomol Interact Bremen, D-28359 Bremen, Germany; [Scharf, Christian; Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Scharf, Christian] Univ Med Greifswald, Dept Otorhinolaryngol, Greifswald, Germany; [Becker, Anke] Univ Freiburg, Inst Biol 3, Fac Biol, Freiburg, Germany	University of Bremen; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School; University of Freiburg	Hauberg-Lotte, L (corresponding author), Univ Bremen, Ctr Biomol Interact Bremen, D-28359 Bremen, Germany.	breinhold@uni-bremen.de	Scharf, Christian/A-7931-2011	Scharf, Christian/0000-0001-6806-6450; Becker, Anke/0000-0003-4561-9184; Volker, Uwe/0000-0002-5689-3448	Deutsche Forschungsgemeinschaft, Germany [RE 756/14-1]; University of Bremen: ZF [02/114/05]	Deutsche Forschungsgemeinschaft, Germany(German Research Foundation (DFG)); University of Bremen: ZF	Funding provided by the Deutsche Forschungsgemeinschaft, Germany (RE 756/14-1 to BR-H); University of Bremen: ZF (02/114/05 to BR-H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Barber CE, 1997, MOL MICROBIOL, V24, P555, DOI 10.1046/j.1365-2958.1997.3721736.x; Barnard AML, 2007, ANAL BIOANAL CHEM, V387, P415, DOI 10.1007/s00216-006-0701-1; Beatson SA, 2002, J BACTERIOL, V184, P3605, DOI 10.1128/JB.184.13.3605-3613.2002; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Bertani I, 2004, APPL ENVIRON MICROB, V70, P5493, DOI 10.1128/AEM.70.9.5493-5502.2004; Bohm M, 2007, MOL PLANT MICROBE IN, V20, P526, DOI 10.1094/MPMI-20-5-0526; Boon C, 2008, ISME J, V2, P27, DOI 10.1038/ISMEJ.2007.76; Boulette ML, 2007, J BACTERIOL, V189, P6957, DOI 10.1128/JB.00621-07; Boyd JM, 2000, MOL MICROBIOL, V36, P153, DOI 10.1046/j.1365-2958.2000.01836.x; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Simionato AVC, 2007, J MASS SPECTROM, V42, P1375, DOI [10.1002/jms.1325, 10.1002/jms.1181]; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; De Pina K, 1999, J BACTERIOL, V181, P670, DOI 10.1128/JB.181.2.670-674.1999; DeLisa MP, 2001, J BACTERIOL, V183, P5239, DOI 10.1128/JB.183.18.5239-5247.2001; Dirix G, 2004, PEPTIDES, V25, P1425, DOI 10.1016/j.peptides.2003.10.028; Dorr J, 1998, MOL MICROBIOL, V30, P7, DOI 10.1046/j.1365-2958.1998.01010.x; Eberl L, 2006, INT J MED MICROBIOL, V296, P103, DOI 10.1016/j.ijmm.2006.01.035; Egener T, 1999, MOL PLANT MICROBE IN, V12, P813, DOI 10.1094/MPMI.1999.12.9.813; Egener T, 1998, MOL PLANT MICROBE IN, V11, P71, DOI 10.1094/MPMI.1998.11.1.71; Ernst FD, 2005, MICROBIOL-SGM, V151, P533, DOI 10.1099/mic.0.27404-0; Ethier J, 2000, MOL MICROBIOL, V38, P891, DOI 10.1046/j.1365-2958.2000.02189.x; Fuqua C, 1998, CURR OPIN MICROBIOL, V1, P183, DOI 10.1016/S1369-5274(98)80009-X; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Gonzalez JE, 2003, MICROBIOL MOL BIOL R, V67, P574, DOI 10.1128/MMBR.67.4.574-592.2003; Hauberg L, 2010, PROTEOMICS, V10, P458, DOI 10.1002/pmic.200900307; HOBBS M, 1993, MOL MICROBIOL, V7, P669, DOI 10.1111/j.1365-2958.1993.tb01158.x; Hurek T, 1997, J BACTERIOL, V179, P4172, DOI 10.1128/jb.179.13.4172-4178.1997; Hurek T, 2003, J BIOTECHNOL, V106, P169, DOI 10.1016/j.jbiotec.2003.07.010; HUREK T, 1994, J BACTERIOL, V176, P1913, DOI 10.1128/jb.176.7.1913-1923.1994; JEFFERSON RA, 1987, EMBO J, V6, P3901; Krause A, 2006, NAT BIOTECHNOL, V24, P1385, DOI 10.1038/nbt1243; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Marketon MM, 2002, J BACTERIOL, V184, P3466, DOI 10.1128/JB.184.13.3466-3475.2002; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Merritt J, 2005, MOL MICROBIOL, V57, P960, DOI 10.1111/j.1365-2958.2005.04733.x; O'Grady EP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-441; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Reinhold-Hurek B, 1998, TRENDS MICROBIOL, V6, P139, DOI 10.1016/S0966-842X(98)01229-3; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; REINHOLDHUREK B, 1993, INT J SYST BACTERIOL, V43, P574, DOI 10.1099/00207713-43-3-574; REINHOLDHUREK B, 1993, J BACTERIOL, V175, P7056, DOI 10.1128/jb.175.21.7056-7065.1993; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sambrook J., 2002, MOL CLONING LAB MANU; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Sperandio V, 2001, J BACTERIOL, V183, P5187, DOI 10.1128/JB.183.17.5187-5197.2001; Steidle A, 2001, APPL ENVIRON MICROB, V67, P5761, DOI 10.1128/AEM.67.12.5761-5770.2001; Stevenson DM, 2005, APPL ENVIRON MICROB, V71, P4672, DOI 10.1128/AEM.71.8.4672-4678.2005; Takle GW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-50; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Whitchurch CB, 2005, MOL MICROBIOL, V55, P1357, DOI 10.1111/j.1365-2958.2005.04479.x; Whiteley M, 2000, J BACTERIOL, V182, P4356, DOI 10.1128/JB.182.15.4356-4360.2000; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Wu SS, 1997, MOL MICROBIOL, V23, P109, DOI 10.1046/j.1365-2958.1997.1791550.x; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48	60	16	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30421	10.1371/journal.pone.0030421	http://dx.doi.org/10.1371/journal.pone.0030421			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276194	gold, Green Published, Green Submitted			2022-12-27	WOS:000301568100045
J	Kumar, R; Lawrence, ML; Watt, J; Cooksey, AM; Burgess, SC; Nanduri, B				Kumar, Ranjit; Lawrence, Mark L.; Watt, James; Cooksey, Amanda M.; Burgess, Shane C.; Nanduri, Bindu			RNA-Seq Based Transcriptional Map of Bovine Respiratory Disease Pathogen "Histophilus somni 2336"	PLOS ONE			English	Article							SMALL NONCODING RNAS; SYSTEMS BIOLOGY; PUBLIC-HEALTH; HOST-PATHOGEN; GENOME; IDENTIFICATION; ANNOTATION; DISCOVERY; COMPLEXITY; REGIONS	Genome structural annotation, i.e., identification and demarcation of the boundaries for all the functional elements in a genome (e.g., genes, non-coding RNAs, proteins and regulatory elements), is a prerequisite for systems level analysis. Current genome annotation programs do not identify all of the functional elements of the genome, especially small non-coding RNAs (sRNAs). Whole genome transcriptome analysis is a complementary method to identify "novel" genes, small RNAs, regulatory regions, and operon structures, thus improving the structural annotation in bacteria. In particular, the identification of non-coding RNAs has revealed their widespread occurrence and functional importance in gene regulation, stress and virulence. However, very little is known about non-coding transcripts in Histophilus somni, one of the causative agents of Bovine Respiratory Disease (BRD) as well as bovine infertility, abortion, septicemia, arthritis, myocarditis, and thrombotic meningoencephalitis. In this study, we report a single nucleotide resolution transcriptome map of H. somni strain 2336 using RNA-Seq method. The RNA-Seq based transcriptome map identified 94 sRNAs in the H. somni genome of which 82 sRNAs were never predicted or reported in earlier studies. We also identified 38 novel potential protein coding open reading frames that were absent in the current genome annotation. The transcriptome map allowed the identification of 278 operon (total 730 genes) structures in the genome. When compared with the genome sequence of a non-virulent strain 129Pt, a disproportionate number of sRNAs (similar to 30%) were located in genomic region unique to strain 2336 (similar to 18% of the total genome). This observation suggests that a number of the newly identified sRNAs in strain 2336 may be involved in strain-specific adaptations.	[Kumar, Ranjit; Lawrence, Mark L.; Nanduri, Bindu] Mississippi State Univ, Coll Vet Med, Mississippi State, MS 39762 USA; [Kumar, Ranjit; Lawrence, Mark L.; Cooksey, Amanda M.; Nanduri, Bindu] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA; [Kumar, Ranjit] Univ Alabama Birmingham, Ctr Clin & Translat Sci, Birmingham, AL USA; [Watt, James] Eagle Appl Sci LLC, San Antonio, TX USA; [Burgess, Shane C.] Univ Arizona, Coll Agr & Life Sci, Tucson, AZ USA	Mississippi State University; Mississippi State University; University of Alabama System; University of Alabama Birmingham; University of Arizona	Kumar, R (corresponding author), Mississippi State Univ, Coll Vet Med, Mississippi State, MS 39762 USA.	ranjit58@gmail.com			Institute for Genomics, Biocomputing and Biotechnology, Mississippi; National Science Foundation (Mississippi) [0903787]; USDA (United States Department of Agriculture) AFRI (Agriculture and Food Research Initiative) [2006-35600-17688]	Institute for Genomics, Biocomputing and Biotechnology, Mississippi; National Science Foundation (Mississippi)(National Science Foundation (NSF)); USDA (United States Department of Agriculture) AFRI (Agriculture and Food Research Initiative)	This project was supported partially by the Institute for Genomics, Biocomputing and Biotechnology, Mississippi and the National Science Foundation (Mississippi EPSCoR (Experimental Program to Stimulate Competitive Research)-0903787) and from USDA (United States Department of Agriculture) AFRI (Agriculture and Food Research Initiative) grant number 2006-35600-17688). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2011, MBIO, V2, DOI 10.1128/mBio.00325-10; Akama T, 2009, J BACTERIOL, V191, P3321, DOI 10.1128/JB.00120-09; Backofen R, 2010, RNA BIOL, V7, P33, DOI 10.4161/rna.7.1.10655; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brouwer RWW, 2008, BRIEF BIOINFORM, V9, P367, DOI 10.1093/bib/bbn019; Bumann D, 2010, J PROTEOMICS, V73, P2267, DOI 10.1016/j.jprot.2010.08.004; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Ellis JA, 2001, VET CLIN N AM-FOOD A, V17, P535, DOI 10.1016/S0749-0720(15)30005-0; Forst CV, 2006, DRUG DISCOV TODAY, V11, P220, DOI 10.1016/S1359-6446(05)03735-9; Griffin D, 1997, VET CLIN N AM-FOOD A, V13, P367, DOI 10.1016/S0749-0720(15)30302-9; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Kapil S, 1997, VET CLIN N AM-FOOD A, V13, P455, DOI 10.1016/S0749-0720(15)30308-X; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Kozhenkov S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-7; Kuckleburg CJ, 2005, MICROB PATHOGENESIS, V38, P23, DOI 10.1016/j.micpath.2004.10.006; Kulkarni RV, 2007, METHODS, V43, P131, DOI 10.1016/j.ymeth.2007.04.001; Kumar R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-350; Landt SG, 2008, MOL MICROBIOL, V68, P600, DOI 10.1111/j.1365-2958.2008.06172.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp080; Livny J, 2007, CURR OPIN MICROBIOL, V10, P96, DOI 10.1016/j.mib.2007.03.005; Mao F, 2008, NUCL ACIDS RES; Martin J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S10; Nannini E, 2010, CURR OPIN PHARMACOL, V10, P516, DOI 10.1016/j.coph.2010.06.006; Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1; Palleja A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-335; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Peng XX, 2009, CURR OPIN MICROBIOL, V12, P432, DOI 10.1016/j.mib.2009.06.003; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Sandal I, 2010, TRENDS MICROBIOL, V18, P90, DOI 10.1016/j.tim.2009.11.006; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sturdevant DE, 2010, FUTURE MICROBIOL, V5, P205, DOI 10.2217/FMB.09.125; Tisserant E, 2011, NEW PHYTOL, V189, P883, DOI 10.1111/j.1469-8137.2010.03597.x; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; van Vliet AHM, 2010, FEMS MICROBIOL LETT, V302, P1, DOI 10.1111/j.1574-6968.2009.01767.x; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106	45	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29435	10.1371/journal.pone.0029435	http://dx.doi.org/10.1371/journal.pone.0029435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276113	Green Published, gold			2022-12-27	WOS:000301568100010
J	Basu, A; Rojas, H; Banerjee, H; Cabrera, IB; Perez, KY; De Leon, M; Casiano, CA				Basu, Anamika; Rojas, Heather; Banerjee, Hiya; Cabrera, Irena B.; Perez, Kayla Y.; De Leon, Marino; Casiano, Carlos A.			Expression of the Stress Response Oncoprotein LEDGF/p75 in Human Cancer: A Study of 21 Tumor Types	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; GROWTH-FACTOR; OXIDATIVE STRESS; FIELD CANCERIZATION; PROSTATE-CANCER; NUP98-LEDGF FUSION; PROTEIN EXPRESSION; PROTEOMIC ANALYSIS; COACTIVATORS P52; GENE	Oxidative stress-modulated signaling pathways have been implicated in carcinogenesis and therapy resistance. The lens epithelium derived growth factor p75 (LEDGF/p75) is a transcription co-activator that promotes resistance to stress-induced cell death. This protein has been implicated in inflammatory and autoimmune conditions, HIV-AIDS, and cancer. Although LEDGF/p75 is emerging as a stress survival oncoprotein, there is scarce information on its expression in human tumors. The present study was performed to evaluate its expression in a comprehensive panel of human cancers. Transcript expression was examined in the Oncomine cancer gene microarray database and in a TissueScan Cancer Survey Panel quantitative polymerase chain reaction (Q-PCR) array. Protein expression was assessed by immunohistochemistry (IHC) in cancer tissue microarrays (TMAs) containing 1735 tissues representing single or replicate cores from 1220 individual cases (985 tumor and 235 normal tissues). A total of 21 major cancer types were analyzed. Analysis of LEDGF/p75 transcript expression in Oncomine datasets revealed significant upregulation (tumor vs. normal) in 15 out of 17 tumor types. The TissueScan Cancer Q-PCR array revealed significantly elevated LEDGF/p75 transcript expression in prostate, colon, thyroid, and breast cancers. IHC analysis of TMAs revealed significant increased levels of LEDGF/p75 protein in prostate, colon, thyroid, liver and uterine tumors, relative to corresponding normal tissues. Elevated transcript or protein expression of LEDGF/p75 was observed in several tumor types. These results further establish LEDGF/p75 as a cancer-related protein, and provide a rationale for ongoing studies aimed at understanding the clinical significance of its expression in specific human cancers.	[Basu, Anamika; Cabrera, Irena B.; Perez, Kayla Y.; De Leon, Marino; Casiano, Carlos A.] Loma Linda Univ, Sch Med, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA; [Basu, Anamika; Cabrera, Irena B.; Perez, Kayla Y.; De Leon, Marino; Casiano, Carlos A.] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA USA; [Rojas, Heather] Loma Linda Univ, Sch Med, Dept Pathol & Human Anat, Loma Linda, CA USA; [Banerjee, Hiya] Med Univ S Carolina, Div Biostat & Epidemiol, Charleston, SC 29425 USA; [Casiano, Carlos A.] Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92354 USA	Loma Linda University; Loma Linda University; Loma Linda University; Medical University of South Carolina; Loma Linda University	Basu, A (corresponding author), Loma Linda Univ, Sch Med, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA.	abasu@llu.edu	De Leon, Marino/A-6922-2009	De Leon, Marino/0000-0001-6576-785X	National Institutes of Health (NIH) National Center on Minority Health and Health Disparities [NIH-NCMHD] [5P20MD001632]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060507] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006988] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Center on Minority Health and Health Disparities [NIH-NCMHD]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by a grant from the National Institutes of Health (NIH) National Center on Minority Health and Health Disparities [NIH-NCMHD 5P20MD001632 (MDL, CAC)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja HG, 2000, CANCER RES, V60, P6227; Basu A, 2011, PROSTATE        0727; Basu A, 2011, PROSTATE, V71, P755, DOI 10.1002/pros.21292; Brown-Bryan TA, 2008, MOL CANCER RES, V6, P1293, DOI 10.1158/1541-7786.MCR-08-0125; Cha MK, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-93; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Daniels T, 2005, PROSTATE, V62, P14, DOI 10.1002/pros.20112; Daugaard M, 2007, CANCER RES, V67, P2559, DOI 10.1158/0008-5472.CAN-06-4121; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Fatma N, 2001, J BIOL CHEM, V276, P48899, DOI 10.1074/jbc.M100733200; Fatma N, 2000, INVEST OPHTH VIS SCI, V41, P2648; Ganapathy V, 2004, ARTHRITIS RHEUM-US, V50, P684, DOI 10.1002/art.20095; Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723; Grand FH, 2005, LEUKEMIA RES, V29, P1469, DOI 10.1016/j.leukres.2005.05.002; Haaland CM, 2009, INT J ONCOL, V35, P537, DOI 10.3892/ijo_00000365; Heaphy CM, 2006, INT J CANCER, V119, P108, DOI 10.1002/ijc.21815; Huang TS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-31; Hussey DJ, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-20; Kalinichenko SV, 2008, LUNG CANCER, V62, P173, DOI 10.1016/j.lungcan.2008.03.022; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; Leoh LS, 2009, PATHOGENESIS THERAPY, P135; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Lou C, 2009, CANCER SCI, V100, P996, DOI 10.1111/j.1349-7006.2009.01138.x; Matsui H, 2001, INVEST OPHTH VIS SCI, V42, P2935; McCready J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-294; Mediavilla-Varela M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-68; Mena S, 2009, MUTAT RES-GEN TOX EN, V674, P36, DOI 10.1016/j.mrgentox.2008.09.017; Merendino AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009247; Morerio C, 2005, LEUKEMIA RES, V29, P467, DOI 10.1016/j.leukres.2004.09.002; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; Ochs RL, 2000, J ALLERGY CLIN IMMUN, V105, P1211, DOI 10.1067/mai.2000.107039; Orntoft TF, 2002, MOL CELL PROTEOMICS, V1, P37, DOI 10.1074/mcp.M100019-MCP200; Pani G, 2010, CANCER METAST REV, V29, P351, DOI 10.1007/s10555-010-9225-4; Poeschla EM, 2008, CELL MOL LIFE SCI, V65, P1403, DOI 10.1007/s00018-008-7540-5; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Roesch-Ely M, 2010, J PATHOL, V221, P462, DOI 10.1002/path.2726; Sapoznik S, 2009, CANCER RES, V69, P9306, DOI 10.1158/0008-5472.CAN-09-1213; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Sharma P, 2000, BIOCHEM BIOPH RES CO, V276, P1320, DOI 10.1006/bbrc.2000.3606; Shin JH, 2008, NEUROSCI LETT, V435, P131, DOI 10.1016/j.neulet.2008.02.029; Singh DP, 2000, BIOCHEM BIOPH RES CO, V267, P373, DOI 10.1006/bbrc.1999.1979; Singh DP, 2000, GENE, V242, P265, DOI 10.1016/S0378-1119(99)00506-5; Singh DP, 2001, BIOCHEM BIOPH RES CO, V283, P943, DOI 10.1006/bbrc.2001.4887; Sutherland HG, 2006, MOL CELL BIOL, V26, P7201, DOI 10.1128/MCB.00459-06; Takeichi T, 2010, J INVEST DERMATOL, V130, P2760, DOI 10.1038/jid.2010.203; Trujillo KA, 2010, INT J CANC      1123; Van Maele B, 2006, TRENDS BIOCHEM SCI, V31, P98, DOI 10.1016/j.tibs.2005.12.002; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wu X, 2002, CELL DEATH DIFFER, V9, P915, DOI 10.1038/sj.cdd.4401063; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003	50	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30132	10.1371/journal.pone.0030132	http://dx.doi.org/10.1371/journal.pone.0030132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276150	Green Submitted, Green Published, gold			2022-12-27	WOS:000301457200035
J	Llamas, B; Holland, ML; Chen, KF; Cropley, JE; Cooper, A; Suter, CM				Llamas, Bastien; Holland, Michelle L.; Chen, Kefei; Cropley, Jennifer E.; Cooper, Alan; Suter, Catherine M.			High-Resolution Analysis of Cytosine Methylation in Ancient DNA	PLOS ONE			English	Article							EPIGENETIC VARIATION; INHERITANCE; PATTERNS; DISEASE; GENOME	Epigenetic changes to gene expression can result in heritable phenotypic characteristics that are not encoded in the DNA itself, but rather by biochemical modifications to the DNA or associated chromatin proteins. Interposed between genes and environment, these epigenetic modifications can be influenced by environmental factors to affect phenotype for multiple generations. This raises the possibility that epigenetic states provide a substrate for natural selection, with the potential to participate in the rapid adaptation of species to changes in environment. Any direct test of this hypothesis would require the ability to measure epigenetic states over evolutionary timescales. Here we describe the first single-base resolution of cytosine methylation patterns in an ancient mammalian genome, by bisulphite allelic sequencing of loci from late Pleistocene Bison priscus remains. Retrotransposons and the differentially methylated regions of imprinted loci displayed methylation patterns identical to those derived from fresh bovine tissue, indicating that methylation patterns are preserved in the ancient DNA. Our findings establish the biochemical stability of methylated cytosines over extensive time frames, and provide the first direct evidence that cytosine methylation patterns are retained in DNA from ancient specimens. The ability to resolve cytosine methylation in ancient DNA provides a powerful means to study the role of epigenetics in evolution.	[Llamas, Bastien] Flinders Univ S Australia, Dept Ophthalmol, Bedford Pk, SA 5042, Australia; [Llamas, Bastien; Chen, Kefei; Cooper, Alan] Univ Adelaide, Australian Ctr Ancient DNA, Adelaide, SA, Australia; [Holland, Michelle L.; Cropley, Jennifer E.; Suter, Catherine M.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Cropley, Jennifer E.; Suter, Catherine M.] Univ New S Wales, Fac Med, Sydney, NSW, Australia	Flinders University South Australia; University of Adelaide; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Llamas, B (corresponding author), Univ Adelaide, Australian Ctr Ancient DNA, Adelaide, SA, Australia.	alan.cooper@adelaide.edu.au; c.suter@victorchang.edu.au	Cooper, Alan/E-8171-2012; Llamas, Bastien/AAK-1693-2021; Llamas, Bastien/Y-2781-2018; Chen, Kefei/AAX-1920-2021	Cooper, Alan/0000-0002-7738-7851; Llamas, Bastien/0000-0002-5550-9176; Llamas, Bastien/0000-0002-5550-9176; Chen, Kefei/0000-0002-2380-3805; Holland, Michelle/0000-0003-0775-2902; Cropley, Jennifer/0000-0001-6078-2604	Australian Research Council (ARC) [DP0773602]; National Health and Medical Research Council (NHMRC) [459412]	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This research was funded by the Australian Research Council (ARC #DP0773602) and the National Health and Medical Research Council (NHMRC #459412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Clark SJ, 2006, NAT PROTOC, V1, P2353, DOI 10.1038/nprot.2006.324; Cooper A, 2000, SCIENCE, V289, P1139; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guerrero-Bosagna C, 2005, EVOL DEV, V7, P341, DOI 10.1111/j.1525-142X.2005.05033.x; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; JABLONKA E, 1989, J THEOR BIOL, V139, P69, DOI 10.1016/S0022-5193(89)80058-X; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Rapp RA, 2005, NEW PHYTOL, V168, P81, DOI 10.1111/j.1469-8137.2005.01491.x; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Richards EJ, 2008, CURR OPIN GENET DEV, V18, P221, DOI 10.1016/j.gde.2008.01.014; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103	21	54	55	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30226	10.1371/journal.pone.0030226	http://dx.doi.org/10.1371/journal.pone.0030226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276161	gold, Green Published			2022-12-27	WOS:000301457200044
J	Tsalkova, T; Mei, FC; Cheng, XD				Tsalkova, Tamara; Mei, Fang C.; Cheng, Xiaodong			A Fluorescence-Based High-Throughput Assay for the Discovery of Exchange Protein Directly Activated by Cyclic AMP (EPAC) Antagonists	PLOS ONE			English	Article							SELECTIVE CAMP ANALOG; CATALYTIC SUBUNIT; I-ALPHA; RAP1; MECHANISM; KINASE; BETA; BINDING	Background: The discovery, more than ten years ago, of exchange proteins directly activated by cAMP (EPAC) as a new family of intracellular cAMP receptors revolutionized the cAMP signaling research field. Extensive studies have revealed that the cAMP signaling network is much more complex and dynamic as many cAMP-related cellular processes, previously thought to be controlled by protein kinase A, are found to be also mediated by EPAC proteins. Although there have been many important discoveries in the roles of EPACs greater understanding of their physiological function in cAMP-mediated signaling is impeded by the absence of EPAC-specific antagonist. Methodology/Principal Findings: To overcome this deficit, we have developed a fluorescence-based high throughput assay for screening EPAC specific antagonists. Our assay is highly reproducible and simple to perform using the "mix and measure" format. A pilot screening using the NCI-DTP diversity set library led to the identification of small chemical compounds capable of specifically inhibiting cAMP-induced EPAC activation while not affecting PKA activity. Conclusions/Significance: Our study establishes a robust high throughput screening assay that can be effectively applied for the discovery of EPAC-specific antagonists, which may provide valuable pharmacological tools for elucidating the biological functions of EPAC and for promoting an understanding of disease mechanisms related to EPAC/cAMP signaling.	[Tsalkova, Tamara] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Tsalkova, T (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.	xcheng@utmb.edu	Cheng, Xiaodong/O-8176-2019	Cheng, Xiaodong/0000-0002-3479-1694	National Institute of Health [5R01GM066170, 1R21NS066510]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066510] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute of Health, 5R01GM066170 and 1R21NS066510. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng XD, 2001, J BIOL CHEM, V276, P4102, DOI 10.1074/jbc.M006447200; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; CHEPURNY O, 2009, J BIOL CHEM; Christensen AE, 2003, J BIOL CHEM; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kraemer A, 2001, J MOL BIOL, V306, P1167, DOI 10.1006/jmbi.2001.4444; Li S, 2011, J BIOL CHEM, V286, P17889, DOI 10.1074/jbc.M111.224535; Mei FC, 2005, MOL BIOSYST, V1, P325, DOI 10.1039/b511267b; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Rehmann H, 2003, J BIOL CHEM; Tsalkova T, 2009, J BIOL CHEM, V284, P23644, DOI 10.1074/jbc.M109.024950; vandenBerghe N, 1997, ONCOGENE, V15, P845, DOI 10.1038/sj.onc.1201407; Vliem MJ, 2008, CHEMBIOCHEM, V9, P2052, DOI 10.1002/cbic.200800216; Yu SN, 2004, BIOCHEMISTRY-US, V43, P1908, DOI 10.1021/bi0354435; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	21	46	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30441	10.1371/journal.pone.0030441	http://dx.doi.org/10.1371/journal.pone.0030441			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276201	Green Submitted, Green Published, gold			2022-12-27	WOS:000301457200063
J	Doi, H; Takahara, T; Tanaka, K				Doi, Hideyuki; Takahara, Teruhiko; Tanaka, Kazuya			Trophic Position and Metabolic Rate Predict the Long-Term Decay Process of Radioactive Cesium in Fish: A Meta-Analysis	PLOS ONE			English	Article							ECOLOGICAL HALF-LIVES; FRESH-WATER FISH; BIOACCUMULATION; CS-137; RADIOCESIUM; TROUT; MODEL; RETENTION; BODY	Understanding the long-term behavior of radionuclides in organisms is important for estimating possible associated risks to human beings and ecosystems. As radioactive cesium (Cs-137) can be accumulated in organisms and has a long physical half-life, it is very important to understand its long-term decay in organisms; however, the underlying mechanisms determining the decay process are little known. We performed a meta-analysis to collect published data on the long-term Cs-137 decay process in fish species to estimate biological (metabolic rate) and ecological (trophic position, habitat, and diet type) influences on this process. From the linear mixed models, we found that 1) trophic position could predict the day of maximum Cs-137 activity concentration in fish; and 2) the metabolic rate of the fish species and environmental water temperature could predict ecological half-lives and decay rates for fish species. These findings revealed that ecological and biological traits are important to predict the long-term decay process of Cs-137 activity concentration in fish.	[Doi, Hideyuki; Takahara, Teruhiko; Tanaka, Kazuya] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 724, Japan	Hiroshima University	Doi, H (corresponding author), Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 724, Japan.	doih@hiroshima-u.ac.jp	Doi, Hideyuki/D-2012-2010	Doi, Hideyuki/0000-0002-2701-3982				Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Baptist J. P., 1962, ACCUMULATION RETENTI; Baudin JP, 2000, WATER RES, V34, P2869, DOI 10.1016/S0043-1354(99)00365-6; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Brittain JE, 2010, HYDROBIOLOGIA, V642, P107, DOI 10.1007/s10750-010-0155-5; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Doi H, 2010, OIKOS, V119, P752, DOI 10.1111/j.1600-0706.2009.18540.x; Hessen DO, 2000, J APPL ECOL, V37, P109, DOI 10.1046/j.1365-2664.2000.00479.x; Leggett RW, 2003, SCI TOTAL ENVIRON, V317, P235, DOI 10.1016/S0048-9697(03)00333-4; Makarieva AM, 2008, P NATL ACAD SCI USA, V105, P16994, DOI 10.1073/pnas.0802148105; Malek MA, 2004, J ENVIRON RADIOACTIV, V77, P191, DOI 10.1016/j.jenvrad.2004.03.006; Man CK, 2000, APPL RADIAT ISOTOPES, V52, P237, DOI 10.1016/S0969-8043(99)00122-0; McIntyre JK, 2007, SCI TOTAL ENVIRON, V372, P571, DOI 10.1016/j.scitotenv.2006.10.035; O'Connor MP, 2007, OIKOS, V116, P1058, DOI 10.1111/j.2006.0030-1299.15534.x; Pinder JE, 2009, J ENVIRON RADIOACTIV, V100, P456, DOI 10.1016/j.jenvrad.2009.03.004; Prohl G, 2006, J ENVIRON RADIOACTIV, V91, P41, DOI 10.1016/j.jenvrad.2006.08.004; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rainbow PS, 2007, ENVIRON INT, V33, P576, DOI 10.1016/j.envint.2006.05.007; Reardon S, 2011, SCIENCE, V332, P292, DOI 10.1126/science.332.6027.292; Rowan DJ, 1995, J APPL ECOL, V32, P739, DOI 10.2307/2404813; ROWAN DJ, 1994, CAN J FISH AQUAT SCI, V51, P2388, DOI 10.1139/f94-240; Smith JT, 2009, J ENVIRON RADIOACTIV, V100, P950, DOI 10.1016/j.jenvrad.2009.07.005; SRIVASTAVA A, 1994, J RADIOAN NUCL CH AR, V182, P63, DOI 10.1007/BF02047967; Sundbom M, 2003, J APPL ECOL, V40, P228, DOI 10.1046/j.1365-2664.2003.00795.x; Topcuoglu S, 2001, CHEMOSPHERE, V44, P691, DOI 10.1016/S0045-6535(00)00290-3; Travnikova IG, 2004, J ENVIRON RADIOACTIV, V77, P63, DOI 10.1016/j.jenvrad.2004.03.003; Vander Zanden MJ, 1996, ECOL MONOGR, V66, P451, DOI 10.2307/2963490; Venables W. N., 2002, STAT COMPLEMENTS MOD; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zhao XG, 2001, MAR ECOL PROG SER, V222, P227, DOI 10.3354/meps222227	31	28	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29295	10.1371/journal.pone.0029295	http://dx.doi.org/10.1371/journal.pone.0029295			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279534	Green Published, Green Submitted, gold			2022-12-27	WOS:000299771900012
J	Tong, ZQ; Balzer, EM; Dallas, MR; Hung, WC; Stebe, KJ; Konstantopoulos, K				Tong, ZiQiu; Balzer, Eric M.; Dallas, Matthew R.; Hung, Wei-Chien; Stebe, Kathleen J.; Konstantopoulos, Konstantinos			Chemotaxis of Cell Populations through Confined Spaces at Single-Cell Resolution	PLOS ONE			English	Article							IN-VITRO; MIGRATION; CYTOSKELETON; INVASION; TUBULIN; DRUGS	Cell migration is crucial for both physiological and pathological processes. Current in vitro cell motility assays suffer from various drawbacks, including insufficient temporal and/or optical resolution, or the failure to include a controlled chemotactic stimulus. Here, we address these limitations with a migration chamber that utilizes a self-sustaining chemotactic gradient to induce locomotion through confined environments that emulate physiological settings. Dynamic real-time analysis of both population-scale and single-cell movement are achieved at high resolution. Interior surfaces can be functionalized through adsorption of extracellular matrix components, and pharmacological agents can be administered to cells directly, or indirectly through the chemotactic reservoir. Direct comparison of multiple cell types can be achieved in a single enclosed system to compare inherent migratory potentials. Our novel microfluidic design is therefore a powerful tool for the study of cellular chemotaxis, and is suitable for a wide range of biological and biomedical applications.	[Tong, ZiQiu; Balzer, Eric M.; Dallas, Matthew R.; Hung, Wei-Chien; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21202 USA; [Tong, ZiQiu; Balzer, Eric M.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Inst NanoBioTechnol, Baltimore, MD USA; [Tong, ZiQiu; Balzer, Eric M.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA; [Dallas, Matthew R.; Hung, Wei-Chien; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Ctr Canc Nanotechnol Excellence, Baltimore, MD USA; [Stebe, Kathleen J.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania	Tong, ZQ (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21202 USA.	konstant@jhu.edu	Tong, Ziqiu/AAR-6182-2020; Konstantopoulos, Konstantinos/A-7045-2011	Tong, Ziqiu/0000-0003-4183-1858; 	National Cancer Institute [T32-CA130840, U54-CA143868, RO1-CA101135]; Kleberg Foundation; National Science Foundation [DGE-0549350]; NATIONAL CANCER INSTITUTE [T32CA130840, R01CA101135, U54CA143868] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kleberg Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute (awards T32-CA130840, U54-CA143868, and RO1-CA101135), Kleberg Foundation, and National Science Foundation (DGE-0549350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar VV, 2008, LAB CHIP, V8, P1507, DOI 10.1039/b803533d; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bhattacharjee N, 2010, INTEGR BIOL-UK, V2, P669, DOI 10.1039/c0ib00038h; Breckenridge MT, 2010, BIOMED MICRODEVICES, V12, P543, DOI 10.1007/s10544-010-9411-8; Campbell K, 2007, LAB CHIP, V7, P264, DOI 10.1039/b610011b; Cavanagh LL, 2008, IMMUNOL CELL BIOL, V86, P428, DOI 10.1038/icb.2008.25; Chaw KC, 2006, MICROVASC RES, V72, P153, DOI 10.1016/j.mvr.2006.06.003; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Decaestecker C, 2007, MED RES REV, V27, P149, DOI 10.1002/med.20078; Downing KH, 2000, ANNU REV CELL DEV BI, V16, P89, DOI 10.1146/annurev.cellbio.16.1.89; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Ghosh M, 2008, LANGMUIR, V24, P8134, DOI 10.1021/la8006525; Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hay ED, 1993, CURR OPIN CELL BIOL, V5, P1029, DOI 10.1016/0955-0674(93)90088-8; Heneweer M, 2005, TOXICOL SCI, V83, P257, DOI 10.1093/toxsci/kfi025; Irimia D, 2006, ANAL CHEM, V78, P3472, DOI 10.1021/ac0518710; Irimia D, 2009, INTEGR BIOL, V1, P506, DOI 10.1039/b908595e; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Kim S, 2010, INTEGR BIOL-UK, V2, P584, DOI 10.1039/c0ib00055h; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; Mosadegh B, 2008, BIOTECHNOL BIOENG, V100, P1205, DOI 10.1002/bit.21851; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Rolli CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008726; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Shaw Leslie M., 2004, V294, P97; Sherwood DR, 2006, TRENDS CELL BIOL, V16, P250, DOI 10.1016/j.tcb.2006.03.004; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; Skoge M, INTEGR BIOL CAMB, V2, P659; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Torisawa YS, 2009, INTEGR BIOL-UK, V1, P649, DOI 10.1039/b915965g; van der Meer AD, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/823148; Wang JS, 2005, CELL MOTIL CYTOSKEL, V62, P35, DOI 10.1002/cm.20083; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wolf K, 2011, TRENDS CELL BIOL, V21, P736, DOI 10.1016/j.tcb.2011.09.006; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; ZICHA D, 1991, J CELL SCI, V99, P769	44	121	122	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29211	10.1371/journal.pone.0029211	http://dx.doi.org/10.1371/journal.pone.0029211			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279529	gold, Green Published, Green Submitted			2022-12-27	WOS:000299771900007
J	Yu, HP; Liu, HL; Wang, LE; Wei, QY				Yu, Hongping; Liu, Hongliang; Wang, Li-E; Wei, Qingyi			A Functional NQO1 609C > T Polymorphism and Risk of Gastrointestinal Cancers: A Meta-Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OXIDOREDUCTASE 1 NQO1; SQUAMOUS-CELL CARCINOMA; DT-DIAPHORASE ACTIVITY; NAD(P)H-QUINONE OXIDOREDUCTASE; COLORECTAL-CANCER; C609T POLYMORPHISM; PROTEASOMAL DEGRADATION; GENE POLYMORPHISMS; HEPATOCELLULAR-CARCINOMA	Background: The functional polymorphism (rs1800566) in the NQO1 gene, a 609C>T substitution, leading to proline-toserine amino-acid and enzyme activity changes, has been implicated in cancer risk, but individually published studies showed inconclusive results. Methodology/Principal Findings: We performed a meta-analysis of 20 publications with a total of 5,491 cases and 5,917 controls, mainly on gastrointestinal (GI) cancers. We summarized the data on the association between the NQO1 609C>T polymorphism and risk of GI cancers and performed subgroup analyses by ethnicity, cancer site, and study quality. We found that the variant CT heterozygous and CT/TT genotypes of the NQO1 609 C>T polymorphism were associated with a modestly increased risk of GI cancers (CT vs. CC; OR = 1.10, 95% CI = 1.01 - 1.19, P-heterogeneity = 0.27, I-2 = 0.15; CT/TT vs. CC: OR = 1.11, 95% CI = 1.02-1.20, P-heterogeneity = 0.14; I-2 = 0.27). Following further stratified analyses, the increased risk was only observed in subgroups of Caucasians, colorectal cancer in Caucasians, and high quality studies. Conclusions: This meta-analysis suggests that the NQO1 609T allele is a low-penetrance risk factor for GI cancers. Although the effect on GI cancers may be modified by ethnicity and cancer sites, small sample seizes of the subgroup analyses suggest that further larger studies are needed, especially for non-colorectal GI cancers in Caucasians and GI cancers in Asians.	[Yu, Hongping; Liu, Hongliang; Wang, Li-E; Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Yu, HP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	hyu1@mdanderson.org; qwei@mdanderson.org	Liu, Hongliang/P-3444-2014	Liu, Hongliang/0000-0001-7639-0904	National Institutes of Health [R01ES011740, R01CA131274]; NATIONAL CANCER INSTITUTE [R01CA131274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health grants R01ES011740 and R01CA131274 (Qingyi Wei). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akkiz H, 2010, ASIAN PAC J CANCER P, V11, P1051; Asher G, 2002, P NATL ACAD SCI USA, V99, P3099, DOI 10.1073/pnas.052706799; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Awadallah NS, 2008, APPL IMMUNOHISTO M M, V16, P24, DOI 10.1097/pai.0b013e31802e91d0; Baglietto L, 2006, J CLIN EPIDEMIOL, V59, P114, DOI 10.1016/j.jclinepi.2005.07.018; Bartsch H, 1998, EUR J CANCER PREV, V7, P215, DOI 10.1097/00008469-199806000-00006; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Begleiter A, 2006, CANCER EPIDEM BIOMAR, V15, P2422, DOI 10.1158/1055-9965.EPI-06-0661; BELINSKY M, 1993, CANCER METAST REV, V12, P103, DOI 10.1007/BF00689804; Bouchard MJ, 2011, CANCER LETT, V305, P123, DOI 10.1016/j.canlet.2010.11.014; Chao C, 2006, CANCER EPIDEM BIOMAR, V15, P979, DOI 10.1158/1055-9965.EPI-05-0899; Chiu MM, 2009, HISTOL HISTOPATHOL, V24, P1223, DOI 10.14670/HH-24.1223; Compare D, 2010, EUR REV MED PHARMACO, V14, P302; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Luzio R, 2010, EUR REV MED PHARMACO, V14, P277; di Martino E, 2007, GENET MED, V9, P341, DOI 10.1097/GIM.0b013e3180654ccd; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Dragani TA, 2010, J HEPATOL, V52, P252, DOI 10.1016/j.jhep.2009.11.015; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Goto Yasuyuki, 2005, Gastric Cancer, V8, P12, DOI 10.1007/s10120-004-0308-1; Grady WM, 2003, GASTROENTEROLOGY, V124, P1574, DOI 10.1016/S0016-5085(03)00376-7; Haerian MS, 2011, J GASTROEN HEPATOL, V26, P1475, DOI 10.1111/j.1440-1746.2011.06831.x; Hamajima Nobuyuki, 2002, Int J Clin Oncol, V7, P103; Hamajima N, 2006, CANCER SCI, V97, P1129, DOI 10.1111/j.1349-7006.2006.00290.x; Harth V, 2000, ARCH TOXICOL, V73, P528, DOI 10.1007/s002040050004; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hlavata I, 2010, ONCOL REP, V24, P1347, DOI 10.3892/or_0000992; Hou LF, 2005, CARCINOGENESIS, V26, P1122, DOI 10.1093/carcin/bgi054; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; Kelsey KT, 1997, BRIT J CANCER, V76, P852, DOI 10.1038/bjc.1997.474; Key TJ, 2011, BRIT J CANCER, V104, P6, DOI 10.1038/sj.bjc.6606032; KUEHL BL, 1995, BRIT J CANCER, V72, P555, DOI 10.1038/bjc.1995.373; Lafuente MJ, 2000, CARCINOGENESIS, V21, P1813, DOI 10.1093/carcin/21.10.1813; Landi S, 2005, PHARMACOGENET GENOM, V15, P535, DOI 10.1097/01.fpc.0000165904.48994.3d; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Le Marchand L, 2009, SURG ONCOL CLIN N AM, V18, P663, DOI 10.1016/j.soc.2009.07.004; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Long DJ, 2000, CANCER RES, V60, P5913; Long DJ, 2001, JNCI-J NATL CANCER I, V93, P1166, DOI 10.1093/jnci/93.15.1166; Lyn-Cook BD, 2006, CELL BIOL TOXICOL, V22, P73, DOI 10.1007/s10565-006-0156-3; Malik MA, 2011, DNA CELL BIOL, V30, P297, DOI 10.1089/dna.2010.1115; MALKINSON AM, 1992, CANCER RES, V52, P4752; Marin A, 1997, BRIT J CANCER, V76, P923, DOI 10.1038/bjc.1997.485; Marjani HA, 2010, GENET MOL RES, V9, P239, DOI 10.4238/vol9-1gmr693; Menon R, 2011, GASTROENTEROL CLIN N, V40, P427, DOI 10.1016/j.gtc.2011.03.002; Milosavljevic T, 2010, EUR REV MED PHARMACO, V14, P259; Misra V, 1998, BRIT J CANCER, V77, P1236, DOI 10.1038/bjc.1998.208; Mitrou P, 2002, IARC Sci Publ, V156, P495; Mitrou PN, 2007, CARCINOGENESIS, V28, P875, DOI 10.1093/carcin/bgl194; Mohelnikova-Duchonova B, 2011, PANCREAS, V40, P72, DOI 10.1097/MPA.0b013e3181f74ad7; Moran JL, 1999, P NATL ACAD SCI USA, V96, P8150, DOI 10.1073/pnas.96.14.8150; Nioi P, 2004, MUTAT RES-FUND MOL M, V555, P149, DOI 10.1016/j.mrfmmm.2004.05.023; Nisa H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-274; Piazuelo MB, 2010, INFECT DIS CLIN N AM, V24, P853, DOI 10.1016/j.idc.2010.07.010; Randi G, 2010, NUTR REV, V68, P389, DOI 10.1111/j.1753-4887.2010.00299.x; Rauth AM, 1997, ONCOL RES, V9, P339; Ross D, 2004, DRUG METAB REV, V36, P639, DOI 10.1081/DMR-200033465; Ross D, 2004, METHOD ENZYMOL, V382, P115; Ross D, 2000, CHEM-BIOL INTERACT, V129, P77, DOI 10.1016/S0009-2797(00)00199-X; ROSVOLD EA, 1995, PHARMACOGENETICS, V5, P199, DOI 10.1097/00008571-199508000-00003; Sachse C, 2002, CARCINOGENESIS, V23, P1839, DOI 10.1093/carcin/23.11.1839; Sameer AS, 2010, ASIAN PAC J CANCER P, V11, P209; Sarbia M, 2003, INT J CANCER, V107, P381, DOI 10.1002/ijc.11430; SCHLAGER JJ, 1990, INT J CANCER, V45, P403, DOI 10.1002/ijc.2910450304; Siegel D, 1999, PHARMACOGENETICS, V9, P113, DOI 10.1097/00008571-199902000-00015; Siegel D, 2001, MOL PHARMACOL, V59, P263, DOI 10.1124/mol.59.2.263; Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238; Sieger D, 2000, FREE RADICAL BIO MED, V29, P246, DOI 10.1016/S0891-5849(00)00310-5; Takagi S, 2002, ANTICANCER RES, V22, P2749; Thakkinstian A, 2004, J BONE MINER RES, V19, P419, DOI 10.1359/JBMR.0301265; Thakkinstian A, 2011, AM J EPIDEMIOL, V173, P1365, DOI 10.1093/aje/kwr025; Tijhuis MJ, 2008, NUTR CANCER, V60, P204, DOI 10.1080/01635580701684849; Tijhuis MJ, 2008, INT J CANCER, V122, P1842, DOI 10.1002/ijc.23246; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Traver RD, 1997, BRIT J CANCER, V75, P69, DOI 10.1038/bjc.1997.11; TRAVER RD, 1992, CANCER RES, V52, P797; Tsvetkov P, 2010, CELL DEATH DIFFER, V17, P103, DOI 10.1038/cdd.2009.67; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; van der Logt EMJ, 2006, MUTAT RES-FUND MOL M, V593, P39, DOI 10.1016/j.mrfmmm.2005.06.018; von Rahden BHA, 2005, INT J CANCER, V113, P506, DOI 10.1002/ijc.20576; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Yaghoobi M, 2010, BRIT J CANCER, V102, P237, DOI 10.1038/sj.bjc.6605380; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638; Zhang JH, 2003, WORLD J GASTROENTERO, V9, P1390, DOI 10.3748/wjg.v9.i7.1390; Zhang JH, 2003, CARCINOGENESIS, V24, P905, DOI 10.1093/carcin/bgg019	89	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30566	10.1371/journal.pone.0030566	http://dx.doi.org/10.1371/journal.pone.0030566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272361	Green Submitted, Green Published, gold			2022-12-27	WOS:000301454400139
J	Both, J; Wu, T; Bras, J; Schaap, GR; Baas, F; Hulsebos, TJM				Both, Joeri; Wu, Thijs; Bras, Johannes; Schaap, Gerard R.; Baas, Frank; Hulsebos, Theo J. M.			Identification of Novel Candidate Oncogenes in Chromosome Region 17p11.2-p12 in Human Osteosarcoma	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; EXPRESSION ANALYSIS; GENE AMPLIFICATION; COPY NUMBER; ARRAY CGH; CANCER; PMP22; AMPLICON; PATHWAY; OVEREXPRESSION	Osteosarcoma is the most common primary malignancy of bone. The tumours are characterized by high genomic instability, including the occurrence of multiple regions of amplifications and deletions. Chromosome region 17p11.2-p12 is amplified in about 25% of cases. In previous studies, COPS3 and PMP22 have been identified as candidate oncogenes in this region. Considering the complexity and variation of the amplification profiles for this segment, the involvement of additional causative oncogenes is to be expected. The aim of the present investigation is to identify novel candidate oncogenes in 17p11.2-p12. We selected 26 of in total 85 osteosarcoma samples (31%) with amplification events in 17p11.2-p12, using quantitative PCR for 8 marker genes. These were subjected to high-resolution SNP array analysis and subsequent GISTIC analysis to identify the most significantly amplified regions. Two major amplification peaks were found in the 17p11.2-p12 region. Overexpression as a consequence of gene amplification is a major mechanism for oncogene activation in tumours. Therefore, to identify the causative oncogenes, we next determined expression levels of all genes within the two segments using expression array data that could be generated for 20 of the selected samples. We identified 11 genes that were overexpressed through amplification in at least 50% of cases. Nine of these, c17orf39, RICH2, c17orf45, TOP3A, COPS3, SHMT1, PRPSAP2, PMP22, and RASD1, demonstrated a significant association between copy number and expression level. We conclude that these genes, including COPS3 and PMP22, are candidate oncogenes in 17p11.2-p12 of importance in osteosarcoma tumourigenesis.	[Both, Joeri; Wu, Thijs; Baas, Frank; Hulsebos, Theo J. M.] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [Bras, Johannes] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Schaap, Gerard R.] Univ Amsterdam, Acad Med Ctr, Dept Orthoped Surg, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Both, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.j.hulsebos@amc.uva.nl	Baas, Frank/F-9574-2010	Baas, Frank/0000-0003-3912-5428	Dutch Cancer Society [UVA 2006-3525]; Department of Orthopedic Surgery, Academic Medical Center, Amsterdam	Dutch Cancer Society(KWF Kankerbestrijding); Department of Orthopedic Surgery, Academic Medical Center, Amsterdam	This work was supported by the Dutch Cancer Society, grant no. UVA 2006-3525. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. J. Bramer (Department of Orthopedic Surgery, Academic Medical Center, Amsterdam) for osteosarcoma samples and support.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Atiye J, 2005, GENE CHROMOSOME CANC, V42, P158, DOI 10.1002/gcc.20120; Attiyeh EF, 2009, GENOME RES, V19, P276, DOI 10.1101/gr.075671.107; Bacci G, 2003, CANCER, V97, P3068, DOI 10.1002/cncr.11456; Benayahu D, 2002, J CELL BIOCHEM, V84, P108, DOI 10.1002/jcb.1270; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Brase JC, 2010, CLIN CANCER RES, V16, P2391, DOI 10.1158/1078-0432.CCR-09-2471; Collin SM, 2009, CANCER EPIDEM BIOMAR, V18, P2528, DOI 10.1158/1055-9965.EPI-09-0223; Evtimova V, 2003, TUMOR BIOL, V24, P189, DOI 10.1159/000074429; Fabris S, 2007, GENE CHROMOSOME CANC, V46, P1109, DOI 10.1002/gcc.20494; FORUS A, 1995, GENE CHROMOSOME CANC, V14, P15, DOI 10.1002/gcc.2870140104; Furuta B, 2002, J NEUROCHEM, V82, P1018, DOI 10.1046/j.1471-4159.2002.01021.x; Gamberi G, 1998, ONCOLOGY-BASEL, V55, P556, DOI 10.1159/000011912; Gordon N, 2010, J AEROSOL MED PULM D, V23, P189, DOI 10.1089/jamp.2009.0812; Guerin E, 2003, LEUKEMIA, V17, P532, DOI 10.1038/sj.leu.2402774; Hawkins DS, 2003, CANCER-AM CANCER SOC, V98, P2447, DOI 10.1002/cncr.11799; Henriksen J, 2003, ONCOGENE, V22, P5358, DOI 10.1038/sj.onc.1206671; Huhne K, 1999, J NEUROSCI RES, V58, P624; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Jarvinen TAH, 2003, CYTOPATHOLOGY, V14, P309, DOI 10.1046/j.0956-5507.2003.00105.x; Kanta SY, 2006, HUM PATHOL, V37, P1333, DOI 10.1016/j.humpath.2006.05.008; Kaur S, 2007, CYTOGENET GENOME RES, V116, P153, DOI 10.1159/000098180; Kelemen LE, 2008, CANCER RES, V68, P2498, DOI 10.1158/0008-5472.CAN-07-5165; Kobayashi K, 2004, ONCOGENE, V23, P3089, DOI 10.1038/sj.onc.1207433; Lau CC, 2004, GENE CHROMOSOME CANC, V39, P11, DOI 10.1002/gcc.10291; Li JS, 2005, J HISTOCHEM CYTOCHEM, V53, P885, DOI 10.1369/jhc.4A6546.2005; Lietman Steven A, 2010, Cleve Clin J Med, V77 Suppl 1, pS8, DOI 10.3949/ccjm.77.s1.02; Lightfoot TJ, 2010, BLOOD, V115, P3923, DOI 10.1182/blood-2009-10-249722; Lockwood WW, 2011, J MOL DIAGN, V13, P289, DOI 10.1016/j.jmoldx.2010.11.020; Lu XY, 2008, MOL CANCER RES, V6, P937, DOI 10.1158/1541-7786.MCR-07-2115; Man TK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-45; MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924; Naef R, 1998, MICROSC RES TECHNIQ, V41, P359, DOI 10.1002/(SICI)1097-0029(19980601)41:5<359::AID-JEMT3>3.0.CO;2-L; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Pimkin M, 2009, J BIOL CHEM, V284, P7960, DOI 10.1074/jbc.M808541200; Rao RG, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-56; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; Rui LX, 2010, CANCER CELL, V18, P590, DOI 10.1016/j.ccr.2010.11.013; Sadikovic B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-202; Sandberg AA, 2003, CANCER GENET CYTOGEN, V145, P1, DOI 10.1016/S0165-4608(03)00105-5; Schwab M, 2004, CANCER LETT, V204, P179, DOI 10.1016/S0304-3835(03)00454-3; Selvarajah S, 2008, CYTOGENET GENOME RES, V122, P5, DOI 10.1159/000151310; Simon R, 2003, INT J CANCER, V107, P764, DOI 10.1002/ijc.11477; Squire JA, 2003, GENE CHROMOSOME CANC, V38, P215, DOI 10.1002/gcc.10273; Vaidyanathan G, 2004, ONCOGENE, V23, P5858, DOI 10.1038/sj.onc.1207774; van Dartel M, 2004, CANCER GENET CYTOGEN, V152, P113, DOI 10.1016/j.cancergencyto.2003.11.003; van Dartel M, 2004, CANCER GENET CYTOGEN, V152, P8, DOI 10.1016/j.cancergencyto.2003.09.024; van Dartel M, 2002, CANCER GENET CYTOGEN, V139, P91, DOI 10.1016/S0165-4608(02)00627-1; Vijayakrishnan J, 2010, HAEMATOL-HEMATOL J, V95, P1405, DOI 10.3324/haematol.2010.022095; Yan T, 2011, CANCER GENE THER, V18, P450, DOI 10.1038/cgt.2011.16; Yan TQ, 2007, CANCER, V109, P1870, DOI 10.1002/cncr.22595; Yang ZQ, 2006, CANCER RES, V66, P11632, DOI 10.1158/0008-5472.CAN-06-2946; Yasuda T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-26	54	28	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30907	10.1371/journal.pone.0030907	http://dx.doi.org/10.1371/journal.pone.0030907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292074	Green Submitted, gold, Green Published			2022-12-27	WOS:000301703800036
J	Kouadir, M; Yang, LF; Tan, RR; Shi, FS; Lu, Y; Zhang, SM; Yin, XM; Zhou, XM; Zhao, DM				Kouadir, Mohammed; Yang, Lifeng; Tan, Rongrong; Shi, Fushan; Lu, Yun; Zhang, Siming; Yin, Xiaomin; Zhou, Xiangmei; Zhao, Deming			CD36 Participates in PrP106-126-Induced Activation of Microglia	PLOS ONE			English	Article							NF-KAPPA-B; PRION PROTEIN-FRAGMENT; BETA-AMYLOID FIBRILS; SCAVENGER RECEPTOR; ALZHEIMERS-DISEASE; INFLAMMATION; PATHOGENESIS; PEPTIDE; MICE; QUANTIFICATION	Microglial activation is a characteristic feature of the pathogenesis of prion diseases. The molecular mechanisms that underlie prion-induced microglial activation are not very well understood. In the present study, we investigated the role of the class B scavenger receptor CD36 in microglial activation induced by neurotoxic prion protein (PrP) fragment 106-126 (PrP106-126). We first examined the time course of CD36 mRNA expression upon exposure to PrP106-126 in BV2 microglia. We then analyzed different parameters of microglial activation in PrP106-126-treated cells in the presence or not of anti-CD36 monoclonal antibody (mAb). The cells were first incubated for 1 h with CD36 monoclonal antibody to block the CD36 receptor, and were then treated with neurotoxic prion peptides PrP106-126. The results showed that PrP106-126 treatment led to a rapid yet transitory increase in the mRNA expression of CD36, upregulated mRNA and protein levels of proinflammatory cytokines (IL-1 beta, IL-6 and TNF-alpha), increased iNOS expression and nitric oxide (NO) production, stimulated the activation of NF-kappa B and caspase-1, and elevated Fyn activity. The blockade of CD36 had no effect on PrP106-126-stimulated NF-kappa B activation and TNF-alpha protein release, abrogated the PrP106-126-induced iNOS stimulation, downregulated IL-1 beta and IL-6 expression at both mRNA and protein levels as well as TNF-alpha mRNA expression, decreased NO production and Fyn phosphorylation, reduced caspase-1 cleavage induced by moderate PrP106-126-treatment, but had no effect on caspase-1 activation after treatment with a high concentration of PrP106-126. Together, these results suggest that CD36 is involved in PrP106-126-induced microglial activation and that the participation of CD36 in the interaction between PrP106-126 and microglia may be mediated by Src tyrosine kinases. Our findings provide new insights into the mechanisms underlying the activation of microglia by neurotoxic prion peptides and open perspectives for new therapeutic strategies for prion diseases by modulation of CD36 signaling.	[Kouadir, Mohammed; Yang, Lifeng; Tan, Rongrong; Shi, Fushan; Lu, Yun; Zhang, Siming; Yin, Xiaomin; Zhou, Xiangmei; Zhao, Deming] China Agr Univ, Coll Vet Med, Natl Anim Transmissible Spongiform Encephalopathy, State Key Labs Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University	Kouadir, M (corresponding author), China Agr Univ, Coll Vet Med, Natl Anim Transmissible Spongiform Encephalopathy, State Key Labs Agrobiotechnol, Beijing 100094, Peoples R China.	zhaodm@cau.edu.cn			Ministry of Agriculture, China [2009ZX08008-010B, 2009ZX08007-008B]; Natural Science Foundation of China [31001048, 30972164, 30871854]; Beijing Natural Science Foundation [6101002]; University of China [IRT0866]	Ministry of Agriculture, China(Ministry of Agriculture & Rural Affairs); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); University of China	1 Ministry of Agriculture, Key Program, China (Project No. 2009ZX08008-010B and No. 2009ZX08007-008B). 2 Ministry of Agriculture Key Program, China (Project No. 2009ZX08007-008B). 3 The Natural Science Foundation of China (Project No. 31001048, No. 30972164, and No. 30871854). 4 Beijing Natural Science Foundation (Project No. 6101002). 5 The Program for Cheung Kong Scholars and Innovative Research Team in University of China (No. IRT0866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Bacot SM, 2003, J LEUKOCYTE BIOL, V74, P118, DOI 10.1189/jlb.1102521; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Bate C, 2005, J NEUROIMMUNOL, V170, P62, DOI 10.1016/j.jneuroim.2005.08.021; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Cho S, 2005, J NEUROSCI, V25, P2504, DOI 10.1523/JNEUROSCI.0035-05.2005; Ciesielski-Treska J, 2004, GLIA, V46, P101, DOI 10.1002/glia.10363; Combs CK, 1999, J NEUROSCI, V19, P928; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; ElKhoury J, 1996, NATURE, V382, P716; Fabrizi C, 2001, J BIOL CHEM, V276, P25692, DOI 10.1074/jbc.M100133200; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Garcao P, 2006, J NEUROSCI RES, V84, P182, DOI 10.1002/jnr.20870; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Graeber MB, 2010, CHANGING FACE MICROG, V6005, P783; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; HUYGEN IC, 1970, ANAL CHEM, V42, P407; Ironside JW, 1998, J PATHOL, V186, P227, DOI 10.1002/(SICI)1096-9896(1998110)186:3&lt;227::AID-PATH174&gt;3.0.CO;2-3; Janabi M, 2000, ARTERIOSCL THROM VAS, V20, P1953, DOI 10.1161/01.ATV.20.8.1953; Julius C, 2008, J GEN VIROL, V89, P1545, DOI 10.1099/vir.0.83622-0; Kouadir M, 2011, DNA CELL BIOL, V30, P893, DOI 10.1089/dna.2011.1234; Kunz A, 2008, J NEUROSCI, V28, P1649, DOI 10.1523/JNEUROSCI.5205-07.2008; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Li W, 2010, J CLIN INVEST, V120, P3996, DOI 10.1172/JCI42823; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Resh MD, 1998, INT J BIOCHEM CELL B, V30, P1159, DOI 10.1016/S1357-2725(98)00089-2; Rezaie P, 2001, BRAIN RES REV, V35, P55, DOI 10.1016/S0165-0173(01)00042-X; Ricciarelli R, 2004, FREE RADICAL BIO MED, V36, P1018, DOI 10.1016/j.freeradbiomed.2004.01.007; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Vallance P, 2002, NAT REV DRUG DISCOV, V1, P939, DOI 10.1038/nrd960; Veerhuis R, 2002, BRAIN RES, V925, P195, DOI 10.1016/S0006-8993(01)03273-5; Wechselberger C, 2002, EXP CELL RES, V281, P1, DOI 10.1006/excr.2002.5655; WILLIAMS AE, 1994, BRAIN RES, V654, P200, DOI 10.1016/0006-8993(94)90480-4; YAO JB, 1992, BRAIN RES, V591, P88, DOI 10.1016/0006-8993(92)90981-E	47	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30756	10.1371/journal.pone.0030756	http://dx.doi.org/10.1371/journal.pone.0030756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292032	Green Submitted, Green Published, gold			2022-12-27	WOS:000301703800028
J	Termote, C; Meyi, MB; Djailo, BD; Huybregts, L; Lachat, C; Kolsteren, P; Van Damme, P				Termote, Celine; Meyi, Marcel Bwama; Djailo, Benoit Dhed'a; Huybregts, Lieven; Lachat, Carl; Kolsteren, Patrick; Van Damme, Patrick			A Biodiverse Rich Environment Does Not Contribute to a Better Diet: A Case Study from DR Congo	PLOS ONE			English	Article							NUTRITIONAL-VALUE; FOOD COMPOSITION; WILD VEGETABLES; WOMEN; SECURITY; CONSUMPTION; TRECULIA; EXAMPLE; HEALTH; ENERGY	The potential of biodiversity to increase and sustain nutrition security is increasingly recognized by the international research community. To date however, dietary assessment studies that have assessed how biodiversity actually contributes to human diets are virtually absent. This study measured the contribution of wild edible plants (WEP) to the dietary quality in the high biodiverse context of DR Congo. The habitual dietary intake was estimated from 2 multiple-pass 24 h dietary recalls for 363 urban and 129 rural women. All WEP were collected during previous ethnobotanical investigations and identified and deposited in the National Botanical Garden of Belgium (BR). Results showed that in a high biodiverse region with precarious food security, WEP are insufficiently consumed to increase nutrition security or dietary adequacy. The highest contribution came from Dacryodes edulis in the village sample contributing 4.8% of total energy intake. Considering the nutrient composition of the many WEP available in the region and known by the indigenous populations, the potential to increase nutrition security is vast. Additional research regarding the dietary contribution of agricultural biodiversity and the nutrient composition of WEP would allow to integrate them into appropriate dietary guidelines for the region and pave the way to domesticate the most interesting WEP.	[Termote, Celine; Van Damme, Patrick] Univ Ghent, Fac Biosci Engn, Lab Trop & Subtrop Agron & Ethnobot, B-9000 Ghent, Belgium; [Meyi, Marcel Bwama] Inst Fac Sci Agron Yangambi, Lab Dev Econ & Environm, Kisangani, DEM REP CONGO; [Djailo, Benoit Dhed'a] Univ Kisangani, Fac Sci, Lab Genet Plant Improvement & Biotechnol, Kisangani, DEM REP CONGO; [Huybregts, Lieven; Lachat, Carl; Kolsteren, Patrick] Univ Ghent, Dept Food Safety & Food Qual, Fac Biosci Engn, B-9000 Ghent, Belgium; [Lachat, Carl; Kolsteren, Patrick] Inst Trop Med, Nutr & Child Hlth Unit, B-2000 Antwerp, Belgium	Ghent University; Ghent University; Institute of Tropical Medicine (ITM)	Termote, C (corresponding author), Univ Ghent, Fac Biosci Engn, Lab Trop & Subtrop Agron & Ethnobot, B-9000 Ghent, Belgium.	celine.termote@ugent.be	Huybregts, Lieven/B-9578-2009; Van Damme, Patrick/H-6693-2018; lachat, carl/AAH-9764-2020; , Patrick/AAI-8779-2020	Huybregts, Lieven/0000-0002-3068-2853; Van Damme, Patrick/0000-0002-2548-633X; lachat, carl/0000-0002-1389-8855; Termote, Celine/0000-0003-3217-0226	VlIR-UOS (Flemish Interuniversity Council - University Cooperation) [ZEIN2004_3000, MPRDC2007_25]; Belgian 'Leopold III fund for Nature Exploration and Conservation'; Belgian 'Leopold III fund for Nature Exploration and Conservation' (http://www.naturalsciences.be/LIII/NL) and 'Stichting Roeping'	VlIR-UOS (Flemish Interuniversity Council - University Cooperation); Belgian 'Leopold III fund for Nature Exploration and Conservation'; Belgian 'Leopold III fund for Nature Exploration and Conservation' (http://www.naturalsciences.be/LIII/NL) and 'Stichting Roeping'	Financial support for this study was provided by VlIR-UOS (Flemish Interuniversity Council - University Cooperation; www.vliruos.be) projects ZEIN2004_3000; MPRDC2007_25. C.T. obtained a grant from the Belgian 'Leopold III fund for Nature Exploration and Conservation' (http://www.naturalsciences.be/LIII/NL) and 'Stichting Roeping' (http://www.vocatio.be/?lang=nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Baingana RK, 2004, J FOOD COMPOS ANAL, V17, P501, DOI 10.1016/j.jfca.2004.03.012; Bharucha Z, 2010, PHILOS T R SOC B, V365, P2913, DOI 10.1098/rstb.2010.0123; Bijttebier J, 1992, C INT AGR NOUV ZAIRC; Burlingame B, 2009, J FOOD COMPOS ANAL, V22, P361, DOI 10.1016/j.jfca.2009.05.003; CFSVA, 2008, AN GLOB SEC AL VULN; Charlier S, 2011, GRAP3A WHAT AGR POLI; Counsell S, 2006, FOREST GOVERNANCE DE; CUNNINGHAM AB, 1988, ECON BOT, V42, P301, DOI 10.1007/BF02860158; de Merode E, 2004, BIOL CONSERV, V118, P573, DOI 10.1016/j.biocon.2003.10.005; Degroote VA, 1965, TABLES COMPOSITION A; DHS-RDC, 2008, DEM HLTH SURV DEM RE; DIFE, 2018, MULT SOURC METH MSM; Dovie DBK, 2007, J ENVIRON MANAGE, V84, P146, DOI 10.1016/j.jenvman.2006.05.017; EDET EE, 1985, FOOD CHEM, V17, P41, DOI 10.1016/0308-8146(85)90091-3; Enujiugha VN, 2003, INT J FOOD SCI TECH, V38, P525, DOI 10.1046/j.1365-2621.2003.00698.x; Eyo ES, 1983, NIG J NUTR SCI, V4, P57; FAO World Health Organization, 2004, VIT MIN REQ HUM NUTR, V2nd ed; Food and Agriculture Organization/World Health Organization/United Nations University, 2001, HUM EN REQ; Gibson R.S., 1999, INTERACTIVE 24 HOUR; Grivetti LE, 2000, NUTR RES REV, V13, P31, DOI 10.1079/095442200108728990; Haubrock J, 2011, J NUTR, V141, P914, DOI 10.3945/jn.109.120394; Huybregts L, 2008, PUBLIC HEALTH NUTR, V11, P581, DOI 10.1017/S1368980007000870; Isong EU, 1999, FOOD CHEM, V64, P489, DOI 10.1016/S0308-8146(98)00139-3; Johns T, 2006, P NUTR SOC, V65, P182, DOI 10.1079/PNS2006494; Jonnalagadda SS, 2000, J AM DIET ASSOC, V100, P303, DOI 10.1016/S0002-8223(00)00095-X; Kengue J, 2002, SAFOU DACRYODES EDUL; Kennedy G, 2010, J NUTR, V140, p2070S, DOI 10.3945/jn.110.123612; Kuhnlein H. V., 2009, INDIGENOUS PEOPLES F; Lartey A, 2008, P NUTR SOC, V67, P105, DOI 10.1017/S0029665108006083; LAWAL RO, 1986, FOOD CHEM, V19, P245, DOI 10.1016/0308-8146(86)90048-8; Leonti M, 2006, ECON BOT, V60, P130, DOI 10.1663/0013-0001(2006)60[130:WGFPIT]2.0.CO;2; Leung W.-T. W., 1968, FOOD COMPOSITION TAB; Lukmanji Z., 2008, TANZANIA FOOD COMPOS; Lutaladio N, 2010, J FOOD COMPOS ANAL, V23, P481, DOI 10.1016/j.jfca.2010.08.001; Lykke AM, 2002, ECOL FOOD NUTR, V41, P119, DOI 10.1080/03670240214492; Nyambose J, 2002, J NUTR, V132, P1313, DOI 10.1093/jn/132.6.1313; Ogle BM, 2001, ECOL FOOD NUTR, V40, P159, DOI 10.1080/03670244.2001.9991646; Ogle BM, 2001, ASIA PAC J CLIN NUTR, V10, P21, DOI 10.1046/j.1440-6047.2001.00206.x; Penafiel D, 2011, ECOHEALTH, V8, P381, DOI 10.1007/s10393-011-0700-3; Rossi L, 2006, PUBLIC HEALTH NUTR, V9, P551, DOI 10.1079/PHN2005928; Shackleton C, 2004, S AFR J SCI, V100, P658; Termote C, 2011, GENET RESOUR CROP EV, V58, P585, DOI 10.1007/s10722-010-9602-4; Termote C, 2010, ECOL FOOD NUTR, V49, P173, DOI 10.1080/03670241003766030; Toledo A, 2006, J FOOD COMPOS ANAL, V19, P477, DOI 10.1016/j.jfca.2006.05.001; Torheim LE, 2010, J NUTR, V140, p2051S, DOI 10.3945/jn.110.123463; [UNDP UNOPS], 1998, MON PROV OR PROGR NA; USDA, 2007, TABL NUTR RET FACT R; Uusiku NP, 2010, J FOOD COMPOS ANAL, V23, P500; Van Damme P., 2008, AFRIKA FOCUS, V21, P45, DOI [10.1163/2031356X-02101005, DOI 10.1163/2031356X-02101005]; Venter CS, 2000, J HUM NUTR DIET, V13, P205, DOI [10.1046/j.1365-277x.2000.00228.x, 10.1046/j.1365-277X.2000.00228.x]; Voster HJ, 2007, AFRICAN J FOOD AGR N, V7; Weinberger K, 2006, ECOL FOOD NUTR, V45, P87, DOI 10.1080/03670240500530626; White F., 1983, VEGETATION AFRICA DE; Willet W, 1998, NUTR EPIDEMIOLOGY	55	53	53	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30533	10.1371/journal.pone.0030533	http://dx.doi.org/10.1371/journal.pone.0030533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291981	Green Published, gold, Green Submitted			2022-12-27	WOS:000301639600029
J	Heaton, PR; Santos, A; Rosas-Acosta, G; Wilson, VG				Heaton, Phillip R.; Santos, Andres; Rosas-Acosta, German; Wilson, Van G.			Analysis of Global Sumoylation Changes Occurring during Keratinocyte Differentiation	PLOS ONE			English	Article							PROTEIN SUMOYLATION; SUMO; UBIQUITIN; ASSOCIATION; FAMILY	Sumoylation is a highly dynamic process that plays a role in a multitude of processes ranging from cell cycle progression to mRNA processing and cancer. A previous study from our lab demonstrated that SUMO plays an important role in keratinocyte differentiation. Here we present a new method of tracking the sumoylation state of proteins by creating a stably transfected HaCaT keratinocyte cell line expressing an inducible SNAP-SUMO3 protein. The SNAP-tag allows covalent fluorescent labeling that is denaturation resistant. When combined with two-dimensional gel electrophoresis, the SNAP-tag technology provides direct visualization of sumoylated targets and can be used to follow temporal changes in the global cohort of sumoylated proteins during dynamic processes such as differentiation. HaCaT keratinocyte cells expressing SNAP-SUMO3 displayed normal morphological and biochemical features that are consistent with typical keratinocyte differentiation. SNAP-SUMO3 also localized normally in these cells with a predominantly nuclear signal and some minor cytoplasmic staining, consistent with previous reports for untagged SUMO2/3. During keratinocyte differentiation the total number of proteins modified by SNAP-SUMO3 was highest in basal cells, decreased abruptly after induction of differentiation, and slowly rebounded beginning between 48 and 72 hours as differentiation progressed. However, within this overall trend the pattern of change for individual sumoylated proteins was highly variable with both increases and decreases in amount over time. From these results we conclude that sumoylation of proteins during keratinocyte differentiation is a complex process which likely reflects and contributes to the biochemical changes that drive differentiation.	[Heaton, Phillip R.; Santos, Andres; Rosas-Acosta, German; Wilson, Van G.] Texas A&M Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, Coll Med, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Heaton, PR (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	wilson@medicine.tamhsc.edu	, Van G Wilson/B-1868-2009		National Institutes of Health (NIH) [CA089298, 5G12RR008124]; T32 Life Sciences Training fellowship; NATIONAL CANCER INSTITUTE [R01CA089298] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 Life Sciences Training fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from the National Institutes of Health (NIH) (CA089298) to VGW and a T32 Life Sciences Training fellowship to PRH. The confocal microscopy conducted at the Border Biomedical Research Center (BBRC) was supported by grant 5G12RR008124 from NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Binda O, 2006, MOL CELL BIOL, V26, P1917, DOI 10.1128/MCB.26.5.1917-1931.2006; Blomster HA, 2009, MOL CELL PROTEOMICS, V8, P1382, DOI 10.1074/mcp.M800551-MCP200; Campos C, 2011, DEV DYNAM, V240, P820, DOI 10.1002/dvdy.22574; Chung TL, 2004, J BIOL CHEM, V279, P39653, DOI 10.1074/jbc.M405637200; Deyrieux AF, 2007, J CELL SCI, V120, P125, DOI 10.1242/jcs.03317; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Heaton PR, 2011, VIRUS RES, V158, P199, DOI 10.1016/j.virusres.2011.04.001; Kamitani T, 1998, J BIOL CHEM, V273, P11349, DOI 10.1074/jbc.273.18.11349; Keppler A, 2009, ACS CHEM BIOL, V4, P127, DOI 10.1021/cb800298u; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Nie MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005905; Vivo M, 2009, CELL CYCLE, V8, P3545, DOI 10.4161/cc.8.21.9954; Yu B, 2009, EXP CELL RES, V315, P3543, DOI 10.1016/j.yexcr.2009.09.011; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	22	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30165	10.1371/journal.pone.0030165	http://dx.doi.org/10.1371/journal.pone.0030165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291911	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600020
J	Orlando, L; Sanchez-Ripoll, Y; Foster, J; Bone, H; Giachino, C; Welham, MJ				Orlando, Luca; Sanchez-Ripoll, Yolanda; Foster, James; Bone, Heather; Giachino, Claudia; Welham, Melanie J.			Differential Coupling of Self-Renewal Signaling Pathways in Murine Induced Pluripotent Stem Cells	PLOS ONE			English	Article							GENE-EXPRESSION; HUMAN ES; MOUSE; ACTIVATION; FIBROBLASTS; GENERATION; MEMORY; TRANSITION; INDUCTION; 3-KINASE	The ability to reprogram somatic cells to induced pluripotent stem cells (iPSCs), exhibiting properties similar to those of embryonic stem cells (ESCs), has attracted much attention, with many studies focused on improving efficiency of derivation and unraveling the mechanisms of reprogramming. Despite this widespread interest, our knowledge of the molecular signaling pathways that are active in iPSCs and that play a role in controlling their fate have not been studied in detail. To address this shortfall, we have characterized the influence of different signals on the behavior of a model mouse iPSC line. We demonstrate significant responses of this iPSC line to the presence of serum, which leads to profoundly enhanced proliferation and, depending on the medium used, a reduction in the capacity of the iPSCs to self-renew. Surprisingly, this iPSC line was less sensitive to withdrawal of LIF compared to ESCs, exemplified by maintenance of expression of a Nanog-GFP reporter and enhanced self-renewal in the absence of LIF. While inhibition of phosphoinositide-3 kinase (PI3K) signaling decreased iPSC self-renewal, inhibition of Gsk-3 promoted it, even in the absence of LIF. High passages of this iPSC line displayed altered characteristics, including genetic instability and a reduced ability to self-renew. However, this second feature could be restored upon inhibition of Gsk-3. Collectively, our data suggest modulation of Gsk-3 activity plays a key role in the control of iPSC fate. We propose that more careful consideration should be given to characterization of the molecular pathways that control the fate of different iPSC lines, since perturbations from those observed in naive pluripotent ESCs could render iPSCs and their derivatives susceptible to aberrant and potentially undesirable behaviors.	[Orlando, Luca; Sanchez-Ripoll, Yolanda; Foster, James; Bone, Heather; Welham, Melanie J.] Univ Bath, Dept Pharm & Pharmacol, Ctr Regenerat Med, Bath BA2 7AY, Avon, England; [Orlando, Luca; Giachino, Claudia] Univ Turin, Dept Clin & Biol Sci, Turin, Italy	University of Bath; University of Turin	Orlando, L (corresponding author), Univ Bath, Dept Pharm & Pharmacol, Ctr Regenerat Med, Bath BA2 7AY, Avon, England.	luca.orlando@unito.it	Orlando, Luca/AAA-1714-2019; Orlando, Luca/E-4902-2012; Giachino, Claudia/M-1894-2019	Orlando, Luca/0000-0002-6182-018X; 	Marie Curie Early Stage Training program [MEST-CT-2005-019822]; Wellcome Trust [087870/Z/08/Z]; Biotechnology and Biological Sciences Research Council [BB/C516528/1] Funding Source: researchfish	Marie Curie Early Stage Training program; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Marie Curie Early Stage Training program MEST-CT-2005-019822 and a VIP Award 087870/Z/08/Z from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boeuf H, 1997, J CELL BIOL, V138, P1207, DOI 10.1083/jcb.138.6.1207; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Bone HK, 2007, J CELL SCI, V120, P1752, DOI 10.1242/jcs.003772; Bone HK, 2009, CHEM BIOL, V16, P15, DOI 10.1016/j.chembiol.2008.11.003; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Di Stefano B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016092; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Jirmanova L, 2002, ONCOGENE, V21, P5515, DOI 10.1038/sj.onc.1205728; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kingham E, 2009, J CELL SCI, V122, P2311, DOI 10.1242/jcs.046557; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Li CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006724; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Paling NRD, 2005, BLOOD, V105, P4290, DOI 10.1182/blood-2004-08-3271; Phanstiel DH, 2011, NAT METHODS, V8, P821, DOI [10.1038/NMETH.1699, 10.1038/nmeth.1699]; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Pritsker M, 2006, P NATL ACAD SCI USA, V103, P6946, DOI 10.1073/pnas.0509861103; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shao LJ, 2009, CELL RES, V19, P296, DOI 10.1038/cr.2009.20; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Storm MP, 2009, STEM CELLS, V27, P764, DOI 10.1002/stem.3; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; WELHAM MJ, 1994, J BIOL CHEM, V269, P21165; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wu GM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001099; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	53	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30234	10.1371/journal.pone.0030234	http://dx.doi.org/10.1371/journal.pone.0030234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291922	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600027
J	Perez-Donoso, JM; Monras, JP; Bravo, D; Aguirre, A; Quest, AF; Osorio-Roman, IO; Aroca, RF; Chasteen, TG; Vasquez, CC				Perez-Donoso, Jose M.; Monras, Juan P.; Bravo, Denisse; Aguirre, Adam; Quest, Andrew F.; Osorio-Roman, Igor O.; Aroca, Ricardo F.; Chasteen, Thomas G.; Vasquez, Claudio C.			Biomimetic, Mild Chemical Synthesis of CdTe-GSH Quantum Dots with Improved Biocompatibility	PLOS ONE			English	Article							SHAPE CONTROL; CELL; NANOPARTICLES; NANOCRYSTALS; GLUTATHIONE; CYTOTOXICITY; TOXICITY; APOPTOSIS; NECROSIS; CADMIUM	Multiple applications of nanotechnology, especially those involving highly fluorescent nanoparticles (NPs) or quantum dots (QDs) have stimulated the research to develop simple, rapid and environmentally friendly protocols for synthesizing NPs exhibiting novel properties and increased biocompatibility. In this study, a simple protocol for the chemical synthesis of glutathione (GSH)-capped CdTe QDs (CdTe-GSH) resembling conditions found in biological systems is described. Using only CdCl2, K2TeO3 and GSH, highly fluorescent QDs were obtained under pH, temperature, buffer and oxygen conditions that allow microorganisms growth. These CdTe-GSH NPs displayed similar size, chemical composition, absorbance and fluorescence spectra and quantum yields as QDs synthesized using more complicated and expensive methods. CdTe QDs were not freely incorporated into eukaryotic cells thus favoring their biocompatibility and potential applications in biomedicine. In addition, NPs entry was facilitated by lipofectamine, resulting in intracellular fluorescence and a slight increase in cell death by necrosis. Toxicity of the as prepared CdTe QDs was lower than that observed with QDs produced by other chemical methods, probably as consequence of decreased levels of Cd+2 and higher amounts of GSH. We present here the simplest, fast and economical method for CdTe QDs synthesis described to date. Also, this biomimetic protocol favors NPs biocompatibility and helps to establish the basis for the development of new, "greener" methods to synthesize cadmium-containing QDs.	[Perez-Donoso, Jose M.; Monras, Juan P.; Vasquez, Claudio C.] Univ Santiago Chile, Lab Microbiol Mol, Dept Biol, Fac Quim & Biol, Santiago, Chile; [Perez-Donoso, Jose M.; Monras, Juan P.] Univ Chile, Lab Bioquim, Fac Ciencias Quim & Farmaceut, Santiago, Chile; [Bravo, Denisse; Aguirre, Adam; Quest, Andrew F.] Univ Chile, Fac Med, Lab Comunicac Celulares, CEMC, Santiago 7, Chile; [Osorio-Roman, Igor O.] Pontificia Univ Catolica Chile, Fac Quim, Dept Quim Inorgan, Santiago, Chile; [Aroca, Ricardo F.] Univ Windsor, Fac Sci, Mat & Surface Sci Grp, Windsor, ON N9B 3P4, Canada; [Chasteen, Thomas G.] Sam Houston State Univ, Dept Chem, Huntsville, TX 77340 USA	Universidad de Santiago de Chile; Universidad de Chile; Universidad de Chile; Pontificia Universidad Catolica de Chile; University of Windsor; Texas State University System; Sam Houston State University	Perez-Donoso, JM (corresponding author), Univ Santiago Chile, Lab Microbiol Mol, Dept Biol, Fac Quim & Biol, Santiago, Chile.	jose.perez@ciq.uchile.cl; claudio.vasquez@usach.cl	Chasteen, Thomas G/B-6601-2009; Pérez-Donoso, José M./G-3668-2013; Osorio, Igor/AEX-9230-2022; Osorio, Igor/E-1083-2016	Pérez-Donoso, José M./0000-0002-9506-1716; Osorio, Igor/0000-0001-7502-8698; Aguirre, Adam/0000-0002-0585-7340	FONDECYT (Fondo Nacional de Investigacion Cientifica y Tecnologica) [1090097, 11100067, 3100049]; Dicyt (Direccion de Investigacion Cientifica y Tecnologica)-USACH (Universidad de Santiago de Chile) [021043PD]; IFS (International Foundation for Science, Sweden) [F/4733]; FONDECYT-FONDAP (Fondo de Investigacion Avanzada en Areas Prioritarias) [15010006]; Robert A. Welch Foundation [X-011]	FONDECYT (Fondo Nacional de Investigacion Cientifica y Tecnologica)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Dicyt (Direccion de Investigacion Cientifica y Tecnologica)-USACH (Universidad de Santiago de Chile); IFS (International Foundation for Science, Sweden)(International Foundation for Science); FONDECYT-FONDAP (Fondo de Investigacion Avanzada en Areas Prioritarias)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYTCONICYT FONDAP); Robert A. Welch Foundation(The Welch Foundation)	This work was supported by FONDECYT (Fondo Nacional de Investigacion Cientifica y Tecnologica) grants # 1090097 (CCV), # 11100067 (IOO) and # 3100049 (JMP). Dicyt (Direccion de Investigacion Cientifica y Tecnologica)-USACH (Universidad de Santiago de Chile) # 021043PD and IFS (International Foundation for Science, Sweden) # F/4733 grants to JMP, FONDECYT-FONDAP (Fondo de Investigacion Avanzada en Areas Prioritarias) grant # 15010006 to AFQ, and grant X-011 from the Robert A. Welch Foundation to TGC, are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2003, NANOTECHNOLOGY, V14, P824, DOI 10.1088/0957-4484/14/7/323; Azzazy HME, 2007, CLIN BIOCHEM, V40, P917, DOI 10.1016/j.clinbiochem.2007.05.018; Bang JH, 2009, ACS NANO, V3, P1467, DOI 10.1021/nn900324q; Bao HF, 2010, ACTA BIOMATER, V6, P3534, DOI 10.1016/j.actbio.2010.03.030; Bao HF, 2010, NANO RES, V3, P481, DOI 10.1007/s12274-010-0008-6; Bao HF, 2006, SMALL, V2, P476, DOI 10.1002/smll.200500346; Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256; Calderon IL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000070; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Chang SQ, 2009, TOXICOL LETT, V188, P104, DOI 10.1016/j.toxlet.2009.03.013; Chasteen TG, 2009, FEMS MICROBIOL REV, V33, P820, DOI 10.1111/j.1574-6976.2009.00177.x; Conroy J, 2008, SMALL, V4, P2006, DOI 10.1002/smll.200800088; DEMAS JN, 1971, J PHYS CHEM-US, V75, P991, DOI 10.1021/j100678a001; Dumas EM, 2009, IEEE T NANOBIOSCI, V8, P58, DOI 10.1109/TNB.2009.2017313; Eom KD, 2006, J NANOSCI NANOTECHNO, V6, P3532, DOI 10.1166/jnn.2006.050; Faraon A, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2742789; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Gaponik N, 2002, J PHYS CHEM B, V106, P7177, DOI 10.1021/jp025541k; Han HY, 2007, ANAL CHIM ACTA, V596, P73, DOI 10.1016/j.aca.2007.05.039; Hardman R, 2006, ENVIRON HEALTH PERSP, V114, P165, DOI 10.1289/ehp.8284; He Y, 2006, J PHYS CHEM B, V110, P13352, DOI 10.1021/jp061719h; Helbig K, 2008, J BACTERIOL, V190, P5431, DOI 10.1128/JB.00271-08; Hetz CA, 2002, J CELL SCI, V115, P4671, DOI 10.1242/jcs.00153; Hoshino A, 2004, BIOCHEM BIOPH RES CO, V314, P46, DOI 10.1016/j.bbrc.2003.11.185; Hoshino A, 2007, J ARTIF ORGANS, V10, P149, DOI 10.1007/s10047-007-0379-y; Kongkanand A, 2008, J AM CHEM SOC, V130, P4007, DOI 10.1021/ja0782706; Lewinski N, 2008, SMALL, V4, P26, DOI 10.1002/smll.200700595; Lovric J, 2005, CHEM BIOL, V12, P1227, DOI 10.1016/j.chembiol.2005.09.008; Lovric J, 2005, J MOL MED, V83, P377, DOI 10.1007/s00109-004-0629-x; Mao WY, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/48/485611; MARTIN RB, 1958, B SOC CHIM BIOL, V40, P1763; Muro S, 2003, AM J PHYSIOL-CELL PH, V285, pC1339, DOI 10.1152/ajpcell.00099.2003; Peng ZA, 2001, J AM CHEM SOC, V123, P183, DOI 10.1021/ja003633m; Perez JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000211; Perez JM, 2006, BIOL RES, V39, P661, DOI 10.4067/S0716-97602006000500009; Samadi N, 2009, J BIOMED NANOTECHNOL, V5, P247, DOI 10.1166/jbn.2009.1029; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schneider R, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/22/225101; Schuler D, 2008, FEMS MICROBIOL REV, V32, P654, DOI 10.1111/j.1574-6976.2008.00116.x; Tian JN, 2009, J COLLOID INTERF SCI, V336, P504, DOI 10.1016/j.jcis.2009.04.064; Turner RJ, 1999, MICROBIOL-UK, V145, P2549, DOI 10.1099/00221287-145-9-2549; Valenzuela M, 2010, J INFECT DIS, V202, P1021, DOI 10.1086/656143; Villena J, 2008, FREE RADICAL BIO MED, V44, P1146, DOI 10.1016/j.freeradbiomed.2007.12.017; Wang J, 2009, CHEMPHYSCHEM, V10, P680, DOI 10.1002/cphc.200800672; Wolcott A, 2006, J PHYS CHEM B, V110, P5779, DOI 10.1021/jp057435z; Wu CH, 2010, CHEM RES TOXICOL, V23, P82, DOI 10.1021/tx900291c; Yang Q, 2003, MATER LETT, V57, P3508, DOI 10.1016/S0167-577X(03)00117-4; Ying E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002222; Zhang LJ, 2009, MICROCHIM ACTA, V166, P61, DOI 10.1007/s00604-009-0164-0; Zhang WJ, 2009, INORG CHEM, V48, P9723, DOI 10.1021/ic9010949; Zheng YG, 2007, ADV MATER, V19, P376, DOI 10.1002/adma.200600342	51	54	55	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30741	10.1371/journal.pone.0030741	http://dx.doi.org/10.1371/journal.pone.0030741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292028	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600074
J	Eitel, J; Meixenberger, K; van Laak, C; Orlovski, C; Hocke, A; Schmeck, B; Hippenstiel, S; N'Guessan, PD; Suttorp, N; Opitz, B				Eitel, Julia; Meixenberger, Karolin; van Laak, Claudia; Orlovski, Christine; Hocke, Andreas; Schmeck, Bernd; Hippenstiel, Stefan; N'Guessan, Philippe Dje; Suttorp, Norbert; Opitz, Bastian			Rac1 Regulates the NLRP3 Inflammasome Which Mediates IL-1beta Production in Chlamydophila pneumoniae Infected Human Mononuclear Cells	PLOS ONE			English	Article							CHLAMYDIA-PNEUMONIAE; CASPASE-1 ACTIVATION; NALP3 INFLAMMASOME; ACTIN CYTOSKELETON; EPITHELIAL-CELLS; GENE-EXPRESSION; HOST-DEFENSE; RHO-GTPASES; MACROPHAGES; TRACHOMATIS	Chlamydophila pneumoniae causes acute respiratory tract infections and has been associated with development of asthma and atherosclerosis. The production of IL-1 beta, a key mediator of acute and chronic inflammation, is regulated on a transcriptional level and additionally on a posttranslational level by inflammasomes. In the present study we show that C. pneumoniae-infected human mononuclear cells produce IL-1 beta protein depending on an inflammasome consisting of NLRP3, the adapter protein ASC and caspase-1. We further found that the small GTPase Rac1 is activated in C. pneumoniae-infected cells. Importantly, studies with specific inhibitors as well as siRNA show that Rac1 regulates inflammasome activation in C. pneumoniae-infected cells. In conclusion, C. pneumoniae infection of mononuclear cells stimulates IL-1 beta production dependent on a NLRP3 inflammasome-mediated processing of proIL-1 beta which is controlled by Rac1.	[Eitel, Julia; Meixenberger, Karolin; van Laak, Claudia; Orlovski, Christine; Hocke, Andreas; Schmeck, Bernd; Hippenstiel, Stefan; N'Guessan, Philippe Dje; Suttorp, Norbert; Opitz, Bastian] Charite, Dept Internal Med Infect Dis & Pulm Med, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Eitel, J (corresponding author), Charite, Dept Internal Med Infect Dis & Pulm Med, D-13353 Berlin, Germany.	bastian.opitz@charite.de		Suttorp, Norbert/0000-0002-3958-1151; Opitz, Bastian/0000-0003-1276-836X; Schmeck, Bernd/0000-0002-2767-3606; Hippenstiel, Stefan/0000-0002-5146-1064	Deutsche Forschungsgemeinschaft [OP 86/5-1, OP 86/7-1, SFB/TR84]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (OP 86/5-1, OP 86/7-1, SFB/TR84 project A1 to B.O., and SFB/TR84 project Z1a to A.C.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2010, J BIOL CHEM, V285, P41637, DOI 10.1074/jbc.M110.137885; Abdul-Sater AA, 2010, MICROBES INFECT, V12, P652, DOI 10.1016/j.micinf.2010.04.008; Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Basak C, 2005, J BIOL CHEM, V280, P4279, DOI 10.1074/jbc.M412820200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Buchholz KR, 2008, INFECT IMMUN, V76, P3150, DOI 10.1128/IAI.00104-08; Bulut Y, 2002, J IMMUNOL, V168, P1435, DOI 10.4049/jimmunol.168.3.1435; Buss C, 2010, J IMMUNOL, V184, P3072, DOI 10.4049/jimmunol.0902947; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Eitel J, 2008, J IMMUNOL, V181, P2664, DOI 10.4049/jimmunol.181.4.2664; Fong IW, 1999, INFECT IMMUN, V67, P6048, DOI 10.1128/IAI.67.11.6048-6055.1999; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hansbro PM, 2004, PHARMACOL THERAPEUT, V101, P193, DOI 10.1016/j.pharmthera.2003.10.007; Harder J, 2009, J IMMUNOL, V183, P5823, DOI 10.4049/jimmunol.0900444; He XB, 2010, J IMMUNOL, V184, P5743, DOI 10.4049/jimmunol.0903937; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Krull M, 2005, THROMB HAEMOSTASIS, V94, P319, DOI 10.1160/TH05-04-0261; Lee DJ, 2000, J BIOL CHEM, V275, P141, DOI 10.1074/jbc.275.1.141; Legrand-Poels S, 2007, J CELL SCI, V120, P1299, DOI 10.1242/jcs.03424; Maass M, 1998, ATHEROSCLEROSIS, V140, pS25, DOI 10.1016/S0021-9150(98)00117-8; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Netea MG, 2002, EUR J IMMUNOL, V32, P1188, DOI 10.1002/1521-4141(200204)32:4<1188::AID-IMMU1188>3.3.CO;2-1; Ojcius DM, 1998, J IMMUNOL, V161, P4220; Opitz B, 2005, CIRC RES, V96, P319, DOI 10.1161/01.RES.0000155721.83594.2c; Opitz B, 2010, AM J RESP CRIT CARE, V181, P1294, DOI 10.1164/rccm.200909-1427SO; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Prebeck S, 2001, J IMMUNOL, V167, P3316, DOI 10.4049/jimmunol.167.6.3316; ROTHERMEL CD, 1989, INFECT IMMUN, V57, P2705, DOI 10.1128/IAI.57.9.2705-2711.1989; SAIKKU P, 1992, ANN INTERN MED, V116, P273, DOI 10.7326/0003-4819-116-4-273; Sasu S, 2001, CIRC RES, V89, P244, DOI 10.1161/hh1501.094184; Schmeck B, 2006, AM J PHYSIOL-LUNG C, V290, pL730, DOI 10.1152/ajplung.00271.2005; Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; SHOR A, 1992, S AFR MED J, V82, P158; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Welter-Stahl L, 2006, CELL MICROBIOL, V8, P1047, DOI 10.1111/j.1462-5822.2006.00686.x; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Wong KW, 2006, J BIOL CHEM, V281, P40379, DOI 10.1074/jbc.M605387200; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	56	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30379	10.1371/journal.pone.0030379	http://dx.doi.org/10.1371/journal.pone.0030379			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276187	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100040
J	Macias, D; Landry, MR; Gershunov, A; Miller, AJ; Franks, PJS				Macias, Diego; Landry, Michael R.; Gershunov, Alexander; Miller, Arthur J.; Franks, Peter J. S.			Climatic Control of Upwelling Variability along the Western North-American Coast	PLOS ONE			English	Article							CALIFORNIA CURRENT SYSTEM; PACIFIC DECADAL OSCILLATION; SOUTHERN CALIFORNIA; EL-NINO; PRODUCTION REGIMES; WIND STRESS; ALBORAN SEA; OCEAN; PRODUCTIVITY; TEMPERATURE	The high biological production of the California Current System (CCS) results from the seasonal development of equatorward alongshore winds that drive coastal upwelling. While several climatic fluctuation patterns influence the dynamics and biological productivity of the CCS, including the El Nino-Southern Oscillation (ENSO), the Pacific Decadal Oscillation index (PDO) and the North Pacific Gyre Oscillation (NPGO), the mechanisms of interaction between climatic oscillations and the CCS upwelling dynamics have remained obscure. Here, we use Singular Spectral Analysis (SSA) to reveal, for the first time, low-frequency concordance between the time series of climatic indices and upwelling intensity along the coast of western North America. Based on energy distributions in annual, semiannual and low-frequency signals, we can divide the coast into three distinct regions. While the annual upwelling signal dominates the energy spectrum elsewhere, low-frequency variability is maximal in the regions south of 33 degrees N. Non-structured variability associated with storms and turbulent mixing is enhanced at northerly locations. We found that the low-frequency signal is significantly correlated with different climatic indices such as PDO, NPGO and ENSO with the correlation patterns being latitude-dependent. We also analyzed the correlations between this upwelling variability and sea surface temperature (SST) and sea level pressure (SLP) throughout the North Pacific to visualize and interpret the large-scale teleconnection dynamics in the atmosphere that drive the low-frequency coastal winds. These results provide new insights into the underlying mechanisms connecting climatic patterns with upwelling dynamics, which could enhance our prediction and forecast capabilities of the effects of future oceanographic and climatic variability in the CCS.	[Macias, Diego] CSIC, Inst Ciencias Marinas Andalucia, Dept Ecol & Coastal Management, Cadiz, Spain; [Landry, Michael R.; Franks, Peter J. S.] Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA; [Gershunov, Alexander; Miller, Arthur J.] Univ Calif San Diego, Scripps Inst Oceanog, CASPO Div, La Jolla, CA 92093 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography	Macias, D (corresponding author), CSIC, Inst Ciencias Marinas Andalucia, Dept Ecol & Coastal Management, Cadiz, Spain.	diego.macias@icman.csic.es	Landry, Michael/HGF-1043-2022; Macías, Diego/G-1972-2010	Macías, Diego/0000-0002-7772-255X; Miller, Arthur/0000-0003-3459-2676	Spanish Ministry of Science [EX2008-0394]; National Science Foundation [OCE 04-17616, OCE10-26607, OCE06-47815, OCE09-60770]; National Oceanic and Atmospheric Administration through the Experimental Climate Prediction Center and Integrated Ocean Observation System [NA17RJ1231]; Directorate For Geosciences [0960770, 1026607] Funding Source: National Science Foundation	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration through the Experimental Climate Prediction Center and Integrated Ocean Observation System; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	DM was funded by a postdoctoral contract by the Spanish Ministry of Science (contract no EX2008-0394). This work was supported by National Science Foundation funding (OCE 04-17616 and OCE10-26607) for the California Current Ecosystem Long Term Ecological Research site. Funding to AJM was provided by the National Science Foundation under OCE06-47815 and OCE09-60770, and by National Oceanic and Atmospheric Administration through the Experimental Climate Prediction Center and Integrated Ocean Observation System (NA17RJ1231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JS, 1980, ANNU REV FLUID MECH, V12, P389, DOI 10.1146/annurev.fl.12.010180.002133; Alvarez A, 2000, GEOPHYS RES LETT, V27, P2709, DOI 10.1029/1999GL011226; Bakun Andrew, 1973, W COAST N AM 1946 71, P112; Berger WH, 1989, DAHL WORKSH PROD OC; Bograd SJ, 2005, J MAR RES, V63, P863, DOI 10.1357/002224005774464229; Bograd SJ, 2001, GEOPHYS RES LETT, V28, P275, DOI 10.1029/2000GL012047; Bograd SJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035933; Carr ME, 2003, DEEP-SEA RES PT II, V50, P3199, DOI 10.1016/j.dsr2.2003.07.015; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; Castro CG, 2002, PROG OCEANOGR, V54, P171, DOI 10.1016/S0079-6611(02)00048-4; CHELTON DB, 1982, J MAR RES, V40, P1095; Chhak K, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030203; Chhak KC, 2009, J CLIMATE, V22, P1255, DOI 10.1175/2008JCLI2639.1; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; Di Lorenzo E, 2003, DEEP-SEA RES PT II, V50, P2371, DOI 10.1016/S0967-0645(03)00125-5; Di Lorenzo E, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038261; Favre A, 2006, CLIM DYNAM, V26, P617, DOI 10.1007/s00382-005-0101-9; Francis RC, 1998, FISH OCEANOGR, V7, P1, DOI 10.1046/j.1365-2419.1998.00052.x; Franco G, 2008, CLIMATIC CHANGE, V87, pS7, DOI 10.1007/s10584-007-9359-8; Ghil M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000092; Gruber N, 2006, DEEP-SEA RES PT I, V53, P1483, DOI 10.1016/j.dsr.2006.06.005; Hare SR, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:IPR>2.0.CO;2; Hickey B. M., 1979, Progress in Oceanography, V8, P191, DOI 10.1016/0079-6611(79)90002-8; Kelly KA, 1998, J GEOPHYS RES-OCEANS, V103, P13067, DOI 10.1029/97JC03760; Kim HJ, 2009, PROG OCEANOGR, V82, P137, DOI 10.1016/j.pocean.2009.05.002; LYNN RJ, 1990, J GEOPHYS RES-OCEANS, V95, P12995, DOI 10.1029/JC095iC08p12995; Lynn RJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001787; Macias D, 2007, J MAR RES, V65, P523, DOI 10.1357/002224007782689085; Mackas DL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027930; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Mantyla AW, 2008, J MARINE SYST, V73, P48, DOI 10.1016/j.jmarsys.2007.08.001; Margolis H, 2009, EPIDEMIOLOGY, V20, pS222, DOI 10.1097/01.ede.0000362743.41229.58; McGowan JA, 2003, DEEP-SEA RES PT II, V50, P2567, DOI 10.1016/S0967-0645(03)00135-8; McGowan John A., 1993, P203; Mendelssohn R, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002330; Mendelssohn R, 2002, PROG OCEANOGR, V53, P141, DOI 10.1016/S0079-6611(02)00028-9; Moore AM, 2009, J PHYS OCEANOGR, V39, P702, DOI 10.1175/2008JPO3740.1; Muller-Karger FE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021346; Murphree T, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016366; Newman M, 2003, J CLIMATE, V16, P3853, DOI 10.1175/1520-0442(2003)016<3853:EVOTPD>2.0.CO;2; Nezlin NP, 2003, REMOTE SENS ENVIRON, V84, P234, DOI 10.1016/S0034-4257(02)00109-8; Parrish R.H., 1981, Biological Oceanography, V1, P175; Rao BD, 1989, IEE T SIGNAL PROCESS, V37; Rebstock GA, 2003, DEEP-SEA RES PT II, V50, P2583, DOI 10.1016/S0967-0645(03)00124-3; Schneider N, 2005, J CLIMATE, V18, P4355, DOI 10.1175/JCLI3527.1; Schwing FB, 1997, J GEOPHYS RES-OCEANS, V102, P3421, DOI 10.1029/96JC03591; Schwing FB, 1996, NOAATMNMFSSWFSC231 U; Schwing FB, 2010, J MARINE SYST, V79, P245, DOI 10.1016/j.jmarsys.2008.11.027; Smith RL, 2001, PROG OCEANOGR, V49, P63, DOI 10.1016/S0079-6611(01)00016-7; SMITH SV, 1993, REV GEOPHYS, V31, P75, DOI 10.1029/92RG02584; Song H, 2011, DYNAM ATMOS OCEANS, V52, P170, DOI 10.1016/j.dynatmoce.2011.03.001; Thomas AC, 2009, PROG OCEANOGR, V83, P386, DOI 10.1016/j.pocean.2009.07.020; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; VAUTARD R, 1992, PHYSICA D, V58, P95, DOI 10.1016/0167-2789(92)90103-T; Wainwright TC, 2007, ECOL MODEL, V202, P120, DOI 10.1016/j.ecolmodel.2006.06.019; Walsh JJ, 2001, NATURE, V350; Wooster WS, 1963, E BOUNDARY CURRENTS, P253	57	36	39	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30436	10.1371/journal.pone.0030436	http://dx.doi.org/10.1371/journal.pone.0030436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276199	Green Published, gold			2022-12-27	WOS:000301457200061
J	Nickerson, NK; Mohammad, KS; Gilmore, JL; Crismore, E; Bruzzaniti, A; Guise, TA; Foley, J				Nickerson, Nicole K.; Mohammad, Khalid S.; Gilmore, Jennifer L.; Crismore, Erin; Bruzzaniti, Angela; Guise, Theresa A.; Foley, John			Decreased Autocrine EGFR Signaling in Metastatic Breast Cancer Cells Inhibits Tumor Growth in Bone and Mammary Fat Pad	PLOS ONE			English	Article							GENE-EXPRESSION; FACTOR RECEPTOR; ZD1839 IRESSA; AMPHIREGULIN; ESTROGEN; GLAND; OSTEOBLASTS; CARCINOMA; TAMOXIFEN; LIGANDS	Breast cancer metastasis to bone triggers a vicious cycle of tumor growth linked to osteolysis. Breast cancer cells and osteoblasts express the epidermal growth factor receptor (EGFR) and produce ErbB family ligands, suggesting participation of these growth factors in autocrine and paracrine signaling within the bone microenvironment. EGFR ligand expression was profiled in the bone metastatic MDA-MB-231 cells (MDA-231), and agonist-induced signaling was examined in both breast cancer and osteoblast-like cells. Both paracrine and autocrine EGFR signaling were inhibited with a neutralizing amphiregulin antibody, PAR34, whereas shRNA to the EGFR was used to specifically block autocrine signaling in MDA-231 cells. The impact of these was evaluated with proliferation, migration and gene expression assays. Breast cancer metastasis to bone was modeled in female athymic nude mice with intratibial inoculation of MDA-231 cells, and cancer cell-bone marrow co-cultures. EGFR knockdown, but not PAR34 treatment, decreased osteoclasts formed in vitro (p, 0.01), reduced osteolytic lesion tumor volume (p<0.01), increased survivorship in vivo (p<0.001), and resulted in decreased MDA-231 growth in the fat pad (p<0.01). Fat pad shEGFR-MDA-231 tumors produced in nude mice had increased necrotic areas and decreased CD31-positive vasculature. shEGFR-MDA-231 cells also produced decreased levels of the proangiogenic molecules macrophage colony stimulating factor-1 (MCSF-1) and matrix metalloproteinase 9 (MMP9), both of which were decreased by EGFR inhibitors in a panel of EGFR-positive breast cancer cells. Thus, inhibiting autocrine EGFR signaling in breast cancer cells may provide a means for reducing paracrine factor production that facilitates microenvironment support in the bone and mammary gland.	[Nickerson, Nicole K.; Gilmore, Jennifer L.; Crismore, Erin; Foley, John] Indiana Univ Sch Med, Med Sci Program, Bloomington, IN USA; [Mohammad, Khalid S.; Guise, Theresa A.] Indiana Univ Sch Med, Dept Med, Div Endocrinol, Indianapolis, IN USA; [Mohammad, Khalid S.; Guise, Theresa A.; Foley, John] Indiana Univ Sch Med, Indiana Univ Canc Ctr, Indianapolis, IN USA; [Bruzzaniti, Angela] Indiana Univ, Sch Dent, Dept Oral Biol, Indianapolis, IN USA; [Bruzzaniti, Angela; Foley, John] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA; [Foley, John] Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Nickerson, NK (corresponding author), Indiana Univ Sch Med, Med Sci Program, Bloomington, IN USA.	jgfoley@indiana.edu	Bruzzaniti, Angela/AAP-2225-2020; Mohammad, Khalid/AAE-9569-2022; Mohammad, Khalid/AFE-4205-2022		Department of Defense [W81XWH-09-1-0003]; Susan G. Komen [KG081561]; Indiana University Breast Cancer Research Program [29-875-62]	Department of Defense(United States Department of Defense); Susan G. Komen(Susan G. Komen Breast Cancer Foundation); Indiana University Breast Cancer Research Program	NKN was supported by a Department of Defense Breast Cancer Research Program, Predoctoral Traineeship Award (W81XWH-09-1-0003); JLG received a Susan G. Komen Postdoctoral Award; and JF received grants from Susan G. Komen for the Cure (KG081561) and the Indiana University Breast Cancer Research Program (29-875-62). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MR, 2009, J ORAL MAXIL SURG, V67, P1373, DOI 10.1016/j.joms.2009.03.048; Balbis A, 2010, J CELL BIOCHEM, V109, P1103, DOI 10.1002/jcb.22505; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; BERTHON P, 1992, INT J CANCER, V52, P92, DOI 10.1002/ijc.2910520117; Bhagavathula N, 2005, AM J PATHOL, V166, P1009, DOI 10.1016/S0002-9440(10)62322-X; Bos PD, 2009, NATURE; Bruzzaniti A, 2009, MOL CELL BIOL, V29, P3644, DOI 10.1128/MCB.00851-08; Ciardiello F, 2001, CLIN CANCER RES, V7, P1459; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; DAVIDSON NE, 1987, MOL ENDOCRINOL, V1, P216, DOI 10.1210/mend-1-3-216; Foley J, SEMIN CELL DEV BIOL; Furugaki K, 2011, CLIN EXP METASTASIS; Gerstenfeld LC, 2006, J HISTOCHEM CYTOCHEM, V54, P1215, DOI 10.1369/jhc.6A6959.2006; Gilmore JL, 2008, BREAST CANCER RES TR, V110, P493, DOI 10.1007/s10549-007-9748-8; Gilmore JL, 2009, MOL CANCER RES, V7, P1714, DOI 10.1158/1541-7786.MCR-09-0131; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Guise TA, 2006, CLIN CANCER RES, V12, p6213S, DOI 10.1158/1078-0432.CCR-06-1007; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hens JR, 2005, BREAST CANCER RES, V7, P220, DOI 10.1186/bcr1306; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Kochupurakkal BS, 2005, J BIOL CHEM, V280, P8503, DOI 10.1074/jbc.M413919200; Lee JE, 2004, ANTICANCER RES, V24, P3961; Lorch G, 2007, BRIT J CANCER, V97, P183, DOI 10.1038/sj.bjc.6603828; Lu X, 2009, GENES DEV; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Mohammad Khalid S., 2008, V455, P37, DOI 10.1007/978-1-59745-104-8_3; Moulder SL, 2001, CANCER RES, V61, P8887; Park SI, 2011, CANC MICROENVIRON; Price JT, 1999, CANCER RES, V59, P5475; Qin L, 2003, J BIOL CHEM, V278, P19723, DOI 10.1074/jbc.M212226200; Qin L, 2005, J CELL BIOCHEM, V96, P632, DOI 10.1002/jcb.20550; Roda JM, 2011, J IMMUNOL, V187, P1970, DOI 10.4049/jimmunol.1100841; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Ryan MA, 2010, NAT MED, V16, P1141, DOI 10.1038/nm.2217; Scandlyn MJ, 2008, BRIT J CANCER, V99, P1056, DOI 10.1038/sj.bjc.6604634; Sebastian J, 1998, CELL GROWTH DIFFER, V9, P777; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Voloshin T, BLOOD; Willmarth NE, 2006, J BIOL CHEM, V281, P37728, DOI 10.1074/jbc.M606532200; Willmarth NE, 2009, CELL SIGNAL, V21, P212, DOI 10.1016/j.cellsig.2008.10.003; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Yang JP, 2008, J CELL PHYSIOL, V214, P730, DOI 10.1002/jcp.21268; Yang XR, J NATL CANC I, V103, P250	49	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30255	10.1371/journal.pone.0030255	http://dx.doi.org/10.1371/journal.pone.0030255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276166	gold, Green Published, Green Submitted			2022-12-27	WOS:000301457200047
J	Chan, CH; Wilbanks, CC; Makhatadze, GI; Wong, KB				Chan, Chi-Ho; Wilbanks, Cecily C.; Makhatadze, George I.; Wong, Kam-Bo			Electrostatic Contribution of Surface Charge Residues to the Stability of a Thermophilic Protein: Benchmarking Experimental and Predicted pKa Values	PLOS ONE			English	Article							PH MOLECULAR-DYNAMICS; PK(A) VALUES; STAPHYLOCOCCAL NUCLEASE; THERMOCOCCUS-CELER; WATER PENETRATION; TITRATION CURVES; RATIONAL DESIGN; SALT BRIDGES; STABILIZATION; OPTIMIZATION	Optimization of the surface charges is a promising strategy for increasing thermostability of proteins. Electrostatic contribution of ionizable groups to the protein stability can be estimated from the differences between the pKa values in the folded and unfolded states of a protein. Using this pKa-shift approach, we experimentally measured the electrostatic contribution of all aspartate and glutamate residues to the stability of a thermophilic ribosomal protein L30e from Thermococcus celer. The pKa values in the unfolded state were found to be similar to model compound pKas. The pKa values in both the folded and unfolded states obtained at 298 and 333 K were similar, suggesting that electrostatic contribution of ionizable groups to the protein stability were insensitive to temperature changes. The experimental pKa values for the L30e protein in the folded state were used as a benchmark to test the robustness of pKa prediction by various computational methods such as H++, MCCE, MEAD, pKD, PropKa, and UHBD. Although the predicted pKa values were affected by crystal contacts that may alter the side-chain conformation of surface charged residues, most computational methods performed well, with correlation coefficients between experimental and calculated pKa values ranging from 0.49 to 0.91 (p<0.01). The changes in protein stability derived from the experimental pKa-shift approach correlate well (r = 0.81) with those obtained from stability measurements of charge-to-alanine substituted variants of the L30e protein. Our results demonstrate that the knowledge of the pKa values in the folded state provides sufficient rationale for the redesign of protein surface charges leading to improved protein stability.	[Chan, Chi-Ho; Wong, Kam-Bo] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Hong Kong, Hong Kong, Peoples R China; [Wilbanks, Cecily C.; Makhatadze, George I.] Rensselaer Polytech Inst, Dept Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Wilbanks, Cecily C.; Makhatadze, George I.] Rensselaer Polytech Inst, Dept Chem, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA; [Wilbanks, Cecily C.; Makhatadze, George I.] Rensselaer Polytech Inst, Dept Biol Chem, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA	Chinese University of Hong Kong; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Chan, CH (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Hong Kong, Hong Kong, Peoples R China.	kbwong@cuhk.edu.hk	Wong, Kam-Bo/G-4258-2013; Wong, Kam-Bo/AAU-9364-2021	Wong, Kam-Bo/0000-0002-6984-5373; Wong, Kam-Bo/0000-0002-6984-5373	Research Council of Hong Kong [479307]; National Science Foundation [MCB-0110396]; Direct For Biological Sciences [0818419] Funding Source: National Science Foundation	Research Council of Hong Kong(Hong Kong Research Grants Council); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the General Research Fund of Research Council of Hong Kong (project no. 479307). Research on electrostatic interactions in GIM lab is supported by a grant from the National Science Foundation (MCB-0110396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasako A, 1997, J BIOL CHEM, V272, P18686, DOI 10.1074/jbc.272.30.18686; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BASHFORD D, OBJECT ORIENTED PROG, P233; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Czepas J, 2004, ACTA CRYSTALLOGR D, V60, P275, DOI 10.1107/S0907444903026271; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Dwyer JJ, 2000, BIOPHYS J, V79, P1610, DOI 10.1016/S0006-3495(00)76411-3; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fitch CA, 2002, BIOPHYS J, V82, P3289, DOI 10.1016/S0006-3495(02)75670-1; Fu HL, 2009, PROTEINS, V77, P491, DOI 10.1002/prot.22509; GILSON MK, 1993, PROTEINS, V15, P266, DOI 10.1002/prot.340150305; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Gribenko AV, 2009, P NATL ACAD SCI USA, V106, P2601, DOI 10.1073/pnas.0808220106; Grimsley GR, 1999, PROTEIN SCI, V8, P1843, DOI 10.1110/ps.8.9.1843; Gunner MR, 2011, PROTEINS, V79, P3306, DOI 10.1002/prot.23124; Jimenez-Cruz CA, 2011, PHYS CHEM CHEM PHYS, V13, P17056, DOI 10.1039/c1cp21193e; Kajander Tommi, 2006, V340, P151; Khandogin J, 2005, BIOPHYS J, V89, P141, DOI 10.1529/biophysj.105.061341; Lee CF, 2005, BIOCHEMISTRY-US, V44, P16817, DOI 10.1021/bi0519654; Lee CF, 2005, J MOL BIOL, V348, P419, DOI 10.1016/j.jmb.2005.02.052; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Loladze VV, 1999, BIOCHEMISTRY-US, V38, P16419, DOI 10.1021/bi992271w; Lumb KJ, 1996, SCIENCE, V271, P1137, DOI 10.1126/science.271.5252.1137; Machuqueiro M, 2011, PROTEINS, V79, P3437, DOI 10.1002/prot.23115; MADURA JD, 1994, REV COMP CH, V5, P229, DOI 10.1002/9780470125823.ch4; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Nielsen JE, 2007, J MOL GRAPH MODEL, V25, P691, DOI 10.1016/j.jmgm.2006.05.007; Nielsen JE, 2009, METHOD ENZYMOL, V454, P233, DOI 10.1016/S0076-6879(08)03809-3; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Peterson RW, 1999, J MOL BIOL, V286, P1609, DOI 10.1006/jmbi.1999.2574; Pokala N, 2001, J STRUCT BIOL, V134, P269, DOI 10.1006/jsbi.2001.4349; Sanchez-Ruiz JM, 2001, TRENDS BIOTECHNOL, V19, P132, DOI 10.1016/S0167-7799(00)01548-1; Schweiker KL, 2007, PROTEIN SCI, V16, P2694, DOI 10.1110/ps.073091607; Schweiker Katrina L., 2009, V490, P261, DOI 10.1007/978-1-59745-367-7_11; Schweiker KL, 2009, METHOD ENZYMOL, V454, P175, DOI 10.1016/S0076-6879(08)03807-X; Shan JF, 2011, PROTEINS, V79, P3346, DOI 10.1002/prot.23098; SHRAGER RI, 1972, BIOCHEMISTRY-US, V11, P541, DOI 10.1021/bi00754a010; Sondergaard CR, 2008, J MOL BIOL, V376, P269, DOI 10.1016/j.jmb.2007.09.070; Street AG, 1999, STRUCTURE, V7, pR105, DOI 10.1016/S0969-2126(99)80062-8; Strickler SS, 2006, BIOCHEMISTRY-US, V45, P2761, DOI 10.1021/bi0600143; Tynan-Connolly BM, 2006, NUCLEIC ACIDS RES, V34, pW48, DOI 10.1093/nar/gkl192; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Warshel A, 2006, BBA-PROTEINS PROTEOM, V1764, P1647, DOI 10.1016/j.bbapap.2006.08.007; Whitten ST, 2000, BIOCHEMISTRY-US, V39, P14292, DOI 10.1021/bi001015c; Wong KB, 2003, PROTEIN SCI, V12, P1483, DOI 10.1110/ps.0302303; Wong KB, 1996, J MOL BIOL, V259, P805, DOI 10.1006/jmbi.1996.0359; YAMAZAKI T, 1994, NMR XRAY EVIDENCE HI; YANG AS, 1992, J MOL BIOL, V227, P889, DOI 10.1016/0022-2836(92)90229-D	50	27	27	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30296	10.1371/journal.pone.0030296	http://dx.doi.org/10.1371/journal.pone.0030296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279578	Green Submitted, Green Published, gold			2022-12-27	WOS:000299771900055
J	Freed, LA; Cann, RL				Freed, Leonard A.; Cann, Rebecca L.			Changes in Timing, Duration, and Symmetry of Molt of Hawaiian Forest Birds	PLOS ONE			English	Article							WHITE-CROWNED SPARROWS; CLIMATE-CHANGE; ANNUAL CYCLE; PASSERINE BIRDS; BREEDING BIRDS; FOOD; COSTS; AKEPA; POPULATION; FEATHERS	Food limitation greatly affects bird breeding performance, but the effect of nutritive stress on molt has barely been investigated outside of laboratory settings. Here we show changes in molting patterns for an entire native Hawaiian bird community at 1650-1900 m elevation on the Island of Hawaii between 1989-1999 and 2000-2006, associated with severe food limitation throughout the year beginning in 2000. Young birds and adults of all species took longer to complete their molt, including months never or rarely used during the 1989-1999 decade. These included the cold winter months and even the early months of the following breeding season. In addition, more adults of most species initiated their molt one to two months earlier, during the breeding season. Suspended molt, indicated by birds temporarily not molting primary flight feathers during the months of peak primary molt, increased in prevalence. Food limitation reached the point where individuals of all species had asymmetric molt, with different primary flight feathers molted on each wing. These multiple changes in molt, unprecedented in birds, had survival consequences. Adult birds captured during January to March, 2000-2004, had lower survival in four of five species with little effect of extended molt. Extended molt may be adaptive for a nutrient stressed bird to survive warm temperatures but not cool winter temperatures that may obliterate the energy savings. The changing molt of Hawaiian birds has many implications for conservation and for understanding life history aspects of molt of tropical birds.	[Freed, Leonard A.] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Cann, Rebecca L.] Univ Hawaii Manoa, Dept Cell & Mol Biol, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Freed, LA (corresponding author), Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA.	lfreed@hawaii.edu			John D. and Catherine T. MacArthur Foundation [8900287]; Environmental Protection Agency [82909301]	John D. and Catherine T. MacArthur Foundation; Environmental Protection Agency(United States Environmental Protection Agency)	John D. and Catherine T. MacArthur Foundation (8900287). Environmental Protection Agency (82909301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; BALDWIN PAUL H., 1953, UNIV CALIFORNIA PUBL ZOOL, V52, P285; BALMFORD A, 1993, P ROY SOC B-BIOL SCI, V252, P245, DOI 10.1098/rspb.1993.0072; Barta Z, 2006, OIKOS, V112, P580, DOI 10.1111/j.0030-1299.2006.14240.x; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Camp R. J., 2009, HCSU011 U HAW HIL; Coppack T, 2004, ADV ECOL RES, V35, P131, DOI 10.1016/S0065-2504(04)35007-5; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; DRENT RH, 1980, ARDEA, V68, P225; EVANS PGH, 1986, IBIS, V128, P558, DOI 10.1111/j.1474-919X.1986.tb02706.x; FOGDEN MPL, 1972, IBIS, V114, P307, DOI 10.1111/j.1474-919X.1972.tb00831.x; FOSTER MS, 1975, CONDOR, V77, P304, DOI 10.2307/1366226; Freed LA, 2005, CONDOR, V107, P753, DOI 10.1650/7820.1; Freed LA, 2001, STUD AVIAN BIOL-SER, P173; Freed LA, 2008, J PARASITOL, V94, P1009, DOI 10.1645/GE-1378.1; Freed LA, 2007, EVOL ECOL RES, V9, P157; Freed LA, 2010, CONDOR, V112, P213, DOI 10.1525/cond.2010.090092; Freed LA, 2009, CURR BIOL, V19, P1736, DOI 10.1016/j.cub.2009.08.044; Freed LA, 2009, EVOL ECOL RES, V11, P731; Freed LA, 2008, EVOL ECOL RES, V10, P931; Fretz JS, 2002, AUK, V119, P166, DOI 10.1642/0004-8038(2002)119[0166:SOFAFA]2.0.CO;2; GWINNER E, 1990, SCIENCE, V249, P906, DOI 10.1126/science.249.4971.906; Hedenstrom A, 1999, J EXP BIOL, V202, P67; Hemborg C, 1998, BEHAV ECOL SOCIOBIOL, V43, P19, DOI 10.1007/s002650050462; Hemborg C, 1999, ANN ZOOL FENN, V36, P1; Jenni L., 1994, BIOL MOULT BIRDS; KING JR, 1985, AM ZOOL, V25, P955; KING JR, 1984, AUK, V101, P168, DOI 10.1093/auk/101.1.168; KLAASSEN M, 1995, OECOLOGIA, V104, P424, DOI 10.1007/BF00341339; LINDSTROM A, 1993, PHYSIOL ZOOL, V66, P490, DOI 10.1086/physzool.66.4.30163805; Marini MA, 2001, CONDOR, V103, P767, DOI 10.1650/0010-5422(2001)103[0767:APOMAR]2.0.CO;2; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; MILLER ALDEN H., 1963, UNIV CALIF PUBL ZOOL, V66, P1; Moller AP, 1997, ASYMMETRY DEV STABIL; Morales J, 2007, ECOSCIENCE, V14, P31, DOI 10.2980/1195-6860(2007)14[31:EMILSA]2.0.CO;2; Moyle RG, 2009, P NATL ACAD SCI USA, V106, P1863, DOI 10.1073/pnas.0809861105; Murphy Mary E., 1996, P158; MURPHY ME, 1988, CAN J ZOOL, V66, P1403, DOI 10.1139/z88-206; NEGRO JJ, 1994, ARDEA, V82, P263; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; Perkins R.C.L., 1903, FAUNA HAWAIIENSIS, V1, Part. 4, P365; POULIN B, 1992, ECOLOGY, V73, P2295, DOI 10.2307/1941476; PRYSJONES RP, 1982, J FIELD ORNITHOL, V53, P352; RALPH CJ, 1994, CONDOR, V96, P151, DOI 10.2307/1369072; RICKLEFS RE, 1980, AUK, V97, P38; Ricklefs Robert T., 1996, P1; Rohwer S, 2008, CONDOR, V110, P799, DOI 10.1525/cond.2008.8320; Scott J.M., 1986, STUD AVIAN BIOL, V9, P1; SNOW D. W., 1964, ZOOLOGICA [NEW YORK], V49, P1; STILES FG, 1980, IBIS, V122, P322, DOI 10.1111/j.1474-919X.1980.tb00886.x; STUTCHBURY BJM, 2001, BEHAV ECOLOGY TROPIC, P1; Swaddle JP, 1996, J AVIAN BIOL, V27, P103, DOI 10.2307/3677139; SWADDLE JP, 1994, P ROY SOC B-BIOL SCI, V255, P147, DOI 10.1098/rspb.1994.0021; THOMAS ALR, 1993, P ROY SOC B-BIOL SCI, V254, P181, DOI 10.1098/rspb.1993.0144; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; Van Riper SG, 2000, BIRDS N AM; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WARD P, 1969, J ZOOL, V157, P25; WILLOUGHBY EJ, 1986, CONDOR, V88, P461, DOI 10.2307/1368272; Wolfe JD, 2009, WILSON J ORNITHOL, V121, P556, DOI 10.1676/08-111.1; ZANN R, 1985, IBIS, V127, P184, DOI 10.1111/j.1474-919X.1985.tb05054.x; [No title captured]	64	29	29	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29834	10.1371/journal.pone.0029834	http://dx.doi.org/10.1371/journal.pone.0029834			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279547	Green Submitted, Green Published, gold			2022-12-27	WOS:000299771900025
J	Zong, M; Satoh, A; Yu, MK; Siu, KY; Ng, WY; Chan, HC; Tanner, JA; Yu, S				Zong, Min; Satoh, Ayano; Yu, Mei Kuen; Siu, Ka Yu; Ng, Wing Yan; Chan, Hsiao Chang; Tanner, Julian A.; Yu, Sidney			TRAPPC9 Mediates the Interaction between p150(Glued) and COPII Vesicles at the Target Membrane	PLOS ONE			English	Article							TO-GOLGI TRANSPORT; ENDOPLASMIC-RETICULUM; INTERMEDIATE COMPARTMENT; MAMMALIAN-CELLS; LIVING CELLS; ER EXIT; APPARATUS; DYNACTIN; PROTEIN; MICROTUBULES	Background: The transport of endoplasmic reticulum (ER)-derived COPII vesicles toward the ER-Golgi intermediate compartment (ERGIC) requires cytoplasmic dynein and is dependent on microtubules. p150(Glued), a subunit of dynactin, has been implicated in the transport of COPII vesicles via its interaction with COPII coat components Sec23 and Sec24. However, whether and how COPII vesicle tether, TRAPP (Transport protein particle), plays a role in the interaction between COPII vesicles and microtubules is currently unknown. Principle Findings: We address the functional relationship between COPII tether TRAPP and dynactin. Overexpressed TRAPP subunits interfered with microtubule architecture by competing p150(Glued) away from the MTOC. TRAPP subunit TRAPPC9 bound directly to p150(Glued) via the same carboxyl terminal domain of p150(Glued) that binds Sec23 and Sec24. TRAPPC9 also inhibited the interaction between p150(Glued) and Sec23/Sec24 both in vitro and in vivo, suggesting that TRAPPC9 serves to uncouple p150(Glued) from the COPII coat, and to relay the vesicle-dynactin interaction at the target membrane. Conclusions: These findings provide a new perspective on the function of TRAPP as an adaptor between the ERGIC membrane and dynactin. By preserving the connection between dynactin and the tethered and/or fused vesicles, TRAPP allows nascent ERGIC to continue the movement along the microtubules as they mature into the cis-Golgi.	[Zong, Min; Siu, Ka Yu; Ng, Wing Yan; Chan, Hsiao Chang; Yu, Sidney] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Satoh, Ayano] Okayama Univ, Okayama, Japan; [Yu, Mei Kuen; Chan, Hsiao Chang; Yu, Sidney] Chinese Univ Hong Kong, Epithelial Cell Biol Res Ctr, Shatin, Hong Kong, Peoples R China; [Tanner, Julian A.; Yu, Sidney] Univ Hong Kong, Dept Biochem, Pokfulam, Hong Kong, Peoples R China	Chinese University of Hong Kong; Okayama University; Chinese University of Hong Kong; University of Hong Kong	Zong, M (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	Sidney.yu@cuhk.edu.hk	Satoh, Ayano/B-2423-2011; Zong, Min/B-6706-2016; Chan, Hsiao Chang/E-1507-2016; Bin Sidney Yu, Siu/R-4936-2018; Tanner, Julian A./C-4412-2009	Satoh, Ayano/0000-0003-3736-1283; Zong, Min/0000-0001-9381-5791; Bin Sidney Yu, Siu/0000-0001-9643-2729; Tanner, Julian A./0000-0002-5459-1526	Hong Kong Research Grant Council [479410]	Hong Kong Research Grant Council(Hong Kong Research Grants Council)	This work is supported by the general research fund to SY (grant number 479410) by the Hong Kong Research Grant Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Cai YY, 2008, CELL, V133, P1202, DOI 10.1016/j.cell.2008.04.049; Choi C, 2011, TRAFFIC, V12, P715, DOI 10.1111/j.1600-0854.2011.01181.x; CORTHESYTHEULAZ I, 1992, J CELL BIOL, V118, P1333, DOI 10.1083/jcb.118.6.1333; Dixit R, 2008, J BIOL CHEM, V283, P33611, DOI 10.1074/jbc.M804840200; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Lord C, 2011, NATURE, V473, P181, DOI 10.1038/nature09969; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Morozova N, 2006, NAT CELL BIOL, V8, P1263, DOI 10.1038/ncb1489; Palmer KJ, 2009, MOL BIOL CELL, V20, P2885, DOI 10.1091/mbc.E08-12-1160; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; ROGALSKI AA, 1984, J CELL BIOL, V99, P1092, DOI 10.1083/jcb.99.3.1092; ROGALSKI AA, 1984, J CELL BIOL, V99, P1101, DOI 10.1083/jcb.99.3.1101; Roghi C, 1999, J CELL SCI, V112, P4673; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; SCRIVENS PJ, 2011, MOL BIOL CELL; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Stephens DJ, 2000, J CELL SCI, V113, P2177; Tang BL, 1997, MOL CELL BIOL, V17, P256, DOI 10.1128/MCB.17.1.256; Trahey Meg, 2010, F1000 Biol Rep, V2, P47; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; Watson P, 2006, J CELL SCI, V119, P2758, DOI 10.1242/jcs.02999; WEHLAND J, 1983, P NATL ACAD SCI-BIOL, V80, P4286, DOI 10.1073/pnas.80.14.4286; YAMASAKI A, 2009, MOL BIOL CELL; Yu S, 2006, J CELL BIOL, V174, P359, DOI 10.1083/jcb.200603044; Zahoor MA, 2010, J GEN VIROL, V91, P1939, DOI 10.1099/vir.0.020990-0; Zong M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023350	36	33	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29995	10.1371/journal.pone.0029995	http://dx.doi.org/10.1371/journal.pone.0029995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279557	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900035
J	Nakamura, Y; Kitamura, N; Shinogi, D; Yoshida, M; Goda, O; Murai, R; Kamino, H; Arakawa, H				Nakamura, Yasuyuki; Kitamura, Noriaki; Shinogi, Daisuke; Yoshida, Masaki; Goda, Olga; Murai, Ryuya; Kamino, Hiroki; Arakawa, Hirofumi			BNIP3 and NIX Mediate Mieap-Induced Accumulation of Lysosomal Proteins within Mitochondria	PLOS ONE			English	Article							CELL-DEATH; PERMEABILITY TRANSITION; APOPTOSIS; DOMAIN; NIP3	Mieap, a p53-inducible protein, controls mitochondrial quality by repairing unhealthy mitochondria. During repair, Mieap induces the accumulation of intramitochondrial lysosomal proteins (designated MALM for Mieap-induced accumulation of lysosome-like organelles within mitochondria) by interacting with NIX, leading to the elimination of oxidized mitochondrial proteins. Here, we report that an additional mitochondrial outer membrane protein, BNIP3, is also involved in MALM. BNIP3 interacts with Mieap in a reactive oxygen species (ROS)-dependent manner via the BH3 domain of BNIP3 and the coiled-coil domains of Mieap. The knockdown of endogenous BNIP3 expression severely inhibited MALM. Although the overexpression of either BNIP3 or NIX did not cause a remarkable change in the mitochondrial membrane potential (MMP), the co-expression of all three exogenous proteins, Mieap, BNIP3 and NIX, caused a dramatic reduction in MMP, implying that the physical interaction of Mieap, BNIP3 and NIX at the mitochondrial outer membrane may regulate the opening of a pore in the mitochondrial double membrane. This effect was not related to cell death. These results suggest that two mitochondrial outer membrane proteins, BNIP3 and NIX, mediate MALM in order to maintain mitochondrial integrity. The physical interaction of Mieap, BNIP3 and NIX at the mitochondrial outer membrane may play a critical role in the translocation of lysosomal proteins from the cytoplasm to the mitochondrial matrix.	[Nakamura, Yasuyuki; Kitamura, Noriaki; Shinogi, Daisuke; Yoshida, Masaki; Goda, Olga; Murai, Ryuya; Kamino, Hiroki; Arakawa, Hirofumi] Natl Canc Ctr, Res Inst, Div Canc Biol, Tokyo 104, Japan	National Cancer Center - Japan	Arakawa, H (corresponding author), Natl Canc Ctr, Res Inst, Div Canc Biol, Tokyo 104, Japan.	harakawa@ncc.go.jp	Arakawa, Hirofumi/L-3459-2013	Arakawa, Hirofumi/0000-0001-6077-0638; KAMINO, HIROKI/0000-0002-2489-0453	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor and Welfare, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	Grant support was provided by a grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a grant-in-aid from the Ministry of Health, Labor and Welfare for the 3rd-Term Comprehensive 10-year Strategy for Cancer Control and for Cancer Research, Japan; and a grant-in-aid for National Cancer Center Research and Development Fund, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bocharov EV, 2007, J BIOL CHEM, V282, P16256, DOI 10.1074/jbc.M701745200; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Cizeau J, 2000, ONCOGENE, V19, P5453, DOI 10.1038/sj.onc.1203929; Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim JY, 2002, ARCH BIOCHEM BIOPHYS, V398, P147, DOI 10.1006/abbi.2001.2673; Kitamura N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016060; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; Miyamoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016054; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16	14	35	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30767	10.1371/journal.pone.0030767	http://dx.doi.org/10.1371/journal.pone.0030767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292033	Green Published, gold, Green Submitted			2022-12-27	WOS:000301703800029
J	Qu, Z; Li, LZ; Luo, JY; Wang, P; Yu, SB; Mou, TM; Zheng, XF; Hu, ZL				Qu, Zhen; Li, Lanzhi; Luo, Junyuan; Wang, Peng; Yu, Sibin; Mou, Tongmin; Zheng, Xingfei; Hu, Zhongli			QTL Mapping of Combining Ability and Heterosis of Agronomic Traits in Rice Backcross Recombinant Inbred Lines and Hybrid Crosses	PLOS ONE			English	Article							GENETIC-BASIS; ORYZA-SATIVA; MAIZE; YIELD; IDENTIFICATION; POPULATION; MARKERS; PERFORMANCE; PREDICTION; COMPONENTS	Background: Combining ability effects are very effective genetic parameters in deciding the next phase of breeding programs. Although some breeding strategies on the basis of evaluating combining ability have been utilized extensively in hybrid breeding, little is known about the genetic basis of combining ability. Combining ability is a complex trait that is controlled by polygenes. With the advent and development of molecular markers, it is feasible to evaluate the genetic bases of combining ability and heterosis of elite rice hybrids through QTL analysis. Methodology/Principal Findings: In the present study, we first developed a QTL-mapping method for dissecting combining ability and heterosis of agronomic traits. With three testcross populations and a BCRIL population in rice, biometric and QTL analyses were conducted for ten agronomic traits. The significance of general combining ability and special combining ability for most of the traits indicated the importance of both additive and non-additive effects on expression levels. A large number of additive effect QTLs associated with performance per se of BCRIL and general combining ability, and dominant effect QTLs associated with special combining ability and heterosis were identified for the ten traits. Conclusions/Significance: The combining ability of agronomic traits could be analyzed by the QTL mapping method. The characteristics revealed by the QTLs for combining ability of agronomic traits were similar with those by multitudinous QTLs for agronomic traits with performance per se of BCRIL. Several QTLs (1-6 in this study) were identified for each trait for combining ability. It demonstrated that some of the QTLs were pleiotropic or linked tightly with each other. The identification of QTLs responsible for combining ability and heterosis in the present study provides valuable information for dissecting genetic basis of combining ability.	[Qu, Zhen; Li, Lanzhi; Zheng, Xingfei; Hu, Zhongli] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Qu, Zhen] Chinese Acad Agr Sci, Key Lab Oil Crop Biol, Minist Agr, Oil Crops Res Inst, Wuhan, Peoples R China; [Li, Lanzhi] Hunan Agr Univ, Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Coll Biosafety Sci & Technol, Changsha, Hunan, Peoples R China; [Luo, Junyuan; Wang, Peng; Yu, Sibin; Mou, Tongmin] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Wuhan University; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Hunan Agricultural University; Huazhong Agricultural University	Qu, Z (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	tongminmou@yahoo.com.cn; huzhongli@whu.edu.cn		, sibin/0000-0003-0458-7526; WANG, PENG/0000-0001-5927-6739	973 Program [2011CB100102, 2006CB101707]; National Natural Science Foundation of China [31000666]; Hunan Provincial Education Department [10C0817]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Education Department(Hunan Provincial Education Department)	This work was financially supported by the 973 Program (No. 2011CB100102 and 2006CB101707), the National Natural Science Foundation of China (No. 31000666) and the Scientific Research Fund of Hunan Provincial Education Department (No. 10C0817). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balestre M, 2008, GENET MOL RES, V7, P1106, DOI 10.4238/vol7-4gmr491; Basbag S, 2007, HEREDITAS, V144, P185, DOI 10.1111/j.2007.0018-0661.01998.x; Cerna FJ, 1997, THEOR APPL GENET, V95, P460, DOI 10.1007/s001220050583; Franco MC, 2001, EUPHYTICA, V118, P265, DOI 10.1023/A:1017560118666; Frascaroli E, 2007, GENETICS, V176, P625, DOI 10.1534/genetics.106.064493; Groh S, 1998, CROP SCI, V38, P1062, DOI 10.2135/cropsci1998.0011183X003800040030x; Hossain M., 1995, Geojournal, V35, P286, DOI 10.1007/BF00989136; Jordan DR, 2003, THEOR APPL GENET, V106, P559, DOI 10.1007/s00122-002-1144-5; Joshi SK, 2004, HEREDITAS, V141, P115, DOI 10.1111/j.1601-5223.2004.01730.x; Joshi SP, 2001, BIOCHEM GENET, V39, P179, DOI 10.1023/A:1010293325482; Li LZ, 2008, GENETICS, V180, P1725, DOI 10.1534/genetics.108.091942; Liu XC, 2004, BREEDING SCI, V54, P341, DOI 10.1270/jsbbs.54.341; MO H, 1991, Acta Agronomica Sinica, V17, P1; Mo HD, 1982, J JIANGSU AGR COLL, V3, P51; ROJAS BA, 1952, AGRON J, V44, P462, DOI 10.2134/agronj1952.00021962004400090002x; Roy Bidhan, 2001, Indian Journal of Genetics and Plant Breeding, V61, P162; Schrag TA, 2006, THEOR APPL GENET, V113, P1037, DOI 10.1007/s00122-006-0363-6; Schrag TA, 2010, THEOR APPL GENET, V120, P451, DOI 10.1007/s00122-009-1208-x; Shukla SK, 2008, PLANT BREEDING, V127, P28, DOI 10.1111/j.1439-0523.2007.01432.x; Verma OP, 2004, FIELD CROP RES, V88, P91, DOI 10.1016/S0378-4290(03)00080-7; WALEJKO RN, 1977, CROP SCI, V17, P647, DOI 10.2135/cropsci1977.0011183X001700040043x; Wang P, 2012, MOL BREEDING, V29, P99, DOI 10.1007/s11032-010-9529-7; Xiao J, 1996, THEOR APPL GENET, V92, P230, DOI 10.1007/BF00223380; Xiao JH, 1996, NATURE, V384, P223, DOI 10.1038/384223a0; XIAO JH, 1995, GENETICS, V140, P745; Xing YZ, 2002, THEOR APPL GENET, V105, P248, DOI 10.1007/s00122-002-0952-y; Xiong LX, 1999, THEOR APPL GENET, V98, P243, DOI 10.1007/s001220051064; You AQ, 2006, GENETICS, V172, P1287, DOI 10.1534/genetics.105.047209; Yu ChuanYuan, 2008, Acta Agronomica Sinica, V34, P1308, DOI 10.1016/S1875-2780(08)60044-9; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226; Yuan L. P., 1988, Hybrid rice. Proceedings of an international symposium, Changsha, China, 6-10 October 1986., P7; ZENG ZB, 1994, GENETICS, V136, P1457	32	43	47	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e28463	10.1371/journal.pone.0028463	http://dx.doi.org/10.1371/journal.pone.0028463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291881	Green Published, gold			2022-12-27	WOS:000301703800002
J	Tanae, K; Horiuchi, T; Matsuo, Y; Katayama, S; Kawamukai, M				Tanae, Katsuhiro; Horiuchi, Tomitaka; Matsuo, Yuzy; Katayama, Satoshi; Kawamukai, Makoto			Histone Chaperone Asf1 Plays an Essential Role in Maintaining Genomic Stability in Fission Yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; DNA-REPLICATION; CELL-CYCLE; S-PHASE; SACCHAROMYCES-CEREVISIAE; CHECKPOINT PATHWAYS; DAMAGE CHECKPOINTS; H3K56 ACETYLATION; IN-VIVO; CHROMATIN	The histone H3-H4 chaperone Asf1 is involved in chromatin assembly (or disassembly), histone exchange, regulation of transcription, and chromatin silencing in several organisms. To investigate the essential functions of Asf1 in Schizosaccharomyces pombe, asf1-ts mutants were constructed by random mutagenesis using PCR. One mutant (asf1-33(ts)) was mated with mutants in 77 different kinase genes to identify synthetic lethal combinations. The asf1-33 mutant required the DNA damage checkpoint factors Chk1 and Rad3 for its survival at the restrictive temperature. Chk1, but not Cds1, was phosphorylated in the asf1-33 mutant at the restrictive temperature, indicating that the DNA damage checkpoint was activated in the asf1-33 mutant. DNA damage occured in the asf1-33 mutant, with degradation of the chromosomal DNA observed through pulse-field gel electrophoresis and the formation of Rad22 foci. Sensitivity to micrococcal nuclease in the asf1-33 mutant was increased compared to the asf1(+) strain at the restrictive temperature, suggesting that asf1 mutations also caused a defect in overall chromatin structure. The Asf1-33 mutant protein was mislocalized and incapable of binding histones. Furthermore, histone H3 levels at the centromeric outer repeat region were decreased in the asf1-33 mutant and heterochromatin structure was impaired. Finally, sim3, which encodes a CenH3 histone chaperone, was identified as a strong suppressor of the asf1-33 mutant. Taken together, these results clearly indicate that Asf1 plays an essential role in maintaining genomic stability in S. pombe.	[Tanae, Katsuhiro; Horiuchi, Tomitaka; Matsuo, Yuzy; Katayama, Satoshi; Kawamukai, Makoto] Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan	Shimane University	Tanae, K (corresponding author), Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan.	kawamuka@life.shimane-u.ac.jp	Kawamukai, Makoto/AET-1038-2022	Kawamukai, Makoto/0000-0003-2929-8798				Adkins MW, 2004, J BIOL CHEM, V279, P52069, DOI 10.1074/jbc.M406113200; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/S0960-9822(03)00869-8; Dohke K, 2008, GENES CELLS, V13, P1027, DOI 10.1111/j.1365-2443.2008.01225.x; Dunleavy EM, 2007, MOL CELL, V28, P1029, DOI 10.1016/j.molcel.2007.10.010; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Greenall A, 2006, J BIOL CHEM, V281, P8732, DOI 10.1074/jbc.M512170200; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Haldar D, 2008, EUKARYOT CELL, V7, P800, DOI 10.1128/EC.00379-07; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; Hodson JA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng134; Kato H, 2008, CELL CYCLE, V7, P1085; KIM UJ, 1988, EMBO J, V7, P2211, DOI 10.1002/j.1460-2075.1988.tb03060.x; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Linger J, 2005, GENETICS, V171, P1513, DOI 10.1534/genetics.105.043000; Lopez-Girona A, 2001, P NATL ACAD SCI USA, V98, P11289, DOI 10.1073/pnas.191557598; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Malay AD, 2008, J BIOL CHEM, V283, P14022, DOI 10.1074/jbc.M800594200; Matsuo Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1992, DOI 10.1271/bbb.60087; Matsuo Y, 2011, J BIOL CHEM, V286, P13775, DOI 10.1074/jbc.M110.169953; Matsuo Y, 2010, BIOSCI BIOTECH BIOCH, V74, P685, DOI 10.1271/bbb.90967; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mousson F, 2007, CHROMOSOMA, V116, P79, DOI 10.1007/s00412-006-0087-z; Murakami H, 2000, BIOCHEM J, V349, P1, DOI 10.1042/0264-6021:3490001; Nakamura T, 2001, MOL BIOL CELL, V12, P3955, DOI 10.1091/mbc.12.12.3955; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Ozoe F, 2002, MOL CELL BIOL, V22, P7105, DOI 10.1128/MCB.22.20.7105-7119.2002; Paul SK, 2009, FEBS J, V276, P5076, DOI 10.1111/j.1742-4658.2009.07204.x; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; Prado F, 2004, EMBO REP, V5, P497, DOI 10.1038/sj.embor.7400128; Ramey CJ, 2004, MOL CELL BIOL, V24, P10313, DOI 10.1128/MCB.24.23.10313-10327.2004; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Rhind N, 2000, J CELL SCI, V113, P3889; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Sanematsu F, 2006, J BIOL CHEM, V281, P13817, DOI 10.1074/jbc.M511590200; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Schulz LL, 2006, FASEB J, V20, P488, DOI 10.1096/fj.05-5020fje; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Shandilya Jayasha, 2007, Subcell Biochem, V41, P111; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Shimada M, 2006, J MOL HISTOL, V37, P253, DOI 10.1007/s10735-006-9039-4; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Umehara T, 2002, GENES CELLS, V7, P59, DOI 10.1046/j.1356-9597.2001.00493.x; Yamane K, 2011, MOL CELL, V41, P56, DOI 10.1016/j.molcel.2010.12.009; Yokoyama M, 2007, DNA REPAIR, V6, P770, DOI 10.1016/j.dnarep.2007.01.005	62	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30472	10.1371/journal.pone.0030472	http://dx.doi.org/10.1371/journal.pone.0030472			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291963	Green Published, gold, Green Submitted			2022-12-27	WOS:000301703800016
J	Grandin, N; Corset, L; Charbonneau, M				Grandin, Nathalie; Corset, Laetitia; Charbonneau, Michel			Genetic and Physical Interactions between Tel2 and the Med15 Mediator Subunit in Saccharomyces cerevisiae	PLOS ONE			English	Article							TELOMERE LENGTH REGULATION; R2TP COMPLEX; CELL-GROWTH; LIFE-SPAN; YEAST; PROTEIN; DNA; TRANSCRIPTION; CHECKPOINT; STABILITY	Background: In budding yeast, the highly conserved Tel2 protein is part of several complexes and its main function is now believed to be in the biogenesis of phosphatidyl inositol 3-kinase related kinases. Principal Findings: To uncover potentially novel functions of Tel2, we set out to isolate temperature-sensitive (ts) mutant alleles of TEL2 in order to perform genetic screenings. MED15/GAL11, a subunit of Mediator, a general regulator of transcription, was isolated as a suppressor of these mutants. The isolated tel2 mutants exhibited a short telomere phenotype that was partially rescued by MED15/GAL11 overexpression. The tel2-15mutant was markedly deficient in the transcription of EST2, coding for the catalytic subunit of telomerase, potentially explaining the short telomere phenotype of this mutant. In parallel, a two-hybrid screen identified an association between Tel2 and Rvb2, a highly conserved member of the AAA+ family of ATPases further found by in vivo co-immunoprecipitation to be tight and constitutive. Transiently overproduced Tel2 and Med15/Gal11 associated together, suggesting a potential role for Tel2 in transcription. Other Mediator subunits, as well as SUA7/TFIIB, also rescued the tel2-ts mutants. Significance: Altogether, the present data suggest the existence of a novel role for Tel2, namely in transcription, possibly in cooperation with Rvb2 and involving the existence of physical interactions with the Med15/Gal11 Mediator subunit.	[Grandin, Nathalie; Charbonneau, Michel] Ecole Normale Super Lyon, BioSci Gerland IFR128, CNRS, UMR 5239, F-69364 Lyon, France; [Grandin, Nathalie; Corset, Laetitia; Charbonneau, Michel] Univ Tours, CNRS, UMR 6239, Tours, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); Universite de Tours	Grandin, N (corresponding author), Ecole Normale Super Lyon, BioSci Gerland IFR128, CNRS, UMR 5239, F-69364 Lyon, France.	Michel.Charbonneau@univ-tours.fr	Charbonneau, Michel/AGN-4817-2022	Charbonneau, Michel/0000-0002-6684-6151; Babin, Laetitia/0000-0002-9912-7321; Nathalie, Grandin/0000-0003-0393-2586	LIGUE contre le Cancer, Comite inter-regional Rhone-Alpes Auvergne	LIGUE contre le Cancer, Comite inter-regional Rhone-Alpes Auvergne	This work was supported by grants from the "LIGUE contre le Cancer, Comite inter-regional Rhone-Alpes Auvergne". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Anderson CM, 2008, GENE DEV, V22, P854, DOI 10.1101/gad.1646208; Anderson CM, 2008, CELL CYCLE, V7, P3695, DOI 10.4161/cc.7.23.7154; Benard C, 2001, DEVELOPMENT, V128, P4045; BOTSTEIN D, 1979, GENE, V8, P17, DOI 10.1016/0378-1119(79)90004-0; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Chang M, 2008, SCIENCE, V320, P60, DOI 10.1126/science.1155132; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dahlseid JN, 2003, EUKARYOT CELL, V2, P134, DOI 10.1128/EC.2.1.134-142.2003; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Flavin P, 2011, FEBS LETT, V585, P2537, DOI 10.1016/j.febslet.2011.07.005; Gallant P, 2007, TRENDS CELL BIOL, V17, P187, DOI 10.1016/j.tcb.2007.02.005; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; GRANDIN N, 1993, MOL CELL BIOL, V13, P2113, DOI 10.1128/MCB.13.4.2113; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Hector RE, 2007, MOL CELL, V27, P851, DOI 10.1016/j.molcel.2007.08.007; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; Huen J, 2010, BIOCHEM CELL BIOL, V88, P29, DOI [10.1139/o09-122, 10.1139/O09-122]; Hurov KE, 2010, GENE DEV, V24, P1939, DOI 10.1101/gad.1934210; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Izumi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000468; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Jiang N, 2003, J BIOL CHEM, V278, P21678, DOI 10.1074/jbc.M300286200; Jonsson ZO, 2001, J BIOL CHEM, V276, P16279, DOI 10.1074/jbc.M011523200; Kanoh J, 2007, GENES CELLS, V12, P1301, DOI 10.1111/j.1365-2443.2007.01142.x; Kota RS, 1998, NUCLEIC ACIDS RES, V26, P1528, DOI 10.1093/nar/26.6.1528; Kota RS, 1999, CHROMOSOMA, V108, P278, DOI 10.1007/s004120050379; Li WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-132; Lim CS, 2001, CURR BIOL, V11, P1706, DOI 10.1016/S0960-9822(01)00526-7; Lim MK, 2007, J MOL BIOL, V374, P9, DOI 10.1016/j.jmb.2007.09.013; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; Moser SC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000451; Ohdate H, 2003, J BIOL CHEM, V278, P14647, DOI 10.1074/jbc.M213220200; Ottaviani A, 2008, BIOCHIMIE, V90, P93, DOI 10.1016/j.biochi.2007.07.022; PINTO I, 1992, CELL, V68, P977, DOI 10.1016/0092-8674(92)90040-J; Porter SE, 1996, NUCLEIC ACIDS RES, V24, P582, DOI 10.1093/nar/24.4.582; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; Runge KW, 1996, MOL CELL BIOL, V16, P3094; Sabourin M, 2008, TRENDS CELL BIOL, V18, P337, DOI 10.1016/j.tcb.2008.04.004; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; Shevchenko A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r167; Shikata M, 2007, J BIOL CHEM, V282, P5346, DOI 10.1074/jbc.M607432200; Stirling PC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002057; SUSSEL L, 1995, GENETICS, V141, P873; SUZUKI Y, 1994, MOL CELL BIOL, V14, P3791, DOI 10.1128/MCB.14.6.3791; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Takai H, 2010, GENE DEV, V24, P2019, DOI 10.1101/gad.1956410; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061; Zhu XF, 2011, MOL CELL BIOL, V31, P2413, DOI 10.1128/MCB.05242-11	55	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30451	10.1371/journal.pone.0030451	http://dx.doi.org/10.1371/journal.pone.0030451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291956	Green Published, gold			2022-12-27	WOS:000301639600020
J	Pan, X; Jones, M; Jiang, J; Zaprazna, K; Yu, DN; Pear, W; Maillard, I; Atchison, ML				Pan, Xuan; Jones, Morgan; Jiang, Jie; Zaprazna, Kristina; Yu, Duonan; Pear, Warren; Maillard, Ivan; Atchison, Michael L.			Increased Expression of PcG Protein YY1 Negatively Regulates B Cell Development while Allowing Accumulation of Myeloid Cells and LT-HSC Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR YY1; HEMATOPOIETIC STEM; SELF-RENEWAL; DNA-BINDING; CYCLIN D3; TARGETED DISRUPTION; FACTOR GATA-3; IN-VIVO; C-MYC; GENE	Ying Yang 1 (YY1) is a multifunctional Polycomb Group (PcG) transcription factor that binds to multiple enhancer binding sites in the immunoglobulin (Ig) loci and plays vital roles in early B cell development. PcG proteins have important functions in hematopoietic stem cell renewal and YY1 is the only mammalian PcG protein with DNA binding specificity. Conditional knock-out of YY1 in the mouse B cell lineage results in arrest at the pro-B cell stage, and dosage effects have been observed at various YY1 expression levels. To investigate the impact of elevated YY1 expression on hematopoetic development, we utilized a mouse in vivo bone marrow reconstitution system. We found that mouse bone marrow cells expressing elevated levels of YY1 exhibited a selective disadvantage as they progressed from hematopoietic stem/progenitor cells to pro-B, pre-B, immature B and re-circulating B cell stages, but no disadvantage of YY1 over-expression was observed in myeloid lineage cells. Furthermore, mouse bone marrow cells expressing elevated levels of YY1 displayed enrichment for cells with surface markers characteristic of long-term hematopoietic stem cells (HSC). YY1 expression induced apoptosis in mouse B cell lines in vitro, and resulted in down-regulated expression of anti-apoptotic genes Bcl-xl and NF kappa B2, while no impact was observed in a mouse myeloid line. B cell apoptosis and LT-HSC enrichment induced by YY1 suggest that novel strategies to induce YY1 expression could have beneficial effects in the treatment of B lineage malignancies while preserving normal HSCs.	[Pan, Xuan; Jiang, Jie; Zaprazna, Kristina; Atchison, Michael L.] Univ Penn, Sch Vet, Dept Anim Biol, Philadelphia, PA 19104 USA; [Jones, Morgan; Maillard, Ivan] Univ Michigan, Dept Med, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Jones, Morgan; Maillard, Ivan] Univ Michigan, Dept Cell & Dev Biol, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Yu, Duonan] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Pear, Warren] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Pan, X (corresponding author), Univ Penn, Sch Vet, Dept Anim Biol, Philadelphia, PA 19104 USA.	atchison@vet.upenn.edu		Maillard, Ivan/0000-0003-1312-6748	National Institutes of Health [GM071830, AI079002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047833, R01AI079002, R01AI091627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM071830 and AI079002 to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; Anderson MK, 2002, DEV BIOL, V246, P103, DOI 10.1006/dbio.2002.0674; Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Austen M, 1998, ONCOGENE, V17, P511, DOI 10.1038/sj.onc.1201968; Bain M, 2005, EUR J CELL BIOL, V84, P543, DOI 10.1016/j.ejcb.2004.12.024; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Calame K, 2007, GENE DEV, V21, P1145, DOI 10.1101/gad.1559007; Cato MH, 2011, MOL CELL BIOL, V31, P127, DOI 10.1128/MCB.00650-10; Chen D, 2001, EXP HEMATOL, V29, P971, DOI 10.1016/S0301-472X(01)00670-1; COLLINS LS, 1987, J IMMUNOL, V138, P1082; Cooper AB, 2006, NAT IMMUNOL, V7, P489, DOI 10.1038/ni1324; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Erkeland SJ, 2003, BLOOD, V101, P1111, DOI 10.1182/blood-2002-04-1207; FINDLEY HW, 1982, BLOOD, V60, P1305; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Galvin KM, 1997, MOL CELL BIOL, V17, P3723, DOI 10.1128/MCB.17.7.3723; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Gil J, 2005, DNA CELL BIOL, V24, P117, DOI 10.1089/dna.2005.24.117; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Gordon SJ, 2003, J IMMUNOL, V170, P5549, DOI 10.4049/jimmunol.170.11.5549; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Hodawadekar S, 2007, EXP CELL RES, V313, P331, DOI 10.1016/j.yexcr.2006.10.015; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Johnson K, 2003, CURR OPIN GENET DEV, V13, P522, DOI 10.1016/j.gde.2003.08.004; Kajiume T, 2004, EXP HEMATOL, V32, P571, DOI 10.1016/j.exphem.2004.03.001; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; LEE JS, 1995, GENE DEV, V9, P1188, DOI 10.1101/gad.9.10.1188; Lichy JH, 1996, NUCLEIC ACIDS RES, V24, P4700, DOI 10.1093/nar/24.23.4700; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Matthias P, 2005, NAT REV IMMUNOL, V5, P497, DOI 10.1038/nri1633; Meccia E, 2003, BBA-GENE STRUCT EXPR, V1626, P1, DOI 10.1016/S0167-4781(03)00018-6; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; Peled JU, 2010, CELL RES, V20, P631, DOI 10.1038/cr.2010.55; Petkova V, 2001, J BIOL CHEM, V276, P7932, DOI 10.1074/jbc.M007411200; RIGGS KJ, 1993, MOL CELL BIOL, V13, P7487, DOI 10.1128/MCB.13.12.7487; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Srinivasan L, 2005, J CELL BIOCHEM, V96, P689, DOI 10.1002/jcb.20562; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Walowitz JL, 1998, J BIOL CHEM, V273, P6656, DOI 10.1074/jbc.273.12.6656; Wang XL, 2008, BBA-MOL CELL RES, V1783, P1876, DOI 10.1016/j.bbamcr.2008.05.015; Wei F, 2009, MOL CELL BIOL, V29, P4612, DOI 10.1128/MCB.00234-09; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Yengi L, 1996, CANCER RES, V56, P1974; Yu D, 2003, BLOOD, V101, P1950, DOI 10.1182/blood-2002-06-1797; Yu DN, 2002, ONCOGENE, V21, P1922, DOI 10.1038/sj.onc.1205244; Zweidler-McKay PA, 2005, BLOOD, V106, P3898, DOI 10.1182/blood-2005-01-0355	61	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30656	10.1371/journal.pone.0030656	http://dx.doi.org/10.1371/journal.pone.0030656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292011	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600068
J	Sun, YL; Huang, LQ; Pelosi, P; Wang, CZ				Sun, Ya-Lan; Huang, Ling-Qiao; Pelosi, Paolo; Wang, Chen-Zhu			Expression in Antennae and Reproductive Organs Suggests a Dual Role of an Odorant-Binding Protein in Two Sibling Helicoverpa Species	PLOS ONE			English	Article							PHEROMONE-SENSITIVE NEURONS; ARMIGERA LEPIDOPTERA; SWISS-MODEL; DROSOPHILA-MELANOGASTER; CHEMICAL-IDENTIFICATION; OVIPOSITION DETERRENTS; CHEMOSENSORY PROTEINS; SOLUBLE-PROTEINS; SEX-PHEROMONE; AEDES-AEGYPTI	Odorant-binding proteins (OBPs) mediate both perception and release of semiochemicals in insects. These proteins are the ideal targets for understanding the olfactory code of insects as well as for interfering with their communication system in order to control pest species. The two sibling Lepidopteran species Helicoverpa armigera and H. assulta are two major agricultural pests. As part of our aim to characterize the OBP repertoire of these two species, here we focus our attention on a member of this family, OBP10, particularly interesting for its expression pattern. The protein is specifically expressed in the antennae of both sexes, being absent from other sensory organs. However, it is highly abundant in seminal fluid, is transferred to females during mating and is eventually found on the surface of fertilised eggs. Among the several different volatile compounds present in reproductive organs, OBP10 binds 1-dodecene, a compound reported as an insect repellent. These results have been verified in both H. armigera and H. assulta with no apparent differences between the two species. The recombinant OBP10 binds, besides 1-dodecene, some linear alcohols and several aromatic compounds. The structural similarity of OBP10 with OBP1 of the mosquito Culex quinquefasciatus, a protein reported to bind an oviposition pheromone, and its affinity with 1-dodecene suggest that OBP10 could be a carrier for oviposition deterrents, favouring spreading of the eggs in these species where cannibalism is active among larvae.	[Sun, Ya-Lan; Huang, Ling-Qiao; Pelosi, Paolo; Wang, Chen-Zhu] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Pelosi, Paolo] Univ Pisa, Dept Biol Crop Plants, Pisa, Italy	Chinese Academy of Sciences; Institute of Zoology, CAS; University of Pisa	Sun, YL (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	ppelosi@agr.unipi.it; czwang@ioz.ac.cn	Rocco, Patricia/I-7460-2012	Rocco, Patricia/0000-0003-1412-7136; Sun, Ya-Lan/0000-0002-4468-1333	National Science Fund for Distinguished Young Scholars [30925026]; National Natural Science Foundation of China [30921063]; Chinese Academy of Sciences [KSCX2-EW-N5, 2009S2-32]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Science Fund for Distinguished Young Scholars (grant no. 30925026) and the Fund for Innovative Research Groups (grant no. 30921063) of the National Natural Science Foundation of China, the Chinese Academy of Sciences innovation program (grant no. KSCX2-EW-N5), and the Chinese Academy of Sciences visiting professorship for senior international scientists (grant no. 2009S2-32), that supported a nine-month visit of P. P. at the Institute of Zoology, Beijing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Calvello M, 2003, CELL MOL LIFE SCI, V60, P1933, DOI 10.1007/s00018-003-3186-5; Dani FR, 2011, CHEM SENSES, V36, P335, DOI 10.1093/chemse/bjq137; Dani FR, 2010, J PROTEOME RES, V9, P1822, DOI 10.1021/pr900969k; DONASCIMENTO RR, 1993, J CHEM ECOL, V19, P1993, DOI 10.1007/BF00983802; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Geiselhardt S, 2008, NATURWISSENSCHAFTEN, V95, P247, DOI 10.1007/s00114-007-0312-5; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo L, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.6701; Iovinella I, 2011, J PROTEOME RES, V10, P3439, DOI 10.1021/pr2000754; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Lagarde A, 2011, BIOCHEM J, V437, P423, DOI 10.1042/BJ20110522; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; LAURENCE BR, 1982, J CHEM SOC CHEM COMM, P59, DOI 10.1039/c39820000059; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Li S, 2008, BIOCHEM BIOPH RES CO, V372, P464, DOI 10.1016/j.bbrc.2008.05.064; Liu ML, 2008, J INSECT PHYSIOL, V54, P656, DOI 10.1016/j.jinsphys.2008.01.002; LIU SH, 1989, J AGR FOOD CHEM, V37, P496, DOI 10.1021/jf00086a050; Mao Y, 2010, P NATL ACAD SCI USA, V107, P19102, DOI 10.1073/pnas.1012274107; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Norris DM, 1991, US Patent, Patent No. 5030660; Pelletier J, 2010, J CHEM ECOL, V36, P245, DOI 10.1007/s10886-010-9762-x; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; Schorkopf DLP, 2009, J EXP BIOL, V212, P1153, DOI 10.1242/jeb.021113; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sirot LK, 2008, INSECT BIOCHEM MOLEC, V38, P176, DOI 10.1016/j.ibmb.2007.10.007; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; THIERY D, 1992, EXPERIENTIA, V48, P697, DOI 10.1007/BF02118323; TSCHINKEL WR, 1975, J INSECT PHYSIOL, V21, P753, DOI 10.1016/0022-1910(75)90008-6; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 2005, COMPREHENSIVE INSECT, V3, P753, DOI DOI 10.1016/B0-44-451924-6/00047-8; Wang CZ, 2001, CHINESE SCI BULL, V46, P489, DOI 10.1007/BF03187264; Xu HY, 2006, J INSECT PHYSIOL, V52, P320, DOI 10.1016/j.jinsphys.2005.11.011; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zhang TT, 2011, BIOCHEM BIOPH RES CO, V407, P393, DOI 10.1016/j.bbrc.2011.03.032; Zhao XC, 2006, J COMP PHYSIOL A, V192, P1037, DOI 10.1007/s00359-006-0141-6; Zong N, 2007, PLANTA, V226, P215, DOI 10.1007/s00425-006-0459-x	44	254	272	8	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30040	10.1371/journal.pone.0030040	http://dx.doi.org/10.1371/journal.pone.0030040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291900	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600011
J	Migdalska, AM; van der Weyden, L; Ismail, O; White, JK; Sanchez-Andrade, G; Logan, DW; Arends, MJ; Adams, DJ				Migdalska, Anna M.; van der Weyden, Louise; Ismail, Ozama; White, Jacqueline K.; Sanchez-Andrade, Gabriela; Logan, Darren W.; Arends, Mark J.; Adams, David J.		Sanger Mouse Genetics Project	Modeling Partial Monosomy for Human Chromosome 21q11.2-q21.1 Reveals Haploinsufficient Genes Influencing Behavior and Fat Deposition	PLOS ONE			English	Article							SOCIAL RECOGNITION; CRITICAL REGION; DELETION; MICE; PATIENT; OBESITY; MEMORY; RESOURCE; TRISOMY; RIP140	Haploinsufficiency of part of human chromosome 21 results in a rare condition known as Monosomy 21. This disease displays a variety of clinical phenotypes, including intellectual disability, craniofacial dysmorphology, skeletal and cardiac abnormalities, and respiratory complications. To search for dosage-sensitive genes involved in this disorder, we used chromosome engineering to generate a mouse model carrying a deletion of the Lipi-Usp25 interval, syntenic with 21q11.2-q21.1 in humans. Haploinsufficiency for the 6 genes in this interval resulted in no gross morphological defects and behavioral analysis performed using an open field test, a test of anxiety, and tests for social interaction were normal in monosomic mice. Monosomic mice did, however, display impaired memory retention compared to control animals. Moreover, when fed a high-fat diet (HFD) monosomic mice exhibited a significant increase in fat mass/fat percentage estimate compared with controls, severe fatty changes in their livers, and thickened subcutaneous fat. Thus, genes within the Lipi-Usp25 interval may participate in memory retention and in the regulation of fat deposition.	[Migdalska, Anna M.; van der Weyden, Louise; Ismail, Ozama; White, Jacqueline K.; Sanchez-Andrade, Gabriela; Logan, Darren W.; Adams, David J.; Sanger Mouse Genetics Project] Wellcome Trust Sanger Inst, Cambridge, England; [Arends, Mark J.] Univ Cambridge, Dept Pathol, Addenbrookes Hosp, Cambridge CB2 1QP, England	Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Migdalska, AM (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	da1@sanger.ac.uk	Migdalska-Richards, Anna/E-4214-2018; Ismail, Ozama/AFQ-9517-2022; Logan, Darren/D-5629-2009; van der Weyden, Louise/AAV-5711-2021	Migdalska-Richards, Anna/0000-0001-6992-0751; Logan, Darren/0000-0003-1545-5510; van der Weyden, Louise/0000-0002-0645-1879; Adams, David/0000-0001-9490-0306; Ismail, Ozama/0000-0002-0871-3924	Wellcome Trust; Cancer Research-UK; Kay Kendall Leukaemia Fund; Cancer Research UK [13031] Funding Source: researchfish; Medical Research Council [G0600717B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research-UK(Cancer Research UK); Kay Kendall Leukaemia Fund; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Wellcome Trust and by Cancer Research-UK. LvdW is supported by the Kay Kendall Leukaemia Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; Ahlbom BE, 1996, AM J MED GENET, V64, P501; Asnicar MA, 2001, ENDOCRINOLOGY, V142, P4394, DOI 10.1210/en.142.10.4394; Besson V, 2007, HUM MOL GENET, V16, P2040, DOI 10.1093/hmg/ddm152; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; CHETTOUH Z, 1995, AM J HUM GENET, V57, P62; Engelmann M, 2011, NAT PROTOC, V6, P1152, DOI 10.1038/nprot.2011.353; HEITMANN BL, 1995, AM J CLIN NUTR, V61, P1213, DOI 10.1093/ajcn/61.6.1213; Joosten AMS, 1997, PRENATAL DIAG, V17, P271, DOI 10.1002/(SICI)1097-0223(199703)17:3<271::AID-PD51>3.0.CO;2-P; Katzaki E, 2010, AM J MED GENET A, V152A, P1711, DOI 10.1002/ajmg.a.33478; Katzenstein JM, 2009, NEUROCASE, V15, P97, DOI 10.1080/13554790802631910; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; KORENBERG JR, 1991, HUM GENET, V87, P112, DOI 10.1007/BF00204163; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Lindstrand A, 2010, CLIN GENET, V77, P145, DOI 10.1111/j.1399-0004.2009.01289.x; Liu PT, 1998, GENETICS, V150, P1155; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan J, 2001, DIABETES, V50, P686, DOI 10.2337/diabetes.50.3.686; Lyle R, 2009, EUR J HUM GENET, V17, P454, DOI 10.1038/ejhg.2008.214; Mitsui S, 2009, EUR J NEUROSCI, V30, P2368, DOI 10.1111/j.1460-9568.2009.07029.x; Mori MA, 2004, AM J MED GENET A, V127A, P69, DOI 10.1002/ajmg.a.20622; Nieters A, 2002, EUR J NUTR, V41, P210, DOI 10.1007/s00394-002-0378-y; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Olson LE, 2007, HUM MOL GENET, V16, P774, DOI 10.1093/hmg/ddm022; POEHLMAN ET, 1986, AM J CLIN NUTR, V43, P723, DOI 10.1093/ajcn/43.5.723; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178; Richter K, 2005, LEARN MEMORY, V12, P407, DOI 10.1101/lm.97505; Riegel M, 2005, EUR J MED GENET, V48, P167, DOI 10.1016/j.ejmg.2005.01.026; Roberson EDO, 2011, EUR J HUM GENET, V19, P235, DOI 10.1038/ejhg.2010.150; Robertson E, 1987, TERATOCARCINOMAS EMB; ROLAND B, 1990, CLIN GENET, V37, P423; Sato M, 2010, FASEB J, V24, P2375, DOI 10.1096/fj.09-145466; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; Tinkel-Vernon H, 2003, AM J MED GENET A, V120A, P142, DOI 10.1002/ajmg.a.10210; Wakui K, 2002, J HUM GENET, V47, P511, DOI 10.1007/s100380200076; Wang DY, 2010, FASEB J, V24, P947, DOI 10.1096/fj.09-140806; Wen XY, 2003, HUM MOL GENET, V12, P1131, DOI 10.1093/hmg/ddg124; White R, 2000, NAT MED, V6, P1368, DOI 10.1038/82183; Yu T, 2010, MAMM GENOME, V21, P258, DOI 10.1007/s00335-010-9262-x; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354	43	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29681	10.1371/journal.pone.0029681	http://dx.doi.org/10.1371/journal.pone.0029681			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276124	Green Submitted, Green Published, gold			2022-12-27	WOS:000301568100015
J	Streitberger, KJ; Sack, I; Krefting, D; Pfuller, C; Braun, J; Paul, F; Wuerfel, J				Streitberger, Kaspar-Josche; Sack, Ingolf; Krefting, Dagmar; Pfueller, Caspar; Braun, Juergen; Paul, Friedemann; Wuerfel, Jens			Brain Viscoelasticity Alteration in Chronic-Progressive Multiple Sclerosis	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; ROBUST; ACCURATE; IMAGES; MRI; OPTIMIZATION; REGISTRATION; DIAGNOSIS; CRITERIA	Introduction: Viscoelastic properties indicate structural alterations in biological tissues at multiple scales with high sensitivity. Magnetic Resonance Elastography (MRE) is a novel technique that directly visualizes and quantitatively measures biomechanical tissue properties in vivo. MRE recently revealed that early relapsing-remitting multiple sclerosis (MS) is associated with a global decrease of the cerebral mechanical integrity. This study addresses MRE and MR volumetry in chronic-progressive disease courses of MS. Methods: We determined viscoelastic parameters of the brain parenchyma in 23 MS patients with primary or secondary chronic progressive disease course in comparison to 38 age-and gender-matched healthy individuals by multifrequency MRE, and correlated the results with clinical data, T2 lesion load and brain volume. Two viscoelastic parameters, the shear elasticity mu and the powerlaw exponent alpha, were reduced according to the springpot model and compared to literature values of relapsing-remitting MS. Results: In chronic-progressive MS patients, mu and alpha were reduced by 20.5% and 6.1%, respectively, compared to healthy controls. MR volumetry yielded a weaker correlation: Total brain volume loss in MS patients was in the range of 7.5% and 1.7% considering the brain parenchymal fraction. All findings were significant (P<0.001). Conclusions: Chronic-progressive MS disease courses show a pronounced reduction of the cerebral shear elasticity compared to early relapsing-remitting disease. The powerlaw exponent alpha decreased only in the chronic-progressive stage of MS, suggesting an alteration in the geometry of the cerebral mechanical network due to chronic neuroinflammation.	[Streitberger, Kaspar-Josche; Sack, Ingolf; Krefting, Dagmar] Charite, Dept Radiol, D-13353 Berlin, Germany; [Pfueller, Caspar; Paul, Friedemann; Wuerfel, Jens] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Pfueller, Caspar; Paul, Friedemann; Wuerfel, Jens] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Pfueller, Caspar; Paul, Friedemann; Wuerfel, Jens] Max Delbruck Ctr Mol Med, Berlin, Germany; [Braun, Juergen] Charite, Inst Med Informat, D-13353 Berlin, Germany; [Wuerfel, Jens] Univ Lubeck, Inst Neuroradiol, Lubeck, Germany; [Paul, Friedemann] Charite, Clin & Expt Multiple Sclerosis Res Ctr, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lubeck; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Streitberger, KJ (corresponding author), Charite, Dept Radiol, D-13353 Berlin, Germany.	ingolf.sack@charite.de	Paul, Friedemann/ABF-9415-2020	paul, friedemann/0000-0002-6378-0070; Braun, Jurgen/0000-0001-5183-7546; Wuerfel, Jens/0000-0002-0034-8053; Krefting, Dagmar/0000-0002-7238-5339	German Research Foundation [Exc 257, Sa 901/3]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation (Exc 257 to F. P. and C. P. and Sa 901/3 to I. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Charil A, 2006, LANCET NEUROL, V5, P841, DOI 10.1016/S1474-4422(06)70572-5; Freimann FB, 2011, NEURORADIOLOGY  0503; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Gurtovenko AA, 2005, ADV POLYM SCI, V182, P171, DOI 10.1007/b135561; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Klatt D, 2007, PHYS MED BIOL, V52, P7281, DOI 10.1088/0031-9155/52/24/006; Klatt D, 2010, PHYS MED BIOL, V55, P6445, DOI 10.1088/0031-9155/55/21/007; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Miller DH, 2002, BRAIN, V125, P1676, DOI 10.1093/brain/awf177; Montalban X, 2010, NEUROLOGY, V74, P427, DOI 10.1212/WNL.0b013e3181cec45c; Muthupillai R, 1996, NAT MED, V2, P601, DOI 10.1038/nm0596-601; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Riek K, 2011, MR ELASTOGRAPHY MICE, P1476; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Sack I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023451; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Sastre-Garriga J, 2005, BRAIN, V128, P1454, DOI 10.1093/brain/awh498; Schregel K, 2011, BIOMECHANICAL PROPER; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Wuerfel J, 2004, BRAIN, V127, P111, DOI 10.1093/brain/awh007; Wuerfel J, 2010, NEUROIMAGE, V49, P2520, DOI 10.1016/j.neuroimage.2009.06.018; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	29	155	160	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29888	10.1371/journal.pone.0029888	http://dx.doi.org/10.1371/journal.pone.0029888			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276134	Green Accepted, Green Published, gold			2022-12-27	WOS:000301568100019
J	Yan, QY; van der Gast, CJ; Yu, YH				Yan, Qingyun; van der Gast, Christopher J.; Yu, Yuhe			Bacterial Community Assembly and Turnover within the Intestines of Developing Zebrafish	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; FAUNAL SIMILARITY; GENETIC-ANALYSIS; NATURE-RESERVES; WASTE-WATER; IN-VIVO; DIVERSITY; MICROBIOTA; TAXA; SIZE	Background: The majority of animal associated microorganisms are present in digestive tract communities. These intestinal communities arise from selective pressures of the gut habitats as well as host's genotype are regarded as an extra 'organ' regulate functions that have not evolved wholly on the host. They are functionally essential in providing nourishment, regulating epithelial development, and influencing immunity in the vertebrate host. As vertebrates are born free of microorganisms, what is poorly understood is how intestinal bacterial communities assemble and develop in conjunction with the development of the host. Methodology/Principal Findings: Set within an ecological framework, we investigated the bacterial community assembly and turnover within the intestinal habitats of developing zebrafish (from larvae to adult animals). Spatial and temporal species-richness relationships and Mantel and partial Mantel tests revealed that turnover was low and that richness and composition was best predicted by time and not intestinal volume (habitat size) or changes in food diet. We also observed that bacterial communities within the zebrafish intestines were deterministically assembled (reflected by the observed low turnover) switching to stochastic assembly in the later stages of zebrafish development. Conclusions/Significance: This study is of importance as it provides a novel insight into how intestinal bacterial communities assemble in tandem with the host's development (from early to adult stages). It is our hope that by studying intestinal microbiota of this vertebrate model with such or some more refined approaches in the future could well provide ecological insights for clinical benefit. In addition, this study also adds to our still fledgling knowledge of how spatial and temporal species-richness relationships are shaped and provides further mounting evidence that bacterial community assembly and dynamics are shaped by both deterministic and stochastic considerations.	[Yan, Qingyun; Yu, Yuhe] Chinese Acad Sci, Inst Hydrobiol, Key Lab Biodivers & Conservat Aquat Organisms, Wuhan, Peoples R China; [van der Gast, Christopher J.] NERC Ctr Ecol & Hydrol, Wallingford, Oxon, England	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; UK Centre for Ecology & Hydrology (UKCEH)	Yan, QY (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Biodivers & Conservat Aquat Organisms, Wuhan, Peoples R China.	yhyu@ihb.ac.cn	van der Gast, Christopher/G-1153-2011	van der Gast, Christopher/0000-0003-1101-4048	Major State Basic Research Development Program of China [2009CB118705]; National Natural Science Foundation of China [30970358]; UK Natural Environment Research Council (NERC); Natural Environment Research Council [CEH010021] Funding Source: researchfish	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Major State Basic Research Development Program of China (2009CB118705) and the National Natural Science Foundation of China (30970358). CJvdG was supported by the UK Natural Environment Research Council (NERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2003, ECOL LETT, V6, P749, DOI 10.1046/j.1461-0248.2003.00497.x; Ager D, 2010, ENVIRON MICROBIOL, V12, P670, DOI 10.1111/j.1462-2920.2009.02107.x; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Ayarza JM, 2011, MICROB ECOL, V61, P486, DOI 10.1007/s00248-010-9762-y; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Barnes RJ, 2010, J HAZARD MATER, V184, P73, DOI 10.1016/j.jhazmat.2010.08.006; Bates JM, 2006, DEV BIOL, V297, P374, DOI 10.1016/j.ydbio.2006.05.006; Belasky P, 1996, PALAEOGEOGR PALAEOCL, V122, P119, DOI 10.1016/0031-0182(95)00092-5; Bell T, 2005, SCIENCE, V308, P1884, DOI 10.1126/science.1111318; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Cremonesi L, 1997, BIOTECHNIQUES, V22, P326, DOI 10.2144/97222rr01; Diamond J.M., 1975, P342; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Farber SA, 2001, SCIENCE, V292, P1385, DOI 10.1126/science.1060418; Faro A, 2009, ZEBRAFISH, V6, P361, DOI 10.1089/zeb.2009.0617; Fowler J., 1998, PRACTICAL STAT FIELD, P130; GILPIN ME, 1980, NATURE, V285, P567, DOI 10.1038/285567a0; GRAFEN A, 2006, MODERN STAT LIFE SCI; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; HIGGS AJ, 1980, NATURE, V285, P568, DOI 10.1038/285568a0; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Hubbell Stephen P., 2001, V32, pi; Kanther M, 2010, CURR OPIN IMMUNOL, V22, P10, DOI 10.1016/j.coi.2010.01.006; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Ofiteru ID, 2010, P NATL ACAD SCI USA, V107, P15345, DOI 10.1073/pnas.1000604107; Oliver A, 2012, MICROBIAL ECOLOGICAL THEORY: CURRENT PERSPECTIVES, P71; PRESTON FW, 1960, ECOLOGY, V41, P611, DOI 10.2307/1931793; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; RAUP DM, 1979, J PALEONTOL, V53, P1213; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rawls JF, 2007, PEDIATR PULM, P146; Rawls JF, 2007, P NATL ACAD SCI USA, V104, P7622, DOI 10.1073/pnas.0702386104; Reche I, 2005, ECOLOGY, V86, P1715, DOI 10.1890/04-1587; Rogers GB, 2010, J CLIN MICROBIOL, V48, P78, DOI 10.1128/JCM.01324-09; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rowan AK, 2003, FEMS MICROBIOL ECOL, V43, P195, DOI 10.1111/j.1574-6941.2003.tb01059.x; Shi XJ, 2008, TOXICOL APPL PHARM, V230, P23, DOI 10.1016/j.taap.2008.01.043; SIMBERLOFF D, 1982, AM NAT, V120, P41, DOI 10.1086/283968; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Smoot JC, 2010, AQUAT BIOL, V8, P105, DOI 10.3354/ab00202; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; van der Gast CJ, 2008, ENVIRON MICROBIOL, V10, P1411, DOI 10.1111/j.1462-2920.2007.01550.x; van der Gast CJ, 2008, ADV APPL MICROBIOL, V64, P167, DOI 10.1016/S0065-2164(08)00406-1; van der Gast CJ, 2006, ENVIRON MICROBIOL, V8, P1048, DOI 10.1111/j.1462-2920.2006.00996.x; van der Gast CJ, 2011, ENVIRON MICROBIOL, V13, P241, DOI 10.1111/j.1462-2920.2010.02326.x; van der Gast CJ, 2005, ENVIRON MICROBIOL, V7, P1220, DOI 10.1111/j.1462-2920.2005.00802.x; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Yu YH, 2008, FEMS MICROBIOL ECOL, V63, P328, DOI 10.1111/j.1574-6941.2007.00430.x	52	69	73	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30603	10.1371/journal.pone.0030603	http://dx.doi.org/10.1371/journal.pone.0030603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276219	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000301457200069
J	Al-Mulla, F; Bitar, MS; Feng, JW; Park, S; Yeung, KC				Al-Mulla, Fahd; Bitar, Milad S.; Feng, Jingwei; Park, Sungdae; Yeung, Kam C.			A New Model for Raf Kinase Inhibitory Protein Induced Chemotherapeutic Resistance	PLOS ONE			English	Article							NF-KAPPA-B; INDUCIBLE EXPRESSION; OXIDATIVE STRESS; CELL SENSITIVITY; CANCER-CELLS; NRF2; KEAP1; RKIP; GENE; UBIQUITINATION	Therapeutic resistance remains the most challenging aspect of treating cancer. Raf kinase inhibitory protein (RKIP) emerged as a molecule capable of sensitizing cancerous cells to radio- and chemotherapy. Moreover, this small evolutionary conserved molecule, endows significant resistance to cancer therapy when its expression is reduced or lost. RKIP has been shown to inhibit the Raf-MEK-ERK, NF kappa B, GRK and activate the GSK3 beta signaling pathways. Inhibition of Raf-MEK-ERK and NF kappa B remains the most prominent pathways implicated in the sensitization of cells to therapeutic drugs. Our purpose was to identify a possible link between RKIP-KEAP 1-NRF2 and drug resistance. To that end, RKIP-KEAP 1 association was tested in human colorectal cancer tissues using immunohistochemistry. RKIP miRNA silencing and its inducible overexpression were employed in HEK-293 immortalized cells, HT29 and HCT116 colon cancer cell lines to further investigate our aim. We show that RKIP enhanced Kelch-like ECH-associated protein1 (KEAP 1) stability in colorectal cancer tissues and HT29 CRC cell line. RKIP silencing in immortalized HEK-293 cells (termed HEK-499) correlated significantly with KEAP 1 protein degradation and subsequent NRF2 addiction in these cells. Moreover, RKIP depletion in HEK-499, compared to control cells, bestowed resistance to supra physiological levels of H2O2 and Cisplatin possibly by upregulating NF-E2-related nuclear factor 2 (NRF2) responsive genes. Similarly, we observed a direct correlation between the extent of apoptosis, after treatment with Adriamycin, and the expression levels of RKIP/KEAP 1 in HT29 but not in HCT116 CRC cells. Our data illuminate, for the first time, the NRF2-KEAP 1 pathway as a possible target for personalized therapeutic intervention in RKIP depleted cancers.	[Al-Mulla, Fahd] Kuwait Univ, Dept Pathol, Hlth Sci Ctr, Fac Med, Safat, Kuwait; [Bitar, Milad S.] Kuwait Univ, Dept Pharmacol, Hlth Sci Ctr, Fac Med, Safat, Kuwait; [Feng, Jingwei; Park, Sungdae; Yeung, Kam C.] Univ Toledo, Dept Biochem & Canc Biol, Coll Med, Toledo, OH 43606 USA	Kuwait University; Kuwait University; University System of Ohio; University of Toledo	Al-Mulla, F (corresponding author), Kuwait Univ, Dept Pathol, Hlth Sci Ctr, Fac Med, Safat, Kuwait.	fahd@al-mulla.org	Al-Mulla, Fahd/E-2068-2015	Al-Mulla, Fahd/0000-0001-5409-3829	Kuwait University [MG02/08]; Kuwait Foundation for the Advancement of Sciences [2006-1302-07]; Research Administration of Kuwait University [GM01/01, GM01/05]; University of Texas Health Science Center (UTHSC); Health Sciences Center, Kuwait University	Kuwait University; Kuwait Foundation for the Advancement of Sciences(Kuwait Foundation for the Advancement of Sciences (KFAS)); Research Administration of Kuwait University; University of Texas Health Science Center (UTHSC); Health Sciences Center, Kuwait University	This study was supported by funds from Kuwait University grant (MG02/08) and the Kuwait Foundation for the Advancement of Sciences grant number (2006-1302-07). RCF is supported by GM01/01 and GM01/05 grants from Research Administration of Kuwait University. KCY was supported in part by a University of Texas Health Science Center (UTHSC) Translation Research Stimulation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the staff of the Research Core Facility (RCF) at the Health Sciences Center, Kuwait University for their excellent support and technical assistance. Mr. Waleed Al-Ali for his help with Immunohistochemistry, Betty Thomas in the Proteomics Unit, Sunitha Pramod for their help with the Western blotting, confocal microscope and tissue culture and Dr. Oliver Rath for the cells used in the study.	Al-Mulla F, 2006, J CLIN ONCOL, V24, P5672, DOI 10.1200/JCO.2006.07.5499; al-Mulla F, 2011, MOL BIOSYST, V7, P928, DOI 10.1039/c0mb00208a; Al-Mulla F, 2011, CANCER RES, V71, P1334, DOI 10.1158/0008-5472.CAN-10-3102; Baritaki S, 2007, J IMMUNOL, V179, P5441, DOI 10.4049/jimmunol.179.8.5441; Baritaki S, 2010, CRIT REV IMMUNOL, V30, P31, DOI 10.1615/CritRevImmunol.v30.i1.20; Baritaki S, 2009, CANCER RES, V69, P8376, DOI 10.1158/0008-5472.CAN-09-1069; Chatterjee D, 2004, J BIOL CHEM, V279, P17515, DOI 10.1074/jbc.M313816200; Chen Y, 2009, MED ONCOL, V26, P463, DOI 10.1007/s12032-008-9147-y; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Cho HY, 2005, FREE RADICAL BIO MED, V38, P325, DOI 10.1016/j.freeradbiomed.2004.10.013; Copple IM, 2010, J BIOL CHEM, V285, P16782, DOI 10.1074/jbc.M109.096545; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Fourquet S, 2010, J BIOL CHEM, V285, P8463, DOI 10.1074/jbc.M109.051714; Fu Z, 2006, PROSTATE, V66, P248, DOI 10.1002/pros.20319; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Hagan S, 2005, CLIN CANCER RES, V11, P7392, DOI 10.1158/1078-0432.CCR-05-0283; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Hu R, 2006, LIFE SCI, V79, P1944, DOI 10.1016/j.lfs.2006.06.019; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jiang T, 2010, CANCER RES, V70, P5486, DOI 10.1158/0008-5472.CAN-10-0713; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Katsuoka F, 2005, J BIOL CHEM, V280, P4483, DOI 10.1074/jbc.M411451200; Keller ET, 2004, CANCER LETT, V207, P131, DOI 10.1016/j.canlet.2004.02.006; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Li HZ, 2008, MOL CANCER RES, V6, P917, DOI 10.1158/1541-7786.MCR-08-0093; Nioi P, 2004, MUTAT RES-FUND MOL M, V555, P149, DOI 10.1016/j.mrfmmm.2004.05.023; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Ruan L, 2010, J CELL BIOCHEM, V110, P975, DOI 10.1002/jcb.22611; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Schuierer MM, 2006, ONCOL REP, V16, P451; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Stacy DR, 2006, HEAD NECK-J SCI SPEC, V28, P813, DOI 10.1002/hed.20430; Tang HH, 2010, FEBS LETT, V584, P662, DOI 10.1016/j.febslet.2009.12.051; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Umemoto M, 2001, BRIT J CANCER, V85, P1032, DOI 10.1054/bjoc.2001.2034; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Woods KM, 2008, INT J RADIAT ONCOL, V72, P153, DOI 10.1016/j.ijrobp.2008.04.072; Wu K, 2009, CRIT REV IMMUNOL, V29, P241, DOI 10.1615/CritRevImmunol.v29.i3.40; Yeung K, 2000, MOL CELL BIOL, V20, P3079, DOI 10.1128/MCB.20.9.3079-3085.2000; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200	46	29	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29532	10.1371/journal.pone.0029532	http://dx.doi.org/10.1371/journal.pone.0029532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279539	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900017
J	Arias, P; Robles-Garcia, V; Sanmartin, G; Flores, J; Cudeiro, J				Arias, Pablo; Robles-Garcia, Veronica; Sanmartin, Gabriel; Flores, Julian; Cudeiro, Javier			Virtual Reality as a Tool for Evaluation of Repetitive Rhythmic Movements in the Elderly and Parkinson's Disease Patients	PLOS ONE			English	Article							EXPOSURE THERAPY; TAPPING TEST; REHABILITATION; ENVIRONMENT; HAND; MECHANISMS; BEHAVIOR; STROKE; WORLD; GAME	This work presents an immersive Virtual Reality (VR) system to evaluate, and potentially treat, the alterations in rhythmic hand movements seen in Parkinson's disease (PD) and the elderly (EC), by comparison with healthy young controls (YC). The system integrates the subjects into a VR environment by means of a Head Mounted Display, such that subjects perceive themselves in a virtual world consisting of a table within a room. In this experiment, subjects are presented in 1st person perspective, so that the avatar reproduces finger tapping movements performed by the subjects. The task, known as the finger tapping test (FT), was performed by all three subject groups, PD, EC and YC. FT was carried out by each subject on two different days (sessions), one week apart. In each FT session all subjects performed FT in the real world (FTREAL) and in the VR (FTVR); each mode was repeated three times in randomized order. During FT both the tapping frequency and the coefficient of variation of inter-tap interval were registered. FTVR was a valid test to detect differences in rhythm formation between the three groups. Intra-class correlation coefficients (ICC) and mean difference between days for FTVR (for each group) showed reliable results. Finally, the analysis of ICC and mean difference between FTVR vs FTREAL, for each variable and group, also showed high reliability. This shows that FT evaluation in VR environments is valid as real world alternative, as VR evaluation did not distort movement execution and detects alteration in rhythm formation. These results support the use of VR as a promising tool to study alterations and the control of movement in different subject groups in unusual environments, such as during fMRI or other imaging studies.	[Arias, Pablo; Robles-Garcia, Veronica; Cudeiro, Javier] Univ A Coruna, Neurosci & Motor Control Grp NEUROcom, Dept Med INEF Galicia, La Coruna, Spain; [Sanmartin, Gabriel; Flores, Julian] Univ Santiago de Compostela, Inst Invest Tecnolox, Santiago De Compostela, Spain	Universidade da Coruna; Universidade de Santiago de Compostela	Arias, P (corresponding author), Univ A Coruna, Neurosci & Motor Control Grp NEUROcom, Dept Med INEF Galicia, La Coruna, Spain.	jcud@udc.es	Robles-García, Veronica/D-5265-2011; Arias, Pablo/C-7926-2015; Arias, Pablo/AAP-9721-2021; Flores, Julian/L-5932-2014	Robles-García, Veronica/0000-0002-5337-6314; Arias, Pablo/0000-0002-9029-5310; Flores, Julian/0000-0002-9607-1756; Cudeiro, Javier/0000-0002-6597-6077	Xunta de Galicia, Spain [2007/000140-0]	Xunta de Galicia, Spain(Xunta de Galicia)	This work was supported by Xunta de Galicia (Conselleria de Educacion-2007/000140-0 and Direccion Xeral de I+D+i; 2010-2012), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovich SV, 2009, RESTOR NEUROL NEUROS, V27, P209, DOI 10.3233/RNN-2009-0471; Albani G, 2002, NEUROL SCI, V23, pS49, DOI 10.1007/s100720200064; Albani G, 2010, STUD HEALTH TECHNOL, V154, P92, DOI 10.3233/978-1-60750-561-7-92; Aoki T, 2003, EXP BRAIN RES, V152, P270, DOI 10.1007/s00221-003-1552-z; Astolfi L, 2004, P ANN INT IEEE EMBS, V26, P4405; August K., 2006, C P IEEE ENG MED BIO, P3692, DOI [10.1109/IEMBS.2006.260144, DOI 10.1109/IEMBS.2006.260144]; Aymerich-Franch L, 2010, CYBERPSYCH BEH SOC N, V13, P649, DOI 10.1089/cyber.2009.0412; Broeren J, 2007, ACTA NEUROL SCAND, V116, P157, DOI 10.1111/j.1600-0404.2007.00821.x; Broeren J, 2007, NEUROREHAB NEURAL RE, V21, P180, DOI 10.1177/1545968306290774; Difede J, 2002, CYBERPSYCHOL BEHAV, V5, P529, DOI 10.1089/109493102321018169; Foki T, 2010, EXP NEUROL, V225, P416, DOI 10.1016/j.expneurol.2010.07.019; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galati G, 2000, EXP BRAIN RES, V133, P156, DOI 10.1007/s002210000375; Garcia-Palacios A, 2002, BEHAV RES THER, V40, P983, DOI 10.1016/S0005-7967(01)00068-7; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Grasso R, 2000, NEUROREPORT, V11, P775, DOI 10.1097/00001756-200003200-00024; Hamilton EC, 2002, SURG ENDOSC, V16, P406, DOI 10.1007/s00464-001-8149-z; Hausdorff JM, 2001, PHYSICA A, V302, P138, DOI 10.1016/S0378-4371(01)00460-5; Henderson A, 2007, TOP STROKE REHABIL, V14, P52, DOI 10.1310/tsr1402-52; Holcombe AO, 2009, TRENDS COGN SCI, V13, P216, DOI 10.1016/j.tics.2009.02.005; Horlings CGC, 2009, NEUROSCI LETT, V451, P227, DOI 10.1016/j.neulet.2008.12.057; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jung SH, 2005, ARCH PHYS MED REHAB, V86, P2218, DOI 10.1016/j.apmr.2005.04.015; Keshner EA, 2004, ASSIST TECHNOL, V16, P54, DOI 10.1080/10400435.2004.10132074; Keshner Emily A, 2004, J Neuroeng Rehabil, V1, P8, DOI 10.1186/1743-0003-1-8; Leijnse JNAL, 2008, J NEUROPHYSIOL, V100, P3225, DOI 10.1152/jn.90570.2008; Malbos E, 2008, CYBERPSYCHOL BEHAV, V11, P695, DOI 10.1089/cpb.2007.0246; Merians AS, 2009, STUD HEALTH TECHNOL, V145, P109, DOI 10.3233/978-1-60750-018-6-109; Mirelman A, 2010, MOVEMENT DISORD, V25, pS303; Mirelman A, 2010, J GERONTOL A; Murray CD, 2007, DISABIL REHABIL, V29, P1465, DOI 10.1080/09638280601107385; NAKAMURA R, 1978, PERCEPT MOTOR SKILL, V46, P63, DOI 10.2466/pms.1978.46.1.63; NAKAMURA R, 1976, ADV PARKINSONISM, P258; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perani D, 2001, NEUROIMAGE, V14, P749, DOI 10.1006/nimg.2001.0872; Riva G., 1998, Virtual Reality, V3, P259, DOI 10.1007/BF01408706; Rothbaum BO, 2000, J CONSULT CLIN PSYCH, V68, P1020, DOI 10.1037/0022-006X.68.6.1020; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Schettino LF, 2006, EXP BRAIN RES, V168, P186, DOI 10.1007/s00221-005-0080-4; SHIMOYAMA I, 1990, ARCH NEUROL-CHICAGO, V47, P681, DOI 10.1001/archneur.1990.00530060095025; Slater M, 1998, HUM FACTORS, V40, P469, DOI 10.1518/001872098779591368; Stavrinou ML, 2007, BRAIN TOPOGR, V19, P137, DOI 10.1007/s10548-007-0020-7; Steele E, 2003, CYBERPSYCHOL BEHAV, V6, P633, DOI 10.1089/109493103322725405; Stredney D, 1998, ST HEAL T, V50, P20; VIDAL M, 2004, BRAIN RES COGN BRAIN, P244; Wallach HS, 2009, BEHAV MODIF, V33, P314, DOI 10.1177/0145445509331926; WANG LCT, 1991, IEEE T ROBOTIC AUTOM, V7, P489, DOI 10.1109/70.86079; Wertham FI, 1929, J NERV MENT DIS, V69, P486, DOI 10.1097/00005053-192905000-00002; Wu G, 1999, ACTA NEUROL BELG, V99, P182; Yambe T, 2002, BIOMED PHARMACOTHER, V56, p367S; You SH, 2005, STROKE, V36, P1166, DOI 10.1161/01.STR.0000162715.43417.91	52	26	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30021	10.1371/journal.pone.0030021	http://dx.doi.org/10.1371/journal.pone.0030021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279559	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900037
J	Kathrani, A; Holder, A; Catchpole, B; Alvarez, L; Simpson, K; Werling, D; Allenspach, K				Kathrani, Aarti; Holder, Angela; Catchpole, Brian; Alvarez, Lorena; Simpson, Kenneth; Werling, Dirk; Allenspach, Karin			TLR5 Risk-Associated Haplotype for Canine Inflammatory Bowel Disease Confers Hyper-Responsiveness to Flagellin	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-5; BLOOD MONONUCLEAR-CELLS; EPITHELIAL BARRIER; DENDRITIC CELLS; MESSENGER-RNA; EXPRESSION; RECOGNITION; BACTERIA; ACTIVATION; RESPONSES	Single nucleotide polymorphisms (SNP) in the TLR5 gene have been associated with human inflammatory bowel disease (IBD) and animal models of this disease. We recently demonstrated a significant association between three non-synonymous SNPs in the canine TLR5 gene and IBD in German shepherd dogs (GSDs). However, so far, no direct link between these SNPs and a disturbance in TLR5 function was shown. In the present study, we determined the functional significance of the canine TLR5 SNPs by transfecting the identified risk-protective and risk-associated haplotype into human embryonic kidney cells (HEK) and assessed nuclear factor-kappa B (NF-kB) activation and CXCL8 production after stimulation. In addition, a whole blood assay for TLR5 activation was developed using blood derived from carrier dogs of either haplotype. There was a significant increase in NF-kappa B activity when cells transfected with the risk-associated TLR5 haplotype were stimulated with flagellin compared to the cells expressing the risk-protective TLR5 haplotype. This difference in NFkB activation correlated with CXCL8 expression in the supernatant measured by ELISA. Furthermore, whole blood taken from carrier dogs of the risk-associated TLR5 haplotype produced significantly more TNF after stimulation with flagellin compared to that taken from carriers of the risk-protective haplotype. Thus, we show for the first time a direct functional impact of the canine IBD risk-associated TLR5 haplotype, which results in hyper-responsiveness to flagellin compared to the IBD risk-protective TLR5 haplotype. Our data potentially suggest that similarly to human IBD and experimental models, TLR5 may also play a role in canine IBD. Blocking the hyper-responsive receptor found in susceptible dogs with IBD may alleviate the inappropriate inflammation seen in this disease.	[Kathrani, Aarti; Alvarez, Lorena; Allenspach, Karin] Univ London, Dept Vet Clin Sci, Royal Vet Coll, Hatfield, Herts, England; [Holder, Angela; Catchpole, Brian; Werling, Dirk] Univ London, Dept Pathol & Infect Dis, Royal Vet Coll, Hatfield, Herts, England; [Simpson, Kenneth] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; Cornell University	Kathrani, A (corresponding author), Univ London, Dept Vet Clin Sci, Royal Vet Coll, Hatfield, Herts, England.	kallenspach@rvc.ac.uk	Werling, Dirk/F-5555-2013	Werling, Dirk/0000-0001-5411-4044	Biological Sciences Research Council; Pfizer	Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer(Pfizer)	Funding was provided by the Biological Sciences Research Council and Pfizer. Pfizer did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biological Sciences Research Council had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Allenspach K, 2007, J VET INTERN MED, V21, P700, DOI 10.1892/0891-6640(2007)21[700:CEIDEO]2.0.CO;2; Allenspach K, 2010, VET MICROBIOL, V146, P326, DOI 10.1016/j.vetmic.2010.05.025; Bachmann M, 2006, CELL MICROBIOL, V8, P289, DOI 10.1111/j.1462-5822.2005.00621.x; Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Fritz JH, 2008, TRENDS IMMUNOL, V29, P41, DOI 10.1016/j.it.2007.10.002; Frolova L, 2008, J HISTOCHEM CYTOCHEM, V56, P267, DOI 10.1369/jhc.7A7303.2007; Gewirtz AT, 2006, AM J PHYSIOL-GASTR L, V290, pG1157, DOI 10.1152/ajpgi.00544.2005; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hendrickson BA, 2002, CLIN MICROBIOL REV, V15, P79, DOI 10.1128/CMR.15.1.79-94.2002; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; House AK, 2008, VET IMMUNOL IMMUNOP, V124, P230, DOI 10.1016/j.vetimm.2008.03.012; Karrasch T, 2007, J IMMUNOL, V178, P6522, DOI 10.4049/jimmunol.178.10.6522; Kathrani A, 2011, TISSUE ANTIGENS, V78, P94, DOI 10.1111/j.1399-0039.2011.01707.x; Kathrani A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015740; Magalhaes JG, 2007, SEMIN IMMUNOL, V19, P106, DOI 10.1016/j.smim.2006.12.006; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Nempont C, 2008, J IMMUNOL, V181, P2036, DOI 10.4049/jimmunol.181.3.2036; Ortega-Cava CF, 2006, CLIN VACCINE IMMUNOL, V13, P132, DOI 10.1128/CVI.13.1.132-138.2006; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Schagat T, 2007, CELL NOTES, V17, P9; Shaykhiev R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001393; Stanislawowski M, 2009, J PHYSIOL PHARMACOL, V60, P71; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Szebeni B, 2008, CLIN EXP IMMUNOL, V151, P34, DOI 10.1111/j.1365-2249.2007.03531.x; Uematsu S, 2009, J GASTROENTEROL, V44, P803, DOI 10.1007/s00535-009-0094-y; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Vicente-Suarez I, 2009, IMMUNOL LETT, V125, P114, DOI 10.1016/j.imlet.2009.06.007; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; Wong CK, 2007, AM J RESP CELL MOL, V37, P85, DOI 10.1165/rcmb.2006-0457OC; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	37	39	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30117	10.1371/journal.pone.0030117	http://dx.doi.org/10.1371/journal.pone.0030117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279566	Green Published, Green Submitted, gold			2022-12-27	WOS:000299771900044
J	Olivier, M; Foret, B; Le Vern, Y; Guilloteau, LA				Olivier, Michel; Foret, Benjamin; Le Vern, Yves; Guilloteau, Laurence A.			Capacities of Migrating CD1b(+) Lymph Dendritic Cells to Present Salmonella Antigens to Naive T Cells	PLOS ONE			English	Article							AFFERENT LYMPH; FUNCTIONAL SPECIALIZATION; IMMUNE-RESPONSE; IFN-GAMMA; IN-VIVO; INFECTION; SHEEP; SUBSETS; IMMUNIZATION; ABORTUSOVIS	Dendritic cells (DCs) are well known as professional antigen-presenting cells (APC) able to initiate specific T-cell responses to pathogens in lymph nodes (LN) draining the site of infection. However, the respective contribution of migratory and LN-resident DCs in this process remains unclear. As DC subsets represent important targets for vaccination strategies, more precise knowledge of DC subsets able to present vaccine antigens to T cells efficiently is required. To investigate the capacities of DCs migrating in the lymph (L-DCs) to initiate a specific T-cell response, we used physiologically generated DCs collected from a pseudoafferent lymphatic cannulation model in sheep. The CD1b(+) L-DCs were assessed for presenting antigens from the vaccine attenuated strain of Salmonella enterica serovar Abortusovis. CD1b(+) L-DCs were able to phagocytose, process and to present efficiently Salmonella antigens to effector/memory T cells in vitro. They were shown to be efficient APC for the priming of allogeneic naive T cells associated with inducing both IFN-gamma and IL-4 responses. They were also efficient in presenting Salmonella antigens to autologous naive T cells associated with inducing both IFN-gamma and IL-10 responses. The capacities of L-DCs to process and present Salmonella antigens to T cells were investigated in vivo after conjunctival inoculation of Salmonella. The CD1b(+) L-DCs collected after inoculation were able to induce the proliferative response of CD4(+) T cells suggesting the in vivo capture of Salmonella antigens by the CD1b(+) L-DCs, and their potential to present them directly to CD4(+) T cells. In this study, CD1b(+) L-DCs present potential characteristics of APC to initiate by themselves T cell priming in the LN. They could be used as target cells for driving immune activation in vaccinal strategies.	[Olivier, Michel; Foret, Benjamin; Le Vern, Yves; Guilloteau, Laurence A.] Inst Natl Rech Agron, Infectiol Anim & Sante Publ UR1282, Nouzilly, France	INRAE	Olivier, M (corresponding author), Inst Natl Rech Agron, Infectiol Anim & Sante Publ UR1282, Nouzilly, France.	Laurence.Guilloteau@tours.inra.fr			Institut National de la Recherche Agronomique (INRA)	Institut National de la Recherche Agronomique (INRA)	This work was funded by the Institut National de la Recherche Agronomique (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson CP, 2008, DEV COMP IMMUNOL, V32, P837, DOI 10.1016/j.dci.2007.12.004; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Allenspach EJ, 2008, IMMUNITY, V29, P795, DOI 10.1016/j.immuni.2008.08.013; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bonneau M, 2006, J LEUKOCYTE BIOL, V79, P268, DOI 10.1189/jlb.0605288; Brunner E, 2002, NONPARAMETRIC ANAL L; BUJDOSO R, 1990, International Reviews of Immunology, V6, P177, DOI 10.3109/08830189009056628; Cagiola M, 2007, VET MICROBIOL, V121, P330, DOI 10.1016/j.vetmic.2006.12.018; Chan SSM, 2008, J LEUKOCYTE BIOL, V83, P272, DOI 10.1189/jlb.0607401; Contreras V, 2010, J IMMUNOL, V185, P3313, DOI 10.4049/jimmunol.1000824; de Veer M, 2010, VACCINE, V28, P6597, DOI 10.1016/j.vaccine.2010.07.056; del Rio ML, 2010, IMMUNOL REV, V234, P268, DOI 10.1111/j.0105-2896.2009.00874.x; Epardaud M, 2004, J LEUKOCYTE BIOL, V76, P553, DOI 10.1189/jlb.0404223; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gohin I, 1997, VET IMMUNOL IMMUNOP, V60, P111, DOI 10.1016/S0165-2427(97)00090-1; Guilloteau LA, 2006, VACCINE, V24, P3461, DOI 10.1016/j.vaccine.2006.02.007; He YK, 2006, IMMUNITY, V24, P643, DOI 10.1016/j.immuni.2006.03.014; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hope JC, 2005, J IMMUNOL METHODS, V301, P114, DOI 10.1016/j.jim.2005.04.010; LANTIER F, 1981, INFECT IMMUN, V34, P492, DOI 10.1128/IAI.34.2.492-497.1981; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Lei LY, 2007, VET IMMUNOL IMMUNOP, V120, P177, DOI 10.1016/j.vetimm.2007.06.031; MACKAY CR, 1992, EUR J IMMUNOL, V22, P887, DOI 10.1002/eji.1830220402; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Mount AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001691; Norimatsu M, 2004, VET IMMUNOL IMMUNOP, V98, P193, DOI 10.1016/j.vetimm.2003.12.008; Pascale F, 2008, J IMMUNOL, V180, P5963, DOI 10.4049/jimmunol.180.9.5963; Pedersen LG, 2002, VET IMMUNOL IMMUNOP, V88, P111, DOI 10.1016/S0165-2427(02)00139-3; Randolph GJ, 2006, IMMUNITY, V25, P15, DOI 10.1016/j.immuni.2006.07.003; Ryan S, 2000, J VIROL, V74, P10096, DOI 10.1128/JVI.74.21.10096-10103.2000; Schwartz-Cornil I, 2006, NAT PROTOC, V1, P874, DOI 10.1038/nprot.2006.147; Segura E, 2009, CURR OPIN IMMUNOL, V21, P105, DOI 10.1016/j.coi.2009.03.011; Suraud V, 2008, MICROBES INFECT, V10, P1370, DOI 10.1016/j.micinf.2008.08.003; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Yrlid U, 2002, J IMMUNOL, V169, P108, DOI 10.4049/jimmunol.169.1.108	37	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30430	10.1371/journal.pone.0030430	http://dx.doi.org/10.1371/journal.pone.0030430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279590	Green Published, Green Submitted, gold			2022-12-27	WOS:000299771900067
J	Cherian, SS; Gunjikar, RS; Banerjee, A; Kumar, S; Arankalle, VA				Cherian, Sarah S.; Gunjikar, Rashmi S.; Banerjee, Arpita; Kumar, Satyendra; Arankalle, Vidya A.			Whole Genomes of Chandipura Virus Isolates and Comparative Analysis with Other Rhabdoviruses	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; DYNEIN LIGHT-CHAIN; STRAND RNA VIRUSES; P-PROTEIN; NUCLEOCAPSID PROTEIN; MATRIX PROTEIN; MONOCLONAL-ANTIBODIES; FUNCTIONAL DOMAINS; SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURE	The Chandipura virus (CHPV) belonging to the Vesiculovirus genus and Rhabdoviridae family, has recently been associated with a number of encephalitis epidemics, with high mortality in children, in different parts of India. No full length genome sequences of CHPV isolates were available in GenBank and little is known about the molecular markers for pathogenesis. In the present study, we provide the complete genomic sequences of four isolates from epidemics during 2003-2007. These sequences along with the deduced sequence of the prototype isolate of 1965 were analysed using phylogeny, motif search, homology modeling and epitope prediction methods. Comparison with other rhaboviruses was also done for functional extrapolations. All CHPV isolates clustered with the Isfahan virus and maintained several functional motifs of other rhabdoviruses. A notable difference with the prototype vesiculovirus, Vesicular Stomatitis Virus was in the L-domain flanking sequences of the M protein that are known to be crucial for interaction with host proteins. With respect to the prototype isolate, significant additional mutations were acquired in the 2003-2007 isolates. Several mutations in G mapped onto probable antigenic sites. A mutation in N mapped onto regions crucial for N-N interaction and a putative T-cell epitope. A mutation in the Casein kinase II phosphorylation site in P may attribute to increased rates of phosphorylation. Gene junction comparison revealed changes in the M-G junction of all the epidemic isolates that may have implications on read-through and gene transcription levels. The study can form the basis for further experimental verification and provide additional insights into the virulence determinants of the CHPV.	[Cherian, Sarah S.; Gunjikar, Rashmi S.; Banerjee, Arpita; Kumar, Satyendra; Arankalle, Vidya A.] Natl Inst Virol, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Cherian, SS (corresponding author), Natl Inst Virol, Pune, Maharashtra, India.	varankalle@yahoo.com	Cherian, Sarah/ABA-6207-2021; Cherian, /411001/H-1332-2016	Arankalle, Vidya/0000-0002-9940-3437	Indian Council of Medical Research, India	Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	The financial support from the Indian Council of Medical Research, India is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arankalle VA, 2005, EMERG INFECT DIS, V11, P123, DOI 10.3201/eid1101.040602; BANERJEE AK, 1987, MICROBIOL REV, V51, P66, DOI 10.1128/MMBR.51.1.66-87.1987; Barr JN, 1997, J VIROL, V71, P1794, DOI 10.1128/JVI.71.3.1794-1801.1997; Basak S, 2003, VIROLOGY, V307, P372, DOI 10.1016/S0042-6822(02)00093-4; Basak S, 2007, BIOSCIENCE REP, V27, P275, DOI 10.1007/s10540-007-9054-z; BHATT PN, 1967, INDIAN J MED RES, V55, P1295; Bhattacharya R, 2006, VIROLOGY, V349, P197, DOI 10.1016/j.virol.2006.01.017; BLUMBERG BM, 1988, VIROLOGY, V164, P487, DOI 10.1016/0042-6822(88)90563-6; Bourhy H, 2005, J GEN VIROL, V86, P2849, DOI 10.1099/vir.0.81128-0; Chadha MS, 2005, AM J TROP MED HYG, V73, P566, DOI 10.4269/ajtmh.2005.73.566; Chattopadhyay D, 1997, VIROLOGY, V239, P11, DOI 10.1006/viro.1997.8838; CHATTOPADHYAY D, 1994, CELL MOL BIOL RES, V40, P693; Chen HL, 2009, ARCH VIROL, V154, P1489, DOI 10.1007/s00705-009-0455-0; CYBINSKI DH, 1990, J GEN VIROL, V71, P2065, DOI 10.1099/0022-1317-71-9-2065; Das SC, 2005, J VIROL, V79, P8101, DOI 10.1128/JVI.79.13.8101-8112.2005; DHANDA V, 1970, INDIAN J MED RES, V58, P179; DIETZSCHOLD B, 1987, VIRUS RES, V8, P103, DOI 10.1016/0168-1702(87)90023-2; Gaudier M, 2002, EMBO J, V21, P2886, DOI 10.1093/emboj/cdf284; Geevarghese G, 2005, J MED ENTOMOL, V42, P495, DOI 10.1603/0022-2585(2005)042[0495:DOCVFS]2.0.CO;2; Green TJ, 2006, ACTA CRYSTALLOGR D, V62, P498, DOI 10.1107/S0907444906006809; Gurav YK, 2010, INDIAN J MED RES, V132, P395; Irie T, 2005, J VIROL, V79, P12617, DOI 10.1128/JVI.79.20.12617-12622.2005; IVERSON LE, 1981, CELL, V23, P477, DOI 10.1016/0092-8674(81)90143-4; Jacob Y, 2001, J VIROL, V75, P9613, DOI 10.1128/JVI.75.20.9613-9622.2001; Jadi RS, 2010, INDIAN J MED RES, V132, P155; Jayakar HR, 2000, J VIROL, V74, P9818, DOI 10.1128/JVI.74.21.9818-9827.2000; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KEMP GE, 1975, B WORLD HEALTH ORGAN, V52, P615; Kongsuwan K, 1998, J GEN VIROL, V79, P2573, DOI 10.1099/0022-1317-79-11-2573; Kopecky SA, 2003, J VIROL, V77, P5524, DOI 10.1128/JVI.77.9.5524-5528.2003; Kulkarni-Kale U, 2005, NUCLEIC ACIDS RES, V33, pW168, DOI 10.1093/nar/gki460; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LAFON M, 1983, J GEN VIROL, V64, P843, DOI 10.1099/0022-1317-64-4-843; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Marriott AC, 2005, ARCH VIROL, V150, P671, DOI 10.1007/s00705-004-0452-2; Marston DA, 2007, J GEN VIROL, V88, P1302, DOI 10.1099/vir.0.82692-0; MASTERS PS, 1989, VIROLOGY, V171, P285, DOI 10.1016/0042-6822(89)90540-0; MASTERS PS, 1987, VIROLOGY, V157, P298, DOI 10.1016/0042-6822(87)90272-8; Mondal A, 2010, VIROLOGY, V407, P33, DOI 10.1016/j.virol.2010.07.032; Mullen G, 2002, MED ENTOMOL, P154; MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345; Nara T, 1997, VACCINE, V15, P79, DOI 10.1016/S0264-410X(96)00100-4; NICHOL ST, 1987, J VIROL, V61, P200, DOI 10.1128/JVI.61.1.200-205.1987; Ogino T, 2010, J GEN VIROL, V91, P1311, DOI 10.1099/vir.0.019307-0; PARKER KC, 1994, J IMMUNOL, V152, P163; Pattnaik AK, 1997, J VIROL, V71, P8167, DOI 10.1128/JVI.71.11.8167-8175.1997; PATTNAIK AK, 1995, VIROLOGY, V206, P760, DOI 10.1016/S0042-6822(95)80005-0; PEIRIS JSM, 1993, J MED PRIMATOL, V22, P240; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; POCH O, 1990, J GEN VIROL, V71, P1153, DOI 10.1099/0022-1317-71-5-1153; Poisson N, 2001, J GEN VIROL, V82, P2691, DOI 10.1099/0022-1317-82-11-2691; Pornillos O, 2002, EMBO J, V21, P2397, DOI 10.1093/emboj/21.10.2397; PREHAUD C, 1988, J VIROL, V62, P1; Raha T, 1999, BIOCHEMISTRY-US, V38, P2110, DOI 10.1021/bi980734c; Raha T, 2000, PROTEIN ENG, V13, P437, DOI 10.1093/protein/13.6.437; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rao BL, 2004, LANCET, V364, P869, DOI 10.1016/S0140-6736(04)16982-1; Raux H, 2000, J VIROL, V74, P10212, DOI 10.1128/JVI.74.21.10212-10216.2000; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; RODRIGUE.FM, 1972, B WORLD HEALTH ORGAN, V46, P173; Rodriguez LL, 2002, J GEN VIROL, V83, P2475, DOI 10.1099/0022-1317-83-10-2475; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schnell MJ, 1995, VIROLOGY, V214, P522, DOI 10.1006/viro.1995.0063; SEIF I, 1985, J VIROL, V53, P926, DOI 10.1128/JVI.53.3.926-934.1985; SLEAT DE, 1993, J VIROL, V67, P1334, DOI 10.1128/JVI.67.3.1334-1339.1993; SPIROPOULOU CF, 1993, J VIROL, V67, P3103, DOI 10.1128/JVI.67.6.3103-3110.1993; Stillman EA, 1998, J VIROL, V72, P5565, DOI 10.1128/JVI.72.7.5565-5572.1998; Tan GS, 2007, P NATL ACAD SCI USA, V104, P7229, DOI 10.1073/pnas.0701397104; Tandale BV, 2008, J MED VIROL, V80, P118, DOI 10.1002/jmv.21041; TESH R, 1977, AM J TROP MED HYG, V26, P299, DOI 10.4269/ajtmh.1977.26.299; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TORDO N, 1988, VIROLOGY, V165, P565, DOI 10.1016/0042-6822(88)90600-9; TORDO N, 1986, P NATL ACAD SCI USA, V83, P3914, DOI 10.1073/pnas.83.11.3914; Venkateswarlu CH, 2009, VACCINE, V27, P2845, DOI 10.1016/j.vaccine.2009.02.089; Walker PJ, 1999, J GEN VIROL, V80, P1211, DOI 10.1099/0022-1317-80-5-1211; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Whelan SPJ, 1999, J VIROL, V73, P297, DOI 10.1128/JVI.73.1.297-306.1999; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yang Y, 1999, J VIROL, V73, P1661, DOI 10.1128/JVI.73.2.1661-1664.1999; Zhu RL, 2011, VIRUS RES, V155, P495, DOI 10.1016/j.virusres.2010.12.006	84	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30315	10.1371/journal.pone.0030315	http://dx.doi.org/10.1371/journal.pone.0030315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272333	Green Published, Green Submitted, gold			2022-12-27	WOS:000301454400111
J	Xu, SX; Ju, JF; Zhou, XM; Wang, L; Zhou, KY; Yang, G				Xu, Shixia; Ju, Jianfeng; Zhou, Xuming; Wang, Lian; Zhou, Kaiya; Yang, Guang			Considerable MHC Diversity Suggests That the Functional Extinction of Baiji Is Not Related to Population Genetic Collapse	PLOS ONE			English	Article							HISTOCOMPATIBILITY COMPLEX POLYMORPHISM; CLASS-II VARIATION; NATURAL-SELECTION; LIPOTES-VEXILLIFER; SEQUENCE VARIATION; FINLESS PORPOISES; LOCI; RECOMBINATION; VARIABILITY; OVERDOMINANT	To further extend our understanding of the mechanism causing the current nearly extinct status of the baiji (Lipotes vexillifer), one of the most critically endangered species in the world, genetic diversity at the major histocompatibility complex (MHC) class II DRB locus was investigated in the baiji. Nine highly divergent DRB alleles were identified in 17 samples, with an average of 28.4 (13.2%) nucleotide difference and 16.7 (23.5%) amino acid difference between alleles. The unexpectedly high levels of DRB allelic diversity in the baiji may partly be attributable to its evolutionary adaptations to the freshwater environment which is regarded to have a higher parasite diversity compared to the marine environment. In addition, balancing selection was found to be the main mechanisms in generating sequence diversity at baiji DRB gene. Considerable sequence variation at the adaptive MHC genes despite of significant loss of neutral genetic variation in baiji genome might suggest that intense selection has overpowered random genetic drift as the main evolutionary forces, which further suggested that the critically endangered or nearly extinct status of the baiji is not an outcome of genetic collapse.	[Xu, Shixia; Ju, Jianfeng; Zhou, Xuming; Wang, Lian; Zhou, Kaiya; Yang, Guang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University	Xu, SX (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China.	gyang@njnu.edu.cn		Zhou, Xuming/0000-0002-1100-6294	National Natural Science Foundation of China (NSFC) [30830016]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research was financially supported by the key project of National Natural Science Foundation of China (NSFC) grant no. 30830016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amills M, 2004, HEREDITY, V93, P266, DOI 10.1038/sj.hdy.6800499; Baker CS, 2006, IMMUNOGENETICS, V58, P283, DOI 10.1007/s00251-006-0080-y; Becker L, 2009, IMMUNOGENETICS, V61, P281, DOI 10.1007/s00251-009-0362-2; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Burnham KP, 2002, J APPL STAT, V29, P245, DOI 10.1080/02664760120108755; CLARKE B, 1966, NATURE, V211, P999, DOI 10.1038/211999a0; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Hedrick PW, 2000, EVOLUTION, V54, P2145; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; IUCN 2011, 2009, IUCN RED LIST THREAT; Kennedy LJ, 2002, IMMUNOGENETICS, V54, P348, DOI 10.1007/s00251-002-0465-5; KLEIN J, 1987, HUM IMMUNOL, V19, P155, DOI 10.1016/0198-8859(87)90066-8; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; KLEIN J, 1986, NATURAL HIST MAJOR H; Lochmiller RL, 1996, OIKOS, V76, P594, DOI 10.2307/3546356; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Mikko S, 1997, J HERED, V88, P499, DOI 10.1093/oxfordjournals.jhered.a023144; Munguia-Vega A, 2007, MOL ECOL, V16, P4051, DOI 10.1111/j.1365-294X.2007.03319.x; Murray BW, 1998, IMMUNOGENETICS, V48, P242, DOI 10.1007/s002510050428; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nevo EN, 1997, PHILOS T R SOC B, V352, P381, DOI 10.1098/rstb.1997.0028; OBRIEN SJ, 1988, TRENDS ECOL EVOL, V3, P254, DOI 10.1016/0169-5347(88)90058-4; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Reeves RR, 2003, 139 IUCN SSC CET SPE, V139; Richardson DS, 2003, MOL ECOL, V12, P3523, DOI 10.1046/j.1365-294X.2003.02005.x; Richman AD, 2003, GENET RES, V82, P89, DOI 10.1017/S0016672303006347; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SATTA Y, 1994, P NATL ACAD SCI USA, V91, P7184, DOI 10.1073/pnas.91.15.7184; Simkova A, 2006, EVOL ECOL, V20, P465, DOI 10.1007/s10682-006-0014-z; SLADE RW, 1992, P ROY SOC B-BIOL SCI, V249, P163, DOI 10.1098/rspb.1992.0099; SMITH JM, 1992, J MOL EVOL, V34, P126; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TAKAHATA N, 1990, GENETICS, V124, P967; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TROWSDALE J, 1989, IMMUNOGENETICS, V29, P19, DOI 10.1007/BF02341609; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Turvey ST, 2010, P ROY SOC B-BIOL SCI, V277, P3139, DOI 10.1098/rspb.2010.0584; Van Bressem MF, 1999, DIS AQUAT ORGAN, V38, P53, DOI 10.3354/dao038053; Vassilakos D, 2009, MOL BIOL EVOL, V26, P681, DOI 10.1093/molbev/msn296; Wan QH, 2006, MOL ECOL, V15, P2441, DOI 10.1111/j.1365-294X.2006.02966.x; Weber DS, 2004, MOL ECOL, V13, P711, DOI 10.1111/j.1365-294X.2004.02095.x; Wegner KM, 2003, J EVOLUTION BIOL, V16, P224, DOI 10.1046/j.1420-9101.2003.00519.x; Xu SX, 2008, MOL PHYLOGENET EVOL, V47, P36, DOI 10.1016/j.ympev.2007.05.026; Xu SX, 2007, IMMUNOGENETICS, V59, P581, DOI 10.1007/s00251-007-0223-9; Xu SX, 2010, J MOL EVOL, V71, P6, DOI 10.1007/s00239-010-9357-8; Yang G, 2005, J HERED, V96, P310, DOI 10.1093/jhered/esi055; Yang G, 2003, ACTA THERIOL, V48, P469, DOI 10.1007/BF03192493; Yang G, 2007, CONSERV BIOL, V20, P60; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YUHKI N, 1990, P NATL ACAD SCI USA, V87, P836, DOI 10.1073/pnas.87.2.836; Zhang X, 2003, AQUAT CONSERV, V13, P51, DOI 10.1002/aqc.547; Zhou K., 1998, Aquatic Mammals, V24, P123; ZHOU K, 1977, Acta Zoologica Sinica, V23, P72; Zhou K., 1982, J NANJING NOR COLL N, V4, P71; ZHOU K, 2002, ENCY MARINE MAMMALS, P58; Zhou K, 1958, CHINESE SCI BULL, V1, P21; Zhou Kaiya, 1994, Reports of the International Whaling Commission Special Issue, V15, P347	69	7	8	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30423	10.1371/journal.pone.0030423	http://dx.doi.org/10.1371/journal.pone.0030423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272349	gold, Green Published, Green Submitted			2022-12-27	WOS:000301454400127
J	Campbell, BC; Wang, SSH				Campbell, Benjamin C.; Wang, Samuel S. -H.			Familial Linkage between Neuropsychiatric Disorders and Intellectual Interests	PLOS ONE			English	Article							NATIONAL COMORBIDITY SURVEY; MENTAL-ILLNESS; CREATIVITY; WRITERS; AUTISM; RELATIVES	From personality to neuropsychiatric disorders, individual differences in brain function are known to have a strong heritable component. Here we report that between close relatives, a variety of neuropsychiatric disorders covary strongly with intellectual interests. We surveyed an entire class of high-functioning young adults at an elite university for prospective major, familial incidence of neuropsychiatric disorders, and demographic and attitudinal questions. Students aspiring to technical majors (science/mathematics/engineering) were more likely than other students to report a sibling with an autism spectrum disorder (p = 0.037). Conversely, students interested in the humanities were more likely to report a family member with major depressive disorder (p = 8.8 x 10(-4)), bipolar disorder (p = 0.027), or substance abuse problems (p = 1.9 x 10(-6)). A combined PREdisposition for Subject MattEr (PRESUME) score based on these disorders was strongly predictive of subject matter interests (p = 9.6 x 10(-8)). Our results suggest that shared genetic (and perhaps environmental) factors may both predispose for heritable neuropsychiatric disorders and influence the development of intellectual interests.	[Campbell, Benjamin C.; Wang, Samuel S. -H.] Princeton Univ, Inst Neurosci, Princeton, NJ 08544 USA; [Campbell, Benjamin C.] Rockefeller Univ, Lab Biol Modeling, New York, NY 10021 USA; [Wang, Samuel S. -H.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Rockefeller University; Princeton University	Campbell, BC (corresponding author), Princeton Univ, Inst Neurosci, Princeton, NJ 08544 USA.	sswang@princeton.edu						Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; ANDREASEN NC, 1987, AM J PSYCHIAT, V144, P1288; Aristotle, 1953, PROBLEMATA, V2; Baron-Cohen S, 2005, ANNU REV NEUROSCI, V28, P109, DOI 10.1146/annurev.neuro.27.070203.144137; Baron-Cohen S, 1998, AUTISM, V2, P296, DOI [10.1177/1362361398023008, DOI 10.1177/1362361398023008]; Baron-Cohen S, 2007, HUM NATURE-INT BIOS, V18, P125, DOI 10.1007/s12110-007-9014-0; Baron-Cohen Simon, 1997, AUTISM, V1, P101, DOI [10.1177/1362361397011010, DOI 10.1177/1362361397011010]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIEDERMAN J, 1992, ARCH GEN PSYCHIAT, V49, P728; Bienvenu OJ, 2011, PSYCHOL MED, V41, P33, DOI 10.1017/S003329171000084X; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Hoekstra RA, 2007, ARCH PEDIAT ADOL MED, V161, P372, DOI 10.1001/archpedi.161.4.372; Jamison K.R., 1993, TOUCHED FIRE MANIC D; Kendler KS, 1997, BRIT J PSYCHIAT, V170, P541, DOI 10.1192/bjp.170.6.541; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Ludwig A. M., 1995, PRICE GREATNESS; LUDWIG AM, 1994, AM J PSYCHIAT, V151, P1650; McAdams DP, 2010, ANNU REV PSYCHOL, V61, P517, DOI 10.1146/annurev.psych.093008.100507; Mullen Anna L., 2010, DEGREES INEQUALITY C; POST F, 1994, BRIT J PSYCHIAT, V165, P22, DOI 10.1192/bjp.165.1.22; Post F, 1996, BRIT J PSYCHIAT, V168, P545, DOI 10.1192/bjp.168.5.545; REGIER D A, 1990, Journal of the American Medical Association, V264, P2511, DOI 10.1001/jama.264.19.2511; Rush Benjamin, 1812, MED INQUIRIES OBSERV; Simonton D.K., 2004, CREATIVITY SCI CHANC; Snow C., 1959, 2 CULTURES SCI REVOL; Windham GC, 2009, AUTISM RES, V2, P183, DOI 10.1002/aur.84	27	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30405	10.1371/journal.pone.0030405	http://dx.doi.org/10.1371/journal.pone.0030405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291951	Green Submitted, Green Published, gold			2022-12-27	WOS:000301703800015
J	Lee, K; Tan, J; Morris, MB; Rizzoti, K; Hughes, J; Cheah, PS; Felquer, F; Liu, X; Piltz, S; Lovell-Badge, R; Thomas, PQ				Lee, Kristie; Tan, Jacqueline; Morris, Michael B.; Rizzoti, Karine; Hughes, James; Cheah, Pike See; Felquer, Fernando; Liu, Xuan; Piltz, Sandra; Lovell-Badge, Robin; Thomas, Paul Q.			Congenital Hydrocephalus and Abnormal Subcommissural Organ Development in Sox3 Transgenic Mice	PLOS ONE			English	Article							X-LINKED HYPOPITUITARISM; TRANSCRIPTION FACTORS; NERVOUS-SYSTEM; GENE; DIFFERENTIATION; EXPRESSION; DEFICIENCY; MECHANISMS; BRAIN; IDENTIFICATION	Congenital hydrocephalus (CH) is a life-threatening medical condition in which excessive accumulation of CSF leads to ventricular expansion and increased intracranial pressure. Stenosis (blockage) of the Sylvian aqueduct (Aq; the narrow passageway that connects the third and fourth ventricles) is a common form of CH in humans, although the genetic basis of this condition is unknown. Mouse models of CH indicate that Aq stenosis is associated with abnormal development of the subcommmissural organ (SCO) a small secretory organ located at the dorsal midline of the caudal diencephalon. Glycoproteins secreted by the SCO generate Reissner's fibre (RF), a thread-like structure that descends into the Aq and is thought to maintain its patency. However, despite the importance of SCO function in CSF homeostasis, the genetic program that controls SCO development is poorly understood. Here, we show that the X-linked transcription factor SOX3 is expressed in the murine SCO throughout its development and in the mature organ. Importantly, overexpression of Sox3 in the dorsal diencephalic midline of transgenic mice induces CH via a dose-dependent mechanism. Histological, gene expression and cellular proliferation studies indicate that Sox3 overexpression disrupts the development of the SCO primordium through inhibition of diencephalic roof plate identity without inducing programmed cell death. This study provides further evidence that SCO function is essential for the prevention of hydrocephalus and indicates that overexpression of Sox3 in the dorsal midline alters progenitor cell differentiation in a dose-dependent manner.	[Lee, Kristie; Hughes, James; Cheah, Pike See; Felquer, Fernando; Liu, Xuan; Piltz, Sandra; Thomas, Paul Q.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Tan, Jacqueline] Murdoch Childrens Res Inst, Pituitary Res Unit, Melbourne, Vic, Australia; [Morris, Michael B.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Morris, Michael B.] Royal N Shore Hosp, Kolling Inst Med Res, Sydney, NSW, Australia; [Morris, Michael B.] Royal N Shore Hosp, Sydney Ctr Dev & Regenerat Med, Sydney, NSW, Australia; [Rizzoti, Karine; Lovell-Badge, Robin] Natl Inst Med Res, MRC, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England; [Cheah, Pike See] Univ Putra Malaysia, Dept Human Anat, Serdang, Malaysia	University of Adelaide; Murdoch Children's Research Institute; University of Sydney; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; University of Sydney; MRC National Institute for Medical Research; Universiti Putra Malaysia	Lee, K (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	paul.thomas@adelaide.edu.au	Thomas, Paul Q/K-4497-2012; Cheah, Pike-See/F-4978-2014; Rizzoti, Karine/AAW-1090-2021; Morris, Michael/AAP-6590-2021	Rizzoti, Karine/0000-0003-0711-5452; Morris, Michael/0000-0002-1286-4784; Cheah, Pike See/0000-0003-2181-2502; Lovell-Badge, Robin/0000-0001-9364-4179	Australian Research Council [DP0881509]; Pfizer Australia; UK Medical Research Council [U117512772]; Medical Research Council [MC_U117562207] Funding Source: researchfish; MRC [MC_U117562207] Funding Source: UKRI	Australian Research Council(Australian Research Council); Pfizer Australia(PfizerPfizer Australia); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Australian Research Council (DP0881509 to PQT; http://www.arc.gov.au/). PQT is a Pfizer Australia Research Fellow. Work in the laboratory of RLB is funded by the UK Medical Research Council(U117512772) and performed under approval of the UK home office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PQT is supported by a Fellowship from Pfizer Australia. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Baas D, 2006, EUR J NEUROSCI, V24, P1020, DOI 10.1111/j.1460-9568.2006.05002.x; Bach A, 2003, DEVELOPMENT, V130, P4025, DOI 10.1242/dev.00609; BALLYCUIF L, 1995, MECH DEVELOP, V53, P23, DOI 10.1016/0925-4773(95)00421-1; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; Blackshear PJ, 2003, DEVELOPMENT, V130, P4539, DOI 10.1242/dev.00661; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Castaneyra-Perdomo A, 2004, EUR J ANAT, V8, P107; Chizhikov VV, 2005, DEV BIOL, V277, P287, DOI 10.1016/j.ydbio.2004.10.011; Chizhikov VV, 2004, NAT REV NEUROSCI, V5, P808, DOI 10.1038/nrn1520; Collignon J, 1996, DEVELOPMENT, V122, P509; Davy BE, 2003, HUM MOL GENET, V12, P1163, DOI 10.1093/hmg/ddg122; Dee CT, 2008, DEV BIOL, V320, P289, DOI 10.1016/j.ydbio.2008.05.542; Dietrich P, 2009, HUM MOL GENET, V18, P142, DOI 10.1093/hmg/ddn324; Estivill-Torrus G, 2001, MECH DEVELOP, V109, P215, DOI 10.1016/S0925-4773(01)00527-5; Galarza M, 2002, NEUROSURG REV, V25, P205, DOI 10.1007/s10143-002-0208-y; Garne E, 2010, EUR J PAEDIATR NEURO, V14, P150, DOI 10.1016/j.ejpn.2009.03.005; Goncalves-Mendes N, 2003, GENE, V312, P263, DOI 10.1016/S0378-1119(03)00622-X; Haverkamp F, 1999, EUR J PEDIATR, V158, P474, DOI 10.1007/s004310051123; Holmberg J, 2008, DEVELOPMENT, V135, P1843, DOI 10.1242/dev.020180; Huh MS, 2009, PHYSIOLOGY, V24, P117, DOI 10.1152/physiol.00039.2008; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Ibanez-Tallon I, 2002, HUM MOL GENET, V11, P715, DOI 10.1093/hmg/11.6.715; LagerstromFermer M, 1997, AM J HUM GENET, V60, P910; Lang B, 2006, J CLIN INVEST, V116, P1924, DOI 10.1172/JCI27597; Laumonnier F, 2002, AM J HUM GENET, V71, P1450, DOI 10.1086/344661; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lim Y, 2007, BRAIN RES REV, V53, P17, DOI 10.1016/j.brainresrev.2006.06.004; Louvi A, 2000, DEVELOPMENT, V127, P4061; Muroyama Y, 2002, GENE DEV, V16, P548, DOI 10.1101/gad.937102; Nakajima M, 2011, BRAIN RES, V1382, P275, DOI 10.1016/j.brainres.2011.01.048; Navratilova P, 2009, DEV BIOL, V327, P526, DOI 10.1016/j.ydbio.2008.10.044; OVERHOLSER MD, 1954, ANAT REC, V120, P917, DOI 10.1002/ar.1091200407; RAKIC P, 1968, AM J ANAT, V122, P317, DOI 10.1002/aja.1001220210; Rizzoti K, 2004, NAT GENET, V36, P247, DOI 10.1038/ng1309; RODRIGUEZ EM, 1990, CELL TISSUE RES, V262, P105, DOI 10.1007/BF00327751; Schlosser A, 2009, J IMMUNOL, V183, P3800, DOI 10.4049/jimmunol.0901526; Shih YH, 2010, DEVELOPMENT, V137, P2671, DOI 10.1242/dev.054130; Solomon NM, 2002, GENOMICS, V79, P553, DOI 10.1006/geno.2002.6741; STRAIN L, 1994, AM J HUM GENET, V54, P236; Sutton E, 2011, J CLIN INVEST, V121, P328, DOI 10.1172/JCI42580; Urase K, 1998, DEV BRAIN RES, V111, P77, DOI 10.1016/S0165-3806(98)00124-2; Vio K, 2000, EXP BRAIN RES, V135, P41, DOI 10.1007/s002210000474; Wolff DJ, 1997, HUM GENET, V100, P256, DOI 10.1007/s004390050501; Wong J, 2007, FRONT BIOSCI, V12, P2085, DOI 10.2741/2213; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Woods KS, 2005, AM J HUM GENET, V76, P833, DOI 10.1086/430134; Zhang J, 2006, J NEUROL, V253, P1255, DOI 10.1007/s00415-006-0245-5; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	50	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e29041	10.1371/journal.pone.0029041	http://dx.doi.org/10.1371/journal.pone.0029041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291885	Green Published, gold, Green Submitted			2022-12-27	WOS:000301703800004
J	Babenko, O; Golubov, A; Ilnytskyy, Y; Kovalchuk, I; Metz, GA				Babenko, Olena; Golubov, Andrey; Ilnytskyy, Yaroslav; Kovalchuk, Igor; Metz, Gerlinde A.			Genomic and Epigenomic Responses to Chronic Stress Involve miRNA-Mediated Programming	PLOS ONE			English	Article							HUMAN CEREBROSPINAL-FLUID; ACTIVATED PROTEIN-KINASE; HIPPOCAMPAL CA3C NEURONS; RECEPTOR SUBUNIT GENES; PROLACTIN-RECEPTOR; ADIPONECTIN RECEPTORS; RESTRAINT STRESS; APICAL DENDRITES; INDUCED ATROPHY; MESSENGER-RNAS	Stress represents a critical influence on motor system function and has been shown to impair movement performance. We hypothesized that stress-induced motor impairments are due to brain-specific changes in miRNA and protein-encoding gene expression. Here we show a causal link between stress-induced motor impairment and associated genetic and epigenetic responses in relevant central motor areas in a rat model. Exposure to two weeks of mild restraint stress altered the expression of 39 genes and nine miRNAs in the cerebellum. In line with persistent behavioural impairments, some changes in gene and miRNA expression were resistant to recovery from stress. Interestingly, stress up-regulated the expression of Adipoq and prolactin receptor mRNAs in the cerebellum. Stress also altered the expression of Prlr, miR-186, and miR-709 in hippocampus and prefrontal cortex. In addition, our findings demonstrate that miR-186 targets the gene Eps15. Furthermore, we found an age-dependent increase in EphrinB3 and GabaA4 receptors. These data show that even mild stress results in substantial genomic and epigenomic changes involving miRNA expression and associated gene targets in the motor system. These findings suggest a central role of miRNA-regulated gene expression in the stress response and in associated neurological function.	[Babenko, Olena; Golubov, Andrey; Ilnytskyy, Yaroslav; Kovalchuk, Igor] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada; [Babenko, Olena; Metz, Gerlinde A.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada; [Metz, Gerlinde A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Lethbridge; University of Lethbridge; University of Calgary	Babenko, O (corresponding author), Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada.	gerlinde.metz@uleth.ca	Golubov, Andrey/P-7993-2019	Golubov, Andrey/0000-0003-0111-8273; Metz, Gerlinde/0000-0002-5801-7716	Alberta Innovates Health Solutions; Canadian Institutes of Health Research	Alberta Innovates Health Solutions; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding provided by Alberta Innovates Health Solutions (http://www.ahfmr.ab.ca/), Canadian Institutes of Health Research (http://www.researchnetrecherchenet.ca/rnr16/srch. do? all = 1&search = true&org = CIHR&sort = program&masterList = true&view = currentOpps&fodAgency = CIHR&fodLanguage = E) and the University of Lethbridge (http://www.uleth.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blazejczyk M, 2007, NADON R GENOME QUEBE; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brandebourg T, 2007, DIABETES OBES METAB, V9, P464, DOI 10.1111/j.1463-1326.2006.00671.x; CARPENTER MK, 1995, J NEUROSCI RES, V42, P199, DOI 10.1002/jnr.490420207; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chugani DC, 2001, ANN NEUROL, V49, P618, DOI 10.1002/ana.1003; CIOSSEK T, 1995, ONCOGENE, V11, P2085; Collins AL, 2006, NEUROGENETICS, V7, P167, DOI 10.1007/s10048-006-0045-1; Colvis CM, 2005, J NEUROSCI, V25, P10379, DOI 10.1523/JNEUROSCI.4119-05.2005; Cupers P, 1997, J BIOL CHEM, V272, P33430, DOI 10.1074/jbc.272.52.33430; DAGOSTINO J, 1982, ACTA ENDOCRINOL-COP, V100, P85, DOI 10.1530/acta.0.1000085; Davis AM, 2000, DEV BRAIN RES, V119, P127, DOI 10.1016/S0165-3806(99)00150-9; DeRijk Roel H, 2010, STRESS MOL BEHAV, P137; Faraday MM, 2002, PHYSIOL BEHAV, V75, P507, DOI 10.1016/S0031-9384(02)00645-5; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; Fujikawa T, 2004, ENDOCRINOLOGY, V145, P2006, DOI 10.1210/en.2003-1446; FUJIKAWA T, 1995, ENDOCRINOLOGY, V136, P5608, DOI 10.1210/en.136.12.5608; Fujita-Shimizu A, 2010, PROG NEURO-PSYCHOPH, V34, P455, DOI 10.1016/j.pnpbp.2009.12.020; Ghez C, 1985, PRINCIPLES NEURAL SC; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hibi K, 2011, ANTICANCER RES, V31, P1293; Hoyda TD, 2009, PHYSL ACTIONS ADIPON; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Imai K, 2008, CLIN CANCER RES, V14, P6487, DOI 10.1158/1078-0432.CCR-08-1086; Ioshikhes I, 2007, DNA CELL BIOL, V26, P265, DOI 10.1089/dna.2006.0566; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jadavji NM, 2008, BEHAV BRAIN RES, V195, P251, DOI 10.1016/j.bbr.2008.09.011; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kibbe WA, 2007, USING LUMI PACKAGE P; Kirkland SW, 2008, BRAIN RES, V1201, P151, DOI 10.1016/j.brainres.2008.01.032; Kos K, 2007, J CLIN ENDOCR METAB, V92, P1129, DOI 10.1210/jc.2006-1841; Kovacs K.J, 2005, TEC BEHAV N 1, V15, P775; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Kusminski CM, 2007, DIABETOLOGIA, V50, P634, DOI 10.1007/s00125-006-0577-9; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu YF, 2007, ENDOCRINOLOGY, V148, P683, DOI 10.1210/en.2006-0708; Ma DQ, 2005, AM J HUM GENET, V77, P377, DOI 10.1086/433195; Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Metz GA, 2005, EUR J NEUROSCI, V22, P1190, DOI 10.1111/j.1460-9568.2005.04285.x; Metz GA, 2005, BEHAV BRAIN RES, V162, P71, DOI 10.1016/j.bbr.2005.03.002; Metz GAS, 2000, BEHAV BRAIN RES, V116, P111, DOI 10.1016/S0166-4328(00)00245-X; Metz GAS, 2001, PHYSIOL BEHAV, V72, P29, DOI 10.1016/S0031-9384(00)00371-1; Miranda JD, 1999, EXP NEUROL, V156, P218, DOI 10.1006/exnr.1998.7012; Nelson PT, 2008, BRAIN PATHOL, V18, P130, DOI 10.1111/j.1750-3639.2007.00120.x; Nelson PT, 2007, J NEUROPATH EXP NEUR, V66, P461, DOI 10.1097/01.jnen.0000240474.27791.f3; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POULTER MO, 1992, J NEUROSCI, V12, P2888, DOI 10.1523/JNEUROSCI.12-08-02888.1992; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Quick JC., 1994, INT J STRESS MANAG, V1, P141, DOI [10.1007/BF01857607, DOI 10.1007/BF01857607]; Rodriguez-Lebron E, 2006, GENE THER, V13, P576, DOI 10.1038/sj.gt.3302702; Rozen S, 2000, Methods Mol Biol, V132, P365; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Sieghart W, 1999, NEUROCHEM INT, V34, P379, DOI 10.1016/S0197-0186(99)00045-5; Smith LT, 2006, P NATL ACAD SCI USA, V103, P982, DOI 10.1073/pnas.0510171102; Soboleva TK, 2005, J THEOR BIOL, V234, P289, DOI 10.1016/j.jtbi.2004.11.025; Spranger J, 2006, DIABETES, V55, P141, DOI 10.2337/diabetes.55.1.141; Tamminga J, 2008, CELL CYCLE, V7, P3731, DOI 10.4161/cc.7.23.7186; Tanida M, 2007, EXP BIOL MED, V232, P390; Torner L, 2001, J NEUROSCI, V21, P3207, DOI 10.1523/JNEUROSCI.21-09-03207.2001; Tsao TS, 2002, EUR J PHARMACOL, V440, P213, DOI 10.1016/S0014-2999(02)01430-9; Wan GQ, 2010, RNA, V16, P1436, DOI 10.1261/rna.2001610; Wang ZQ, 2010, DIABETES-METAB RES, V26, P109, DOI 10.1002/dmrr.1060; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Willson CA, 2006, J MOL HISTOL, V37, P369, DOI 10.1007/s10735-006-9067-0; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322; Zinger M, 2003, J CLIN ENDOCR METAB, V88, P689, DOI 10.1210/jc.2002-021255	75	53	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e29441	10.1371/journal.pone.0029441	http://dx.doi.org/10.1371/journal.pone.0029441			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291890	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600002
J	Li, M; Yu, Y; Yan, J; Yan, LY; Zhao, Y; Li, R; Liu, P; Hsueh, AJ; Qiao, J				Li, Min; Yu, Yang; Yan, Jie; Yan, Li-Ying; Zhao, Yue; Li, Rong; Liu, Ping; Hsueh, Aaron J.; Qiao, Jie			The Role of Cilostazol, a Phosphodiesterase 3 Inhibitor, on Oocyte Maturation and Subsequent Pregnancy in Mice	PLOS ONE			English	Article							IN-VITRO; TYPE-3 INHIBITOR; ISOENZYME INHIBITORS; HEALTH-BENEFITS; RHESUS MACAQUES; OVULATION; MOUSE; CELLS; CAMP; LUTEINIZATION	It is important to identify effective contraceptive drugs that cause minimal disruption to physiological processes. Phosphodiesterase 3 (PDE3) inhibitors suppress meiosis in oocytes by decreasing the level of cAMP and blocking the extrusion of the first polar body. In this study, we tested the PDE3 inhibitor, cilostazol, as a potential contraceptive agent. The effects of cilostazol treatment in vitro and in vivo on the suppression of oocyte maturation in a mouse model were investigated. The results indicated that treatment with increasing concentrations of cilostazol led to a dose-dependent arrest in meiosis progression. The effective in vitro concentration was 1 mM and was 300 mg/kg in vivo. The effect of cilostazol was reversible. After removal of the drug, meiosis resumed and mouse oocytes matured in vitro, and showed normal chromosome alignment and spindle organization. After fertilization using an ICSI method, the oocytes showed normal morphology, fertilization rate, embryo cleavage, blastocyst formation, and number of viable pups when compared with controls. The offspring showed similar body weight and fertility. In vivo, the mice became infertile if the drug was injected sequentially, and became pregnant following discontinuation of cilostazol. More importantly, no side effects of cilostazol were observed in treated female mice as demonstrated by blood pressure and heart rate monitoring. It is concluded that cilostazol, a drug routinely used for intermittent claudication, can effectively inhibit oocyte maturation in vitro and in vivo, does not affect the developmental potential of oocytes following drug removal and has few side effects in female mice treated with this drug. These findings suggest that cilostazol may be a potential new contraceptive agent that may facilitate an efficacy and safety study of this drug.	[Li, Min; Yu, Yang; Yan, Jie; Yan, Li-Ying; Zhao, Yue; Li, Rong; Liu, Ping; Qiao, Jie] Peking Univ, Hosp 3, Dept Obstet & Gynecol, Beijing 100871, Peoples R China; [Yan, Li-Ying; Zhao, Yue; Hsueh, Aaron J.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Program Reprod & Stem Cell Biol, Stanford, CA 94305 USA; [Li, Min; Yu, Yang; Yan, Jie; Li, Rong; Liu, Ping; Qiao, Jie] Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing, Peoples R China; [Li, Rong; Qiao, Jie] Minist Educ, Key Lab Assisted Reprod, Beijing, Peoples R China	Peking University; Stanford University	Li, M (corresponding author), Peking Univ, Hosp 3, Dept Obstet & Gynecol, Beijing 100871, Peoples R China.	aaron.hsueh@stanford.edu; jie.qiao@263.net		Yu, Yang/0000-0002-4310-1966	Ministry of Science and Technology of China [2011CB944504]; National Natural Science Funds for Distinguished Young Scholar [31000661]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Funds for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported in part by the Ministry of Science and Technology of China Grants (973 program; 2011CB944504) to Q.J., and by the National Natural Science Funds for Distinguished Young Scholar (31000661) to Y.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHANNING CP, 1978, CLIN ENDOCRINOL META, V7, P601, DOI 10.1016/S0300-595X(78)80011-5; Conti M, 2002, MOL CELL ENDOCRINOL, V187, P153, DOI 10.1016/S0303-7207(01)00686-4; Dawson DL, 1998, CIRCULATION, V98, P678, DOI 10.1161/01.CIR.98.7.678; Jee BC, 2009, FERTIL STERIL, V91, P2037, DOI 10.1016/j.fertnstert.2008.03.041; Jensen JT, 2008, CONTRACEPTION, V77, P303, DOI 10.1016/j.contraception.2008.01.003; Jensen JT, 2010, CONTRACEPTION, V81, P165, DOI 10.1016/j.contraception.2009.09.015; Jensen JT, 2000, OBSTET GYN CLIN N AM, V27, P705, DOI 10.1016/S0889-8545(05)70169-8; Jensen JT, 2005, CONTRACEPTION, V71, P68, DOI 10.1016/j.contraception.2004.07.007; Jensen JT, 2002, HUM REPROD, V17, P2079, DOI 10.1093/humrep/17.8.2079; Kaunitz AM, 1999, CONTRACEPTION, V59, p29S, DOI 10.1016/S0010-7824(98)00135-8; KAWAMURA K, 1985, ARZNEIMITTELFORSCH, V35-2, P1149; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Liang CG, 2005, ENDOCRINOLOGY, V146, P4437, DOI 10.1210/en.2005-0309; Liu YG, 2001, CARDIOVASC DRUG REV, V19, P369, DOI 10.1111/j.1527-3466.2001.tb00076.x; Masciarelli S, 2004, J CLIN INVEST, V114, P196, DOI 10.1172/JCI2004210804; Nogueira D, 2005, REPRODUCTION, V130, P177, DOI 10.1530/rep.1.00652; Nogueira D, 2003, BIOL REPROD, V69, P2045, DOI 10.1095/biolreprod.103.021105; Nogueira D, 2003, BIOL REPROD, V69, P1042, DOI 10.1095/biolreprod.103.015982; RACOWSKY C, 1984, J REPROD FERTIL, V72, P107, DOI 10.1530/jrf.0.0720107; Richard FJ, 2001, BIOL REPROD, V65, P1444, DOI 10.1095/biolreprod65.5.1444; RICHARDS JS, 1988, ANNU REV PHYSIOL, V50, P441; Sasseville M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-47; Schror K, 2002, DIABETES OBES METAB, V4, pS14, DOI 10.1046/j.1463-1326.2002.0040s2s14.x; Shakur Y, 2002, CARDIOVASC DRUG THER, V16, P417, DOI 10.1023/A:1022186402442; Shu YM, 2008, HUM REPROD, V23, P504, DOI 10.1093/humrep/dem344; Soderling SH, 2000, CURR OPIN CELL BIOL, V12, P174, DOI 10.1016/S0955-0674(99)00073-3; Thomas RE, 2004, BIOL REPROD, V71, P1142, DOI 10.1095/biolreprod.103.024828; Thomas RE, 2002, DEV BIOL, V244, P215, DOI 10.1006/dbio.2002.0609; Tsafriri A, 1996, DEV BIOL, V178, P393, DOI 10.1006/dbio.1996.0226; Vanhoutte L, 2007, HUM REPROD, V22, P1239, DOI 10.1093/humrep/dem007; Wiersma A, 1998, J CLIN INVEST, V102, P532, DOI 10.1172/JCI2566; Wu SN, 2004, ENDOCRINOLOGY, V145, P1175, DOI 10.1210/en.2003-1430	32	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30649	10.1371/journal.pone.0030649	http://dx.doi.org/10.1371/journal.pone.0030649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292006	Green Submitted, Green Published, gold			2022-12-27	WOS:000301639600041
J	Ghannad-Rezaie, M; Wang, X; Mishra, B; Collins, C; Chronis, N				Ghannad-Rezaie, Mostafa; Wang, Xing; Mishra, Bibhudatta; Collins, Catherine; Chronis, Nikos			Microfluidic Chips for In Vivo Imaging of Cellular Responses to Neural Injury in Drosophila Larvae	PLOS ONE			English	Article							WALLERIAN DEGENERATION; AXONAL REGENERATION; CAENORHABDITIS-ELEGANS; NERVE REGENERATION; LASER-ABLATION; TRANSPORT; MECHANISMS; DYNAMICS; CALCIUM; EXPRESSION	With powerful genetics and a translucent cuticle, the Drosophila larva is an ideal model system for live imaging studies of neuronal cell biology and function. Here, we present an easy-to-use approach for high resolution live imaging in Drosophila using microfluidic chips. Two different designs allow for non-invasive and chemical-free immobilization of 3rd instar larvae over short (up to 1 hour) and long (up to 10 hours) time periods. We utilized these 'larva chips' to characterize several subcellular responses to axotomy which occur over a range of time scales in intact, unanaesthetized animals. These include waves of calcium which are induced within seconds of axotomy, and the intracellular transport of vesicles whose rate and flux within axons changes dramatically within 3 hours of axotomy. Axonal transport halts throughout the entire distal stump, but increases in the proximal stump. These responses precede the degeneration of the distal stump and regenerative sprouting of the proximal stump, which is initiated after a 7 hour period of dormancy and is associated with a dramatic increase in F-actin dynamics. In addition to allowing for the study of axonal regeneration in vivo, the larva chips can be utilized for a wide variety of in vivo imaging applications in Drosophila.	[Ghannad-Rezaie, Mostafa; Chronis, Nikos] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Wang, Xing; Mishra, Bibhudatta; Collins, Catherine] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Chronis, Nikos] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ghannad-Rezaie, M (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	collinca@umich.edu; chronis@umich.edu	CHRONIS, NIKOS/AAJ-5084-2021	CHRONIS, NIKOS/0000-0003-3830-1979; /0000-0003-1928-1909; Collins, Catherine/0000-0002-1608-6692	National Science Foundation [IOS-0842701]; National Institutes of Health [5R21NS062313, NS069844]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS062313, R01NS069844] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Science Foundation, (grant number IOS-0842701) and the National Institutes of Health (grant numbers 5R21NS062313 and NS069844). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; Aggarwal N, 2006, IEEE T IMAGE PROCESS, V15, P582, DOI 10.1109/TIP.2005.863021; Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Ayaz D, 2008, J NEUROSCI, V28, P6010, DOI 10.1523/JNEUROSCI.0101-08.2008; Banerjee S, 2008, J NEUROSCI RES, V86, P1189, DOI 10.1002/jnr.21574; Chokshi TV, 2009, LAB CHIP, V9, P151, DOI 10.1039/b807345g; Chung K, 2009, LAB CHIP, V9, P2764, DOI 10.1039/b910703g; Chung SH, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-30; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Dutta D, 2002, GENESIS, V34, P146, DOI 10.1002/gene.10113; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Freeman MR, 2006, TRENDS NEUROSCI, V29, P82, DOI 10.1016/j.tins.2005.12.002; Fuger P, 2007, NAT PROTOC, V2, P3285, DOI 10.1038/nprot.2007.472; Fujioka M, 2003, DEVELOPMENT, V130, P5385, DOI 10.1242/dev.00770; Ghosh-Roy A, 2010, J NEUROSCI, V30, P3175, DOI 10.1523/JNEUROSCI.5464-09.2010; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Guo SX, 2008, NAT METHODS, V5, P531, DOI 10.1038/NMETH.1203; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Kamber D, 2009, EXP NEUROL, V219, P112, DOI 10.1016/j.expneurol.2009.05.004; Knoferle J, 2010, P NATL ACAD SCI; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu HH, 2004, EXP NEUROL, V189, P199, DOI 10.1016/j.expneurol.2004.06.006; Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Martin SM, 2010, DEVELOPMENT, V137, P3985, DOI 10.1242/dev.053611; Miller KE, 2005, CURR BIOL, V15, P684, DOI 10.1016/j.cub.2005.02.061; Misgeld T, 2007, NAT METHODS, V4, P559, DOI 10.1038/NMETH1055; Mondal S, 2011, TRAFFIC, V12, P372, DOI 10.1111/j.1600-0854.2010.01157.x; Neumann B, 2011, DEV DYNAM, V240, P1365, DOI 10.1002/dvdy.22606; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Rao S, 2001, J NEUROBIOL, V49, P159, DOI 10.1002/neu.1072; Richardson PM, 2009, NEUROSURGERY, V65, pA74, DOI 10.1227/01.NEU.0000352378.26755.C3; Rietdorf J., 2004, EUROPEAN ADV LIGHT M; Sandstrom DJ, 2008, ANESTHESIOLOGY, V108, P434, DOI 10.1097/ALN.0b013e318164cfda; Sandstrom DJ, 2004, J PHYSIOL-LONDON, V558, P489, DOI 10.1113/jphysiol.2004.065748; Schmid A, 2008, NAT NEUROSCI, V11, P659, DOI 10.1038/nn.2122; Scholey JM, 1996, J CELL BIOL, V133, P1, DOI 10.1083/jcb.133.1.1; Stone MC, 2010, MOL BIOL CELL, V21, P767, DOI 10.1091/mbc.E09-11-0967; Sun F, 2010, CURR OPIN NEUROBIOL, V20, P510, DOI 10.1016/j.conb.2010.03.013; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wu Z, 2007, P NATL ACAD SCI USA, V104, P15132, DOI 10.1073/pnas.0707001104; Xiong X, 2010, J CELL BIOL, V191, P211, DOI 10.1083/jcb.201006039; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Yoo S, 2010, EXP NEUROL, V223, P19, DOI 10.1016/j.expneurol.2009.08.011; Zhu S, 2000, IEEE T IMAGE PROCESS, V9, P287, DOI 10.1109/83.821744; Ziv NE, 1997, J NEUROSCI, V17, P3568	54	68	70	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e29869	10.1371/journal.pone.0029869	http://dx.doi.org/10.1371/journal.pone.0029869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291895	Green Submitted, Green Published, gold			2022-12-27	WOS:000301570600007
J	Kakinohana, O; Hefferan, MP; Miyanohara, A; Nejime, T; Marsala, S; Juhas, S; Juhasova, J; Motlik, J; Kucharova, K; Strnadel, J; Platoshyn, O; Lazar, P; Galik, J; Vinay, L; Marsala, M				Kakinohana, Osamu; Hefferan, Michael P.; Miyanohara, Atsushi; Nejime, Tetsuya; Marsala, Silvia; Juhas, Stefan; Juhasova, Jana; Motlik, Jan; Kucharova, Karolina; Strnadel, Jan; Platoshyn, Oleksandr; Lazar, Peter; Galik, Jan; Vinay, Laurent; Marsala, Martin			Combinational Spinal GAD65 Gene Delivery and Systemic GABA-Mimetic Treatment for Modulation of Spasticity	PLOS ONE			English	Article							INTRATHECAL BACLOFEN; CORD-INJURY; UPTAKE INHIBITOR; DORSAL-HORN; RATS; TIAGABINE; VECTORS; RIGIDITY; NEURONS; CELLS	Background: Loss of GABA-mediated pre-synaptic inhibition after spinal injury plays a key role in the progressive increase in spinal reflexes and the appearance of spasticity. Clinical studies show that the use of baclofen (GABA(B) receptor agonist), while effective in modulating spasticity is associated with major side effects such as general sedation and progressive tolerance development. The goal of the present study was to assess if a combined therapy composed of spinal segment-specific upregulation of GAD65 (glutamate decarboxylase) gene once combined with systemic treatment with tiagabine (GABA uptake inhibitor) will lead to an antispasticity effect and whether such an effect will only be present in GAD65 gene over-expressing spinal segments. Methods/Principal Findings: Adult Sprague-Dawley (SD) rats were exposed to transient spinal ischemia (10 min) to induce muscle spasticity. Animals then received lumbar injection of HIV1-CMV-GAD65 lentivirus (LVs) targeting ventral alpha-motoneuronal pools. At 2-3 weeks after lentivirus delivery animals were treated systemically with tiagabine (4, 10, 20 or 40 mg/kg or vehicle) and the degree of spasticity response measured. In a separate experiment the expression of GAD65 gene after spinal parenchymal delivery of GAD65-lentivirus in naive minipigs was studied. Spastic SD rats receiving spinal injections of the GAD65 gene and treated with systemic tiagabine showed potent and tiagabine-dose-dependent alleviation of spasticity. Neither treatment alone (i.e., GAD65-LVs injection only or tiagabine treatment only) had any significant antispasticity effect nor had any detectable side effect. Measured antispasticity effect correlated with increase in spinal parenchymal GABA synthesis and was restricted to spinal segments overexpressing GAD65 gene. Conclusions/Significance: These data show that treatment with orally bioavailable GABA-mimetic drugs if combined with spinal-segment-specific GAD65 gene overexpression can represent a novel and highly effective anti-spasticity treatment which is associated with minimal side effects and is restricted to GAD65-gene over-expressing spinal segments.	[Kakinohana, Osamu; Hefferan, Michael P.; Nejime, Tetsuya; Marsala, Silvia; Platoshyn, Oleksandr; Marsala, Martin] Univ Calif San Diego, Dept Anesthesiol, Neuroregenerat Lab, La Jolla, CA 92093 USA; [Miyanohara, Atsushi] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Miyanohara, Atsushi] Univ Calif San Diego, Gene Therapy Program, La Jolla, CA 92093 USA; [Juhas, Stefan; Juhasova, Jana; Motlik, Jan; Strnadel, Jan] AS CR, Inst Anim Physiol & Genet, Libechov, Czech Republic; [Kucharova, Karolina] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Lazar, Peter] Univ Vet Med & Pharm, Dept Breeding & Dis Game & Fish, Kosice, Slovakia; [Galik, Jan; Marsala, Martin] Slovak Acad Sci, Inst Neurobiol, Kosice 04001, Slovakia; [Galik, Jan] Safarik Univ, Inst Biol & Ecol, Fac Sci, Kosice, Slovakia; [Vinay, Laurent] CNRS, UMR6196, Lab Plasticite & Physiopathol Motricite, Marseille, France; [Vinay, Laurent] Aix Marseille Univ, Marseille, France	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Sanford Burnham Prebys Medical Discovery Institute; University of Veterinary Medicine Kosice; Slovak Academy of Sciences; University of Pavol Jozef Safarik Kosice; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Kakinohana, O (corresponding author), Univ Calif San Diego, Dept Anesthesiol, Neuroregenerat Lab, La Jolla, CA 92093 USA.	mmarsala@ucsd.edu	Motlik, Jan/G-7148-2014; Strnadel, Jan/I-3983-2014; Juhasova, Jana/G-7144-2014; Strnadel, Jan/Y-5172-2018; Galik, Jan/I-2324-2016; Juhas, Stefan/G-7141-2014	Juhasova, Jana/0000-0001-7022-6812; Strnadel, Jan/0000-0002-7233-6537; Galik, Jan/0000-0001-9581-9585; Juhas, Stefan/0000-0002-2866-0727; Kucharova, Karolina/0000-0002-3196-748X	California Institute for Regenerative Medicine [RC1-00131-1-M.M.]; NIH [NS051644-M.M., P30 NS047101]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS051644] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the California Institute for Regenerative Medicine (RC1-00131-1-M.M.) and the NIH (NS051644-M.M. and P30 NS047101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boorman GI, 1996, ELECTROMYOGR MOTOR C, V101, P84, DOI 10.1016/0924-980X(95)00262-J; Boulenguez P, 2009, CURR OPIN NEUROBIOL, V19, P587, DOI 10.1016/j.conb.2009.10.005; Brodie MJ, 1995, EPILEPSIA, V36, pS7, DOI 10.1111/j.1528-1157.1995.tb06015.x; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Chu ML, 2006, DEV MED CHILD NEUROL, V48, P456, DOI 10.1017/S0012162206000983; Dachy B, 2002, CLIN NEUROPHYSIOL, V113, P336, DOI 10.1016/S1388-2457(02)00010-X; Dalby NO, 2000, NEUROPHARMACOLOGY, V39, P2399, DOI 10.1016/S0028-3908(00)00075-7; Dodiya HB, 2010, MOL THER, V18, P579, DOI 10.1038/mt.2009.216; EDWARDS FR, 1989, J PHYSIOL-LONDON, V416, P539, DOI 10.1113/jphysiol.1989.sp017776; EIDE PK, 1995, NEUROSURGERY, V37, P1080, DOI 10.1227/00006123-199512000-00007; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Feldmann RG, 1980, SPASTICITY DISORDERE, P485; FINKJENSEN A, 1992, EUR J PHARMACOL, V220, P197, DOI 10.1016/0014-2999(92)90748-S; GUSTAVSON LE, 1995, EPILEPSIA, V36, P605, DOI 10.1111/j.1528-1157.1995.tb02575.x; Hartley RS, 1999, J COMP NEUROL, V407, P1, DOI 10.1002/(SICI)1096-9861(19990428)407:1<1::AID-CNE1>3.0.CO;2-Z; Hughes DI, 2005, P NATL ACAD SCI USA, V102, P9038, DOI 10.1073/pnas.0503646102; Ichiyama RM, 2011, J NEUROSCI, V31, P26, DOI 10.1523/JNEUROSCI.6433-09.2011; JIMENEZ I, 1991, EXP BRAIN RES, V85, P103; Kakinohana O, 2006, NEUROSCIENCE, V141, P1569, DOI 10.1016/j.neuroscience.2006.04.083; Kakinohana O, 2004, EXP NEUROL, V190, P122, DOI 10.1016/j.expneurol.2004.07.014; Katz R, 1999, J PHYSIOLOGY-PARIS, V93, P379, DOI 10.1016/S0928-4257(00)80065-0; Kornum BR, 2010, EXP NEUROL, V222, P70, DOI 10.1016/j.expneurol.2009.12.009; Krach LE, 2001, J CHILD NEUROL, V16, P31, DOI 10.1177/088307380101600106; LAZORTHES Y, 1990, J NEUROSURG, V72, P393, DOI 10.3171/jns.1990.72.3.0393; Li YR, 2004, J NEUROPHYSIOL, V91, P767, DOI 10.1152/jn.00788.2003; Luo J, 2002, SCIENCE, V298, P425, DOI 10.1126/science.1074549; MACDONELL RAL, 1989, J NEUROL NEUROSUR PS, V52, P1110, DOI 10.1136/jnnp.52.9.1110; Maedai Y, 2007, BRAIN RES, V1136, P43, DOI 10.1016/j.brainres.2006.11.061; Marsala M, 2005, J NEUROTRAUM, V22, P1348, DOI 10.1089/neu.2005.22.1348; Maurice V, 2001, ADAMS VICTORS PRINCI; Mazzocchio R, 1997, BRAIN, V120, P991, DOI 10.1093/brain/120.6.991; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; Meunier A, 2008, J NEUROSCI METH, V167, P148, DOI 10.1016/j.jneumeth.2007.07.022; Meythaler JM, 2003, ARCH PHYS MED REHAB, V84, P638, DOI 10.1016/S0003-9993(03)00105-9; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Nielsen JF, 2002, CLIN NEUROL NEUROSUR, V104, P142, DOI 10.1016/S0303-8467(02)00009-4; NOWAK LM, 1982, BRAIN RES, V244, P155, DOI 10.1016/0006-8993(82)90913-1; Podrygajlo G, 2010, NEUROSCI LETT, V468, P207, DOI 10.1016/j.neulet.2009.10.092; Price TJ, 2005, CURR TOP MED CHEM, V5, P547, DOI 10.2174/1568026054367629; Remy-Neris O, 1999, EXP BRAIN RES, V129, P433, DOI 10.1007/s002210050910; Rosche J, 2002, SPINAL CORD, V40, P261, DOI 10.1038/sj.sc.3101313; Schousboe A, 2004, BIOCHEM PHARMACOL, V68, P1557, DOI 10.1016/j.bcp.2004.06.041; SIDDALL P, 1995, NEUROREPORT, V6, P1241, DOI 10.1097/00001756-199506090-00003; Soni BM, 2003, SPINAL CORD, V41, P586, DOI 10.1038/sj.sc.3101471; Stempien L, 2000, AM J PHYS MED REHAB, V79, P536, DOI 10.1097/00002060-200011000-00010; Taira Y, 1996, STROKE, V27, P1850, DOI 10.1161/01.STR.27.10.1850; TARLOV IM, 1967, ARCH NEUROL-CHICAGO, V16, P536, DOI 10.1001/archneur.1967.00470230088012; Tillakaratne NJK, 2002, J NEUROSCI, V22, P3130, DOI 10.1523/JNEUROSCI.22-08-03130.2002; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Usvald D, 2010, CELL TRANSPLANT, V19, P1103, DOI 10.3727/096368910X503406; Wang XL, 2004, SEIZURE-EUR J EPILEP, V13, P574, DOI 10.1016/j.seizure.2004.01.007; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558; YEE JK, 1994, P NATL ACAD SCI USA, V91, P9564, DOI 10.1073/pnas.91.20.9564	55	13	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30561	10.1371/journal.pone.0030561	http://dx.doi.org/10.1371/journal.pone.0030561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291989	gold, Green Published, Green Submitted			2022-12-27	WOS:000301570600059
J	Niu, YC; Li, ST; Na, LX; Feng, RN; Liu, LY; Li, Y; Sun, CH				Niu, Yucun; Li, Songtao; Na, Lixin; Feng, Rennan; Liu, Liyan; Li, Ying; Sun, Changhao			Mangiferin Decreases Plasma Free Fatty Acids through Promoting Its Catabolism in Liver by Activation of AMPK	PLOS ONE			English	Article							PERFUSED-RAT-LIVER; INSULIN-RESISTANCE; HEPATIC STEATOSIS; OXIDATION; TISSUE; TRIGLYCERIDES; MECHANISM; EXERCISE; MUSCLE; CELLS	Mangiferin has been shown to have the effect of improving dyslipidemia. Plasma free fatty acids (FFA) are closely associated with blood lipid metabolism as well as many diseases including metabolic syndrome. This study is to investigate whether mangiferin has effects on FFA metabolism in hyperlipidemic rats. Wistar rats were fed a high-fat diet and administered mangiferin simultaneously for 6 weeks. Mangiferin (50, 100, 150 mg/kg BW) decreased dose-dependently FFA and triglycerides (TG) levels in plasma, and their accumulations in liver, but increased the beta-hydroxybutyrate levels in both plasma and liver of hyperlipidemic rats. HepG2 cells were treated with oleic acid (OA, 0.2 mmol/L) to simulate the condition of high level of plasma FFA in vitro, and were treated with different concentrations of mangiferin simultaneously for 24 h. We found that mangiferin significantly increased FFA uptake, significantly decreased intracellular FFA and TG accumulations in HepG2 cells. Mangiferin significantly increased AMP-activated protein kinase (AMPK) phosphorylation and its downstream proteins involved in fatty acid translocase (CD36) and carnitine palmitoyltransferase 1 (CPT1), but significantly decreased acyl-CoA: diacylgycerol acyltransferase 2 (DGAT2) expression and acetyl-CoA carboxylase (ACC) activity by increasing its phosphorylation level in both in vivo and in vitro studies. Furthermore, these effects were reversed by Compound C, an AMPK inhibitor in HepG2 cells. For upstream of AMPK, mangiferin increased AMP/ATP ratio, but had no effect on LKB1 phosphorylation. In conclusion, mangiferin decreased plasma FFA levels through promoting FFA uptake and oxidation, inhibiting FFA and TG accumulations by regulating the key enzymes expression in liver through AMPK pathway. Therefore, mangiferin is a possible beneficial natural compound for metabolic syndrome by improving FFA metabolism.	[Niu, Yucun; Li, Songtao; Na, Lixin; Feng, Rennan; Liu, Liyan; Li, Ying; Sun, Changhao] Harbin Med Univ, Coll Publ Hlth, Dept Nutr & Food Hyg, Harbin, Heilongjiang, Peoples R China	Harbin Medical University	Niu, YC (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Nutr & Food Hyg, Harbin, Heilongjiang, Peoples R China.	sun2002changhao@yahoo.com	SUN, CHANG/GXM-3680-2022		National Natural Science Foundation of China [81102112]; National High Technology Research and Development Program of China (863 program) [2010AA023002]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K99AA023002, R00AA023002] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the National Natural Science Foundation of China (No. 81102112) and National High Technology Research and Development Program of China (863 program) (No. 2010AA023002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumrad N, 1998, J LIPID RES, V39, P2309; BATES EJ, 1977, FEBS LETT, V84, P225, DOI 10.1016/0014-5793(77)80693-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boden G, 2005, DIABETES, V54, P880, DOI 10.2337/diabetes.54.3.880; Boden G, 1999, P ASSOC AM PHYSICIAN, V111, P241, DOI 10.1046/j.1525-1381.1999.99220.x; Boden G., 2008, ENDOCRIN METAB CLIN, V37, p[635, viii], DOI DOI 10.1016/1A:12008.06.007; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Budinger GRS, 1996, AM J PHYSIOL-LUNG C, V270, pL44, DOI 10.1152/ajplung.1996.270.1.L44; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Diraison F, 1998, AM J PHYSIOL-ENDOC M, V274, pE321, DOI 10.1152/ajpendo.1998.274.2.E321; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; HAHN SE, 1992, BIOCHEM PHARMACOL, V43, P625, DOI 10.1016/0006-2952(92)90586-8; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Harwood HJ, 2003, J BIOL CHEM, V278, P37099, DOI 10.1074/jbc.M304481200; Holloway GP, 2006, J PHYSIOL-LONDON, V571, P201, DOI 10.1113/jphysiol.2005.102178; Huang THW, 2006, TOXICOL APPL PHARM, V210, P225, DOI 10.1016/j.taap.2005.05.003; Ix JH, J AM SOC NEPHROL, V21, P406; Julius U, 2003, EXP CLIN ENDOCR DIAB, V111, P246, DOI 10.1055/s-2003-41284; Kovacs P, 2005, BEST PRACT RES CL EN, V19, P625, DOI 10.1016/j.beem.2005.07.003; Liu L, CANADIAN J CHEM, V88, P898; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Miura T, 2001, BIOL PHARM BULL, V24, P1009, DOI 10.1248/bpb.24.1009; Miura T, 2001, BIOL PHARM BULL, V24, P1091, DOI 10.1248/bpb.24.1091; Muruganandan S, 2005, J ETHNOPHARMACOL, V97, P497, DOI 10.1016/j.jep.2004.12.010; PELKONEN R, 1968, DIABETES, V17, P76, DOI 10.2337/diab.17.2.76; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; SATO T, 1992, CHEM PHARM BULL, V40, P721, DOI 10.1248/cpb.40.721; Smith H O, 1974, Methods Enzymol, V29, P282; SOLERARG.C, 1974, BIOCHIMIE, V56, P757, DOI 10.1016/S0300-9084(74)80047-7; Teusink B, 2003, DIABETES, V52, P614, DOI 10.2337/diabetes.52.3.614; Whitman SC, 1998, J LIPID RES, V39, P1008; Wilding JPH, 2007, DIABETIC MED, V24, P934, DOI 10.1111/j.1464-5491.2007.02186.x	33	77	84	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30782	10.1371/journal.pone.0030782	http://dx.doi.org/10.1371/journal.pone.0030782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292039	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600077
J	Sola, C; Paganini, H; Egea, AL; Moyano, AJ; Garnero, A; Kevric, I; Culasso, C; Vindel, A; Lopardo, H; Bocco, JL				Sola, Claudia; Paganini, Hugo; Egea, Ana L.; Moyano, Alejandro J.; Garnero, Analia; Kevric, Ines; Culasso, Catalina; Vindel, Ana; Lopardo, Horacio; Bocco, Jose L.		Study Grp CA-MRSA Children	Spread of Epidemic MRSA-ST5-IV Clone Encoding PVL as a Major Cause of Community Onset Staphylococcal Infections in Argentinean Children	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; AUREUS CA-MRSA; METHICILLIN-RESISTANT; MOLECULAR EPIDEMIOLOGY; PCR STRATEGY; STRAINS; EMERGENCE; EVOLUTION; CORDOBA; SUSCEPTIBILITY	Background: Community-associated methicillin-resistant Staphylococcus aureus-(CA-MRSA) strains have emerged in Argentina. We investigated the clinical and molecular evolution of community-onset MRSA infections (CO-MRSA) in children of Cordoba, Argentina, 2005-2008. Additionally, data from 2007 were compared with the epidemiology of these infections in other regions of the country. Methodology/Principal Findings: Two datasets were used: i) lab-based prospective surveillance of CA-MRSA isolates from 3 Cordoba pediatric hospitals-(CBAH1-H3) in 2007-2008 (compared to previously published data of 2005) and ii) a sampling of CO-MRSA from a study involving both, healthcare-associated community-onset-(HACO) infections in children with risk-factors for healthcare-associated infections-(HRFs), and CA-MRSA infections in patients without HRFs detected in multiple centers of Argentina in 2007. Molecular typing was performed on the CA-MRSA-(n:99) isolates from the CBAH1-H3-dataset and on the HACO-MRSA-(n: 51) and CA-MRSA-(n: 213) isolates from other regions. Between 2005-2008, the annual proportion of CA-MRSA/CA-S. aureus in Cordoba hospitals increased from 25% to 49%, P<0.01. Total CA-MRSA infections increased 3.6 fold-(5.1 to 18.6 cases/100,000 annual-visits, P<0.0001), associated with an important increase of invasive CA-MRSA infections-(8.5 fold). In all regions analyzed, a single genotype prevailed in both CA-MRSA (82%) and HACO-MRSA(57%), which showed pulsed-field-gel electrophoresis-(PFGE)-type-"I", sequence-type-5-(ST5), SCCmec-type-IVa, spa-t311, and was positive for PVL. The second clone, pulsotype-N/ST30/CC30/SCCmecIVc/t019/PVL+, accounted for 11.5% of total CA-MRSA infections. Importantly, the first 4 isolates of Argentina belonging to South American-USA300 clone-(USA300/ST8/CC8/SCCmecIVc/t008/PVL+/ACME(-)) were detected. We also demonstrated that a HA-MRSA clone-(pulsotype-C/ST100/CC5) caused 2% and 10% of CA-MRSA and HACO-MRSA infections respectively and was associated with a SCCmec type closely related to SCCmecIV(2B&5). Conclusions/Significance: The dissemination of epidemic MRSA clone, ST5-IV-PVL+ was the main cause of increasing staphylococcal community-onset infections in Argentinean children (2003-2008), conversely to other countries. The predominance of this clone, which has capacity to express the h-VISA phenotype, in healthcare-associated community-onset cases suggests that it has infiltrated into hospital-settings.	[Sola, Claudia; Egea, Ana L.; Moyano, Alejandro J.; Kevric, Ines; Bocco, Jose L.] Consejo Nacl Invest Cient & Tecn, CIBICI, Dept Bioquim Clin, RA-1033 Buenos Aires, DF, Argentina; [Paganini, Hugo] Univ Nacl Cordoba, Fac Ciencias Quim, RA-5000 Cordoba, Argentina; [Paganini, Hugo; Lopardo, Horacio] Hosp Pediat Prof Dr Juan P Garrahan, Autonomous City Buenos A, Argentina; [Garnero, Analia; Culasso, Catalina] Hosp Ninos Santisima Trinidad Cordoba, Cordoba, Argentina; [Vindel, Ana] Inst Salud Carlos III, Ctr Nacl Microbiol, Lab Infecc Nosocomi, Madrid, Spain	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Hospital de Pediatria Doctor Juan Garrahan; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Sola, C (corresponding author), Consejo Nacl Invest Cient & Tecn, CIBICI, Dept Bioquim Clin, RA-1033 Buenos Aires, DF, Argentina.	jbocco@fcq.unc.edu.ar	Moyano, Alejandro/AAB-9092-2019	Moyano, Alejandro/0000-0002-4976-7611; Bocco, Jose Luis/0000-0002-9682-1270	National Council for Scientific Research and Technology of Argentina [CONICET-PIP-2009-2011]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 07-01630]; Secretaria de Ciencia y Tecnica-Universidad Nacional de Cordoba (SECyT-UNC)	National Council for Scientific Research and Technology of Argentina; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Secretaria de Ciencia y Tecnica-Universidad Nacional de Cordoba (SECyT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT))	This work was supported by the National Council for Scientific Research and Technology of Argentina (CONICET-PIP-2009-2011 to CS), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT - PICT 07-01630 to JLB) and Secretaria de Ciencia y Tecnica-Universidad Nacional de Cordoba (SECyT-UNC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit SR, 2008, EMERG INFECT DIS, V14, P1216, DOI 10.3201/eid1408.071183; Bhattacharya D, 2007, J CLIN MICROBIOL, V45, P1798, DOI 10.1128/JCM.01747-06; Blanco R, 2011, J CLIN MICROBIOL, V49, P433, DOI 10.1128/JCM.02201-10; Breurec S, 2011, CLIN MICROBIOL INFEC, V17, P160, DOI 10.1111/j.1469-0691.2010.03219.x; Cercenado E, 2008, DIAGN MICR INFEC DIS, V61, P143, DOI 10.1016/j.diagmicrobio.2008.01.001; Chua K, 2011, CLIN INFECT DIS, V52, P99, DOI 10.1093/cid/ciq067; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI; Corso A, 1998, MICROB DRUG RESIST, V4, P277, DOI 10.1089/mdr.1998.4.277; Dauwalder O, 2008, J CLIN MICROBIOL, V46, P3454, DOI 10.1128/JCM.01050-08; David MZ, 2008, J INFECT DIS, V197, P1235, DOI 10.1086/533502; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deurenberg RH, 2009, CURR MOL MED, V9, P100, DOI 10.2174/156652409787581637; Ellington MJ, 2009, EUR J CLIN MICROBIOL, V28, P1113, DOI 10.1007/s10096-009-0757-x; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Gardella N, 2008, DIAGN MICR INFEC DIS, V62, P343, DOI 10.1016/j.diagmicrobio.2008.07.008; Gerber JS, 2009, CLIN INFECT DIS, V49, P65, DOI 10.1086/599348; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Gonzalez BE, 2005, PEDIATRICS, V115, P642, DOI 10.1542/peds.2004-2300; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Heusser R, 2007, ANTIMICROB AGENTS CH, V51, P390, DOI 10.1128/AAC.00921-06; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klevens RM, 2006, EMERG INFECT DIS, V12, P1991; Limbago B, 2009, J CLIN MICROBIOL, V47, P1344, DOI 10.1128/JCM.02264-08; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Ma XX, 2005, EMERG INFECT DIS, V11, P973; Maree CL, 2007, EMERG INFECT DIS, V13, P236, DOI 10.3201/eid1302.060781; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P236, DOI 10.1111/j.1469-0691.2006.01635.x; Monecke S, 2009, CLIN MICROBIOL INFEC, V15, P770, DOI 10.1111/j.1469-0691.2009.02792.x; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Morrison MA, 2006, J HOSP INFECT, V62, P241, DOI 10.1016/j.jhin.2005.07.011; Niniou I, 2008, EUR J CLIN MICROBIOL, V27, P831, DOI 10.1007/s10096-008-0513-7; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Oliveira DC, 2006, ANTIMICROB AGENTS CH, V50, P3457, DOI 10.1128/AAC.00629-06; Orscheln RC, 2009, CLIN INFECT DIS, V49, P536, DOI 10.1086/600881; Paganinia H, 2008, ARCH ARGENT PEDIATR, V106, P397, DOI 10.1590/S0325-00752008000500005; Reyes J, 2009, CLIN INFECT DIS, V49, P1861, DOI 10.1086/648426; Rodriguez-Noriega E, 2010, INT J INFECT DIS, V14, pE560, DOI 10.1016/j.ijid.2009.08.018; Rossney AS, 2007, J CLIN MICROBIOL, V45, P2554, DOI 10.1128/JCM.00245-07; Satola SW, 2011, J CLIN MICROBIOL, V49, P177, DOI 10.1128/JCM.01128-10; Sola C, 2007, EUR J CLIN MICROBIOL, V26, P281, DOI 10.1007/s10096-007-0278-4; Sola C, 2006, J CLIN MICROBIOL, V44, P192, DOI 10.1128/JCM.44.1.192-200.2006; Sola C, 2002, J CLIN MICROBIOL, V40, P1427, DOI 10.1128/JCM.40.4.1427-1435.2002; Sola C, 2008, J CLIN MICROBIOL, V46, P1826, DOI 10.1128/JCM.01949-07; Sola C, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-15; Tokumoto MB, 2007, INT J ANTIMICROB AG, V30, P469, DOI 10.1016/j.ijantimicag.2007.06.007; Tristan A, 2007, EMERG INFECT DIS, V13, P594, DOI 10.3201/eid1304.061316; Wootton M, 2007, J CLIN MICROBIOL, V45, P329, DOI 10.1128/JCM.01508-06; Zaoutis TE, 2006, PEDIATR INFECT DIS J, V25, P343, DOI 10.1097/01.inf.0000207403.67197.cc	55	57	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30487	10.1371/journal.pone.0030487	http://dx.doi.org/10.1371/journal.pone.0030487			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291965	Green Submitted, Green Published, gold			2022-12-27	WOS:000301570600046
J	Zhang, C; Zhang, LL; Huang, L; Luo, R; Wen, J				Zhang, Chuan; Zhang, Lingli; Huang, Liang; Luo, Rong; Wen, Jin			Clinical Pharmacists on Medical Care of Pediatric Inpatients: A Single-Center Randomized Controlled Trial	PLOS ONE			English	Article							ADVERSE DRUG EVENTS; PHARMACEUTICAL CARE; ELDERLY PATIENTS; OUTCOMES; IMPACT; DISCHARGE; THERAPY; TEAM; PARTICIPATION; PROGRAM	Objective:To explore the best interventions and working patterns of clinical pharmacists in pediatrics and to determine the effectiveness of clinical pharmacists in pediatrics. Methods: We conducted a randomized controlled trial of 160 pediatric patients with nerve system disease, respiratory system disease or digestive system disease, who were randomly allocated into two groups, with 80 in each group. Interventions by clinical pharmacists in the experimental group included answering questions of physicians and nurses, giving advice on treating patients, checking prescriptions and patient counseling at discharge. In the control group, patients were treated without clinical pharmacist interventions. Results: Of the 109 interventions provided by clinical pharmacists during 4 months, 47 were consultations for physicians and nurses, 31 were suggestions of treatment, with 30 accepted by physicians (96.77%) and 31 were medical errors found in 641 prescriptions. Five adverse drug reactions were submitted to the adverse drug reaction monitoring network, with three in the experimental group and two in the control group. The average length of stay (LOS) for patients with respiratory system diseases in the experimental group was 6.45 days, in comparison with 10.83 days in the control group, which was statistically different (p value<0.05); Average drug compliance rate in the experimental group was 81.41%, in comparison with 70.17% of the control group, which was statistically different (p value<0.05). Cost of drugs and hospitalization and rate of readmission in two weeks after discharge in the two groups were not statistically different. Conclusion: Participation by clinical pharmacists in the pharmacotherapy of pediatric patients can reduce LOS of patients with respiratory system disease and improve compliance rate through discharge education, showing no significant effects on prevention of ADR, reduction of cost of drugs and hospitalization and readmission rate in two weeks.	[Zhang, Chuan; Zhang, Lingli; Huang, Liang] Sichuan Univ, Dept Pharm, W China Univ Hosp 2, Chengdu 610064, Peoples R China; [Luo, Rong] Sichuan Univ, Dept Pediat, W China Univ Hosp 2, Chengdu 610064, Peoples R China; [Wen, Jin] Sichuan Univ, Chinese Cochrane Ctr, Chinese Evidence Based Med Ctr, W China Hosp, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Zhang, C (corresponding author), Sichuan Univ, Dept Pharm, W China Univ Hosp 2, Chengdu 610064, Peoples R China.	zhang_Lingli2000@163.com						*AC HLTH CTR, 2003, LEAD CHANG 21 CENT; Al-Rashed SA, 2002, BRIT J CLIN PHARMACO, V54, P657, DOI 10.1046/j.1365-2125.2002.01707.x; [Anonymous], 2010, PROMOTING SAFETY MED; Bailey TC, 1997, PHARMACOTHERAPY, V17, P277; BJORNSON DC, 1993, AM J HOSP PHARM, V50, P1875, DOI 10.1093/ajhp/50.9.1875; Bolas H, 2004, PHARM WORLD SCI, V26, P114, DOI 10.1023/B:PHAR.0000018601.11248.89; Boyko WL, 1997, AM J HEALTH-SYST PH, V54, P1591, DOI 10.1093/ajhp/54.14.1591; CLAPHAM CE, 1988, AM J HOSP PHARM, V45, P2329, DOI 10.1093/ajhp/45.11.2329; COL N, 1990, ARCH INTERN MED, V150, P841, DOI 10.1001/archinte.150.4.841; COLE P, 1971, AM J HOSP PHARM, V28, P954, DOI 10.1093/ajhp/28.12.954; Condren ME, 2004, ANN PHARMACOTHER, V38, P574, DOI 10.1345/aph.1D384; Conroy S, 2000, BRIT MED J, V320, P79, DOI 10.1136/bmj.320.7227.79; DESTACHE CJ, 1989, DICP ANN PHARMAC, V23, P33, DOI 10.1177/106002808902300106; Devlin JW, 1979, AM J HOSP PHARM, V36, P785; DICE JE, 1981, AM J HOSP PHARM, V38, P1487, DOI 10.1093/ajhp/38.10.1487; EDWARDS M, 1984, PRACTITIONER, V228, P291; FOLLI HL, 1987, PEDIATRICS, V79, P718; Fortescue EB, 2003, PEDIATRICS, V111, P722, DOI 10.1542/peds.111.4.722; Gentry CA, 2000, AM J HEALTH-SYST PH, V57, P268, DOI 10.1093/ajhp/57.3.268; GIBSON JT, 1975, AM J HOSP PHARM, V32, P495, DOI 10.1093/ajhp/32.5.495; Gibson JT, 1975, AM J HOSP PHARM, V35, P495; Gums JG, 1999, PHARMACOTHERAPY, V19, P1369, DOI 10.1592/phco.19.18.1369.30898; Guy J, 2003, J Child Health Care, V7, P277, DOI 10.1177/13674935030074004; HAIG GM, 1991, AM J HOSP PHARM, V48, P1457, DOI 10.1093/ajhp/48.7.1457; Impicciatore P, 2001, BRIT J CLIN PHARMACO, V52, P77, DOI 10.1046/j.0306-5251.2001.01407.x; Kohn LT., 2000, ERR IS HUMAN BUILDIN, P245; KOREN G, 1991, Journal of Pharmacy Technology, V7, P219; Krupicka MI, 2002, CRIT CARE MED, V30, P919, DOI 10.1097/00003246-200204000-00035; Kucukarslan SN, 2003, ARCH INTERN MED, V163, P2014, DOI 10.1001/archinte.163.17.2014; Lal L S, 1995, Hosp Pharm, V30, P1107; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; LIPTON HL, 1994, GERONTOLOGIST, V34, P307, DOI 10.1093/geront/34.3.307; Nazareth I, 2001, AGE AGEING, V30, P33, DOI 10.1093/ageing/30.1.33; Nikolaus T, 2001, AGE AGEING, V30, P33; PARKIN DM, 1976, BMJ-BRIT MED J, V2, P686, DOI 10.1136/bmj.2.6037.686; Sanghera N, 2006, DRUG SAFETY, V29, P1031, DOI 10.2165/00002018-200629110-00003; Smith L, 1997, BRIT J CLIN PHARMACO, V44, P163, DOI 10.1046/j.1365-2125.1997.00629.x; Smythe MA, 1998, ANN PHARMACOTHER, V32, P294, DOI 10.1345/aph.17068; Strong D K, 1993, Can J Hosp Pharm, V46, P101; Virani A., 2003, CAN J HOSP PHARM, V56, P158; WILLIFORD SL, 1995, MIL MED, V160, P561, DOI 10.1093/milmed/160.11.561; Wong IC, 2004, DRUG SAFETY, V27, P661, DOI 10.2165/00002018-200427090-00004; WORONIECKI CL, 1982, AM J HOSP PHARM, V39, P1907, DOI 10.1093/ajhp/39.11.1907	43	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30856	10.1371/journal.pone.0030856	http://dx.doi.org/10.1371/journal.pone.0030856			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292061	gold, Green Published, Green Submitted			2022-12-27	WOS:000301570600087
J	Hartmann, S; Helm, C; Nickel, B; Meyer, M; Struck, TH; Tiedemann, R; Selbig, J; Bleidorn, C				Hartmann, Stefanie; Helm, Conrad; Nickel, Birgit; Meyer, Matthias; Struck, Torsten H.; Tiedemann, Ralph; Selbig, Joachim; Bleidorn, Christoph			Exploiting Gene Families for Phylogenomic Analysis of Myzostomid Transcriptome Data	PLOS ONE			English	Article							SPECIES TREES; GENOME; PROGRAM; DUPLICATION; SUPERMATRIX; ALGORITHM; SEQUENCES; NUCLEAR; EVENTS; INFER	Background: In trying to understand the evolutionary relationships of organisms, the current flood of sequence data offers great opportunities, but also reveals new challenges with regard to data quality, the selection of data for subsequent analysis, and the automation of steps that were once done manually for single-gene analyses. Even though genome or transcriptome data is available for representatives of most bilaterian phyla, some enigmatic taxa still have an uncertain position in the animal tree of life. This is especially true for myzostomids, a group of symbiotic ( or parasitic) protostomes that are either placed with annelids or flatworms. Methodology: Based on similarity criteria, Illumina-based transcriptome sequences of one myzostomid were compared to protein sequences of one additional myzostomid and 29 reference metazoa and clustered into gene families. These families were then used to investigate the phylogenetic position of Myzostomida using different approaches: Alignments of 989 sequence families were concatenated, and the resulting superalignment was analyzed under a Maximum Likelihood criterion. We also used all 1,878 gene trees with at least one myzostomid sequence for a supertree approach: the individual gene trees were computed and then reconciled into a species tree using gene tree parsimony. Conclusions: Superalignments require strictly orthologous genes, and both the gene selection and the widely varying amount of data available for different taxa in our dataset may cause anomalous placements and low bootstrap support. In contrast, gene tree parsimony is designed to accommodate multilocus gene families and therefore allows a much more comprehensive data set to be analyzed. Results of this supertree approach showed a well-resolved phylogeny, in which myzostomids were part of the annelid radiation, and major bilaterian taxa were found to be monophyletic.	[Hartmann, Stefanie; Selbig, Joachim] Univ Potsdam, Dept Bioinformat, Inst Biochem & Biol, Potsdam, Germany; [Helm, Conrad; Bleidorn, Christoph] Univ Leipzig, Inst Biol 2, Leipzig, Germany; [Nickel, Birgit; Meyer, Matthias] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Struck, Torsten H.] Zool Res Museum Alexander Koenig, Bonn, Germany; [Tiedemann, Ralph; Bleidorn, Christoph] Univ Potsdam, Dept Evolutionary Biol, Inst Biochem & Biol, Potsdam, Germany	University of Potsdam; Leipzig University; Max Planck Society; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); University of Potsdam	Hartmann, S (corresponding author), Univ Potsdam, Dept Bioinformat, Inst Biochem & Biol, Potsdam, Germany.	bleidorn@rz.uni-leipzig.de	Hartmann, Stefanie/H-4413-2011	Tiedemann, Ralph/0000-0002-2604-6336; Bleidorn, Christoph/0000-0001-7295-6616	Deutsche Forschungsgemeinschaft [BL787/2-1, BL787/2-2, TI349/4-1]; European Union due to ASSEMBLE [227799]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union due to ASSEMBLE	This study was funded by the priority program "Deep Metazoan Phylogeny" of the Deutsche Forschungsgemeinschaft (www.dfg.de) (BL787/2-1 and BL787/2-2 to CB, TI349/4-1 to RT). CB was supported by the European Union due to ASSEMBLE (http://www.assemblemarine.org) grant agreement no. 227799. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bansal MS, 2007, LECT NOTES COMPUT SC, V4453, P238; Bansal MS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S42; Berglund-Sonnhammer AC, 2006, J MOL EVOL, V63, P240, DOI 10.1007/s00239-005-0096-1; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bleidorn C, 2007, MOL BIOL EVOL, V24, P1690, DOI 10.1093/molbev/msm086; Bleidorn C, 2009, DEV GENES EVOL, V219, P211, DOI 10.1007/s00427-009-0282-z; Bleidorn C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-150; Boutet Emmanuel, 2007, V406, P89; Burleigh JG, 2011, SYST BIOL, V60, P117, DOI 10.1093/sysbio/syq072; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Cotton JA, 2003, MOL PHYLOGENET EVOL, V29, P298, DOI 10.1016/S1055-7903(03)00109-X; Cotton JA, 2002, P ROY SOC B-BIOL SCI, V269, P1555, DOI 10.1098/rspb.2002.2074; COTTON JA, 2004, COMPU BIOL, V4, P107; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Eeckhaut I, 2000, P ROY SOC B-BIOL SCI, V267, P1383, DOI 10.1098/rspb.2000.1154; Eeckhaut I, 2005, HYDROBIOLOGIA, V535, P253, DOI 10.1007/s10750-004-5636-y; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; FECKHAUT I, 1993, DIS AQUAT ORGAN, V15, P207; GOODMAN M, 1979, SYST ZOOL, V28, P132, DOI 10.2307/2412519; Hartmann S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-95; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Holton TA, 2010, GENOME BIOL EVOL, V2, P310, DOI 10.1093/gbe/evq016; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kircher M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-382; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Lanterbecq D, 2010, MOL PHYLOGENET EVOL, V54, P357, DOI 10.1016/j.ympev.2009.08.011; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Matthee CA, 2004, SYST BIOL, V53, P433, DOI 10.1080/10635150490445715; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Meyer M., 2010, COLD SPRING HARB PRO; Page R D M, 2002, Pac Symp Biocomput, P536; Paps J, 2009, P ROY SOC B-BIOL SCI, V276, P1245, DOI 10.1098/rspb.2008.1574; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Sanderson MJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S3; Slowinski JB, 1999, SYST BIOL, V48, P814, DOI 10.1080/106351599260030; Slowinski JB, 1997, MOL PHYLOGENET EVOL, V8, P349, DOI 10.1006/mpev.1997.0434; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Wehe A, 2008, BIOINFORMATICS, V24, P1540, DOI 10.1093/bioinformatics/btn230; Zmasek CM, 2001, BIOINFORMATICS, V17, P821, DOI 10.1093/bioinformatics/17.9.821	47	29	29	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29843	10.1371/journal.pone.0029843	http://dx.doi.org/10.1371/journal.pone.0029843			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276131	Green Submitted, gold, Green Published			2022-12-27	WOS:000301568100017
J	Shoji, M; Yoshizaki, S; Mizuguchi, H; Okuda, K; Shimada, M				Shoji, Masaki; Yoshizaki, Shinji; Mizuguchi, Hiroyuki; Okuda, Kenji; Shimada, Masaru			Immunogenic Comparison of Chimeric Adenovirus 5/35 Vector Carrying Optimized Human Immunodeficiency Virus Clade C Genes and Various Promoters	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSES; T-CELLS; RECOMBINANT ADENOVIRUS; THERAPEUTIC LEVELS; VACCINE VECTOR; RHESUS-MONKEYS; MVA VECTORS; IN-VIVO; HIV; TYPE-1	Adenovirus vector-based vaccine is a promising approach to protect HIV infection. However, a recent phase IIb clinical trial using the vector did not show its protective efficacy against HIV infection. To improve the vaccine, we explored the transgene protein expression and its immunogenicity using optimized codon usage, promoters and adaptors. We compared protein expression and immunogenicity of adenovirus vector vaccines carrying native or codon usage-optimized HIV-1 clade C gag and env genes expression cassettes driven by different promoters (CMV, CMVi, and CA promoters) and adapters (IRES and F2A). The adenovirus vector vaccine containing optimized gag gene produced higher Gag protein expression and induced higher immune responses than the vector containing native gag gene in mice. Furthermore, CA promoter generated higher transgene expression and elicited higher immune responses than other two popularly used promoters (CMV and CMVi). The second gene expression using F2A adaptor resulted in higher protein expression and immunity than that of using IRES and direct fusion protein. Taken together, the adenovirus vector containing the expression cassette with CA promoter, optimized HIV-1 clade C gene and an F2A adaptor produced the best protein expression and elicited the highest transgene-specific immune responses. This finding would be promising for vaccine design and gene therapy.	[Shoji, Masaki; Yoshizaki, Shinji; Shimada, Masaru] Yokohama City Univ, Dept Mol Biodef Res, Yokohama, Kanagawa 232, Japan; [Shoji, Masaki; Mizuguchi, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biochem & Mol Biol, Osaka, Japan; [Mizuguchi, Hiroyuki] Natl Inst Biomed Innovat, Lab Gene Transfer & Regulat, Ibaraki, Osaka, Japan; [Okuda, Kenji] Fukushimura Hosp, Choju Med Inst, Toyohasi, Aichi, Japan	Yokohama City University; Osaka University; National Institute of Health Sciences - Japan	Shoji, M (corresponding author), Yokohama City Univ, Dept Mol Biodef Res, Yokohama, Kanagawa 232, Japan.	mshimada@yokohama-cu.ac.jp		Mizuguchi, Hiroyuki/0000-0003-0594-8178; Shimada, Masaru/0000-0002-5271-4238	Ministry of Education, Science, Sports and Culture of Japan; Yokohama City University, Japan; Research Foundation for Advanced Medical Research Center; Japanese National Institute of Biomedical Innovation [05 1]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokohama City University, Japan; Research Foundation for Advanced Medical Research Center; Japanese National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was partially supported by a grant-in-aid from the Ministry of Education, Science, Sports and Culture of Japan; a grant for the Strategic Research Project of Yokohama City University, Japan; Research Foundation for Advanced Medical Research Center and a grant from the Japanese National Institute of Biomedical Innovation (No. 05 1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abe S, 2009, J GENE MED, V11, P570, DOI 10.1002/jgm.1332; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Churchyard GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021225; Clay TM, 2001, CLIN CANCER RES, V7, P1127; Fang JM, 2007, MOL THER, V15, P1153, DOI 10.1038/sj.mt.6300142; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; Gao F, 2003, AIDS RES HUM RETROV, V19, P817, DOI 10.1089/088922203769232610; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Matano T, 2004, J EXP MED, V199, P1709, DOI 10.1084/jem.20040432; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Mizuguchi H, 1999, HUM GENE THER, V10, P2013, DOI 10.1089/10430349950017374; Mizuguchi H, 2002, GENE, V285, P69, DOI 10.1016/S0378-1119(02)00410-9; MOLLA A, 1992, NATURE, V356, P255, DOI 10.1038/356255a0; Moore JP, 2008, SCIENCE, V320, P753, DOI 10.1126/science.1154258; MOUNTFORD PS, 1995, TRENDS GENET, V11, P179, DOI 10.1016/S0168-9525(00)89040-X; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; SESHIDHAR RP, 2003, VIROLOGY, V311, P384; Shimada M, 2009, GENE THER, V16, P218, DOI 10.1038/gt.2008.152; Shinoda K, 2004, VACCINE, V22, P3676, DOI 10.1016/j.vaccine.2004.03.015; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; van Harmelen J, 2001, AIDS RES HUM RETROV, V17, P1527, DOI 10.1089/08892220152644232; WADELL G, 1984, CURR TOP MICROBIOL, V110, P191; Wang HB, 2010, GENE THER, V17, P4, DOI 10.1038/gt.2009.122; Whiteside TL, 2003, CLIN CANCER RES, V9, P641; Xin KQ, 2007, VACCINE, V25, P3809, DOI 10.1016/j.vaccine.2007.01.117; Xin KQ, 2005, GENE THER, V12, P1769, DOI 10.1038/sj.gt.3302590; Xu ZL, 2001, GENE, V272, P149, DOI 10.1016/S0378-1119(01)00550-9; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004	48	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30302	10.1371/journal.pone.0030302	http://dx.doi.org/10.1371/journal.pone.0030302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276174	Green Published, gold, Green Submitted			2022-12-27	WOS:000301457200052
J	Baird, E; Byrne, MJ; Smolka, J; Warrant, EJ; Dacke, M				Baird, Emily; Byrne, Marcus J.; Smolka, Jochen; Warrant, Eric J.; Dacke, Marie			The Dung Beetle Dance: An Orientation Behaviour?	PLOS ONE			English	Article							NAVIGATION; BALL	An interesting feature of dung beetle behaviour is that once they have formed a piece of dung into a ball, they roll it along a straight path away from the dung pile. This straight-line orientation ensures that the beetles depart along the most direct route, guaranteeing that they will not return to the intense competition (from other beetles) that occurs near the dung pile. Before rolling a new ball away from the dung pile, dung beetles perform a characteristic "dance," in which they climb on top of the ball and rotate about their vertical axis. This dance behaviour can also be observed during the beetles' straight-line departure from the dung pile. The aim of the present study is to investigate the purpose of the dung beetle dance. To do this, we explored the circumstances that elicit dance behaviour in the diurnal ball-rolling dung beetle, Scarabaeus (Kheper) nigroaeneus. Our results reveal that dances are elicited when the beetles lose control of their ball or lose contact with it altogether. We also find that dances can be elicited by both active and passive deviations of course and by changes in visual cues alone. In light of these results, we hypothesise that the dung beetle dance is a visually mediated mechanism that facilitates straight-line orientation in ball-rolling dung beetles by allowing them to 1) establish a roll bearing and 2) return to this chosen bearing after experiencing a disturbance to the roll path.	[Baird, Emily; Smolka, Jochen; Warrant, Eric J.; Dacke, Marie] Lund Univ, Dept Biol, Lund, Sweden; [Byrne, Marcus J.] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa	Lund University; University of Witwatersrand	Baird, E (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Emily.Baird@biol.lu.se	Baird, Emily/G-8763-2014; Byrne, Marcus/AAF-9789-2021; Smolka, Jochen/N-6282-2014	Baird, Emily/0000-0003-3625-3897; Smolka, Jochen/0000-0003-2958-0697; Byrne, Marcus/0000-0002-5155-2599; Warrant, Eric/0000-0001-7480-7016	United States Air Force Office of Scientific Research [FA8655-07-C-4011]; Swedish Research Council; Wenner-Gren Foundation; Crafoord Foundation; Royal Physiographic Society of Lund	United States Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Wenner-Gren Foundation; Crafoord Foundation; Royal Physiographic Society of Lund	This study was funded by the United States Air Force Office of Scientific Research (grant no. FA8655-07-C-4011), the Swedish Research Council, Wenner-Gren Foundation, Crafoord Foundation and the Royal Physiographic Society of Lund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird E, 2010, J COMP PHYSIOL A, V196, P801, DOI 10.1007/s00359-010-0559-8; BARTHOLOMEW GA, 1978, J EXP BIOL, V73, P65; Byrne M, 2003, J COMP PHYSIOL A, V189, P411, DOI 10.1007/s00359-003-0415-1; Cheung A, 2007, BIOL CYBERN, V97, P47, DOI 10.1007/s00422-007-0158-0; Dacke M, 2004, P ROY SOC B-BIOL SCI, V271, P361, DOI 10.1098/rspb.2003.2594; Dacke M, 2003, NATURE, V424, P33, DOI 10.1038/424033a; Dacke M, 2003, J EXP BIOL, V206, P1535, DOI 10.1242/jeb.00289; Lent DD, 2010, P NATL ACAD SCI USA, V107, P16348, DOI 10.1073/pnas.1006021107; MATTHEWS ERIC G., 1963, PSYCHE, V70, P75, DOI 10.1155/1963/23630; Muller M, 2010, CURR BIOL, V20, P1368, DOI 10.1016/j.cub.2010.06.035; ROSSEL S, 1984, J COMP PHYSIOL, V154, P607, DOI 10.1007/BF01350213; SANTSCHI F, 1911, REV SUISSE ZOOL, V19, P305; Ugolini A, 2006, J COMP PHYSIOL A, V192, P45, DOI 10.1007/s00359-005-0046-9; WEHNER R, 1990, ETHOL ECOL EVOL, V2, P27, DOI 10.1080/08927014.1990.9525492	14	34	35	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30211	10.1371/journal.pone.0030211	http://dx.doi.org/10.1371/journal.pone.0030211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279572	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900050
J	Mostaghel, EA; Solomon, KR; Pelton, K; Freeman, MR; Montgomery, RB				Mostaghel, Elahe A.; Solomon, Keith R.; Pelton, Kristine; Freeman, Michael R.; Montgomery, R. Bruce			Impact of Circulating Cholesterol Levels on Growth and Intratumoral Androgen Concentration of Prostate Tumors	PLOS ONE			English	Article							DEPRIVATION THERAPY; CANCER-RISK; RECEPTOR MUTATIONS; SERUM-CHOLESTEROL; DIETARY PATTERNS; LOWERING DRUGS; LIPID RAFTS; STATIN USE; MEN; PROGRESSION	Prostate cancer (PCa) is the second most common cancer in men. Androgen deprivation therapy (ADT) leads to tumor involution and reduction of tumor burden. However, tumors eventually reemerge that have overcome the absence of gonadal androgens, termed castration resistant PCa (CRPC). Theories underlying the development of CRPC include androgen receptor (AR) mutation allowing for promiscuous activation by non-androgens, AR amplification and overexpression leading to hypersensitivity to low androgen levels, and/or tumoral uptake and conversion of adrenally derived androgens. More recently it has been proposed that prostate tumor cells synthesize their own androgens through de novo steroidogenesis, which involves the step-wise synthesis of androgens from cholesterol. Using the in vivo LNCaP PCa xenograft model, previous data from our group demonstrated that a hypercholesterolemia diet potentiates prostatic tumor growth via induction of angiogenesis. Using this same model we now demonstrate that circulating cholesterol levels are significantly associated with tumor size (R = 0.3957, p = 0.0049) and intratumoral levels of testosterone (R = 0.41, p = 0.0023) in LNCaP tumors grown in hormonally intact mice. We demonstrate tumoral expression of cholesterol uptake genes as well as the spectrum of steroidogenic enzymes necessary for androgen biosynthesis from cholesterol. Moreover, we show that circulating cholesterol levels are directly correlated with tumoral expression of CYP17A, the critical enzyme required for de novo synthesis of androgens from cholesterol (R = 0.4073, p = 0.025) Since hypercholesterolemia does not raise circulating androgen levels and the adrenal gland of the mouse synthesizes minimal androgens, this study provides evidence that hypercholesterolemia increases intratumoral de novo steroidogenesis. Our results are consistent with the hypothesis that cholesterol-fueled intratumoral androgen synthesis may accelerate the growth of prostate tumors, and suggest that treatment of CRPC may be optimized by inclusion of cholesterol reduction therapies in conjunction with therapies targeting androgen synthesis and the AR.	[Mostaghel, Elahe A.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Mostaghel, Elahe A.; Montgomery, R. Bruce] Univ Washington, Dept Med, Seattle, WA USA; [Solomon, Keith R.; Pelton, Kristine] Childrens Hosp Boston, Dept Orthopaed Surg, Boston, MA USA; [Solomon, Keith R.; Freeman, Michael R.] Childrens Hosp Boston, Dept Urol, Boston, MA USA; [Solomon, Keith R.] Harvard Univ, Sch Med, Dept Orthopaed Surg, Boston, MA USA; [Freeman, Michael R.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Freeman, Michael R.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Mostaghel, EA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	keith.solomon@childrens.harvard.edu			Prostate Cancer Foundation; Damon Runyon Cancer Research Foundation [CI-40-08]; National Institutes of Health [P50 CA97186, R01 CA101046, R01 CA143777]; United States Army Department of Defense [PCRP W81XWH-08-1-0150]; NATIONAL CANCER INSTITUTE [R01CA101046, P50CA097186, R01CA143777] Funding Source: NIH RePORTER	Prostate Cancer Foundation; Damon Runyon Cancer Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Prostate Cancer Foundation (EAM); Damon Runyon Cancer Research Foundation (Damon Runyon-Genentech Clinical Investigator Award CI-40-08, EAM), and the National Institutes of Health (Pacific Northwest Prostate Cancer SPORE P50 CA97186, EAM, RBM; R01 CA101046, KRS; R01 CA143777, MRF) and the United States Army Department of Defense (PCRP W81XWH-08-1-0150, MRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Attard G, 2009, J CLIN ONCOL, V27, P3742, DOI 10.1200/JCO.2008.20.0642; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Batty GD, 2011, CANCER CAUSE CONTROL, V22, P311, DOI 10.1007/s10552-010-9691-6; Breau RH, 2010, J UROLOGY, V184, P494, DOI 10.1016/j.juro.2010.03.149; Browning DRL, 2007, INT J CANCER, V120, P833, DOI 10.1002/ijc.22366; Colombel M, 2005, CANCER RES, V65, P300; Dale KM, 2006, JAMA-J AM MED ASSOC, V295, P74, DOI 10.1001/jama.295.1.74; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dillard PR, 2008, MOL CELL ENDOCRINOL, V295, P115, DOI 10.1016/j.mce.2008.08.013; Farwell WR, 2011, JNCI-J NATL CANCER I, V103, P885, DOI 10.1093/jnci/djr108; Fenton MA, 1997, CLIN CANCER RES, V3, P1383; Flick ED, 2007, CANCER EPIDEM BIOMAR, V16, P2218, DOI 10.1158/1055-9965.EPI-07-0197; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; Friis S, 2005, INT J CANCER, V114, P643, DOI 10.1002/ijc.20758; Geller J, 1979, Prog Clin Biol Res, V33, P103; GELLER J, 1979, J STEROID BIOCHEM, V11, P631, DOI 10.1016/0022-4731(79)90092-X; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Gutt R, 2010, J CLIN ONCOL, V28, P2653, DOI 10.1200/JCO.2009.27.3003; Hall SA, 2007, CANCER EPIDEM BIOMAR, V16, P1587, DOI 10.1158/1055-9965.EPI-07-0306; Hamilton RJ, 2010, CANCER-AM CANCER SOC, V116, P3389, DOI 10.1002/cncr.25308; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Iso H, 2009, INT J CANCER, V125, P2679, DOI 10.1002/ijc.24668; Jacobs EJ, 2007, CANCER EPIDEM BIOMAR, V16, P2213, DOI 10.1158/1055-9965.EPI-07-0448; Jurado J, 2004, AM J CARDIOL, V93, P641, DOI 10.1016/j.amjcard.2003.11.040; Knopp RH, 2003, EUR HEART J, V24, P729, DOI 10.1016/S0195-668X(02)00807-2; Kolonel LN, 1999, JNCI-J NATL CANCER I, V91, P414, DOI 10.1093/jnci/91.5.414; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Labrie F, 2004, SEMIN REPROD MED, V22, P299, DOI 10.1055/s-2004-861547; Liao YD, 2003, INT J CANCER, V107, P676, DOI 10.1002/ijc.11471; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Michaud DS, 2001, CANCER CAUSE CONTROL, V12, P557, DOI 10.1023/A:1011256201044; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Mondul AM, 2010, CANCER CAUSE CONTROL, V21, P61, DOI 10.1007/s10552-009-9434-8; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Mostaghel EA, 2008, BEST PRACT RES CL EN, V22, P243, DOI 10.1016/j.beem.2008.01.003; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Murtola TJ, 2007, CANCER EPIDEM BIOMAR, V16, P2226, DOI 10.1158/1055-9965.EPI-07-0599; Nishiyama T, 2004, CLIN CANCER RES, V10, P7121, DOI 10.1158/1078-0432.CCR-04-0913; Page ST, 2007, J ANDROL, V28, P734, DOI 10.2164/jandrol.107.002790; Platz EA, 2008, INT J CANCER, V123, P1693, DOI 10.1002/ijc.23715; Platz EA, 2006, JNCI-J NATL CANCER I, V98, P1819, DOI 10.1093/jnci/djj499; Platz EA, 2009, CANCER EPIDEM BIOMAR, V18, P2807, DOI 10.1158/1055-9965.EPI-09-0472; Reid AHM, 2008, NAT CLIN PRACT UROL, V5, P610, DOI 10.1038/ncpuro1237; Ross RW, 2008, CANCER-AM CANCER SOC, V112, P1247, DOI 10.1002/cncr.23304; Schaffner C P, 1981, Prog Clin Biol Res, V75A, P279; Shimizu Y, 2007, BJU INT, V100, P685, DOI 10.1111/j.1464-410X.2007.07014.x; Singer EA, 2008, EXPERT OPIN PHARMACO, V9, P211, DOI 10.1517/14656566.9.2.211 ; Singer EA, 2008, CAN J UROL, V15, P4381; Solomon KR, 2008, TRENDS ENDOCRIN MET, V19, P113, DOI 10.1016/j.tem.2007.12.004; Solomon KR, 2009, AM J PATHOL, V174, P1017, DOI 10.2353/ajpath.2009.080551; Swyer GIM, 1942, CANCER RES, V2, P372; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; Taplin ME, 1999, CANCER RES, V59, P2511; Taplin ME, 2003, J CLIN ONCOL, V21, P2673, DOI 10.1200/JCO.2003.11.102; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Thibault A, 1996, CLIN CANCER RES, V2, P483; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; VANWEERDEN WM, 1992, LIFE SCI, V50, P857, DOI 10.1016/0024-3205(92)90204-3; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Walker M, 2005, INT J CANCER, V116, P592, DOI 10.1002/ijc.21112; Wu K, 2006, CANCER EPIDEM BIOMAR, V15, P167, DOI 10.1158/1055-9965.EPI-05-0100; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Zhuang LY, 2005, J CLIN INVEST, V115, P959; Zhuang LY, 2002, CANCER RES, V62, P2227	69	92	95	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30062	10.1371/journal.pone.0030062	http://dx.doi.org/10.1371/journal.pone.0030062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279565	Green Published, Green Submitted, gold			2022-12-27	WOS:000299771900043
J	Shieh, JM; Wei, TT; Tang, YA; Huang, SM; Wen, WL; Chen, MY; Cheng, HC; Salunke, SB; Chen, CS; Lin, PP; Chen, CT; Wang, YC				Shieh, Jiunn-Min; Wei, Tzu-Tang; Tang, Yen-An; Huang, Sin-Ming; Wen, Wei-Ling; Chen, Mei-Yu; Cheng, Hung-Chi; Salunke, Santosh B.; Chen, Ching-Shih; Lin, Pinpin; Chen, Chien-Tien; Wang, Yi-Ching			Mitochondrial Apoptosis and FAK Signaling Disruption by a Novel Histone Deacetylase Inhibitor, HTPB, in Antitumor and Antimetastatic Mouse Models	PLOS ONE			English	Article							FOCAL ADHESION KINASE; CELL-DEATH; CANCER-THERAPY; ACTIVATION; HALLMARKS; FIBRONECTIN; COMBINATION; MECHANISMS; PATHWAYS; PROTEINS	Background: Compound targeting histone deacetylase (HDAC) represents a new era in molecular cancer therapeutics. However, effective HDAC inhibitors for the treatment of solid tumors remain to be developed. Methodology/Principal Findings: Here, we propose a novel HDAC inhibitor, N-Hydroxy-4-(4-phenylbutyryl-amino) benzamide (HTPB), as a potential chemotherapeutic drug for solid tumors. The HDAC inhibition of HTPB was confirmed using HDAC activity assay. The antiproliferative and anti-migratory mechanisms of HTPB were investigated by cell proliferation, flow cytometry, DNA ladder, caspase activity, Rho activity, F-actin polymerization, and gelatin-zymography for matrix metalloproteinases (MMPs). Mice with tumor xenograft and experimental metastasis model were used to evaluate effects on tumor growth and metastasis. Our results indicated that HTPB was a pan-HDAC inhibitor in suppressing cell viability specifically of lung cancer cells but not of the normal lung cells. Upon HTPB treatment, cell cycle arrest was induced and subsequently led to mitochondria-mediated apoptosis. HTPB disrupted F-actin dynamics via downregulating RhoA activity. Moreover, HTPB inhibited activity of MMP2 and MMP9, reduced integrin-beta 1/focal adhesion complex formation and decreased pericellular poly-fibronectin assemblies. Finally, intraperitoneal injection or oral administration of HTPB efficiently inhibited A549 xenograft tumor growth in vivo without side effects. HTPB delayed lung metastasis of 4T1 mouse breast cancer cells. Acetylation of histone and non-histone proteins, induction of apoptotic-related proteins and dephosphorylation of focal adhesion kinase were confirmed in treated mice. Conclusions/Significance: These results suggested that intrinsic apoptotic pathway may involve in anti-tumor growth effects of HTPB in lung cancer cells. HTPB significantly suppresses tumor metastasis partly through inhibition of integrin-beta 1/FAK/MMP/RhoA/F-actin pathways. We have provided convincing preclinical evidence that HTPB is a potent HDAC targeted inhibitor and is thus a promising candidate for lung cancer chemotherapy.	[Shieh, Jiunn-Min] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Wei, Tzu-Tang; Chen, Mei-Yu; Wang, Yi-Ching] Natl Cheng Kung Univ, Dept Pharmacol, Tainan 70101, Taiwan; [Tang, Yen-An; Cheng, Hung-Chi; Wang, Yi-Ching] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Huang, Sin-Ming; Wen, Wei-Ling] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Cheng, Hung-Chi] Natl Cheng Kung Univ, Inst Biochem, Tainan 70101, Taiwan; [Salunke, Santosh B.; Chen, Chien-Tien] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan; [Chen, Ching-Shih] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Lin, Pinpin] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Taiwan	Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University; National Taiwan Normal University; National Cheng Kung University; National Tsing Hua University; University System of Ohio; Ohio State University; National Health Research Institutes - Taiwan	Shieh, JM (corresponding author), Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan.	ctchen@mx.nthu.edu.tw; ycw5798@mail.ncku.edu.tw	Wang, Yi-Ching/J-8702-2019; Lin, PinPin/A-2006-2019; Lin, Pinpin/B-2668-2010; WEI, TZU-TANG/AAT-8447-2020	Wang, Yi-Ching/0000-0002-7694-2067; Lin, PinPin/0000-0001-5459-907X; Lin, Pinpin/0000-0001-5459-907X; 	Chi Mei Medical Center, Taiwan [CMNCKU9906]; National Science Council, Taiwan [NSC100-2325-B-400-012, NSC 100-2325-B-006-009]	Chi Mei Medical Center, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants CMNCKU9906 from the Chi Mei Medical Center, Taiwan (JMS) and NSC100-2325-B-400-012 (PL) and NSC 100-2325-B-006-009 from the National Science Council, Taiwan (YCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carew JS, 2008, CANCER LETT, V269, P7, DOI 10.1016/j.canlet.2008.03.037; Cheng HC, 2003, J BIOL CHEM, V278, P24600, DOI 10.1074/jbc.M303424200; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Gojo I, 2007, BLOOD, V109, P2781, DOI 10.1182/blood-2006-05-021873; Gossage L, 2010, CLIN CANCER RES, V16, P1973, DOI 10.1158/1078-0432.CCR-09-3182; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Lazebnik Y, 2010, NAT REV CANCER, V10, P232, DOI 10.1038/nrc2827; Levitzki A, 2010, MOL ASPECTS MED, V31, P287, DOI 10.1016/j.mam.2010.04.001; Liu LT, 2003, CANCER RES, V63, P3069; Lu Q, 2005, J MED CHEM, V48, P5530, DOI 10.1021/jm0503749; Ma XJ, 2009, DRUGS, V69, P1911, DOI 10.2165/11315680-000000000-00000; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marsoni S, 2008, EPIGENETICS-US, V3, P164, DOI 10.4161/epi.3.3.6253; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nemunaitis JJ, 2003, CANCER J, V9, P58, DOI 10.1097/00130404-200301000-00010; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Reuter JA, 2009, CANCER CELL, V15, P477, DOI 10.1016/j.ccr.2009.04.002; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Siddiqa A, 2008, CANCER BIOL THER, V7, P740, DOI 10.4161/cbt.7.5.6163; Takada Y, 2006, J BIOL CHEM, V281, P5612, DOI 10.1074/jbc.M507213200; Tang YA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012417; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	33	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30240	10.1371/journal.pone.0030240	http://dx.doi.org/10.1371/journal.pone.0030240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279574	Green Published, Green Submitted, gold			2022-12-27	WOS:000299771900051
J	Lerch, JK; Kuo, F; Motti, D; Morris, R; Bixby, JL; Lemmon, VP				Lerch, Jessica K.; Kuo, Frank; Motti, Dario; Morris, Richard; Bixby, John L.; Lemmon, Vance P.			Isoform Diversity and Regulation in Peripheral and Central Neurons Revealed through RNA-Seq	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; CELL-DIFFERENTIATION; OVER-REPRESENTATION; NERVE REGENERATION; AXON REGENERATION; SENSORY NEURONS; BINDING SITES; SPINAL-CORD; TRANSCRIPTION	To fully understand cell type identity and function in the nervous system there is a need to understand neuronal gene expression at the level of isoform diversity. Here we applied Next Generation Sequencing of the transcriptome (RNA-Seq) to purified sensory neurons and cerebellar granular neurons (CGNs) grown on an axonal growth permissive substrate. The goal of the analysis was to uncover neuronal type specific isoforms as a prelude to understanding patterns of gene expression underlying their intrinsic growth abilities. Global gene expression patterns were comparable to those found for other cell types, in that a vast majority of genes were expressed at low abundance. Nearly 18% of gene loci produced more than one transcript. More than 8000 isoforms were differentially expressed, either to different degrees in different neuronal types or uniquely expressed in one or the other. Sensory neurons expressed a larger number of genes and gene isoforms than did CGNs. To begin to understand the mechanisms responsible for the differential gene/isoform expression we identified transcription factor binding sites present specifically in the upstream genomic sequences of differentially expressed isoforms, and analyzed the 3' untranslated regions (3' UTRs) for microRNA (miRNA) target sites. Our analysis defines isoform diversity for two neuronal types with diverse axon growth capabilities and begins to elucidate the complex transcriptional landscape in two neuronal populations.	[Lerch, Jessica K.; Kuo, Frank; Motti, Dario; Morris, Richard; Bixby, John L.; Lemmon, Vance P.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Morris, Richard; Bixby, John L.] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, Miami, FL 33136 USA; [Bixby, John L.] Univ Miami, Miller Sch Med, Dept Cellular & Mol Pharmacol, Miami, FL 33136 USA; [Lemmon, Vance P.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Lerch, JK (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.	jbixby@miami.edu; vlemmon@med.miami.edu	Lemmon, Vance/A-7410-2010	Lemmon, Vance/0000-0003-3550-7576; Bixby, John/0000-0003-1633-5318; Motti, Dario/0000-0002-7714-4040	National Institutes of Health [HD057632, NS059866]; U.S. Army [W81XWH-05-1-0061]; Buoniconti Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army(United States Department of DefenseUnited States Army); Buoniconti Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (HD057632), (NS059866), U.S. Army (W81XWH-05-1-0061), and the Buoniconti Foundation. VPL holds the Walter G. Ross Distinguished Chair in Developmental Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beck D, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-19; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Blackmore MG, 2010, MOL CELL NEUROSCI, V44, P43, DOI 10.1016/j.mcn.2010.02.002; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Buchser WJ, 2006, BIOTECHNIQUES, V41, P619, DOI 10.2144/000112279; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Chen H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00098; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; GALLO V, 1987, J NEUROSCI, V7, P2203; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Kazantseva A, 2009, J NEUROCHEM, V109, P807, DOI 10.1111/j.1471-4159.2009.06005.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Malin D, 2009, J CELL SCI, V122, P995, DOI 10.1242/jcs.040378; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Marstrand TT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001623; MCQUARRIE IG, 1973, ARCH NEUROL-CHICAGO, V29, P53, DOI 10.1001/archneur.1973.00490250071008; MCQUARRIE IG, 1977, BRAIN RES, V132, P443, DOI 10.1016/0006-8993(77)90193-7; Mercer TR, 2011, NUCLEIC ACIDS RES, V39, P2393, DOI 10.1093/nar/gkq1158; Miyazaki K, 2009, NUCLEIC ACIDS RES, V37, P1438, DOI 10.1093/nar/gkn1082; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Musatov S, 2004, P NATL ACAD SCI USA, V101, P3627, DOI 10.1073/pnas.0308289101; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; OTTEN U, 1980, NATURE, V287, P158, DOI 10.1038/287158a0; Park C, 2011, GASTROENTEROLOGY, V141, P164, DOI 10.1053/j.gastro.2011.03.058; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Perbellini R, 2011, NEUROMUSCULAR DISORD, V21, P81, DOI 10.1016/j.nmd.2010.11.012; Polo-Parada L, 2004, J NEUROSCI, V24, P1852, DOI 10.1523/JNEUROSCI.4406-03.2004; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; SEGAL RA, 1992, NEURON, V9, P1041, DOI 10.1016/0896-6273(92)90064-K; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Smith RP, 2011, MOL CELL NEUROSCI, V46, P32, DOI 10.1016/j.mcn.2010.07.015; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Sui SJH, 2007, NUCLEIC ACIDS RES, V35, pW245, DOI 10.1093/nar/gkm427; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Thangnipon W, 1983, Brain Res, V313, P177; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; Ueda HR, 2004, P NATL ACAD SCI USA, V101, P3765, DOI 10.1073/pnas.0306244101; Usher LC, 2010, J NEUROSCI, V30, P4693, DOI 10.1523/JNEUROSCI.0302-10.2010; Valen E, 2009, GENOME RES, V19, P255, DOI 10.1101/gr.084541.108; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wickramasinghe SR, 2008, NEURON, V58, P532, DOI 10.1016/j.neuron.2008.03.006; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	62	47	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30417	10.1371/journal.pone.0030417	http://dx.doi.org/10.1371/journal.pone.0030417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272348	Green Submitted, Green Published, gold			2022-12-27	WOS:000301454400126
J	Galloway-Pena, J; Roh, JH; Latorre, M; Qin, X; Murray, BE				Galloway-Pena, Jessica; Roh, Jung Hyeob; Latorre, Mauricio; Qin, Xiang; Murray, Barbara E.			Genomic and SNP Analyses Demonstrate a Distant Separation of the Hospital and Community-Associated Clades of Enterococcus faecium	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CLUSTAL-W; POPULATIONS; EVOLUTION; IDENTIFICATION; COMMENSAL; SOFTWARE; RATES; GENE; MEGA	Recent studies have pointed to the existence of two subpopulations of Enterococcus faecium, one containing primarily commensal/community-associated (CA) strains and one that contains most clinical or hospital-associated (HA) strains, including those classified by multi-locus sequence typing (MLST) as belonging to the CC17 group. The HA subpopulation more frequently has IS16, pathogenicity island(s), and plasmids or genes associated with antibiotic resistance, colonization, and/or virulence. Supporting the two clades concept, we previously found a 3-10% difference between four genes from HA-clade strains vs. CA-clade strains, including 5% difference between pbp5-R of ampicillin-resistant, HA strains and pbp5-S of ampicillin-sensitive, CA strains. To further investigate the core genome of these subpopulations, we studied 100 genes from 21 E. faecium genome sequences; our analyses of concatenated sequences, SNPs, and individual genes all identified two distinct groups. With the concatenated sequence, HA-clade strains differed by 0-1% from one another while CA clade strains differed from each other by 0-1.1%, with 3.5-4.2% difference between the two clades. While many strains had a few genes that grouped in one clade with most of their genes in the other clade, one strain had 28% of its genes in the CA clade and 72% in the HA clade, consistent with the predicted role of recombination in the evolution of E. faecium. Using estimates for Escherichia coli, molecular clock calculations using sSNP analysis indicate that these two clades may have diverged >= 1 million years ago or, using the higher mutation rate for Bacillus anthracis, similar to 300,000 years ago. These data confirm the existence of two clades of E. faecium and show that the differences between the HA and CA clades occur at the core genomic level and long preceded the modern antibiotic era.	[Galloway-Pena, Jessica; Roh, Jung Hyeob; Murray, Barbara E.] Univ Texas Med Sch, Dept Med, Div Infect Dis, Houston, TX 77030 USA; [Galloway-Pena, Jessica; Roh, Jung Hyeob; Murray, Barbara E.] Univ Texas Med Sch, Ctr Study Emerging & Reemerging Pathogens, Houston, TX USA; [Galloway-Pena, Jessica; Murray, Barbara E.] Univ Texas Med Sch, Dept Microbiol & Mol Genet, Houston, TX USA; [Latorre, Mauricio] Univ Chile, INTA, Lab Bioinformat & Expres Genica, Santiago, Chile; [Qin, Xiang] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Universidad de Chile; Baylor College of Medicine	Galloway-Pena, J (corresponding author), Univ Texas Med Sch, Dept Med, Div Infect Dis, Houston, TX 77030 USA.	BEM.asst@uth.tmc.edu	Galloway-Pena, Jessica/J-5496-2019	Galloway-Pena, Jessica/0000-0003-1081-254X	National Institutes of Health (NIH) from National Institute of Allergy and Infectious Diseases (NIAID) [R01AI067861]; NIH [T32 A155449, F31AI092891]; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI092891, R01AI067861] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from National Institute of Allergy and Infectious Diseases (NIAID); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	B.E.M. was supported in part by National Institutes of Health (NIH) grant R01AI067861 from the National Institute of Allergy and Infectious Diseases (NIAID). J.G.P. was supported by NIH grant T32 A155449 and is currently supported by NIH grant F31AI092891, also from the NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Foster JT, 2009, J BACTERIOL, V191, P2864, DOI 10.1128/JB.01581-08; Galloway-Pena JR, 2011, ANTIMICROB AGENTS CH, V55, P3272, DOI 10.1128/AAC.00099-11; Galloway-Pena JR, 2009, J INFECT DIS, V200, P1566, DOI 10.1086/644790; Hendrickx APA, 2007, J BACTERIOL, V189, P8321, DOI 10.1128/JB.00664-07; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Klare I, 2003, INT J FOOD MICROBIOL, V88, P269, DOI 10.1016/S0168-1605(03)00190-9; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kuo CH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-35; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leavis HL, 2007, PLOS PATHOG, V3, P75, DOI 10.1371/journal.ppat.0030007; Leavis HL, 2006, CURR OPIN MICROBIOL, V9, P454, DOI 10.1016/j.mib.2006.07.001; Lenski RE, 2003, J MOL EVOL, V56, P498, DOI 10.1007/s00239-002-2423-0; Nallapareddy SR, 2003, MOL MICROBIOL, V47, P1733, DOI 10.1046/j.1365-2958.2003.03417.x; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Panesso D, 2010, J CLIN MICROBIOL, V48, P1562, DOI 10.1128/JCM.02526-09; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Rice LB, 2003, J INFECT DIS, V187, P508, DOI 10.1086/367711; Sillanpaa J, 2009, J CLIN MICROBIOL, V47, P896, DOI 10.1128/JCM.02283-08; SNEATH PHA, 1962, NATURE, V193, P855, DOI 10.1038/193855a0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000455; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Top J, 2008, FEMS IMMUNOL MED MIC, V52, P297, DOI 10.1111/j.1574-695X.2008.00383.x; Turner KME, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-30; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; van Schaik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-239; Werner G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-80; Willems RJL, 2011, FEMS MICROBIOL REV, V35, P872, DOI 10.1111/j.1574-6976.2011.00284.x; Willems RJL, 2009, FUTURE MICROBIOL, V4, P1125, DOI [10.2217/fmb.09.82, 10.2217/FMB.09.82]; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	34	84	86	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30187	10.1371/journal.pone.0030187	http://dx.doi.org/10.1371/journal.pone.0030187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291916	gold, Green Published, Green Submitted			2022-12-27	WOS:000301703800009
J	Kumari, S; Misra, P; Tandon, R; Samant, M; Sundar, S; Dube, A				Kumari, Shraddha; Misra, Pragya; Tandon, Rati; Samant, Mukesh; Sundar, Shyam; Dube, Anuradha			Leishmania donovani: Immunostimulatory Cellular Responses of Membrane and Soluble Protein Fractions of Splenic Amastigotes in Cured Patient and Hamsters	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; T-CELL; CUTANEOUS LEISHMANIASIS; PROTECTIVE IMMUNITY; INFECTED PATIENTS; ANTIGENS; VACCINE; PROMASTIGOTES; IMMUNIZATION; INTERLEUKIN-12	Visceral leishmaniasis (VL), caused by the intracellular parasite Leishmania donovani, L. chagasi and L. infantum is characterized by defective cell-mediated immunity (CMI) and is usually fatal if not treated properly. An estimated 350 million people worldwide are at risk of acquiring infection with Leishmania parasites with approximately 500,000 cases of VL being reported each year. In the absence of an efficient and cost-effective antileishmanial drug, development of an appropriate long-lasting vaccine against VL is the need of the day. In VL, the development of a CMI, capable of mounting Th1-type of immune responses, play an important role as it correlate with recovery from and resistance to disease. Resolution of infection results in lifelong immunity against the disease which indicates towards the feasibility of a vaccine against the disease. Most of the vaccination studies in Leishmaniasis have been focused on promastigote-an infective stage of parasite with less exploration of pathogenic amastigote form, due to the cumbersome process of its purified isolation. In the present study, we have isolated and purified splenic amastigotes of L. donovani, following the traditional protocol with slight modification. These were fractionated into five membranous and soluble subfractions each i.e MAF1-5 and SAF1-5 and were subjected for evaluation of their ability to induce cellular responses. Out of five sub-fractions from each of membrane and soluble, only four viz. MAF2, MAF3, SAF2 and SAF3 were observed to stimulate remarkable lymphoproliferative, IFN-gamma, IL-12 responses and Nitric Oxide production, in Leishmania-infected cured/exposed patients and hamsters. Results suggest the presence of Th-1 type immunostimulatory molecules in these sub-fractions which may further be exploited for developing a successful subunit vaccine from the less explored pathogenic stage against VL.	[Kumari, Shraddha; Misra, Pragya; Tandon, Rati; Samant, Mukesh; Dube, Anuradha] CSIR, Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India; [Kumari, Shraddha] Rikshosp Radiumhosp Med Ctr, Inst Canc Res, Dept Immunol, Oslo, Norway; [Samant, Mukesh] Univ Laval, CHUL Res Ctr, Res Ctr Infect Dis, Dept Med Biol, Quebec City, PQ, Canada; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); University of Oslo; Laval University; Banaras Hindu University (BHU)	Kumari, S (corresponding author), CSIR, Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India.	anuradha_dube@hotmail.com		Dube, Anuradha/0000-0002-5122-400X	Department of Biotechnology (DBT), New Delhi [BT/PR6048/MED/14/735/2005]; Council of Scientific and Industrial Research (CSIR), New Delhi	Department of Biotechnology (DBT), New Delhi(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Department of Biotechnology (DBT), New Delhi (Grant number: BT/PR6048/MED/14/735/2005) and for Senior Research Fellowship to SK, PM, RT and MS by Council of Scientific and Industrial Research (CSIR), New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFONSO LCC, 1994, SCIENCE, V263, P235, DOI 10.1126/science.7904381; Afrin F, 2002, INFECT IMMUN, V70, P6697, DOI 10.1128/IAI.70.12.6697-6706.2002; ASSREUY J, 1994, EUR J IMMUNOL, V24, P672, DOI 10.1002/eji.1830240328; BATES PA, 1993, FEMS MICROBIOL LETT, V107, P53, DOI 10.1111/j.1574-6968.1993.tb06003.x; Bhowmick S, 2007, VACCINE, V25, P6544, DOI 10.1016/j.vaccine.2007.05.042; Bloom S, 2005, J CLIN INVEST, V115, P2300; Burchmore RJS, 2001, INT J PARASITOL, V31, P1311, DOI 10.1016/S0020-7519(01)00259-4; Cabral SM, 2008, IMMUNOLOGY, V123, P555, DOI 10.1111/j.1365-2567.2007.02725.x; CHAMPSI J, 1988, INFECT IMMUN, V56, P3272, DOI 10.1128/IAI.56.12.3272-3279.1988; CHANG KP, 1980, SCIENCE, V209, P1240, DOI 10.1126/science.7403880; Charest H, 1996, J BIOL CHEM, V271, P17081, DOI 10.1074/jbc.271.29.17081; CHOUDHRY A, 1990, T ROY SOC TROP MED H, V84, P363, DOI 10.1016/0035-9203(90)90319-A; Coler RN, 2002, INFECT IMMUN, V70, P4215, DOI 10.1128/IAI.70.8.4215-4225.2002; CONNELL ND, 1993, P NATL ACAD SCI USA, V90, P11473, DOI 10.1073/pnas.90.24.11473; Costa SR, 1999, MEM I OSWALDO CRUZ, V94, P367, DOI 10.1590/S0074-02761999000300015; Descoteaux A, 2002, MICROBES INFECT, V4, P975, DOI 10.1016/S1286-4579(02)01624-6; Desjeux P, 2004, NAT REV MICROBIOL, V2, P692, DOI 10.1038/nrmicro981; Diefenbach A, 1999, SCIENCE, V284, P951, DOI 10.1126/science.284.5416.951; DING AH, 1988, J IMMUNOL, V141, P2407; EPERON S, 1989, J PROTOZOOL, V36, P502, DOI 10.1111/j.1550-7408.1989.tb01086.x; Garg R, 2006, VACCINE, V24, P2900, DOI 10.1016/j.vaccine.2005.12.053; Garg R, 2005, CLIN EXP IMMUNOL, V140, P149, DOI 10.1111/j.1365-2249.2005.02745.x; Garg R, 2005, VACCINE, V23, P1189, DOI 10.1016/j.vaccine.2004.06.054; Garg R, 2006, INDIAN J MED RES, V123, P439; GHALIB HW, 1995, J IMMUNOL, V154, P4623; GICHERU MM, 1994, ACTA TROP, V58, P345, DOI 10.1016/0001-706X(94)90028-0; GIFAWESEN C, 1989, INFECT IMMUN, V57, P3091, DOI 10.1128/IAI.57.10.3091-3096.1989; GLASER TA, 1991, MOL BIOCHEM PARASIT, V45, P337, DOI 10.1016/0166-6851(91)90102-C; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Handman E, 2001, CLIN MICROBIOL REV, V14, P229, DOI 10.1128/CMR.14.2.229-243.2001; JAFFE CL, 1990, J IMMUNOL, V144, P699; KAHL LP, 1989, J IMMUNOL, V142, P4441; Khalil EAG, 2000, LANCET, V356, P1565, DOI 10.1016/S0140-6736(00)03128-7; Kumari S, 2008, VACCINE, V26, P4813, DOI 10.1016/j.vaccine.2008.06.102; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIEW FY, 1991, IMMUNOL LETT, V30, P193, DOI 10.1016/0165-2478(91)90024-5; McMahon-Pratt D, 1998, PARASITOL TODAY, V14, P31, DOI 10.1016/S0169-4758(97)01164-2; MELBY PC, 1991, REV INFECT DIS, V13, P1009; MELBY PC, 1989, INFECT IMMUN, V57, P2971, DOI 10.1128/IAI.57.10.2971-2976.1989; Molloy MP, 1998, ELECTROPHORESIS, V19, P837, DOI 10.1002/elps.1150190539; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; Murray HW, 1997, J EXP MED, V185, P867, DOI 10.1084/jem.185.5.867; PAN AA, 1984, EXP PARASITOL, V58, P72, DOI 10.1016/0014-4894(84)90022-5; Pham NK, 2005, INFECT IMMUN, V73, P8322, DOI 10.1128/IAI.73.12.8322-8333.2005; REED SG, 1993, CURR OPIN IMMUNOL, V5, P524, DOI 10.1016/0952-7915(93)90033-O; Rochette A, 2009, MOL BIOCHEM PARASIT, V165, P32, DOI 10.1016/j.molbiopara.2008.12.012; RODRIGUES V, 1992, PARASITE IMMUNOL, V14, P49, DOI 10.1111/j.1365-3024.1992.tb00005.x; RUSSO DM, 1993, J IMMUNOL, V150, P4713; Samant M, 2007, PARASITOLOGY, V134, P1175, DOI 10.1017/S0031182007002569; Santoni V, 2000, ELECTROPHORESIS, V21, P3329, DOI 10.1002/1522-2683(20001001)21:16<3329::AID-ELPS3329>3.0.CO;2-F; SCOTT DA, 1987, BIOCHEM PHARMACOL, V36, P2043, DOI 10.1016/0006-2952(87)90508-9; Silvestre R, 2006, IMMUNOLOGY, V119, P529, DOI 10.1111/j.1365-2567.2006.02468.x; Skeiky YAW, 1998, J IMMUNOL, V161, P6171; SYPEK JP, 1993, J EXP MED, V177, P1797, DOI 10.1084/jem.177.6.1797; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Tripathi P, 2006, CLIN EXP IMMUNOL, V143, P380, DOI 10.1111/j.1365-2249.2005.03000.x; WHITE AC, 1990, J INFECT DIS, V161, P1313, DOI 10.1093/infdis/161.6.1313; WHITE AC, 1992, AM J TROP MED HYG, V46, P123, DOI 10.4269/ajtmh.1992.46.123	59	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30746	10.1371/journal.pone.0030746	http://dx.doi.org/10.1371/journal.pone.0030746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292030	Green Published, gold, Green Submitted			2022-12-27	WOS:000301703800027
J	Li, Y; O'Neill, C				Li, Yan; O'Neill, Chris			Persistence of Cytosine Methylation of DNA following Fertilisation in the Mouse	PLOS ONE			English	Article							PATERNAL GENOME; PREIMPLANTATION; EMBRYO; EXPRESSION; CULTURE; DEMETHYLATION; PATTERNS; ZYGOTES; MAINTENANCE; ACTIVATION	Normal development of the mammalian embryo requires epigenetic reprogramming of the genome. The level of cytosine methylation of CpG-rich (5meC) regions of the genome is a major epigenetic regulator and active global demethylation of 5meC throughout the genome is reported to occur within the first cell-cycle following fertilization. An enzyme or mechanism capable of catalysing such rapid global demethylation has not been identified. The mouse is a widely used model for studying developmental epigenetics. We have reassessed the evidence for this phenomenon of genome-wide demethylation following fertilisation in the mouse. We found when using conventional methods of immunolocalization that 5meC showed a progressive acid-resistant antigenic masking during zygotic maturation which gave the appearance of demethylation. Changing the unmasking strategy by also performing tryptic digestion revealed a persistence of a methylated state. Analysis of methyl binding domain 1 protein (MBD1) binding confirmed that the genome remained methylated following fertilisation. The maintenance of this methylated state over the first several cell-cycles required the actions of DNA methyltransferase activity. The study shows that any 5meC remodelling that occurs during early development is not explained by a global active loss of 5meC staining during the cleavage stage of development and global loss of methylation following fertilization is not a major component of epigenetic reprogramming in the mouse zygote.	[Li, Yan; O'Neill, Chris] Univ Sydney, Sydney Med Sch, Ctr Dev & Regenerat Med, Kolling Inst Med Res, Sydney, NSW 2006, Australia	University of Sydney; Kolling Institute of Medical Research	Li, Y (corresponding author), Univ Sydney, Sydney Med Sch, Ctr Dev & Regenerat Med, Kolling Inst Med Res, Sydney, NSW 2006, Australia.	chris.oneill@sydney.edu.au			Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by project grants from the Australian National Health and Medical Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenot PG, 1997, DEVELOPMENT, V124, P4615; Barton SC, 2001, HUM MOL GENET, V10, P2983, DOI 10.1093/hmg/10.26.2983; Beaujean N, 2004, BIOL REPROD, V71, P185, DOI 10.1095/biolreprod.103.026559; Beaujean N, 2004, P NATL ACAD SCI USA, V101, P7636, DOI 10.1073/pnas.0400730101; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Jeong YS, 2007, INT J DEV BIOL, V51, P707, DOI 10.1387/ijdb.072450yj; Jin XL, 2010, BIOL REPROD, V82, P459, DOI 10.1095/biolreprod.109.078758; Kim SH, 2004, BIOCHEM BIOPH RES CO, V324, P58, DOI 10.1016/j.bbrc.2004.09.023; Kurihara Y, 2008, DEV BIOL, V313, P335, DOI 10.1016/j.ydbio.2007.10.033; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Li A, 2007, BIOL REPROD, V76, P362, DOI 10.1095/biolreprod.106.056838; Ma J, 2001, BIOL REPROD, V64, P1713, DOI 10.1095/biolreprod64.6.1713; Mahsoudi B, 2007, BIOL REPROD, V77, P889, DOI 10.1095/biolreprod.106.057885; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morgan HD, 2008, BIOL REPROD, V79, P618, DOI 10.1095/biolreprod.108.068213; Mu XF, 2011, BIOL REPROD, V85, P524, DOI 10.1095/biolreprod.110.089334; O'Neill C, 1998, BIOL REPROD, V58, P1303, DOI 10.1095/biolreprod58.5.1303; ONeill C, 1997, BIOL REPROD, V56, P229, DOI 10.1095/biolreprod56.1.229; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Polanski Z, 2008, INT J DEV BIOL, V52, P295, DOI 10.1387/ijdb.072347zp; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Santenard A, 2010, NAT CELL BIOL, V12, P853, DOI 10.1038/ncb2089; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Shi W, 2004, BIOL REPROD, V71, P340, DOI 10.1095/biolreprod.103.024554; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Stojanov T, 1999, MOL HUM REPROD, V5, P116, DOI 10.1093/molehr/5.2.116; TARKOWSKI AK, 1966, CYTOGENETICS, V5, P394, DOI 10.1159/000129914; Veron N, 2011, NATURE, V473, P293, DOI 10.1038/473293a; Young LE, 2004, ANIM REPROD SCI, V82-3, P61, DOI 10.1016/j.anireprosci.2004.05.020	40	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30687	10.1371/journal.pone.0030687	http://dx.doi.org/10.1371/journal.pone.0030687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292019	Green Published, Green Submitted, gold			2022-12-27	WOS:000301703800024
J	Fargier, R; Menoret, M; Boulenger, V; Nazir, TA; Paulignan, Y				Fargier, Raphael; Menoret, Mathilde; Boulenger, Veronique; Nazir, Tatjana A.; Paulignan, Yves			Grasp It Loudly! Supporting Actions with Semantically Congruent Spoken Action Words	PLOS ONE			English	Article							MOTOR SYSTEM; FUNCTIONAL-ORGANIZATION; INFERIOR AREA-6; MACAQUE MONKEY; LANGUAGE; SPEECH; REPRESENTATION; CORTEX; TALK; HAND	Evidence for cross-talk between motor and language brain structures has accumulated over the past several years. However, while a significant amount of research has focused on the interaction between language perception and action, little attention has been paid to the potential impact of language production on overt motor behaviour. The aim of the present study was to test whether verbalizing during a grasp-to-displace action would affect motor behaviour and, if so, whether this effect would depend on the semantic content of the pronounced word (Experiment I). Furthermore, we sought to test the stability of such effects in a different group of participants and investigate at which stage of the motor act language intervenes (Experiment II). For this, participants were asked to reach, grasp and displace an object while overtly pronouncing verbal descriptions of the action ("grasp" and "put down") or unrelated words (e. g. "butterfly" and "pigeon"). Fine-grained analyses of several kinematic parameters such as velocity peaks revealed that when participants produced action-related words their movements became faster compared to conditions in which they did not verbalize or in which they produced words that were not related to the action. These effects likely result from the functional interaction between semantic retrieval of the words and the planning and programming of the action. Therefore, links between (action) language and motor structures are significant to the point that language can refine overt motor behaviour.	[Fargier, Raphael; Menoret, Mathilde; Nazir, Tatjana A.; Paulignan, Yves] Univ Lyon 1, CNRS, UCBL, Inst Sci Cognit,L2C2, F-69365 Lyon, France; [Boulenger, Veronique] Univ Lyon, Lab Dynam Langage, Inst Sci Homme, CNRS,UMR 5596, Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS)	Fargier, R (corresponding author), Univ Lyon 1, CNRS, UCBL, Inst Sci Cognit,L2C2, F-69365 Lyon, France.	raphael.fargier@isc.cnrs.fr	Boulenger, Véronique/AAQ-2881-2020; Boulenger, Veronique/P-6339-2015; Fargier, Raphaël/P-7125-2019	Boulenger, Véronique/0000-0001-8701-8278; Fargier, Raphaël/0000-0002-0165-0238; Menoret, Mathilde/0000-0002-9431-4339; Paulignan, Yves/0000-0001-9474-3080; Nazir, Tatjana/0000-0002-6313-9259	CNRS (Centre National de la Recherche Scientifique); Universite Claude Bernard Lyon1; DGA (Direction Generale de l'Armement)	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Universite Claude Bernard Lyon1; DGA (Direction Generale de l'Armement)	This research was supported by the CNRS (Centre National de la Recherche Scientifique), a PhD fellowship from the Universite Claude Bernard Lyon1, and a PhD fellowship from the DGA (Direction Generale de l'Armement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravena P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011751; Aziz-Zadeh L, 2008, J PHYSIOL-PARIS, V102, P35, DOI 10.1016/j.jphysparis.2008.03.012; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Barbieri F, 2009, BRAIN LANG, V110, P1, DOI 10.1016/j.bandl.2009.01.002; Bergen BK, 2005, CONSTR APPROACH LANG, V3, P147; Bernardis P, 2006, NEUROPSYCHOLOGIA, V44, P178, DOI 10.1016/j.neuropsychologia.2005.05.007; Boulenger V, 2008, J PHYSIOL-PARIS, V102, P130, DOI 10.1016/j.jphysparis.2008.03.015; Boulenger V, 2006, J COGNITIVE NEUROSCI, V18, P1607, DOI 10.1162/jocn.2006.18.10.1607; Boulenger V, 2009, CEREB CORTEX, V19, P1905, DOI 10.1093/cercor/bhn217; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; Candidi M, 2010, EUR J NEUROSCI, V32, P677, DOI 10.1111/j.1460-9568.2010.07305.x; CASTIELLO U, 1991, BRAIN, V114, P2639, DOI 10.1093/brain/114.6.2639; Cattaneo L, 2007, P NATL ACAD SCI USA, V104, P17825, DOI 10.1073/pnas.0706273104; Chersi F., 2010, FRONT NEUROROBOT, V4; Chieffi S, 2009, BEHAV BRAIN RES, V203, P200, DOI 10.1016/j.bbr.2009.05.003; Colebatch JG, 2007, MOVEMENT DISORD, V22, P601, DOI 10.1002/mds.21323; Dalla Volta R, 2009, EXP BRAIN RES, V196, P403, DOI 10.1007/s00221-009-1864-8; Davidson PR, 2004, EXP BRAIN RES, V155, P334, DOI 10.1007/s00221-003-1730-z; Desai RH, 2010, CEREB CORTEX, V20, P468, DOI 10.1093/cercor/bhp115; Fabbri-Destro M, 2009, EXP BRAIN RES, V192, P521, DOI 10.1007/s00221-008-1578-3; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Frak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009728; Gentilucci M, 2004, NEUROPSYCHOLOGIA, V42, P1554, DOI 10.1016/j.neuropsychologia.2004.03.002; GENTILUCCI M, 1988, EXP BRAIN RES, V71, P475, DOI 10.1007/BF00248741; Gentilucci M, 1998, EUR J NEUROSCI, V10, P752, DOI 10.1046/j.1460-9568.1998.00060.x; Gentilucci M, 2000, EXP BRAIN RES, V133, P468, DOI 10.1007/s002210000431; Gentilucci M, 2008, Q J EXP PSYCHOL, V61, P944, DOI 10.1080/17470210701625683; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Glenberg AM, 2008, CURR BIOL, V18, pR290, DOI 10.1016/j.cub.2008.02.036; Glover S, 2004, EXP BRAIN RES, V154, P103, DOI 10.1007/s00221-003-1659-2; Goldin-Meadow S, 2005, TRENDS COGN SCI, V9, P234, DOI 10.1016/j.tics.2005.03.006; Goldin-Meadow S, 1999, TRENDS COGN SCI, V3, P419, DOI 10.1016/S1364-6613(99)01397-2; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Indefrey P., 2000, NEW COGNITIVE NEUROS, P845; Jeannerod M., 1982, ADV ANAL VISUAL BEHA, P387; Jeannerod M., 1981, ATTENTION PERFORM, P153; Kritikos A, 2011, Q J EXP PSYCHOL HOVE; Liuzzi G, 2008, NEUROPSYCHOLOGIA, V46, P2824, DOI 10.1016/j.neuropsychologia.2008.05.015; Meister IG, 2003, NEUROPSYCHOLOGIA, V41, P401, DOI 10.1016/S0028-3932(02)00179-3; Meteyard L, 2012, CORTEX, V48, P788, DOI 10.1016/j.cortex.2010.11.002; Nazir TA, 2008, Q J EXP PSYCHOL, V61, P933, DOI 10.1080/17470210701625667; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2004, J COGNITIVE NEUROSCI, V16, P374, DOI 10.1162/089892904322926719; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Raposo A, 2009, NEUROPSYCHOLOGIA, V47, P388, DOI 10.1016/j.neuropsychologia.2008.09.017; Riehle A, 2005, FRON NEUROS, P213; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Seyal M, 1999, CLIN NEUROPHYSIOL, V110, P424, DOI 10.1016/S1388-2457(98)00019-4; Terao Y, 2001, J NEUROSCI, V21, P1600, DOI 10.1523/JNEUROSCI.21-05-01600.2001; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Tokimura H, 1996, ANN NEUROL, V40, P628, DOI 10.1002/ana.410400413; Urgesi C, 2010, CEREB CORTEX, V20, P2511, DOI 10.1093/cercor/bhp292; van Dam WO, 2010, NEUROIMAGE, V53, P1318, DOI 10.1016/j.neuroimage.2010.06.071; Weiss PH, 2000, NEUROPSYCHOLOGIA, V38, P1136, DOI 10.1016/S0028-3932(00)00029-4; Zwaan RA, 2006, J EXP PSYCHOL GEN, V135, P1, DOI 10.1037/0096-3445.135.1.1	59	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30663	10.1371/journal.pone.0030663	http://dx.doi.org/10.1371/journal.pone.0030663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292014	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600045
J	Lopez-Garrido, J; Casadesus, J				Lopez-Garrido, Javier; Casadesus, Josep			Crosstalk between Virulence Loci: Regulation of Salmonella enterica Pathogenicity Island 1 (SPI-1) by Products of the std Fimbrial Operon	PLOS ONE			English	Article							DNA ADENINE METHYLATION; III SECRETION SYSTEM; SEROVAR TYPHIMURIUM INVASION; GENE-EXPRESSION; ESCHERICHIA-COLI; CELL INVASION; BACTERIAL PATHOGENESIS; PROTEIN SECRETION; CHROMOSOMAL GENES; INTESTINAL-MUCOSA	Invasion of intestinal epithelial cells is a critical step in Salmonella infection and requires the expression of genes located in Salmonella pathogenicity island 1 (SPI-1). A key factor for SPI-1 expression is DNA adenine (Dam) methylation, which activates synthesis of the SPI-1 transcriptional activator HilD. Dam-dependent regulation of hilD is postranscriptional (and therefore indirect), indicating the involvement of unknown cell functions under Dam methylation control. A genetic screen has identified the std fimbrial operon as the missing link between Dam methylation and SPI-1. We show that all genes in the std operon are part of a single transcriptional unit, and describe three previously uncharacterized ORFs (renamed stdD, stdE, and stdF). We present evidence that two such loci (stdE and stdF) are involved in Dam-dependent control of Salmonella SPI-1: in a Dam(-) background, deletion of stdE or stdF suppresses SPI-1 repression; in a Dam(+) background, constitutive expression of StdE and/or StdF represses SPI-1. Repression of SPI-1 by products of std operon explains the invasion defect of Salmonella Dam(-) mutants, which constitutively express the std operon. Dam-dependent repression of std in the ileum may be required to permit invasion, as indicated by two observations: constitutive expression of StdE and StdF reduces invasion of epithelial cells in vitro (1,000 fold) and attenuates Salmonella virulence in the mouse model (>60 fold). In turn, crosstalk between std and SPI-1 may play a role in intestinal infections by preventing expression of SPI-1 in the caecum, an intestinal compartment in which the std operon is known to be expressed.	[Lopez-Garrido, Javier; Casadesus, Josep] Univ Seville, Dept Genet, Seville, Spain	University of Sevilla	Lopez-Garrido, J (corresponding author), Univ Seville, Dept Genet, Seville, Spain.	casadesus@us.es	Casadesús, Josep/C-6222-2016	Casadesús, Josep/0000-0002-2308-293X; Lopez-Garrido, Javier/0000-0002-8907-502X	Spanish Ministry of Science and Innovation [BIO2010-15023, CSD2008-00013]; European Regional Fund	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Fund	This study was supported by grant BIO2010-15023 from the Spanish Ministry of Science and Innovation and the European Regional Fund, and grant CSD2008-00013 from the Consolider-Ingenio 2010 Program of the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altier C, 2005, J MICROBIOL, V43, P85; Altier C, 2000, INFECT IMMUN, V68, P6790, DOI 10.1128/IAI.68.12.6790-6797.2000; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baek CH, 2009, J BACTERIOL, V191, P1278, DOI 10.1128/JB.01142-08; Balbontin R, 2006, J BACTERIOL, V188, P8160, DOI 10.1128/JB.00847-06; Baxter MA, 2005, INFECT IMMUN, V73, P1377, DOI 10.1128/IAI.73.3.1377-1385.2005; Baxter MA, 2003, INFECT IMMUN, V71, P1295, DOI 10.1128/IAI.71.3.1295-1305.2003; Boddicker JD, 2004, INFECT IMMUN, V72, P2002, DOI 10.1128/IAI.72.4.2002-2013.2004; Bustamante VH, 2008, P NATL ACAD SCI USA, V105, P14591, DOI 10.1073/pnas.0801205105; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; CHAN RK, 1972, VIROLOGY, V50, P883, DOI 10.1016/0042-6822(72)90442-4; Chaudhuri RR, 2008, NUCLEIC ACIDS RES, V36, pD543, DOI 10.1093/nar/gkm928; Chessa D, 2009, MOL MICROBIOL, V71, P864, DOI 10.1111/j.1365-2958.2008.06566.x; Chubiz JEC, 2010, J BACTERIOL, V192, P6261, DOI 10.1128/JB.00635-10; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Darwin KH, 1999, CLIN MICROBIOL REV, V12, P405, DOI 10.1128/CMR.12.3.405; Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ellermeier CD, 2005, MOL MICROBIOL, V57, P691, DOI 10.1111/j.1365-2958.2005.04737.x; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Ellermeier CD, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P123, DOI 10.1007/0-387-30746-x_7; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; Fahlen TF, 2000, FEMS IMMUNOL MED MIC, V28, P25, DOI 10.1016/S0928-8244(99)00199-6; Falkow S, 1996, CELLULAR MOL BIOL, P2723; Fortune DR, 2006, INFECT IMMUN, V74, P331, DOI 10.1128/IAI.74.1.331-339.2006; FRETER R, 1981, INFECT IMMUN, V34, P241, DOI 10.1128/IAI.34.1.241-249.1981; Garcia-Del Portillo F, 1999, P NATL ACAD SCI USA, V96, P11578, DOI 10.1073/pnas.96.20.11578; GARZON A, 1995, GENETICS, V140, P427; Groisman EA, 1997, TRENDS MICROBIOL, V5, P343, DOI 10.1016/S0966-842X(97)01099-8; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Hardt WD, 1998, P NATL ACAD SCI USA, V95, P2574, DOI 10.1073/pnas.95.5.2574; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; Hensel M, 2004, INT J MED MICROBIOL, V294, P95, DOI 10.1016/j.ijmm.2004.06.025; Humphries A, 2005, INFECT IMMUN, V73, P5329, DOI 10.1128/IAI.73.9.5329-5338.2005; Humphries AD, 2003, MOL MICROBIOL, V48, P1357, DOI 10.1046/j.1365-2958.2003.03507.x; Jakomin M, 2008, J BACTERIOL, V190, P7406, DOI 10.1128/JB.01136-08; Jones BD, 2005, J MICROBIOL, V43, P110; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Kelly BG, 2009, FOOD CHEM TOXICOL, V47, P951, DOI 10.1016/j.fct.2008.02.006; Knodler LA, 2002, MOL MICROBIOL, V43, P1089, DOI 10.1046/j.1365-2958.2002.02820.x; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; Lim S, 2007, NUCLEIC ACIDS RES, V35, P1822, DOI 10.1093/nar/gkm060; Lopez-Garrido J, 2010, GENETICS, V184, P637, DOI 10.1534/genetics.109.108985; Lostroh CP, 2001, MICROBES INFECT, V3, P1281; Lucas S, 2010, COMPLETE SEQUENCE EN; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; Martinez LC, 2011, MOL MICROBIOL, V80, P1637, DOI 10.1111/j.1365-2958.2011.07674.x; Miller J.H., 1972, EXPT MOL GENETICS; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Olekhnovich IN, 2006, J MOL BIOL, V357, P373, DOI 10.1016/j.jmb.2006.01.007; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; Porwollik S, 2003, MICROBES INFECT, V5, P977, DOI 10.1016/S1286-4579(03)00186-2; Queiroz MH, 2011, MICROBIOL-SGM, V157, P2504, DOI 10.1099/mic.0.049197-0; Saini S, 2010, J BACTERIOL, V192, P2459, DOI 10.1128/JB.00047-10; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Segura I, 2004, J MICROBIOL METH, V56, P83, DOI 10.1016/j.mimet.2003.09.004; Takaya A, 2005, MOL MICROBIOL, V55, P839, DOI 10.1111/j.1365-2958.2004.04425.x; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Teixido L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019711; Thanassi DG, 1998, CURR OPIN MICROBIOL, V1, P223, DOI 10.1016/S1369-5274(98)80015-5; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; Troxell B, 2011, J BACTERIOL, V193, P497, DOI 10.1128/JB.00942-10; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Weening EH, 2005, INFECT IMMUN, V73, P3358, DOI 10.1128/IAI.73.6.3358-3366.2005; Wood MW, 1998, MOL MICROBIOL, V29, P883, DOI 10.1046/j.1365-2958.1998.00984.x	72	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30499	10.1371/journal.pone.0030499	http://dx.doi.org/10.1371/journal.pone.0030499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291968	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600048
J	Nandi, P; Ghosh, S; Jana, K; Sen, PC				Nandi, Pinki; Ghosh, Swatilekha; Jana, Kuladip; Sen, Parimal C.			Elucidation of the Involvement of p14, a Sperm Protein during Maturation, Capacitation and Acrosome Reaction of Caprine Spermatozoa	PLOS ONE			English	Article							SEMINAL PLASMA; MAMMALIAN FERTILIZATION; BOVINE SPERMATOZOA; KINASE-C; LOCALIZATION; CA2+-ATPASE; CALCIUM; RAT	Mammalian sperm capacitation is an essential prerequisite to fertilization. Although progress is being made in understanding the physiology and biochemistry of capacitation, little has been yet explored about the potential role(s) of individual sperm cell protein during this process. Therefore elucidation of the role of different sperm proteins in the process of capacitation might be of great importance to understand the process of fertilization. The present work describes the partial characterization of a 14-kDa protein (p14) detected in goat spermatozoa using an antibody directed against the purified protein. Confocal microscopic analysis reveals that the protein is present in both the intracellular and extracellular regions of the acrosomal and postacrosomal portion of caudal sperm head. Though subcellular localization shows that p14 is mainly cytosolic, however it is also seen to be present in peripheral plasma membrane and soluble part of acrosome. Immuno-localization experiment shows change in the distribution pattern of this protein upon induction of capacitation in sperm cells. Increased immunolabeling in the anterior head region of live spermatozoa is also observed when these cells are incubated under capacitating conditions, whereas most sperm cells challenged with the calcium ionophore A23187 to acrosome react, lose their labeling almost completely. Intracellular distribution of p14 also changes significantly during acrosome reaction. Interestingly, on the other hand the antibody raised against this 14-kDa sperm protein enhances the forward motility of caprine sperm cells. Rose-Bengal staining method shows that this anti-p14 antibody also decreases the number of acrosome reacted cells if incubated with capacitated sperm cells before induction of acrosome reaction. All these results taken together clearly indicate that p14 is intimately involved and plays a critical role in the acrosomal membrane fusion event.	[Nandi, Pinki; Ghosh, Swatilekha; Jana, Kuladip; Sen, Parimal C.] Bose Inst, Div Mol Med, Kolkata, India	Department of Science & Technology (India); Bose Institute	Nandi, P (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	parimalsen@gmail.com	Jana, Kuladip/GXG-3481-2022	Jana, Kuladip/0000-0003-4748-253X	Council of Scientific and Industrial Research [37(1299)/07/EMR-II]; Bose Institute	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Bose Institute(Department of Science & Technology (India))	This work was funded by the Council of Scientific and Industrial Research [37(1299)/07/EMR-II] and by the Bose Institute. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boue F, 1996, BIOL REPROD, V54, P1009, DOI 10.1095/biolreprod54.5.1009; Breitbart H, 2002, MOL CELL ENDOCRINOL, V187, P139, DOI 10.1016/S0303-7207(01)00704-3; Breitbart H, 1997, Rev Reprod, V2, P165, DOI 10.1530/revreprod/2.3.165; Brucker C, 1995, HUM REPROD UPDATE, V1, P51, DOI 10.1093/humupd/1.1.51; CHANG MC, 1957, NATURE, V179, P258, DOI 10.1038/179258a0; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Cooper TG, 1986, EPIDIDYMIS SPERM MAT; CORNWALL GA, 1995, J ANDROL, V16, P379; Curi SM, 2003, ARCH ANDROLOGY, V49, P343, DOI 10.1080/01485010390219656; Das S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012039; DEJONGE FH, 1988, HORM BEHAV, V22, P100, DOI 10.1016/0018-506X(88)90034-7; ECCLESTON ED, 1994, MOL REPROD DEV, V37, P110, DOI 10.1002/mrd.1080370115; Florman HM, 1998, BIOL REPROD, V59, P12, DOI 10.1095/biolreprod59.1.12; Grasa P, 2009, REPRODUCTION, V137, P655, DOI 10.1530/REP-08-0280; Harlow E., 1988, ANTIBODIES LAB MANUA; HENAULT MA, 1995, BIOL REPROD, V52, P390, DOI 10.1095/biolreprod52.2.390; Kim KS, 2001, BIOL REPROD, V64, P36, DOI 10.1095/biolreprod64.1.36; Lalancette C, 2001, BIOL REPROD, V65, P628, DOI 10.1095/biolreprod65.2.628; Lax Y, 1997, BIOL REPROD, V56, P454, DOI 10.1095/biolreprod56.2.454; MACEK MB, 1988, GAMETE RES, V20, P93, DOI 10.1002/mrd.1120200109; Maiti A, 2009, J CELL PHYSIOL, V220, P394, DOI 10.1002/jcp.21778; MILLER DJ, 1990, BIOL REPROD, V42, P899, DOI 10.1095/biolreprod42.6.899; MYLES DG, 1991, ANN NY ACAD SCI, V637, P486, DOI 10.1111/j.1749-6632.1991.tb27332.x; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; ROLDAN ERS, 1988, BIOCHEM BIOPH RES CO, V155, P901, DOI 10.1016/S0006-291X(88)80581-3; Sengupta T, 2008, MOL CELL BIOCHEM, V311, P93, DOI 10.1007/s11010-007-9700-6; Sengupta T, 2007, COMP BIOCHEM PHYS B, V146, P131, DOI 10.1016/j.cbpb.2006.10.093; Tantibhedhyangkul J, 2002, BIOL REPROD, V67, P212, DOI 10.1095/biolreprod67.1.212; Therien I, 1997, BIOL REPROD, V57, P1080, DOI 10.1095/biolreprod57.5.1080; Tsai PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011204; Visconti PE, 1998, BIOL REPROD, V59, P1, DOI 10.1095/biolreprod59.1.1; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; WOLF DE, 1984, J CELL BIOL, V98, P1678, DOI 10.1083/jcb.98.5.1678; Yanagimachi R., 1994, P189	34	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30552	10.1371/journal.pone.0030552	http://dx.doi.org/10.1371/journal.pone.0030552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291985	Green Submitted, Green Published, gold			2022-12-27	WOS:000301570600056
J	Rodriguez-Ezpeleta, N; Embley, TM				Rodriguez-Ezpeleta, Naiara; Embley, T. Martin			The SAR11 Group of Alpha-Proteobacteria Is Not Related to the Origin of Mitochondria	PLOS ONE			English	Article							GENOME; PHYLOGENOMICS; EVOLUTION; SEQUENCE; ALIGNMENT; PROTEINS; PACKAGE	Although free living, members of the successful SAR11 group of marine alpha-proteobacteria contain a very small and A+T rich genome, two features that are typical of mitochondria and related obligate intracellular parasites such as the Rickettsiales. Previous phylogenetic analyses have suggested that Candidatus Pelagibacter ubique, the first cultured member of this group, is related to the Rickettsiales+mitochondria clade whereas others disagree with this conclusion. In order to determine the evolutionary position of the SAR11 group and its relationship to the origin of mitochondria, we have performed phylogenetic analyses on the concatenation of 24 proteins from 5 mitochondria and 71 proteobacteria. Our results support that SAR11 group is not the sistergroup of the Rickettsiales+mitochondria clade and confirm that the position of this group in the alpha-proteobacterial tree is strongly affected by tree reconstruction artefacts due to compositional bias. As a consequence, genome reduction and bias toward a high A+T content may have evolved independently in the SAR11 species, which points to a different direction in the quest for the closest relatives to mitochondria and Rickettsiales. In addition, our analyses raise doubts about the monophyly of the newly proposed Pelagibacteraceae family.	[Rodriguez-Ezpeleta, Naiara; Embley, T. Martin] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Rodriguez-Ezpeleta, N (corresponding author), Txatxarramendi Ugartea ZG, AZTI Tecnalia, Marine Res Unit, Sukarrieta, Bizkaia, Spain.	nrodriguez@azti.es	Rodriguez-Ezpeleta, Naiara/B-7138-2014	Rodriguez-Ezpeleta, Naiara/0000-0001-6735-6755; Embley, Thomas Martin/0000-0002-1484-340X	Programa de Formacion de Investigadores del Departamento de Educacion, Universidades e Investigacion (Government of Basque Country); Royal Society	Programa de Formacion de Investigadores del Departamento de Educacion, Universidades e Investigacion (Government of Basque Country); Royal Society(Royal Society of London)	NR-E was supported by the Programa de Formacion de Investigadores del Departamento de Educacion, Universidades e Investigacion (Government of Basque Country). TME was supported by a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Brindefalk B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024457; Davidov Y, 2006, ENVIRON MICROBIOL, V8, P2179, DOI 10.1111/j.1462-2920.2006.01101.x; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Embley TM, 2006, PHILOS T R SOC B, V361, P1055, DOI 10.1098/rstb.2006.1844; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; Foster PG, 2004, SYST BIOL, V53, P485, DOI 10.1080/10635150490445779; Foster PG, 1997, J MOL EVOL, V44, P282, DOI 10.1007/PL00006145; Georgiades K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024857; Gillespie JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002018; Gillespie JJ, 2010, INFECT IMMUN, V78, P1809, DOI 10.1128/IAI.01384-09; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Gupta RS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-106; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2006, BMC EVOL BI IN PRESS; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Meyer MM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-268; Moran NA, 2003, CURR OPIN MICROBIOL, V6, P512, DOI 10.1016/j.mib.2003.08.001; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Poiata E, 2009, RNA, V15, P2046, DOI 10.1261/rna.1824209; Roure B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S2; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stechmann A, 2008, CURR BIOL, V18, P580, DOI 10.1016/j.cub.2008.03.037; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013; Tripp HJ, 2009, ENVIRON MICROBIOL, V11, P230, DOI 10.1111/j.1462-2920.2008.01758.x; Viklund J, 2011, MOL BIOL EV IN PRESS; Vinogradov SN, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-31; Wang CX, 2007, J BACTERIOL, V189, P1954, DOI 10.1128/JB.01203-06; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; WOESE CR, 1991, SYST APPL MICROBIOL, V14, P364, DOI 10.1016/S0723-2020(11)80311-5; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069	42	59	60	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30520	10.1371/journal.pone.0030520	http://dx.doi.org/10.1371/journal.pone.0030520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291975	Green Submitted, Green Published, gold			2022-12-27	WOS:000301570600053
J	Friedland, KD; Stock, C; Drinkwater, KF; Link, JS; Leaf, RT; Shank, BV; Rose, JM; Pilskaln, CH; Fogarty, MJ				Friedland, Kevin D.; Stock, Charles; Drinkwater, Kenneth F.; Link, Jason S.; Leaf, Robert T.; Shank, Burton V.; Rose, Julie M.; Pilskaln, Cynthia H.; Fogarty, Michael J.			Pathways between Primary Production and Fisheries Yields of Large Marine Ecosystems	PLOS ONE			English	Article							FISH PRODUCTION; GLOBAL FISHERIES; GROWTH-RATES; PHYTOPLANKTON; TEMPERATURE; MODEL; TRENDS; CARBON; RATIO; LAKE	The shift in marine resource management from a compartmentalized approach of dealing with resources on a species basis to an approach based on management of spatially defined ecosystems requires an accurate accounting of energy flow. The flow of energy from primary production through the food web will ultimately limit upper trophic-level fishery yields. In this work, we examine the relationship between yield and several metrics including net primary production, chlorophyll concentration, particle-export ratio, and the ratio of secondary to primary production. We also evaluate the relationship between yield and two additional rate measures that describe the export of energy from the pelagic food web, particle export flux and mesozooplankton productivity. We found primary production is a poor predictor of global fishery yields for a sample of 52 large marine ecosystems. However, chlorophyll concentration, particle-export ratio, and the ratio of secondary to primary production were positively associated with yields. The latter two measures provide greater mechanistic insight into factors controlling fishery production than chlorophyll concentration alone. Particle export flux and mesozooplankton productivity were also significantly related to yield on a global basis. Collectively, our analyses suggest that factors related to the export of energy from pelagic food webs are critical to defining patterns of fishery yields. Such trophic patterns are associated with temperature and latitude and hence greater yields are associated with colder, high latitude ecosystems.	[Friedland, Kevin D.; Leaf, Robert T.] NOAA, Natl Marine Fisheries Serv, Narragansett, RI 02882 USA; [Stock, Charles] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ USA; [Drinkwater, Kenneth F.] Inst Marine Res, N-5024 Bergen, Norway; [Drinkwater, Kenneth F.] Bjerknes Ctr Climate Res, Bergen, Norway; [Link, Jason S.; Shank, Burton V.; Fogarty, Michael J.] Natl Marine Fisheries Serv, Woods Hole, MA 02543 USA; [Rose, Julie M.] Natl Marine Fisheries Serv, Milford, MA USA; [Pilskaln, Cynthia H.] Sch Marine Sci & Technol, New Bedford, MA USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Institute of Marine Research - Norway; Bjerknes Centre for Climate Research; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Friedland, KD (corresponding author), NOAA, Natl Marine Fisheries Serv, Narragansett, RI 02882 USA.	kevin.friedland@noaa.gov	Leaf, Robert/AAE-7345-2019; Stock, Charles A/H-1281-2012	Leaf, Robert/0000-0002-2955-3149; Stock, Charles A/0000-0001-9549-8013; Link, Jason/0000-0003-2740-7161	Comparative Analysis of Marine Ecosystems Organization (CAMEO); Marine Ecosystems of Norway; US (MENU); Research Council of Norway	Comparative Analysis of Marine Ecosystems Organization (CAMEO); Marine Ecosystems of Norway; US (MENU); Research Council of Norway(Research Council of Norway)	This work was in part supported by Comparative Analysis of Marine Ecosystems Organization (CAMEO) grants for Fisheries Production Modeling Workshops to J. Link and B. Megrey (2010) and J. Link and S. Gaichas (2011). And, by the Marine Ecosystems of Norway and the US (MENU) project, part II, funded by the Research Council of Norway, which supported K. Drinkwater. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Armstrong RA, 1999, J PLANKTON RES, V21, P445, DOI 10.1093/plankt/21.3.445; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Bissinger JE, 2008, LIMNOL OCEANOGR, V53, P487, DOI 10.4319/lo.2008.53.2.0487; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Campbell J, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001444; Carr ME, 2006, DEEP-SEA RES PT II, V53, P741, DOI 10.1016/j.dsr2.2006.01.028; Chassot E, 2007, MAR ECOL PROG SER, V343, P45, DOI 10.3354/meps06919; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Cloern JE, 1995, LIMNOL OCEANOGR, V40, P1313, DOI 10.4319/lo.1995.40.7.1313; Collie JS, 2009, ICES J MAR SCI, V66, P2223, DOI 10.1093/icesjms/fsp180; Conti L, 2010, MAR ECOL PROG SER, V410, P233, DOI 10.3354/meps08630; CUSHING DH, 1971, ADV MAR BIOL, V9, P255, DOI 10.1016/S0065-2881(08)60344-2; DOWNING JA, 1990, CAN J FISH AQUAT SCI, V47, P1929, DOI 10.1139/f90-217; Dunne JP, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002390; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Frank KT, 2006, ECOL LETT, V9, P1096, DOI 10.1111/j.1461-0248.2006.00961.x; Friedrichs MAM, 2009, J MARINE SYST, V76, P113, DOI 10.1016/j.jmarsys.2008.05.010; Gaichas S, 2009, PROG OCEANOGR, V81, P47, DOI 10.1016/j.pocean.2009.04.005; Garrison LP, 2000, MAR ECOL PROG SER, V202, P231, DOI 10.3354/meps202231; GAVIS J, 1975, LIMNOL OCEANOGR, V20, P211, DOI 10.4319/lo.1975.20.2.0211; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; HARGRAVE BT, 1985, MAR ECOL PROG SER, V20, P221, DOI 10.3354/meps020221; Hirst AG, 2003, LIMNOL OCEANOGR, V48, P1988, DOI 10.4319/lo.2003.48.5.1988; HOUDE ED, 1993, ESTUARIES, V16, P161, DOI 10.2307/1352488; HOUDE ED, 1989, FISH B-NOAA, V87, P471; HUNTLEY ME, 1992, AM NAT, V140, P201, DOI 10.1086/285410; Irigoien X, 2005, J PLANKTON RES, V27, P313, DOI 10.1093/plankt/fbi011; IVERSON RL, 1990, LIMNOL OCEANOGR, V35, P1593, DOI 10.4319/lo.1990.35.7.1593; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Jones R., 1982, THEORY MANAGEMENT TR, V9, P195; Kiorboe T, 1997, SCI MAR, V61, P141; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; Legendre L, 1998, MAR ECOL PROG SER, V164, P1, DOI 10.3354/meps164001; Libralato S, 2008, MAR ECOL PROG SER, V355, P107, DOI 10.3354/meps07224; Link JS, 2009, PROG OCEANOGR, V81, P29, DOI 10.1016/j.pocean.2009.04.004; Link JS, 2005, AQUATIC FOOD WEBS: AN ECOSYSTEM APPROACH, P98; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; Marquis E, 2011, ICES J MAR SCI, V68, P803, DOI 10.1093/icesjms/fsr027; Megrey BA, 2009, PROG OCEANOGR, V81, P2, DOI 10.1016/j.pocean.2009.04.002; MELACK JM, 1976, T AM FISH SOC, V105, P575, DOI 10.1577/1548-8659(1976)105<575:PPAFYI>2.0.CO;2; MICHAELS AF, 1988, DEEP-SEA RES, V35, P473, DOI 10.1016/0198-0149(88)90126-4; MOREL A, 1989, LIMNOL OCEANOGR, V34, P1545, DOI 10.4319/lo.1989.34.8.1545; Myers RA, 1998, REV FISH BIOL FISHER, V8, P285, DOI 10.1023/A:1008828730759; NIXON SW, 1988, LIMNOL OCEANOGR, V33, P1005, DOI 10.4319/lo.1988.33.4_part_2.1005; O'Brien TD, 2005, NMFSFSPO73 NOAA, V73; OGLESBY RT, 1977, J FISH RES BOARD CAN, V34, P2271, DOI 10.1139/f77-305; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pauly D, 2007, AMBIO, V36, P290, DOI 10.1579/0044-7447(2007)36[290:TSAUPD]2.0.CO;2; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Ramseier Rene O., 2000, Journal of Northwest Atlantic Fishery Science, V27, P35, DOI 10.2960/J.v27.a4; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Rose JM, 2007, LIMNOL OCEANOGR, V52, P886, DOI 10.4319/lo.2007.52.2.0886; ROSS ST, 1986, COPEIA, P352, DOI 10.2307/1444996; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Saba VS, 2011, BIOGEOSCIENCES, V8, P489, DOI 10.5194/bg-8-489-2011; Sathyendranath S, 2009, MAR ECOL PROG SER, V383, P73, DOI 10.3354/meps07998; Sherman K, 2009, AMBIO, V38, P215, DOI 10.1579/0044-7447-38.4.215; SIMBERLOFF D, 1991, ANNU REV ECOL SYST, V22, P115, DOI 10.1146/annurev.es.22.110191.000555; Sokal R. R., 1981, BIOMETRY; Stock C, 2010, DEEP-SEA RES PT I, V57, P95, DOI 10.1016/j.dsr.2009.10.006; Stock CA, 2011, PROG OCEANOGR, V88, P1, DOI 10.1016/j.pocean.2010.09.001; Sverdrup H.U., 1953, ICES J MAR SCI, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; Ware D, 2000, FISH OCEANOGR, P161; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Watson R, 2004, FISH FISH, V5, P168, DOI 10.1111/j.1467-2979.2004.00142.x; Wehrens R., 2007, PLS PARTIAL LEAST SQ; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141	70	159	165	4	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e28945	10.1371/journal.pone.0028945	http://dx.doi.org/10.1371/journal.pone.0028945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276100	gold, Green Published, Green Submitted			2022-12-27	WOS:000301568100006
J	Saha, MN; Jiang, H; Yang, YJ; Zhu, XY; Wang, XM; Schimmer, AD; Qiu, LG; Chang, H				Saha, Manujendra N.; Jiang, Hua; Yang, Yijun; Zhu, Xiaoyun; Wang, Xiaoming; Schimmer, Aaron D.; Qiu, Lugui; Chang, Hong			Targeting p53 via JNK Pathway: A Novel Role of RITA for Apoptotic Signaling in Multiple Myeloma	PLOS ONE			English	Article							JUN NH2-TERMINAL KINASE; SMALL-MOLECULE RITA; N-TERMINAL KINASE; ACTIVATED PROTEIN-KINASE; C-JUN; IN-VITRO; ANTIMYELOMA ACTIVITY; DEPENDENT APOPTOSIS; EFFICIENT APOPTOSIS; STRESS	The low frequency of p53 alterations e.g., mutations/deletions (similar to 10%) in multiple myeloma (MM) makes this tumor type an ideal candidate for p53-targeted therapies. RITA is a small molecule which can induce apoptosis in tumor cells by activating the p53 pathway. We previously showed that RITA strongly activates p53 while selectively inhibiting growth of MM cells without inducing genotoxicity, indicating its potential as a drug lead for p53-targeted therapy in MM. However, the molecular mechanisms underlying the pro-apoptotic effect of RITA are largely undefined. Gene expression analysis by microarray identified a significant number of differentially expressed genes associated with stress response including c-Jun N-terminal kinase (JNK) signaling pathway. By Western blot analysis we further confirmed that RITA induced activation of p53 in conjunction with up-regulation of phosphorylated ASK-1, MKK-4 and c-Jun. These results suggest that RITA induced the activation of JNK signaling. Chromatin immunoprecipitation (ChIP) analysis showed that activated c-Jun binds to the activator protein-1 (AP-1) binding site of the p53 promoter region. Disruption of the JNK signal pathway by small interfering RNA (siRNA) against JNK or JNK specific inhibitor, SP-600125 inhibited the activation of p53 and attenuated apoptosis induced by RITA in myeloma cells carrying wild type p53. On the other hand, p53 transcriptional inhibitor, PFT-alpha or p53 siRNA not only inhibited the activation of p53 transcriptional targets but also blocked the activation of c-Jun suggesting the presence of a positive feedback loop between p53 and JNK. In addition, RITA in combination with dexamethasone, known as a JNK activator, displays synergistic cytotoxic responses in MM cell lines and patient samples. Our study unveils a previously undescribed mechanism of RITA-induced p53-mediated apoptosis through JNK signaling pathway and provides the rationale for combination of p53 activating drugs with JNK activators in the treatment of MM.	[Saha, Manujendra N.; Yang, Yijun; Zhu, Xiaoyun; Chang, Hong] Toronto Gen Hosp, Res Inst, Div Mol & Cellular Biol, Toronto, ON, Canada; [Saha, Manujendra N.; Yang, Yijun; Zhu, Xiaoyun; Chang, Hong] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Jiang, Hua] Shanghai Jiao Tong Univ, Dept Hematol Oncol, Shanghai Childrens Med Ctr, Shanghai 200030, Peoples R China; [Wang, Xiaoming; Schimmer, Aaron D.] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Qiu, Lugui] Chinese Acad Med Sci, Inst Hematol, Tianjin, Peoples R China; [Qiu, Lugui] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Qiu, Lugui] Peking Union Med Coll, Tianjin, Peoples R China; [Chang, Hong] Univ Hlth Network, Dept Lab Hematol & Med Oncol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Shanghai Jiao Tong University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Saha, MN (corresponding author), Toronto Gen Hosp, Res Inst, Div Mol & Cellular Biol, Toronto, ON, Canada.	Hong.Chang@uhn.on.ca		Schimmer, Aaron/0000-0003-4023-3899	Canadian Institute of Health Research (CIHR); Leukemia and Lymphoma Society of Canada (LLSC); Cancer Research Society (CRS)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Leukemia and Lymphoma Society of Canada (LLSC); Cancer Research Society (CRS)	This study is supported in part by the grants from Canadian Institute of Health Research (CIHR), Leukemia and Lymphoma Society of Canada (LLSC), and Cancer Research Society (CRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler V, 1997, P NATL ACAD SCI USA, V94, P1686, DOI 10.1073/pnas.94.5.1686; Anderson KC, 2005, SEMIN HEMATOL, V42, pS3, DOI 10.1053/j.seminhematol.2005.10.001; Avet-Loiseau H, 1999, BRIT J HAEMATOL, V106, P717, DOI 10.1046/j.1365-2141.1999.01615.x; Barre B, 2005, J BIOL CHEM, V280, P15673, DOI 10.1074/jbc.M413203200; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Carew JS, 2008, CANCER RES, V68, P4783, DOI 10.1158/0008-5472.CAN-07-6483; Chang H, 2005, BLOOD, V105, P358, DOI 10.1182/blood-2004-04-1363; Chen LJ, 2010, BLOOD, V115, P61, DOI 10.1182/blood-2009-03-210526; Chng WJ, 2007, LEUKEMIA, V21, P582, DOI 10.1038/sj.leu.2404524; Enge M, 2009, CANCER CELL, V15, P171, DOI 10.1016/j.ccr.2009.01.019; Fan MY, 2001, CANCER RES, V61, P4450; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; GINSBERG D, 1990, ONCOGENE, V5, P1285; Grinkevich VV, 2009, CANCER CELL, V15, P441, DOI 10.1016/j.ccr.2009.03.021; Hideshima T, 2003, BLOOD, V101, P1530, DOI 10.1182/blood-2002-08-2543; Hideshima T, 2006, BLOOD, V107, P4053, DOI 10.1182/blood-2005-08-3434; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Kobayashi T, 2010, LEUKEMIA, V24, P843, DOI 10.1038/leu.2010.25; Krajewski M, 2005, NAT MED, V11, P1135, DOI 10.1038/nm1105-1135; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; MILNE DM, 1995, J BIOL CHEM, V270, P5511, DOI 10.1074/jbc.270.10.5511; Nahi H, 2008, BRIT J HAEMATOL, V141, P445, DOI 10.1111/j.1365-2141.2008.07046.x; Raab MS, 2009, BLOOD, V113, P1513, DOI 10.1182/blood-2008-05-157040; Rinaldo C, 2009, CANCER RES, V69, P6241, DOI 10.1158/0008-5472.CAN-09-0337; Saha MN, 2010, MOL CANCER THER, V9, P3041, DOI 10.1158/1535-7163.MCT-10-0471; Saha MN, 2010, CANCER BIOL THER, V9, P936, DOI 10.4161/cbt.9.11.11882; Saha MN, 2010, CANCER BIOL THER, V10, P567, DOI 10.4161/cbt.10.6.12535; Saha MN, 2010, J CLIN PATHOL, V63, P204, DOI 10.1136/jcp.2009.070961; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Schroeter H, 2003, BIOCHEM J, V372, P359, DOI 10.1042/BJ20030201; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; She QB, 2002, ONCOGENE, V21, P1580, DOI 10.1038/sj.onc.1205239; Shimada K, 2003, CARCINOGENESIS, V24, P1067, DOI 10.1093/carcin/bgg058; Singh AV, 2011, BLOOD, V117, P5692, DOI 10.1182/blood-2010-12-323857; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Zhang H, 2002, J BIOL CHEM, V277, P43648, DOI 10.1074/jbc.M203214200; Zhang JP, 2000, CLIN EXP IMMUNOL, V122, P20, DOI 10.1046/j.1365-2249.2000.01344.x; Zhao CY, 2010, CANCER RES, V70, P3372, DOI 10.1158/0008-5472.CAN-09-2787; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318	42	55	60	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30215	10.1371/journal.pone.0030215	http://dx.doi.org/10.1371/journal.pone.0030215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276160	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100026
J	Kotrschal, A; Rasanen, K; Kristjansson, BK; Senn, M; Kolm, N				Kotrschal, Alexander; Rasanen, Katja; Kristjansson, Bjarni K.; Senn, Mike; Kolm, Niclas			Extreme Sexual Brain Size Dimorphism in Sticklebacks: A Consequence of the Cognitive Challenges of Sex and Parenting?	PLOS ONE			English	Article							GASTEROSTEUS-ACULEATUS; MATE CHOICE; EVOLUTION; DIVERGENCE; SELECTION; SYSTEM; MORPHS	Selection pressures that act differently on males and females produce numerous differences between the sexes in morphology and behaviour. However, apart from the controversial report that males have slightly heavier brains than females in humans, evidence for substantial sexual dimorphism in brain size is scarce. This apparent sexual uniformity is surprising given that sexually distinct selection pressures are ubiquitous and that brains are one of the most plastic vertebrate organs. Here we demonstrate the highest level of sexual brain size dimorphism ever reported in any vertebrate: male three-spined stickleback of two morphs in an Icelandic lake have 23% heavier brains than females. We suggest that this dramatic sexual size dimorphism is generated by the many cognitively demanding challenges that males are faced in this species, such as an elaborate courtship display, the construction of an ornate nest and a male-only parental care system. However, we consider also alternative explanations for smaller brains in females, such as life-history trade-offs. Our demonstration of unprecedented levels of sexual dimorphism in brain size in the three-spined stickleback implies that behavioural and life-history differences among the sexes can have strong effects also on neural development and proposes new fields of research for understanding brain evolution.	[Kotrschal, Alexander; Kolm, Niclas] Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden; [Rasanen, Katja; Senn, Mike] Eawag, Dept Aquat Ecol, Zurich, Switzerland; [Rasanen, Katja; Senn, Mike] ETH, Inst Integrat Biol, Zurich, Switzerland; [Kristjansson, Bjarni K.] Holar Univ Coll, Dept Aquaculture & Fish Biol, Holar, Iceland	Uppsala University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich	Kotrschal, A (corresponding author), Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden.	alexander.kotrschal@ebc.uu.se	Kristjánsson, Bjarni K./B-4349-2013; Kotrschal, Alexander/ABB-8987-2021; Kotrschal, Alexander/AEV-1376-2022	Kristjánsson, Bjarni K./0000-0001-6984-5771; Kotrschal, Alexander/0000-0003-3473-1402; Rasanen, Katja/0000-0002-6293-2634; Kolm, Niclas/0000-0001-5791-336X	Swedish Research Council; Icelandic Research Council [090225022]; Carl Tryggers Foundation [CTS 09: 202]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Icelandic Research Council; Carl Tryggers Foundation	This work was funded through grants from the Swedish Research Council (2009-5157,www.vr.se) to NK and from the Icelandic Research Council to KR and BKK (090225022, www.rannis.is). AK was supported by a Carl Tryggers Foundation postdoctoral stipend (CTS 09: 202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Andersson Malte, 1994; Bakker TCM, 1999, NATURE, V401, P234, DOI 10.1038/45727; Bell A.M., 1994, EVOLUTIONARY BIOL TH; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Einarsson A, 2004, AQUAT ECOL, V38, P317, DOI 10.1023/B:AECO.0000032090.72702.a9; Forstmeier W, 2011, ANATOMICAL IN PRESS; Gahr M, 1994, DIFFERENCES SEXES; Garamszegi LZ, 2005, BEHAV ECOL, V16, P335, DOI 10.1093/beheco/arh167; Garamszegi LZ, 2005, P ROY SOC B-BIOL SCI, V272, P159, DOI 10.1098/rspb.2004.2940; Gislason GM, 1998, INT VER THEOR ANGEW, V26, P2244; GITTLEMAN JL, 1994, P NATL ACAD SCI USA, V91, P5495, DOI 10.1073/pnas.91.12.5495; Gonda A, 2009, J EVOLUTION BIOL, V22, P1721, DOI 10.1111/j.1420-9101.2009.01782.x; Gonzalez-Voyer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014355; Gonzalez-Voyer A, 2009, P ROY SOC B-BIOL SCI, V276, P161, DOI 10.1098/rspb.2008.0979; HEDRICK AV, 1989, TRENDS ECOL EVOL, V4, P136, DOI 10.1016/0169-5347(89)90212-7; Iwaniuk AN, 2001, CAN J ZOOL, V79, P759, DOI 10.1139/cjz-79-5-759; Jacobs LF, 1996, TRENDS ECOL EVOL, V11, pA82; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kotrschal K, 1998, REV FISH BIOL FISHER, V8, P373, DOI 10.1023/A:1008839605380; Kristjansson BK, 2002, BIOL J LINN SOC, V76, P247, DOI 10.1046/j.1095-8312.2002.00063.x; Lefebvre L, 1997, ANIM BEHAV, V53, P549, DOI 10.1006/anbe.1996.0330; Madden J, 2001, P ROY SOC B-BIOL SCI, V268, P833, DOI 10.1098/rspb.2000.1425; Maklakov AA, 2011, BIOL LETTERS, V7, P730, DOI 10.1098/rsbl.2011.0341; MCARDLE BH, 1988, CAN J ZOOL, V66, P2329, DOI 10.1139/z88-348; MILINSKI M, 1992, P ROY SOC B-BIOL SCI, V250, P229, DOI 10.1098/rspb.1992.0153; Olafsdottir GA, 2007, J EVOLUTION BIOL, V20, P1870, DOI 10.1111/j.1420-9101.2007.01375.x; Olafsdottir GA, 2006, BIOL LETTERS, V2, P250, DOI 10.1098/rsbl.2006.0456; Pakkenberg H, 1964, ACTA ANATOMICA, P56; Park PJ, 2010, J EVOLUTION BIOL, V23, P1261, DOI 10.1111/j.1420-9101.2010.01987.x; Pitnick S, 2006, P ROY SOC B-BIOL SCI, V273, P719, DOI 10.1098/rspb.2005.3367; SCHLUTER D, 1992, NATURE, V359, P181, DOI 10.1038/359181a0; Senn M, 2010, THESIS U ZURICH SWIT; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Titschack E, 1921, ZOOLOGISCHE JB ABTEI, V39, P83; Witelson SF, 2006, BRAIN, V129, P386, DOI 10.1093/brain/awh696	37	51	51	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30055	10.1371/journal.pone.0030055	http://dx.doi.org/10.1371/journal.pone.0030055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276144	Green Published, gold, Green Submitted			2022-12-27	WOS:000301457200030
J	Rueda, CM; Velilla, PA; Chougnet, CA; Montoya, CJ; Rugeles, MT				Mauricio Rueda, Cesar; Andrea Velilla, Paula; Chougnet, Claire A.; Julio Montoya, Carlos; Teresa Rugeles, Maria			HIV-Induced T-Cell Activation/Exhaustion in Rectal Mucosa Is Controlled Only Partially by Antiretroviral Treatment	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; EXPRESS HIGH-LEVELS; MICROBIAL TRANSLOCATION; INFECTED PATIENTS; INDOLEAMINE 2,3-DIOXYGENASE; DISEASE PROGRESSION; IMMUNE RESTORATION; VIRAL SUPPRESSION; PD-1 EXPRESSION; DENDRITIC CELLS	Peripheral blood T-cells from untreated HIV-1-infected patients exhibit reduced immune responses, usually associated with a hyperactivated/exhausted phenotype compared to HAART treated patients. However, it is not clear whether HAART ameliorates this altered phenotype of T-cells in the gastrointestinal-associated lymphoid tissue (GALT), the main site for viral replication. Here, we compared T-cells from peripheral blood and GALT of two groups of chronically HIV-1-infected patients: untreated patients with active viral replication, and patients on suppressive HAART. We characterized the T-cell phenotype by measuring PD-1, CTLA-4, HLA-DR, CD25, Foxp3 and granzyme A expression by flow cytometry; mRNA expression of T-bet, GATA-3, ROR-gamma t and Foxp3, and was also evaluated in peripheral blood mononuclear cells and rectal lymphoid cells. In HIV-1+ patients, the frequency of PD-1(+) and CTLA-4(+) T-cells (both CD4+ and CD8+ T cells) was higher in the GALT than in the blood. The expression of PD-1 by T-cells from GALT was higher in HIV-1-infected subjects with active viral replication compared to controls. Moreover, the expression per cell of PD-1 and CTLA-4 in CD4(+) T-cells from blood and GALT was positively correlated with viral load. HAART treatment decreased the expression of CTLA-4 in CD8(+) T cells from blood and GALT to levels similar as those observed in controls. Frequency of Granzyme A(+) CD8(+) T-cells in both tissues was low in the untreated group, compared to controls and HAART-treated patients. Finally, a switch towards Treg polarization was found in untreated patients, in both tissues. Together, these findings suggest that chronic HIV-1 infection results in an activated/exhausted T-cell phenotype, despite T-cell polarization towards a regulatory profile; these alterations are more pronounced in the GALT compared to peripheral blood, and are only partiality modulated by HAART.	[Mauricio Rueda, Cesar; Andrea Velilla, Paula; Julio Montoya, Carlos; Teresa Rugeles, Maria] Univ Antioquia, Grp Inmunovirol, Medellin, Antioquia, Colombia; [Chougnet, Claire A.] Univ Cincinnati, Coll Med, Dept Pediat, Div Mol Immunol,Cincinnati Childrens Hosp Res Fdn, Cincinnati, OH USA	Universidad de Antioquia; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Rueda, CM (corresponding author), Univ Antioquia, Grp Inmunovirol, Medellin, Antioquia, Colombia.	mtrugel@udea.edu.co		Velilla, Paula A/0000-0003-0885-1320	Colciencias [111540820490-1]; Vicerrectoria de Investigaciones, Universidad de Antioquia, Medellin, Colombia; National Institutes of Health [R01 AI068524]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068524] Funding Source: NIH RePORTER	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Vicerrectoria de Investigaciones, Universidad de Antioquia, Medellin, Colombia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Colciencias (grant 111540820490-1), Programa de Sostenibilidad 2011-2012 (Vicerrectoria de Investigaciones, Universidad de Antioquia, Medellin, Colombia) and National Institutes of Health R01 AI068524 (to CAC). CMR is a recipient of a doctoral scholarship. The funders had no role in the design of the study, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Aiuti F, 2006, AIDS REV, V8, P88; Andersson J, 1999, AIDS, V13, P1295, DOI 10.1097/00002030-199907300-00005; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Boasso A, 2005, BLOOD, V105, P1574, DOI 10.1182/blood-2004-06-2089; Brandt L, 2011, JAIDS-J ACQ IMM DEF, V57, P101, DOI 10.1097/QAI.0b013e318215a991; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9; Cassol E, 2010, J INFECT DIS, V202, P723, DOI 10.1086/655229; Che KF, 2010, EUR J IMMUNOL, V40, P2248, DOI 10.1002/eji.201040377; Chege D, 2011, AIDS, V25, P741, DOI 10.1097/QAD.0b013e328344cefb; Chen W, 2008, J IMMUNOL, V181, P5396, DOI 10.4049/jimmunol.181.8.5396; D'Souza M, 2007, J IMMUNOL, V179, P1979, DOI 10.4049/jimmunol.179.3.1979; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Eggena MP, 2005, J INFECT DIS, V191, P694, DOI 10.1086/427516; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Fulop T, 2010, BIOGERONTOLOGY, V11, P547, DOI 10.1007/s10522-010-9287-2; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Ito T, 2005, J IMMUNOL, V174, P6648, DOI 10.4049/jimmunol.174.11.6648; Jansen CA, 2005, AIDS, V19, P1145, DOI 10.1097/01.aids.0000176214.17990.94; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kaufmann DE, 2009, J IMMUNOL, V182, P5891, DOI 10.4049/jimmunol.0803771; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Khaitan Alka, 2011, Curr HIV/AIDS Rep, V8, P4, DOI 10.1007/s11904-010-0066-0; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Lages CS, 2008, J IMMUNOL, V181, P1835, DOI 10.4049/jimmunol.181.3.1835; Levy JA, 2009, AIDS, V23, P147, DOI 10.1097/QAD.0b013e3283217f9f; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Muthumani K, 2008, J VIROL, V82, P11536, DOI 10.1128/JVI.00485-08; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Nowroozalizadeh S, 2010, J INFECT DIS, V201, P1150, DOI 10.1086/651430; Park MJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2361; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; Roberts T, 2007, J INFECT DIS, V195, P870, DOI 10.1086/511277; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Salgado M, 2011, CLIN IMMUNOL, V139, P110, DOI 10.1016/j.clim.2011.02.008; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Shacklett BL, 2004, J IMMUNOL, V173, P641, DOI 10.4049/jimmunol.173.1.641; Shaw JM, 2011, J VIROL, V85, P11422, DOI 10.1128/JVI.05608-11; Stylianou E, 2000, CLIN EXP IMMUNOL, V119, P479, DOI 10.1046/j.1365-2249.2000.01144.x; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Yang OO, 2005, VIROLOGY, V332, P16, DOI 10.1016/j.virol.2004.11.028; Yu G, 2008, TRANSPL IMMUNOL, V18, P208, DOI 10.1016/j.trim.2007.08.006; Zhang D, 2003, BLOOD, V101, P226, DOI 10.1182/blood-2002-03-0791	55	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30307	10.1371/journal.pone.0030307	http://dx.doi.org/10.1371/journal.pone.0030307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276176	Green Submitted, Green Published, gold			2022-12-27	WOS:000301457200053
J	Dolegowska, B; Blogowski, W; Domanski, L				Dolegowska, Barbara; Blogowski, Wojciech; Domanski, Leszek			Association between the Perioperative Antioxidative Ability of Platelets and Early Post-Transplant Function of Kidney Allografts: A Pilot Study	PLOS ONE			English	Article							REPERFUSION INJURY; ACTIVATION; EXPRESSION; MARKERS; PREDICT	Background: Recent studies have demonstrated that the actions of platelets may unfavorably influence post-transplant function of organ allografts. In this study, the association between post-transplant graft function and the perioperative activity of platelet antioxidants was examined among kidney recipients divided into early (EGF), slow (SGF), and delayed graft function (DGF) groups. Methodology/Principal Findings: Activities of superoxide dismutase, catalase, glutathione transferase (GST), glutathione peroxidase, and glucose-6-phosphate dehydrogenase (G6P) were determined and levels of glutathione, oxidized glutathione, and isoprostane were measured in blood samples collected immediately before and during the first and fifth minutes of renal allograft reperfusion. Our results demonstrated a significant increase in isoprostane levels in all groups. Interestingly, in DGF patients, significantly lower levels of perioperative activity of catalase (p < 0.02) and GST (p < 0.02) were observed. Moreover, in our study, the activity of platelet antioxidants was associated with intensity of perioperative oxidative stress. For discriminating SGF/DGF from EGF, sensitivity, specificity, and positive and negative predictive values of platelet antioxidants were 81-91%, 50-58%, 32-37%, and 90-90.5%, respectively. Conclusions: During renal transplantation, significant changes occur in the activity of platelet antioxidants. These changes seem to be associated with post-transplant graft function and can be potentially used to differentiate between EGF and SGF/DGF. To the best of our knowledge, this is the first study to reveal the potential protective role of platelets in the human transplantation setting.	[Dolegowska, Barbara; Blogowski, Wojciech] Pomeranian Med Univ, Dept Lab Diagnost & Mol Med, Szczecin, Poland; [Domanski, Leszek] Pomeranian Med Univ, Dept Nephrol Transplantat & Internal Med, Szczecin, Poland	Pomeranian Medical University; Pomeranian Medical University	Dolegowska, B (corresponding author), Pomeranian Med Univ, Dept Lab Diagnost & Mol Med, Szczecin, Poland.	drannab@wp.pl	Dolegowska, Barbara/O-4851-2014; Domanski, Leszek LD/P-1621-2014	Dolegowska, Barbara/0000-0003-3138-1013; Domanski, Leszek LD/0000-0002-4712-7821				Dolegowska B, 2010, NEPHROL DIAL TRANSPL, V25, P4061, DOI 10.1093/ndt/gfq320; Dolegowska B, 2010, J AM COLL SURGEONS, V211, P587, DOI 10.1016/j.jamcollsurg.2010.06.391; Dolegowska B, 2009, CLIN TRANSPLANT, V23, P716, DOI 10.1111/j.1399-0012.2009.00983.x; Dolegowska B, 2009, TRANSPL INT, V22, P546, DOI 10.1111/j.1432-2277.2008.00829.x; Dolegowska B, 2009, PLATELETS, V20, P242, DOI 10.1080/09537100902849836; Domanski L, 2006, TRANSPL P, V38, P35, DOI 10.1016/j.transproceed.2005.11.083; ECHLER G, 1983, AM J MED TECHNOL, V49, P259; Esch JSA, 2010, PLATELETS, V21, P348, DOI 10.3109/09537101003739897; Freedman JE, 2008, ARTERIOSCL THROM VAS, V28, pS11, DOI 10.1161/ATVBAHA.107.159178; Godin N, 2010, KIDNEY INT, V77, P1086, DOI 10.1038/ki.2010.63; Hariharan N, 2011, ANTIOXID REDOX SIGN, V14, P2179, DOI 10.1089/ars.2010.3488; Juttner B, 2009, THROMB RES, V124, P433, DOI 10.1016/j.thromres.2009.06.011; Kirk AD, 2009, AM J TRANSPLANT, V9, P14, DOI 10.1111/j.1600-6143.2008.02473.x; Kitamura M, 2008, CLIN EXP NEPHROL, V12, P317, DOI 10.1007/s10157-008-0060-7; Kosieradzki M, 2003, TRANSPLANTATION, V75, P1221, DOI 10.1097/01.TP.0000065282.46425.87; Kwiatkowski S, 2009, BIOMARKERS, V14, P406, DOI 10.1080/13547500903045583; Lee DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022360; Martel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018812; Moreno JM, 2010, J PHYSIOL PHARMACOL, V61, P325; Morrell CN, 2007, AM J TRANSPLANT, V7, P2447, DOI 10.1111/j.1600-6143.2007.01958.x; Pacchiarini L, 1996, HAEMATOLOGICA, V81, P497; Pandey NR, 2000, INT J CARDIOL, V76, P33, DOI 10.1016/S0167-5273(00)00344-2; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Reid TJ, 1999, TRANSFUSION, V39, P616, DOI 10.1046/j.1537-2995.1999.39060616.x; Renner B, 2010, J IMMUNOL, V185, P4393, DOI 10.4049/jimmunol.0903239; Rothwell SW, 2000, TRANSFUSION, V40, P988, DOI 10.1046/j.1537-2995.2000.40080988.x; Schroppel B, 2010, J AM SOC NEPHROL, V21, P536, DOI 10.1681/ASN.2009040390; Shaheen MF, 2010, TRANSPL P, V42, P273, DOI 10.1016/j.transproceed.2009.12.052; Shapiro MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023011; Smyth SS, 2009, J THROMB HAEMOST, V7, P1759, DOI 10.1111/j.1538-7836.2009.03586.x; Sternberg DI, 2008, J THORAC CARDIOV SUR, V135, P679, DOI 10.1016/j.jtcvs.2007.09.058; Tahara M, 2005, TRANSPLANTATION, V80, P213, DOI 10.1097/01.TP.0000165092.07375.C9; Wachowicz B, 2002, PLATELETS, V13, P175, DOI 10.1080/09533710022149395; Xu H, 2006, J CLIN INVEST, V116, P769, DOI 10.1172/JCI27155; Yuan Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025811; Zynek-Litwin M, 2010, NEPHROL DIAL TRANSPL, V25, P2346, DOI 10.1093/ndt/gfq041	36	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29779	10.1371/journal.pone.0029779	http://dx.doi.org/10.1371/journal.pone.0029779			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279544	gold, Green Published, Green Submitted			2022-12-27	WOS:000299771900022
J	Pan, N; Jahan, I; Kersigo, J; Duncan, JS; Kopecky, B; Fritzsch, B				Pan, Ning; Jahan, Israt; Kersigo, Jennifer; Duncan, Jeremy S.; Kopecky, Benjamin; Fritzsch, Bernd			A Novel Atoh1 "Self-Terminating" Mouse Model Reveals the Necessity of Proper Atoh1 Level and Duration for Hair Cell Differentiation and Viability	PLOS ONE			English	Article							INNER-EAR MORPHOGENESIS; SENSORY EPITHELIA; MOLECULAR-BASIS; NULL MICE; MATH1; EXPRESSION; HEARING; GENE; SURVIVAL; FATE	Atonal homolog1 (Atoh1) is a bHLH transcription factor essential for inner ear hair cell differentiation. Targeted expression of Atoh1 at various stages in development can result in hair cell differentiation in the ear. However, the level and duration of Atoh1 expression required for proper hair cell differentiation and maintenance remain unknown. We generated an Atoh1 conditional knockout (CKO) mouse line using Tg(Atoh1-cre), in which the cre expression is driven by an Atoh1 enhancer element that is regulated by Atoh1 protein to "self-terminate'' its expression. The mutant mice show transient, limited expression of Atoh1 in all hair cells in the ear. In the organ of Corti, reduction and delayed deletion of Atoh1 result in progressive loss of almost all the inner hair cells and the majority of the outer hair cells within three weeks after birth. The remaining cells express hair cell marker Myo7a and attract nerve fibers, but do not differentiate normal stereocilia bundles. Some Myo7a-positive cells persist in the cochlea into adult stages in the position of outer hair cells, flanked by a single row of pillar cells and two to three rows of disorganized Deiters cells. Gene expression analyses of Atoh1, Barhl1 and Pou4f3, genes required for survival and maturation of hair cells, reveal earlier and higher expression levels in the inner compared to the outer hair cells. Our data show that Atoh1 is crucial for hair cell mechanotransduction development, viability, and maintenance and also suggest that Atoh1 expression level and duration may play a role in inner vs. outer hair cell development. These genetically engineered Atoh1 CKO mice provide a novel model for establishing critical conditions needed to regenerate viable and functional hair cells with Atoh1 therapy.	[Pan, Ning; Jahan, Israt; Kersigo, Jennifer; Duncan, Jeremy S.; Kopecky, Benjamin; Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa	Pan, N (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	ning-pan@uiowa.edu; bernd-fritzsch@uiowa.edu	Duncan, Jeremy/E-8176-2013; Duncan, Jeremy/K-7230-2013	Fritzsch, Bernd/0000-0002-4882-8398; Duncan, Jeremy/0000-0002-5555-3273	NIH [R01 DC 005590, P30 DC 010362]; Office of the Vice President for Research; College of Liberal Arts & Sciences at the University of Iowa; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005590, P30DC010362] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Vice President for Research; College of Liberal Arts & Sciences at the University of Iowa; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH grants R01 DC 005590 (to B. F.) and P30 DC 010362 (http://www.nidcd.nih.gov). The authors also acknowledge the support from the Office of the Vice President for Research (https://research.uiowa.edu/ovpr/office-vp-research) and College of Liberal Arts & Sciences (http://www.clas.uiowa.edu) at the University of Iowa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyantseva IA, 2003, TRENDS MOL MED, V9, P458, DOI 10.1016/j.molmed.2003.09.008; Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bermingham-McDonogh O, 2006, J COMP NEUROL, V496, P172, DOI 10.1002/cne.20944; Bouchard M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-89; Chellappa R, 2008, MOL CELL BIOL, V28, P1905, DOI 10.1128/MCB.01454-07; Chen P, 2002, DEVELOPMENT, V129, P2495; Christophorou NAD, 2010, DEV BIOL, V345, P180, DOI 10.1016/j.ydbio.2010.07.007; Cotanche DA, 2010, HEARING RES, V266, P18, DOI 10.1016/j.heares.2010.04.012; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Duncan J, 2011, JOVE-J VIS EXP, DOI 10.3791/2451; Duncan JS, 2011, INT J DEV BIOL, V55, P297, DOI 10.1387/ijdb.103178jd; Friedman TB, 1999, AM J MED GENET, V89, P147, DOI 10.1002/(SICI)1096-8628(19990924)89:3<147::AID-AJMG5>3.0.CO;2-6; Fritzsch B, 2004, PROG BRAIN RES, V146, P265, DOI 10.1016/S0079-6123(03)46017-2; Fritzsch B, 2005, DEV DYNAM, V233, P570, DOI 10.1002/dvdy.20370; Fritzsch B, 2006, BIOESSAYS, V28, P1181, DOI 10.1002/bies.20502; Fritzsch B, 2011, HEARING RES, V276, P16, DOI 10.1016/j.heares.2011.01.007; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; Helms AW, 2000, DEVELOPMENT, V127, P1185; Hertzano R, 2004, HUM MOL GENET, V13, P2143, DOI 10.1093/hmg/ddh218; Hildebrand MS, 2008, MOL THER, V16, P224, DOI 10.1038/sj.mt.6300351; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Izumikawa M, 2008, HEARING RES, V240, P52, DOI 10.1016/j.heares.2008.02.007; Jacques BE, 2007, DEVELOPMENT, V134, P3021, DOI 10.1242/dev.02874; Jahan I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011661; Jahan I, 2010, CELL TISSUE RES, V341, P95, DOI 10.1007/s00441-010-0984-6; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049; Klisch TJ, 2011, P NATL ACAD SCI USA, V108, P3288, DOI 10.1073/pnas.1100230108; Kopecky B, 2011, PHARMACEUTICALS, V4, P848, DOI 10.3390/ph4060848; Krijnen PAJ, 2010, J MOL CELL CARDIOL, V49, P781, DOI 10.1016/j.yjmcc.2010.07.017; Li SG, 2002, DEVELOPMENT, V129, P3523; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Maricich SM, 2009, J NEUROSCI, V29, P11123, DOI 10.1523/JNEUROSCI.2232-09.2009; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Ohyama T, 2010, J NEUROSCI, V30, P15044, DOI 10.1523/JNEUROSCI.3547-10.2010; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Pan N, 2011, HEARING RES, V275, P66, DOI 10.1016/j.heares.2010.12.002; Pan N, 2009, CELL TISSUE RES, V337, P407, DOI 10.1007/s00441-009-0826-6; Pauley S, 2008, PANMINERVA MED, V50, P41; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Pirvola U, 2000, J NEUROSCI, V20, P6125, DOI 10.1523/JNEUROSCI.20-16-06125.2000; Poirrier AL, 2010, TOXICOL LETT, V193, P41, DOI 10.1016/j.toxlet.2009.12.003; Praetorius M, 2010, ACTA OTO-LARYNGOL, V130, P215, DOI 10.3109/00016480903019251; Rose MF, 2009, NEURON, V64, P341, DOI 10.1016/j.neuron.2009.10.023; Schlosser G, 2010, INT REV CEL MOL BIO, V283, P129, DOI 10.1016/S1937-6448(10)83004-7; Sciarretta C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-103; Sekerkova G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002032; Shibata SB, 2010, EXP NEUROL, V223, P464, DOI 10.1016/j.expneurol.2010.01.011; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Xiang MQ, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-2; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zou D, 2008, HUM MOL GENET, V17, P3340, DOI 10.1093/hmg/ddn229	53	85	92	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30358	10.1371/journal.pone.0030358	http://dx.doi.org/10.1371/journal.pone.0030358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279587	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900064
J	Collett, GP; Goh, XF; Linton, EA; Redman, CWG; Sargent, IL				Collett, Gavin P.; Goh, Xue Fang; Linton, Elizabeth A.; Redman, Christopher W. G.; Sargent, Ian L.			RhoE Is Regulated by Cyclic AMP and Promotes Fusion of Human BeWo Choriocarcinoma Cells	PLOS ONE			English	Article							HUMAN TROPHOBLASTIC CELLS; SYNCYTIAL FUSION; EXPRESSION; DIFFERENTIATION; APOPTOSIS; TRANSCRIPTION; PROTEINS; PLACENTA; RECEPTOR; GCM1	Fusion of placental villous cytotrophoblasts with the overlying syncytiotrophoblast is essential for the maintenance of successful pregnancy, and disturbances in this process have been implicated in pathological conditions such as pre-eclampsia and intra-uterine growth retardation. In this study we examined the role of the Rho GTPase family member RhoE in trophoblast differentiation and fusion using the BeWo choriocarcinoma cell line, a model of villous cytotrophoblast fusion. Treatment of BeWo cells with the cell permeable cyclic AMP analogue dibutyryl cyclic AMP (dbcAMP) resulted in a strong upregulation of RhoE at 24h, coinciding with the onset of fusion. Using the protein kinase A (PKA)-specific cAMP analogue N-6-phenyl-cAMP, and a specific inhibitor of PKA (14-22 amide, PKI), we found that upregulation of RhoE by cAMP was mediated through activation of PKA signalling. Silencing of RhoE expression by RNA interference resulted in a significant decrease in dbcAMP-induced fusion. However, expression of differentiation markers human chorionic gonadotrophin and placental alkaline phosphatase was unaffected by RhoE silencing. Finally, we found that RhoE upregulation by dbcAMP was significantly reduced under hypoxic conditions in which cell fusion is impaired. These results show that induction of RhoE by cAMP is mediated through PKA and promotes BeWo cell fusion but has no effect on functional differentiation, supporting evidence that these two processes may be controlled by separate or diverging pathways.	[Collett, Gavin P.; Goh, Xue Fang; Linton, Elizabeth A.; Redman, Christopher W. G.; Sargent, Ian L.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England	University of Oxford	Collett, GP (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.	Gavin.Collett@obs-gyn.ox.ac.uk			Wellcome Trust [GR079862MA]; MRC [MR/J003360/1] Funding Source: UKRI; Medical Research Council [MR/J003360/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust, programme grant no. GR079862MA (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nasiry S, 2006, HUM REPROD, V21, P193, DOI 10.1093/humrep/dei272; Alsat E, 1996, J CELL PHYSIOL, V168, P346, DOI 10.1002/(SICI)1097-4652(199608)168:2<346::AID-JCP13>3.0.CO;2-1; Benirschke K., 2000, PATHOLOGY HUMAN PLAC; Boswell SA, 2007, J BIOL CHEM, V282, P4850, DOI 10.1074/jbc.M610532200; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Chang CW, 2005, MOL CELL BIOL, V25, P8401, DOI 10.1128/MCB.25.19.8401-8414.2005; Chen CP, 2008, BIOL REPROD, V79, P815, DOI 10.1095/biolreprod.108.069765; Chiang MH, 2009, J BIOL CHEM, V284, P17411, DOI 10.1074/jbc.M109.016170; Collett GP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010529; Esnault C, 2008, P NATL ACAD SCI USA, V105, P17532, DOI 10.1073/pnas.0807413105; Fortier M, 2008, CELL DEATH DIFFER, V15, P1221, DOI 10.1038/cdd.2008.34; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Frendo JL, 2003, J CELL SCI, V116, P3413, DOI 10.1242/jcs.00648; Getsios S, 2003, DEV BIOL, V257, P41, DOI 10.1016/S0012-1606(03)00041-1; Han J, 2010, ENDOCRINOLOGY, V151, P1732, DOI 10.1210/en.2009-0845; Heazell AEP, 2008, PLACENTA, V29, P175, DOI 10.1016/j.placenta.2007.11.002; Huppertz B, 2006, MICRON, V37, P509, DOI 10.1016/j.micron.2005.12.011; Keryer G, 1998, J CELL SCI, V111, P995; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029; Kudo Y, 2003, BBA-MOL BASIS DIS, V1638, P63, DOI 10.1016/S0925-4439(03)00043-7; Lee SH, 2010, MOL CELLS, V29, P311, DOI 10.1007/s10059-010-0053-8; Liang CY, 2010, BIOL REPROD, V83, P387, DOI 10.1095/biolreprod.110.083915; Liebig T, 2009, MOL BIOL CELL, V20, P452, DOI 10.1091/mbc.E07-11-1197; Lin L, 1999, PLACENTA, V20, P109, DOI 10.1053/plac.1998.0337; Madigan JP, 2009, BIOCHEM J, V424, P153, DOI 10.1042/BJ20082377; MIDGLEY AR, 1963, SCIENCE, V141, P349, DOI 10.1126/science.141.3578.349; Muroi Y, 2009, REPRODUCTION, V138, P945, DOI 10.1530/REP-09-0082; Ongusaha PP, 2006, CURR BIOL, V16, P2466, DOI 10.1016/j.cub.2006.10.056; Orendi K, 2010, REPRODUCTION, V140, P759, DOI 10.1530/REP-10-0221; Parast MM, 2001, DEV BIOL, V230, P43, DOI 10.1006/dbio.2000.0102; Poch E, 2007, EXP CELL RES, V313, P719, DOI 10.1016/j.yexcr.2006.11.006; Potgens AJG, 2002, PLACENTA, V23, pS107, DOI 10.1053/plac.2002.0772; Rashid-Doubell F, 2007, PLACENTA, V28, P139, DOI 10.1016/j.placenta.2005.12.005; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riou P, 2010, BIOESSAYS, V32, P986, DOI 10.1002/bies.201000060; Robinson JM, 2009, BIOL REPROD, V81, P33, DOI 10.1095/biolreprod.108.074591; Rote NS, 2004, PLACENTA, V25, P673, DOI 10.1016/j.placenta.2004.02.008; Ruebner M, 2010, J MOL MED, V88, P1143, DOI 10.1007/s00109-010-0656-8; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Schubert SW, 2008, NUCLEIC ACIDS RES, V36, P3834, DOI 10.1093/nar/gkn306; Shimomura A, 2009, J VET MED SCI, V71, P1591, DOI 10.1292/jvms.001591; Shurin GV, 2008, J IMMUNOTHER, V31, P491, DOI 10.1097/CJI.0b013e318176fae4; Talens-Visconti R, 2010, J NEUROCHEM, V112, P1074, DOI 10.1111/j.1471-4159.2009.06526.x; Tannetta DS, 2008, PLACENTA, V29, P680, DOI 10.1016/j.placenta.2008.04.009; Vargas A, 2008, PLACENTA, V29, P170, DOI 10.1016/j.placenta.2007.10.012; Villalonga P, 2004, MOL CELL BIOL, V24, P7829, DOI 10.1128/MCB.24.18.7829-7840.2004; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200	48	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30453	10.1371/journal.pone.0030453	http://dx.doi.org/10.1371/journal.pone.0030453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272352	Green Submitted, gold, Green Published			2022-12-27	WOS:000301454400130
J	Govero, J; Doray, B; Bai, HD; Kornfeld, S				Govero, Jennifer; Doray, Balraj; Bai, Hongdong; Kornfeld, Stuart			Analysis of Gga Null Mice Demonstrates a Non-Redundant Role for Mammalian GGA2 during Development	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; UBIQUITIN-BINDING; VHS DOMAINS; PROTEINS; RECRUITMENT; MEMAPSIN-2; RECEPTORS; INTERACTS; CLATHRIN; PROMOTES	Numerous studies using cultured mammalian cells have shown that the three GGAs (Golgi-localized, gamma-ear containing, ADP-ribosylation factor-binding proteins) function in the transport of cargo proteins between the trans-Golgi network and endosomes. However, the in vivo role(s) of these adaptor proteins and their possible functional redundancy has not been analyzed. In this study, the genes encoding GGAs1-3 were disrupted in mice by insertional mutagenesis. Loss of GGA1 or GGA3 alone was well tolerated whereas the absence of GGA2 resulted in embryonic or neonatal lethality, depending on the genetic background of the mice. Thus, GGA2 mediates a vital function that cannot be compensated for by GGA1and/or GGA3. The combined loss of GGA1 and GGA3 also resulted in a high incidence of neonatal mortality but in this case the expression level of GGA2 may be inadequate to compensate for the loss of the other two GGAs. We conclude that the three mammalian GGAs are essential proteins that are not fully redundant.	[Govero, Jennifer; Doray, Balraj; Bai, Hongdong; Kornfeld, Stuart] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Govero, J (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.	skornfel@dom.wustl.edu		Doray, Balraj/0000-0003-3347-5013	Washington University School of Medicine Diabetes Research Training Center (DRTC) Transgenic; DRTC [NIH P60 DK020579]; Alzheimer's Disease Research Center [NIH P50-AG05681]; National Institutes of Health [CA08759]; NATIONAL CANCER INSTITUTE [R37CA008759, R01CA008759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P60DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER	Washington University School of Medicine Diabetes Research Training Center (DRTC) Transgenic; DRTC; Alzheimer's Disease Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank the Washington University School of Medicine Diabetes Research Training Center (DRTC) Transgenic and ES Cell Core Facility (DRTC grant NIH P60 DK020579) and the Alzheimer's Disease Research Center (NIH P50-AG05681) for partly funding generation of the Gga null mice. This work was supported by the National Institutes of Health Grant CA08759 (to SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Boucher R, 2008, HISTOCHEM CELL BIOL, V130, P315, DOI 10.1007/s00418-008-0436-5; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Costaguta G, 2001, MOL BIOL CELL, V12, P1885, DOI 10.1091/mbc.12.6.1885; del Castillo FJ, 2010, HUM MOL GENET, V19, P262, DOI 10.1093/hmg/ddp490; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Doray B, 2002, P NATL ACAD SCI USA, V99, P8072, DOI 10.1073/pnas.082235699; Doray B, 2002, J BIOL CHEM, V277, P18477, DOI 10.1074/jbc.M201879200; Doray B, 2008, TRAFFIC, V9, P1551, DOI 10.1111/j.1600-0854.2008.00786.x; Eissenberg JC, 2011, TRAFFIC, V12, P1821, DOI 10.1111/j.1600-0854.2011.01285.x; Galy B, 2004, RNA, V10, P1019, DOI 10.1261/rna.7220704; Ghosh P, 2003, J CELL BIOL, V163, P755, DOI 10.1083/jcb.200308038; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; He XY, 2002, FEBS LETT, V524, P183, DOI 10.1016/S0014-5793(02)03052-1; Hida T, 2007, ARCH HISTOL CYTOL, V70, P303, DOI 10.1679/aohc.70.303; Hirst J, 2011, BMC CELL BIOL, V20, P22; Hirst J, 2007, TRAFFIC, V8, P594, DOI 10.1111/j.1600-0854.2007.00556.x; Hirst J, 2009, TRAFFIC, V10, P1696, DOI 10.1111/j.1600-0854.2009.00983.x; Jacobsen L, 2002, FEBS LETT, V511, P155, DOI 10.1016/S0014-5793(01)03299-9; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Kzhyshkowska J, 2004, J LEUKOCYTE BIOL, V76, P1151, DOI 10.1189/jlb.0504300; Mardones GA, 2007, MOL BIOL CELL, V18, P3486, DOI 10.1091/mbc.E07-02-0190; McKay MM, 2004, TRAFFIC, V5, P102, DOI 10.1111/j.1600-0854.2004.00160.x; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Osokine I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040034; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Shiba Y, 2004, J BIOL CHEM, V279, P7105, DOI 10.1074/jbc.M311702200; Stauber T, 2010, J BIOL CHEM, V285, P34537, DOI 10.1074/jbc.M110.162545; Takatsu H, 2001, J BIOL CHEM, V276, P28541, DOI 10.1074/jbc.C100218200; The Jackson Laboratory, 2007, GEN BACKGR UND IMP M; Valor LM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001303; Vogel P, 2009, VET PATHOL, V46, P313, DOI 10.1354/vp.46-2-313; Voss AK, 1998, DEV DYNAM, V212, P258; Wang J, 2007, MOL BIOL CELL, V18, P2646, DOI 10.1091/mbc.E06-10-0897; Yogosawa S, 2006, BIOCHEM BIOPH RES CO, V350, P82, DOI 10.1016/j.bbrc.2006.09.013; Zhang JJ, 2009, MOL CELL BIOL, V29, P6097, DOI 10.1128/MCB.00505-09; Zhu GY, 2003, FEBS LETT, V537, P171, DOI 10.1016/S0014-5793(03)00095-4; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	41	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30184	10.1371/journal.pone.0030184	http://dx.doi.org/10.1371/journal.pone.0030184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291915	Green Published, gold			2022-12-27	WOS:000301703800008
J	Lang, C; Guo, XL; Kerschensteiner, M; Bareyre, FM				Lang, Claudia; Guo, Xiaoli; Kerschensteiner, Martin; Bareyre, Florence M.			Single Collateral Reconstructions Reveal Distinct Phases of Corticospinal Remodeling after Spinal Cord Injury	PLOS ONE			English	Article							DEVELOPING NEUROMUSCULAR-JUNCTIONS; C3-C5 PROPRIOSPINAL NEURONS; POSTNATAL-DEVELOPMENT; AXON REGENERATION; NERVOUS-SYSTEM; CONSTITUTIVE ACTIVITY; DESCENDING PATHWAYS; MOTOR-NEURONS; TRACT; PLASTICITY	Background: Injuries to the spinal cord often result in severe functional deficits that, in case of incomplete injuries, can be partially compensated by axonal remodeling. The corticospinal tract (CST), for example, responds to a thoracic transection with the formation of an intraspinal detour circuit. The key step for the formation of the detour circuit is the sprouting of new CST collaterals in the cervical spinal cord that contact local interneurons. How individual collaterals are formed and refined over time is incompletely understood. Methodology/Principal Findings: We traced the hindlimb corticospinal tract at different timepoints after lesion to show that cervical collateral formation is initiated in the first 10 days. These collaterals can then persist for at least 24 weeks. Interestingly, both major and minor CST components contribute to the formation of persistent CST collaterals. We then developed an approach to label single CST collaterals based on viral gene transfer of the Cre recombinase to a small number of cortical projection neurons in Thy1-STP-YFP or Thy1-Brainbow mice. Reconstruction and analysis of single collaterals for up to 12 weeks after lesion revealed that CST remodeling evolves in 3 phases. Collateral growth is initiated in the first 10 days after lesion. Between 10 days and 3-4 weeks after lesion elongated and highly branched collaterals form in the gray matter, the complexity of which depends on the CST component they originate from. Finally, between 3-4 weeks and 12 weeks after lesion the size of CST collaterals remains largely unchanged, while the pattern of their contacts onto interneurons matures. Conclusions/Significance: This study provides a comprehensive anatomical analysis of CST reorganization after injury and reveals that CST remodeling occurs in distinct phases. Our results and techniques should facilitate future efforts to unravel the mechanisms that govern CST remodeling and to promote functional recovery after spinal cord injury.	[Lang, Claudia; Guo, Xiaoli; Kerschensteiner, Martin; Bareyre, Florence M.] Univ Munich, Inst Clin Neuroimmunol, Res Unit Therapy Dev, Munich, Germany	University of Munich	Lang, C (corresponding author), Univ Munich, Inst Clin Neuroimmunol, Res Unit Therapy Dev, Munich, Germany.	martin.kerschensteiner@med.uni-muenchen.de; florence.bareyre@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft (DFG) [SFB 870, SFB 571]; German Federal Ministry of Education and Research (BMBF); BMBF Competence Network Multiple Sclerosis; Verein Therapieforschung fur MS-Kranke e.V.	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF Competence Network Multiple Sclerosis; Verein Therapieforschung fur MS-Kranke e.V.	Work in F.M.B.'s lab is supported by grants from the Deutsche Forschungsgemeinschaft (DFG, SFB 870) and the German Federal Ministry of Education and Research (BMBF). Work in M.K.'s lab is financed through grants from the Deutsche Forschungsgemeinschaft (DFG; Emmy-Noether Program, SFB 571 and SFB 870), the BMBF Competence Network Multiple Sclerosis and the "Verein Therapieforschung fur MS-Kranke e.V.". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSTERMARK B, 1987, BRAIN RES, V404, P389, DOI 10.1016/0006-8993(87)91401-6; ALSTERMARK B, 1987, BRAIN RES, V404, P395, DOI 10.1016/0006-8993(87)91402-8; ALSTERMARK B, 1990, NEUROSCI RES, V8, P131, DOI 10.1016/0168-0102(90)90065-M; ALSTERMARK B, 1987, NEUROSCI LETT, V74, P291, DOI 10.1016/0304-3940(87)90312-0; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; BALICEGORDON RJ, 1993, NEURON, V11, P801, DOI 10.1016/0896-6273(93)90110-D; BALICEGORDON RJ, 1993, J NEUROSCI, V13, P834; Ballermann M, 2006, EUR J NEUROSCI, V23, P1988, DOI 10.1111/j.1460-9568.2006.04726.x; Bareyre FM, 2011, P NATL ACAD SCI USA, V108, P6282, DOI 10.1073/pnas.1015239108; Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Bigbee AJ, 2007, BEHAV BRAIN RES, V180, P95, DOI 10.1016/j.bbr.2007.02.029; BLIGHT AR, 1993, ADV NEUROL, V59, P91; Bomze HM, 2001, NAT NEUROSCI, V4, P38, DOI 10.1038/82881; Brosamle C, 2000, J NEUROCYTOL, V29, P499, DOI 10.1023/A:1007297712821; Brosamle C, 1997, J COMP NEUROL, V386, P293, DOI 10.1002/(SICI)1096-9861(19970922)386:2<293::AID-CNE9>3.0.CO;2-X; BROWN LT, 1971, EXP BRAIN RES, V13, P432; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Burns SP, 1997, ARCH PHYS MED REHAB, V78, P1169, DOI 10.1016/S0003-9993(97)90326-9; CABANA T, 1985, DEV BRAIN RES, V23, P69, DOI 10.1016/0165-3806(85)90007-0; CALLAWAY EM, 1987, NATURE, V328, P422, DOI 10.1038/328422a0; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; CURFS MHJM, 1994, DEV BRAIN RES, V78, P182, DOI 10.1016/0165-3806(94)90025-6; de Leon RD, 1998, J NEUROPHYSIOL, V79, P1329, DOI 10.1152/jn.1998.79.3.1329; de Leon RD, 2001, PHYS THER, V81, P1904, DOI 10.1093/ptj/81.12.1904; Dobkin BH, 2000, PROG BRAIN RES, V128, P99; Donoghue JP, 1995, CURR OPIN NEUROBIOL, V5, P749, DOI 10.1016/0959-4388(95)80102-2; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fouad K, 2010, J NEUROPHYSIOL, V104, P2975, DOI 10.1152/jn.00499.2010; Fouad K, 2001, CURR BIOL, V11, P1766, DOI 10.1016/S0960-9822(01)00535-8; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Gianino S, 1999, DEV BRAIN RES, V112, P189, DOI 10.1016/S0165-3806(98)00168-0; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; Herzog A, 1997, J NEUROSCI METH, V72, P57, DOI 10.1016/S0165-0270(96)00156-2; Hill CE, 2001, EXP NEUROL, V171, P153, DOI 10.1006/exnr.2001.7734; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Ichiyama RM, 2008, J NEUROSCI, V28, P7370, DOI 10.1523/JNEUROSCI.1881-08.2008; JANKOWSKA E, 1974, EXP BRAIN RES, V21, P169; JOOSTEN EAJ, 1992, J COMP NEUROL, V326, P133, DOI 10.1002/cne.903260112; Kaas JH, 1999, NEURON, V22, P657, DOI 10.1016/S0896-6273(00)80725-4; Kerschensteiner M, 2004, J EXP MED, V200, P1027, DOI 10.1084/jem.20040452; Li Q, 2000, EXP BRAIN RES, V134, P187, DOI 10.1007/s002210000454; Li Q, 2002, J COMP NEUROL, V447, P57, DOI 10.1002/cne.10203; Little JW, 1999, ARCH PHYS MED REHAB, V80, P587, DOI 10.1016/S0003-9993(99)90204-6; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Low LK, 2008, P NATL ACAD SCI USA, V105, P8136, DOI 10.1073/pnas.0803849105; Martin JH, 1999, NEUROREPORT, V10, P2277, DOI 10.1097/00001756-199908020-00010; Martin JH, 2005, NEUROSCIENTIST, V11, P161, DOI 10.1177/1073858404270843; Miller S, 1997, J PHYSL, V230, p30P; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; NUDO RJ, 1990, J COMP NEUROL, V296, P559, DOI 10.1002/cne.902960405; NUDO RJ, 1988, J COMP NEUROL, V277, P53, DOI 10.1002/cne.902770105; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; OUDEGA M, 1994, J COMP NEUROL, V347, P115, DOI 10.1002/cne.903470109; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; RIDGE RMAP, 1984, J NEUROSCI, V4, P2614; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; STANFIELD BB, 1985, NATURE, V313, P135, DOI 10.1038/313135a0; STANFIELD BB, 1982, NATURE, V298, P371, DOI 10.1038/298371a0; Steward O, 2008, J NEUROSCI, V28, P6836, DOI 10.1523/JNEUROSCI.5372-07.2008; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; TERASHIMA T, 1995, NEUROSCI RES, V22, P139, DOI 10.1016/0168-0102(95)00895-9; Uematsu J, 1996, BRAIN DEV-JPN, V18, P29, DOI 10.1016/0387-7604(95)00102-6; van Hedel HJA, 2010, RESTOR NEUROL NEUROS, V28, P123, DOI 10.3233/RNN-2010-0508; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798	69	36	37	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30461	10.1371/journal.pone.0030461	http://dx.doi.org/10.1371/journal.pone.0030461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291960	gold, Green Published, Green Submitted			2022-12-27	WOS:000301639600023
J	Ling, Q; Xu, X; Wei, Q; Liu, XL; Guo, HJ; Zhuang, L; Chen, JJ; Xia, Q; Xie, HY; Wu, J; Zheng, SS; Li, LJ				Ling, Qi; Xu, Xiao; Wei, Qiang; Liu, Xiaoli; Guo, Haijun; Zhuang, Li; Chen, Jiajia; Xia, Qi; Xie, Haiyang; Wu, Jian; Zheng, Shusen; Li, Lanjuan			Downgrading MELD Improves the Outcomes after Liver Transplantation in Patients with Acute-on-Chronic Hepatitis B Liver Failure	PLOS ONE			English	Article							DISEASE SCORING SYSTEM; DONOR LIVER; HEPATORENAL-SYNDROME; HANGZHOU EXPERIENCE; PREDICTION VALUE; PLASMA-EXCHANGE; SUPPORT-SYSTEM; MODEL; KIDNEY; RECONSTRUCTION	Background: High score of model for end-stage liver diseases (MELD) before liver transplantation (LT) indicates poor prognosis. Artificial liver support system (ALSS) has been proved to effectively improve liver and kidney functions, and thus reduce the MELD score. We aim to evaluate whether downgrading MELD score could improve patient survival after LT. Methodology/Principal Findings: One hundred and twenty-six LT candidates with acute-on-chronic hepatitis B liver failure and MELD score >= 30 were included in this prospective study. Of the 126 patients, 42 received emergency LT within 72 h (ELT group) and the other 84 were given ALSS as salvage treatment. Of the 84 patients, 33 were found to have reduced MELD score (<30) on the day of LT (DGM group), 51 underwent LT with persistent high MELD score (N-DGM group). The median waiting time for a donor was 10 for DGM group and 9.5 days for N-DGM group. In N-DGM group there is a significantly higher overall mortality (43.1%) than that in ELT group (16.7%) and DGM group (15.2%). N-DGM (vs. ECT and DGM) was the only independent risk factor of overall mortality (P = 0.003). Age >40 years and the interval from last ALSS to LT >48 h were independent negative influence factors of downgrading MELD. Conclusions/Significance: Downgrading MELD for liver transplant candidates with MELD score >= 30 was effective in improving patient prognosis. An appropriate ALSS treatment within 48 h prior to LT is potentially beneficial.	[Ling, Qi; Xu, Xiao; Wei, Qiang; Guo, Haijun; Zhuang, Li; Xie, Haiyang; Wu, Jian; Zheng, Shusen; Li, Lanjuan] Zhejiang Univ Sch Med, Div Hepatobiliary & Pancreat Surg, Key Lab Combined Multiorgan Transplantat, Minist Publ Hlth,Dept Surg,Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China; [Liu, Xiaoli; Chen, Jiajia; Xia, Qi] Zhejiang Univ Sch Med, Affiliated Hosp 1, Dept Infect Dis, State Key Lab Diag & Treatment Infect Dis, Hangzhou, Zhejiang, Peoples R China		Ling, Q (corresponding author), Zhejiang Univ Sch Med, Div Hepatobiliary & Pancreat Surg, Key Lab Combined Multiorgan Transplantat, Minist Publ Hlth,Dept Surg,Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China.	zyzss@zju.edu.cn; ljli@mail.hz.zj.cn	Liu, Xiaoli/HGE-7614-2022		Chinese High Tech Research & Development (863) Program [2011AA020104]; National Natural Science Foundation of China [81121002]; Technology Group Project for Infectious Disease Control of Zhejiang Province [2009R50041]	Chinese High Tech Research & Development (863) Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Group Project for Infectious Disease Control of Zhejiang Province	This work was supported by the Chinese High Tech Research & Development (863) Program (2011AA020104), Science Fund for Creative Research Groups of the National Natural Science Foundation of China (81121002) and the Technology Group Project for Infectious Disease Control of Zhejiang Province (2009R50041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1053/jhep.1996.v23.ajhep0230164; Artificial Liver Group Chinese Association of Infectious and Parasitic Diseases, 2002, Zhonghua Gan Zang Bing Za Zhi, V10, P329; Cai QC, 2009, HEPATOB PANCREAT DIS, V8, P479; Chen YS, 2007, INT J ARTIF ORGANS, V30, P906, DOI 10.1177/039139880703001008; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; Deschenes M, 1998, TRANSPLANTATION, V66, P302, DOI 10.1097/00007890-199808150-00005; Du WB, 2005, TRANSPL P, V37, P4359, DOI 10.1016/j.transproceed.2005.11.044; Gao F, 2009, HEPATOB PANCREAT DIS, V8, P29; Jia Ji-dong, 2004, Zhonghua Gan Zang Bing Za Zhi, V12, P698; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kuramitsu K, 2007, TRANSPLANTATION, V84, P166, DOI 10.1097/01.tp.0000269103.87633.06; Li LJ, 2006, THER APHER DIAL, V10, P160, DOI 10.1111/j.1744-9987.2006.00358.x; Liu CL, 2003, TRANSPLANTATION, V76, P1174, DOI 10.1097/01.TP.0000087341.88471.E5; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Liu Q, 2009, BLOOD PURIFICAT, V28, P331, DOI 10.1159/000232940; Lu SC, 2010, TRANSPL INT, V23, P23, DOI 10.1111/j.1432-2277.2009.00935.x; Mao WL, 2010, ASAIO J, V56, P475, DOI 10.1097/MAT.0b013e3181e6bf13; Moreau R, 2010, LIVER TRANSPLANT, V16, pS72, DOI 10.1002/lt.22143; O'Riordan A, 2010, TRANSPLANTATION, V89, P1378, DOI 10.1097/TP.0b013e3181d9e195; Pillay SP, 1997, AUST NZ J SURG, V67, P187, DOI 10.1111/j.1445-2197.1997.tb01938.x; Ruiz R, 2007, LIVER TRANSPLANT, V13, P838, DOI 10.1002/lt.21149; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Wang Wei-lin, 2005, Zhonghua Yi Xue Za Zhi, V85, P3460; Wang ZX, 2007, TRANSPL P, V39, P1501, DOI 10.1016/j.transproceed.2007.02.070; Wu J, 2008, TRANSPL INT, V21, P843, DOI 10.1111/j.1432-2277.2008.00690.x; Xu X, 2008, HEPATOB PANCREAT DIS, V7, P465; Xu X, 2007, LIVER INT, V27, P816, DOI 10.1111/j.1478-3231.2007.01494.x; Xu XA, 2010, HEPATOB PANCREAT DIS, V9, P259; Xu XA, 2009, TRANSPLANTATION, V87, P1514, DOI 10.1097/TP.0b013e3181a4430b; Yan S, 2009, HEPATOB PANCREAT DIS, V8, P575; Yu JW, 2008, J GASTROEN HEPATOL, V23, P1242, DOI 10.1111/j.1440-1746.2008.05484.x; Zheng SS, 2006, LIVER TRANSPLANT, V12, P253, DOI 10.1002/lt.20701	32	31	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30322	10.1371/journal.pone.0030322	http://dx.doi.org/10.1371/journal.pone.0030322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291934	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600013
J	Muili, KA; Gopalakrishnan, S; Meyer, SL; Eells, JT; Lyons, JA				Muili, Kamaldeen A.; Gopalakrishnan, Sandeep; Meyer, Stacy L.; Eells, Janis T.; Lyons, Jeri-Anne			Amelioration of Experimental Autoimmune Encephalomyelitis in C57BL/6 Mice by Photobiomodulation Induced by 670 nm Light	PLOS ONE			English	Article							NEAR-INFRARED LIGHT; NITRIC-OXIDE SYNTHASE; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; EMITTING DIODE IRRADIATION; IN-VITRO; GLATIRAMER ACETATE; MITOCHONDRIAL DYSFUNCTION; MYOCARDIAL-INFARCTION; PHOTODYNAMIC THERAPY; IMMUNE-RESPONSE	Background: The approved immunomodulatory agents for the treatment of multiple sclerosis (MS) are only partially effective. It is thought that the combination of immunomodulatory and neuroprotective strategies is necessary to prevent or reverse disease progression. Irradiation with far red/near infrared light, termed photobiomodulation, is a therapeutic approach for inflammatory and neurodegenerative diseases. Data suggests that near-infrared light functions through neuroprotective and anti-inflammatory mechanisms. We sought to investigate the clinical effect of photobiomodulation in the Experimental Autoimmune Encephalomyelitis (EAE) model of multiple sclerosis. Methodology/Principal Findings: The clinical effect of photobiomodulation induced by 670 nm light was investigated in the C57BL/6 mouse model of EAE. Disease was induced with myelin oligodendrocyte glycoprotein (MOG) according to standard laboratory protocol. Mice received 670 nm light or no light treatment (sham) administered as suppression and treatment protocols. 670 nm light reduced disease severity with both protocols compared to sham treated mice. Disease amelioration was associated with down-regulation of proinflammatory cytokines (interferon-gamma, tumor necrosis factor-alpha) and up-regulation of anti-inflammatory cytokines (IL-4, IL-10) in vitro and in vivo. Conclusion/Significance: These studies document the therapeutic potential of photobiomodulation with 670 nm light in the EAE model, in part through modulation of the immune response.	[Muili, Kamaldeen A.; Gopalakrishnan, Sandeep; Meyer, Stacy L.; Eells, Janis T.; Lyons, Jeri-Anne] Univ Wisconsin, Dept Hlth Sci, Coll Hlth Sci, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Muili, KA (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat Gastroenterol, Pittsburgh, PA USA.	jlyons@uwm.edu			Quantum Biomedical; Graduate School, UW-Milwaukee; College of Health Sciences, UW-Milwaukee	Quantum Biomedical; Graduate School, UW-Milwaukee; College of Health Sciences, UW-Milwaukee	Funding was provided by Quantum Biomedical ($5000 for pilot studies); Graduate School, UW-Milwaukee ($10,000); and the College of Health Sciences, UW-Milwaukee: ($5000 [JAL]; $500 [KAM and SLM]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackroyd R, 2001, PHOTOCHEM PHOTOBIOL, V74, P656, DOI 10.1562/0031-8655(2001)074<0656:THOPAP>2.0.CO;2; Aharoni R, 2005, P NATL ACAD SCI USA, V102, P19045, DOI 10.1073/pnas.0509438102; Albarracin R, 2011, INVEST OPHTH VIS SCI, V52, P3582, DOI 10.1167/iovs.10-6664; Albertini R, 2008, PHOTOMED LASER SURG, V26, P19, DOI 10.1089/pho.2007.2119; Andrews HE, 2005, MED HYPOTHESES, V64, P669, DOI 10.1016/j.mehy.2004.09.001; Arany PR, 2007, WOUND REPAIR REGEN, V15, P866, DOI 10.1111/j.1524-475X.2007.00306.x; BAUER J, 1994, J NEUROSCI RES, V38, P365, DOI 10.1002/jnr.490380402; Bjartmar C, 2001, HDB MULTIPLE SCLEROS, P325; Caminero A, 2011, J NEUROIMMUNOL, V234, P1, DOI 10.1016/j.jneuroim.2011.03.004; Cavaletti G, 2001, INT J TISSUE REACT, V23, P21; Chabannes D, 2002, PHOTODERMATOL PHOTO, V18, P238, DOI 10.1034/j.1600-0781.2002.02o754.x; Chen ACH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022453; Chung H, 2011, ANN BIOMEDICAL ENG; Craner MJ, 2005, GLIA, V49, P220, DOI 10.1002/glia.20112; Cross AH, 2006, J NEUROIMMUNOL, V173, P79, DOI 10.1016/j.jneuroim.2005.11.022; Cross AH, 1996, J NEUROIMMUNOL, V71, P145, DOI 10.1016/S0165-5728(96)00147-6; CROSS AH, 1994, J CLIN INVEST, V93, P2684, DOI 10.1172/JCI117282; Croxford AL, 2011, BBA-MOL BASIS DIS, V1812, P177, DOI 10.1016/j.bbadis.2010.06.010; Dalton DK, 2005, J NEUROIMMUNOL, V160, P110, DOI 10.1016/j.jneuroim.2004.11.004; Desmet KD, 2006, PHOTOMED LASER SURG, V24, P121, DOI 10.1089/pho.2006.24.121; Duda PW, 2000, J CLIN INVEST, V105, P967, DOI 10.1172/JCI8970; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033; Eells JT, 2004, INVEST OPHTH VIS SCI, V45, P828; Eells JT, 2008, LIGHT ACTIVATED TISS, P39; Eells JT, 2006, INVESTIGATIVE OPHTHA, V47; ElGhorr AA, 1997, IMMUNOLOGY, V92, P26, DOI 10.1046/j.1365-2567.1997.d01-2292.x; Fitzgerald M, 2010, J NEUROTRAUM, V27, P2107, DOI 10.1089/neu.2010.1426; Genain CP, 1995, J CLIN INVEST, V96, P2966, DOI 10.1172/JCI118368; Ribeiro MAG, 2009, PHOTOMED LASER SURG, V27, P49, DOI 10.1089/pho.2007.2215; Hamblin M.R., 2006, P SOC PHOTO-OPT INS, V6140, P1, DOI DOI 10.1117/12.646294; HAUSER SL, 1984, J IMMUNOL, V132, P1276; Hendriks JJA, 2003, BIOCHEM PHARMACOL, V65, P877, DOI 10.1016/S0006-2952(02)01609-X; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Hussien Y, 2001, J NEUROIMMUNOL, V121, P102, DOI 10.1016/S0165-5728(01)00432-5; Johnson KP, 2007, NEUROLOGIST, V13, P182, DOI 10.1097/01.nrl.0000263760.53418.5b; Kahl KG, 2004, NEUROSCI LETT, V358, P58, DOI 10.1016/j.neulet.2003.12.095; Khalili K, 2007, NEUROLOGY, V68, P985, DOI 10.1212/01.wnl.0000257832.38943.2b; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Leong S, 1996, PHOTOCHEM PHOTOBIOL, V64, P751, DOI 10.1111/j.1751-1097.1996.tb01830.x; Liang HL, 2008, NEUROSCIENCE, V153, P963, DOI 10.1016/j.neuroscience.2008.03.042; Lou JN, 1999, LAB INVEST, V79, P1015; LYONS RF, 1987, ANN PLAS SURG, V18, P47, DOI 10.1097/00000637-198701000-00011; MALE D, 1990, CELL IMMUNOL, V127, P1, DOI 10.1016/0008-8749(90)90109-5; Mitton D, 2008, PHOTODIAGN PHOTODYN, V5, P103, DOI 10.1016/j.pdpdt.2008.04.004; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Oron U, 2001, LASER SURG MED, V28, P204, DOI 10.1002/lsm.1039; Oron U, 2001, CIRCULATION, V103, P296; Poyton RO, 2011, DISCOV MED, V11, P154; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Qi XP, 2007, INVEST OPHTH VIS SCI, V48, P681, DOI 10.1167/iovs.06-0553; Qi XP, 2006, J BIOL CHEM, V281, P31950, DOI 10.1074/jbc.M603717200; Roberts JE, 2000, ANN NY ACAD SCI, V917, P435; SCHLUESENER HJ, 1987, J IMMUNOL, V139, P4016; Shaw VE, 2010, J COMP NEUROL, V518, P25, DOI 10.1002/cne.22207; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stuve O, 1996, ANN NEUROL, V40, P853, DOI 10.1002/ana.410400607; Suryani S, 2007, J NEUROIMMUNOL, V183, P96, DOI 10.1016/j.jneuroim.2006.11.023; ULLRICH SE, 1990, J IMMUNOL, V145, P489; Ullrich SE, 2000, J DERMATOL SCI, V23, pS10, DOI 10.1016/S0923-1811(99)00073-0; Ullrich SE, 2007, PHOTOCHEM PHOTOBIOL, V83, P1095, DOI 10.1111/j.1751-1097.2007.00184.x; VERMEER BJ, 1994, J PHOTOCH PHOTOBIO B, V24, P149, DOI 10.1016/1011-1344(94)07033-4; Waldburger KE, 1996, AM J PATHOL, V148, P375; Walterscheid JP, 2002, METHODS, V28, P71, DOI 10.1016/S1046-2023(02)00212-8; Weber MS, 2011, BBA-MOL BASIS DIS, V1812, P239, DOI 10.1016/j.bbadis.2010.06.009; Whelan HT, 2003, J CLIN LASER MED SUR, V21, P67, DOI 10.1089/104454703765035484; Whelan HT, 2002, J CLIN LASER MED SUR, V20, P319, DOI 10.1089/104454702320901107; Whelan HT, 2001, J CLIN LASER MED SUR, V19, P305, DOI 10.1089/104454701753342758; Wong-Riley MTT, 2001, NEUROREPORT, V12, P3033, DOI 10.1097/00001756-200110080-00011; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Ying R, 2008, BRAIN RES, V1243, P167, DOI 10.1016/j.brainres.2008.09.057; Zhang R, 2009, J MOL CELL CARDIOL, V46, P4, DOI 10.1016/j.yjmcc.2008.09.707	77	59	59	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30655	10.1371/journal.pone.0030655	http://dx.doi.org/10.1371/journal.pone.0030655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292010	Green Submitted, Green Published, gold			2022-12-27	WOS:000301639600044
J	Renner, B; Schmalzle, R; Schupp, HT				Renner, Britta; Schmaelzle, Ralf; Schupp, Harald T.			First Impressions of HIV Risk: It Takes Only Milliseconds to Scan a Stranger	PLOS ONE			English	Article							COLLEGE-STUDENTS; CONDOM-USE; EVENT; INTUITION; ATTENTION; FACES	Research indicates that many people do not use condoms consistently but instead rely on intuition to identify sexual partners high at risk for HIV infection. The present studies examined neural correlates for first impressions of HIV risk and determined the association of perceived HIV risk with other trait characteristics. Participants were presented with 120 self-portraits retrieved from a popular online photo-sharing community (www.flickr.com). Factor analysis of various explicit ratings of trait characteristics yielded two orthogonal factors: (1) a 'valence-approach' factor encompassing perceived attractiveness, healthiness, valence, and approach tendencies, and (2) a 'safeness' factor, entailing judgments of HIV risk, trustworthiness, and responsibility. These findings suggest that HIV risk ratings systematically relate to cardinal features of a high-risk HIV stereotype. Furthermore, event-related brain potential recordings revealed neural correlates of first impressions about HIV risk. Target persons perceived as risky elicited a differential brain response in a time window from 220-340 ms and an increased late positive potential in a time window from 350-700 ms compared to those perceived as safe. These data suggest that impressions about HIV risk can be formed in a split second and despite a lack of information about the actual risk profile. Findings of neural correlates of risk impressions and their relationship to key features of the HIV risk stereotype are discussed in the context of the risk as feelings' theory.	[Renner, Britta] Univ Konstanz, Dept Psychol Psychol Assessment & Hlth Psychol, Constance, Germany; [Schmaelzle, Ralf; Schupp, Harald T.] Univ Konstanz, Dept Psychol, Constance, Germany	University of Konstanz; University of Konstanz	Renner, B (corresponding author), Univ Konstanz, Dept Psychol Psychol Assessment & Hlth Psychol, Constance, Germany.	britta.renner@uni-konstanz.de	Renner, Britta/AAW-1895-2020	Renner, Britta/0000-0001-8385-2839; Schmalzle, Ralf/0000-0002-0179-1364	German Research Foundation [RE 1583/3-1]	German Research Foundation(German Research Foundation (DFG))	This research was supported by the German Research Foundation (RE 1583/3-1 granted to Britta Renner and Harald Schupp, http://www.dfg.de/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agocha VB, 1999, PERS SOC PSYCHOL B, V25, P746, DOI 10.1177/0146167299025006009; [Anonymous], 1999, Popul Rep H, P1; Bar M, 2006, EMOTION, V6, P269, DOI 10.1037/1528-3542.6.2.269; Broaddus MR, 2010, SEX ROLES, V62, P603, DOI 10.1007/s11199-009-9728-z; Civic D, 2000, J SEX MARITAL THER, V26, P95, DOI 10.1080/009262300278678; Dijkstra P, 2000, J APPL SOC PSYCHOL, V30, P1738, DOI 10.1111/j.1559-1816.2000.tb02465.x; Flaisch T, 2009, NEUROIMAGE, V45, P1339, DOI 10.1016/j.neuroimage.2008.12.073; GOLD RS, 1992, AIDS CARE, V4, P305, DOI 10.1080/09540129208253101; Gosling SD, 2002, J PERS SOC PSYCHOL, V82, P379, DOI 10.1037//0022-3514.82.3.379; Grammer K, 2003, BIOL REV, V78, P385, DOI 10.1017/S1464793102006085; Harris PR, 2008, J PERS SOC PSYCHOL, V95, P1225, DOI 10.1037/a0013315; Hodgkinson GP, 2008, BRIT J PSYCHOL, V99, P1, DOI 10.1348/000712607X216666; KELLER ML, 1993, AIDS EDUC PREV, V5, P220; Kissler J, 2006, PROG BRAIN RES, V156, P147, DOI 10.1016/S0079-6123(06)56008-X; LANG PJ, 1979, PSYCHOPHYSIOLOGY, V16, P495, DOI 10.1111/j.1469-8986.1979.tb01511.x; LEWICKI P, 1986, J EXP PSYCHOL LEARN, V12, P135, DOI 10.1037/0278-7393.12.1.135; Lieberman MD, 2000, PSYCHOL BULL, V126, P109, DOI 10.1037/0033-2909.126.1.109; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Lust SA, 2009, PSYCHOPHYSIOLOGY, V46, P420, DOI 10.1111/j.1469-8986.2008.00775.x; Masaro CL, 2008, SEX TRANSM DIS, V35, P566, DOI 10.1097/OLQ.0b013e3181660c43; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; Norton TR, 2005, J APPL SOC PSYCHOL, V35, P2493, DOI 10.1111/j.1559-1816.2005.tb02112.x; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Onen NF, 2010, AIDS CARE, V22, P711, DOI 10.1080/09540120903373573; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Renner B., 2011, OXFORD HDB HLTH PSYC, P639; Renner B., 2003, Z GESUNDHEITSPSYCHOL, V11, P112, DOI DOI 10.1026//0943-8149.11.3.112; Schaller M, 2007, SYD SYM SOC PSYCHOL, P293; Schmalzle R, 2012, SOC COGN AFFECT NEUR, V7, P667, DOI 10.1093/scan/nsr039; Schmalzle R, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00043; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 2003, PSYCHOL SCI, V14, P7, DOI 10.1111/1467-9280.01411; Slovic P, 2006, CURR DIR PSYCHOL SCI, V15, P322, DOI 10.1111/j.1467-8721.2006.00461.x; Thompson SC, 1996, J APPL SOC PSYCHOL, V26, P189, DOI 10.1111/j.1559-1816.1996.tb01845.x; Thompson SC, 2002, AIDS EDUC PREV, V14, P505, DOI 10.1521/aeap.14.8.505.24115; Thompson SC, 1999, J APPL SOC PSYCHOL, V29, P1128, DOI 10.1111/j.1559-1816.1999.tb02032.x; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; UNAIDS/WHO, 2008, 0936E UNAIDSWHO; WEINSTEIN ND, 1980, J PERS SOC PSYCHOL, V39, P806, DOI 10.1037/0022-3514.39.5.806; WILLIAMS SS, 1992, J APPL SOC PSYCHOL, V22, P921, DOI 10.1111/j.1559-1816.1992.tb00934.x	42	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30460	10.1371/journal.pone.0030460	http://dx.doi.org/10.1371/journal.pone.0030460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	910LV	22291959	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600022
J	Audard, V; Pawlak, A; Candelier, M; Lang, P; Sahali, D				Audard, Vincent; Pawlak, Andre; Candelier, Marina; Lang, Philippe; Sahali, Djillali			Upregulation of Nuclear Factor-Related Kappa B Suggests a Disorder of Transcriptional Regulation in Minimal Change Nephrotic Syndrome	PLOS ONE			English	Article							CHROMATIN-REMODELING COMPLEX; OF-THE-LITERATURE; CELL ACTIVATION; AP-1; INDUCTION; PATHOGENESIS; NEPHROPATHY; EXPRESSION; HISTONE; IL-4	Immune mechanisms underlying the pathophysiology of idiopathic nephrotic syndrome, the most frequent glomerular disease in children, are believed to involve a systemic disorder of T cell function and cell mediated immunity. How these perturbations take place remains unclear. We report here that NFRKB, a member of the chromatin remodeling complex, is upregulated in MCNS relapse, mainly in CD4+T cells and B cells and undergo post-translational modifications including sumoylation. We showed that NFRKB was highly expressed in nuclear compartment during the relapse, while it was restricted to cytoplasm in remission. NFRKB induced the activation of AP1 signaling pathway by upregulating the expression of c-jun. We showed that NFRKB promotes hypomethylation of genomic DNA, suggesting its implication in regulation of gene expression by enhancing the binding of transcription factors through chromatin remodeling. These results suggest for the first time that NFRKB may be involved in the disorders of transcriptional regulation commonly observed in MCNS relapse.	[Audard, Vincent; Pawlak, Andre; Candelier, Marina; Lang, Philippe; Sahali, Djillali] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Audard, Vincent; Pawlak, Andre; Candelier, Marina; Lang, Philippe; Sahali, Djillali] Univ Paris Est, Creteil, France; [Audard, Vincent; Lang, Philippe; Sahali, Djillali] Grp Hosp Henri Mondor Albert Chenevier, AP HP, Serv Nephrol, Creteil, France; [Audard, Vincent; Lang, Philippe; Sahali, Djillali] Hop Henri Mondor, Inst Francilien Rech Nephrol & Transplantat, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Audard, V (corresponding author), Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France.	vincent.audard@hmn.aphp.fr	Pawlak, André/L-9044-2018; pawlak, andré/Q-2495-2019; Sahali, Djillali/Q-5742-2018	Pawlak, André/0000-0002-5486-212X; pawlak, andré/0000-0002-5486-212X; Sahali, Djillali/0000-0003-3663-4470; AUDARD, Vincent/0000-0001-5343-2550	Programme National de Recherche sur les maladies des reins et des voies urinaires (PNRNU, INSERM); French Kidney Foundation; Association pour l'Utilisation du Rein Artificiel (AURA)	Programme National de Recherche sur les maladies des reins et des voies urinaires (PNRNU, INSERM); French Kidney Foundation; Association pour l'Utilisation du Rein Artificiel (AURA)	This work was supported in part by the Programme National de Recherche sur les maladies des reins et des voies urinaires (PNRNU, INSERM), a grant from the French Kidney Foundation and the Association pour l'Utilisation du Rein Artificiel (AURA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Audard V, 2006, KIDNEY INT, V69, P2251, DOI 10.1038/sj.ki.5000341; Ballestar E, 2011, NAT REV RHEUMATOL, V7, P264, DOI 10.1038/nrrheum.2011.16; Berger SL, 1999, CURR OPIN CELL BIOL, V11, P336, DOI 10.1016/S0955-0674(99)80046-5; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Eddy AA, 2003, LANCET, V362, P629, DOI 10.1016/S0140-6736(03)14184-0; Elie V, 2011, PEDIAT NEPHROL; FRANCIS DA, 1995, INT IMMUNOL, V7, P151, DOI 10.1093/intimm/7.2.151; Jonsson ZO, 2004, MOL CELL, V16, P465, DOI 10.1016/j.molcel.2004.09.033; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Karras A, 2005, NEPHROL DIAL TRANSPL, V20, P1075, DOI 10.1093/ndt/gfh615; KLEMSZ MJ, 1989, J IMMUNOL, V143, P1032; Krukowski K, 2011, BRAIN BEHAV IMMUN, V25, P239, DOI 10.1016/j.bbi.2010.07.244; Liu B, 2008, CURR OPIN CELL BIOL, V20, P288, DOI 10.1016/j.ceb.2008.03.014; Llort AG, 2002, NEPHRON, V92, P950, DOI 10.1159/000065576; Mathieson PW, 2007, SEMIN IMMUNOPATHOL, V29, P415, DOI 10.1007/s00281-007-0094-z; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Murr R, 2010, ADV GENET, V70, P101, DOI [10.1016/B978-0-12-380866-0.60005-8, 10.1016/S0065-2660(10)70005-5]; Nakayama M, 2002, AM J KIDNEY DIS, V39, P503, DOI 10.1053/ajkd.2002.31400; ORMAN SV, 1986, ARCH INTERN MED, V146, P1827, DOI 10.1001/archinte.146.9.1827; Rincon Mercedes, 1997, Genes and Function, V1, P51; Sahali D, 2002, J AM SOC NEPHROL, V13, P1238, DOI 10.1681/ASN.V1351238; Sahali D, 2001, J AM SOC NEPHROL, V12, P1648, DOI 10.1681/ASN.V1281648; Saito K, 2010, J BIOCHEM, V147, P833, DOI 10.1093/jb/mvq020; SHALHOUB RJ, 1974, LANCET, V2, P556; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Smith KM, 2002, IMMUNOLOGY, V106, P144, DOI 10.1046/j.1365-2567.2002.01427.x; Valanciute A, 2004, J IMMUNOL, V172, P688, DOI 10.4049/jimmunol.172.1.688; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Zhang SY, 2011, CONTRIB NEPHROL, V169, P94, DOI 10.1159/000313947	32	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30523	10.1371/journal.pone.0030523	http://dx.doi.org/10.1371/journal.pone.0030523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291976	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600054
J	Chen, XH; Yang, JF; Gan, SZ; Yang, YF				Chen, Xuhai; Yang, Jianfeng; Gan, Shuzhen; Yang, Yufang			The Contribution of Sound Intensity in Vocal Emotion Perception: Behavioral and Electrophysiological Evidence	PLOS ONE			English	Article							THETA BAND POWER; FACIAL EXPRESSIONS; EEG; PROSODY; SYNCHRONIZATION; COMMUNICATION; APPRAISAL; PLEASANT; IMPACT; MUSIC	Although its role is frequently stressed in acoustic profile for vocal emotion, sound intensity is frequently regarded as a control parameter in neurocognitive studies of vocal emotion, leaving its role and neural underpinnings unclear. To investigate these issues, we asked participants to rate the angry level of neutral and angry prosodies before and after sound intensity modification in Experiment 1, and recorded electroencephalogram (EEG) for mismatching emotional prosodies with and without sound intensity modification and for matching emotional prosodies while participants performed emotional feature or sound intensity congruity judgment in Experiment 2. It was found that sound intensity modification had significant effect on the rating of angry level for angry prosodies, but not for neutral ones. Moreover, mismatching emotional prosodies, relative to matching ones, induced enhanced N2/P3 complex and theta band synchronization irrespective of sound intensity modification and task demands. However, mismatching emotional prosodies with reduced sound intensity showed prolonged peak latency and decreased amplitude in N2/P3 complex and smaller theta band synchronization. These findings suggest that though it cannot categorically affect emotionality conveyed in emotional prosodies, sound intensity contributes to emotional significance quantitatively, implying that sound intensity should not simply be taken as a control parameter and its unique role needs to be specified in vocal emotion studies.	[Chen, Xuhai; Yang, Jianfeng; Gan, Shuzhen; Yang, Yufang] Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Chen, Xuhai; Gan, Shuzhen] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, XH (corresponding author), Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China.	yangyf@psych.ac.cn			National Natural Science Foundation of China [31070989]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (31070989). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftanas LI, 2003, INT J PSYCHOPHYSIOL, V50, P205, DOI 10.1016/S0167-8760(03)00156-9; Aftanas LI, 2001, NEUROSCI LETT, V303, P115, DOI 10.1016/S0304-3940(01)01703-7; Audibert N, 2005, LECT NOTES COMPUT SC, V3784, P527; Bach DR, 2008, CEREB CORTEX, V18, P145, DOI 10.1093/cercor/bhm040; Bach DR, 2009, INT J PSYCHOPHYSIOL, V74, P28, DOI 10.1016/j.ijpsycho.2009.06.004; Banse R, 1996, J PERS SOC PSYCHOL, V70, P14; Banziger T, 2005, SPEECH COMMUN, V46, P52; Belin P, 1998, J NEUROSCI, V18, P6388; Breitenstein C, 2001, COGNITION EMOTION, V15, P57, DOI 10.1080/0269993004200114; Bulut M, 2008, J ACOUST SOC AM, V123, P4547, DOI 10.1121/1.2909562; Campanella S, 2002, BIOL PSYCHOL, V59, P171, DOI 10.1016/S0301-0511(02)00005-4; Cavanagh JF, 2010, NEUROIMAGE, V49, P3198, DOI 10.1016/j.neuroimage.2009.11.080; Chen XH, 2011, BIOL PSYCHOL, V86, P158, DOI 10.1016/j.biopsycho.2010.11.004; Cohen MX, 2007, NEUROIMAGE, V35, P968, DOI 10.1016/j.neuroimage.2006.11.056; Cowie R, 2003, SPEECH COMMUN, V40, P5, DOI 10.1016/S0167-6393(02)00071-7; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dien J., 2004, EVENT RELATED POTENT, P57; Ethofer T, 2009, CURR BIOL, V19, P1028, DOI 10.1016/j.cub.2009.04.054; Fuentemilla L, 2008, BRAIN RES, V1220, P93, DOI 10.1016/j.brainres.2007.07.079; Gobl C, 2003, SPEECH COMMUN, V40, P189, DOI 10.1016/S0167-6393(02)00082-1; Goydke KN, 2004, COGNITIVE BRAIN RES, V21, P351, DOI 10.1016/j.cogbrainres.2004.06.009; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; Hsiao FJ, 2009, BIOL PSYCHOL, V81, P58, DOI 10.1016/j.biopsycho.2009.01.007; Juslin PN, 2001, EMOTION, V1, P381, DOI 10.1037//1528-3542.1.4.381; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002; Knyazev GG, 2009, NEUROSCIENCE, V164, P1588, DOI 10.1016/j.neuroscience.2009.09.057; Knyazev GG, 2010, EMOTION, V10, P678, DOI 10.1037/a0019175; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kotz SA, 2007, BRAIN RES, V1151, P107, DOI 10.1016/j.brainres.2007.03.015; Lakshminarayanan K, 2003, BRAIN LANG, V84, P250, DOI 10.1016/S0093-934X(02)00516-3; Laukka P, 2005, COGNITION EMOTION, V19, P633, DOI 10.1080/02699930441000445; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel S, 2011, BIOL PSYCHOL, V87, P93, DOI 10.1016/j.biopsycho.2011.02.010; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pittam J, 1993, HDB EMOTIONS; Planalp Sally, 1998, HDB COMMUNICATION EM, P29; ROSS ED, 1986, J PHONETICS, V14, P283, DOI 10.1016/S0095-4470(19)30669-2; Sammler D, 2007, PSYCHOPHYSIOLOGY, V44, P293, DOI 10.1111/j.1469-8986.2007.00497.x; Scherer KR, 2003, SPEECH COMMUN, V40, P227, DOI 10.1016/S0167-6393(02)00084-5; Schirmer A, 2007, BRAIN RES, V1176, P103, DOI 10.1016/j.brainres.2007.08.008; SMITH CA, 1985, J PERS SOC PSYCHOL, V48, P813, DOI 10.1037/0022-3514.48.4.813; Steinhauer K, 1999, NAT NEUROSCI, V2, P191, DOI 10.1038/5757; Tajadura-Jimenez A, 2010, EMOTION, V10, P216, DOI 10.1037/a0018422; Tao JH, 2005, LECT NOTES COMPUT SC, V3784, P449; Tzur G, 2007, NEUROPSYCHOLOGIA, V45, P3122, DOI 10.1016/j.neuropsychologia.2007.05.004; Tzur G, 2009, BEHAV BRAIN RES, V198, P420, DOI 10.1016/j.bbr.2008.11.041; Yordanova J, 1998, PSYCHOPHYSIOLOGY, V35, P116, DOI 10.1111/1469-8986.3510116; Yuan JJ, 2010, NEUROSCIENCE, V169, P1758, DOI 10.1016/j.neuroscience.2010.06.024	50	10	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30278	10.1371/journal.pone.0030278	http://dx.doi.org/10.1371/journal.pone.0030278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	909NE	22291928	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600029
J	Manabe, T; Pham, TPT; Kudo, K; Vu, TTV; Takasaki, J; Tuan, ND; Co, DX; Minh, DH; Izumi, S; Binh, NG; Chau, NQ; Hanh, TT				Manabe, Toshie; Pham Thi Phuong Thuy; Kudo, Koichiro; Vu Thi Tuong Van; Takasaki, Jin; Nguyen Dang Tuan; Dao Xuan Co; Dang Hung Minh; Izumi, Shinyu; Nguyen Gia Binh; Ngo Quy Chau; Tran Thuy Hanh			Impact of Education and Network for Avian Influenza H5N1 in Human: Knowledge, Clinical Practice, and Motivation on Medical Providers in Vietnam	PLOS ONE			English	Article								Background: Knowledge, clinical practice, and professional motivation of medical providers relating to H5N1 infection have an important influence on care for H5N1 patients who require early diagnosis and early medical intervention. Methods/Principal Findings: Novel educational programs including training and workshops for medical providers relating to H5N1 infection in Vietnam were originally created and implemented in 18 provincial hospitals in northern Vietnam between 2008 and 2010. A self-administered, structured questionnaire survey was conducted in 8 provincial hospitals where both educational training and workshops were previously provided. A total of 326 medical providers, including physicians, nurses, and laboratory technicians who attended or did not attend original programs were enrolled in the survey. Knowledge, clinical attitudes and practice (KAP), including motivation surrounding caring for H5N1 patients, were evaluated. The study indicated a high level of knowledge and motivation in all professional groups, with especially high levels in laboratory technicians. Conferences and educational programs were evaluated to be the main scientific information resources for physicians, along with information from colleagues. The chest radiographs and the initiation of antiviral treatment in the absence of RT-PCR result were identified as gaps in education. Factors possibly influencing professional motivation for caring for H5N1 patients included healthcare profession, the hospital where the respondents worked, age group, attendance at original educational programs and at educational programs which were conducted by international health-related organizations. Conclusions: Educational programs provide high knowledge and motivation for medical providers in Vietnam caring for H5N1 patients. Additional educational programs related to chest radiographs and an initiation of treatment in the absence of RT-PCR are needed. Networking is also necessary for sharing updated scientific information and practical experiences. These enhanced KAPs by educational programs and integrated systems among hospitals should result in appropriate care for H5N1 patients and may reduce morbidity and mortality.	[Manabe, Toshie; Kudo, Koichiro; Takasaki, Jin; Izumi, Shinyu] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Pham Thi Phuong Thuy] NCGM BMH Med Collaborat Ctr, Hanoi, Vietnam; [Vu Thi Tuong Van; Nguyen Dang Tuan; Dao Xuan Co; Dang Hung Minh; Nguyen Gia Binh; Ngo Quy Chau; Tran Thuy Hanh] Bach Mai Hosp, Hanoi, Vietnam	National Center for Global Health & Medicine - Japan	Manabe, T (corresponding author), Natl Ctr Global Hlth & Med, Tokyo, Japan.	manabe@dcc.go.jp		Ngo, Quy Chau/0000-0002-6787-2757	Japan Initiative for Global Research Network on Infectious Diseases on the Ministry of Education, Culture, Sports, Science and Technology-Japan	Japan Initiative for Global Research Network on Infectious Diseases on the Ministry of Education, Culture, Sports, Science and Technology-Japan	The study is supported by the Japan Initiative for Global Research Network on Infectious Diseases on the Ministry of Education, Culture, Sports, Science and Technology-Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Adisasmito W, 2010, J INFECT DIS, V202, P1154, DOI 10.1086/656316; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Manabe T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023711; Shinde V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014809; WHO, 2010, CUM NUMB CONF HUM CA; World Health Organization, 2010, WKLY EPIDEMIOL REC, V86, P161	9	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30384	10.1371/journal.pone.0030384	http://dx.doi.org/10.1371/journal.pone.0030384			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291946	Green Submitted, gold, Green Published			2022-12-27	WOS:000301570600036
J	Renga, B; Mencarelli, A; D'Amore, C; Cipriani, S; D'Auria, MV; Sepe, V; Chini, MG; Monti, MC; Bifulco, G; Zampella, A; Fiorucci, S				Renga, Barbara; Mencarelli, Andrea; D'Amore, Claudio; Cipriani, Sabrina; D'Auria, Maria Valeria; Sepe, Valentina; Chini, Maria Giovanna; Monti, Maria Chiara; Bifulco, Giuseppe; Zampella, Angela; Fiorucci, Stefano			Discovery That Theonellasterol a Marine Sponge Sterol Is a Highly Selective FXR Antagonist That Protects against Liver Injury in Cholestasis	PLOS ONE			English	Article							CONSTITUTIVE ANDROSTANE RECEPTOR; NATURAL-PRODUCT GUGGULSTERONE; PREGNANE-X-RECEPTOR; NUCLEAR RECEPTORS; BILE-ACIDS; AGONISTS; BINDING; HEPATOPROTECTION; INHIBITION; ACTIVATION	Background: The farnesoid-x-receptor (FXR) is a bile acid sensor expressed in the liver and gastrointestinal tract. Despite FXR ligands are under investigation for treatment of cholestasis, a biochemical condition occurring in a number of liver diseases for which available therapies are poorly effective, mice harboring a disrupted FXR are protected against liver injury caused by bile acid overload in rodent models of cholestasis. Theonellasterol is a 4-methylene-24-ethylsteroid isolated from the marine sponge Theonella swinhoei. Here, we have characterized the activity of this theonellasterol on FXR-regulated genes and biological functions. Principal Findings: Interrogation of HepG2 cells, a human hepatocyte cell line, by microarray analysis and transactivation assay shows that theonellasterol is a selective FXR antagonist, devoid of any agonistic or antagonistic activity on a number of human nuclear receptors including the vitamin D receptor, PPARs, PXR, LXRs, progesterone, estrogen, glucorticoid and thyroid receptors, among others. Exposure of HepG2 cells to theonellasterol antagonizes the effect of natural and synthetic FXR agonists on FXR-regulated genes, including SHP, OST alpha, BSEP and MRP4. A proof-of-concept study carried out to investigate whether FXR antagonism rescues mice from liver injury caused by the ligation of the common bile duct, a model of obstructive cholestasis, demonstrated that theonellasterol attenuates injury caused by bile duct ligation as measured by assessing serum alanine aminostrasferase levels and extent of liver necrosis at histopathology. Analysis of genes involved in bile acid uptake and excretion by hepatocytes revealed that theonellasterol increases the liver expression of MRP4, a basolateral transporter that is negatively regulated by FXR. Administering bile duct ligated mice with an FXR agonist failed to rescue from liver injury and downregulated the expression of MRP4. Conclusions: FXR antagonism in vivo results in a positive modulation of MRP4 expression in the liver and is a feasible strategy to target obstructive cholestasis.	[Renga, Barbara; Mencarelli, Andrea; D'Amore, Claudio; Cipriani, Sabrina; Fiorucci, Stefano] Univ Perugia, Dipartimento Med Clin & Sperimentale, Nuova Fac Med & Chirurg, I-06100 Perugia, Italy; [D'Auria, Maria Valeria; Sepe, Valentina; Zampella, Angela] Univ Naples Federico II, Dipartimento Chim Sostanze Nat, Naples, Italy; [Chini, Maria Giovanna; Monti, Maria Chiara; Bifulco, Giuseppe] Univ Salerno, Dipartimento Sci Farmaceut & Biomed, I-84100 Salerno, Italy	University of Perugia; University of Naples Federico II; University of Salerno	Renga, B (corresponding author), Univ Perugia, Dipartimento Med Clin & Sperimentale, Nuova Fac Med & Chirurg, I-06100 Perugia, Italy.	fiorucci@unipg.it	Chini, Maria Giovanna/C-8066-2014; Bifulco, Giuseppe/A-5413-2011; D'Auria, Maria Valeria/K-2586-2012; Sepe, Valentina/F-5994-2010; Fiorucci, Stefano/I-1251-2012; Monti, Maria Chiara/A-4105-2011	Bifulco, Giuseppe/0000-0002-1788-5170; D'Auria, Maria Valeria/0000-0003-3450-7304; Monti, Maria Chiara/0000-0002-1337-2909; D'Amore, Claudio/0000-0001-9217-9404; Chini, Maria Giovanna/0000-0002-3943-5883; Zampella, Angela/0000-0002-6170-279X; Sepe, Valentina/0000-0002-0169-4441	MAREX: Exploring Marine Resources for Bioactive Compounds: From Discovery to Sustainable Production and Industrial Applications [245137]	MAREX: Exploring Marine Resources for Bioactive Compounds: From Discovery to Sustainable Production and Industrial Applications	This work was supported by grants from MAREX: Exploring Marine Resources for Bioactive Compounds: From Discovery to Sustainable Production and Industrial Applications (Call FP7-KBBE-2009-3, Project nr. 245137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akwabi-Ameyaw A, 2008, BIOORG MED CHEM LETT, V18, P4339, DOI 10.1016/j.bmcl.2008.06.073; Akwabi-Ameyaw A, 2011, BIOORG MED CHEM LETT, V21, P6154, DOI 10.1016/j.bmcl.2011.08.034; Beilke LD, 2009, DRUG METAB DISPOS, V37, P1035, DOI 10.1124/dmd.108.023317; Bobeldijk I, 2008, J CHROMATOGR B, V871, P306, DOI 10.1016/j.jchromb.2008.05.008; Bridgham JT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000497; Brobst DE, 2004, J PHARMACOL EXP THER, V310, P528, DOI 10.1124/jpet.103.064329; Burris TP, 2005, MOL PHARMACOL, V67, P948, DOI 10.1124/mol.104.007054; Carlson EE, 2010, ACS CHEM BIOL, V5, P639, DOI 10.1021/cb100105c; De Marino S, 2011, J MED CHEM, V54, P3065, DOI 10.1021/jm200169t; Downes M, 2003, MOL CELL, V11, P1079, DOI 10.1016/S1097-2765(03)00104-7; Fiorucci S, 2011, MINI-REV MED CHEM, V11, P753, DOI 10.2174/138955711796355258; Fiorucci S, 2004, GASTROENTEROLOGY, V127, P1497, DOI 10.1053/j.gastro.2004.08.001; Fiorucci S, 2009, TRENDS PHARMACOL SCI, V30, P570, DOI 10.1016/j.tips.2009.08.001; Fiorucci S, 2009, CURR OPIN GASTROEN, V25, P252, DOI 10.1097/MOG.0b013e328324f87e; Huang JG, 2011, J PHARMACEUT BIOMED, V55, P1111, DOI 10.1016/j.jpba.2011.03.035; Jonker JW, 2012, J STEROID BIOCHEM, V130, P147, DOI 10.1016/j.jsbmb.2011.06.012; KHO E, 1981, J ORG CHEM, V46, P1836, DOI 10.1021/jo00322a019; KOBAYASHI M, 1989, TETRAHEDRON LETT, V30, P2963, DOI 10.1016/S0040-4039(00)99170-6; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Liu YP, 2003, J CLIN INVEST, V112, P1678, DOI 10.1172/JCI200318945; Mennone A, 2006, HEPATOLOGY, V43, P1013, DOI 10.1002/hep.21158; Meyer U, 2005, J MED CHEM, V48, P6948, DOI 10.1021/jm0505056; Mi LZ, 2003, MOL CELL, V11, P1093, DOI 10.1016/S1097-2765(03)00112-6; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nishimura S, 2010, NAT CHEM BIOL, V6, P519, DOI [10.1038/nchembio.387, 10.1038/NCHEMBIO.387]; Owsley E, 2003, BIOCHEM BIOPH RES CO, V304, P191, DOI 10.1016/S0006-291X(03)00551-5; Renga B, 2011, BBA-GENE REGUL MECH, V1809, P157, DOI 10.1016/j.bbagrm.2011.01.008; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sepe V, 2011, J MED CHEM      1129; Soisson SM, 2008, P NATL ACAD SCI USA, V105, P5337, DOI 10.1073/pnas.0710981105; Stedman CAM, 2005, P NATL ACAD SCI USA, V102, P2063, DOI 10.1073/pnas.0409794102; Stedman C, 2006, P NATL ACAD SCI USA, V103, P11323, DOI 10.1073/pnas.0604772103; Teng S, 2007, BRIT J PHARMACOL, V151, P367, DOI 10.1038/sj.bjp.0707235; Urizar NL, 2002, SCIENCE, V296, P1703, DOI 10.1126/science.1072891; Wu J, 2002, MOL ENDOCRINOL, V16, P1590, DOI 10.1210/me.16.7.1590; Ye L, 2007, J CHROMATOGR B, V860, P10, DOI 10.1016/j.jchromb.2007.09.031	36	53	54	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30443	10.1371/journal.pone.0030443	http://dx.doi.org/10.1371/journal.pone.0030443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291955	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600043
J	Toth, K; Stratil, TF; Madsen, EB; Ye, JY; Popp, C; Antolin-Llovera, M; Grossmann, C; Jensen, ON; Schussler, A; Parniske, M; Ott, T				Toth, Katalin; Stratil, Thomas F.; Madsen, Esben B.; Ye, Juanying; Popp, Claudia; Antolin-Llovera, Meritxell; Grossmann, Christina; Jensen, Ole N.; Schuessler, Arthur; Parniske, Martin; Ott, Thomas			Functional Domain Analysis of the Remorin Protein LjSYMREM1 in Lotus japonicus	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE; HIGHLY SELECTIVE ENRICHMENT; PHOSPHORYLATED PEPTIDES; BACTERIAL-INFECTION; TITANIUM-DIOXIDE; MEMBRANE RAFTS; ROOT-NODULES; COILED-COIL; NODULATION; GENE	In legumes rhizobial infection during root nodule symbiosis (RNS) is controlled by a conserved set of receptor proteins and downstream components MtSYMREM1, a protein of the Remorin family in Medicago truncatula, was shown to interact with at least three receptor-like kinases (RLKs) that are essential for RNS. Remorins are comprised of a conserved C-terminal domain and a variable N-terminal region that defines the six different Remorin groups. While both N and C terminal regions of Remorins belonging to the same phylogenetic group are similar to each other throughout the plant kingdom, the N-terminal domains of legume-specific group 2 Remorins show exceptional high degrees of sequence divergence suggesting evolutionary specialization of this protein within this clade. We therefore identified and characterized the MtSYMREM1 ortholog from Lotus japonicus (LjSYMREM1), a model legume that forms determinate root nodules. Here, we resolved its spatio-temporal regulation and showed that over-expression of LjSYMREM1 increases nodulation on transgenic roots. Using a structure-function approach we show that protein interactions including Remorin oligomerization are mainly mediated and stabilized by the Remorin C-terminal region with its coiled-coil domain while the RLK kinase domains transiently interact in vivo and phosphoroylate a residue in the N-terminal region of the LjSYMREM1 protein in vitro. These data provide novel insights into the mechanism of this putative molecular scaffold protein and underline its importance during rhizobial infection.	[Toth, Katalin; Stratil, Thomas F.; Madsen, Esben B.; Popp, Claudia; Antolin-Llovera, Meritxell; Schuessler, Arthur; Parniske, Martin; Ott, Thomas] Univ Munich, Dept Genet, Martinsried, Germany; [Toth, Katalin] Eotvos Lorand Univ, Dept Genet, Budapest, Hungary; [Madsen, Esben B.; Grossmann, Christina] Aarhus Univ, Dept Mol Biol, Ctr Carbohydrate Recognit & Signalling, DK-8000 Aarhus, Denmark; [Ye, Juanying; Jensen, Ole N.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark	University of Munich; Eotvos Lorand University; Aarhus University; University of Southern Denmark	Toth, K (corresponding author), Univ Munich, Dept Genet, Martinsried, Germany.	Thomas.Ott@biologie.uni-muenchen.de	Parniske, Martin/M-3781-2019; Schüßler, Arthur/F-1681-2011; Ott, Thomas/G-7056-2011; Parniske, Martin/F-2202-2011; Ott, Thomas/H-8192-2013; Jensen, Ole N/J-1763-2012	Parniske, Martin/0000-0001-8561-747X; Parniske, Martin/0000-0001-8561-747X; Ott, Thomas/0000-0002-4494-9811; Jensen, Ole N/0000-0003-1862-8528; Popp, Claudia/0000-0003-1482-7909	Deutsche Forschungsgemeinschaft (DFG) [OT423/2-1, SPP1212, Pa493/5-1]; Bayerisches Hochschulzentrum fur Mittel-, Ost- und Sudosteuropa; German Academic Exchange Service; Danish Research Council "Plant Phosphoproteomics"; Danish National Research Foundation; LMU Exzellenz-Initiative [ZUK 22/1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bayerisches Hochschulzentrum fur Mittel-, Ost- und Sudosteuropa; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Danish Research Council "Plant Phosphoproteomics"; Danish National Research Foundation(Danmarks Grundforskningsfond); LMU Exzellenz-Initiative	This work is supported by the Deutsche Forschungsgemeinschaft (DFG) (www.dfg.de)in frame of an Emmy-Noether grant (TO, project OT423/2-1) and of the Priority Program SPP1212 PlantMicro (Pa493/5-1; MA-L and MP) of the DFG. Two consecutive research fellowships to KT provided by the Bayerisches Hochschulzentrum fur Mittel-, Ost- und Sudosteuropa and the German Academic Exchange Service. JY and OJ were supported by a grant from the Danish Research Council "Plant Phosphoproteomics" and CG was funded by the Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Jessica Folgmann and Karl-Heinz Braun for their excellent technical assistance. Entry clones were kindly provided by Jens Stougaard (University of Aarhus, Denmark). We would also like to acknowledge Riyaz A. Bhat (CEA/CNRS/Mediterranean University Aix-Marseille, Cadarache, France) for providing the vectors p35S-GW-Cerulean-nos and p35S-GW-mOrange-nos. Furthermore we would also like to thank Zsuzsanna Buzas (University of Budapest, Hungary) for providing the empty yeast split-ubiquitin vectors and for her scientific support of the project. We also thank the LMU Exzellenz-Initiative that kindly funded the FLIM-FRET equipment (grant ZUK 22/1).	Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Bariola PA, 2004, PLANT MOL BIOL, V55, P579, DOI 10.1007/s11103-004-1520-4; Bayle V, 2008, PLANT PHYSIOL, V148, P51, DOI 10.1104/pp.108.117358; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bersoult A, 2005, MOL PLANT MICROBE IN, V18, P869, DOI 10.1094/MPMI-18-0869; Colebatch G, 2004, PLANT J, V39, P487, DOI 10.1111/j.1365-313X.2004.02150.x; FARMER EE, 1991, J BIOL CHEM, V266, P3140; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; Gage DJ, 2002, J BACTERIOL, V184, P7042, DOI 10.1128/JB.184.24.7042-7046.2002; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Haney CH, 2010, P NATL ACAD SCI USA, V107, P478, DOI 10.1073/pnas.0910081107; Haney CH, 2011, PLANT CELL; HEIDSTRA R, 1994, PLANT PHYSIOL, V105, P787, DOI 10.1104/pp.105.3.787; Hogslund N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006556; Jarsch IK, 2011, MOL PLANT MICROBE IN, V24, P7, DOI 10.1094/MPMI-07-10-0166; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Kistner C, 2005, PLANT CELL, V17, P2217, DOI 10.1105/tpc.105.032714; Koushik SV, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940367; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lefebvre B, 2007, PLANT PHYSIOL, V144, P402, DOI 10.1104/pp.106.094102; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; Limpens E, 2005, P NATL ACAD SCI USA, V102, P10375, DOI 10.1073/pnas.0504284102; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Lombari P, 2005, LOTUS JAPONICUS HDB; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Madsen EB, 2011, PLANT J, V65, P404, DOI 10.1111/j.1365-313X.2010.04431.x; Madsen LH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1009; Maekawa T, 2008, MOL PLANT MICROBE IN, V21, P375, DOI 10.1094/MPMI-21-4-0375; Mbengue M, 2010, PLANT CELL, V22, P3474, DOI 10.1105/tpc.110.075861; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Popp C, 2011, CURR OPIN PLANT BIOL, V14, P458, DOI 10.1016/j.pbi.2011.03.016; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; Raffaele S, 2007, PLANT PHYSIOL, V145, P593, DOI 10.1104/pp.107.108639; Raffaele S, 2009, PLANT CELL, V21, P1541, DOI 10.1105/tpc.108.064279; Rairdan GJ, 2008, PLANT CELL, V20, P739, DOI 10.1105/tpc.107.056036; Reymond P, 1996, PLANT CELL, V8, P2265, DOI 10.1105/tpc.8.12.2265; Skirpan AL, 2001, PLANT PHYSIOL, V126, P1480, DOI 10.1104/pp.126.4.1480; Smit P, 2007, PLANT PHYSIOL, V145, P183, DOI 10.1104/pp.107.100495; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; STOUGAARD J, 1987, P NATL ACAD SCI USA, V84, P5754, DOI 10.1073/pnas.84.16.5754; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Widjaja I, 2009, PROTEOMICS, V9, P138, DOI 10.1002/pmic.200800293; Ye JY, 2010, J PROTEOME RES, V9, P3561, DOI 10.1021/pr100075x	45	67	70	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30817	10.1371/journal.pone.0030817	http://dx.doi.org/10.1371/journal.pone.0030817			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292047	gold, Green Published, Green Submitted			2022-12-27	WOS:000301570600083
J	Li, AL; Song, YX; Wang, ZN; Gao, P; Miao, Y; Zhu, JL; Yue, ZY; Xu, HM				Li, Ai-Lin; Song, Yong-Xi; Wang, Zhen-Ning; Gao, Peng; Miao, Yuan; Zhu, Jin-Liang; Yue, Zhen-Yu; Xu, Hui-Mian			Polymorphisms and a Haplotype in Heparanase Gene Associations with the Progression and Prognosis of Gastric Cancer in a Northern Chinese Population	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PARAFFIN-EMBEDDED TISSUE; MALDI-TOF MS; MESSENGER-RNA; EXPRESSION; RISK; SUSCEPTIBILITY; EPIDEMIOLOGY; DNA; METASTASIS	Background: Human heparanase plays an important role in cancer development and single nucleotide polymorphisms (SNPs) in the heparanase gene (HPSE) have been shown to be correlated with gastric cancer. The present study examined the associations between individual SNPs or haplotypes in HPSE and susceptibility, clinicopathological parameters and prognosis of gastric cancer in a large sample of the Han population in northern China. Methodology/Principal Findings: Genomic DNA was extracted from formalin-fixed, paraffin-embedded normal gastric tissue samples from 404 patients and from blood from 404 healthy controls. Six SNPs were genotyped by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. A chi-square (chi 2) test and unconditional logistic regression were used to analyze the risk of gastric cancer; a Log-rank test and Cox proportional hazards model were used to produce survival analysis and a Kaplan-Meier method was used to map survival curves. The mean genotyping success rates were more than 99% in both groups. Haplotype CA in the block composed of rs11099592 and rs4693608 had a greater distribution in the group of Borrmann types 3 and 4 (P = 0.037), the group of a greater number of lymph node metastases (N3 vs N0 group, P = 0.046), and moreover was correlated to poor survival (CG vs CA: HR = 0.645, 95%CI: 0.421-0.989, P = 0.044). In addition, genotypes rs4693608 AA and rs4364254 TT were associated with poor survival (P = 0.030, HR = 1.527, 95%CI: 1.042-2.238 for rs4693608 AA; P = 0.013, HR = 1.546, 95%CI: 1.096-2.181 for rs4364254 TT). There were no correlations between individual SNPs or haplotypes and gastric cancer risk. Conclusions/Significance: A functional haplotype in HPSE was found, which included the important SNP rs4693608. SNPs in HPSE play an important role in gastric cancer progression and survival, and perhaps may be a molecular marker for prognosis and treatment values.	[Li, Ai-Lin; Song, Yong-Xi; Wang, Zhen-Ning; Gao, Peng; Zhu, Jin-Liang; Yue, Zhen-Yu; Xu, Hui-Mian] China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China; [Li, Ai-Lin] China Med Univ, Hosp 1, Dept Radiotherapy, Shenyang, Peoples R China; [Miao, Yuan] China Med Univ, Hosp 1, Dept Pathol, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Wang, ZN (corresponding author), China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China.	josieon826@yahoo.com.cn	wang, zhen ning/E-1878-2011; Miao, Yuan/AAG-9754-2021; yue, zhenyu/GRF-4856-2022; Gao, Peng/B-8031-2013	wang, zhen ning/0000-0003-0557-3097; 	National Science Foundation of China [30972879, 81172370]; Specialized Research Fund for the Doctoral Program of Higher Education [200801590006]; Natural Science Foundation of Liaoning Province [20092129]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was supported by the National Science Foundation of China (No. 30972879 and No. 81172370), a Specialized Research Fund for the Doctoral Program of Higher Education (No. 200801590006) and the Natural Science Foundation of Liaoning Province (No. 20092129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bernig T, 2006, EXPERT REV MOL DIAGN, V6, P319, DOI 10.1586/14737159.6.3.319; Bonnen PE, 2002, GENOME RES, V12, P1846, DOI 10.1101/gr.483802; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Cannon-Albright LA, 2011, BMC RES NOTES, P4; Chanock S, 2003, SEMIN HEMATOL, V40, P321, DOI 10.1016/S0037-1963(03)00198-7; Chen JQ, 2004, WORLD J GASTROENTERO, V10, P776; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Endo K, 2001, ANTICANCER RES, V21, P3365; Friedmann Y, 2000, AM J PATHOL, V157, P1167, DOI 10.1016/S0002-9440(10)64632-9; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gilbert MTP, 2007, ELECTROPHORESIS, V28, P2361, DOI 10.1002/elps.200600589; Hagleitner MM, 2011, PEDIATR BLOOD CANCER, V56, P35, DOI 10.1002/pbc.22654; Hennig G, 2010, CLIN CHEM, V56, P1845, DOI 10.1373/clinchem.2010.151233; Horn H, 2010, PHARMACOGENET GENOM, V20, P598, DOI 10.1097/FPC.0b013e32833deb16; Jaremko M, 2005, HUM MUTAT, V25, P232, DOI 10.1002/humu.20141; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Justenhoven C, 2004, CANCER EPIDEM BIOMAR, V13, P2059; Krejs GJ, 2010, DIGEST DIS, V28, P600, DOI 10.1159/000320277; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Levy-Adam F, 2008, PLOS ONE, P3; Lips EH, 2005, CANCER RES, V65, P10188, DOI 10.1158/0008-5472.CAN-05-2486; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Nasser NJ, 2008, CELL MOL LIFE SCI, V65, P1706, DOI 10.1007/s00018-008-7584-6; Ohkawa T, 2004, LAB INVEST, V84, P1289, DOI 10.1038/labinvest.3700159; Ostrovsky O, 2007, LEUKEMIA, V21, P2296, DOI 10.1038/sj.leu.2404821; Ostrovsky O, 2007, ACTA HAEMATOL-BASEL, V117, P57, DOI 10.1159/000096790; Ostrovsky O, 2010, BLOOD, V115, P2319, DOI 10.1182/blood-2009-08-236455; Ostrovsky O, 2009, J LEUKOCYTE BIOL, V86, P445, DOI 10.1189/jlb.1208735; Overdevest JB, 2009, CLIN CHEM, V55, P684, DOI 10.1373/clinchem.2008.118554; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Pusch W, 2002, PHARMACOGENOMICS, V3, P537, DOI 10.1517/14622416.3.4.537; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Ralph S, 2007, CANCER SCI, V98, P844, DOI 10.1111/j.1349-7006.2007.00461.x; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Sun T, 2006, CLIN CANCER RES, V12, P7009, DOI 10.1158/1078-0432.CCR-06-0464; Tregouet DA, 2004, EUR J HUM GENET, V12, P971, DOI 10.1038/sj.ejhg.5201238; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vlodavsky I, 2008, CONNECT TISSUE RES, V49, P207, DOI 10.1080/03008200802143281; Wang ZN, 2005, J SURG ONCOL, V90, P59, DOI 10.1002/jso.20250; Wang ZN, 2005, MODERN PATHOL, V18, P205, DOI 10.1038/modpathol.3800282; Winter PC, 2008, LEUKEMIA, V22, P1629, DOI 10.1038/leu.2008.36; Xu YY, 2009, ASIAN PAC J CANCER P, V10, P151; Yin M, 2009, AM J TRANSL RES, V1, P44; Yue ZY, 2010, J SURG ONCOL, V102, P68, DOI 10.1002/jso.21584; Zhou H, 2011, PLOS ONE, P6	48	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30277	10.1371/journal.pone.0030277	http://dx.doi.org/10.1371/journal.pone.0030277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276173	Green Published, gold, Green Submitted			2022-12-27	WOS:000301568100031
J	Martinaud, O; Pouliquen, D; Gerardin, E; Loubeyre, M; Hirsbein, D; Hannequin, D; Cohen, L				Martinaud, Olivier; Pouliquen, Dorothee; Gerardin, Emmanuel; Loubeyre, Maud; Hirsbein, David; Hannequin, Didier; Cohen, Laurent			Visual Agnosia and Posterior Cerebral Artery Infarcts: An Anatomical-Clinical Study	PLOS ONE			English	Article							FUSIFORM FACE AREA; PURE TOPOGRAPHICAL DISORIENTATION; WORD FORM AREA; OBJECT RECOGNITION; TERRITORY INFARCTS; NEURAL BASIS; PARAHIPPOCAMPAL; CORTEX; PROSOPAGNOSIA; DISSOCIATIONS	Background: To evaluate systematically the cognitive deficits following posterior cerebral artery (PCA) strokes, especially agnosic visual disorders, and to study anatomical-clinical correlations. Methods and Findings: We investigated 31 patients at the chronic stage (mean duration of 29.1 months post infarct) with standardized cognitive tests. New experimental tests were used to assess visual impairments for words, faces, houses, and objects. Forty-one healthy subjects participated as controls. Brain lesions were normalized, combined, and related to occipitotemporal areas responsive to specific visual categories, including words (VWFA), faces (FFA and OFA), houses (PPA) and common objects (LOC). Lesions were located in the left hemisphere in 15 patients, in the right in 13, and bilaterally in 3. Visual field defects were found in 23 patients. Twenty patients had a visual disorder in at least one of the experimental tests (9 with faces, 10 with houses, 7 with phones, 3 with words). Six patients had a deficit just for a single category of stimulus. The regions of maximum overlap of brain lesions associated with a deficit for a given category of stimuli were contiguous to the peaks of the corresponding functional areas as identified in normal subjects. However, the strength of anatomical-clinical correlations was greater for words than for faces or houses, probably due to the stronger lateralization of the VWFA, as compared to the FFA or the PPA. Conclusions: Agnosic visual disorders following PCA infarcts are more frequent than previously reported. Dedicated batteries of tests, such as those developed here, are required to identify such deficits, which may escape clinical notice. The spatial relationships of lesions and of regions activated in normal subjects predict the nature of the deficits, although individual variability and bilaterally represented systems may blur those correlations.	[Martinaud, Olivier; Pouliquen, Dorothee; Loubeyre, Maud; Hannequin, Didier] Rouen Univ Hosp, Dept Neurol, Rouen, France; [Martinaud, Olivier; Cohen, Laurent] GH Pitie Salpetriere, CRICM, INSERM, UMR S 975, Paris, France; [Martinaud, Olivier; Cohen, Laurent] Univ Paris 06, Fac Med Pitie Salpetriere, Paris, France; [Gerardin, Emmanuel] Rouen Univ Hosp, Dept Neuroradiol, Rouen, France; [Hirsbein, David] Rouen Univ Hosp, Dept Ophthalmol, Rouen, France; [Hannequin, Didier] Fac Med & Pharm, IFRMP, INSERM, U614, Rouen, France; [Cohen, Laurent] Hop La Pitie Salpetriere, AP HP, Dept Neurol, Paris, France	CHU de Rouen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Rouen; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Martinaud, O (corresponding author), Rouen Univ Hosp, Dept Neurol, Rouen, France.	olivier.martinaud@chu-rouen.fr	Martinaud, Olivier/AAS-9307-2020	cohen, laurent/0000-0002-5010-9085				Agniel A, 1992, PROTOCOLE MONTREAL T; Aguirre GK, 1999, BRAIN, V122, P1613, DOI 10.1093/brain/122.9.1613; Baddeley A.D., 1994, DOORS PEOPLE TEST TE; Barrash J, 1998, J CLIN EXP NEUROPSYC, V20, P807, DOI 10.1076/jcen.20.6.807.1114; Barrash J, 2000, NEUROPSYCHOLOGIA, V38, P820, DOI 10.1016/S0028-3932(99)00131-1; Barton JJS, 2008, NEUROPSYCHOLOGIA, V46, P2214, DOI 10.1016/j.neuropsychologia.2008.02.014; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Benton A., 1983, CONTRIBUTION NEUROPS; BENTON AL, 1978, ARCH NEUROL-CHICAGO, V35, P364, DOI 10.1001/archneur.1978.00500300038006; BINDER JR, 1992, BRAIN, V115, P1807, DOI 10.1093/brain/115.6.1807; BRANDT T, 1995, NERVENARZT, V66, P267; Busigny T, 2010, NEUROPSYCHOLOGIA, V48, P2051, DOI 10.1016/j.neuropsychologia.2010.03.026; Cai Q, 2010, CEREB CORTEX, V20, P1153, DOI 10.1093/cercor/bhp175; Cals N, 2002, J NEUROL, V249, P855, DOI 10.1007/s00415-002-0742-0; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2004, NEUROIMAGE, V23, P1256, DOI 10.1016/j.neuroimage.2004.07.052; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Crawford JR, 2005, NEUROPSYCHOLOGY, V19, P664, DOI 10.1037/0894-4105.19.5.664; DAMASIO AR, 1983, NEUROLOGY, V33, P1573, DOI 10.1212/WNL.33.12.1573; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Deloche G., 1997, DO80; DERENZI E, 1986, NEUROPSYCHOLOGIA, V24, P385; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Dien J, 2009, NEUROPSYCHOLOGIA, V47, P1, DOI 10.1016/j.neuropsychologia.2008.08.024; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Downing PE, 2007, J NEUROSCI, V27, P226, DOI 10.1523/JNEUROSCI.3619-06.2007; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Duchaine B, 2005, J COGNITIVE NEUROSCI, V17, P249, DOI 10.1162/0898929053124857; Duchaine BC, 2003, NEUROCASE, V9, P380, DOI 10.1076/neur.9.5.380.16556; Duchaine BC, 2003, NEUROPSYCHOLOGIA, V41, P713, DOI 10.1016/S0028-3932(02)00222-1; Duchaine BC, 2003, PERCEPTION, V32, P827, DOI 10.1068/p5067; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Epstein R, 2001, COGNITIVE NEUROPSYCH, V18, P481, DOI 10.1080/02643290125929; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Epstein RA, 2007, J NEUROSCI, V27, P6141, DOI 10.1523/JNEUROSCI.0799-07.2007; Farah M., 2004, VISUAL AGNOSIA, V2nd; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Garrido L, 2008, J NEUROPSYCHOL, V2, P119, DOI 10.1348/174866407X246843; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Gilaie-Dotan S, 2007, CEREB CORTEX, V17, P325, DOI 10.1093/cercor/bhj150; Golarai G, 2007, NAT NEUROSCI, V10, P512, DOI 10.1038/nn1865; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; HABIB M, 1987, CORTEX, V23, P73, DOI 10.1016/S0010-9452(87)80020-5; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; HECAEN H, 1980, CORTEX, V16, P525, DOI 10.1016/S0010-9452(80)80001-3; Henry C, 2005, NEUROPSYCHOLOGIA, V43, P1983, DOI 10.1016/j.neuropsychologia.2005.04.007; Ishai A, 2002, NEUROIMAGE, V17, P1729, DOI 10.1006/nimg.2002.1330; Ishai A, 2005, BRAIN RES BULL, V67, P87, DOI 10.1016/j.brainresbull.2005.05.027; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kumral E, 2004, EUR J NEUROL, V11, P237, DOI 10.1046/j.1468-1331.2003.00750.x; Leff AP, 2006, J NEUROL NEUROSUR PS, V77, P1004, DOI 10.1136/jnnp.2005.086983; Leff AP, 2001, BRAIN, V124, P510, DOI 10.1093/brain/124.3.510; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Mendez MF, 2003, NEUROPSYCHOLOGIA, V41, P1387, DOI 10.1016/S0028-3932(03)00041-1; MILANDRE L, 1994, REV NEUROL-FRANCE, V150, P133; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park S, 2009, NEUROIMAGE, V47, P1747, DOI 10.1016/j.neuroimage.2009.04.058; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; PESSIN MS, 1987, ANN NEUROL, V21, P290, DOI 10.1002/ana.410210311; Pflugshaupt T, 2009, BRAIN, V132, P1907, DOI 10.1093/brain/awp141; Pourtois G, 2005, J COGNITIVE NEUROSCI, V17, P1043, DOI 10.1162/0898929054475181; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; Rhodes G, 2004, J COGNITIVE NEUROSCI, V16, P189, DOI 10.1162/089892904322984508; Riddoch M. J., 1993, BORB BIRMINGHAM OBJE; Rossion B, 2003, BRAIN, V126, P2381, DOI 10.1093/brain/awg241; Servan J, 1992, CEREBROVASC DIS; Sewards TV, 2011, NEUROPSYCHOLOGIA, V49, P277, DOI 10.1016/j.neuropsychologia.2010.11.018; Sivan A.B., 1992, BENTON VISUAL RETENT; Takahashi N, 2002, CORTEX, V38, P717, DOI 10.1016/S0010-9452(08)70039-X; Tatu L, 1998, NEUROLOGY, V50, P1699, DOI 10.1212/WNL.50.6.1699; Van der Linden M, 2004, EVALUATION TROUBLES, P25; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; Warrington E.K., 1984, RECOGNITION MEMORY T; Wechsler D., 1997, WECHSLER ADULT INTEL; Yamamoto Y, 1999, ARCH NEUROL-CHICAGO, V56, P824, DOI 10.1001/archneur.56.7.824	85	26	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30433	10.1371/journal.pone.0030433	http://dx.doi.org/10.1371/journal.pone.0030433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276198	Green Submitted, Green Published, gold			2022-12-27	WOS:000301568100047
J	Elsaesser, O; Leiter, U; Buettner, PG; Eigentler, TK; Meier, F; Weide, B; Metzler, G; Breuninger, H; Garbe, C				Elsaesser, Otmar; Leiter, Ulrike; Buettner, Petra G.; Eigentler, Thomas K.; Meier, Friedegund; Weide, Benjamin; Metzler, Gisela; Breuninger, Helmut; Garbe, Claus			Prognosis of Sentinel Node Staged Patients with Primary Cutaneous Melanoma	PLOS ONE			English	Article							LYMPH-NODES; BIOPSY; RECURRENCE; PATTERNS; LYMPHADENECTOMY; EXPERIENCE	Background: This study investigated survival probabilities and prognostic factors in sentinel lymph node biopsy (SLNB) staged patients with cutaneous melanoma (CM) with the aim of defining subgroups of patients who are at higher risk for recurrences and who should be considered for adjuvant clinical trials. Methods: Patients with primary CM who underwent SLNB in the Department of Dermatology, University of Tuebingen, Germany, between 1996 and 2009 were included into this study. Survival probabilities and prognostic factors were evaluated by Kaplan-Meier and multivariate Cox proportional hazard models. Results: 1909 SLNB staged patients were evaluated. Median follow-up time was 44 months. Median tumor thickness was 1.8 mm, ulceration was present in 31.8% of cases. The 5-year Overall Survival (OS) was 90.3% in SLNB negative patients (IB 96.2%, IIA 87.0%, IIB 78.1%, IIC 72.6%). Patients with micrometastases (stage IIIA/B) had a 5-year OS rate of 70.9% which was clearly less favorable than for stages I-II. Multivariate analysis revealed tumor thickness, ulceration, body site, histopathologic subtype and SLNB status as independent significant prognostic factors. Conclusion: Survival rates of patients with primary CM in stages I-II were shown to be much more favorable than previously reported from non sentinel node staged collectives. For future clinical trials, sample size calculations should be adapted using survival probabilities based on sentinel node staging.	[Elsaesser, Otmar; Leiter, Ulrike; Eigentler, Thomas K.; Meier, Friedegund; Weide, Benjamin; Metzler, Gisela; Breuninger, Helmut; Garbe, Claus] Univ Tubingen, Ctr Dermatooncol, Dept Dermatol, Tubingen, Germany; [Elsaesser, Otmar; Leiter, Ulrike; Eigentler, Thomas K.; Meier, Friedegund; Weide, Benjamin; Metzler, Gisela; Breuninger, Helmut; Garbe, Claus] Univ Tubingen, Cent Malignant Melanoma Registry, German Dermatol Soc, Tubingen, Germany; [Buettner, Petra G.; Garbe, Claus] James Cook Univ, Skin Canc Res Grp, Sch Publ Hlth & Trop Med, Townsville, Qld 4811, Australia	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; James Cook University	Elsaesser, O (corresponding author), Univ Tubingen, Ctr Dermatooncol, Dept Dermatol, Tubingen, Germany.	ulrike.leiter@med.uni-tuebingen.de	Weide, Benjamin/N-3698-2013; Garbe, Claus/ABH-2128-2021; Eigentler, Thomas/K-8570-2015	Garbe, Claus/0000-0001-8530-780X; Eigentler, Thomas/0000-0003-0019-2770; Leiter, Ulrike/0000-0002-8019-1577				Balch CM, 2010, J CLIN ONCOL, V28, P2452, DOI 10.1200/JCO.2009.27.1627; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balch CM, 2009, J AM ACAD DERMATOL, V60, P872, DOI 10.1016/j.jaad.2008.09.067; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Cascinelli N, 2000, ANN SURG ONCOL, V7, P469, DOI 10.1007/s10434-000-0469-z; Chao C, 2002, AM J SURG, V184, P520, DOI 10.1016/S0002-9610(02)01102-9; Essner R, 1999, ANN SURG ONCOL, V6, P442, DOI 10.1007/s10434-999-0442-4; Gadd MA, 1999, ARCH SURG-CHICAGO, V134, P381, DOI 10.1001/archsurg.134.4.381; Garbe C, 2002, RECENT RESULTS CANC, V160, P205; Gershenwald JE, 1998, J CLIN ONCOL, V16, P2253, DOI 10.1200/JCO.1998.16.6.2253; Kunte C, 2010, MELANOMA RES, V20, P330, DOI 10.1097/CMR.0b013e32833ba9ff; Mandala M, 2009, EUR J CANCER, V45, P2537, DOI 10.1016/j.ejca.2009.05.034; McMasters KM, 2001, SURGERY, V130, P151, DOI 10.1067/msy.2001.115830; Morton DL, 2005, ANN SURG, V242, P302, DOI 10.1097/01.sla.0000181092.50141.fa; Morton Donald L, 2008, Nat Clin Pract Oncol, V5, P510, DOI 10.1038/ncponc1205; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Nowecki ZI, 2003, MELANOMA RES, V13, P35, DOI 10.1097/00008390-200302000-00007; Phan GQ, 2009, CANCER CONTROL, V16, P234, DOI 10.1177/107327480901600305; van der Ploeg APT, 2011, J CLIN ONCOL, V29, P2206, DOI 10.1200/JCO.2010.31.6760; Wagner JD, 2000, PLAST RECONSTR SURG, V105, P1774, DOI 10.1097/00006534-200004050-00028; Yee VSK, 2005, ANN SURG ONCOL, V12, P429, DOI 10.1245/ASO.2005.03.074; Zogakis TG, 2005, ARCH SURG-CHICAGO, V140, P865, DOI 10.1001/archsurg.140.9.865	22	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29791	10.1371/journal.pone.0029791	http://dx.doi.org/10.1371/journal.pone.0029791			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276129	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000301457200023
J	Addessi, E; Borgi, M; Palagi, E				Addessi, Elsa; Borgi, Marta; Palagi, Elisabetta			Is Primatology an Equal-Opportunity Discipline?	PLOS ONE			English	Article							GENDER-DIFFERENCES; WOMENS UNDERREPRESENTATION; SCIENCE; FEMALE; PUBLICATION; OUTPUT; INDEX; BIAS	The proportion of women occupying academic positions in biological sciences has increased in the past few decades, but women are still under-represented in senior academic ranks compared to their male colleagues. Primatology has been often singled out as a model of "equal-opportunity'' discipline because of the common perception that women are more represented in Primatology than in similar fields. But is this indeed true? Here we show that, although in the past 15 years the proportion of female primatologists increased from the 38% of the early 1990s to the 57% of 2008, Primatology is far from being an "equal-opportunity'' discipline, and suffers the phenomenon of "glass ceiling'' as all the other scientific disciplines examined so far. In fact, even if Primatology does attract more female students than males, at the full professor level male members significantly outnumber females. Moreover, regardless of position, IPS male members publish significantly more than their female colleagues. Furthermore, when analyzing gender difference in scientific productivity in relation to the name order in the publications, it emerged that the scientific achievements of female primatologists (in terms of number and type of publications) do not always match their professional achievements (in terms of academic position). However, the gender difference in the IPS members' number of publications does not correspond to a similar difference in their scientific impact (as measured by their H index), which may indicate that female primatologists' fewer articles are of higher impact than those of their male colleagues.	[Addessi, Elsa; Palagi, Elisabetta] CNR, Ist Sci & Tecnol Cogniz, Unita Primatol Cognitiva, Rome, Italy; [Palagi, Elisabetta] Univ Pisa, Ctr Interdipartimentale Museo Storia Nat & Terr, Pisa, Italy; [Borgi, Marta] Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University of Pisa; Istituto Superiore di Sanita (ISS)	Addessi, E (corresponding author), CNR, Ist Sci & Tecnol Cogniz, Unita Primatol Cognitiva, Rome, Italy.	elsa.addessi@istc.cnr.it; betta.palagi@museo.unipi.it	Addessi, Elsa/B-8329-2015; Borgi, Marta/J-9249-2016	Addessi, Elsa/0000-0002-5553-7732; Borgi, Marta/0000-0001-7496-6383				Bornmann L, 2007, J INFORMETR, V1, P226, DOI 10.1016/j.joi.2007.03.001; Burrelli J, 2008, 08308 NSF DIV SCI RE; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Ceci SJ, 2009, PSYCHOL BULL, V135, P218, DOI 10.1037/a0014412; *COMM GEND DIFF CA, 2009, GEND DIFF CRIT TRANS; Costas R, 2007, J INFORMETR, V1, P193, DOI 10.1016/j.joi.2007.02.001; Crangle CE, 2009, NATURE, V459, P774, DOI 10.1038/459774c; Cyranoski D, 2001, NATURE, V410, P404, DOI 10.1038/35068702; Ding WW, 2006, SCIENCE, V313, P665, DOI 10.1126/science.1124832; Ecklund EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022590; European Commission Directorate General for Research, 2009, 23856 EUR DIR GEN RE; Fedigan L. M., 1997, WOMEN HUMAN EVOLUTIO, P56; Fedigan LM, 2001, WOMEN CULTURE SOC, P46; FEDIGAN LM, 1994, AM ANTHROPOL, V96, P529, DOI 10.1525/aa.1994.96.3.02a00050; Haraway Donna, 1986, FEMINIST APPROACHES, P77; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hrdy S. B., 1986, FEMINIST APPROACHES, P119; Ledin A, 2007, EMBO REP, V8, P982, DOI 10.1038/sj.embor.7401109; Marsh H.W., 2009, NATURE, V459, P602; Marsh HW, 2008, AM PSYCHOL, V63, P160, DOI 10.1037/0003-066X.63.3.160; Martinez ED, 2007, EMBO REP, V8, P977, DOI 10.1038/sj.embor.7401110; National Science Foundation Division of Science Resources Statistics, 2003, 03322 NSF DIV SCI RE; Noble Brian E., 2000, P436; Nusslein-Volhard C, 2008, CURR BIOL, V18, pR185, DOI 10.1016/j.cub.2008.01.052; Penas CS, 2006, J INF SCI, V32, P480, DOI 10.1177/0165551506066058; Steinpreis RE, 1999, SEX ROLES, V41, P509, DOI 10.1023/A:1018839203698; Strum S. C., 1999, NEW PHYS ANTHR, P67; Symonds MRE, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000127; Trix F, 2003, DISCOURSE SOC, V14, P191, DOI 10.1177/0957926503014002277; Turner TR, 2002, AM J PHYS ANTHROPOL, V118, P111, DOI 10.1002/ajpa.10062; Wenneras C, 1997, NATURE, V387, P341, DOI 10.1038/387341a0; Wilson E K, 2001, Trends Cell Biol, V11, P453, DOI 10.1016/S0962-8924(01)02182-1; Yamamoto MEE, 2000, PRIMATOL BRASIL, V7, P349; 2008, NATURE, V451, P865	34	16	17	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30458	10.1371/journal.pone.0030458	http://dx.doi.org/10.1371/journal.pone.0030458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	907XU	22272353	Green Submitted, Green Published, gold			2022-12-27	WOS:000301454400131
J	Adetifa, IMO; Antonio, M; Okoromah, CAN; Ebruke, C; Inem, V; Nsekpong, D; Bojang, A; Adegbola, RA				Adetifa, Ifedayo M. O.; Antonio, Martin; Okoromah, Christy A. N.; Ebruke, Chinelo; Inem, Victor; Nsekpong, David; Bojang, Abdoulie; Adegbola, Richard A.			Pre-Vaccination Nasopharyngeal Pneumococcal Carriage in a Nigerian Population: Epidemiology and Population Biology	PLOS ONE			English	Article							RESISTANT STREPTOCOCCUS-PNEUMONIAE; ACUTE OTITIS-MEDIA; RISK-FACTORS; SUSCEPTIBILITY PATTERNS; HAEMOPHILUS-INFLUENZAE; INVASIVE DISEASE; ANTIBIOTIC-RESISTANCE; SEROTYPE DISTRIBUTION; CONJUGATE VACCINE; CHILDREN	Background: Introduction of pneumococcal vaccines in Nigeria is a priority as part of the Accelerated Vaccine Introduction Initiative (AVI) of the Global Alliance for Vaccines and Immunisation (GAVI). However, country data on the burden of pneumococcal disease (IPD) is limited and coverage by available conjugate vaccines is unknown. This study was carried out to describe the pre vaccination epidemiology and population biology of pneumococcal carriage in Nigeria. Methods: This was a cross sectional survey. Nasopharyngeal swabs (NPS) were obtained from a population sample in 14 contiguous peri-urban Nigerian communities. Data on demographic characteristics and risk factor for carriage were obtained from all study participants. Pneumococci isolated from NPS were characterised by serotyping, antimicrobial susceptibility and Multi Locus Sequencing Typing (MLST). Results: The prevalence of pneumococcal carriage was 52.5%. Carriage was higher in children compared to adults (67.4% vs. 26%), highest (approximate to 90%) in infants aged <9 months and reduced significantly with increasing age (P<0.001). Serotypes 19F (18.6%) and 6A (14.4%) were most predominant. Potential vaccine coverage was 43.8%, 45.0% and 62% for PCV-7, PCV-10 and PCV-13 respectively. There were 16 novel alleles, 72 different sequence types (STs) from the isolates and 3 Sequence Types (280, 310 and 5543) were associated with isolates of more than one serotype indicative of serotype switching. Antimicrobial resistance was high for cotrimoxazole (93%) and tetracycline (84%), a third of isolates had intermediate resistance to penicillin. Young age was the only risk factor significantly associated with carriage. Conclusions: Pneumococcal carriage and serotype diversity is highly prevalent in Nigeria especially in infants. Based on the coverage of serotypes in this study, PCV-13 is the obvious choice to reduce disease burden and prevalence of drug resistant pneumococci. However, its use will require careful monitoring. Our findings provide sound baseline data for impact assessment following vaccine introduction in Nigeria.	[Adetifa, Ifedayo M. O.; Antonio, Martin; Ebruke, Chinelo; Nsekpong, David; Bojang, Abdoulie; Adegbola, Richard A.] Med Res Council MRC Unit, Fajara, Gambia; [Okoromah, Christy A. N.] Univ Lagos, Coll Med, Dept Paediat & Child Hlth, Lagos, Nigeria; [Inem, Victor] Univ Lagos, Coll Med, Dept Community Hlth & Primary Care, Lagos, Nigeria	University of London; London School of Hygiene & Tropical Medicine; University of Lagos; University of Lagos	Adetifa, IMO (corresponding author), Med Res Council MRC Unit, Fajara, Gambia.	iadetifa@mrc.gm; radegbola@hotmail.com		OKOROMAH, CHRISTY/0000-0001-9623-604X	International Society for Infectious Diseases (ISID); Medical Research Council (UK); European and Developing Countries Clinical Trials Partnership Career Development Fellowship [CG_ta_2005_40203_001]; MRC [MC_U190081991, MC_U190074190] Funding Source: UKRI; Medical Research Council [MC_U190074190, MC_U190081991] Funding Source: researchfish	International Society for Infectious Diseases (ISID); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European and Developing Countries Clinical Trials Partnership Career Development Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by an International Society for Infectious Diseases (ISID) Small Grant to IMOA (Spring 2008), a Medical Research Council (UK) Intramural funding to RAA and MA. IMOA also received support from a European and Developing Countries Clinical Trials Partnership Career Development Fellowship (grant number CG_ta_2005_40203_001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2006, TROP MED INT HEALTH, V11, P1128, DOI 10.1111/j.1365-3156.2006.01652.x; Akanbi MO, 2009, AFR J RESPIR MED, P10; Antonio M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-81; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; BLOCK SL, 1995, PEDIATR INFECT DIS J, V14, P751, DOI 10.1097/00006454-199509000-00005; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Boken DJ, 1996, PEDIATR INFECT DIS J, V15, P667, DOI 10.1097/00006454-199608000-00006; Dagan R, 2002, J INFECT DIS, V185, P927, DOI 10.1086/339525; Department of Infectious Disease Epidemiology IC, EBURSTV3; Dheda K, 2007, J INFECTION, V55, P169, DOI 10.1016/j.jinf.2007.02.005; Donkor ES, 2010, SCAND J INFECT DIS, V42, P254, DOI 10.3109/00365540903490000; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; Falade AG, 2009, CLIN INFECT DIS, V48, pS190, DOI 10.1086/596500; Farrell DJ, 2007, PEDIATR INFECT DIS J, V26, P123, DOI 10.1097/01.inf.0000253059.84602.c3; Feikin DR, 2003, PEDIATR INFECT DIS J, V22, P564, DOI 10.1097/00006454-200306000-00016; Gertz RE, 2003, J CLIN MICROBIOL, V41, P4194, DOI 10.1128/JCM.41.9.4194-4216.2003; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Greenberg D, 2006, CLIN INFECT DIS, V42, P897, DOI 10.1086/500935; Guillemot D, 1998, JAMA-J AM MED ASSOC, V279, P365, DOI 10.1001/jama.279.5.365; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Jain A, 2005, TROP MED INT HEALTH, V10, P234, DOI 10.1111/j.1365-3156.2004.01379.x; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Joloba ML, 2001, INT J ANTIMICROB AG, V17, P395, DOI 10.1016/S0924-8579(00)00345-9; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Lynch JP, 2010, CURR OPIN PULM MED, V16, P217, DOI 10.1097/MCP.0b013e3283385653; Marchisio P, 2002, EMERG INFECT DIS, V8, P479; Melnick N, 2010, J CLIN MICROBIOL, V48, P2311, DOI 10.1128/JCM.00410-10; Mudhune S, 2009, CLIN INFECT DIS, V48, pS147, DOI 10.1086/596494; Nwachukwu NOA, 2008, AFRICAN J RESP M SEP, V16; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; ONYEMELUKWE GC, 1982, J INFECTION, V5, P157, DOI 10.1016/S0163-4453(82)91772-8; OYEDEJI G A, 1985, Nigerian Journal of Paediatrics, V12, P111; Principi N, 1999, PEDIATR INFECT DIS J, V18, P517, DOI 10.1097/00006454-199906000-00008; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rivera-Olivero IA, 2007, CLIN INFECT DIS, V45, P1427, DOI 10.1086/522984; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Russell FM, 2006, ANN TROP PAEDIATR, V26, P187, DOI 10.1179/146532806X120273; Saha SK, 2003, J CLIN MICROBIOL, V41, P5582, DOI 10.1128/JCM.41.12.5582-5587.2003; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; SILVERMAN M, 1977, ARCH DIS CHILD, V52, P925, DOI 10.1136/adc.52.12.925; Soewignjo S, 2001, CLIN INFECT DIS, V32, P1039, DOI 10.1086/319605; Syrjanen RK, 2005, PEDIATR INFECT DIS J, V24, P801, DOI 10.1097/01.inf.0000178072.83531.4f; UNICEF W. H. O, 2006, PNEUM FORG KILL CHIL; Ussery XT, 1996, PEDIATR INFECT DIS J, V15, P986, DOI 10.1097/00006454-199611000-00011; WHO, 2007, WORLD HLTH STAT; WHO, 2008, INT MAN CHILDH ILLN; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	54	60	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30548	10.1371/journal.pone.0030548	http://dx.doi.org/10.1371/journal.pone.0030548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291984	Green Submitted, Green Published, gold			2022-12-27	WOS:000301639600032
J	Bronmark, C; Lakowitz, T; Nilsson, PA; Ahlgren, J; Lennartsdotter, C; Hollander, J				Bronmark, Christer; Lakowitz, Thomas; Nilsson, P. Anders; Ahlgren, Johan; Lennartsdotter, Charlotte; Hollander, Johan			Costs of Inducible Defence along a Resource Gradient	PLOS ONE			English	Article							FRESH-WATER SNAIL; PHENOTYPIC PLASTICITY; LIFE-HISTORY; TRAIT COMPENSATION; SHELL MORPHOLOGY; TRADE-OFF; PREDATORS; EVOLUTION; BEHAVIOR; GROWTH	In addition to having constitutive defence traits, many organisms also respond to predation by phenotypic plasticity. In order for plasticity to be adaptive, induced defences should incur a benefit to the organism in, for example, decreased risk of predation. However, the production of defence traits may include costs in fitness components such as growth, time to reproduction, or fecundity. To test the hypothesis that the expression of phenotypic plasticity incurs costs, we performed a common garden experiment with a freshwater snail, Radix balthica, a species known to change morphology in the presence of molluscivorous fish. We measured a number of predator-induced morphological and behavioural defence traits in snails that we reared in the presence or absence of chemical cues from fish. Further, we quantified the costs of plasticity in fitness characters related to fecundity and growth. Since plastic responses may be inhibited under limited resource conditions, we reared snails in different densities and thereby levels of competition. Snails exposed to predator cues grew rounder and thicker shells, traits confirmed to be adaptive in environments with fish. Defence traits were consistently expressed independent of density, suggesting strong selection from predatory molluscivorous fish. However, the expression of defence traits resulted in reduced growth rate and fecundity, particularly with limited resources. Our results suggest full defence in predator related traits regardless of resource availability, and costs of defence consequently paid in traits related to fitness.	[Bronmark, Christer; Lakowitz, Thomas; Nilsson, P. Anders; Ahlgren, Johan; Lennartsdotter, Charlotte; Hollander, Johan] Lund Univ, Dept Biol, Lund, Sweden	Lund University	Bronmark, C (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Johan.Hollander@biol.lu.se	Ahlgren, Johan/C-3021-2011; Nilsson, Anders/H-6836-2014	Ahlgren, Johan/0000-0002-6506-289X; Nilsson, Anders/0000-0002-3541-9835; Hollander, Johan/0000-0002-4207-2956	Swedish Research Council; Formas; Marie Curie European Reintegration Grant	Swedish Research Council(Swedish Research CouncilEuropean Commission); Formas(Swedish Research Council Formas); Marie Curie European Reintegration Grant(European Commission)	The study was supported by grants from the Swedish Research Council (to CB), Formas (to PAN) and the Marie Curie European Reintegration Grant (to JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JE, 1991, OECOLOGIA, V87, P435, DOI 10.1007/BF00634603; Aloi JE, 1991, VERH INTERNAT VEREIN, V24, P2936; ANHOLT BR, 1995, ECOLOGY, V76, P2230, DOI 10.2307/1941696; Arnold SJ, 1999, EVOLUTION, V53, P1516, DOI 10.1111/j.1558-5646.1999.tb05415.x; Bernot RJ, 2001, OECOLOGIA, V129, P139, DOI 10.1007/s004420100705; BRONMARK C, 1989, J MOLLUS STUD, V55, P299, DOI 10.1093/mollus/55.2.299; Bronmark C, 2011, PLOS ONE IN PRESS; Cross WF, 2002, OIKOS, V96, P251, DOI 10.1034/j.1600-0706.2002.960207.x; CROWL TA, 1990, SCIENCE, V247, P949, DOI 10.1126/science.247.4945.949; DeWitt TJ, 1999, ANIM BEHAV, V58, P397, DOI 10.1006/anbe.1999.1158; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; DeWitt TJ, 2000, EVOL ECOL RES, V2, P129; GOMULKIEWICZ R, 1992, EVOLUTION, V46, P390, DOI [10.2307/2409860, 10.1111/j.1558-5646.1992.tb02047.x]; HARVELL CD, 1990, Q REV BIOL, V65, P323, DOI 10.1086/416841; Hoverman JT, 2005, OECOLOGIA, V144, P481, DOI 10.1007/s00442-005-0082-8; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Kawata M, 2005, HYDROBIOLOGIA, V533, P229, DOI 10.1007/s10750-004-2740-y; Koperski P, 1998, FRESHWATER BIOL, V39, P317, DOI 10.1046/j.1365-2427.1998.00282.x; LaFiandra EM, 2004, OECOLOGIA, V138, P350, DOI 10.1007/s00442-003-1412-3; Lakowitz T, 2008, FRESHWATER BIOL, V53, P2184, DOI 10.1111/j.1365-2427.2008.02045.x; Laurila A, 1998, OIKOS, V83, P307, DOI 10.2307/3546842; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Luttbeg B, 2003, ECOLOGY, V84, P1140, DOI 10.1890/0012-9658(2003)084[1140:PSAEDA]2.0.CO;2; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; OSENBERG CW, 1989, ECOL MONOGR, V59, P405, DOI 10.2307/1943074; Phillips P.C., 1998, H2BOOT BOOTSTRAP EST; Quinn GP, 2003, EXPT DESIGN DATA ANA; Relyea RA, 2002, AM NAT, V159, P272, DOI 10.1086/338540; Relyea RA, 2004, ECOLOGY, V85, P172, DOI 10.1890/03-0169; Relyea RA, 2003, OECOLOGIA, V134, P596, DOI 10.1007/s00442-002-1161-8; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Relyea RA, 2007, OECOLOGIA, V152, P389, DOI 10.1007/s00442-007-0675-5; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Rundle SD, 2001, P ROY SOC B-BIOL SCI, V268, P1463, DOI 10.1098/rspb.2001.1682; Scheiner SM, 1998, EVOLUTION, V52, P368, DOI 10.1111/j.1558-5646.1998.tb01638.x; Steiner UK, 2007, OECOLOGIA, V152, P201, DOI 10.1007/s00442-006-0645-3; Steiner UK, 2007, AM NAT, V169, P118, DOI 10.1086/509939; Teplitsky C, 2007, ECOLOGY, V88, P1641, DOI 10.1890/06-1703.1; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Turner AM, 2004, OIKOS, V104, P561, DOI 10.1111/j.0030-1299.2004.12615.x; Turner AM, 1996, ANIM BEHAV, V51, P747, DOI 10.1006/anbe.1996.0079; Van Buskirk J, 2000, ECOLOGY, V81, P2813, DOI 10.1890/0012-9658(2000)081[2813:TCOAID]2.0.CO;2; Van Buskirk J, 2000, J EVOLUTION BIOL, V13, P336; Van Buskirk J, 2009, J EVOLUTION BIOL, V22, P852, DOI 10.1111/j.1420-9101.2009.01685.x; Van Buskirk J, 1998, OIKOS, V82, P20; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537	49	17	17	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30467	10.1371/journal.pone.0030467	http://dx.doi.org/10.1371/journal.pone.0030467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291961	Green Submitted, gold, Green Published			2022-12-27	WOS:000301639600024
J	Cerone, L; Neufeld, Z				Cerone, Luca; Neufeld, Zoltan			Differential Gene Expression Regulated by Oscillatory Transcription Factors	PLOS ONE			English	Article							INCOHERENT FEEDFORWARD LOOP; FOLD-CHANGE DETECTION; NETWORK MOTIFS; DYNAMICS; TIME	Cells respond to changes in the internal and external environment by a complex regulatory system whose end-point is the activation of transcription factors controlling the expression of a pool of ad-hoc genes. Recent experiments have shown that certain stimuli may trigger oscillations in the concentration of transcription factors such as NF-kappa B and p53 influencing the final outcome of the genetic response. In this study we investigate the role of oscillations in the case of three different well known gene regulatory mechanisms using mathematical models based on ordinary differential equations and numerical simulations. We considered the cases of direct regulation, two-step regulation and feed-forward loops, and characterized their response to oscillatory input signals both analytically and numerically. We show that in the case of indirect two-step regulation the expression of genes can be turned on or off in a frequency dependent manner, and that feed-forward loops are also able to selectively respond to the temporal profile of oscillating transcription factors.	[Cerone, Luca; Neufeld, Zoltan] Univ Coll Dublin, Sch Math Sci, Dublin 2, Ireland; [Cerone, Luca; Neufeld, Zoltan] Univ Coll Dublin, Complex & Adapt Syst Lab, Dublin 2, Ireland; [Neufeld, Zoltan] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia	University College Dublin; University College Dublin; University of Queensland	Cerone, L (corresponding author), Univ Coll Dublin, Sch Math Sci, Dublin 2, Ireland.	luca.cerone@ucd.ie	Neufeld, Zoltan/C-3008-2011	Neufeld, Zoltan/0000-0003-3236-9278; Cerone, Luca/0000-0003-2902-9416	Irish Research Council for Science, Engineering and Technology	Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and Technology)	L.C. was supported by the Irish Research Council for Science, Engineering and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U., 2007, INTRO SYSTEMS BIOL; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Aulehla A, 2008, CURR OPIN CELL BIOL, V20, P632, DOI 10.1016/j.ceb.2008.09.002; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Cournac A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-29; Csikasz-Nagy A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.73; Dolmetsch R, 1994, ANNU REV GENET, V28, P373; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Iqbal J, 2008, BIOCHEM BIOPH RES CO, V371, P906, DOI 10.1016/j.bbrc.2008.03.113; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kalir S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100010; Kaplan S, 2008, MOL SYSTEMS BIOL, V4; Kruse K, 2005, CURR OPIN CELL BIOL, V17, P20, DOI 10.1016/j.ceb.2004.12.007; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Maeda YT, 2006, J MOL BIOL, V359, P1107, DOI 10.1016/j.jmb.2006.03.064; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Paszek P, 2010, CURRENT OPINION GENE; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Shoval O, 2010, P NATL ACAD SCI USA, V107, P15995, DOI 10.1073/pnas.1002352107; Sun L, 2008, BIOCHEM BIOPH RES CO, V371, P912, DOI 10.1016/j.bbrc.2008.03.112; Sun L, 2008, BIOCHEM BIOPH RES CO, V371, P900, DOI 10.1016/j.bbrc.2008.03.114; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Tay S, 2010, NATURE; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457	34	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30283	10.1371/journal.pone.0030283	http://dx.doi.org/10.1371/journal.pone.0030283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291930	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600010
J	Chun, RF; Peercy, BE; Adams, JS; Hewison, M				Chun, Rene F.; Peercy, Bradford E.; Adams, John S.; Hewison, Martin			Vitamin D Binding Protein and Monocyte Response to 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D: Analysis by Mathematical Modeling	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN MAMMARY CELLS; D-RECEPTOR; SERUM; METABOLISM; LIGAND; D-3; MITOCHONDRIAL; ACTIVATION; EXPRESSION	Vitamin D binding protein (DBP) plays a key role in the bioavailability of active 1,25-dihydroxyvitamin D (1,25(OH)(2)D) and its precursor 25-hydroxyvitamin D (25OHD), but accurate analysis of DBP-bound and free 25OHD and 1,25(OH)(2)D is difficult. To address this, two new mathematical models were developed to estimate: 1) serum levels of free 25OHD/1,25(OH)(2)D based on DBP concentration and genotype; 2) the impact of DBP on the biological activity of 25OHD/1,25(OH)(2)D in vivo. The initial extracellular steady state (eSS) model predicted that 50 nM 25OHD and 100 pM 1,25(OH)(2)D),<0.1% 25OHD and <1.5% 1,25(OH)(2)D are 'free' in vivo. However, for any given concentration of total 25OHD, levels of free 25OHD are higher for low affinity versus high affinity forms of DBP. The eSS model was then combined with an intracellular (iSS) model that incorporated conversion of 25OHD to 1,25(OH)(2)D via the enzyme CYP27B1, as well as binding of 1,25(OH)(2)D to the vitamin D receptor (VDR). The iSS model was optimized to 25OHD/1,25(OH)(2)D-mediated in vitro dose-responsive induction of the vitamin D target gene cathelicidin (CAMP) in human monocytes. The iSS model was then used to predict vitamin D activity in vivo (100% serum). The predicted induction of CAMP in vivo was minimal at basal settings but increased with enhanced expression of VDR (5-fold) and CYP27B1 (10-fold). Consistent with the eSS model, the iSS model predicted stronger responses to 25OHD for low affinity forms of DBP. Finally, the iSS model was used to compare the efficiency of endogenously synthesized versus exogenously added 1,25(OH)(2)D. Data strongly support the endogenous model as the most viable mode for CAMP induction by vitamin D in vivo. These novel mathematical models underline the importance of DBP as a determinant of vitamin D 'status' in vivo, with future implications for clinical studies of vitamin D status and supplementation.	[Chun, Rene F.; Adams, John S.; Hewison, Martin] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Chun, Rene F.; Adams, John S.; Hewison, Martin] Orthoped Hosp, Dept Orthoped Surg, Los Angeles, CA 90007 USA; [Chun, Rene F.; Adams, John S.; Hewison, Martin] Orthoped Hosp, Res Ctr, Los Angeles, CA USA; Univ Maryland Baltimore Cty, Dept Math & Stat, Baltimore, MD USA	University of California System; University of California Los Angeles; University System of Maryland; University of Maryland Baltimore County	Chun, RF (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.	rchun@mednet.ucla.edu	Adams, John S/I-3365-2013; Chun, Rene/A-9415-2010	Adams, John S/0000-0001-9607-5020; Chun, Rene/0000-0002-0190-0807	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000124] Funding Source: Medline; NCRR NIH HHS [UL1 RR033176] Funding Source: Medline; NIAID NIH HHS [P30 AI028697] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; ARNAUD J, 1993, HUM GENET, V92, P183; BIKLE DD, 1989, ENDOCRINOLOGY, V124, P649, DOI 10.1210/endo-124-2-649; BIKLE DD, 1985, J CLIN ENDOCR METAB, V61, P969, DOI 10.1210/jcem-61-5-969; BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954, DOI 10.1210/jcem-63-4-954; Carlberg C, 2009, ANTICANCER RES, V29, P3485; Chlon TM, 2008, J NUTR, V138, P1323, DOI 10.1093/jn/138.7.1323; Chun RF, 2010, J CLIN ENDOCR METAB, V95, P3368, DOI 10.1210/jc.2010-0195; DUNN JF, 1988, ANN NY ACAD SCI, V538, P69; EIL C, 1981, P NATL ACAD SCI-BIOL, V78, P2562, DOI 10.1073/pnas.78.4.2562; Eto TA, 1998, ANAL BIOCHEM, V258, P53, DOI 10.1006/abio.1998.2567; FELDMAN H, 1972, ANAL BIOCHEM, V45, P530, DOI 10.1016/0003-2697(72)90216-3; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Hammond GL, 2002, OBSTET GYN CLIN N AM, V29, P411, DOI 10.1016/S0889-8545(02)00008-6; Hewison M, 2003, J IMMUNOL, V170, P5382, DOI 10.4049/jimmunol.170.11.5382; HEWISON M, 1994, J IMMUNOL, V153, P5709; Hewison M, 2010, MOL CELL ENDOCRINOL, V321, P103, DOI 10.1016/j.mce.2010.02.013; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; KAMBOH MI, 1986, HUM GENET, V72, P281, DOI 10.1007/BF00290950; Krombach F, 1997, ENVIRON HEALTH PERSP, V105, P1261, DOI 10.2307/3433544; Krutzik SR, 2008, J IMMUNOL, V181, P7115, DOI 10.4049/jimmunol.181.10.7115; Lauridsen AL, 2001, CLIN CHEM, V47, P753; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Lou YR, 2010, J STEROID BIOCHEM, V118, P162, DOI 10.1016/j.jsbmb.2009.11.011; MENDEL CM, 1989, ENDOCR REV, V10, P232, DOI 10.1210/edrv-10-3-232; Nelson CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015469; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Nykjaer A, 2001, P NATL ACAD SCI USA, V98, P13895, DOI 10.1073/pnas.241516998; Pike JW, 2011, VITAMIN D, P97; Powe CE, 2011, J BONE MINER RES, V26, P1609, DOI 10.1002/jbmr.387; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; Ren SY, 2005, J BIOL CHEM, V280, P20604, DOI 10.1074/jbc.M414522200; Ross AC, 2011, J AM DIET ASSOC, V111, P524, DOI 10.1016/j.jada.2011.01.004; Rowling MJ, 2006, J NUTR, V136, P2754, DOI 10.1093/jn/136.11.2754; Sakaki T, 2005, FRONT BIOSCI, V10, P119; Spina CS, 2006, ANTICANCER RES, V26, P2515; Tang EKY, 2010, J STEROID BIOCHEM, V119, P171, DOI 10.1016/j.jsbmb.2010.02.022; Toell A, 2000, BIOCHEM J, V352, P301, DOI 10.1042/0264-6021:3520301; Tsuji RF, 2003, CLIN EXP ALLERGY, V33, P249, DOI 10.1046/j.1365-2222.2003.01575.x; Urushino N, 2006, BIOCHEMISTRY-US, V45, P4405, DOI 10.1021/bi060072o; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; VIETH R, 1979, J BIOL CHEM, V254, P2455; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; White P, 2002, J IMMUNOL, V168, P869, DOI 10.4049/jimmunol.168.2.869; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888	50	79	80	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30773	10.1371/journal.pone.0030773	http://dx.doi.org/10.1371/journal.pone.0030773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292037	Green Submitted, Green Published, gold			2022-12-27	WOS:000301639600054
J	Takeuchi, H; Sugiura, M; Sassa, Y; Sekiguchi, A; Yomogida, Y; Taki, Y; Kawashima, R				Takeuchi, Hikaru; Sugiura, Motoaki; Sassa, Yuko; Sekiguchi, Atsushi; Yomogida, Yukihito; Taki, Yasuyuki; Kawashima, Ryuta			Neural Correlates of the Difference between Working Memory Speed and Simple Sensorimotor Speed: An fMRI Study	PLOS ONE			English	Article							ADULT AGE-DIFFERENCES; STRUCTURAL BRAIN VARIATION; INTELLIGENCE; BACK; CONSTRAINTS; MEDIATION; COGNITION; NETWORKS	The difference between the speed of simple cognitive processes and the speed of complex cognitive processes has various psychological correlates. However, the neural correlates of this difference have not yet been investigated. In this study, we focused on working memory (WM) for typical complex cognitive processes. Functional magnetic resonance imaging data were acquired during the performance of an N-back task, which is a measure of WM for typical complex cognitive processes. In our N-back task, task speed and memory load were varied to identify the neural correlates responsible for the difference between the speed of simple cognitive processes (estimated from the 0-back task) and the speed of WM. Our findings showed that this difference was characterized by the increased activation in the right dorsolateral prefrontal cortex (DLPFC) and the increased functional interaction between the right DLPFC and right superior parietal lobe. Furthermore, the local gray matter volume of the right DLPFC was correlated with participants' accuracy during fast WM tasks, which in turn correlated with a psychometric measure of participants' intelligence. Our findings indicate that the right DLPFC and its related network are responsible for the execution of the fast cognitive processes involved in WM. Identified neural bases may underlie the psychometric differences between the speed with which subjects perform simple cognitive tasks and the speed with which subjects perform more complex cognitive tasks, and explain the previous traditional psychological findings.	[Takeuchi, Hikaru; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 980, Japan; [Sugiura, Motoaki; Sekiguchi, Atsushi; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan; [Sassa, Yuko; Taki, Yasuyuki; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Div Dev Cognit Neurosci, Sendai, Miyagi 980, Japan; [Yomogida, Yukihito] Japan Soc Promot Sci, Tokyo, Japan; [Yomogida, Yukihito] Tamagawa Univ, Brain Sci Inst, Tokyo, Japan	Tohoku University; Tohoku University; Tohoku University; Japan Society for the Promotion of Science	Takeuchi, H (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 980, Japan.	takehi@idac.tohoku.ac.jp	Takeuchi, Hikaru/D-1057-2011	Takeuchi, Hikaru/0000-0002-8022-9694; Yomogida, Yukihito/0000-0001-5026-4440	JST/RISTEX; JST/CREST; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [KAKENHI 18680026]; 21st Century Center of Excellence (COE) (MEXT); A Strategic Research and Education Center for an Integrated Approach	JST/RISTEX(Japan Science & Technology Agency (JST)); JST/CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 21st Century Center of Excellence (COE) (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); A Strategic Research and Education Center for an Integrated Approach	This study was supported by JST/RISTEX, JST/CREST, a Grant-in-Aid for Young Scientists (A) (KAKENHI 18680026) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), and the 21st Century Center of Excellence (COE) Program (MEXT), "A Strategic Research and Education Center for an Integrated Approach to Language and Cognition" (Tohoku University). No particular numbers exist unless specified. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A. D, 1986, WORKING MEMORY; BORS DA, 1995, INTELLIGENCE, V20, P229, DOI 10.1016/0160-2896(95)90009-8; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Diedrichsen J, 2005, NEUROIMAGE, V27, P624, DOI 10.1016/j.neuroimage.2005.04.039; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fry AF, 2000, BIOL PSYCHOL, V54, P1, DOI 10.1016/S0301-0511(00)00051-X; Gaser C., 2007, VBM TOOLBOX SPM2 VBM; Good CD, 2000, NEUROIMAGE, P11; Gu XS, 2007, NEUROIMAGE, V36, P256, DOI 10.1016/j.neuroimage.2007.02.025; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; Haier RJ, 2005, COGN AFFECT BEHAV NE, V5, P246, DOI 10.3758/CABN.5.2.246; Jansma JM, 2000, NEUROIMAGE, V12, P688, DOI 10.1006/nimg.2000.0645; Jensen, 1987, SPEED INFORMATION PR, P74; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; LARSON GE, 1988, INTELLIGENCE, V12, P131, DOI 10.1016/0160-2896(88)90012-8; Loose R, 2006, BRAIN RES, V1090, P146, DOI 10.1016/j.brainres.2006.03.039; May CP, 1998, J EXP PSYCHOL HUMAN, V24, P363, DOI 10.1037/0096-1523.24.2.363; Menon V, 2000, NEUROIMAGE, V12, P357, DOI 10.1006/nimg.2000.0613; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Peelle JE, 2004, BRAIN LANG, V91, P315, DOI 10.1016/j.bandl.2004.05.007; Pochon JB, 2002, P NATL ACAD SCI USA, V99, P5669, DOI 10.1073/pnas.082111099; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; SALTHOUSE TA, 1993, DEV PSYCHOL, V29, P722, DOI 10.1037/0012-1649.29.4.722; SALTHOUSE TA, 1991, PSYCHOL SCI, V2, P179, DOI 10.1111/j.1467-9280.1991.tb00127.x; SALTHOUSE TA, 1992, DEV PSYCHOL, V28, P905, DOI 10.1037/0012-1649.28.5.905; SALTHOUSE TA, 1994, DEV PSYCHOL, V30, P240, DOI 10.1037/0012-1649.30.2.240; Song M, 2008, NEUROIMAGE, V41, P1168, DOI 10.1016/j.neuroimage.2008.02.036; Takeuchi H, 2010, REV NEUROSCIENCE, V21, P427; Thomason ME, 2008, NEUROIMAGE, V41, P1493, DOI 10.1016/j.neuroimage.2008.03.029; Tisserand DJ, 2003, CORTEX, V39, P1107, DOI 10.1016/S0010-9452(08)70880-3; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; van Veen V, 2008, J COGNITIVE NEUROSCI, V20, P1952, DOI 10.1162/jocn.2008.20146; Vernon PA, 1987, SPEED INFORMATION PR, P1	39	20	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30579	10.1371/journal.pone.0030579	http://dx.doi.org/10.1371/journal.pone.0030579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291992	gold, Green Submitted, Green Published			2022-12-27	WOS:000301570600062
J	Bragado, P; Estrada, Y; Sosa, MS; Avivar-Valderas, A; Cannan, D; Genden, E; Teng, M; Ranganathan, AC; Wen, HC; Kapoor, A; Bernstein, E; Aguirre-Ghiso, JA				Bragado, Paloma; Estrada, Yeriel; Sosa, Maria Soledad; Avivar-Valderas, Alvaro; Cannan, David; Genden, Eric; Teng, Marita; Ranganathan, Aparna C.; Wen, Huei-Chi; Kapoor, Avnish; Bernstein, Emily; Aguirre-Ghiso, Julio A.			Analysis of Marker-Defined HNSCC Subpopulations Reveals a Dynamic Regulation of Tumor Initiating Properties	PLOS ONE			English	Article							CANCER STEM-CELLS; ALDEHYDE DEHYDROGENASE; HUMAN CARCINOMA; UROKINASE RECEPTOR; MELANOMA-CELLS; IN-VIVO; CHROMATIN-STRUCTURE; SELF-RENEWAL; COLON-CANCER; GROWTH	Head and neck squamous carcinoma (HNSCC) tumors carry dismal long-term prognosis and the role of tumor initiating cells (TICs) in this cancer is unclear. We investigated in HNSCC xenografts whether specific tumor subpopulations contributed to tumor growth. We used a CFSE-based label retentions assay, CD49f (alpha 6-integrin) surface levels and aldehyde dehydrogenase (ALDH) activity to profile HNSCC subpopulations. The tumorigenic potential of marker-positive and -negative subpopulations was tested in nude (Balb/c nu/nu) and NSG (NOD.Cg-Prkdc(scid) Il2rg(tm1Wjl)/SzJ) mice and chicken embryo chorioallantoic membrane (CAM) assays. Here we identified in HEp3, SQ20b and FaDu HNSCC xenografts a subpopulation of G0/G1-arrested slow-cycling CD49f(high)/ALDH1A1(high)/H3K4/K27me3(low) subpopulation (CD49f+) of tumor cells. A strikingly similar CD49f(high)/H3K27me3(low) subpopulation is also present in primary human HNSCC tumors and metastases. While only sorted CD49f(high)/ALDH(high), label retaining cells (LRC) proliferated immediately in vivo, with time the CD49f(low)/ALDH(low), non-LRC (NLRC) tumor cell subpopulations were also able to regain tumorigenic capacity; this was linked to restoration of CD49f(high)/ALDH(high), label retaining cells. In addition, CD49f is required for HEp3 cell tumorigenicity and to maintain low levels of H3K4/K27me3. CD49f+ cells also displayed reduced expression of the histone-lysine N-methyltransferase EZH2 and ERK1/2phosphorylation. This suggests that although transiently quiescent, their unique chromatin structure is poised for rapid transcriptional activation. CD49f- cells can "reprogram" and also achieve this state eventually. We propose that in HNSCC tumors, epigenetic mechanisms likely driven by CD49f signaling dynamically regulate HNSCC xenograft phenotypic heterogeneity. This allows multiple tumor cell subpopulations to drive tumor growth suggesting that their dynamic nature renders them a "moving target" and their eradication might require more persistent strategies.	[Bragado, Paloma; Estrada, Yeriel; Sosa, Maria Soledad; Avivar-Valderas, Alvaro; Wen, Huei-Chi; Aguirre-Ghiso, Julio A.] Mt Sinai Sch Med, Div Hematol & Oncol, Dept Med, New York, NY 10029 USA; [Bragado, Paloma; Estrada, Yeriel; Sosa, Maria Soledad; Avivar-Valderas, Alvaro; Cannan, David; Genden, Eric; Teng, Marita; Ranganathan, Aparna C.; Aguirre-Ghiso, Julio A.] Mt Sinai Sch Med, Dept Otolaryngol, New York, NY USA; [Kapoor, Avnish; Bernstein, Emily] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA; [Kapoor, Avnish; Bernstein, Emily] Mt Sinai Sch Med, Dept Dermatol, New York, NY USA; [Bernstein, Emily; Aguirre-Ghiso, Julio A.] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Bernstein, Emily; Aguirre-Ghiso, Julio A.] Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Bragado, P (corresponding author), Mt Sinai Sch Med, Div Hematol & Oncol, Dept Med, New York, NY 10029 USA.	julio.aguirre-ghiso@mssm.edu	Wen, Huei-Chi/ABD-7417-2021; Bragado Domingo, Paloma/A-8679-2015	Bragado Domingo, Paloma/0000-0002-7642-1245; Aguirre-Ghiso, Julio/0000-0002-6694-6507	National Institutes of Health-Nactional Cancer Institute [5R24CA095823-04]; National Science Fundation [DBI-9724504]; National Institutes of Health [1 S10RR0 9145-01]; Samuel Waxman Cancer Research Foundation; National Cancer Institute [CA109182]; national institute of environmental Health Science [ES017146]; New York State Stem cell Science (NYSTEM); NYSTEM IDEA [C024285]; National Institute of Dental and Craneofacial Research [DE020121]; NATIONAL CANCER INSTITUTE [R24CA095823, R01CA109182] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE020121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017146] Funding Source: NIH RePORTER	National Institutes of Health-Nactional Cancer Institute; National Science Fundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samuel Waxman Cancer Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); national institute of environmental Health Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); New York State Stem cell Science (NYSTEM); NYSTEM IDEA; National Institute of Dental and Craneofacial Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Confocal laser scanning microscopy was performed at the Mount Sinai School of medicine-Microscopy Shared Resources Facility, supported with funding from National Institutes of Health-Nactional Cancer Institute shared resources grant (5R24CA095823-04), National Science Fundation Major Research Instrumentation grant (DBI-9724504) and National Institutes of Health shared instrumentation grant (1 S10RR0 9145-01). This work was supported by grants from the Samuel Waxman Cancer Research Foundation Tumor Dormancy Program, National Cancer Institute (CA109182), national institute of environmental Health Science (ES017146) and New York State Stem cell Science (NYSTEM) to J.A.A-G, NYSTEM IDEA Award C024285 to E. B., and National Institute of Dental and Craneofacial Research (DE020121 to A.C.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2008, CANCER RES, V68, P4018, DOI 10.1158/0008-5472.CAN-07-6334; Aguirre-Ghiso JA, 2004, CANCER RES, V64, P7336, DOI 10.1158/0008-5472.CAN-04-0113; Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863; Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brummendorf TH, 1998, J EXP MED, V188, P1117, DOI 10.1084/jem.188.6.1117; Brummendorf TH, 1999, ANN NY ACAD SCI, V872, P265, DOI 10.1111/j.1749-6632.1999.tb08471.x; Cho DY, 2011, CELL TRANSPLANT, V20, P121, DOI 10.3727/096368910X532774; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; CORTESINA G, 1995, ACTA OTO-LARYNGOL, V115, P328, DOI 10.3109/00016489509139322; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; Dontu G, 2005, STEM CELL REV, V1, P207, DOI 10.1385/SCR:1:3:207; Essers MAG, 2010, MOL ONCOL, V4, P443, DOI 10.1016/j.molonc.2010.06.001; Garzino-Demo P, 1998, ORAL ONCOL, V34, P204, DOI 10.1016/S1368-8375(97)00059-6; Ghiso JAA, 1999, EUR J BIOCHEM, V263, P295, DOI 10.1046/j.1432-1327.1999.00507.x; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Graziano M, 1998, EXP CELL RES, V240, P75, DOI 10.1006/excr.1997.3900; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Inoue K, 2009, LAB INVEST, V89, P844, DOI 10.1038/labinvest.2009.48; Izadyar F, 2011, HUM REPROD, V26, P1296, DOI 10.1093/humrep/der026; Jiang S, 2010, HISTOCHEM CELL BIOL, V133, P455, DOI 10.1007/s00418-010-0684-z; Jo MJ, 2010, CANCER RES, V70, P8948, DOI 10.1158/0008-5472.CAN-10-1936; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Lindeman LC, 2010, INT J DEV BIOL, V54, P803, DOI 10.1387/ijdb.103081ll; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Myers Eugene N, 2010, Otolaryngol Pol, V64, P204, DOI 10.1016/S0030-6657(10)70017-2; Myers Eugene N, 2010, Otolaryngol Pol, V64, P136, DOI 10.1016/S0030-6657(10)70049-4; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Odoux C, 2008, CANCER RES, V68, P6932, DOI 10.1158/0008-5472.CAN-07-5779; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; OSSOWSKI L, 1988, CELL, V52, P321, DOI 10.1016/S0092-8674(88)80025-4; OSSOWSKI L, 1983, CELL, V33, P323, DOI 10.1016/0092-8674(83)90414-2; OSSOWSKI L, 1983, CELL, V35, P611, DOI 10.1016/0092-8674(83)90093-4; OSSOWSKI L, 1987, J CELL PHYSIOL, V133, P288, DOI 10.1002/jcp.1041330212; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Trusolino L, 2000, FASEB J, V14, P1629, DOI 10.1096/fj.14.11.1629; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Weinberg R, 2010, NAT MED, V16, P758, DOI 10.1038/nm0710-758; WENZEL CT, 1995, ARCH OTOLARYNGOL, V121, P1279; Yang L, 2006, CANCER RES, V66, P7957, DOI 10.1158/0008-5472.CAN-05-3208	61	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29974	10.1371/journal.pone.0029974	http://dx.doi.org/10.1371/journal.pone.0029974			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276135	Green Submitted, Green Published, gold			2022-12-27	WOS:000301568100020
J	Emberson, JR; Kearney, PM; Blackwell, L; Newman, C; Reith, C; Bhala, N; Holland, L; Peto, R; Keech, A; Collins, R; Simes, J; Baigent, C				Emberson, Jonathan R.; Kearney, Patricia M.; Blackwell, Lisa; Newman, Connie; Reith, Christina; Bhala, Neeraj; Holland, Lisa; Peto, Richard; Keech, Anthony; Collins, Rory; Simes, John; Baigent, Colin		Cholesterol Treatment Trialists	Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; SERUM-CHOLESTEROL; FOLLOW-UP; RISK; ATORVASTATIN; SIMVASTATIN; PRAVASTATIN; PREVENTION; MORTALITY; PROSPER	Background: Statin therapy reduces the risk of occlusive vascular events, but uncertainty remains about potential effects on cancer. We sought to provide a detailed assessment of any effects on cancer of lowering LDL cholesterol (LDL-C) with a statin using individual patient records from 175,000 patients in 27 large-scale statin trials. Methods and Findings: Individual records of 134,537 participants in 22 randomised trials of statin versus control (median duration 4.8 years) and 39,612 participants in 5 trials of more intensive versus less intensive statin therapy (median duration 5.1 years) were obtained. Reducing LDL-C with a statin for about 5 years had no effect on newly diagnosed cancer or on death from such cancers in either the trials of statin versus control (cancer incidence: 3755 [1.4% per year [py]] versus 3738 [1.4% py], RR 1.00 [95% CI 0.96-1.05]; cancer mortality: 1365 [0.5% py] versus 1358 [0.5% py], RR 1.00 [95% CI 0.93-1.08]) or in the trials of more versus less statin (cancer incidence: 1466 [1.6% py] vs 1472 [1.6% py], RR 1.00 [95% CI 0.93-1.07]; cancer mortality: 447 [0.5% py] versus 481 [0.5% py], RR 0.93 [95% CI 0.82-1.06]). Moreover, there was no evidence of any effect of reducing LDL-C with statin therapy on cancer incidence or mortality at any of 23 individual categories of sites, with increasing years of treatment, for any individual statin, or in any given subgroup. In particular, among individuals with low baseline LDL-C (<2 mmol/L), there was no evidence that further LDL-C reduction (from about 1.7 to 1.3 mmol/L) increased cancer risk (381 [1.6% py] versus 408 [1.7% py]; RR 0.92 [99% CI 0.76-1.10]). Conclusions: In 27 randomised trials, a median of five years of statin therapy had no effect on the incidence of, or mortality from, any type of cancer (or the aggregate of all cancer).	[Emberson, Jonathan R.; Kearney, Patricia M.; Reith, Christina; Bhala, Neeraj; Holland, Lisa; Peto, Richard; Collins, Rory; Baigent, Colin] Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; [Emberson, Jonathan R.; Blackwell, Lisa; Reith, Christina; Bhala, Neeraj; Holland, Lisa; Peto, Richard; Collins, Rory; Baigent, Colin] Epidemiol Studies Unit CTSU, Oxford, England; [Kearney, Patricia M.] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Newman, Connie] NYU, Med Ctr, Div Endocrinol & Metab, New York, NY 10016 USA; [Keech, Anthony; Simes, John] Univ Sydney, NHMRC, Clin Trial Ctr, Sydney, NSW 2006, Australia	Radcliffe Infirmary; University of Oxford; University of Oxford; University College Cork; New York University; University of Sydney	Emberson, JR (corresponding author), Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England.		Maggioni, Aldo Pietro/AAL-5334-2020; Simes, Robert John/P-1497-2014	Maggioni, Aldo Pietro/0000-0003-2764-6779; Bhala, Neeraj/0000-0003-2502-1177; Newman, Connie/0000-0001-9144-056X; MacMahon, Stephen/0000-0003-2064-7699; Yusuf, Salim/0000-0003-4776-5601; Marschner, Ian/0000-0002-6225-1572; Buck, Georgina/0000-0001-5909-4265; Kearney, Patricia/0000-0001-9599-3540; Colhoun, Helen/0000-0002-8345-3288; Emberson, Jonathan/0000-0001-7792-9422; Jardine, Alan/0000-0001-5815-9370	UK Medical Research Council; British Heart Foundation; Cancer Research UK; European Community; Australian National Health and Medical Research Council; National Heart Foundation, Australia; BHF Centre of Research Excellence, Oxford, UK [RE/08/04]; Astra Zeneca; Bristol Myers Squibb; Merck; Novartis; Pfizer; Medical Research Council [MC_U137686849] Funding Source: researchfish; MRC [MC_U137686849] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); European Community(European Commission); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation, Australia(National Heart Foundation of Australia); BHF Centre of Research Excellence, Oxford, UK; Astra Zeneca(AstraZeneca); Bristol Myers Squibb(Bristol-Myers Squibb); Merck(Merck & Company); Novartis(Novartis); Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) in the UK and National Health and Medical Research Council Clinical Trials Centre (CTC) in Australia coordinate this collaboration jointly. The meta-analysis work of CTSU is supported by the UK Medical Research Council, British Heart Foundation, Cancer Research UK and, previously, the European Community Biomed Programme. The CTC is supported by a programme grant from the Australian National Health and Medical Research Council, and a grant from the National Heart Foundation, Australia. JE acknowledges support from the BHF Centre of Research Excellence, Oxford, UK (RE/08/04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Most of the trials in this report were supported by research grants from the manufacturers of statins (Astra Zeneca, Bristol Myers Squibb, Merck, Novartis and Pfizer), but no support from the pharmaceutical industry has been received for this meta-analysis work.; The authors have read the journal's policy and have the following conflicts: AK and JS have received honoraria from Solvay for lectures related to these studies. CN has worked as a consultant for Merck. Most of the trials in this report were supported by research grants from the manufacturers of statins (Astra Zeneca, Bristol Myers Squibb, Merck, Novartis and Pfizer), but no support from the pharmaceutical industry has been received for this meta-analysis work. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alsheikh-Ali AA, 2008, J AM COLL CARDIOL, V52, P1141, DOI 10.1016/j.jacc.2008.06.037; Alsheikh-Ali AA, 2007, J AM COLL CARDIOL, V50, P409, DOI 10.1016/j.jacc.2007.02.073; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Athyros VG, 2002, CURR MED RES OPIN, V18, P220, DOI 10.1185/030079902125000787; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bonovas S, 2007, J CLIN ONCOL, V25, P3462, DOI 10.1200/JCO.2007.10.8936; Browning DRL, 2007, INT J CANCER, V120, P833, DOI 10.1002/ijc.22366; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Collins R, 2002, LANCET, V360, P1618, DOI 10.1016/S0140-6736(02)11650-3; Dale KM, 2006, JAMA-J AM MED ASSOC, V295, P74, DOI 10.1001/jama.295.1.74; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; DOWNS JR, 1995, AM J CARDIOL, V75, P1130; Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Heart Protection Study Collaborative Group, 2011, Lancet, V378, P2013, DOI 10.1016/S0140-6736(11)61125-2; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; JACOBS D, 1992, CIRCULATION, V86, P1046, DOI 10.1161/01.CIR.86.3.1046; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Kuoppala J, 2008, EUR J CANCER, V44, P2122, DOI 10.1016/j.ejca.2008.06.025; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; LAW MR, 1991, CANCER CAUSE CONTROL, V2, P253, DOI 10.1007/BF00052142; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Poynter JN, 2005, NEW ENGL J MED, V352, P2184, DOI 10.1056/NEJMoa043792; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sharp SJ, 1997, EPIDEMIOLOGY, V8, P132, DOI 10.1097/00001648-199703000-00002; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Simes RJ, 2002, LANCET, V359, P1379; Solomon KR, 2008, TRENDS ENDOCRIN MET, V19, P113, DOI 10.1016/j.tem.2007.12.004; Strandberg TE, 2004, LANCET, V364, P771, DOI 10.1016/S0140-6736(04)16936-5	30	232	237	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29849	10.1371/journal.pone.0029849	http://dx.doi.org/10.1371/journal.pone.0029849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276132	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000301457200024
J	Puig, KL; Floden, AM; Adhikari, R; Golovko, MY; Combs, CK				Puig, Kendra L.; Floden, Angela M.; Adhikari, Ramchandra; Golovko, Mikhail Y.; Combs, Colin K.			Amyloid Precursor Protein and Proinflammatory Changes Are Regulated in Brain and Adipose Tissue in a Murine Model of High Fat Diet-Induced Obesity	PLOS ONE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; BODY-MASS INDEX; TUMOR-NECROSIS-FACTOR; MONOCYTIC LINEAGE CELLS; INSULIN-RESISTANCE; MICROGLIAL CELLS; METABOLIC SYNDROME; INTERFERON-GAMMA; MESSENGER-RNAS; OLDER-ADULTS	Background: Middle age obesity is recognized as a risk factor for Alzheimer's disease (AD) although a mechanistic linkage remains unclear. Based upon the fact that obese adipose tissue and AD brains are both areas of proinflammatory change, a possible common event is chronic inflammation. Since an autosomal dominant form of AD is associated with mutations in the gene coding for the ubiquitously expressed transmembrane protein, amyloid precursor protein (APP) and recent evidence demonstrates increased APP levels in adipose tissue during obesity it is feasible that APP serves some function in both disease conditions. Methodology/Principal Findings: To determine whether diet-induced obesity produced proinflammatory changes and altered APP expression in brain versus adipose tissue, 6 week old C57BL6/J mice were maintained on a control or high fat diet for 22 weeks. Protein levels and cell-specific APP expression along with markers of inflammation and immune cell activation were compared between hippocampus, abdominal subcutaneous fat and visceral pericardial fat. APP stimulation-dependent changes in macrophage and adipocyte culture phenotype were examined for comparison to the in vivo changes. Conclusions/Significance: Adipose tissue and brain from high fat diet fed animals demonstrated increased TNF-alpha and microglial and macrophage activation. Both brains and adipose tissue also had elevated APP levels localizing to neurons and macrophage/adipocytes, respectively. APP agonist antibody stimulation of macrophage cultures increased specific cytokine secretion with no obvious effects on adipocyte culture phenotype. These data support the hypothesis that high fat diet-dependent obesity results in concomitant pro-inflammatory changes in brain and adipose tissue that is characterized, in part, by increased levels of APP that may be contributing specifically to inflammatory changes that occur.	[Puig, Kendra L.; Floden, Angela M.; Adhikari, Ramchandra; Golovko, Mikhail Y.; Combs, Colin K.] Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks	Puig, KL (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58201 USA.	colin.combs@med.und.edu		Golovko, Mikhail/0000-0003-1749-3158	NIH/NCRR [1P20 RR17699]; NIH/NIA [1R01AG026330]; National Science Foundation Research Experience for Undergraduates (REU) [0639227]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026330] Funding Source: NIH RePORTER	NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Science Foundation Research Experience for Undergraduates (REU)(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH/NCRR 1P20 RR17699, NIH/NIA 1R01AG026330, and in part by National Science Foundation Research Experience for Undergraduates (REU) Site Grant no. 0639227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Antuna-Puente B, 2008, DIABETES METAB, V34, P2, DOI 10.1016/j.diabet.2007.09.004; Balakrishnan K, 2005, J ALZHEIMERS DIS, V8, P269; BANATI RB, 1995, J CEREBR BLOOD F MET, V15, P647, DOI 10.1038/jcbfm.1995.80; BANATI RB, 1994, NEUROPATH APPL NEURO, V20, P194; BANATI RB, 1995, GLIA, V14, P209, DOI 10.1002/glia.440140306; BANATI RB, 1994, NEUROREPORT, V5, P1359, DOI 10.1097/00001756-199406270-00016; BANATI RB, 1993, GLIA, V9, P199, DOI 10.1002/glia.440090305; Barile L, 1993, Arch Med Res, V24, P189; BAUER J, 1991, FEBS LETT, V282, P335, DOI 10.1016/0014-5793(91)80508-Z; BENDOTTI C, 1988, P NATL ACAD SCI USA, V85, P3628, DOI 10.1073/pnas.85.10.3628; Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.x; Bitting L, 1996, J BIOL CHEM, V271, P16084, DOI 10.1074/jbc.271.27.16084; BLUME AJ, 1989, NEUROBIOL AGING, V10, P406, DOI 10.1016/0197-4580(89)90077-8; Blume AJ, 1989, NEUROBIOL AGING, V10, P412; Borst SE, 2005, LIFE SCI, V77, P2156, DOI 10.1016/j.lfs.2005.03.021; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGESS AW, 1977, J BIOL CHEM, V252, P1998; Coenen KR, 2007, DIABETES, V56, P564, DOI 10.2337/db06-1375; Combs CK, 1999, J NEUROSCI, V19, P928; DOHERTY TM, 1993, J IMMUNOL, V151, P7151; Eskelinen MH, 2008, INT J GERIATR PSYCH, V23, P741, DOI 10.1002/gps.1969; Fain JN, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/513948; Fain JN, 2010, OBESITY, V18, P890, DOI 10.1038/oby.2009.335; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; Fernyhough ME, 2004, CYTOTECHNOLOGY, V46, P163, DOI 10.1007/s10616-005-2602-0; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Floden AM, 2006, J NEUROSCI, V26, P4644, DOI 10.1523/JNEUROSCI.4822-05.2006; FORLONI G, 1992, MOL BRAIN RES, V16, P128, DOI 10.1016/0169-328X(92)90202-M; Forti P, 2010, J AM GERIATR SOC, V58, P487, DOI 10.1111/j.1532-5415.2010.02731.x; GEHRMANN J, 1995, NEUROPATH APPL NEURO, V21, P277, DOI 10.1111/j.1365-2990.1995.tb01062.x; GEHRMANN J, 1995, GLIA, V15, P141, DOI 10.1002/glia.440150206; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Golovko MY, 2008, J LIPID RES, V49, P893, DOI 10.1194/jlr.D700030-JLR200; Gomez-Casanovas E, 2001, ARTHRITIS RHEUM, V44, P66, DOI 10.1002/1529-0131(200101)44:1<66::AID-ANR10>3.0.CO;2-H; Gunstad J, 2008, INT J NEUROSCI, V118, P1582, DOI 10.1080/00207450701392282; Gunstad J, 2007, COMPR PSYCHIAT, V48, P57, DOI 10.1016/j.comppsych.2006.05.001; Gunstad J, 2006, J GERIATR PSYCH NEUR, V19, P59, DOI 10.1177/0891988705284738; HAASS C, 1991, J NEUROSCI, V11, P3783; Hayden KM, 2007, NEUROLOGY, V69, P275, DOI 10.1212/01.wnl.0000265223.25679.2a; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Hughes TF, 2009, NEUROLOGY, V72, P1741, DOI 10.1212/WNL.0b013e3181a60a58; HUNG AY, 1992, P NATL ACAD SCI USA, V89, P9439, DOI 10.1073/pnas.89.20.9439; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Jeong SK, 2005, DEMENT GERIATR COGN, V19, P91, DOI 10.1159/000082659; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; Kim DH, 2008, AM J PHYSIOL-ENDOC M, V295, pE1038, DOI 10.1152/ajpendo.00061.2008; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Kohjima M, 2010, ENDOCRINOLOGY, V151, P1532, DOI 10.1210/en.2009-1196; Laitinen MH, 2006, DEMENT GERIATR COGN, V22, P99, DOI 10.1159/000093478; LANG E, 1992, BIOCHEM BIOPH RES CO, V187, P783, DOI 10.1016/0006-291X(92)91264-Q; Leahey TM, 2007, NUTR NEUROSCI, V10, P205, DOI 10.1080/10284150701676156; LEBLANC AC, 1991, FEBS LETT, V292, P171, DOI 10.1016/0014-5793(91)80861-V; Lee YH, 2008, OBESITY, V16, P1493, DOI 10.1038/oby.2008.267; Lee YH, 2007, J CARDIOPULM REHABIL, V27, P2; Lee YH, 2009, NEUROENDOCRINOLOGY, V90, P383, DOI 10.1159/000235555; Levin-Allerhand J A, 2002, J Nutr Health Aging, V6, P315; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lorton D, 1996, J NEUROIMMUNOL, V67, P21, DOI 10.1016/S0165-5728(96)00030-6; Lorton D, 2000, NEUROBIOL AGING, V21, P463, DOI 10.1016/S0197-4580(00)00092-0; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Matsubara Y, 2009, ANN NUTR METAB, V54, P258, DOI 10.1159/000229506; McGillicuddy FC, 2009, J BIOL CHEM, V284, P31936, DOI 10.1074/jbc.M109.061655; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Meijer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017154; MONNING U, 1994, FEBS LETT, V342, P267, DOI 10.1016/0014-5793(94)80514-8; MONNING U, 1995, J BIOL CHEM, V270, P7104, DOI 10.1074/jbc.270.13.7104; Moroz N, 2008, J ALZHEIMERS DIS, V15, P29; NAKARAI H, 2011, INNATE IMMUN; O'Rourke RW, 2009, INT J OBESITY, V33, P978, DOI 10.1038/ijo.2009.133; OHYAGI Y, 1993, MOL BRAIN RES, V18, P127, DOI 10.1016/0169-328X(93)90181-N; Poitou C, 2006, OBESITY, V14, P309, DOI 10.1038/oby.2006.40; Poussin C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003385; Profenno LA, 2008, AM J MED GENET B, V147B, P822, DOI 10.1002/ajmg.b.30694; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Raffaitin C, 2009, DIABETES CARE, V32, P169, DOI 10.2337/dc08-0272; Razay G, 2007, ARCH NEUROL-CHICAGO, V64, P93, DOI 10.1001/archneur.64.1.93; Razay G, 2006, DEMENT GERIATR COGN, V22, P173, DOI 10.1159/000094586; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; Schmechel D E, 1988, Alzheimer Dis Assoc Disord, V2, P96, DOI 10.1097/00002093-198802020-00002; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SMITH CJ, 1993, MOL BRAIN RES, V17, P328, DOI 10.1016/0169-328X(93)90018-K; SOLA C, 1993, MOL BRAIN RES, V17, P41, DOI 10.1016/0169-328X(93)90071-V; Sommer G, 2009, J CELL BIOCHEM, V108, P1418, DOI 10.1002/jcb.22382; Sondag CM, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-22; Sondag CM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-1; Sondag CM, 2006, J NEUROCHEM, V97, P449, DOI 10.1111/j.1471-4159.2006.03759.x; Sondag CM, 2004, J BIOL CHEM, V279, P14456, DOI 10.1074/jbc.M313747200; Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x; van Dielen FMH, 2001, INT J OBESITY, V25, P1759, DOI 10.1038/sj.ijo.0801825; Wallet MA, 2010, CELL IMMUNOL, V262, P84, DOI 10.1016/j.cellimm.2010.02.013; Wang J, 2005, FASEB J, V19, P659, DOI 10.1096/fj.04-3182fje; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P103, DOI 10.2174/156720507780362047; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P117, DOI 10.2174/156720507780362065; WILLOUGHBY DA, 1992, EXP NEUROL, V118, P332, DOI 10.1016/0014-4886(92)90191-R; Wu SZ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-2	103	98	98	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30378	10.1371/journal.pone.0030378	http://dx.doi.org/10.1371/journal.pone.0030378			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276186	Green Submitted, gold, Green Published			2022-12-27	WOS:000301457200056
J	Ho, T; Vessey, KA; Cappai, R; Dinet, V; Mascarelli, F; Ciccotosto, GD; Fletcher, EL				Ho, Tracy; Vessey, Kirstan A.; Cappai, Roberto; Dinet, Virginie; Mascarelli, Frederic; Ciccotosto, Giuseppe D.; Fletcher, Erica L.			Amyloid Precursor Protein Is Required for Normal Function of the Rod and Cone Pathways in the Mouse Retina	PLOS ONE			English	Article							STARBURST AMACRINE CELLS; ALZHEIMERS-DISEASE; DIRECTION SELECTIVITY; TRANSGENIC MICE; BIPOLAR CELLS; OSCILLATORY POTENTIALS; COGNITIVE IMPAIRMENT; COPPER LEVELS; IN-VIVO; A-BETA	Amyloid precursor protein (APP) is a transmembrane glycoprotein frequently studied for its role in Alzheimer's disease. Our recent study in APP knockout (KO) mice identified an important role for APP in modulating normal neuronal development in the retina. However the role APP plays in the adult retina and whether it is required for vision is unknown. In this study we evaluated the role of APP in retinal function and morphology comparing adult wildtype (WT) and APP-KO mice. APP was expressed on neuronal cells of the inner retina, including horizontal, cone bipolar, amacrine and ganglion cells in WT mice. The function of the retina was assessed using the electroretinogram and although the rod photoreceptor responses were similar in APP-KO and WT mice, the post-photoreceptor, inner retinal responses of both the rod and cone pathways were reduced in APP-KO mice. These changes in inner retinal function did not translate to a substantial change in visual acuity as assessed using the optokinetic response or to changes in the gross cellular structure of the retina. These findings indicate that APP is not required for basic visual function, but that it is involved in modulating inner retinal circuitry.	[Ho, Tracy; Vessey, Kirstan A.; Fletcher, Erica L.] Univ Melbourne, Dept Anat & Cell Biol, Melbourne, Vic, Australia; [Ho, Tracy; Cappai, Roberto; Ciccotosto, Giuseppe D.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Ho, Tracy; Cappai, Roberto; Ciccotosto, Giuseppe D.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia; [Dinet, Virginie; Mascarelli, Frederic] Univ Paris 05, Ctr Rech Cordeliers, Paris, France; [Dinet, Virginie; Mascarelli, Frederic] Inst Natl Sante & Rech Med, Paris, France; [Dinet, Virginie; Mascarelli, Frederic] Univ Paris 06, Paris, France	University of Melbourne; University of Melbourne; University of Melbourne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Ho, T (corresponding author), Univ Melbourne, Dept Anat & Cell Biol, Melbourne, Vic, Australia.	e.fletcher@unimelb.edu.au	Mascarelli, Frederic/L-8916-2018; Cappai, Roberto/B-3347-2010; Fletcher, Erica/E-6364-2012	Dinet, virginie/0000-0002-5458-0253; Cappai, Roberto/0000-0002-9505-8496; Fletcher, Erica/0000-0001-9412-9523; Ho, Tracy/0000-0002-9277-7823; Vessey, Kirstan/0000-0003-1031-1964	National Health and Medical Research Council (NHMRC) of Australia [566815, 400202]; Retina Australia; Macular Degeneration Foundation; Agence Nationale de la Recherche	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Retina Australia; Macular Degeneration Foundation; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia (No. 566815 to ELF, No. 400202 to RC), and with grants from Retina Australia, the Macular Degeneration Foundation and the Agence Nationale de la Recherche (FM and VD). RC is an NHMRC Senior Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer AU, 2002, EUR NEUROL, V47, P165, DOI 10.1159/000047976; Bellingham SA, 2004, J NEUROCHEM, V91, P423, DOI 10.1111/j.1471-4159.2004.02731.x; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; Chen ST, 1997, NEUROREPORT, V8, P713, DOI 10.1097/00001756-199702100-00027; Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z; Danesh-Meyer HV, 2006, NEUROLOGY, V67, P1852, DOI 10.1212/01.wnl.0000244490.07925.8b; Dinet V, 2011, ACTA NEUROPATHOL, V121, P351, DOI 10.1007/s00401-010-0762-2; Dong CJ, 2002, VISION RES, V42, P1081, DOI 10.1016/S0042-6989(02)00032-9; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Dutescu RM, 2009, GRAEF ARCH CLIN EXP, V247, P1213, DOI 10.1007/s00417-009-1060-3; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fletcher EL, 1998, J COMP NEUROL, V396, P351, DOI 10.1002/(SICI)1096-9861(19980706)396:3<351::AID-CNE6>3.0.CO;2-1; Goldblum D, 2007, INVEST OPHTH VIS SCI, V48, P5085, DOI 10.1167/iovs.06-1249; Guo L, 2007, P NATL ACAD SCI USA, V104, P13444, DOI 10.1073/pnas.0703707104; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Herard AS, 2006, NEUROBIOL AGING, V27, P1740, DOI 10.1016/j.neurobiolaging.2005.10.020; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; HOOD DC, 1990, VISUAL NEUROSCI, V5, P379, DOI 10.1017/S0952523800000468; Iseri PK, 2006, J NEURO-OPHTHALMOL, V26, P18, DOI 10.1097/01.wno.0000204645.56873.26; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Kaden D, 2011, EUR J CELL BIOL; Kirby E, 2010, J ALZHEIMERS DIS, V21, P15, DOI 10.3233/JAD-2010-080785; Lee KJ, 2010, NEUROSCIENCE, V169, P344, DOI 10.1016/j.neuroscience.2010.04.078; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Lee S, 2010, NEURON, V68, P1159, DOI 10.1016/j.neuron.2010.11.031; Lei B, 2006, INVEST OPHTH VIS SCI, V47, P2732, DOI 10.1167/iovs.05-1461; LOFFLER KU, 1995, INVEST OPHTH VIS SCI, V36, P24; Lukasiewicz PD, 2004, VISION RES, V44, P3289, DOI 10.1016/j.visres.2004.07.023; Lyubarsky A, 1996, J GEN PHYSIOL, V107, P19, DOI 10.1085/jgp.107.1.19; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; May CA, 2008, ACTA OPHTHALMOL, V86, P395, DOI 10.1111/j.1600-0420.2007.01054.x; McKinnon SJ, 2002, INVEST OPHTH VIS SCI, V43, P1077; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; MOYA KL, 1994, DEV BIOL, V161, P597, DOI 10.1006/dbio.1994.1055; Needham BE, 2008, J PATHOL, V215, P155, DOI 10.1002/path.2343; Ning A, 2008, INVEST OPHTH VIS SCI, V49, P5136, DOI 10.1167/iovs.08-1849; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Parisi V, 2001, CLIN NEUROPHYSIOL, V112, P1860, DOI 10.1016/S1388-2457(01)00620-4; Phipps JA, 2004, INVEST OPHTH VIS SCI, V45, P4592, DOI 10.1167/iovs.04-0842; Pinto LH, 2007, VISUAL NEUROSCI, V24, P111, DOI 10.1017/S0952523807070149; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Shimazawa M, 2008, J NEUROCHEM, V107, P279, DOI 10.1111/j.1471-4159.2008.05606.x; Shirato S, 2008, EXP EYE RES, V86, P914, DOI 10.1016/j.exer.2008.03.008; Ueno S, 2004, INVEST OPHTH VIS SCI, V45, P1033, DOI 10.1167/iovs.03-0657; Vessey KA, 2011, J COMP NEUROL, V519, P506, DOI 10.1002/cne.22530; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wang X, 2000, EXP BRAIN RES, V132, P476, DOI 10.1007/s002210000360; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Weymouth AE, 2008, PROG RETIN EYE RES, V27, P1, DOI 10.1016/j.preteyeres.2007.09.003; White AR, 1999, BRAIN RES, V842, P439, DOI 10.1016/S0006-8993(99)01861-2; White AR, 1998, J NEUROSCI, V18, P6207; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Yang L, 2007, NEUROSCIENCE, V149, P768, DOI 10.1016/j.neuroscience.2007.08.025; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zhou ZJ, 2008, J PHYSIOL-LONDON, V586, P4371, DOI 10.1113/jphysiol.2008.159020	63	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29892	10.1371/journal.pone.0029892	http://dx.doi.org/10.1371/journal.pone.0029892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279552	gold, Green Published			2022-12-27	WOS:000299771900030
J	Stefan, MI; Marshall, DP; Le Novere, N				Stefan, Melanie I.; Marshall, David P.; Le Novere, Nicolas			Structural Analysis and Stochastic Modelling Suggest a Mechanism for Calmodulin Trapping by CaMKII	PLOS ONE			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; D-ASPARTIC ACID; DENDRITIC SPINE; MOLECULAR-BASIS; MUTANT MICE; CALCIUM; ACTIVATION; ALPHA; AUTOPHOSPHORYLATION	Activation of CaMKII by calmodulin and the subsequent maintenance of constitutive activity through autophosphorylation at threonine residue 286 (Thr286) are thought to play a major role in synaptic plasticity. One of the effects of autophosphorylation at Thr286 is to increase the apparent affinity of CaMKII for calmodulin, a phenomenon known as "calmodulin trapping". It has previously been suggested that two binding sites for calmodulin exist on CaMKII, with high and low affinities, respectively. We built structural models of calmodulin bound to both of these sites. Molecular dynamics simulation showed that while binding of calmodulin to the supposed low-affinity binding site on CaMKII is compatible with closing (and hence, inactivation) of the kinase, and could even favour it, binding to the high-affinity site is not. Stochastic simulations of a biochemical model showed that the existence of two such binding sites, one of them accessible only in the active, open conformation, would be sufficient to explain calmodulin trapping by CaMKII. We can explain the effect of CaMKII autophosphorylation at Thr286 on calmodulin trapping: It stabilises the active state and therefore makes the high-affinity binding site accessible. Crucially, a model with only one binding site where calmodulin binding and CaMKII inactivation are strictly mutually exclusive cannot reproduce calmodulin trapping. One of the predictions of our study is that calmodulin binding in itself is not sufficient for CaMKII activation, although high-affinity binding of calmodulin is.	[Stefan, Melanie I.; Marshall, David P.; Le Novere, Nicolas] EMBL European Bioinformat Inst, Hinxton, S Cambs, England	European Molecular Biology Laboratory (EMBL)	Stefan, MI (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	lenov@ebi.ac.uk		Stefan, Melanie/0000-0002-6086-7357				[Anonymous], 2009, PYMOL MOL GRAPH SYST; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Bers DM, 2009, J CARDIOVASC PHARM, V54, P180, DOI 10.1097/FJC.0b013e3181a25078; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Brnjic S, 2010, MOL BIOSYST, V6, P767, DOI 10.1039/b920805d; Byrne MJ, 2009, J COMPUT NEUROSCI, V27, P621, DOI 10.1007/s10827-009-0173-3; Case D. A., 2002, AMBER 7; Chin D, 2002, BIOCHEMISTRY-US, V41, P14001, DOI 10.1021/bi025640o; Cohen MB, 2009, J CELL BIOCHEM, V106, P363, DOI 10.1002/jcb.22022; de Diego I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000552; Dosemeci A, 1996, BIOPHYS J, V70, P2493, DOI 10.1016/S0006-3495(96)79821-1; HANLEY RM, 1988, BIOCHEM BIOPH RES CO, V152, P122, DOI 10.1016/S0006-291X(88)80688-0; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hoffman L, 2011, EMBO J, V30, P1251, DOI 10.1038/emboj.2011.40; Holmes WR, 2000, J COMPUT NEUROSCI, V8, P65, DOI 10.1023/A:1008969032563; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Jama AM, 2009, J BIOL CHEM, V284, P28146, DOI 10.1074/jbc.M109.005900; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; Kubota Y, 2001, J COMPUT NEUROSCI, V11, P263, DOI 10.1023/A:1013727331979; Le Novere N, 2001, BIOINFORMATICS, V17, P575, DOI 10.1093/bioinformatics/17.6.575; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Lucic V, 2008, EUR BIOPHYS J BIOPHY, V38, P83, DOI 10.1007/s00249-008-0362-4; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1985, J PHYSIOL-LONDON, V361, P65, DOI 10.1113/jphysiol.1985.sp015633; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Miller P, 2005, PLOS BIOL, V3, P705, DOI 10.1371/journal.pbio.0030107; Okamoto H, 2000, BIOSYSTEMS, V55, P65, DOI 10.1016/S0303-2647(99)00084-2; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; Pepke S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000675; Petersen JD, 2003, J NEUROSCI, V23, P11270; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHULMAN H, 1978, NATURE, V271, P478, DOI 10.1038/271478a0; SCHULMAN H, 1978, P NATL ACAD SCI USA, V75, P5432, DOI 10.1073/pnas.75.11.5432; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Singla SI, 2001, J BIOL CHEM, V276, P29353, DOI 10.1074/jbc.M101744200; Stefan MI, 2008, P NATL ACAD SCI USA, V105, P10768, DOI 10.1073/pnas.0804672105; Strack S, 1997, J NEUROCHEM, V68, P2119; Tse JKY, 2007, BIOCHEMISTRY-US, V46, P4017, DOI 10.1021/bi700013y; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6404, DOI 10.1021/bi036224m; Wall ME, 1997, STRUCTURE, V5, P1599, DOI 10.1016/S0969-2126(97)00308-0; Waxham MN, 1998, J BIOL CHEM, V273, P17579, DOI 10.1074/jbc.273.28.17579; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Yamauchi T, 2005, BIOL PHARM BULL, V28, P1342, DOI 10.1248/bpb.28.1342; Zeng SY, 2010, J NEUROPHYSIOL, V103, P1798, DOI 10.1152/jn.91235.2008; Zhabotinsky AM, 2000, BIOPHYS J, V79, P2211, DOI 10.1016/S0006-3495(00)76469-1	56	11	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29406	10.1371/journal.pone.0029406	http://dx.doi.org/10.1371/journal.pone.0029406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279535	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000299771900013
J	Poche, RA; Sharma, R; Garcia, MD; Wada, AM; Nolte, MJ; Udan, RS; Paik, JH; DePinho, RA; Bartlett, JD; Dickinson, ME				Poche, Ross A.; Sharma, Ramaswamy; Garcia, Monica D.; Wada, Aya M.; Nolte, Mark J.; Udan, Ryan S.; Paik, Ji-Hye; DePinho, Ronald A.; Bartlett, John D.; Dickinson, Mary E.			Transcription Factor FoxO1 Is Essential for Enamel Biomineralization	PLOS ONE			English	Article							AMELOGENESIS-IMPERFECTA; TGF-BETA; MICE DISPLAY; MOUSE MODEL; TOOTH; EXPRESSION; MUTATION; AMELOBLASTIN; PROTEIN; CBFA1	The Transforming growth factor beta (Tgf-beta) pathway, by signaling via the activation of Smad transcription factors, induces the expression of many diverse downstream target genes thereby regulating a vast array of cellular events essential for proper development and homeostasis. In order for a specific cell type to properly interpret the Tgf-beta signal and elicit a specific cellular response, cell-specific transcriptional co-factors often cooperate with the Smads to activate a discrete set of genes in the appropriate temporal and spatial manner. Here, via a conditional knockout approach, we show that mice mutant for Forkhead Box O transcription factor FoxO1 exhibit an enamel hypomaturation defect which phenocopies that of the Smad3 mutant mice. Furthermore, we determined that both the FoxO1 and Smad3 mutant teeth exhibit changes in the expression of similar cohort of genes encoding enamel matrix proteins required for proper enamel development. These data raise the possibility that FoxO1 and Smad3 act in concert to regulate a common repertoire of genes necessary for complete enamel maturation. This study is the first to define an essential role for the FoxO family of transcription factors in tooth development and provides a new molecular entry point which will allow researchers to delineate novel genetic pathways regulating the process of biomineralization which may also have significance for studies of human tooth diseases such as amelogenesis imperfecta.	[Poche, Ross A.; Garcia, Monica D.; Wada, Aya M.; Udan, Ryan S.; Dickinson, Mary E.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Dickinson, Mary E.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Sharma, Ramaswamy; Bartlett, John D.] Harvard Univ, Sch Dent Med, Forsyth Inst, Dept Cytokine Biol, Cambridge, MA 02138 USA; [Sharma, Ramaswamy; Bartlett, John D.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Cambridge, MA 02138 USA; [Nolte, Mark J.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Paik, Ji-Hye] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Dept Med Oncol, Boston, MA 02115 USA; [DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Dept Med, Boston, MA 02115 USA; [DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Dept Genet, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Boston, MA USA	Baylor College of Medicine; Baylor College of Medicine; Harvard University; Forsyth Institute; Harvard School of Dental Medicine; Harvard University; Harvard School of Dental Medicine; University of Texas System; UTMD Anderson Cancer Center; Cornell University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Poche, RA (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	mdickins@bcm.edu	Sharma, Ramaswamy/F-8401-2012; Bartlett, John/L-9832-2017	Bartlett, John/0000-0003-2052-6299; DePinho, Ronald/0000-0002-5625-577X; Poche, Ross/0000-0002-5228-2383	National Institutes of Health [R01EB005173, P20EB0070769]; High Resolution Electron Microscopy Facility, University of Texas, M.D. Anderson Cancer Center [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM084897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); High Resolution Electron Microscopy Facility, University of Texas, M.D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by funding from the National Institutes of Health R01EB005173 (to MED) and P20EB0070769 (to MED) as well as Institutional Core Grant #CA16672 High Resolution Electron Microscopy Facility, University of Texas, M.D. Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg T, 2004, J HISTOCHEM CYTOCHEM, V52, P131, DOI 10.1177/002215540405200113; ALDRED MJ, 1992, HUM GENET, V90, P413; Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Barron MJ, 2010, HUM MOL GENET, V19, P1230, DOI 10.1093/hmg/ddq001; Bartlett JD, 1999, CRIT REV ORAL BIOL M, V10, P425, DOI 10.1177/10454411990100040101; Bronckers ALJJ, 2001, MECH DEVELOP, V101, P255, DOI 10.1016/S0925-4773(00)00562-1; Caterina JJ, 2002, J BIOL CHEM, V277, P49598, DOI 10.1074/jbc.M209100200; D'Souza RN, 1999, DEVELOPMENT, V126, P2911; DEAKINS M., 1941, JOUR DENTAL RES, V20, P117, DOI 10.1177/00220345410200020201; Dhamija S, 2001, J BIOL CHEM, V276, P35159, DOI 10.1074/jbc.M010719200; Dobrowolski R, 2008, HUM MOL GENET, V17, P539, DOI 10.1093/hmg/ddm329; EASTOE JE, 1979, J DENT RES, V58, P753, DOI 10.1177/00220345790580022701; Flenniken AM, 2005, DEVELOPMENT, V132, P4375, DOI 10.1242/dev.02011; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Harada H, 2002, DEVELOPMENT, V129, P1533; Hu CC, 1997, J DENT RES, V76, P1720, DOI 10.1177/00220345970760110201; Hu JCC, 2008, J BIOL CHEM, V283, P10858, DOI 10.1074/jbc.M710565200; Huang XF, 2010, CHIN J DENT RES, V13, P7; Ito Y, 2001, J BIOL CHEM, V276, P44163, DOI 10.1074/jbc.M011424200; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kim JW, 2005, J MED GENET, V42, P271, DOI 10.1136/jmg.2004.024505; Kobayashi I, 2006, BONE, V38, P836, DOI 10.1016/j.bone.2005.10.026; Krebsbach PH, 1996, J BIOL CHEM, V271, P4431; Kurosaka H, 2011, STEM CELLS, V29, P1792, DOI 10.1002/stem.722; LAGERSTROM M, 1991, GENOMICS, V10, P971, DOI 10.1016/0888-7543(91)90187-J; Lee SK, 2010, J DENT RES, V89, P46, DOI 10.1177/0022034509352844; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Masuya H, 2005, HUM MOL GENET, V14, P575, DOI 10.1093/hmg/ddi054; Michon F, 2010, DEV BIOL, V340, P355, DOI 10.1016/j.ydbio.2010.01.019; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nagy A., 2003, MANIPULATING MOUSE E; Ozdemir D, 2005, J DENT RES, V84, P1031, DOI 10.1177/154405910508401112; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Papagerakis P, 2008, J DENT RES, V87, P56, DOI 10.1177/154405910808700109; Rajpar MH, 2001, HUM MOL GENET, V10, P1673, DOI 10.1093/hmg/10.16.1673; Robinson C, 1997, CIBA F SYMP, V205, P156; Sawada T, 2012, ACTA HISTOC IN PRESS; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Simmer JP, 2009, J BIOL CHEM, V284, P19110, DOI 10.1074/jbc.M109.013623; SMITH CE, 1995, INT J DEV BIOL, V39, P153; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Smith CE, 2009, EUR J ORAL SCI, V117, P485, DOI 10.1111/j.1600-0722.2009.00666.x; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Takamori K, 2008, J DENT RES, V87, P238, DOI 10.1177/154405910808700307; Teixeira CC, 2010, J BIOL CHEM, V285, P31055, DOI 10.1074/jbc.M109.079962; TERMINE JD, 1980, J BIOL CHEM, V255, P9760; Toth K, 2010, J CELL PHYSIOL, V223, P601, DOI 10.1002/jcp.22046; Tsuchiya M, 2009, EUR J ORAL SCI, V117, P105, DOI 10.1111/j.1600-0722.2009.00612.x; WARSHAWSKY H, 1974, ANAT RECORD, V179, P423, DOI 10.1002/ar.1091790403; Wilt FH, 2005, DEV BIOL, V280, P15, DOI 10.1016/j.ydbio.2005.01.019; Wright JT, 2006, EUR J ORAL SCI, V114, P13, DOI 10.1111/j.1600-0722.2006.00291.x; Xu X, 2003, INT J DEV BIOL, V47, P31; Xu X, 2008, DEV CELL, V15, P322, DOI 10.1016/j.devcel.2008.06.004; Xu YC, 2007, J BIOL CHEM, V282, P29882, DOI 10.1074/jbc.M702097200; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yokozeki M, 2003, BIOCHEM BIOPH RES CO, V305, P684, DOI 10.1016/S0006-291X(03)00806-4; Zhou YL, 2000, J BIOL CHEM, V275, P12273, DOI 10.1074/jbc.275.16.12273	66	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30357	10.1371/journal.pone.0030357	http://dx.doi.org/10.1371/journal.pone.0030357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291941	Green Submitted, Green Published, gold			2022-12-27	WOS:000301639600016
J	Silventoinen, K; Baker, JL; Sorensen, TIA				Silventoinen, Karri; Baker, Jennifer L.; Sorensen, Thorkild I. A.			Growth in Height in Childhood and Risk of Coronary Heart Disease in Adult Men and Women	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; BIRTH-WEIGHT; BLOOD-PRESSURE; MORTALITY; CHILDREN; HEALTH; COHORT; AGE; DETERMINANTS; METAANALYSIS	Background: Adult height is inversely associated with the risk of coronary heart disease (CHD), but it is still unknown which phase of the human growth period is critical for the formation of this association. We investigated the association between growth in height from 7 to 13 years of age and the risk of CHD in adulthood. Methods and Findings: The heights of almost all children born 1930 through 1976 who attended school in the Copenhagen municipality (232,063 children) were measured annually from 7 to 13 years of age. Birth weight data were available since 1936. Fatal and non-fatal CHD events were ascertained by register linkage until 2008 (25,214 cases). Hazard ratios (HR) with 95% confidence intervals (CI) were estimated by Cox proportional hazards regression for height z-scores (standard deviation units) and change in height z-scores. Height z-scores were inversely related to the risk of CHD. The association was strongest at 7 years of age (HR = 0.91, CI 0.90-0.92 in boys and 0.88, CI 0.86-0.90 in girls) and steadily weakened thereafter, yet it still remained at 13 years of age (HR = 0.95, CI 0.94-0.97 and 0.91, CI 0.89-0.93, boys and girls respectively). The associations were not modified by birth weight. Independent of the age-specific risk, rapid growth was associated with an increased CHD risk, most pronounced between 9 and 11 years in girls (HR = 1.22, CI 1.14-1.31) and between 11 and 13 years in boys (HR = 1.28, CI 1.22-1.33) per unit increase in z-score. Adjustment for body mass index somewhat strengthened the associations of CHD risk with height and weakened the association with growth. Conclusions/Significance: Risk of CHD in adulthood is inversely related to height at ages 7 through 13 years, but strongest in the youngest, and, independently hereof, the risk increased by growth velocity.	[Silventoinen, Karri] Univ Helsinki, Dept Social Res, Populat Res Unit, Helsinki, Finland; [Silventoinen, Karri] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Baker, Jennifer L.; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark	University of Helsinki; University of Helsinki; University of Copenhagen	Silventoinen, K (corresponding author), Univ Helsinki, Dept Social Res, Populat Res Unit, Helsinki, Finland.	karri.silventoinen@helsinki.fi	Baker, Jennifer L./AAH-4693-2020; Baker, Jennifer/F-1917-2010	Baker, Jennifer L./0000-0002-9649-6615; Baker, Jennifer/0000-0002-9649-6615; Silventoinen, Karri/0000-0003-1759-3079	National Institute of Diabetes and Digestive and Kidney Diseases [F32DK070491]; Lundbeck Foundation [R13-A1317]; Danish National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK070491] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Lundbeck Foundation(Lundbeckfonden); Danish National Science Foundation(Danmarks Grundforskningsfond); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (F32DK070491 to JLB), the Lundbeck Foundation (R13-A1317) and by the Danish National Science Foundation. KS works in the Academy of Finland Centre of Excellence in Complex Disease Genetics. The study is part of the activities in the Danish Obesity Research Centre, DanORC, see www.danorc.dk. The funders no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002728; Andersen TF, 1999, DAN MED BULL, V46, P263; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Baker JL, 2009, INT J EPIDEMIOL, V38, P656, DOI 10.1093/ije/dyn164; Barker DJP, 2009, ANN HUM BIOL, V36, P445, DOI 10.1080/03014460902980295; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Eriksson JG, 2007, HYPERTENSION, V49, P1415, DOI 10.1161/HYPERTENSIONAHA.106.085597; Eveleth P. B., 2003, WORLDWIDE VARIATION; Feng Y, 2008, ATHEROSCLEROSIS, V196, P590, DOI 10.1016/j.atherosclerosis.2007.06.016; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; Frontini MG, 2003, INT J OBESITY, V27, P1398, DOI 10.1038/sj.ijo.0802422; Gamborg M, 2007, AM J EPIDEMIOL, V166, P634, DOI 10.1093/aje/kwm042; Gunnell DJ, 1998, J EPIDEMIOL COMMUN H, V52, P142, DOI 10.1136/jech.52.3.142; Hardy R, 2006, J HYPERTENS, V24, P59, DOI 10.1097/01.hjh.0000198033.14848.93; Juel K, 1999, DAN MED BULL, V46, P354; Juul A, 2006, INT J ANDROL, V29, P247, DOI 10.1111/j.1365-2605.2005.00556.x; Kindblom JM, 2006, DIABETES, V55, P3047, DOI 10.2337/db06-0192; Mackenbach JP, 2000, EUR HEART J, V21, P1141, DOI 10.1053/euhj.1999.1990; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Nwasokwa ON, 1997, AM HEART J, V133, P147, DOI 10.1016/S0002-8703(97)70202-3; OSMOND C, 1993, BRIT MED J, V307, P1519, DOI 10.1136/bmj.307.6918.1519; Paajanen TA, 2010, EUR HEART J, V31, P1802, DOI 10.1093/eurheartj/ehq155; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; Sandhu J, 2006, J CLIN ENDOCR METAB, V91, P3150, DOI 10.1210/jc.2005-2318; Silventoinen K, 2006, AM J EPIDEMIOL, V163, P615, DOI 10.1093/aje/kwj081; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Silventoinen K, 2008, PEDIATRICS, V121, pE885, DOI 10.1542/peds.2007-1615; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Song YM, 2003, AM J EPIDEMIOL, V158, P479, DOI 10.1093/aje/kwg173; Sorensen HT, 1999, AM J EPIDEMIOL, V149, P726; WAALER HT, 1984, ACTA MED SCAND, P1; Wehkalampi K, 2008, AM J HUM BIOL, V20, P417, DOI 10.1002/ajhb.20748	32	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30476	10.1371/journal.pone.0030476	http://dx.doi.org/10.1371/journal.pone.0030476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291964	Green Published, gold, Green Submitted			2022-12-27	WOS:000301639600025
J	Allen, IC; Lich, JD; Arthur, JC; Jania, CM; Roberts, RA; Callaway, JB; Tilley, SL; Ting, JPY				Allen, Irving C.; Lich, John D.; Arthur, Janelle C.; Jania, Corey M.; Roberts, Reid A.; Callaway, Justin B.; Tilley, Stephen L.; Ting, Jenny P. -Y.			Characterization of NLRP12 during the Development of Allergic Airway Disease in Mice	PLOS ONE			English	Article							NF-KAPPA-B; CUTTING EDGE; IN-VIVO; SIGNALING PATHWAYS; PROTEIN; ACTIVATION; MONARCH-1; GENES; CELLS; CATERPILLER	Among the 22 members of the nucleotide binding-domain, leucine rich repeat-containing (NLR) family, less than half have been functionally characterized. Of those that have been well studied, most form caspase-1 activating inflammasomes. NLRP12 is a unique NLR that has been shown to attenuate inflammatory pathways in biochemical assays and mediate the lymph node homing of activated skin dendritic cells in contact hypersensitivity responses. Since the mechanism between these two important observations remains elusive, we further evaluated the contribution of NLRP12 to organ specific adaptive immune responses by focusing on the lung, which, like skin, is exposed to both exogenous and endogenous inflammatory agents. In models of allergic airway inflammation induced by either acute ovalbumin (OVA) exposure or chronic house dust mite (HDM) antigen exposure, Nlrp12(-/-) mice displayed subtle differences in eosinophil and monocyte infiltration into the airways. However, the overall development of allergic airway disease and airway function was not significantly altered by NLRP12 deficiency. Together, the combined data suggest that NLRP12 does not play a vital role in regulating Th2 driven airway inflammation using common model systems that are physiologically relevant to human disease. Thus, the allergic airway inflammation models described here should be appropriate for subsequent studies that seek to decipher the contribution of NLRP12 in mediating the host response to agents associated with asthma exacerbation.	[Allen, Irving C.; Lich, John D.; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Inst Inflammatory Dis, Chapel Hill, NC 27599 USA; [Allen, Irving C.; Lich, John D.; Ting, Jenny P. -Y.] Univ N Carolina, Ctr Translat Immunol, Chapel Hill, NC USA; [Allen, Irving C.; Arthur, Janelle C.; Roberts, Reid A.; Callaway, Justin B.; Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Jania, Corey M.; Tilley, Stephen L.] Univ N Carolina, Dept Med, Div Pulm & Crit Care Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Allen, IC (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Inst Inflammatory Dis, Chapel Hill, NC 27599 USA.	panyun@med.unc.edu		Arthur, Janelle/0000-0002-4796-0207; Allen, Irving/0000-0001-9573-5250	National Institutes of Health [A1063031, U19-AI067798, U19-AI077437, DK38108, DE016326, HL068141, F32-AI-082895-01, T32-AR007416, T32-CA009156]; Sandler Program; National Institutes of Health National Research Service; American Cancer Society; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077437, U19AI067798, F32AI082895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038108, K01DK092355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Program; National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health A1063031, U19-AI067798, U19-AI077437, DK38108, DE016326 and HL068141 (J.P.Y. Ting) and F32-AI-082895-01; T32-AR007416 and T32-CA009156 (I.C. Allen). J.P.Y.T. is a Sandler Program Award Recipient. This work was also supported by a National Institutes of Health National Research Service Trainee Award (J.C.A.) and the American Cancer Society (J.D.L. and I.C.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen IC, 2006, AM J PHYSIOL-LUNG C, V291, pL1005, DOI 10.1152/ajplung.00174.2006; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Arthur JC, 2010, J IMMUNOL, V185, P4515, DOI 10.4049/jimmunol.1002227; Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Cressman VL, 1998, AM J RESP CELL MOL, V19, P853, DOI 10.1165/ajrcmb.19.6.3194; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Hisbergues M, 2007, CLIN EXP ALLERGY, V37, P1286, DOI 10.1111/j.1365-2222.2007.02792.x; Jin HL, 2009, J ALLERGY CLIN IMMUN, V123, P875, DOI 10.1016/j.jaci.2009.02.007; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; Lovgren AK, 2006, AM J PHYSIOL-LUNG C, V291, pL144, DOI 10.1152/ajplung.00492.2005; Macaluso F, 2007, EXP DERMATOL, V16, P692, DOI 10.1111/j.1600-0625.2007.00589.x; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Patel M, 2005, J IMMUNOL, V174, P7558, DOI 10.4049/jimmunol.174.12.7558; Rao KMK, 2006, J TOXICOL ENV HEAL A, V69, P481, DOI 10.1080/15287390500247025; Stevenson CS, 2010, PHARM THER; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Williams KL, 2003, J IMMUNOL, V170, P5354, DOI 10.4049/jimmunol.170.11.5354; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Wu Q, 2007, AM J PHYSIOL-LUNG C, V292, pL1064, DOI 10.1152/ajplung.00301.2006; Yu M, 2006, J CLIN INVEST, V116, P1633, DOI 10.1172/JCI25702	23	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30612	10.1371/journal.pone.0030612	http://dx.doi.org/10.1371/journal.pone.0030612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291998	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600063
J	Hornak, M; Oracova, E; Hulinska, P; Urbankova, L; Rubes, J				Hornak, Miroslav; Oracova, Eva; Hulinska, Pavlina; Urbankova, Leona; Rubes, Jiri			Aneuploidy Detection in Pigs Using Comparative Genomic Hybridization: From the Oocytes to Blastocysts	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; INNER CELL MASS; CHROMOSOMAL-ABNORMALITIES; PORCINE EMBRYOS; GENETIC-ANALYSIS; VITRO; GILTS; SPERM; DAY-6; STAGE	Data on the frequency of aneuploidy in farm animals are lacking and there is the need for a reliable technique which is capable of detecting all chromosomes simultaneously in a single cell. With the employment of comparative genomic hybridization coupled with the whole genome amplification technique, this study brings new information regarding the aneuploidy of individual chromosomes in pigs. Focus is directed on in vivo porcine blastocysts and late morulas, 4.7% of which were found to carry chromosomal abnormality. Further, ploidy abnormalities were examined using FISH in a sample of porcine embryos. True polyploidy was relatively rare (1.6%), whilst mixoploidy was presented in 46.8% of embryos, however it was restricted to only a small number of cells per embryo. The combined data indicates that aneuploidy is not a prevalent cause of embryo mortality in pigs.	[Hornak, Miroslav; Oracova, Eva; Hulinska, Pavlina; Rubes, Jiri] Vet Res Inst, CS-62132 Brno, Czech Republic; [Urbankova, Leona] Inst Anim Sci, Kostelec Nad Orlici, Czech Republic	Czech Veterinary Research Institute; Czech Research Institute of Animal Science	Hornak, M (corresponding author), Vet Res Inst, CS-62132 Brno, Czech Republic.	hornak@vri.cz			Grant Agency of the Ministry of Agriculture of the Czech Republic [MZE QH81068]; CEITEC - Central European Institute of Technology [CZ.1.05/1.1.00/02.0068]	Grant Agency of the Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic); CEITEC - Central European Institute of Technology	The work was supported by the Grant Agency of the Ministry of Agriculture of the Czech Republic, project MZE QH81068 and by the project CEITEC - Central European Institute of Technology (CZ.1.05/1.1.00/02.0068) from the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COONEN E, 1994, HUM REPROD, V9, P533, DOI 10.1093/oxfordjournals.humrep.a138540; Coppola G, 2007, CHROMOSOME RES, V15, P399, DOI 10.1007/s10577-007-1125-2; DOLCH KM, 1981, AM J VET RES, V42, P344; Ducos A, 1998, J HERED, V89, P136, DOI 10.1093/jhered/89.2.136; Frumkin T, 2008, MOL CELL ENDOCRINOL, V282, P112, DOI 10.1016/j.mce.2007.11.009; Gabriel AS, 2011, J MED GENET, V48, P433, DOI 10.1136/jmg.2010.088070; Gutierrez-Mateo C, 2011, FERTIL STERIL, V95, P953, DOI 10.1016/j.fertnstert.2010.09.010; Hornak M, 2009, CYTOGENET GENOME RES, V126, P210, DOI 10.1159/000245922; Hornak M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018892; Johnson DS, 2010, MOL HUM REPROD, V16, P944, DOI 10.1093/molehr/gaq062; Keskintepe L, 2007, REPROD BIOMED ONLINE, V15, P303, DOI 10.1016/S1472-6483(10)60343-4; King WA, 2008, CYTOGENET GENOME RES, V120, P81, DOI 10.1159/000118743; KOENIG JLF, 1993, BIOL REPROD, V49, P1158, DOI 10.1095/biolreprod49.6.1158; Lechniak D, 2007, THERIOGENOLOGY, V68, P755, DOI 10.1016/j.theriogenology.2007.06.012; LONG SE, 1982, J REPROD FERTIL, V66, P645, DOI 10.1530/jrf.0.0660645; McCauley TC, 2003, THERIOGENOLOGY, V60, P1569, DOI 10.1016/S0093-691X(03)00172-9; MCFEELY RA, 1967, J REPROD FERTIL, V13, P579, DOI 10.1530/jrf.0.0130579; MOON RG, 1975, J REPROD FERTIL, V45, P147, DOI 10.1530/jrf.0.0450147; Pauciullo A, 2009, ITAL J ANIM SCI, V8, P123, DOI 10.4081/ijas.2009.s2.123; Rambags BPB, 2005, MOL REPROD DEV, V72, P77, DOI 10.1002/mrd.20302; Rubes J, 1999, CYTOGENET CELL GENET, V85, P200, DOI 10.1159/000015293; Sosnowski J, 2003, THERIOGENOLOGY, V60, P571, DOI 10.1016/S0093-691X(03)00044-X; Ulloa CMU, 2008, J REPROD DEVELOP, V54, P22, DOI 10.1262/jrd.19102; VANDERHOEVEN FA, 1985, J REPROD FERTIL, V75, P593, DOI 10.1530/jrf.0.0750593; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Vozdova M, 2001, THERIOGENOLOGY, V56, P771, DOI 10.1016/S0093-691X(01)00606-9; YERLE M, 1994, MAMM GENOME, V5, P34, DOI 10.1007/BF00360565; Zijlstra C, 2008, THERIOGENOLOGY, V70, P923, DOI 10.1016/j.theriogenology.2008.05.055; Zuccotti M, 1998, MOL REPROD DEV, V50, P305, DOI 10.1002/(SICI)1098-2795(199807)50:3&lt;305::AID-MRD6&gt;3.0.CO;2-N; Zudova D, 2003, CYTOGENET GENOME RES, V102, P179, DOI 10.1159/000075745	30	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30335	10.1371/journal.pone.0030335	http://dx.doi.org/10.1371/journal.pone.0030335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291937	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600032
J	Yoo, DE; Park, JT; Oh, HJ; Kim, SJ; Lee, MJ; Shin, DH; Han, SH; Yoo, TH; Choi, KH; Kang, SW				Yoo, Dong Eun; Park, Jung Tak; Oh, Hyung Jung; Kim, Seung Jun; Lee, Mi Jung; Shin, Dong Ho; Han, Seung Hyeok; Yoo, Tae-Hyun; Choi, Kyu Hun; Kang, Shin-Wook			Good Glycemic Control Is Associated with Better Survival in Diabetic Patients on Peritoneal Dialysis: A Prospective Observational Study	PLOS ONE			English	Article							GLUCOSE CONTROL; MORTALITY; COMPLICATIONS; PREDICTOR; THERAPY	Background: The effect of glycemic control after starting peritoneal dialysis (PD) on the survival of diabetic PD patients has largely been unexplored, especially in Asian population. Methods: We conducted a prospective observational study, in which 140 incident PD patients with diabetes were recruited. Patients were divided into tertiles according to the means of quarterly HbA1C levels measured during the first year after starting PD. We examined the association between HbA1C and all-cause mortality using Cox proportional hazards models. Results: The mean age was 58.7 years, 59.3% were male, and the mean follow-up duration was 3.5 years (range 0.4-9.5 years). The mean HbA1C levels were 6.3%, 7.1%, and 8.5% in the 1st, 2nd, and 3rd tertiles, respectively. Compared to the 1st tertile, the all-cause mortality rates were higher in the 2nd [hazard ratio (HR), 4.16; 95% confidence interval (CI), 0.91-18.94; p = 0.065] and significantly higher in the 3rd (HR, 13.16; 95% CI, 2.67-64.92; p = 0.002) tertiles (p for trend = 0.005), after adjusting for confounding factors. Cardiovascular mortality, however, did not differ significantly among the tertiles (p for trend = 0.682). In contrast, non-cardiovascular deaths, most of which were caused by infection, were more frequent in the 2nd (HR, 7.67; 95% CI, 0.68-86.37; p = 0.099) and the 3rd (HR, 51.24; 95% CI, 3.85-681.35; p = 0.003) tertiles than the 1st tertile (p for trend = 0.007). Conclusions: Poor glycemic control is associated with high mortality rates in diabetic PD patients, suggesting that better glycemic control may improve the outcomes of these patients.	[Yoo, Dong Eun; Park, Jung Tak; Oh, Hyung Jung; Kim, Seung Jun; Lee, Mi Jung; Shin, Dong Ho; Han, Seung Hyeok; Yoo, Tae-Hyun; Choi, Kyu Hun; Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System	Yoo, DE (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Severance Biomed Sci Inst, Seoul, South Korea.	kswkidney@yuhs.ac	Han, Seung Hyeok/W-8825-2019; Han, Seung Hyeok/K-4559-2018; Kim, Seung Jun/N-5248-2019	Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Kim, Seung Jun/0000-0002-6913-6358; Yoo, Tae-Hyun/0000-0002-9183-4507; Choi, Kyu Hun/0000-0003-0095-9011; Park, Jung Tak/0000-0002-2325-8982; Lee, Mi Jung/0000-0001-8888-029X; Kang, Shin-Wook/0000-0002-5677-4756	Yonsei University; National Research Foundation of Korea; Korea government (MEST) [2011-0030711]; Ministry of Health and Welfare, Republic of Korea [A102065]	Yonsei University; National Research Foundation of Korea(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the Brain Korea 21 Project for Medical Science, Yonsei University, by the National Research Foundation of Korea grant funded by the Korea government (MEST) (No. 2011-0030711), and by a grant of the Korea Healthcare Technology Research & Development Project, Ministry of Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; BLAGG CR, 1991, AM J KIDNEY DIS, V17, P458, DOI 10.1016/S0272-6386(12)80641-X; Bopp C, 2008, CRIT CARE, V12, DOI 10.1186/cc6164; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chung SH, 2010, NEPHROL DIAL TRANSPL, V25, P3742, DOI 10.1093/ndt/gfq233; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Duong U, 2011, CLIN J AM SOC NEPHRO, V6, P1041, DOI 10.2215/CJN.08921010; Genuth S, 2003, DIABETES CARE, V26, P3160; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Jin Dong Chan, 2011, Korean Journal of Internal Medicine, V26, P123, DOI 10.3904/kjim.2011.26.2.123; Kalantar-Zadeh K, 2007, DIABETES CARE, V30, P1049, DOI 10.2337/dc06-2127; KREDIET RT, 1986, NEPHRON, V42, P133, DOI 10.1159/000183652; Morioka T, 2001, DIABETES CARE, V24, P909, DOI 10.2337/diacare.24.5.909; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Oomichi T, 2006, DIABETES CARE, V29, P1496, DOI 10.2337/dc05-1887; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shurraw S, 2010, AM J KIDNEY DIS, V55, P875, DOI 10.1053/j.ajkd.2009.12.038; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; United States Renal Data System, 2010, AM J KIDNEY DIS, V52, pS212; Wade CE, 2008, CRIT CARE, V12, DOI 10.1186/cc7012; WATSON PE, 1980, AM J CLIN NUTR, V33, P27, DOI 10.1093/ajcn/33.1.27; Wei M, 1998, DIABETES CARE, V21, P1167, DOI 10.2337/diacare.21.7.1167; Williams ME, 2006, KIDNEY INT, V70, P1503, DOI 10.1038/sj.ki.5001789; Wu MS, 1999, PERITON DIALYSIS INT, V19, pS179	26	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30072	10.1371/journal.pone.0030072	http://dx.doi.org/10.1371/journal.pone.0030072			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291903	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600013
J	Ciriza, J; Hall, D; Lu, A; De Sena, JR; Al-Kuhlani, M; Garcia-Ojeda, ME				Ciriza, Jesus; Hall, Dominique; Lu, Alison; De Sena, Joseph Robert; Al-Kuhlani, Mufadhal; Garcia-Ojeda, Marcos E.			Single-Cell Analysis of Murine Long-Term Hematopoietic Stem Cells Reveals Distinct Patterns of Gene Expression during Fetal Migration	PLOS ONE			English	Article							BONE-MARROW; N-CADHERIN; ADHESION MOLECULE-1; ENDOCHONDRAL OSSIFICATION; SELECTIN LIGANDS; PROGENITOR CELLS; NICHE; LIVER; ENGRAFTMENT; DIFFERENTIATION	Background: Long-term hematopoietic stem cells (LT-HSCs) migrate from the fetal liver (FL) to the fetal bone marrow (FBM) during development. Various adhesion and chemotactic receptor genes have been implicated in the migration of adult LT-HSCs. However, their role in the migration of fetal LT-HSCs is not clearly understood due, in part, to the rare number of these cells in fetal tissues, which preclude classical gene expression analysis. The aim of this study is to characterize the expression of migration related genes in fetal LT-HSC across different anatomical locations during development. Methodology/Principal Findings: We isolated fetal LT-HSC from different developmental stages, as well as different anatomical locations, and performed single-cell multiplex RT-qPCR and flow cytometry analysis of eight molecules involved in adult LT-HSC migration. Our results show that the gene expression of the chemokine receptor Cxcr4 in LT-HSC varies across developmental microenvironments and times, while the cadherin Cdh2 (Ncad) and the calcium receptor Casr show higher gene expression and variability only in FBM at 17.5 days post coitum (dpc). The cadherin Cdh5 (Vecad) maintains high expression variability only during fetal development, while the integrin subunit Itga5 (alpha 5) increases its variability after 14.5 dpc. The integrin subunits Itga4 (alpha 4) and Itgal (Lfa1), as well as the selectin ligand Selplg (Psgl1), did not show differences in their expression in single LT-HSCs irrespective of the developmental times or anatomical microenvironments studied. Conclusions/Significance: Our data demonstrate that the expression pattern of phenotypically identical, single LT-HSCs fluctuates as a function of developmental stage and anatomical microenvironment. This is the first exhaustive gene expression comparison of migration-related molecules in fetal tissues across developmental times, enhancing the understanding of LT-HSC migration fate decisions during development.	[Ciriza, Jesus; Hall, Dominique; Lu, Alison; De Sena, Joseph Robert; Al-Kuhlani, Mufadhal; Garcia-Ojeda, Marcos E.] Univ Calif Merced, Sch Nat Sci, Merced, CA 95344 USA	University of California System; University of California Merced	Ciriza, J (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA 95344 USA.	mgarcia-ojeda@ucmerced.edu	Ciriza, Jesus/M-3821-2018	Ciriza, Jesus/0000-0002-8666-622X	University of California; Government of Navarra, Spain; California Institute [TG2-01163]	University of California(University of California System); Government of Navarra, Spain; California Institute	This work was funded by the University of California Merced start-up funds. JC was partially funded by a postdoctoral fellowship from the Government of Navarra, Spain and the California Institute for Regenerative Medicine Stem Cell Training Program Award (TG2-01163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Ayres-Silva JD, 2011, CELL TISSUE RES, V344, P455, DOI 10.1007/s00441-011-1170-1; Benson DA, 2010, NUCL ACIDS RES; Bradley JA, 2002, NAT REV IMMUNOL, V2, P859, DOI 10.1038/nri934; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Castro CHM, 2004, J CELL SCI, V117, P2853, DOI 10.1242/jcs.01133; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075; Ciriza J, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt14; Domen J, 1999, MOL MED TODAY, V5, P201, DOI 10.1016/S1357-4310(99)01464-1; Frenette PS, 1998, P NATL ACAD SCI USA, V95, P14423, DOI 10.1073/pnas.95.24.14423; Hidalgo A, 2002, J CLIN INVEST, V110, P559, DOI 10.1172/JCI200214047; Hosokawa K, 2010, BLOOD, V116, P554, DOI 10.1182/blood-2009-05-224857; Jacobsen K, 1996, BLOOD, V87, P73; Kaplan RN, 2007, TRENDS MOL MED, V13, P72, DOI 10.1016/j.molmed.2006.12.003; Katayama Y, 2003, BLOOD, V102, P2060, DOI 10.1182/blood-2003-04-1212; Kawabata T, 1999, P NATL ACAD SCI USA, V96, P5663, DOI 10.1073/pnas.96.10.5663; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2009, CELL STEM CELL, V4, P170, DOI 10.1016/j.stem.2008.10.005; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2005, BLOOD, V106, P903, DOI 10.1182/blood-2004-12-4960; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Lam BS, 2010, BLOOD; Lefebvre V, 2010, CURR TOP DEV BIOL, V90, P291, DOI 10.1016/S0070-2153(10)90008-2; Li HY, 2010, AM J PHYSIOL-CELL PH, V299, pC422, DOI 10.1152/ajpcell.00562.2009; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Mazo IB, 1999, J LEUKOCYTE BIOL, V66, P25, DOI 10.1002/jlb.66.1.25; McKinney-Freeman SL, 2009, BLOOD, V114, P268, DOI 10.1182/blood-2008-12-193888; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Papayannopoulou T, 2001, BLOOD, V97, P1282, DOI 10.1182/blood.V97.5.1282; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; RITTER MA, 1993, IMMUNOL TODAY, V14, P462, DOI 10.1016/0167-5699(93)90250-O; Schweitzer KM, 1996, AM J PATHOL, V148, P165; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van der Loo JCM, 1998, J CLIN INVEST, V102, P1051, DOI 10.1172/JCI3687; Walter U, 2000, EUR J IMMUNOL, V30, P1224, DOI 10.1002/1521-4141(200004)30:4<1224::AID-IMMU1224>3.0.CO;2-B; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Warren LA, 2007, AGING CELL, V6, P775, DOI 10.1111/j.1474-9726.2007.00337.x; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006; Wu JY, 2009, J BONE MINER RES, V24, P759, DOI [10.1359/JBMR.090225, 10.1359/jbmr.090225]; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	55	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30542	10.1371/journal.pone.0030542	http://dx.doi.org/10.1371/journal.pone.0030542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276210	gold, Green Submitted, Green Published			2022-12-27	WOS:000301568100054
J	Kim, SH; Pezzoli, L; Yacouba, H; Coulibaly, T; Djingarey, MH; Perea, WA; Wierzba, TF				Kim, Sung Hye; Pezzoli, Lorenzo; Yacouba, Harouna; Coulibaly, Tiekoura; Djingarey, Mamoudou H.; Perea, William A.; Wierzba, Thomas F.			Whom and Where Are We Not Vaccinating? Coverage after the Introduction of a New Conjugate Vaccine against Group A Meningococcus in Niger in 2010	PLOS ONE			English	Article							IMMUNIZATION COVERAGE; BURKINA-FASO; MENINGITIS; CAMPAIGN; AFRICA	MenAfriVac is a new conjugate vaccine against Neisseria meningitidis serogroup A developed for the African "meningitis belt". In Niger, the first two phases of the MenAfriVac introduction campaign were conducted targeting 3,135,942 individuals aged 1 to 29 years in the regions of Tillaberi, Niamey, and Dosso, in September and December 2010. We evaluated the campaign and determined which sub-populations or areas had low levels of vaccination coverage in the regions of Tillaberi and Niamey. After Phase I, conducted in the Filingue district, we estimated coverage using a 30615 cluster-sampling survey and nested lot quality assurance (LQA) analysis in the clustered samples to identify which subpopulations (defined by age 1-14/15-29 and sex) had unacceptable vaccination coverage (<70%). After Phase II, we used Clustered Lot Quality Assurance Sampling (CLQAS) to assess if any of eight districts in Niamey and Tillaberi had unacceptable vaccination coverage (<75%) and estimated overall coverage. Estimated vaccination coverage was 77.4% (95% CI: 84.6-70.2) as documented by vaccination cards and 85.5% (95% CI: 79.7-91.2) considering verbal history of vaccination for Phase I; 81.5% (95% CI: 86.1-77.0) by card and 93.4% (95% CI: 91.0-95.9) by verbal history for Phase II. Based on vaccination cards, in Filingue, we identified both the male and female adult (age 15-29) subpopulations as not reaching 70% coverage; and we identified three (one in Tillaberi and two in Niamey) out of eight districts as not reaching 75% coverage confirmed by card. Combined use of LQA and cluster sampling was useful to estimate vaccination coverage and to identify pockets with unacceptable levels of coverage (adult population and three districts). Although overall vaccination coverage was satisfactory, we recommend continuing vaccination in the areas or sub-populations with low coverage and reinforcing the social mobilization of the adult population.	[Kim, Sung Hye; Wierzba, Thomas F.] Int Vaccine Inst, Translat Res Div, Seoul, South Korea; [Pezzoli, Lorenzo] Consultant Meningitis Vaccine Project, London, England; [Yacouba, Harouna] Minist Publ Hlth, Dept Surveillance Stat & Epidem Response, Niamey, Niger; [Coulibaly, Tiekoura] World Hlth Org, Expanded Programme Immunizat, Niamey, Niger; [Djingarey, Mamoudou H.] World Hlth Org, Meningitis Vaccine Project Focal Point, Intercountry Support Team W Africa, Ouagadougou, Burkina Faso; [Perea, William A.] World Hlth Org, Epidem Readiness & Intervent, Geneva, Switzerland	International Vaccine Institute; World Health Organization; World Health Organization; World Health Organization	Kim, SH (corresponding author), World Hlth Org, Div Pacific Tech Support, Suva, Fiji.	sunghye.kim@post.harvard.edu	Pezzoli, Lorenzo/AAA-9894-2019		government of the Republic of Korea	government of the Republic of Korea(Korean Government)	The study was supported by the government of the Republic of Korea, via Air-ticket Solidarity Contribution, to the government of Niger.(www.odakorea.go.kr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P47; [Anonymous], 1996, MON IMM SERV US LOT; BORGDORFF MW, 1988, J TROP MED HYG, V91, P35; Deitchler M, 2007, INT J EPIDEMIOL, V36, P858, DOI 10.1093/ije/dym092; Greenland K, 2011, TROP MED INT HEALTH, V16, P863, DOI 10.1111/j.1365-3156.2011.02770.x; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; Haddad S, 2010, HEALTH POLICY PLANN, V25, P393, DOI 10.1093/heapol/czq007; HOSHAWWOODARD S, 2001, DESCRIPTION COMPARIS; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; LaForce FM, 2011, HEALTH AFFAIR, V30, P1049, DOI 10.1377/hlthaff.2011.0328; LANATA CF, 1990, INT J EPIDEMIOL, V19, P1086, DOI 10.1093/ije/19.4.1086; MYATT M, 2001, SAMPLELQ SAMPLE SIZE; Pezzoli L, 2011, EPIDEMIOL INFECT, P1, DOI DOI 10.1017/S0950268811000331; Pezzoli L, 2010, TROP MED INT HEALTH, V15, P540, DOI 10.1111/j.1365-3156.2010.02482.x; Pezzoli L, 2009, TROP MED INT HEALTH, V14, P355, DOI 10.1111/j.1365-3156.2009.02231.x; Singh J, 1996, B WORLD HEALTH ORGAN, V74, P269; Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812; Stephens DS, 2008, J INFECT DIS, V197, P643, DOI 10.1086/527402; Stephens DS, 2004, CURR INFECT DIS REP, V6, P351; Thompson F, 2011, B WORLD HEALTH ORGAN, V89, P550, DOI 10.2471/BLT.11.020811; Trotter CL, 2005, AM J EPIDEMIOL, V162, P89, DOI 10.1093/aje/kwi160; WHO, 2005, IMM COV CLUST SURV R; World Health Organization, 1997, WKLY EPIDEMIOL REC, V72, P313; World Health Organization, 2010, WKLY EPIDEMIOL REC, V84, P325; Zuber PLF, 2003, J INFECT DIS, V187, pS86, DOI 10.1086/368052	25	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29116	10.1371/journal.pone.0029116	http://dx.doi.org/10.1371/journal.pone.0029116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276104	gold, Green Published, Green Submitted			2022-12-27	WOS:000301568100008
J	Wang, Y; Sun, G; Ji, ZH; Xing, C; Liang, YC				Wang, Yao; Sun, Guang; Ji, Zhaohua; Xing, Chong; Liang, Yanchun			Weighted Change-Point Method for Detecting Differential Gene Expression in Breast Cancer Microarray Data	PLOS ONE			English	Article							PROSTATE-CANCER; GASTRIC-CANCER; HISTONE DEACETYLASES; TRANSCRIPTION FACTOR; COLORECTAL-CANCER; PROTEIN; OVEREXPRESSION; METHYLATION; ACTIVATION; PATTERNS	In previous work, we proposed a method for detecting differential gene expression based on change-point of expression profile. This non-parametric change-point method gave promising result in both simulation study and public dataset experiment. However, the performance is still limited by the less sensitiveness to the right bound and the statistical significance of the statistics has not been fully explored. To overcome the insensitiveness to the right bound we modified the original method by adding a weight function to the D-n statistic. Simulation study showed that the weighted change-point statistics method is significantly better than the original NPCPS in terms of ROC, false positive rate, as well as change-point estimate. The mean absolute error of the estimated change-point by weighted change-point method was 0.03, reduced by more than 50% comparing with the original 0.06, and the mean FPR was reduced by more than 55%. Experiment on microarray Dataset I resulted in 3974 differentially expressed genes out of total 5293 genes; experiment on microarray Dataset II resulted in 9983 differentially expressed genes among total 12576 genes. In summary, the method proposed here is an effective modification to the previous method especially when only a small subset of cancer samples has DGE.	[Wang, Yao; Xing, Chong; Liang, Yanchun] Jilin Univ, Key Lab Symbol Computat & Knowledge Engn, Natl Educ Minist, Coll Comp Sci & Technol, Changchun 130023, Peoples R China; [Sun, Guang] China Japan Union Hosp, Dept Breast & Thyroid Surg, Changchun, Peoples R China; [Ji, Zhaohua] Jilin Univ, Dept Commun Engn, Changchun 130023, Peoples R China; [Ji, Zhaohua] Inner Mongolia Normal Univ, Coll Comp Sci & Technol, Hohhot, Peoples R China; [Xing, Chong] Changchun Univ, Guanghua Coll, Changchun, Peoples R China	Jilin University; Jilin University; Jilin University; Inner Mongolia Normal University; Changchun University	Liang, YC (corresponding author), Jilin Univ, Key Lab Symbol Computat & Knowledge Engn, Natl Educ Minist, Coll Comp Sci & Technol, Changchun 130023, Peoples R China.	ycliang@jlu.edu.cn			National High-technology Development Project [2009AA02Z307]; National Natural Science Foundation of China [10872077, 60703025]; Education Department of Jilin Province of China [2011449]; Natural Science Foundation of Inner Mongolia of China [2011MS0907]; Research Program at Universities of Inner Mongolia Autonomous Region [NJ10320]	National High-technology Development Project(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department of Jilin Province of China; Natural Science Foundation of Inner Mongolia of China; Research Program at Universities of Inner Mongolia Autonomous Region	This work was supported in part by the National High-technology Development Project (2009AA02Z307), the National Natural Science Foundation of China (10872077, 60703025), the Education Department of Jilin Province (2011449) of China, the Natural Science Foundation of Inner Mongolia (2011MS0907) of China, and Research Program at Universities of Inner Mongolia Autonomous Region (NJ10320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Banine F, 2005, CANCER RES, V65, P3542, DOI 10.1158/0008-5472.CAN-04-3554; Brent R, 2000, CELL, V100, P169, DOI 10.1016/S0092-8674(00)81693-1; Cheng CW, 2010, CLIN CHIM ACTA, V411, P234, DOI 10.1016/j.cca.2009.11.009; Chong PK, 2010, PROTEOMICS, V10, P3210, DOI 10.1002/pmic.201000127; Davies Simon R, 2008, J Exp Ther Oncol, V7, P327; Drenth JPH, 1996, IMMUNOLOGY, V88, P355, DOI 10.1046/j.1365-2567.1996.d01-672.x; Dunn TA, 2006, AM J PATHOL, V169, P1843, DOI 10.2353/ajpath.2006.060316; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Entschladen F, 2011, CELL CYCLE, V10, P1086, DOI 10.4161/cc.10.7.15208; Field JK, 2005, INT J ONCOL, V27, P105; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Graham K, 2010, BRIT J CANCER, V102, P1284, DOI 10.1038/sj.bjc.6605576; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Han X, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-476; Han Yan-Chun, 2007, Ai Zheng, V26, P48; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hayashi H, 2010, INT J CANCER, V126, P2563, DOI 10.1002/ijc.24987; Hu JH, 2008, BIOINFORMATICS, V24, P2193, DOI 10.1093/bioinformatics/btn372; Ji ZH, 2010, INT J DATA IN PRESS; Kim JH, 2004, HEPATOLOGY, V39, P129, DOI 10.1002/hep.20017; Kumar D, 2011, PROJECT INFORM FUNCT; Kumar S, 2000, MODERN PATHOL, V13, P988, DOI 10.1038/modpathol.3880179; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Lian H, 2008, BIOSTATISTICS, V9, P411, DOI 10.1093/biostatistics/kxm042; Liang P, 2003, NAT REV CANCER, V3, P869, DOI 10.1038/nrc1214; Liu Y, 2011, J INVEST DERMATOL, V131, P1570, DOI 10.1038/jid.2011.62; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Lyons-Weiler J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-110; Ma Z, 2007, CURR BIOL, V17, P722, DOI 10.1016/j.cub.2007.03.014; MacDonald JW, 2006, BIOINFORMATICS, V22, P2950, DOI 10.1093/bioinformatics/btl433; Menigatti M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-124; MIETTINEN M, 1987, ARCH PATHOL LAB MED, V111, P813; Motadi L, 2005, P AM ASS CANC RES, V46; Nandana S, 2010, PROSTATE, V70, P591, DOI 10.1002/pros.21093; Pan Wei, 2003, Functional & Integrative Genomics, V3, P117; Pasini FS, 2006, P AM ASS CANC RES, V47; Renier C, 2010, J NEURO-ONCOL, V96, P331, DOI 10.1007/s11060-009-9971-8; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Smith PG, 2005, BLOOD, V105, P308, DOI 10.1182/blood-2004-01-0240; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Storey JD, 2003, SAM THRESHOLDING FAL; Tan ZP, 2000, J CHINA U SCI TECHNO, V6, P270; Tibshirani R, 2007, BIOSTATISTICS, V8, P2, DOI 10.1093/biostatistics/kxl005; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomonaga T, 2005, CANCER RES, V65, P4683, DOI 10.1158/0008-5472.CAN-04-3613; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020060; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Wu BL, 2007, BIOSTATISTICS, V8, P566, DOI 10.1093/biostatistics/kxl029; Wu P, 2010, CELL DEATH DIFFER, V17, P109, DOI 10.1038/cdd.2009.142; Yang Y., 2008, Experimental Oncology, V30, P81; Zegerman P, 2000, ONCOGENE, V19, P161, DOI 10.1038/sj.onc.1203234; Zhang HB, 2011, NAT NEUROSCI, V14, P874, DOI 10.1038/nn.2835; Zhaohua Ji, 2010, Proceedings of the 2010 3rd International Congress on Image and Signal Processing (CISP 2010 ), P3142, DOI 10.1109/CISP.2010.5648037	57	22	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29860	10.1371/journal.pone.0029860	http://dx.doi.org/10.1371/journal.pone.0029860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276133	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100018
J	Akiyama, R; Agren, J				Akiyama, Reiko; Agren, Jon			Magnitude and Timing of Leaf Damage Affect Seed Production in a Natural Population of Arabidopsis thaliana (Brassicaceae)	PLOS ONE			English	Article							INDUCED RESPONSES; FITNESS COMPONENTS; PLANT-RESISTANCE; HERBIVORY; TOLERANCE; DEFOLIATION; EVOLUTION; ECOLOGY; DEFENSE; COSTS	Background: The effect of herbivory on plant fitness varies widely. Understanding the causes of this variation is of considerable interest because of its implications for plant population dynamics and trait evolution. We experimentally defoliated the annual herb Arabidopsis thaliana in a natural population in Sweden to test the hypotheses that (a) plant fitness decreases with increasing damage, (b) tolerance to defoliation is lower before flowering than during flowering, and (c) defoliation before flowering reduces number of seeds more strongly than defoliation during flowering, but the opposite is true for effects on seed size. Methodology/Principal Findings: In a first experiment, between 0 and 75% of the leaf area was removed in May from plants that flowered or were about to start flowering. In a second experiment, 0, 25%, or 50% of the leaf area was removed from plants on one of two occasions, in mid April when plants were either in the vegetative rosette or bolting stage, or in mid May when plants were flowering. In the first experiment, seed production was negatively related to leaf area removed, and at the highest damage level, also mean seed size was reduced. In the second experiment, removal of 50% of the leaf area reduced seed production by 60% among plants defoliated early in the season at the vegetative rosettes, and by 22% among plants defoliated early in the season at the bolting stage, but did not reduce seed output of plants defoliated one month later. No seasonal shift in the effect of defoliation on seed size was detected. Conclusions/Significance: The results show that leaf damage may reduce the fitness of A. thaliana, and suggest that in this population leaf herbivores feeding on plants before flowering should exert stronger selection on defence traits than those feeding on plants during flowering, given similar damage levels.	[Akiyama, Reiko; Agren, Jon] Uppsala Univ, Dept Ecol & Genet, Evolutionary Biol Ctr, Uppsala, Sweden	Uppsala University	Akiyama, R (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	reiko.akiyama@ebc.uu.se	Ågren, Jon/E-6093-2011	Ågren, Jon/0000-0001-9573-2463	Nakajima Foundation; Tullbergs stiftelse; Sernanders stiftelse; Linneska stipendiestiftelsen; Swedish Research Council	Nakajima Foundation; Tullbergs stiftelse; Sernanders stiftelse; Linneska stipendiestiftelsen; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by stipends from the Nakajima Foundation, Tullbergs stiftelse, Sernanders stiftelse, and Linneska stipendiestiftelsen to RA, and by a grant from the Swedish Research Council to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1999, EVOLUTION, V53, P1093, DOI [10.2307/2640814, 10.1111/j.1558-5646.1999.tb04524.x]; Agrawal AA, 1998, SCIENCE, V279, P1201, DOI 10.1126/science.279.5354.1201; Al-Shehbaz Ihsan A, 2002, Arabidopsis Book, V1, pe0001, DOI 10.1199/tab.0001; Arany AM, 2005, PLANT BIOLOGY, V7, P549, DOI 10.1055/s-2005-865831; Banta JA, 2010, OIKOS, V119, P359, DOI 10.1111/j.1600-0706.2009.17726.x; Barto EK, 2005, OECOLOGIA, V146, P169, DOI 10.1007/s00442-005-0207-0; BELSKY AJ, 1986, AM NAT, V127, P870, DOI 10.1086/284531; Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; Boege K, 2007, ECOL LETT, V10, P177, DOI 10.1111/j.1461-0248.2006.01012.x; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Cipollini D, 2003, BASIC APPL ECOL, V4, P79, DOI 10.1078/1439-1791-00134; Del-Val EK, 2005, J ECOL, V93, P1005, DOI 10.1111/j.1365-2745.2005.01011.x; Diaz C, 2008, PLANT PHYSIOL, V147, P1437, DOI 10.1104/pp.108.119040; Du DL, 2008, AM J BOT, V95, P84, DOI 10.3732/ajb.95.1.84; Earley EJ, 2009, AM J BOT, V96, P786, DOI 10.3732/ajb.0800149; Garcia MB, 2002, AM J BOT, V89, P1295, DOI 10.3732/ajb.89.8.1295; Handley R, 2005, ECOL ENTOMOL, V30, P284, DOI 10.1111/j.0307-6946.2005.00699.x; Harvey JA, 2007, PLANT ECOL, V189, P117, DOI 10.1007/s11258-006-9204-6; Hochwender CG, 2000, OECOLOGIA, V122, P361, DOI 10.1007/s004420050042; HORTON M, 1994, AM J BOT, V81, P278, DOI 10.2307/2445453; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Karban R, 1997, INDUCED RESPONSE HER; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Knight TM, 2003, AM J BOT, V90, P1207, DOI 10.3732/ajb.90.8.1207; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; KRANNITZ PG, 1991, AM J BOT, V78, P446, DOI 10.2307/2444967; Lehtila K, 2004, ECOL STU AN, V173, P257; Maron JL, 2006, P R SOC B, V273, P2575, DOI 10.1098/rspb.2006.3587; Marshall DL, 2005, ANN BOT-LONDON, V95, P1049, DOI 10.1093/aob/mci116; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; Matthes MC, 2008, PLANTA, V228, P1021, DOI 10.1007/s00425-008-0804-3; Mauricio R, 1997, ECOLOGY, V78, P1301, DOI 10.1890/0012-9658(1997)078[1301:VITDSO]2.0.CO;2; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; Napp-Zinn K, 1985, CRC HDB FLOWERING, V1, P492; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; OBESO JR, 1994, OIKOS, V71, P506, DOI 10.2307/3545839; RATCLIFFE D, 1961, J ECOL, V49, P187, DOI 10.2307/2257433; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Sullivan AT, 2009, ECOLOGY, V90, P1346, DOI 10.1890/08-0629.1; Susko DJ, 2009, PLANT ECOL, V202, P169, DOI 10.1007/s11258-008-9462-6; Tifffn P, 2002, ECOLOGY, V83, P1981, DOI 10.1890/0012-9658(2002)083[1981:CATODA]2.0.CO;2; Tiffin P, 1999, AM NAT, V154, P700, DOI 10.1086/303271; TRUMBLE JT, 1993, ANNU REV ENTOMOL, V38, P93, DOI 10.1146/annurev.en.38.010193.000521; Tucker C, 2010, OECOLOGIA, V164, P1005, DOI 10.1007/s00442-010-1738-6; Wentzell AM, 2008, PLANT PHYSIOL, V147, P415, DOI 10.1104/pp.107.115279; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114; Wise MJ, 2007, AM NAT, V169, P443, DOI 10.1086/512044; Wolfinger, 1996, SAS SYSTEM MIXED MOD, P423	51	24	24	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30015	10.1371/journal.pone.0030015	http://dx.doi.org/10.1371/journal.pone.0030015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276140	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000301457200028
J	Motta, FN; Bastos, IMD; Faudry, E; Ebel, C; Lima, MM; Neves, D; Ragno, M; Barbosa, JARG; de Freitas, SM; Santana, JM				Motta, Flavia Nader; Bastos, Izabela M. D.; Faudry, Eric; Ebel, Christine; Lima, Meire M.; Neves, David; Ragno, Michel; Barbosa, Joao Alexandre R. G.; de Freitas, Sonia Maria; Santana, Jaime Martins			The Trypanosoma cruzi Virulence Factor Oligopeptidase B (OPBTc) Assembles into an Active and Stable Dimer	PLOS ONE			English	Article							CHAGAS-DISEASE CARDIOMYOPATHY; PROLYL OLIGOPEPTIDASE; MAMMALIAN-CELLS; LEISHMANIA-MAJOR; PEPTIDASE; PARASITE; PURIFICATION; PROTEINS; BRUCEI; ULTRACENTRIFUGATION	Oligopeptidase B, a processing enzyme of the prolyl oligopeptidase family, is considered as an important virulence factor in trypanosomiasis. Trypanosoma cruzi oligopeptidase B (OPBTc) is involved in host cell invasion by generating a Ca2+-agonist necessary for recruitment and fusion of host lysosomes at the site of parasite attachment. The underlying mechanism remains unknown and further structural and functional characterization of OPBTc may help clarify its physiological function and lead to the development of new therapeutic molecules to treat Chagas disease. In the present work, size exclusion chromatography and analytical ultracentrifugation experiments demonstrate that OPBTc is a dimer in solution, an association salt and pH-resistant and independent of intermolecular disulfide bonds. The enzyme retains its dimeric structure and is fully active up to 42 degrees C. OPBTc is inactivated and its tertiary, but not secondary, structure is disrupted at higher temperatures, as monitored by circular dichroism and fluorescence spectroscopy. It has a highly stable secondary structure over a broad range of pH, undergoes subtle tertiary structure changes at low pH and is less stable under moderate ionic strength conditions. These results bring new insights into the structural properties of OPBTc, contributing to future studies on the rational design of OPBTc inhibitors as a promising strategy for Chagas disease chemotherapy.	[Motta, Flavia Nader; Bastos, Izabela M. D.; Lima, Meire M.; Neves, David; Santana, Jaime Martins] Univ Brasilia, Dept Cell Biol, Pathogen Host Interface Lab, Brasilia, DF, Brazil; [Bastos, Izabela M. D.] Univ Brasilia, Fac Ceilandia, Brasilia, DF, Brazil; [Faudry, Eric; Ragno, Michel] INSERM, UMR S Biol Canc & Infect 1036, Grenoble, France; [Faudry, Eric; Ragno, Michel] CNRS, ERL 5261, Grenoble, France; [Faudry, Eric; Ragno, Michel] UJF Grenoble 1, Grenoble, France; [Faudry, Eric; Ragno, Michel] CEA, DSV iRTSV, Grenoble, France; [Ebel, Christine] CEA, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Ebel, Christine] CNRS, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Ebel, Christine] Univ Grenoble 1, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Barbosa, Joao Alexandre R. G.] Univ Catolica Brasilia, Programa Posgrad Ciencias Genom & Biotecnol, Brasilia, DF, Brazil; [de Freitas, Sonia Maria] Univ Brasilia, Dept Cell Biol, Biophys Lab, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Universidade Catolica de Brasilia; Universidade de Brasilia	Motta, FN (corresponding author), Univ Brasilia, Dept Cell Biol, Pathogen Host Interface Lab, Brasilia, DF, Brazil.	jsantana@unb.br	Santana, Jaime/H-5319-2013; Barbosa, João/GVT-7916-2022; Barbosa, João Alexandre/E-2261-2012; Faudry, Eric/I-9154-2014	Barbosa, João Alexandre/0000-0002-0534-481X; Faudry, Eric/0000-0001-9958-6029; Bastos, Izabela/0000-0002-2785-4255; Ebel, Christine/0000-0002-6912-500X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF; PRONEX); Financiadora de Estudos e Projetos (FINEP); Laboratorio Nacional de Luz Sincrotron (LNLS)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF; PRONEX); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Laboratorio Nacional de Luz Sincrotron (LNLS)	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF; PRONEX), Financiadora de Estudos e Projetos (FINEP) and Laboratorio Nacional de Luz Sincrotron (LNLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastos IMD, 2005, BIOCHEM J, V388, P29, DOI 10.1042/BJ20041049; Bastos IMD, 2010, MICROBES INFECT, V12, P457, DOI 10.1016/j.micinf.2010.02.007; Bilate AMB, 2008, REV INST MED TROP SP, V50, P67, DOI 10.1590/S0036-46652008000200001; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; Burleigh BA, 1997, J CELL BIOL, V136, P609, DOI 10.1083/jcb.136.3.609; BURLEIGH BA, 1995, J BIOL CHEM, V270, P5172, DOI 10.1074/jbc.270.10.5172; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; Coetzer THT, 2008, BIOCHIMIE, V90, P336, DOI 10.1016/j.biochi.2007.10.011; Cunha-Neto E, 2011, AUTOIMMUN REV, V10, P163, DOI 10.1016/j.autrev.2010.09.019; Guedes HLD, 2007, PARASITOL RES, V101, P853, DOI [10.1007/s00436-007-0552-5, 10.1007/s00436-007-0630-8]; Faudry E, 2007, FEBS J, V274, P3601, DOI 10.1111/j.1742-4658.2007.05893.x; Fernandes LC, 2005, MICROBES INFECT, V7, P375, DOI 10.1016/j.micinf.2004.11.009; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Gerczei T, 2000, J MOL GRAPH MODEL, V18, P7, DOI 10.1016/S1093-3263(99)00042-X; Ismail NIM, 2010, J BIOCHEM, V147, P201, DOI 10.1093/jb/mvp156; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Lakowicz JR, 2004, PRINCIPLE FLUORESCEN, P698; Lauria-Pires L, 2000, AM J TROP MED HYG, V63, P111, DOI 10.4269/ajtmh.2000.63.111; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; McLuskey K, 2010, J BIOL CHEM, V285, P39249, DOI 10.1074/jbc.M110.156679; Morty RE, 2005, J BIOL CHEM, V280, P10925, DOI 10.1074/jbc.M410066200; Morty RE, 2005, FEBS LETT, V579, P2191, DOI 10.1016/j.febslet.2005.03.014; Morty RE, 1998, FEBS LETT, V433, P251, DOI 10.1016/S0014-5793(98)00914-4; Munday JC, 2011, MOL BIOCHEM PARASIT, V175, P49, DOI 10.1016/j.molbiopara.2010.09.003; Polgar L, 1997, PROTEINS, V28, P375; Ponstingl H, 2005, PROG BIOPHYS MOL BIO, V89, P9, DOI 10.1016/j.pbiomolbio.2004.07.010; Qureshi SH, 2003, BIOCHEMISTRY-US, V42, P1684, DOI 10.1021/bi0271042; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rea D, 2006, ACTA CRYSTALLOGR F, V62, P808, DOI 10.1107/S1744309106027874; Rumfeldt JAO, 2008, PROG BIOPHYS MOL BIO, V98, P61, DOI 10.1016/j.pbiomolbio.2008.05.004; SANTANA JM, 1992, BIOCHEM BIOPH RES CO, V187, P1466, DOI 10.1016/0006-291X(92)90467-Y; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Swenerton RK, 2011, J BIOL CHEM, V286, P429, DOI 10.1074/jbc.M110.138313; Tsuji A, 2004, J BIOCHEM, V136, P673, DOI 10.1093/jb/mvh163; Usuki H, 2009, BBA-PROTEINS PROTEOM, V1794, P1673, DOI 10.1016/j.bbapap.2009.07.024; Westerhuis WHJ, 2000, ANAL BIOCHEM, V284, P143, DOI 10.1006/abio.2000.4684; Yoshida Nobuko, 2008, V47, P82	38	23	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30431	10.1371/journal.pone.0030431	http://dx.doi.org/10.1371/journal.pone.0030431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276197	gold, Green Published, Green Submitted			2022-12-27	WOS:000301457200060
J	Paulus, MP; Flagan, T; Simmons, AN; Gillis, K; Kotturi, S; Thom, N; Johnson, DC; Van Orden, KF; Davenport, PW; Swain, JL				Paulus, Martin P.; Flagan, Taru; Simmons, Alan N.; Gillis, Kristine; Kotturi, Sante; Thom, Nathaniel; Johnson, Douglas C.; Van Orden, Karl F.; Davenport, Paul W.; Swain, Judith L.			Subjecting Elite Athletes to Inspiratory Breathing Load Reveals Behavioral and Neural Signatures of Optimal Performers in Extreme Environments	PLOS ONE			English	Article							AIR-FLOW RESISTANCE; INSULAR CORTEX; RESISTIVE LOADS; MAGNITUDE ESTIMATION; ENDURANCE EXERCISE; DYNAMIC EXERCISE; CENTRAL GOVERNOR; CENTRAL COMMAND; BRAIN; ACTIVATION	Background: It is unclear whether and how elite athletes process physiological or psychological challenges differently than healthy comparison subjects. In general, individuals optimize exercise level as it relates to differences between expected and experienced exertion, which can be conceptualized as a body prediction error. The process of computing a body prediction error involves the insular cortex, which is important for interoception, i.e. the sense of the physiological condition of the body. Thus, optimal performance may be related to efficient minimization of the body prediction error. We examined the hypothesis that elite athletes, compared to control subjects, show attenuated insular cortex activation during an aversive interoceptive challenge. Methodology/Principal Findings: Elite adventure racers (n = 10) and healthy volunteers (n = 11) performed a continuous performance task with varying degrees of a non-hypercapnic breathing load while undergoing functional magnetic resonance imaging. The results indicate that (1) non-hypercapnic inspiratory breathing load is an aversive experience associated with a profound activation of a distributed set of brain areas including bilateral insula, dorsolateral prefrontal cortex and anterior cingulated; (2) adventure racers relative to comparison subjects show greater accuracy on the continuous performance task during the aversive interoceptive condition; and (3) adventure racers show an attenuated right insula cortex response during and following the aversive interoceptive condition of non-hypercapnic inspiratory breathing load. Conclusions/Significance: These findings support the hypothesis that elite athletes during an aversive interoceptive condition show better performance and an attenuated insular cortex activation during the aversive experience. Interestingly, differential modulation of the right insular cortex has been found previously in elite military personnel and appears to be emerging as an important brain system for optimal performance in extreme environments.	[Paulus, Martin P.; Flagan, Taru; Simmons, Alan N.; Kotturi, Sante] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Paulus, Martin P.; Gillis, Kristine; Thom, Nathaniel; Johnson, Douglas C.; Van Orden, Karl F.; Swain, Judith L.] OptiBrain Consortium, San Diego, CA USA; [Paulus, Martin P.; Simmons, Alan N.] Vet Affairs San Diego Hlth Care Syst, San Diego, CA USA; [Davenport, Paul W.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA; [Swain, Judith L.] Singapore Inst Clin Sci A STAR, Singapore, Singapore; [Swain, Judith L.] Natl Univ Singapore, Singapore 117548, Singapore	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; State University System of Florida; University of Florida; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore	Paulus, MP (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	mpaulus@ucsd.edu	Simmons, Alan N/A-9815-2008	Simmons, Alan N/0000-0003-3963-2112; Paulus, Martin/0000-0002-0825-3606	Veterans Affairs Health Care System Center for Stress and Mental Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	Veterans Affairs Health Care System Center for Stress and Mental Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by the Veterans Affairs Health Care System Center for Stress and Mental Health (http://cesamh.org/staff/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen D, 2011, J PHYSIOL-LONDON, V589, P3, DOI 10.1113/jphysiol.2010.201434; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Alexander-Miller S, 2010, BIOL PSYCHOL, V84, P147, DOI 10.1016/j.biopsycho.2010.03.004; Allen SC, 2009, AGE AGEING, V38, P548, DOI 10.1093/ageing/afp110; Anglem N, 2008, WILD ENVIRON MED, V19, P30, DOI 10.1580/07-WEME-OR-091.1; [Anonymous], 2009, OPP NEUR FUT ARM APP, P1; Barratt E.S., 1983, BIOL BASES SENSATION, P77; BORG GUNNAR, 1962, ACTA SOC MED UPSALIENSIS, V67, P91; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Chan PYS, 2008, J APPL PHYSIOL, V105, P1106, DOI 10.1152/japplphysiol.90722.2008; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2007, HDB EMOTIONS, P272; Davenport PW, 2007, J APPL PHYSIOL, V102, P276, DOI 10.1152/japplphysiol.01436.2005; Davenport PW, 2009, RESP PHYSIOL NEUROBI, V167, P72, DOI 10.1016/j.resp.2008.10.001; DAVENPORT PW, 1986, J APPL PHYSIOL, V60, P1843, DOI 10.1152/jappl.1986.60.6.1843; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Eddy WF, 1996, MAGNET RESON MED, V36, P923, DOI 10.1002/mrm.1910360615; Evans KC, 2010, BIOL PSYCHOL, V84, P13, DOI 10.1016/j.biopsycho.2010.02.005; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; Fudge JL, 2005, J COMP NEUROL, V490, P101, DOI 10.1002/cne.20660; Galambos SA, 2005, BRIT J SPORT MED, V39, P351, DOI 10.1136/bjsm.2005.018440; Gibson AS, 2004, BRIT J SPORT MED, V38, P797, DOI 10.1136/bjsm.2003.009852; GOTTFRIED SB, 1978, CHEST, V73, P286, DOI 10.1378/chest.73.2.286; Gray MA, 2007, NEURON, V54, P183, DOI 10.1016/j.neuron.2007.03.024; Hampson DB, 2001, SPORTS MED, V31, P935, DOI 10.2165/00007256-200131130-00004; Haxby JV, 2000, NEUROIMAGE, V11, P145, DOI 10.1006/nimg.1999.0527; Hilty L, 2010, HUM BRAIN MAPP; Homma I, 2008, EXP PHYSIOL, V93, P1011, DOI 10.1113/expphysiol.2008.042424; Jasmin L, 2004, J COMP NEUROL, V468, P425, DOI 10.1002/cne.10978; Jones CU, 2010, J PHYSIOTHER, V56, P179, DOI 10.1016/S1836-9553(10)70023-0; Kifle Y, 1997, AM J RESP CRIT CARE, V156, P1530, DOI 10.1164/ajrccm.156.5.9703011; Knafelc M, 1999, J APPL PHYSIOL, V87, P516, DOI 10.1152/jappl.1999.87.2.516; Littell RC, 2000, STAT MED, V19, P1793, DOI 10.1002/1097-0258(20000715)19:13<1793::AID-SIM482>3.3.CO;2-H; LOFASO F, 1992, RESP PHYSIOL, V89, P75, DOI 10.1016/0034-5687(92)90072-5; LOPATA M, 1977, AM REV RESPIR DIS, V115, P73; Lovero KL, 2009, NEUROIMAGE, V45, P976, DOI 10.1016/j.neuroimage.2008.12.070; Lucas SJE, 2008, J SPORT SCI, V26, P477, DOI 10.1080/02640410701552872; Marcora S, 2010, J APPL PHYSIOL, V108, P454, DOI 10.1152/japplphysiol.00976.2009a; Marcora SM, 2008, EUR J APPL PHYSIOL, V104, P929, DOI 10.1007/s00421-008-0818-3; Marcora SM, 2009, J APPL PHYSIOL, V106, P857, DOI 10.1152/japplphysiol.91324.2008; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Nielsen JB, 2008, J PHYSIOL-LONDON, V586, P65, DOI 10.1113/jphysiol.2007.142661; Noakes TD, 2001, J EXP BIOL, V204, P3225; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Paulus MP, 2010, BRAIN STRUCT FUNCT, V214, P451, DOI 10.1007/s00429-010-0258-9; Paulus MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010096; Paulus MP, 2009, NEUROSCI BIOBEHAV R, V33, P1080, DOI 10.1016/j.neubiorev.2009.05.003; Philippe RA, 2005, PERCEPT MOTOR SKILL, V101, P440, DOI 10.2466/PMS.101.6.440-444; Raux M, 2007, J PHYSIOL-LONDON, V578, P569, DOI 10.1113/jphysiol.2006.120246; REVELETTE WR, 1990, J APPL PHYSIOL, V68, P282, DOI 10.1152/jappl.1990.68.1.282; Rolls ET, 2004, ANAT REC PART A, V281A, P1212, DOI 10.1002/ar.a.20126; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Shipp S, 2005, PHILOS T R SOC B, V360, P797, DOI 10.1098/rstb.2005.1630; Skudlarski P, 1999, NEUROIMAGE, V9, P311, DOI 10.1006/nimg.1999.0402; Tucker R, 2009, BRIT J SPORT MED, V43, P392, DOI 10.1136/bjsm.2008.050799; von Leupoldt A, 2005, CHEST, V128, P3345, DOI 10.1378/chest.128.5.3345; von Leupoldt A, 2007, RESP MED, V101, P839, DOI 10.1016/j.rmed.2006.06.033; Williamson JW, 2001, J APPL PHYSIOL, V90, P1392, DOI 10.1152/jappl.2001.90.4.1392; Williamson JW, 1999, J APPL PHYSIOL, V87, P1213; Williamson JW, 2002, J APPL PHYSIOL, V92, P1317, DOI 10.1152/japplphysiol.00939.2001; Williamson JW, 2006, EXP PHYSIOL, V91, P51, DOI 10.1113/expphysiol.2005.032037; Williamson JW, 1997, J PHYSIOL-LONDON, V503, P277, DOI 10.1111/j.1469-7793.1997.277bh.x; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672; Zuckerman M, 2007, PERS INDIV DIFFER, V43, P1303, DOI 10.1016/j.paid.2007.03.021	71	67	68	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29394	10.1371/journal.pone.0029394	http://dx.doi.org/10.1371/journal.pone.0029394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	907YS	22276111	Green Published, gold, Green Submitted			2022-12-27	WOS:000301457200012
J	Siddiqui, S; Tsuchiya, K; Risse, PA; Bullimore, SR; Benedetti, A; Martin, JG				Siddiqui, Sana; Tsuchiya, Kimitake; Risse, Paul-Andre; Bullimore, Sharon R.; Benedetti, Andrea; Martin, James G.			Site of Allergic Airway Narrowing and the Influence of Exogenous Surfactant in the Brown Norway Rat	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; MICROVASCULAR LEAKAGE; PULMONARY SURFACTANT; ANTIGEN CHALLENGE; TISSUE MECHANICS; LUNG-FUNCTION; HISTAMINE; RESPONSES; METHACHOLINE; CONSTRICTION	Background: The parameters R-N (Newtonian resistance), G (tissue damping), and H (tissue elastance) of the constant phase model of respiratory mechanics provide information concerning the site of altered mechanical properties of the lung. The aims of this study were to compare the site of allergic airway narrowing implied from respiratory mechanics to a direct assessment by morphometry and to evaluate the effects of exogenous surfactant administration on the site and magnitude of airway narrowing. Methods: We induced airway narrowing by ovalbumin sensitization and challenge and we tested the effects of a natural surfactant lacking surfactant proteins A and D (Infasurf (R)) on airway responses. Sensitized, mechanically ventilated Brown Norway rats underwent an aerosol challenge with 5% ovalbumin or vehicle. Other animals received nebulized surfactant prior to challenge. Three or 20 minutes after ovalbumin challenge, airway luminal areas were assessed on snap-frozen lungs by morphometry. Results: At 3 minutes, R-N and G detected large airway narrowing whereas at 20 minutes G and H detected small airway narrowing. Surfactant inhibited R-N at the peak of the early allergic response and ovalbumin-induced increase in bronchoalveolar lavage fluid cysteinyl leukotrienes and amphiregulin but not IgE-induced mast cell activation in vitro. Conclusion: Allergen challenge triggers the rapid onset of large airway narrowing, detected by R-N and G, and subsequent peripheral airway narrowing detected by G and H. Surfactant inhibits airway narrowing and reduces mast cell-derived mediators.	[Siddiqui, Sana] McGill Univ, Meakins Christie Labs, Dept Med, Montreal, PQ, Canada; McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada	McGill University; McGill University	Siddiqui, S (corresponding author), McGill Univ, Meakins Christie Labs, Dept Med, Montreal, PQ, Canada.	james.martin@mcgill.ca		Martin, James/0000-0001-7574-5363	Canadian Institutes of Health Research [MOP-93747]; J. T. Costello Memorial Research Fund; Quebec Respiratory Health Training Program; McGill Internal Studentship (Alexander McFee Fellowship)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); J. T. Costello Memorial Research Fund; Quebec Respiratory Health Training Program; McGill Internal Studentship (Alexander McFee Fellowship)	This work was supported by a grant from the Canadian Institutes of Health Research (MOP-93747) and the J. T. Costello Memorial Research Fund. SS was supported by a studentship from the Quebec Respiratory Health Training Program (2008-2009) and a McGill Internal Studentship (Alexander McFee Fellowship 2009-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIRAV I, 1993, J APPL PHYSIOL, V75, P2239, DOI 10.1152/jappl.1993.75.5.2239; Babu KS, 2003, EUR RESPIR J, V21, P1046, DOI 10.1183/09031936.03.00069202; Bates JHT, 2009, IEEE ENG MED BIO, P170, DOI 10.1109/IEMBS.2009.5333302; BATES JHT, 1994, J APPL PHYSIOL, V76, P616, DOI 10.1152/jappl.1994.76.2.616; Bayat S, 2009, AM J RESP CRIT CARE, V180, P296, DOI 10.1164/rccm.200808-1211OC; BROWN RH, 1993, J APPL PHYSIOL, V74, P2615, DOI 10.1152/jappl.1993.74.6.2615; Chen BT, 2004, MAGN RESON MED, V52, P1080, DOI 10.1002/mrm.20251; CHURCH MK, 1975, BRIT J PHARMACOL, V55, pP315; DU T, 1992, AM REV RESPIR DIS, V146, P1037, DOI 10.1164/ajrccm/146.4.1037; Enomoto Y, 2009, J ALLERGY CLIN IMMUN, V124, P913, DOI 10.1016/j.jaci.2009.08.044; EVANS TW, 1988, AM REV RESPIR DIS, V138, P395, DOI 10.1164/ajrccm/138.2.395; FREDBERG JJ, 1985, J APPL PHYSIOL, V58, P1914, DOI 10.1152/jappl.1985.58.6.1914; Gillis HL, 1999, ANN BIOMED ENG, V27, P14, DOI 10.1114/1.161; Hall GL, 1999, CLIN EXP ALLERGY, V29, P562, DOI 10.1046/j.1365-2222.1999.00471.x; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; HEROLD CJ, 1991, RADIOLOGY, V181, P369, DOI 10.1148/radiology.181.2.1924774; Hite RD, 2005, AM J PHYSIOL-LUNG C, V288, pL610, DOI 10.1152/ajplung.00273.2004; Hohlfeld JM, 1999, AM J RESP CRIT CARE, V159, P1803, DOI 10.1164/ajrccm.159.6.9806145; Jarjour NN, 1999, AM J RESP CRIT CARE, V160, P336, DOI 10.1164/ajrccm.160.1.9806155; Kaczka DW, 2009, J APPL PHYSIOL, V106, P520, DOI 10.1152/japplphysiol.90576.2008; KOBAYASHI T, 1991, J APPL PHYSIOL, V71, P530, DOI 10.1152/jappl.1991.71.2.530; LAM S, 1991, J ALLERGY CLIN IMMUN, V87, P842, DOI 10.1016/0091-6749(91)90131-7; Lundblad LKA, 2007, AM J RESP CRIT CARE, V175, P768, DOI 10.1164/rccm.200610-1410OC; Lutchen KR, 1996, J APPL PHYSIOL, V80, P1841, DOI 10.1152/jappl.1996.80.5.1841; LUTCHEN KR, 1994, J APPL PHYSIOL, V77, P373, DOI 10.1152/jappl.1994.77.1.373; Lutchen KR, 1997, J APPL PHYSIOL, V83, P1192, DOI 10.1152/jappl.1997.83.4.1192; Macklem PT, 1996, AM J RESP CRIT CARE, V153, P83, DOI 10.1164/ajrccm.153.1.8542167; Malherbe DC, 2005, AM J PHYSIOL-LUNG C, V289, pL856, DOI 10.1152/ajplung.00009.2005; MARTIN JG, 1993, AM REV RESPIR DIS, V147, P104, DOI 10.1164/ajrccm/147.1.104; NAGASE T, 1994, AM J RESP CRIT CARE, V150, P218, DOI 10.1164/ajrccm.150.1.8025752; Olivenstein R, 1997, PULM PHARMACOL THER, V10, P223, DOI 10.1006/pupt.1997.0095; PLOPPER CG, 1983, EXP LUNG RES, V5, P79, DOI 10.3109/01902148309061506; Saez AO, 1996, J APPL PHYSIOL, V80, P437, DOI 10.1152/jappl.1996.80.2.437; SCHURCH S, 1978, P NATL ACAD SCI USA, V75, P3417, DOI 10.1073/pnas.75.7.3417; Siddiqui S, 2010, J APPL PHYSIOL, V109, P1170, DOI 10.1152/japplphysiol.01168.2009; Tamaoka M, 2008, EUR RESPIR J, V32, P1213, DOI 10.1183/09031936.00166907; Wang JY, 2007, IMMUNOBIOLOGY, V212, P417, DOI 10.1016/j.imbio.2007.01.002; Wang SW, 2005, J ALLERGY CLIN IMMUN, V115, P287, DOI 10.1016/j.jaci.2004.11.037; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931; Wright SM, 2000, J APPL PHYSIOL, V89, P1283, DOI 10.1152/jappl.2000.89.4.1283; YAGER D, 1989, J APPL PHYSIOL, V66, P2873, DOI 10.1152/jappl.1989.66.6.2873; YU SH, 1993, BIOCHIM BIOPHYS ACTA, V1167, P264, DOI 10.1016/0005-2760(93)90228-2; Zerhouni E A, 1993, J Thorac Imaging, V8, P265, DOI 10.1097/00005382-199323000-00002	45	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29381	10.1371/journal.pone.0029381	http://dx.doi.org/10.1371/journal.pone.0029381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276110	Green Published, Green Submitted, gold			2022-12-27	WOS:000301457200011
J	Kisa, O; Tarhan, G; Gunal, S; Albay, A; Durmaz, R; Saribas, Z; Zozio, T; Alp, A; Ceyhan, I; Tombak, A; Rastogi, N				Kisa, Ozgul; Tarhan, Gulnur; Gunal, Selami; Albay, Ali; Durmaz, Riza; Saribas, Zeynep; Zozio, Thierry; Alp, Alpaslan; Ceyhan, Ismail; Tombak, Ahmet; Rastogi, Nalin			Distribution of Spoligotyping Defined Genotypic Lineages among Drug-Resistant Mycobacterium tuberculosis Complex Clinical Isolates in Ankara, Turkey	PLOS ONE			English	Article							GENETIC DIVERSITY; GLOBAL DISTRIBUTION; EASTERN TURKEY; EPIDEMIOLOGY; STRAINS; FAMILIES; DATABASE	Background: Investigation of genetic heterogeneity and spoligotype-defined lineages of drug-resistant Mycobacterium tuberculosis clinical isolates collected during a three-year period in two university hospitals and National Tuberculosis Reference and Research Laboratory in Ankara, Turkey. Methods and Findings: A total of 95 drug-resistant M. tuberculosis isolates collected from three different centers were included in this study. Susceptibility testing of the isolates to four major antituberculous drugs was performed using proportion method on Lowenstein-Jensen medium and BACTEC 460-TB system. All clinical isolates were typed by using spoligotyping and IS6110-restriction fragment length polymorphism (RFLP) methods. Seventy-three of the 95 (76.8%) drug resistant M. tuberculosis isolates were isoniazid-resistant, 45 (47.4%) were rifampicin-resistant, 32 (33.7%) were streptomycin-resistant and 31 (32.6%) were ethambutol-resistant. The proportion of multidrug-resistant isolates (MDR) was 42.1%. By using spoligotyping, 35 distinct patterns were observed; 75 clinical isolates were grouped in 15 clusters (clustering rate of 79%) and 20 isolates displayed unique patterns. Five of these 20 unique patterns corresponded to orphan patterns in the SITVIT2 database, while 4 shared types containing 8 isolates were newly created. The most prevalent M. tuberculosis lineages were: Haarlem (23/95, 24.2%), ill-defined T superfamily (22/95, 23.2%), the Turkey family (19/95, 20%; previously designated as LAM7-TUR), Beijing (6/95, 6.3%), and Latin-America & Mediterranean (LAM, 5/95 or 5.3%), followed by Manu (3/95, 3.2%) and S (1/95, 1%) lineages. Four of the six Beijing family isolates (66.7%) were MDR. A combination of IS6110-RFLP and spoligotyping reduced the clustering rate from 79% to 11.5% among the drug resistant isolates. Conclusions: The results obtained showed that ill-defined T, Haarlem, the Turkey family (previously designated as LAM7-TUR family with high phylogeographical specifity for Turkey), Beijing and LAM were predominant lineages observed in almost 80% of the drug-Resistant M. tuberculosis complex clinical isolates in Ankara, Turkey.	[Kisa, Ozgul; Albay, Ali] Gulhane Mil Med Acad, Dept Med Microbiol, Ankara, Turkey; [Kisa, Ozgul; Albay, Ali] Hacettepe Univ, Sch Med, Ankara, Turkey; [Tarhan, Gulnur; Ceyhan, Ismail; Tombak, Ahmet] Refik Saydam Hyg Ctr, TB Reference & Res Lab, Ankara, Turkey; [Gunal, Selami; Durmaz, Riza] Inonu Univ, Dept Med Microbiol, Fac Med, Malatya, Turkey; [Saribas, Zeynep; Alp, Alpaslan] Hacettepe Univ, Fac Med, Dept Med Microbiol, TR-06100 Ankara, Turkey; [Zozio, Thierry; Rastogi, Nalin] Inst Pasteur Guadeloupe, WHO Supranat TB Reference Lab, Unite TB & Mycobacteries, Abymes, Guadeloupe, France	Gulhane Military Medical Academy; Hacettepe University; Refik Saydam Hifzissihha Merkezi Baskanligi; Inonu University; Hacettepe University	Kisa, O (corresponding author), Gulhane Mil Med Acad, Dept Med Microbiol, Ankara, Turkey.	okisa@gata.edu.tr	RASTOGI, NALIN/AAP-1958-2020; ALP, ALPASLAN/I-8366-2013; Günal, Selami/AAA-7246-2021	RASTOGI, NALIN/0000-0002-7199-7747; ALP, ALPASLAN/0000-0001-7856-7590; Günal, Selami/0000-0002-4752-5176; Albay, Ali/0000-0003-2778-8910				Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Balci I, 2000, J INT MED RES, V28, P300, DOI 10.1177/147323000002800606; Bengisun JS, 2000, SCAND J INFECT DIS, V32, P507, DOI 10.1080/003655400458785; Brudey K, 2004, J CLIN MICROBIOL, V42, P3046, DOI 10.1128/JCM.42.7.3046-3051.2004; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Cavusoglu C, 2004, ANN SAUDI MED, V24, P102, DOI 10.5144/0256-4947.2004.102; Cohn DL, 1997, CLIN INFECT DIS, V24, pS121, DOI 10.1093/clinids/24.Supplement_1.S121; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Durmaz R, 2007, J CLIN MICROBIOL, V45, P4027, DOI 10.1128/JCM.01308-07; Durmaz R, 2007, INFECT GENET EVOL, V7, P513, DOI 10.1016/j.meegid.2007.03.003; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Filliol I, 2002, EMERG INFECT DIS, V8, P1347, DOI 10.3201/eid0811.020125; Gencer B, 2005, AM J INFECT DIS, V1, P5; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kent PT, 1985, GUIDE LEVEL 3 LAB; Kisa O, 2003, INT J ANTIMICROB AG, V22, P456, DOI 10.1016/S0924-8579(03)00160-2; Kisa O, 2007, RES MICROBIOL, V158, P318, DOI 10.1016/j.resmic.2007.01.004; Kulkarni S, 2005, RES MICROBIOL, V156, P588, DOI 10.1016/j.resmic.2005.01.005; *MIN HLTH TURK, 2010, FIGHT TUB 2010 REP; Otlu B, 2009, NEW MICROBIOL, V32, P255; Puustinen K, 2003, J CLIN MICROBIOL, V41, P1525, DOI 10.1128/JCM.41.4.1525-1528.2003; SIDDIQI SH, 1996, BACTEC TB SYSTEM PRO; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Sola C, 2001, EMERG INFECT DIS, V7, P390; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; TAHAOGLU K, 1994, TUBERCLE LUNG DIS, V75, P324, DOI 10.1016/0962-8479(94)90076-0; Toungoussova OS, 2002, J CLIN MICROBIOL, V40, P1930, DOI 10.1128/JCM.40.6.1930-1937.2002; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Zozio T, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-44	31	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30331	10.1371/journal.pone.0030331	http://dx.doi.org/10.1371/journal.pone.0030331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279583	Green Published, gold			2022-12-27	WOS:000299771900060
J	Hinds, AL; Woody, EZ; Van Ameringen, M; Schmidt, LA; Szechtman, H				Hinds, Andrea L.; Woody, Erik Z.; Van Ameringen, Michael; Schmidt, Louis A.; Szechtman, Henry			When Too Much Is Not Enough: Obsessive-Compulsive Disorder as a Pathology of Stopping, Rather than Starting	PLOS ONE			English	Article							SECURITY-MOTIVATION; RESPONSE-INHIBITION; BEHAVIORAL-INHIBITION; IMPULSIVE CHOICE; POTENTIAL THREAT; SYMPTOM; SIGNAL; MODEL; DOPAMINE; SYSTEMS	Background: In obsessive-compulsive disorder (OCD), individuals feel compelled to repeatedly perform security-related behaviors, even though these behaviours seem excessive and unwarranted to them. The present research investigated two alternative ways of explaining such behavior: (1) a dysfunction of activation-a starting problem-in which the level of excitation in response to stimuli suggesting potential danger is abnormally strong; versus (2) a dysfunction of terminationa stopping problem-in which the satiety-like process for shutting down security-related thoughts and actions is abnormally weak. Method: In two experiments, 70 patients with OCD (57 with washing compulsions, 13 with checking compulsions) and 72 controls were exposed to contamination cues-immersing a hand in wet diapers -and later allowed to wash their hands, first limited to 30 s and then for as long as desired. The intensity of activation of security motivation was measured objectively by change in respiratory sinus arrythmia. Subjective ratings (e. g., contamination) and behavioral measures (e. g., duration of hand washing) were also collected. Results: Compared to controls, OCD patients with washing compulsions did not differ significantly in their levels of initial activation to the threat of contamination; however, they were significantly less able to reduce this activation by engaging in the corrective behavior of hand-washing. Further, the deactivating effect of hand-washing in OCD patients with checking compulsions was similar to that for controls, indicating that the dysfunction of termination in OCD is specific to the patient's symptom profile. Conclusions: These results are the first to show that OCD is characterized by a reduced ability of security-related behavior to terminate motivation evoked by potential danger, rather than a heightened initial sensitivity to potential threat. They lend support to the security-motivation theory of OCD (Szechtman & Woody, 2004) and have important implications both for research into the biological mechanisms underlying OCD and for the development of new treatment approaches.	[Hinds, Andrea L.; Van Ameringen, Michael; Szechtman, Henry] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Woody, Erik Z.] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada; [Schmidt, Louis A.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada	McMaster University; University of Waterloo; McMaster University	Hinds, AL (corresponding author), McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada.	szechtma@mcmaster.ca	Szechtman, Henry/A-4706-2009; Van+Ameringen, Michael/AAA-6940-2021	Szechtman, Henry/0000-0003-3986-4482; Van+Ameringen, Michael/0000-0002-4357-5184	Canadian Institutes of Health Research (CIHR) [MOP-74553, CIHR MOP-64424]; Frederick Banting and Charles Best Canada Graduate Scholarship [CIHR GSD-104525]; Canadian Foundation for Innovation (CFI); Janssen-Ortho Inc.; NIH (National Institutes of Health); Pfizer Inc.; Shire; Wyeth-Ayerst	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Frederick Banting and Charles Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Janssen-Ortho Inc.; NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Inc.(Pfizer); Shire; Wyeth-Ayerst	This research was supported by operating grants from the Canadian Institutes of Health Research (CIHR MOP-74553 and CIHR MOP-64424). ALH was supported by a Frederick Banting and Charles Best Canada Graduate Scholarship (CIHR GSD-104525). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Ms. Hinds, Dr. Woody, Dr. Schmidt, and Dr. Szechtman report no competing interests. In the last 24 months, Dr. Van Ameringen has received research grant support from the Canadian Foundation for Innovation (CFI), Janssen-Ortho Inc., NIH (National Institutes of Health), Pfizer Inc., Shire, and Wyeth-Ayerst. He is a member of the Speaker's Bureau for Biovail, GlaxoSmithKline, Janssen-Ortho Inc., Lundbeck, and Pfizer Inc. He has participated in advisory boards for Astra Zeneca, Biovail, Eli Lilly, Janssen-Ortho Inc., Labo Pharm, Lundbeck, Pfizer Inc., Servier, Shire and Valiant. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abed RT, 1998, BEHAV NEUROL, V11, P245; Aron AR, 2009, NEUROSCI BIOBEHAV R, V33, P611, DOI 10.1016/j.neubiorev.2008.10.003; Belayachi S, 2010, CONSCIOUS COGN, V19, P534, DOI 10.1016/j.concog.2010.02.001; Besiroglu L, 2007, DEPRESS ANXIETY, V24, P461, DOI 10.1002/da.20240; Beste C, 2010, NEUROPSYCHOLOGIA, V48, P366, DOI 10.1016/j.neuropsychologia.2009.09.023; Boyer P, 2006, BEHAV BRAIN SCI, V29, P595, DOI 10.1017/S0140525X06009332; Boyer P, 2011, NEUROSCI BIOBEHAV R, V35, P1034, DOI 10.1016/j.neubiorev.2010.08.010; Brown H, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00218; Burns GL, 1996, BEHAV RES THER, V34, P163, DOI 10.1016/0005-7967(95)00035-6; Chamberlain SR, 2007, AM J PSYCHIAT, V164, P335, DOI 10.1176/appi.ajp.164.2.335; Chamberlain SR, 2005, NEUROSCI BIOBEHAV R, V29, P399, DOI 10.1016/j.neubiorev.2004.11.006; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Collier G, 2004, PHYSIOL BEHAV, V82, P149, DOI 10.1016/j.physbeh.2004.04.041; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Eagle DM, 2011, J NEUROSCI, V31, P7349, DOI 10.1523/JNEUROSCI.6182-10.2011; Eagle DM, 2010, NEUROSCI BIOBEHAV R, V34, P50, DOI 10.1016/j.neubiorev.2009.07.003; Eagle DM, 2009, NEUROPSYCHOPHARMACOL, V34, P1311, DOI 10.1038/npp.2008.202; First MB, 2002, STRUCTURED CLIN INTE; Flannelly KJ, 2007, J NERV MENT DIS, V195, P996, DOI 10.1097/NMD.0b013e31815c19b1; Groman SM, 2009, NEUROSCI BIOBEHAV R, V33, P690, DOI 10.1016/j.neubiorev.2008.08.008; Hinds AL, 2010, BIOL PSYCHOL, V85, P331, DOI 10.1016/j.biopsycho.2010.08.003; Hoffman KL, 2009, BEHAV BRAIN RES, V204, P182, DOI 10.1016/j.bbr.2009.06.010; Huey ED, 2008, J NEUROPSYCH CLIN N, V20, P390, DOI 10.1176/appi.neuropsych.20.4.390; Joel D, 2006, PSYCHOPHARMACOLOGY, V186, P487, DOI 10.1007/s00213-006-0387-2; Khodarahimi S, 2009, J CONTEMP PSYCHOTHER, V39, P203, DOI 10.1007/s10879-009-9110-z; Lazarov A, 2012, J BEHAV THER EXP PSY, V43, P556, DOI 10.1016/j.jbtep.2011.07.007; Lazarov A, 2010, BEHAV RES THER, V48, P516, DOI 10.1016/j.brat.2010.02.007; Leahy RL, 2007, COGN BEHAV PRACT, V14, P297, DOI 10.1016/j.cbpra.2006.08.002; Hoffman KL, 2011, EXPERT OPIN DRUG DIS, V6, P725, DOI 10.1517/17460441.2011.577772; Mataix-Cols D, 2004, ARCH GEN PSYCHIAT, V61, P564, DOI 10.1001/archpsyc.61.6.564; Mataix-Cols D, 2002, AM J PSYCHIAT, V159, P263, DOI 10.1176/appi.ajp.159.2.263; Moran TH, 2004, PHYSIOL BEHAV, V82, P175, DOI 10.1016/j.physbeh.2004.04.048; Moritz S, 2007, BEHAV RES THER, V45, P2044, DOI 10.1016/j.brat.2007.03.003; Moritz S, 2006, NEUROPSYCHOLOGY, V20, P737, DOI 10.1037/0894-4105.20.6.737; Moritz S, 2009, BEHAV MODIF, V33, P763, DOI 10.1177/0145445509344217; Moritz S, 2009, BEHAV COGN PSYCHOTH, V37, P179, DOI 10.1017/S1352465808005043; Neuberg SL, 2011, NEUROSCI BIOBEHAV R, V35, P1042, DOI 10.1016/j.neubiorev.2010.08.011; Nielen MM, 2009, PSYCHOL MED, V39, P1519, DOI 10.1017/S0033291709005297; Penades R, 2007, EUR PSYCHIAT, V22, P404, DOI 10.1016/j.eurpsy.2006.05.001; Pietrefesa AS, 2009, BEHAV THER, V40, P251, DOI 10.1016/j.beth.2008.06.003; PITMAN RK, 1987, COMPR PSYCHIAT, V28, P334, DOI 10.1016/0010-440X(87)90070-8; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; PORGES SW, 1992, BIOL PSYCHOL, V34, P93, DOI 10.1016/0301-0511(92)90012-J; Reed G.F, 1985, OBSESSIONAL EXPERIEN; REED GF, 1977, BRIT J PSYCHIAT, V130, P184, DOI 10.1192/bjp.130.2.184; Robbins TW, 2007, PHILOS T R SOC B, V362, P917, DOI 10.1098/rstb.2007.2097; Rotge JY, 2008, ACTA PSYCHIAT SCAND, V117, P465, DOI 10.1111/j.1600-0447.2008.01173.x; Saxena S, 2001, Semin Clin Neuropsychiatry, V6, P82, DOI 10.1053/scnp.2001.21833; Saxena S, 1998, BRIT J PSYCHIAT, V173, P26; Sclafani A, 2004, PHYSIOL BEHAV, V82, P89, DOI 10.1016/j.physbeh.2004.04.045; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smith GP, 1996, NEUROSCI BIOBEHAV R, V20, P41, DOI 10.1016/0149-7634(95)00038-G; Stein D J, 2000, Curr Psychiatry Rep, V2, P341, DOI 10.1007/s11920-000-0079-2; Strubbe JH, 2004, PSYCHOL REV, V111, P128, DOI 10.1037/0033-295X.111.1.128; Summerfeldt LJ, 1999, BEHAV RES THER, V37, P297, DOI 10.1016/S0005-7967(98)00134-X; Summerfeldt LJ, 2004, J CLIN PSYCHOL, V60, P1155, DOI 10.1002/jclp.20080; Sun R, 2011, COGN COMPUT, V3, P341, DOI 10.1007/s12559-011-9099-y; Szechtman H, 2004, PSYCHOL REV, V111, P111, DOI 10.1037/0033-295X.111.1.111; Taylor S, 2005, PSYCHOL REV, V112, P650, DOI 10.1037/0033-295X.112.3.650; TEITELBAUM P, 1955, J COMP PHYSIOL PSYCH, V48, P156, DOI 10.1037/h0043164; Tooby J, 2006, BEHAV BRAIN SCI, V29, P631, DOI 10.1017/S0140525X06009538; Trower P., 1990, HDB SOCIAL EVALUATIO, P11, DOI [DOI 10.1007/978-1-4899-2504-6_2, 10.1007/978-1-4899-2504-6_2]; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Wahl K, 2008, J ANXIETY DISORD, V22, P143, DOI 10.1016/j.janxdis.2007.02.009; Winstanley CA, 2004, NEUROPSYCHOPHARMACOL, V29, P1331, DOI 10.1038/sj.npp.1300434; Winstanley CA, 2005, NEUROPSYCHOPHARMACOL, V30, P669, DOI 10.1038/sj.npp.1300610; Winstanley CA, 2004, PSYCHOPHARMACOLOGY, V176, P376, DOI 10.1007/s00213-004-1884-9; WISE S, 1989, OBSESSIVE COMPULSIVE, P327; Woods SC, 2004, AM J PHYSIOL-GASTR L, V286, pG7, DOI 10.1152/ajpgi.00448.2003; Woody EZ, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-11; Woody EZ, 2011, NEUROSCI BIOBEHAV R, V35, P1019, DOI 10.1016/j.neubiorev.2010.08.003; Woody EZ, 2005, PSYCHOL REV, V112, P658, DOI 10.1037/0033-295X.112.3.658; Zeeb FD, 2010, PSYCHOPHARMACOLOGY, V211, P87, DOI 10.1007/s00213-010-1871-2	73	45	45	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30586	10.1371/journal.pone.0030586	http://dx.doi.org/10.1371/journal.pone.0030586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	911FX	22291994	Green Submitted, Green Published, gold			2022-12-27	WOS:000301703800020
J	Priya, NG; Ojha, A; Kajla, MK; Raj, A; Rajagopal, R				Priya, Natarajan Gayatri; Ojha, Abhishek; Kajla, Mayur K.; Raj, Anand; Rajagopal, Raman			Host Plant Induced Variation in Gut Bacteria of Helicoverpa armigera	PLOS ONE			English	Article							CULTURE-INDEPENDENT METHODS; DROSOPHILA-MELANOGASTER; MICROBIAL COMMUNITIES; COTTON BOLLWORM; BT-COTTON; DIVERSITY; RESISTANCE; MIDGUT; LEAVES; HUBNER	Helicoverpa are important polyphagous agricultural insect pests and they have a worldwide distribution. In this study, we report the bacterial community structure in the midgut of fifth instar larvae of Helicoverpa armigera, a species prevalent in the India, China, South Asia, South East Asia, Southern & Eastern Africa and Australia. Using culturable techniques, we isolated and identified members of Bacillus firmus, Bacillus niabense, Paenibacillus jamilae, Cellulomonas variformis, Acinetobacter schindleri, Micrococcus yunnanesis, Enterobacter sp., and Enterococcus cassiliflavus in insect samples collected from host plants grown in different parts of India. Besides these the presence of Sphingomonas, Ralstonia, Delftia, Paracoccus and Bacteriodetes was determined by culture independent molecular analysis. We found that Enterobacter and Enterococcus were universally present in all our Helicoverpa samples collected from different crops and in different parts of India. The bacterial diversity varied greatly among insects that were from different host plants than those from the same host plant of different locations. This result suggested that the type of host plant greatly influences the midgut bacterial diversity of H. armigera, more than the location of the host plant. On further analyzing the leaf from which the larva was collected, it was found that the H. armigera midgut bacterial community was similar to that of the leaf phyllosphere. This finding indicates that the bacterial flora of the larval midgut is influenced by the leaf surface bacterial community of the crop on which it feeds. Additionally, we found that laboratory made media or the artificial diet is a poor bacterial source for these insects compared to a natural diet of crop plant.	[Priya, Natarajan Gayatri; Rajagopal, Raman] Univ Delhi, Dept Zool, Delhi 110007, India; [Ojha, Abhishek] Int Ctr Genet Engn & Biotechnol, New Delhi, India; [Raj, Anand] Natl Dope Testing Lab, New Delhi, India; [Kajla, Mayur K.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	University of Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Wisconsin System; University of Wisconsin Madison	Priya, NG (corresponding author), Univ Delhi, Dept Zool, Delhi 110007, India.	zoorajagopal@gmail.com			Department of Biotechnology, Govt. of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	The authors thank the Department of Biotechnology, Govt. of India for funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Cash HL, 2005, ASM NEWS, V71, P77; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Egert M, 2005, APPL ENVIRON MICROB, V71, P4556, DOI 10.1128/AEM.71.8.4556-4566.2005; Ellis RJ, 1999, FEMS MICROBIOL ECOL, V28, P345, DOI 10.1111/j.1574-6941.1999.tb00589.x; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Gavriel S, 2011, J APPL ENTOMOL, V135, P564, DOI 10.1111/j.1439-0418.2010.01605.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gunning RV, 1996, PESTIC BIOCHEM PHYS, V54, P12, DOI 10.1006/pest.1996.0004; Hao OJ, 2002, CHEMOSPHERE, V46, P797, DOI 10.1016/S0045-6535(01)00182-5; Hui XA, 2006, CAN J MICROBIOL, V52, P1085, DOI 10.1139/W06-064; Jackson CR, 2011, MICROB ECOL, V61, P113, DOI 10.1007/s00248-010-9742-2; Kapur M, 2010, CURR MICROBIOL, V61, P118, DOI 10.1007/s00284-010-9585-6; Kinkel LL, 2000, MICROBIAL ECOL, V39, P1, DOI 10.1007/s002489900182; Kranthi KR, 2004, CURR SCI INDIA, V87, P1096; Kruse JJ, 1999, ECOL ENTOMOL, V24, P37, DOI 10.1046/j.1365-2311.1999.00176.x; Lambais MR, 2006, SCIENCE, V312, P1917, DOI 10.1126/science.1124696; Lei P, 2004, J XIAN JIAOTONG U, V38, P657; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liebhold AM, 1995, USDA GEN TECHNICA NE; Patankar AG, 2001, INSECT BIOCHEM MOLEC, V31, P453, DOI 10.1016/S0965-1748(00)00150-8; Rajendran L, 2007, J PLANT INTERACT, V2, P1, DOI 10.1080/17429140701420003; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; SCOBLE M. J., 1992, LEPIDOPTERA FORM FUN; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Suda W, 2008, MICROBES ENVIRON, V23, P248, DOI 10.1264/jsme2.23.248; WILSON GR, 1993, J INVERTEBR PATHOL, V62, P87, DOI 10.1006/jipa.1993.1079	33	115	127	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30768	10.1371/journal.pone.0030768	http://dx.doi.org/10.1371/journal.pone.0030768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292034	Green Submitted, Green Published, gold			2022-12-27	WOS:000301703800030
J	Dave, S; Kaur, NJ; Nanduri, R; Dkhar, HK; Kumar, A; Gupta, P				Dave, Sandeep; Kaur, Naval Jit; Nanduri, Ravikanth; Dkhar, H. Kitdorlang; Kumar, Ashwani; Gupta, Pawan			Inhibition of Adipogenesis and Induction of Apoptosis and Lipolysis by Stem Bromelain in 3T3-L1 Adipocytes	PLOS ONE			English	Article							MITOTIC CLONAL EXPANSION; NECROSIS-FACTOR-ALPHA; PPAR-GAMMA; ACTIVATED RECEPTOR; INSULIN-RESISTANCE; DOWN-REGULATION; ADIPOSE-TISSUE; T-CELLS; DIFFERENTIATION; OBESITY	The phytotherapeutic protein stem bromelain (SBM) is used as an anti-obesity alternative medicine. We show at the cellular level that SBM irreversibly inhibits 3T3-L1 adipocyte differentiation by reducing adipogenic gene expression and induces apoptosis and lipolysis in mature adipocytes. At the molecular level, SBM suppressed adipogenesis by downregulating C/EBP alpha and PPAR gamma independent of C/EBP beta gene expression. Moreover, mRNA levels of adipocyte fatty acid-binding protein (ap2), fatty acid synthase (FAS), lipoprotein lipase (LPL), CD36, and acetyl-CoA carboxylase (ACC) were also downregulated by SBM. Additionally, SBM reduced adiponectin expression and secretion. SBM's ability to repress PPAR gamma expression seems to stem from its ability to inhibit Akt and augment the TNF alpha pathway. The Akt-TSC2-mTORC1 pathway has recently been described for PPAR gamma expression in adipocytes. In our experiments, TNF alpha upregulation compromised cell viability of mature adipocytes (via apoptosis) and induced lipolysis. Lipolytic response was evident by downregulation of anti-lipolytic genes perilipin, phosphodiestersae-3B (PDE3B), and GTP binding protein G(i)alpha(1), as well as sustained expression of hormone sensitive lipase (HSL). These data indicate that SBM, together with all-trans retinoic-acid (atRA), may be a potent modulator of obesity by repressing the PPAR gamma-regulated adipogenesis pathway at all stages and by augmenting TNF alpha-induced lipolysis and apoptosis in mature adipocytes.	[Dave, Sandeep; Kaur, Naval Jit; Nanduri, Ravikanth; Dkhar, H. Kitdorlang; Kumar, Ashwani; Gupta, Pawan] Inst Microbial Technol CSIR, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Gupta, P (corresponding author), Inst Microbial Technol CSIR, Chandigarh, India.	pawan@imtech.res.in	Kumar, Ashwani/AAU-5045-2020; NANDURI, RAVIKANTH/Q-9729-2018	Kumar, Ashwani/0000-0002-6240-6810; NANDURI, RAVIKANTH/0000-0002-0031-2333; Gupta, Pawan/0000-0001-6692-7237; Dave, Sandeep/0000-0003-2832-2098	DBT-India [BT/PR11538/BRB, BT/01/IYBA/2009]	DBT-India(Department of Biotechnology (DBT) India)	Facilities provided by IMTECH (a constituent laboratory of CSIR) are gratefully acknowledged. Financial support provided to P.G. by DBT-India vide project no BT/PR11538/BRB and BT/01/IYBA/2009 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi MC, 2003, PATHOPHYSIOL HAEMO T, V33, P290, DOI 10.1159/000083816; Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Arimura N, 2004, J BIOL CHEM, V279, P10070, DOI 10.1074/jbc.M308522200; Barnwell SG, 1998, MED APPL BROMELAIN, P1; Barth H, 2005, EUR J MED RES, V10, P325; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Bhui K, 2011, MOL CARCINOG; Bray G A, 2001, Rev Endocr Metab Disord, V2, P403, DOI 10.1023/A:1011808701117; Castell JV, 1997, AM J PHYSIOL-GASTR L, V273, pG139, DOI 10.1152/ajpgi.1997.273.1.G139; Chapman MJ, 2003, ATHEROSCLEROSIS, V171, P1, DOI 10.1016/S0021-9150(03)00156-4; Dave S, 2010, INT J BIOCHEM CELL B, V42, P938, DOI 10.1016/j.biocel.2010.02.004; De Smet PAGM, 2002, NEW ENGL J MED, V347, P2046, DOI 10.1056/NEJMra020398; Engwerda CR, 2001, CELL IMMUNOL, V210, P5, DOI 10.1006/cimm.2001.1793; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Feldmann M, 2008, J CLIN INVEST, V118, P3533, DOI 10.1172/JCI37346; Fujisaki S, 1984, PREVENTIVE TREATING, P1; Gasic S, 1999, J BIOL CHEM, V274, P6770, DOI 10.1074/jbc.274.10.6770; Grabovac V, 2006, INT J PHARMACEUT, V326, P153, DOI 10.1016/j.ijpharm.2006.06.042; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gupta P, 2003, BBA-PROTEINS PROTEOM, V1646, P131, DOI 10.1016/S1570-9639(02)00554-X; Gupta P, 2003, INT J BIOL MACROMOL, V33, P167, DOI 10.1016/j.ijbiomac.2003.08.001; Gupta P, 2007, NUCLEIC ACIDS RES, V35, P2269, DOI 10.1093/nar/gkl1147; HALE LP, 1992, J IMMUNOL, V149, P3809; Hassan M, 2007, BIOCHEM BIOPH RES CO, V361, P208, DOI 10.1016/j.bbrc.2007.07.021; HIRSCH J, 1969, J LIPID RES, V10, P77; Ioannou YA, 1996, NUCLEIC ACIDS RES, V24, P992; Ka SO, 2009, INT J MOL MED, V23, P633, DOI 10.3892/ijmm_00000174; Kalra N, 2008, TOXICOL APPL PHARM, V226, P30, DOI 10.1016/j.taap.2007.08.012; Kawaji A, 2010, BIOL PHARM BULL, V33, P773, DOI 10.1248/bpb.33.773; Kong J, 2006, AM J PHYSIOL-ENDOC M, V290, pE916, DOI 10.1152/ajpendo.00410.2005; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Landstrom TR, 2000, BIOCHEM J, V346, P337, DOI 10.1042/bj3460337; Lee J, 2009, OBESITY, V17, P226, DOI 10.1038/oby.2008.472; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maurer HR, 2001, CELL MOL LIFE SCI, V58, P1234, DOI 10.1007/PL00000936; Maurer R, 2004, US6803038: Use of bromelaine proteases for inhibiting blood coagulation, P1, Patent No. 6803038; Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309; Mynott TL, 1999, J IMMUNOL, V163, P2568; Mynott TL, 1998, Patent U, P1, Patent No. 5824305; Ozes ON, 1999, NATURE, V401, P82; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Prins JB, 1997, DIABETES, V46, P1939, DOI 10.2337/diabetes.46.12.1939; Prins JB, 1997, CLIN SCI, V92, P3, DOI 10.1042/cs0920003; Rodrigo R, 2007, FUND CLIN PHARMACOL, V21, P111, DOI 10.1111/j.1472-8206.2006.00466.x; RONCARI DAK, 1981, METABOLISM, V30, P425, DOI 10.1016/0026-0495(81)90174-8; Ryden M, 2004, BIOCHEM BIOPH RES CO, V318, P168, DOI 10.1016/j.bbrc.2004.04.010; Schultz DR, 2003, SEMIN ARTHRITIS RHEU, V32, P345, DOI 10.1053/sarh.2003.50005; SEIFERT J, 1979, Z GASTROENTEROL, V17, P1; Souza SC, 1998, J BIOL CHEM, V273, P24665, DOI 10.1074/jbc.273.38.24665; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; SURYAWAN A, 1993, COMP BIOCHEM PHYS A, V105, P485, DOI 10.1016/0300-9629(93)90424-3; Tamai M, LAB INVEST, V90, P1385; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; VANHOOF G, 1997, PHARM ENZYMES, P131; Villarroya F, 1999, INT J OBESITY, V23, P1, DOI 10.1038/sj.ijo.0800799; Wan XZ, 2001, BIOCHEM BIOPH RES CO, V284, P99, DOI 10.1006/bbrc.2001.4923; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; WHITE RR, 1988, BIOPHARM DRUG DISPOS, V9, P397, DOI 10.1002/bod.2510090408; Xie S, 2009, P NATL ACAD SCI USA, V106, P13353, DOI 10.1073/pnas.0905724106; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Yanagiya T, 2007, OBESITY, V15, P572, DOI 10.1038/oby.2007.547; Yuan GF, 2006, ASIA PAC J CLIN NUTR, V15, P143; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]	70	54	55	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30831	10.1371/journal.pone.0030831	http://dx.doi.org/10.1371/journal.pone.0030831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292054	gold, Green Submitted, Green Published			2022-12-27	WOS:000301639600059
J	Lakadamyali, M; Babcock, H; Bates, M; Zhuang, XW; Lichtman, J				Lakadamyali, Melike; Babcock, Hazen; Bates, Mark; Zhuang, Xiaowei; Lichtman, Jeff			3D Multicolor Super-Resolution Imaging Offers Improved Accuracy in Neuron Tracing	PLOS ONE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; FLUORESCENCE MICROSCOPY; LOCALIZATION MICROSCOPY; CELLS; RESOLUTION; SYNAPSES; CIRCUIT; MARKERS; STORM	The connectivity among neurons holds the key to understanding brain function. Mapping neural connectivity in brain circuits requires imaging techniques with high spatial resolution to facilitate neuron tracing and high molecular specificity to mark different cellular and molecular populations. Here, we tested a three-dimensional (3D), multicolor super-resolution imaging method, stochastic optical reconstruction microscopy (STORM), for tracing neural connectivity using cultured hippocampal neurons obtained from wild-type neonatal rat embryos as a model system. Using a membrane specific labeling approach that improves labeling density compared to cytoplasmic labeling, we imaged neural processes at 44 nm 2D and 116 nm 3D resolution as determined by considering both the localization precision of the fluorescent probes and the Nyquist criterion based on label density. Comparison with confocal images showed that, with the currently achieved resolution, we could distinguish and trace substantially more neuronal processes in the super-resolution images. The accuracy of tracing was further improved by using multicolor super-resolution imaging. The resolution obtained here was largely limited by the label density and not by the localization precision of the fluorescent probes. Therefore, higher image resolution, and thus higher tracing accuracy, can in principle be achieved by further improving the label density.	[Lakadamyali, Melike; Lichtman, Jeff] Harvard Univ, Dept Mol & Cellular, Cambridge, MA 02138 USA; [Babcock, Hazen; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Bates, Mark] Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute	Lakadamyali, M (corresponding author), Inst Ciencies Fotoniques, Barcelona, Spain.	melike.lakadamyali@icfo.es		Babcock, Hazen/0000-0003-4835-3692; Bates, Mark/0000-0003-0668-5277	HHMI [43667]; Gatsby Charitable Foundation [GAT3036]	HHMI(Howard Hughes Medical Institute); Gatsby Charitable Foundation	This work is supported in part by a Collaborative Innovation Award (#43667) from HHMI (http://www.hhmi.org/) and in part by a grant from the Gatsby Charitable Foundation (#GAT3036) (http://www.gatsby.org.uk/). XZ is a Howard Hughes Medical Institute Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANKER G, 1998, CULTURING NERVE CELL; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Dempsey GT, 2011, NAT METHODS; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Mishchenko Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008853; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Smith SJ, 2007, CURR OPIN NEUROBIOL, V17, P601, DOI 10.1016/j.conb.2007.11.004; Webster P, 2008, METHOD CELL BIOL, V88, P45, DOI 10.1016/S0091-679X(08)00403-2	28	58	60	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30826	10.1371/journal.pone.0030826	http://dx.doi.org/10.1371/journal.pone.0030826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292051	Green Submitted, Green Published, gold			2022-12-27	WOS:000301639600058
J	Brentnall, TA; Lai, LA; Coleman, J; Bronner, MP; Pan, S; Chen, R				Brentnall, Teresa A.; Lai, Lisa A.; Coleman, Joshua; Bronner, Mary P.; Pan, Sheng; Chen, Ru			Arousal of Cancer-Associated Stroma: Overexpression of Palladin Activates Fibroblasts to Promote Tumor Invasion	PLOS ONE			English	Article							FAMILIAL PANCREATIC-CANCER; PROTEIN PALLADIN; CARCINOMA-CELLS; HUMAN BREAST; EXPRESSION; INVADOPODIA; PROGRESSION; GROWTH; MICE; DIFFERENTIATION	Background: Cancer-associated fibroblasts, comprised of activated fibroblasts or myofibroblasts, are found in the stroma surrounding solid tumors. These myofibroblasts promote invasion and metastasis of cancer cells. Mechanisms regulating the activation of the fibroblasts and the initiation of invasive tumorigenesis are of great interest. Upregulation of the cytoskeletal protein, palladin, has been detected in the stromal myofibroblasts surrounding many solid cancers and in expression screens for genes involved in invasion. Using a pancreatic cancer model, we investigated the functional consequence of overexpression of exogenous palladin in normal fibroblasts in vitro and its effect on the early stages of tumor invasion. Principal Findings: Palladin expression in stromal fibroblasts occurs very early in tumorigenesis. In vivo, concordant expression of palladin and the myofibroblast marker, alpha smooth muscle actin (alpha-SMA), occurs early at the dysplastic stages in peri-tumoral stroma and progressively increases in pancreatic tumorigenesis. In vitro introduction of exogenous 90 kD palladin into normal human dermal fibroblasts (HDFs) induces activation of stromal fibroblasts into myofibroblasts as marked by induction of alpha-SMA and vimentin, and through the physical change of cell morphology. Moreover, palladin expression in the fibroblasts enhances cellular migration, invasion through the extracellular matrix, and creation of tunnels through which cancer cells can follow. The fibroblast invasion and creation of tunnels results from the development of invadopodia-like cellular protrusions which express invadopodia proteins and proteolytic enzymes. Palladin expression in fibroblasts is triggered by the co-culture of normal fibroblasts with k-ras-expressing epithelial cells. Conclusions: Overall, palladin expression can impart myofibroblast properties, in turn promoting the invasive potential of these peri-tumoral cells with invadopodia-driven degradation of extracellular matrix. Palladin expression in fibroblasts can be triggered by k-ras expression in adjacent epithelial cells. This data supports a model whereby palladin-activated fibroblasts facilitate stromal-dependent metastasis and outgrowth of tumorigenic epithelium.	[Brentnall, Teresa A.; Lai, Lisa A.; Pan, Sheng; Chen, Ru] Univ Washington, Dept Med, GI Div, Seattle, WA 98195 USA; [Coleman, Joshua; Bronner, Mary P.] Cleveland Clin Fdn, Dept Anat Pathol, Cleveland, OH 44195 USA; [Bronner, Mary P.] Univ Utah, Div Anat Pathol, Salt Lake City, UT USA	University of Washington; University of Washington Seattle; Cleveland Clinic Foundation; Utah System of Higher Education; University of Utah	Brentnall, TA (corresponding author), Univ Washington, Dept Med, GI Div, Seattle, WA 98195 USA.	teribr@u.washington.edu			Gene and Mary Ann Walters Fund for Pancreatic Cancer Research; Canary Foundation; NIH NCI [5K07 CA116296]; NATIONAL CANCER INSTITUTE [K07CA116296, P30CA015704] Funding Source: NIH RePORTER	Gene and Mary Ann Walters Fund for Pancreatic Cancer Research; Canary Foundation; NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Gene and Mary Ann Walters Fund for Pancreatic Cancer Research (T. A. B.), the Canary Foundation (T. A. B.), and NIH NCI 5K07 CA116296 (R. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attanasio F, 2011, EUR J CELL BIOL, V90, P115, DOI 10.1016/j.ejcb.2010.05.004; Bartsch DK, 2010, CLIN GENET, V77, P333, DOI 10.1111/j.1399-0004.2009.01352.x; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Boukhelifa M, 2001, MOL BIOL CELL, V12, P2721, DOI 10.1091/mbc.12.9.2721; Bowden ET, 2001, METHOD CELL BIOL, V63, P613; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Denys H, 2008, CANCER LETT, V266, P263, DOI 10.1016/j.canlet.2008.02.068; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Feldmann G, 2007, J HEPATO-BILIARY-PAN, V14, P224, DOI 10.1007/s00534-006-1166-5; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010; Goicoechea SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010347; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gupta V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021494; Hayward SW, 2001, CANCER RES, V61, P8135; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Ji BA, 2009, GASTROENTEROLOGY, V137, P1072, DOI 10.1053/j.gastro.2009.05.052; Jin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012823; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Klein AP, 2009, CANCER EPIDEM BIOMAR, V18, P1328, DOI 10.1158/1055-9965.EPI-09-0056; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Laurent-Matha V, 2005, J CELL BIOL, V168, P489, DOI 10.1083/jcb.200403078; Liu XS, 2007, J CELL BIOCHEM, V100, P1288, DOI 10.1002/jcb.21126; Lochter A, 1997, J BIOL CHEM, V272, P5007, DOI 10.1074/jbc.272.8.5007; Maffini MV, 2004, J CELL SCI, V117, P1495, DOI 10.1242/jcs.01000; Malmstrom J, 2004, MOL CELL PROTEOMICS, V3, P466, DOI 10.1074/mcp.M300108-MCP200; McCullough KD, 1997, CANCER RES, V57, P1807; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Olumi AF, 1999, CANCER RES, V59, P5002; Orr JW, 1972, TISSUE INTERACTIONS, P291; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Pogue-Geile KL, 2006, PLOS MED, V3, P2216, DOI 10.1371/journal.pmed.0030516; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; Ryu B, 2001, CANCER RES, V61, P1833; Sahai E, 2010, NAT REV MOL CELL BIO, V11, DOI 10.1038/nrm3000; Salaria SN, 2007, CANCER BIOL THER, V6, P324, DOI 10.4161/cbt.6.3.3904; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Slater E, 2007, PLOS MED, V4, P774, DOI 10.1371/journal.pmed.0040164; Takkunen M, 2010, J CELL MOL MED, V14, P1569, DOI 10.1111/j.1582-4934.2009.00868.x; Tanwar PS, 2011, CANCER RES, V71, P1584, DOI 10.1158/0008-5472.CAN-10-3166; Tuxhorn JA, 2001, J UROLOGY, V166, P2472, DOI 10.1016/S0022-5347(05)65620-0; Ueda T, 2002, J CLIN PATHOL, V55, P853, DOI 10.1136/jcp.55.11.853; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Wang Y, 2007, SCI STKE, V400, P1; Weaver AM, 2008, CURR BIOL, V18, pR362, DOI 10.1016/j.cub.2008.02.028; Weinger Ilene, 2005, Purinergic Signal, V1, P281, DOI 10.1007/s11302-005-8132-6; Welsch T, 2007, CURR MOL MED, V7, P504; Xu ZH, 2010, AM J PATHOL, V177, P2585, DOI 10.2353/ajpath.2010.090899; Yamamoto S, 2007, MODERN PATHOL, V20, P1278, DOI 10.1038/modpathol.3800966; Zogopoulous G, 2007, HUM GENET, V121, P635, DOI 10.1007/s00439-007-0361-z	62	68	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30219	10.1371/journal.pone.0030219	http://dx.doi.org/10.1371/journal.pone.0030219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291919	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600025
J	Neves, J; Uchikawa, M; Bigas, A; Giraldez, F				Neves, Joana; Uchikawa, Masanori; Bigas, Anna; Giraldez, Fernando			The Prosensory Function of Sox2 in the Chicken Inner Ear Relies on the Direct Regulation of Atoh1	PLOS ONE			English	Article							NEURAL PROGENITOR IDENTITY; SENSORY ORGAN DEVELOPMENT; HAIR-CELLS; MATH1 EXPRESSION; VERTEBRATE NEUROGENESIS; DEVELOPING COCHLEA; MAMMALIAN COCHLEA; OTIC PLACODE; NOTCH; DIFFERENTIATION	The proneural gene Atoh1 is crucial for the development of inner ear hair cells and it requires the function of the transcription factor Sox2 through yet unknown mechanisms In the present work, we used the chicken ernbryo and HEK293T cells to explore the regulation of Atoh1 by Sox2. The results show that hair cells derive from Sox2-positive otic progenitors and that Sox2 directly activates Atoh1 through a transcriptional activator function that requires the integrity of Sox2 DNA binding domain. Atoh1 activation depends on Sox transcription factor binding sites (SoxTFBS) present in the Atoh1 3' enhancer where Sox2 directly binds, as shown by site directed mutagenesis and chromatin immunoprecipitation (ChIP). In the inner ear, Atoh1 enhancer activity is detected in the neurosensory domain and it depends on Sox2. Dominant negative competition (Sox2HMG-Engrailed) and mutation of the SoxTFBS abolish the reporter activity in vivo. Moreover, ChIP assay in isolated otic vesicles shows that Sox2 is bound to the Atoh1 enhancer in vivo. However, besides activating Atoh1, Sox2 also promotes the expression of Atoh1 negative regulators and the temporal profile of Atoh1 activation by Sox2 is transient suggesting that Sox2 triggers an incoherent feed-forward loop. These results provide a mechanism for the prosensory function of Sox2 in the inner ear. We suggest that sensory competence is established early in otic development through the activation of Atoh1 by Sox2, however, hair cell differentiation is prevented until later stages by the parallel activation of negative regulators of Atoh1 function.	[Neves, Joana; Giraldez, Fernando] Univ Pompeu Fabra, CEXS, Barcelona, Spain; [Uchikawa, Masanori] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Bigas, Anna] IMIM Hosp Mar, Program Canc Res, Barcelona, Spain	Pompeu Fabra University; Osaka University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Neves, J (corresponding author), Univ Pompeu Fabra, CEXS, Parc Rec Biomed Barcelona PRBB, Barcelona, Spain.	fernando.giraldez@upf.edu	Giraldez, Fernando/C-9821-2014; Bigas, Anna/A-7457-2014	Mendes Neves, Joana/0000-0002-1027-3489; Bigas, Anna/0000-0003-4801-6899	MICINN (Ministry of Science and Innovation) [BFU-2008-00714, PLE-2009-0098]; RTICCS/FEDER (Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Spain/Spanish Federation for Rare Diseases), Spain [RD06/0020/0098, 2009SGR23]; FCT (The Foundation for Science and Technology), Portugal [SFRH/BPD/70691/2010]; National Institute of Child Health and Human Development; Grants-in-Aid for Scientific Research [23770248] Funding Source: KAKEN	MICINN (Ministry of Science and Innovation)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); RTICCS/FEDER (Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Spain/Spanish Federation for Rare Diseases), Spain; FCT (The Foundation for Science and Technology), Portugal; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by grants MICINN (Ministry of Science and Innovation) BFU-2008-00714, PLE-2009-0098, RTICCS/FEDER (Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Spain/Spanish Federation for Rare Diseases) (RD06/0020/0098) and 2009SGR23, Spain, and the fellowship SFRH/BPD/70691/2010 to Joana Neves from FCT (The Foundation for Science and Technology), Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Donna Fekete and Thomas Schimmang for reading the manuscript; Pau Formosa and Marta Ibanes for inspiring comments; Marta Linares, Miguel Sas, Ivan Vachkov for excellent technical assistance; and Jordi Guiu, Maria Mulero, Lluis Espinosa, and Pura's Lab (Pura Munoz, CEXS UPF) for technical advice. Hisato Kondoh (GFSB-Osaka University) helped this project from its very initial steps. Jane Johnson (CBN, University of Texas) kindly shared reporters constructs with us. Guy Richardson (University of Sussex, Brighton, UK) kindly provided us with the HCA antibody and Islet1 and MyoVIIa monoclonal antibodies were obtained from the Developmental Studies Hybridoma Bank under the auspices of the National Institute of Child Health and Human Development and maintained by the University of Iowa, Department of Biological Sciences (Iowa City, IA).	Abello G, 2010, DEV BIOL, V339, P166, DOI 10.1016/j.ydbio.2009.12.027; Adam J, 1998, DEVELOPMENT, V125, P4645; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Alsina B, 2004, DEV BIOL, V267, P119, DOI 10.1016/j.ydbio.2003.11.012; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bell D, 2008, DEV BIOL, V322, P109, DOI 10.1016/j.ydbio.2008.07.011; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Chakravarthy H, 2008, J CELL PHYSIOL, V216, P651, DOI 10.1002/jcp.21440; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Cimadamore F, CELL STEM CELL, V8, P538; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Ebert PJ, 2003, DEVELOPMENT, V130, P1949, DOI 10.1242/dev.00419; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hayashi T, 2008, DEV BIOL, V316, P87, DOI 10.1016/j.ydbio.2008.01.006; Helms AW, 2000, DEVELOPMENT, V127, P1185; Hume CR, 2007, GENE EXPR PATTERNS, V7, P798, DOI 10.1016/j.modgep.2007.05.002; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jahan I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011661; Jeon SJ, 2011, J NEUROSCI, V31, P8351, DOI 10.1523/JNEUROSCI.6366-10.2011; Jones JM, 2006, J NEUROSCI, V26, P550, DOI 10.1523/JNEUROSCI.3859-05.2006; Kamaid A, 2010, J NEUROSCI, V30, P11426, DOI 10.1523/JNEUROSCI.2570-10.2010; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Li SD, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-20; Ma QF, 2000, JARO-J ASSOC RES OTO, V1, P129, DOI 10.1007/s101620010017; Mak ACY, 2009, GENE EXPR PATTERNS, V9, P444, DOI 10.1016/j.gep.2009.04.003; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Neves J, 2007, J COMP NEUROL, V503, P487, DOI 10.1002/cne.21299; Neves J, 2011, DEVELOPMENT, V138, P735, DOI 10.1242/dev.060657; Norton JD, 2000, J CELL SCI, V113, P3897; Nowling TK, 2000, J BIOL CHEM, V275, P3810, DOI 10.1074/jbc.275.6.3810; Pevny L, 2005, CURR OPIN NEUROBIOL, V15, P7, DOI 10.1016/j.conb.2005.01.016; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Pujades C, 2006, DEV BIOL, V292, P55, DOI 10.1016/j.ydbio.2006.01.001; Puligilla C, 2010, J NEUROSCI, V30, P714, DOI 10.1523/JNEUROSCI.3852-09.2010; Raft S, 2007, DEVELOPMENT, V134, P4405, DOI 10.1242/dev.009118; Robert-Moreno A, 2008, EMBO J, V27, P1886, DOI 10.1038/emboj.2008.113; Sandberg M, 2005, NAT NEUROSCI, V8, P995, DOI 10.1038/nn1493; Satoh T, 2005, DEVELOPMENT, V132, P1687, DOI 10.1242/dev.01730; Sweet EM, DEV BIOL, V358, P113; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tateya T, 2011, DEV BIOL, V352, P329, DOI 10.1016/j.ydbio.2011.01.038; Timmer J, 2001, GENESIS, V29, P123, DOI 10.1002/gene.1015; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zine A, 2002, HEARING RES, V170, P22, DOI 10.1016/S0378-5955(02)00449-5	52	48	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30871	10.1371/journal.pone.0030871	http://dx.doi.org/10.1371/journal.pone.0030871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292066	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600090
J	Wang, WY; Chiueh, TS; Sun, JR; Tsao, SM; Lu, JJ				Wang, Wei-Yao; Chiueh, Tzong-Shi; Sun, Jun-Ren; Tsao, Shin-Ming; Lu, Jang-Jih			Molecular Typing and Phenotype Characterization of Methicillin-Resistant Staphylococcus aureus Isolates from Blood in Taiwan	PLOS ONE			English	Article							GRAM-POSITIVE PATHOGENS; PROTEIN-A; WESTERN-AUSTRALIA; MRSA BACTEREMIA; UNITED-STATES; COMMUNITY; INFECTIONS; VANCOMYCIN; GENES; MEC	Background: Staphylococcus aureus causes a variety of severe infections such as bacteremia and sepsis. At present, 60-80% of S. aureus isolates from Taiwan are methicillin resistant (MRSA). It has been shown that certain MRSA clones circulate worldwide. The goals of this study were to identify MRSA clones in Taiwan and to correlate the molecular types of isolates with their phenotypes. Methods: A total of 157 MRSA isolates from bacteremic patients were collected from nine medical centers. They were typed based on polymorphisms in agr, SCCmec, MLST, spa, and dru. Phenotypes characterized included Panton-Valentine leucocidin (pvl), inducible macrolide-lincosamide-streptogramin B resistance (MLSBi), vancomycin (VA) and daptomycin (DAP) minimal inhibitory concentrations (MIC), and superantigenic toxin gene profiles. Difference between two consecutive samples was determined by Mann-Whitney-U test, and difference between two categorical variables was determined by Fisher's exact test. Results: Four major MRSA clone complexes CC1, CC5, CC8, and CC59 were found, including 4 CC1, 9 CC5, 111 CC8, and 28 CC59 isolates. These clones had the following molecular types: CC1: SCCmecIV and ST573; CC5: SCCmecII and ST5; CC8: SCCmecIII, ST239, and ST241, and CC59: SCCmecIV, SCCmecV(T), ST59, and ST338. The toxin gene profiles of these clones were CC1: sec-seg-(sei)-sell-selm-(seln)-selo; CC5: sec-seg-sei-sell-selm-(seln)-selp-tst1; CC8: sea-selk-selq, and CC59: seb-selk-selq. Most isolates with SCCmecV(T), ST59, spat437, and dru11 types were pvl(+) (13 isolates), while multidrug resistance (>= 4 antimicrobials) were associated with SCCmecIII, ST239, spa t037, agrI, and dru14 (119 isolates) (p<0.001). One hundred and twenty four isolates with the following molecular types had higher VA MIC: SCCmecII and SCCmecIII; ST5, ST239, and ST241; spa t002, t037, and t421; dru4, dru10, dru12, dru13, and dru14 (p<0.05). No particular molecular types were found to be associated with MLSBi phenotype. Conclusions: Four major MRSA clone complexes were found in Taiwan. Further studies are needed to delineate the evolution of MRSA isolates.	[Wang, Wei-Yao; Chiueh, Tzong-Shi; Sun, Jun-Ren; Lu, Jang-Jih] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Wang, Wei-Yao; Chiueh, Tzong-Shi; Sun, Jun-Ren; Lu, Jang-Jih] Tri Serv Gen Hosp, Taipei, Taiwan; [Chiueh, Tzong-Shi; Sun, Jun-Ren] Natl Def Med Ctr, Dept Pathol, Div Clin Pathol, Taipei, Taiwan; [Wang, Wei-Yao] Fong Yuan Hosp, Div Infect Dis, Taichung, Taiwan; [Tsao, Shin-Ming] Chung Shan Med Univ Hosp, Div Clin Microbiol, Taichung, Taiwan; [Tsao, Shin-Ming] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Lu, Jang-Jih] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Lu, Jang-Jih] Linkou Chang Gung Mem Hosp, Dept Lab Med, Tao Yuan, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; Chang Gung Memorial Hospital	Wang, WY (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	janglu45@gmail.com		Sun, jun-ren/0000-0002-8769-9170	National Science Council (NSC) [98-2320-B-039-032-MY3]; China Medical University Hospital, Taiwan [DMR-100-121]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); China Medical University Hospital, Taiwan	This work was supported by grants from the National Science Council (NSC 98-2320-B-039-032-MY3) and China Medical University Hospital (DMR-100-121), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, PERFORMANCE STANDARD, V19; Becker K, 2003, J CLIN MICROBIOL, V41, P1434, DOI 10.1128/JCM.41.4.1434-1439.2003; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Carpenter CF, 2004, CLIN INFECT DIS, V38, P994, DOI 10.1086/383472; Chen CJ, 2007, DIAGN MICR INFEC DIS, V59, P287, DOI 10.1016/j.diagmicrobio.2007.05.015; Chi Chia-Yu, 2010, J Clin Microbiol, V48, P292, DOI 10.1128/JCM.01788-09; Coombs GW, 2010, ANTIMICROB AGENTS CH, V54, P1914, DOI 10.1128/AAC.01287-09; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P1079, DOI 10.1128/AAC.50.3.1079-1082.2006; Daum RS, 2007, NEW ENGL J MED, V357, P380, DOI 10.1056/NEJMcp070747; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P159, DOI [10.1128/JCM.41.1.159-163.2002, 10.1128/JCM.41.1.159-163.2003]; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Dohin B, 2007, PEDIATR INFECT DIS J, V26, P1042, DOI 10.1097/INF.0b013e318133a85e; Donnio PY, 2004, J ANTIMICROB CHEMOTH, V53, P808, DOI 10.1093/jac/dkh185; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; Frenay HME, 1996, EUR J CLIN MICROBIOL, V15, P60, DOI 10.1007/BF01586186; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Gilot P, 2002, J CLIN MICROBIOL, V40, P4060, DOI 10.1128/JCM.40.11.4060-4067.2002; Hague NZ, 2010, CHEST, V138, P1356, DOI 10.1378/chest.09-2453; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Higuchi W, 2008, BIOCHEM BIOPH RES CO, V377, P752, DOI 10.1016/j.bbrc.2008.10.009; Ho CM, 2010, EUR J CLIN MICROBIOL, V29, P383, DOI 10.1007/s10096-009-0868-4; Ho CM, 2011, EUR J CLIN MICROBIOL, DOI [10.1007/s10096-10011-11338-10093, DOI 10.1007/S10096-10011-11338-10093]; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; Holtfreter S, 2005, ARCH IMMUNOL THER EX, V53, P13; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Hussain FM, 2000, PEDIATR INFECT DIS J, V19, P1163, DOI 10.1097/00006454-200012000-00009; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; JEVONS MP, 1963, LANCET, V1, P904; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Larkin EA, 2009, CURR MED CHEM, V16, P4003, DOI 10.2174/092986709789352321; Liao CH, 2010, CLIN MICROBIOL INFEC, V16, P463, DOI 10.1111/j.1469-0691.2009.02885.x; Liao CH, 2005, DIAGN MICR INFEC DIS, V53, P85, DOI 10.1016/j.diagmicrobio.2005.06.009; Lin SH, 2010, J ANTIMICROB CHEMOTH, V65, P1792, DOI 10.1093/jac/dkq188; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lo WT, 2010, BRIT J DERMATOL, V162, P1110, DOI 10.1111/j.1365-2133.2010.09679.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lu PL, 2008, NEPHROL DIAL TRANSPL, V23, P1659, DOI 10.1093/ndt/gfm806; Maree CL, 2007, EMERG INFECT DIS, V13, P236, DOI 10.3201/eid1302.060781; McDonald LC, 2004, INT J ANTIMICROB AG, V23, P362, DOI 10.1016/j.ijantimicag.2003.09.021; Moise-Broder PA, 2004, CLIN INFECT DIS, V38, P1700, DOI 10.1086/421092; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Omoe K, 2005, FEMS MICROBIOL LETT, V246, P191, DOI 10.1016/j.femsle.2005.04.007; Palmqvist N, 2002, MICROB PATHOGENESIS, V33, P239, DOI 10.1006/mpat.2002.0533; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Sakoulas G, 2004, J CLIN MICROBIOL, V42, P2398, DOI 10.1128/JCM.42.6.2398-2402.2004; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; Senna JPM, 2002, J CLIN MICROBIOL, V40, P2254, DOI 10.1128/JCM.40.6.2254-2256.2002; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Tristan A, 2007, J HOSP INFECT, V65, P105, DOI 10.1016/S0195-6701(07)60025-5; UDO EE, 1993, J HOSP INFECT, V25, P97, DOI 10.1016/0195-6701(93)90100-E; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Wang JL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-159; Wang JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009489; Wang WY, 2009, J CLIN MICROBIOL, V47, P3617, DOI 10.1128/JCM.00539-09	62	58	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30394	10.1371/journal.pone.0030394	http://dx.doi.org/10.1371/journal.pone.0030394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291948	Green Submitted, gold, Green Published			2022-12-27	WOS:000301570600038
J	Du, H; Guan, GB; Xie, J; Sun, Y; Tong, YJ; Zhang, LX; Huang, GH				Du, Han; Guan, Guobo; Xie, Jing; Sun, Yuan; Tong, Yaojun; Zhang, Lixin; Huang, Guanghua			Roles of Candida albicans Gat2, a GATA-Type Zinc Finger Transcription Factor, in Biofilm Formation, Filamentous Growth and Virulence	PLOS ONE			English	Article							REGULATES HYPHAL DEVELOPMENT; PROTEIN-KINASE; PATHWAY; CPH2; EFG1	Candida albicans is the most common human fungal pathogen, causing not only superficial infections, but also life-threatening systemic disease. C. albicans can grow in several morphological forms including unicellular yeast-form, elongated hyphae and pseudohyphae. In certain natural environments, C. albicans also exists as biofilms, which are structured and surface-attached microbial communities. Transcription factors play a critical role in morphogenesis and biofilm development. In this study, we identified four adhesion-promoting transcription factors (Tec1, Cph1, Ume6 and Gat2) by screening a transcription factor overexpression library. Sequence analysis indicates that Gat2 is a GATA-type zinc finger transcription factor. Here we showed that the gat2/gat2 mutant failed to form biofilms on the plastic and silicone surfaces. Overexpression of GAT2 gene promoted filamentous and invasive growth on agar containing Lee's medium, while deletion of this gene had an opposite effect. However, inactivation of Gat2 had no obvious effect on N-acetyl-glucosamine (GlcNAc) induced hyphal development. In a mouse model of systemic infection, the gat2/gat2 mutant showed strongly attenuated virulence. Our results suggest that Gat2 plays a critical role in C. albicans biofilm formation, filamentous growth and virulence.	[Du, Han; Guan, Guobo; Xie, Jing; Sun, Yuan; Huang, Guanghua] Chinese Acad Sci, State Key Lab Mycol, Inst Microbiol, Beijing, Peoples R China; [Xie, Jing; Tong, Yaojun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Tong, Yaojun; Zhang, Lixin] Chinese Acad Sci, Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Du, H (corresponding author), Chinese Acad Sci, State Key Lab Mycol, Inst Microbiol, Beijing, Peoples R China.	huanggh@im.ac.cn	Guan, Guobo/AAK-1827-2021; Tong, Yaojun/U-6068-2018	Tong, Yaojun/0000-0003-4042-2462; Huang, Guanghua/0000-0002-4761-7548; Du, Han/0000-0002-8488-6755; Zhang, Lixin/0000-0003-0894-9520	Chinese Academy of Sciences; National Natural Science Foundation of China [30873129]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is supported by the grant of "100 Talent Program'' from Chinese Academy of Sciences to GH and National Natural Science Foundation of China (30873129) to LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie GS, 1999, J MED MICROBIOL, V48, P671, DOI 10.1099/00222615-48-7-671; Banerjee M, 2008, MOL BIOL CELL, V19, P1354, DOI 10.1091/mbc.E07-11-1110; Chen JY, 2002, MOL MICROBIOL, V46, P1335, DOI 10.1046/j.1365-2958.2002.03249.x; Chen JY, 2000, MOL CELL BIOL, V20, P8696, DOI 10.1128/MCB.20.23.8696-8708.2000; Cottier F, 2009, FEMS MICROBIOL LETT, V295, P1, DOI 10.1111/j.1574-6968.2009.01564.x; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Hnisz D, 2011, METHODS MOL BIOL, V734, P303, DOI 10.1007/978-1-61779-086-7_15; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Huang GH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000806; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; Lane S, 2001, MOL CELL BIOL, V21, P6418, DOI 10.1128/MCB.21.19.6418-6428.2001; Leberer E, 1996, P NATL ACAD SCI USA, V93, P13217, DOI 10.1073/pnas.93.23.13217; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Sahni N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000363; Schweizer A, 2000, MOL MICROBIOL, V38, P435, DOI 10.1046/j.1365-2958.2000.02132.x; SIMONETTI N, 1974, NATURE, V250, P344, DOI 10.1038/250344a0; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Yi S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001117	28	40	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29707	10.1371/journal.pone.0029707	http://dx.doi.org/10.1371/journal.pone.0029707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276126	Green Published, Green Submitted, gold			2022-12-27	WOS:000301457200020
J	Sanchez-Gracia, A; Castresana, J				Sanchez-Gracia, Alejandro; Castresana, Jose			Impact of Deep Coalescence on the Reliability of Species Tree Inference from Different Types of DNA Markers in Mammals	PLOS ONE			English	Article							GENE TREES; DIVERGENCE TIMES; POPULATION SIZES; MOLECULAR CLOCK; PHYLOGEOGRAPHY; EVOLUTION; PHYLOGENETICS; PROBABILITY; SEQUENCES; GENEALOGY	An important challenge for phylogenetic studies of closely related species is the existence of deep coalescence and gene tree heterogeneity. However, their effects can vary between species and they are often neglected in phylogenetic analyses. In addition, a practical problem in the reconstruction of shallow phylogenies is to determine the most efficient set of DNA markers for a reliable estimation. To address these questions, we conducted a multilocus simulation study using empirical values of nucleotide diversity and substitution rates obtained from a wide range of mammals and evaluated the performance of both gene tree and species tree approaches to recover the known speciation times and topological relationships. We first show that deep coalescence can be a serious problem, more than usually assumed, for the estimation of speciation times in mammals using traditional gene trees. Furthermore, we tested the performance of different sets of DNA markers in the determination of species trees using a coalescent approach. Although the best estimates of speciation times were obtained, as expected, with the use of an increasing number of nuclear loci, our results show that similar estimations can be obtained with a much lower number of genes and the incorporation of a mitochondrial marker, with its high information content. Thus, the use of the combined information of both nuclear and mitochondrial markers in a species tree framework is the most efficient option to estimate recent speciation times and, consequently, the underlying species tree.	[Sanchez-Gracia, Alejandro; Castresana, Jose] Inst Evolutionary Biol CSIC UPF, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE)	Sanchez-Gracia, A (corresponding author), Univ Barcelona, Dept Genet, Barcelona, Spain.	jose.castresana@csic.es	Sanchez-Gracia, Alejandro/F-4686-2014; Castresana, Jose/K-3437-2014	Sanchez-Gracia, Alejandro/0000-0003-4543-4577; Castresana, Jose/0000-0002-9391-8050	Ministerio de Ciencia e Innovacion (Spain) [CGL2008-00434/BOS]; Juan de la Cierva from the Ministerio de Ciencia e Innovacion (Spain)	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Juan de la Cierva from the Ministerio de Ciencia e Innovacion (Spain)	This work was supported by grant number CGL2008-00434/BOS from the Plan Nacional I+ D+ I of the Ministerio de Ciencia e Innovacion (Spain) to JC. AS-G was supported by a Juan de la Cierva postdoctoral contract from the Ministerio de Ciencia e Innovacion (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnason U, 1998, J MOL EVOL, V47, P718, DOI 10.1007/PL00006431; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Brito PH, 2009, GENETICA, V135, P439, DOI 10.1007/s10709-008-9293-3; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Egea R, 2007, NUCLEIC ACIDS RES, V35, pD624, DOI 10.1093/nar/gkl833; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Huang HT, 2009, SYST BIOL, V58, P527, DOI 10.1093/sysbio/syp047; Igea J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-369; Knowles LL, 2009, ANNU REV ECOL EVOL S, V40, P593, DOI 10.1146/annurev.ecolsys.38.091206.095702; Knowles LL, ESTIMATING SPECIES T; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; Nabholz B, 2008, GENETICS, V178, P351, DOI 10.1534/genetics.107.073346; Nichols R, 2001, TRENDS ECOL EVOL, V16, P358, DOI 10.1016/S0169-5347(01)02203-0; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Rannala B, 2003, GENETICS, V164, P1645; Rosenberg NA, 2002, THEOR POPUL BIOL, V61, P225, DOI 10.1006/tpbi.2001.1568; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Soria-Carrasco V, 2007, BIOINFORMATICS, V23, P2954, DOI 10.1093/bioinformatics/btm466; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TAJIMA F, 1983, GENETICS, V105, P437; TAKAHATA N, 1989, GENETICS, V122, P957; TAKAHATA N, 1985, GENETICS, V110, P325; Yang ZH, 1999, J MOL EVOL, V48, P274, DOI 10.1007/PL00006470	33	33	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30239	10.1371/journal.pone.0030239	http://dx.doi.org/10.1371/journal.pone.0030239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276164	Green Published, Green Submitted, gold			2022-12-27	WOS:000301457200046
J	Toole, JL; Cha, M; Gonzalez, MC				Toole, Jameson L.; Cha, Meeyoung; Gonzalez, Marta C.			Modeling the Adoption of Innovations in the Presence of Geographic and Media Influences	PLOS ONE			English	Article							INFORMATION-FLOW; SOCIAL CONTAGION; DIFFUSION; DYNAMICS	While there is a large body of work examining the effects of social network structure on innovation adoption, models to date have lacked considerations of real geography or mass media. In this article, we show these features are crucial to making more accurate predictions of a social contagion and technology adoption at a city-to-city scale. Using data from the adoption of the popular micro-blogging platform, Twitter, we present a model of adoption on a network that places friendships in real geographic space and exposes individuals to mass media influence. We show that homophily both among individuals with similar propensities to adopt a technology and geographic location is critical to reproducing features of real spatiotemporal adoption. Furthermore, we estimate that mass media was responsible for increasing Twitter's user base two to four fold. To reflect this strength, we extend traditional contagion models to include an endogenous mass media agent that responds to those adopting an innovation as well as influencing agents to adopt themselves.	[Toole, Jameson L.] MIT, Engn Syst Div, Cambridge, MA 02139 USA; [Cha, Meeyoung] Korea Adv Inst Sci & Technol, Grad Sch Culture Technol, Taejon 305701, South Korea; [Gonzalez, Marta C.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Korea Advanced Institute of Science & Technology (KAIST); Massachusetts Institute of Technology (MIT)	Toole, JL (corresponding author), MIT, Engn Syst Div, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jltoole@mit.edu	Gonzalez, Marta C./E-9456-2011; Cha, Meeyoung/B-6925-2011	Gonzalez, Marta C./0000-0002-8482-0318; 	National Science Foundation; NEC Corporation Fund; Solomon Buchsbaum Research Fund	National Science Foundation(National Science Foundation (NSF)); NEC Corporation Fund; Solomon Buchsbaum Research Fund	This work was funded in part by the National Science Foundation through a Graduate Research Fellowship to Jameson L. Toole, and the awards from NEC Corporation Fund and the Solomon Buchsbaum Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaway AW, 2003, J RETAILING, V79, P137, DOI 10.1016/S0022-4359(03)00037-X; BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215; Baum MA, 2006, J POLIT, V68, P946, DOI 10.1111/j.1468-2508.2006.00482.x; BURT RS, 1987, AM J SOCIOL, V92, P1287, DOI 10.1086/228667; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Centola D, 2007, PHYSICA A, V374, P449, DOI 10.1016/j.physa.2006.06.018; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Dietz K, 1967, J ROYAL STAT SOC A, P130; Dodds PS, 2005, J THEOR BIOL, V232, P587, DOI 10.1016/j.jtbi.2004.09.006; Fowler JH, 2008, PS-POLIT SCI POLIT, V41, P533, DOI 10.1017/S1049096508080712; Garber T, 2004, MARKET SCI, V23, P419, DOI 10.1287/mksc.1040.0051; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Jones BF, 2008, SCIENCE, V322, P1259, DOI 10.1126/science.1158357; Karrer B, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016101; KATZ E, 1957, PUBLIC OPIN QUART, V21, P61, DOI 10.1086/266687; Kleinberg J, CASCADING BEHAV NETW; Leskovec J, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P497; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; Liben-Nowell D, 2008, P NATL ACAD SCI USA, V105, P4633, DOI 10.1073/pnas.0708471105; Lopez-Pintado D, 2008, RATION SOC, V20, P399, DOI 10.1177/1043463108096787; Newman MEJ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021904; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Pease A, 2008, INT J PRESS/POLIT, V13, P386, DOI 10.1177/1940161208321948; Rahmandad H, 2008, MANAGE SCI, V54, P998, DOI 10.1287/mnsc.1070.0787; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Romero DM, 2011, P WORLD WID WEB C; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; SCHELLING TC, 1973, J CONFLICT RESOLUT, V17, P381, DOI 10.1177/002200277301700302; Valente TW, 1995, QUANTITATIVE METHODS; Van den Bulte C, 2001, AM J SOCIOL, V106, P1409, DOI 10.1086/320819; Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Watts DJ, INUENTIALS NETWORKS; Wu F, 2004, PHYSICA A, V337, P327, DOI 10.1016/j.physa.2004.01.030; Yang J., 2011, P 4 ACM INT C WEB SE, P177	39	58	58	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29528	10.1371/journal.pone.0029528	http://dx.doi.org/10.1371/journal.pone.0029528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	907YS	22276119	Green Published, Green Submitted, gold			2022-12-27	WOS:000301457200017
J	Wang, ZR; Shah, AD; Tate, AR; Denaxas, S; Shawe-Taylor, J; Hemingway, H				Wang, Zhuoran; Shah, Anoop D.; Tate, A. Rosemary; Denaxas, Spiros; Shawe-Taylor, John; Hemingway, Harry			Extracting Diagnoses and Investigation Results from Unstructured Text in Electronic Health Records by Semi-Supervised Machine Learning	PLOS ONE			English	Article							SYSTEM	Background: Electronic health records are invaluable for medical research, but much of the information is recorded as unstructured free text which is time-consuming to review manually. Aim: To develop an algorithm to identify relevant free texts automatically based on labelled examples. Methods: We developed a novel machine learning algorithm, the 'Semi-supervised Set Covering Machine' (S3CM), and tested its ability to detect the presence of coronary angiogram results and ovarian cancer diagnoses in free text in the General Practice Research Database. For training the algorithm, we used texts classified as positive and negative according to their associated Read diagnostic codes, rather than by manual annotation. We evaluated the precision (positive predictive value) and recall (sensitivity) of S3CM in classifying unlabelled texts against the gold standard of manual review. We compared the performance of S3CM with the Transductive Vector Support Machine (TVSM), the original fully-supervised Set Covering Machine (SCM) and our 'Freetext Matching Algorithm' natural language processor. Results: Only 60% of texts with Read codes for angiogram actually contained angiogram results. However, the S3CM algorithm achieved 87% recall with 64% precision on detecting coronary angiogram results, outperforming the fully-supervised SCM (recall 78%, precision 60%) and TSVM (recall 2%, precision 3%). For ovarian cancer diagnoses, S3CM had higher recall than the other algorithms tested (86%). The Freetext Matching Algorithm had better precision than S3CM (85% versus 74%) but lower recall (62%). Conclusions: Our novel S3CM machine learning algorithm effectively detected free texts in primary care records associated with angiogram results and ovarian cancer diagnoses, after training on pre-classified test sets. It should be easy to adapt to other disease areas as it does not rely on linguistic rules, but needs further testing in other electronic health record datasets.	[Wang, Zhuoran; Shawe-Taylor, John] UCL, Dept Comp Sci, London, England; [Wang, Zhuoran] Heriot Watt Univ, Sch Math & Comp Sci, Edinburgh, Midlothian, Scotland; [Shah, Anoop D.; Denaxas, Spiros; Hemingway, Harry] UCL, Dept Epidemiol & Publ Hlth, Clin Epidemiol Grp, London, England; [Tate, A. Rosemary] Univ Sussex, Dept Informat, Brighton, E Sussex, England	University of London; University College London; Heriot Watt University; University of London; University College London; University of Sussex	Wang, ZR (corresponding author), UCL, Dept Comp Sci, London, England.	anoop@doctors.org.uk	Hemingway, Harry/C-1219-2009; Shah, Anoop Dinesh/D-4396-2014; Tate, Anne Rosemary/AAK-4512-2020	Hemingway, Harry/0000-0003-2279-0624; Shah, Anoop Dinesh/0000-0002-8907-5724; Denaxas, Spiros/0000-0001-9612-7791; Shawe-Taylor, John/0000-0002-2030-0073	Wellcome Trust [086091/Z/08/Z, 0938/30/Z/10/Z]; National Institute of Health Research [RP-PG-0407-10314]; European Community under the PASCAL2 Network of Excellence; National Institute for Health Research [RP-PG-0407-10314] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Health Research(National Institute for Health Research (NIHR)); European Community under the PASCAL2 Network of Excellence(European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The research leading to these results has received funding from the Wellcome Trust (086091/Z/08/Z; http://www.wellcome.ac.uk/) and the National Institute of Health Research (RP-PG-0407-10314; http://www.nihr.ac.uk/) under the project CALIBER (Cardiovascular Disease Research Using Linked Bespoke Studies). This work was supported in part by the IST Programme of the European Community, under the PASCAL2 Network of Excellence. Anoop Shah is supported by a Wellcome Trust Clinical Research Training Fellowship (0938/30/Z/10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aronson AR, 2007, P WORKSH BIONLP 2007, P105; Clark C, 2008, J AM MED INFORM ASSN, V15, P36, DOI 10.1197/jamia.M2442; Crammer K., 2007, BIOLOGICAL TRANSLATI, P129; DeLisle S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013377; Friedman C, 2004, J AM MED INFORM ASSN, V11, P392, DOI 10.1197/jamia.M1552; Fung BCM, 2003, SIAM PROC S, P59; Ginter F, 2009, INT J MED INFORM, V78, pE1, DOI 10.1016/j.ijmedinf.2009.02.003; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Li Y, 2010, P 1 ACM INT HLTH INF, P744; MARCHAND M, 2002, J MACHINE LEARNING R, V3, P723; NHS Information Centre, 2011, READ COD; Pakhomov Sergeui, 2008, AMIA Annu Symp Proc, P545; Pakhomov SSV, 2007, AM HEART J, V153, P666, DOI 10.1016/j.ahj.2006.12.022; Pakhomov SV, 2005, J BIOMED INFORM, V38, P145, DOI 10.1016/j.jbi.2004.11.016; Rosales R, 2007, ICMLA 2007: SIXTH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS, PROCEEDINGS, P530, DOI 10.1109/ICMLA.2007.103; Rosales Romer, 2010, AMIA Annu Symp Proc, V2010, P682; Savova GK, 2008, J AM MED INFORM ASSN, V15, P25, DOI 10.1197/jamia.M2437; Schulz S, 2002, P M ASS COMP LING JU, P61; Sindhwani V., 2006, Proceedings of the Twenty-Ninth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P477, DOI 10.1145/1148170.1148253; Suominen H., 2008, P ICML UAI COLT WORK; Tate AR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000025; Tate AR, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-42	22	42	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30412	10.1371/journal.pone.0030412	http://dx.doi.org/10.1371/journal.pone.0030412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	907YS	22276193	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000301457200058
J	Zhang, XT; Ding, L; Kang, LG; Wang, ZY				Zhang, XinTian; Ding, Ling; Kang, LianGuo; Wang, Zhao-Yi			Estrogen Receptor-Alpha 36 Mediates Mitogenic Antiestrogen Signaling in ER-Negative Breast Cancer Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ICI 182,780 FASLODEX; PURE ANTIESTROGEN; REMAINING CHALLENGES; VARIANT ER-ALPHA-36; HIPPOCAMPAL-NEURONS; TAMOXIFEN TREATMENT; INDUCED APOPTOSIS; PLASMA-MEMBRANE; SRC	It is prevailingly thought that the antiestrogens tamoxifen and ICI 182, 780 are competitive antagonists of the estrogenbinding site of the estrogen receptor-alpha (ER-alpha). However, a plethora of evidence demonstrated both antiestrogens exhibit agonist activities in different systems such as activation of the membrane-initiated signaling pathways. The mechanisms by which antiestrogens mediate estrogen-like activities have not been fully established. Previously, a variant of ER-a, EP-a36, has been cloned and showed to mediate membrane-initiated estrogen and antiestrogen signaling in cells only expressing ER-a36. Here, we investigated the molecular mechanisms underlying the antiestrogen signaling in ERnegative breast cancer MDA-MB-231 and MDA-MB-436 cells that express high levels of endogenous ER-alpha 36. We found that the effects of both 4-hydoxytamoxifen (4-OHT) and ICI 182, 780 (ICI) exhibited a non-monotonic, or biphasic dose response curve; antiestrogens at low concentrations, elicited a mitogenic signaling pathway to stimulate cell proliferation while at high concentrations, antiestrogens inhibited cell growth. Antiestrogens at l nM induced the phosphorylation of the Src-Y416 residue, an event to activate Src, while at 5 mM induced Src-Y527 phosphorylation that inactivates Src. Antiestrogens at 1 nM also induced phosphorylation of the MAPK/ERK and activated the Cyclin D1 promoter activity through the Src/EGFR/ STAT5 pathways but not at 5 mu M. Knock-down of ER-alpha 36 abrogated the biphasic antiestrogen signaling in these cells. Our results thus indicated that ER-alpha 36 mediates biphasic antiestrogen signaling in the ER-negative breast cancer cells and Src functions as a switch of antiestrogen signaling dependent on concentrations of antiestrogens through the EGFR/STAT5 pathway.	[Zhang, XinTian; Kang, LianGuo; Wang, Zhao-Yi] Creighton Univ, Dept Med Microbiol & Immunol, Sch Med, Omaha, NE 68178 USA; [Ding, Ling] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Oncol, Hangzhou 310003, Zhejiang, Peoples R China	Creighton University; Zhejiang University	Zhang, XT (corresponding author), Creighton Univ, Dept Med Microbiol & Immunol, Sch Med, Omaha, NE 68178 USA.	zywang@creighton.edu			United States National Institutes of Health (NIH) [DK070016]; Nebraska Tobacco Settlement Biomedical Research Program Award [LB-595]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070016] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Tobacco Settlement Biomedical Research Program Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a United States National Institutes of Health (NIH) grant DK070016 and a Nebraska Tobacco Settlement Biomedical Research Program Award (LB-595) to Z.Y. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinton RD, 2001, LEARN MEMORY, V8, P121, DOI 10.1101/lm.39601; Brockman JL, 2002, MOL ENDOCRINOL, V16, P774, DOI 10.1210/me.16.4.774; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Cowell LN, 2006, ONCOGENE, V25, P7597, DOI 10.1038/sj.onc.1209747; Das SK, 1997, P NATL ACAD SCI USA, V94, P12786, DOI 10.1073/pnas.94.24.12786; DAUVOIS S, 1992, P NATL ACAD SCI USA, V89, P4037, DOI 10.1073/pnas.89.9.4037; Dudley MW, 2000, P NATL ACAD SCI USA, V97, P3696, DOI 10.1073/pnas.040558197; FAWELL SE, 1990, P NATL ACAD SCI USA, V87, P6883, DOI 10.1073/pnas.87.17.6883; Fox EM, 2008, MOL ENDOCRINOL, V22, P1781, DOI 10.1210/me.2007-0419; Gu Q, 1999, ENDOCRINOLOGY, V140, P660, DOI 10.1210/en.140.2.660; HOWELL A, 1990, BAILLIERE CLIN ENDOC, V4, P67, DOI 10.1016/S0950-351X(05)80316-7; Kang LG, 2010, J CELL MOL MED, V14, P1485, DOI 10.1111/j.1582-4934.2009.00877.x; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Kurebayashi J, 1998, ONCOLOGY-BASEL, V55, P23, DOI 10.1159/000055256; Lee LMJ, 2008, ANTICANCER RES, V28, P479; Lin SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009013; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; MAHFOUDI A, 1995, P NATL ACAD SCI USA, V92, P4206, DOI 10.1073/pnas.92.10.4206; Mandlekar S, 2000, CANCER RES, V60, P5995; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Nethrapalli IS, 2001, ENDOCRINOLOGY, V142, P5145, DOI 10.1210/en.142.12.5145; Nichols M, 1998, EMBO J, V17, P765, DOI 10.1093/emboj/17.3.765; NICHOLSON RI, 1995, ANN NY ACAD SCI, V761, P148, DOI 10.1111/j.1749-6632.1995.tb31376.x; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Obrero M, 2002, J BIOL CHEM, V277, P45695, DOI 10.1074/jbc.M208092200; OSBORNE CK, 1992, J CLIN ONCOL, V10, P304, DOI 10.1200/JCO.1992.10.2.304; OSBORNE CK, 1991, J NATL CANCER I, V83, P1477, DOI 10.1093/jnci/83.20.1477; Pearce ST, 2003, J BIOL CHEM, V278, P7630, DOI 10.1074/jbc.M211129200; Pendaries C, 2002, P NATL ACAD SCI USA, V99, P2205, DOI 10.1073/pnas.042688499; Robertson JA, 2001, J STEROID BIOCHEM, V77, P281, DOI 10.1016/S0960-0760(01)00061-9; Segars JH, 2002, TRENDS ENDOCRIN MET, V13, P349, DOI 10.1016/S1043-2760(02)00633-1; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shi L, 2009, J CLIN ONCOL, V27, P3423, DOI 10.1200/JCO.2008.17.2254; Sibonga JD, 1998, ENDOCRINOLOGY, V139, P3736, DOI 10.1210/en.139.9.3736; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; SUPERTIFURGA G, 1995, BIOESSAYS, V17, P321, DOI 10.1002/bies.950170408; Vranic S, 2011, J CLIN PATHOL, V64, P54, DOI 10.1136/jcp.2010.082776; WAKELING AE, 1991, CANCER RES, V51, P3867; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Wong JK, 2003, J NEUROSCI, V23, P4984; Wu JB, 2005, INT J ONCOL, V27, P1647; Yamashita H, 2003, ONCOGENE, V22, P1638, DOI 10.1038/sj.onc.1206277; Zhang CC, 2000, J BIOL CHEM, V275, P479, DOI 10.1074/jbc.275.1.479; Zhang XT, 2011, ONCOGENE, V30, P770, DOI 10.1038/onc.2010.458; Zhao LQ, 2006, J PHARMACOL EXP THER, V319, P1124, DOI 10.1124/jpet.106.109504; Zhao LQ, 2005, BRAIN RES REV, V49, P472, DOI 10.1016/j.brainresrev.2005.01.009; Zou Y, 2009, FEBS LETT, V583, P1368, DOI 10.1016/j.febslet.2009.03.047; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	52	44	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30174	10.1371/journal.pone.0030174	http://dx.doi.org/10.1371/journal.pone.0030174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276155	Green Submitted, Green Published, gold			2022-12-27	WOS:000301457200039
J	Zhao, L; Gu, AH; Ji, GX; Zou, P; Zhao, P; Lu, AL				Zhao, Lin; Gu, Aihua; Ji, Guixiang; Zou, Peng; Zhao, Peng; Lu, Ailin			The Association between ATM IVS 22-77 T > C and Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DNA-DAMAGE RESPONSE; BREAST-CANCER; ATAXIA-TELANGIECTASIA; GENETIC POLYMORPHISMS; SUSCEPTIBILITY; VARIANTS; COMMON; MUTATIONS; REPAIR	Background and Objectives: It has become increasingly clear that ATM ( ataxia-telangiectasia-mutated) safeguards genome stability, which is a cornerstone of cellular homeostasis, and ATM IVS 22-77 T>C affects the normal activity of ATM proteins. However, the association between the ATM IVS 22-77 T>C genetic variant and cancer risk is controversial. Therefore, we conducted a systematic meta-analysis to estimate the overall cancer risk associated with the polymorphism and to quantify any potential between-study heterogeneity. Methods: A total of nine studies including 4,470 cases and 4,862 controls were analyzed for ATM IVS 22-77 T>C association with cancer risk in this meta-analysis. Heterogeneity among articles and their publication bias were also tested. Results: Our results showed that no association reached the level of statistical significance in the overall risk. Interestingly, in the stratified analyses, we observed an inverse relationship in lung and breast cancer. Conclusion: Further functional research on the ATM mechanism should be performed to explain the inconsistent results in different cancer types.	[Zhao, Lin; Zou, Peng; Zhao, Peng; Lu, Ailin] Nanjing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Gu, Aihua; Ji, Guixiang] Nanjing Med Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Ji, Guixiang] Minist Environm Protect, Nanjing Inst Environm Sci, Key Lab Pesticide Environm Assessment & Pollut Co, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zhao, L (corresponding author), Nanjing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	zhaopeng@njmu.edu.cn; luailin.eric@163.com	Zhao, Peng/HDO-7507-2022		National Natural Science Foundation of China [30901534]; Jiangsu Province's Natural Science Foundation [BK2009444]; 135 Key Medical Project of Jiangsu Province [XK201117]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province's Natural Science Foundation(Natural Science Foundation of Jiangsu Province); 135 Key Medical Project of Jiangsu Province	This work is supported by the National Natural Science Foundation of China (grant 30901534); Jiangsu Province's Natural Science Foundation (Project no. BK2009444); and the Grant for the 135 Key Medical Project of Jiangsu Province (no. XK201117) in language editing fee and publication fee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2006, ONCOGENE, V25, P5906, DOI 10.1038/sj.onc.1209873; Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Akulevich NM, 2009, ENDOCR-RELAT CANCER, V16, P491, DOI 10.1677/ERC-08-0336; Angele S, 2003, CANCER RES, V63, P8717; Brennan P, 2007, HUM MOL GENET, V16, P1794, DOI 10.1093/hmg/ddm127; Buchholz TA, 2004, CANCER, V100, P1345, DOI 10.1002/cncr.20133; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Gao LB, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-117; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Gonzalez-Hormazabal P, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-117; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Jaworowska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025057; Kim JH, 2006, HUM MOL GENET, V15, P1181, DOI 10.1093/hmg/ddl033; Landi S, 2006, CANCER RES, V66, P11062, DOI 10.1158/0008-5472.CAN-06-1039; Lee KM, 2005, CANCER EPIDEM BIOMAR, V14, P821, DOI 10.1158/1055-9965.EPI-04-0330; Lee SA, 2010, NUTR CANCER, V62, P1087, DOI 10.1080/01635581.2010.492088; Li DH, 2006, J CLIN ONCOL, V24, P1720, DOI 10.1200/JCO.2005.04.4206; Li DH, 2009, CLIN CANCER RES, V15, P740, DOI 10.1158/1078-0432.CCR-08-1607; Lo YL, 2010, LUNG CANCER, V69, P148, DOI 10.1016/j.lungcan.2009.11.007; MANTEL N, 1959, J NATL CANCER I, V22, P719; Pande M, 2011, CARCINOGENESIS, V32, P1493, DOI 10.1093/carcin/bgr136; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Pugh TJ, 2009, CLIN CANCER RES, V15, P5008, DOI 10.1158/1078-0432.CCR-08-3357; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Ricaud L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000430; Ricceri F, 2011, MUTAT RES; Rotman G, 1998, HUM MOL GENET, V7, P1555, DOI 10.1093/hmg/7.10.1555; Sandoval N, 1999, HUM MOL GENET, V8, P69, DOI 10.1093/hmg/8.1.69; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sehrawat B, 2011, HUM GENET, V130, P529, DOI 10.1007/s00439-011-0973-1; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stankovic T, 1998, AM J HUM GENET, V62, P334, DOI 10.1086/301706; Sugimura Haruhiko, 2011, Front Biosci (Schol Ed), V3, P1463; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Yang HS, 2007, INT J CANCER, V121, P2254, DOI 10.1002/ijc.22918	42	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29479	10.1371/journal.pone.0029479	http://dx.doi.org/10.1371/journal.pone.0029479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276117	Green Published, Green Submitted, gold			2022-12-27	WOS:000301457200015
J	Cintra, DE; Ropelle, ER; Moraes, JC; Pauli, JR; Morari, J; de Souza, CT; Grimaldi, R; Stahl, M; Carvalheira, JB; Saad, MJ; Velloso, LA				Cintra, Dennys E.; Ropelle, Eduardo R.; Moraes, Juliana C.; Pauli, Jose R.; Morari, Joseane; de Souza, Claudio T.; Grimaldi, Renato; Stahl, Marcela; Carvalheira, Jose B.; Saad, Mario J.; Velloso, Licio A.			Unsaturated Fatty Acids Revert Diet-Induced Hypothalamic Inflammation in Obesity	PLOS ONE			English	Article							LEPTIN RECEPTOR; FOOD-INTAKE; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; IN-VIVO; ENERGY; BRAIN; ACCUMULATION; SENSITIVITY; INHIBITION	Background: In experimental models, hypothalamic inflammation is an early and determining factor in the installation and progression of obesity. Pharmacological and gene-based approaches have proven efficient in restraining inflammation and correcting the obese phenotypes. However, the role of nutrients in the modulation of hypothalamic inflammation is unknown. Methodology/Principal Findings: Here we show that, in a mouse model of diet-induced obesity, partial substitution of the fatty acid component of the diet by flax seed oil (rich in C18:3) or olive oil (rich in C18:1) corrects hypothalamic inflammation, hypothalamic and whole body insulin resistance, and body adiposity. In addition, upon icv injection in obese rats, both omega 3 and omega 9 pure fatty acids reduce spontaneous food intake and body mass gain. These effects are accompanied by the reversal of functional and molecular hypothalamic resistance to leptin/insulin and increased POMC and CART expressions. In addition, both, omega 3 and omega 9 fatty acids inhibit the AMPK/ACC pathway and increase CPT1 and SCD1 expression in the hypothalamus. Finally, acute hypothalamic injection of omega 3 and omega 9 fatty acids activate signal transduction through the recently identified GPR120 unsaturated fatty acid receptor. Conclusions/Significance: Unsaturated fatty acids can act either as nutrients or directly in the hypothalamus, reverting diet-induced inflammation and reducing body adiposity. These data show that, in addition to pharmacological and genetic approaches, nutrients can also be attractive candidates for controlling hypothalamic inflammation in obesity.	[Cintra, Dennys E.; Moraes, Juliana C.; Morari, Joseane; de Souza, Claudio T.; Velloso, Licio A.] Univ Estadual Campinas, Lab Cell Signaling, Campinas, SP, Brazil; [Ropelle, Eduardo R.; Pauli, Jose R.; Carvalheira, Jose B.; Saad, Mario J.; Velloso, Licio A.] Univ Estadual Campinas, Dept Internal Med, Campinas, SP, Brazil; [Cintra, Dennys E.] Univ Estadual Campinas, Fac Sci Appl, Campinas, SP, Brazil; [Grimaldi, Renato; Stahl, Marcela] Univ Estadual Campinas, Fac Food Engn, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Cintra, DE (corresponding author), Univ Estadual Campinas, Lab Cell Signaling, Campinas, SP, Brazil.	lavelloso.unicamp@gmail.com	Carvalheira, Jose Barreto Campello/E-8562-2013; Velloso, Licio/AAJ-3778-2020; Pauli, José Rdrigo/AAD-2763-2021; Carvalheira, Jose B/H-8405-2012; Ropelle, Eduardo R/C-3977-2012; Cintra, Dennys E/N-7758-2017; Saad, Mario/ABD-8262-2020; Morari, Joseane/G-2568-2016	Carvalheira, Jose Barreto Campello/0000-0002-0136-0943; Pauli, José Rdrigo/0000-0002-6129-1521; Ropelle, Eduardo R/0000-0003-1655-9557; Cintra, Dennys E/0000-0002-7954-5630; Morari, Joseane/0000-0002-0728-4283; Contin Moraes Garotti, Juliana/0000-0002-7143-0644	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Araujo EP, 2007, ENDOCRINOLOGY, V148, P5991, DOI 10.1210/en.2007-0132; Arruda AP, 2010, ENDOCRINOLOGY, V151, P683, DOI 10.1210/en.2009-0865; Bertelli DF, 2006, ENDOCRINOLOGY, V147, P5385, DOI 10.1210/en.2006-0280; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bjornholm M, 2007, J CLIN INVEST, V117, P1354, DOI 10.1172/JCI30688; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cotero VE, 2009, AM J PHYSIOL-ENDOC M, V296, pE1101, DOI 10.1152/ajpendo.90932.2008; De Souza CT, 2007, FASEB J, V21, P1153, DOI 10.1096/fj.06-7148com; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501; Figlewicz DP, 2009, AM J PHYSIOL-REG I, V296, pR9, DOI 10.1152/ajpregu.90725.2008; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; JOHNSON AK, 1975, BRAIN RES, V86, P399, DOI 10.1016/0006-8993(75)90891-4; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Lam TKT, 2007, NAT MED, V13, P171, DOI 10.1038/nm1540; LEE TH, 1985, NEW ENGL J MED, V312, P1217, DOI 10.1056/NEJM198505093121903; Martins EF, 2004, DIABETES METAB, V30, P21, DOI 10.1016/S1262-3636(07)70085-X; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Moraes JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005045; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; Myers MG, 2004, RECENT PROG HORM RES, V59, P287, DOI 10.1210/rp.59.1.287; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7; Plum L, 2006, J CLIN INVEST, V116, P1761, DOI 10.1172/JCI29063; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Reynolds CM, 2009, J NUTR, V139, P2351, DOI 10.3945/jn.109.113035; Rivellese AA, 2003, BIOMED PHARMACOTHER, V57, P84, DOI 10.1016/S0753-3322(03)00003-9; Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Thaler JP, 2010, FRONT NEUROENDOCRIN, V31, P79, DOI 10.1016/j.yfrne.2009.10.002; van den Pol AN, 2003, NEURON, V40, P1059, DOI 10.1016/S0896-6273(03)00809-2; Velloso LA, 2008, NEUROIMMUNOMODULAT, V15, P189, DOI 10.1159/000153423; Weinstein JR, 2008, GLIA, V56, P16, DOI 10.1002/glia.20585; Wisse BE, 2009, CELL METAB, V10, P241, DOI 10.1016/j.cmet.2009.09.003; Yang L, 2008, CELL, V135, P20, DOI 10.1016/j.cell.2008.09.030; Zabolotny JM, 2008, J BIOL CHEM, V283, P14230, DOI 10.1074/jbc.M800061200; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	40	242	247	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30571	10.1371/journal.pone.0030571	http://dx.doi.org/10.1371/journal.pone.0030571			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279596	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900073
J	Shiota, S; Watada, M; Matsunari, O; Iwatani, S; Suzuki, R; Yamaoka, Y				Shiota, Seiji; Watada, Masahide; Matsunari, Osamu; Iwatani, Shun; Suzuki, Rumiko; Yamaoka, Yoshio			Helicobacter pylori iceA, Clinical Outcomes, and Correlation with cagA: A Meta-Analysis	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; GASTRIC EPITHELIAL-CELLS; PEPTIC-ULCER DISEASE; KAPPA-B ACTIVATION; DUODENAL-ULCER; VIRULENCE FACTORS; TURKISH PATIENTS; BABA2 GENOTYPES; VACA GENOTYPES; STRAINS	Background: Although the iceA (induced by contact with epithelium) allelic types of Helicobacter pylori have been reported to be associated with peptic ulcer, the importance of iceA on clinical outcomes based on subsequent studies is controversial. The aim of this study was to estimate the magnitude of the risk for clinical outcomes associated with iceA. Methods: A literature search was performed using the PubMed and EMBASE databases for articles published through April 2011. Published case-control studies examining the relationship between iceA and clinical outcomes (gastritis, peptic ulcer, including gastric ulcer and duodenal ulcer, and gastric cancer) were included. Results: Fifty studies with a total of 5,357 patients were identified in the search. Infection with iceA1-positive H. pylori increased the overall risk for peptic ulcer by 1.26-fold (95% confidence interval [CI], 1.09-1.45). However, the test for heterogeneity was significant among these studies. Sensitivity analysis showed that the presence of iceA1 was significantly associated with peptic ulcer (odds ratio [OR] = 1.25, 95% CI = 1.08-1.44). The presence of iceA2 was inversely associated with peptic ulcer (OR = 0.76, 95% CI = 0.65-0.89). The presence of iceA was not associated with gastric cancer. Most studies examined the cagA status; however, only 15 studies examined the correlation and only 2 showed a positive correlation between the presence of cagA and iceA1. Conclusion: Our meta-analysis confirmed the importance of the presence of iceA for peptic ulcer, although the significance was marginal.	[Shiota, Seiji; Watada, Masahide; Matsunari, Osamu; Iwatani, Shun; Suzuki, Rumiko; Yamaoka, Yoshio] Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu City, Oita, Japan; [Shiota, Seiji; Watada, Masahide; Matsunari, Osamu] Oita Univ, Fac Med, Dept Gen Med, Yufu City, Oita, Japan; [Yamaoka, Yoshio] Baylor Coll Med, Dept Med Gastroenterol, Houston, TX 77030 USA; [Yamaoka, Yoshio] Michael E DeBakey VA Med Ctr, Houston, TX USA	Oita University; Oita University; Baylor College of Medicine; Baylor College of Medicine	Shiota, S (corresponding author), Oita Univ, Fac Med, Dept Environm & Prevent Med, Hasama Machi, Yufu City, Oita, Japan.	yyamaoka@oita-u.ac.jp		Yamaoka, Yoshio/0000-0002-1222-5819; Shiota, Seiji/0000-0001-9811-218X	National Institutes of Health [DK62813]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22390085, 22659087]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This report is based on work supported in part by grants from the National Institutes of Health (DK62813) (YY), and grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (22390085 and 22659087)(YY). The funders had no role in study design data collection and analysis, decision to publish, or preparation of the manuscript.	Amjad N, 2010, WORLD J GASTROENTERO, V16, P4443, DOI 10.3748/wjg.v16.i35.4443; Ando T, 2004, HELICOBACTER, V9, P443, DOI 10.1111/j.1083-4389.2004.00261.x; [Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P1; Arents NLA, 2001, AM J GASTROENTEROL, V96, P2603, DOI 10.1111/j.1572-0241.2001.04104.x; Ashour AAR, 2001, J CLIN MICROBIOL, V39, P1746, DOI 10.1128/JCM.39.5.1746-1750.2001; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Baglan PH, 2006, J MICROBIOL, V44, P409; Bartchewsky W, 2009, SCAND J GASTROENTERO, V44, P153, DOI 10.1080/00365520802530853; Basso D, 2008, GASTROENTEROLOGY, V135, P91, DOI 10.1053/j.gastro.2008.03.041; Ben Mansour K, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-10; Caner V, 2007, WORLD J GASTROENTERO, V13, P2581, DOI 10.3748/wjg.v13.i18.2581; Chang YJ, 2004, MOL PHARMACOL, V66, P1465, DOI 10.1124/mol.104.005199; Chattopadhyay S, 2002, J CLIN MICROBIOL, V40, P2622, DOI 10.1128/JCM.40.7.2622-2625.2002; Chomvarin C, 2008, INT J INFECT DIS, V12, P30, DOI 10.1016/j.ijid.2007.03.012; de Sablet T, 2011, GUT, V60, P1189, DOI 10.1136/gut.2010.234468; Dharne Mahesh Shantappa, 2007, Indian J Pathol Microbiol, V50, P740; Vega AE, 2010, INT J INFECT DIS, V14, pE85, DOI 10.1016/j.ijid.2009.11.022; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Erzin Y, 2006, HELICOBACTER, V11, P574, DOI 10.1111/j.1523-5378.2006.00461.x; Figueiredo C, 2001, SCAND J GASTROENTERO, V36, P128, DOI 10.1080/003655201750065861; Gatti LL, 2006, ACTA TROP, V100, P232, DOI 10.1016/j.actatropica.2006.08.014; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; Han Yue Hua, 2004, Chin J Dig Dis, V5, P181, DOI 10.1111/j.1443-9573.2004.00175.x; Ho YW, 2004, WORLD J GASTROENTERO, V10, P3274, DOI 10.3748/wjg.v10.i22.3274; Ito Y, 2000, J CLIN MICROBIOL, V38, P483, DOI 10.1128/JCM.38.2.483-488.2000; Kersulyte D, 1999, MOL MICROBIOL, V31, P31, DOI 10.1046/j.1365-2958.1999.01140.x; Kidd M, 2001, GUT, V49, P629, DOI 10.1136/gut.49.5.629; Kim SY, 2001, J KOREAN MED SCI, V16, P579, DOI 10.3346/jkms.2001.16.5.579; Koehler CI, 2003, J CLIN PATHOL-MOL PA, V56, P36, DOI 10.1136/mp.56.1.36; Leanza AG, 2004, CLIN MICROBIOL INFEC, V10, P811, DOI 10.1111/j.1198-743X.2004.00940.x; Leodolter A, 2003, SCAND J GASTROENTERO, V38, P498, DOI 10.1080/00365520310002481; Lin HJ, 2004, WORLD J GASTROENTERO, V10, P2493, DOI 10.3748/wjg.v10.i17.2493; Linpisarn Sukanya, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P356; Maeda S, 1998, GUT, V42, P338, DOI 10.1136/gut.42.3.338; Maeda S, 2002, J GASTROEN HEPATOL, V17, P556, DOI 10.1046/j.1440-1746.2002.02738.x; Miciuleviciene J, 2008, MEDICINA-LITHUANIA, V44, P449, DOI 10.3390/medicina44060058; Miehlke S, 2001, AM J GASTROENTEROL, V96, P1008, DOI 10.1111/j.1572-0241.2001.03685.x; Mizushima T, 2001, J CLIN MICROBIOL, V39, P2463, DOI 10.1128/JCM.39.7.2463-2465.2001; Momenah AM, 2007, SAUDI MED J, V28, P382; Mukhopadhyay AK, 2000, J BACTERIOL, V182, P3219, DOI 10.1128/JB.182.11.3219-3227.2000; Nishiya D, 2000, SCAND J GASTROENTERO, V35, P36, DOI 10.1080/003655200750024506; Peek RM, 1998, P ASSOC AM PHYSICIAN, V110, P531; Perng CL, 2003, J GASTROEN HEPATOL, V18, P1244, DOI 10.1046/j.1440-1746.2003.03214.x; Rahman M, 2003, J CLIN MICROBIOL, V41, P2008, DOI 10.1128/JCM.41.5.2008-2014.2003; Ribeiro ML, 2003, FEMS IMMUNOL MED MIC, V36, P181, DOI 10.1016/S0928-8244(03)00029-4; Russo F, 2003, ALIMENT PHARM THER, V17, P421, DOI 10.1046/j.1365-2036.2003.01443.x; Saha DR, 2009, WORLD J GASTROENTERO, V15, P1105, DOI 10.3748/wjg.15.1105; Sheu SM, 2002, J FORMOS MED ASSOC, V101, P18; SHIOTA S, 2011, GUT IN PRESS; Shiota S, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-13; Smith SI, 2002, J MED MICROBIOL, V51, P851, DOI 10.1099/0022-1317-51-10-851; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tham KT, 2001, HUM PATHOL, V32, P264, DOI 10.1053/hupa.2001.21136; van Doorn LJ, 1998, GASTROENTEROLOGY, V115, P58, DOI 10.1016/S0016-5085(98)70365-8; Wong BCY, 2001, HELICOBACTER, V6, P317, DOI 10.1046/j.1523-5378.2001.00040.x; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3839, DOI 10.1093/nar/gkf504; Yamaoka Y, 1999, J CLIN MICROBIOL, V37, P2274, DOI 10.1128/JCM.37.7.2274-2279.1999; Yamaoka Y, 2002, FEBS LETT, V517, P180, DOI 10.1016/S0014-5793(02)02617-0; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P414, DOI 10.1053/gast.2002.34781; Zhang ZY, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-49; Zheng PY, 2000, GUT, V47, P18, DOI 10.1136/gut.47.1.18	61	41	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30354	10.1371/journal.pone.0030354	http://dx.doi.org/10.1371/journal.pone.0030354			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279585	gold, Green Published, Green Submitted			2022-12-27	WOS:000299771900062
J	van Dijk, AE; van Eijsden, M; Stronks, K; Gemke, RJBJ; Vrijkotte, TGM				van Dijk, Aimee E.; van Eijsden, Manon; Stronks, Karien; Gemke, Reinoud J. B. J.; Vrijkotte, Tanja G. M.			Prenatal Stress and Balance of the Child's Cardiac Autonomic Nervous System at Age 5-6 Years	PLOS ONE			English	Article							MATERNAL PSYCHOSOCIAL STRESS; HEART-RATE-VARIABILITY; HPA AXIS; RISK; DEPRESSION; PREGNANCY; ANXIETY; BORN; REACTIVITY; SYMPTOMS	Objective: Autonomic nervous system (ANS) misbalance is a potential causal factor in the development of cardiovascular disease. The ANS may be programmed during pregnancy due to various maternal factors. Our aim is to study maternal prenatal psychosocial stress as a potential disruptor of cardiac ANS balance in the child. Methods: Mothers from a prospective birth cohort (ABCD study) filled out a questionnaire at gestational week 16 [IQR 12-20], that included validated instruments for state anxiety, depressive symptoms, pregnancy-related anxiety, parenting daily hassles and job strain. A cumulative stress score was also calculated (based on 80(th) percentiles). Indicators of cardiac ANS in the offspring at age 5-6 years are: pre-ejection period (PEP), heart rate (HR), respiratory sinus arrhythmia (RSA) and cardiac autonomic balance (CAB), measured with electrocardiography and impedance cardiography in resting supine and sitting positions. Results: 2,624 mother-child pairs, only single births, were available for analysis. The stress scales were not significantly associated with HR, PEP, RSA and CAB (p >= 0.17). Accumulation of maternal stress was also not associated with HR, PEP, RSA and CAB (p >= 0.07). Conclusion: Results did not support the hypothesis that prenatal maternal psychosocial stress deregulates cardiac ANS balance in the offspring, at least in rest, and at the age of five-six years.	[van Dijk, Aimee E.; Stronks, Karien; Vrijkotte, Tanja G. M.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [van Dijk, Aimee E.; van Eijsden, Manon] Publ Hlth Serv Amsterdam GGD, Dept Epidemiol Documentat & Hlth Promot, Amsterdam, Netherlands; [Gemke, Reinoud J. B. J.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; Vrije Universiteit Amsterdam	van Dijk, AE (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.e.vandijk@amc.uva.nl		Stronks, Karien/0000-0002-0921-2232; Vrijkotte, Tanja/0000-0003-3641-4048	Netherlands Heart Foundation (Nederlandse Hartstichting)	Netherlands Heart Foundation (Nederlandse Hartstichting)(Netherlands Heart Foundation)	Financial support for the current study was granted by the Netherlands Heart Foundation (Nederlandse Hartstichting). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, CES D NEDERLANDSE VE; BARKER DJP, 2001, FETAL ORIGINS CARDIO; Bathula R, 2010, DIABETOLOGIA, V53, P2120, DOI 10.1007/s00125-010-1818-5; Berntson GG, 2008, PSYCHOPHYSIOLOGY, V45, P643, DOI 10.1111/j.1469-8986.2008.00652.x; BIAN XP, 1993, TERATOLOGY, V47, P109, DOI 10.1002/tera.1420470203; Camm AJ, 1996, CIRCULATION, V93, P1043; Choi JB, 2006, PSYCHOSOM MED, V68, P421, DOI 10.1097/01.psy.0000221378.09239.6a; Cohen G, 2008, CIRCULATION, V118, P1848, DOI 10.1161/CIRCULATIONAHA.108.783902; CRNIC KA, 1990, CHILD DEV, V61, P1628, DOI 10.2307/1130770; Defares P, 1980, PSYCHOLOOG, V15, P460; Diego MA, 2009, EARLY HUM DEV, V85, P65, DOI 10.1016/j.earlhumdev.2008.07.002; Dierckx B, 2009, PSYCHOSOM MED, V71, P313, DOI 10.1097/PSY.0b013e318198a82c; DiPietro JA, 2003, EARLY HUM DEV, V74, P125, DOI 10.1016/j.earlhumdev.2003.07.001; Entringer S, 2010, CURR OPIN ENDOCRINOL, V17, P507, DOI 10.1097/MED.0b013e3283405921; Entringer S, 2009, HORM BEHAV, V55, P292, DOI 10.1016/j.yhbeh.2008.11.006; Field T, 2004, INFANT BEHAV DEV, V27, P216, DOI 10.1016/j.infbeh.2003.09.010; Galland BC, 2006, J APPL PHYSIOL, V100, P933, DOI 10.1152/japplphysiol.01275.2005; Gillespie CF, 2005, PSYCHOSOM MED, V67, pS26, DOI 10.1097/01.psy.0000163456.22154.d2; Glover V, 2010, NEUROSCI BIOBEHAV R, V35, P17, DOI 10.1016/j.neubiorev.2009.11.008; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Glynn LM, 2001, AM J OBSTET GYNECOL, V184, P637, DOI 10.1067/mob.2001.111066; Goedhart AD, 2008, THESIS VU U AMSTERDA; Groenendaal JH, 1996, DAGELIJKSE BESLOMMER; Houtman ILD, 1998, OCCUP ENVIRON MED, V55, P73, DOI 10.1136/oem.55.2.73; Hughes JW, 2004, J PSYCHOSOM RES, V57, P353, DOI 10.1016/j.jpsychores.2004.02.016; Huizink AC, 2004, EARLY HUM DEV, V79, P81, DOI 10.1016/j.earlhumdev.2004.04.014; IJzerman RG, 2003, CIRCULATION, V108, P566, DOI 10.1161/01.CIR.0000081778.35370.1B; Jacob S, 2009, INFANT MENT HEALTH J, V30, P82, DOI 10.1002/imhj.20204; Jones A, 2008, EUR HEART J, V29, P2164, DOI 10.1093/eurheartj/ehn292; Jones NA, 1998, INFANT BEHAV DEV, V21, P537; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; McMillen IC, 2001, REPRODUCTION, V122, P195, DOI 10.1530/rep.0.1220195; Monk C, 2004, J AM ACAD CHILD PSY, V43, P283, DOI 10.1097/00004583-200403000-00009; Monk C, 2000, DEV PSYCHOBIOL, V36, P67, DOI 10.1002/(SICI)1098-2302(200001)36:1<67::AID-DEV7>3.3.CO;2-3; O'Donnell K, 2009, DEV NEUROSCI-BASEL, V31, P285, DOI 10.1159/000216539; Quigley KS, 2006, PSYCHOPHYSIOLOGY, V43, P357, DOI 10.1111/j.1469-8986.2006.00405.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Riese H, 2003, BEHAV RES METH INS C, V35, P467, DOI 10.3758/BF03195525; Segar JL, 1998, AM J PHYSIOL-REG I, V274, pR160, DOI 10.1152/ajpregu.1998.274.1.R160; Spielberger C. D., 1970, STAI MANUAL STATE TR; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Van Den Bergh BRH., 1990, PREPERINAT PSYCHOL J, V5, P119; van Dijk AE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-251; van Eijsden M, 2011, INT J EPIDEMIOL, V40, P1176, DOI 10.1093/ije/dyq128; Vrijkotte TGM, 2004, PSYCHOSOM MED, V66, P656, DOI 10.1097/01.psy.0000138283.65547.78; Wadhwa PD, 2005, PSYCHONEUROENDOCRINO, V30, P724, DOI 10.1016/j.psyneuen.2005.02.004; Wadhwa PD., 2006, PERINATAL PROGRAMMIN, P29; Woods SM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.041	48	23	23	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30413	10.1371/journal.pone.0030413	http://dx.doi.org/10.1371/journal.pone.0030413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272345	Green Published, gold			2022-12-27	WOS:000301454400123
J	Pan, D; Das, A; Liu, D; Veazey, RS; Pahar, B				Pan, Diganta; Das, Arpita; Liu, David; Veazey, Ronald S.; Pahar, Bapi			Isolation and Characterization of Intestinal Epithelial Cells from Normal and SIV-Infected Rhesus Macaques	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVATED MEMORY CELLS; CD4(+)CD8(+) T-CELLS; CLASS-II; TRANSENDOTHELIAL MIGRATION; GENE-EXPRESSION; MONOCLONAL-ANTIBODY; IL-10 RECEPTORS; MUCOSAL REPAIR	Impairment of intestinal epithelial barriers contributes to the progression of HIV/ SIV infection and leads to generalized HIVinduced immune-cell activation during chronic infection. Rhesus macaques are the major animal model for studying HIV pathogenesis. However, detailed characterization of isolated rhesus epithelial cells (ECs) from intestinal tissues is not well defined. It is also not well documented whether isolated ECs had any other cell contaminants from intestinal tissues during the time of processing that might hamper interpretation of EC preparations or cultures. In this study, we identify and characterize ECs based on flow cytometry and immunohistochemistry methods using various enzymatic and mechanical isolation techniques to enrich ECs from intestinal tissues. This study shows that normal healthy ECs differentially express HLA-DR, CD23, CD27, CD90, CD95 and IL-10R markers. Early apoptosis and upregulation of ICAM-1 and HLA-DR in intestinal ECs are thought to be the key features in SIV mediated enteropathy. The data suggest that intestinal ECs might be playing an important role in mucosal immune responses by regulating the expression of different important regulatory and adhesion molecules and their function.	[Pan, Diganta; Liu, David; Veazey, Ronald S.; Pahar, Bapi] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA 70433 USA; [Das, Arpita] Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA; [Veazey, Ronald S.; Pahar, Bapi] Tulane Univ, Sch Med, New Orleans, LA 70112 USA	Tulane University; Tulane University; Tulane University	Pan, D (corresponding author), Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA 70433 USA.	bpahar@tulane.edu	Pahar, Bapi/AFM-3129-2022	Pahar, Bapi/0000-0003-1949-973X; Das, Arpita/0000-0002-5878-7091	National Institutes of Health [P20 RR020159, R21 AI080395, R01 AI084793, RR000164]; amfAR grant [106719-40-RGRL]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020159, P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084793, R21AI080395] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); amfAR grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by National Institutes of Health grants P20 RR020159, R21 AI080395 (BP), R01 AI084793 (RSV), RR000164, and amfAR grant-106719-40-RGRL (BP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN GG, 1990, DEVELOPMENT, V110, P353; AUBRY JP, 1992, NATURE, V358, P505, DOI 10.1038/358505a0; BATEN A, 1992, FASEB J, V6, P2726, DOI 10.1096/fasebj.6.9.1377141; Bernstein CN, 1996, CLIN EXP IMMUNOL, V106, P160; Bhatt RI, 2003, CYTOM PART A, V54A, P89, DOI 10.1002/cyto.a.10058; BLOOM S, 1995, CLIN EXP IMMUNOL, V101, P157; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; Bomsel M, 2002, NAT MED, V8, P114, DOI 10.1038/nm0202-114; Bradley JS, 2009, BIOFACTORS, V35, P258, DOI 10.1002/biof.41; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Das A, 2011, CLIN IMMUNOL, V140, P223, DOI 10.1016/j.clim.2011.04.018; Das A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016524; Denning TL, 2000, INT IMMUNOL, V12, P133, DOI 10.1093/intimm/12.2.133; Desnues B, 2006, CLIN VACCINE IMMUNOL, V13, P170, DOI 10.1128/CVI.13.2.170-178.2006; Ding YZ, 2001, J IMMUNOL, V167, P6884, DOI 10.4049/jimmunol.167.12.6884; DIPPOLD W, 1993, GUT, V34, P1593, DOI 10.1136/gut.34.11.1593; Dorosko SM, 2010, J VIROL, V84, P10533, DOI 10.1128/JVI.01263-10; Du ZM, 2006, J IMMUNOL, V176, P4785, DOI 10.4049/jimmunol.176.8.4785; DUSTIN ML, 1986, J IMMUNOL, V137, P245; Elbim C, 2001, J IMMUNOL, V166, P5201, DOI 10.4049/jimmunol.166.8.5201; FONTI R, 1994, INT J COLORECTAL DIS, V9, P13, DOI 10.1007/BF00304294; Frick AG, 2000, J IMMUNOL, V164, P4185, DOI 10.4049/jimmunol.164.8.4185; George MD, 2005, J VIROL, V79, P2709, DOI 10.1128/JVI.79.5.2709-2719.2005; George MD, 2003, VIROLOGY, V312, P84, DOI 10.1016/S0042-6822(03)00207-1; Gomperts BN, 2006, J IMMUNOL, V176, P1916, DOI 10.4049/jimmunol.176.3.1916; GREENWOOD J, 1995, IMMUNOLOGY, V86, P408; Haeryfar SMM, 2004, J IMMUNOL, V173, P3581, DOI 10.4049/jimmunol.173.6.3581; Han DC, 2003, ORAL MICROBIOL IMMUN, V18, P350, DOI 10.1046/j.0902-0055.2003.00094.x; Hershberg RM, 1997, J CLIN INVEST, V100, P204, DOI 10.1172/JCI119514; Hladik Florian, 2009, Curr HIV/AIDS Rep, V6, P20, DOI 10.1007/s11904-009-0004-1; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hu Shiu-Lok, 2005, Current Drug Targets - Infectious Disorders, V5, P193, DOI 10.2174/1568005054201508; KAISERLIAN D, 1993, IMMUNOLOGY, V80, P90; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; Lai CF, 1996, J BIOL CHEM, V271, P13968, DOI 10.1074/jbc.271.24.13968; LATZA U, 1990, J CLIN PATHOL, V43, P213, DOI 10.1136/jcp.43.3.213; Leon F, 2004, LAB INVEST, V84, P804, DOI 10.1038/labinvest.3700099; Li QS, 2008, J INFECT DIS, V197, P420, DOI 10.1086/525046; MacDonald EM, 2007, BIOL REPROD, V77, P1049, DOI 10.1095/biolreprod.107.063933; Maingat F, 2011, FASEB J, V25, P2211, DOI 10.1096/fj.10-175992; Mattapallil JJ, 2004, AIDS, V18, P13, DOI 10.1097/00002030-200401020-00002; MAYER L, 1991, GASTROENTEROLOGY, V100, P3, DOI 10.1016/0016-5085(91)90575-6; MCDONALD GB, 1987, J CLIN PATHOL, V40, P312, DOI 10.1136/jcp.40.3.312; Meng G, 2002, NAT MED, V8, P150, DOI 10.1038/nm0202-150; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; MOLLER P, 1994, INT J CANCER, V57, P371, DOI 10.1002/ijc.2910570314; Nagashima R, 1996, J HISTOCHEM CYTOCHEM, V44, P721, DOI 10.1177/44.7.8675993; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; OPPENHEIMERMARKS N, 1991, J IMMUNOL, V147, P2913; Pahar B, 2006, EUR J IMMUNOL, V36, P583, DOI 10.1002/eji.200535520; Pahar B, 2009, VIROLOGY, V387, P273, DOI 10.1016/j.virol.2009.02.014; Park SM, 2010, INFLAMM BOWEL DIS, V16, P1063, DOI 10.1002/ibd.21195; Parkos CA, 1996, MOL MED, V2, P489, DOI 10.1007/BF03401908; PearcePratt R, 1996, BIOL REPROD, V54, P173, DOI 10.1095/biolreprod54.1.173; POCHON S, 1992, J EXP MED, V176, P389, DOI 10.1084/jem.176.2.389; Poles MA, 2001, J VIROL, V75, P8390, DOI 10.1128/JVI.75.18.8390-8399.2001; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Ramesh G, 2005, CLIN DIAGN LAB IMMUN, V12, P192, DOI 10.1128/CDLI.12.1.192-197.2005; REIF AE, 1964, J EXP MED, V120, P413, DOI 10.1084/jem.120.3.413; Reiss Y, 1998, EUR J IMMUNOL, V28, P3086, DOI 10.1002/(SICI)1521-4141(199810)28:10<3086::AID-IMMU3086>3.3.CO;2-Q; Roche JK, 2000, METH MOLEC MED, V50, P15; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; Saada JI, 2006, J IMMUNOL, V177, P5968, DOI 10.4049/jimmunol.177.9.5968; Saalbach A, 2005, ONCOGENE, V24, P4710, DOI 10.1038/sj.onc.1208559; Saalbach A, 1998, ARCH DERMATOL RES, V290, P360, DOI 10.1007/s004030050318; Salik E, 1999, AM J RESP CELL MOL, V21, P365, DOI 10.1165/ajrcmb.21.3.3529; SANDERSON IR, 1993, IMMUNOLOGY, V79, P434; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Shattock RJ, 2008, PLOS MED, V5, P537, DOI 10.1371/journal.pmed.0050081; Taguchi M, 1998, J EXP MED, V187, P1927, DOI 10.1084/jem.187.12.1927; Takasugi K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2015; Tokugawa Y, 1997, MOL IMMUNOL, V34, P1263, DOI 10.1016/S0161-5890(98)00010-8; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; VANDERLINDEN PJQ, 1994, FERTIL STERIL, V61, P85; Veazey RS, 1997, CLIN IMMUNOL IMMUNOP, V82, P230, DOI 10.1006/clin.1996.4318; Vroling AB, 2008, ALLERGY, V63, P1110, DOI 10.1111/j.1398-9995.2008.01785.x; Vugmeyster Y, 2004, CYTOM PART A, V61A, P69, DOI 10.1002/cyto.a.20039; Wang XL, 2008, BLOOD, V112, P4981, DOI 10.1182/blood-2008-05-160077; WHITEHEAD RH, 1987, IN VITRO CELL DEV B, V23, P436; WILLIAMS AF, 1982, SCIENCE, V216, P696, DOI 10.1126/science.6177036; Wira CR, 2005, AM J REPROD IMMUNOL, V53, P65, DOI 10.1111/j.1600-0897.2004.00248.x; Xu HB, 2010, J IMMUNOL, V185, P7340, DOI 10.4049/jimmunol.1001642; Yoshino N, 2000, EXP ANIM TOKYO, V49, P97, DOI 10.1538/expanim.49.97; Zhao W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000726	85	42	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30247	10.1371/journal.pone.0030247	http://dx.doi.org/10.1371/journal.pone.0030247			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291924	Green Submitted, Green Published, gold			2022-12-27	WOS:000301703800010
J	Deng, SM; Yang, Y; Han, Y; Li, XF; Wang, XP; Li, XY; Zhang, ZP; Wang, YJ				Deng, Sanming; Yang, Ye; Han, Yong; Li, Xiaofei; Wang, Xiaoping; Li, Xueyong; Zhang, Zhipei; Wang, Yunjie			UCP2 Inhibits ROS-Mediated Apoptosis in A549 under Hypoxic Conditions	PLOS ONE			English	Article							UNCOUPLING PROTEIN-2; CANCER-CELLS; HEPG2 CELLS; MITOCHONDRIAL; EXPRESSION; PROTECTION; ACTIVATION	The Crosstalk between a tumor and its hypoxic microenvironment has become increasingly important. However, the exact role of UCP2 function in cancer cells under hypoxia remains unknown. In this study, UCP2 showed anti-apoptotic properties in A549 cells under hypoxic conditions. Over-expression of UCP2 in A549 cells inhibited reactive oxygen species (ROS) accumulation (P<0.001) and apoptosis (P<0.001) compared to the controls when the cells were exposed to hypoxia. Moreover, over-expression of UCP2 inhibited the release of cytochrome C and reduced the activation of caspase-9. Conversely, suppression of UCP2 resulted in the ROS generation (P=0.006), the induction of apoptosis (P<0.001), and the release of cytochrome C from mitochondria to the cytosolic fraction, thus activating caspase-9. These data suggest that over-expression of UCP2 has anti-apoptotic properties by inhibiting ROS-mediated apoptosis in A549 cells under hypoxic conditions.	[Deng, Sanming; Han, Yong; Li, Xiaofei; Wang, Xiaoping; Zhang, Zhipei; Wang, Yunjie] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Shaanxi Provinc, Peoples R China; [Deng, Sanming] Chinese Peoples Armed Police Force, Dept Thorac Surg, Hosp Med Coll, Tianjin, Peoples R China; [Yang, Ye] Shaanxi Prov Peoples Hosp, Dept Thorac Surg, Xian, Shaanxi Provinc, Peoples R China; [Li, Xueyong] Fourth Mil Med Univ, Tangdu Hosp, Dept Plast & Burns, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Xi'an Medical University; Air Force Military Medical University	Deng, SM (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Shaanxi Provinc, Peoples R China.	wangyjphd@yahoo.cn	Li, xiaofei/GXF-7187-2022		Fourth Military Medical University	Fourth Military Medical University	All the financial support of this paper is from the Fourth Military Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Bae SK, 1998, CANCER LETT, V126, P97, DOI 10.1016/S0304-3835(97)00538-7; Baffy G, 2010, MITOCHONDRION, V10, P243, DOI 10.1016/j.mito.2009.12.143; Bodyak N, 2007, AM J PHYSIOL-HEART C, V293, pH829, DOI 10.1152/ajpheart.01409.2006; Chung YM, 2003, FREE RADICAL BIO MED, V34, P434, DOI 10.1016/S0891-5849(02)01301-1; Collins P, 2005, LIVER INT, V25, P880, DOI 10.1111/j.1478-3231.2005.01104.x; Derdak Z, 2008, CANCER RES, V68, P2813, DOI 10.1158/0008-5472.CAN-08-0053; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Flachs P, 2007, FEBS LETT, V581, P1093, DOI 10.1016/j.febslet.2007.02.012; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hendriksen EM, 2009, MICROVASC RES, V77, P96, DOI 10.1016/j.mvr.2008.11.002; Ho PWL, 2010, NEUROTOX RES, V17, P332, DOI 10.1007/s12640-009-9109-y; Horimoto M, 2004, CLIN CANCER RES, V10, P6203, DOI 10.1158/1078-0432.CCR-04-0419; Jezek P, 1998, INT J BIOCHEM CELL B, V30, P1163, DOI 10.1016/S1357-2725(98)00076-4; Johnson  D., 1967, METHOD ENZYMOL, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9; Kim JY, 2003, FEBS LETT, V549, P94, DOI 10.1016/S0014-5793(03)00795-6; Lee SM, 2006, CANCER LETT, V242, P231, DOI 10.1016/j.canlet.2005.11.001; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Liu XW, 2010, PHARMACOL RES, V62, P416, DOI 10.1016/j.phrs.2010.07.002; Mailloux RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013289; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Namgaladze D, 2010, ATHEROSCLEROSIS, V208, P142, DOI 10.1016/j.atherosclerosis.2009.07.020; Otrock ZK, 2009, CRIT REV ONCOL HEMAT, V70, P93, DOI 10.1016/j.critrevonc.2009.01.001; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Piret JP, 2004, EXP CELL RES, V295, P340, DOI 10.1016/j.yexcr.2004.01.024; Plin C, 2004, EUR J PHARMACOL, V495, P111, DOI 10.1016/j.ejphar.2004.05.042; Rohwer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012038; Santandreu FM, 2010, FREE RADICAL BIO MED, V49, P658, DOI 10.1016/j.freeradbiomed.2010.05.031; Savagner F, 2001, J CLIN ENDOCR METAB, V86, P4920, DOI 10.1210/jc.86.10.4920; Shyu KG, 2007, EXP CELL RES, V313, P1181, DOI 10.1016/j.yexcr.2007.01.013; Solaini G, 2010, BBA-BIOENERGETICS, V1797, P1171, DOI 10.1016/j.bbabio.2010.02.011; van Laarhoven HWM, 2006, INT J RADIAT ONCOL, V64, P473, DOI 10.1016/j.ijrobp.2005.07.982; Vaupel P, 2005, TRANSFUS CLIN BIOL, V12, P5, DOI 10.1016/j.tracli.2004.11.005; Yoshiba S, 2009, ORAL ONCOL, V45, P109, DOI 10.1016/j.oraloncology.2008.04.002; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	35	57	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30714	10.1371/journal.pone.0030714	http://dx.doi.org/10.1371/journal.pone.0030714			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292025	Green Published, gold, Green Submitted			2022-12-27	WOS:000301639600049
J	Dey, AK; Burke, B; Sun, YD; Sirokman, K; Nandi, A; Hartog, K; Lian, Y; Geonnotti, AR; Montefiori, D; Franti, M; Martin, G; Carfi, A; Kessler, P; Martin, L; Srivastava, IK; Barnett, SW				Dey, Antu K.; Burke, Brian; Sun, Yide; Sirokman, Klara; Nandi, Avishek; Hartog, Karin; Lian, Ying; Geonnotti, Anthony R.; Montefiori, David; Franti, Michael; Martin, Gregoire; Carfi, Andrea; Kessler, Pascal; Martin, Loic; Srivastava, Indresh K.; Barnett, Susan W.			Elicitation of Neutralizing Antibodies Directed against CD4-Induced Epitope(s) Using a CD4 Mimetic Cross-Linked to a HIV-1 Envelope Glycoprotein	PLOS ONE			English	Article							IMMUNE-RESPONSES; PARTIAL DELETION; IMMUNOGENIC PROPERTIES; RATIONAL DESIGN; SHIV CHALLENGE; AMINO-ACIDS; N-TERMINUS; B-CELL; GP120; MACAQUES	The identification of HIV-1 envelope glycoprotein (Env) structures that can generate broadly neutralizing antibodies (BNAbs) is pivotal to the development of a successful vaccine against HIV-1 aimed at eliciting effective humoral immune responses. To that end, the production of novel Env structure(s) that might induce BNAbs by presentation of conserved epitopes, which are otherwise occluded, is critical. Here, we focus on a structure that stabilizes Env in a conformation representative of its primary (CD4) receptor-bound state, thereby exposing highly conserved "CD4 induced" (CD4i) epitope(s) known to be important for co-receptor binding and subsequent virus infection. A CD4-mimetic miniprotein, miniCD4 (M64U1-SH), was produced and covalently complexed to recombinant, trimeric gp140 envelope glycoprotein (gp140) using site-specific disulfide linkages. The resulting gp140-miniCD4 (gp140-S-S-M64U1) complex was recognized by CD4i antibodies and the HIV-1 co-receptor, CCR5. The gp140-miniCD4 complex elicited the highest titers of CD4i binding antibodies as well as enhanced neutralizing antibodies against Tier 1 viruses as compared to gp140 protein alone following immunization of rabbits. Neutralization against HIV-2(7312/V434M) and additional serum mapping confirm the specific elicitation of antibodies directed to the CD4i epitope(s). These results demonstrate the utility of structure-based approach in improving immunogenic response against specific region, such as the CD4i epitope(s) here, and its potential role in vaccine application.	[Dey, Antu K.; Burke, Brian; Sun, Yide; Sirokman, Klara; Nandi, Avishek; Hartog, Karin; Lian, Ying; Franti, Michael; Carfi, Andrea; Srivastava, Indresh K.; Barnett, Susan W.] Novartis Vaccines & Diagnost, Cambridge, MA USA; [Geonnotti, Anthony R.; Montefiori, David] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Martin, Gregoire; Kessler, Pascal; Martin, Loic] CEA, Serv Ingn Mol Prot, Gif Sur Yvette, France	Novartis; Duke University; CEA; UDICE-French Research Universities; Universite Paris Saclay	Dey, AK (corresponding author), Novartis Vaccines & Diagnost, Cambridge, MA USA.	susan.barnett@novartis.com	Dey, Antu/A-1305-2013; MARTIN, Loïc/E-1627-2011	MARTIN, Loïc/0000-0002-7940-2955; Martin, Gregoire/0000-0001-8240-6108; Dey, Antu/0000-0001-7438-9379	NIH HIVRAD (HIV Research and Design) [5P01 AI066287]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI066287] Funding Source: NIH RePORTER	NIH HIVRAD (HIV Research and Design)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIH HIVRAD (HIV Research and Design) grant, # 5P01 AI066287. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnet SW, 2001, J VIROL, V75, P5526, DOI 10.1128/JVI.75.12.5526-5540.2001; Barnett SW, 2010, J VIROL, V84, P5975, DOI 10.1128/JVI.02533-09; Barnetta SW, 2008, AIDS, V22, P339, DOI 10.1097/QAD.0b013e3282f3ca57; Bogers WMJM, 2008, VIROLOGY, V382, P217, DOI 10.1016/j.virol.2008.09.016; Buckner C, 2004, VIROLOGY, V320, P167, DOI 10.1016/j.virol.2003.12.003; Burke B, 2009, VIROLOGY, V387, P147, DOI 10.1016/j.virol.2009.02.005; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Cherpelis S, 2001, J VIROL, V75, P1547, DOI 10.1128/JVI.75.3.1547-1550.2001; Crooks Emma T., 2005, Human Antibodies, V14, P101; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Derby NR, 2006, J VIROL, V80, P8745, DOI 10.1128/JVI.00956-06; DeVico A, 2007, P NATL ACAD SCI USA, V104, P17477, DOI 10.1073/pnas.0707399104; Dey AK, 2005, J VIROL, V79, P13806, DOI 10.1128/JVI.79.21.13806-13810.2005; Dey AK, 2008, VIROLOGY, V372, P187, DOI 10.1016/j.virol.2007.10.018; Dey AK, 2007, VIROLOGY, V360, P199, DOI 10.1016/j.virol.2006.09.046; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Douek DC, 2006, CELL, V124, P677, DOI 10.1016/j.cell.2006.02.005; Farzan M, 2000, J BIOL CHEM, V275, P33516, DOI 10.1074/jbc.M007228200; Forsell MNE, 2009, CURR OPIN HIV AIDS, V4, P380, DOI 10.1097/COH.0b013e32832edc19; Forsell MNE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000171; Fouts T, 2002, P NATL ACAD SCI USA, V99, P11842, DOI 10.1073/pnas.182412199; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Guan YJ, 2009, P NATL ACAD SCI USA, V106, P3952, DOI 10.1073/pnas.0813392106; Haynes BF, 2011, CASE CONTROL STUDY R; He YX, 2003, VACCINE, V21, P4421, DOI 10.1016/S0264-410X(03)00451-1; HU SL, 1992, AIDS RES HUM RETROV, V8, P1489, DOI 10.1089/aid.1992.8.1489; HU SL, 1992, SCIENCE, V255, P456, DOI 10.1126/science.1531159; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Lewis GK, 2011, J VIROL, V85, P13097, DOI 10.1128/JVI.05072-11; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lubeck MD, 1997, NAT MED, V3, P651, DOI 10.1038/nm0697-651; Martin G, 2011, J BIOL CHEM; Martin G, 2008, VIROLOGY, V381, P241, DOI 10.1016/j.virol.2008.08.039; Martin L, 2003, NAT BIOTECHNOL, V21, P71, DOI 10.1038/nbt768; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; MOORE JP, 1992, J VIROL, V66, P235, DOI 10.1128/JVI.66.1.235-243.1992; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Pantophlet R, 2003, J VIROL, V77, P5889, DOI 10.1128/JVI.77.10.5889-5901.2003; Pinter A, 2007, CURR HIV RES, V5, P542, DOI 10.2174/157016207782418470; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Selvarajah S, 2005, J VIROL, V79, P12148, DOI 10.1128/JVI.79.19.12148-12163.2005; Spearman P, 2011, J INFECT DIS, V203, P1165, DOI 10.1093/infdis/jiq175; Srivastava IK, 2003, J VIROL, V77, P11244, DOI 10.1128/JVI.77.20.11244-11259.2003; Srivastava IK, 2003, J VIROL, V77, P2310, DOI 10.1128/JVI.77.4.2310-2320.2003; Srivastava IK, 2002, J VIROL, V76, P2835, DOI 10.1128/JVI.76.6.2835-2847.2002; Stricher F, 2008, J MOL BIOL, V382, P510, DOI 10.1016/j.jmb.2008.06.069; THALI M, 1991, J VIROL, V65, P5007, DOI 10.1128/JVI.65.9.5007-5012.1991; THALI M, 1991, J VIROL, V65, P6188, DOI 10.1128/JVI.65.11.6188-6193.1991; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Vaine M, 2010, VACCINE, V28, P2999, DOI 10.1016/j.vaccine.2010.02.006; Van Herrewege Y, 2008, J ANTIMICROB CHEMOTH, V61, P818, DOI 10.1093/jac/dkn042; Varadarajan R, 2005, J VIROL, V79, P1713, DOI 10.1128/JVI.79.3.1713-1723.2005; Verschoor EJ, 1999, J VIROL, V73, P3292, DOI 10.1128/JVI.73.4.3292-3300.1999; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu L, 2006, VACCINE, V24, P4995, DOI 10.1016/j.vaccine.2006.03.083; Wu X, SCIENCE, V329, P856; Xiang SH, 2002, AIDS RES HUM RETROV, V18, P1207, DOI 10.1089/08892220260387959; Xu R, 2006, AIDS RES HUM RETROV, V22, P1022, DOI 10.1089/aid.2006.22.1022; Zhang PF, 2002, J VIROL, V76, P644, DOI 10.1128/JVI.76.2.644-655.2002; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	71	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30233	10.1371/journal.pone.0030233	http://dx.doi.org/10.1371/journal.pone.0030233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291921	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600007
J	Manion, M; Rodriguez, B; Medvik, K; Hardy, G; Harding, CV; Schooley, RT; Pollard, R; Asmuth, D; Murphy, R; Barker, E; Brady, KE; Landay, A; Funderburg, N; Sieg, SF; Lederman, MM				Manion, Maura; Rodriguez, Benigno; Medvik, Kathleen; Hardy, Gareth; Harding, Clifford V.; Schooley, Robert T.; Pollard, Richard; Asmuth, David; Murphy, Robert; Barker, Edward; Brady, Kirsten E.; Landay, Alan; Funderburg, Nick; Sieg, Scott F.; Lederman, Michael M.			Interferon-Alpha Administration Enhances CD8+T Cell Activation in HIV Infection	PLOS ONE			English	Article							CD8(+) T-CELLS; PLASMACYTOID DENDRITIC CELLS; APOPTOSIS-INDUCING LIGAND; VIRUS TYPE-1 INFECTION; CHRONIC HEPATITIS-C; IMMUNE ACTIVATION; ANTIRETROVIRAL THERAPY; IFN-ALPHA; I INTERFERON; MICROBIAL TRANSLOCATION	Background: Type I interferons play important roles in innate immune defense. In HIV infection, type I interferons may delay disease progression by inhibiting viral replication while at the same time accelerating disease progression by contributing to chronic immune activation. Methods: To investigate the effects of type I interferons in HIV-infection, we obtained cryopreserved peripheral blood mononuclear cell samples from 10 subjects who participated in AIDS Clinical Trials Group Study 5192, a trial investigating the activity of systemic administration of IFN alpha for twelve weeks to patients with untreated HIV infection. Using flow cytometry, we examined changes in cell cycle status and expression of activation antigens by circulating T cells and their maturation subsets before, during and after IFNa treatment. Results: The proportion of CD38+HLA-DR+CD8+ T cells increased from a mean of 11.7% at baseline to 24.1% after twelve weeks of interferon treatment (p = 0.006). These frequencies dropped to an average of 20.1% six weeks after the end of treatment. In contrast to CD8+ T cells, the frequencies of activated CD4+ T cells did not change with administration of type I interferon (mean percentage of CD38+DR+ cells = 2.62% at baseline and 2.17% after 12 weeks of interferon therapy). As plasma HIV levels fell with interferon therapy, this was correlated with a "paradoxical" increase in CD8+ T cell activation (p<0.001). Conclusion: Administration of type I interferon increased expression of the activation markers CD38 and HLA DR on CD8+ T cells but not on CD4+ T cells of HIV+ persons. These observations suggest that type I interferons may contribute to the high levels of CD8+ T cell activation that occur during HIV infection.	[Manion, Maura; Rodriguez, Benigno; Medvik, Kathleen; Funderburg, Nick; Sieg, Scott F.; Lederman, Michael M.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Ctr AIDS Res, Div Infect Dis, Cleveland, OH 44106 USA; [Hardy, Gareth; Harding, Clifford V.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA; [Schooley, Robert T.] Univ Calif San Diego, Div Infect Dis, La Jolla, CA 92093 USA; [Pollard, Richard; Asmuth, David] Univ Calif Davis, Div Infect Dis, Sacramento, CA 95817 USA; [Murphy, Robert] Northwestern Univ, Feinberg Sch Med, Ctr AIDS Res, Div Infect Dis, Chicago, IL 60611 USA; [Barker, Edward; Brady, Kirsten E.; Landay, Alan] Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA	Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; University of California System; University of California San Diego; University of California System; University of California Davis; Northwestern University; Feinberg School of Medicine; Rush University	Manion, M (corresponding author), Case Western Reserve Univ, Univ Hosp Case Med Ctr, Ctr AIDS Res, Div Infect Dis, Cleveland, OH 44106 USA.	lederman.michael@clevelandactu.org	Funderburg, Nicholas/L-8022-2013; Rodriguez, Benigno/C-3365-2009; Sieg, Scott/AAV-2429-2021	Rodriguez, Benigno/0000-0001-9736-7957; Murphy, Robert/0000-0003-3936-2052; Barker, Edward/0000-0003-3773-9565; Funderburg, Nicholas/0000-0003-3113-1217; Asmuth, David/0000-0003-0916-7950	National Institutes of Health (NIH) [1U01-AI068636, 1U01-AI069471, 1U01-AI069432, 1U01-AI069484]; Immunology Support Laboratory [AI 068636, AI 36219]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL108743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069432, R01AI065361, P30AI036219, U01AI069484, UM1AI068636, U01AI068636, U01AI069471] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Immunology Support Laboratory; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial Support: National Institutes of Health (NIH; grant 1U01-AI068636 to the AIDS Clinical Trials Group [ACTG], grant 1U01-AI069471 to Northwestern University, grant 1U01-AI069432 to University of California, San Diego, grant 1U01-AI069484 to Duke University, Immunology Support Laboratory grant AI 068636 and AI 36219 for the Center for AIDS Research at Case Western Reserve University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anselmi A, 2007, CLIN EXP IMMUNOL, V150, P442, DOI 10.1111/j.1365-2249.2007.03526.x; Asmuth DM, 2010, J INFECT DIS, V201, P1686, DOI 10.1086/652420; Audige A, 2006, J IMMUNOL, V177, P6227, DOI 10.4049/jimmunol.177.9.6227; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Biron CA, 1998, SEMIN IMMUNOL, V10, P383, DOI 10.1006/smim.1998.0138; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Choudhary SK, 2007, J VIROL, V81, P8838, DOI 10.1128/JVI.02663-06; Costa P, 2009, EUR J IMMUNOL, V39, P147, DOI 10.1002/eji.200838532; Decrion AZ, 2005, CURR HIV RES, V3, P243, DOI 10.2174/1570162054368057; DEWIT R, 1988, LANCET, V2, P1214; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Emilie D, 2001, AIDS, V15, P1435, DOI 10.1097/00002030-200107270-00014; Ensoli B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013540; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Funderburg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001915; GIORGI JV, 1994, J INFECT DIS, V170, P775, DOI 10.1093/infdis/170.4.775; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Haas DW, 2000, AIDS RES HUM RETROV, V16, P183, DOI 10.1089/088922200309278; Hardy GAD, 2009, BLOOD, V113, P5497, DOI 10.1182/blood-2008-11-190231; Hatzakis A, 2001, J INTERF CYTOK RES, V21, P861, DOI 10.1089/107999001753238114; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hellerstein MK, 2003, J CLIN INVEST, V112, P956, DOI 10.1172/JCI200317533; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; Herbeuval JP, 2005, BLOOD, V105, P2458, DOI 10.1182/blood-2004-08-3058; Herbeuval JP, 2005, P NATL ACAD SCI USA, V102, P13974, DOI 10.1073/pnas.0505251102; Hirsch I, 2010, TRENDS IMMUNOL, V31, P391, DOI 10.1016/j.it.2010.07.004; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hunt PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015924; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Juno JA, 2010, AIDS REV, V12, P164; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kelleher AD, 1996, J INFECT DIS, V173, P321, DOI 10.1093/infdis/173.2.321; Kovacs A, 2010, J INFECT DIS, V201, P823, DOI 10.1086/650997; Kovacs JA, 2001, J EXP MED, V194, P1731, DOI 10.1084/jem.194.12.1731; KOVACS JA, 1989, ANN INTERN MED, V111, P280, DOI 10.7326/0003-4819-111-4-280; LANE HC, 1988, LANCET, V2, P1218; Lapenta C, 1999, VIROLOGY, V263, P78, DOI 10.1006/viro.1999.9869; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Lederman MM, 1998, J INFECT DIS, V178, P70, DOI 10.1086/515591; Leng QB, 2001, J ACQ IMMUN DEF SYND, V27, P389, DOI 10.1097/00126334-200108010-00010; LEVIN S, 1982, ISRAEL J MED SCI, V18, P439; Levy JA, 2001, TRENDS IMMUNOL, V22, P312, DOI 10.1016/S1471-4906(01)01925-1; Li QS, 2004, J INFECT DIS, V189, P572, DOI 10.1086/381396; MACE K, 1989, VIROLOGY, V168, P399, DOI 10.1016/0042-6822(89)90282-1; MACE K, 1991, RES VIROLOGY, V142, P213, DOI 10.1016/0923-2516(91)90059-C; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Marrack P, 1998, IMMUNOL REV, V165, P279, DOI 10.1111/j.1600-065X.1998.tb01245.x; Matikainen S, 1999, BLOOD, V93, P1980, DOI 10.1182/blood.V93.6.1980.406k20_1980_1991; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Mohri H, 1998, SCIENCE, V279, P1223, DOI 10.1126/science.279.5354.1223; Moir S, 2004, J EXP MED, V200, P587, DOI 10.1084/jem.20032236; MUROCACHO CA, 1995, J IMMUNOL, V154, P5555; Perry CM, 2001, DRUGS, V61, P2263, DOI 10.2165/00003495-200161150-00013; Picker LJ, 2005, NAT IMMUNOL, V6, P430, DOI 10.1038/ni0505-430; Picker LJ, 2006, CURR OPIN IMMUNOL, V18, P399, DOI 10.1016/j.coi.2006.05.001; Portales P, 2003, AIDS, V17, P495, DOI 10.1097/00002030-200303070-00004; Reddy KR, 2002, ADV DRUG DELIVER REV, V54, P571, DOI 10.1016/S0169-409X(02)00028-5; Ribeiro RM, 2002, P NATL ACAD SCI USA, V99, P15572, DOI 10.1073/pnas.242358099; Rodriguez B, 2006, AIDS, V20, P1379, DOI 10.1097/01.aids.0000233571.51899.ab; Rosenzweig M, 1998, P NATL ACAD SCI USA, V95, P6388, DOI 10.1073/pnas.95.11.6388; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Schandene L, 2000, BLOOD, V96, P4285; Sedaghat AR, 2008, J VIROL, V82, P1870, DOI 10.1128/JVI.02228-07; Sieg SF, 2005, J INFECT DIS, V192, P62, DOI 10.1086/430620; Skillman DR, 1996, J INFECT DIS, V173, P1107, DOI 10.1093/infdis/173.5.1107; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Stein TP, 1997, CYTOKINE, V9, P143, DOI 10.1006/cyto.1996.0148; Tomescu C, 2007, J IMMUNOL, V179, P2097, DOI 10.4049/jimmunol.179.4.2097; ULLUM H, 1995, J EXP MED, V182, P789, DOI 10.1084/jem.182.3.789; VONSYDOW M, 1991, AIDS RES HUM RETROV, V7, P375, DOI 10.1089/aid.1991.7.375; Yim HCH, 2009, AIDS, V23, P1473, DOI 10.1097/QAD.0b013e32832d7abe	75	38	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30306	10.1371/journal.pone.0030306	http://dx.doi.org/10.1371/journal.pone.0030306			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291932	Green Submitted, Green Published, gold			2022-12-27	WOS:000301639600011
J	Kajiho, H; Fukushima, S; Kontani, K; Katada, T				Kajiho, Hiroaki; Fukushima, Shinichi; Kontani, Kenji; Katada, Toshiaki			RINL, Guanine Nucleotide Exchange Factor Rab5-Subfamily, Is Involved in the EphA8-Degradation Pathway with Odin	PLOS ONE			English	Article							DOMAIN-CONTAINING PROTEINS; EPIDERMAL-GROWTH-FACTOR; SMALL GTPASE RAB5; MEMBRANE TRAFFICKING; ENDOCYTOSIS; BINDING; RECEPTOR; REGULATOR; TRANSPORT; DYNAMICS	The Rab family of small guanosine triphosphatases (GTPases) plays a vital role in membrane trafficking. Its active GTP-bound state is driven by guanine nucleotide-exchange factors (GEFs). Ras and Rab interactor (or Ras interaction/interference)-like (RINL), which contains a conserved VPS9 domain critical for GEF action, was recently identified as a new Rab5 subfamily GEF in vitro. However, its detailed function and interacting molecules have not yet been fully elucidated. Here we found that RINL has GEF activity for the Rab5 subfamily proteins by measuring their GTP-bound forms in cultured cells. We also found that RINL interacts with odin, a member of the ankyrin-repeat and sterile-alpha motif (SAM) domain-containing (Anks) protein family. In addition, the Eph tyrosine kinase receptor EphA8 formed a ternary complex with both RINL and odin. Interestingly, RINL expression in cultured cells reduced EphA8 levels in a manner dependent on both its GEF activity and interaction with odin. In addition, knockdown of RINL increased EphA8 level in HeLa cells. Our findings suggest that RINL, as a GEF for Rab5 subfamily, is implicated in the EphA8-degradation pathway via its interaction with odin.	[Kajiho, Hiroaki; Fukushima, Shinichi; Kontani, Kenji; Katada, Toshiaki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Tokyo, Japan	University of Tokyo	Kajiho, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Tokyo, Japan.	katada@mol.f.u-tokyo.ac.jp		Kajiho, Hiroaki/0000-0001-6376-7629	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by research grants (to H.K., K.K. and T.K.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and Japan Society for the Promotion of Science (JSPS) (URL: http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Barbieri MA, 2003, J BIOL CHEM, V278, P32027, DOI 10.1074/jbc.M304324200; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Deininger K, 2008, P NATL ACAD SCI USA, V105, P12539, DOI 10.1073/pnas.0801174105; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Emaduddin M, 2008, CELL COMMUN SIGNAL, V6, P7; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Kajiho H, 2003, J CELL SCI, V116, P4159, DOI 10.1242/jcs.00718; Kajiho H, J BIOL CHEM; Kauppi M, 2002, J CELL SCI, V115, P899; Kim J, 2010, MOL CELL BIOL, V30, P1582, DOI 10.1128/MCB.01605-09; Kimura T, 2006, J BIOL CHEM, V281, P10598, DOI 10.1074/jbc.M510531200; Mesa R, 2005, EXP CELL RES, V304, P339, DOI 10.1016/j.yexcr.2004.11.017; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Saito K, 2005, METHOD ENZYMOL, V403, P276, DOI 10.1016/S0076-6879(05)03023-5; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Shin J, 2007, MOL CELL BIOL, V27, P8113, DOI 10.1128/MCB.00794-07; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; Woller B, 2011, BBA-MOL CELL RES, V1813, P1198, DOI 10.1016/j.bbamcr.2011.03.005; Yoshikawa M, 2008, BIOCHEM BIOPH RES CO, V372, P168, DOI 10.1016/j.bbrc.2008.05.027; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XJ, 2006, J CELL SCI, V119, P1053, DOI 10.1242/jcs.02810	29	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30575	10.1371/journal.pone.0030575	http://dx.doi.org/10.1371/journal.pone.0030575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291991	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600061
J	Azrak, S; Ayyasamy, V; Zirpoli, G; Ambrosone, C; Bandera, EV; Bovbjerg, DH; Jandorf, L; Ciupak, G; Davis, W; Pawlish, KS; Liang, P; Singh, K				Azrak, Sami; Ayyasamy, Vanniarajan; Zirpoli, Gary; Ambrosone, Christine; Bandera, Elisa V.; Bovbjerg, Dana H.; Jandorf, Lina; Ciupak, Gregory; Davis, Warren; Pawlish, Karen S.; Liang, Ping; Singh, Keshav			CAG Repeat Variants in the POLG1 Gene Encoding mtDNA Polymerase-Gamma and Risk of Breast Cancer in African-American Women	PLOS ONE			English	Article							DNA; ASSOCIATION; MUTATIONS; POLYMORPHISM	The DNA polymerase-gamma (POLG) gene, which encodes the catalytic subunit of enzyme responsible for directing mitochondrial DNA replication in humans, contains a polyglutamine tract encoded by CAG repeats of varying length. The length of the CAG repeat has been associated with the risk of testicular cancer, and other genomic variants that impact mitochondrial function have been linked to breast cancer risk in African-American (AA) women. We evaluated the potential role of germline POLG-CAG repeat variants in breast cancer risk in a sample of AA women (100 cases and 100 age-matched controls) who participated in the Women's Circle of Health Study, an ongoing multi-institutional, case-control study of breast cancer. Genotyping was done by fragment analysis in a blinded manner. Results from this small study suggest the possibility of an increased risk of breast cancer in women with minor CAG repeat variants of POLG, but no statistically significant differences in CAG repeat length were observed between cases and controls (multivariate-adjusted odds ratio 1.74; 95% CI, 0.49-6.21). Our study suggests that POLG-CAG repeat length is a potential risk factor for breast cancer that needs to be explored in larger population-based studies.	[Azrak, Sami; Liang, Ping] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada; [Ayyasamy, Vanniarajan; Singh, Keshav] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Zirpoli, Gary; Ambrosone, Christine; Ciupak, Gregory; Davis, Warren] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Bandera, Elisa V.] Canc Inst New Jersey, New Brunswick, NJ USA; [Bovbjerg, Dana H.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Jandorf, Lina] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA; [Pawlish, Karen S.] New Jersey Dept Hlth & Senior Serv, New Jersey State Canc Registry, Trenton, NJ USA; [Singh, Keshav] Univ Alabama Birmingham, Dept Genet, Ctr Free Rad Biol, Ctr Aging, Birmingham, AL USA; [Singh, Keshav] Univ Alabama Birmingham, Dept Pathol, Ctr Free Rad Biol, Ctr Aging, Birmingham, AL 35294 USA; [Singh, Keshav] Univ Alabama Birmingham, Dept Environm Hlth, Ctr Free Rad Biol, Ctr Aging, Birmingham, AL USA; [Singh, Keshav] Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Birmingham, AL USA	Brock University; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Icahn School of Medicine at Mount Sinai; New Jersey Department of Health & Senior Services; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Azrak, S (corresponding author), Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada.	kksingh@uab.edu	Azrak, Sami/ABF-3764-2021; Liang, Ping/D-2709-2009; Vanniarajan, A./AAB-4896-2022; Bandera, Elisa V/M-4169-2014; Liang, Ping/S-3790-2018	Liang, Ping/0000-0003-4423-0636; Bandera, Elisa V/0000-0002-8789-2755; Liang, Ping/0000-0003-4423-0636; AZRAK, SAMI/0000-0003-1714-0977	National Institutes of Health [R01 121904, R01 116430, R21 153097]; U.S. Army Medical Research and Material Command (USARMMC) [DAMD-17-01-1-0334]; National Cancer Institute [R01 CA100598]; Breast Cancer Research Foundation; Centers for Disease Control and Prevention for its support of the NJSCR [DP07-703]; National Cancer Institute's SEER [N01-PC-95001-20]; NATIONAL CANCER INSTITUTE [K22CA138563, R01CA100598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Medical Research and Material Command (USARMMC); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; Centers for Disease Control and Prevention for its support of the NJSCR(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Cancer Institute's SEER; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the National Institutes of Health (R01 121904 and 116430 and R21 153097) to KS. The WCHS is supported by grants from the U.S. Army Medical Research and Material Command (USARMMC) (DAMD-17-01-1-0334), the National Cancer Institute (R01 CA100598), and the Breast Cancer Research Foundation. The New Jersey State Cancer Registry (NJSCR) is a participant in the Centers for Disease Control and Prevention's National Program of Cancer Registries (NPCR) and is a National Cancer Institute SEER Expansion Registry. The authors acknowledge the Centers for Disease Control and Prevention for its support of the NJSCR under cooperative agreement DP07-703 awarded to the New Jersey Department of Health & Senior Services. The collection of State of New Jersey cancer incidence data is also supported by the National Cancer Institute's SEER Program under contract N01-PC-95001-20. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosone CB, 2009, J ONCOL, V2009, DOI 10.1155/2009/871250; Amend K, 2006, CANCER RES, V66, P8327, DOI 10.1158/0008-5472.CAN-06-1927; Blomberg JM, 2008, ANN ONCOL, V19, P1910; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chen XH, 2002, AIDS RES HUM RETROV, V18, P531, DOI 10.1089/088922202753747879; Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021; Heidari M, 2008, NEUROL SCI, V29, P489, DOI 10.1007/s10072-008-1026-y; Jensen M, 2004, HUM REPROD, V19, P65, DOI 10.1093/humrep/deh038; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70; Nowak R, 2005, ANN ONCOL, V16, P1211, DOI 10.1093/annonc/mdi205; Rovio A, 1999, EUR J HUM GENET, V7, P140, DOI 10.1038/sj.ejhg.5200244; Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759; Singh KK, 2009, J HUM GENET, V54, P516, DOI 10.1038/jhg.2009.71; Tsezou A, 2008, BREAST, V17, P159, DOI 10.1016/j.breast.2007.08.007; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955	17	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29548	10.1371/journal.pone.0029548	http://dx.doi.org/10.1371/journal.pone.0029548			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276120	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000301568100012
J	Iqbal, S; Zhang, SM; Driss, A; Liu, ZR; Kim, HRC; Wang, YR; Ritenour, C; Zhau, HE; Kucuk, O; Chung, LWK; Wu, DQ				Iqbal, Shareen; Zhang, Shumin; Driss, Adel; Liu, Zhi-Ren; Kim, Hyeong-Reh Choi; Wang, Yanru; Ritenour, Chad; Zhau, Haiyen E.; Kucuk, Omer; Chung, Leland W. K.; Wu, Daqing			PDGF Upregulates Mcl-1 Through Activation of beta-Catenin and HIF-1 alpha-Dependent Signaling in Human Prostate Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; EPITHELIAL-MESENCHYMAL TRANSITION; TYROSINE KINASE INHIBITORS; BONE METASTASIS; PROGNOSTIC-SIGNIFICANCE; LEUKEMIA-1 EXPRESSION; IMATINIB MESYLATE; FACTOR-ALPHA; GENE; CHEMOTHERAPY	Background: Aberrant platelet derived growth factor (PDGF) signaling has been associated with prostate cancer (PCa) progression. However, its role in the regulation of PCa cell growth and survival has not been well characterized. Methodology/Principal Findings: Using experimental models that closely mimic clinical pathophysiology of PCa progression, we demonstrated that PDGF is a survival factor in PCa cells through upregulation of myeloid cell leukemia-1 (Mcl-1). PDGF treatment induced rapid nuclear translocation of beta-catenin, presumably mediated by c-Abl and p68 signaling. Intriguingly, PDGF promoted formation of a nuclear transcriptional complex consisting of b-catenin and hypoxiainducible factor (HIF)-1 alpha, and its binding to Mcl-1 promoter. Deletion of a putative hypoxia response element (HRE) within the Mcl-1 promoter attenuated PDGF effects on Mcl-1 expression. Blockade of PDGF receptor (PDGFR) signaling with a pharmacological inhibitor AG-17 abrogated PDGF induction of Mcl-1, and induced apoptosis in metastatic PCa cells. Conclusions/Significance: Our study elucidated a crucial survival mechanism in PCa cells, indicating that interruption of the PDGF-Mcl-1 survival signal may provide a novel strategy for treating PCa metastasis.	[Iqbal, Shareen; Zhang, Shumin; Wang, Yanru; Ritenour, Chad; Wu, Daqing] Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA; [Iqbal, Shareen; Zhang, Shumin; Wang, Yanru; Ritenour, Chad; Kucuk, Omer; Wu, Daqing] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA; [Driss, Adel] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA; [Liu, Zhi-Ren] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Kim, Hyeong-Reh Choi] Wayne State Univ, Sch Med, Dept Pathol, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA; [Zhau, Haiyen E.; Chung, Leland W. K.] Cedars Sinai Med Ctr, Dept Med, Urooncol Res Program, Los Angeles, CA 90048 USA; [Kucuk, Omer] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA	Emory University; Emory University; Morehouse School of Medicine; University System of Georgia; Georgia State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Cedars Sinai Medical Center; Emory University	Iqbal, S (corresponding author), Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA.	Leland.Chung@cshs.org; dwu2@emory.edu	Driss, Adel/X-6772-2019; Driss, Adel/A-4151-2008	, Shareen/0000-0002-9489-7781	Department of Defense [PC060566, PC060866]; American Cancer Society [RSG-10-140-01]; Emory University Research Committee; National Cancer Institute [1R43CA141870, P01 CA98912, R01 CA122602]; Georgia Cancer Coalition Distinguished Scholar; NATIONAL CANCER INSTITUTE [P01CA098912, R01CA122602, R43CA141870] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); Emory University Research Committee; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Coalition Distinguished Scholar; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Department of Defense PC060566, American Cancer Society RSG-10-140-01, Emory University Research Committee Award, Kennedy Seed Grant (D.W.), National Cancer Institute grant 1R43CA141870 (A.W.), National Cancer Institute grants P01 CA98912, R01 CA122602, Department of Defense PC060866 (L.W.K.C.), Georgia Cancer Coalition Distinguished Scholar Grant (O.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul C, 2000, CELL MOL LIFE SCI, V57, P684, DOI 10.1007/PL00000728; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Cavarretta IT, 2007, ONCOGENE, V26, P2822, DOI 10.1038/sj.onc.1210097; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; Chott A, 1999, AM J PATHOL, V155, P1271, DOI 10.1016/S0002-9440(10)65229-7; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Clevers H, 2004, CANCER CELL, V5, P5, DOI 10.1016/S1535-6108(03)00339-8; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fischer ANM, 2007, ONCOGENE, V26, P3395, DOI 10.1038/sj.onc.1210121; FUDGE K, 1994, MODERN PATHOL, V7, P549; GAZIT A, 1989, J MED CHEM, V32, P2344, DOI 10.1021/jm00130a020; George DJ, 2002, UROLOGY, V60, P115, DOI 10.1016/S0090-4295(02)01589-3; Heldin CH, 2002, ARCH BIOCHEM BIOPHYS, V398, P284, DOI 10.1006/abbi.2001.2707; Hofer MD, 2004, NEOPLASIA, V6, P503, DOI 10.1593/neo.04157; Isomoto H, 2005, HEPATOLOGY, V42, P1329, DOI 10.1002/hep.20966; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; KIM L, 1995, MOL CELL BIOL, V15, P4553; Kim SJ, 2004, CANCER RES, V64, P4201, DOI 10.1158/0008-5472.CAN-03-3763; Kitadai Y, 2006, INT J CANCER, V119, P2567, DOI 10.1002/ijc.22229; Ko YJ, 2001, CLIN CANCER RES, V7, P800; Kodama M, 2010, CANCER SCI, V101, P1984, DOI 10.1111/j.1349-7006.2010.01639.x; Kong DJ, 2008, STEM CELLS, V26, P1425, DOI 10.1634/stemcells.2007-1076; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Langley RR, 2004, CANCER RES, V64, P3727, DOI 10.1158/0008-5472.CAN-03-3863; Mathew P, 2004, J CLIN ONCOL, V22, P3323, DOI 10.1200/JCO.2004.10.116; Mathew P, 2007, CLIN CANCER RES, V13, P5816, DOI 10.1158/1078-0432.CCR-07-1269; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Ostman A, 2004, CYTOKINE GROWTH F R, V15, P275, DOI 10.1016/j.cytogfr.2004.03.002; Ostman A, 2007, ADV CANCER RES, V97, P247, DOI 10.1016/S0065-230X(06)97011-0; Paulsson J, 2009, AM J PATHOL, V175, P334, DOI 10.2353/ajpath.2009.081030; Pienta KJ, 2005, CA-CANCER J CLIN, V55, P300, DOI 10.3322/canjclin.55.5.300; Pietras K, 2002, CANCER RES, V62, P5476; Pietras K, 2003, CANCER CELL, V3, P439, DOI 10.1016/S1535-6108(03)00089-8; Pietras K, 2008, PLOS MED, V5, P123, DOI 10.1371/journal.pmed.0050019; RANA A, 1993, BRIT J UROL, V72, P933, DOI 10.1111/j.1464-410X.1993.tb16301.x; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Song N, 2009, CANCER RES, V69, P6057, DOI 10.1158/0008-5472.CAN-08-2007; Truica CI, 2000, CANCER RES, V60, P4709; Uehara H, 2003, J NATL CANCER I, V95, P458, DOI 10.1093/jnci/95.6.458; Wang JM, 1999, MOL CELL BIOL, V19, P6195; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; Wu D, 2007, ONCOGENE, V26, P5070, DOI 10.1038/sj.onc.1210316; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; Xu JC, 2006, PROSTATE, V66, P1664, DOI 10.1002/pros.20488; Yang LQ, 2007, J BIOL CHEM, V282, P16811, DOI 10.1074/jbc.M610488200; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yokote K, 1996, J BIOL CHEM, V271, P30942, DOI 10.1074/jbc.271.48.30942; Zhang SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-9; Zhau HE, 2008, CLIN EXP METASTAS, V25, P601, DOI 10.1007/s10585-008-9183-1	54	39	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30764	10.1371/journal.pone.0030764	http://dx.doi.org/10.1371/journal.pone.0030764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276222	gold, Green Published, Green Submitted			2022-12-27	WOS:000301568100062
J	Marks, DJB; Fisk, MD; Koo, CY; Pavlou, M; Peck, L; Lee, SF; Lawrence, D; Macrae, MB; Wilson, APR; Brown, JS; Miller, RF; Zumla, AI				Marks, Daniel J. B.; Fisk, Marie D.; Koo, Chieh Y.; Pavlou, Menelaos; Peck, Lorraine; Lee, Simon F.; Lawrence, David; Macrae, M. Bruce; Wilson, A. Peter R.; Brown, Jeremy S.; Miller, Robert F.; Zumla, Alimuddin I.			Thoracic Empyema: A 12-Year Study from a UK Tertiary Cardiothoracic Referral Centre	PLOS ONE			English	Article							CELL DISTRIBUTION WIDTH; COMPLICATED PARAPNEUMONIC EFFUSIONS; PLEURAL INFECTION; THORACOSCOPIC DECORTICATION; CONJUGATE VACCINE; BACTERIOLOGY; CHILDREN; DISEASE; ADULTS; TUBERCULOSIS	Background: Empyema is an increasingly frequent clinical problem worldwide, and has substantial morbidity and mortality. Our objectives were to identify the clinical, surgical and microbiological features, and management outcomes, of empyema. Methods: A retrospective observational study over 12 years (1999-2010) was carried out at The Heart Hospital, London, United Kingdom. Patients with empyema were identified by screening the hospital electronic 'Clinical Data Repository'. Demographics, clinical and microbiological characteristics, underlying risk factors, peri-operative blood tests, treatment and outcomes were identified. Univariable and multivariable statistical analyses were performed. Results: Patients (n = 406) were predominantly male (74.1%); median age = 53 years (IQR = 37-69). Most empyema were community-acquired (87.4%) and right-sided (57.4%). Microbiological diagnosis was obtained in 229 (56.4%) patients, and included streptococci (16.3%), staphylococci (15.5%), Gram-negative organisms (8.9%), anaerobes (5.7%), pseudomonads (4.4%) and mycobacteria (9.1%); 8.4% were polymicrobial. Most (68%) cases were managed by open thoracotomy and decortication. Video-assisted thoracoscopic surgery (VATS) reduced hospitalisation from 10 to seven days (P = 0.0005). All-cause complication rate was 25.1%, and 28 day mortality 5.7%. Predictors of early mortality included: older age (P = 0.006), major co-morbidity (P = 0.01), malnutrition (P = 0.001), elevated red cell distribution width (RDW, P<0.001) and serum alkaline phosphatase (P = 0.004), and reduced serum albumin (P = 0.01) and haemoglobin (P = 0.04). Conclusions: Empyema remains an important cause of morbidity and hospital admissions. Microbiological diagnosis was only achieved in just over 50% of cases, and tuberculosis is a notable causative organism. Treatment of empyema with VATS may reduce duration of hospital stay. Raised RDW appears to associate with early mortality.	[Marks, Daniel J. B.; Fisk, Marie D.; Peck, Lorraine; Lee, Simon F.] Univ Coll London Hosp NHS Fdn Trust, Heart Hosp, Dept Cardiol, London, England; [Marks, Daniel J. B.; Koo, Chieh Y.] UCL, Dept Med, London, England; [Pavlou, Menelaos; Miller, Robert F.] UCL, Sch Med, Res Dept Infect & Populat Hlth, London W1N 8AA, England; [Lee, Simon F.] Inst Mol & Cellular Biol, Div Infect & Immun, Oporto, Portugal; [Lawrence, David] Univ Coll London Hosp NHS Fdn Trust, Heart Hosp, Dept Cardiothorac Surg, London, England; [Brown, Jeremy S.] UCL, Ctr Resp Res, London, England; [Zumla, Alimuddin I.] UCL, Sch Med, Dept Infect, London W1N 8AA, England; [Macrae, M. Bruce; Wilson, A. Peter R.; Zumla, Alimuddin I.] Univ Coll London Hosp NHS Fdn Trust, Dept Clin Microbiol, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; Universidade do Porto; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London	Marks, DJB (corresponding author), Univ Coll London Hosp NHS Fdn Trust, Heart Hosp, Dept Cardiol, London, England.	a.zumla@ucl.ac.uk	Laurell, Thomas/B-5524-2013; ZUMLA, Alimuddin/ABA-8208-2020	Laurell, Thomas/0000-0002-2486-3607; ZUMLA, Alimuddin/0000-0002-5111-5735; Miller, Robert/0000-0003-2067-4291; Wilson, Andrew Peter Richard/0000-0003-1109-5650; Brown, Jeremy/0000-0002-5650-5361; Fisk, Marie/0000-0002-1292-7642	Department of Health [813] Funding Source: Medline; National Institute for Health Research [ACF-2009-18-030] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Ahmed RA, 2006, AM J MED, V119, P877, DOI 10.1016/j.amjmed.2006.03.042; BAYNES RD, 1987, AM J CLIN PATHOL, V87, P196, DOI 10.1093/ajcp/87.2.196; Bender JM, 2009, EMERG INFECT DIS, V15, P44, DOI 10.3201/eid1501.080618; Blaschke AJ, 2011, PEDIATR INFECT DIS J, V30, P289, DOI 10.1097/INF.0b013e3182002d14; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cakal B, 2009, DIGEST DIS SCI, V54, P842, DOI 10.1007/s10620-008-0436-2; Cardillo G, 2010, EUR J CARDIO-THORAC, V37, P814, DOI 10.1016/j.ejcts.2009.10.026; Chen CH, 2007, CHEST, V132, P532, DOI 10.1378/chest.07-0005; Chen W, 2009, SOUTH MED J, V102, P909, DOI 10.1097/SMJ.0b013e3181b22c52; Christopoulou-Aletra H, 2008, ANN THORAC SURG, V85, P1132, DOI 10.1016/j.athoracsur.2007.11.031; COKER RJ, 1994, J ROY SOC MED, V87, P65; Davies CWH, 1999, AM J RESP CRIT CARE, V160, P1682, DOI 10.1164/ajrccm.160.5.9903002; Davies HE, 2010, THORAX, V65, P41, DOI 10.1136/thx.2010.137000; Ferguson AD, 1996, QJM-MON J ASSOC PHYS, V89, P285; Ferrer J, 1997, EUR RESPIR J, V10, P942; Finley C, 2008, CAN RESPIR J, V15, P85, DOI 10.1155/2008/975312; Foster S, 2007, CURR OPIN PULM MED, V13, P319, DOI 10.1097/MCP.0b013e3281864691; Gopi A, 2007, CHEST, V131, P880, DOI 10.1378/chest.06-2063; HORAN TC, 1992, AM J INFECT CONTROL, V20, P271, DOI 10.1016/S0196-6553(05)80201-9; Isik T, 2011, CORON ARTERY DIS; Khwaja S, 2005, CHEST, V128, P246, DOI 10.1378/chest.128.1.246; Lee SF, 2010, CURR OPIN PULM MED, V16, P194, DOI 10.1097/MCP.0b013e32833883f5; Li STT, 2010, PEDIATRICS, V125, P26, DOI 10.1542/peds.2009-0184; Liang SJ, 2007, SOUTH MED J, V100, P1075, DOI 10.1097/SMJ.0b013e318158ba49; Lippi G, 2009, ARCH PATHOL LAB MED, V133, P628, DOI 10.1043/1543-2165-133.4.628; Maskell NA, 2005, NEW ENGL J MED, V352, P865, DOI 10.1056/NEJMoa042473; Maskell NA, 2006, AM J RESP CRIT CARE, V174, P817, DOI 10.1164/rccm.200601-074OC; Meyer CN, 2011, SCAND J INFECT DIS, V43, P165, DOI 10.3109/00365548.2010.536162; Noursadeghi M, 2006, LANCET INFECT DIS, V6, P794, DOI 10.1016/S1473-3099(06)70656-9; Plathow C, 2005, INVEST RADIOL, V40, P173, DOI 10.1097/00004424-200503000-00007; Porcel JM, 2009, LUNG, V187, P263, DOI 10.1007/s00408-009-9165-3; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Roxburgh CSD, 2008, ARCH DIS CHILD, V93, P316, DOI 10.1136/adc.2007.126540; Sogaard Mette, 2011, Clin Epidemiol, V3, P85, DOI 10.2147/CLEP.S16931; St Peter SD, 2009, J PEDIATR SURG, V44, P106, DOI 10.1016/j.jpedsurg.2008.10.018; Tong BC, 2010, ANN THORAC SURG, V89, P220, DOI 10.1016/j.athoracsur.2009.09.021; Tu CY, 2006, INTENS CARE MED, V32, P570, DOI 10.1007/s00134-005-0064-7; van Kimmenade RRJ, 2010, EUR J HEART FAIL, V12, P129, DOI 10.1093/eurjhf/hfp179; Wilson APR, 2004, BRIT MED J, V329, P720, DOI 10.1136/bmj.38232.646227.DE; Wrightson JM, 2011, THORAX, V66, P450, DOI 10.1136/thx.2009.129940; Zumla A, 2009, LANCET INFECT DIS, V9, P197, DOI 10.1016/S1473-3099(09)70045-3	41	65	69	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30074	10.1371/journal.pone.0030074	http://dx.doi.org/10.1371/journal.pone.0030074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276145	gold, Green Published, Green Submitted			2022-12-27	WOS:000301568100024
J	Rosendahl, J; Tonjes, A; Schleinitz, D; Kovacs, P; Wiegand, J; Ruffert, C; Jesinghaus, M; Schober, R; Herms, M; Grutzmann, R; Schulz, HU; Stickel, F; Werner, J; Bugert, P; Bluher, M; Stumvoll, M; Bohm, S; Berg, T; Wittenburg, H; Mossner, J; Morsche, RT; Derikx, M; Keim, V; Witt, H; Drenth, JPH				Rosendahl, Jonas; Toenjes, Anke; Schleinitz, Dorit; Kovacs, Peter; Wiegand, Johannes; Ruffert, Claudia; Jesinghaus, Moritz; Schober, Robert; Herms, Max; Gruetzmann, Robert; Schulz, Hans-Ulrich; Stickel, Felix; Werner, Jens; Bugert, Peter; Blueher, Matthias; Stumvoll, Michael; Boehm, Stephan; Berg, Thomas; Wittenburg, Henning; Moessner, Joachim; Morsche, Rene Te; Derikx, Monique; Keim, Volker; Witt, Heiko; Drenth, Joost P. H.			A Common Variant of PNPLA3 (p.I148M) Is Not Associated with Alcoholic Chronic Pancreatitis	PLOS ONE			English	Article							HEREDITARY PANCREATITIS; LIVER; SUSCEPTIBILITY; POLYMORPHISM; INHIBITOR; MUTATION; FIBROSIS; GENE	Background: Chronic pancreatitis (CP) is an inflammatory disease that in some patients leads to exocrine and endocrine dysfunction. In industrialized countries the most common aetiology is chronic alcohol abuse. Descriptions of associated genetic alterations in alcoholic CP are rare. However, a common PNPLA3 variant (p.I148M) is associated with the development of alcoholic liver cirrhosis (ALC). Since, alcoholic CP and ALC share the same aetiology PNPLA3 variant (p.I148M) possibly influences the development of alcoholic CP. Methods: Using melting curve analysis we genotyped the variant in 1510 patients with pancreatitis or liver disease (961 German and Dutch alcoholic CP patients, 414 German patients with idiopathic or hereditary CP, and 135 patients with ALC). In addition, we included in total 2781 healthy controls in the study. Results: The previously published overrepresentation of GG-genotype was replicated in our cohort of ALC (p-value <0.0001, OR 2.3, 95% CI 1.6-3.3). Distributions of genotype and allele frequencies of the p.I148M variant were comparable in patients with alcoholic CP, idiopathic and hereditary CP and in healthy controls. Conclusions: The absence of an association of PNPLA3 p.I148M with alcoholic CP seems not to point to a common pathway in the development of alcoholic CP and alcoholic liver cirrhosis.	[Rosendahl, Jonas; Wiegand, Johannes; Ruffert, Claudia; Jesinghaus, Moritz; Schober, Robert; Herms, Max; Boehm, Stephan; Berg, Thomas; Wittenburg, Henning; Moessner, Joachim; Keim, Volker] Univ Leipzig, Div Gastroenterol & Rheumatol, Dept Internal Med Neurol & Dermatol, Leipzig, Germany; [Toenjes, Anke; Blueher, Matthias; Stumvoll, Michael] Univ Leipzig, Div Endocrinol, Dept Internal Med Neurol & Dermatol, Leipzig, Germany; [Toenjes, Anke; Blueher, Matthias; Stumvoll, Michael] Univ Leipzig, IFB Adipos Dis, Leipzig, Germany; [Schleinitz, Dorit; Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res Leipzig, Leipzig, Germany; [Gruetzmann, Robert] Tech Univ Dresden, Dept Gen Thorac & Vasc Surg, Univ Hosp Carl Gustav Carus, D-01062 Dresden, Germany; [Schulz, Hans-Ulrich] Univ Magdeburg, Dept Surg, D-39106 Magdeburg, Germany; [Stickel, Felix] Univ Bern, Inselspital, Dept Visceral Surg & Med, CH-3010 Bern, Switzerland; [Werner, Jens] Heidelberg Univ, Dept Surg, D-6900 Heidelberg, Germany; [Bugert, Peter] Heidelberg Univ, Med Fac Mannheim, Inst Transfus Med & Immunol, German Red Cross Blood Serv Baden Wurttemberg Hes, D-6800 Mannheim, Germany; [Morsche, Rene Te; Derikx, Monique; Drenth, Joost P. H.] Radboud Univ Nijmegen, Dept Gastroenterol & Hepatol, Nijmegen Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Witt, Heiko] Tech Univ Munich, Dept Pediat, Munich, Germany; [Witt, Heiko] Tech Univ Munich, EKFZ, Munich, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Otto von Guericke University; University of Bern; University Hospital of Bern; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Radboud University Nijmegen; Technical University of Munich; Technical University of Munich	Rosendahl, J (corresponding author), Univ Leipzig, Div Gastroenterol & Rheumatol, Dept Internal Med Neurol & Dermatol, Leipzig, Germany.	jonas.rosendahl@medizin.uni-leipzig.de	Schober, Robert/ABC-9480-2020; te Morsche, R/P-9143-2015; Drenth, J.P.H./H-8025-2014; Drenth, Joost/V-7436-2019; Stumvoll, Michael/ABE-1121-2021	Stumvoll, Michael/0000-0001-6225-8240; Kovacs, Peter/0000-0002-0290-5423; Berg, Thomas/0000-0003-0003-6241	Deutsche Forschungsgemeinschaft [RO 3929/1-1, RO 3939/2-1]; Colora Stiftung gGmbH	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Colora Stiftung gGmbH	This work was supported by the Deutsche Forschungsgemeinschaft RO 3929/1-1 & RO 3939/2-1 (to Dr. Rosendahl) and by a grant of the Colora Stiftung gGmbH (to Dr. Rosendahl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriulli A, 2010, PANCREAS, V39, P1205, DOI 10.1097/MPA.0b013e3181df27c0; ANGELINI G, 1985, AM J GASTROENTEROL, V80, P998; Apte MV, 2003, BEST PRACT RES CL GA, V17, P593, DOI 10.1016/S1521-6918(03)00050-7; Caradonna P, 1996, ITAL J GASTROENTEROL, V28, P91; Derikx MHM, 2010, BEST PRACT RES CL GA, V24, P251, DOI 10.1016/j.bpg.2010.02.001; Gauderman W, QUANTO 1 1 COMPUTER; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Kitahara K, 2008, DIS MARKERS, V25, P175, DOI 10.1155/2008/426764; Kotronen A, 2009, DIABETOLOGIA, V52, P1056, DOI 10.1007/s00125-009-1285-z; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Muller T, 2011, J HEPATOL IN PRESS; Nakamura Y, 2004, J GASTROENTEROL, V39, P879, DOI 10.1007/s00535-004-1405-y; Pace A, 2009, CLIN GASTROENTEROL H, V7, P1241, DOI 10.1016/j.cgh.2009.06.010; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Stickel F, 2011, HEPATOLOGY, V53, P86, DOI 10.1002/hep.24017; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Trepo E, 2011, J HEPATOL IN PRESS; Trepo E, 2011, HEPATOLOGY, V54, P60, DOI 10.1002/hep.24350; Valenti L, 2011, HEPATOLOGY, V53, P791, DOI 10.1002/hep.24123; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 2001, JAMA-J AM MED ASSOC, V285, P2716, DOI 10.1001/jama.285.21.2716-a; Witt H, 2006, NAT GENET, V38, P668, DOI 10.1038/ng1797	25	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29433	10.1371/journal.pone.0029433	http://dx.doi.org/10.1371/journal.pone.0029433			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276112	Green Published, gold, Green Submitted			2022-12-27	WOS:000301568100009
J	Toivonen, R; Kivela, M; Saramaki, J; Viinikainen, M; Vanhatalo, M; Sams, M				Toivonen, Riitta; Kivela, Mikko; Saramaki, Jari; Viinikainen, Mikko; Vanhatalo, Maija; Sams, Mikko			Networks of Emotion Concepts	PLOS ONE			English	Article							ASPERGER-SYNDROME; COMPLEX NETWORKS; VALENCE; CULTURE; ADULTS; WORLD	The aim of this work was to study the similarity network and hierarchical clustering of Finnish emotion concepts. Native speakers of Finnish evaluated similarity between the 50 most frequently used Finnish words describing emotional experiences. We hypothesized that methods developed within network theory, such as identifying clusters and specific local network structures, can reveal structures that would be difficult to discover using traditional methods such as multidimensional scaling (MDS) and ordinary cluster analysis. The concepts divided into three main clusters, which can be described as negative, positive, and surprise. Negative and positive clusters divided further into meaningful sub-clusters, corresponding to those found in previous studies. Importantly, this method allowed the same concept to be a member in more than one cluster. Our results suggest that studying particular network structures that do not fit into a low-dimensional description can shed additional light on why subjects evaluate certain concepts as similar. To encourage the use of network methods in analyzing similarity data, we provide the analysis software for free use (http://www.becs.tkk.fi/similaritynets/).	[Toivonen, Riitta; Kivela, Mikko; Saramaki, Jari; Viinikainen, Mikko; Vanhatalo, Maija; Sams, Mikko] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci BECS, Espoo, Finland	Aalto University	Toivonen, R (corresponding author), Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci BECS, Espoo, Finland.	mikko.sams@aalto.fi	Kivelä, Mikko/G-6678-2011; Sams, Mikko E/G-7060-2012; Saramaki, Jari P/E-5226-2011	Kivelä, Mikko/0000-0003-2049-1954; 	Academy of Finland; Finnish Center of Excellence Program [213470]; ComMIT graduate school; Graduate School of Electronics, Telecommunication and Automation	Academy of Finland(Academy of Finland); Finnish Center of Excellence Program; ComMIT graduate school; Graduate School of Electronics, Telecommunication and Automation	We acknowledge the Academy of Finland, the Finnish Center of Excellence Program 2006-2011, Project No. 213470. Dr. Toivonen was partially supported by the ComMIT graduate school. Dr. Viinikainen was partially supported by the Graduate School of Electronics, Telecommunication and Automation. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Alonso-Arbiol I, 2006, COGNITION EMOTION, V20, P836, DOI 10.1080/02699930500405469; Alvarado N, 1998, MOTIV EMOTION, V22, P329, DOI 10.1023/A:1021356424065; [Anonymous], THESIS U OULU; [Anonymous], 1980, GEN PSYCHOEVOLUTIONA; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BOLLOBAS B., 2001, RANDOM GRAPHS, V73, DOI 10.1017/CBO9780511814068.008; BRETHERTON I, 1982, DEV PSYCHOL, V18, P906, DOI 10.1037/0012-1649.18.6.906; Cosmides L., 2000, HDB EMOTIONS, V2nd; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Cunningham WA, 2004, J COGNITIVE NEUROSCI, V16, P1717, DOI 10.1162/0898929042947919; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Estivill-Castro, 2002, SIGKDD EXPLORATIONS, V4, P65, DOI DOI 10.1145/568574.568575; Fontaine JRJ, 2007, PSYCHOL SCI, V18, P1050, DOI 10.1111/j.1467-9280.2007.02024.x; Fortunato S, 2008, COMMUNITY STRUCTURE; Golan O, 2006, DEV PSYCHOPATHOL, V18, P591, DOI 10.1017/S0954579406060305; Kruskal J.B., 1978, MULTIDIMENSIONAL SCA; Kumpula JM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026109; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Lee UV, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041920; Leising D, 2009, J RES PERS, V43, P707, DOI 10.1016/j.jrp.2009.03.009; Lewis PA, 2007, CEREB CORTEX, V17, P742, DOI 10.1093/cercor/bhk024; Makinen V, 2010, HIMMELI NETWORK VISU; Ogarkova A, 2009, SOC SCI INFORM, V48, P339, DOI 10.1177/0539018409106196; ORTONY A, 1990, PSYCHOL REV, V97, P315, DOI 10.1037/0033-295X.97.3.315; Osgood C.E., 1975, CROSS CULTURAL UNIVE; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; RUSSELL JA, 1977, J RES PERS, V11, P273, DOI 10.1016/0092-6566(77)90037-X; RUSSELL JA, 1994, J PERS SOC PSYCHOL, V67, P186, DOI 10.1037/0022-3514.67.2.186; RUSSELL JA, 1991, PSYCHOL BULL, V110, P426, DOI 10.1037/0033-2909.110.3.426; Russell JA, 2000, HDB EMOTION; Schimmack U, 1997, J PERS SOC PSYCHOL, V73, P645; SCHLOSBERG H, 1954, PSYCHOL REV, V61, P81, DOI 10.1037/h0054570; SCOTT J., 1991, SOCIAL NETWORK ANAL; SHAVER P, 1987, J PERS SOC PSYCHOL, V52, P1061, DOI 10.1037//0022-3514.52.6.1061; Shaver PR, 2001, ASIAN J SOC PSYCHOL, V4, P201, DOI 10.1111/1467-839X.00086; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Tellegen A, 1999, PSYCHOL SCI, V10, P297, DOI 10.1111/1467-9280.00157; Tellegen A, 1999, PSYCHOL SCI, V10, P307, DOI 10.1111/1467-9280.00159; TRAVERS J, 1969, SOCIOMETRY, V32, P425, DOI 10.2307/2786545; TVERSKY A, 1977, PSYCHOL REV, V84, P327, DOI 10.1037/h0026750; Viinikainen M, 2010, HUM BRAIN MAPP, V31, P1030, DOI 10.1002/hbm.20915; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; Widen SC, 2008, COGNITIVE DEV, V23, P291, DOI 10.1016/j.cogdev.2008.01.002; Wierzbicka A., 1997, UNDERSTANDING CULTUR; Wundt W, 1902, GRUNDZUGE PHYSL PSYC, V2	50	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e28883	10.1371/journal.pone.0028883	http://dx.doi.org/10.1371/journal.pone.0028883			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	909MH	22276099	Green Published, gold, Green Submitted			2022-12-27	WOS:000301568100005
J	Leong, HS; Lizardo, MM; Ablack, A; McPherson, VA; Wandless, TJ; Chambers, AF; Lewis, JD				Leong, Hon S.; Lizardo, Michael M.; Ablack, Amber; McPherson, Victor A.; Wandless, Thomas J.; Chambers, Ann F.; Lewis, John D.			Imaging the Impact of Chemically Inducible Proteins on Cellular Dynamics In Vivo	PLOS ONE			English	Article							E-CADHERIN EXPRESSION; TUMOR-CELLS; DOXYCYCLINE; SPECIFICITY; METASTASIS; INHIBITION; CARCINOMA; BEHAVIOR; STEPS	The analysis of dynamic events in the tumor microenvironment during cancer progression is limited by the complexity of current in vivo imaging models. This is coupled with an inability to rapidly modulate and visualize protein activity in real time and to understand the consequence of these perturbations in vivo. We developed an intravital imaging approach that allows the rapid induction and subsequent depletion of target protein levels within human cancer xenografts while assessing the impact on cell behavior and morphology in real time. A conditionally stabilized fluorescent E-cadherin chimera was expressed in metastatic breast cancer cells, and the impact of E-cadherin induction and depletion was visualized using real-time confocal microscopy in a xenograft avian embryo model. We demonstrate the assessment of protein localization, cell morphology and migration in cells undergoing epithelial-mesenchymal and mesenchymal-epithelial transitions in breast tumors. This technique allows for precise control over protein activity in vivo while permitting the temporal analysis of dynamic biophysical parameters.	[Leong, Hon S.; Ablack, Amber; McPherson, Victor A.; Lewis, John D.] London Reg Canc Program, Translat Prostate Canc Res Grp, London, ON, Canada; [Lizardo, Michael M.; Chambers, Ann F.; Lewis, John D.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Wandless, Thomas J.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Stanford University	Leong, HS (corresponding author), London Reg Canc Program, Translat Prostate Canc Res Grp, London, ON, Canada.	John.Lewis@lhsc.on.ca	Chambers, Ann F/L-6285-2015	Chambers, Ann F/0000-0002-9509-5123; Leong, Hon/0000-0001-7801-1402	Canadian Cancer Society Research Institute [700537]; Canadian Institutes of Health Research [84535]; Canadian Breast Cancer Research Alliance from the Canadian Breast Cancer Foundation [016506]; Cancer Research Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073046] Funding Source: NIH RePORTER	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Research Alliance from the Canadian Breast Cancer Foundation; Cancer Research Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant #700537 from the Canadian Cancer Society Research Institute and grant #84535 from the Canadian Institutes of Health Research to JDL, and grant #016506 from the Canadian Breast Cancer Research Alliance with special funding from the Canadian Breast Cancer Foundation and the Cancer Research Society. HSL is funded by a CBCF Post-Doctoral fellowship. MML is funded by the Pamela Greenaway Translational Breast Cancer Research Unit. AFC is Canada Research Chair in Oncology, supported by the Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Agha-Mohammadi S, 2004, J GENE MED, V6, P817, DOI 10.1002/jgm.566; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; Born AK, 2009, EUR CELLS MATER, V18, P49; Boyer B, 2000, BIOCHEM PHARMACOL, V60, P1091, DOI 10.1016/S0006-2952(00)00427-5; CHEN WC, 1991, J CELL BIOL, V114, P319, DOI 10.1083/jcb.114.2.319; Chi NC, 2010, P NATL ACAD SCI USA, V107, P14662, DOI 10.1073/pnas.0909432107; Fainaru O, 2008, FASEB J, V22, P3728, DOI 10.1096/fj.08-110494; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gotzmann J, 2002, J CELL SCI, V115, P1189; Hashimoto T, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-1; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Maksimov VF, 2006, B EXP BIOL MED+, V142, P367, DOI 10.1007/s10517-006-0368-9; Mbalaviele G, 1996, CANCER RES, V56, P4063; Mohammadi SA, 1997, GENE THER, V4, P993, DOI 10.1038/sj.gt.3300491; Moses MA, 2006, NEW ENGL J MED, V354, P2621, DOI 10.1056/NEJMc053410; Ozduman K, 2008, J NEUROSCI, V28, P1882, DOI 10.1523/JNEUROSCI.4905-07.2008; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Pincus Z, 2007, J MICROSC-OXFORD, V227, P140, DOI 10.1111/j.1365-2818.2007.01799.x; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Sarrio D, 2004, ONCOGENE, V23, P3272, DOI 10.1038/sj.onc.1207439; Smith GN, 1999, ARTHRITIS RHEUM, V42, P1140, DOI 10.1002/1529-0131(199906)42:6<1140::AID-ANR10>3.0.CO;2-7; Souter LH, 2010, LAB INVEST, V90, P1247, DOI 10.1038/labinvest.2010.97; SUOMALAINEN K, 1992, ANTIMICROB AGENTS CH, V36, P227, DOI 10.1128/AAC.36.1.227; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Xylas J, 2010, BIOMED OPT EXPRESS, V1, P1387, DOI 10.1364/BOE.1.001387; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	32	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30177	10.1371/journal.pone.0030177	http://dx.doi.org/10.1371/journal.pone.0030177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276156	Green Published, Green Submitted, gold			2022-12-27	WOS:000301457200040
J	Lonneborg, R; Varga, E; Brzezinski, P				Lonneborg, Rosa; Varga, Edina; Brzezinski, Peter			Directed Evolution of the Transcriptional Regulator DntR: Isolation of Mutants with Improved DNT-Response	PLOS ONE			English	Article							NITROAROMATIC COMPOUNDS; 2,4-DINITROTOLUENE; STRAIN; GENE; BIODEGRADATION; DEGRADATION; BIOSENSORS; PATHWAYS; BENM	The transcriptional regulator DntR, which previously has been isolated from bacterial strains capable of degrading 2,4dinitrotoluene (DNT), was engineered in order to improve the ability to detect DNT. A directed evolution strategy was employed, where sequence diversity first was created by random mutagenesis in three subsequent rounds, followed by recombination of previously selected mutants. A gfp gene was used as a reporter for transcriptional activity mediated by DntR and cells with higher GFP expression after addition of DNT were sorted out using fluorescence-activated cell sorting (FACS). A DntR mutant, which displayed 10 times higher induction levels than wild-type DntR in response to DNT was isolated. This mutant still maintained low levels of gfp expression in the absence of DNT. The detection limit was,10 mM, a 25-fold improvement compared to wild-type DntR. The functional role of some substitutions found in this clone is discussed in the framework of the structural changes observed when comparing the recently determined structures of DntR with and without bound inducer ligand.	[Lonneborg, Rosa; Varga, Edina; Brzezinski, Peter] Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Stockholm University	Lonneborg, R (corresponding author), Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	Rosa@dbb.su.se; peterb@dbb.su.se		/0000-0002-7679-1369	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Swedish Research Council (www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; CRAWFORD RL, 1995, CURR OPIN BIOTECH, V6, P329, DOI 10.1016/0958-1669(95)80055-7; Devesse L, MOL MICROBIOL, V81, P354; Ezezika OC, 2007, J MOL BIOL, V367, P616, DOI 10.1016/j.jmb.2006.09.090; Galvao TC, 2006, CURR OPIN BIOTECH, V17, P34, DOI 10.1016/j.copbio.2005.12.002; Galvao TC, 2007, MOL MICROBIOL, V65, P907, DOI 10.1111/j.1365-2958.2007.05832.x; Huang WE, 2005, ENVIRON MICROBIOL, V7, P1339, DOI 10.1111/j.1462-5822.2005.00821.x; Jaworski JW, 2008, LANGMUIR, V24, P4938, DOI 10.1021/la7035289; Jenkins TF, 2001, TALANTA, V54, P501, DOI 10.1016/S0039-9140(00)00547-6; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Johnson GR, 2003, APPL MICROBIOL BIOT, V62, P110, DOI 10.1007/s00253-003-1341-4; Johnson GR, 2002, J BACTERIOL, V184, P4219, DOI 10.1128/JB.184.15.4219-4232.2002; Jones RM, 2003, J BACTERIOL, V185, P5847, DOI 10.1128/JB.185.19.5847-5853.2003; Ju KS, 2009, MOL MICROBIOL, V74, P826, DOI 10.1111/j.1365-2958.2009.06904.x; Lessner DJ, 2003, J BACTERIOL, V185, P3895, DOI 10.1128/JB.185.13.3895-3904.2003; Lonneborg R, 2011, SEARCH BIOSENSOR DNT; Lonneborg R, 2007, J MOL BIOL, V372, P571, DOI 10.1016/j.jmb.2007.06.076; Nagatomo K, 2009, TALANTA, V79, P1142, DOI 10.1016/j.talanta.2009.02.018; Pellinen T, 2004, ANAL BIOCHEM, V330, P52, DOI 10.1016/j.ab.2004.03.064; Radhika V, 2007, NAT CHEM BIOL, V3, P325, DOI 10.1038/nchembio882; Ruangprasert A, 2010, J MOL BIOL, V404, P568, DOI 10.1016/j.jmb.2010.09.053; SCHELL MA, 1985, GENE, V36, P301, DOI 10.1016/0378-1119(85)90185-4; Scholz O, 2003, J MOL BIOL, V329, P217, DOI 10.1016/S0022-2836(03)00427-3; Shin HJ, 2010, J BIOTECHNOL, V150, P246, DOI 10.1016/j.jbiotec.2010.09.936; Smirnova IA, 2004, J MOL BIOL, V340, P405, DOI 10.1016/j.jmb.2004.04.071; SPAIN JC, 1995, ANNU REV MICROBIOL, V49, P523, DOI 10.1146/annurev.mi.49.100195.002515; SPANGGORD RJ, 1991, APPL ENVIRON MICROB, V57, P3200, DOI 10.1128/AEM.57.11.3200-3205.1991; Stocker J, 2003, ENVIRON SCI TECHNOL, V37, P4743, DOI 10.1021/es034258b; Tang SY, 2008, J AM CHEM SOC, V130, P5267, DOI 10.1021/ja7109053; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375	31	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29994	10.1371/journal.pone.0029994	http://dx.doi.org/10.1371/journal.pone.0029994			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276138	Green Published, gold, Green Submitted			2022-12-27	WOS:000301457200026
J	Yamamoto, T; Takano, T; Higuchi, W; Iwao, Y; Singur, O; Reva, I; Otsuka, Y; Nakayashiki, T; Mori, H; Reva, G; Kuznetsov, V; Potapov, V				Yamamoto, Tatsuo; Takano, Tomomi; Higuchi, Wataru; Iwao, Yasuhisa; Singur, Olga; Reva, Ivan; Otsuka, Yuta; Nakayashiki, Toru; Mori, Hirotada; Reva, Galina; Kuznetsov, Vladimir; Potapov, Vladimir			Comparative Genomics and Drug Resistance of a Geographic Variant of ST239 Methicillin-Resistant Staphylococcus aureus Emerged in Russia	PLOS ONE			English	Article							ANTIMICROBIAL AGENTS; GENETIC BACKGROUNDS; COMMUNITY; IDENTIFICATION; EVOLUTION; SEQUENCE; MRSA; HOSPITALS; OUTBREAK; CLONES	Two distinct classes of methicillin-resistant Staphylococcus aureus (MRSA) are spreading in hospitals (as hospital-acquired MRSA, HA-MRSA) and in the community (as community-acquired MRSA, CA-MRSA). Multilocus sequence type (ST) 239 MRSA, one of the most worldwide-disseminated lineages, has been noted as a representative HA-MRSA. Here, we isolated ST239 MRSA (spa type 3 [t037] and staphylococcal cassette chromosome mec [SCCmec] type III.1.1.1) and its novel variant with ST239/spa351 (t030)/SCCmecIII.1.1.4 (SCCmecIII(R)) not only from hospitals but also from patients with urethritis in the community in Russia. The Russian variant (strain 16K) possessed a hybrid genome consisting of CC8 and CC30, similar to the ST239/spa3/SCCmecIII.1.1.1 HA-MRSA (TW20) genome, but with marked diversity. The 16K' CC30 section had SCCmecIII(R) carrying the dcs-carrying unit (which corresponded to the SCCmecIVc J3 joining region of ST30 CA-MRSA), lacked SCCmercury, and possessed a novel mobile element structure (MES16K) carrying the ccrC-carrying unit (with the recombinase gene ccrC1 allele 3) and drug resistance tranposons. The Russian variant included strains with a high ability to transfer its multiple drug resistance by conjugation; e. g., for strain 16K, the transfer frequency of a chloramphenicol resistance plasmid (p16K-1 with 2.9 kb in size) reached 1.4x10(-2), followed by Tn554 conjugative transfer at 3.6x10(-4). The Russian variant, which has been increasing recently, included divergent strains with different plasmid patterns and pulsed field gel electrophoresis profiles. The data demonstrate the alternative nature of ST239 MRSA as CA-MRSA and also as a drug resistance disseminator, and its micro but dynamic evolution in Russia.	[Yamamoto, Tatsuo; Takano, Tomomi; Higuchi, Wataru; Iwao, Yasuhisa; Singur, Olga; Reva, Ivan] Niigata Univ, Div Bacteriol, Dept Infect Dis Control & Int Med, Grad Sch Med & Dent Sci, Niigata, Japan; [Singur, Olga; Reva, Galina; Kuznetsov, Vladimir; Potapov, Vladimir] Vladivostok State Med Univ, Vladivostok, Russia; [Otsuka, Yuta; Nakayashiki, Toru; Mori, Hirotada] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara, Japan	Niigata University; Nara Institute of Science & Technology	Yamamoto, T (corresponding author), Niigata Univ, Div Bacteriol, Dept Infect Dis Control & Int Med, Grad Sch Med & Dent Sci, Niigata, Japan.	tatsuoy@med.niigata-u.ac.jp		Reva, Ivan/0000-0002-3727-393X; Reva, Galina/0000-0001-6502-4271	Heiwa Nakajima Foundation, Japan	Heiwa Nakajima Foundation, Japan	This study was supported, in part, by a grant from Heiwa Nakajima Foundation, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, M100S18 CLIN LAB STA; Baranovich T, 2007, EUROSURVEILLANCE, V12; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P707; Conceicao T, 2007, CLIN MICROBIOL INFEC, V13, P971, DOI 10.1111/j.1469-0691.2007.01794.x; de Bentzmann S, 2004, J INFECT DIS, V190, P1506, DOI 10.1086/424521; de Lencastre Herminia, 1997, Clin Microbiol Infect, V3, P289; de Sousa MA, 2005, J CLIN MICROBIOL, V43, P5150, DOI 10.1128/JCM.43.10.5150-5157.2005; de Sousa MA, 2004, FEMS IMMUNOL MED MIC, V40, P101, DOI 10.1016/S0928-8244(03)00370-5; de Sousa MA, 1998, J CLIN MICROBIOL, V36, P2590, DOI 10.1128/JCM.36.9.2590-2596.1998; Edgeworth JD, 2007, CLIN INFECT DIS, V44, P493, DOI 10.1086/511034; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Gilot P, 2002, J CLIN MICROBIOL, V40, P4060, DOI 10.1128/JCM.40.11.4060-4067.2002; Gomez MI, 2006, J BIOL CHEM, V281, P20190, DOI 10.1074/jbc.M601956200; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Haroche J, 2002, ANTIMICROB AGENTS CH, V46, P2337, DOI 10.1128/AAC.46.8.2337-2343.2002; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Higuchi W, 2010, J INFECT CHEMOTHER, V16, P144, DOI 10.1007/s10156-010-0029-9; Higuchi W, 2008, BIOCHEM BIOPH RES CO, V377, P752, DOI 10.1016/j.bbrc.2008.10.009; Holden MTG, 2010, J BACTERIOL, V192, P888, DOI 10.1128/JB.01255-09; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Kadlec K, 2010, ANTIMICROB AGENTS CH, V54, P3475, DOI 10.1128/AAC.00464-10; Kahl BC, 2007, SCIENCE, V315, P1082, DOI 10.1126/science.1139628; KERR S, 1990, J HOSP INFECT, V16, P35, DOI 10.1016/0195-6701(90)90047-R; MARPLES RR, 1985, J HOSP INFECT, V6, P342, DOI 10.1016/0195-6701(85)90040-4; MURPHY E, 1984, NATURE, V307, P292, DOI 10.1038/307292a0; Noto MJ, 2008, J BACTERIOL, V190, P1276, DOI 10.1128/JB.01128-07; Oliveira D., 1998, Clin Microbiol Infect, V4, P373, DOI 10.1111/j.1469-0691.1998.tb00081.x; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Oliveira DC, 2001, MICROB DRUG RESIST, V7, P349, DOI 10.1089/10766290152773365; Queck SY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000533; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Sanches IS, 1996, MICROB DRUG RESIST, V2, P319, DOI 10.1089/mdr.1996.2.319; Shi D, 2011, PEDIATR INT, V53, P211, DOI 10.1111/j.1442-200X.2010.03246.x; Strommenger B, 2004, EUR J CLIN MICROBIOL, V23, P15, DOI 10.1007/s10096-003-1046-8; Takano T, 2008, ANTIMICROB AGENTS CH, V52, P837, DOI 10.1128/AAC.01001-07; Takano T, 2009, J INFECT CHEMOTHER, V15, P54, DOI 10.1007/s10156-008-0665-5; Takizawa Y, 2005, J CLIN MICROBIOL, V43, P3356, DOI 10.1128/JCM.43.7.3356-3363.2005; Taneike I, 2006, FEBS LETT, V580, P2323, DOI 10.1016/j.febslet.2006.03.049; TEIXEIRA LA, 1995, J CLIN MICROBIOL, V33, P2400, DOI 10.1128/JCM.33.9.2400-2404.1995; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Witte W, 1999, J ANTIMICROB CHEMOTH, V44, P1, DOI 10.1093/jac/44.suppl_1.1; Yamamoto T, 2006, ANTIMICROB AGENTS CH, V50, P4077, DOI 10.1128/AAC.00847-06; Yamamoto T, 2010, J INFECT CHEMOTHER, V16, P225, DOI 10.1007/s10156-010-0045-9; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	45	30	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29187	10.1371/journal.pone.0029187	http://dx.doi.org/10.1371/journal.pone.0029187			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276107	Green Published, gold			2022-12-27	WOS:000301457200008
J	Ellis, EC; Antill, EC; Kreft, H				Ellis, Erle C.; Antill, Erica C.; Kreft, Holger			All Is Not Loss: Plant Biodiversity in the Anthropocene	PLOS ONE			English	Article							LAND-USE CHANGE; GLOBAL PATTERNS; SPECIES-RICHNESS; ANTHROPOGENIC TRANSFORMATION; BIOTIC HOMOGENIZATION; SPATIALLY EXPLICIT; INVASIONS; CONSERVATION; POPULATION; DIVERSITY	Anthropogenic global changes in biodiversity are generally portrayed in terms of massive native species losses or invasions caused by recent human disturbance. Yet these biodiversity changes and others caused directly by human populations and their use of land tend to co-occur as long-term biodiversity change processes in the Anthropocene. Here we explore contemporary anthropogenic global patterns in vascular plant species richness at regional landscape scales by combining spatially explicit models and estimates for native species loss together with gains in exotics caused by species invasions and the introduction of agricultural domesticates and ornamental exotic plants. The patterns thus derived confirm that while native losses are likely significant across at least half of Earth's ice-free land, model predictions indicate that plant species richness has increased overall in most regional landscapes, mostly because species invasions tend to exceed native losses. While global observing systems and models that integrate anthropogenic species loss, introduction and invasion at regional landscape scales remain at an early stage of development, integrating predictions from existing models within a single assessment confirms their vast global extent and significance while revealing novel patterns and their potential drivers. Effective global stewardship of plant biodiversity in the Anthropocene will require integrated frameworks for observing, modeling and forecasting the different forms of anthropogenic biodiversity change processes at regional landscape scales, towards conserving biodiversity within the novel plant communities created and sustained by human systems.	[Ellis, Erle C.; Antill, Erica C.] Univ Maryland, Dept Geog & Environm Syst, Baltimore, MD 21201 USA; [Kreft, Holger] Univ Gottingen, Biodivers Macroecol & Conservat Biogeog Grp, Gottingen, Germany	University System of Maryland; University of Maryland Baltimore; University of Gottingen	Ellis, EC (corresponding author), Univ Maryland, Dept Geog & Environm Syst, Baltimore, MD 21201 USA.	ece@umbc.edu	Ellis, Erle C./B-8264-2008; Kreft, Holger/AAY-7573-2020; Kreft, Holger/A-4736-2008	Ellis, Erle C./0000-0002-2006-3362; Kreft, Holger/0000-0003-4471-8236; Kreft, Holger/0000-0003-4471-8236				[Anonymous], 2004, HOTSPOTS REVISITED E; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chytry M, 2009, DIVERS DISTRIB, V15, P98, DOI 10.1111/j.1472-4642.2008.00515.x; Chytry M, 2008, J APPL ECOL, V45, P448, DOI 10.1111/j.1365-2664.2007.01398.x; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Goldewijk KK, 2010, HOLOCENE, V20, P565, DOI 10.1177/0959683609356587; Golding J, 2010, ANN BOT-LONDON, V105, P689, DOI 10.1093/aob/mcq043; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Huston MA, 2005, ECOL APPL, V15, P1864, DOI 10.1890/03-5281; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Jones JPG, 2011, J APPL ECOL, V48, P9, DOI 10.1111/j.1365-2664.2010.01917.x; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; Kerr JT, 2007, SCIENCE, V316, P1581, DOI 10.1126/science.1133267; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mayfield MM, 2010, GLOBAL ECOL BIOGEOGR, V19, P423, DOI 10.1111/j.1466-8238.2010.00532.x; McElwain JC, 2007, TRENDS ECOL EVOL, V22, P548, DOI 10.1016/j.tree.2007.09.003; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Muchoney DM, 2010, ECOL RES, V25, P937, DOI 10.1007/s11284-010-0756-5; Norris K, 2010, BIOL CONSERV, V143, P2341, DOI 10.1016/j.biocon.2009.12.032; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Nunez MA, 2010, BIOL INVASIONS, V12, P707, DOI 10.1007/s10530-009-9517-1; Olden JD, 2006, J BIOGEOGR, V33, P2027, DOI 10.1111/j.1365-2699.2006.01572.x; Pautasso M, 2007, ECOL LETT, V10, P16, DOI 10.1111/j.1461-0248.2006.00993.x; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; Perrings C, 2011, SCIENCE, V331, P1139, DOI 10.1126/science.1202400; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pitman NCA, 2002, SCIENCE, V298, P989, DOI 10.1126/science.298.5595.989; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosenzweig ML, 2001, EVOL ECOL RES, V3, P361; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Scholes RJ, 2008, SCIENCE, V321, P1044, DOI 10.1126/science.1162055; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Smith RM, 2006, BIOL CONSERV, V129, P312, DOI 10.1016/j.biocon.2005.10.045; Stohigren TJ, 2008, ECOL LETT, V11, P313, DOI 10.1111/j.1461-0248.2008.01153.x; Stohlgren TJ, 2006, BIOL INVASIONS, V8, P427, DOI 10.1007/s10530-005-6422-0; Stohlgren TJ, 2003, FRONT ECOL ENVIRON, V1, P11; Stork NE, 2010, BIODIVERS CONSERV, V19, P357, DOI 10.1007/s10531-009-9761-9; Thuiller W, 2006, ECOLOGY, V87, P1755, DOI 10.1890/0012-9658(2006)87[1755:IBESTA]2.0.CO;2; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wardle DA, 2011, SCIENCE, V332, P1273, DOI 10.1126/science.1197479; Winter M, 2009, P NATL ACAD SCI USA, V106, P21721, DOI 10.1073/pnas.0907088106	69	161	167	5	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30535	10.1371/journal.pone.0030535	http://dx.doi.org/10.1371/journal.pone.0030535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272360	Green Published, gold, Green Submitted			2022-12-27	WOS:000301454400138
J	Jones, PL; Pask, GM; Romaine, IM; Taylor, RW; Reid, PR; Waterson, AG; Sulikowski, GA; Zwiebel, LJ				Jones, Patrick L.; Pask, Gregory M.; Romaine, Ian M.; Taylor, Robert W.; Reid, Paul R.; Waterson, Alex G.; Sulikowski, Gary A.; Zwiebel, Laurence J.			Allosteric Antagonism of Insect Odorant Receptor Ion Channels	PLOS ONE			English	Article							CONSERVATION; GENE	Background: At a molecular level, insects utilize members of several highly divergent and unrelated families of cell-surface chemosensory receptors for detection of volatile odorants. Most odors are detected via a family of odorant receptors (ORs), which form heteromeric complexes consisting of a well-conserved OR co-receptor (Orco) ion channel and a non-conserved tuning OR that provides coding specificity to each complex. Orco functions as a non-selective cation channel and is expressed in the majority of olfactory receptor neurons (ORNs). As the destructive behaviors of many insects are principally driven by olfaction, Orco represents a novel target for behavior-based control strategies. While many natural and synthetic odorants have been shown to agonize Orco/Or complexes, only a single direct Orco modulator, VUAA1, has been described. In an effort to identify additional Orco modulators, we have investigated the structure/activity relationships around VUAA1. Results: A search of our compound library identified several VUAA1 analogs that were selected for evaluation against HEK cells expressing Orco from the malaria vector Anopheles gambiae (AgOrco). While the majority of compounds displayed no activity, many of these analogs possess no intrinsic efficacy, but instead, act as competitive VUAA1 antagonists. Using calcium mobilization assays, patch clamp electrophysiology, and single sensillum in vivo recording, we demonstrate that one such candidate, VU0183254, is a specific allosteric modulator of OR signaling, capable of broadly inhibiting odor-mediated OR complex activation. Conclusions: We have described and characterized the first Orco antagonist, that is capable of non-competitively inhibiting odorant-evoked activation of OR complexes, thereby providing additional insight into the structure/function of this unique family of ligand-gated ion channels. While Orco antagonists are likely to have limited utility in insect control programs, they represent important pharmacological tools that will facilitate the investigation of the molecular mechanisms underlying insect olfactory signal transduction.	[Jones, Patrick L.; Pask, Gregory M.; Taylor, Robert W.; Zwiebel, Laurence J.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA; [Romaine, Ian M.; Reid, Paul R.; Waterson, Alex G.; Sulikowski, Gary A.; Zwiebel, Laurence J.] Vanderbilt Univ, Dept Chem, Vanderbilt Inst Chem Biol, Nashville, TN USA; [Waterson, Alex G.; Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Inst Global Hlth, Ctr Mol Neurosci, Nashville, TN USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Program Dev Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Jones, PL (corresponding author), Genzyme Corp, Waltham, MA 02451 USA.	l.zwiebel@vanderbilt.edu		Zwiebel, Laurence/0000-0001-6686-7289	Foundation for the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056402] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the Foundation for the National Institutes of Health to Dr. Zwiebel through the Grand Challenges in Global Health Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bohbot JD, 2011, MED VET ENTOMOL, V25, P436, DOI 10.1111/j.1365-2915.2011.00949.x; Bohbot JD, 2011, CHEM SENSES, V36, P149, DOI 10.1093/chemse/bjq105; Carey AF, 2011, P NATL ACAD SCI USA, V108, P12987, DOI 10.1073/pnas.1103472108; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Gilliot C., 2005, ENTOMOLOGY; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kenakin T, 2006, J PHARMACOL EXP THER, V319, P710, DOI 10.1124/jpet.106.107375; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Turner SL, 2011, NATURE, V474, P87, DOI 10.1038/nature10081; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	31	53	69	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30304	10.1371/journal.pone.0030304	http://dx.doi.org/10.1371/journal.pone.0030304			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272331	Green Published, Green Submitted, gold			2022-12-27	WOS:000301454400109
J	van Velzen, R; Weitschek, E; Felici, G; Bakker, FT				van Velzen, Robin; Weitschek, Emanuel; Felici, Giovanni; Bakker, Freek T.			DNA Barcoding of Recently Diverged Species: Relative Performance of Matching Methods	PLOS ONE			English	Article							MOLECULAR MARKERS; FEATURE-SELECTION; IDENTIFICATION; DIPTERA; FISH; CLASSIFICATION; DIVERSITY; SEQUENCES; REVEALS; ASSUMPTION	Recently diverged species are challenging for identification, yet they are frequently of special interest scientifically as well as from a regulatory perspective. DNA barcoding has proven instrumental in species identification, especially in insects and vertebrates, but for the identification of recently diverged species it has been reported to be problematic in some cases. Problems are mostly due to incomplete lineage sorting or simply lack of a 'barcode gap' and probably related to large effective population size and/or low mutation rate. Our objective was to compare six methods in their ability to correctly identify recently diverged species with DNA barcodes: neighbor joining and parsimony (both tree-based), nearest neighbor and BLAST (similarity-based), and the diagnostic methods DNA-BAR, and BLOG. We analyzed simulated data assuming three different effective population sizes as well as three selected empirical data sets from published studies. Results show, as expected, that success rates are significantly lower for recently diverged species (similar to 75%) than for older species (similar to 97%) (P<0.00001). Similarity-based and diagnostic methods significantly outperform tree-based methods, when applied to simulated DNA barcode data (P<0.00001). The diagnostic method BLOG had highest correct query identification rate based on simulated (86.2%) as well as empirical data (93.1%), indicating that it is a consistently better method overall. Another advantage of BLOG is that it offers species-level information that can be used outside the realm of DNA barcoding, for instance in species description or molecular detection assays. Even though we can confirm that identification success based on DNA barcoding is generally high in our data, recently diverged species remain difficult to identify. Nevertheless, our results contribute to improved solutions for their accurate identification.	[van Velzen, Robin; Bakker, Freek T.] Wageningen Univ, Biosystemat Grp, Wageningen, Netherlands; [van Velzen, Robin] Wageningen Univ, Netherlands Ctr Biodivers Naturalis, Sect NHN, Wageningen Branch, Wageningen, Netherlands; [Weitschek, Emanuel; Felici, Giovanni] CNR, Ist Anal Sistemi & Informat Antonio Ruberti, Rome, Italy; [Weitschek, Emanuel] Univ Roma Tre, Dept Informat & Automat, Rome, Italy	Wageningen University & Research; Wageningen University & Research; Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); Roma Tre University	van Velzen, R (corresponding author), Wageningen Univ, Biosystemat Grp, Wageningen, Netherlands.	robin.vanvelzen@wur.nl	van Velzen, Robin/A-1653-2009; Weitschek, Emanuel/U-7158-2019; FELICI, GIOVANNI/P-4103-2015	van Velzen, Robin/0000-0002-6444-7608; Weitschek, Emanuel/0000-0002-8045-2925; FELICI, GIOVANNI/0000-0003-0544-5407; Bakker, Freek T./0000-0003-0227-6687	NCB Naturalis	NCB Naturalis	This work was supported by the National Herbarium of the Netherlands (now NCB Naturalis). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2011, BARCODE LIFE DATA PO; [Anonymous], 2011, BLOG BARCODING LOGIC; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Armstrong KF, 1997, B ENTOMOL RES, V87, P111, DOI 10.1017/S0007485300027243; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Aveskamp MM, 2009, MOL PLANT PATHOL, V10, P403, DOI [10.1111/J.1364-3703.2009.00540.X, 10.1111/j.1364-3703.2009.00540.x]; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Azpurua J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000627; Bastos AD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-26; Bertolazzi P, 2008, COMPUT MATH APPL, V55, P889, DOI 10.1016/j.camwa.2006.12.093; Bertolazzi P, 2010, CH CRC DATA MIN KNOW, P257; Bertolazzi P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S7; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bonferroni CE, 1935, STUDI ONORE PROFESSO, P13; Boykin LM, 2006, B ENTOMOL RES, V96, P457, DOI 10.1079/BER2006438; Bucciarelli G, 2002, J EXP MAR BIOL ECOL, V273, P143, DOI 10.1016/S0022-0981(02)00138-7; Castillo DM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-258; Damm S, 2010, MOL ECOL, V19, P3881, DOI 10.1111/j.1365-294X.2010.04720.x; DasGupa B, 2005, BIOINFORMATICS, V21, P3424, DOI 10.1093/bioinformatics/bti547; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dexter KG, 2010, ECOL MONOGR, V80, P267, DOI 10.1890/09-0267.1; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; EDWARDS AWF, 1963, ANN HUM GENET, V27, P104; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Felici G, 2002, INFORMS J COMPUT, V14, P20, DOI 10.1287/ijoc.14.1.20.7709; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff P, 2008, CLADISTICS, V24, P91; Griffiths AM, 2010, P ROY SOC B-BIOL SCI, V277, P1497, DOI 10.1098/rspb.2009.2111; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hsieh CH, 2007, ENVIRON ENTOMOL, V36, P952, DOI 10.1603/0046-225X(2007)36[952:EFMMAP]2.0.CO;2; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hudson R, 1990, OXFORD SURVEY EVOLUT, V7; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kaila L, 2006, ZOOTAXA, P1; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kuksa P, 2009, BMC BIOINFORMATICS, V10; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lemmon AR, 2004, SYST BIOL, V53, P265, DOI 10.1080/10635150490423520; Little DP, 2008, CLADISTICS, V24, P97; Little DP, 2011, PLOS ONE, V6; Lou M, 2010, MOL PHYLOGENET EVOL, V56, P187, DOI 10.1016/j.ympev.2010.01.002; Maddison W.P., 2010, MESQUITE MODULAR SYS; Maddison WP, 2010, COALESCENCE PACKAGE; Matz MV, 2005, PHILOS T R SOC B, V360, P1969, DOI 10.1098/rstb.2005.1728; May GE, 2006, MOL ECOL, V15, P1021, DOI 10.1111/j.1365-294X.2006.02814.x; McBride CS, 2009, MOL ECOL, V18, P3639, DOI 10.1111/j.1365-294X.2009.04309.x; McFadden CS, 2011, MOL ECOL RESOUR, V11, P19, DOI 10.1111/j.1755-0998.2010.02875.x; McKeon SN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-271; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Munch K, 2008, PHILOS T R SOC B, V363, P3997, DOI 10.1098/rstb.2008.0169; Neigel J, 2007, CORAL REEFS, V26, P487, DOI 10.1007/s00338-007-0248-4; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Nichols R, 2001, TRENDS ECOL EVOL, V16, P358, DOI 10.1016/S0169-5347(01)02203-0; Nielsen R, 2006, SYST BIOL, V55, P162, DOI 10.1080/10635150500431239; Nolan DV, 2007, VET MICROBIOL, V124, P82, DOI 10.1016/j.vetmic.2007.03.019; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paredes-Esquivel C, 2009, MOL PHYLOGENET EVOL, V50, P141, DOI 10.1016/j.ympev.2008.10.011; Petit N, 2009, J EVOLUTION BIOL, V22, P515, DOI 10.1111/j.1420-9101.2008.01672.x; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reid BN, 2011, MOL ECOL RESOUR, V11, P956, DOI 10.1111/j.1755-0998.2011.03032.x; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarkar IN, 2002, J BIOMED INFORM, V35, P111, DOI 10.1016/S1532-0464(02)00504-X; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Sarkar IN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014689; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Seo TK, 2010, J MOL EVOL, V71, P250, DOI 10.1007/s00239-010-9380-9; Skoracka A, 2010, B ENTOMOL RES, V100, P263, DOI 10.1017/S0007485309990216; Steel M, 2001, MATH BIOSCI, V170, P91, DOI 10.1016/S0025-5564(00)00061-4; Van Velzen R, 2009, ZOOTAXA, P53, DOI 10.11646/zootaxa.2197.1.5; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Wallman JF, 2001, FORENSIC SCI INT, V120, P60, DOI 10.1016/S0379-0738(01)00426-1; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, AQUAT BIOL, V3, P71, DOI 10.3354/ab00068; Weitschek E, 2011, 1107 IASICNR; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; WILCOXON F, 1947, BIOMETRICS, V3, P119, DOI 10.2307/3001946; Yassin A, 2008, MOL ECOL RESOUR, V8, P491, DOI 10.1111/j.1471-8286.2007.02020.x; Yassin A, 2010, MOL PHYLOGENET EVOL, V57, P509, DOI 10.1016/j.ympev.2010.08.020; Zemlak TS, 2009, MOL ECOL RESOUR, V9, P237, DOI 10.1111/j.1755-0998.2009.02649.x; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zou SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026619	102	123	135	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30490	10.1371/journal.pone.0030490	http://dx.doi.org/10.1371/journal.pone.0030490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272356	gold, Green Submitted, Green Published			2022-12-27	WOS:000301454400134
J	Johansson, AL; Collins, R; Arner, ESJ; Brzezinski, P; Hogbom, M				Johansson, Ann-Louise; Collins, Ruairi; Arner, Elias S. J.; Brzezinski, Peter; Hogbom, Martin			Biochemical Discrimination between Selenium and Sulfur 2: Mechanistic Investigation of the Selenium Specificity of Human Selenocysteine Lyase	PLOS ONE			English	Article							SYNECHOCYSTIS-SP PCC-6803; NIFS-LIKE PROTEIN; ESCHERICHIA-COLI; CYSTEINE DESULFURASE; PERSULFIDE INTERMEDIATE; DELIVERY PROTEIN; GENE CLONING; BETA-LYASE; C-DES; PURIFICATION	Selenium is an essential trace element incorporated into selenoproteins as selenocysteine. Selenocysteine (Sec) lyases (SCLs) and cysteine (Cys) desulfurases (CDs) catalyze the removal of selenium or sulfur from Sec or Cys, respectively, and generally accept both substrates. Intriguingly, human SCL (hSCL) is specific for Sec even though the only difference between Sec and Cys is a single chalcogen atom. The crystal structure of hSCL was recently determined and gain-of-function protein variants that also could accept Cys as substrate were identified. To obtain mechanistic insight into the chemical basis for its substrate discrimination, we here report time-resolved spectroscopic studies comparing the reactions of the Sec-specific wild-type hSCL and the gain-of-function D146K/H389T variant, when given Cys as a substrate. The data are interpreted in light of other studies of SCL/CD enzymes and offer mechanistic insight into the function of the wild-type enzyme. Based on these results and previously available data we propose a reaction mechanism whereby the Sec over Cys specificity is achieved using a combination of chemical and physico-mechanical control mechanisms.	[Johansson, Ann-Louise; Brzezinski, Peter; Hogbom, Martin] Stockholm Univ, Arrhenius Labs Nat Sci C4, Stockholm Ctr Biomembrane Res, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Collins, Ruairi] Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, Stockholm, Sweden; [Arner, Elias S. J.] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, Stockholm, Sweden	Stockholm University; Karolinska Institutet; Karolinska Institutet	Johansson, AL (corresponding author), Stockholm Univ, Arrhenius Labs Nat Sci C4, Stockholm Ctr Biomembrane Res, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	hogbom@dbb.su.se	Arnér, Elias/K-6737-2019; Arnér, Elias S.J./J-5832-2012	Arnér, Elias/0000-0002-4807-6114; Arnér, Elias S.J./0000-0002-4807-6114; Hogbom, Martin/0000-0001-5574-9383	Swedish Cancer Society; Swedish Research Council [2010-5061]; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg foundation; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Wellcome Trust	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by the Swedish Cancer Society to MH and ESJA, the Swedish Research Council (2010-5061), the Swedish Foundation for Strategic Research, and the Knut and Alice Wallenberg foundation to MH. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 2009, BBA-GEN SUBJECTS, V1790, P1415, DOI 10.1016/j.bbagen.2009.03.003; Angstwurm MWA, 2006, CURR OPIN CLIN NUTR, V9, P233, DOI 10.1097/01.mco.0000222105.30795.7f; Arner ESJ, 2010, EXP CELL RES, V316, P1296, DOI 10.1016/j.yexcr.2010.02.032; Behshad E, 2004, BIOCHEMISTRY-US, V43, P12220, DOI 10.1021/bi049143e; Behshad E, 2009, BIOCHEMISTRY-US, V48, P12014, DOI 10.1021/bi802161u; Campanini B, 2006, J BIOL CHEM, V281, P38769, DOI 10.1074/jbc.M607098200; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Collins R, 2012, PLOS ONE IN PRESS; DAHER R, 1992, J TRACE ELEM ELECT H, V6, P189; ESAKI N, 1985, ARCH BIOCHEM BIOPHYS, V238, P418, DOI 10.1016/0003-9861(85)90182-1; ESAKI N, 1982, J BIOL CHEM, V257, P4386; Hondal RJ, 2011, AMINO ACIDS, V41, P73, DOI 10.1007/s00726-010-0494-6; Kaiser JT, 2000, J MOL BIOL, V297, P451, DOI 10.1006/jmbi.2000.3581; Kaiser JT, 2003, J BIOL CHEM, V278, P357, DOI 10.1074/jbc.M209862200; Lacourciere GM, 1998, J BIOL CHEM, V273, P30921, DOI 10.1074/jbc.273.47.30921; Letavayova L, 2006, TOXICOLOGY, V227, P1, DOI 10.1016/j.tox.2006.07.017; Lima CD, 2002, J MOL BIOL, V315, P1199, DOI 10.1006/jmbi.2001.5308; Mihara H, 2000, J BIOCHEM-TOKYO, V127, P559, DOI 10.1093/oxfordjournals.jbchem.a022641; Mihara H, 2000, J BIOL CHEM, V275, P6195, DOI 10.1074/jbc.275.9.6195; Mihara H, 2002, J BIOCHEM, V131, P679, DOI 10.1093/oxfordjournals.jbchem.a003151; Mihara H, 1997, J BIOL CHEM, V272, P22417, DOI 10.1074/jbc.272.36.22417; Mihara H, 1999, J BIOL CHEM, V274, P14768, DOI 10.1074/jbc.274.21.14768; Olmo M, 2002, J BIOCHEM, V132, P433, DOI 10.1093/oxfordjournals.jbchem.a003240; Omi R, 2010, J BIOL CHEM, V285, P12133, DOI 10.1074/jbc.M109.084475; Reich HJ, 2002, HELV CHIM ACTA, V85, P3748, DOI 10.1002/1522-2675(200211)85:11<3748::AID-HLCA3748>3.0.CO;2-0; Schomburg L, 2004, CELL MOL LIFE SCI, V61, P1988, DOI 10.1007/s00018-004-4114-z; Seebach D, 1977, LIEBIGS ANN CHEM, P846; Suzuki KT, 2007, BBA-GEN SUBJECTS, V1770, P1053, DOI 10.1016/j.bbagen.2007.03.007; Tirupati B, 2004, BIOCHEMISTRY-US, V43, P12210, DOI 10.1021/bi0491447; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yoshizawa S, 2009, BBA-GEN SUBJECTS, V1790, P1404, DOI 10.1016/j.bbagen.2009.03.010; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	34	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30528	10.1371/journal.pone.0030528	http://dx.doi.org/10.1371/journal.pone.0030528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291978	Green Published, gold, Green Submitted			2022-12-27	WOS:000301703800019
J	Ambrosone, A; Marchesano, V; Tino, A; Hobmayer, B; Tortiglione, C				Ambrosone, Alfredo; Marchesano, Valentina; Tino, Angela; Hobmayer, Bert; Tortiglione, Claudia			Hymyc1 Downregulation Promotes Stem Cell Proliferation in Hydra vulgaris	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; C-MYC; CAENORHABDITIS-ELEGANS; GENETIC INTERFERENCE; CYCLE KINETICS; IN-VIVO; EXPRESSION; DIFFERENTIATION; ATTENUATA; GROWTH	Hydra is a unique model for studying the mechanisms underlying stem cell biology. The activity of the three stem cell lineages structuring its body constantly replenishes mature cells lost due to normal tissue turnover. By a poorly understood mechanism, stem cells are maintained through self-renewal while concomitantly producing differentiated progeny. In vertebrates, one of many genes that participate in regulating stem cell homeostasis is the protooncogene c-myc, which has been recently identified also in Hydra, and found expressed in the interstitial stem cell lineage. In the present paper, by developing a novel strategy of RNA interference-mediated gene silencing (RNAi) based on an enhanced uptake of small interfering RNAi (siRNA), we provide molecular and biological evidence for an unexpected function of the Hydra myc gene (Hymyc1) in the homeostasis of the interstitial stem cell lineage. We found that Hymyc1 inhibition impairs the balance between stem cell self renewal/differentiation, as shown by the accumulation of stem cell intermediate and terminal differentiation products in genetically interfered animals. The identical phenotype induced by the 10058-F4 inhibitor, a disruptor of c-Myc/Max dimerization, demonstrates the specificity of the RNAi approach. We show the kinetic and the reversible feature of Hymyc1 RNAi, together with the effects displayed on regenerating animals. Our results show the involvement of Hymyc1 in the control of interstitial stem cell dynamics, provide new clues to decipher the molecular control of the cell and tissue plasticity in Hydra, and also provide further insights into the complex myc network in higher organisms. The ability of Hydra cells to uptake double stranded RNA and to trigger a RNAi response lays the foundations of a comprehensive analysis of the RNAi response in Hydra allowing us to track back in the evolution and the origin of this process.	[Ambrosone, Alfredo; Marchesano, Valentina; Tino, Angela; Tortiglione, Claudia] CNR, Ist Cibernet E Caianiello, Pozzuoli, Italy; [Hobmayer, Bert] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; [Hobmayer, Bert] Univ Innsbruck, Ctr Mol Biosci, A-6020 Innsbruck, Austria	Consiglio Nazionale delle Ricerche (CNR); Istituto di Cibernetica "Eduardo Caianiello" (ICIB-CNR); University of Innsbruck; University of Innsbruck	Ambrosone, A (corresponding author), CNR, Ist Cibernet E Caianiello, Pozzuoli, Italy.	c.tortiglione@cib.na.cnr.it	Tortiglione, Claudia/N-3290-2019; Tino, Angela/E-8425-2014; Tortiglione, Claudia/K-5200-2014	Tortiglione, Claudia/0000-0003-1447-7611; Tino, Angela/0000-0002-9673-1064; Tortiglione, Claudia/0000-0003-1447-7611; Marchesano, Valentina/0000-0001-8140-3191; Ambrosone, Alfredo/0000-0002-1897-4028	NanoSci-ERA net project NANOTRUCK; Austrian Science Fund (FWF) [P 20734] Funding Source: researchfish	NanoSci-ERA net project NANOTRUCK; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the NanoSci-ERA net project NANOTRUCK (2009-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; ASKEW DS, 1991, ONCOGENE, V6, P1915; Bode HR, 1996, J CELL SCI, V109, P1155; Bosch TCG, 2009, BIOESSAYS, V31, P478, DOI 10.1002/bies.200800183; CAMPBELL RD, 1974, J CELL SCI, V16, P349; Cardenas MM, 2003, DEV BIOL, V264, P495, DOI 10.1016/j.ydbio.2003.08.022; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Chera S, 2006, J CELL SCI, V119, P846, DOI 10.1242/jcs.02807; Chera S, 2009, DEV CELL, V17, P279, DOI 10.1016/j.devcel.2009.07.014; DAVID CN, 1973, ROUX ARCH DEV BIOL, V171, P259, DOI 10.1007/BF00577724; DAVID CN, 1972, J CELL SCI, V11, P557; de la Cova C, 2006, SEMIN CANCER BIOL, V16, P303, DOI 10.1016/j.semcancer.2006.07.010; Demeterco C, 2002, J CLIN ENDOCR METAB, V87, P3475, DOI 10.1210/jc.87.7.3475; Duffy DJ, 2010, DEVELOPMENT, V137, P3057, DOI 10.1242/dev.046631; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; EVAN GI, 1993, CURR OPIN GENET DEV, V3, P44, DOI 10.1016/S0959-437X(05)80339-9; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gallant P, 2009, ADV CANCER RES, V103, P111, DOI 10.1016/S0065-230X(09)03005-X; Galliot B, 2006, SEMIN CELL DEV BIOL, V17, P492, DOI 10.1016/j.semcdb.2006.05.005; Gee L, 2010, DEV BIOL, V340, P116, DOI 10.1016/j.ydbio.2009.12.036; Gheysen G, 2007, TRENDS BIOTECHNOL, V25, P89, DOI 10.1016/j.tibtech.2007.01.007; Gomez-Curet I, 2006, J PEDIATR SURG, V41, P207, DOI 10.1016/j.jpedsurg.2005.10.025; Grens A, 1996, DEV BIOL, V180, P473, DOI 10.1006/dbio.1996.0321; Hartl M, 2010, P NATL ACAD SCI US; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Hobmayer B, 1990, DEVELOPMENT, V109, P897; Hobmayer B, 1990, DEVELOPMENT, V109, P887; HOLSTEIN TW, 1991, DEV BIOL, V148, P602, DOI 10.1016/0012-1606(91)90277-A; HOLSTEIN TW, 1990, DEV BIOL, V142, P392, DOI 10.1016/0012-1606(90)90360-U; Howard KA, 2009, ADV DRUG DELIVER REV, V61, P710, DOI 10.1016/j.addr.2009.04.001; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Hunter R. J., 1988, ZETA POTENTIAL COLLO; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim DH, 2008, BIOTECHNIQUES, V44, P613, DOI 10.2144/000112792; Laurenti E, 2009, CURR OPIN CELL BIOL, V21, P844, DOI 10.1016/j.ceb.2009.09.006; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohmann JU, 2000, GENE DEV, V14, P2771, DOI 10.1101/gad.830100; Lohmann JU, 1999, DEV BIOL, V214, P211, DOI 10.1006/dbio.1999.9407; Miljkovic M, 2002, DEV BIOL, V246, P377, DOI 10.1006/dbio.2002.0676; Naito Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-392; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Sambrook J., 2002, MOL CLONING LAB MANU; SHI YF, 1992, SCIENCE, V257, P212, DOI 10.1126/science.1378649; Smith KM, 2000, DEVELOPMENT, V127, P4743; SPROULL F, 1979, J CELL SCI, V38, P171; Timmons L, 2003, MOL BIOL CELL, V14, P2972, DOI 10.1091/mbc.E03-01-0858; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Torchilin VP, 2003, P NATL ACAD SCI USA, V100, P1972, DOI 10.1073/pnas.0435906100; Tortiglione C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007698; Watanabe H, 2009, SEMIN CELL DEV BIOL, V20, P1114, DOI 10.1016/j.semcdb.2009.09.008; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wilson A, 2009, CURR OPIN GENET DEV, V19, P461, DOI 10.1016/j.gde.2009.08.005; Wittlieb J, 2006, P NATL ACAD SCI USA, V103, P6208, DOI 10.1073/pnas.0510163103; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641	58	26	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30660	10.1371/journal.pone.0030660	http://dx.doi.org/10.1371/journal.pone.0030660			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292012	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600069
J	Zhang, TW; Fang, YJ; Wang, XM; Deng, X; Zhang, XW; Hu, SN; Yu, J				Zhang, Tongwu; Fang, Yongjun; Wang, Xumin; Deng, Xin; Zhang, Xiaowei; Hu, Songnian; Yu, Jun			The Complete Chloroplast and Mitochondrial Genome Sequences of Boea hygrometrica: Insights into the Evolution of Plant Organellar Genomes	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; DNA-SEQUENCE; GENE; L.; ORGANIZATION; SELECTION; CONTAINS; INTRONS; SHOWS	The complete nucleotide sequences of the chloroplast (cp) and mitochondrial (mt) genomes of resurrection plant Boea hygrometrica (Bh, Gesneriaceae) have been determined with the lengths of 153,493 bp and 510,519 bp, respectively. The smaller chloroplast genome contains more genes (147) with a 72% coding sequence, and the larger mitochondrial genome have less genes (65) with a coding faction of 12%. Similar to other seed plants, the Bh cp genome has a typical quadripartite organization with a conserved gene in each region. The Bh mt genome has three recombinant sequence repeats of 222 bp, 843 bp, and 1474 bp in length, which divide the genome into a single master circle (MC) and four isomeric molecules. Compared to other angiosperms, one remarkable feature of the Bh mt genome is the frequent transfer of genetic material from the cp genome during recent Bh evolution. We also analyzed organellar genome evolution in general regarding genome features as well as compositional dynamics of sequence and gene structure/organization, providing clues for the understanding of the evolution of organellar genomes in plants. The cp-derived sequences including tRNAs found in angiosperm mt genomes support the conclusion that frequent gene transfer events may have begun early in the land plant lineage.	[Zhang, Tongwu; Fang, Yongjun] Zhejiang Univ, James D Watson Inst Genome Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Tongwu; Fang, Yongjun; Wang, Xumin; Zhang, Xiaowei; Hu, Songnian; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Deng, Xin] Chinese Acad Sci, Inst Bot, CAS Key Lab Photosynth & Mol Physiol, Res Ctr Plant Mol & Dev Biol, Beijing, Peoples R China	Zhejiang University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Institute of Botany, CAS	Zhang, TW (corresponding author), Zhejiang Univ, James D Watson Inst Genome Sci, Hangzhou 310003, Zhejiang, Peoples R China.	zhangxw@big.ac.cn; husn@big.ac.cn; junyu@big.ac.cn	wang, xumin/HII-8627-2022; Zhang, Tongwu/M-4975-2015; Xin, deng/AAH-4009-2020; 郑, 征/C-8514-2011; Hu, Songnian/C-6509-2013	Hu, Songnian/0000-0003-3966-3111	Chinese Academy of Sciences [KSCX2-EW-R-01-04]; Natural Science Foundation of China [90919024, 30900831]; Ministry of Science and Technology [2008ZX10004-013]; Ministry of Science and Technology of the People's Republic of China [2011CB944100]	Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work is supported by grants from Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-R-01-04), Natural Science Foundation of China (90919024), Natural Science Foundation of China (30900831), from the Ministry of Science and Technology as the National Science and Technology Key Project (2008ZX10004-013), and the National Basic Research Program (973 Program) from the Ministry of Science and Technology of the People's Republic of China (2011CB944100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2010, IDENTIFICATION QUANT; Alverson AJ, 2011, PLANT CELL OLINE; Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Arrieta-Montiel M, 2001, GENETICS, V158, P851; Besnard G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-80; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chaw SM, 2008, MOL BIOL EVOL, V25, P603, DOI 10.1093/molbev/msn009; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Deng X, 1999, PLANT MOL BIOL REP, V17, P279, DOI 10.1023/A:1007635714367; Dombrovska O, 2004, MOL PHYLOGENET EVOL, V32, P246, DOI 10.1016/j.ympev.2003.12.013; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fujii S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-209; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Goulding SE, 1996, MOL GEN GENET, V252, P195, DOI 10.1007/BF02173220; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Hansen DR, 2007, MOL PHYLOGENET EVOL, V45, P547, DOI 10.1016/j.ympev.2007.06.004; Hecht J, 2011, GENOME BIOL EVOLUTIO; Jiang GQ, 2007, PLANTA, V225, P1405, DOI 10.1007/s00425-006-0449-z; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Li LB, 2009, J MOL EVOL, V68, P665, DOI 10.1007/s00239-009-9240-7; Liu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025836; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; LONSDALE DM, 1988, PHILOS T ROY SOC B, V319, P149, DOI 10.1098/rstb.1988.0039; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Malek O, 1998, RNA, V4, P1599, DOI 10.1017/S1355838298981262; MARECHALDROUARD L, 1990, NUCLEIC ACIDS RES, V18, P3689, DOI 10.1093/nar/18.13.3689; Matsuo M, 2005, PLANT CELL, V17, P665, DOI 10.1105/tpc.104.027706; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Ogihara Y, 2005, NUCLEIC ACIDS RES, V33, P6235, DOI 10.1093/nar/gki925; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Qiu YL, 2010, J SYST EVOL, V48, P391, DOI 10.1111/j.1759-6831.2010.00097.x; Qiu YL, 2004, J MOL EVOL, V59, P80, DOI 10.1007/s00239-004-2606-y; Robbens S, 2007, MOL BIOL EVOL, V24, P956, DOI 10.1093/molbev/msm012; SMALL I, 1989, CELL, V58, P69, DOI 10.1016/0092-8674(89)90403-0; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; Terasawa K, 2007, MOL BIOL EVOL, V24, P699, DOI 10.1093/molbev/msl198; Tian XJ, 2006, PLANT PHYSIOL, V140, P401, DOI 10.1104/pp.105.070060; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; Wang D, 2007, MOL BIOL EVOL, V24, P2040, DOI 10.1093/molbev/msm133; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang M, 2010, PLOS ONE, V5; Zhang TW, 2011, PLANT METHO IN PRESS	52	117	136	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30531	10.1371/journal.pone.0030531	http://dx.doi.org/10.1371/journal.pone.0030531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291979	gold, Green Published, Green Submitted			2022-12-27	WOS:000301570600055
J	Gonzalez, RG; Lev, MH; Goldmacher, GV; Smith, WS; Payabvash, S; Harris, GJ; Halpern, EF; Koroshetz, WJ; Camargo, ECS; Dillon, WP; Furie, KL				Gonzalez, R. Gilberto; Lev, Michael H.; Goldmacher, Gregory V.; Smith, Wade S.; Payabvash, Seyedmehdi; Harris, Gordon J.; Halpern, Elkan F.; Koroshetz, Walter J.; Camargo, Erica C. S.; Dillon, William P.; Furie, Karen L.			Improved Outcome Prediction Using CT Angiography in Addition to Standard Ischemic Stroke Assessment: Results from the STOPStroke Study	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; DIAGNOSTIC-APPROACH; SCORE; MISMATCH; TISSUE; INFARCTION; RISK	Purpose: To improve ischemic stroke outcome prediction using imaging information from a prospective cohort who received admission CT angiography (CTA). Methods: In a prospectively designed study, 649 stroke patients diagnosed with acute ischemic stroke had admission NIH stroke scale scores, noncontrast CT (NCCT), CTA, and 6-month outcome assessed using the modified Rankin scale (mRS) scores. Poor outcome was defined as mRS>2. Strokes were classified as "major'' by the (1) Alberta Stroke Program Early CT Score (ASPECTS+) if NCCT ASPECTS was <= 7; (2) Boston Acute Stroke Imaging Scale (BASIS+) if they were ASPECTS+ or CTA showed occlusion of the distal internal carotid, proximal middle cerebral, or basilar arteries; and (3) NIHSS for scores>10. Results: Of 649 patients, 253 (39.0%) had poor outcomes. NIHSS, BASIS, and age, but not ASPECTS, were independent predictors of outcome. BASIS and NIHSS had similar sensitivities, both superior to ASPECTS (p<0.0001). Combining NIHSS with BASIS was highly predictive: 77.6% (114/147) classified as NIHSS>10/BASIS+ had poor outcomes, versus 21.5% (77/358) with NIHSS <= 10/BASIS- (p<0.0001), regardless of treatment. The odds ratios for poor outcome is 12.6 (95% CI: 7.9 to 20.0) in patients who are NIHSS>10/BASIS+ compared to patients who are NIHSS <= 10/BASIS-; the odds ratio is 5.4 (95% CI: 3.5 to 8.5) when compared to patients who are only NIHSS>10 or BASIS+. Conclusions: BASIS and NIHSS are independent outcome predictors. Their combination is stronger than either instrument alone in predicting outcomes. The findings suggest that CTA is a significant clinical tool in routine acute stroke assessment.	[Gonzalez, R. Gilberto; Lev, Michael H.; Goldmacher, Gregory V.; Payabvash, Seyedmehdi; Harris, Gordon J.; Halpern, Elkan F.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Gonzalez, R. Gilberto; Lev, Michael H.; Goldmacher, Gregory V.; Payabvash, Seyedmehdi; Harris, Gordon J.; Halpern, Elkan F.; Camargo, Erica C. S.; Furie, Karen L.] Harvard Univ, Sch Med, Boston, MA USA; [Smith, Wade S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Halpern, Elkan F.] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [Koroshetz, Walter J.] Natl Inst Neurol Disorders & Stroke, Bethesda, MD USA; [Camargo, Erica C. S.; Furie, Karen L.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Dillon, William P.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco	Gonzalez, RG (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.	rggonzalez@partners.org	Payabvash, Sam/I-1859-2019	Payabvash, Sam/0000-0003-4628-0370; Dillon, William/0000-0002-7222-4615	National Institute of Health Agency for Health Care Policy and Research (AHCPR) [R01 HS11392-01A1]; GE Healthcare; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS011392] Funding Source: NIH RePORTER	National Institute of Health Agency for Health Care Policy and Research (AHCPR); GE Healthcare(General ElectricGE Healthcare); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was supported by the National Institute of Health Agency for Health Care Policy and Research (AHCPR), R01 HS11392-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Michael H. Lev has read the journal's policy and has the following conflicts: He receives research support from GE Healthcare, and is Consultant to Co-Axia, GE Healthcare, and Millennium Pharmaceuticals. Otherwise, the other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Calvet D, 2009, STROKE, V40, P187, DOI 10.1161/STROKEAHA.108.515817; Camargo ECS, 2007, RADIOLOGY, V244, P541, DOI 10.1148/radiol.2442061028; Caplan LR, 2004, JAMA-J AM MED ASSOC, V292, P1883, DOI 10.1001/jama.292.15.1883; Chang KC, 2002, STROKE, V33, P2670, DOI 10.1161/01.STR.0000034396.68980.39; Choi JY, 2006, CEREBROVASC DIS, V22, P384, DOI 10.1159/000094856; Cipriano LE, 2009, AM J NEURORADIOL, V30, P703, DOI 10.3174/ajnr.A1441; Davalos A, 2004, NEUROLOGY, V62, P2187, DOI 10.1212/01.WNL.0000130570.41127.EA; Delgado Almandoz J, 2010, ACUTE ISCHEMIC STROK, P57; Giles MF, 2010, STROKE, V41, P1907, DOI 10.1161/STROKEAHA.110.578971; Ingall TJ, 2004, STROKE, V35, P2418, DOI 10.1161/01.STR.0000140891.70547.56; Johnston KC, 2003, STROKE, V34, P200, DOI 10.1161/01.STR.0000047102.61863.E3; Lev MH, 1999, RADIOLOGY, V213, P150, DOI 10.1148/radiology.213.1.r99oc10150; Lima FO, 2010, AM J NEURORADIOL, V31, P817, DOI 10.3174/ajnr.A1927; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Nabavi DG, 2002, STROKE, V33, P2819, DOI 10.1161/01.STR.0000043074.39077.60; Obach V, 2011, STROKE J CEREBRAL CI; Paciaroni M, 2009, EXPERT OPIN BIOL TH, V9, P773, DOI 10.1517/14712590902991497; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; RANKIN J, 1957, Scott Med J, V2, P200; Rundek T, 2000, NEUROLOGY, V55, P1180, DOI 10.1212/WNL.55.8.1180; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; Smith WS, 2006, NEUROCRIT CARE, V4, P14, DOI 10.1385/NCC:4:1:014; Smith WS, 2009, STROKE; Torres-Mozqueda F, 2008, AM J NEURORADIOL, V29, P1111, DOI 10.3174/ajnr.A1000; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604	28	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30352	10.1371/journal.pone.0030352	http://dx.doi.org/10.1371/journal.pone.0030352			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276182	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100037
J	Stevens, AA; Tappon, SC; Garg, A; Fair, DA				Stevens, Alexander A.; Tappon, Sarah C.; Garg, Arun; Fair, Damien A.			Functional Brain Network Modularity Captures Inter- and Intra-Individual Variation in Working Memory Capacity	PLOS ONE			English	Article							SHORT-TERM-MEMORY; PREDICTS INDIVIDUAL-DIFFERENCES; COMMUNITY STRUCTURE; CONNECTIVITY; ORGANIZATION; ATTENTION; SYSTEM	Background: Cognitive abilities, such as working memory, differ among people; however, individuals also vary in their own day-to-day cognitive performance. One potential source of cognitive variability may be fluctuations in the functional organization of neural systems. The degree to which the organization of these functional networks is optimized may relate to the effective cognitive functioning of the individual. Here we specifically examine how changes in the organization of large-scale networks measured via resting state functional connectivity MRI and graph theory track changes in working memory capacity. Methodology/Principal Findings: Twenty-two participants performed a test of working memory capacity and then underwent resting-state fMRI. Seventeen subjects repeated the protocol three weeks later. We applied graph theoretic techniques to measure network organization on 34 brain regions of interest (ROI). Network modularity, which measures the level of integration and segregation across sub-networks, and small-worldness, which measures global network connection efficiency, both predicted individual differences in memory capacity; however, only modularity predicted intra-individual variation across the two sessions. Partial correlations controlling for the component of working memory that was stable across sessions revealed that modularity was almost entirely associated with the variability of working memory at each session. Analyses of specific sub-networks and individual circuits were unable to consistently account for working memory capacity variability. Conclusions/Significance: The results suggest that the intrinsic functional organization of an a priori defined cognitive control network measured at rest provides substantial information about actual cognitive performance. The association of network modularity to the variability in an individual's working memory capacity suggests that the organization of this network into high connectivity within modules and sparse connections between modules may reflect effective signaling across brain regions, perhaps through the modulation of signal or the suppression of the propagation of noise.	[Stevens, Alexander A.; Tappon, Sarah C.; Garg, Arun] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Stevens, Alexander A.; Tappon, Sarah C.; Fair, Damien A.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Stevens, AA (corresponding author), Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA.	stevenal@ohsu.edu			Fischer Family Foundation; National Institute for Mental Health [MH077105]; National Institute of Drug Abuse [DA021695]; The Oregon Clinical and Translational Research Institute [MH091238]; Medical Research Foundation; United Negro College; Ford Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH091238, R01MH077105, R00MH091238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021695] Funding Source: NIH RePORTER	Fischer Family Foundation; National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); The Oregon Clinical and Translational Research Institute; Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United Negro College; Ford Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the Fischer Family Foundation, the National Institute for Mental Health (MH077105), and the National Institute of Drug Abuse (DA021695) to AAS. The Oregon Clinical and Translational Research Institute grant MH091238, Medical Research Foundation, United Negro College Fund/Merck, and Ford Foundation funded DAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Bassett D. S., 2011, P NATL ACAD SCI US; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chee MWL, 2008, J NEUROSCI, V28, P5519, DOI 10.1523/JNEUROSCI.0733-08.2008; Cowan N, 2005, COGNITIVE PSYCHOL, V51, P42, DOI 10.1016/j.cogpsych.2004.12.001; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Engle Randall W., 1999, MODELS WORKING MEMOR, P102; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fukuda K, 2010, PSYCHON B REV, V17, P673, DOI 10.3758/17.5.673; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Karrer B, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046119; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schoofs D, 2008, PSYCHONEUROENDOCRINO, V33, P643, DOI 10.1016/j.psyneuen.2008.02.004; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P624, DOI 10.1162/jocn.1997.9.5.624; Simon H. A., 1962, P AM PHILOS SOC, V106, P467, DOI DOI 10.1080/14759550302804; Spoormaker VI, 2010, J NEUROSCI, V30, P11379, DOI 10.1523/JNEUROSCI.2015-10.2010; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262	43	133	135	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30468	10.1371/journal.pone.0030468	http://dx.doi.org/10.1371/journal.pone.0030468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276205	Green Submitted, Green Published, gold			2022-12-27	WOS:000301568100049
J	Zhang, R; Lu, SM; Meng, LS; Min, ZX; Tian, J; Valenzuela, RK; Guo, TW; Tian, LF; Zhao, WX; Ma, J				Zhang, Rui; Lu, Shemin; Meng, Liesu; Min, Zixin; Tian, Juan; Valenzuela, Robert K.; Guo, Tingwei; Tian, Lifang; Zhao, Wenxiang; Ma, Jie			Genetic Evidence for the Association between the Early Growth Response 3 (EGR3) Gene and Schizophrenia	PLOS ONE			English	Article							NMDA RECEPTOR HYPOFUNCTION; TRANSCRIPTION FACTOR; CHINESE POPULATION; BIPOLAR DISORDER; COMMON VARIANTS; GAMMA-SUBUNIT; FAS LIGAND; SUSCEPTIBILITY; EXPRESSION; CALCINEURIN	Recently, two genome scan meta-analysis studies have found strong evidence for the association of loci on chromosome 8p with schizophrenia. The early growth response 3 (EGR3) gene located in chromosome 8p21.3 was also found to be involved in the etiology of schizophrenia. However, subsequent studies failed to replicate this finding. To investigate the genetic role of EGR3 in Chinese patients, we genotyped four SNPs (average interval similar to 2.3 kb) in the chromosome region of EGR3 in 470 Chinese schizophrenia patients and 480 healthy control subjects. The SNP rs35201266 (located in intron 1 of EGR3) showed significant differences between cases and controls in both genotype frequency distribution (P = 0.016) and allele frequency distribution (P = 0.009). Analysis of the haplotype rs35201266-rs3750192 provided significant evidence for association with schizophrenia (P = 0.0012); a significant difference was found for the common haplotype AG (P = 0.0005). Furthermore, significant associations were also found in several other two-, and three-SNP tests of haplotype analyses. The meta-analysis revealed a statistically significant association between rs35201266 and schizophrenia (P = 0.0001). In summary, our study supports the association of EGR3 with schizophrenia in our Han Chinese sample, and further functional exploration of the EGR3 gene will contribute to the molecular basis for the complex network underlying schizophrenia pathogenesis.	[Zhang, Rui; Lu, Shemin; Meng, Liesu; Min, Zixin; Tian, Juan; Tian, Lifang; Zhao, Wenxiang; Ma, Jie] Xi An Jiao Tong Univ, Sch Med, Dept Genet & Mol Biol, Xian 710049, Shaanxi, Peoples R China; [Zhang, Rui; Lu, Shemin; Meng, Liesu; Min, Zixin; Tian, Juan; Tian, Lifang; Zhao, Wenxiang; Ma, Jie] Xi An Jiao Tong Univ, Sch Med, Dept Epidemiol & Hlth Stat, Xian 710049, Shaanxi, Peoples R China; [Valenzuela, Robert K.] Univ Arizona, Arizona Hlth Sci Ctr, Tucson, AZ USA; [Guo, Tingwei] Albert Einstein Coll Med, New York, NY USA	Xi'an Jiaotong University; Xi'an Jiaotong University; University of Arizona; University of Arizona Health Sciences; Yeshiva University	Ma, J (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Genet & Mol Biol, Xian 710049, Shaanxi, Peoples R China.	majie.paper@gmail.com	Lu, Shemin/AAI-6479-2021; Lu, Shemin/M-3350-2018	Lu, Shemin/0000-0002-5535-8320; Lu, Shemin/0000-0001-8250-850X; Zhang, Rui/0000-0002-8664-6915	National Natural Science Foundation of China [30800618]; Ministry of Education, People's Republic of China [20090201120062]; President Foundation of Xi'an Jiaotong University [XJJ2008005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, People's Republic of China(Ministry of Education, China); President Foundation of Xi'an Jiaotong University	This study was supported by funding from the National Natural Science Foundation of China (No. 30800618), the Ministry of Education, People's Republic of China (No. 20090201120062), and the President Foundation of Xi'an Jiaotong University (No. XJJ2008005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts M, 2009, ARCH GEN PSYCHIAT, V66, P828, DOI 10.1001/archgenpsychiatry.2009.82; Ashe PC, 2001, PROG NEURO-PSYCHOPH, V25, P691, DOI 10.1016/S0278-5846(01)00159-2; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beveridge NJ, 2010, MOL PSYCHIATR, V15, P1176, DOI 10.1038/mp.2009.84; Bian L, 2005, BIOL PSYCHIAT, V58, P731, DOI 10.1016/j.biopsych.2005.05.013; Droin NM, 2003, MOL CELL BIOL, V23, P7638, DOI 10.1128/MCB.23.21.7638-7647.2003; du Bois TM, 2007, BRAIN RES REV, V53, P260, DOI 10.1016/j.brainresrev.2006.09.001; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gallitano-Mendel A, 2007, NEUROSCIENCE, V148, P633, DOI 10.1016/j.neuroscience.2007.05.050; Gallitano-Mendel A, 2008, NEUROPSYCHOPHARMACOL, V33, P1266, DOI 10.1038/sj.npp.1301505; Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; Guo AY, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-10; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; Hildeman DA, 2003, J CLIN INVEST, V111, P575, DOI 10.1172/JCI200318007; Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7; Jacobson C, 2004, P NATL ACAD SCI USA, V101, P12218, DOI 10.1073/pnas.0404240101; Kim SH, 2010, AM J MED GENET B, V153B, P1355, DOI 10.1002/ajmg.b.31115; Kyogoku C, 2011, PSYCHIAT RES, V185, P16, DOI 10.1016/j.psychres.2009.11.003; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lee SM, 2010, J BIOL CHEM, V285, P22036, DOI 10.1074/jbc.M110.108878; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li L, 2007, MOL CELL NEUROSCI, V35, P76, DOI 10.1016/j.mcn.2007.02.004; Liu BC, 2010, PROG NEURO-PSYCHOPH, V34, P506, DOI 10.1016/j.pnpbp.2010.02.005; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lohoff FW, 2008, NEUROPSYCHOBIOLOGY, V57, P55, DOI 10.1159/000129668; Ma J, 2006, MOL PSYCHIATR, V11, P479, DOI 10.1038/sj.mp.4001788; Ma X, 2011, GENES BRAIN BEHAV; Mansour HA, 2009, BIPOLAR DISORD, V11, P701, DOI 10.1111/j.1399-5618.2009.00756.x; Mexal S, 2005, MOL BRAIN RES, V139, P317, DOI 10.1016/j.molbrainres.2005.06.006; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Nieratschker Vanessa, 2010, Front Behav Neurosci, V4, P23, DOI 10.3389/fnbeh.2010.00023; O'Donovan KJ, 2000, J NEUROCHEM, V75, P1352, DOI 10.1046/j.1471-4159.2000.0751352.x; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Riley B, 2010, MOL PSYCHIATR, V15, P29, DOI 10.1038/mp.2009.109; Roberts DS, 2006, J BIOL CHEM, V281, P29431, DOI 10.1074/jbc.C600167200; Roberts DS, 2005, P NATL ACAD SCI USA, V102, P11894, DOI 10.1073/pnas.0501434102; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; SHAM PC, 1994, ACTA PSYCHIAT SCAND, V89, P135, DOI 10.1111/j.1600-0447.1994.tb01501.x; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suarez BK, 2006, AM J HUM GENET, V78, P315, DOI 10.1086/500272; Tabares-Seisdedos R, 2009, MOL PSYCHIATR, V14, P563, DOI 10.1038/mp.2009.2; Wang XY, 2004, BIOCHEM BIOPH RES CO, V319, P1281, DOI 10.1016/j.bbrc.2004.05.119; Wong J, 2010, NEUROSCIENCE, V169, P1071, DOI 10.1016/j.neuroscience.2010.05.037; Yamada K, 2007, P NATL ACAD SCI USA, V104, P2815, DOI 10.1073/pnas.0610765104; Yamada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020468; Yamagata K, 1994, Learn Mem, V1, P140; Zhang FY, 2011, BIOL PSYCHIAT, V69, P914, DOI 10.1016/j.biopsych.2011.01.003; Zhang R, 2011, MOL PSYCHIATR, V16, P360, DOI 10.1038/mp.2010.55; Zhang R, 2010, PSYCHIAT RES, V180, P5, DOI 10.1016/j.psychres.2010.04.037	61	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30237	10.1371/journal.pone.0030237	http://dx.doi.org/10.1371/journal.pone.0030237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276163	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100027
J	Chhabra, S; Dolezal, O; Collins, BM; Newman, J; Simpson, JS; Macreadie, IG; Fernley, R; Peat, TS; Swarbrick, JD				Chhabra, Sandeep; Dolezal, Olan; Collins, Brett M.; Newman, Janet; Simpson, Jamie S.; Macreadie, Ian G.; Fernley, Ross; Peat, Thomas S.; Swarbrick, James D.			Structure of S. aureus HPPK and the Discovery of a New Substrate Site Inhibitor	PLOS ONE			English	Article							COLI 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE; THERMAL SHIFT ASSAYS; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; DRUG DISCOVERY; CONFORMATIONAL TRANSITIONS; BIOLOGICAL MACROMOLECULES; DIPOLAR COUPLINGS	The first structural and biophysical data on the folate biosynthesis pathway enzyme and drug target, 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase (SaHPPK), from the pathogen Staphylococcus aureus is presented. HPPK is the second essential enzyme in the pathway catalysing the pyrophosphoryl transfer from cofactor (ATP) to the substrate (6-hydroxymethyl-7,8-dihydropterin, HMDP). In-silico screening identified 8-mercaptoguanine which was shown to bind with an equilibrium dissociation constant, K-d, of similar to 13 mu M as measured by isothermal titration calorimetry (ITC) and surface plasmon resonance (SPR). An IC50 of similar to 41 mu M was determined by means of a luminescent kinase assay. In contrast to the biological substrate, the inhibitor has no requirement for magnesium or the ATP cofactor for competitive binding to the substrate site. The 1.65 angstrom resolution crystal structure of the inhibited complex showed that it binds in the pterin site and shares many of the key intermolecular interactions of the substrate. Chemical shift and N-15 heteronuclear NMR measurements reveal that the fast motion of the pterin-binding loop (L2) is partially dampened in the SaHPPK/HMDP/alpha,beta-methylene adenosine 5'-triphosphate (AMPCPP) ternary complex, but the ATP loop (L3) remains mobile on the mu s-ms timescale. In contrast, for the SaHPPK/8-mercaptoguanine/AMPCPP ternary complex, the loop L2 becomes rigid on the fast timescale and the L3 loop also becomes more ordered - an observation that correlates with the large entropic penalty associated with inhibitor binding as revealed by ITC. NMR data, including N-15-H-1 residual dipolar coupling measurements, indicate that the sulfur atom in the inhibitor is important for stabilizing and restricting important motions of the L2 and L3 catalytic loops in the inhibited ternary complex. This work describes a comprehensive analysis of a new HPPK inhibitor, and may provide a foundation for the development of novel antimicrobials targeting the folate biosynthetic pathway.	[Chhabra, Sandeep; Simpson, Jamie S.; Swarbrick, James D.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Chhabra, Sandeep; Dolezal, Olan; Newman, Janet; Fernley, Ross; Peat, Thomas S.] CSIRO, Div Engn & Mat Sci, Parkville, Vic, Australia; [Collins, Brett M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Macreadie, Ian G.] RMIT Univ, Sch Appl Sci, Bundoora, Vic, Australia	Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Royal Melbourne Institute of Technology (RMIT)	Chhabra, S (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.	j.swarbrick@monash.edu	Simpson, Jamie S/A-1700-2012; Macreadie, Ian/L-4437-2019; Macreadie, Ian G/F-5997-2010; Dolezal, Olan/E-1691-2015; Macreadie, Ian/Q-7430-2019; Newman, Janet M/D-1857-2011; Peat, Thomas S/F-9817-2010; Chhabra, Sandeep/T-5468-2018; Collins, Brett/J-1563-2014; Simpson, Jamie/ABC-7083-2020; chhabra, sandeep/R-9942-2017	Simpson, Jamie S/0000-0002-8894-422X; Macreadie, Ian G/0000-0001-5335-7220; Macreadie, Ian/0000-0001-5335-7220; Newman, Janet M/0000-0003-2666-3219; Peat, Thomas S/0000-0002-6488-0831; Chhabra, Sandeep/0000-0002-5225-1333; Collins, Brett/0000-0002-6070-3774; Simpson, Jamie/0000-0002-8894-422X; DOLEZAL, OLAN/0000-0002-5823-6978	Australian Research Council [FT100100027]	Australian Research Council(Australian Research Council)	Brett Collins is supported by an Australian Research Council Future Fellowship (FT100100027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra M, 2004, ANN PHARMACOTHER, V38, P338, DOI 10.1345/aph.1D156; [Anonymous], 2011, LIGPREP VERS 2 3; [Anonymous], 2005, ROCS VERS 2 1 1; Bagby S, 1997, J BIOMOL NMR, V10, P279, DOI 10.1023/A:1018359305544; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bax A, 2003, PROTEIN SCI, V12, P1, DOI 10.1110/ps.0233303; BEAVO JA, 1970, MOL PHARMACOL, V6, P597; Bermingham A, 2002, BIOESSAYS, V24, P637, DOI 10.1002/bies.10114; Bermingham A, 2000, J BIOL CHEM, V275, P17962, DOI 10.1074/jbc.M000331200; Besier S, 2008, J CLIN MICROBIOL, V46, P3829, DOI 10.1128/JCM.01440-08; Black MT, 2005, ADV DRUG DELIVER REV, V57, P1528, DOI 10.1016/j.addr.2005.04.006; Blaszczyk J, 2004, STRUCTURE, V12, P467, DOI 10.1016/j.str.2004.02.003; Blaszczyk J, 2004, BIOCHEMISTRY-US, V43, P1469, DOI 10.1021/bi036053l; Blaszczyk J, 2003, BIOCHEMISTRY-US, V42, P1573, DOI 10.1021/bi0267994; Blaszczyk J, 2000, STRUCTURE, V8, P1049, DOI 10.1016/S0969-2126(00)00502-5; Blaszczyk J, 2007, ACTA CRYSTALLOGR D, V63, P1169, DOI 10.1107/S0907444907047452; Chhabra S, 2010, ACTA CRYSTALLOGR F, V66, P575, DOI 10.1107/S1744309110010857; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derrick JR, 2008, VITAM HORM, V79, P411, DOI 10.1016/S0083-6729(08)00415-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Frey KM, 2009, J MOL BIOL, V387, P1298, DOI 10.1016/j.jmb.2009.02.045; Garcon A, 2006, J MOL BIOL, V360, P644, DOI 10.1016/j.jmb.2006.05.038; Gibson CL, 2009, ORG BIOMOL CHEM, V7, P1829, DOI 10.1039/b818339b; Goddard T., 2001, SPARKY; GOODMAN MG, 1983, J IMMUNOL, V130, P551; Hennig M, 1999, J MOL BIOL, V287, P211, DOI 10.1006/jmbi.1999.2623; Hevener KE, 2010, J MED CHEM, V53, P166, DOI 10.1021/jm900861d; Hidron AI, 2009, LANCET INFECT DIS, V9, P384, DOI 10.1016/S1473-3099(09)70133-1; Huber W, 2005, J MOL RECOGNIT, V18, P273, DOI 10.1002/jmr.744; Kalra Sukirti, 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-8; Katsamba P, 2009, P NATL ACAD SCI USA, V106, P11594, DOI 10.1073/pnas.0905349106; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawrence MC, 2005, J MOL BIOL, V348, P655, DOI 10.1016/j.jmb.2005.03.021; Lescop E, 2009, BIOCHEMISTRY-US, V48, P302, DOI 10.1021/bi8016262; Li GY, 2006, BIOCHEMISTRY-US, V45, P12573, DOI 10.1021/bi061057m; Li Y, 2002, BIOCHEMISTRY-US, V41, P8777, DOI 10.1021/bi025968h; Lipsitz RS, 2004, ANNU REV BIOPH BIOM, V33, P387, DOI 10.1146/annurev.biophys.33.110502.140306; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; MICHAEL MA, 1993, J MED CHEM, V36, P3431, DOI 10.1021/jm00074a025; MILLER RL, 1972, BIOCHEMISTRY-US, V11, P4723, DOI 10.1021/bi00775a014; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myszka DG, 1997, BIOPHYS CHEM, V64, P127, DOI 10.1016/S0301-4622(96)02230-2; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Papalia G, 2010, ANAL BIOCHEM, V403, P30, DOI 10.1016/j.ab.2010.03.044; Pemble CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014165; Proctor RA, 2008, CLIN INFECT DIS, V46, P584, DOI 10.1086/525536; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Rush TS, 2005, J MED CHEM, V48, P1489, DOI 10.1021/jm040163o; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Shi GB, 2000, BBA-PROTEIN STRUCT M, V1478, P289, DOI 10.1016/S0167-4838(00)00043-1; Shi GB, 2001, J MED CHEM, V44, P1364, DOI 10.1021/jm0004493; Stammers DK, 1999, FEBS LETT, V456, P49, DOI 10.1016/S0014-5793(99)00860-1; STOECKLER JD, 1982, BIOCHEM PHARMACOL, V31, P163, DOI 10.1016/0006-2952(82)90206-4; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Swarbrick J., 2008, OPEN ENZYM INHIB J, V1, P12, DOI [10.2174/1874940200801010012, DOI 10.2174/1874940200801010012]; Swarbrick JD, 2005, J BIOL CHEM, V280, P8471, DOI 10.1074/jbc.M412318200; TALARICO TL, 1991, J BACTERIOL, V173, P7029, DOI 10.1128/jb.173.21.7029-7032.1991; Talluri S, 1996, J MAGN RESON SER B, V112, P200, DOI 10.1006/jmrb.1996.0132; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Xiao B, 1999, STRUCTURE, V7, P489, DOI 10.1016/S0969-2126(99)80065-3; Zander J, 2010, ANTIMICROB AGENTS CH, V54, P1226, DOI 10.1128/AAC.00705-09; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	71	21	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29444	10.1371/journal.pone.0029444	http://dx.doi.org/10.1371/journal.pone.0029444			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276115	gold, Green Published, Green Submitted			2022-12-27	WOS:000301457200013
J	Haeri, M; Knox, BE				Haeri, Mohammad; Knox, Barry E.			Rhodopsin Mutant P23H Destabilizes Rod Photoreceptor Disk Membranes	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; OUTER SEGMENT MEMBRANES; TRANSGENE EXPRESSION; MODEL; PROTEIN; CELLS; DEGENERATION; DEATH; MICE; RAT	Mutations in rhodopsin cause retinitis pigmentosa in humans and retinal degeneration in a multitude of other animals. We utilized high-resolution live imaging of the large rod photoreceptors from transgenic frogs (Xenopus) to compare the properties of fluorescently tagged rhodopsin, Rho-EGFP, and Rho(P23H)-EGFP. The mutant was abnormally distributed both in the inner and outer segments (OS), accumulating in the OS to a concentration of similar to 0.1% compared to endogenous opsin. Rho(P23H)-EGFP formed dense fluorescent foci, with concentrations of mutant protein up to ten times higher than other regions. Wild-type transgenic Rho-EGFP did not concentrate in OS foci when co-expressed in the same rod with Rho P23H EGFP. Outer segment regions containing fluorescent foci were refractory to fluorescence recovery after photobleaching, while foci in the inner segment exhibited recovery kinetics similar to OS regions without foci and Rho-EGFP. The Rho P23H EGFP foci were often in older, more distal OS disks. Electron micrographs of OS revealed abnormal disk membranes, with the regular disk bilayers broken into vesiculotubular structures. Furthermore, we observed similar OS disturbances in transgenic mice expressing Rho(P23H), suggesting such structures are a general consequence of mutant expression. Together these results show that mutant opsin disrupts OS disks, destabilizing the outer segment possibly via the formation of aggregates. This may render rods susceptible to mechanical injury or compromise OS function, contributing to photoreceptor loss.	[Haeri, Mohammad] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Ctr Vis Res, Syracuse, NY USA; SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Ctr Vis Res, Syracuse, NY USA; SUNY Upstate Med Univ, Dept Ophthalmol, Ctr Vis Res, Syracuse, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Haeri, M (corresponding author), SUNY Upstate Med Univ, Dept Neurosci & Physiol, Ctr Vis Res, Syracuse, NY USA.	knoxb@upstate.edu			National Institutes of Health [EY-11256, EY-12975]; Research to Prevent Blindness (Unrestricted Grant to State University of New York; Upstate Medical University, Department of Ophthalmology; Fight For Sight, and Lions of Central New York; NATIONAL EYE INSTITUTE [R01EY012975, R01EY011256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (Unrestricted Grant to State University of New York(Research to Prevent Blindness (RPB)); Upstate Medical University, Department of Ophthalmology; Fight For Sight, and Lions of Central New York; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health Grants EY-11256 and EY-12975 (to BEK), Research to Prevent Blindness (Unrestricted Grant to State University of New York, Upstate Medical University, Department of Ophthalmology), Fight For Sight, and Lions of Central New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batni S, 1996, J BIOL CHEM, V271, P3179, DOI 10.1074/jbc.271.6.3179; Batni S, 2000, METHOD ENZYMOL, V316, P50; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Besharse JC, 1979, LIGHT MEMBRANE BIOGE, P409; Calvert PD, 2010, J GEN PHYSIOL, V135, P173, DOI 10.1085/jgp.200910322; Dillin A, 2011, PHILOS T R SOC B, V366, P94, DOI 10.1098/rstb.2010.0271; Dowling J, 1961, STRUCTURE EYE, P85; Frederick JM, 2001, INVEST OPHTH VIS SCI, V42, P826; Galy A, 2005, HUM MOL GENET, V14, P2547, DOI 10.1093/hmg/ddi258; Haeri M, 2011, METHODS MOL IN PRESS; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Knox BE, 1998, FEBS LETT, V423, P117, DOI 10.1016/S0014-5793(98)00018-0; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Mani SS, 2001, J BIOL CHEM, V276, P36557, DOI 10.1074/jbc.M101685200; McKibbin C, 2007, J MOL BIOL, V374, P1309, DOI 10.1016/j.jmb.2007.10.013; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Moritz OL, 2001, J BIOL CHEM, V276, P28242, DOI 10.1074/jbc.M101476200; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; Noorwez SM, 2004, J BIOL CHEM, V279, P16278, DOI 10.1074/jbc.M312101200; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Peet JA, 2004, J CELL SCI, V117, P3049, DOI 10.1242/jcs.01167; Petters RM, 1997, NAT BIOTECHNOL, V15, P965, DOI 10.1038/nbt1097-965; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; Saliba RS, 2002, J CELL SCI, V115, P2907; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Sullivan LS, 2002, INVEST OPHTH VIS SCI, V47, P3052; Tam BM, 2006, INVEST OPHTH VIS SCI, V47, P3234, DOI 10.1167/iovs.06-0213; ULSHAFER RJ, 1986, INVEST OPHTH VIS SCI, V27, P1587; Whitaker SL, 2004, J BIOL CHEM, V279, P49010, DOI 10.1074/jbc.M406080200	34	51	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30101	10.1371/journal.pone.0030101	http://dx.doi.org/10.1371/journal.pone.0030101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276148	Green Published, Green Submitted, gold			2022-12-27	WOS:000301457200033
J	Ostroumova, OS; Efimova, SS; Schagina, LV				Ostroumova, Olga S.; Efimova, Svetlana S.; Schagina, Ludmila V.			Probing Amphotericin B Single Channel Activity by Membrane Dipole Modifiers	PLOS ONE			English	Article							LIPID-BILAYER MEMBRANES; POLYENE ANTIBIOTICS; MOLECULAR-DYNAMICS; H-2 NMR; CHOLESTEROL; PHLORETIN; PERMEABILITY; MODULATION; GRAMICIDIN; STEROL	The effects of dipole modifiers and their structural analogs on the single channel activity of amphotericin B in sterol-containing planar phosphocholine membranes are studied. It is shown that the addition of phloretin in solutions bathing membranes containing cholesterol or ergosterol decreases the conductance of single amphotericin B channels. Quercetin decreases the channel conductance in cholesterol-containing bilayers while it does not affect the channel conductance in ergosterol-containing membranes. It is demonstrated that the insertion of styryl dyes, such as RH 421, RH 237 or RH 160, in bilayers with either cholesterol or ergosterol leads to the increase of the current amplitude of amphotericin B pores. Introduction of 5a-androstan-3b-ol into a membrane-forming solution increases the amphotericin B channel conductance in a concentration-dependent manner. All the effects are likely to be attributed to the influence of the membrane dipole potential on the conductance of single amphotericin B channels. However, specific interactions of some dipole modifiers with polyene-sterol complexes might also contribute to the activity of single amphotericin B pores. It has been shown that the channel dwell time increases with increasing sterol concentration, and it is higher for cholesterol-containing membranes than for bilayers including ergosterol, 6-ketocholestanol, 7-ketocholestanol or 5a-androstan-3b-ol. These findings suggest that the processes of association/dissociation of channel forming molecules depend on the membrane fluidity.	[Ostroumova, Olga S.; Efimova, Svetlana S.; Schagina, Ludmila V.] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Ostroumova, OS (corresponding author), Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia.	ostroumova@mail.cytspb.rssi.ru	Efimova, Svetlana S./I-8716-2014; Ostroumova, Olga S./N-8636-2013	Efimova, Svetlana S./0000-0002-2429-2007; Ostroumova, Olga/0000-0002-7312-4579	Russian Foundation for Basic Research [09-04-00883]; Russian State Contract [P1372]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian State Contract	This work was partly supported by: the Russian Foundation for Basic Research (no. 09-04-00883) http://www.rfbr.ru/rffi/ru/; SS-3796.2010.4 http://www.extech.ru;the program "Molecular and Cell Biology" of the Russian Academy of Sciences http://www.molbiol.edu.ru; the Russian State Contract #P1372 (MES, FTP,, SSEPIR..) http://www.kadryedu.ru. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN OS, 1976, J GEN PHYSIOL, V67, P749, DOI 10.1085/jgp.67.6.749; ANDREOLI TE, 1974, ANN NY ACAD SCI, V235, P448, DOI 10.1111/j.1749-6632.1974.tb43283.x; Asandei A, 2008, COLLOID SURFACE B, V67, P99, DOI 10.1016/j.colsurfb.2008.08.006; Asawakarn T, 2001, J BIOL CHEM, V276, P38457, DOI 10.1074/jbc.M103269200; Baran M, 2009, BIOPHYS CHEM, V141, P162, DOI 10.1016/j.bpc.2009.01.010; BORISOVA MP, 1986, J MEMBRANE BIOL, V90, P13, DOI 10.1007/BF01869681; BROCKMAN H, 1994, CHEM PHYS LIPIDS, V73, P57, DOI 10.1016/0009-3084(94)90174-0; Busath DD, 1998, BIOPHYS J, V75, P2830, DOI 10.1016/S0006-3495(98)77726-4; Buzon V, 2006, BIOCHEMISTRY-US, V45, P15768, DOI 10.1021/bi060622i; Cladera J, 2003, J PHARM SCI, V92, P1018, DOI 10.1002/jps.10344; CRAVEN PC, 1985, ANTIMICROB AGENTS CH, V27, P868, DOI 10.1128/AAC.27.5.868; Cseh R, 2000, EUR BIOPHYS J BIOPHY, V29, P172, DOI 10.1007/s002490000082; Czub J, 2006, J PHYS CHEM B, V110, P16743, DOI 10.1021/jp061916g; DEKRUIJFF B, 1974, BIOCHIM BIOPHYS ACTA, V339, P30, DOI 10.1016/0005-2736(74)90330-7; Duffin RL, 2003, LANGMUIR, V19, P1439, DOI 10.1021/la025892q; Gabrielska J, 2006, FEBS LETT, V580, P2677, DOI 10.1016/j.febslet.2006.04.021; GAWRISCH K, 1992, BIOPHYS J, V61, P1213, DOI 10.1016/S0006-3495(92)81931-8; HSUCHEN CC, 1973, ANTIMICROB AGENTS CH, V4, P309, DOI 10.1128/AAC.4.3.309; JORDAN PC, 1983, BIOPHYS J, V41, P189, DOI 10.1016/S0006-3495(83)84419-1; Luchian T, 2006, LANGMUIR, V22, P8452, DOI 10.1021/la0613777; Malev VV, 2002, BIOPHYS J, V82, P1985, DOI 10.1016/S0006-3495(02)75547-1; Malkov DY, 1996, BBA-BIOMEMBRANES, V1278, P197, DOI 10.1016/0005-2736(95)00197-2; MARTY A, 1975, J GEN PHYSIOL, V65, P515, DOI 10.1085/jgp.65.4.515; Matsumori N, 2009, J AM CHEM SOC, V131, P11855, DOI 10.1021/ja9033473; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; Neumann A, 2010, J AM CHEM SOC, V132, P18266, DOI 10.1021/ja1074344; Neumann A, 2009, J PHYS CHEM B, V113, P15875, DOI 10.1021/jp905133f; Ostroumova OS, 2007, LANGMUIR, V23, P6889, DOI 10.1021/la7005452; Ostroumova OS, 2011, BBA-BIOMEMBRANES, V1808, P2051, DOI 10.1016/j.bbamem.2011.04.005; Ostroumova OS, 2010, LANGMUIR, V26, P15092, DOI 10.1021/la102691y; Paquet MJ, 2002, CHEM PHYS LIPIDS, V119, P1, DOI 10.1016/S0009-3084(02)00071-3; Passechnik VI, 2002, BIOELECTROCHEMISTRY, V55, P47, DOI 10.1016/S1567-5394(01)00167-0; REYES J, 1983, J MEMBRANE BIOL, V72, P93, DOI 10.1007/BF01870317; Rog T, 2009, BBA-BIOMEMBRANES, V1788, P97, DOI 10.1016/j.bbamem.2008.08.022; Rokitskaya TI, 1997, BIOPHYS J, V73, P850, DOI 10.1016/S0006-3495(97)78117-7; Severina II, 2001, IUBMB LIFE, V52, P321, DOI 10.1080/152165401317291183; Shigemi A, 2011, INT J ANTIM IN PRESS, P30; SHINITZKY M, 1976, BIOCHIM BIOPHYS ACTA, V433, P133, DOI 10.1016/0005-2736(76)90183-8; Smondyrev AM, 2001, CHEM PHYS LIPIDS, V112, P31, DOI 10.1016/S0009-3084(01)00160-8; Starke-Peterkovic T, 2006, BIOPHYS J, V90, P4060, DOI 10.1529/biophysj.105.074666; THEWALT JL, 1992, BIOPHYS J, V63, P1176, DOI 10.1016/S0006-3495(92)81681-8; Venegas B, 2003, BIOPHYS J, V85, P2323, DOI 10.1016/S0006-3495(03)74656-6; ZHENG C, 1992, BIOPHYS J, V63, P935, DOI 10.1016/S0006-3495(92)81673-9	44	31	38	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30261	10.1371/journal.pone.0030261	http://dx.doi.org/10.1371/journal.pone.0030261			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276169	Green Published, gold, Green Submitted			2022-12-27	WOS:000301457200049
J	Walker, BK				Walker, Brian K.			Spatial Analyses of Benthic Habitats to Define Coral Reef Ecosystem Regions and Potential Biogeographic Boundaries along a Latitudinal Gradient	PLOS ONE			English	Article							SOUTHEAST FLORIDA; SPECIES-RICHNESS; ACROPORA-CERVICORNIS; BROWARD COUNTY; NEARSHORE HARDBOTTOM; GEOGRAPHICAL RANGE; BISCAYNE BAY; MARINE; SEAGRASS; FISH	Marine organism diversity typically attenuates latitudinally from tropical to colder climate regimes. Since the distribution of many marine species relates to certain habitats and depth regimes, mapping data provide valuable information in the absence of detailed ecological data that can be used to identify and spatially quantify smaller scale (10 s km) coral reef ecosystem regions and potential physical biogeographic barriers. This study focused on the southeast Florida coast due to a recognized, but understudied, tropical to subtropical biogeographic gradient. GIS spatial analyses were conducted on recent, accurate, shallow-water (0-30 m) benthic habitat maps to identify and quantify specific regions along the coast that were statistically distinct in the number and amount of major benthic habitat types. Habitat type and width were measured for 209 evenly-spaced cross-shelf transects. Evaluation of groupings from a cluster analysis at 75% similarity yielded five distinct regions. The number of benthic habitats and their area, width, distance from shore, distance from each other, and LIDAR depths were calculated in GIS and examined to determine regional statistical differences. The number of benthic habitats decreased with increasing latitude from 9 in the south to 4 in the north and many of the habitat metrics statistically differed between regions. Three potential biogeographic barriers were found at the Boca, Hillsboro, and Biscayne boundaries, where specific shallow-water habitats were absent further north; Middle Reef, Inner Reef, and oceanic seagrass beds respectively. The Bahamas Fault Zone boundary was also noted where changes in coastal morphologies occurred that could relate to subtle ecological changes. The analyses defined regions on a smaller scale more appropriate to regional management decisions, hence strengthening marine conservation planning with an objective, scientific foundation for decision making. They provide a framework for similar regional analyses elsewhere.	Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA	Nova Southeastern University	Walker, BK (corresponding author), Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA.	walkerb@nova.edu			National Oceanic and Atmospheric Administration [NA03NOS4260046]	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	This manuscript is a result of research partially funded by the National Oceanic and Atmospheric Administration Coastal Ocean Program under award NA03NOS4260046 to Nova Southeastern University for the National Coral Reef Institute (NCRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2009, CLIMATE CHANGE IMPAC, DOI DOI 10.1111/j.1365-2664.2010.01827.x; Ashton Kyle G., 2001, Diversity and Distributions, V7, P289, DOI 10.1046/j.1366-9516.2001.00115.x; Austin DF, 1981, SPANISH RIVER PAPERS, V9, P11; Banks KW, 2007, CORAL REEFS, V26, P617, DOI 10.1007/s00338-007-0231-0; Banks KW, 2008, REEF TRACT CONTINENT, P175; Baron RM, 2004, ESTUAR COAST SHELF S, V60, P431, DOI 10.1016/j.ecss.2004.02.002; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; Brock JC, 2008, CORAL REEFS, V27, P555, DOI 10.1007/s00338-008-0370-y; Brock JC, 2009, J COASTAL RES, V25, P1, DOI [10.2112/SI53-001.1, 10.2112/S153-001.1]; CALDER DR, 1992, CAN J ZOOL, V70, P1078, DOI 10.1139/z92-151; Cantillo A.Y., 2000, BISCAYNE BAY ENV HIS; Chardon R, 1982, CARTOGR GEOGR INF SC, V9, P47; CHARDON RE, 1978, GEOLOGY, V6, P333, DOI 10.1130/0091-7613(1978)6<333:CBCBBA>2.0.CO;2; Chown SL, 2000, TRENDS ECOL EVOL, V15, P311, DOI 10.1016/S0169-5347(00)01910-8; Costa BM, 2009, REMOTE SENS ENVIRON, V113, P1082, DOI 10.1016/j.rse.2009.01.015; CSA International Inc, 2009, EC FUNCT NEARSH HARD; Dahdouh-Guebas Farid, 2002, Environment Development and Sustainability, V4, P93, DOI 10.1023/A:1020887204285; DAWES CJ, 1995, B MAR SCI, V57, P59; Dodge RE, 1987, GROWTH RATE STONY CO; Engle VD, 1999, J BIOGEOGR, V26, P1007, DOI 10.1046/j.1365-2699.1999.00341.x; Finkl CW, 2008, J COASTAL RES, V24, P823, DOI 10.2112/08A-0001.1; Foster G, 2009, J COASTAL RES, V25, P16, DOI [10.2112/SI53-003.1, 10.2112/S153-003.1]; FRANCE R, 1992, AM NAT, V139, P342, DOI 10.1086/285330; Fraser RH, 1996, AM NAT, V148, P138, DOI 10.1086/285915; Gilliam DS, 2007, SE FLORIDA CORAL REE; GILMORE MD, 1976, J SEDIMENT PETROL, V46, P519; Ginsburg N. R., 1953, J SEDIMENT PETROL, V23, P85, DOI DOI 10.1306/D4269558-2B26-11D7-8648000102C1865D; Grober-Dunsmore R, 2007, CORAL REEFS, V26, P201, DOI 10.1007/s00338-006-0180-z; Hayden BP, 1976, J BIOGEOGR, V3, P71, DOI DOI 10.2307/3038100; HECK KL, 1979, J BIOGEOGR, V6, P183, DOI 10.2307/3038051; Herren L, 2004, 2 FLOR DEP ENV PROT; HUMM HAROLD J., 1964, BULL MAR SCI GULF CARIBBEAN, V14, P306; HUTCHINS LW, 1947, ECOL MONOGR, V17, P325, DOI 10.2307/1948663; International Hydrographic Organization, 1998, INT HYDR ORG SPEC PU; Jordan L.K.B, 2006, P 10 INT COR REEF S, P1391; Kendall MS, 2008, MAR GEOD, V31, P75, DOI 10.1080/01490410802053617; Kiessling W, 2001, GEOLOGY, V29, P751, DOI 10.1130/0091-7613(2001)029<0751:PSOPR>2.0.CO;2; Kleypas Joan A., 2007, V192, P386; LIDZ BH, 1991, J COASTAL RES, V7, P203; LIGHTY RG, 1978, NATURE, V276, P59, DOI 10.1038/276059a0; Lindeman KC, 1999, FISH B-NOAA, V97, P508; Lirman D, 2003, ESTUARIES, V26, P131, DOI 10.1007/BF02691700; Locarnini R. A., 2006, NOAA ATLAS NESDIS, V61, P182; Lourie SA, 2004, CONSERV BIOL, V18, P1004, DOI 10.1111/j.1523-1739.2004.00137.x; Lugo AE, 1999, J BIOGEOGR, V26, P1025, DOI 10.1046/j.1365-2699.1999.00329.x; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; Moyer RP, 2003, CORAL REEFS, V22, P447, DOI 10.1007/s00338-003-0334-1; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; National Oceanographic Data Center, 2009, COAST WAT TEMP TABL; ODUM HT, 1957, LIMNOL OCEANOGR, V2, P85, DOI 10.4319/lo.1957.2.2.0085; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pielou E.C., 1979, BIOGEOGRAPHY; Pittman SJ, 2007, ECOL MODEL, V204, P9, DOI 10.1016/j.ecolmodel.2006.12.017; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; RAPOPORT EH, 1994, PHILOS T ROY SOC B, V343, P71, DOI 10.1098/rstb.1994.0009; Richardson LL, 2006, RE S D I PR, V9, P1, DOI 10.1007/1-4020-3968-9_1; Riegl B, 2005, DEV GIS MAPS SE FLOR; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; THORHAUG A, 1981, AMBIO, V10, P295; Valentine JW, 2008, PALEOBIOLOGY, V34, P169, DOI 10.1666/0094-8373(2008)034[0169:IDALG]2.0.CO;2; Vargas-Angel B, 2006, CORAL REEFS, V25, P110, DOI 10.1007/s00338-005-0070-9; Vargas-Angel B, 2003, CORAL REEFS, V22, P465, DOI 10.1007/s00338-003-0336-z; Veron J.E.N, 1995, CORAL SPACE TIME BIO; VOSS GILBERT L., 1955, BULL MARINE SCI GULF AND CARIBBEAN, V5, P203; Walker BK, 2002, 3D VISUALIZATION COR; Walker BK, 2009, RM069 DEP; Walker BK, 2008, J COASTAL RES, V24, P1138, DOI 10.2112/06-0809.1; Walker BK, 2009, J COASTAL RES, V25, P39, DOI [10.2112/S153-005.1, 10.2112/SI53-005.1]; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474	71	29	29	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30466	10.1371/journal.pone.0030466	http://dx.doi.org/10.1371/journal.pone.0030466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276204	Green Published, gold, Green Submitted			2022-12-27	WOS:000301457200065
J	Saha, DJ; Morasso, P				Saha, Devjani J.; Morasso, Pietro			Stabilization Strategies for Unstable Dynamics	PLOS ONE			English	Article							HUMAN MULTIJOINT ARM; END-POINT STIFFNESS; INVERTED PENDULUM; POSTURAL CONTROL; ADAPTIVE-CONTROL; FEEDBACK-CONTROL; CONTROL MODEL; IMPEDANCE; COORDINATION; INSTABILITY	Background: When humans are faced with an unstable task, two different stabilization mechanisms are possible: a high-stiffness strategy, based on the inherent elastic properties of muscles/tools/manipulated objects, or a low-stiffness strategy, based on an explicit positional feedback mechanism. Specific constraints related to the dynamics of the task and/or the neuromuscular system often force people to adopt one of these two strategies. Methodology/Findings: This experiment was designed such that subjects could achieve stability using either strategy, with a marked difference in terms of effort and control requirements between the two strategies. The task was to balance a virtual mass in an unstable environment via two elastic linkages that connected the mass to each hand. The dynamics of the mass under the influence of the unstable force field and the forces applied through the linkages were simulated using a bimanual, planar robot. The two linkages were non-linear, with a stiffness that increased with the amount of stretch. The mass could be stabilized by stretching the linkages to achieve a stiffness that was greater than the instability coefficient of the unstable field (high-stiffness), or by balancing the mass with sequences of small force impulses (low-stiffness). The results showed that 62% of the subjects quickly adopted the high-stiffness strategy, with stiffness ellipses that were aligned along the direction of instability. The remaining subjects applied the low-stiffness strategy, with no clear preference for the orientation of the stiffness ellipse. Conclusions: The choice of a strategy was based on the bimanual coordination of the hands: high-stiffness subjects achieved stability quickly by separating the hands to stretch the linkages, while the low-stiffness subjects kept the hands close together and took longer to achieve stability but with lower effort. We suggest that the existence of multiple solutions leads to different types of skilled behavior in unstable environments.	[Saha, Devjani J.] Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA; [Saha, Devjani J.; Morasso, Pietro] IIT, Robot Brain & Cognit Sci RBCS Dept, Genoa, Italy; [Morasso, Pietro] Univ Genoa, DIST, Genoa, Italy	Northwestern University; Istituto Italiano di Tecnologia - IIT; University of Genoa	Saha, DJ (corresponding author), Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA.	dsaha4@gmail.com			EU [ICT-231724]; Whitaker International Fellowship	EU(European Commission); Whitaker International Fellowship	This work was supported in part by the EU, under FP7 project HUMOUR (grant n. ICT-231724), and the Whitaker International Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006169; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; BROWN IL, 1997, REDUCTIONIST APPROAC, P148; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Casadio Maura, 2006, Technol Health Care, V14, P123; Darainy M, 2007, J NEUROPHYSIOL, V97, P2676, DOI 10.1152/jn.01081.2006; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Franklin DW, 2003, EXP BRAIN RES, V152, P211, DOI 10.1007/s00221-003-1540-3; Ganesh G, 2010, J NEUROPHYSIOL, V104, P382, DOI 10.1152/jn.01058.2009; Gomi H, 1998, J NEUROSCI, V18, P8965; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HOGAN N, 1984, IEEE T AUTOMAT CONTR, V29, P681, DOI 10.1109/TAC.1984.1103644; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; Lakie M, 2003, J PHYSIOL-LONDON, V551, P357, DOI 10.1113/jphysiol.2002.036939; Loram ID, 2007, J PHYSIOL-LONDON, V584, P677, DOI 10.1113/jphysiol.2007.140053; Loram ID, 2011, J PHYSIOL-LONDON, V589, P307, DOI 10.1113/jphysiol.2010.194712; Loram ID, 2005, J PHYSIOL-LONDON, V564, P295, DOI 10.1113/jphysiol.2004.076307; Loram ID, 2001, J PHYSIOL-LONDON, V532, P879, DOI 10.1111/j.1469-7793.2001.0879e.x; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Milner TE, 2002, EXP BRAIN RES, V143, P515, DOI 10.1007/s00221-002-1049-1; MILTON JG, 2008, EPL, V83; MUSSAIVALDI FA, 1985, J NEUROSCI, V5, P2732; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perreault EJ, 2002, J NEUROPHYSIOL, V87, P2808, DOI 10.1152/jn.2002.87.6.2808; Perreault EJ, 2008, J NEUROPHYSIOL, V99, P2101, DOI 10.1152/jn.01094.2007; Peterka RJ, 2000, BIOL CYBERN, V82, P335, DOI 10.1007/s004220050587; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; ZENZERI JMP, 2010, 33 ANN INT IEEE ENG	32	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30301	10.1371/journal.pone.0030301	http://dx.doi.org/10.1371/journal.pone.0030301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279580	Green Published, gold			2022-12-27	WOS:000299771900057
J	Vermeer, PD; Bell, M; Lee, K; Vermeer, D; Wieking, BG; Bilal, E; Bhanot, G; Drapkin, RI; Ganesan, S; Klingelhutz, AJ; Hendriks, WJ; Lee, J				Vermeer, Paola D.; Bell, Megan; Lee, Kimberly; Vermeer, DanielW.; Wieking, Byrant G.; Bilal, Erhan; Bhanot, Gyan; Drapkin, Ronny I.; Ganesan, Shridar; Klingelhutz, Aloysius J.; Hendriks, Wiljan J.; Lee, Johnh.			ErbB2, EphrinB1, Src Kinase and PTPN13 Signaling Complex Regulates MAP Kinase Signaling in Human Cancers	PLOS ONE			English	Article							HER-2 CODON-655 POLYMORPHISM; HUMAN-PAPILLOMAVIRUS TYPE-16; SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR GENE; HUMAN-BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; CLINICAL-IMPLICATIONS; TRANSMEMBRANE DOMAIN; INVASIVE GROWTH; EXPRESSION	In non-cancerous cells, phosphorylated proteins exist transiently, becoming de-phosphorylated by specific phosphatases that terminate propagation of signaling pathways. In cancers, compromised phosphatase activity and/or expression occur and contribute to tumor phenotype. The non-receptor phosphatase, PTPN13, has recently been dubbed a putative tumor suppressor. It decreased expression in breast cancer correlates with decreased overall survival. Here we show that PTPN13 regulates a new signaling complex in breast cancer consisting of ErbB2, Src, and EphrinB1. To our knowledge, this signaling complex has not been previously described. Co-immunoprecipitation and localization studies demonstrate that EphrinB1, a PTPN13 substrate, interacts with ErbB2. In addition, the oncogenic V660E ErbB2 mutation enhances this interaction, while Src kinase mediates EphrinB1 phosphorylation and subsequent MAP Kinase signaling. Decreased PTPN13 function further enhances signaling. The association of oncogene kinases (ErbB2, Src), a signaling transmembrane ligand (EphrinB1) and a phosphatase tumor suppressor (PTPN13) suggest that EphrinB1 may be a relevant therapeutic target in breast cancers harboring ErbB2-activating mutations and decreased PTPN13 expression.	[Vermeer, Paola D.; Bell, Megan; Lee, Kimberly; Vermeer, DanielW.; Wieking, Byrant G.; Lee, Johnh.] Sanford Res Univ S Dakota, Canc Biol Res Ctr, Sioux Falls, SD USA; [Bilal, Erhan] IBM Res Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY USA; [Bhanot, Gyan] Rutgers State Univ, Piscataway, NJ USA; [Drapkin, Ronny I.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Ganesan, Shridar] Canc Inst New Jersey, New Brunswick, NJ USA; [Klingelhutz, Aloysius J.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Hendriks, Wiljan J.] Raboud Univ Nijmegen Med Ctr, NCMLS, Cell Biol Lab, Nijmegen, Netherlands; [Lee, Johnh.] Sanford Hlth, Dept Otolaryngol Head & Neck Surg, Sioux Falls, SD USA	Sanford Health; International Business Machines (IBM); Rutgers State University New Brunswick; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; University of Iowa; Radboud University Nijmegen; Sanford Health	Vermeer, PD (corresponding author), Sanford Res Univ S Dakota, Canc Biol Res Ctr, Sioux Falls, SD USA.	John.Lee@SanfordHealth.org	Klingelhutz, Aloysius/L-9081-2018; Drapkin, Ronny/E-9944-2016	Klingelhutz, Aloysius/0000-0003-4258-5046; Hendriks, Wiljan/0000-0001-9481-8281; Drapkin, Ronny/0000-0002-6912-6977	National Institutes of Health/National Institute of Dental and Craniofacial Research [7R01DE018386-03]; State of South Dakota [3SB161]	National Institutes of Health/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); State of South Dakota	This work was supported by 7R01DE018386-03 from the National Institutes of Health/National Institute of Dental and Craniofacial Research and the State of South Dakota Translational Cancer sub-award 3SB161. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaan OD, 2008, CANCER METAST REV, V27, P205, DOI 10.1007/s10555-008-9114-2; Aguila B, 2007, BRIT J PHARMACOL, V152, P1312, DOI 10.1038/sj.bjp.0707497; Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Alexe G, 2007, CANCER RES, V67, P10669, DOI 10.1158/0008-5472.CAN-07-0539; Beevers AJ, 2010, BIOCHEMISTRY-US, V49, P2811, DOI 10.1021/bi902087v; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Chacon RD, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2574; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Dromard M, 2007, CANCER RES, V67, P6806, DOI 10.1158/0008-5472.CAN-07-0513; Erdmann KS, 2003, EUR J BIOCHEM, V270, P4789, DOI 10.1046/j.1432-1033.2003.03895.x; Fessler SP, 2009, BREAST CANCER RES TR, V118, P113, DOI 10.1007/s10549-009-0412-3; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; FOSTER SA, 1994, J VIROL, V68, P5698, DOI 10.1128/JVI.68.9.5698-5705.1994; Gajria D, 2011, EXPERT REV ANTICANC, V11, P263, DOI 10.1586/ERA.10.226; Gianni L, 2011, LANCET ONCOL, V12, P236, DOI 10.1016/S1470-2045(11)70033-X; Glondu-Lassis M, 2010, CANCER RES, V70, P5116, DOI 10.1158/0008-5472.CAN-09-4368; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Gutierrez C, 2011, ARCH PATHOL LAB MED, V135, P55, DOI 10.1043/2010-0454-RAR.1; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Hoover AC, 2009, ONCOGENE, V28, P3960, DOI 10.1038/onc.2009.251; Hoover AC, 2007, ARCH OTOLARYNGOL, V133, P495, DOI 10.1001/archotol.133.5.495; Jahanzeb M, 2008, CLIN BREAST CANCER, V8, P324, DOI 10.3816/CBC.2008.n.037; Kang Y, 1990, Nihon Geka Hokan, V59, P10; Kong L, 2011, MOL CELL BIOCHEM, V348, P11, DOI 10.1007/s11010-010-0632-1; Kruszyna L, 2010, CLIN BIOCHEM, V43, P545, DOI 10.1016/j.clinbiochem.2009.12.016; Lee HS, 2009, MOL BIOL CELL, V20, P124, DOI 10.1091/mbc.E08-06-0662; Lee SH, 2001, HUM PATHOL, V32, P250, DOI 10.1053/hupa.2001.22769; Makarov R, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-98; Marcotte R, 2009, MOL CELL BIOL, V29, P5858, DOI 10.1128/MCB.01731-08; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; MOSS DW, 1976, CLIN CHIM ACTA, V67, P169, DOI 10.1016/0009-8981(76)90256-4; Moyano JV, 2006, J CLIN INVEST, V116, P261, DOI 10.1172/JCI25888; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Niu JG, 2009, CARCINOGENESIS, V30, P2053, DOI 10.1093/carcin/bgp265; Oliveras-Ferraros C, 2008, INT J ONCOL, V33, P1165, DOI 10.3892/ijo_00000106; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Papadopoulou E, 2008, NEOPLASMA, V55, P113; Papadopoulou E, 2007, NEOPLASMA, V54, P365; Papadopoulou E, 2010, INT J BIOL MARKER, V25, P126, DOI 10.1177/172460081002500302; PAPEWALIS J, 1991, NUCLEIC ACIDS RES, V19, P5452, DOI 10.1093/nar/19.19.5452-a; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Revillion F, 2009, INT J CANCER, V124, P638, DOI 10.1002/ijc.23989; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Rothschild SI, 2010, CLIN LUNG CANCER, V11, P238, DOI 10.3816/CLC.2010.n.030; Saad F, 2010, CANCER TREAT REV, V36, P177, DOI 10.1016/j.ctrv.2009.11.005; Schenone S, 2010, EXPERT OPIN INV DRUG, V19, P931, DOI 10.1517/13543784.2010.499898; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Song RXD, 2007, ENDOCRINOLOGY, V148, P4091, DOI 10.1210/en.2007-0240; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spanos WC, 2008, J VIROL, V82, P2493, DOI 10.1128/JVI.02188-07; Spanos WC, 2009, ARCH OTOLARYNGOL, V135, P1137, DOI 10.1001/archoto.2009.159; Tanaka M, 2005, EMBO J, V24, P3700, DOI 10.1038/sj.emboj.7600831; Ueda M, 2006, INT J GYNECOL CANCER, V16, P325, DOI 10.1111/j.1525-1438.2006.00349.x; Vogel CL, 2001, ONCOLOGY-BASEL, V61, P37, DOI 10.1159/000055400; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Wu CH, 2009, ORAL ONCOL, V45, P579, DOI 10.1016/j.oraloncology.2008.07.018; Xie DW, 2000, J NATL CANCER I, V92, P412, DOI 10.1093/jnci/92.5.412; Xu Z, 2003, J BIOL CHEM, V278, P24767, DOI 10.1074/jbc.M302454200; Yeh SH, 2006, CLIN CANCER RES, V12, P1097, DOI 10.1158/1078-0432.CCR-05-1383; Yehiely F, 2006, TRENDS MOL MED, V12, P537, DOI 10.1016/j.molmed.2006.09.004; Zubor P, 2006, NEOPLASMA, V53, P49	67	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30447	10.1371/journal.pone.0030447	http://dx.doi.org/10.1371/journal.pone.0030447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279592	gold, Green Published			2022-12-27	WOS:000299771900069
J	Wallis, RS; Jakubiec, W; Mitton-Fry, M; Ladutko, L; Campbell, S; Paige, D; Silvia, A; Miller, PF				Wallis, Robert S.; Jakubiec, Wesley; Mitton-Fry, Mark; Ladutko, Lynn; Campbell, Sheldon; Paige, Darcy; Silvia, Annette; Miller, Paul F.			Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide	PLOS ONE			English	Article							BACTERICIDAL ACTIVITY; MYCOBACTERIUM-TUBERCULOSIS; DIARYLQUINOLINE TMC207; MULTIDRUG-RESISTANT; MURINE MODEL; PHARMACOKINETICS; TOLERANCE; IMMUNITY	There presently is no rapid method to assess the bactericidal activity of new regimens for tuberculosis. This study examined PNU-100480, TMC207, PA-824, SQ109, and pyrazinamide, singly and in various combinations, against intracellular M. tuberculosis, using whole blood culture (WBA). The addition of 1,25-dihydroxy vitamin D facilitated detection of the activity of TMC207 in the 3-day cultures. Pyrazinamide failed to show significant activity against a PZA-resistant strain (M. bovis BCG), and was not further considered. Low, mid, and high therapeutic concentrations of each remaining drug were tested individually and in a paired checkerboard fashion. Observed bactericidal activity was compared to that predicted by the sum of the effects of individual drugs. Combinations of PNU-100480, TMC207, and SQ109 were fully additive, whereas those including PA-824 were less than additive or antagonistic. The cumulative activities of 2, 3, and 4 drug combinations were predicted based on the observed concentration-activity relationship, published pharmacokinetic data, and, for PNU-100480, published WBA data after oral dosing. The most active regimens, including PNU-100480, TMC207, and SQ109, were predicted to have cumulative activity comparable to standard TB therapy. Further testing of regimens including these compounds is warranted. Measurement of whole blood bactericidal activity can accelerate the development of novel TB regimens.	[Wallis, Robert S.; Mitton-Fry, Mark; Paige, Darcy; Silvia, Annette; Miller, Paul F.] Pfizer Inc, Groton, CT 06340 USA; [Jakubiec, Wesley; Ladutko, Lynn; Campbell, Sheldon] VA Connecticut Healthcare, West Haven, CT USA; [Campbell, Sheldon] Yale Univ, New Haven, CT USA	Pfizer; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Wallis, RS (corresponding author), Pfizer Inc, Groton, CT 06340 USA.	robert.wallis@pfizer.com	Wallis, Robert S/A-8018-2009	Wallis, Robert S/0000-0001-6152-5183; Mitton-Fry, Mark/0000-0002-6715-8836; Jakubiec, Wesley M./0000-0002-5927-8424	Pfizer	Pfizer(Pfizer)	The study was supported by Pfizer, of which some authors are employees and shareholders. All authors jointly undertook study design, data collection, analysis, decision to publish, and preparation of the manuscript.	Ahmad Z, 2011, ANTIMICROB AGENTS CH, V55, P239, DOI 10.1128/AAC.00849-10; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Andries K, 2010, ANTIMICROB AGENTS CH, V54, P4540, DOI 10.1128/AAC.00934-10; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Cheon SH, 2002, CLIN DIAGN LAB IMMUN, V9, P901, DOI 10.1128/CDLI.9.4.901-907.2002; Dhillon J, 2010, TUBERCULOSIS, V90, P301, DOI 10.1016/j.tube.2010.07.004; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Ginsberg AM, 2009, ANTIMICROB AGENTS CH, V53, P3720, DOI 10.1128/AAC.00106-09; HAXAIRETHEEUWES, 2011, UN WORLD C LUNG HLTH, V42; Hu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020958; Janulionis E, 2005, INFECT IMMUN, V73, P2595, DOI 10.1128/IAI.73.5.2595-2601.2005; Janulionis E, 2004, ANTIMICROB AGENTS CH, V48, P3133, DOI 10.1128/AAC.48.8.3133-3135.2004; Jia L, 2006, BRIT J PHARMACOL, V147, P476, DOI 10.1038/sj.bjp.0706650; KIM KS, 1987, J ANTIMICROB CHEMOTH, V19, P475, DOI 10.1093/jac/19.4.475; Koul A, 2008, J BIOL CHEM, V283, P25273, DOI 10.1074/jbc.M803899200; Manjunatha Ujjini, 2009, Commun Integr Biol, V2, P215; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; Mendez S, 2009, ANTIMICROB AGENTS CH, V53, P5114, DOI 10.1128/AAC.01146-09; Reddy VM, 2010, ANTIMICROB AGENTS CH, V54, P2840, DOI 10.1128/AAC.01601-09; Rustomjee R, 2008, ANTIMICROB AGENTS CH, V52, P2831, DOI 10.1128/AAC.01204-07; Scorpio A, 1997, J CLIN MICROBIOL, V35, P106, DOI 10.1128/JCM.35.1.106-110.1997; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Tam VH, 2004, ANTIMICROB AGENTS CH, V48, P4315, DOI 10.1128/AAC.48.11.4315-4321.2004; TASNEEN R, 2011, ANTIMICROB AGENTS CH; TUOMANEN E, 1986, REV INFECT DIS, V8, pS279; Veziris N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017556; Wallis RS, 2011, ANTIMICROB AGENTS CH, V55, P567, DOI 10.1128/AAC.01179-10; Wallis RS, 2003, J INFECT DIS, V187, P270, DOI 10.1086/346053; Wallis RS, 2001, J INFECT DIS, V183, P1300, DOI 10.1086/319679; Wallis RS, 1999, ANTIMICROB AGENTS CH, V43, P2600, DOI 10.1128/AAC.43.11.2600; WALLIS RS, 2011, INT WORKSH CLIN PHAR, V4, P19; Williams KN, 2009, ANTIMICROB AGENTS CH, V53, P1314, DOI 10.1128/AAC.01182-08; Williams KN, 2009, AM J RESP CRIT CARE, V180, P371, DOI 10.1164/rccm.200904-0611OC	33	60	63	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30479	10.1371/journal.pone.0030479	http://dx.doi.org/10.1371/journal.pone.0030479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279595	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900072
J	Zhang, J; Chen, FJ; Li, WL; Xiong, Q; Yang, MK; Zheng, P; Li, CY; Pei, JF; Ge, F				Zhang, Jia; Chen, Fangjin; Li, Wenliang; Xiong, Qian; Yang, Mingkun; Zheng, Peng; Li, Chongyang; Pei, Jianfeng; Ge, Feng			14-3-3 zeta Interacts with Stat3 and Regulates Its Constitutive Activation in Multiple Myeloma Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; PHOSPHORYLATION-DEPENDENT BINDING; MM-PBSA METHOD; IN-VIVO; PROSTATE-CANCER; PHOSPHATASE 2A; APOPTOSIS; RAF-1; 14-3-3-PROTEINS; IDENTIFICATION	The 14-3-3 proteins are a family of regulatory signaling molecules that interact with other proteins in a phosphorylation-dependent manner and function as adapter or scaffold proteins in signal transduction pathways. One family member, 14-3-3 zeta, is believed to function in cell signaling, cycle control, and apoptotic death. A systematic proteomic analysis done in our laboratory has identified signal transducers and activators of transcription 3 (Stat3) as a novel 14-3-3 zeta interacting protein. Following our initial finding, in this study, we provide evidence that 14-3-3 zeta interacts physically with Stat3. We further demonstrate that phosphorylation of Stat3 at Ser727 is vital for 14-3-3 zeta interaction and mutation of Ser727 to Alanine abolished 14-3-3 zeta/Stat3 association. Inhibition of 14-3-3 zeta protein expression in U266 cells inhibited Stat3 Ser727 phosphorylation and nuclear translocation, and decreased both Stat3 DNA binding and transcriptional activity. Moreover, 14-3-3 zeta is involved in the regulation of protein kinase C (PKC) activity and 14-3-3 zeta binding to Stat3 protects Ser727 dephosphorylation from protein phosphatase 2A (PP2A). Taken together, our findings support the model that multiple signaling events impinge on Stat3 and that 14-3-3 zeta serves as an essential coordinator for different pathways to regulate Stat3 activation and function in MM cells.	[Zhang, Jia; Xiong, Qian; Yang, Mingkun; Zheng, Peng; Li, Chongyang; Ge, Feng] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China; [Chen, Fangjin; Pei, Jianfeng] Peking Univ, Ctr Theoret Biol, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Li, Wenliang] Tokai Univ, Sch Sci & Technol, Tokyo 151, Japan	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Peking University; Tokai University	Zhang, J (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China.	jfpei@pku.edu.cn; gefeng@ihb.ac.cn	ge, feng/E-9158-2011; Pei, Jianfeng/U-9790-2019; Qian, Xiong/R-8785-2018; ge, feng/AGA-6334-2022; Xiong, Qian/O-9468-2019	ge, feng/0000-0002-1032-280X; Pei, Jianfeng/0000-0002-8482-1185; Qian, Xiong/0000-0002-0547-039X; ge, feng/0000-0002-1032-280X; Xiong, Qian/0000-0002-0547-039X	Chinese Academy of Sciences; Japan Society for the Promotion of Science	Chinese Academy of Sciences(Chinese Academy of Sciences); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Hundred Talents Program of the Chinese Academy of Sciences (to FG) and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN A, 1995, J BIOL CHEM, V270, P5706, DOI 10.1074/jbc.270.11.5706; Aziz MH, 2010, ONCOGENE, V29, P3100, DOI 10.1038/onc.2010.63; Aziz MH, 2007, CANCER RES, V67, P8828, DOI 10.1158/0008-5472.CAN-07-1604; Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Brummer T, 2008, EMBO J, V27, P2305, DOI 10.1038/emboj.2008.159; Buettner R, 2002, CLIN CANCER RES, V8, P945; Campanera JM, 2010, MOLECULES, V15, P2730, DOI 10.3390/molecules15042730; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chaudhri M, 2003, BIOCHEM BIOPH RES CO, V300, P679, DOI 10.1016/S0006-291X(02)02902-9; Craft JW, 2005, J BIOMOL NMR, V33, P15, DOI 10.1007/s10858-005-1199-0; Czirjak G, 2008, J BIOL CHEM, V283, P15672, DOI 10.1074/jbc.M800712200; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dhillon AS, 2009, CELL SIGNAL, V21, P1645, DOI 10.1016/j.cellsig.2009.07.001; Fanger GR, 1998, J BIOL CHEM, V273, P3476, DOI 10.1074/jbc.273.6.3476; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Ge F, 2010, J PROTEOME RES, V9, P5848, DOI 10.1021/pr100616g; Ge F, 2009, J PROTEOME RES, V8, P3006, DOI 10.1021/pr9001004; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; ISOBE T, 1992, FEBS LETT, V308, P121, DOI 10.1016/0014-5793(92)81257-M; Kim JH, 2009, J BIOL CHEM, V284, P35425, DOI 10.1074/jbc.M109.051516; Kuhn B, 2004, J COMPUT CHEM, V25, P1865, DOI 10.1002/jcc.20111; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li XD, 2007, BIOORGAN MED CHEM, V15, P220, DOI 10.1016/j.bmc.2006.09.074; Lufei C, 2007, ONCOGENE, V26, P7656, DOI 10.1038/sj.onc.1210567; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mora LB, 2002, CANCER RES, V62, P6659; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Neal CL, 2010, EXPERT OPIN THER TAR, V14, P1343, DOI 10.1517/14728222.2010.531011; Nelson EA, 2008, BLOOD, V112, P5095, DOI 10.1182/blood-2007-12-129718; Ni HY, 2003, BRIT J HAEMATOL, V121, P849, DOI 10.1046/j.1365-2141.2003.04368.x; Niemantsverdriet M, 2008, ONCOGENE, V27, P1315, DOI 10.1038/sj.onc.1210742; Old WM, 2009, MOL CELL, V34, P115, DOI 10.1016/j.molcel.2009.03.007; PARANT MR, 1990, FEBS LETT, V269, P331, DOI 10.1016/0014-5793(90)81187-S; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Podar K, 2007, BLOOD, V109, P1669, DOI 10.1182/blood-2006-08-042747; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Sui SH, 2008, PROTEOMICS, V8, P2024, DOI 10.1002/pmic.200700896; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; TANJI M, 1994, J NEUROCHEM, V63, P1908; Tzivion G, 2006, SEMIN CANCER BIOL, V16, P203, DOI 10.1016/j.semcancer.2006.03.004; Van der Hoeven PCJ, 2000, BIOCHEM J, V345, P297, DOI 10.1042/0264-6021:3450297; van der Hoeven PCJ, 2000, BIOCHEM J, V347, P781, DOI 10.1042/0264-6021:3470781; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Wagoner JA, 2006, P NATL ACAD SCI USA, V103, P8331, DOI 10.1073/pnas.0600118103; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; WheelerJones CPD, 1996, BIOCHEM J, V315, P41, DOI 10.1042/bj3150041; WILLIAM LJ, 1983, CHEM PHYS J, V79, P926; Woetmann A, 1999, P NATL ACAD SCI USA, V96, P10620, DOI 10.1073/pnas.96.19.10620; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yam WK, 2009, J CHEM INF MODEL, V49, P1558, DOI 10.1021/ci8003495; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995	63	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29554	10.1371/journal.pone.0029554	http://dx.doi.org/10.1371/journal.pone.0029554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279540	Green Submitted, Green Published, gold			2022-12-27	WOS:000299771900018
J	Puffenberger, EG; Jinks, RN; Sougnez, C; Cibulskis, K; Willert, RA; Achilly, NP; Cassidy, RP; Fiorentini, CJ; Heiken, KF; Lawrence, JJ; Mahoney, MH; Miller, CJ; Nair, DT; Politi, KA; Worcester, KN; Setton, RA; DiPiazza, R; Sherman, EA; Eastman, JT; Francklyn, C; Robey-Bond, S; Rider, NL; Gabriel, S; Morton, DH; Strauss, KA				Puffenberger, Erik G.; Jinks, Robert N.; Sougnez, Carrie; Cibulskis, Kristian; Willert, Rebecca A.; Achilly, Nathan P.; Cassidy, Ryan P.; Fiorentini, Christopher J.; Heiken, Kory F.; Lawrence, Johnny J.; Mahoney, Molly H.; Miller, Christopher J.; Nair, Devika T.; Politi, Kristin A.; Worcester, Kimberly N.; Setton, Roni A.; DiPiazza, Rosa; Sherman, Eric A.; Eastman, James T.; Francklyn, Christopher; Robey-Bond, Susan; Rider, Nicholas L.; Gabriel, Stacey; Morton, D. Holmes; Strauss, Kevin A.			Genetic Mapping and Exome Sequencing Identify Variants Associated with Five Novel Diseases	PLOS ONE			English	Article							POSTERIOR COLUMN ATAXIA; INTERACTING PROTEIN; TRANSFER-RNA; C-MYC; MUTATIONS; DEATH; DOMAIN; SNIP1; IDENTIFICATION; DISCOVERY	The Clinic for Special Children (CSC) has integrated biochemical and molecular methods into a rural pediatric practice serving Old Order Amish and Mennonite (Plain) children. Among the Plain people, we have used single nucleotide polymorphism (SNP) microarrays to genetically map recessive disorders to large autozygous haplotype blocks (mean = 4.4 Mb) that contain many genes (mean = 79). For some, uninformative mapping or large gene lists preclude disease-gene identification by Sanger sequencing. Seven such conditions were selected for exome sequencing at the Broad Institute; all had been previously mapped at the CSC using low density SNP microarrays coupled with autozygosity and linkage analyses. Using between 1 and 5 patient samples per disorder, we identified sequence variants in the known disease-causing genes SLC6A3 and FLVCR1, and present evidence to strongly support the pathogenicity of variants identified in TUBGCP6, BRAT1, SNIP1, CRADD, and HARS. Our results reveal the power of coupling new genotyping technologies to population-specific genetic knowledge and robust clinical data.	[Puffenberger, Erik G.; Rider, Nicholas L.; Morton, D. Holmes; Strauss, Kevin A.] Clin Special Children, Strasburg, PA 17579 USA; [Puffenberger, Erik G.; Jinks, Robert N.; Willert, Rebecca A.; Achilly, Nathan P.; Cassidy, Ryan P.; Fiorentini, Christopher J.; Heiken, Kory F.; Lawrence, Johnny J.; Mahoney, Molly H.; Miller, Christopher J.; Politi, Kristin A.; Worcester, Kimberly N.; Setton, Roni A.; DiPiazza, Rosa; Rider, Nicholas L.; Morton, D. Holmes; Strauss, Kevin A.] Franklin & Marshall Coll, Dept Biol, Lancaster, PA 17604 USA; [Puffenberger, Erik G.; Jinks, Robert N.; Willert, Rebecca A.; Achilly, Nathan P.; Cassidy, Ryan P.; Fiorentini, Christopher J.; Heiken, Kory F.; Lawrence, Johnny J.; Mahoney, Molly H.; Miller, Christopher J.; Nair, Devika T.; Politi, Kristin A.; Worcester, Kimberly N.; Setton, Roni A.; DiPiazza, Rosa; Rider, Nicholas L.; Morton, D. Holmes; Strauss, Kevin A.] Franklin & Marshall Coll, Biol Fdn, Behav Program, Lancaster, PA 17604 USA; [Sougnez, Carrie; Cibulskis, Kristian; Gabriel, Stacey] Broad Inst, Boston, MA USA; [Sherman, Eric A.] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA; [Eastman, James T.] Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth, Madison, WI USA; [Francklyn, Christopher; Robey-Bond, Susan] Univ Vermont, Coll Med, Burlington, VT USA; [Rider, Nicholas L.; Morton, D. Holmes; Strauss, Kevin A.] Lancaster Gen Hosp, Lancaster, PA USA	Franklin & Marshall College; Franklin & Marshall College; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Swarthmore College; University of Wisconsin System; University of Wisconsin Madison; University of Vermont	Puffenberger, EG (corresponding author), Clin Special Children, Strasburg, PA 17579 USA.	epuffenberger@clinicforspecialchildren.org	Nair, Devika/GZK-5946-2022; Cibulskis, Kristian/AAC-7380-2019	Cibulskis, Kristian/0000-0003-1343-1582; Politi, Kristin/0000-0002-8974-6727; Setton, Roni/0000-0002-8829-364X; Sherman, Erin/0000-0002-1835-8604; Nair, Devika/0000-0002-7044-9028; Puffenberger, Erik/0000-0002-6388-9148	Howard Hughes Medical Institute; Eyler Endowment for Biochemistry at Franklin & Marshall College; Mr. Sam Lombardo; Franklin & Marshall College; National Human Genome Research Institute of the National Institutes of Health (NIH) [U54 HG003067]; DHM; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054899] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Eyler Endowment for Biochemistry at Franklin & Marshall College; Mr. Sam Lombardo; Franklin & Marshall College; National Human Genome Research Institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); DHM; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the following: an award to Franklin & Marshall College from the Howard Hughes Medical Institute's Undergraduate Science Education Program; the Eyler Endowment for Biochemistry at Franklin & Marshall College; Mr. Sam Lombardo; Franklin & Marshall College; grants from the National Human Genome Research Institute of the National Institutes of Health (NIH), U54 HG003067, to the Broad Institute for the Large Scale Sequencing Program; and DHM through a gift from the John D. and Catherine T. MacArthur Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglipay JA, 2006, J BIOL CHEM, V281, P9710, DOI 10.1074/jbc.M510332200; Ahmad M, 1997, CANCER RES, V57, P615; Anastasio N, 2010, AM J HUM GENET, V87, P553, DOI 10.1016/j.ajhg.2010.09.005; Barzilai A, 2010, APOPTOSIS, V15, P1371, DOI 10.1007/s10495-010-0501-0; Becker J, 2011, AM J HUM GENET; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Berube C, 2005, P NATL ACAD SCI USA, V102, P14314, DOI 10.1073/pnas.0506475102; Bhattacherjee V, 2009, INT J DEV BIOL, V53, P1097, DOI 10.1387/ijdb.072489vb; Biton S, 2008, DNA REPAIR, V7, P1028, DOI 10.1016/j.dnarep.2008.03.006; Bolze A, 2010, AM J HUM GENET, V87, P873, DOI 10.1016/j.ajhg.2010.10.028; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; Caliskan M, 2011, HUM MOL GENET; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Engel T, 2010, FASEB J, V24, P853, DOI 10.1096/fj.09-145870; Francklyn C, 2005, AMINOACYL TRNA SYNTH, P135; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Fujii M, 2006, MOL CELL, V24, P771, DOI 10.1016/j.molcel.2006.11.006; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Glazer Nicole L, 2011, Circ Cardiovasc Genet, V4, P100, DOI 10.1161/CIRCGENETICS.111.959510; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706; Higgins JJ, 1997, NEUROLOGY, V49, P1717, DOI 10.1212/WNL.49.6.1717; Jabado O, 2004, CELL DEATH DIFFER, V11, P618, DOI 10.1038/sj.cdd.4401397; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kim RH, 2001, J BIOL CHEM, V276, P46297, DOI 10.1074/jbc.M103819200; Kim RH, 2000, GENE DEV, V14, P1605; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028; Lubin FD, 2007, J NEUROCHEM, V103, P1381, DOI 10.1111/j.1471-4159.2007.04863.x; MCKUSICK VA, 1966, ARCH OPHTHALMOL-CHIC, V75, P597; MCKUSICK VA, 1964, COLD SPRING HARB SYM, V29, P99, DOI 10.1101/SQB.1964.029.01.015; MCKUSICK VA, 1964, B JOHNS HOPKINS HOSP, V115, P203; MONTENEGRO G, 2011, ANN NEUROL; Morris LGT, 2010, ONCOGENE, V29, P3453, DOI 10.1038/onc.2010.127; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ostergaard P, 2011, J MED GENET; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101; Puffenberger EG, 2003, AM J MED GENET C, V121C, P18, DOI 10.1002/ajmg.c.20003; Puffenberger EG, 2007, BRAIN, V130, P1929, DOI 10.1093/brain/awm100; Rajadhyaksha AM, 2010, AM J HUM GENET, V87, P643, DOI 10.1016/j.ajhg.2010.10.013; ROE BA, 1975, NUCLEIC ACIDS RES, V2, P21, DOI 10.1093/nar/2.1.21; Shearwin-Whyatt LM, 2000, CELL DEATH DIFFER, V7, P155, DOI 10.1038/sj.cdd.4400632; Sherman EA, 2008, AM J HUM GENET, V83, P604, DOI 10.1016/j.ajhg.2008.09.018; Sirmaci A, 2010, AM J HUM GENET, V87, P679, DOI 10.1016/j.ajhg.2010.09.018; Stenson PD, 2008, J MED GENET, V45, P124, DOI 10.1136/jmg.2007.055210; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Strauss KA, 2005, AM J MED GENET A, V138A, P262, DOI 10.1002/ajmg.a.30961; Strauss KA, 2008, CLIN IMMUNOL, V128, P31, DOI 10.1016/j.clim.2008.02.016; Strauss KA, 2009, ANNU REV GENOM HUM G, V10, P513, DOI 10.1146/annurev-genom-082908-150040; Tan ZQ, 2002, BRAIN RES, V929, P129, DOI 10.1016/S0006-8993(01)03360-1; Toyo-oka K, 2004, HUM MOL GENET, V13, P1057, DOI 10.1093/hmg/ddh116; Ueberham U, 2009, INT J DEV NEUROSCI, V27, P501, DOI 10.1016/j.ijdevneu.2009.04.001; Viosca J, 2010, NEUROBIOL DIS, V37, P186, DOI 10.1016/j.nbd.2009.10.001; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Wei K, 2007, GENESIS, V45, P382, DOI 10.1002/dvg.20304; Wey A, 2010, ONCOTARGET, V1, P120, DOI 10.18632/oncotarget.116; Yan W, 1996, BIOCHEMISTRY-US, V35, P6559, DOI 10.1021/bi952889f	65	204	221	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e28936	10.1371/journal.pone.0028936	http://dx.doi.org/10.1371/journal.pone.0028936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22279524	gold, Green Published			2022-12-27	WOS:000301454400004
J	Shin, YJ; Kim, JH				Shin, Yong Jae; Kim, Jeong-Ho			The Role of EZH2 in the Regulation of the Activity of Matrix Metalloproteinases in Prostate Cancer Cells	PLOS ONE			English	Article							GROUP PROTEIN EZH2; TISSUE INHIBITOR; TUMOR-GROWTH; HISTONE METHYLTRANSFERASE; DNA METHYLATION; BREAST-CANCER; EXPRESSION; POLYCOMB; METASTASIS; INVASION	Degradation of the extracellular matrix (ECM), a critical step in cancer metastasis, is determined by the balance between MMPs (matrix metalloproteinases) and their inhibitors TIMPs (tissue inhibitors of metalloproteinases). In cancer cells, this balance is shifted towards MMPs, promoting ECM degradation. Here, we show that EZH2 plays an active role in this process by repressing the expression of TIMP2 and TIMP3 in prostate cancer cells. The TIMP genes are derepressed by knockdown of EZH2 expression in human prostate cancer cells but repressed by overexpression of EZH2 in benign human prostate epithelial cells. EZH2 catalyzes H3K27 trimethylation and subsequent DNA methylation of the TIMP gene promoters. Overexpression of EZH2 confers an invasive phenotype on benign prostate epithelial cells; however, this phenotype is suppressed by cooverexpression of TIMP3. EZH2 knockdown markedly reduces the proteolytic activity of MMP-9, thereby decreasing the invasive activity of prostate cancer cells. These results suggest that the transcriptional repression of the TIMP genes by EZH2 may be a major mechanism to shift the MMPs/TIMPs balance in favor of MMP activity and thus to promote ECM degradation and subsequent invasion of prostate cancer cells.	[Shin, Yong Jae; Kim, Jeong-Ho] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA	George Washington University	Shin, YJ (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmjxk@gwu.edu	Shin, Yong Jae/A-3102-2012		National Institute of General Medical Sciences, the National Institute of Health [GM087470]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087470] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, the National Institute of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grant GM087470 (J-HK) from the National Institute of General Medical Sciences, the National Institute of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht AL, 2008, J APPL TOXICOL, V28, P283, DOI 10.1002/jat.1277; Anania MC, 2011, ONCOGENE, V30, P3011, DOI 10.1038/onc.2011.18; Beke L, 2007, ONCOGENE, V26, P4590, DOI 10.1038/sj.onc.1210248; Bian JH, 1996, CARCINOGENESIS, V17, P1805, DOI 10.1093/carcin/17.9.1805; Bode W, 1999, ANN NY ACAD SCI, V878, P73, DOI 10.1111/j.1749-6632.1999.tb07675.x; Brehmer B, 2003, PROSTATE CANCER P D, V6, P217, DOI 10.1038/sj.pcan.4500657; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Daja MM, 2003, PROSTATE CANCER P D, V6, P15, DOI 10.1038/sj.pcan.4500609; DECLERCK YA, 1992, CANCER RES, V52, P701; Denhardt D T, 1992, Matrix Suppl, V1, P281; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Freije JMP, 2003, ADV EXP MED BIOL, V532, P91; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Imren S, 1996, CANCER RES, V56, P2891; Jarvelainen H, 2009, PHARMACOL REV, V61, P198, DOI 10.1124/pr.109.001289; John Anitha, 2001, Pathology and Oncology Research, V7, P14; Karanikolas BDW, 2009, MOL CANCER RES, V7, P1456, DOI 10.1158/1541-7786.MCR-09-0121; KAWAMATA H, 1995, INT J CANCER, V63, P680, DOI 10.1002/ijc.2910630513; KHOKHA R, 1992, J NATL CANCER I, V84, P1017, DOI 10.1093/jnci/84.13.1017; KHOKHA R, 1989, SCIENCE, V243, P947, DOI 10.1126/science.2465572; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; LECO KJ, 1994, J BIOL CHEM, V269, P9352; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pulukuri SM, 2007, ONCOGENE, V26, P5229, DOI 10.1038/sj.onc.1210329; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Rao ZY, 2010, CARCINOGENESIS, V31, P1576, DOI 10.1093/carcin/bgq150; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Sudo T, 2005, BRIT J CANCER, V92, P1754, DOI 10.1038/sj.bjc.6602531; Trojan L, 2005, ANTICANCER RES, V25, P183; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang MS, 1997, ONCOGENE, V14, P2767, DOI 10.1038/sj.onc.1201245; Watanabe M, 1996, CANCER, V77, P1676, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1676::AID-CNCR14>3.3.CO;2-#; Weikert S, 2005, INT J MOL MED, V16, P349; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Yu J, 2010, ONCOGENE, V29, P5370, DOI 10.1038/onc.2010.269; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016	52	91	100	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30393	10.1371/journal.pone.0030393	http://dx.doi.org/10.1371/journal.pone.0030393			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272343	Green Published, Green Submitted, gold			2022-12-27	WOS:000301454400121
J	Ferraris, L; Butel, MJ; Campeotto, F; Vodovar, M; Roze, JC; Aires, J				Ferraris, Laurent; Butel, Marie Jose; Campeotto, Florence; Vodovar, Michel; Roze, Jean Christophe; Aires, Julio			Clostridia in Premature Neonates' Gut: Incidence, Antibiotic Susceptibility, and Perinatal Determinants Influencing Colonization	PLOS ONE			English	Article							PRETERM INFANTS; NECROTIZING ENTEROCOLITIS; BACTERIAL-COLONIZATION; MICROFLORA; MICROBIOTA; DIFFICILE; FLORA; RESISTANT; BOWEL; PCR	Background: Although premature neonates (PN) gut microbiota has been studied, data about gut clostridial colonization in PN are scarce. Few studies have reported clostridia colonization in PN whereas Bacteroides and bifidobacteria have been seldom isolated. Such aberrant gut microbiota has been suggested to be a risk factor for the development of intestinal infections. Besides, PN are often treated by broad spectrum antibiotics, but little is known about how antibiotics can influence clostridial colonization based on their susceptibility patterns. The aim of this study was to report the distribution of Clostridium species isolated in feces from PN and to determine their antimicrobial susceptibility patterns. Additionally, clostridial colonization perinatal determinants were analyzed. Results: Of the 76 PN followed until hospital discharge in three French neonatal intensive care units (NICUs), 79% were colonized by clostridia. Clostridium sp. colonization, with a high diversity of species, increased throughout the hospitalization. Antibiotic courses had no effect on the clostridial colonization incidence although strains were found susceptible (except C. difficile) to anti-anaerobe molecules tested. However, levels of colonization were decreased by either antenatal or neonatal (during more than 10 days) antibiotic courses (p = 0.006 and p = 0.001, respectively). Besides, incidence of colonization was depending on the NICU (p = 0.048). Conclusion: This study shows that clostridia are part of the PN gut microbiota. It provides for the first time information on the status of clostridia antimicrobial susceptibility in PN showing that strains were susceptible to most antibiotic molecules. Thus, the high prevalence of this genus is not linked to a high degree of resistance to antimicrobial agents or to the use of antibiotics in NICUs. The main perinatal determinant influencing PN clostridia colonization appears to be the NICU environment.	[Ferraris, Laurent; Butel, Marie Jose; Campeotto, Florence; Aires, Julio] Univ Paris 05, Fac Sci Pharmaceut & Biol, EA4065, Paris, France; [Vodovar, Michel] Inst Puericulture, Paris, France; [Roze, Jean Christophe] Univ Nantes, Dept Med Neonatale, Ctr Invest Clin, CHU Nantes,INSERM,CIC004, Nantes, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Ferraris, L (corresponding author), Univ Paris 05, Fac Sci Pharmaceut & Biol, EA4065, Paris, France.	julio.aires@parisdescartes.fr	roze, jean christophe/B-5433-2012; Rozé, Jean-Christophe/AAS-1314-2021	Roze, Jean-Christophe/0000-0003-3367-512X; Aires, Julio/0000-0002-8090-4565				Alfa MJ, 2002, CLIN INFECT DIS, V35, pS101, DOI 10.1086/341929; BENNET R, 1986, PEDIATR INFECT DIS J, V5, P533, DOI 10.1097/00006454-198609000-00009; Biasucci G, 2010, EARLY HUM DEV, V86, pS13, DOI 10.1016/j.earlhumdev.2010.01.004; Bjornvad CR, 2008, AM J PHYSIOL-GASTR L, V295, pG1092, DOI 10.1152/ajpgi.00414.2007; BLAKEY JL, 1982, J MED MICROBIOL, V15, P519, DOI 10.1099/00222615-15-4-519; BLAKEY JL, 1985, J PEDIATR GASTR NUTR, V4, P591, DOI 10.1097/00005176-198508000-00017; Blondeau JM, 2009, J ANTIMICROB CHEMOTH, V63, P238, DOI 10.1093/jac/dkn477; BROOK I, 1982, J INFECTION, V4, P253, DOI 10.1016/S0163-4453(82)92584-1; BROOK I, 1995, J MED MICROBIOL, V42, P78, DOI 10.1099/00222615-42-2-78; Brook I, 2010, ANAEROBE, V16, P183, DOI 10.1016/j.anaerobe.2009.12.001; Butel MJ, 2007, J PEDIATR GASTR NUTR, V44, P577, DOI 10.1097/MPG.0b013e3180406b20; Butel MJ, 1998, J MED MICROBIOL, V47, P391, DOI 10.1099/00222615-47-5-391; Campeotto F, 2011, BRIT J NUTR, V105, P1843, DOI 10.1017/S0007114510005702; CASHORE WJ, 1981, J PEDIATR-US, V98, P308, DOI 10.1016/S0022-3476(81)80667-1; Chang JY, 2011, J PEDIATR GASTR NUTR, V53, P512, DOI 10.1097/MPG.0b013e318227e518; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; de Man P, 2000, LANCET, V355, P973, DOI 10.1016/S0140-6736(00)90015-1; de Vos N, 1982, Eur J Clin Microbiol, V1, P267; DELACOCHETIERE MF, 2004, PEDIATR RES, V56, P1; Gewolb IH, 1999, ARCH DIS CHILD-FETAL, V80, pF167, DOI 10.1136/fn.80.3.F167; Goldstein EJC, 2003, ANTIMICROB AGENTS CH, V47, P1968, DOI 10.1128/AAC.47.6.1968-1971.2003; Goldstein EJC, 2009, DIAGN MICR INFEC DIS, V63, P447, DOI 10.1016/j.diagmicrobio.2009.01.022; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; HOWARD FM, 1977, LANCET, V2, P1099; Jacquot A, 2011, J PEDIATR-US, V158, P390, DOI 10.1016/j.jpeds.2010.09.007; Johnson EA, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P889; Kalia VC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-18; KOSLOSKE AM, 1985, J PEDIATR SURG, V20, P155, DOI 10.1016/S0022-3468(85)80290-6; KOSLOSKE AM, 1978, LANCET, V2, P1014, DOI 10.1016/S0140-6736(78)92337-1; Magne F, 2006, FEMS MICROBIOL ECOL, V57, P128, DOI 10.1111/j.1574-6941.2006.00097.x; MAGOT M, 1981, J GEN MICROBIOL, V127, P113; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Millar MR, 1996, J CLIN MICROBIOL, V34, P2506, DOI 10.1128/JCM.34.10.2506-2510.1996; Morowitz MJ, 2010, PEDIATRICS, V125, P777, DOI 10.1542/peds.2009-3149; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Mutlu E, 2007, J MED MICROBIOL, V56, P921, DOI 10.1099/jmm.0.47176-0; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Obladen M, 2009, NEONATOLOGY, V96, P203, DOI 10.1159/000215590; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; ROTIMI VO, 1985, J HYG-CAMBRIDGE, V94, P309, DOI 10.1017/S0022172400061532; Roudiere L, 2009, J MICROBIOL METH, V79, P156, DOI 10.1016/j.mimet.2009.08.005; Rouge C, 2009, AM J CLIN NUTR, V89, P1828, DOI 10.3945/ajcn.2008.26919; Schwiertz A, 2003, PEDIATR RES, V54, P393, DOI 10.1203/01.PDR.0000078274.74607.7A; Siggers RH, 2011, J NUTR BIOCHEM, V22, P511, DOI 10.1016/j.jnutbio.2010.08.002; Smith B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-73; STARK PL, 1982, J HYG-CAMBRIDGE, V89, P59, DOI 10.1017/S0022172400070546; STURM R, 1980, PEDIATRICS, V66, P928; Waligora-Dupriet AJ, 2005, PEDIATR RES, V58, P629, DOI 10.1203/01.PDR.0000180538.13142.84; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Woo PCY, 2005, J CLIN PATHOL, V58, P301, DOI 10.1136/jcp.2004.022830	51	49	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30594	10.1371/journal.pone.0030594	http://dx.doi.org/10.1371/journal.pone.0030594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291996	Green Published, gold, Green Submitted			2022-12-27	WOS:000301703800021
J	Ayele, B; Aemere, A; Gebre, T; Tadesse, Z; Stoller, NE; See, CW; Yu, SN; Gaynor, BD; McCulloch, CE; Porco, TC; Emerson, PM; Lietman, TM; Keenan, JD				Ayele, Berhan; Aemere, Abaineh; Gebre, Teshome; Tadesse, Zerihun; Stoller, Nicole E.; See, Craig W.; Yu, Sun N.; Gaynor, Bruce D.; McCulloch, Charles E.; Porco, Travis C.; Emerson, Paul M.; Lietman, Thomas M.; Keenan, Jeremy D.			Reliability of Measurements Performed by Community-Drawn Anthropometrists from Rural Ethiopia	PLOS ONE			English	Article							CHILD UNDERNUTRITION; GROWTH	Background: Undernutrition is an important risk factor for childhood mortality, and remains a major problem facing many developing countries. Millennium Development Goal 1 calls for a reduction in underweight children, implemented through a variety of interventions. To adequately judge the impact of these interventions, it is important to know the reproducibility of the main indicators for undernutrition. In this study, we trained individuals from rural communities in Ethiopia in anthropometry techniques and measured intra-and inter-observer reliability. Methods and Findings: We trained 6 individuals without prior anthropometry experience to perform weight, height, and middle upper arm circumference (MUAC) measurements. Two anthropometry teams were dispatched to 18 communities in rural Ethiopia and measurements performed on all consenting pre-school children. Anthropometry teams performed a second independent measurement on a convenience sample of children in order to assess intra-anthropometrist reliability. Both teams measured the same children in 2 villages to assess inter-anthropometrist reliability. We calculated several metrics of measurement reproducibility, including the technical error of measurement (TEM) and relative TEM. In total, anthropometry teams performed measurements on 606 pre-school children, 84 of which had repeat measurements performed by the same team, and 89 of which had measurements performed by both teams. Intra-anthropometrist TEM (and relative TEM) were 0.35 cm (0.35%) for height, 0.05 kg (0.39%) for weight, and 0.18 cm (1.27%) for MUAC. Corresponding values for inter-anthropometrist reliability were 0.67 cm (0.75%) for height, 0.09 kg (0.79%) for weight, and 0.22 kg (1.53%) for MUAC. Inter-anthropometrist measurement error was greater for smaller children than for larger children. Conclusion: Measurements of height and weight were more reproducible than measurements of MUAC and measurements of larger children were more reliable than those for smaller children. Community-drawn anthropometrists can provide reliable measurements that could be used to assess the impact of interventions for childhood undernutrition.	[Ayele, Berhan; Gebre, Teshome; Tadesse, Zerihun] Carter Ctr, Addis Ababa, Ethiopia; [Aemere, Abaineh] Goncha Siso Enese Woreda Hlth Off, Gindewoin, Ethiopia; [Stoller, Nicole E.; See, Craig W.; Yu, Sun N.; Gaynor, Bruce D.; Porco, Travis C.; Lietman, Thomas M.; Keenan, Jeremy D.] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; [Gaynor, Bruce D.; Porco, Travis C.; Lietman, Thomas M.; Keenan, Jeremy D.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA; [McCulloch, Charles E.; Porco, Travis C.; Lietman, Thomas M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Emerson, Paul M.] Emory Univ, Carter Ctr, Atlanta, GA 30322 USA; [Lietman, Thomas M.] Univ Calif San Francisco, Inst Global Hlth, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Emory University; University of California System; University of California San Francisco	Ayele, B (corresponding author), Carter Ctr, Addis Ababa, Ethiopia.	jeremy.keenan@ucsf.edu	Gebre, Teshome/F-2973-2011; Keenan, Jeremy David/AAO-5882-2020	Gebre, Teshome/0000-0002-9884-0344; Keenan, Jeremy David/0000-0002-7118-1457; Emerson, Paul/0000-0002-6478-8816	National Institutes of Health (National Eye Institute) [EY016214, K23EY019071]; National Center for Research Resources [KL2 RR024130]; Bernard Osher Foundation; That Man May See; Harper Inglis Trust; Bodri Foundation; South Asia Research Fund; Research to Prevent Blindness; International Trachoma Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K23EY019071, U10EY016214, K23EY019881] Funding Source: NIH RePORTER	National Institutes of Health (National Eye Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Bernard Osher Foundation; That Man May See; Harper Inglis Trust; Bodri Foundation; South Asia Research Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); International Trachoma Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (National Eye Institute grants EY016214 and K23EY019071; and National Center for Research Resources/Office of the Director grant number KL2 RR024130, which funds the University of California, San Francisco Clinical and Translational Science Institute), the Bernard Osher Foundation, That Man May See, the Harper Inglis Trust, the Bodri Foundation, the South Asia Research Fund, Research to Prevent Blindness, and the International Trachoma Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WHO ANTHR TRAIN VID; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bisimwa G, 2009, FOOD NUTR BULL, V30, P120, DOI 10.1177/156482650903000203; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; Department of Economic and Social Affairs of the United Nations Secretariat, 2011, MILL DEV GOALS REP 2; Drukker DM, 2003, STATA J, V3, P168, DOI 10.1177/1536867X0300300206; Gebre T, 2012, LANCET IN PRESS; HESSEL PA, 1986, INT J EPIDEMIOL, V15, P122, DOI 10.1093/ije/15.1.122; House JI, 2009, LANCET, V373, P1111, DOI 10.1016/S0140-6736(09)60323-8; Kennedy G, 2006, PUBLIC HEALTH NUTR, V9, P187, DOI 10.1079/PHN2005835; MELVILLE B, 1995, PUBLIC HEALTH, V109, P111, DOI 10.1016/S0033-3506(05)80004-6; Menon Purnima, 2000, Food and Nutrition Bulletin, V21, P282; Ngirabega JDD, 2010, REV EPIDEMIOL SANTE, V58, P409, DOI 10.1016/j.respe.2010.07.002; Norton K, 1996, ANTHROPOMETRICA TXB; Onyango AW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035320500494464; Rah JH, 2010, MATERN CHILD NUTR, V6, P27, DOI 10.1111/j.1740-8709.2009.00197.x; Stoller NE, 2011, INT HEALTH, V3, P75, DOI 10.1016/j.inhe.2011.03.004; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; World Health Organization, 2008, WHO CHILD GROWTH STA; World Health Organization, 1995, REPORT WHO EXPERT CO, V854	22	31	31	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30345	10.1371/journal.pone.0030345	http://dx.doi.org/10.1371/journal.pone.0030345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291939	Green Published, gold, Green Submitted			2022-12-27	WOS:000301639600015
J	Baumstarck, K; Pelletier, J; Aghababian, V; Reuter, F; Klemina, I; Berbis, J; Loundou, A; Auquier, P				Baumstarck, Karine; Pelletier, Jean; Aghababian, Valerie; Reuter, Francoise; Klemina, Irina; Berbis, Julie; Loundou, Anderson; Auquier, Pascal			Is the Concept of Quality of Life Relevant for Multiple Sclerosis Patients with Cognitive Impairment? Preliminary Results of a Cross-Sectional Study	PLOS ONE			English	Article							NOTTINGHAM HEALTH PROFILE; STROOP INTERFERENCE; RELIABILITY; DYSFUNCTION; VALIDATION; VALIDITY; SCHIZOPHRENIA; DEMENTIA; LESIONS; IMPACT	Background: Cognitive impairment occurs in about 50% of multiple sclerosis (MS) patients, and the use of self-reported outcomes for evaluating treatment and managing care among subjects with cognitive dysfunction has been questioned. The aim of this study was to provide new evidence about the suitability of self-reported outcomes for use in this specific population by exploring the internal structure, reliability and external validity of a specific quality of life (QoL) instrument, the Multiple Sclerosis International Quality of Life questionnaire (MusiQoL). Methods: Design: cross-sectional study. Inclusion criteria: MS patients of any disease subtype. Data collection: sociodemographic (age, gender, marital status, education level, and occupational activity) and clinical data (MS subtype, Expanded Disability Status Scale, disease duration); QoL (MusiQoL and SF36); and neuropsychological performance (Stroop color-word test). Statistical analysis: confirmatory factor analysis, item-dimension correlations, Cronbach's alpha coefficients, Rasch statistics, relationships between MusiQoL dimensions and other parameters. Principal Findings: One hundred and twenty-four consecutive patients were enrolled. QoL scores did not differ between the 69 cognitively non-impaired patients and the 55 cognitively impaired patients, except for the symptoms dimension. The confirmatory factor analysis performed among the impaired subjects showed that the structure of the questionnaire matched with the initial structure of the MusiQoL. The unidimensionality of the MusiQoL dimensions was preserved, and the internal validity indices were satisfactory and close to those of the reference population. Conclusions/Significance: Our study suggests that executive dysfunction did not compromise the reliability and the validity of the self-reported QoL questionnaires.	[Baumstarck, Karine; Berbis, Julie; Loundou, Anderson; Auquier, Pascal] Nord Univ Hosp, APHM, Self Perceived Hlth Assessment Res Unit EA3279, Marseille, France; [Baumstarck, Karine; Berbis, Julie; Loundou, Anderson; Auquier, Pascal] Nord Univ Hosp, APHM, Dept Publ Hlth, Marseille, France; [Pelletier, Jean; Reuter, Francoise; Klemina, Irina] Timone Univ Hosp, APHM, Dept Neurol, Marseille, France; [Pelletier, Jean; Reuter, Francoise; Klemina, Irina] Timone Univ Hosp, APHM, CRMBM CNRS6612, Marseille, France; [Aghababian, Valerie] Aix Marseille Univ, Psychol Cognit Language & Emot Res Ctr EA 3273, Aix En Provence, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Baumstarck, K (corresponding author), Nord Univ Hosp, APHM, Self Perceived Hlth Assessment Res Unit EA3279, Marseille, France.	karine.baumstarck@univmed.fr	Berbis, Julie/F-2338-2018	Berbis, Julie/0000-0001-6135-3342; Baumstarck, Karine/0000-0003-3602-6766	Hospitalier Recherche Clinique; French Institut de Recherche en Sante Publique (CUD-QV); Assistance Publique, Hopitaux de Marseille (Marseille, France)	Hospitalier Recherche Clinique; French Institut de Recherche en Sante Publique (CUD-QV); Assistance Publique, Hopitaux de Marseille (Marseille, France)	This work was supported by institutional grants from the French 2004 Programme Hospitalier Recherche Clinique and from the French 2009 Institut de Recherche en Sante Publique (CUD-QV). The sponsor was represented by Assistance Publique, Hopitaux de Marseille (Marseille, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron A, 2006, J NEUROL SCI, V245, P47, DOI 10.1016/j.jns.2005.05.019; Achiron A, 2003, J NEUROL NEUROSUR PS, V74, P443, DOI 10.1136/jnnp.74.4.443; Amato MP, 2006, J NEUROL SCI, V245, P41, DOI 10.1016/j.jns.2005.08.019; Amato MP, 2004, J NEUROL, V251, P1472, DOI 10.1007/s00415-004-0567-0; Auquier P, 2003, SCHIZOPHR RES, V63, P137, DOI 10.1016/S0920-9964(02)00355-9; Baro E, 2006, QUAL LIFE RES, V15, P575, DOI 10.1007/s11136-005-3691-0; Baumstarck-Barrau K, 2011, J REV NEUROL PARIS; Baumstarck-Barrau K, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-17; Beiske AG, 2012, ACTA NEUROL SCAND, V125, P171, DOI 10.1111/j.1600-0404.2011.01518.x; Benedict RHB, 2004, MULT SCLER J, V10, P675, DOI 10.1191/1352458504ms1098oa; Benito-Leon J, 2002, EUR J NEUROL, V9, P497, DOI 10.1046/j.1468-1331.2002.00450.x; Bureau-Chalot F, 2002, GERONTOLOGY, V48, P220, DOI 10.1159/000058354; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; DAVID HP, 1990, STUD FAMILY PLANN, V21, P1, DOI 10.2307/1966587; Denney DR, 2009, J INT NEUROPSYCH SOC, V15, P451, DOI 10.1017/S1355617709090730; FEINSTEIN A, 1992, J NEUROL NEUROSUR PS, V55, P869, DOI 10.1136/jnnp.55.10.869; Feuillet L, 2007, MULT SCLER, V13, P124, DOI 10.1177/1352458506071196; Fischer JS, 2000, ANN NEUROL, V48, P885, DOI 10.1002/1531-8249(200012)48:6<885::AID-ANA9>3.3.CO;2-T; Flachenecker P, 2011, NERVENARZT; Foong J, 1997, BRAIN, V120, P15, DOI 10.1093/brain/120.1.15; Gerbauld L, 2006, REV NEUROL-FRANCE, V162, P970, DOI 10.1016/S0035-3787(06)75107-4; Godefroy O., 2008, FONCTIONS EXECUTIVES; Gold SM, 2003, MULT SCLER J, V9, P404, DOI 10.1191/1352458503ms927oa; Goverover Y, 2005, MULT SCLER J, V11, P203, DOI 10.1191/1352458505ms1153oa; Hoe J, 2005, AGE AGEING, V34, P130, DOI 10.1093/ageing/afi030; HOUX PJ, 1993, EXP AGING RES, V19, P209, DOI 10.1080/03610739308253934; Jensen A R, 1965, Acta Psychol (Amst), V24, P398; LAUTENSCHLAGER GJ, 1989, APPL PSYCH MEAS, V13, P204; Leplege A, 1998, J CLIN EPIDEMIOL, V51, P1013, DOI 10.1016/S0895-4356(98)00093-6; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lowry R., SIGNIFICANCE DIFFERE; Marrie RA, 2003, MULT SCLER, V9, P621, DOI 10.1191/1352458503ms971oa; Mitchell AJ, 2005, LANCET NEUROL, V4, P556, DOI 10.1016/S1474-4422(05)70166-6; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Nishiyama T, 2010, QUAL LIFE RES, V19, P25, DOI 10.1007/s11136-009-9556-1; Orley J, 1998, BRIT J PSYCHIAT, V172, P291, DOI 10.1192/bjp.172.4.291; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Polman CH, 2005, MULT SCLER, V11, P5, DOI 10.1191/1352458505ms1135oa; Prakash RS, 2008, MULT SCLER J, V14, P1250, DOI 10.1177/1352458508095004; Pujol J, 2001, NEUROIMAGE, V13, P68, DOI 10.1006/nimg.2000.0662; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; Riemsma R P, 2001, Health Technol Assess, V5, P1; Sartori E, 2006, J NEUROL SCI, V245, P169, DOI 10.1016/j.jns.2005.07.016; Simeoni MC, 2008, MULT SCLER J, V14, P219, DOI 10.1177/1352458507080733; Solari Alessandra, 2005, Health Qual Life Outcomes, V3, P16, DOI 10.1186/1477-7525-3-16; Triantafyllou N, 2009, J CLIN NEUROL, V5, P173, DOI 10.3988/jcn.2009.5.4.173; Vitkovitch M, 2002, NEUROPSYCHOLOGIA, V40, P1570, DOI 10.1016/S0028-3932(02)00022-2; Voruganti L, 1998, PSYCHOL MED, V28, P165, DOI 10.1017/S0033291797005874; Ware J. E., 1997, MAP R WINDOWS MULTIT; Wong JGWS, 2005, QUAL LIFE RES, V14, P687, DOI 10.1007/s11136-004-1215-y; Wright B., 1999, MEASUREMENT ESSENTIA, V2nd	51	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30627	10.1371/journal.pone.0030627	http://dx.doi.org/10.1371/journal.pone.0030627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	909NE	22292002	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600066
J	Korthagen, NM; van Moorsel, CHM; Barlo, NP; Kazemier, KM; Ruven, HJT; Grutters, JC				Korthagen, Nicoline M.; van Moorsel, Coline H. M.; Barlo, Nicole P.; Kazemier, Karin M.; Ruven, Henk J. T.; Grutters, Jan C.			Association between Variations in Cell Cycle Genes and Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							EPITHELIAL-CELLS; INHIBITOR P21; CANCER; SURVIVAL; EXPRESSION; APOPTOSIS; DISEASES; INJURY; RISK; P53	Idiopathic pulmonary fibrosis (IPF) is a devastating and progressive lung disease. Its aetiology is thought to involve damage to the epithelium and abnormal repair. Alveolar epithelial cells near areas of remodelling show an increased expression of proapoptotic molecules. Therefore, we investigated the role of genes involved in cell cycle control in IPF. Genotypes for five single nucleotide polymorphisms (SNPs) in the tumour protein 53 (TP53) gene and four SNPs in cyclin-dependent kinase inhibitor 1A (CDKN1A), the gene encoding p21, were determined in 77 IPF patients and 353 controls. In peripheral blood mononuclear cells (PBMC) from 16 healthy controls mRNA expression of TP53 and CDKN1A was determined. Rs12951053 and rs12602273, in TP53, were significantly associated with survival in IPF patients. Carriers of a minor allele had a 4-year survival of 22% versus 57% in the non-carrier group (p = 0.006). Rs2395655 and rs733590, in CDKN1A, were associated with an increased risk of developing IPF. In addition, the rs2395655 G allele correlated with progression of the disease as it increased the risk of a rapid decline in lung function. Functional experiments showed that rs733590 correlated significantly with CDKN1A mRNA expression levels in healthy controls. This is the first study to show that genetic variations in the cell cycle genes encoding p53 and p21 are associated with IPF disease development and progression. These findings support the idea that cell cycle control plays a role in the pathology of IPF. Variations in TP53 and CDKN1A can impair the response to cell damage and increase the loss of alveolar epithelial cells.	[Korthagen, Nicoline M.; van Moorsel, Coline H. M.; Barlo, Nicole P.; Grutters, Jan C.] St Antonius Hosp, Ctr Interstitial Lung Dis, Nieuwegein, Netherlands; [Korthagen, Nicoline M.; van Moorsel, Coline H. M.; Kazemier, Karin M.; Grutters, Jan C.] Univ Med Ctr Utrecht, Div Heart & Lungs, Utrecht, Netherlands	St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center	Korthagen, NM (corresponding author), St Antonius Hosp, Ctr Interstitial Lung Dis, Nieuwegein, Netherlands.	j.grutters@antoniusziekenhuis.nl	Korthagen, Nicoline M./AAA-4338-2021	Korthagen, Nicoline M./0000-0002-9277-0795				Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Baumgartner KB, 1997, AM J RESP CRIT CARE, V155, P242, DOI 10.1164/ajrccm.155.1.9001319; Bhaskaran M, 2007, J BIOL CHEM, V282, P3968, DOI 10.1074/jbc.M609060200; Bouros D, 2002, CHEST, V121, P1278, DOI 10.1378/chest.121.4.1278; Canman C E, 1997, Adv Pharmacol, V41, P429, DOI 10.1016/S1054-3589(08)61068-6; Choi YY, 2008, J HUM GENET, V53, P87, DOI 10.1007/s10038-007-0222-6; Collard HR, 2003, AM J RESP CRIT CARE, V168, P538, DOI 10.1164/rccm.200211-1311OC; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Doss CGP, 2008, FUNCT INTEGR GENOMIC, V8, P309, DOI 10.1007/s10142-008-0086-7; Egan JJ, 2005, THORAX, V60, P270, DOI 10.1136/thx.2004.035436; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; Grutters JC, 2005, EUR RESPIR J, V25, P915, DOI 10.1183/09031936.05.00133404; HANSON D, 1995, CHEST, V108, P305, DOI 10.1378/chest.108.2.305; Heron M, 2009, CLIN IMMUNOL, V133, P117, DOI 10.1016/j.clim.2009.06.007; Inoshima I, 2004, AM J PHYSIOL-LUNG C, V286, pL727, DOI 10.1152/ajplung.00209.2003; KASTAN MB, 1993, ADV EXP MED BIOL, V339, P291; King TE, 2005, CHEST, V127, P171, DOI 10.1378/chest.127.1.171; Krtolica A, 2002, INT J BIOCHEM CELL B, V34, P1401, DOI 10.1016/S1357-2725(02)00053-5; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Mapel DW, 1998, THORAX, V53, P469, DOI 10.1136/thx.53.6.469; Nakashima N, 2005, J CLIN PATHOL, V58, P583, DOI 10.1136/jcp.2004.022632; Navaratnam V, 2011, THORAX, V66, P462, DOI 10.1136/thx.2010.148031; Plataki M, 2005, CHEST, V127, P266, DOI 10.1378/chest.127.1.266; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Rudd RM, 2007, THORAX, V62, P62, DOI 10.1136/thx.2005.045591; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; van Moorsel CHM, 2010, AM J RESP CRIT CARE, V182, P1419, DOI 10.1164/rccm.200906-0953OC; Vancheri C, 2010, EUR RESPIR J, V35, P496, DOI 10.1183/09031936.00077309; Verleden GM, 2001, EUR RESPIR J, V18, p17S; Warburton David, 2008, Proc Am Thorac Soc, V5, P703, DOI 10.1513/pats.200801-012AW	34	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30442	10.1371/journal.pone.0030442	http://dx.doi.org/10.1371/journal.pone.0030442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291954	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600042
J	Holten-Andersen, L; Dalsgaard, I; Buchmann, K				Holten-Andersen, Lars; Dalsgaard, Inger; Buchmann, Kurt			Baltic Salmon, Salmo salar, from Swedish River Lule Alv Is More Resistant to Furunculosis Compared to Rainbow Trout	PLOS ONE			English	Article							ONCORHYNCHUS-MYKISS WALBAUM; BACTERIAL KIDNEY-DISEASE; FARMED ATLANTIC SALMON; AEROMONAS-SALMONICIDA; GYRODACTYLUS-SALARIS; COMPARATIVE SUSCEPTIBILITY; GAIRDNERI RICHARDSON; BROOK TROUT; CLASS-I; INFECTION	Background: Furunculosis, caused by Aeromonas salmonicida, continues to be a major health problem for the growing salmonid aquaculture. Despite effective vaccination programs regular outbreaks occur at the fish farms calling for repeated antibiotic treatment. We hypothesized that a difference in natural susceptibility to this disease might exist between Baltic salmon and the widely used rainbow trout. Study Design: A cohabitation challenge model was applied to investigate the relative susceptibility to infection with A. salmonicida in rainbow trout and Baltic salmon. The course of infection was monitored daily over a 30-day period post challenge and the results were summarized in mortality curves. Results: A. salmonicida was recovered from mortalities during the entire test period. At day 30 the survival was 6.2% and 34.0% for rainbow trout and Baltic salmon, respectively. Significant differences in susceptibility to A. salmonicida were demonstrated between the two salmonids and hazard ratio estimation between rainbow trout and Baltic salmon showed a 3.36 higher risk of dying from the infection in the former. Conclusion: The finding that Baltic salmon carries a high level of natural resistance to furunculosis might raise new possibilities for salmonid aquaculture in terms of minimizing disease outbreaks and the use of antibiotics.	[Holten-Andersen, Lars; Buchmann, Kurt] Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Frederiksberg C, Denmark; [Holten-Andersen, Lars; Dalsgaard, Inger] Tech Univ Denmark, Div Vet Diagnost & Res, Natl Vet Inst, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark	Holten-Andersen, L (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Frederiksberg C, Denmark.	lhoa@life.ku.dk		Dalsgaard, Inger/0000-0003-2066-1060; Buchmann, Kurt/0000-0002-2747-237X	Danish Research Council for Strategic Research [2101-07-0086]	Danish Research Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This study was funded by the Danish Research Council for Strategic Research (Grant #2101-07-0086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKE TA, 1993, FISH RES, V17, P69, DOI 10.1016/0165-7836(93)90008-U; BAKKE TA, 1990, J FISH BIOL, V37, P577, DOI 10.1111/j.1095-8649.1990.tb05890.x; BEACHAM TD, 1992, T AM FISH SOC, V121, P456, DOI 10.1577/1548-8659(1992)121&lt;0456:GVIDRA&gt;2.3.CO;2; Berg A, 2006, FISKEN HAVET, V9; BRUNO DW, 1986, J FISH DIS, V9, P523, DOI 10.1111/j.1365-2761.1986.tb01049.x; Buchmann K, 1997, DIS AQUAT ORGAN, V28, P201, DOI 10.3354/dao028201; Buchmann K, 1997, AQUACULTURE, V156, P335, DOI 10.1016/S0044-8486(97)00097-5; Buchmann K, 2001, J FISH DIS, V24, P245, DOI 10.1046/j.1365-2761.2001.00294.x; CIPRIANO RC, 1994, J WILDLIFE DIS, V30, P577, DOI 10.7589/0090-3558-30.4.577; CIPRIANO RC, 1982, PROG FISH CULT, V44, P12, DOI 10.1577/1548-8659(1982)44[12:FIBT]2.0.CO;2; CIPRIANO RC, 1986, T AM FISH SOC, V115, P83, DOI 10.1577/1548-8659(1986)115&lt;83:SOSTF&gt;2.0.CO;2; CIPRIANO RC, 1983, T AM FISH SOC, V112, P95, DOI 10.1577/1548-8659(1983)112&lt;95:ROSTAS&gt;2.0.CO;2; Dalgaard MB, 2003, DIS AQUAT ORGAN, V53, P173, DOI 10.3354/dao053173; Dalsgaard I, 2000, J FISH DIS, V23, P199, DOI 10.1046/j.1365-2761.2000.00242.x; ELLIS AE, 1988, MICROB PATHOGENESIS, V4, P299, DOI 10.1016/0882-4010(88)90090-3; FREEDMAN SJ, 1991, COMP BIOCHEM PHYS B, V98, P549, DOI 10.1016/0305-0491(91)90252-9; GJEDREM T, 1978, AQUACULTURE, V13, P135, DOI 10.1016/0044-8486(78)90107-2; Gjedrem T., 1995, Aquaculture Research, V26, P129, DOI 10.1111/j.1365-2109.1995.tb00892.x; GRIFFIN BR, 1983, DEV COMP IMMUNOL, V7, P253, DOI 10.1016/0145-305X(83)90006-X; Grimholt U, 2003, IMMUNOGENETICS, V55, P210, DOI 10.1007/s00251-003-0567-8; HAYFORD CO, 1930, T AM FISH SOC, V60, P109; Heinecke RD, 2007, J FISH DIS, V30, P733, DOI 10.1111/j.1365-2761.2007.00885.x; HJELMELAND K, 1983, J FISH BIOL, V23, P13, DOI 10.1111/j.1095-8649.1983.tb02878.x; Hoover GJ, 1998, COMP BIOCHEM PHYS B, V120, P559, DOI 10.1016/S0305-0491(98)10042-1; Hoover GJ, 1998, FASEB J, V12, pA807; HUNTLY PJ, 1988, BIOCHEM SOC T, V16, P999, DOI 10.1042/bst0160999; Kania PW, 2010, J HELMINTHOL, V84, P166, DOI 10.1017/S0022149X09990460; Kania P, 2007, DIS AQUAT ORGAN, V76, P81, DOI 10.3354/dao076081; Kjoglum S, 2008, SCAND J IMMUNOL, V67, P160, DOI 10.1111/j.1365-3083.2007.02052.x; Koppang EO, 2005, J FISH DIS, V28, P13, DOI 10.1111/j.1365-2761.2004.00583.x; Koppang EO, 2008, J IMMUNOL, V181, P4807, DOI 10.4049/jimmunol.181.7.4807; Langefors A, 2001, P ROY SOC B-BIOL SCI, V268, P479, DOI 10.1098/rspb.2000.1378; LEE KK, 1991, DIS AQUAT ORGAN, V11, P207, DOI 10.3354/dao011207; Lindenstrom T, 2006, J FISH DIS, V29, P123, DOI 10.1111/j.1365-2761.2006.00696.x; Lohm J, 2002, P ROY SOC B-BIOL SCI, V269, P2029, DOI 10.1098/rspb.2002.2114; MAGNADOTTIR B, 1995, VET IMMUNOL IMMUNOP, V49, P127, DOI 10.1016/0165-2427(95)05461-E; MCCARTHY DH, 1983, J FISH DIS, V6, P231, DOI 10.1111/j.1365-2761.1983.tb00071.x; McIntosh D, 2008, J ANTIMICROB CHEMOTH, V61, P1221, DOI 10.1093/jac/dkn123; MICHEL C, 1990, J FISH BIOL, V37, P617, DOI 10.1111/j.1095-8649.1990.tb05894.x; Miller RA, 2006, AM J VET RES, V67, P1837, DOI 10.2460/ajvr.67.11.1837; Nilsson J, 2001, MOL ECOL, V10, P89, DOI 10.1046/j.1365-294X.2001.01168.x; Odegard J, 2007, AQUACULTURE, V271, P173, DOI 10.1016/j.aquaculture.2007.06.006; Odegard J, 2006, AQUACULTURE, V259, P116, DOI 10.1016/j.aquaculture.2006.05.034; Ottinger CA, 1999, COMP BIOCHEM PHYS C, V123, P53, DOI 10.1016/S0742-8413(99)00009-2; Pedersen K, 2008, J FISH DIS, V31, P659, DOI 10.1111/j.1365-2761.2008.00941.x; PRESS CM, 1995, BRIT VET J, V151, P45, DOI 10.1016/S0007-1935(05)80064-8; Ringo E, 2004, CELL TISSUE RES, V318, P305, DOI 10.1007/s00441-004-0934-2; Rolland JB, 2003, J FISH DIS, V26, P511, DOI 10.1046/j.1365-2761.2003.00473.x; SAKAI M, 1991, FISH PATHOL, V26, P159, DOI 10.3147/jsfp.26.159; Smith VJ, 2000, FISH SHELLFISH IMMUN, V10, P243, DOI 10.1006/fsim.1999.0254	50	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29571	10.1371/journal.pone.0029571	http://dx.doi.org/10.1371/journal.pone.0029571			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276121	Green Published, gold			2022-12-27	WOS:000301568100013
J	Abraham, CG; Kulesza, CA				Abraham, Christopher G.; Kulesza, Caroline A.			Polycomb Repressive Complex 2 Targets Murine Cytomegalovirus Chromatin for Modification and Associates with Viral Replication Centers	PLOS ONE			English	Article							HISTONE MODIFICATIONS; GENE-EXPRESSION; GROUP PROTEINS; FACULTATIVE HETEROCHROMATIN; TRANSCRIPTIONAL REPRESSORS; DENDRITIC CELLS; LATENCY; INFECTION; REACTIVATION; GENOME	Regulation of viral transcription by chromatin structure has emerged as a fundamental determinant in the establishment of lytic and latent herpesvirus infections. The Polycomb group (PcG) of epigenetic repressors promotes heterochromatin formation by trimethylating histone H3 on lysine-27 (H3K27me3) and regulates development, stem cell renewal and differentiation and the cell cycle. These cellular processes are tightly coupled to the molecular switch between lytic and latent herpesvirus infections. Using chromatin immunoprecipitation analysis, we observed enrichment of H3K27me3 at the major immediate-early (MIE) locus of murine cytomegalovirus (MCMV) very early following infection of permissive fibroblasts. As lytic replication progressed, we observed a loss of H3K27me3 enrichment concomitant with the appearance of H3K4me3. However, late during infection, as viral replication centers are established, we observed a significant increase in PcG protein association with chromatin. Additionally, in co-immunofluorescence assays using confocal microscopy, we detected strong enrichments for PcG protein within the viral replication compartment, suggesting an association between viral DNA synthesis machinery and PcG proteins. Together, our results suggest a novel, dynamic interaction between PcG epigenetic repressors and MCMV genomes.	[Abraham, Christopher G.; Kulesza, Caroline A.] Univ Colorado, Dept Microbiol, Sch Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Abraham, CG (corresponding author), Univ Colorado, Dept Microbiol, Sch Med, Aurora, CO 80045 USA.	caroline.kulesza@ucdenver.edu			University of Colorado Denver School of Medicine;  [T32AI052066]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052066] Funding Source: NIH RePORTER	University of Colorado Denver School of Medicine; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by University of Colorado Denver School of Medicine Academic Enhancement Funds to CAK. CGA is supported by the pre-doctoral training grant T32AI052066. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Aoto T, 2008, J BIOL CHEM, V283, P18905, DOI 10.1074/jbc.M709322200; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bartova E, 2008, J HISTOCHEM CYTOCHEM, V56, P711, DOI 10.1369/jhc.2008.951251; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Castillo JP, 2002, GENE, V290, P19, DOI 10.1016/S0378-1119(02)00566-8; Cliffe AR, 2009, J VIROL, V83, P8182, DOI 10.1128/JVI.00712-09; Cuevas-Bennett C, 2008, J VIROL, V82, P9525, DOI 10.1128/JVI.00946-08; Dittmer D, 1997, J VIROL, V71, P1629, DOI 10.1128/JVI.71.2.1629-1634.1997; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Francis NJ, 2009, CELL CYCLE, V8, P3521, DOI 10.4161/cc.8.21.9876; Giordani NV, 2008, J VIROL, V82, P6056, DOI 10.1128/JVI.02661-07; Groves IJ, 2009, J GEN VIROL, V90, P2364, DOI 10.1099/vir.0.012526-0; Gunther T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000935; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; Ioudinkova E, 2006, GENE, V384, P120, DOI 10.1016/j.gene.2006.07.021; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kurz SK, 1999, J VIROL, V73, P8612, DOI 10.1128/JVI.73.10.8612-8622.1999; Kwiatkowski DL, 2009, J VIROL, V83, P8173, DOI 10.1128/JVI.00686-09; Liu XF, 2008, J VIROL, V82, P10922, DOI 10.1128/JVI.00865-08; Liu XF, 2010, J VIROL, V84, P3631, DOI 10.1128/JVI.02380-09; Lukashchuk V, 2008, J VIROL, V82, P12543, DOI 10.1128/JVI.01215-08; Martinez AM, 2006, CELL CYCLE, V5, P1189, DOI 10.4161/cc.5.11.2781; Mocarski E., 2007, FIELDS VIROLOGY; Murphy JC, 2002, EMBO J, V21, P1112, DOI 10.1093/emboj/21.5.1112; Nevels M, 2004, P NATL ACAD SCI USA, V101, P17234, DOI 10.1073/pnas.0407933101; Nitzsche A, 2008, J VIROL, V82, P11167, DOI 10.1128/JVI.01218-08; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Reddehase MJ, 2002, J CLIN VIROL, V25, pS23; Reeves MB, 2005, J GEN VIROL, V86, P2949, DOI 10.1099/vir.0.81161-0; Reeves MB, 2005, P NATL ACAD SCI USA, V102, P4140, DOI 10.1073/pnas.0408994102; Sanchez V, 2003, J VIROL, V77, P13214, DOI 10.1128/JVI.77.24.13214-13224.2003; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sinclair J, 2008, J CLIN VIROL, V41, P180, DOI 10.1016/j.jcv.2007.11.014; SMITH MG, 1954, P SOC EXP BIOL MED, V86, P435; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Takacs M, 2010, BBA-GENE REGUL MECH, V1799, P228, DOI 10.1016/j.bbagrm.2009.10.005; Terhune SS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000965; Toth Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001013; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Wagner M, 1999, J VIROL, V73, P7056, DOI 10.1128/JVI.73.8.7056-7060.1999; Wang QY, 2005, P NATL ACAD SCI USA, V102, P16055, DOI 10.1073/pnas.0505850102; Zhang ZG, 2003, J VIROL, V77, P12660, DOI 10.1128/JVI.77.23.12660-12670.2003	49	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29410	10.1371/journal.pone.0029410	http://dx.doi.org/10.1371/journal.pone.0029410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279536	Green Published, Green Submitted, gold			2022-12-27	WOS:000299771900014
J	Brandman, R; Brandman, Y; Pande, VS				Brandman, Relly; Brandman, Yigal; Pande, Vijay S.			Sequence Coevolution between RNA and Protein Characterized by Mutual Information between Residue Triplets	PLOS ONE			English	Article							HIGH-RESOLUTION STRUCTURES; RIBOSOME; ACID; EVOLUTION	Coevolving residues in a multiple sequence alignment provide evolutionary clues of biophysical interactions in 3D structure. Despite a rich literature describing amino acid coevolution within or between proteins and nucleic acid coevolution within RNA, to date there has been no direct evidence of coevolution between protein and RNA. The ribosome, a structurally conserved macromolecular machine composed of over 50 interacting protein and RNA chains, provides a natural example of RNA/protein interactions that likely coevolved. We provide the first direct evidence of RNA/protein coevolution by characterizing the mutual information in residue triplets from a multiple sequence alignment of ribosomal protein L22 and neighboring 23S RNA. We define residue triplets as three positions in the multiple sequence alignment, where one position is from the 23S RNA and two positions are from the L22 protein. We show that residue triplets with high mutual information are more likely than residue doublets to be proximal in 3D space. Some high mutual information residue triplets cluster in a connected series across the L22 protein structure, similar to patterns seen in protein coevolution. We also describe RNA nucleotides for which switching from one nucleotide to another (or between purines and pyrimidines) results in a change in amino acid distribution for proximal amino acid positions. Multiple crystal structures for evolutionarily distinct ribosome species can provide structural evidence for these differences. For one residue triplet, a pyrimidine in one species is a purine in another, and RNA/protein hydrogen bonds are present in one species but not the other. The results provide the first direct evidence of RNA/protein coevolution by using higher order mutual information, suggesting that biophysical constraints on interacting RNA and protein chains are indeed a driving force in their evolution.	[Brandman, Relly; Brandman, Yigal; Pande, Vijay S.] Stanford Univ, Stanford, CA 94305 USA	Stanford University	Brandman, R (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	pande@stanford.edu	Pande, Vijay/ABE-8145-2020		Stanford Bio-X	Stanford Bio-X	RB is funded by a Stanford Bio-X Graduate Student Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashan A, 2008, TRENDS MICROBIOL, V16, P326, DOI 10.1016/j.tim.2008.05.001; Berisio R, 2003, NAT STRUCT BIOL, V10, P366, DOI 10.1038/nsb915; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Cheng AC, 2003, J MOL BIOL, V327, P781, DOI 10.1016/S0022-2836(03)00091-3; CHIU DKY, 1991, COMPUT APPL BIOSCI, V7, P347; Cover T. M., 1991, ELEMENTS INFORM THEO; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; LEVITT M, 1969, NATURE, V224, P759, DOI 10.1038/224759a0; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Morozova N, 2006, BIOINFORMATICS, V22, P2746, DOI 10.1093/bioinformatics/btl470; Poon A, 2005, GENETICS, V170, P989, DOI 10.1534/genetics.104.039438; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Unge J, 1998, STRUCTURE, V6, P1577, DOI 10.1016/S0969-2126(98)00155-5; Wollenberg KR, 2000, P NATL ACAD SCI USA, V97, P3288, DOI 10.1073/pnas.070154797; YANOFSKY C, 1964, SCIENCE, V146, P1593, DOI 10.1126/science.146.3651.1593; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211	23	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30022	10.1371/journal.pone.0030022	http://dx.doi.org/10.1371/journal.pone.0030022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279560	gold, Green Published, Green Submitted			2022-12-27	WOS:000299771900038
J	Chappell, JM; Iqbal, A; Abbott, D				Chappell, James M.; Iqbal, Azhar; Abbott, Derek			Analysis of Two-Player Quantum Games in an EPR Setting Using Clifford's Geometric Algebra	PLOS ONE			English	Article							HILBERT-SPACE; STRATEGIES; ENTANGLEMENT; STATES	The framework for playing quantum games in an Einstein-Podolsky-Rosen (EPR) type setting is investigated using the mathematical formalism of geometric algebra (GA). The main advantage of this framework is that the players' strategy sets remain identical to the ones in the classical mixed-strategy version of the game, and hence the quantum game becomes a proper extension of the classical game, avoiding a criticism of other quantum game frameworks. We produce a general solution for two-player games, and as examples, we analyze the games of Prisoners' Dilemma and Stag Hunt in the EPR setting. The use of GA allows a quantum-mechanical analysis without the use of complex numbers or the Dirac Bra-ket notation, and hence is more accessible to the non-physicist.	[Chappell, James M.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA, Australia; [Chappell, James M.; Iqbal, Azhar; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Chappell, JM (corresponding author), Univ Adelaide, Sch Chem & Phys, Adelaide, SA, Australia.	james.m.chappell@adelaide.edu.au	Abbott, Derek/E-8352-2011; Iqbal, Azhar/E-8749-2011	Abbott, Derek/0000-0002-0945-2674; Iqbal, Azhar/0000-0002-5221-9384				Aharon N, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.052310; Ahmed A, 2008, ARXIV08081391; ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Bell J. S., 1964, PHYSICS, V1, P195, DOI [10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Bell J. S., 1987, QUANTUM MECH; BELL JS, 1966, REV MOD PHYS, V38, P447, DOI 10.1103/RevModPhys.38.447; Benjamin SC, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.030301; Binmore K., 2007, GAME THEORY VERY SHO, V173; Blaquiere A., 1980, DYNAMICAL SYSTEMS MI, P33, DOI 10.1007/978-3-7091-4330-8_2; Bleiler SA, 2008, ARXIV08081389; Bohm D., 1951, QUANTUM THEORY; Cereceda JL, 2000, FOUND PHYS LETT, V13, P427, DOI 10.1023/A:1007828731477; Chappell J, 2011, ARXIV11013619; Chappell J, 2011, ARXIV11063748; Chappell JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021623; Chappell JM, 2010, PHYS LETT A, V374, P4104, DOI 10.1016/j.physleta.2010.08.024; Chappell JM, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.054801; Cheon T, 2006, PHYS LETT A, V348, P147, DOI 10.1016/j.physleta.2005.08.066; Cheon T, 2006, AIP CONF PROC, V864, P254, DOI 10.1063/1.2400897; Christian J, 2007, QUANTPH0703179 ARXIV; CHRISTIAN J, 2011, ARXIV11060748; CLAUSER JF, 1978, REP PROG PHYS, V41, P1881, DOI 10.1088/0034-4885/41/12/002; de Sabbata V., 2007, GEOMETRIC ALGEBRA AP; Doran C., 2003, GEOMETRIC ALGEBRA PH, DOI DOI 10.1017/CBO9780511807497; Du JF, 2002, PHYS LETT A, V302, P229, DOI 10.1016/S0375-9601(02)01144-1; Du JF, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137902; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Eisert J, 1999, PHYS REV LETT, V83, P3077, DOI 10.1103/PhysRevLett.83.3077; Flitney AP, 2002, FLUCT NOISE LETT, V2, pR175, DOI 10.1142/S0219477502000981; Flitney AP, 2007, PHYS LETT A, V363, P381, DOI 10.1016/j.physleta.2006.11.044; Flitney AP, 2005, J PHYS A-MATH GEN, V38, P449, DOI 10.1088/0305-4470/38/2/011; Flitney AP, 2003, P ROY SOC A-MATH PHY, V459, P2463, DOI 10.1098/rspa.2003.1136; Guo H, 2008, DECIS SUPPORT SYST, V46, P318, DOI 10.1016/j.dss.2008.07.001; Havel T, 2004, QUANTPH0403136 ARXIV; HESTENES D, 1984, CLIFFORD ALGEBRA GEO, V5; Hestenes D., 1999, NEW FDN CLASSICAL ME, VSecond; Ichikawa T, 2007, ANN PHYS-NEW YORK, V322, P531, DOI 10.1016/j.aop.2006.05.001; Ichikawa T, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/13/135303; Iqbal A, 2005, J PHYS A-MATH GEN, V38, P9551, DOI 10.1088/0305-4470/38/43/009; Iqbal A, 2004, J PHYS A-MATH GEN, V37, P5873, DOI 10.1088/0305-4470/37/22/012; Iqbal A, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.052328; Iqbal A, 2001, PHYS LETT A, V280, P249, DOI 10.1016/S0375-9601(01)00082-2; Iqbal A, 2009, PHYS LETT A, V373, P2537, DOI 10.1016/j.physleta.2009.05.020; Iqbal A, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.014803; Iqbal A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061122; Iqbal A, 2008, PHYS LETT A, V372, P6564, DOI 10.1016/j.physleta.2008.09.026; Johnson N, 2001, PHYS REV A, V63; Li Q, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/44/445303; Marinatto L, 2000, PHYS LETT A, V272, P291, DOI 10.1016/S0375-9601(00)00441-2; Mendes RV, 2005, QUANTUM INF PROCESS, V4, P1, DOI 10.1007/s11128-005-3192-7; MERMIN ND, 1990, AM J PHYS, V58, P731, DOI 10.1119/1.16503; MERMIN ND, 1990, PHYS REV LETT, V65, P1838, DOI 10.1103/PhysRevLett.65.1838; Meyer DA, 1999, PHYS REV LETT, V82, P1052, DOI 10.1103/PhysRevLett.82.1052; Nawaz A, 2004, J PHYS A-MATH GEN, V37, P11457, DOI 10.1088/0305-4470/37/47/014; Ozdemir SK, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/2/043; Parker R, 2001, QUANTPH0106055 ARXIV; Peres Asher., 1993, QUANTUM THEORY CONCE, V57; Piotrowski EW, 2003, INT J THEOR PHYS, V42, P1089, DOI 10.1023/A:1025443111388; Piotrowski EW, 2002, PHYSICA A, V312, P208, DOI 10.1016/S0378-4371(02)00842-7; Ramzan M, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/5/055307; Rasmusen E., 2007, GAMES INFORM INTRO G; Shimamura J, 2004, INT J QUANTUM INF, V2, P79, DOI 10.1142/S0219749904000092; Shimamura J, 2004, PHYS LETT A, V328, P20, DOI 10.1016/j.physleta.2004.06.006; Szekeres P, 2004, COURSE MODERN MATH P; Vaidman L, 1999, FOUND PHYS, V29, P755, DOI 10.1023/A:1018826607583; van Enk SJ, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.024306; Wiesner S., 1983, SIGACT News, V15, P78, DOI 10.1145/1008908.1008920	67	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29015	10.1371/journal.pone.0029015	http://dx.doi.org/10.1371/journal.pone.0029015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279525	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900003
J	Toda, K; Sugase-Miyamoto, Y; Mizuhiki, T; Inaba, K; Richmond, BJ; Shidara, M				Toda, Koji; Sugase-Miyamoto, Yasuko; Mizuhiki, Takashi; Inaba, Kiyonori; Richmond, Barry J.; Shidara, Munetaka			Differential Encoding of Factors Influencing Predicted Reward Value in Monkey Rostral Anterior Cingulate Cortex	PLOS ONE			English	Article							PRIMATE FRONTAL-CORTEX; ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; NEURONAL SIGNALS; DOPAMINE NEURONS; MACAQUE MONKEY; RHESUS-MONKEY; CONNECTIONS; AMYGDALA; MOTIVATION	Background: The value of a predicted reward can be estimated based on the conjunction of both the intrinsic reward value and the length of time to obtain it. The question we addressed is how the two aspects, reward size and proximity to reward, influence the responses of neurons in rostral anterior cingulate cortex (rACC), a brain region thought to play an important role in reward processing. Methods and Findings: We recorded from single neurons while two monkeys performed a multi-trial reward schedule task. The monkeys performed 1-4 sequential color discrimination trials to obtain a reward of 1-3 liquid drops. There were two task conditions, a valid cue condition, where the number of trials and reward amount were associated with visual cues, and a random cue condition, where the cue was picked from the cue set at random. In the valid cue condition, the neuronal firing is strongly modulated by the predicted reward proximity during the trials. Information about the predicted reward amount is almost absent at those times. In substantial subpopulations, the neuronal responses decreased or increased gradually through schedule progress to the predicted outcome. These two gradually modulating signals could be used to calculate the effect of time on the perception of reward value. In the random cue condition, little information about the reward proximity or reward amount is encoded during the course of the trial before reward delivery, but when the reward is actually delivered the responses reflect both the reward proximity and reward amount. Conclusions: Our results suggest that the rACC neurons encode information about reward proximity and amount in a manner that is dependent on utility of reward information. The manner in which the information is represented could be used in the moment-to-moment calculation of the effect of time and amount on predicted outcome value.	[Toda, Koji; Mizuhiki, Takashi; Inaba, Kiyonori; Shidara, Munetaka] Univ Tsukuba, Doctoral Program Kansei Behav & Brain Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Sugase-Miyamoto, Yasuko] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan; [Mizuhiki, Takashi; Shidara, Munetaka] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Richmond, Barry J.] NIMH, Neuropsychol Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Toda, K (corresponding author), Univ Tsukuba, Doctoral Program Kansei Behav & Brain Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan.	mshidara@md.tsukuba.ac.jp	sugase-miyamoto, yasuko/N-2769-2016	sugase-miyamoto, yasuko/0000-0003-3097-3789	Ministry of Education, Culture, Sports, Science and Technology of Japan [17022052]; 21st Century COE; AIST/Japan; US National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002619] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 21st Century COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AIST/Japan; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported by Grant-in-Aid for JSPS Fellows (KT), Grant-in-Aid for Scientific Research on Priority Areas -System study on higher-order brain functions-from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant No. 17022052 to MS), and 21st Century COE Program (MS) and AIST/Japan (YS). BJR is supported by the Intramural Research Program of the US National Institute of Mental Health. The authors thank JSPS for providing travel support for BJR in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1977, P IEEE, V65, P762, DOI 10.1109/PROC.1977.10559; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; ARIKUNI T, 1994, NEUROSCI RES, V21, P19, DOI 10.1016/0168-0102(94)90065-5; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Belova MA, 2008, J NEUROSCI, V28, P10023, DOI 10.1523/JNEUROSCI.1400-08.2008; Bermudez MA, 2010, J NEUROPHYSIOL, V104, P3424, DOI 10.1152/jn.00540.2010; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Fiorillo CD, 2008, NAT NEUROSCI, V11, P966, DOI 10.1038/nn.2159; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; GOLDMANRAKIC PS, 1989, P NATL ACAD SCI USA, V86, P9015, DOI 10.1073/pnas.86.22.9015; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Hayden BY, 2011, J NEUROSCI, V31, P4178, DOI 10.1523/JNEUROSCI.4652-10.2011; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; HAYS AV, 1982, WESCON C P, P1; Hikosaka K, 2004, EUR J NEUROSCI, V19, P1046, DOI 10.1111/j.0953-816X.2004.03120.x; Hosokawa T, 2007, NEUROSCI RES, V57, P434, DOI 10.1016/j.neures.2006.12.003; Isomura Y, 2003, J NEUROSCI, V23, P8002; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Kennerley SW, 2009, J NEUROPHYSIOL, V102, P3352, DOI 10.1152/jn.00273.2009; Kennerley SW, 2009, EUR J NEUROSCI, V29, P2061, DOI 10.1111/j.1460-9568.2009.06743.x; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kobayashi S, 2008, J NEUROSCI, V28, P7837, DOI 10.1523/JNEUROSCI.1600-08.2008; Kondo H, 2005, J COMP NEUROL, V493, P479, DOI 10.1002/cne.20796; La Camera G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000131; Lee D, 2007, J NEUROSCI, V27, P8170, DOI 10.1523/JNEUROSCI.1561-07.2007; Liu Z, 2000, J NEUROPHYSIOL, V83, P1677, DOI 10.1152/jn.2000.83.3.1677; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Minamimoto T, 2009, J NEUROPHYSIOL, V101, P437, DOI 10.1152/jn.90959.2008; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Sallet J, 2007, COGN AFFECT BEHAV NE, V7, P327, DOI 10.3758/CABN.7.4.327; SAUNDERS RC, 1990, EXP BRAIN RES, V81, P443; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Shidara M, 1998, J NEUROSCI, V18, P2613; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Simmons JM, 2008, CEREB CORTEX, V18, P93, DOI 10.1093/cercor/bhm034; Simmons JM, 2010, J NEUROSCI, V30, P15878, DOI 10.1523/JNEUROSCI.1802-10.2010; Sugase-Miyamoto Y, 2005, J NEUROSCI, V25, P11071, DOI 10.1523/JNEUROSCI.1796-05.2005; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Van Hoesen G. W. M., 1993, NEUROBIOLOGY CINGULA, P249, DOI DOI 10.1007/978-1-4899-6704-6_9; Venables WN., 2002, MODERN APPL STAT S 4; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Walton ME, 2007, COGN AFFECT BEHAV NE, V7, P413, DOI 10.3758/CABN.7.4.413; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321; WILLIAMS SM, 1993, CEREB CORTEX, V3, P199, DOI 10.1093/cercor/3.3.199; Yukie M, 2009, CINGULATE NEUROBIOLO, P145	59	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30190	10.1371/journal.pone.0030190	http://dx.doi.org/10.1371/journal.pone.0030190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279569	Green Submitted, Green Published, gold			2022-12-27	WOS:000299771900047
J	Zhang, YW; Luo, YL; Tian, JQ; Asiri, AM; Al-Youbi, AO; Sun, XP				Zhang, Yingwei; Luo, Yonglan; Tian, Jingqi; Asiri, Abdullah M.; Al-Youbi, Abdulrahman O.; Sun, Xuping			Rectangular Coordination Polymer Nanoplates: Large-Scale, Rapid Synthesis and Their Application as a Fluorescent Sensing Platform for DNA Detection	PLOS ONE			English	Article							PROBES; NANOBELTS; ABILITY	In this paper, we report on the large-scale, rapid synthesis of uniform rectangular coordination polymer nanoplates (RCPNs) assembled from Cu(II) and 4,4'-bipyridine for the first time. We further demonstrate that such RCPNs can be used as a very effective fluorescent sensing platform for multiple DNA detection with a detection limit as low as 30 pM and a high selectivity down to single-base mismatch. The DNA detection is accomplished by the following two steps: (1) RCPN binds dye-labeled single-stranded DNA (ssDNA) probe, which brings dye and RCPN into close proximity, leading to fluorescence quenching; (2) Specific hybridization of the probe with its target generates a double-stranded DNA (dsDNA) which detaches from RCPN, leading to fluorescence recovery. It suggests that this sensing system can well discriminate complementary and mismatched DNA sequences. The exact mechanism of fluorescence quenching involved is elucidated experimentally and its use in a human blood serum system is also demonstrated successfully.	[Zhang, Yingwei; Luo, Yonglan; Tian, Jingqi; Sun, Xuping] Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun, Jilin, Peoples R China; [Tian, Jingqi] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Asiri, Abdullah M.; Al-Youbi, Abdulrahman O.; Sun, Xuping] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia; [Asiri, Abdullah M.; Al-Youbi, Abdulrahman O.; Sun, Xuping] King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah 21413, Saudi Arabia	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; King Abdulaziz University; King Abdulaziz University	Zhang, YW (corresponding author), Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun, Jilin, Peoples R China.	sunxp@ciac.jl.cn	alyoubi, Abdulrahman/G-5962-2011; Asiri, Abdullah M./C-3458-2009	Asiri, Abdullah M./0000-0001-7905-3209; TIAN, Jingqi/0000-0002-3695-7563	National Basic Research Program of China [2011CB935800]; National Natural Science Foundation of China [21175129]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (No. 2011CB935800) and the National Natural Science Foundation of China (No. 21175129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARD V, 2001, MOL FLUROSCENCE PRIN; BURR HE, 1982, NUCLEIC ACIDS RES, V10, P719, DOI 10.1093/nar/10.2.719; Dubertret B, 2001, NAT BIOTECHNOL, V19, P365, DOI 10.1038/86762; Eddaoudi M, 2001, ACCOUNTS CHEM RES, V34, P319, DOI 10.1021/ar000034b; Gao H, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/28/285203; Gopi A, 2007, CHEST, V131, P880, DOI 10.1378/chest.06-2063; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; He SJ, 2010, ADV FUNCT MATER, V20, P453, DOI 10.1002/adfm.200901639; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; James SL, 2003, CHEM SOC REV, V32, P276, DOI 10.1039/b200393g; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Li D, 2010, ACCOUNTS CHEM RES, V43, P631, DOI 10.1021/ar900245u; Li HL, 2011, SMALL, V7, P1562, DOI 10.1002/smll.201100068; Li HL, 2011, MACROMOL RAPID COMM, V32, P899, DOI 10.1002/marc.201100108; Li HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018958; Li HL, 2011, CHEM COMMUN, V47, P2625, DOI 10.1039/c0cc05394e; Li HL, 2011, CHEM COMMUN, V47, P961, DOI 10.1039/c0cc04326e; Li HX, 2004, ANAL CHEM, V76, P5414, DOI 10.1021/ac049173n; Liu S, 2011, NANOSCALE, V3, P967, DOI 10.1039/c0nr00873g; Lu CH, 2009, ANGEW CHEM INT EDIT, V48, P4785, DOI 10.1002/anie.200901479; Luo YL, 2011, ELECTROCHIM ACTA, V56, P8371, DOI 10.1016/j.electacta.2011.07.024; MASLAK P, 1991, J AM CHEM SOC, V113, P1062, DOI 10.1021/ja00003a061; Maxwell DJ, 2002, J AM CHEM SOC, V124, P9606, DOI 10.1021/ja025814p; Mederos A, 1999, COORDIN CHEM REV, V193-5, P857, DOI 10.1016/S0010-8545(99)00050-8; Mederos A, 1999, COORDIN CHEM REV, V193-5, P913, DOI 10.1016/S0010-8545(99)00084-3; Moeller R., 2005, IEE Proceedings Nanobiotechnology, V152, P47, DOI 10.1049/ip-nbt:20045020; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; Ray PC, 2007, PLASMONICS, V2, P173, DOI 10.1007/s11468-007-9036-9; Song SP, 2009, ANGEW CHEM INT EDIT, V48, P8670, DOI 10.1002/anie.200901887; Spokoyny AM, 2009, CHEM SOC REV, V38, P1218, DOI 10.1039/b807085g; Sun XP, 2005, J AM CHEM SOC, V127, P13102, DOI 10.1021/ja0534809; Tian JQ, 2011, LANGMUIR, V27, P874, DOI 10.1021/la103799e; Varghese N, 2009, CHEMPHYSCHEM, V10, P206, DOI 10.1002/cphc.200800459; Wang L, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1294; Yang RH, 2008, ANAL CHEM, V80, P7408, DOI 10.1021/ac801118p; Yang RH, 2008, J AM CHEM SOC, V130, P8351, DOI 10.1021/ja800604z; Zhang YW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020569; Zhang YW, 2011, LANGMUIR, V27, P2170, DOI 10.1021/la105092f	38	37	42	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30426	10.1371/journal.pone.0030426	http://dx.doi.org/10.1371/journal.pone.0030426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279589	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900066
J	Tronholm, A; Leliaert, F; Sanson, M; Afonso-Carrillo, J; Tyberghein, L; Verbruggen, H; De Clerck, O				Tronholm, Ana; Leliaert, Frederik; Sanson, Marta; Afonso-Carrillo, Julio; Tyberghein, Lennert; Verbruggen, Heroen; De Clerck, Olivier			Contrasting Geographical Distributions as a Result of Thermal Tolerance and Long-Distance Dispersal in Two Allegedly Widespread Tropical Brown Algae	PLOS ONE			English	Article							SPECIES DELIMITATION; PROPAGULE DISPERSAL; MOLECULAR PHYLOGENY; DNA TAXONOMY; MARINE; PACIFIC; CHLOROPHYTA; EVOLUTION; GENUS; BIOGEOGRAPHY	Background: Many tropical marine macroalgae are reported from all three ocean basins, though these very wide distributions may simply be an artifact resulting from inadequate taxonomy that fails to take into account cryptic diversity. Alternatively, pantropical distributions challenge the belief of limited intrinsic dispersal capacity of marine seaweeds and the effectiveness of the north-south oriented continents as dispersal barriers. We aimed to re-assess the distribution of two allegedly circumtropical brown algae, Dictyota ciliolata and D. crenulata, and interpret the realized geographical range of the respective species in relation to their thermal tolerance and major tectonic and climatic events during the Cenozoic. Methodology/Principal Findings: Species delimitation was based on 184 chloroplast encoded psbA sequences, using a Generalized Mixed Yule Coalescent method. Phylogenetic relationships were inferred by analyzing a six-gene dataset. Divergence times were estimated using relaxed molecular clock methods and published calibration data. Distribution ranges of the species were inferred from DNA-confirmed records, complemented with credible literature data and herbarium vouchers. Temperature tolerances of the species were determined by correlating distribution records with local SST values. We found considerable conflict between traditional and DNA-based species definitions. Dictyota crenulata consists of several pseudocryptic species, which have restricted distributions in the Atlantic Ocean and Pacific Central America. In contrast, the pantropical distribution of D. ciliolata is confirmed and linked to its significantly wider temperature tolerance. Conclusions/Significance: Tectonically driven rearrangements of physical barriers left an unequivocal imprint on the current diversity patterns of marine macroalgae, as witnessed by the D. crenulata-complex. The nearly circumglobal tropical distribution of D. ciliolata, however, demonstrates that the north-south oriented continents do not present absolute dispersal barriers for species characterized by wide temperature tolerances.	[Tronholm, Ana; Leliaert, Frederik; Tyberghein, Lennert; Verbruggen, Heroen; De Clerck, Olivier] Univ Ghent, Phycol Res Grp, B-9000 Ghent, Belgium; [Tronholm, Ana; Leliaert, Frederik; Tyberghein, Lennert; Verbruggen, Heroen; De Clerck, Olivier] Univ Ghent, Ctr Mol Phylogenet & Evolut, B-9000 Ghent, Belgium; [Tronholm, Ana; Sanson, Marta; Afonso-Carrillo, Julio] Univ La Laguna, Dept Biol Vegetal Bot, E-38207 San Cristobal la Laguna, Canary Islands, Spain	Ghent University; Ghent University; Universidad de la Laguna	Tronholm, A (corresponding author), Univ Ghent, Phycol Res Grp, B-9000 Ghent, Belgium.	olivier.declerck@ugent.be	Verbruggen, Heroen/C-6951-2009; Leliaert, Frederik/A-9162-2009; Sansón, Marta/F-9070-2016; De Clerck, Olivier/A-9083-2010; Afonso-Carrillo, Julio/ABE-7384-2021; Afonso-Carrillo, Julio/ABF-1398-2020; De Clerck, Olivier/ABC-2683-2020; De Clerck, Olivier/AAU-4295-2020	Verbruggen, Heroen/0000-0002-6305-4749; Leliaert, Frederik/0000-0002-4627-7318; De Clerck, Olivier/0000-0002-3699-8402; Afonso-Carrillo, Julio/0000-0001-9455-6904; De Clerck, Olivier/0000-0002-3699-8402; Sanson, Marta/0000-0003-0531-1484; Tronholm, Ana/0000-0002-0151-2804	Canarian Agency for Research, Innovation and Information Society (ACIISI); Research Foundation-Flanders (FWO) [G.0142.05]; Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT); King Leopold III Fund for Nature Exploration and Conservation	Canarian Agency for Research, Innovation and Information Society (ACIISI); Research Foundation-Flanders (FWO)(FWO); Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); King Leopold III Fund for Nature Exploration and Conservation	AT was funded through a PhD fellowship from the Canarian Agency for Research, Innovation and Information Society (ACIISI). Funding was provided by the Research Foundation-Flanders (FWO, research grant G.0142.05 and postdoctoral fellowships to FL and HV). LT is funded by the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT), and received support from the King Leopold III Fund for Nature Exploration and Conservation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott IA, 2004, MARINE GREEN BROWN A; Bijl PK, 2009, NATURE, V461, P776, DOI 10.1038/nature08399; Breeman AM, 2002, EUR J PHYCOL, V37, P45, DOI 10.1017/S0967026201003420; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; BRIGGS JC, 1961, EVOLUTION, V15, P545, DOI 10.2307/2406322; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Clarke Andrew, 2009, P250; Coates Anthony G., 1996, P21; Coyne J.A., 2004, SPECIATION; De Clerck O, 2005, J PHYCOL, V41, P391, DOI 10.1111/j.1529-8817.2005.04189.x; De Clerck O., 2003, GENUS DICTYOTA INDIA; De Clerck O, 2006, J PHYCOL, V42, P1271, DOI 10.1111/j.1529-8817.2006.00279.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fama P, 2002, J PHYCOL, V38, P1040, DOI 10.1046/j.1529-8817.2002.t01-1-01237.x; Frey MA, 2008, MOL PHYLOGENET EVOL, V48, P1067, DOI 10.1016/j.ympev.2008.05.009; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Herren LW, 2006, CORAL REEFS, V25, P287, DOI 10.1007/s00338-006-0096-7; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hwang Il-Ki, 2004, Algae, V19, P161; Hwang Il-Ki, 2004, ALGAE, V19, P175; Hwang IK, 2009, PHYCOLOGIA, V48, P1, DOI 10.2216/07-68.1; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; John D. M, 2004, NOVA HEDWIGIA S, V127, P139; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Kinlan BP, 2005, DIVERS DISTRIB, V11, P139, DOI 10.1111/j.1366-9516.2005.00158.x; Kooistra WHCF, 2002, MOL PHYLOGENET EVOL, V24, P121, DOI 10.1016/S1055-7903(02)00221-X; Kraft GT, 2009, MARINE BETHIC ALGAE; Leliaert F, 2009, MOL PHYLOGENET EVOL, V53, P122, DOI 10.1016/j.ympev.2009.06.004; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Lessios HA, 2006, P ROY SOC B-BIOL SCI, V273, P2201, DOI 10.1098/rspb.2006.3543; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Maggs C A, 2007, UNRAVELLING ALGAE PR, V75, P103, DOI DOI 10.1201/9780849379901.CH6; Malaquias MAE, 2009, J BIOGEOGR, V36, P1760, DOI 10.1111/j.1365-2699.2009.02118.x; Marko PB, 2002, MOL BIOL EVOL, V19, P2005, DOI 10.1093/oxfordjournals.molbev.a004024; Marlow JR, 2000, SCIENCE, V290, P2288; McCartney MA, 2000, MOL ECOL, V9, P1391, DOI 10.1046/j.1365-294x.2000.01022.x; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; NORTON TA, 1992, BRIT PHYCOL J, V27, P293, DOI 10.1080/00071619200650271; O'Dea A, 2007, P NATL ACAD SCI USA, V104, P5501, DOI 10.1073/pnas.0610947104; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Paulay G, 2002, INTEGR COMP BIOL, V42, P922, DOI 10.1093/icb/42.5.922; Pedroche PF, 2008, CATALOGO ALGAS BENTO; Peeters FJC, 2004, NATURE, V430, P661, DOI 10.1038/nature02785; PIELOU EC, 1977, J BIOGEOGR, V4, P299, DOI 10.2307/3038189; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; POR FD, 1971, SYST ZOOL, V20, P138, DOI 10.2307/2412054; Rambaut A., 2007, TRACER V1 4; Rogl F., 1984, GEOL J, P171; SANTELICES B, 1990, OCEANOGR MAR BIOL, V28, P177; SANTELICES B, 1980, PHYCOLOGIA, V19, P1, DOI 10.2216/i0031-8884-19-1-1.1; Santelices Bernabe, 1998, Diversity and Distributions, V4, P71, DOI 10.1046/j.1472-4642.1998.00005.x; Schneider C.W, 1991, SEAWEEDS SE US; Setchell WA, 1915, ANN MO BOT GARD, V2, P287; SHANNON LV, 1985, OCEANOGR MAR BIOL, V23, P105; Silberfeld T, 2010, MOL PHYLOGENET EVOL, V56, P659, DOI 10.1016/j.ympev.2010.04.020; Silva P.C., 1996, CATALOGUE BENTHIC MA; Stam WT, 2006, J PHYCOL, V42, P1113, DOI 10.1111/j.1529-8817.2006.00271.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLOR W. R., 1960, MARINE ALGAE E TROPI; Tronholm A, 2010, THESIS U LA LAGUNA L; Tronholm A, 2010, J PHYCOL, V46, P1301, DOI 10.1111/j.1529-8817.2010.00908.x; Tyberghein L, 2011, GLOBAL ECOL BIOGEOGR, DOI 0.1111/j.1466-8238.2011.00656.x; van der Strate HJ, 2002, J PHYCOL, V38, P572, DOI 10.1046/j.1529-8817.2002.t01-1-01170.x; VANDENHOEK C, 1987, HELGOLANDER MEERESUN, V41, P261; VANDENHOEK C, 1982, BIOL J LINN SOC, V18, P81; Verbruggen H, 2005, MOL PHYLOGENET EVOL, V37, P789, DOI 10.1016/j.ympev.2005.06.015; Verbruggen H, 2006, EUR J PHYCOL, V41, P337, DOI 10.1080/09670260600709315; Verbruggen H, 2009, GLOBAL ECOL BIOGEOGR, V18, P393, DOI 10.1111/j.1466-8238.2009.00463.x; Wysor B, 2003, BOT MAR, V46, P151, DOI 10.1515/BOT.2003.016; Zuccarello GC, 2002, EUR J PHYCOL, V37, P403, DOI 10.1017/S0967026202003827	71	38	39	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30813	10.1371/journal.pone.0030813	http://dx.doi.org/10.1371/journal.pone.0030813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292046	Green Published, gold			2022-12-27	WOS:000301703800032
J	Onyango, LA; Dunstan, RH; Gottfries, J; von Eiff, C; Roberts, TK				Onyango, Laura A.; Dunstan, R. Hugh; Gottfries, Johan; von Eiff, Christof; Roberts, Timothy K.			Effect of Low Temperature on Growth and Ultra-Structure of Staphylococcus spp	PLOS ONE			English	Article							SMALL-COLONY VARIANTS; COAGULASE-NEGATIVE STAPHYLOCOCCI; PACEMAKER-RELATED INFECTION; CELL-WALL; VANCOMYCIN RESISTANCE; PERSISTENT INFECTIONS; AUREUS STRAIN; EPIDERMIDIS; MODEL; PEPTIDOGLYCAN	The effect of temperature fluctuation is an important factor in bacterial growth especially for pathogens such as the staphylococci that have to remain viable during potentially harsh and prolonged transfer conditions between hosts. The aim of this study was to investigate the response of S. aureus, S. epidermidis, and S. lugdunensis when exposed to low temperature (4 degrees C) for prolonged periods, and how this factor affected their subsequent growth, colony morphology, cellular ultra-structure, and amino acid composition in the non-cytoplasmic hydrolysate fraction. Clinical isolates were grown under optimal conditions and then subjected to 4 degrees C conditions for a period of 8 wks. Cold-stressed and reference control samples were assessed under transmission electron microscopy (TEM) to identify potential ultra-structural changes. To determine changes in amino acid composition, cells were fractured to remove the lipid and cytoplasmic components and the remaining structural components were hydrolysed. Amino acid profiles for the hydrolysis fraction were then analysed for changes by using principal component analysis (PCA). Exposure of the three staphylococci to prolonged low temperature stress resulted in the formation of increasing proportions of small colony variant (SCV) phenotypes. TEM revealed that SCV cells had significantly thicker and more diffuse cell-walls than their corresponding WT samples for both S. aureus and S. epidermidis, but the changes were not significant for S. lugdunensis. Substantial species-specific alterations in the amino acid composition of the structural hydrolysate fraction were also observed in the cold-treated cells. The data indicated that the staphylococci responded over prolonged periods of cold-stress treatment by transforming into SCV populations. The observed ultra-structural and amino acid changes were proposed to represent response mechanisms for staphylococcal survival amidst hostile conditions, thus maintaining the viability of the species until favourable conditions arise again.	[Onyango, Laura A.; Dunstan, R. Hugh; Roberts, Timothy K.] Univ Newcastle, Sch Environm & Life Sci, Environm & Pathogen Microbiol Lab, Newcastle, NSW 2300, Australia; [Gottfries, Johan] Gothenburg Univ, Dept Chem, Gothenburg, Sweden; [von Eiff, Christof] Univ Munster, Inst Med Microbiol, Munster, Germany	University of Newcastle; University of Gothenburg; University of Munster	Onyango, LA (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Environm & Pathogen Microbiol Lab, Newcastle, NSW 2300, Australia.	Hugh.Dunstan@newcastle.edu.au	Gottfries, Johan/M-3445-2016; Roberts, Tim K/A-4286-2009; Onyango, Laura A./H-4675-2019	Gottfries, Johan/0000-0001-7135-4664; Onyango, Laura/0000-0002-5240-2023	University of Newcastle; Gideon Lang Scholarship; Harold Stannet Williams and Judith Mason research grant	University of Newcastle; Gideon Lang Scholarship; Harold Stannet Williams and Judith Mason research grant	This work was supported by a University of Newcastle International Scholarship, the Gideon Lang Scholarship and the Harold Stannet Williams and Judith Mason research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qatouseh LF, 2010, J MOL MED, V88, P565, DOI 10.1007/s00109-010-0597-2; Adler H, 2003, EUR J CLIN MICROBIOL, V22, P746, DOI 10.1007/s10096-003-1029-9; BADDOUR LM, 1988, J INFECT DIS, V157, P757, DOI 10.1093/infdis/157.4.757; Brown GK, 2001, AUST VET J, V79, P554, DOI 10.1111/j.1751-0813.2001.tb10747.x; Butt HL, 1998, J MED MICROBIOL, V47, P577, DOI 10.1099/00222615-47-7-577; Cui L, 2003, J CLIN MICROBIOL, V41, P5, DOI 10.1128/JCM.41.1.5-14.2003; Cui LZ, 2000, ANTIMICROB AGENTS CH, V44, P2276, DOI 10.1128/AAC.44.9.2276-2285.2000; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Dmitriev BA, 2004, J BACTERIOL, V186, P7141, DOI 10.1128/JB.186.21.7141-7148.2004; Dykstra MJ, 2003, BIOL ELECT MICROSCOP; Frank K. L., 2008, Clinical Microbiology Newsletter, V30, P55, DOI 10.1016/j.clinmicnews.2008.03.004; Glauert AM, 1975, FIXATION DEHYDRATION; Hanaki H, 1998, J ANTIMICROB CHEMOTH, V42, P315, DOI 10.1093/jac/42.3.315; Hoffstadt RE, 1932, J INFECT DIS, V51, P216, DOI 10.1093/infdis/51.2.216; HOGT AH, 1983, FEMS MICROBIOL LETT, V18, P211; Jackson JE, 1991, USERS GUIDE PRINCIPA; Jonsson IM, 2003, MICROB PATHOGENESIS, V34, P73, DOI 10.1016/S0882-4010(02)00208-5; Kahl BC, 2003, J CLIN MICROBIOL, V41, P410, DOI 10.1128/JCM.41.1.410-413.2003; Kipp F, 2004, J CLIN MICROBIOL, V42, P1277, DOI 10.1128/JCM.42.3.1277-1279.2004; Leung MJ, 1998, J CLIN MICROBIOL, V36, P3096, DOI 10.1128/JCM.36.10.3096-3098.1998; McNamara PJ, 2000, INT J ANTIMICROB AG, V14, P117, DOI 10.1016/S0924-8579(99)00170-3; Noskin GA, 2005, ARCH INTERN MED, V165, P1756, DOI 10.1001/archinte.165.15.1756; Onyango Laura A., 2008, Journal of Nutritional & Environmental Medicine (Abingdon), V17, P56, DOI 10.1080/13590840801887272; Prescott L.M, 2002, MICROBIOLOGY, V5th; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; SANYAL D, 1993, J MED MICROBIOL, V39, P204, DOI 10.1099/00222615-39-3-204; SCHABERG DR, 1991, AM J MED, V91, pS72, DOI 10.1016/0002-9343(91)90346-Y; Seifert H, 2005, EMERG INFECT DIS, V11, P1283, DOI 10.3201/eid1108.041177; Seifert H, 2003, EMERG INFECT DIS, V9, P1316; SHERRIS JC, 1952, J CLIN PATHOL, V5, P354, DOI 10.1136/jcp.5.4.354; Sianglum W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016628; Sieradzki K, 1997, J BACTERIOL, V179, P2557, DOI 10.1128/jb.179.8.2557-2566.1997; Sifri CD, 2006, INFECT IMMUN, V74, P1091, DOI 10.1128/IAI.74.2.1091-1096.2006; Singh VK, 2008, APPL ENVIRON MICROB, V74, P5882, DOI 10.1128/AEM.00882-08; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Vaudaux P, 2002, INFECT IMMUN, V70, P5428, DOI 10.1128/IAI.70.10.5428-5437.2002; von Eiff C, 2003, CURRENT PERSPECTIVES, P253; von Eiff C, 2006, INJURY, V37, P26, DOI 10.1016/j.injury.2006.04.006; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639	40	49	49	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e29031	10.1371/journal.pone.0029031	http://dx.doi.org/10.1371/journal.pone.0029031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291884	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600001
J	Eren, MI; Lycett, SJ				Eren, Metin I.; Lycett, Stephen J.			Why Levallois? A Morphometric Comparison of Experimental 'Preferential' Levallois Flakes versus Debitage Flakes	PLOS ONE			English	Article							MIDDLE STONE-AGE; TECHNOLOGY; EVOLUTION; ORIGINS; CORES; SHAPE	Background: Middle Palaeolithic stone artefacts referred to as 'Levallois' have caused considerable debate regarding issues of technological predetermination, cognition and linguistic capacities in extinct hominins. Their association with both Neanderthals and early modern humans has, in particular, fuelled such debate. Yet, controversy exists regarding the extent of 'predetermination' and 'standardization' in so-called 'preferential Levallois flakes' (PLFs). Methodology/Principal Findings: Using an experimental and morphometric approach, we assess the degree of standardization in PLFs compared to the flakes produced during their manufacture. PLFs possess specific properties that unite them robustly as a group or 'category' of flake. The properties that do so, relate most strongly to relative flake thicknesses across their surface area. PLFs also exhibit significantly less variability than the flakes generated during their production. Again, this is most evident in flake thickness variables. A further aim of our study was to assess whether the particular PLF attributes identified during our analyses can be related to current knowledge regarding flake functionality and utility. Conclusions/Significance: PLFs are standardized in such a manner that they may be considered 'predetermined' with regard to a specific set of properties that distinguishes them statistically from a majority of other flakes. Moreover, their attributes can be linked to factors that, based on current knowledge, are desirable features in flake tools (e. g. durability, capacity for retouch, and reduction of torque). As such, our results support the hypothesis that the lengthy, multi-phase, and hierarchically organized process of Levallois reduction was a deliberate, engineered strategy orientated toward specific goals. In turn, our results support suggestions that Levallois knapping relied on a cognitive capacity for long-term working memory. This is consistent with recent evidence suggesting that cognitive distinctions between later Pleistocene hominins such as the Neanderthals and anatomically modern humans were not as sharp as some scholars have previously suggested.	[Eren, Metin I.; Lycett, Stephen J.] Univ Kent, Dept Anthropol, Canterbury, Kent, England	University of Kent	Eren, MI (corresponding author), Univ Kent, Dept Anthropol, Canterbury, Kent, England.	S.J.Lycett@kent.ac.uk			Leverhulme Trust	Leverhulme Trust(Leverhulme Trust)	MIE is supported by a Leverhulme Trust Early Career Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; BINFORD LR, 1980, AM ANTIQUITY, V45, P4, DOI 10.2307/279653; Black J.T, 1992, MULTIVARIATE DATA AN; Boeda E., 1994, CONCEPT LEVALLOIS VA; Boeda Eric, 1988, MUTATION, V8, P41; BORDES F, 1968, OLD STONE AGE; Bordes F., 1980, B SOC PREHISTORIQUE, V77, P45, DOI [10.3406/BSPF.1980.5242, DOI 10.3406/BSPF.1980.5242]; Bordes F, 1950, ANTHROPOLOGIE, V54, P19; Bradley B., 1977, THESIS CAMBRIDGE U; Brantingham PJ, 2001, J ARCHAEOL SCI, V28, P747, DOI 10.1006/jasc.2000.0594; Braun DR, 2008, J ARCHAEOL SCI, V35, P1216, DOI 10.1016/j.jas.2007.08.015; Braun DR, 2009, J ARCHAEOL SCI, V36, P1605, DOI 10.1016/j.jas.2009.03.025; Chatterton P, 1975, SAY IT MOTU INSTANT; Chazan M, 1997, J HUM EVOL, V33, P719, DOI 10.1006/jhev.1997.0167; Chomsky N., 2006, LANGUAGE MIND; Commont V, 1909, C PREH FRANC 5 SESS, P115; DAVIDSON I, 1993, TOOLS, LANGUAGE AND COGNITION IN HUMAN EVOLUTION, P363; Delagnes A., 1995, DEFINITION INTERPRET, P201; Dibble E., 1995, DEFINITION INTERPRET, P41; Dibble H.L., 1995, DEFINITION INTERPRET; DIBBLE HL, 1989, HUMAN REVOLUTION, P415; Eren MI, 2009, LITHIC TECHNOL, V34, P119, DOI 10.1080/01977261.2009.11721077; Feblot-Augustins J., 1999, MIDDLE PALAEOLITHIC, P193; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Geneste J.M., 1989, LHOMME NEANDERTAL, V6, P75; HAYDEN B, 1993, J HUM EVOL, V24, P113, DOI 10.1006/jhev.1993.1010; HOLLOWAY RL, 1969, CURR ANTHROPOL, V10, P395, DOI 10.1086/201036; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Inizan Marie -Louise, 1999, PRE HIST PIERRE TAIL; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Kelly RL., 2007, FORAGING SPECTRUM DI, DOI 10.2307/j.ctv2sx9gc9; Key AJM, 2011, J ARCHAEOL SCI, V38, P1663, DOI 10.1016/j.jas.2011.02.032; Klein RG, 2009, HUMAN CARE HUMAN BIO; KUHN SL, 1994, AM ANTIQUITY, V59, P426, DOI 10.2307/282456; Kuhn SL, 2010, STONE TOOLS AND THE EVOLUTION OF HUMAN COGNITION, P105; Lieberman DE, 2011, EVOLUTION HUMAN HEAD; Lieberman P., 1984, BIOL EVOLUTION LANGU; Lycett SJ, 2006, J ARCHAEOL SCI, V33, P847, DOI 10.1016/j.jas.2005.10.014; Lycett SJ, 2010, J ARCHAEOL SCI, V37, P1110, DOI 10.1016/j.jas.2009.12.011; Machin AJ, 2007, J ARCHAEOL SCI, V34, P883, DOI 10.1016/j.jas.2006.09.008; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Mellars Paul A., 1996, NEANDERTHAL LEGACY A; Moncel MH, 2011, CURR ANTHROPOL, V52, P37, DOI 10.1086/658179; Morgan LE, 2008, GEOLOGY, V36, P967, DOI 10.1130/G25213A.1; Mortillet Gabriel de, 1883, PREHISTOIRE ANTIQUIT; Noble W., 1996, HUMAN EVOLUTION LANG; Pelegrin J, 2005, STONE KNAPPING NECES, P23; Pepere M., 1986, B SOC PREHISTORIQUE, V83, P115; Peresani M, 2011, P NATL ACAD IN PRESS; Pittman JS, 1959, SOC EC PALEONTOLOGIS, V7, P121; Porat N, 2002, J HUM EVOL, V43, P107, DOI 10.1006/jhev.2002.0562; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Prasciunas MM, 2007, AM ANTIQUITY, V72, P334, DOI 10.2307/40035817; Rensink E., 1988, HELINIUM, V28, P17; Rolian C, 2011, J HUM EVOL, V61, P26, DOI 10.1016/j.jhevol.2011.01.008; Sandgathe D. M., 2004, LITHIC TECHNOLOGY, V29, P147, DOI DOI 10.1080/01977261.2004.11721017; Schlanger N, 1996, CAMB ARCHAEOL J, V6, P231, DOI DOI 10.1017/S0959774300001724; Shea J, 2001, J ARCHAEOL SCI, V28, P807, DOI 10.1006/jasc.2000.0590; Shennan S., 1997, QUANTIFYING ARCHAEOL; Simao J, 2002, BEHAV BRAIN SCI, V25, P419, DOI 10.1017/S0140525X02380075; Sisk ML, 2009, J ARCHAEOL SCI, V36, P2039, DOI 10.1016/j.jas.2009.05.023; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Surovell T., 2009, BEHAV ECOLOGY LITHIC; Tryon CA, 2006, CURR ANTHROPOL, V47, P367, DOI 10.1086/503066; Turq A., 1992, MIDDLE PALEOLITHIC A, V72, P75; Van Peer P., 1992, LEVALLOIS REDUCTION, V13; White M. J., 1995, LITHICS, V16, P27; Wynn T, 2004, J HUM EVOL, V46, P467, DOI 10.1016/j.jhevol.2004.01.005; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	69	110	111	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e29273	10.1371/journal.pone.0029273	http://dx.doi.org/10.1371/journal.pone.0029273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	909NE	22291888	Green Submitted, Green Published, gold			2022-12-27	WOS:000301570600004
J	Reinhard, DA; Konrath, SH; Lopez, WD; Cameron, HG				Reinhard, David A.; Konrath, Sara H.; Lopez, William D.; Cameron, Heather G.			Expensive Egos: Narcissistic Males Have Higher Cortisol	PLOS ONE			English	Article							SALIVARY CORTISOL; SELF-ESTEEM; CARDIOVASCULAR REACTIVITY; PERSONALITY-INVENTORY; ORAL-CONTRACEPTIVES; SOCIAL SUPPORT; DISPLACED AGGRESSION; THREATENED EGOTISM; STRESS APPRAISAL; SEX-DIFFERENCES	Background: Narcissism is characterized by grandiosity, low empathy, and entitlement. There has been limited research regarding the hormonal correlates of narcissism, despite the potential health implications. This study examined the role of participant narcissism and sex on basal cortisol concentrations in an undergraduate population. Methods and Findings: Participants were 106 undergraduate students (79 females, 27 males, mean age 20.1 years) from one Midwestern and one Southwestern American university. Narcissism was assessed using the Narcissistic Personality Inventory, and basal cortisol concentrations were collected from saliva samples in a laboratory setting. Regression analyses examined the effect of narcissism and sex on cortisol (log). There were no sex differences in basal cortisol, F(1,97)=.20, p=.65, and narcissism scores, F(1,97)=.00, p=.99. Stepwise linear regression models of sex and narcissism and their interaction predicting cortisol concentrations showed no main effects when including covariates, but a significant interaction, beta=.27, p=.04. Narcissism was not related to cortisol in females, but significantly predicted cortisol in males. Examining the effect of unhealthy versus healthy narcissism on cortisol found that unhealthy narcissism was marginally related to cortisol in females, beta=.27, p=.06, but significantly predicted higher basal cortisol in males, beta=.72, p=.01, even when controlling for potential confounds. No relationship was found between sex, narcissism, or their interaction on self-reported stress. Conclusions: Our findings suggest that the HPA axis is chronically activated in males with unhealthy narcissism. This constant activation of the HPA axis may have important health implications.	[Reinhard, David A.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA; [Konrath, Sara H.; Cameron, Heather G.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Konrath, Sara H.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA; [Lopez, William D.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	University of Virginia; University of Michigan System; University of Michigan; University of Rochester; University of Michigan System; University of Michigan	Reinhard, DA (corresponding author), Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA.	skonrath@umich.edu		Konrath, Sara/0000-0001-9182-0095	Institute for Research on Women and Gender at the University of Michigan	Institute for Research on Women and Gender at the University of Michigan	The authors gratefully acknowledge a grant from the Institute for Research on Women and Gender at the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKHTAR S, 1982, AM J PSYCHIAT, V139, P12; ANSSEAU M, 1993, PSYCHONEUROENDOCRINO, V18, P37, DOI 10.1016/0306-4530(93)90053-N; ASHTON WA, 1993, SEX ROLES, V28, P461, DOI 10.1007/BF00289608; BUNTROCK CN, 1992, PERS INDIV DIFFER, V13, P1223, DOI 10.1016/0191-8869(92)90258-Q; Bushman BJ, 1998, J PERS SOC PSYCHOL, V75, P219, DOI 10.1037/0022-3514.75.1.219; Campbell WK, 2000, J RES PERS, V34, P329, DOI 10.1006/jrpe.2000.2282; Campbell WK, 1999, J PERS SOC PSYCHOL, V77, P1254, DOI 10.1037/0022-3514.77.6.1254; Campbell WK, 2002, PERS SOC PSYCHOL B, V28, P484, DOI 10.1177/0146167202287006; Campbell WK, 2002, J PERS SOC PSYCHOL, V83, P340, DOI [10.1037/0022-3514.83.2.340, 10.1037//0022-3514.83.2.340]; Edelstein RS, 2010, J RES PERS, V44, P565, DOI 10.1016/j.jrp.2010.06.008; Edwards, 2010, STANDARD, V9, P1; EMMONS RA, 1984, J PERS ASSESS, V48, P291, DOI 10.1207/s15327752jpa4803_11; EMMONS RA, 1987, J PERS SOC PSYCHOL, V52, P11, DOI 10.1037/0022-3514.52.1.11; Exline JJ, 2004, J PERS SOC PSYCHOL, V87, P894, DOI 10.1037/0022-3514.87.6.894; Farwell L, 1998, J PERS, V66, P65, DOI 10.1111/1467-6494.00003; Foster JD, 2003, J RES PERS, V37, P469, DOI 10.1016/S0092-6566(03)00026-6; FUKUNISHI I, 1995, J PSYCHOSOM RES, V39, P215, DOI 10.1016/0022-3999(94)00094-L; GABRIEL MT, 1994, J PERS, V62, P143, DOI 10.1111/j.1467-6494.1994.tb00798.x; GASPARD UJ, 1983, CONTRACEPTION, V27, P577, DOI 10.1016/0010-7824(83)90023-9; Heaney JLJ, 2010, INT J PSYCHOPHYSIOL, V78, P201, DOI 10.1016/j.ijpsycho.2010.07.009; Horvath S, 2009, J EXP SOC PSYCHOL, V45, P1252, DOI 10.1016/j.jesp.2009.07.011; JOHNSON EO, 1992, NEUROSCI BIOBEHAV R, V16, P115, DOI 10.1016/S0149-7634(05)80175-7; Kelsey RM, 2002, PSYCHOPHYSIOLOGY, V39, P322, DOI 10.1017/S004857720139306X; Kelsey RM, 2001, PSYCHOPHYSIOLOGY, V38, P292; KERNIS MH, 1994, J RES PERS, V28, P4, DOI 10.1006/jrpe.1994.1002; KING AC, 1990, J PSYCHOSOM RES, V34, P461, DOI 10.1016/0022-3999(90)90070-K; KIRSCHBAUM C, 1992, PSYCHOSOM MED, V54, P648, DOI 10.1097/00006842-199211000-00004; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Konrath S, 2006, PSYCHOL SCI, V17, P995, DOI 10.1111/j.1467-9280.2006.01818.x; Kunkel AW, 1998, SEX DIFFERENCES AND SIMILARITIES IN COMMUNICATIONS, P101; LASH SJ, 1990, BEHAV MODIF, V14, P3, DOI 10.1177/01454455900141001; LASH SJ, 1991, HEALTH PSYCHOL, V10, P392, DOI 10.1037/0278-6133.10.6.392; Latendresse G, 2008, BIOL RES NURS, V10, P54, DOI 10.1177/1099800408320970; Martinez MA, 2008, PERS INDIV DIFFER, V44, P140, DOI 10.1016/j.paid.2007.07.012; Melamed S, 1996, PSYCHOSOM MED, V58, P500, DOI 10.1097/00006842-199609000-00012; Mente A, 1999, PERS INDIV DIFFER, V27, P683, DOI 10.1016/S0191-8869(98)00268-2; MEULENBERG PMM, 1987, CLIN CHIM ACTA, V165, P379, DOI 10.1016/0009-8981(87)90183-5; Miller JD, 2008, J PERS, V76, P449, DOI 10.1111/j.1467-6494.2008.00492.x; MILLER SB, 1993, PSYCHOSOM MED, V55, P78, DOI 10.1097/00006842-199301000-00013; MORF CC, 1993, PERS SOC PSYCHOL B, V19, P668, DOI 10.1177/0146167293196001; Morf CC, 2001, PSYCHOL INQ, V12, P177, DOI 10.1207/S15327965PLI1204_1; NICKELSEN T, 1989, EXP CLIN ENDOCRINOL, V94, P275, DOI 10.1055/s-0029-1210910; Paulhus DL, 1998, J PERS SOC PSYCHOL, V74, P1197, DOI 10.1037/0022-3514.74.5.1197; Paulhus DL, 1998, J PERS, V66, P1025, DOI 10.1111/1467-6494.00041; Pruessner JC, 1997, LIFE SCI, V61, P2539, DOI 10.1016/S0024-3205(97)01008-4; Puustinen PJ, 2011, EUR ARCH PSY CLIN N, V261, P277, DOI 10.1007/s00406-010-0134-x; RASKIN R, 1988, J PERS SOC PSYCHOL, V54, P890, DOI 10.1037/0022-3514.54.5.890; RASKIN R, 1988, J PERS, V56, P393, DOI 10.1111/j.1467-6494.1988.tb00892.x; RASKIN R, 1991, J PERS, V59, P19, DOI 10.1111/j.1467-6494.1991.tb00766.x; RASKIN R, 1989, J PERS ASSESS, V53, P66, DOI 10.1207/s15327752jpa5301_8; Reevy GM, 2001, SEX ROLES, V44, P437, DOI 10.1023/A:1011930128829; RHODEWALT F, 1995, J RES PERS, V29, P1, DOI 10.1006/jrpe.1995.1001; Rhodewalt F, 2002, J RES PERS, V36, P97, DOI 10.1006/jrpe.2002.2342; Robins RW, 2001, J PERS SOC PSYCHOL, V80, P340, DOI 10.1037//0022-3514.80.2.340; Rutledge T, 2006, STRESS ITS IMPACT SO, P1; Santos J, 1999, AM J PHYSIOL-GASTR L, V277, pG391, DOI 10.1152/ajpgi.1999.277.2.G391; Scherwitz L, 1985, SELF INVOLVEMENT RIS; Scherwitz L, 1988, SELF REFERENCE CORON; Sedikides C, 2004, J PERS SOC PSYCHOL, V87, P400, DOI 10.1037/0022-3514.87.3.400; Sgoifo A, 2003, NEUROSCI BIOBEHAV R, V27, P179, DOI 10.1016/S0149-7634(03)00019-8; SHAPIRO D, 1995, PSYCHOPHYSIOLOGY, V32, P425, DOI 10.1111/j.1469-8986.1995.tb02093.x; Smith TW, 1998, HEALTH PSYCHOL, V17, P537, DOI 10.1037/0278-6133.17.6.537; Sommer KL, 2009, J APPL SOC PSYCHOL, V39, P1083, DOI 10.1111/j.1559-1816.2009.00473.x; Twenge JM, 2003, PERS SOC PSYCHOL B, V29, P261, DOI 10.1177/0146167202239051; Twenge JM, 2008, J PERS, V76, P902; VINING RF, 1983, ANN CLIN BIOCHEM, V20, P329, DOI 10.1177/000456328302000601; WARRENBURG S, 1989, J BEHAV MED, V12, P407, DOI 10.1007/BF00844875; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON PJ, 1992, J PERS DISORD, V6, P434, DOI 10.1521/pedi.1992.6.4.434; WATSON PJ, 1987, SEX ROLES, V16, P335, DOI 10.1007/BF00289546; WATSON PJ, 1984, J PERS ASSESS, V48, P301, DOI 10.1207/s15327752jpa4803_12; WATSON PJ, 1993, J PERS ASSESS, V61, P41, DOI 10.1207/s15327752jpa6101_4; WATSON PJ, 1995, J PSYCHOL, V129, P61, DOI 10.1080/00223980.1995.9914948; Whembolua GLS, 2006, HORM BEHAV, V49, P478, DOI 10.1016/j.yhbeh.2005.10.005; WINK P, 1991, J PERS SOC PSYCHOL, V61, P590	75	33	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30858	10.1371/journal.pone.0030858	http://dx.doi.org/10.1371/journal.pone.0030858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	909NE	22292062	Green Submitted, Green Published, gold			2022-12-27	WOS:000301570600088
J	Rezk, BM; Yoshida, T; Semprun-Prieto, L; Higashi, Y; Sukhanov, S; Delafontaine, P				Rezk, Bashir M.; Yoshida, Tadashi; Semprun-Prieto, Laura; Higashi, Yusuke; Sukhanov, Sergiy; Delafontaine, Patrice			Angiotensin II Infusion Induces Marked Diaphragmatic Skeletal Muscle Atrophy	PLOS ONE			English	Article							GROWTH-FACTOR-I; OBSTRUCTIVE PULMONARY-DISEASE; CONGESTIVE-HEART-FAILURE; SATELLITE CELLS; STEM-CELL; MYOGENIC PROGENITORS; MOLECULAR REGULATION; GENE-EXPRESSION; BONE-MARROW; WEIGHT-LOSS	Advanced congestive heart failure (CHF) and chronic kidney disease (CKD) are characterized by increased angiotensin II (Ang II) levels and are often accompanied by significant skeletal muscle wasting that negatively impacts mortality and morbidity. Both CHF and CKD patients have respiratory muscle dysfunction, however the potential effects of Ang II on respiratory muscles are unknown. We investigated the effects of Ang II on diaphragm muscle in FVB mice. Ang II induced significant diaphragm muscle wasting (18.7 +/- 1.6% decrease in weight at one week) and reduction in fiber cross-sectional area. Expression of the E3 ubiquitin ligases atrogin-1 and muscle ring finger-1 (MuRF-1) and of the pro-apoptotic factor BAX was increased after 24 h of Ang II infusion (4.4 +/- 0.3 fold, 3.1 +/- 0.5 fold and 1.6 +/- 0.2 fold, respectively, compared to sham infused control) suggesting increased muscle protein degradation and apoptosis. In Ang II infused animals, there was significant regeneration of injured diaphragm muscles at 7 days as indicated by an increase in the number of myofibers with centralized nuclei and high expression of embryonic myosin heavy chain (E-MyHC, 11.2 +/- 3.3 fold increase) and of the satellite cell marker M-cadherin (59.2 +/- 22.2% increase). Furthermore, there was an increase in expression of insulin-like growth factor-1 (IGF-1, 1.8 +/- 0.3 fold increase) in Ang II infused diaphragm, suggesting the involvement of IGF-1 in diaphragm muscle regeneration. Bone-marrow transplantation experiments indicated that although there was recruitment of bone-marrow derived cells to the injured diaphragm in Ang II infused mice (267.0 +/- 74.6% increase), those cells did not express markers of muscle stem cells or regenerating myofibers. In conclusion, Ang II causes marked diaphragm muscle wasting, which may be important for the pathophysiology of respiratory muscle dysfunction and cachexia in conditions such as CHF and CKD.	[Rezk, Bashir M.; Yoshida, Tadashi; Semprun-Prieto, Laura; Higashi, Yusuke; Sukhanov, Sergiy; Delafontaine, Patrice] Tulane Univ, Sch Med, Inst Heart & Vasc, New Orleans, LA 70112 USA	Tulane University	Rezk, BM (corresponding author), Southern Univ, Dept Nat Sci, New Orleans, LA USA.	pdelafon@tulane.edu		Delafontaine, Patrice/0000-0003-3744-3617; Sukhanov, Sergiy/0000-0002-9223-4263; Yoshida, Tadashi/0000-0002-4544-1497	United States National Institutes of Health/National Heart, Lung, and Blood Institute [R01-HL070241, R01-HL080682]; National Institutes of Health/National Center for Research Resources [P20RR018766]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070241, R01HL080682] Funding Source: NIH RePORTER	United States National Institutes of Health/National Heart, Lung, and Blood Institute; National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants R01-HL070241 and R01-HL080682 from the United States National Institutes of Health/National Heart, Lung, and Blood Institute and grant P20RR018766 from the National Institutes of Health/National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Brink M, 1996, J CLIN INVEST, V97, P2509, DOI 10.1172/JCI118698; Brink M, 2001, ENDOCRINOLOGY, V142, P1489, DOI 10.1210/en.142.4.1489; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Chakravarthy MV, 2000, J APPL PHYSIOL, V89, P1365, DOI 10.1152/jappl.2000.89.4.1365; Chakravarthy MV, 2000, J BIOL CHEM, V275, P35942, DOI 10.1074/jbc.M005832200; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Du J, 1996, ENDOCRINOLOGY, V137, P1378, DOI 10.1210/en.137.4.1378; Silva ACSE, 2006, PEDIATR RES, V60, P734, DOI 10.1203/01.pdr.0000246100.14061.bc; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Glass D, 2010, ANN NY ACAD SCI, V1211, P25, DOI 10.1111/j.1749-6632.2010.05809.x; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Gonzalez-Villalobos RA, 2008, AM J PHYSIOL-RENAL, V295, pF772, DOI 10.1152/ajprenal.00019.2008; GRAZIANI G, 1993, KIDNEY INT, V44, P107, DOI 10.1038/ki.1993.219; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hayashi S, 2004, HISTOCHEM CELL BIOL, V122, P427, DOI 10.1007/s00418-004-0704-y; Honda H, 2010, J MUSCLE RES CELL M, V31, P71, DOI 10.1007/s10974-010-9209-6; Hughes PD, 1999, AM J RESP CRIT CARE, V160, P529, DOI 10.1164/ajrccm.160.2.9810081; Kanazawa H, 2000, AM J RESP CRIT CARE, V162, P1235, DOI 10.1164/ajrccm.162.4.9909120; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; MANCINI DM, 1992, CIRCULATION, V86, P909, DOI 10.1161/01.CIR.86.3.909; Masson S, 1998, PHARMACOL RES, V37, P213, DOI 10.1006/phrs.1998.0288; McClung JM, 2007, AM J RESP CRIT CARE, V175, P150, DOI 10.1164/rccm.200601-142OC; McKenzie DK, 2009, J APPL PHYSIOL, V107, P621, DOI 10.1152/japplphysiol.00163.2009; Meyer FJ, 2001, CIRCULATION, V103, P2153; Musaro A, 2004, P NATL ACAD SCI USA, V101, P1206, DOI 10.1073/pnas.0303792101; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Ottenheijm CAC, 2007, AM J RESP CRIT CARE, V175, P1233, DOI 10.1164/rccm.200701-020PP; Ottenheijm CAC, 2006, AM J RESP CRIT CARE, V174, P997, DOI 10.1164/rccm.200605-721OC; Otto A, 2009, J ANAT, V215, P477, DOI 10.1111/j.1469-7580.2009.01138.x; Pocock SJ, 2008, EUR HEART J, V29, P2641, DOI 10.1093/eurheartj/ehn420; Roig E, 2000, EUR HEART J, V21, P53, DOI 10.1053/euhj.1999.1740; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Scheidegger KJ, 1999, J BIOL CHEM, V274, P3522, DOI 10.1074/jbc.274.6.3522; Schillaci R, 1998, CELL IMMUNOL, V183, P157, DOI 10.1006/cimm.1997.1237; Scime A, 2009, FRONT BIOSCI-LANDMRK, V14, P3012, DOI 10.2741/3431; Semprun-Prieto LC, 2011, BIOCHEM BIOPH RES CO, V409, P217, DOI 10.1016/j.bbrc.2011.04.122; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; Strassburg S, 2005, INT J BIOCHEM CELL B, V37, P1938, DOI 10.1016/j.biocel.2005.03.013; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; van Hees HWH, 2007, AM J PHYSIOL-HEART C, V293, pH819, DOI 10.1152/ajpheart.00085.2007; Vlahakos DV, 1999, AM J MED, V106, P158, DOI 10.1016/S0002-9343(98)00390-8; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Watchko JF, 2002, J APPL PHYSIOL, V93, P407, DOI 10.1152/japplphysiol.01242.2001; Wong E, 2011, HEART LUNG CIRC, V20, P289, DOI 10.1016/j.hlc.2011.01.009; Yoshida T, 2010, AM J PHYSIOL-HEART C, V298, pH1565, DOI 10.1152/ajpheart.00146.2010; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571	54	44	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30276	10.1371/journal.pone.0030276	http://dx.doi.org/10.1371/journal.pone.0030276			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276172	Green Published, gold, Green Submitted			2022-12-27	WOS:000301568100030
J	Dorfberger, S; Adi-Japha, E; Karni, A				Dorfberger, Shoshi; Adi-Japha, Esther; Karni, Avi			Sequence Specific Motor Performance Gains after Memory Consolidation in Children and Adolescents	PLOS ONE			English	Article							MOVEMENT SEQUENCE; INTERMANUAL TRANSFER; SKILLED PERFORMANCE; CORTEX PLASTICITY; PHASE GAINS; ACQUISITION; DISCRIMINATION; REPRESENTATION; INTERFERENCE; EXPERIENCE	Memory consolidation for a trained sequence of finger opposition movements, in 9- and 12-year-old children, was recently found to be significantly less susceptible to interference by a subsequent training experience, compared to that of 17-year-olds. It was suggested that, in children, the experience of training on any sequence of finger movements may affect the performance of the sequence elements, component movements, rather than the sequence as a unit; the latter has been implicated in the learning of the task by adults. This hypothesis implied a possible childhood advantage in the ability to transfer the gains from a trained to the reversed, untrained, sequence of movements. Here we report the results of transfer tests undertaken to test this proposal in 9-, 12-, and 17-year-olds after training in the finger-to-thumb opposition sequence (FOS) learning task. Our results show that the performance gains in the trained sequence partially transferred from the left, trained hand, to the untrained hand at 48-hours after a single training session in the three age-groups tested. However, there was very little transfer of the gains from the trained to the untrained, reversed, sequence performed by either hand. The results indicate sequence specific post-training gains in FOS performance, as opposed to a general improvement in performance of the individual, component, movements that comprised both the trained and untrained sequences. These results do not support the proposal that the reduced susceptibility to interference, in children before adolescence, reflects a difference in movement syntax representation after training.	[Dorfberger, Shoshi; Karni, Avi] Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, IL-31999 Haifa, Israel; [Dorfberger, Shoshi; Karni, Avi] Univ Haifa, Learning Disabil Dept, IL-31999 Haifa, Israel; [Adi-Japha, Esther] Bar Ilan Univ, Sch Educ, Ramat Gan, Israel	University of Haifa; University of Haifa; Bar Ilan University	Dorfberger, S (corresponding author), Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, IL-31999 Haifa, Israel.	shoshke16@gmail.com	Adi-Japha, Esther/O-9945-2019; /GLU-1786-2022	Adi-Japha, Esther/0000-0001-9757-0031; /0000-0001-9757-0031				Adi-Japha E, 2008, J EXP PSYCHOL LEARN, V34, P1544, DOI 10.1037/a0013217; Balas M, 2007, EXP BRAIN RES, V180, P237, DOI 10.1007/s00221-007-0851-1; Balas M, 2007, EXP BRAIN RES, V178, P499, DOI 10.1007/s00221-006-0757-3; BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; Dorfberger S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000240; Fischer S, 2007, J COGNITIVE NEUROSCI, V19, P214, DOI 10.1162/jocn.2007.19.2.214; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Kantak SS, 2010, NAT NEUROSCI, V13, P923, DOI 10.1038/nn.2596; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1995, NATURE, V377, P155; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Karni A, 1996, COGNITIVE BRAIN RES, V5, P39, DOI 10.1016/S0926-6410(96)00039-0; Karni A, 1997, CURR OPIN NEUROBIOL, V7, P530, DOI 10.1016/S0959-4388(97)80033-5; Kirsch W, 2010, EXP BRAIN RES, V202, P927, DOI 10.1007/s00221-010-2184-8; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Meulemans T, 1998, J EXP CHILD PSYCHOL, V69, P199, DOI 10.1006/jecp.1998.2442; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; RAMACHANDRAN VS, 1973, PERCEPTION, V2, P371, DOI 10.1068/p020371; Rand MK, 2000, EXP BRAIN RES, V131, P293, DOI 10.1007/s002219900283; Rozanov S, 2010, BRAIN RES, V1331, P80, DOI 10.1016/j.brainres.2010.03.019; Savion-Lemieux T, 2010, EXP BRAIN RES, V204, P271, DOI 10.1007/s00221-010-2311-6; Savion-Lemieux T, 2009, EXP BRAIN RES, V195, P293, DOI 10.1007/s00221-009-1786-5; Schulze K, 2002, CORTEX, V38, P805, DOI 10.1016/S0010-9452(08)70047-9; van Mier HI, 2006, NEUROPSYCHOLOGIA, V44, P939, DOI 10.1016/j.neuropsychologia.2005.08.010; Witt K, 2010, NEUROSCIENCE, V171, P227, DOI 10.1016/j.neuroscience.2010.07.062; Xiao LQ, 2008, CURR BIOL, V18, P1922, DOI 10.1016/j.cub.2008.10.030	28	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e28673	10.1371/journal.pone.0028673	http://dx.doi.org/10.1371/journal.pone.0028673			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	907YS	22276097	Green Published, gold, Green Submitted			2022-12-27	WOS:000301457200003
J	Smith, P; Siddharth, J; Pearson, R; Holway, N; Shaxted, M; Butler, M; Clark, N; Jamontt, J; Watson, RP; Sanmugalingam, D; Parkinson, SJ				Smith, Philip; Siddharth, Jay; Pearson, Ruth; Holway, Nicholas; Shaxted, Mark; Butler, Matt; Clark, Natalie; Jamontt, Joanna; Watson, Robert P.; Sanmugalingam, Devika; Parkinson, Scott J.			Host Genetics and Environmental Factors Regulate Ecological Succession of the Mouse Colon Tissue-Associated Microbiota	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; IN-SITU HYBRIDIZATION; CROHNS-DISEASE; EXPERIMENTAL COLITIS; ULCERATIVE-COLITIS; HUMAN INTESTINE; MICE; BACTERIA; SUSCEPTIBILITY; MICROFLORA	Background: The integration of host genetics, environmental triggers and the microbiota is a recognised factor in the pathogenesis of barrier function diseases such as IBD. In order to determine how these factors interact to regulate the host immune response and ecological succession of the colon tissue-associated microbiota, we investigated the temporal interaction between the microbiota and the host following disruption of the colonic epithelial barrier. Methodology/Principal Findings: Oral administration of DSS was applied as a mechanistic model of environmental damage of the colon and the resulting inflammation characterized for various parameters over time in WT and Nod2 KO mice. Results: In WT mice, DSS damage exposed the host to the commensal flora and led to a migration of the tissue-associated bacteria from the epithelium to mucosal and submucosal layers correlating with changes in proinflammatory cytokine profiles and a progressive transition from acute to chronic inflammation of the colon. Tissue-associated bacteria levels peaked at day 21 post-DSS and declined thereafter, correlating with recruitment of innate immune cells and development of the adaptive immune response. Histological parameters, immune cell infiltration and cytokine biomarkers of inflammation were indistinguishable between Nod2 and WT littermates following DSS, however, Nod2 KO mice demonstrated significantly higher tissue-associated bacterial levels in the colon. DSS damage and Nod2 genotype independently regulated the community structure of the colon microbiota. Conclusions/Significance: The results of these experiments demonstrate the integration of environmental and genetic factors in the ecological succession of the commensal flora in mammalian tissue. The association of Nod2 genotype (and other host polymorphisms) and environmental factors likely combine to influence the ecological succession of the tissue-associated microflora accounting in part for their association with the pathogenesis of inflammatory bowel diseases.	[Smith, Philip; Siddharth, Jay; Pearson, Ruth; Shaxted, Mark; Butler, Matt; Clark, Natalie; Jamontt, Joanna; Watson, Robert P.; Sanmugalingam, Devika; Parkinson, Scott J.] Novartis Inst Biomed Res, Gastrointestinal Dis Area, Horsham, W Sussex, England; [Holway, Nicholas] Novartis Inst Biomed Res Informat Technol, Horsham, W Sussex, England; [Parkinson, Scott J.] Novartis Inst Biomed Res Dev & Mol Pathways, Basel, Switzerland	Novartis; Novartis	Smith, P (corresponding author), Novartis Inst Biomed Res, Gastrointestinal Dis Area, Horsham, W Sussex, England.	scott.parkinson@novartis.com		Holway, Nicholas/0000-0002-2126-5118; Siddharth, Jay/0000-0003-3288-400X				Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barreau F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000523; Borley NR, 2002, DIS COLON RECTUM, V45, P377, DOI 10.1007/s10350-004-6186-0; Collado MC, 2007, VET MICROBIOL, V121, P299, DOI 10.1016/j.vetmic.2006.12.006; Chen CS, 2009, MOL CELL PROTEOMICS, V8, P1765, DOI 10.1074/mcp.M800593-MCP200; D'Haens GR, 2008, GASTROENTEROLOGY, V135, P1123, DOI 10.1053/j.gastro.2008.07.010; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Fallani M, 2011, MICROBIOL-SGM, V157, P1385, DOI 10.1099/mic.0.042143-0; Fellani M, 2010, J PEDIAT GASTROENTER, V51, P77; Feller M, 2010, CLIN INFECT DIS, V50, P473, DOI 10.1086/649923; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Furrie E, 2004, GUT, V53, P91, DOI 10.1136/gut.53.1.91; Fyderek K, 2009, WORLD J GASTROENTERO, V15, P5287, DOI 10.3748/wjg.15.5287; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Hoffmann C, 2009, INFECT IMMUN, V77, P4668, DOI 10.1128/IAI.00493-09; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lichtenstein GR, 2009, AM J GASTROENTEROL, V104, P465, DOI 10.1038/ajg.2008.168; Lu HF, 2011, MICROB ECOL, V61, P693, DOI 10.1007/s00248-010-9801-8; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Meinzer U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002769; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Melgar S, 2008, INT IMMUNOPHARMACOL, V8, P836, DOI 10.1016/j.intimp.2008.01.036; Mow WS, 2004, GASTROENTEROLOGY, V126, P414, DOI 10.1053/j.gastro.2003.11.015; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Perez LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010915; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rath HC, 2001, INFECT IMMUN, V69, P2277, DOI 10.1128/IAI.69.4.2277-2285.2001; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Savino F, 2011, ACTA PAEDIATR, V100, P75, DOI 10.1111/j.1651-2227.2010.01988.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCHMIDT TM, 1994, METHOD ENZYMOL, V235, P205; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Strugala V, 2008, INT J CLIN PRACT, V62, P762, DOI 10.1111/j.1742-1241.2007.01665.x; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P4225, DOI 10.1128/AEM.68.9.4225-4232.2002	44	28	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30273	10.1371/journal.pone.0030273	http://dx.doi.org/10.1371/journal.pone.0030273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272321	Green Submitted, gold, Green Published			2022-12-27	WOS:000301454400099
J	Elliott, MA; Twomey, D; Glennon, M				Elliott, Mark A.; Twomey, Deirdre; Glennon, Mark			The Dynamics of Visual Experience, an EEG Study of Subjective Pattern Formation	PLOS ONE			English	Article							FLICKER-INDUCED COLOR; STROBOSCOPIC PATTERNS; NEURONAL RESPONSES; STIMULUS; SYNCHRONIZATION; STRIATE; CORTEX; PHENOMENOLOGY; FREQUENCY	Background: Since the origin of psychological science a number of studies have reported visual pattern formation in the absence of either physiological stimulation or direct visual-spatial references. Subjective patterns range from simple phosphenes to complex patterns but are highly specific and reported reliably across studies. Methodology/Principal Findings: Using independent-component analysis (ICA) we report a reduction in amplitude variance consistent with subjective-pattern formation in ventral posterior areas of the electroencephalogram (EEG). The EEG exhibits significantly increased power at delta/theta and gamma-frequencies (point and circle patterns) or a series of high-frequency harmonics of a delta oscillation (spiral patterns). Conclusions/Significance: Subjective-pattern formation may be described in a way entirely consistent with identical pattern formation in fluids or granular flows. In this manner, we propose subjective-pattern structure to be represented within a spatio-temporal lattice of harmonic oscillations which bind topographically organized visual-neuronal assemblies by virtue of low frequency modulation.	[Elliott, Mark A.; Twomey, Deirdre; Glennon, Mark] Natl Univ Ireland Galway, Sch Psychol, Galway, Ireland; [Elliott, Mark A.] Kyushu Univ, Ctr Appl Perceptual Res, Dept Acoust Design, Fukuoka 812, Japan	Ollscoil na Gaillimhe-University of Galway; Kyushu University	Elliott, MA (corresponding author), Natl Univ Ireland Galway, Sch Psychol, Galway, Ireland.	mark.elliott@nuigalway.ie		Elliott, Mark/0000-0003-2560-8760				Allefeld C, 2011, CONSCIOUS COGN, V20, P1344, DOI 10.1016/j.concog.2010.10.026; [Anonymous], 1967, MESCAL MECH HALLUCIN; Becker C, 2006, CONSCIOUS COGN, V15, P175, DOI 10.1016/j.concog.2005.05.004; Becker C, 2009, CONSCIOUS COGN, V18, P266, DOI 10.1016/j.concog.2008.05.001; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Benham CE, 1895, NATURE, V2, P321; BROWN CR, 1948, J EXP PSYCHOL, V38, P188, DOI 10.1037/h0054433; Dayan P., 2001, THEORETICAL NEUROSCI, P460; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; EFRON R, 1963, BRAIN, V86, P261, DOI 10.1093/brain/86.2.261; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P9136, DOI 10.1073/pnas.88.20.9136; Fechner GT, 1838, ANN PHYS, P227; Ffytche DH, 1998, NAT NEUROSCI, V1, P738, DOI 10.1038/3738; Ffytche DH, 2008, CORTEX, V44, P1067, DOI 10.1016/j.cortex.2008.04.005; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gail A, 2000, CEREB CORTEX, V10, P840, DOI 10.1093/cercor/10.9.840; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gollub JP, 1999, REV MOD PHYS, V71, pS396, DOI 10.1103/RevModPhys.71.S396; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Herrmann C. S., 2001, P 17 ANN M INT SOC P, P427; Koffka K, 1922, PSYCHOL BULL, V19, P531, DOI 10.1037/h0072422; Kohler W, 1949, GESTALT PSYCHOL INTR; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Kudrolli A, 1996, PHYSICA D, V97, P133, DOI 10.1016/0167-2789(96)00099-1; MELO F, 1995, PHYS REV LETT, V75, P3838, DOI 10.1103/PhysRevLett.75.3838; Mentis MJ, 1997, NEUROIMAGE, V5, P116, DOI 10.1006/nimg.1997.0256; NICHOLLS MER, 1994, Q J EXP PSYCHOL-A, V47, P291, DOI 10.1080/14640749408401113; Nikolaev AR, 2010, CEREB CORTEX, V20, P365, DOI 10.1093/cercor/bhp107; PURKINJE J, 1819, BEITRAGE KENNTNIS SE; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; SMYTHIES JR, 1959, BRIT J PSYCHOL, V50, P106, DOI 10.1111/j.2044-8295.1959.tb00688.x; SMYTHIES JR, 1959, BRIT J PSYCHOL, V50, P305, DOI 10.1111/j.2044-8295.1959.tb00710.x; SMYTHIES JR, 1960, BRIT J PSYCHOL, V51, P247, DOI 10.1111/j.2044-8295.1960.tb00747.x; SMYTHIES JR, 1957, NATURE, V179, P523, DOI 10.1038/179523a0; STERIADE M, 1993, NEUROSCIENCE, V56, P1, DOI 10.1016/0306-4522(93)90556-U; Umbanhowar PB, 1996, NATURE, V382, P793, DOI 10.1038/382793a0; Vigario RN, 1997, ELECTROEN CLIN NEURO, V103, P395, DOI 10.1016/S0013-4694(97)00042-8; Wackermann J, 2008, CORTEX, V44, P1364, DOI 10.1016/j.cortex.2007.05.003; Walter WG, 1950, PERSPECTIVES NEUROPS, P67	41	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30830	10.1371/journal.pone.0030830	http://dx.doi.org/10.1371/journal.pone.0030830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292053	Green Published, gold, Green Submitted			2022-12-27	WOS:000301703800033
J	Hawley, DM; Fleischer, RC				Hawley, Dana M.; Fleischer, Robert C.			Contrasting Epidemic Histories Reveal Pathogen-Mediated Balancing Selection on Class II MHC Diversity in a Wild Songbird	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL-SELECTION; HOUSE FINCHES; EVOLUTIONARY GENETICS; CARPODACUS-MEXICANUS; PARASITE RESISTANCE; DISEASE RESISTANCE; POPULATION; INFECTION; SURVIVAL	The extent to which pathogens maintain the extraordinary polymorphism at vertebrate Major Histocompatibility Complex (MHC) genes via balancing selection has intrigued evolutionary biologists for over half a century, but direct tests remain challenging. Here we examine whether a well-characterized epidemic of Mycoplasmal conjunctivitis resulted in balancing selection on class II MHC in a wild songbird host, the house finch (Carpodacus mexicanus). First, we confirmed the potential for pathogen-mediated balancing selection by experimentally demonstrating that house finches with intermediate to high multi-locus MHC diversity are more resistant to challenge with Mycoplasma gallisepticum. Second, we documented sequence and diversity-based signatures of pathogen-mediated balancing selection at class II MHC in exposed host populations that were absent in unexposed, control populations across an equivalent time period. Multi-locus MHC diversity significantly increased in exposed host populations following the epidemic despite initial compromised diversity levels from a recent introduction bottleneck in the exposed host range. We did not observe equivalent changes in allelic diversity or heterozygosity across eight neutral microsatellite loci, suggesting that the observations reflect selection rather than neutral demographic processes. Our results indicate that a virulent pathogen can exert sufficient balancing selection on class II MHC to rescue compromised levels of genetic variation for host resistance in a recently bottlenecked population. These results provide evidence for Haldane's long-standing hypothesis that pathogens directly contribute to the maintenance of the tremendous levels of genetic variation detected in natural populations of vertebrates.	[Hawley, Dana M.; Fleischer, Robert C.] Smithsonian Inst, Ctr Conservat & Evolutionary Genet, Washington, DC 20560 USA	Smithsonian Institution	Hawley, DM (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	hawleyd@vt.edu		Hawley, Dana/0000-0001-9573-2914	Smithsonian Institution (SI); SI Molecular Evolution Postdoctoral Fellowship; National Science Foundation/National Institutes of Health [DEB-0094456]	Smithsonian Institution (SI)(Smithsonian Institution); SI Molecular Evolution Postdoctoral Fellowship; National Science Foundation/National Institutes of Health(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Smithsonian Institution (SI) Genetics Program and an SI Molecular Evolution Postdoctoral Fellowship, with partial support from the National Science Foundation/National Institutes of Health Ecology of Infectious Disease Program (DEB-0094456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Babik W, 2009, MOL ECOL RESOUR, V9, P713, DOI 10.1111/j.1755-0998.2009.02622.x; Balakrishnan CN, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-29; BENCINA D, 1994, AVIAN PATHOL, V23, P19, DOI 10.1080/03079459408418972; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Bollmer JL, 2007, IMMUNOGENETICS, V59, P593, DOI 10.1007/s00251-007-0221-y; Bollmer JL, 2010, J HERED, V101, P448, DOI 10.1093/jhered/esq018; Bonneaud C, 2006, EVOLUTION, V60, P383, DOI 10.1111/j.0014-3820.2006.tb01114.x; Bonneaud C, 2011, P NATL ACAD SCI USA, V108, P7899, DOI 10.1073/pnas.1018580108; Bowen L, 2004, IMMUNOGENETICS, V56, P12, DOI 10.1007/s00251-004-0655-4; Brouwer L, 2010, MOL ECOL, V19, P3444, DOI 10.1111/j.1365-294X.2010.04750.x; Campbell KL, 2010, NAT GENET, V42, P536, DOI 10.1038/ng.574; Dhondt AA, 1998, J WILDLIFE DIS, V34, P265, DOI 10.7589/0090-3558-34.2.265; Doxiadis GGM, 2001, IMMUNOL REV, V183, P76, DOI 10.1034/j.1600-065x.2001.1830106.x; Duckworth RA, 2003, AUK, V120, P528, DOI 10.1642/0004-8038(2003)120[0528:FCOMGI]2.0.CO;2; Edwards SV, 1995, MOL ECOL, V4, P719, DOI 10.1111/j.1365-294X.1995.tb00272.x; Eimes JA, 2011, J EVOLUTION BIOL, V24, P1847, DOI 10.1111/j.1420-9101.2011.02311.x; Ekblom R, 2007, MOL ECOL, V16, P1439, DOI 10.1111/j.1365-294X.2007.03281.x; ELLIOTT J. J., 1953, AUK, V70, P31; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferguson W, 2008, MOL BIOL EVOL, V25, P1609, DOI 10.1093/molbev/msn106; Fleischer RC, 2000, AUK, V117, P1051, DOI 10.1642/0004-8038(2000)117[1051:IOTEHE]2.0.CO;2; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GRACE MB, 1995, HUM MUTAT, V6, P232, DOI 10.1002/humu.1380060306; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; Hawley DM, 2010, J EVOLUTION BIOL, V23, P1680, DOI 10.1111/j.1420-9101.2010.02035.x; Hawley DM, 2008, CONSERV GENET, V9, P637, DOI 10.1007/s10592-007-9381-4; Hawley DM, 2006, MOL ECOL, V15, P263, DOI 10.1111/j.1365-294X.2005.02767.x; Hawley DM, 2005, BIOL LETTERS, V1, P326, DOI 10.1098/rsbl.2005.0303; Hess CM, 2007, GENETICA, V129, P217, DOI 10.1007/s10709-006-9016-6; Hill AVS, 2006, ANNU REV GENET, V40, P469, DOI 10.1146/annurev.genet.40.110405.090546; Hill AVS, 1998, ANNU REV IMMUNOL, V16, P593, DOI 10.1146/annurev.immunol.16.1.593; Hochachka WM, 2000, P NATL ACAD SCI USA, V97, P5303, DOI 10.1073/pnas.080551197; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; Hughes AL, 2008, ANN NY ACAD SCI, V1133, P162, DOI 10.1196/annals.1438.001; JANEWAY CA, 2002, IMMUNOLOGY; Jarvi SI, 2004, MOL ECOL, V13, P2157, DOI 10.1111/j.1365-294X.2004.02228.x; Jeffery KJM, 2000, MICROBES INFECT, V2, P1335, DOI 10.1016/S1286-4579(00)01287-9; Kaufman J, 2000, PHILOS T R SOC B, V355, P1077, DOI 10.1098/rstb.2000.0645; Kloch A, 2010, MOL ECOL, V19, P255, DOI 10.1111/j.1365-294X.2009.04476.x; Kollias GV, 2004, J WILDLIFE DIS, V40, P79, DOI 10.7589/0090-3558-40.1.79; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Kurtz J, 2004, P ROY SOC B-BIOL SCI, V271, P197, DOI 10.1098/rspb.2003.2567; Landry C, 2001, MOL ECOL, V10, P2525, DOI 10.1046/j.1365-294X.2001.01383.x; Loiseau C, 2011, P ROY SOC B-BIOL SCI, V278, P1264, DOI 10.1098/rspb.2010.1968; Miller HC, 2004, MOL ECOL, V13, P3709, DOI 10.1111/j.1365-294X.2004.02368.x; Miller KM, 2001, GENETICA, V111, P237, DOI 10.1023/A:1013716020351; Nielsen R, 2001, HEREDITY, V86, P641, DOI 10.1046/j.1365-2540.2001.00895.x; Oliver MK, 2009, P ROY SOC B-BIOL SCI, V276, P1119, DOI 10.1098/rspb.2008.1525; Oliver MK, 2009, MOL ECOL, V18, P80, DOI 10.1111/j.1365-294X.2008.04015.x; Ottova E, 2007, BIOL J LINN SOC, V90, P525, DOI 10.1111/j.1095-8312.2007.00743.x; Paterson S, 1998, P NATL ACAD SCI USA, V95, P3714, DOI 10.1073/pnas.95.7.3714; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; Rakus KL, 2008, FISH SHELLFISH IMMUN, V24, P734, DOI 10.1016/j.fsi.2007.11.015; Raymond CK, 2005, GENOME RES, V15, P1250, DOI 10.1101/gr.3554305; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Sato A, 2011, MOL BIOL EVOL, V28, P1943, DOI 10.1093/molbev/msr015; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; SHE JX, 1991, P NATL ACAD SCI USA, V88, P453, DOI 10.1073/pnas.88.2.453; Siddle HV, 2010, P ROY SOC B-BIOL SCI, V277, P2001, DOI 10.1098/rspb.2009.2362; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Staszewski V, 2008, P ROY SOC B-BIOL SCI, V275, P2101, DOI 10.1098/rspb.2008.0515; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van Oosterhout C, 2006, HEREDITY, V97, P111, DOI 10.1038/sj.hdy.6800843; Westerdahl H, 2005, P ROY SOC B-BIOL SCI, V272, P1511, DOI 10.1098/rspb.2005.3113; Westerdahl H, 2007, J ORNITHOL, V148, pS469, DOI 10.1007/s10336-007-0230-5; Worley K, 2010, MOL ECOL, V19, P3064, DOI 10.1111/j.1365-294X.2010.04724.x	71	38	39	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30222	10.1371/journal.pone.0030222	http://dx.doi.org/10.1371/journal.pone.0030222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291920	Green Submitted, Green Published, gold			2022-12-27	WOS:000301570600026
J	Millioni, R; Polati, R; Menini, M; Puricelli, L; Miuzzo, M; Tessari, P; Novelli, E; Righetti, PG; Cecconi, D				Millioni, Renato; Polati, Rita; Menini, Michele; Puricelli, Lucia; Miuzzo, Manuela; Tessari, Paolo; Novelli, Enrico; Righetti, Pier Giorgio; Cecconi, Daniela			Polar Electrophoresis: Shape of Two-Dimensional Maps Is as Important as Size	PLOS ONE			English	Article							PH GRADIENT GELS; PROTEOMIC ANALYSIS; REPRODUCIBILITY; PROTEINS; IMPROVE; LONG	The performance of two-dimensional electrophoresis in conventional gels in Cartesian coordinates (2-DE) vs. polar coordinates (2-PE) is here evaluated. Although 2-DE is performed in much longer Immobiline gels in the first dimension (17 cm) vs. barely 7 cm in 2-PE, an equivalent resolving power is found. Moreover, due to the possibility of running up to seven Immobiline strips in the radial gel format, the reproducibility of spot position is seen to be higher, this resulting in a 20% higher matching efficiency. As an extra bonus, strings of "isobaric" spots (i.e. polypeptides of identical mass with different pI values) are more resolved in the radial gel format, especially in the 10 to 30 kDa region, where the gel area fans out leaving extra space for spot resolution. In conclusion, this novel gel format in the second dimension of 2D gels is seen as an important improvement of this technique, still one of the most popular in proteome analysis.	[Millioni, Renato; Puricelli, Lucia; Tessari, Paolo] Univ Padua, Dept Med, Padua, Italy; [Polati, Rita; Menini, Michele; Cecconi, Daniela] Univ Verona, Dept Biotechnol, Prote & Mass Spectrometry Lab, I-37100 Verona, Italy; [Miuzzo, Manuela] CNR, Inst Neurosci, Padua, Italy; [Novelli, Enrico] Univ Padua, Dept Publ Hlth Comparat Pathol & Vet Hyg, Legnaro, Italy; [Righetti, Pier Giorgio] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, Milan, Italy	University of Padua; University of Verona; Consiglio Nazionale delle Ricerche (CNR); University of Padua; Polytechnic University of Milan	Millioni, R (corresponding author), Univ Padua, Dept Med, Padua, Italy.	daniela.cecconi@univr.it	Cecconi, Daniela/AAC-7952-2019; Millioni, Renato/ABG-1799-2020	Cecconi, Daniela/0000-0002-7314-8941; NOVELLI, Enrico/0000-0001-6448-5156; Tessari, Paolo/0000-0002-4570-9238				BJELLQVIST B, 1982, J BIOCHEM BIOPH METH, V6, P317, DOI 10.1016/0165-022X(82)90013-6; Bruschi M, 2003, PROTEOMICS, V3, P821, DOI 10.1002/pmic.200300361; Campostrini N, 2005, PROTEOMICS, V5, P2385, DOI 10.1002/pmic.200401253; Candiano G, 2002, ELECTROPHORESIS, V23, P292, DOI 10.1002/1522-2683(200202)23:2<292::AID-ELPS292>3.0.CO;2-5; Cecconi D, 2008, J PROTEOME RES, V7, P2670, DOI 10.1021/pr700712p; Cecconi D, 2009, PROTEOMICS, V9, P1952, DOI 10.1002/pmic.200701089; Fuxius S, 2008, PROTEOMICS, V8, P1780, DOI 10.1002/pmic.200701074; Herbert B, 2001, ELECTROPHORESIS, V22, P2046, DOI 10.1002/1522-2683(200106)22:10<2046::AID-ELPS2046>3.0.CO;2-C; KLOSE J, 1984, CLIN CHEM, V30, P2014; Millioni R, ELECTROPHORESIS, V31, P465; Millioni R, ELECTROPHORESIS, V31, P3863; Millioni R, AMINO ACIDS; Oguri T, 2002, PROTEOMICS, V2, P666, DOI 10.1002/1615-9861(200206)2:6<666::AID-PROT666>3.0.CO;2-V; Poland J, 2003, ELECTROPHORESIS, V24, P1271, DOI 10.1002/elps.200390163; Timms JF, 2008, PROTEOMICS, V8, P4886, DOI 10.1002/pmic.200800298; YOUNG DA, 1984, CLIN CHEM, V30, P2104; Yuan Q, 2003, ACTA BIOCH BIOPH SIN, V35, P611; Zhan XQ, 2003, ELECTROPHORESIS, V24, P1834, DOI 10.1002/elps.200305389	18	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30911	10.1371/journal.pone.0030911	http://dx.doi.org/10.1371/journal.pone.0030911			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292075	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600096
J	Jiang, GY; Wang, Y; Dai, SD; Liu, Y; Stoecker, M; Wang, ED; Wang, EH				Jiang, Guiyang; Wang, Yan; Dai, Shundong; Liu, Yang; Stoecker, Maggie; Wang, Endi; Wang, Enhua			P120-Catenin Isoforms 1 and 3 Regulate Proliferation and Cell Cycle of Lung Cancer Cells via beta-Catenin and Kaiso Respectively	PLOS ONE			English	Article							MEDIATED TRANSCRIPTIONAL REPRESSION; NUCLEAR-LOCALIZATION; PARTNER KAISO; P120(CTN); GENE; EXPRESSION; INVASION; TARGET	Background: The different mechanisms involved in p120-catenin (p120ctn) isoforms' 1/3 regulation of cell cycle progression are still not elucidated to date. Methods and Findings: We found that both cyclin D1 and cyclin E could be effectively restored by restitution of p120ctn-1A or p120ctn-3A in p120ctn depleted lung cancer cells. When the expression of cyclin D1 was blocked by co-transfection with siRNA-cyclin D1 in p120ctn depleted cells restoring p120ctn-1A or 3A, the expression of cyclin E was slightly decreased, not increased, implying that p120ctn isoforms 1 and 3 cannot up-regulate cyclin E directly but may do so through up-regulation of cyclin D1. Interestingly, overexpression of p120ctn-1A increased beta-catenin and cyclin D1 expression, while co-transfection with siRNA targeting beta-catenin abolishes the effect of p120ctn-1A on up-regulation of cyclin D1, suggesting a role of beta-catenin in mediating p120ctn-1A's regulatory function on cyclin D1 expression. On the other hand, overexpression of p120ctn isoform 3A reduced nuclear Kaiso localization, thus decreasing the binding of Kaiso to KBS on the cyclin D1 promoter and thereby enhancing the expression of cyclin D1 gene by relieving the repressor effect of Kaiso. Because overexpressing NLS-p120ctn-3A (p120ctn-3A nuclear target localization plasmids) or inhibiting nuclear export of p120ctn-3 by Leptomycin B (LMB) caused translocation of Kaiso to the nucleus, it is plausible that the nuclear export of Kaiso is p120ctn-3-dependent. Conclusions: Our results suggest that p120ctn isoforms 1 and 3 up-regulate cyclin D1, and thereby cyclin E, resulting in the promotion of cell proliferation and cell cycle progression in lung cancer cells probably via different protein mediators, namely, beta-catenin for isoform 1 and Kaiso, a negative transcriptional factor of cyclin D1, for isoform 3.	[Jiang, Guiyang; Wang, Yan; Dai, Shundong; Liu, Yang; Wang, Enhua] China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Peoples R China; [Jiang, Guiyang; Wang, Yan; Dai, Shundong; Liu, Yang; Wang, Enhua] China Med Univ, Coll Basic Med Sci, Shenyang, Peoples R China; [Stoecker, Maggie; Wang, Endi] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	China Medical University; China Medical University; Duke University	Jiang, GY (corresponding author), China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Peoples R China.	wangeh@hotmail.com	cmu, wy/HDO-5017-2022		National Natural Science Foundation of China [81071905, 30901475, 81071717, 30900562]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grants 81071905 to Enhua Wang, 30901475 to Yan Wang, 81071717 to Shundong Dai, and 30900562 to Yang Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blagosklonny MV, 2002, CELL CYCLE, V1, P103, DOI 10.4161/cc.1.2.108; Chartier NT, 2007, CANCER RES, V67, P9781, DOI 10.1158/0008-5472.CAN-07-0233; Dai SD, 2010, LUNG CANCER, V67, P205, DOI 10.1016/j.lungcan.2009.06.013; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; Hong JY, 2010, J CELL SCI, V123, P4351, DOI 10.1242/jcs.067199; Iioka H, 2009, FEBS LETT, V583, P627, DOI 10.1016/j.febslet.2009.01.012; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Kelly KF, 2004, J CELL SCI, V117, P6143, DOI 10.1242/jcs.01541; Kelly KF, 2004, J CELL SCI, V117, P2675, DOI 10.1242/jcs.01101; Liu Y, 2009, EXP CELL RES, V315, P890, DOI 10.1016/j.yexcr.2008.12.016; Liu Y, 2009, CANCER SCI, V100, P441, DOI 10.1111/j.1349-7006.2008.01067.x; Mo YY, 1996, CANCER RES, V56, P2633; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Roczniak-Ferguson A, 2003, J CELL SCI, V116, P4201, DOI 10.1242/jcs.00724; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Spring CM, 2005, EXP CELL RES, V305, P253, DOI 10.1016/j.yexcr.2005.01.007; van Hengel J, 1999, P NATL ACAD SCI USA, V96, P7980, DOI 10.1073/pnas.96.14.7980; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455	21	27	27	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30303	10.1371/journal.pone.0030303	http://dx.doi.org/10.1371/journal.pone.0030303			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276175	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100032
J	Rahman, MA; Spurrier, N; Mahmood, MA; Rahman, M; Choudhury, SR; Leeder, S				Rahman, Muhammad Aziz; Spurrier, Nicola; Mahmood, Mohammad Afzal; Rahman, Mahmudur; Choudhury, Sohel Reza; Leeder, Stephen			Is There Any Association between Use of Smokeless Tobacco Products and Coronary Heart Disease in Bangladesh?	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SMOKING-CESSATION; PUBLIC-HEALTH; SNUFF USERS; MOIST SNUFF; FOLLOW-UP; RISK; MORTALITY; COHORT	Background: Most epidemiological studies exploring the association between smokeless tobacco (SLT) use and coronary heart disease (CHD) have been in Western populations, and have focused on SLT products used in those countries. Few studies come from South Asian countries. Our objective was to determine the association between SLT use and CHD among non-smoking adults in Bangladesh. Methods: A matched case-control study of non-smoking Bangladeshi adults aged 40-75 years was conducted in 2010. Incident cases of CHD were selected from two cardiac hospitals. Community controls, matched to CHD cases, were selected from neighbourhoods, and hospital controls were selected from outpatient departments of the same hospitals. The Rose Angina Questionnaire (RAQ) was also used to re-classify cases and controls. Results: The study enrolled 302 cases, 1,208 community controls and 302 hospital controls. Current use was higher among community controls (38%) compared to cases (33%) and hospital controls (32%). Current use of SLT was not significantly associated with an increased risk of CHD when community controls were used (adjusted OR 0.87, 95% CI 0.63-1.19), or when hospital controls were used (adjusted OR 1.00, 95% CI 0.63-1.60), or when both control groups were combined (adjusted OR 1.00, 95% CI 0.74-1.34). Risk of CHD did not increase with use of individual types except gul, frequency, duration, past use of SLT products, or using the RAQ to re-classify cases and controls. There was a significant association between gul use and CHD when both controls were combined (adjusted OR 2.93, 95% CI 1.28-6.70). Conclusions: There was no statistically significant association between SLT use in general and CHD among non-smoking adults in Bangladesh. Further research on the association between gul use and CHD in Bangladesh along with SLT use and CHD in other parts of the subcontinent will guide public health policy and interventions that focus on SLT-related diseases.	[Rahman, Muhammad Aziz; Spurrier, Nicola; Mahmood, Mohammad Afzal] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia; [Rahman, Mahmudur] Inst Epidemiol Dis Control & Res, Dhaka, Bangladesh; [Choudhury, Sohel Reza] Natl Heart Fdn Hosp & Res Inst, Dhaka, Bangladesh; [Leeder, Stephen] Univ Sydney, Menzies Ctr Hlth Policy, Sydney, NSW 2006, Australia	University of Adelaide; University of Sydney	Rahman, MA (corresponding author), Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia.	aziz.rahman@adelaide.edu.au	Rahman, Muhammad Aziz/B-3380-2009	Rahman, Muhammad Aziz/0000-0003-1665-7966	Discipline of Public Health; University of Adelaide; Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh; National Heart Foundation Hospital & Research Institute (NHFH& RI), Dhaka, Bangladesh	Discipline of Public Health; University of Adelaide; Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh; National Heart Foundation Hospital & Research Institute (NHFH& RI), Dhaka, Bangladesh	Funding for this study was provided by the Discipline of Public Health, The University of Adelaide. Additionally, human resource and in-kind support for the research was also provided by the Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh and the National Heart Foundation Hospital & Research Institute (NHFH& RI), Dhaka, Bangladesh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accortt NA, 2002, AM J EPIDEMIOL, V156, P730, DOI 10.1093/aje/kwf106; AOAC International, 2004, OFF METH AN NIC TOB; Asplund K, 2003, PROG CARDIOVASC DIS, V45, P383, DOI 10.1053/pcad.2003.00102; Benowitz N L, 1997, Adv Dent Res, V11, P336; BENOWITZ NL, 1991, TRENDS CARDIOVAS MED, V1, P315, DOI 10.1016/1050-1738(91)90068-P; Boffetta P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3060; BOLINDER G, 1994, AM J PUBLIC HEALTH, V84, P399, DOI 10.2105/AJPH.84.3.399; BOLINDER GM, 1992, J INTERN MED, V232, P327, DOI 10.1111/j.1365-2796.1992.tb00593.x; Choudhury K, 2007, J HEALTH POPUL NUTR, V25, P456; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Efroymson D, 2001, TOB CONTROL, V10, P212, DOI 10.1136/tc.10.3.212; Flora MS, 2009, TOB CONTROL, V18, P445, DOI 10.1136/tc.2008.028142; Foulds J, 2003, TOB CONTROL, V12, P349, DOI 10.1136/tc.12.4.349; Guh JY, 2007, AM J CLIN NUTR, V85, P1229, DOI 10.1093/ajcn/85.5.1229; Gupta PC, 2005, INT J EPIDEMIOL, V34, P1395, DOI 10.1093/ije/dyi196; Gupta PC, 2003, RESPIROLOGY, V8, P419, DOI 10.1046/j.1440-1843.2003.00507.x; Haglund B, 2007, SCAND J PUBLIC HEALT, V35, P618, DOI 10.1080/14034940701436949; Hansson J, 2009, J INTERN MED, V265, P717, DOI 10.1111/j.1365-2796.2009.02081.x; Henley SJ, 2005, CANCER CAUSE CONTROL, V16, P347, DOI 10.1007/s10552-004-5519-6; Henningfield JE, 2001, TOB CONTROL, V10, P253, DOI 10.1136/tc.10.3.253; Hergens MP, 2008, J INTERN MED, V264, P187, DOI 10.1111/j.1365-2796.2008.01939.x; Hergens MP, 2005, EPIDEMIOLOGY, V16, P12, DOI 10.1097/01.ede.0000147108.92895.ba; HUHTASAARI F, 1992, BRIT MED J, V305, P1252, DOI 10.1136/bmj.305.6864.1252; Huhtasaari F, 1999, J AM COLL CARDIOL, V34, P1784, DOI 10.1016/S0735-1097(99)00409-X; Infante-Rivard C, 2003, AM J EPIDEMIOL, V157, P176, DOI 10.1093/aje/kwf174; International Agency for Research on Cancer, 2007, IARC MONOGR EVAL CAR, V89; Janzon E, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-21; Johansson SE, 2005, EUR J CARDIOV PREV R, V12, P387, DOI 10.1097/01.hjr.0000169189.22302.99; KAWACHI I, 1993, ANN INTERN MED, V119, P992, DOI 10.7326/0003-4819-119-10-199311150-00005; Kochar D K, 2007, J Assoc Physicians India, V55, P271; Lee PN, 2011, REGUL TOXICOL PHARM, V59, P197, DOI 10.1016/j.yrtph.2010.12.002; Lin WY, 2008, AM J CLIN NUTR, V87, P1204, DOI 10.1093/ajcn/87.5.1204; Malson JL, 2001, TOB CONTROL, V10, P181, DOI 10.1136/tc.10.2.181; McElduff P, 1998, AUST NZ J PUBL HEAL, V22, P787, DOI 10.1111/j.1467-842X.1998.tb01494.x; McKee M, 2007, INT J EPIDEMIOL, V36, P805, DOI 10.1093/ije/dym101; Melikian AA, 2009, BIOMARKERS, V14, P85, DOI 10.1080/13547500902965401; Rahman M, 2003, J CLIN EPIDEMIOL, V56, P101, DOI 10.1016/S0895-4356(02)00507-3; Rahman M. A., 2011, Journal of Public Health and Epidemiology, V3, P593; Rahman MA, 2008, PUBLIC HEALTH, V122, P1331, DOI 10.1016/j.puhe.2008.05.015; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Stanfill SB, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.037465; Stepanov I, 2005, INT J CANCER, V116, P16, DOI 10.1002/ijc.20966; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Wermberg P, 2007, J INTERN MED, V262, P360, DOI 10.1111/j.1365-2796.2007.01813.x; WEST DW, 1984, INT J EPIDEMIOL, V13, P235, DOI 10.1093/ije/13.2.235; World Health Organization-Bangladesh, 2006, IMP TOB REL ILLN BAN; World Health Organization-Bangladesh, 2009, GLOB AD TOB SURV BAN; Yatsuya H, 2010, AM J EPIDEMIOL, V172, P600, DOI 10.1093/aje/kwq191; Yen AMF, 2008, AM J CLIN NUTR, V87, P70, DOI 10.1093/ajcn/87.1.70	49	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30584	10.1371/journal.pone.0030584	http://dx.doi.org/10.1371/journal.pone.0030584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276217	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100059
J	Bhattarai, N; Charlton, J; Rudisill, C; Gulliford, MC				Bhattarai, Nawaraj; Charlton, Judith; Rudisill, Caroline; Gulliford, Martin C.			Coding, Recording and Incidence of Different Forms of Coronary Heart Disease in Primary Care	PLOS ONE			English	Article							GENERAL-PRACTICE; MORTALITY; DECLINE; PREVALENCE; MANAGEMENT; ANGINA; UK	Objectives: To evaluate the coding, recording and incidence of coronary heart disease (CHD) in primary care electronic medical records. Methods: Data were drawn from the UK General Practice Research Database. Analyses evaluated the occurrence of 271 READ medical diagnostic codes, including categories for 'Angina', 'Myocardial Infarction', 'Coronary Artery Bypass Grafting' (CABG), 'percutaneous transluminal coronary angioplasty' (PCTA) and 'Other Coronary Heart Disease'. Time-to-event analyses were implemented to evaluate occurrences of different groups of codes after the index date. Results: Among 300,020 participants aged greater than 30 years there were 75,197 unique occurrences of coronary heart disease codes in 24,244 participants, with 12,495 codes for incident events and 62,702 for prevalent events. Among incident event codes, 3,607 (28.87%) were for angina, 3,262 (26.11%) were for MI, 514 (4.11%) for PCTA, 161 (1.29%) for CABG and 4,951 (39.62%) were for 'Other CHD'. Among prevalent codes, 20,254 (32.30%) were for angina, 3,644 (5.81%) for MI, 34,542 (55.09%) for 'Other CHD' and 4,262 (6.80%) for CABG or PCTA. Among 3,685 participants initially diagnosed exclusively with 'Other CHD' codes, 17.1% were recorded with angina within 5 years, 5.6% with myocardial infarction, 6.3% with CABG and 8.6% with PCTA. From 2000 to 2010, the overall incidence of CHD declined, as did the incidence of angina, but the incidence of MI did not change. The frequency of CABG declined, while PCTA increased. Conclusion: In primary care electronic records, a substantial proportion of coronary heart disease events are recorded with codes that do not distinguish between different clinical presentations of CHD. The results draw attention to the need to improve coding practice in primary care. The results also draw attention to the importance of code selection in research studies and the need for sensitivity analyses using different sets of codes.	[Bhattarai, Nawaraj; Charlton, Judith; Gulliford, Martin C.] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England; [Rudisill, Caroline] London Sch Econ, Dept Social Policy & LSE Hlth, London WC2A 2AE, England	University of London; King's College London; University of London; London School Economics & Political Science	Bhattarai, N (corresponding author), Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England.	nawaraj.bhattarai@kcl.ac.uk	Gulliford, Martin C/I-8606-2018	Gulliford, Martin C/0000-0003-1898-9075	National Prevention Research Initiative (NPRI) through the Medical Research Council; MRC [G0900845] Funding Source: UKRI; Medical Research Council [G0900845] Funding Source: researchfish	National Prevention Research Initiative (NPRI) through the Medical Research Council; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the National Prevention Research Initiative (NPRI) through the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, NHS CONN HLTH NHS CL; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; CLARKE KW, 1994, BRIT HEART J, V71, P38; Commission for health care audit and inspection, 2005, NAT SERV FRAM REP GE; Davies AR, 2007, EUR HEART J, V28, P2142, DOI 10.1093/eurheartj/ehm272; GANDHI MM, 1995, BRIT J GEN PRACT, V45, P11; Gulliford MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007168; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; Hardoon SL, 2011, EUROPEAN HEART J; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Lampe FC, 2001, HEART, V86, P499, DOI 10.1136/heart.86.5.499; Lawson DH, 1998, QJM-MON J ASSOC PHYS, V91, P445, DOI 10.1093/qjmed/91.6.445; McGovern MP, 2008, FAM PRACT, V25, P33, DOI 10.1093/fampra/cmm073; National Statistics, 2000, KEY HLTH STAT GEN PR; Scarborough P, 2010, CORONARY HEART DIS S; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; GEN PRACTICE RES DAT	18	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29776	10.1371/journal.pone.0029776	http://dx.doi.org/10.1371/journal.pone.0029776			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276128	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000301457200022
J	LaPointe, LC; Pedersen, SK; Dunne, R; Brown, GS; Pimlott, L; Gaur, S; McEvoy, A; Thomas, M; Wattchow, D; Molloy, PL; Young, GP				LaPointe, Lawrence C.; Pedersen, Susanne K.; Dunne, Robert; Brown, Glenn S.; Pimlott, Letitia; Gaur, Snigdha; McEvoy, Aidan; Thomas, Melissa; Wattchow, David; Molloy, Peter L.; Young, Graeme P.			Discovery and Validation of Molecular Biomarkers for Colorectal Adenomas and Cancer with Application to Blood Testing	PLOS ONE			English	Article							GENE-EXPRESSION; MICROARRAY DATA; SURVEILLANCE; STANDARD; ARRAY; PCR; RNA	Background & Aims: Colorectal cancer incidence and deaths are reduced by the detection and removal of early-stage, treatable neoplasia but we lack proven biomarkers sensitive for both cancer and pre-invasive adenomas. The aims of this study were to determine if adenomas and cancers exhibit characteristic patterns of biomarker expression and to explore whether a tissue-discovered (and validated) biomarker is differentially expressed in the plasma of patients with colorectal adenomas or cancer. Methods: Candidate RNA biomarkers were identified by oligonucleotide microarray analysis of colorectal specimens (222 normal, 29 adenoma, 161 adenocarcinoma and 50 colitis) and validated in a previously untested cohort of 68 colorectal specimens using a custom-designed oligonucleotide microarray. One validated biomarker, KIAA1199, was assayed using qRT-PCR on plasma extracted RNA from 20 colonoscopy-confirmed healthy controls, 20 patients with adenoma, and 20 with cancer. Results: Genome-wide analysis uncovered reproducible gene expression signatures for both adenomas and cancers compared to controls. 386/489 (79%) of the adenoma and 439/529 (83%) of the adenocarcinoma biomarkers were validated in independent tissues. We also identified genes differentially expressed in adenomas compared to cancer. KIAA1199 was selected for further analysis based on consistent up-regulation in neoplasia, previous studies and its interest as an uncharacterized gene. Plasma KIAA1199 RNA levels were significantly higher in patients with either cancer or adenoma (31/40) compared to neoplasia-free controls (6/20). Conclusions: Colorectal neoplasia exhibits characteristic patterns of gene expression. KIAA1199 is differentially expressed in neoplastic tissues and KIAA1199 transcripts are more abundant in the plasma of patients with either cancer or adenoma compared to controls.	[LaPointe, Lawrence C.; Pimlott, Letitia; Wattchow, David; Young, Graeme P.] Flinders Univ S Australia, Flinders Ctr Canc Prevent & Control, Adelaide, SA, Australia; [LaPointe, Lawrence C.; Pedersen, Susanne K.; Gaur, Snigdha; McEvoy, Aidan; Thomas, Melissa] Clin Genom Pty Ltd, Sydney, NSW, Australia; [Brown, Glenn S.; Molloy, Peter L.] CSIRO Food & Nutr Sci, Preventat Hlth Natl Res Flagship, Sydney, NSW, Australia; [Dunne, Robert] CSIRO Math & Informat Sci, Preventat Hlth Natl Res Flagship, Sydney, NSW, Australia	Flinders University South Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	LaPointe, LC (corresponding author), Flinders Univ S Australia, Flinders Ctr Canc Prevent & Control, Adelaide, SA, Australia.	larry.lapointe@flinders.edu.au	Molloy, Peter L/H-7931-2013	Molloy, Peter L/0000-0002-7788-3417; LaPointe, Lawrence/0000-0002-8906-1867; , Susanne/0000-0002-5518-1959; Young, Graeme/0000-0001-9458-8383	Flinders University of South Australia; Commonwealth Scientific and Industrial Research Organisation (CSIRO) of Australia; Clinical Genomics Pty Ltd.	Flinders University of South Australia; Commonwealth Scientific and Industrial Research Organisation (CSIRO) of Australia; Clinical Genomics Pty Ltd.	This work was co-funded by Flinders University of South Australia and the Commonwealth Scientific and Industrial Research Organisation (CSIRO) of Australia. Drs. Dunne, Molloy and Brown are employed by CSIRO. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding was also provided by Clinical Genomics Pty Ltd., a company involved in the discovery and commercialization of biomarkers for colorectal cancer. Drs. LaPointe, Pedersen, Gaur, McEvoy and Thomas are employed by Clinical Genomics Pty Ltd and Prof. Young is a paid consultant of Clinical Genomics Pty Ltd. The funder thus played roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript. Mrs. Pimlott and Dr. Wattchow have nothing to disclose.; This work was co-funded by Clinical Genomics Pty Ltd, a company involved in the discovery and commercialization of biomarkers for colorectal cancer. Drs. LaPointe, Pedersen, Gaur, McEvoy and Thomas are employed by Clinical Genomics Pty Ltd. Prof. Young is a paid consultant of Clinical Genomics Pty Ltd. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Birkenkamp-Demtroder K, 2002, CANCER RES, V62, P4352; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Chan SK, 2008, CANCER EPIDEM BIOMAR, V17, P543, DOI 10.1158/1055-9965.EPI-07-2615; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Donia D, 2005, J VIROL METHODS, V126, P157, DOI 10.1016/j.jviromet.2005.02.004; Ebert C, 2010, MATH LANG 10 11 BIEN, VVIII, P297; Galamb O, 2010, BRIT J CANCER, V102, P765, DOI 10.1038/sj.bjc.6605515; Galamb O, 2008, CANCER EPIDEM BIOMAR, V17, P2835, DOI 10.1158/1055-9965.EPI-08-0231; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Lane JM, 2010, GASTROENTEROLOGY, V139, P1918, DOI 10.1053/j.gastro.2010.08.005; LaPointe LC, 2008, PHYSIOL GENOMICS, V33, P50, DOI 10.1152/physiolgenomics.00185.2006; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; Markowitz AJ, 1999, SEMIN ONCOL, V26, P485; Matsuzaki S, 2009, ANN SURG ONCOL, V16, P2042, DOI 10.1245/s10434-009-0469-6; Michishita E, 2006, CANCER LETT, V239, P71, DOI 10.1016/j.canlet.2005.07.028; Nannini M, 2009, CANCER TREAT REV, V35, P201, DOI 10.1016/j.ctrv.2008.10.006; Park DI, 2010, AM J GASTROENTEROL, V105, P2017, DOI 10.1038/ajg.2010.179; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Pradervand S, 2008, BIOTECHNIQUES, V44, P759, DOI 10.2144/000112751; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Ransohoff DF, 2004, GASTROENTEROLOGY, V127, P1028, DOI 10.1053/j.gastro.2004.08.030; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Young G, 2003, TXB GASTROENTEROLOGY, V2, P1883; Young GP, 2009, NAT CLIN PRACT GASTR, V6, P140, DOI 10.1038/ncpgasthep1358	33	30	34	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29059	10.1371/journal.pone.0029059	http://dx.doi.org/10.1371/journal.pone.0029059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276102	gold, Green Submitted, Green Published			2022-12-27	WOS:000301457200004
J	Xu, B; Tong, N; Chen, SQ; Yang, Y; Zhang, XW; Liu, J; Hu, XN; Sha, GZ; Chen, M				Xu, Bin; Tong, Na; Chen, Shu-Qiu; Yang, Yu; Zhang, Xiao-Wen; Liu, Jin; Hu, Xiang-Nong; Sha, Guo-Zhu; Chen, Ming			Contribution of HOGG1 Ser(326)Cys Polymorphism to the Development of Prostate Cancer in Smokers: Meta-Analysis of 2779 Cases and 3484 Controls	PLOS ONE			English	Article							REPAIR GENES; RISK; 8-HYDROXYGUANINE; GLYCOSYLASE-1; ASSOCIATION; EXCISION; SMOKING; OGG1	The HOGG1 gene catalyzes the excision of modified bases and removal of DNA damage adducts. It may play an important role in the prevention of carcinogenesis. Ser(326)Cys polymorphism localizes in exon 7 of the hOGG1 gene. It takes the form of an amino acid substitution, from serine to cysteine, in codon 326. Several epidemiological association studies have been conducted on this polymorphism and its relationship with the risk of prostate cancer. However, results have been conflicting. To resolve this conflict, we conducted a meta-analysis on the association between this polymorphism and prostate cancer, taking into account race, country, sources of controls, and smoking status. A total of nine studies covering 2779 cases and 3484 controls were included in the current meta-analysis. Although no significant association was found between hOGG1 Ser(326)Cys polymorphism and prostate cancer susceptibility in the pooled analysis, individuals with Ser/Cys+Cys/Cys genotypes were found to have greater risk of prostate cancer if they were also smokers (OR = 2.66, 95% CI = 1.5824.47) rather than non-smokers (OR = 2.18, 95% CI = 1.1324.19), compared with those with Ser/Ser genotype. In conclusion, our meta-analysis demonstrates that hOGG1 Ser(326)Cys polymorphism is a risk factor for prostate cancer in smokers. Further studies are needed to confirm this relationship.	[Xu, Bin; Chen, Shu-Qiu; Yang, Yu; Zhang, Xiao-Wen; Liu, Jin; Hu, Xiang-Nong; Sha, Guo-Zhu; Chen, Ming] Southeast Univ, Affiliated Zhongda Hosp, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Xu, Bin; Chen, Ming] Southeast Univ, Sch Med, Surg Res Ctr, Nanjing, Jiangsu, Peoples R China; [Tong, Na] Nanjing Med Univ, Dept Occupat Med & Environm Hlth, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China; Nanjing Medical University	Xu, B (corresponding author), Southeast Univ, Affiliated Zhongda Hosp, Dept Urol, Nanjing, Jiangsu, Peoples R China.	mingchenseu@gmail.com			National Natural Science Foundation of China [81070592]; Natural Science Foundation of Jiangsu Province [BK2009275]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by National Natural Science Foundation of China (No. 81070592) and Natural Science Foundation of Jiangsu Province (BK2009275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boiteux S, 2000, ARCH BIOCHEM BIOPHYS, V377, P1, DOI 10.1006/abbi.2000.1773; Chen L, 2003, J UROLOGY, V170, P2471, DOI 10.1097/01.ju.0000087498.23008.bb; Dherin C, 1999, NUCLEIC ACIDS RES, V27, P4001, DOI 10.1093/nar/27.20.4001; Dhillon VS, 2009, UROL ONCOL; Hickey K, 2001, EPIDEMIOL REV, V23, P115, DOI 10.1093/oxfordjournals.epirev.a000776; Huncharek M, 2010, AM J PUBLIC HEALTH, V100, P693, DOI 10.2105/AJPH.2008.150508; Janssen K, 2001, MUTAT RES-DNA REPAIR, V486, P207, DOI 10.1016/S0921-8777(01)00096-9; KAMIYA H, 1992, CANCER RES, V52, P3483; KIM EJ, 2010, UROL ONCOL; Kohno T, 1998, ONCOGENE, V16, P3219, DOI 10.1038/sj.onc.1201872; LAMAESTRA S, 2011, TOXICOL SCI; Lavender NA, 2010, PROSTATE, V70, P113, DOI 10.1002/pros.21048; Mittal RD, 2011, MECH AGEING DEV; Nam RK, 2005, CLIN CANCER RES, V11, P8391, DOI 10.1158/1078-0432.CCR-05-1226; NGO TC, 2011, UROL ONCOL; Nock NL, 2006, CARCINOGENESIS, V27, P1842, DOI 10.1093/carcin/bgl022; Xu JF, 2002, CANCER RES, V62, P2253; YUN SJ, 2011, ANN ONCOL; Zhang JJ, 2010, UROLOGY, V75, P779, DOI 10.1016/j.urology.2009.08.063	19	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30309	10.1371/journal.pone.0030309	http://dx.doi.org/10.1371/journal.pone.0030309			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279581	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900058
J	Tatrai, E; Simo, M; Iljicsov, A; Nemeth, J; DeBuc, DC; Somfai, GM				Tatrai, Erika; Simo, Magdolna; Iljicsov, Anna; Nemeth, Janos; DeBuc, Delia Cabrera; Somfai, Gabor Mark			In Vivo Evaluation of Retinal Neurodegeneration in Patients with Multiple Sclerosis	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; GANGLION-CELL COMPLEX; DIAGNOSTIC-ACCURACY; ALZHEIMERS-DISEASE; PARKINSON-DISEASE; MACULAR THICKNESS; IMPAIRMENT; NEURITIS; PATHOLOGY	Objective: To evaluate macular morphology in the eyes of patients with multiple sclerosis (MS) with or without optic neuritis (ON) in previous history. Methods: Optical coherence tomography (OCT) examination was performed in thirty-nine patients with MS and in thirty-three healthy subjects. The raw macular OCT data were processed using OCTRIMA software. The circumpapillary retinal nerve fiber layer (RNFL) thickness and the weighted mean thickness of the total retina and 6 intraretinal layers were obtained for each eye. The eyes of MS patients were divided into a group of 39 ON-affected eyes, and into a group of 34 eyes with no history of ON for the statistical analyses. Receiver operating characteristic (ROC) curves were constructed to determine which parameter can discriminate best between the non-affected group and controls. Results: The circumpapillary RNFL thickness was significantly decreased in the non-affected eyes compared to controls group only in the temporal quadrant (p = 0.001) while it was decreased in the affected eyes of the MS patients in all quadrants compared to the non-affected eyes (p < 0.05 in each comparison). The thickness of the total retina, RNFL, ganglion cell layer and inner plexiform layer complex (GCL+IPL) and ganglion cell complex (GCC, comprising the RNFL and GCL+IPL) in the macula was significantly decreased in the non-affected eyes compared to controls (p, 0.05 for each comparison) and in the ON-affected eyes compared to the non-affected eyes (p, 0.001 for each comparison). The largest area under the ROC curve (0.892) was obtained for the weighted mean thickness of the GCC. The EDSS score showed the strongest correlation with the GCL+IPL and GCC thickness (p = 0.007, r = 0.43 for both variables). Conclusions: Thinning of the inner retinal layers is present in eyes of MS patients regardless of previous ON. Macular OCT image segmentation might provide a better insight into the pathology of neuronal loss and could therefore play an important role in the diagnosis and follow-up of patients with MS.	[Tatrai, Erika; Nemeth, Janos; Somfai, Gabor Mark] Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary; [Simo, Magdolna; Iljicsov, Anna] Semmelweis Univ, Dept Neurol, Budapest, Hungary; [DeBuc, Delia Cabrera] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA	Semmelweis University; Semmelweis University; Bascom Palmer Eye Institute; University of Miami	Tatrai, E (corresponding author), Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary.	tatrai.erika@gmail.com		Somfai, Gabor Mark/0000-0001-6329-442X; Nemeth, Janos/0000-0001-8575-4888; Cabrera DeBuc, Delia/0000-0002-4726-894X	Juvenile Diabetes Research Foundation; National Institutes of Health (NIH) [P30-EY014801]; Research to Prevent Blindness, Inc.; Hungarian Academy of Sciences; NATIONAL EYE INSTITUTE [P30EY014801] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported in part by a Juvenile Diabetes Research Foundation grant, a National Institutes of Health (NIH) center core grant P30-EY014801, by an unrestricted grant to the University of Miami from Research to Prevent Blindness, Inc. and by the Zsigmond Diabetes Fund of the Hungarian Academy of Sciences. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The University of Miami and Dr. DeBuc hold a pending patent used in the study and have the potential for financial benefit from its future commercialization. All other authors of the manuscript report no disclosures. The data of the patent are the following: Name: System and method for early detection of diabetic retinopathy using optical coherence tomography Pub. No.: WO/2010/080576 International Application No.: PCT/US2009/068653 This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Almarcegui C, 2010, NEUROPHYSIOL CLIN, V40, P129, DOI 10.1016/j.neucli.2009.12.001; Altintas O, 2008, DOC OPHTHALMOL, V116, P137, DOI 10.1007/s10633-007-9091-8; [Anonymous], 1991, OPHTHALMOLOGY, V98, P741; Bock M, 2010, CLIN NEUROL NEUROSUR, V112, P647, DOI 10.1016/j.clineuro.2010.04.014; Burkholder BM, 2009, ARCH NEUROL-CHICAGO, V66, P1366, DOI 10.1001/archneurol.2009.230; Costello F, 2010, CAN J OPHTHALMOL, V45, P520, DOI 10.3129/i10-063; Davies EC, 2011, J NEURO-OPHTHALMOL, V31, P260, DOI 10.1097/WNO.0b013e318221b434; Debuc DC, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3470116; Debuc DC, 2010, MED SCI MONITOR, V16, pMT15; DeBuc DC, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3268773; Fernandez DC, 2005, OPT EXPRESS, V13, P10200, DOI 10.1364/OPEX.13.010200; Fisher JB, 2006, OPHTHALMOLOGY, V113, P324, DOI 10.1016/j.ophtha.2005.10.040; Fjeldstad C, 2011, J CLIN NEUROSCI, V18, P1469, DOI 10.1016/j.jocn.2011.04.008; Garas A, 2011, EYE, V25, P57, DOI 10.1038/eye.2010.139; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Hajee ME, 2009, ARCH OPHTHALMOL-CHIC, V127, P737, DOI 10.1001/archophthalmol.2009.106; Henderson APD, 2008, BRAIN, V131, P277, DOI 10.1093/brain/awm285; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Inzelberg R, 2004, VISION RES, V44, P2793, DOI 10.1016/j.visres.2004.06.009; Ishikawa H, 2005, INVEST OPHTH VIS SCI, V46, P2012, DOI 10.1167/iovs.04-0335; KERRISON JB, 1994, RETINA-J RET VIT DIS, V14, P445, DOI 10.1097/00006982-199414050-00010; Kim NR, 2010, INVEST OPHTH VIS SCI, V51, P4646, DOI 10.1167/iovs.09-5053; Kim NR, 2011, J GLAUCOMA; Klistorner A, 2009, DOC OPHTHALMOL, V118, P129, DOI 10.1007/s10633-008-9147-4; Massin P, 2001, ARCH OPHTHALMOL-CHIC, V119, P1135, DOI 10.1001/archopht.119.8.1135; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Parisi V, 1999, INVEST OPHTH VIS SCI, V40, P2520; Parisi V, 2001, CLIN NEUROPHYSIOL, V112, P1860, DOI 10.1016/S1388-2457(01)00620-4; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Pueyo V, 2008, MULT SCLER J, V14, P609, DOI 10.1177/1352458507087326; Saidha S., 2011, MULT SCLER; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Schulze A, 2011, GRAEF ARCH CLIN EXP, V249, P1039, DOI 10.1007/s00417-010-1585-5; Sepulcre J, 2007, NEUROLOGY, V68, P1488, DOI 10.1212/01.wnl.0000260612.51849.ed; Shahidi M, 2005, AM J OPHTHALMOL, V139, P1056, DOI 10.1016/j.ajo.2005.01.012; Silber E, 1999, J NEUROL SCI, V170, P11, DOI 10.1016/S0022-510X(99)00178-1; Syc SB, 2011, BRAIN; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Tatrai E, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3573817; Tegetmeyer H, 2011, NEURO-OPHTHALMOLOGY, V35, P101, DOI 10.3109/01658107.2011.580885	40	45	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30922	10.1371/journal.pone.0030922	http://dx.doi.org/10.1371/journal.pone.0030922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292076	Green Published, Green Submitted, gold			2022-12-27	WOS:000301703800037
J	Dello, SAWG; Reisinger, KW; van Dam, RM; Bemelmans, MHA; van Kuppevelt, TH; van den Broek, MAJ; Damink, SWMO; Poeze, M; Buurman, WA; Dejong, CHC				Dello, Simon A. W. G.; Reisinger, Kostan W.; van Dam, Ronald M.; Bemelmans, Marc H. A.; van Kuppevelt, Toin H.; van den Broek, Maartje A. J.; Damink, Steven W. M. Olde; Poeze, Martijn; Buurman, Wim A.; Dejong, Cornelis H. C.			Total Intermittent Pringle Maneuver during Liver Resection Can Induce Intestinal Epithelial Cell Damage and Endotoxemia	PLOS ONE			English	Article							ACID-BINDING PROTEIN; HEPATIC RESECTION; BACTERIAL TRANSLOCATION; OCCLUSION; EXPRESSION; MORTALITY; INJURY; PHASE	Objectives: The intermittent Pringle maneuver (IPM) is frequently applied to minimize blood loss during liver transection. Clamping the hepatoduodenal ligament blocks the hepatic inflow, which leads to a non circulating (hepato) splanchnic outflow. Also, IPM blocks the mesenteric venous drainage (as well as the splenic drainage) with raising pressure in the microvascular network of the intestinal structures. It is unknown whether the IPM is harmful to the gut. The aim was to investigate intestinal epithelial cell damage reflected by circulating intestinal fatty acid binding protein levels (I-FABP) in patients undergoing liver resection with IPM. Methods: Patients who underwent liver surgery received total IPM (total-IPM) or selective IPM (sel-IPM). A selective IPM was performed by selectively clamping the right portal pedicle. Patients without IPM served as controls (no-IPM). Arterial blood samples were taken immediately after incision, ischemia and reperfusion of the liver, transection, 8 hours after start of surgery and on the first post-operative day. Results: 24 patients (13 males) were included. 7 patients received cycles of 15 minutes and 5 patients received cycles of 30 minutes of hepatic inflow occlusion. 6 patients received cycles of 15 minutes selective hepatic occlusion and 6 patients underwent surgery without inflow occlusion. Application of total-IPM resulted in a significant increase in I-FABP 8 hours after start of surgery compared to baseline (p<0.005). In the no-IPM group and sel-IPM group no significant increase in IFABP at any time point compared to baseline was observed. Conclusion: Total-IPM in patients undergoing liver resection is associated with a substantial increase in arterial I-FABP, pointing to intestinal epithelial injury during liver surgery.	[Dello, Simon A. W. G.; Reisinger, Kostan W.; van Dam, Ronald M.; Bemelmans, Marc H. A.; van den Broek, Maartje A. J.; Damink, Steven W. M. Olde; Poeze, Martijn; Buurman, Wim A.; Dejong, Cornelis H. C.] Maastricht Univ, Dept Surg, Med Ctr, Maastricht, Netherlands; [Dello, Simon A. W. G.; Reisinger, Kostan W.; van Dam, Ronald M.; Bemelmans, Marc H. A.; van den Broek, Maartje A. J.; Damink, Steven W. M. Olde; Poeze, Martijn; Buurman, Wim A.; Dejong, Cornelis H. C.] Maastricht Univ, Nutrim Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Dept Biochem, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Damink, Steven W. M. Olde] Royal Free Hosp, Dept Surg, London NW3 2QG, England; [Damink, Steven W. M. Olde] UCL, Div Surg & Intervent Sci, London, England	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Radboud University Nijmegen; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London	Dello, SAWG (corresponding author), Maastricht Univ, Dept Surg, Med Ctr, Maastricht, Netherlands.	S.dello@maastrichtuniversity.nl	Damink, Steven WM Olde/U-7919-2019; van Kuppevelt, A.H.M.S.M./L-4463-2015	Damink, Steven WM Olde/0000-0002-5202-9345; 	Maastricht University	Maastricht University	Simon Dello was supported by a Kootstra Talent Fellowship from Maastricht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belghiti J, 1998, J Hepatobiliary Pancreat Surg, V5, P69, DOI 10.1007/PL00009953; Cescon M, 2009, ANN SURG, V249, P995, DOI 10.1097/SLA.0b013e3181a63c74; Cherqui D, 2000, ARCH SURG-CHICAGO, V135, P302, DOI 10.1001/archsurg.135.3.302; Chouillard Elie K, 2010, Ann Surg Innov Res, V4, P2, DOI 10.1186/1750-1164-4-2; Clavien PA, 2003, ANN SURG, V238, P843, DOI 10.1097/01.sla.0000098620.27623.7d; Clavien PA, 2000, ANN SURG, V232, P155, DOI 10.1097/00000658-200008000-00001; Dejong C, 2003, ADV SURG PRACTICE, P146; Derikx JPM, 2007, SHOCK, V28, P544, DOI 10.1097/shk.0b013e3180644e32; Derikx JPM, 2009, J CLIN GASTROENTEROL, V43, P727, DOI 10.1097/MCG.0b013e31819194b0; Derikx JPM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003954; Farid SG, 2010, ANN SURG, V251, P91, DOI 10.1097/SLA.0b013e3181bfda3c; Ferri M, 1997, ARCH SURG-CHICAGO, V132, P162; Figueras J, 2005, ANN SURG, V241, P582, DOI 10.1097/01.sla.0000157168.26021.b8; Filos KS, 2004, INJURY, V35, P35, DOI 10.1016/S0020-1383(03)00288-2; GROSS K, 1985, J PEDIATR SURG, V20, P320, DOI 10.1016/S0022-3468(85)80211-6; Holland J, 2005, AM J SURG, V190, P393, DOI 10.1016/j.amjsurg.2005.03.038; Imamura H, 2003, ARCH SURG-CHICAGO, V138, P1198, DOI 10.1001/archsurg.138.11.1198; Kanda T, 1996, GASTROENTEROLOGY, V110, P339, DOI 10.1053/gast.1996.v110.pm8566578; Kanda T, 2011, J GASTROENTEROL, V46, P492, DOI 10.1007/s00535-011-0373-2; King KL, 2001, S AFR J SURG, V39, P46; Kooby DA, 2003, ANN SURG, V237, P860; Ochiai H, 1997, J SURG RES, V73, P129, DOI 10.1006/jsre.1997.5217; Patel A, 2004, TRANSPLANTATION, V78, P1479, DOI 10.1097/01.TP.0000144182.27897.1E; Pelsers MMAL, 2003, CLIN BIOCHEM, V36, P529, DOI 10.1016/S0009-9120(03)00096-1; Poon Ronnie Tung-Ping, 2004, Liver Transpl, V10, pS39, DOI 10.1002/lt.20040; Pringle JH, 1908, ANN SURG, V48, P541, DOI 10.1097/00000658-190810000-00005; Rahbari NN, 2008, BRIT J SURG, V95, P424, DOI 10.1002/bjs.6141; Schindl MJ, 2005, GUT, V54, P289, DOI 10.1136/gut.2004.046524; Sheen-Chen SM, 2011, ANN SURG, V253, P561, DOI 10.1097/SLA.0b013e31820652f4; Topal B, 2007, SURG ENDOSC, V21, P1142, DOI 10.1007/s00464-006-9083-x; Unno N, 2006, J SURG RES, V135, P213, DOI 10.1016/j.jss.2006.03.042; van de Poll MCG, 2007, WORLD J SURG, V31, P2033, DOI 10.1007/s00268-007-9182-4; van den Broek MAJ, 2011, J HEPATOL, V55, P337, DOI 10.1016/j.jhep.2010.11.024; Vauthey JN, 2006, J CLIN ONCOL, V24, P2065, DOI 10.1200/JCO.2005.05.3074	34	32	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30539	10.1371/journal.pone.0030539	http://dx.doi.org/10.1371/journal.pone.0030539			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291982	Green Published, gold, Green Submitted			2022-12-27	WOS:000301639600030
J	Huang, YY; Lu, HM; Liu, S; Droz-Rosario, R; Shen, ZY				Huang, Yi-Yuan; Lu, Huimei; Liu, Stephany; Droz-Rosario, Roberto; Shen, Zhiyuan			Requirement of Mouse BCCIP for Neural Development and Progenitor Proliferation	PLOS ONE			English	Article							DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; PROTEIN; REPAIR; BRAIN; BRCA2; NEUROGENESIS; INHIBITION; EXPRESSION; PREVENTION	Multiple DNA repair pathways are involved in the orderly development of neural systems at distinct stages. The homologous recombination (HR) pathway is required to resolve stalled replication forks and critical for the proliferation of progenitor cells during neural development. BCCIP is a BRCA2 and CDKN1A interacting protein implicated in HR and inhibition of DNA replication stress. In this study, we determined the role of BCCIP in neural development using a conditional BCCIP knock-down mouse model. BCCIP deficiency impaired embryonic and postnatal neural development, causing severe ataxia, cerebral and cerebellar defects, and microcephaly. These development defects are associated with spontaneous DNA damage and subsequent cell death in the proliferative cell populations of the neural system during embryogenesis. With in vitro neural spheroid cultures, BCCIP deficiency impaired neural progenitor's self-renewal capability, and spontaneously activated p53. These data suggest that BCCIP and its anti-replication stress functions are essential for normal neural development by maintaining an orderly proliferation of neural progenitors.	[Huang, Yi-Yuan; Lu, Huimei; Liu, Stephany; Droz-Rosario, Roberto; Shen, Zhiyuan] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Huang, YY (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA.	shenzh@umdnj.edu		Shen, Zhiyuan/0000-0003-2834-0309	NIH [R01CA156706]; Cancer Institute of New Jersey [P30CA072720]; NATIONAL CANCER INSTITUTE [P30CA072720, R01CA156706] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Institute of New Jersey; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NIH R01CA156706 to ZS, and by the Transgenic & Knockout Mouse and the Histopathology & Imaging shared resources of The Cancer Institute of New Jersey (P30CA072720). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ash SC, 2008, BIOCHEM BIOPH RES CO, V371, P333, DOI 10.1016/j.bbrc.2008.04.084; Audhya A, 2003, EMBO J, V22, P4223, DOI 10.1093/emboj/cdg397; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Fan JJ, 2009, CELL CYCLE, V8, P3019; Frappart PO, 2007, EMBO J, V26, P2732, DOI 10.1038/sj.emboj.7601703; Frappart PO, 2005, NAT MED, V11, P538, DOI 10.1038/nm1228; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Katyal S, 2008, MECH AGEING DEV, V129, P483, DOI 10.1016/j.mad.2008.03.008; Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375; Liu JM, 2001, ONCOGENE, V20, P336, DOI 10.1038/sj.onc.1204098; Lu HM, 2005, MOL CELL BIOL, V25, P1949, DOI 10.1128/MCB.25.5.1949-1957.2005; Lu HM, 2007, NUCLEIC ACIDS RES, V35, P7160, DOI 10.1093/nar/gkm732; Lu HM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002291; Mao NH, 2007, DNA REPAIR, V6, P1651, DOI 10.1016/j.dnarep.2007.05.012; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; Meng X, 2007, ONCOGENE, V26, P6253, DOI 10.1038/sj.onc.1210460; Meng XB, 2004, CELL CYCLE, V3, P1457, DOI 10.4161/cc.3.11.1213; Meng XB, 2004, CELL CYCLE, V3, P343; Meng XB, 2003, GENE, V302, P139, DOI 10.1016/S0378-1119(02)01098-3; Narasimhaiah R, 2005, CEREB CORTEX, V15, P696, DOI 10.1093/cercor/bhh171; O'Driscoll M, 2008, DNA REPAIR, V7, P1039, DOI 10.1016/j.dnarep.2008.03.018; Ono T, 2000, J BIOL CHEM, V275, P31145, DOI 10.1074/jbc.M003031200; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; Phillips-Mason PJ, 2008, J CELL BIOCHEM, V105, P1059, DOI 10.1002/jcb.21907; RUIZ IAA, 2002, NAT REV NEUROSCI, V3, P24, DOI DOI 10.1038/NRN704; Takahashi E, 2009, BRAIN RES, V1279, P50, DOI 10.1016/j.brainres.2009.05.016; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wilson DM, 2008, MECH AGEING DEV, V129, P349, DOI 10.1016/j.mad.2008.02.013; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	30	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30638	10.1371/journal.pone.0030638	http://dx.doi.org/10.1371/journal.pone.0030638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292003	gold, Green Published, Green Submitted			2022-12-27	WOS:000301639600038
J	Lecube, A; Baena-Fustegueras, JA; Fort, JM; Pelegri, D; Hernandez, C; Simo, R				Lecube, Albert; Antonio Baena-Fustegueras, Juan; Manuel Fort, Jose; Pelegri, Dolors; Hernandez, Cristina; Simo, Rafael			Diabetes Is the Main Factor Accounting for Hypomagnesemia in Obese Subjects	PLOS ONE			English	Article							SERUM IONIZED MAGNESIUM; METABOLIC SYNDROME; DIETARY MAGNESIUM; TYPE-2; MELLITUS; INSULIN; RISK; HYPERTENSION; ASSOCIATIONS; MENOPAUSE	Objective: Type 2 diabetes (T2DM) and obesity are associated with magnesium deficiency. We aimed to determine whether the presence of type 2 diabetes and the degree of metabolic control are related to low serum magnesium levels in obese individuals. Methods: A) Case-control study: 200 obese subjects [50 with T2DM (cases) and 150 without diabetes (controls)] prospectively recruited. B) Interventional study: the effect of bariatric surgery on serum magnesium levels was examined in a subset of 120 obese subjects (40 with type 2 diabetes and 80 without diabetes). Results: Type 2 diabetic patients showed lower serum magnesium levels [0.75 +/- 0.07 vs. 0.81 +/- 0.06 mmol/L; mean difference -0.06 (95% CI -0.09 to -0.04); p<0.001] than non-diabetic patients. Forty-eight percent of diabetic subjects, but only 15% of non-diabetic subjects showed a serum magnesium concentration lower than 0.75 mmol/L. Significant negative correlations between magnesium and fasting plasma glucose, HbA1c, HOMA-IR, and BMI were detected. Multiple linear regression analysis showed that fasting plasma glucose and HbA1c independently predicted serum magnesium. After bariatric surgery serum magnesium increased only in those patients in whom diabetes was resolved, but remain unchanged in those who not, without difference in loss weight between groups. Changes in serum magnesium negatively correlated with changes in fasting plasma glucose and HbA1c. Absolute changes in HbA1c independently predicted magnesium changes in the multiple linear regression analysis. Conclusions: Our results provide evidence that the presence of diabetes and the degree of metabolic control are essential in accounting for the lower levels of magnesium that exist in obese subjects.	[Lecube, Albert; Hernandez, Cristina; Simo, Rafael] Univ Autonoma Barcelona, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Inst Salud Carlos III, Diabet & Metab Res Unit,Inst Recerca, E-08193 Barcelona, Spain; [Lecube, Albert; Hernandez, Cristina; Simo, Rafael] Univ Autonoma Barcelona, Dept Endocrinol, Hosp Univ Vall dHebron VHIR, E-08193 Barcelona, Spain; [Antonio Baena-Fustegueras, Juan; Manuel Fort, Jose] Univ Autonoma Barcelona, Endocrinol Surg Unit, Hosp Univ Vall dHebron, Dept Gen Surg, E-08193 Barcelona, Spain; [Pelegri, Dolors] Univ Autonoma Barcelona, Dept Biochem, Hosp Vall dHebron, E-08193 Barcelona, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona	Lecube, A (corresponding author), Univ Autonoma Barcelona, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Inst Salud Carlos III, Diabet & Metab Res Unit,Inst Recerca, E-08193 Barcelona, Spain.	alecube@vhebron.net	Lecube, Albert/H-3813-2019; Fustegueras, Juan Antonio Baena/E-2912-2012; Peinado-Onsurbe, Julia/A-4677-2016	Lecube, Albert/0000-0001-9684-0183; Fustegueras, Juan Antonio Baena/0000-0001-8543-6863; Peinado-Onsurbe, Julia/0000-0002-3880-5061; Hernandez, Cristina/0000-0002-3109-1721; Simo Canonge, Rafael/0000-0003-0475-3096	Instituto de Salud Carlos III (CIBERDEM); Generalitat de Catalunya [2009-SGR-739]	Instituto de Salud Carlos III (CIBERDEM)(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya)	This study was supported by grants from the Instituto de Salud Carlos III (CIBERDEM) and the Generalitat de Catalunya (2009-SGR-739). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus ZS, 1999, J AM SOC NEPHROL, V10, P1616; Barbagallo M, 2007, ARCH BIOCHEM BIOPHYS, V458, P40, DOI 10.1016/j.abb.2006.05.007; BRINK EJ, 1992, PROG FOOD NUTR SCI, V16, P125; Buchwald H., 2004, JAMA (Journal of the American Medical Association), V292, P1724, DOI 10.1001/jama.292.14.1724; Corica F, 2006, J AM COLL NUTR, V25, P210, DOI 10.1080/07315724.2006.10719534; Corsonello A, 2000, AM J NEPHROL, V20, P187, DOI 10.1159/000013582; EIBL NL, 1995, DIABETES CARE, V18, P188, DOI 10.2337/diacare.18.2.188; Guerrero-Romero F, 2006, DIABETES-METAB RES, V22, P471, DOI 10.1002/dmrr.644; Haglin L, 2007, ACTA DIABETOL, V44, P138, DOI 10.1007/s00592-007-0254-6; HENROTTE JG, 1988, MAGNESIUM, V7, P306; Johansson HE, 2009, OBES SURG, V19, P1250, DOI 10.1007/s11695-008-9536-5; Kao WHL, 1999, ARCH INTERN MED, V159, P2151, DOI 10.1001/archinte.159.18.2151; Larsson SC, 2007, J INTERN MED, V262, P208, DOI 10.1111/j.1365-2796.2007.01840.x; LINDSAY R, 1980, CLIN SCI, V58, P255, DOI 10.1042/cs0580255; Lopez-Ridaura R, 2004, DIABETES CARE, V27, P134, DOI 10.2337/diacare.27.1.134; MA J, 1995, J CLIN EPIDEMIOL, V48, P927, DOI 10.1016/0895-4356(94)00200-A; Maggio M, 2011, INT J ANDROL; MCNAIR P, 1982, EUR J CLIN INVEST, V12, P81, DOI 10.1111/j.1365-2362.1982.tb00942.x; Montagnana M, 2008, CLIN LAB, V54, P169; Muneyyirci-Delale O, 1999, FERTIL STERIL, V71, P869, DOI 10.1016/S0015-0282(99)00065-5; NADLER JL, 1995, ENDOCRIN METAB CLIN, V24, P623, DOI 10.1016/S0889-8529(18)30035-5; PAOLISSO G, 1986, DIABETOLOGIA, V29, P644, DOI 10.1007/BF00869264; Pham PCT, 2005, CLIN NEPHROL, V63, P429; Pham PCT, 2007, CLIN J AM SOC NEPHRO, V2, P366, DOI 10.2215/CJN.02960906; Ricos C, 1999, SCAND J CLIN LAB INV, V59, P491; Rodriguez-Moran M, 2004, MAGNESIUM RES, V17, P189; Rodriguez-Moran M, 2003, DIABETES CARE, V26, P1147, DOI 10.2337/diacare.26.4.1147; RYZEN E, 1989, J AM COLL NUTR, V8, P580; Sales CH, 2006, CLIN NUTR, V25, P554, DOI 10.1016/j.clnu.2006.03.003; Schulze MB, 2007, ARCH INTERN MED, V167, P956, DOI 10.1001/archinte.167.9.956; Shuen AY, 2009, CLIN CHIM ACTA, V409, P28, DOI 10.1016/j.cca.2009.08.007; Song CH, 2007, EUR J CLIN NUTR, V61, P682, DOI 10.1038/sj.ejcn.1602568; Takaya J, 2004, MAGNESIUM RES, V17, P126; Topf JM, 2003, REV ENDOCR METAB DIS, V4, P195, DOI 10.1023/A:1022950321817; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WINEGRAD AI, 1987, DIABETES, V36, P396, DOI 10.2337/diab.36.3.396	36	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30599	10.1371/journal.pone.0030599	http://dx.doi.org/10.1371/journal.pone.0030599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291997	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600036
J	Zhang, CC; Helmsing, S; Zagrebelsky, M; Schirrmann, T; Marschall, ALJ; Schungel, M; Korte, M; Hust, M; Dubel, S				Zhang, Congcong; Helmsing, Saskia; Zagrebelsky, Marta; Schirrmann, Thomas; Marschall, Andrea L. J.; Schuengel, Manuela; Korte, Martin; Hust, Michael; Duebel, Stefan			Suppression of p75 Neurotrophin Receptor Surface Expression with Intrabodies Influences Bcl-xL mRNA Expression and Neurite Outgrowth in PC12 Cells	PLOS ONE			English	Article							NERVE-GROWTH-FACTOR; UNFOLDED PROTEIN RESPONSE; HIPPOCAMPAL-NEURONS; RECOMBINANT ANTIBODIES; ENDOPLASMIC-RETICULUM; PHAGE DISPLAY; TRKA RECEPTORS; IN-VITRO; P75(NTR); CHAIN	Background: Although p75 neurotrophin receptor (p75NTR) is the first neurotrophin receptor isolated, its diverse physiological functions and signaling have remained elusive for many years. Loss-of-function phenotypic analyses for p75NTR were mainly focused at the genetic level; however these approaches were impacted by off-target effect, insufficient stability, unspecific stress response or alternative active splicing products. In this study, p75NTR surface expression was suppressed for the first time at the protein level by endoplasmic reticulum (ER) retained intrabodies. Results: Three monoclonal recombinant antibody fragments (scFv) with affinities in the low nanomolar range to murine p75NTR were isolated by antibody phage display. To suppress p75NTR cell surface expression, the encoding genes of these scFvs extended by the ER retention peptide KDEL were transiently transfected into the neuron-like rat pheochromocytoma cell line PC12 and the mouse neuroblastoma x mouse spinal cord hybrid cell line NSC19. The ER retained intrabody construct, SH325-G7-KDEL, mediated a downregulation of p75NTR cell surface expression as shown by flow cytometry. This effect was maintained over a period of at least eight days without activating an unfolded protein response (UPR). Moreover, the ER retention of p75NTR resulted in downregulation of mRNA levels of the anti-apoptotic protein Bcl-xL as well as in strong inhibition of NGF-induced neurite outgrowth in PC12 cells. Conclusion: The ER retained intrabody SH325-G7-KDEL not only induces phenotypic knockdown of this p75NTR but also p75NTR-associated cellular responses in PC12 cells.	[Zhang, Congcong; Helmsing, Saskia; Schirrmann, Thomas; Marschall, Andrea L. J.; Hust, Michael; Duebel, Stefan] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem & Biotechnol, Braunschweig, Germany; [Zagrebelsky, Marta; Korte, Martin] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Braunschweig, Germany; [Schuengel, Manuela] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat, D-3000 Hannover, Germany	Braunschweig University of Technology; Braunschweig University of Technology; Hannover Medical School	Zhang, CC (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem & Biotechnol, Braunschweig, Germany.	s.duebel@tu-bs.de	Marschall, Andrea L. J./AAU-2263-2020	Marschall, Andrea L. J./0000-0002-9505-0427; Zhang, Congcong/0000-0001-9995-3079; Dubel, Stefan/0000-0001-8811-7390; Zagrebelsky, Marta/0000-0003-1083-7413; Hust, Michael/0000-0003-3418-6045	Graduate College "Molecular Complexes of Biomedical Relevance" of the Land Niedersachsen, Germany; EU [222635]; Affinity Proteome [24181]	Graduate College "Molecular Complexes of Biomedical Relevance" of the Land Niedersachsen, Germany; EU(European Commission); Affinity Proteome	This project was funded by the Graduate College "Molecular Complexes of Biomedical Relevance" of the Land Niedersachsen, Germany, and the EU consortia Affinomics (Project No. 222635) and Affinity Proteome (Project No 24181) within the FP7 (http://www.affinomics.org/ and http://www.proteomebinders.org/apframestarthome.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Bando Y, 2003, EUR J NEUROSCI, V18, P829, DOI 10.1046/j.1460-9568.2003.02818.x; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Boldicke T, 2007, J CELL MOL MED, V11, P54, DOI 10.1111/j.1582-4934.2007.00002.x; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Brann AB, 1999, J NEUROSCI, V19, P8199; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Bui NT, 2002, J NEUROCHEM, V81, P594, DOI 10.1046/j.1471-4159.2002.00841.x; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Catts VS, 2008, EUR J NEUROSCI, V28, P883, DOI 10.1111/j.1460-9568.2008.06390.x; Colwill K, 2011, NAT METHODS, V8, P551, DOI [10.1038/NMETH.1607, 10.1038/nmeth.1607]; Couzin J, 2004, SCIENCE, V306, P1124, DOI 10.1126/science.306.5699.1124; Dechant G, 1997, CURR OPIN NEUROBIOL, V7, P413, DOI 10.1016/S0959-4388(97)80071-2; DUBEL S, 1992, CELL BIOPHYS, V21, P69; Dubel S, 2010, TRENDS BIOTECHNOL, V28, P333, DOI 10.1016/j.tibtech.2010.05.001; Dykxhoorn DM, 2006, GENE THER, V13, P541, DOI 10.1038/sj.gt.3302703; Epa WR, 2004, J NEUROCHEM, V89, P344, DOI 10.1111/j.1471-4159.2004.02344.x; Famulok M, 2000, ACCOUNTS CHEM RES, V33, P591, DOI 10.1021/ar960167q; Fish RJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-9; Gargano N, 1997, J NEUROSCI RES, V50, P1; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Hust Michael, 2007, V408, P243, DOI 10.1007/978-1-59745-547-3_14; Hust M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-14; Hust M, 2011, J BIOTECHNOL, V152, P159, DOI 10.1016/j.jbiotec.2010.09.945; Hust M, 2009, NEW BIOTECHNOL, V25, P424, DOI 10.1016/j.nbt.2009.03.004; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; Ito H, 2003, J NEUROSCI RES, V72, P211, DOI 10.1002/jnr.10564; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kimpinski K, 1999, NEUROSCIENCE, V93, P253, DOI 10.1016/S0306-4522(99)00156-6; Leverrier Y, 1999, CELL DEATH DIFFER, V6, P290, DOI 10.1038/sj.cdd.4400492; Li JD, 2007, PROTEIN ENG DES SEL, V20, P491, DOI 10.1093/protein/gzm038; Liao W, 2008, BIOCHEM BIOPH RES CO, V373, P235, DOI 10.1016/j.bbrc.2008.06.020; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; MAHONEY WC, 1979, J BIOL CHEM, V254, P6572; Majdan M, 1997, J NEUROSCI, V17, P6988; Makkerh JPS, 2005, EMBO REP, V6, P936, DOI 10.1038/sj.embor.7400503; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; MARKS JD, 1992, BIO-TECHNOL, V10, P779, DOI 10.1038/nbt0792-779; Mersmann M, 2010, NEW BIOTECHNOL, V27, P118, DOI 10.1016/j.nbt.2009.10.007; Michaelsen K, 2010, EUR J NEUROSCI, V32, P1854, DOI 10.1111/j.1460-9568.2010.07460.x; Mollova S, 2010, ANTIBODY ENGINEERING, VOL 2, SECOND EDITION, P3, DOI 10.1007/978-3-642-01147-4_1; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; OLDEN K, 1979, P NATL ACAD SCI USA, V76, P791, DOI 10.1073/pnas.76.2.791; Paul CE, 2004, J NEUROSCI, V24, P1917, DOI 10.1523/JNEUROSCI.5397-03.2004; Rondot S, 2001, NAT BIOTECHNOL, V19, P75, DOI 10.1038/83567; Rosch H, 2005, P NATL ACAD SCI USA, V102, P7362, DOI 10.1073/pnas.0502460102; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; ROVELLI G, 1993, P NATL ACAD SCI USA, V90, P8717, DOI 10.1073/pnas.90.18.8717; Schofield DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r254; Schor NF, 2005, PROG NEUROBIOL, V77, P201, DOI 10.1016/j.pneurobio.2005.10.006; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Soltes G, 2007, J BIOTECHNOL, V127, P626, DOI 10.1016/j.jbiotec.2006.08.015; Strebe N, 2009, J IMMUNOL METHODS, V341, P30, DOI 10.1016/j.jim.2008.10.012; Taussig MJ, 2007, NAT METHODS, V4, P13, DOI 10.1038/nmeth0107-13; Tuffereau C, 1998, EMBO J, V17, P7250, DOI 10.1093/emboj/17.24.7250; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Yoon SO, 1998, J NEUROSCI, V18, P3273; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005	65	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30684	10.1371/journal.pone.0030684	http://dx.doi.org/10.1371/journal.pone.0030684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292018	Green Published, gold, Green Submitted			2022-12-27	WOS:000301639600047
J	Lu, Y; Wang, L; Liu, PY; Yang, P; You, M				Lu, Yan; Wang, Liang; Liu, Pengyuan; Yang, Ping; You, Ming			Gene-Expression Signature Predicts Postoperative Recurrence in Stage I Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							VINORELBINE PLUS CISPLATIN; SURVIVAL; CARCINOMA; FBXW7	About 30% stage I non-small cell lung cancer (NSCLC) patients undergoing resection will recur. Robust prognostic markers are required to better manage therapy options. The purpose of this study is to develop and validate a novel gene-expression signature that can predict tumor recurrence of stage I NSCLC patients. Cox proportional hazards regression analysis was performed to identify recurrence-related genes and a partial Cox regression model was used to generate a gene signature of recurrence in the training dataset -142 stage I lung adenocarcinomas without adjunctive therapy from the Director's Challenge Consortium. Four independent validation datasets, including GSE5843, GSE8894, and two other datasets provided by Mayo Clinic and Washington University, were used to assess the prediction accuracy by calculating the correlation between risk score estimated from gene expression and real recurrence-free survival time and AUC of time-dependent ROC analysis. Pathway-based survival analyses were also performed. 104 probesets correlated with recurrence in the training dataset. They are enriched in cell adhesion, apoptosis and regulation of cell proliferation. A 51-gene expression signature was identified to distinguish patients likely to develop tumor recurrence (Dxy = -0.83, P<le-16) and this signature was validated in four independent datasets with AUC >85%. Multiple pathways including leukocyte transendothelial migration and cell adhesion were highly correlated with recurrence-free survival. The gene signature is highly predictive of recurrence in stage I NSCLC patients, which has portant prognostic and therapeutic implications for the future management of these patients.	[Lu, Yan; Liu, Pengyuan] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Lu, Yan; Liu, Pengyuan; You, Ming] Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA; [Wang, Liang] Mayo Clin, Dept Lab Med, Rochester, MN USA; [Wang, Liang] Mayo Clin, Dept Pathol, Rochester, MN USA; [Yang, Ping] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [You, Ming] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Mayo Clinic; Mayo Clinic; Mayo Clinic; Medical College of Wisconsin	Lu, Y (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	myou@mcw.edu			National Institutes of Health [1R01CA129533-01A1]; Healthier Wisconsin; Department of Laboratory Medicine and Pathology, Mayo Clinic; NATIONAL CANCER INSTITUTE [R01CA129533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Healthier Wisconsin; Department of Laboratory Medicine and Pathology, Mayo Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant 1R01CA129533-01A1 (MY), fund from A Healthier Wisconsin (YL) and a fund from Department of Laboratory Medicine and Pathology, Mayo Clinic (LW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKRITAS MG, 1994, ANN STAT, V22, P1299, DOI 10.1214/aos/1176325630; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; Borczuk AC, 2004, AM J RESP CRIT CARE, V170, P167, DOI 10.1164/rccm.200401-066OC; Buyse M, 2008, STAT METHODS MED RES, V17, P467, DOI 10.1177/0962280207081864; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Fernandez-Borja M, 2010, CARDIOVASC RES, V86, P202, DOI 10.1093/cvr/cvq003; FLEHINGER BJ, 1992, CHEST, V101, P1013, DOI 10.1378/chest.101.4.1013; ICHINOSE Y, 1994, J THORAC CARDIOV SUR, V108, P158; Iwatsuki M, 2010, INT J CANCER, V126, P1828, DOI 10.1002/ijc.24879; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim HS, 2009, APMIS, V117, P140, DOI 10.1111/j.1600-0463.2009.02433.x; Le Chevalier T, 2004, LUNG CANCER, V46, pS33, DOI 10.1016/S0169-5002(04)80039-4; Li HZ, 2004, BIOINFORMATICS, V20, P208, DOI 10.1093/bioinformatics/bth900; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Qiu H, 2011, CANCER LETT, V307, P47, DOI 10.1016/j.canlet.2011.03.015; Quigley RL, 1996, ARCH SURG-CHICAGO, V131, P438; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; STRAUSS GM, 1995, J CLIN ONCOL, V13, P1265, DOI 10.1200/JCO.1995.13.5.1265; Strauss GM, 2004, 9633 CALGB; Sun ZF, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-35; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Wigle DA, 2002, CANCER RES, V62, P3005; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623	28	61	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30880	10.1371/journal.pone.0030880	http://dx.doi.org/10.1371/journal.pone.0030880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292069	gold, Green Published, Green Submitted			2022-12-27	WOS:000301570600093
J	Ber, S; Lee, C; Voiculescu, O; Surani, MA				Ber, Suzan; Lee, Caroline; Voiculescu, Octavian; Surani, M. Azim			Dedifferentiation of Foetal CNS Stem Cells to Mesendoderm-Like Cells through an EMT Process	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EARLY CHICK-EMBRYOS; GROWTH-FACTOR-BETA; NEURAL-CREST; TGF-BETA; SLUG EXPRESSION; E-CADHERIN; P53-MEDIATED APOPTOSIS; DEFINITIVE ENDODERM; SIGNALING PATHWAYS	Tissue-specific stem cells are considered to have a limited differentiation potential. Recently, this notion was challenged by reports that showed a broader differentiation potential of neural stem cells, in vitro and in vivo, although the molecular mechanisms that regulate plasticity of neural stem cells are unknown. Here, we report that neural stem cells derived from mouse embryonic cortex respond to Lif and serum in vitro and undergo epithelial to mesenchymal transition (EMT)-mediated dedifferentiation process within 48 h, together with transient upregulation of pluripotency markers and, more notably, upregulation of mesendoderm genes, Brachyury (T) and Sox17. These induced putative mesendoderm cells were injected into early gastrulating chick embryos, which revealed that they integrated more efficiently into mesoderm and endoderm lineages compared to non-induced cells. We also found that TGF beta and Jak/Stat pathways are necessary but not sufficient for the induction of mesendodermal phenotype in neural stem cells. These results provide insights into the regulation of plasticity of neural stem cells through EMT. Dissecting the regulatory pathways involved in these processes may help to gain control over cell fate decisions.	[Ber, Suzan; Lee, Caroline; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge, England; [Voiculescu, Octavian] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Cambridge; University of Cambridge	Ber, S (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge, England.	sb681@cam.ac.uk; a.surani@gurdon.cam.ac.uk	Voiculescu, Octavian/A-7571-2010	Voiculescu, Octavian/0000-0003-0714-1482; Surani, Azim/0000-0002-8640-4318; Ber, Suzan/0000-0003-4219-6032	DTI of CellCentric Ltd [TP/4/BIO/6/I/22020]; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784B, G0800784] Funding Source: researchfish	DTI of CellCentric Ltd; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by The Technology Programme (DTI Project Number TP/4/BIO/6/I/22020) of CellCentric Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernemann C, 2011, STEM CELLS, V29, P1496, DOI 10.1002/stem.709; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chng ZZ, 2010, CELL STEM CELL, V6, P59, DOI 10.1016/j.stem.2009.11.015; Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196; Cimadamore F, 2011, CELL STEM CELL, V8, P538, DOI 10.1016/j.stem.2011.03.011; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Curchoe CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013890; Direkze NC, 2003, STEM CELLS, V21, P514, DOI 10.1634/stemcells.21-5-514; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; Fuxe J, 2010, CELL CYCLE, V9, P2363, DOI 10.4161/cc.9.12.12050; Gammill LS, 2003, NAT REV NEUROSCI, V4, P795, DOI 10.1038/nrn1219; Gilbert SF, 2006, DEV BIOL; Gotzmann J, 2006, ONCOGENE, V25, P3170, DOI 10.1038/sj.onc.1209083; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Heisenberg CP, 2008, CURR OPIN GENET DEV, V18, P311, DOI 10.1016/j.gde.2008.07.011; Holmberg J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018454; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li X, 2007, ONCOGENE, V26, P4489, DOI 10.1038/sj.onc.1210241; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mercado-Pimentel ME, 2007, CELLS TISSUES ORGANS, V185, P146, DOI 10.1159/000101315; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; Park KS, 2010, DEVELOPMENT, V137, P2691, DOI 10.1242/dev.050096; Poulain M, 2006, DEVELOPMENT, V133, P2189, DOI 10.1242/dev.02387; Sailer MHM, 2005, J CELL SCI, V118, P5849, DOI 10.1242/jcs.02708; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shioiri M, 2006, BRIT J CANCER, V94, P1816, DOI 10.1038/sj.bjc.6603193; Stern CD, 1997, INT J DEV BIOL, V41, P379; Swetha G, 2011, J CELL MOL MED, V15, P396, DOI 10.1111/j.1582-4934.2009.00937.x; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Uchikado Y, 2005, CLIN CANCER RES, V11, P1174; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; VIDRICAIRE G, 1994, DEVELOPMENT, V120, P115; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Voiculescu O, 2008, NAT PROTOC, V3, P419, DOI 10.1038/nprot.2008.10; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Yang HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-301; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	59	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30759	10.1371/journal.pone.0030759	http://dx.doi.org/10.1371/journal.pone.0030759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276221	gold, Green Published, Green Submitted			2022-12-27	WOS:000301568100061
J	Ekouevi, DK; Stringer, E; Coetzee, D; Tih, P; Creek, T; Stinson, K; Westfall, AO; Welty, T; Chintu, N; Chi, BH; Wilfert, C; Shaffer, N; Stringer, J; Dabis, F				Ekouevi, Didier K.; Stringer, Elizabeth; Coetzee, David; Tih, Pius; Creek, Tracy; Stinson, Kathryn; Westfall, Andrew O.; Welty, Thomas; Chintu, Namwinga; Chi, Benjamin H.; Wilfert, Cathy; Shaffer, Nathan; Stringer, Jeff; Dabis, Francois			Health Facility Characteristics and Their Relationship to Coverage of PMTCT of HIV Services across Four African Countries: The PEARL Study	PLOS ONE			English	Article								Background: Health facility characteristics associated with effective prevention of mother-to-child transmission of HIV (PMTCT) coverage in sub-Saharan are poorly understood. Methodology/Principal Findings: We conducted surveys in health facilities with active PMTCT services in Cameroon, Cote d'Ivoire, South Africa, and Zambia. Data was compiled via direct observation and exit interviews. We constructed composite scores to describe provision of PMTCT services across seven topical areas: antenatal quality, PMTCT quality, supplies available, patient satisfaction, patient understanding of medication, and infrastructure quality. Pearson correlations and Generalized Estimating Equations (GEE) to account for clustering of facilities within countries were used to evaluate the relationship between the composite scores, total time of visit and select individual variables with PMTCT coverage among women delivering. Between July 2008 and May 2009, we collected data from 32 facilities; 78% were managed by the government health system. An opt-out approach for HIV testing was used in 100% of facilities in Zambia, 63% in Cameroon, and none in Cote d'Ivoire or South Africa. Using Pearson correlations, PMTCT coverage (median of 55%, (IQR: 33-68) was correlated with PMTCT quality score (rho = 0.51; p = 0.003); infrastructure quality score (rho = 0.43; p = 0.017); time spent at clinic (rho = 0.47; p = 0.013); patient understanding of medications score (rho = 0.51; p = 0.006); and patient satisfaction quality score (rho = 0.38; p = 0.031). PMTCT coverage was marginally correlated with the antenatal quality score (rho = 0.304; p = 0.091). Using GEE adjustment for clustering, the, antenatal quality score became more strongly associated with PMTCT coverage (p<0.001) and the PMTCT quality score and patient understanding of medications remained marginally significant. Conclusions/Results: We observed a positive relationship between an antenatal quality score and PMTCT coverage but did not identify a consistent set of variables that predicted PMTCT coverage.	[Ekouevi, Didier K.; Welty, Thomas] Programme PAC CI, Abidjan, Cote Ivoire; [Ekouevi, Didier K.; Welty, Thomas; Dabis, Francois] Univ Victor Segalen, Inst Natl Sante & Rech Med, Bordeaux, France; [Stringer, Elizabeth; Westfall, Andrew O.; Chintu, Namwinga; Chi, Benjamin H.; Stringer, Jeff] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Coetzee, David; Stinson, Kathryn] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Tih, Pius] Cameroon Baptist Hlth Convent Hlth Board, Bamenda, Cameroon; [Creek, Tracy] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Wilfert, Cathy] Elizabeth Glaser Pediat AIDS Fdn, Washington, DC USA; [Shaffer, Nathan] World Hlth Org, Geneva, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Cape Town; Centers for Disease Control & Prevention - USA; World Health Organization	Ekouevi, DK (corresponding author), Programme PAC CI, Abidjan, Cote Ivoire.	didier.ekouevi@gmail.com	EKOUEVI, Didier K/E-7960-2014; Stringer, Jeffrey S. A./AAU-2342-2021; DABIS, FRANCOIS/S-9298-2019	DABIS, FRANCOIS/0000-0002-1614-8857; Westfall, Andrew/0000-0002-0468-4695	U.S. Centers for Disease Control and Prevention [T0906150021/CDC-Centers for Disease Control/EGPAF AM3]; Elizabeth Glaser Pediatric AIDS Foundation from the Bill and Melinda Gates Foundation [351-07]	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Elizabeth Glaser Pediatric AIDS Foundation from the Bill and Melinda Gates Foundation	This study was supported by the U.S. Centers for Disease Control and Prevention, Global AIDS Program of Atlanta, Georgia (Contract T0906150021/CDC-Centers for Disease Control/EGPAF AM3) and by the Elizabeth Glaser Pediatric AIDS Foundation (grant number #351-07 from the Bill and Melinda Gates Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chandisarewa W, 2007, B WORLD HEALTH ORGAN, V85, P843, DOI 10.2471/BLT.06.035188; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; Doherty Tanya M, 2005, Afr Health Sci, V5, P213; Ekouevi DK, 2004, AIDS, V18, P697, DOI 10.1097/00002030-200403050-00018; Mandala J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-314; Oladapo Olufemi T, 2008, Afr J Reprod Health, V12, P71; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; Stringer EM, 2011, JAMA-J AM MED ASSOC, V3, P293; WHO, 2009, UN ACC SCAL PRIOR HI; WHO, 2010, GUID CAR TREATM SUPP	10	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29823	10.1371/journal.pone.0029823	http://dx.doi.org/10.1371/journal.pone.0029823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276130	gold, Green Published, Green Submitted			2022-12-27	WOS:000301568100016
J	Lange, Y; Ye, J; Steck, TL				Lange, Yvonne; Ye, Jin; Steck, Theodore L.			Activation Mobilizes the Cholesterol in the Late Endosomes-Lysosomes of Niemann Pick Type C Cells	PLOS ONE			English	Article							PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; CYCLODEXTRIN OVERCOMES; STEROL TRANSPORT; TRAFFICKING; HOMEOSTASIS; NPC2; DISEASE; RED; MOVEMENT	A variety of intercalating amphipaths increase the chemical activity of plasma membrane cholesterol. To test whether intracellular cholesterol can be similarly activated, we examined NPC1 and NPC2 fibroblasts, since they accumulate large amounts of cholesterol in their late endosomes and lysosomes (LE/L). We gauged the mobility of intracellular sterol from its appearance at the surface of the intact cells, as determined by its susceptibility to cholesterol oxidase and its isotope exchange with extracellular 2-(hydroxypropyl)-beta-cyclodextrin-cholesterol. The entire cytoplasmic cholesterol pool in these cells was mobile, exchanging with the plasma membrane with an apparent half-time of similar to 3-4 hours, similar to 4-5 times slower than that for wild type human fibroblasts (half-time similar to 0.75 hours). The mobility of the intracellular cholesterol was increased by the membrane-intercalating amphipaths chlorpromazine and 1-octanol. Chlorpromazine also promoted the net transfer of LE/L cholesterol to serum and cyclodextrin. Surprisingly, the mobility of LE/L cholesterol was greatly stimulated by treating intact NPC cells with glutaraldehyde or formaldehyde. Similar effects were seen with wild type fibroblasts in which the LE/L cholesterol pool had been expanded using U18666A. We also showed that the cholesterol in the intracellular membranes of fixed wild-type fibroblasts was mobile; it was rapidly oxidized by cholesterol oxidase and was rapidly replenished by exogenous sterol. We conclude that a) the cholesterol in NPC cells can exit the LE/L (and the extensive membranous inclusions therein) over a few hours; b) this mobility is stimulated by the activation of the cholesterol with intercalating amphipaths; c) intracellular cholesterol is even more mobile in fixed cells; and d) amphipaths that activate cholesterol might be useful in treating NPC disease.	[Lange, Yvonne; Ye, Jin] Rush Univ, Dept Pathol, Med Ctr, Chicago, IL 60612 USA; [Steck, Theodore L.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Rush University; University of Chicago	Lange, Y (corresponding author), Rush Univ, Dept Pathol, Med Ctr, Chicago, IL 60612 USA.	ylange@rush.edu	Steck, Theodore/GWM-4373-2022; Lange, Yvonne/A-7794-2009	Steck, Theodore/0000-0002-8391-9244; 	National Institutes of Health [HL28448]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028448, R55HL028448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Work was supported by National Institutes of Health grant HL28448. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hammed M, 2010, J LIPID RES, V51, P1747, DOI 10.1194/jlr.M003822; Abi-Mosleh L, 2009, P NATL ACAD SCI USA, V106, P19316, DOI 10.1073/pnas.0910916106; Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Ahn KW, 2004, BIOCHEMISTRY-US, V43, P827, DOI 10.1021/bi035697q; Bi XN, 2010, SUBCELL BIOCHEM, V51, P319, DOI 10.1007/978-90-481-8622-8_11; Blanchette-Mackie EJ, 2000, BBA-MOL CELL BIOL L, V1486, P171, DOI 10.1016/S1388-1981(00)00055-X; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; COXEY RA, 1993, J LIPID RES, V34, P1165; Cruz JC, 2000, J BIOL CHEM, V275, P4013, DOI 10.1074/jbc.275.6.4013; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Devlin C, 2010, TRAFFIC, V11, P601, DOI 10.1111/j.1600-0854.2010.01046.x; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Gallala HD, 2011, J NEUROCHEM, V116, P702, DOI 10.1111/j.1471-4159.2010.07014.x; Garver WS, 2010, J LIPID RES, V51, P406, DOI 10.1194/jlr.P000331; Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P1; Hui C, 2006, CELL SIGNAL, V18, P1844, DOI 10.1016/j.cellsig.2006.04.006; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Jacquez J. A., 1985, COMPARTMENTAL ANAL B; Jansen M, 2011, TRAFFIC, V12, P218, DOI 10.1111/j.1600-0854.2010.01142.x; Jimenez-Lopez JM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-33; JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2; KODAVANTI UP, 1990, J BIOCHEM TOXICOL, V5, P245, DOI 10.1002/jbt.2570050407; Kuroda Y, 2010, TOXICOL IN VITRO, V24, P661, DOI 10.1016/j.tiv.2009.09.018; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Lange Y, 2000, J BIOL CHEM, V275, P17468, DOI 10.1074/jbc.M000875200; LANGE Y, 1983, J BIOL CHEM, V258, P5130; Lange Y, 2005, J BIOL CHEM, V280, P36126, DOI 10.1074/jbc.M507149200; LANGE Y, 1995, J LIPID RES, V36, P1092; Lange Y, 2004, P NATL ACAD SCI USA, V101, P11664, DOI 10.1073/pnas.0404766101; Lange Y, 2002, J LIPID RES, V43, P198; LANGE Y, 1991, J BIOL CHEM, V266, P21439; Lange Y, 1997, J BIOL CHEM, V272, P13103, DOI 10.1074/jbc.272.20.13103; LANGE Y, 1984, BIOCHIM BIOPHYS ACTA, V769, P551, DOI 10.1016/0005-2736(84)90053-1; LANGE Y, 1980, J BIOL CHEM, V255, P9331; LANGE Y, 1994, J BIOL CHEM, V269, P29371; Lange Y, 1998, J BIOL CHEM, V273, P18915, DOI 10.1074/jbc.273.30.18915; Lange Y, 1999, J LIPID RES, V40, P2264; Lange Y, 2008, PROG LIPID RES, V47, P319, DOI 10.1016/j.plipres.2008.03.001; Lange Y, 2007, BIOCHEMISTRY-US, V46, P2233, DOI 10.1021/bi6023397; Lange Y, 2009, J LIPID RES, V50, P1881, DOI 10.1194/jlr.M900116-JLR200; Lange Y, 2009, BIOCHEMISTRY-US, V48, P8505, DOI 10.1021/bi900951r; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; MATSUZAWA Y, 1980, J LIPID RES, V21, P202; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Millat G, 2001, AM J HUM GENET, V69, P1013, DOI 10.1086/324068; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Olsen BN, 2011, BIOPHYS J, V100, P948, DOI 10.1016/j.bpj.2010.12.3728; Olsen BN, 2009, J AM CHEM SOC, V131, P4854, DOI 10.1021/ja8095224; Pham NA, 2005, J INHERIT METAB DIS, V28, P991, DOI 10.1007/s10545-005-0117-7; Prinz WA, 2007, PROG LIPID RES, V46, P297, DOI 10.1016/j.plipres.2007.06.002; Prinz WA, 2010, CELL, V143, P870, DOI 10.1016/j.cell.2010.11.031; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Ramirez CM, 2011, J LIPID RES, V52, P688, DOI 10.1194/jlr.M013789; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Rothblat GH, 1999, J LIPID RES, V40, P781; Russell A D, 1976, Prog Med Chem, V13, P271, DOI 10.1016/S0079-6468(08)70140-1; Schoer JK, 2000, BIOCHEMISTRY-US, V39, P7662, DOI 10.1021/bi992686h; SLOTTE JP, 1989, BIOCHIM BIOPHYS ACTA, V985, P90, DOI 10.1016/0005-2736(89)90108-9; SOKOL J, 1988, J BIOL CHEM, V263, P3411; Steck TL, 2010, TRENDS CELL BIOL, V20, P680, DOI 10.1016/j.tcb.2010.08.007; Steck TL, 2002, BIOPHYS J, V83, P2118, DOI 10.1016/S0006-3495(02)73972-6; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Underwood KW, 1996, J LIPID RES, V37, P1556; Vance JE, 2011, CURR OPIN LIPIDOL, V22, P204, DOI 10.1097/MOL.0b013e3283453e69	69	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30051	10.1371/journal.pone.0030051	http://dx.doi.org/10.1371/journal.pone.0030051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276143	Green Published, gold, Green Submitted			2022-12-27	WOS:000301568100023
J	Xuan, Y; Meng, C; Yang, YH; Zhu, CZ; Wang, L; Yan, Q; Lin, CL; Yu, CS				Xuan, Yun; Meng, Chun; Yang, Yanhui; Zhu, Chaozhe; Wang, Liang; Yan, Qian; Lin, Chunlan; Yu, Chunshui			Resting-State Brain Activity in Adult Males Who Stutter	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ALTERED FUNCTIONAL CONNECTIVITY; INDEPENDENT COMPONENT ANALYSIS; LOW-FREQUENCY FLUCTUATION; SUPPLEMENTARY MOTOR AREA; DEVELOPMENTAL STUTTERERS; SPEECH PRODUCTION; NONSTUTTERING ADULTS; ACTIVATION PATTERNS; PREFRONTAL CORTEX	Although developmental stuttering has been extensively studied with structural and task-based functional magnetic resonance imaging (fMRI), few studies have focused on resting-state brain activity in this disorder. We investigated resting-state brain activity of stuttering subjects by analyzing the amplitude of low-frequency fluctuation (ALFF), region of interest (ROI)-based functional connectivity (FC) and independent component analysis (ICA)-based FC. Forty-four adult males with developmental stuttering and 46 age-matched fluent male controls were scanned using resting-state fMRI. ALFF, ROI-based FCs and ICA-based FCs were compared between male stuttering subjects and fluent controls in a voxel-wise manner. Compared with fluent controls, stuttering subjects showed increased ALFF in left brain areas related to speech motor and auditory functions and bilateral prefrontal cortices related to cognitive control. However, stuttering subjects showed decreased ALFF in the left posterior language reception area and bilateral non-speech motor areas. ROI-based FC analysis revealed decreased FC between the posterior language area involved in the perception and decoding of sensory information and anterior brain area involved in the initiation of speech motor function, as well as increased FC within anterior or posterior speech-and language-associated areas and between the prefrontal areas and default-mode network (DMN) in stuttering subjects. ICA showed that stuttering subjects had decreased FC in the DMN and increased FC in the sensorimotor network. Our findings support the concept that stuttering subjects have deficits in multiple functional systems (motor, language, auditory and DMN) and in the connections between them.	[Xuan, Yun] Tianjin Med Univ, Dept Anat, Tianjin, Peoples R China; [Meng, Chun; Zhu, Chaozhe] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Yang, Yanhui] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Wang, Liang; Yu, Chunshui] Tianjin Med Univ Gen Hosp, Dept Radiol, Tianjin, Peoples R China; [Yan, Qian] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Lin, Chunlan] Beijing Prof Lin Stuttering Correct Ctr, Beijing, Peoples R China	Tianjin Medical University; Beijing Normal University; Capital Medical University; Tianjin Medical University; Chinese Academy of Sciences; Institute of Psychology, CAS	Xuan, Y (corresponding author), Tianjin Med Univ, Dept Anat, Tianjin, Peoples R China.	chunshuiyu@yahoo.cn	Chaozhe, Zhu/AAK-7737-2020	Chaozhe, Zhu/0000-0002-9247-9607; Yu, Chunshui/0000-0001-5648-5199	Natural Science Foundation of China [30870694]; Program for New Century Excellent Talents in University [NCET-07-0568]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by Natural Science Foundation of China, 30870694; and Program for New Century Excellent Talents in University, NCET-07-0568. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; Beal DS, 2007, NEUROREPORT, V18, P1257, DOI 10.1097/WNR.0b013e3282202c4d; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blomgren M, 2003, J FLUENCY DISORD, V28, P337, DOI 10.1016/j.jfludis.2003.08.002; Bloodstein O., 1995, HDB STUTTERING; Bloodstein O., 2008, HDB STUTTERING; BORDEN GJ, 1983, J SPEECH HEAR RES, V26, P389, DOI 10.1044/jshr.2603.389; Braun AR, 1997, BRAIN, V120, P761, DOI 10.1093/brain/120.5.761; Brown S, 2005, HUM BRAIN MAPP, V25, P105, DOI 10.1002/hbm.20140; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chang SE, 2011, CEREB CORTE IN PRESS; Chang SE, 2008, NEUROIMAGE, V39, P1333, DOI 10.1016/j.neuroimage.2007.09.067; Chang SE, 2009, NEUROIMAGE, V46, P201, DOI 10.1016/j.neuroimage.2009.01.066; Chung SJ, 2004, MOVEMENT DISORD, V19, P1106, DOI 10.1002/mds.20136; Corbera S, 2005, NEUROLOGY, V65, P1246, DOI 10.1212/01.wnl.0000180969.03719.81; Cunnington R, 1996, HUM MOVEMENT SCI, V15, P627, DOI 10.1016/0167-9457(96)00018-8; Cykowski MD, 2008, CEREB CORTEX, V18, P571, DOI 10.1093/cercor/bhm093; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Nil LF, 2003, J FLUENCY DISORD, V28, P357, DOI 10.1016/j.jfludis.2003.07.002; De Nil LF, 2000, J SPEECH LANG HEAR R, V43, P1038, DOI 10.1044/jslhr.4304.1038; De Nil LF, 2008, BRAIN LANG, V107, P114, DOI 10.1016/j.bandl.2008.07.003; DENIL LF, 1991, BRAIN, V114, P2145, DOI 10.1093/brain/114.5.2145; Denny M, 2000, J SPEECH LANG HEAR R, V43, P1024, DOI 10.1044/jslhr.4304.1024; FISH CH, 1965, CALIF MED, V103, P337; Forster DC, 2001, DEV NEUROPSYCHOL, V19, P125, DOI 10.1207/S15326942DN1902_1; Foundas AL, 2004, NEUROLOGY, V63, P1640, DOI 10.1212/01.WNL.0000142993.33158.2A; Foundas AL, 2003, NEUROLOGY, V61, P1378, DOI 10.1212/01.WNL.0000094320.44334.86; Foundas AL, 2001, NEUROLOGY, V57, P207, DOI 10.1212/WNL.57.2.207; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox PT, 2000, BRAIN, V123, P1985, DOI 10.1093/brain/123.10.1985; Fox PT, 1996, NATURE, V382, P158, DOI 10.1038/382158a0; Fridriksson J, 2009, J SPEECH LANG HEAR R, V52, P812, DOI 10.1044/1092-4388(2008/06-0197); Giraud AL, 2008, BRAIN LANG, V104, P190, DOI 10.1016/j.bandl.2007.04.005; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Hoshi E, 2006, NEUROSCI RES, V54, P73, DOI 10.1016/j.neures.2005.10.013; Howell P, 2010, EXP NEUROL, V225, P55, DOI 10.1016/j.expneurol.2010.06.012; Huang XQ, 2010, NEUROIMAGE, V49, P2901, DOI 10.1016/j.neuroimage.2009.11.072; Ingham RJ, 2000, BRAIN LANG, V75, P163, DOI 10.1006/brln.2000.2351; Ingham RJ, 1996, J SPEECH HEAR RES, V39, P1208, DOI 10.1044/jshr.3906.1208; Jancke L, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-23; Jeon HA, 2009, NEUROIMAGE, V48, P449, DOI 10.1016/j.neuroimage.2009.06.049; Jones RD, 2002, HUM MOVEMENT SCI, V21, P603, DOI 10.1016/S0167-9457(02)00165-3; Kell CA, 2009, BRAIN, V132, P2747, DOI 10.1093/brain/awp185; Loucks TMJ, 2006, J MOTOR BEHAV, V38, P238, DOI 10.3200/JMBR.38.3.238-247; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lu C, 2009, NEUROSCIENCE, V161, P1008, DOI 10.1016/j.neuroscience.2009.04.020; Lu CM, 2010, EXP NEUROL, V221, P146, DOI 10.1016/j.expneurol.2009.10.016; Lu CM, 2010, CORTEX, V46, P49, DOI 10.1016/j.cortex.2009.02.017; Mechelli A, 2007, HUM BRAIN MAPP, V28, P205, DOI 10.1002/hbm.20272; Neumann K, 2005, J FLUENCY DISORD, V30, P23, DOI 10.1016/j.jfludis.2004.12.002; Neumann K, 2003, J FLUENCY DISORD, V28, P381, DOI 10.1016/j.jfludis.2003.07.003; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papoutsi M, 2009, CEREB CORTEX, V19, P2156, DOI 10.1093/cercor/bhn239; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; POOL KD, 1991, ARCH NEUROL-CHICAGO, V48, P509, DOI 10.1001/archneur.1991.00530170069022; Preibisch C, 2003, NEUROIMAGE, V20, P1356, DOI 10.1016/S1053-8119(03)00376-8; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Riley G., 1994, STUTTERING SEVERITY; Riva-Posse P, 2008, PARKINSONISM RELAT D, V14, P415, DOI 10.1016/j.parkreldis.2007.11.006; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; Salmelin R, 2000, BRAIN, V123, P1184, DOI 10.1093/brain/123.6.1184; Schafer RJ, 2009, NEUROIMAGE, V46, P882, DOI 10.1016/j.neuroimage.2009.02.017; Scott SK, 2003, NEUROIMAGE, V19, P870, DOI 10.1016/S1053-8119(03)00083-1; Seery CH, 2007, J FLUENCY DISORD, V32, P197, DOI 10.1016/j.jfludis.2007.07.001; Smits-Bandstra S, 2007, J FLUENCY DISORD, V32, P251, DOI 10.1016/j.jfludis.2007.06.001; Sommer M, 2002, LANCET, V360, P380, DOI 10.1016/S0140-6736(02)09610-1; Stager SV, 2003, J FLUENCY DISORD, V28, P319, DOI 10.1016/j.jfludis.2003.08.004; Toyomura A, 2011, NEUROIMAGE IN PRESS; Tsujimoto S, 2011, TRENDS COGN SCI, V15, P169, DOI 10.1016/j.tics.2011.02.001; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Borsel J, 2003, BRAIN LANG, V85, P369, DOI 10.1016/S0093-934X(02)00588-6; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Villalobos ME, 2005, NEUROIMAGE, V25, P916, DOI 10.1016/j.neuroimage.2004.12.022; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Watkins KE, 2008, BRAIN, V131, P50, DOI 10.1093/brain/awm241; WEBSTER WG, 1986, NEUROPSYCHOLOGIA, V24, P813, DOI 10.1016/0028-3932(86)90080-1; Whitney C, 2009, J COGNITIVE NEUROSCI, V21, P697, DOI 10.1162/jocn.2009.21056; Wilson SM, 2008, CEREB CORTEX, V18, P230, DOI 10.1093/cercor/bhm049; Wirth M, 2011, NEUROIMAGE, V54, P3057, DOI 10.1016/j.neuroimage.2010.10.039; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; WU JC, 1995, NEUROREPORT, V6, P501, DOI 10.1097/00001756-199502000-00024; Xiong JH, 1999, HUM BRAIN MAPP, V8, P151, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<151::AID-HBM13>3.0.CO;2-5; Yairi E, 2007, J FLUENCY DISORD, V32, P165, DOI 10.1016/j.jfludis.2007.04.001; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yu CS, 2008, HUM BRAIN MAPP, V29, P533, DOI 10.1002/hbm.20420; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang ZQ, 2010, HUM BRAIN MAPP, V31, P1851, DOI 10.1002/hbm.20982; Zheng ZZ, 2010, J COGNITIVE NEUROSCI, V22, P1770, DOI 10.1162/jocn.2009.21324; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	101	43	44	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30570	10.1371/journal.pone.0030570	http://dx.doi.org/10.1371/journal.pone.0030570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276215	gold, Green Submitted, Green Published			2022-12-27	WOS:000301568100057
J	Peterson, E; De, P; Nuttall, R				Peterson, Emily; De, Prithwish; Nuttall, Robert			BMI, Diet and Female Reproductive Factors as Risks for Thyroid Cancer: A Systematic Review	PLOS ONE			English	Review							BODY-MASS INDEX; LOS-ANGELES-COUNTY; UNITED-STATES; POOLED ANALYSIS; ANTHROPOMETRIC FACTORS; INCREASING INCIDENCE; IODINE SUFFICIENCY; PHYSICAL-ACTIVITY; NEW-CALEDONIA; TIME TRENDS	Background: Thyroid cancer incidence rates have been increasing worldwide but the reason behind this is unclear. Both the increasing use of diagnostic technologies allowing the detection of thyroid cancer and a true increase in thyroid cancer incidence have been proposed. This review assesses the role of body mass index (BMI), diet, and reproductive factors on the thyroid cancer trend. Methods: Epidemiologic studies of the selected risk factors up to June 2010 were reviewed and critically assessed. Results: Among the thirty-seven studies reviewed and despite variation in the risk estimates, most papers supported a small but positive association for BMI (risk estimate range: 1.1-2.3 in males and 1.0-7.4 in females.). Among specific dietary components, there was no consistent association of thyroid cancer risk with iodine intake through fortification (risk estimate range: 0.49-1.6) or fish consumption (risk estimate range 0.6-2.2), nor with diets high in cruciferous vegetables (risk estimate range 0.6-1.9). A small number of studies showed a consistent protective effect of diets high in non-cruciferous vegetable (risk estimate range: 0.71-0.92). Among reproductive factors (pregnancy, parity, number of live births, use of prescription hormones, menstrual cycle regularity, and menopausal status), none were consistently associated with higher thyroid cancer risk. Conclusions: BMI had the strongest link to thyroid cancer risk among those examined. Detailed examinations of population-level risk factors can help identify and support prevention efforts to reduce the burden of thyroid cancer.	[Peterson, Emily; De, Prithwish] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [De, Prithwish; Nuttall, Robert] Canadian Canc Soc, Toronto, ON, Canada	University of Toronto; Canadian Cancer Society (CCS)	Peterson, E (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada.	Prithwish.De@cancer.ca						Bleyer A, 2006, CANC EPIDEMIOLOGY OL; Bosetti C, 2002, CANCER CAUSE CONTROL, V13, P765, DOI 10.1023/A:1020243527152; Bosetti C, 2001, CANCER CAUSE CONTROL, V12, P375, DOI 10.1023/A:1011267123398; Brindel P, 2009, CANCER CAUSE CONTROL, V20, P581, DOI 10.1007/s10552-008-9266-y; Burgess JR, 2000, J CLIN ENDOCR METAB, V85, P1513, DOI 10.1210/jc.85.4.1513; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Clavel-Chapelon F, 2010, INT J CANCER, V126, P2984, DOI 10.1002/ijc.25066; Colonna M, 2007, EUR J CANCER, V43, P891, DOI 10.1016/j.ejca.2006.11.024; Dal Maso L, 2000, CANCER CAUSE CONTROL, V11, P137, DOI 10.1023/A:1008938520101; Dal Maso L, 2009, CANCER CAUSE CONTROL, V20, P75, DOI 10.1007/s10552-008-9219-5; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Derwahl M, 1999, J CLIN ENDOCR METAB, V84, P829, DOI 10.1210/jc.84.3.829; Enewold L, 2009, CANCER EPIDEM BIOMAR, V18, P784, DOI 10.1158/1055-9965.EPI-08-0960; Feldt-Rasmussen U, 2001, THYROID, V11, P483, DOI 10.1089/105072501300176435; Fioretti F, 1999, INT J EPIDEMIOL, V28, P626, DOI 10.1093/ije/28.4.626; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Guignard R, 2007, AM J EPIDEMIOL, V166, P1140, DOI 10.1093/aje/kwm204; Haselkorn T, 2000, CANCER CAUSE CONTROL, V11, P163, DOI 10.1023/A:1008932123830; Haymart MR, 2008, J CLIN ENDOCR METAB, V93, P809, DOI 10.1210/jc.2007-2215; Horn-Ross PL, 2002, CANCER EPIDEM BIOMAR, V11, P43; Horn-Ross PL, 2001, CANCER EPIDEM BIOMAR, V10, P979; KANNO J, 1990, TOXICOL PATHOL, V18, P239, DOI 10.1177/019262339001800202; Kent WDT, 2007, CAN MED ASSOC J, V177, P1357, DOI 10.1503/cmaj.061730; Kilfoy BA, 2009, CANCER CAUSE CONTROL, V20, P525, DOI 10.1007/s10552-008-9260-4; Knobel M, 2007, ARQ BRAS ENDOCRINOL, V51, P701, DOI 10.1590/S0004-27302007000500007; KOLONEL LN, 1990, CANCER CAUSE CONTROL, V1, P223, DOI 10.1007/BF00117474; Leenhardt L, 2004, THYROID, V14, P1056, DOI 10.1089/thy.2004.14.1056; Leitzmann MF, 2010, INT J CANCER, V126, P2947, DOI 10.1002/ijc.24913; Lind P, 1998, THYROID, V8, P1179, DOI 10.1089/thy.1998.8.1179; Liu S, 2001, BRIT J CANCER, V85, P1335, DOI 10.1054/bjoc.2001.2061; Mack WJ, 2002, ANN EPIDEMIOL, V12, P395, DOI 10.1016/S1047-2797(01)00281-2; Markaki I, 2003, EUR J CANCER, V39, P1912, DOI 10.1016/S0959-8049(03)00432-5; Meinhold CL, 2010, AM J EPIDEMIOL, V171, P242, DOI 10.1093/aje/kwp354; Memon A, 2002, BRIT J CANCER, V86, P1745, DOI 10.1038/sj.bjc.6600303; Mitchell I, 2007, SURGERY, V142, P823, DOI 10.1016/j.surg.2007.09.011; Mulla ZD, 2000, ANN EPIDEMIOL, V10, P24, DOI 10.1016/S1047-2797(99)00044-7; Pettersson B, 1996, INT J CANCER, V65, P13, DOI 10.1002/(SICI)1097-0215(19960103)65:1&lt;13::AID-IJC3&gt;3.0.CO;2-4; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Reynolds RM, 2005, CLIN ENDOCRINOL, V62, P156, DOI 10.1111/j.1365-2265.2004.02187.x; Roberts DL, 2010, ANNU REV MED, V61, P301, DOI 10.1146/annurev.med.080708.082713; Rossing MA, 2001, CANCER CAUSE CONTROL, V12, P881, DOI 10.1023/A:1013757030600; Harach HR, 2008, ENDOCR PATHOL, V19, P209, DOI 10.1007/s12022-008-9038-y; Schottenfeld D, 2006, CANC EPIDEMIOLOGY PR; Shakhtarin VV, 2003, INT J EPIDEMIOL, V32, P584, DOI 10.1093/ije/dyg205; Shields M, 2010, FITNESS CANADIAN ADU; Smailyte G, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-284; Suzuki T, 2008, CANCER CAUSE CONTROL, V19, P1233, DOI 10.1007/s10552-008-9194-x; Trichopoulos D., 2008, TXB CANC EPIDEMIOLOG; Truong T, 2007, EUR J CANCER PREV, V16, P62, DOI 10.1097/01.cej.0000236244.32995.e1; UNICEF, 2008, SUST EL IOD DEF; WCRA/ AICR, 2007, FOOD NUTR PHYS ACT P; WILLIAMS ED, 1977, CANCER, V39, P215, DOI 10.1002/1097-0142(197701)39:1<215::AID-CNCR2820390134>3.0.CO;2-#; Yu GP, 2010, THYROID, V20, P465, DOI 10.1089/thy.2008.0281	53	117	124	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29177	10.1371/journal.pone.0029177	http://dx.doi.org/10.1371/journal.pone.0029177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276106	Green Published, Green Submitted, gold			2022-12-27	WOS:000301457200007
J	Baioui, A; Ambach, W; Walter, B; Vaitl, D				Baioui, Ali; Ambach, Wolfgang; Walter, Bertram; Vaitl, Dieter			Psychophysiology of False Memories in a Deese-Roediger-McDermott Paradigm with Visual Scenes	PLOS ONE			English	Article							ILLUSORY RECOGNITION MEMORY; GUILTY KNOWLEDGE TEST; CONCEALED INFORMATION; ORIENTING RESPONSE; STIMULUS NOVELTY; SKIN-CONDUCTANCE; AUTONOMIC DISCRIMINATION; REMEMBERING WORDS; BRAIN POTENTIALS; TRUE	Remembering something that has not in fact been experienced is commonly referred to as false memory. The Deese-Roediger-McDermott (DRM) paradigm is a well-elaborated approach to this phenomenon. This study attempts to investigate the peripheral physiology of false memories induced in a visual DRM paradigm. The main research question is whether false recognition is different from true recognition in terms of accompanying physiological responses. Sixty subjects participated in the experiment, which included a study phase with visual scenes each showing a group of interrelated items in social contexts. Subjects were divided into an experimental group undergoing a classical DRM design and a control group without DRM manipulation. The control group was implemented in order to statistically control for possible biases produced by memorability differences between stimulus types. After a short retention interval, a pictorial recognition phase was conducted in the manner of a Concealed Information Test. Simultaneous recordings of electrodermal activity, respiration line length, phasic heart rate, and finger pulse waveform length were used. Results yielded a significant Group by Item Type interaction, showing that true recognition is accompanied by greater electrodermal activity than false recognition. Results are discussed in the light of Sokolov's Orienting Reflex, the Preliminary Process Theory and the Concealed Information Test. Implications and restrictions of the introduced design features are critically discussed. This study demonstrates the applicability of measures of peripheral physiology to the field of false memory research.	[Baioui, Ali; Walter, Bertram; Vaitl, Dieter] Univ Giessen, Bender Inst Neuroimaging, Giessen, Germany; [Ambach, Wolfgang; Vaitl, Dieter] Inst Frontier Areas Psychol & Mental Hlth, Freiburg, Germany	Justus Liebig University Giessen	Baioui, A (corresponding author), Univ Giessen, Bender Inst Neuroimaging, Giessen, Germany.	Ali.A.Baioui@psychol.uni-giessen.de	Walter, Bertram/AAD-4695-2021		Institute for Frontier Areas of Psychology and Mental Health (Freiburg, Germany)	Institute for Frontier Areas of Psychology and Mental Health (Freiburg, Germany)	This study was solely financed by the Institute for Frontier Areas of Psychology and Mental Health (Freiburg, Germany) where the study was conducted. No additional grants or funding were involved. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2008, CEREB CORTEX, V18, P2811, DOI 10.1093/cercor/bhn037; Allen JJ, 2011, MEMORY DETECTION THE, P231; Allen JJB, 2009, SOC NEUROSCI-UK, V4, P473, DOI 10.1080/17470910802109939; Amato-Henderson SL, 1997, DISS ABSTR INT B, V57, P5370; Ambach W, 2008, INT J PSYCHOPHYSIOL, V70, P95, DOI 10.1016/j.ijpsycho.2008.07.002; BARRY RJ, 1988, INT J PSYCHOPHYSIOL, V6, P343, DOI 10.1016/0167-8760(88)90023-2; Barry RJ, 2009, NEUROBIOL LEARN MEM, V92, P235, DOI 10.1016/j.nlm.2008.07.007; BAUER RM, 1984, NEUROPSYCHOLOGIA, V22, P457, DOI 10.1016/0028-3932(84)90040-X; BAUER RM, 1988, BRAIN COGNITION, V8, P240, DOI 10.1016/0278-2626(88)90052-8; Ben-Shakhar G, 2003, J APPL PSYCHOL, V88, P131, DOI 10.1037/0021-9010.88.1.131; BenShakhar G, 1996, PSYCHOPHYSIOLOGY, V33, P671, DOI 10.1111/j.1469-8986.1996.tb02363.x; BENSHAKHAR G, 1985, PSYCHOPHYSIOLOGY, V22, P292, DOI 10.1111/j.1469-8986.1985.tb01603.x; BENSHAKHAR G, 1989, PSYCHOPHYSIOLOGY, V26, P29, DOI 10.1111/j.1469-8986.1989.tb03129.x; BENSHAKHAR G, 1994, PSYCHOPHYSIOLOGY, V31, P402, DOI 10.1111/j.1469-8986.1994.tb02448.x; BENSHAKHAR G, 1987, J EXP PSYCHOL GEN, V116, P91, DOI 10.1037/0096-3445.116.2.91; BERNSTEIN AS, 1985, BIOL PSYCHOL, V21, P183, DOI 10.1016/0301-0511(85)90029-8; BERNSTEIN AS, 1979, PSYCHOPHYSIOLOGY, V16, P263, DOI 10.1111/j.1469-8986.1979.tb02989.x; BRADLEY MT, 1981, PSYCHOPHYSIOLOGY, V18, P307, DOI 10.1111/j.1469-8986.1981.tb03040.x; Brainerd CJ, 2005, J EXP PSYCHOL LEARN, V31, P554, DOI 10.1037/0278-7393.31.3.554; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; Clancy SA, 2002, J ABNORM PSYCHOL, V111, P455, DOI 10.1037//0021-843X.111.3.455; Curran T, 2001, J COGNITIVE NEUROSCI, V13, P201, DOI 10.1162/089892901564261; DEESE J, 1959, J EXP PSYCHOL, V58, P17, DOI 10.1037/h0046671; Dockree PM, 2006, BRAIN, V129, P128, DOI 10.1093/brain/awh664; Elaad E, 2008, BIOL PSYCHOL, V77, P284, DOI 10.1016/j.biopsycho.2007.11.001; Elaad E, 2006, INT J PSYCHOPHYSIOL, V61, P226, DOI 10.1016/j.ijpsycho.2005.10.005; Gallo DA, 1997, PSYCHON B REV, V4, P271, DOI 10.3758/BF03209405; Gallo DA, 2001, PSYCHON B REV, V8, P579, DOI 10.3758/BF03196194; Gallo DA, 2010, MEM COGNITION, V38, P833, DOI 10.3758/MC.38.7.833; Gamer M, 2006, INT J PSYCHOPHYSIOL, V60, P76, DOI 10.1016/j.ijpsycho.2005.05.006; Gati I, 1996, PSYCHOPHYSIOLOGY, V33, P637, DOI 10.1111/j.1469-8986.1996.tb02358.x; GATI I, 1990, J EXP PSYCHOL GEN, V119, P251, DOI 10.1037/0096-3445.119.3.251; Gonsalves B, 2004, PSYCHOL SCI, V15, P655, DOI 10.1111/j.0956-7976.2004.00736.x; Gronau N, 2005, J APPL PSYCHOL, V90, P147, DOI 10.1037/0021-9010.90.1.147; Israel L, 1997, PSYCHON B REV, V4, P577, DOI 10.3758/BF03214352; Jelinek L, 2009, J BEHAV THER EXP PSY, V40, P374, DOI 10.1016/j.jbtep.2009.02.003; Kim H, 2007, J NEUROSCI, V27, P12190, DOI 10.1523/JNEUROSCI.3408-07.2007; KIRCHER JC, 2003, COMPUTERIZED POLYGRA, V2; Koutstaal W, 1997, J MEM LANG, V37, P555, DOI 10.1006/jmla.1997.2529; Koutstaal W, 2001, J MEM LANG, V44, P399, DOI 10.1006/jmla.2000.2734; LAZARUS RS, 1951, PSYCHOL REV, V58, P113, DOI 10.1037/h0054104; Lim CL, 1997, INT J PSYCHOPHYSIOL, V25, P97, DOI 10.1016/S0167-8760(96)00713-1; LOFTUS EF, 1974, J VERB LEARN VERB BE, V13, P585, DOI 10.1016/S0022-5371(74)80011-3; LOFTUS EF, 1978, J EXP PSYCHOL-HUM L, V4, P19, DOI 10.1037/0278-7393.4.1.19; LYKKEN DT, 1971, PSYCHOPHYSIOLOGY, V8, P656, DOI 10.1111/j.1469-8986.1971.tb00501.x; LYKKEN DT, 1974, AM PSYCHOL, V29, P725, DOI 10.1037/h0037441; LYKKEN DT, 1959, J APPL PSYCHOL, V43, P385, DOI 10.1037/h0046060; MALTZMAN I, 1979, PSYCHOPHYSIOLOGY, V16, P274, DOI 10.1111/j.1469-8986.1979.tb02990.x; MCCLEARY RA, 1949, J PERS, V18, P171, DOI 10.1111/j.1467-6494.1949.tb01238.x; Miller AR, 2001, J EXP PSYCHOL LEARN, V27, P354, DOI 10.1037/0278-7393.27.2.354; Miller MB, 1999, PSYCHOL REV, V106, P398, DOI 10.1037/0033-295X.106.2.398; Miller MB, 1998, NEUROPSYCHOLOGIA, V36, P513, DOI 10.1016/S0028-3932(97)00148-6; Moritz S, 2006, PSYCHOL MED, V36, P659, DOI 10.1017/S0033291706007252; Nessler D, 2004, PSYCHOPHYSIOLOGY, V41, P679, DOI 10.1111/j.1469-8986.2004.00195.x; Nessler D, 2001, COGNITIVE BRAIN RES, V10, P283, DOI 10.1016/S0926-6410(00)00049-5; Neuschatz JS, 2003, J EXP PSYCHOL LEARN, V29, P35, DOI 10.1037/0278-7393.29.1.35; Pavlov I.P., 1927, CONDITIONED REFLEXES; RITZ T, 1995, DIAGNOSTICA, V41, P53; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Rosenfeld J.P., 2011, MEMORY DETECTION THE, P63, DOI [10.1017/CBO9780511975196.005, DOI 10.1017/CBO9780511975196.005]; Schacter DL, 2004, NEURON, V44, P149, DOI 10.1016/j.neuron.2004.08.017; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; Schacter DL, 1996, NEURON, V17, P267, DOI 10.1016/S0896-6273(00)80158-0; Seamon JG, 2000, J MEM LANG, V42, P120, DOI 10.1006/jmla.1999.2676; Slotnick SD, 2004, NAT NEUROSCI, V7, P664, DOI 10.1038/nn1252; Sokolov E.N., 1963, PERCEPTION CONDITION; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; TIMM HW, 1982, J APPL PSYCHOL, V67, P391, DOI 10.1037/0021-9010.67.4.391; TRANEL D, 1985, SCIENCE, V228, P1453, DOI 10.1126/science.4012303; Velden M., 1987, J PSYCHOPHYSIOL, V1, P173; Verschuere B, 2004, PSYCHOPHYSIOLOGY, V41, P461, DOI 10.1111/j.1469-8986.00167.x; Verschuere B, 2007, BIOL PSYCHOL, V76, P52, DOI 10.1016/j.biopsycho.2007.06.001	73	8	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30416	10.1371/journal.pone.0030416	http://dx.doi.org/10.1371/journal.pone.0030416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	907XU	22272347	Green Published, gold, Green Submitted			2022-12-27	WOS:000301454400125
J	Baurhoo, B; Ferket, P; Ashwell, CM; de Oliviera, J; Zhao, X				Baurhoo, Bushansingh; Ferket, Peter; Ashwell, Chris M.; de Oliviera, Jean; Zhao, Xin			Cell Walls of Saccharomyces cerevisiae Differentially Modulated Innate Immunity and Glucose Metabolism during Late Systemic Inflammation	PLOS ONE			English	Article							ADIPOSE-TISSUE; MUSCLE CATABOLISM; ESCHERICHIA-COLI; SMALL-INTESTINE; EXPRESSION; LIPOPOLYSACCHARIDE; GLUCONEOGENESIS; ACTIVATION; CHICKEN; GENES	Background: Salmonella causes acute systemic inflammation by using its virulence factors to invade the intestinal epithelium. But, prolonged inflammation may provoke severe body catabolism and immunological diseases. Salmonella has become more life-threatening due to emergence of multiple-antibiotic resistant strains. Mannose-rich oligosaccharides (MOS) from cells walls of Saccharomyces cerevisiae have shown to bind mannose-specific lectin of Gram-negative bacteria including Salmonella, and prevent their adherence to intestinal epithelial cells. However, whether MOS may potentially mitigate systemic inflammation is not investigated yet. Moreover, molecular events underlying innate immune responses and metabolic activities during late inflammation, in presence or absence of MOS, are unknown. Methods and Principal Findings: Using a Salmonella LPS-induced systemic inflammation chicken model and microarray analysis, we investigated the effects of MOS and virginiamycin (VIRG, a sub-therapeutic antibiotic) on innate immunity and glucose metabolism during late inflammation. Here, we demonstrate that MOS and VIRG modulated innate immunity and metabolic genes differently. Innate immune responses were principally mediated by intestinal IL-3, but not TNF-alpha, IL-1 or IL-6, whereas glucose mobilization occurred through intestinal gluconeogenesis only. MOS inherently induced IL-3 expression in control hosts. Consequent to LPS challenge, IL-3 induction in VIRG hosts but not differentially expressed in MOS hosts revealed that MOS counteracted LPS's detrimental inflammatory effects. Metabolic pathways are built to elucidate the mechanisms by which VIRG host's higher energy requirements were met: including gene up-regulations for intestinal gluconeogenesis (PEPCK) and liver glycolysis (ENO2), and intriguingly liver fatty acid synthesis through ATP citrate synthase (CS) down-regulation and ATP citrate lyase (ACLY) and malic enzyme (ME) up-regulations. However, MOS host's lower energy demands were sufficiently met through TCA citrate-derived energy, as indicated by CS up-regulation. Conclusions: MOS terminated inflammation earlier than VIRG and reduced glucose mobilization, thus representing a novel biological strategy to alleviate Salmonella-induced systemic inflammation in human and animal hosts.	[Baurhoo, Bushansingh; Zhao, Xin] McGill Univ, Dept Anim Sci, Quebec City, PQ, Canada; [Ferket, Peter; Ashwell, Chris M.; de Oliviera, Jean] N Carolina State Univ, Dept Poultry Sci, Raleigh, NC 27695 USA	McGill University; University of North Carolina; North Carolina State University	Baurhoo, B (corresponding author), McGill Univ, Dept Anim Sci, Quebec City, PQ, Canada.	baurhoo.bushansingh@mail.mcgill.ca; xin.zhao@mcgill.ca	Zhao, Xin/M-4312-2015; Ashwell, Christopher/N-1332-2016	Zhao, Xin/0000-0002-1078-7332; de Oliveira, Jean Eduardo/0000-0002-7133-9197; Ashwell, Christopher/0000-0002-8190-1147; Ferket, Peter/0000-0002-2897-4312	Saskatchewan Chicken Industry Development Fund (SCIDF); James McGill Professorship	Saskatchewan Chicken Industry Development Fund (SCIDF); James McGill Professorship	This investigation was supported by the Saskatchewan Chicken Industry Development Fund (SCIDF) and James McGill Professorship fund to XZ. BB is a doctoral fellow of the Natural Sciences and Engineering Research Council (NSERC) of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Baurhoo B, 2007, POULTRY SCI, V86, P2509, DOI 10.3382/ps.2007-00136; Baurhoo B, 2009, POULTRY SCI, V88, P2262, DOI 10.3382/ps.2008-00562; Behera AK, 2002, J BIOL CHEM, V277, P25601, DOI 10.1074/jbc.M200211200; CDC, 2011, SALM SER ENT; Ceciliani F, 2002, PROTEIN PEPTIDE LETT, V9, P211, DOI 10.2174/0929866023408779; CHEEMADH.S, 1973, EUR J BIOCHEM, V38, P98, DOI 10.1111/j.1432-1033.1973.tb03038.x; Chidakel A, 2005, THYROID, V15, P899, DOI 10.1089/thy.2005.15.899; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Croset M, 2001, DIABETES, V50, P740, DOI 10.2337/diabetes.50.4.740; Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Druyan S, 2008, POULTRY SCI, V87, P2418, DOI 10.3382/ps.2007-00513; Ebner S, 2002, J IMMUNOL, V168, P6199, DOI 10.4049/jimmunol.168.12.6199; Eid A, 2006, J AM SOC NEPHROL, V17, P398, DOI 10.1681/ASN.2005070742; FEINGOLD KR, 1992, J LIPID RES, V33, P1765; Ferrer JC, 2003, FEBS LETT, V546, P127, DOI 10.1016/S0014-5793(03)00565-9; FLATT JP, 1966, J BIOL CHEM, V241, P2862; FLORES EA, 1989, J CLIN INVEST, V83, P1614, DOI 10.1172/JCI114059; Gao J, 2008, POULTRY SCI, V87, P1377, DOI 10.3382/ps.2007-00418; Garosi P, 2005, BRIT J NUTR, V93, P425, DOI 10.1079/BJN20041385; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gomez-Verduzco G, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-11; Griffin AJ, 2011, MUCOSAL IMMUNOL, V4, P371, DOI 10.1038/mi.2011.2; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Harden LM, 2008, BRAIN BEHAV IMMUN, V22, P838, DOI 10.1016/j.bbi.2007.12.006; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hasenstein JR, 2007, AVIAN DIS, V51, P561, DOI 10.1637/0005-2086(2007)51[561:CGGCAW]2.0.CO;2; Hillgartner FB, 1998, AM J PHYSIOL-ENDOC M, V274, pE493; Holecek M, 1995, PHYSIOL RES, V44, P399; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Kochan Z, 1997, METABOLISM, V46, P10, DOI 10.1016/S0026-0495(97)90160-8; Kogut MH, 2005, ANIM BIOTECHNOL, V16, P165, DOI 10.1080/10495390500264896; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Lopez-Bojorquez L, 2004, ARCH MED RES, V35, P465, DOI 10.1016/j.arcmed.2004.07.006; Galdeano CM, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-64; Martin G, 2007, BIOCHEM J, V401, P465, DOI 10.1042/BJ20061148; Morral N, 2007, J LIPID RES, V48, P1499, DOI 10.1194/jlr.M700090-JLR200; Nsenga R, 2009, FRONT MED CHINA, V3, P437; OFEK I, 1978, INFECT IMMUN, V22, P247, DOI 10.1128/IAI.22.1.247-254.1978; OHEA EK, 1968, COMP BIOCHEM PHYSIOL, V26, P111, DOI 10.1016/0010-406X(68)90317-4; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pearce NJ, 1998, BIOCHEM J, V334, P113, DOI 10.1042/bj3340113; Stern CD, 2005, DEV CELL, V8, P9, DOI 10.1016/j.devcel.2004.11.018; Stumvoll M, 1998, AM J PHYSIOL-ENDOC M, V274, pE817, DOI 10.1152/ajpendo.1998.274.5.E817; Szymanska-Czerwinska M, 2009, CENT EUR J IMMUNOL, V34, P1; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang PH, 2009, COMP BIOCHEM PHYS B, V153, P327, DOI 10.1016/j.cbpb.2009.04.003; WATERSON RM, 1972, J BIOL CHEM, V247, P5258; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; World Health Organization, 2011, COMPL KILLS ANT RES; Xie H, 2000, POULTRY SCI, V79, P33, DOI 10.1093/ps/79.1.33; Xu JC, 2004, P NATL ACAD SCI USA, V101, P3112, DOI 10.1073/pnas.0308450100; Yoo JY, 2003, P NATL ACAD SCI USA, V100, P1157, DOI 10.1073/pnas.0336385100; Zhao CW, 2001, APPL ENVIRON MICROB, V67, P5431, DOI 10.1128/AEM.67.12.5431-5436.2001	60	27	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30323	10.1371/journal.pone.0030323	http://dx.doi.org/10.1371/journal.pone.0030323			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272335	Green Published, Green Submitted, gold			2022-12-27	WOS:000301454400113
J	Hulsmans, M; Geeraert, B; De Keyzer, D; Mertens, A; Lannoo, M; Vanaudenaerde, B; Hoylaerts, M; Benhabiles, N; Tsatsanis, C; Mathieu, C; Holvoet, P				Hulsmans, Maarten; Geeraert, Benjamine; De Keyzer, Dieuwke; Mertens, Ann; Lannoo, Matthias; Vanaudenaerde, Bart; Hoylaerts, Marc; Benhabiles, Nora; Tsatsanis, Christos; Mathieu, Chantal; Holvoet, Paul			Interleukin-1 Receptor-Associated Kinase-3 Is a Key Inhibitor of Inflammation in Obesity and Metabolic Syndrome	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; IRAK-M; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; ADIPONECTIN; EXPRESSION; MONOCYTES; RISK; MACROPHAGES	Background: Visceral obesity is associated with the rising incidence of type 2 diabetes and metabolic syndrome. Low-grade chronic inflammation and oxidative stress synergize in obesity and obesity-induced disorders. Objective: We searched a cluster of molecules that support interactions between these stress conditions in monocytes. Methods: RNA expressions in blood monocytes of two independent cohorts comprising 21 and 102 obese persons and 46 age-matched controls were determined by microarray and independently validated by quantitative RT-PCR analysis. The effect of three-month weight loss after bariatric surgery was determined. The effect of RNA silencing on inflammation and oxidative stress was studied in human monocytic THP-1 cells. Results: Interleukin-1 receptor-associated kinase-3 (IRAK3), key inhibitor of IRAK/NF kappa B-mediated chronic inflammation, is downregulated in monocytes of obese persons. Low IRAK3 was associated with high superoxide dismutase-2 (SOD2), a marker of mitochondrial oxidative stress. A comparable expression profile was also detected in visceral adipose tissue of the same obese subjects. Low IRAK3 and high SOD2 was associated with a high prevalence of metabolic syndrome (odds ratio: 9.3; sensitivity: 91%; specificity: 77%). By comparison, the odds ratio of high-sensitivity C-reactive protein, a widely used marker of systemic inflammation, was 4.3 (sensitivity: 69%; specificity: 66%). Weight loss was associated with an increase in IRAK3 and a decrease in SOD2, in association with a lowering of systemic inflammation and a decreasing number of metabolic syndrome components. We identified the increase in reactive oxygen species in combination with obesity-associated low adiponectin and high glucose and interleukin-6 as cause of the decrease in IRAK3 in THP-1 cells in vitro. Conclusion: IRAK3 is a key inhibitor of inflammation in association with obesity and metabolic syndrome. Our data warrant further evaluation of IRAK3 as a diagnostic and prognostic marker, and as a target for intervention.	[Hulsmans, Maarten; Geeraert, Benjamine; De Keyzer, Dieuwke; Benhabiles, Nora; Holvoet, Paul] Katholieke Univ Leuven, Dept Cardiovasc Dis, Atherosclerosis & Metab Unit, Louvain, Belgium; [Mertens, Ann; Mathieu, Chantal] Katholieke Univ Leuven, Dept Expt Med, Expt Med & Endocrinol Sect, Louvain, Belgium; [Lannoo, Matthias] Katholieke Univ Leuven, Div Abdominal Surg, Louvain, Belgium; [Vanaudenaerde, Bart] Katholieke Univ Leuven, Dept Pathophysiol, Pneumol Sect, Louvain, Belgium; [Hoylaerts, Marc] Katholieke Univ Leuven, Dept Mol & Cellular Med, Ctr Mol & Vasc Biol, Louvain, Belgium; [Tsatsanis, Christos] Univ Crete, Sch Med, Dept Clin Chem, Iraklion, Greece	KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; University of Crete	Hulsmans, M (corresponding author), Katholieke Univ Leuven, Dept Cardiovasc Dis, Atherosclerosis & Metab Unit, Louvain, Belgium.	paul.holvoet@med.kuleuven.be	HOLVOET, PAUL/T-8434-2017; Hulsmans, Maarten/AAI-9547-2020; Tsatsanis, Christos/AAM-9362-2020; mathieu, chantal/ABD-5505-2021; lannoo, matthias/AAB-1706-2020	HOLVOET, PAUL/0000-0001-9201-0772; Hulsmans, Maarten/0000-0003-1009-658X; Tsatsanis, Christos/0000-0003-1214-4151; mathieu, chantal/0000-0002-4055-5233; Hoylaerts, Marc/0000-0002-6474-3933; Lannoo, matthias/0000-0001-7815-1157; Vanaudenaerde, Bart/0000-0001-6435-6901; Mertens, Ann/0000-0002-1649-4311	Belgian Federal Government [P06/30]; Bijzonder Onderzoeksfonds of the Katholieke Universiteit Leuven [OT/06/56, PF/10/014]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [G.0548.08, G0846.11]	Belgian Federal Government; Bijzonder Onderzoeksfonds of the Katholieke Universiteit Leuven(KU Leuven); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO)	Funding was provided by the Interuniversitaire Attractiepolen Programma of the Belgian Federal Government (P06/30), the Bijzonder Onderzoeksfonds of the Katholieke Universiteit Leuven (OT/06/56 and PF/10/014) and by the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (G.0548.08, G0846.11, and Vascular Biology Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Camhi SM, 2010, METABOLISM, V59, P54, DOI 10.1016/j.metabol.2009.07.008; Chou MY, 2008, J INTERN MED, V263, P479, DOI 10.1111/j.1365-2796.2008.01968.x; Cummings David E., 2004, Journal of Clinical Endocrinology & Metabolism, V89, P2608, DOI 10.1210/jc.2004-0433; Dasu MR, 2008, DIABETES, V57, P3090, DOI 10.2337/db08-0564; Dekker JM, 2008, J CLIN ENDOCR METAB, V93, P1489, DOI 10.1210/jc.2007-1436; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Geeraert B, 2007, J THROMB HAEMOST, V5, P2529, DOI 10.1111/j.1538-7836.2007.02786.x; Holvoet P, 2006, CLIN CHEM, V52, P760, DOI 10.1373/clinchem.2005.064337; Holvoet P, 2004, DIABETES, V53, P1068, DOI 10.2337/diabetes.53.4.1068; Holvoet P, 2008, Verh K Acad Geneeskd Belg, V70, P193; Holvoet P, 2008, JAMA-J AM MED ASSOC, V299, P2287, DOI 10.1001/jama.299.19.2287; Holvoet P, 2006, ARTERIOSCL THROM VAS, V26, P1558, DOI 10.1161/01.ATV.0000226553.01555.02; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hulsmans M, 2010, J CELL MOL MED, V14, P70, DOI 10.1111/j.1582-4934.2009.00978.x; Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E; Knight J, 2001, NATURE, V410, P860, DOI 10.1038/35073680; Kobayashi H, 2011, J IMMUNOL, V186, P403, DOI 10.4049/jimmunol.1001906; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Ladunga I, 2002, CURR PROTOC BIOINFOR; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Motoshima H, 2004, BIOCHEM BIOPH RES CO, V315, P264, DOI 10.1016/j.bbrc.2004.01.049; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Patino R, 2000, AM J CARDIOL, V85, P1288, DOI 10.1016/S0002-9149(00)00757-8; Pickl WF, 1996, J IMMUNOL, V157, P3850; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Rosati O, 2002, BIOCHEM BIOPH RES CO, V293, P1472, DOI 10.1016/S0006-291X(02)00411-4; Salio M, 2000, EUR J IMMUNOL, V30, P705, DOI 10.1002/1521-4141(200002)30:2<705::AID-IMMU705>3.0.CO;2-P; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Standiford TJ, 2011, ONCOGENE, V30, P2475, DOI 10.1038/onc.2010.619; Takahashi K, 2003, J BIOL CHEM, V278, P46654, DOI 10.1074/jbc.M309895200; Van Guilder GP, 2006, OBESITY, V14, P2127, DOI 10.1038/oby.2006.248; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; Zacharioudaki V, 2009, J IMMUNOL, V182, P6444, DOI 10.4049/jimmunol.0803694	42	57	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30414	10.1371/journal.pone.0030414	http://dx.doi.org/10.1371/journal.pone.0030414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272346	gold, Green Submitted, Green Published			2022-12-27	WOS:000301454400124
J	Huang, YJA; Grant, J; Roper, S				Huang, Yijen A.; Grant, Jeff; Roper, Stephen			Glutamate May Be an Efferent Transmitter That Elicits Inhibition in Mouse Taste Buds	PLOS ONE			English	Article							EXCITATORY AMINO-ACIDS; TO-CELL COMMUNICATION; RECEPTOR-CELLS; NERVE-FIBERS; III CELLS; RAT; SEROTONIN; EXPRESSION; ATP; HEMICHANNELS	Recent studies suggest that l-glutamate may be an efferent transmitter released from axons innervating taste buds. In this report, we determined the types of ionotropic synaptic glutamate receptors present on taste cells and that underlie this postulated efferent transmission. We also studied what effect glutamate exerts on taste bud function. We isolated mouse taste buds and taste cells, conducted functional imaging using Fura 2, and used cellular biosensors to monitor taste-evoked transmitter release. The findings show that a large fraction of Presynaptic (Type III) taste bud cells (similar to 50%) respond to 100 mM glutamate, NMDA, or kainic acid (KA) with an increase in intracellular Ca2+. In contrast, Receptor (Type II) taste cells rarely (4%) responded to 100 mM glutamate. At this concentration and with these compounds, these agonists activate glutamatergic synaptic receptors, not glutamate taste (umami) receptors. Moreover, applying glutamate, NMDA, or KA caused taste buds to secrete 5-HT, a Presynaptic taste cell transmitter, but not ATP, a Receptor cell transmitter. Indeed, glutamate-evoked 5-HT release inhibited taste-evoked ATP secretion. The findings are consistent with a role for glutamate in taste buds as an inhibitory efferent transmitter that acts via ionotropic synaptic glutamate receptors.	[Huang, Yijen A.; Grant, Jeff; Roper, Stephen] Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33124 USA; [Roper, Stephen] Univ Miami, Sch Med, Program Neurosci, Miami, FL USA	University of Miami; University of Miami	Huang, YJA (corresponding author), Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33124 USA.	sroper@med.miami.edu		Roper, Stephen/0000-0001-6049-8320; Tilahin, Shimelis/0000-0001-8975-8026	National Institutes of Health [2R01DC007630, 5R01DC000374]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007630, R01DC000374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was funded to SR by National Institutes of Health grants 2R01DC007630 and 5R01DC000374. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caicedo A, 2000, J NEUROSCI, V20, P7978; Cao Y, 2009, P NATL ACAD SCI USA, V106, P4006, DOI 10.1073/pnas.0808672106; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chaudhari N, 1996, J NEUROSCI, V16, P3817; Dando R, 2009, J PHYSIOL-LONDON, V587, P5899, DOI 10.1113/jphysiol.2009.180083; Dvoryanchikov G, 2007, J COMP NEUROL, V505, P302, DOI 10.1002/cne.21494; Dvoryanchikov G, 2011, J NEUROSCI, V31, P5782, DOI 10.1523/JNEUROSCI.5559-10.2011; FILIN VA, 1968, B EXP BIOL MED-USSR, V65, P9, DOI 10.1007/BF00810184; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; FUJIMOTO S, 1970, ANAT REC, V168, P393, DOI 10.1002/ar.1091680306; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hayashi Y, 1996, BIOPHYS J, V71, P1057, DOI 10.1016/S0006-3495(96)79306-2; Heath TP, 2006, J NEUROSCI, V26, P12664, DOI 10.1523/JNEUROSCI.3459-06.2006; Herness S, 1997, NEUROREPORT, V8, P3257, DOI 10.1097/00001756-199710200-00014; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2008, J PHYSIOL-LONDON, V586, P2903, DOI 10.1113/jphysiol.2008.151233; Huang YJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025471; Huang YJA, 2011, J NEUROSCI, V31, P13654, DOI 10.1523/JNEUROSCI.3356-11.2011; Huang YA, 2009, J NEUROSCI, V29, P13909, DOI 10.1523/JNEUROSCI.2351-09.2009; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; JEFTINIJA S, 1991, NEUROSCI LETT, V125, P191, DOI 10.1016/0304-3940(91)90025-O; Kaya N, 2004, AM J PHYSIOL-REG I, V286, pR649, DOI 10.1152/ajpregu.00572.2003; Kim JW, 2006, CHEM SENSES, V31, P213, DOI 10.1093/chemse/bjj021; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lin WH, 1999, J NEUROPHYSIOL, V82, P2061, DOI 10.1152/jn.1999.82.5.2061; Lu SG, 2003, NEUROSCI LETT, V351, P157, DOI 10.1016/j.neulet.2003.07.016; Ma HZ, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-5; Maruyama Y, 2006, J NEUROSCI, V26, P2227, DOI 10.1523/JNEUROSCI.4329-05.2006; Mathes CM, 2011, CHEM SENSES, V36, P515, DOI 10.1093/chemse/bjr011; MILLER IJ, 1971, J GEN PHYSIOL, V57, P1, DOI 10.1085/jgp.57.1.1; MURAYAMA N, 1988, J GEN PHYSIOL, V91, P685, DOI 10.1085/jgp.91.5.685; MURRAY R G, 1969, Journal of Ultrastructure Research, V27, P444, DOI 10.1016/S0022-5320(69)80043-2; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Niki M, 2011, CELL MOL NEUROBIOL, V31, P1033, DOI 10.1007/s10571-011-9702-5; NINOMIYA Y, 1991, PHYSIOL BEHAV, V49, P913, DOI 10.1016/0031-9384(91)90203-Z; Ogura T, 2002, J NEUROPHYSIOL, V87, P2643, DOI 10.1152/jn.2002.87.6.2643; Ohtubo Y, 2011, BRAIN RES, V1367, P13, DOI 10.1016/j.brainres.2010.10.060; Omote K, 1998, BRAIN RES, V787, P161, DOI 10.1016/S0006-8993(97)01568-0; RIDDLE DR, 1990, BRAIN RES, V533, P113, DOI 10.1016/0006-8993(90)91803-O; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; ROYER SM, 1988, J COMP NEUROL, V270, P11, DOI 10.1002/cne.902700103; TAKEDA M, 1980, CELL TISSUE RES, V210, P71; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Vandenbeuch A, 2004, NEUROSCI LETT, V358, P137, DOI 10.1016/j.neulet.2004.01.013; Vandenbeuch A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-77; Willis WD, 1999, EXP BRAIN RES, V124, P395, DOI 10.1007/s002210050637; YAMAMOTO T, 1991, PHYSIOL BEHAV, V49, P919, DOI 10.1016/0031-9384(91)90204-2; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao FL, 2005, P NATL ACAD SCI USA, V102, P11100, DOI 10.1073/pnas.0501988102	52	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30662	10.1371/journal.pone.0030662	http://dx.doi.org/10.1371/journal.pone.0030662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292013	Green Submitted, Green Published, gold			2022-12-27	WOS:000301703800023
J	Schmid, MW; Schmidt, A; Klostermeier, UC; Barann, M; Rosenstiel, P; Grossniklaus, U				Schmid, Marc W.; Schmidt, Anja; Klostermeier, Ulrich C.; Barann, Matthias; Rosenstiel, Philip; Grossniklaus, Ueli			A Powerful Method for Transcriptional Profiling of Specific Cell Types in Eukaryotes: Laser-Assisted Microdissection and RNA Sequencing	PLOS ONE			English	Article							POLLEN-TUBE GUIDANCE; GENE-EXPRESSION; SEQ; TOOL; NORMALIZATION; DEMETHYLATION; LANDSCAPE; DISCOVERY; ALIGNMENT; REVEALS	The acquisition of distinct cell fates is central to the development of multicellular organisms and is largely mediated by gene expression patterns specific to individual cells and tissues. A spatially and temporally resolved analysis of gene expression facilitates the elucidation of transcriptional networks linked to cellular identity and function. We present an approach that allows cell type-specific transcriptional profiling of distinct target cells, which are rare and difficult to access, with unprecedented sensitivity and resolution. We combined laser-assisted microdissection (LAM), linear amplification starting from <1 ng of total RNA, and RNA-sequencing (RNA-Seq). As a model we used the central cell of the Arabidopsis thaliana female gametophyte, one of the female gametes harbored in the reproductive organs of the flower. We estimated the number of expressed genes to be more than twice the number reported previously in a study using LAM and ATH1 microarrays, and identified several classes of genes that were systematically underrepresented in the transcriptome measured with the ATH1 microarray. Among them are many genes that are likely to be important for developmental processes and specific cellular functions. In addition, we identified several intergenic regions, which are likely to be transcribed, and describe a considerable fraction of reads mapping to introns and regions flanking annotated loci, which may represent alternative transcript isoforms. Finally, we performed a de novo assembly of the transcriptome and show that the method is suitable for studying individual cell types of organisms lacking reference sequence information, demonstrating that this approach can be applied to most eukaryotic organisms.	[Schmid, Marc W.; Schmidt, Anja; Grossniklaus, Ueli] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Schmid, Marc W.; Schmidt, Anja; Grossniklaus, Ueli] Univ Zurich, Zurich Basel Plant Sci Ctr, Zurich, Switzerland; [Klostermeier, Ulrich C.; Barann, Matthias; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany	University of Zurich; University of Zurich; University of Kiel	Schmid, MW (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	grossnik@botinst.uzh.ch	Rosenstiel, Philip/A-5137-2009; Grossniklaus, Ueli/E-9995-2016; Schmidt, Anja/AAS-5288-2021	Rosenstiel, Philip/0000-0002-9692-8828; Grossniklaus, Ueli/0000-0002-0522-8974; Schmidt, Anja/0000-0002-3276-3243; Schmid, Marc W/0000-0001-9554-5318	University of Zurich; Stiftung fuer wissenschaftliche Forschung through Baumgarten Stiftung; Swiss National Science Foundation; DFG Clusters of Excellence	University of Zurich; Stiftung fuer wissenschaftliche Forschung through Baumgarten Stiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); DFG Clusters of Excellence	This work was supported by the University of Zurich, and grants of the "Stiftung fuer wissenschaftliche Forschung" (through support by the "Baumgarten Stiftung") and the Swiss National Science Foundation to UG. The study was supported by Life Technologies by contributing, in part, sequencing reagents, which had no influence on the design of the study. PR is supported by the DFG Clusters of Excellence "Future Ocean" and "Inflammation at Interfaces" and the NGFN Network Genomics of Chronic Inflammatory Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Autran D, 2011, CELL, V145, P707, DOI 10.1016/j.cell.2011.04.014; Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; Bolstad B, 2005, BIOINFORMATICS COMPU; Brooks L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000476; Chen CB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-280; Chen YH, 2007, PLANT CELL, V19, P3563, DOI 10.1105/tpc.107.053967; Christensen CA, 1997, SEX PLANT REPROD, V10, P49, DOI 10.1007/s004970050067; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Day RC, 2007, INT J PLANT GENOMICS; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Grossniklaus U, 1998, SEMIN CELL DEV BIOL, V9, P227, DOI 10.1006/scdb.1997.0214; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Jones-Rhoades MW, 2007, PLOS GENET, V3, P1848, DOI 10.1371/journal.pgen.0030171; Kamme F, 2003, J NEUROSCI, V23, P3607; Kerk NM, 2003, PLANT PHYSIOL, V132, P27, DOI 10.1104/pp.102.018127; Klostermeier UC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-305; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Marton ML, 2005, SCIENCE, V307, P573, DOI 10.1126/science.1104954; Morse Alison M, 2010, J Biomol Tech, V21, P141; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nodine MD, 2010, GENE DEV, V24, P2678, DOI 10.1101/gad.1986710; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Schmidt A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001155; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tariq MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr547; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wust SE, 2010, CURR BIOL, V20, P1; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	44	81	84	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e29685	10.1371/journal.pone.0029685	http://dx.doi.org/10.1371/journal.pone.0029685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291893	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000301703800005
J	McMullen, AB; Baidwan, GS; McCarthy, KD				McMullen, Allison B.; Baidwan, Gurlal S.; McCarthy, Ken D.			Morphological and Behavioral Changes in the Pathogenesis of a Novel Mouse Model of Communicating Hydrocephalus	PLOS ONE			English	Article							KAOLIN-INDUCED HYDROCEPHALUS; NEURAL STEM-CELLS; ADULT SUBVENTRICULAR ZONE; H-TX RAT; CONGENITAL HYDROCEPHALUS; HYH MICE; CONDITIONAL EXPRESSION; G(I)-COUPLED RECEPTOR; EPENDYMAL DENUDATION; MAMMALIAN BRAIN	The Ro1 model of hydrocephalus represents an excellent model for studying the pathogenesis of hydrocephalus due to its complete penetrance and inducibility, enabling the investigation of the earliest cellular and histological changes in hydrocephalus prior to overt pathology. Hematoxylin and eosin staining, immunofluorescence and electron microscopy were used to characterize the histopathological events of hydrocephalus in this model. Additionally, a broad battery of behavioral tests was used to investigate behavioral changes in the Ro1 model of hydrocephalus. The earliest histological changes observed in this model were ventriculomegaly and disorganization of the ependymal lining of the aqueduct of Sylvius, which occurred concomitantly. Ventriculomegaly led to thinning of the ependyma, which was associated with periventricular edema and areas of the ventricular wall void of cilia and microvilli. Ependymal denudation was subsequent to severe ventriculomegaly, suggesting that it is an effect, rather than a cause, of hydrocephalus in the Ro1 model. Additionally, there was no closure of the aqueduct of Sylvius or any blockages within the ventricular system, even with severe ventriculomegaly, suggesting that the Ro1 model represents a model of communicating hydrocephalus. Interestingly, even with severe ventriculomegaly, there were no behavioral changes, suggesting that the brain is able to compensate for the structural changes that occur in the pathogenesis of hydrocephalus if the disorder progresses at a sufficiently slow rate.	[McMullen, Allison B.; Baidwan, Gurlal S.; McCarthy, Ken D.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	McMullen, AB (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA.	kdmc@med.unc.edu			National Institutes of Health [HD058207-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD058207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by an R21 awarded to Ken D. McCarthy by the National Institutes of Health (HD058207-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Bakar EE, 2010, J KOREAN NEUROSURG S, V47, P191, DOI 10.3340/jkns.2010.47.3.191; BANNISTER CM, 1979, ACTA NEUROCHIR, V46, P159, DOI 10.1007/BF01407689; Barbara B, 2010, CURR NEUROPHARMACOL, V8, P97, DOI 10.2174/157015910791233204; Batiz LF, 2006, NEUROBIOL DIS, V23, P152, DOI 10.1016/j.nbd.2006.02.009; Bloch O, 2006, J CEREBR BLOOD F MET, V26, P1527, DOI 10.1038/sj.jcbfm.9600306; Boillat CA, 1999, EUR J PEDIATR SURG, V9, P44; BRUNI JE, 1985, BRAIN RES REV, V9, P1, DOI 10.1016/0165-0173(85)90016-5; Christensen Jacob Haaber, 2003, Ugeskr Laeger, V165, P466; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Danilov AI, 2009, GLIA, V57, P136, DOI 10.1002/glia.20741; Davy BE, 2003, HUM MOL GENET, V12, P1163, DOI 10.1093/hmg/ddg122; Dawe HR, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-33; Del Bigio MR, 2003, ANN NEUROL, V53, P337, DOI 10.1002/ana.10453; Del Bigio MR, 2002, NEUROSURGERY, V51, P460, DOI 10.1097/00006123-200208000-00029; DelBigio MR, 1997, J NEUROPATH EXP NEUR, V56, P1053, DOI 10.1097/00005072-199709000-00010; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dominguez-Pinos MD, 2005, J NEUROPATH EXP NEUR, V64, P595, DOI 10.1097/01.jnen.0000171648.86718.bb; ESTANOL BV, 1981, J NEUROL NEUROSUR PS, V44, P305, DOI 10.1136/jnnp.44.4.305; FERNELL E, 1986, ACTA PAEDIATR SCAND, V75, P975, DOI 10.1111/j.1651-2227.1986.tb10326.x; Fletcher JM, 1996, ARCH NEUROL-CHICAGO, V53, P549, DOI 10.1001/archneur.1996.00550060093022; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Hong HK, 2004, P NATL ACAD SCI USA, V101, P1748, DOI 10.1073/pnas.0308268100; JENSEN F, 1979, ACTA NEUROCHIR, V47, P91, DOI 10.1007/BF01404666; Jimenez AJ, 2009, J NEUROPATH EXP NEUR, V68, P1006, DOI 10.1097/NEN.0b013e3181b44a5a; Jimenez AJ, 2001, J NEUROPATH EXP NEUR, V60, P1105, DOI 10.1093/jnen/60.11.1105; Jones HC, 2000, CHILD NERV SYST, V16, P578, DOI 10.1007/s003810000330; JONES HC, 1995, CHILD NERV SYST, V11, P655, DOI 10.1007/BF00300725; JONES HC, 1988, NEUROPATH APPL NEURO, V14, P263, DOI 10.1111/j.1365-2990.1988.tb00887.x; Khan OH, 2006, EXP NEUROL, V200, P311, DOI 10.1016/j.expneurol.2006.02.113; Kiefer M, 1998, CHILD NERV SYST, V14, P263, DOI 10.1007/s003810050222; Lawson R F, 1973, Surg Neurol, V1, P115; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lopes LD, 2009, EXP NEUROL, V219, P187, DOI 10.1016/j.expneurol.2009.05.015; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Miller Janet M, 2007, Cerebrospinal Fluid Res, V4, P5, DOI 10.1186/1743-8454-4-5; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Paez P, 2007, J NEUROPATH EXP NEUR, V66, P1082, DOI 10.1097/nen.0b013e31815c1952; Peng J, 2008, ENDOCRINOLOGY, V149, P1329, DOI 10.1210/en.2007-0235; PIATT JH, 1993, PEDIATR NEUROSURG, V19, P233, DOI 10.1159/000120738; Rahme R, 2010, MED HYPOTHESES, V74, P95, DOI 10.1016/j.mehy.2009.07.043; RAIMONDI AJ, 1976, J NEUROSURG, V45, P66, DOI 10.3171/jns.1976.45.1.0066; Redfern CH, 2000, P NATL ACAD SCI USA, V97, P4826, DOI 10.1073/pnas.97.9.4826; Roberta A, 2010, CURR NEUROPHARMACOL, V8, P84, DOI 10.2174/157015910791233178; SAINTEROSE C, 1992, PEDIATR NEUROSURG, V17, P2, DOI 10.1159/000120557; SARNAT HB, 1995, J NEUROPATH EXP NEUR, V54, P1, DOI 10.1097/00005072-199501000-00001; Schrander-Stumpel C, 1998, EUR J PEDIATR, V157, P355, DOI 10.1007/s004310050830; Simon TD, 2008, J NEUROS-PEDIATR, V1, P131, DOI 10.3171/PED/2008/1/2/131; STOLL C, 1992, EUR J EPIDEMIOL, V8, P797, DOI 10.1007/BF00145322; Sweger EJ, 2009, THESIS U N CAROLINA; Sweger EJ, 2007, J NEUROSCI, V27, P2309, DOI 10.1523/JNEUROSCI.4565-06.2007; Tarazi RA, 2008, CLIN NEUROPSYCHOL, V22, P585, DOI 10.1080/13854040701425940; Vertinsky Alexandra T, 2007, Top Magn Reson Imaging, V18, P31, DOI 10.1097/RMR.0b013e3180d0a753; Wada M, 1988, Neurol Med Chir (Tokyo), V28, P955, DOI 10.2176/nmc.28.955; Wagner C, 2003, J NEUROPATH EXP NEUR, V62, P1019, DOI 10.1093/jnen/62.10.1019; Yeates KO, 2003, J INT NEUROPSYCH SOC, V9, P653, DOI 10.1017/S1355617703940057; YOSHIDA Y, 1990, Neurologia Medico-Chirurgica, V30, P445, DOI 10.2176/nmc.30.445	60	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30159	10.1371/journal.pone.0030159	http://dx.doi.org/10.1371/journal.pone.0030159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291910	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600005
J	Hu, J; Lou, DH; Carow, B; Winerdal, ME; Rottenberg, M; Wikstrom, AC; Norstedt, G; Winqvist, O				Hu, Jin; Lou, DaoHua; Carow, Berit; Winerdal, Malin E.; Rottenberg, Martin; Wikstrom, Ann-Charlotte; Norstedt, Gunnar; Winqvist, Ola			LPS Regulates SOCS2 Transcription in a Type I Interferon Dependent Autocrine-Paracrine Loop	PLOS ONE			English	Article							CYTOKINE SIGNALING 2; TOLL-LIKE RECEPTORS; DENDRITIC CELLS; NEGATIVE REGULATION; IMMUNE-RESPONSES; IRF FAMILY; SUPPRESSOR; INDUCTION; MACROPHAGES; PROTEINS	Recent studies suggest that SOCS2 is involved in the regulation of TLR signaling. In this study, we found that the expression of SOCS2 is regulated in human monocyte-derived DC by ligands stimulating TLR2, 3, 4, 5, 8 and 9 signaling. SOCS2 induction by LPS was dependent on the type I IFN regulated transcription factors IRF1 and IRF3 as shown by using silencing RNAs for IRFs. Blocking endogenous type I IFN signaling, by neutralizing antibodies to the receptor IFNAR2, abolished SOCS2 mRNA expression after TLR4 stimulation. Transcription factors STAT3, 5 and 6 displayed putative binding sites in the promoter regions of the human SOCS2 gene. Subsequent silencing experiments further supported that STAT3 and STAT5 are involved in LPS induced SOCS2 regulation. In mice we show that SOCS2 mRNA induction is 45% lower in bone marrow derived macrophages derived from MyD88(-/-) mice, and do not increase in BMMs from IRF3(-/-) mice after BCG infection. In conclusion, our results suggest that TLR4 signaling indirectly increases SOCS2 in late phase mainly via the production of endogenous type I IFN, and that subsequent IFN receptor signaling activates SOCS2 via STAT3 and STAT5.	[Hu, Jin; Lou, DaoHua; Winerdal, Malin E.; Winqvist, Ola] Karolinska Inst, Translat Immunol Unit, Dept Med, Stockholm, Sweden; [Norstedt, Gunnar] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Wikstrom, Ann-Charlotte] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Lou, DaoHua; Rottenberg, Martin] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Hu, Jin] Guangxi Med Univ, Dept Trauma Orthoped & Hand Surg, Affiliated Hosp 1, Nanning, Peoples R China	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Guangxi Medical University	Hu, J (corresponding author), Karolinska Inst, Translat Immunol Unit, Dept Med, Stockholm, Sweden.	ola.winqvist@karolinska.se	Carow, Berit/AAE-3970-2020	Carow, Berit/0000-0002-8760-6253; Rottenberg, Martin/0000-0003-0514-7434; Norstedt, Gunnar/0000-0002-7759-3241; winqvist, Ola/0000-0003-0842-4441	Swedish Cancer Society; Wallenberg Foundation; Soderbergs Foundation, Thematic centre for immunomodulatory treatment of autoimmunity and cancer; Swedish Research Council	Swedish Cancer Society(Swedish Cancer Society); Wallenberg Foundation(European Commission); Soderbergs Foundation, Thematic centre for immunomodulatory treatment of autoimmunity and cancer; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Cancer Society, the Wallenberg Foundation, the Soderbergs Foundation, Thematic centre for immunomodulatory treatment of autoimmunity and cancer, and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Cheng SM, 2009, BLOOD, V113, P5192, DOI 10.1182/blood-2008-10-183525; Crespo A, 2000, BIOCHEM J, V349, P99, DOI 10.1042/0264-6021:3490099; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Frobose H, 2006, MOL ENDOCRINOL, V20, P1587, DOI 10.1210/me.2005-0301; Gabriele L, 2007, CYTOKINE GROWTH F R, V18, P503, DOI 10.1016/j.cytogfr.2007.06.008; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007178; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mathis D, 2011, NAT REV IMMUNOL, V11, P81, DOI 10.1038/nri2922; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Molavi O, 2008, IMMUNOL CELL BIOL, V86, P506, DOI 10.1038/icb.2008.27; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Noppert SJ, 2007, IMMUNOL CELL BIOL, V85, P446, DOI 10.1038/sj.icb.7100099; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Posselt G, 2011, J IMMUNOL, V187, P2875, DOI 10.4049/jimmunol.1003348; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Rothfuchs AG, 2001, J IMMUNOL, V167, P6453, DOI 10.4049/jimmunol.167.11.6453; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schmitz F, 2007, EUR J IMMUNOL, V37, P315, DOI 10.1002/eji.200636767; Tailor P, 2006, CELL RES, V16, P134, DOI 10.1038/sj.cr.7310018; Tailor P, 2007, IMMUNITY, V27, P228, DOI 10.1016/j.immuni.2007.06.009; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Uddin S, 2003, BIOCHEM BIOPH RES CO, V308, P325, DOI 10.1016/S0006-291X(03)01382-2; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Vidal OM, 2007, MOL ENDOCRINOL, V21, P293, DOI 10.1210/me.2006-0096; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	40	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30166	10.1371/journal.pone.0030166	http://dx.doi.org/10.1371/journal.pone.0030166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291912	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600021
J	Maheswaran, H; Barton, P				Maheswaran, Hendramoorthy; Barton, Pelham			Intensive Case Finding and Isoniazid Preventative Therapy in HIV Infected Individuals in Africa: Economic Model and Value of Information Analysis	PLOS ONE			English	Article							TUBERCULOSIS PREVENTIVE THERAPY; ACCESSING ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS ANALYSIS; SUB-SAHARAN AFRICA; PULMONARY TUBERCULOSIS; ACTIVE TUBERCULOSIS; EXPECTED VALUE; SOUTH-AFRICA; ADULTS; DIAGNOSIS	Background: Tuberculosis (TB) accounts of much of the morbidity and mortality associated with HIV. We evaluate the cost-effectiveness of different strategies to actively screen for TB disease in HIV positive individuals, where isoniazid preventative therapy (IPT) is given to those screening negative, and use value of information analysis (VOI) to identify future research priorities. Methodology/Principal Findings: We built an individual sampling model to investigate the costs (2010 US Dollars) and consequences of screening for TB, and providing TB treatment or IPT in adults testing HIV positive in Sub-Saharan Africa. A systematic review and meta-analysis was conducted to assess performance of the nine different TB screening strategies evaluated. Probabilistic sensitivity analysis was conducted to incorporate decision uncertainty, and expected value of perfect information for the entire model and for groups of parameters was calculated. Screening all HIV infected individuals with sputum microscopy was the least costly strategy, with other strategies not cost-effective at WHO recommended thresholds. Screening those with TB symptoms with sputum microscopy and CXR would be cost-effective at a threshold ICER of $7,800 per quality-adjusted life year (QALY), but associated with significant uncertainty. VOI analysis suggests further information would be of value. Conclusions/Significance: Resource-constrained countries in sub-Saharan Africa wishing to scale up TB preventative services in their HIV infected populations should consider expanding laboratory facilities to enable increased screening for TB with sputum microscopy, whilst improved estimates of the TB prevalence in the population to be screened are needed, as it may influence the optimal strategy.	[Maheswaran, Hendramoorthy] Univ Warwick, Sch Med, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England; [Barton, Pelham] Univ Birmingham, Sch Hlth & Populat Sci, Hlth Econ Unit, Birmingham, W Midlands, England	University of Warwick; University of Birmingham	Maheswaran, H (corresponding author), Univ Warwick, Sch Med, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England.	H.Maheswaran@warwick.ac.uk		Maheswaran, Hendramoorthy/0000-0002-7375-4845				Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bakari M, 2000, E AFRICAN MED J, V77; Balcells ME, 2006, EMERG INFECT DIS, V12, P744; Barton GR, 2008, VALUE HEALTH, V11, P886, DOI 10.1111/j.1524-4733.2008.00358.x; Barton Pelham, 2004, J Health Serv Res Policy, V9, P110, DOI 10.1258/135581904322987535; Bell JC, 1999, AIDS, V13, P1549, DOI 10.1097/00002030-199908200-00016; Briggs A, 2008, DECISION MODELLING H; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Chheng R, 2008, INT J TUBERC LUNG D, V12, pS54; Churchyard GJ, 2007, J INFECT DIS, V196, pS52, DOI 10.1086/518662; Claxton K, 2001, INT J TECHNOL ASSESS, V17, P38, DOI 10.1017/S0266462301104058; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Connolly C, 1999, AIDS, V13, P1543, DOI 10.1097/00002030-199908200-00015; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Craig D, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13620; Day JH, 2006, INT J TUBERC LUNG D, V10, P523; DCPP, 2005, 9 DCPP; de Jonghe E, 1994, Int J Health Plann Manage, V9, P151, DOI 10.1002/hpm.4740090204; den Boon S, 2006, INT J TUBERC LUNG D, V10, P876; Dowdy DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004057; ERS, 2009, EC RES SERV ERS INT; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Felli JC, 1999, HEALTH ECON, V8, P263, DOI 10.1002/(SICI)1099-1050(199905)8:3<263::AID-HEC426>3.0.CO;2-S; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Getahun H, 2010, AIDS, V24, pS57, DOI 10.1097/01.aids.0000391023.03037.1f; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Gordin FM, 1997, NEW ENGL J MED, V337, P315, DOI 10.1056/NEJM199707313370505; GUELAR A, 1993, AIDS, V7, P1345, DOI 10.1097/00002030-199310000-00007; Guo N, 2008, VALUE HEALTH, V11, P1154, DOI 10.1111/j.1524-4733.2008.00355.x; Harries AD, 1997, T ROY SOC TROP MED H, V91, P416, DOI 10.1016/S0035-9203(97)90262-5; Hausler HP, 2006, B WORLD HEALTH ORGAN, V84, P528, DOI 10.2471/BLT.04.018606; Hawken MP, 1997, AIDS, V11, P875, DOI 10.1097/00002030-199707000-00006; Hinderaker SG, 2009, INT J TUBERC LUNG D, V13, P1560; Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) 2009, 2009, AIDS EP UPD DEC 2009; Khan FA, 2010, CLIN INFECT DIS, V50, P1288, DOI 10.1086/651686; Kimerling ME, 2002, INT J TUBERC LUNG D, V6, P988; Kizito KW, 2011, T ROY SOC TROP MED H, V105, P52, DOI 10.1016/j.trstmh.2010.08.015; Koerkamp BG, 2006, HEALTH ECON, V15, P383, DOI 10.1002/hec.1064; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Lara AM, 2008, AIDS, V22, pS123, DOI 10.1097/01.aids.0000327633.85221.9a; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2009, INT J TUBERC LUNG D, V13, P1186; Lewis JJ, 2009, AM J RESP CRIT CARE, V180, P1271, DOI 10.1164/rccm.200806-846OC; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Marais BJ, 2010, LANCET, V375, P2179, DOI 10.1016/S0140-6736(10)60554-5; Marra CA, 2008, CHEST, V133, P396, DOI 10.1378/chest.07-1494; Mase SR, 2007, INT J TUBERC LUNG D, V11, P485; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; Mohammed A, 2004, INT J TUBERC LUNG D, V8, P792; Mosimaneotsile B, 2003, LANCET, V362, P1551, DOI 10.1016/S0140-6736(03)14745-9; Mosimaneotsile B, 2010, JAIDS-J ACQ IMM DEF, V54, P71, DOI 10.1097/QAI.0b013e3181c3cbf0; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Okello D, 2003, INT J TUBERC LUNG D, V7, pS72; Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X; Robberstad Bjarne, 2010, Cost Eff Resour Alloc, V8, P5, DOI 10.1186/1478-7547-8-5; Rose DN, 1998, ANN INTERN MED, V129, P779, DOI 10.7326/0003-4819-129-10-199811150-00005; Rylance J, 2010, LANCET INFECT DIS, V10, P886, DOI 10.1016/S1473-3099(10)70201-2; Shah S, 2009, JAIDS-J ACQ IMM DEF, V50, P537, DOI 10.1097/QAI.0b013e318196761c; Shargie EB, 2007, PLOS MED, V4, P280, DOI 10.1371/journal.pmed.0040037; Shrestha RK, 2007, INT J TUBERC LUNG D, V11, P747; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Sutton BS, 2009, INT J TUBERC LUNG D, V13, P713; Tappenden P, 2004, HEALTH TECHNOL ASSES, V8, P1; Tekle B, 2002, INT J TUBERC LUNG D, V6, P573; Trajman A, 2010, INT J TUBERC LUNG D, V14, P551; van Cleeff MRA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-111; van Halsema CL, 2010, AIDS, V24, P1051, DOI 10.1097/QAD.0b013e32833849df; WB (2010) World Bank, 2010, GROSS NAT INC PER CA; Were W, 2009, INT J TUBERC LUNG D, V13, P47; Whalen CC, 1997, NEW ENGL J MED, V337, P801, DOI 10.1056/NEJM199709183371201; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2001, WHO COMM MACR HLTH M; *WHO, 2009, GLOB TUB CONTR SHORT; *WHO, 2008, WHO JOINT HIV TB DEP; WHO, 2007, GLOB TB DAT; World Health Organisation, 2003, MAK CHOIC HLTH WHO G; World Health Organisation, 2007, WHO CAS DEF HIV SURV; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC	86	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30457	10.1371/journal.pone.0030457	http://dx.doi.org/10.1371/journal.pone.0030457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	909NE	22291958	Green Submitted, Green Published, gold			2022-12-27	WOS:000301570600044
J	Rappl, G; Riet, T; Awerkiew, S; Schmidt, A; Hombach, AA; Pfister, H; Abken, H				Rappl, Gunter; Riet, Tobias; Awerkiew, Sabine; Schmidt, Annette; Hombach, Andreas A.; Pfister, Herbert; Abken, Hinrich			The CD3-Zeta Chimeric Antigen Receptor Overcomes TCR Hypo-Responsiveness of Human Terminal Late-Stage T Cells	PLOS ONE			English	Article							IMMUNOLOGICAL SYNAPSE; GENE-THERAPY; GALECTIN-3; LYMPHOCYTES; CANCER; ACTIVATION; TOLERANCE; EFFECTOR	Adoptive therapy of malignant diseases with tumor-specific cytotoxic T cells showed remarkable efficacy in recent trials. Repetitive T cell receptor (TCR) engagement of target antigen, however, inevitably ends up in hypo-responsive cells with terminally differentiated KLRG-1(+) CD57(+) CD7(-) phenotype limiting their therapeutic efficacy. We here revealed that hypo-responsiveness of CMV-specific late-stage CD8(+) T cells is due to reduced TCR synapse formation compared to younger cells. Membrane anchoring of TCR components contributes to T cell hypo-responsiveness since dislocation of galectin-3 from the synapse by swainsonine restored both TCR synapse formation and T cell response. Transgenic expression of a CD3-zeta signaling chimeric antigen receptor (CAR) recovered hypo-responsive T cells to full effector functions indicating that the defect is restricted to TCR membrane components while synapse formation of the transgenic CAR was not blocked. CAR engineered late-stage T cells released cytokines and mediated redirected cytotoxicity as efficiently as younger effector T cells. Our data provide a rationale for TCR independent, CAR mediated activation in the adoptive cell therapy to avoid hypo-responsiveness of late-stage T cells upon repetitive antigen encounter.	[Rappl, Gunter; Riet, Tobias; Hombach, Andreas A.; Abken, Hinrich] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; [Awerkiew, Sabine; Pfister, Herbert] Univ Cologne, Inst Virol, D-50931 Cologne, Germany; [Schmidt, Annette] Bundeswehr Inst Pharmacol & Toxicol, Munich, Germany; [Rappl, Gunter; Pfister, Herbert; Abken, Hinrich] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne	Rappl, G (corresponding author), Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany.	gunter.rappl@uni-koeln.de		Riet, Tobias/0000-0002-8211-7071; Hombach, Andreas/0000-0001-9328-8442	Deutsche Krebshilfe, Bonn; Faculty of Medicine, University of Cologne [45/2010]	Deutsche Krebshilfe, Bonn(Deutsche Krebshilfe); Faculty of Medicine, University of Cologne	The work in this manuscript was supported by a grant from the Deutsche Krebshilfe, Bonn, and by the Fortune Program of the Faculty of Medicine, University of Cologne (45/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold CR, 2011, J CLIN IMMUNOL, V31, P137, DOI 10.1007/s10875-010-9499-x; Attig S, 2009, CANCER RES, V69, P8412, DOI 10.1158/0008-5472.CAN-09-0852; Bartelt RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005430; Boding L, 2009, J IMMUNOL, V183, P4994, DOI 10.4049/jimmunol.0901539; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Bridgeman JS, 2010, J IMMUNOL, V184, P6938, DOI 10.4049/jimmunol.0901766; Buchholz VR, 2011, CURR OPIN IMMUNOL, V23, P549, DOI 10.1016/j.coi.2011.05.002; Chen HY, 2009, P NATL ACAD SCI USA, V106, P14496, DOI 10.1073/pnas.0903497106; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Demotte N, 2010, CANCER RES, V70, P7476, DOI 10.1158/0008-5472.CAN-10-0761; Dustin ML, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002311; Effros RB, 2011, EXP GERONTOL, V46, P135, DOI 10.1016/j.exger.2010.08.027; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Garber K, 2011, J NATL CANCER I, V103, P1079, DOI 10.1093/jnci/djr281; Grigorian A, 2010, METHOD ENZYMOL, V480, P245, DOI 10.1016/S0076-6879(10)80012-6; Hombach Andreas, 2003, Methods Mol Biol, V207, P365; Hsu DK, 2009, IMMUNOL REV, V230, P114, DOI 10.1111/j.1600-065X.2009.00798.x; Jorritsma A, 2011, CURR GENE THER, V11, P276, DOI 10.2174/156652311796150390; KAULEN H, 1993, YEAR IMMUN, V7, P106; Klebanoff CA, 2011, IMMUNOL REV, V239, P27, DOI 10.1111/j.1600-065X.2010.00979.x; Larbi A, 2011, AGEING RES REV, V10, P370, DOI 10.1016/j.arr.2010.09.008; Linnemann C, 2011, J INVEST DERMATOL, V131, P1806, DOI 10.1038/jid.2011.160; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Neeson P, 2010, GENE THER, V17, P1105, DOI 10.1038/gt.2010.59; Ohno-Iwashita Y, 2010, GERIATR GERONTOL INT, V10, pS41, DOI 10.1111/j.1447-0594.2010.00600.x; Park TS, 2011, TRENDS BIOTECHNOL, V29, P550, DOI 10.1016/j.tibtech.2011.04.009; Powell DJ, 2006, J IMMUNOL, V177, P6527, DOI 10.4049/jimmunol.177.9.6527; Ramos CA, 2011, EXPERT OPIN BIOL TH, V11, P855, DOI 10.1517/14712598.2011.573476; Rappl G, 2008, REJUV RES, V11, P543, DOI 10.1089/rej.2007.0612; Roszik J, 2011, EUR J IMMUNOL, V41, P1288, DOI 10.1002/eji.200940233; Simpson RJ, 2010, EXERC IMMUNOL REV, V16, P40; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; Turtle CJ, 2011, CURR OPIN IMMUNOL, V23, P299, DOI 10.1016/j.coi.2010.12.012; Vazquez-Cintron EJ, 2010, J IMMUNOL, V185, P7133, DOI 10.4049/jimmunol.1001157; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x	36	9	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30713	10.1371/journal.pone.0030713	http://dx.doi.org/10.1371/journal.pone.0030713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292024	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600073
J	Wang, CW; Lee, JH; Kim, CH				Wang, Chuanwu; Lee, Jee H.; Kim, Chang H.			Optimal Population of FoxP3(+) T Cells in Tumors Requires an Antigen Priming-Dependent Trafficking Receptor Switch	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; FOSTERS IMMUNE PRIVILEGE; TGF-BETA; REGULATORY-CELLS; HODGKIN-LYMPHOMA; GASTRIC-CANCER; MURINE MODEL; IN-VIVO; DIFFERENTIATION; CONVERSION	FoxP3(+) T cells populate tumors and regulate anti-tumor immunity. The requirement for optimal population of FoxP3(+) regulatory T cells in tumors remains unclear. We investigated the migration requirement and stability of tumor-associated FoxP3(+) T cells. We found that only memory, but not naive, FoxP3(+) T cells are highly enriched in tumors. Almost all of the tumor-infiltrating FoxP3(+) T cells express Helios, an antigen associated either with thymus-generated FoxP3(+) T cells or activated T cells in the periphery. The tumor-infiltrating FoxP3(+) T cells largely lack CD62L and CCR7, two trafficking receptors required for T cell migration into secondary lymphoid tissues. Instead, the tumor infiltrating FoxP3(+) T cells highly express memory/tumor-associated CCR8 and CXCR4. Antigen priming is required for induction of this trafficking receptor phenotype in FoxP3(+) T cells and only antigen primed, but not antigen-inexperienced naive, FoxP3(+) T cells can efficiently migrate into tumors. While the migration of FoxP3(+) T cells into tumors was a readily detectable event, generation of induced FoxP3(+) T cells within tumors was unexpectedly inefficient. Genetic marking of current and ex-FoxP3(+) T cells revealed that tumor-infiltrating FoxP3(+) T cells are highly stable and do not readily convert back to FoxP3(-) T cells. Taken together, our results indicate that population of tumors with thymus-generated FoxP3(+) T cells requires an antigen priming-dependent trafficking receptor switch in lymphoid tissues.	[Wang, Chuanwu; Lee, Jee H.; Kim, Chang H.] Purdue Univ, Lab Immunol & Hematopoiesis, Dept Comparat Pathobiol, Purdue Canc Ctr,Bindley Biosci Ctr, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Wang, CW (corresponding author), Purdue Univ, Lab Immunol & Hematopoiesis, Dept Comparat Pathobiol, Purdue Canc Ctr,Bindley Biosci Ctr, W Lafayette, IN 47907 USA.	chkim@purdue.edu	Wang, Chuanwu/N-3186-2013; Wang, Chuanwu/E-9117-2012; Kim, Chang/ABG-8200-2020	Kim, Chang/0000-0003-4618-9139	NIH [R01AI074745, R01DK076616, R01AI080769, 1S10RR028293]; DOD [W81XWH-07-1-0555]; Sidney Kimmel Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080769, R01AI074745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076616] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Sidney Kimmel Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been supported by the grants from NIH (R01AI074745, R01DK076616, R01AI080769, and 1S10RR028293), DOD (W81XWH-07-1-0555), and Sidney Kimmel Foundation to CH Kim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; AWWAD M, 1988, J EXP MED, V168, P2193, DOI 10.1084/jem.168.6.2193; Badoual C, 2006, CLIN CANCER RES, V12, P465, DOI 10.1158/1078-0432.CCR-05-1886; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Baumgartner J, 2007, J SURG RES, V141, P72, DOI 10.1016/j.jss.2007.03.053; Ben-Shoshan J, 2008, EUR J IMMUNOL, V38, P2412, DOI 10.1002/eji.200838318; Betts G, 2007, BRIT J CANCER, V96, P1849, DOI 10.1038/sj.bjc.6603824; Campbell DJ, 2007, NAT REV IMMUNOL, V7, P305, DOI 10.1038/nri2061; Carreras J, 2006, BLOOD, V108, P2957, DOI 10.1182/blood-2006-04-018218; Casares N, 2003, J IMMUNOL, V171, P5931, DOI 10.4049/jimmunol.171.11.5931; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Elkord E, 2011, CLIN IMMUNOL, V140, P218, DOI 10.1016/j.clim.2011.04.014; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Ishida T, 2006, CANCER RES, V66, P5716, DOI 10.1158/0008-5472.CAN-06-0261; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Kim CH, 2006, EXP HEMATOL, V34, P1033, DOI 10.1016/j.exphem.2006.03.014; Kim Chang H, 2005, Curr Opin Hematol, V12, P298, DOI 10.1097/01.moh.0000166496.18773.e3; Kim CH, 2009, ADV EXP MED BIOL, V665, P17; Lee J, 2006, J IMMUNOL PENDING; Lee JH, 2007, J IMMUNOL, V178, P301, DOI 10.4049/jimmunol.178.1.301; Lee JH, 2011, J IMMUNOL, V187, P1778, DOI 10.4049/jimmunol.1003919; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Lutsiak MEC, 2008, J IMMUNOL, V180, P5871, DOI 10.4049/jimmunol.180.9.5871; Mailloux AW, 2009, J IMMUNOL, V182, P2753, DOI 10.4049/jimmunol.0801124; Mittal S, 2008, BLOOD, V111, P5359, DOI 10.1182/blood-2007-08-105395; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Mizukami Y, 2008, BRIT J CANCER, V98, P148, DOI 10.1038/sj.bjc.6604149; Mizukami Y, 2008, INT J CANCER, V122, P2286, DOI 10.1002/ijc.23392; Moo-Young TA, 2009, J IMMUNOTHER, V32, P12, DOI 10.1097/CJI.0b013e318189f13c; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; NORTH RJ, 1984, J EXP MED, V159, P1295, DOI 10.1084/jem.159.5.1295; NORTH RJ, 1982, J EXP MED, V155, P1063, DOI 10.1084/jem.155.4.1063; Onizuka S, 1999, CANCER RES, V59, P3128; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shimizu J, 1999, J IMMUNOL, V163, P5211; Siddiqui SA, 2007, CLIN CANCER RES, V13, P2075, DOI 10.1158/1078-0432.CCR-06-2139; Stephens GL, 2007, IMMUNITY, V27, P417, DOI 10.1016/j.immuni.2007.08.008; Tan MCB, 2009, J IMMUNOL, V182, P1746, DOI 10.4049/jimmunol.182.3.1746; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Valzasina B, 2006, CANCER RES, V66, P4488, DOI 10.1158/0008-5472.CAN-05-4217; Wald O, 2006, J IMMUNOL, V177, P6983, DOI 10.4049/jimmunol.177.10.6983; Wang C, 2009, MUCOSAL IMMUNOL, V2, P173, DOI 10.1038/mi.2008.84; Wang CW, 2010, J IMMUNOL, V184, P5519, DOI 10.4049/jimmunol.0903942; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Xu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020282; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	59	26	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30793	10.1371/journal.pone.0030793	http://dx.doi.org/10.1371/journal.pone.0030793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292042	gold, Green Published, Green Submitted			2022-12-27	WOS:000301570600080
J	Leal, MC; Puga, J; Serodio, J; Gomes, NCM; Calado, R				Leal, Miguel Costa; Puga, Joao; Serodio, Joao; Gomes, Newton C. M.; Calado, Ricardo			Trends in the Discovery of New Marine Natural Products from Invertebrates over the Last Two Decades - Where and What Are We Bioprospecting?	PLOS ONE			English	Article							BIODIVERSITY HOTSPOTS; COMMUNITY; SPONGES; DEEP; DRUGS	It is acknowledged that marine invertebrates produce bioactive natural products that may be useful for developing new drugs. By exploring untapped geographical sources and/or novel groups of organisms one can maximize the search for new marine drugs to treat human diseases. The goal of this paper is to analyse the trends associated with the discovery of new marine natural products from invertebrates (NMNPI) over the last two decades. The analysis considers different taxonomical levels and geographical approaches of bioprospected species. Additionally, this research is also directed to provide new insights into less bioprospected taxa and world regions. In order to gather the information available on NMNPI, the yearly-published reviews of Marine Natural Products covering 1990-2009 were surveyed. Information on source organisms, specifically taxonomical information and collection sites, was assembled together with additional geographical information collected from the articles originally describing the new natural product. Almost 10000 NMNPI were discovered since 1990, with a pronounced increase between decades. Porifera and Cnidaria were the two dominant sources of NMNPI worldwide. The exception was polar regions where Echinodermata dominated. The majority of species that yielded the new natural products belong to only one class of each Porifera and Cnidaria phyla (Demospongiae and Anthozoa, respectively). Increased bioprospecting efforts were observed in the Pacific Ocean, particularly in Asian countries that are associated with the Japan Biodiversity Hotspot and the Kuroshio Current. Although results show comparably less NMNPI from polar regions, the number of new natural products per species is similar to that recorded for other regions. The present study provides information to future bioprospecting efforts addressing previously unexplored taxonomic groups and/or regions. We also highlight how marine invertebrates, which in some cases have no commercial value, may become highly valuable in the ongoing search for new drugs from the sea.	[Leal, Miguel Costa; Serodio, Joao; Gomes, Newton C. M.; Calado, Ricardo] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Leal, Miguel Costa; Serodio, Joao; Gomes, Newton C. M.; Calado, Ricardo] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Leal, Miguel Costa] Skidaway Inst Oceanog, Savannah, GA USA; [Puga, Joao] Bio3 Estudos & Projectos Biol & Valorizacao Recu, Ida, Almada, Portugal	Universidade de Aveiro; Universidade de Aveiro; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography	Leal, MC (corresponding author), Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.	miguecleal@ua.pt; rjcalado@hotmail.com	Gomes, Newton Carlos Marcial/K-3211-2015; Gomes, Newton CM/F-7430-2012; Puga, João/A-6694-2017; Gomes, Newton Carlos Marcial/AAV-4603-2021; Calado, Ricardo Jorge Guerra/C-7035-2008; Puga, João/U-9086-2018; Leal, Miguel Costa/C-8611-2009; Jansen, Nils/G-1835-2011; Serôdio, João/B-8201-2008	Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Gomes, Newton CM/0000-0003-1934-0091; Puga, João/0000-0003-3156-9948; Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Calado, Ricardo Jorge Guerra/0000-0002-1670-9335; Puga, João/0000-0003-3156-9948; Leal, Miguel Costa/0000-0003-0672-6251; Serôdio, João/0000-0002-9047-1740	FCT [SFRH/BD/63783/2009]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This research was not funded by any agency or project. Only Miguel C. Leal was supported by a grant from FCT(SFRH/BD/63783/2009). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appeltans W, 2011, WORLD REGISTER MARIN; Ausubel J.H., 2010, 1 CENSUS MARINE LIFE; Avila C, 2008, MAR ECOL-EVOL PERSP, V29, P1, DOI 10.1111/j.1439-0485.2007.00215.x; BAKUS G J, 1974, Biotropica, V6, P229, DOI 10.2307/2989667; BERGMANN W, 1955, J ORG CHEM, V20, P1501, DOI 10.1021/jo01128a007; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blunt JW, 2008, NAT PROD REP, V25, P35, DOI 10.1039/b701534h; Blunt JW, 2007, NAT PROD REP, V24, P31, DOI 10.1039/b603047p; Blunt JW, 2011, NAT PROD REP, V28, P196, DOI 10.1039/c005001f; Blunt JW, 2010, NAT PROD REP, V27, P165, DOI 10.1039/b906091j; Blunt JW, 2009, NAT PROD REP, V26, P170, DOI 10.1039/b805113p; Blunt JW, 2003, NAT PROD REP, V20, P1, DOI 10.1039/b207130b; Blunt JW, 2004, NAT PROD REP, V21, P1, DOI 10.1039/b305250h; Blunt JW, 2005, NAT PROD REP, V22, P15, DOI 10.1039/b415080p; Blunt JW, 2006, NAT PROD REP, V23, P26, DOI 10.1039/b502792f; Blunt JW, 2008, DICT MARINE NATURAL, P2108; Brandt A, 2004, DEEP-SEA RES PT II, V51, P1457, DOI 10.1016/j.dsr2.2004.08.006; Cavanagh R.D., 2007, OVERVIEW CONSERVATIO; Chin YW, 2006, AAPS J, V8, pE239, DOI 10.1007/BF02854894; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Davidson SK, 1999, BIOL BULL, V196, P273, DOI 10.2307/1542952; DAYTON PK, 1974, ECOL MONOGR, V44, P105, DOI 10.2307/1942321; Duckworth A, 2009, MAR BIOTECHNOL, V11, P669, DOI 10.1007/s10126-009-9213-2; Duh CY, 1998, TETRAHEDRON LETT, V39, P7121, DOI 10.1016/S0040-4039(98)01512-3; Faulkner DJ, 2000, ANTON LEEUW INT J G, V77, P135, DOI 10.1023/A:1002405815493; Faulkner DJ, 2000, NAT PROD REP, V17, P7, DOI 10.1039/a809395d; Faulkner DJ, 2001, NAT PROD REP, V18, P1, DOI 10.1039/b006897g; Faulkner DJ, 1997, NAT PROD REP, V14, P259, DOI 10.1039/np9971400259; FAULKNER DJ, 1995, NAT PROD REP, V12, P223, DOI 10.1039/np9951200223; FAULKNER DJ, 1994, NAT PROD REP, V11, P355, DOI 10.1039/np9941100355; FAULKNER DJ, 1977, TETRAHEDRON, V33, P1421, DOI 10.1016/0040-4020(77)88001-0; FAULKNER DJ, 1992, NAT PROD REP, V9, P323, DOI 10.1039/np9920900323; Faulkner DJ, 1996, NAT PROD REP, V13, P75, DOI 10.1039/np9961300075; FAULKNER DJ, 1993, NAT PROD REP, V10, P497, DOI 10.1039/np9931000497; Faulkner DJ, 1998, NAT PROD REP, V15, P113; Faulkner DJ, 1999, NAT PROD REP, V16, P155; Faulkner DJ, 2002, NAT PROD REP, V19, P1, DOI 10.1039/b009029h; Gianni M, 2004, HIGH SEAS BOTTOM TRA, P88; Haefner B, 2003, DRUG DISCOV TODAY, V8, P536, DOI 10.1016/S1359-6446(03)02713-2; Harvey A, 2000, DRUG DISCOV TODAY, V5, P294, DOI 10.1016/S1359-6446(00)01511-7; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Hay ME., 1996, OCEANOGRAPHY, V9, P10, DOI [10.5670/oceanog.1996.21, DOI 10.5670/OCEANOG.1996.21]; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hooper J, 2007, UN INFORMAL CONSULTA; Ianora A, 2006, ESTUAR COAST, V29, P531, DOI 10.1007/BF02784281; Laport MS, 2009, CURR PHARM BIOTECHNO, V10, P86, DOI 10.2174/138920109787048625; Lin YS, 2009, TETRAHEDRON, V65, P9157, DOI 10.1016/j.tet.2009.09.031; Marris E, 2006, NATURE, V443, P904, DOI 10.1038/443904a; McFadden CS, 2010, INTEGR COMP BIOL, V50, P389, DOI 10.1093/icb/icq056; McGinn AP, 1999, SAFEGUARDING HLTH OC; McGovern TM, 2003, MOL ECOL, V12, P1207, DOI 10.1046/j.1365-294X.2003.01758.x; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; Munro MHG, 1999, J BIOTECHNOL, V70, P15, DOI 10.1016/S0168-1656(99)00052-8; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Paul VJ, 2008, NAT PROD REP, V25, P662, DOI 10.1039/b702742g; Paul VJ, 2011, NAT PROD REP, V28, P345, DOI 10.1039/c0np00040j; Paul VJ, 2004, NAT PROD REP, V21, P189, DOI 10.1039/b302334f; Ramesh P, 1999, J NAT PROD, V62, P1019, DOI 10.1021/np980449u; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Sala E, 2006, ANNU REV ENV RESOUR, V31, P93, DOI 10.1146/annurev.energy.31.020105.100235; Sherman K, 2005, MAR ECOL PROG SER, V300, P275; Skropeta D, 2008, NAT PROD REP, V25, P1131, DOI 10.1039/b808743a; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Spranger T, 2005, J INT BIOTECHNOLOGY, V2, P155; Su JH, 2009, CHEM PHARM BULL, V57, P1189, DOI 10.1248/cpb.57.1189; Tan G, 2006, CURR DRUG TARGETS, V7, P265, DOI 10.2174/138945006776054942; Wen T, 2008, J NAT PROD, V71, P1133, DOI 10.1021/np070640g; Wliffels RH, 2008, TRENDS BIOTECHNOL, V26, P26, DOI 10.1016/j.tibtech.2007.10.002; Yu SJ, 2006, STEROIDS, V71, P955, DOI 10.1016/j.steroids.2006.07.002	69	183	190	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30580	10.1371/journal.pone.0030580	http://dx.doi.org/10.1371/journal.pone.0030580			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276216	gold, Green Published			2022-12-27	WOS:000301568100058
J	Lv, HN; Ren, JH; Ma, SG; Xu, S; Qu, J; Liu, ZJ; Zhou, Q; Chen, XG; Yu, SS				Lv, Haining; Ren, Jinhong; Ma, Shuanggang; Xu, Song; Qu, Jing; Liu, Zhenjia; Zhou, Qing; Chen, Xiaoguang; Yu, Shishan			Synthesis, Biological Evaluation and Mechanism Studies of Deoxytylophorinine and Its Derivatives as Potential Anticancer Agents	PLOS ONE			English	Article							PHENANTHROINDOLIZIDINE ALKALOIDS PERGULARININE; NF-KAPPA-B; CELL-GROWTH; CYNANCHUM-VINCETOXICUM; THYMIDYLATE SYNTHASE; TYLOPHORA ALKALOIDS; CYTOTOXIC ACTIVITY; PROTEIN-SYNTHESIS; INHIBITION; PHENANTHRENE	Previous studies indicated that (+)-13a-(S)-Deoxytylophorinine (1) showed profound anti-cancer activities both in vitro and in vivo and could penetrate the blood brain barrier to distribute well in brain tissues. CNS toxicity, one of the main factors to hinder the development of phenanthroindolizidines, was not obviously found in 1. Based on its fascinating activities, thirty-four derivatives were designed, synthesized; their cytotoxic activities in vitro were tested to discover more excellent anticancer agents. Considering the distinctive mechanism of 1 and interesting SAR of deoxytylophorinine and its derivatives, the specific impacts of these compounds on cellular progress as cell signaling transduction pathways and cell cycle were proceeded with seven representative compounds. 1 as well as three most potent compounds, 9, 32, 33, and three less active compounds, 12, 16, 35, were selected to proform this study to have a relatively deep view of cancer cell growth-inhibitory characteristics. It was found that the expressions of phospho-Akt, Akt, phospho-ERK, and ERK in A549 cells were greater down-regulated by the potent compounds than by the less active compounds in the Western blot analysis. To the best of our knowledge, this is the first report describing phenanthroindolizidines alkaloids display influence on the crucial cell signaling proteins, ERK. Moreover, the expressions of cyclin A, cyclin D1 and CDK2 proteins depressed more dramatically when the cells were treated with 1, 9, 32, and 33. Then, these four excellent compounds were subjected to flow cytometric analysis, and an increase in S-phase was observed in A549 cells. Since the molecular level assay results of Western blot for phospho-Akt, Akt, phospho-ERK, ERK, and cyclins were relevant to the potency of compounds in cellular level, we speculated that this series of compounds exhibit anticancer activities through blocking PI3K and MAPK signaling transduction pathways and interfering with the cell cycle progression.	[Lv, Haining] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Lv, HN (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China.	chxg@imm.ac.cn; yushishan@imm.ac.cn	Ma, Shuang-Gang/AAY-5970-2020		National Natural Science Foundation of China [90713039, 21132009]; National Science and Technology Project of China [2009ZX09311-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Project of China	This work was financed by National Natural Science Foundation of China (Grant No. 90713039 and No. 21132009) and National Science and Technology Project of China (Grant No. 2009ZX09311-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An TY, 2001, PHYTOCHEMISTRY, V58, P1267, DOI 10.1016/S0031-9422(01)00382-X; BAUMGARTNER B, 1990, PHYTOCHEMISTRY, V29, P3327, DOI 10.1016/0031-9422(90)80209-Y; BREMMER ML, 1983, J ORG CHEM, V48, P3661, DOI 10.1021/jo00169a009; BUCKLEY TF, 1983, J ORG CHEM, V48, P4222, DOI 10.1021/jo00171a014; CAPO M, 1989, J NAT PROD, V52, P389, DOI 10.1021/np50062a030; Chuang TH, 2006, ORG BIOMOL CHEM, V4, P860, DOI 10.1039/b516152e; DOLZ H, 1982, BIOCHEMISTRY-US, V21, P3181; DONALDSO.GR, 1968, BIOCHEM BIOPH RES CO, V31, P104, DOI 10.1016/0006-291X(68)90037-5; FABER L, 1973, HELV CHIM ACTA, V56, P2882, DOI 10.1002/hlca.19730560824; Ganguly T, 2002, PHYTOMEDICINE, V9, P288, DOI 10.1078/0944-7113-00146; Gao W, 2008, BIOORG MED CHEM LETT, V18, P704, DOI 10.1016/j.bmcl.2007.11.054; Gao WL, 2007, BIOORG MED CHEM LETT, V17, P4338, DOI 10.1016/j.bmcl.2007.05.021; Gao WL, 2004, CANCER RES, V64, P678, DOI 10.1158/0008-5472.CAN-03-1904; GOVINDACHARI TR, 1978, HETEROCYCLES, V11, P587; GRANT P, 1974, J BACTERIOL, V120, P1308, DOI 10.1128/JB.120.3.1308-1314.1974; GUPTA RS, 1980, MOL PHARMACOL, V18, P136; GUPTA RS, 1977, BIOCHEMISTRY-US, V16, P3209, DOI 10.1021/bi00633a026; HUANG MT, 1972, MOL PHARMACOL, V8, P538; Huang XS, 2004, PLANTA MED, V70, P441, DOI 10.1055/s-2004-818973; Ikeda T, 2011, BIOORG MED CHEM LETT, V21, P342, DOI 10.1016/j.bmcl.2010.11.008; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Komatsu H, 2001, J MED CHEM, V44, P1833, DOI 10.1021/jm0004042; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee ER, 2006, BBA-MOL CELL RES, V1763, P958, DOI 10.1016/j.bbamcr.2006.06.006; Lee SK, 2003, PLANTA MED, V69, P21, DOI 10.1055/s-2003-37021; Li H, 2006, LETT ORG CHEM, V3, P806, DOI 10.2174/157017806779117067; Lin JC, 2009, J MED CHEM, V52, P1903, DOI 10.1021/jm801344j; Liu ZJ, 2011, J ASIAN NAT PROD RES, V13, P400, DOI 10.1080/10286020.2011.566868; Liu ZJ, 2011, CHEMOTHERAPY, V57, P310, DOI 10.1159/000329506; Min HY, 2010, CHEM BIODIVERS, V7, P409, DOI 10.1002/cbdv.200900040; MULCHANDANI N B, 1971, Chemistry and Industry, V19, P505; MULCHANDANI NB, 1976, PHYTOCHEMISTRY, V15, P1561, DOI 10.1016/S0031-9422(00)88937-2; MULCHANDANI NB, 1984, PHYTOCHEMISTRY, V23, P1206, DOI 10.1016/S0031-9422(00)82650-3; Persons DL, 1999, CLIN CANCER RES, V5, P1007; Rao KN, 1997, CHEM-BIOL INTERACT, V106, P201, DOI 10.1016/S0009-2797(97)00065-3; Rao KN, 2000, TOXICOL IN VITRO, V14, P53, DOI 10.1016/S0887-2333(99)00092-2; Rao KN, 1998, CANCER LETT, V128, P183, DOI 10.1016/S0304-3835(98)00061-5; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Shih YW, 2007, J AGR FOOD CHEM, V55, P11035, DOI 10.1021/jf072423r; Staerk D, 2002, J NAT PROD, V65, P1299, DOI 10.1021/np0106384; Su CR, 2008, BIOORGAN MED CHEM, V16, P6233, DOI 10.1016/j.bmc.2008.04.032; Suffness M., 1980, ANTICANCER AGENTS BA, P465; Takashi I, 2010, Patent, Patent No. [WO2010047126, 2010047126]; TANNER U, 1993, ARCH PHARM, V326, P67, DOI 10.1002/ardp.19933260203; Wang KL, 2008, TETRAHEDRON, V64, P7504, DOI 10.1016/j.tet.2008.06.003; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wang ZW, 2011, SYNTHESIS-STUTTGART, P979, DOI 10.1055/s-0030-1259487; Wang ZW, 2010, EUR J ORG CHEM, V2010, P292, DOI 10.1002/ejoc.200900920; Yang CW, 2007, BIOCHEM BIOPH RES CO, V354, P942, DOI 10.1016/j.bbrc.2007.01.065; Yang CW, 2006, MOL PHARMACOL, V69, P749, DOI 10.1124/mol.105.017764; Yang XM, 2009, J MED CHEM, V52, P5262, DOI 10.1021/jm9009263; Zhao S, 1999, BIOORGAN MED CHEM, V7, P1637, DOI 10.1016/S0968-0896(99)00078-4	52	32	35	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30342	10.1371/journal.pone.0030342	http://dx.doi.org/10.1371/journal.pone.0030342			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276180	Green Submitted, Green Published, gold			2022-12-27	WOS:000301457200054
J	Rodger, EJ; Suetani, RJ; Jones, GT; Kleffmann, T; Carne, A; Legge, M; McCormick, SPA				Rodger, Euan J.; Suetani, Rachel J.; Jones, Gregory T.; Kleffmann, Torsten; Carne, Alan; Legge, Michael; McCormick, Sally P. A.			Proteomic Analysis of Aortae from Human Lipoprotein(a) Transgenic Mice Shows an Early Metabolic Response Independent of Atherosclerosis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; EXPRESSING HUMAN APOLIPOPROTEIN(A); LOW-DENSITY-LIPOPROTEIN; OXIDIZED PHOSPHOLIPIDS; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; PROXIMAL AORTA; HYPERCHOLESTEROLEMIA; DEFICIENT; ATHEROGENESIS	Background: Elevated low density lipoprotein (LDL) and lipoprotein(a) are independent risk factors for the development of atherosclerosis. Using a proteomic approach we aimed to determine early changes in arterial protein expression in transgenic mice containing both human LDL and lipoprotein(a) in circulation. Methods and Results: Plasma lipid analyses showed the lipoprotein(a) transgenic mice had significantly higher lipid levels than wildtype, including a much increased LDL and high density lipoprotein (HDL) cholesterol. Analysis of aortae from lipoprotein(a) mice showed lipoprotein(a) accumulation but no lipid accumulation or foam cells, leaving the arteries essentially atherosclerosis free. Using two-dimensional gel electrophoresis and mass spectrometry, we identified 34 arterial proteins with significantly altered abundance (P<0.05) in lipoprotein(a) transgenic mice compared to wildtype including 17 that showed a >= 2 fold difference. Some proteins of interest showed a similarly altered abundance at the transcript level. These changes collectively indicated an initial metabolic response that included a down regulation in energy, redox and lipid metabolism proteins and changes in structural proteins at a stage when atherosclerosis had not yet developed. Conclusions: Our study shows that human LDL and lipoprotein(a) promote changes in the expression of a unique set of arterial proteins which may be early indicators of the metabolic disturbances preceding atherosclerosis.	[Rodger, Euan J.; Suetani, Rachel J.; Carne, Alan; Legge, Michael; McCormick, Sally P. A.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Jones, Gregory T.] Univ Otago, Dept Surg Sci, Dunedin, New Zealand; [Kleffmann, Torsten] Univ Otago, Ctr Prot Res, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Rodger, EJ (corresponding author), Univ Otago, Dept Biochem, Dunedin, New Zealand.	sally.mccormick@otago.ac.nz	Carne, Alan/R-6260-2019	Carne, Alan/0000-0003-3665-1940; Kleffmann, Torsten/0000-0001-9305-5980; Jones, Gregory T/0000-0002-6950-4210; McCormick, Sally/0000-0001-9857-0703	Marsden Fund of New Zealand [UOO 010]; National Heart Foundation [1105]	Marsden Fund of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); National Heart Foundation(National Heart Foundation of Australia)	This work was funded by a grant from the Marsden Fund of New Zealand (Grant No. UOO 010, http://www.royalsociety.org.nz/programmes/funds/marsden). EJR was funded by a National Heart Foundation PhD scholarship (Grant No. 1105, http://www.heartfoundation.org.nz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bartels ED, 2002, DIABETES, V51, P1233, DOI 10.2337/diabetes.51.4.1233; Bennet A, 2008, ARCH INTERN MED, V168, P598, DOI 10.1001/archinte.168.6.598; Berg K, 2002, ATHEROSCLEROSIS, V163, P99, DOI 10.1016/S0021-9150(01)00772-9; CALLOW MJ, 1994, P NATL ACAD SCI USA, V91, P2130, DOI 10.1073/pnas.91.6.2130; CALLOW MJ, 1995, J CLIN INVEST, V96, P1639, DOI 10.1172/JCI118203; CHIESA G, 1992, J BIOL CHEM, V267, P24369; Collins AR, 2009, CIRC RES, V104, pe42, DOI 10.1161/CIRCRESAHA.108.188771; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Danik JS, 2006, JAMA-J AM MED ASSOC, V296, P1363, DOI 10.1001/jama.296.11.1363; Feil S, 2004, CIRC RES, V94, P863, DOI 10.1161/01.RES.0000126417.38728.F6; Forstermann U, 2008, NAT CLIN PRACT CARD, V5, P338, DOI 10.1038/ncpcardio1211; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Julka S, 2004, J PROTEOME RES, V3, P350, DOI 10.1021/pr0340734; Kamstrup PR, 2008, CIRCULATION, V117, P176, DOI 10.1161/CIRCULATIONAHA.107.715698; LAWN RM, 1992, NATURE, V360, P670, DOI 10.1038/360670a0; LINTON MF, 1993, J CLIN INVEST, V92, P3029, DOI 10.1172/JCI116927; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; MANCINI FP, 1995, ARTERIOSCL THROM VAS, V15, P1911, DOI 10.1161/01.ATV.15.11.1911; MARCOVINA SM, 1995, CLIN CHEM, V41, P246; Mayr M, 2005, ARTERIOSCL THROM VAS, V25, P2135, DOI 10.1161/01.ATV.0000183928.25844.f6; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; PEDERSEN TR, 1994, LANCET, V344, P1383; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schneider M, 2005, J LIPID RES, V46, P769, DOI 10.1194/jlr.M400467-JLR200; Shen JB, 2010, CIRC RES, V106, P1351, DOI 10.1161/CIRCRESAHA.109.213900; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Tsimikas S, 2008, CURR OPIN LIPIDOL, V19, P369, DOI 10.1097/MOL.0b013e328308b622; Tsimikas S, 2006, J AM COLL CARDIOL, V47, P2219, DOI 10.1016/j.jacc.2006.03.001; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631; Williamson K. S., 2003, METHODS PHARM TOXICO; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	37	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30383	10.1371/journal.pone.0030383	http://dx.doi.org/10.1371/journal.pone.0030383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276189	gold, Green Submitted, Green Published			2022-12-27	WOS:000301457200057
J	Gottfries, J; Melgar, S; Michaelsson, E				Gottfries, Johan; Melgar, Silvia; Michaelsson, Erik			Modelling of Mouse Experimental Colitis by Global Property Screens: A Holistic Approach to Assess Drug Effects in Inflammatory Bowel Disease	PLOS ONE			English	Article							GAMMA; MICE	Preclinical disease models play an important role in the establishment of new treatment paradigms, identification of biomarkers and assessment of drug efficacy and safety. However, the accuracy of these models in context of the human disease are sometimes questioned, e. g. due to trials failing to confirm efficacy in humans. We suggest that one reason behind this gap in predictability may relate to how the preclinical data is analyzed and interpreted. In the present paper, we introduce a holistic approach to analyze and illustrate data in context of one of the most commonly used colitis models, i.e. the mouse dextran sulphate sodium (DSS) colitis model. Diseased mice were followed over time along disease progression and by use of tool pharmacological compounds activating nuclear hormone receptors, respectively. A new multivariate statistics approach was applied including principal component analysis (PCA) with treatment prediction subsequent to establishing the principal component analysis model. Thus, several studies could be overlaid and compared to each other in a new, comprehensive and holistic way. This method, named mouse colitis global property screening, appears applicable not only to any animal modelling series of studies but also to human clinical studies. The prerequisites for the study set up and calculations are delineated and examples of new learnings from the global property screening will be presented.	[Gottfries, Johan] Univ Gothenburg, Dept Chem, Gothenburg, Sweden; [Melgar, Silvia] Natl Univ Ireland, Alimentary Pharmabiot Ctr, Univ Coll Cork, Cork, Ireland; [Michaelsson, Erik] AstraZeneca R&D, Dept Biosci Cardiovasc & Gastrointestinal IMED, Molndal, Sweden	University of Gothenburg; University College Cork; AstraZeneca	Gottfries, J (corresponding author), Univ Gothenburg, Dept Chem, Gothenburg, Sweden.	erik.michaelsson@astrazeneca.com	Gottfries, Johan/M-3445-2016; Melgar, Silvia/I-4191-2019	Gottfries, Johan/0000-0001-7135-4664; Melgar, Silvia/0000-0001-7463-3343; Michaelsson, Erik/0000-0001-8643-2821	AstraZeneca R&D, Molndal, Sweden	AstraZeneca R&D, Molndal, Sweden(AstraZeneca)	The study was funded by and performed at AstraZeneca R&D, Molndal, Sweden. The study design, generation of data, analysis of data, decision to publish as well as preparation of the manuscript were performed by the authors, of which E. M. is employed by AstraZeneca R&D.	Byrne FR, 2006, CURR OPIN DRUG DISC, V9, P207; Calciano MA, 2010, ALZHEIMERS DEMENT, V6, P386, DOI 10.1016/j.jalz.2009.12.004; Chalmers I, 2006, J ROY SOC MED, V99, P337, DOI 10.1258/jrsm.99.7.337; GOTTFRIES CG, 2009, B IACFS ME, V17, P168; Gottfries J, 2004, CHEMOMETR INTELL LAB, V73, P47, DOI 10.1016/j.chemolab.2003.11.011; Gottfries J, 2001, J GERIATR PSYCH NEUR, V14, P109, DOI 10.1177/089198870101400302; JACKSON EJ, USERS GUIDE PRINCIPA; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Koboziev I, 2011, INFLAMM BOWEL DIS, V17, P1229, DOI 10.1002/ibd.21557; Larsson AE, 2006, INFLAMM BOWEL DIS, V12, P478, DOI 10.1097/00054725-200606000-00006; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; MODIGLIANI R, 1990, GASTROENTEROLOGY, V98, P811, DOI 10.1016/0016-5085(90)90002-I; Navarro V, 2006, J PHYSIOL BIOCHEM, V62, P137, DOI 10.1007/BF03174074; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Oprea TI, 2001, J COMB CHEM, V3, P157, DOI 10.1021/cc0000388; Roth-Cline MD, 2006, CIRCULATION, V113, P2253, DOI 10.1161/CIRCULATIONAHA.105.604512; Saccenti E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020747; Tanaka T, 2001, CANCER RES, V61, P2424; van der Greef Jan, 2006, Drug Discov Today Technol, V3, P205, DOI 10.1016/j.ddtec.2006.05.003; Vanhoutte K, 2009, BIOINFORMATION, V3, P275, DOI 10.6026/97320630003275; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639	21	6	6	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30005	10.1371/journal.pone.0030005	http://dx.doi.org/10.1371/journal.pone.0030005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279558	gold, Green Submitted, Green Published			2022-12-27	WOS:000299771900036
J	Lewis-Evans, B; de Waard, D; Jolij, J; Brookhuis, KA				Lewis-Evans, Ben; de Waard, Dick; Jolij, Jacob; Brookhuis, Karel A.			What You May Not See Might Slow You Down Anyway: Masked Images and Driving	PLOS ONE			English	Article							EMOTIONAL RESPONSE; GENDER-DIFFERENCES; DRIVER BEHAVIOR; FEAR-RELEVANT; RISK; STIMULI; AMYGDALA; INFORMATION; EXPLICIT; AROUSAL	Many theories of driver behaviour suggest that unconscious or implicit emotions play a functional role in the shaping and control of behaviour. This has not been experimentally tested however. Therefore, in this study the effects of emotive masked images on driver behaviour were examined. While driving a simulator, participants were repeatedly exposed to negative or neutral emotionally laden target images that were sandwich masked by emotionally neutral images. These images were encountered across two different trials each of which consisted of 3-4 minutes of driving on a rural road. The results indicate an effect of the negative target images primarily in reducing the extent of familiarisation occurring between the first and second experimental drives. This is evident in a reduced decrease in heart rate and a reduced increase in high band heart rate variability and actual travelling speed from the first to second drives if the negative target image was presented in the second drive. In addition to these findings there was no clear effect of the target image on subjective ratings of effort or feelings of risk. There was however an effect of gender, with the majority of the effects found in the study being limited to the larger female dataset. These findings suggest that unconscious or implicit emotional stimuli may well influence driver behaviour without explicit awareness.	[Lewis-Evans, Ben; de Waard, Dick; Brookhuis, Karel A.] Univ Groningen, Traff & Environm Psychol Grp, Groningen, Netherlands; [Jolij, Jacob] Univ Groningen, Vis & Cognit Grp, Groningen, Netherlands; [Brookhuis, Karel A.] Delft Univ Technol, Delft, Netherlands	University of Groningen; University of Groningen; Delft University of Technology	Lewis-Evans, B (corresponding author), Univ Groningen, Traff & Environm Psychol Grp, Groningen, Netherlands.	b.lewis.evans@rug.nl	Jolij, Jacob/A-9560-2009; de Waard, Dick/G-8458-2016; Lewis-Evans, Ben/E-2383-2012	Jolij, Jacob/0000-0002-9137-052X; de Waard, Dick/0000-0003-0262-4573; Lewis-Evans, Ben/0000-0003-3672-1072				Aust ML, 2011, THEOR ISS ERGON SCI, V12, P44, DOI 10.1080/14639220903470213; Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Carlson JM, 2009, EVOL PSYCHOL, V7, P534, DOI 10.1177/147470490900700404; Carlsson K, 2004, EMOTION, V4, P340, DOI 10.1037/1528-3542.4.4.340; Chentsova-Dutton YE, 2007, COGNITION EMOTION, V21, P162, DOI 10.1080/02699930600911333; Damasio A.R., 2005, DESCARTES ERROR EMOT; Damasio A. R., 2003, LOOKING SPINOZA JOY; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; DeWaard D, 1996, MEASUREMENT DRIVERS; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; Fuller R, 2005, ACCIDENT ANAL PREV, V37, P461, DOI 10.1016/j.aap.2004.11.003; FULLER R, 1984, ERGONOMICS, V27, P1139, DOI 10.1080/00140138408963596; FULLER R, 2011, 4 INT C TRAFF TRANSP; FULLER R, 2008, CONDITIONS INAPPROPR; Glascher J, 2003, J NEUROSCI, V23, P10274; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Halpern D., 2013, SEX DIFFERENCES COGN, V4th; Harbluk JL, 2007, ACCIDENT ANAL PREV, V39, P372, DOI 10.1016/j.aap.2006.08.013; HEINO A, 1996, RISK TAKING CAR DRIV; Hirschberger G, 2010, J EXP SOC PSYCHOL, V46, P172, DOI 10.1016/j.jesp.2009.10.005; HUBERTWALLANDER B, 2010, WILEY INTERDISCIPLIN, P1; Jolij J, 2005, P NATL ACAD SCI USA, V102, P10747, DOI 10.1073/pnas.0500834102; Keltner D, 1999, COGNITION EMOTION, V13, P467, DOI 10.1080/026999399379140; Kimura Doreen., 2000, SEX COGNITION, V1; Kimura Y, 2004, PHYSIOL BEHAV, V82, P727, DOI 10.1016/j.physbeh.2004.06.010; KINNEAR N, 2009, DRIVING YOU FEEL PSY; KROSNICK JA, 1992, PERS SOC PSYCHOL B, V18, P152, DOI 10.1177/0146167292182006; Lewis-Evans B, 2006, ACCIDENT ANAL PREV, V38, P610, DOI 10.1016/j.aap.2005.12.005; Lithari C, 2010, BRAIN TOPOGR, V23, P27, DOI 10.1007/s10548-009-0130-5; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; MCKENNA FP, 1988, ERGONOMICS, V31, P469, DOI 10.1080/00140138808966692; MICHON JA, 1989, ACCIDENT ANAL PREV, V21, P341, DOI 10.1016/0001-4575(89)90025-0; Michon JA, 1985, HUMAN BEHAV TRAFFIC, P485, DOI DOI 10.1007/978-1-4613-2173-6_19; MULDER G, 1981, PSYCHOPHYSIOLOGY, V18, P392, DOI 10.1111/j.1469-8986.1981.tb02470.x; MULDER LJM, 1992, BIOL PSYCHOL, V34, P205, DOI 10.1016/0301-0511(92)90016-N; MULDER LJM, 2005, HDB ERGONOMICS HUMAN; Naatanen R., 1974, ACCIDENT ANAL PREV, V6, P243, DOI DOI 10.1016/0001-4575(74)90003-7; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Ohman A, 1998, J EXP PSYCHOL GEN, V127, P69, DOI 10.1037/0096-3445.127.1.69; OHMAN A, 1994, J ABNORM PSYCHOL, V103, P231, DOI 10.1037/0021-843X.103.2.231; Patterson T., 2000, SPEED REV LIT IMPACT; Pegna AJ, 2005, NAT NEUROSCI, V8, P24, DOI 10.1038/nn1364; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Pessoa L, 2005, CURR OPIN NEUROBIOL, V15, P188, DOI 10.1016/j.conb.2005.03.002; PETIT C, 2009, EVALUATING DISTRACTI, P261; Proverbio AM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-56; Robinson MD, 1998, COGNITION EMOTION, V12, P667, DOI 10.1080/026999398379493; SCHAAP N, 2008, DRIVERS BEHAV REACTI; Siegel P, 2009, CONSCIOUS COGN, V18, P939, DOI 10.1016/j.concog.2009.08.001; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Subrahmanyam K., 1994, J APPL DEV PSYCHOL, V15, P13, DOI DOI 10.1016/0193-3973(94)90004-3; SUMMALA H, 1988, ERGONOMICS, V31, P491, DOI 10.1080/00140138808966694; Summala H., 2005, TRAFFIC TRANSPORT PS, P383; Summala H., 2007, MODELLING DRIVER BEH, P189, DOI DOI 10.1007/978-1-84628-618-6_11; SUMMALA H, 1997, HIERARCHICAL MODEL B, P41; TAYLOR DH, 1964, ERGONOMICS, V7, P439, DOI 10.1080/00140136408930761; VAA T, 2011, DRIVER DISTRACTION I; Vaa T., 2007, MODELLING DRIVER BEH, P208, DOI DOI 10.1007/978-1-84628-618-6; VAA T, 2003, 6662003 TOI; Weiskrantz L, 1996, CURR OPIN NEUROBIOL, V6, P215, DOI 10.1016/S0959-4388(96)80075-4; Whalen PJ, 1998, J NEUROSCI, V18, P411; WILDE GJS, 1988, ERGONOMICS, V31, P441, DOI 10.1080/00140138808966691; WILDE GJS, 1976, HUM FACTORS, V18, P477, DOI 10.1177/001872087601800506; Williams LM, 2007, NEUROSCIENTIST, V13, P349, DOI 10.1177/10738584070130040801; World Health Organization, 2009, GLOB STAT REP ROAD S; [No title captured]	70	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29857	10.1371/journal.pone.0029857	http://dx.doi.org/10.1371/journal.pone.0029857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	885IH	22279549	Green Submitted, gold, Green Published			2022-12-27	WOS:000299771900027
J	Trindade, A; Djokovic, D; Gigante, J; Badenes, M; Pedrosa, AR; Fernandes, AC; Lopes-da-Costa, L; Krasnoperov, V; Liu, R; Gill, PS; Duarte, A				Trindade, Alexandre; Djokovic, Dusan; Gigante, Joana; Badenes, Marina; Pedrosa, Ana-Rita; Fernandes, Ana-Carina; Lopes-da-Costa, Luis; Krasnoperov, Valery; Liu, Ren; Gill, Parkash S.; Duarte, Antonio			Low-Dosage Inhibition of DII4 Signaling Promotes Wound Healing by Inducing Functional Neo-Angiogenesis	PLOS ONE			English	Article							TUMOR-GROWTH; VASCULAR MORPHOGENESIS; THERAPEUTIC ANGIOGENESIS; LYMPHATIC DEVELOPMENT; DLL4; NOTCH; BLOCKADE; LIGAND; REGENERATION; VESSELS	Recent findings regarding DII4 function in physiological and pathological conditions indicate that this Notch ligand may constitute an important therapeutic target. DII4 appears to be a major anti-angiogenic agent, occupying a central role in various angiogenic pathways. The first trials of anti-DII4 therapy in mice demonstrated a paradoxical effect, as it reduced tumor perfusion and growth despite leading to an increase in vascular density. This is seen as the result of insufficient maturation of the newly formed vasculature causing a circulatory defect and increased tumor hypoxia. As DII4 function is known to be closely dependent on expression levels, we envisioned that the therapeutic anti-DII4 dosage could be modulated to result in the increase of adequately functional blood vessels. This would be useful in conditions where vascular function is a limiting factor for recovery, like wound healing and tissue hypoxia, especially in diabetic patients. Our experimental results in mice confirmed this possibility, revealing that low dosage inhibition of DII4/Notch signaling causes improved vascular function and accelerated wound healing.	[Trindade, Alexandre; Djokovic, Dusan; Gigante, Joana; Badenes, Marina; Pedrosa, Ana-Rita; Fernandes, Ana-Carina; Lopes-da-Costa, Luis; Duarte, Antonio] Univ Tecn Lisboa, Ctr Interdisciplinar Invest Sanidade Anim CIISA, Lisbon, Portugal; [Trindade, Alexandre; Djokovic, Dusan; Duarte, Antonio] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Krasnoperov, Valery] Vasgene Therapeut, Los Angeles, CA USA; [Liu, Ren; Gill, Parkash S.] Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA; [Gill, Parkash S.] Univ So Calif, Dept Med, Los Angeles, CA 90089 USA	Universidade de Lisboa; Instituto Gulbenkian de Ciencia; University of Southern California; University of Southern California	Trindade, A (corresponding author), Univ Tecn Lisboa, Ctr Interdisciplinar Invest Sanidade Anim CIISA, Lisbon, Portugal.	parkashg@med.usc.edu; aduarte@fmv.utl.pt	Duarte, Antonio/V-1178-2018; Trindade, Alexandre/J-3606-2013; Pedrosa, Ana Rita/AAX-9857-2021; Trindade, Alexandre/AAC-9726-2019	Duarte, Antonio/0000-0002-9255-3635; Trindade, Alexandre/0000-0002-3104-9259; Pedrosa, Ana Rita/0000-0002-4421-6968; Badenes, Marina/0000-0001-6872-891X; Gigante Carinhas, Joana/0000-0002-2414-7651; DJOKOVIC, DUSAN/0000-0002-1013-8455; Lopes-da-Costa, Luis/0000-0001-5165-3034	U.S. National Cancer Institute [RO1 CA 079218-07]; Portuguese Fundacao para a Ciencia e Tecnologia [PTDC/CVT/71084/2006]; NATIONAL CANCER INSTITUTE [R01CA079218] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the U.S. National Cancer Institute (RO1 CA 079218-07 to P. S. G.) and by the Portuguese Fundacao para a Ciencia e Tecnologia (PTDC/CVT/71084/2006 to A. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Balfour JAB, 1999, BIODRUGS, V11, P359, DOI 10.2165/00063030-199911050-00007; Benedito R, 2005, GENE EXPR PATTERNS, V5, P750, DOI 10.1016/j.modgep.2005.04.004; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Butler MG, 2009, BIRTH DEFECTS RES C, V87, P222, DOI 10.1002/bdrc.20155; Chigurupati S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001167; Djokovic D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-641; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001; Erber R, 2006, EMBO J, V25, P628, DOI 10.1038/sj.emboj.7600949; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Franz MG, 2007, CURR PROB SURG, V44, P691, DOI 10.1067/j.cpsurg.2007.07.001; Fung E, 2007, CIRCULATION, V115, P2948, DOI 10.1161/CIRCULATIONAHA.106.675462; Gratton JP, 2003, CANCER CELL, V4, P31, DOI 10.1016/S1535-6108(03)00168-5; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hogan BM, 2009, DEVELOPMENT, V136, P4001, DOI 10.1242/dev.039990; Jakobsson L, 2009, BIOCHEM SOC T, V37, P1233, DOI 10.1042/BST0371233; Karamysheva AF, 2008, BIOCHEMISTRY-MOSCOW+, V73, P751, DOI 10.1134/S0006297908070031; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; Madeddu P, 2005, EXP PHYSIOL, V90, P315, DOI 10.1113/expphysiol.2004.028571; Mosch B, 2010, J ONCOL, V2010, DOI 10.1155/2010/135285; Niessen K, 2011, BLOOD, V118, P1989, DOI 10.1182/blood-2010-11-319129; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; SAWAMIPHAK S, 2010, NATURE; Scehnet JS, 2007, BLOOD, V109, P4753, DOI 10.1182/blood-2006-12-063933; Segarra M, 2008, BLOOD, V112, P1904, DOI 10.1182/blood-2007-11-126045; Shibuya M, 2008, BMB REP, V41, P278, DOI 10.5483/BMBRep.2008.41.4.278; Shutter JR, 2000, GENE DEV, V14, P1313; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Tongers J, 2008, CIRCULATION, V118, P9, DOI 10.1161/CIRCULATIONAHA.108.784371; Trindade A, 2008, BLOOD, V112, P1720, DOI 10.1182/blood-2007-09-112748; WANG Y, 2010, NATURE; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Yan MH, 2007, CLIN CANCER RES, V13, P7243, DOI 10.1158/1078-0432.CCR-07-1393; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751	41	25	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29863	10.1371/journal.pone.0029863	http://dx.doi.org/10.1371/journal.pone.0029863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279550	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900028
J	Beermann, S; Glage, S; Jonigk, D; Seifert, R; Neumann, D				Beermann, Silke; Glage, Silke; Jonigk, Danny; Seifert, Roland; Neumann, Detlef			Opposite Effects of Mepyramine on JNJ 7777120-Induced Amelioration of Experimentally Induced Asthma in Mice in Sensitization and Provocation	PLOS ONE			English	Article							HISTAMINE H-4 RECEPTOR; AIRWAY HYPERRESPONSIVENESS; SELECTIVE HISTAMINE; MOUSE MODEL; INFLAMMATION; EOSINOPHILIA; MODULATION; DEFICIENCY; ACTIVATION; EXPRESSION	Background: Histamine is detected in high concentrations in the airways during an allergic asthma response. In a murine model of allergic asthma, JNJ 7777120, an antagonist at the histamine H-4 receptor, reduces asthmatic symptoms, while the histamine H-1 receptor-selective antagonist mepyramine is virtually without effect. In the present study, we analyzed the effect of combined antagonism at the histamine H-1 and H-4 receptors in a murine asthma model in relation to the timing of their application, i.e. sensitization or provocation. Methodology/Principal Findings: Asthma was induced in mice by sensitization and provocation with ovalbumin. JNJ 7777120 and/or mepyramine were injected subcutaneously either during sensitization or during provocation, and typical asthma parameters were analyzed. JNJ 7777120, but not mepyramine, reduced serum concentrations of anti-OVA IgE, inflammatory infiltrations in lung tissue, and eosinophilia in bronchoalveolar-lavage (BAL)-fluids independently of the timing of application. Upon application of JNJ 7777120 plus mepyramine in combination during provocation, mepyramine inhibited the effects of JNJ 7777120. In contrast, when applied during sensitization, mepyramine enhanced the disease-ameliorating effects of JNJ 7777120. Conclusions/Significance: Our study indicates that both histamine H-1 and H-4 receptors play important roles in the course of murine experimental asthma. Unexpectedly, the contribution of these receptors to the pathogenesis differs between the two phases, sensitization or provocation. Since in human asthma, repeated contact to the allergen is not only provocation but also a boost of sensitization, a combined pharmacological targeting of histamine H-1 and H-4 receptors could be taken into consideration as an option for the prevention of asthma and maybe other allergic diseases.	[Beermann, Silke; Seifert, Roland; Neumann, Detlef] Hannover Med Sch, Inst Pharmacol, D-3000 Hannover, Germany; [Glage, Silke] Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany; [Jonigk, Danny] Hannover Med Sch, Inst Pathol, D-3000 Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Beermann, S (corresponding author), Hannover Med Sch, Inst Pharmacol, D-3000 Hannover, Germany.	neumann.detlef@mh-hannover.de	Neumann, Detlef/F-6182-2011; Seifert, Roland/G-3189-2013	Neumann, Detlef/0000-0003-0145-7507; 	German Research Foundation (DFG) via the Collaborative Research Centre (SFB) [587]	German Research Foundation (DFG) via the Collaborative Research Centre (SFB)	This study was funded by the German Research Foundation (DFG) via the Collaborative Research Centre (SFB) 587. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIN WA, 1949, LANCET, V257, P47; Bakker Remko A, 2002, Clin Allergy Immunol, V17, P27; Bryce PJ, 2006, J CLIN INVEST, V116, P1624, DOI 10.1172/JCI26150; Cowden JM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-86; D'Amato G, 2010, J INVEST ALLERG CLIN, V20, P95; De Bie JJ, 1998, BRIT J PHARMACOL, V124, P857, DOI 10.1038/sj.bjp.0701901; Dunford PJ, 2006, J IMMUNOL, V176, P7062, DOI 10.4049/jimmunol.176.11.7062; Durrant DM, 2010, IMMUNOL INVEST, V39, P526, DOI 10.3109/08820131003615498; Gutzmer R, 2002, J ALLERGY CLIN IMMUN, V109, P524, DOI 10.1067/mai.2002.121944; Hartwig C, 2008, EXP TOXICOL PATHOL, V60, P425, DOI 10.1016/j.etp.2008.05.010; Hartwig C, 2008, CYTOKINE, V42, P298, DOI 10.1016/j.cyto.2008.02.012; Hofstra CL, 2003, J PHARMACOL EXP THER, V305, P1212, DOI 10.1124/jpet.102.046581; Huang JF, 2008, CURR ALLERGY ASTHM R, V8, P21, DOI 10.1007/s11882-008-0005-y; James Alan L, 2002, Curr Allergy Asthma Rep, V2, P166, DOI 10.1007/s11882-002-0012-3; JARJOUR NN, 1991, AM REV RESPIR DIS, V144, P83, DOI 10.1164/ajrccm/144.1.83; Jonigk D, 2011, AM J PATHOL, V178, P599, DOI 10.1016/j.ajpath.2010.10.032; Jutel M, 2009, CLIN EXP ALLERGY, V39, P1786, DOI 10.1111/j.1365-2222.2009.03374.x; Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564; Kenakin T, 2010, J RECEPT SIG TRANSD, V30, P313, DOI 10.3109/10799893.2010.503964; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Koarai A, 2003, AM J RESP CRIT CARE, V167, P758, DOI 10.1164/rccm.200206-619OC; Kozma GT, 2003, INT IMMUNOL, V15, P963, DOI 10.1093/intimm/dxg095; Liu CL, 2001, MOL PHARMACOL, V59, P420, DOI 10.1124/mol.59.3.420; Mehlhop PD, 1997, P NATL ACAD SCI USA, V94, P1344, DOI 10.1073/pnas.94.4.1344; Mitchell J, 2010, CURR OPIN INVEST DR, V11, P527; Miyamoto K, 2006, INT ARCH ALLERGY IMM, V140, P215, DOI 10.1159/000093246; Morgan RK, 2007, J IMMUNOL, V178, P8081, DOI 10.4049/jimmunol.178.12.8081; Neumann D, 2010, PHARMACOLOGY, V85, P217, DOI 10.1159/000285088; Nguyen T, 2001, MOL PHARMACOL, V59, P427, DOI 10.1124/mol.59.3.427; Oda T, 2000, J BIOL CHEM, V275, P36781, DOI 10.1074/jbc.M006480200; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Rosenwasser LJ, 2011, CURR ALLERGY ASTHM R, V11, P178, DOI 10.1007/s11882-011-0179-6; Rosethorne EM, 2011, MOL PHARMACOL, V79, P749, DOI 10.1124/mol.110.068395; Rossbach K, 2009, EXP DERMATOL, V18, P57, DOI 10.1111/j.1600-0625.2008.00762.x; Schnell D, 2011, NAUNYNSCHMIEDEBERGS; Seifert R, 2011, MOL PHARMACOL, V79, P631, DOI 10.1124/mol.111.071266; Seifert R, 2009, MOL PHARMACOL, V75, P13, DOI 10.1124/mol.108.052944; Thurmond RL, 2004, J PHARMACOL EXP THER, V309, P404, DOI 10.1124/jpet.103.061754; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; Tschernig T, 2008, CURR DRUG TARGETS, V9, P466, DOI 10.2174/138945008784533543; Zimmermann AS, 2011, INFLAMM RES, V60, P1153, DOI 10.1007/s00011-011-0379-5; Zosky GR, 2008, CLIN EXP ALLERGY, V38, P829, DOI 10.1111/j.1365-2222.2007.02884.x	42	26	27	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30285	10.1371/journal.pone.0030285	http://dx.doi.org/10.1371/journal.pone.0030285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272324	Green Published, Green Submitted, gold			2022-12-27	WOS:000301454400102
J	Lakshminarasimhan, H; Chattarji, S				Lakshminarasimhan, Harini; Chattarji, Sumantra			Stress Leads to Contrasting Effects on the Levels of Brain Derived Neurotrophic Factor in the Hippocampus and Amygdala	PLOS ONE			English	Article							SPATIAL MEMORY; MESSENGER-RNA; BDNF; EXPRESSION; CORTICOSTERONE; DEPRESSION; PITUITARY; INTENSITY; RECOVERY; NEUROBIOLOGY	Recent findings on stress induced structural plasticity in rodents have identified important differences between the hippocampus and amygdala. The same chronic immobilization stress (CIS, 2h/day) causes growth of dendrites and spines in the basolateral amygdala (BLA), but dendritic atrophy in hippocampal area CA3. CIS induced morphological changes also differ in their temporal longevity-BLA hypertrophy, unlike CA3 atrophy, persists even after 21 days of stress-free recovery. Furthermore, a single session of acute immobilization stress (AIS, 2h) leads to a significant increase in spine density 10 days, but not 1 day, later in the BLA. However, little is known about the molecular correlates of the differential effects of chronic and acute stress. Because BDNF is known to be a key regulator of dendritic architecture and spines, we investigated if the levels of BDNF expression reflect the divergent effects of stress on the hippocampus and amygdala. CIS reduces BDNF in area CA3, while it increases it in the BLA of male Wistar rats. CIS-induced increase in BDNF expression lasts for at least 21 days after the end of CIS in the BLA. But CIS-induced decrease in area CA3 BDNF levels, reverses to normal levels within the same period. Finally, BDNF is up regulated in the BLA 1 day after AIS and this increase persists even 10 days later. In contrast, AIS fails to elicit any significant change in area CA3 at either time points. Together, these findings demonstrate that both acute and chronic stress trigger opposite effects on BDNF levels in the BLA versus area CA3, and these divergent changes also follow distinct temporal profiles. These results point to a role for BDNF in stress-induced structural plasticity across both hippocampus and amygdala, two brain areas that have also been implicated in the cognitive and affective symptoms of stress-related psychiatric disorders.	[Lakshminarasimhan, Harini; Chattarji, Sumantra] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Lakshminarasimhan, H (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	shona@ncbs.res.in			National Centre for Biological Sciences (NCBS); Wellcome Trust, UK [GR 0701339 MA]	National Centre for Biological Sciences (NCBS); Wellcome Trust, UK(Wellcome Trust)	This work was supported by National Centre for Biological Sciences (NCBS) and grant GR 0701339 MA from the Wellcome Trust, UK (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Cordero MI, 1998, BEHAV NEUROSCI, V112, P885, DOI 10.1037/0735-7044.112.4.885; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Garcia A, 2000, NEUROENDOCRINOLOGY, V72, P114, DOI 10.1159/000054578; Govindarajan A, 2006, P NATL ACAD SCI USA, V103, P13208, DOI 10.1073/pnas.0605180103; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; LUINE V, 1994, BRAIN RES, V639, P167, DOI 10.1016/0006-8993(94)91778-7; Marmigere F, 2003, HIPPOCAMPUS, V13, P646, DOI 10.1002/hipo.10109; Marquez C, 2002, BRAIN RES, V926, P181, DOI 10.1016/S0006-8993(01)03112-2; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; MOGHADDAM B, 1994, BRAIN RES, V655, P251, DOI 10.1016/0006-8993(94)91622-5; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; NIBUYA M, 1995, J NEUROSCI, V15, P7539; OTTENWELLER JE, 1992, PHYSIOL BEHAV, V51, P689, DOI 10.1016/0031-9384(92)90104-A; PITMAN DL, 1988, PHYSIOL BEHAV, V43, P47, DOI 10.1016/0031-9384(88)90097-2; Radecki DT, 2005, HIPPOCAMPUS, V15, P246, DOI 10.1002/hipo.20048; Rattiner LM, 2004, LEARN MEMORY, V11, P727, DOI 10.1101/lm.83304; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Reznikov LR, 2007, EUR J NEUROSCI, V25, P3109, DOI 10.1111/j.1460-9568.2007.05560.x; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; Schaaf MJM, 1997, J NEUROSCI RES, V48, P334, DOI 10.1002/(SICI)1097-4547(19970515)48:4<334::AID-JNR5>3.0.CO;2-C; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; SHORS TJ, 1992, SCIENCE, V257, P537, DOI 10.1126/science.1636089; Siuciak JA, 1997, PHARMACOL BIOCHEM BE, V56, P131, DOI 10.1016/S0091-3057(96)00169-4; SMITH MA, 1995, ENDOCRINOLOGY, V136, P3743, DOI 10.1210/en.136.9.3743; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Taliaz D, 2011, J NEUROSCI, V31, P4475, DOI 10.1523/JNEUROSCI.5725-10.2011; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Vyas A, 2002, J NEUROSCI, V22, P6810; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8	40	168	173	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30481	10.1371/journal.pone.0030481	http://dx.doi.org/10.1371/journal.pone.0030481			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272355	gold, Green Published, Green Submitted			2022-12-27	WOS:000301454400133
J	Gamaleddin, I; Zvonok, A; Makriyannis, A; Goldberg, SR; Le Foll, B				Gamaleddin, Islam; Zvonok, Alexander; Makriyannis, Alexandros; Goldberg, Steven R.; Le Foll, Bernard			Effects of a Selective Cannabinoid CB2 Agonist and Antagonist on Intravenous Nicotine Self Administration and Reinstatement of Nicotine Seeking	PLOS ONE			English	Article							RECEPTOR ANTAGONIST; ENDOCANNABINOID SYSTEM; NEUROPATHIC PAIN; HUMAN BRAIN; RATS; ACTIVATION; MICE; INHIBITION; ADDICTION; BEHAVIOR	Over the last decade there have been significant advances in the discovery and understanding of the cannabinoid system along with the development of pharmacologic tools that modulate its function. Characterization of the crosstalk between nicotine addiction and the cannabinoid system may have significant implications on our understanding of the neurobiological mechanisms underlying nicotine dependence. Two types of cannabinoid receptors (CB1 and CB2) have been identified. CB1 receptors are expressed in the brain and modulate drug taking and drug seeking for various drugs of abuse, including nicotine. CB2 receptors have been recently identified in the brain and have been proposed to play a functional role in mental disorders and drug addiction. Our objective was to explore the role of CB2 receptors on intravenous nicotine self administration under two schedules of reinforcement (fixed and progressive ratio) and on nicotine seeking induced by nicotine priming or by nicotine associated cues. For this, we evaluated the effects of various doses of the selective CB2 antagonist AM630 (1.25 to 5 mg/kg) and CB2 agonist AM1241 (1 to 10 mg/kg) on these behavioral responses in rats. Different groups of male Long Evans rats were trained to lever press for nicotine at a unit dose of 30 mu g/kg/infusion. Subsequently, animals were randomized using a Latin-square design and injected with either AM1241 or AM630 using a counterbalanced within subject design. Administration of the CB2 ligands did not affect either nicotinetaking nicotine-seeking behavior. Our results do not support the involvement of CB2 receptors in nicotine-taking or nicotine-seeking behavior.	[Gamaleddin, Islam; Le Foll, Bernard] Ctr Addict & Mental Hlth, Translat Addict Res Lab, Toronto, ON, Canada; [Le Foll, Bernard] Univ Toronto, Inst Med Sci, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Le Foll, Bernard] Univ Toronto, Inst Med Sci, Dept Psychiat, Toronto, ON M5S 1A1, Canada; [Le Foll, Bernard] Univ Toronto, Inst Med Sci, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A1, Canada; [Gamaleddin, Islam; Le Foll, Bernard] Ctr Addict & Mental Hlth, Addict Program, Toronto, ON, Canada; [Goldberg, Steven R.] Natl Inst Drug Abuse, US Dept HHS, Intramural Res Program, NIH, Baltimore, MD USA; [Zvonok, Alexander; Makriyannis, Alexandros] Northeastern Univ, Ctr Drug Discovery, Bouve Coll Hlth Sci, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Northeastern University	Gamaleddin, I (corresponding author), Ctr Addict & Mental Hlth, Translat Addict Res Lab, Toronto, ON, Canada.	bernard_lefoll@camh.net	Makriyannis, Alexandros/GRF-1518-2022; Le Foll, Bernard/K-2952-2014	Makriyannis, Alexandros/0000-0003-3272-3687; Le Foll, Bernard/0000-0002-6406-4973	Canadian Tobacco Control Research Initiative [73776 45000 0802]; Egyptian Ministry of Higher Education - Ain Shams University; Centre for Addiction and Mental Health CAMH; CFI - LOF [940707]; NIDA, NIH, DHHS; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000001] Funding Source: NIH RePORTER	Canadian Tobacco Control Research Initiative; Egyptian Ministry of Higher Education - Ain Shams University; Centre for Addiction and Mental Health CAMH; CFI - LOF(Canada Foundation for Innovation); NIDA, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by a student grant from Canadian Tobacco Control Research Initiative (Grant # 73776 45000 0802) by the Egyptian Ministry of Higher Education - Ain Shams University, by the Centre for Addiction and Mental Health CAMH, CFI - LOF # 940707 and by the Intramural Research Program of NIDA, NIH, DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benito C, 2005, J NEUROSCI, V25, P2530, DOI 10.1523/JNEUROSCI.3923-04.2005; Cinar R, 2009, J PHARMACOL EXP THER, V330, P567, DOI 10.1124/jpet.109.152710; Cohen C, 2002, BEHAV PHARMACOL, V13, P451, DOI 10.1097/00008877-200209000-00018; Cohen C, 2005, PHARMACOL BIOCHEM BE, V81, P387, DOI 10.1016/j.pbb.2005.01.024; CORRIGALL WA, 1989, PSYCHOPHARMACOLOGY, V99, P473, DOI 10.1007/BF00589894; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Forget B, 2005, PSYCHOPHARMACOLOGY, V181, P722, DOI 10.1007/s00213-005-0015-6; Forget B, 2010, BIOL PSYCHIAT, V68, P265, DOI 10.1016/j.biopsych.2010.01.029; Forget B, 2010, NEUROPSYCHOPHARMACOL, V35, P1751, DOI 10.1038/npp.2010.42; Forget B, 2009, PSYCHOPHARMACOLOGY, V205, P613, DOI 10.1007/s00213-009-1569-5; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gamaleddin I, 2011, ADDICT BIOL IN PRESS, DOI [10.1111/j.1369-1600.2011.00314.x, DOI 10.1111/J.1369-1600.2011.00314.X.ADDICT]; Gamaleddin I, 2011, BRIT J PHARMACOL, V164, P1652, DOI 10.1111/j.1476-5381.2011.01440.x; Garcia-Gutierrez MS, 2010, BRIT J PHARMACOL, V160, P1773, DOI 10.1111/j.1476-5381.2010.00819.x; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Ibrahim MM, 2003, P NATL ACAD SCI USA, V100, P10529, DOI 10.1073/pnas.1834309100; Ishiguro H, 2007, PHARMACOGENOMICS J, V7, P380, DOI 10.1038/sj.tpj.6500431; Ishiguro H, 2010, BIOL PSYCHIAT, V67, P974, DOI 10.1016/j.biopsych.2009.09.024; Khaled MATM, 2010, INT J NEUROPSYCHOPH, V13, P181, DOI 10.1017/S1461145709991064; Khasabova IA, 2011, BEHAV PHARMACOL, V22, P607, DOI 10.1097/FBP.0b013e3283474a6d; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Le Foll B, 2004, NEUROREPORT, V15, P2139, DOI 10.1097/00001756-200409150-00028; Le Foll B, 2007, CAN MED ASSOC J, V177, P1373, DOI 10.1503/cmaj.070627; Malan TP, 2002, CHEM PHYS LIPIDS, V121, P191, DOI 10.1016/S0009-3084(02)00155-X; Mukherjee S, 2004, EUR J PHARMACOL, V505, P1, DOI 10.1016/j.ejphar.2004.09.058; Nunez E, 2004, SYNAPSE, V53, P208, DOI 10.1002/syn.20050; Onaivi ES, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001640; Rahn EJ, 2007, BRIT J PHARMACOL, V152, P765, DOI 10.1038/sj.bjp.0707333; ROBERTS DCS, 1993, PSYCHOPHARMACOLOGY, V111, P215, DOI 10.1007/BF02245526; Scherma M, 2011, BR J PHARM; Scherma M, 2008, J PHARMACOL EXP THER, V327, P482, DOI 10.1124/jpet.108.142224; Shoaib M, 2008, NEUROPHARMACOLOGY, V54, P438, DOI 10.1016/j.neuropharm.2007.10.011; Sticht MA, 2011, BR J PHARM; Valenzano KJ, 2005, NEUROPHARMACOLOGY, V48, P658, DOI 10.1016/j.neuropharm.2004.12.008; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Xi ZX, 2011, NAT NEUROSCI, V14, P1160, DOI 10.1038/nn.2874; Yamamoto W, 2008, EUR J PHARMACOL, V583, P56, DOI 10.1016/j.ejphar.2008.01.010; Zislis G, 2007, NEUROPHARMACOLOGY, V53, P958, DOI 10.1016/j.neuropharm.2007.09.007	41	55	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e29900	10.1371/journal.pone.0029900	http://dx.doi.org/10.1371/journal.pone.0029900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291896	Green Submitted, Green Published, gold			2022-12-27	WOS:000301703800006
J	Zygmunt, BM; Weissmann, SF; Guzman, CA				Zygmunt, Beata M.; Weissmann, Sebastian F.; Guzman, Carlos A.			NKT Cell Stimulation with alpha-Galactosylceramide Results in a Block of Th17 Differentiation after Intranasal Immunization in Mice	PLOS ONE			English	Article							KILLER T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; DENDRITIC CELLS; ACTIVATION; IL-17; IDENTIFICATION; POPULATION; INDUCTION; INFECTION; ARTHRITIS	In a previous study we demonstrated that intranasal (i.n.) vaccination promotes a Th17 biased immune response. Here, we show that co-administration of a pegylated derivative of alpha-galactosylceramide (alpha GCPEG) with an antigen, even in the presence of Th17-polarizing compounds, results in a strong blocking of Th17 differentiation. Additional studies demonstrated that this phenomenon is specifically dependent on soluble factors, like IL-4 and IFN gamma, which are produced by NKT cells. Even NK1.1 negative NKT cells, which by themselves produce IL-17A, are able to block Th17 differentiation. It follows that the use of alpha GCPEG as adjuvant would enable to tailor Th17 responses, according to the specific clinical needs. This knowledge expands our understanding of the role played by NKT cells in overall control of the cytokine microenvironment, as well as in the overall shaping of adaptive immune responses.	[Zygmunt, Beata M.; Weissmann, Sebastian F.; Guzman, Carlos A.] Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Zygmunt, BM (corresponding author), Babraham Inst, Babraham Res Campus, Cambridge, England.	beata.zygmunt@bbsrc.ac.uk; carlos.guzman@helmholtz-hzi.de			Marie Curie Early Stage Training of the European Community [MEST-2004-504990]; European Commission [044115]; German Research Foundation [EXC 62/1]; Indo-German Science Centre for Infectious Diseases [IG-SCID TwinPro-03]	Marie Curie Early Stage Training of the European Community; European Commission(European CommissionEuropean Commission Joint Research Centre); German Research Foundation(German Research Foundation (DFG)); Indo-German Science Centre for Infectious Diseases	This work was in part supported by the Marie Curie Early Stage Training of the European Community's Sixth Framework Programme under the contract number MEST-2004-504990, the European Commission under the project PANFLUVAC (contract No. 044115), the Excellence Cluster "From Regenerative Biology to Reconstructive Therapy" by the German Research Foundation (EXC 62/1), and the Indo-German Science Centre for Infectious Diseases (IG-SCID TwinPro-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chen HJ, 1997, J IMMUNOL, V159, P2240; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Ebensen T, 2007, J IMMUNOL, V179, P2065, DOI 10.4049/jimmunol.179.4.2065; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Ko SY, 2005, J IMMUNOL, V175, P3309, DOI 10.4049/jimmunol.175.5.3309; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Mars LT, 2009, P NATL ACAD SCI USA, V106, P6238, DOI 10.1073/pnas.0809317106; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Oh K, EUR J IMMUNOL, V41, P392; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Singh AK, 2001, J EXP MED, V194, P1801, DOI 10.1084/jem.194.12.1801; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Uemura Y, 2009, J IMMUNOL, V183, P201, DOI 10.4049/jimmunol.0900873; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845; Zygmunt BM, 2009, J IMMUNOL, V183, P6933, DOI 10.4049/jimmunol.0901144	27	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30382	10.1371/journal.pone.0030382	http://dx.doi.org/10.1371/journal.pone.0030382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291945	Green Published, gold, Green Submitted			2022-12-27	WOS:000301703800014
J	Garcia-Herrero, CM; Rubio-Cabezas, O; Azriel, S; Gutierrez-Nogues, A; Aragones, A; Vincent, O; Campos-Barros, A; Argente, J; Navas, MA				Garcia-Herrero, Carmen-Maria; Rubio-Cabezas, Oscar; Azriel, Sharona; Gutierrez-Nogues, Angel; Aragones, Angel; Vincent, Olivier; Campos-Barros, Angel; Argente, Jesus; Navas, Maria-Angeles			Functional Characterization of MODY2 Mutations Highlights the Importance of the Fine-Tuning of Glucokinase and Its Role in Glucose Sensing	PLOS ONE			English	Article							BETA-CELL GLUCOKINASE; HUMAN PANCREATIC GLUCOKINASE; SITE-DIRECTED MUTAGENESIS; REGULATORY PROTEIN; NONSENSE MUTATION; DIABETES THERAPY; GENE-MUTATIONS; HYPERGLYCEMIA; HYPOGLYCEMIA; HOMEOSTASIS	Glucokinase (GK) acts as a glucose sensor in the pancreatic beta-cell and regulates insulin secretion. Heterozygous mutations in the human GK-encoding GCK gene that reduce the activity index increase the glucose-stimulated insulin secretion threshold and cause familial, mild fasting hyperglycaemia, also known as Maturity Onset Diabetes of the Young type 2 (MODY2). Here we describe the biochemical characterization of five missense GK mutations: p.Ile130Thr, p.Asp205His, p.Gly223Ser, p.His416Arg and p.Ala449Thr. The enzymatic analysis of the corresponding bacterially expressed GST-GK mutant proteins show that all of them impair the kinetic characteristics of the enzyme. In keeping with their position within the protein, mutations p.Ile130Thr, p.Asp205His, p.Gly223Ser, and p.His416Arg strongly decrease the activity index of GK, affecting to one or more kinetic parameters. In contrast, the p.Ala449Thr mutation, which is located in the allosteric activator site, does not affect significantly the activity index of GK, but dramatically modifies the main kinetic parameters responsible for the function of this enzyme as a glucose sensor. The reduced Kcat of the mutant (3.21 +/- 0.28 s(-1) vs 47.86 +/- 2.78 s(-1)) is balanced by an increased glucose affinity (S-0.5 = 1.33 +/- 0.08 mM vs 7.86 +/- 0.09 mM) and loss of cooperativity for this substrate. We further studied the mechanism by which this mutation impaired GK kinetics by measuring the differential effects of several competitive inhibitors and one allosteric activator on the mutant protein. Our results suggest that this mutation alters the equilibrium between the conformational states of glucokinase and highlights the importance of the fine-tuning of GK and its role in glucose sensing.	[Garcia-Herrero, Carmen-Maria; Gutierrez-Nogues, Angel; Navas, Maria-Angeles] Univ Complutense Madrid, Fac Med, Dept Bioquim & Biol Mol 3, Madrid, Spain; [Garcia-Herrero, Carmen-Maria; Gutierrez-Nogues, Angel; Navas, Maria-Angeles] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain; [Garcia-Herrero, Carmen-Maria; Navas, Maria-Angeles] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Rubio-Cabezas, Oscar; Campos-Barros, Angel; Argente, Jesus] Univ Autonoma Madrid, Serv Endocrinol, Hosp Infantil Univ Nino Jesus, Inst Invest La Princesa, Madrid, Spain; [Rubio-Cabezas, Oscar; Campos-Barros, Angel; Argente, Jesus] Univ Autonoma Madrid, Dept Pediat, Madrid, Spain; [Rubio-Cabezas, Oscar; Argente, Jesus] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Azriel, Sharona] Hosp Univ Infanta Sofia, Serv Endocrinol, Madrid, Spain; [Aragones, Angel] Hosp Virgen de la Salud, Serv Pediat, Toledo, Spain; [Vincent, Olivier] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain	Complutense University of Madrid; Hospital Clinico San Carlos; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Autonomous University of Madrid; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Hospital Universitario Infanta Sofia; Complejo Hospitalario de Toledo; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Garcia-Herrero, CM (corresponding author), Univ Complutense Madrid, Fac Med, Dept Bioquim & Biol Mol 3, Madrid, Spain.	manavas@med.ucm.es	Argente, Jesús/K-1167-2014; Gutierrez, Angel/E-7261-2012; Argente, Jesús/M-5226-2019; Barros, Angel Campos/E-6427-2018; vincent, Olivier/H-1620-2015	Argente, Jesús/0000-0001-5826-0276; Argente, Jesús/0000-0001-5826-0276; Barros, Angel Campos/0000-0003-4649-2971; vincent, Olivier/0000-0003-4355-5367; Navas, Maria Angeles/0000-0001-6858-2172; Gutierrez-Nogues, Angel/0000-0003-0986-1897	Instituto de Salud Carlos III [PI02/1663, PI06/90459, PI06/0153, PI10/00424, CM06/00013]; Direccion General de Universidades e investigacion de la Consejeria de Educacion de la Comunidad de Madrid-Universidad Complutense de Madrid [CCG10-UCM/BIO-4728]; Ministerio de Ciencia e Innovacion of Spain	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Direccion General de Universidades e investigacion de la Consejeria de Educacion de la Comunidad de Madrid-Universidad Complutense de Madrid; Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Instituto de Salud Carlos III (grants PI02/1663 and PI06/90459 to AC-B; grants PI06/0153 and PI10/00424 to M-AN) and the Direccion General de Universidades e investigacion de la Consejeria de Educacion de la Comunidad de Madrid-Universidad Complutense de Madrid (grant CCG10-UCM/BIO-4728 to M-AN). CMG-H was supported by a predoctoral FPU fellowship from the Ministerio de Ciencia e Innovacion of Spain. OR-C was supported by a Rio-Hortega research training fellowship from the Instituto de Salud Carlos III (CM06/00013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Borowiec M, 2011, ACTA DIABETOL, V48, P203, DOI 10.1007/s00592-011-0279-8; Brocklehurst KJ, 2004, BIOCHEM J, V378, P693, DOI 10.1042/BJ20031414; Brocklehurst KJ, 2004, DIABETES, V53, P535, DOI 10.2337/diabetes.53.3.535; BYRNE MM, 1994, J CLIN INVEST, V93, P1120, DOI 10.1172/JCI117064; Christesen HBT, 2004, FRONT DIABETES, V16, P75; Davis EA, 1999, DIABETOLOGIA, V42, P1175, DOI 10.1007/s001250051289; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Dunten P, 2004, FRONT DIABETES, V16, P145; Efanov AM, 2005, ENDOCRINOLOGY, V146, P3696, DOI 10.1210/en.2005-0377; Galan M, 2006, BIOCHEM J, V393, P389, DOI 10.1042/BJ20051137; Garcia-Herrero CM, 2007, DIABETOLOGIA, V50, P325, DOI 10.1007/s00125-006-0542-7; Gloyn AL, 2004, FRONT DIABETES, V16, P92; Heredia VV, 2006, J BIOL CHEM, V281, P40201, DOI 10.1074/jbc.M607987200; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Mahalingam B, 1999, DIABETES, V48, P1698, DOI 10.2337/diabetes.48.9.1698; Marotta DE, 2005, ARCH BIOCHEM BIOPHYS, V436, P23, DOI 10.1016/j.abb.2005.01.018; Matschinsky FM, 2006, DIABETES, V55, P1; Matschinsky FM, 2011, HANDB EXP PHARMACOL, V203, P357, DOI 10.1007/978-3-642-17214-4_15; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; Molnes J, 2011, FEBS J, V278, P2372, DOI 10.1111/j.1742-4658.2011.08160.x; Moukil MA, 2000, DIABETES, V49, P195, DOI 10.2337/diabetes.49.2.195; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Pearson ER, 2001, DIABETES, V50, pS101, DOI 10.2337/diabetes.50.2007.S101; Rubio-Cabezas O, 2008, PEDIATR DIABETES, V9, P245, DOI 10.1111/j.1399-5448.2007.00361.x; Sagen JV, 2006, DIABETES, V55, P1713, DOI 10.2337/db05-1513; Shiota C, 1999, J BIOL CHEM, V274, P37125, DOI 10.1074/jbc.274.52.37125; Slosberg ED, 2001, DIABETES, V50, P1813, DOI 10.2337/diabetes.50.8.1813; TAKEDA J, 1993, J BIOL CHEM, V268, P15200; TIPPETT PS, 1982, J BIOL CHEM, V257, P2846; VANSCHAFTINGEN E, 1994, FASEB J, V8, P414, DOI 10.1096/fasebj.8.6.8168691; VeigadaCunha M, 1996, DIABETOLOGIA, V39, P1173, DOI 10.1007/BF02658503; Velho G, 2004, FRONT DIABETES, V16, P42; Velho G, 1997, DIABETOLOGIA, V40, P217, DOI 10.1007/s001250050666; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; XU LZ, 1994, J BIOL CHEM, V269, P27458; Zelent D, 2005, BIOCHEM SOC T, V33, P306, DOI 10.1042/BST0330306	39	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30518	10.1371/journal.pone.0030518	http://dx.doi.org/10.1371/journal.pone.0030518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291974	gold, Green Submitted, Green Published			2022-12-27	WOS:000301639600027
J	Jiao, Y; Lu, L; Williams, RW; Smeyne, RJ				Jiao, Yun; Lu, Lu; Williams, Robert W.; Smeyne, Richard J.			Genetic Dissection of Strain Dependent Paraquat-induced Neurodegeneration in the Substantia Nigra Pars Compacta	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; PARKINSONS-DISEASE; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP; CELL-DEATH; RAT-BRAIN; ENVIRONMENTAL ENRICHMENT; PROTEIN PHOSPHATASE; LIPID-PEROXIDATION; HERBICIDE PARAQUAT; NERVOUS-SYSTEM	The etiology of the vast majority of Parkinson's disease (PD) cases is unknown. It is generally accepted that there is an interaction between exposures to environmental agents with underlying genetic sensitivity. Recent epidemiological studies have shown that people living in agricultural communities have an increased risk of PD. Within these communities, paraquat (PQ) is one of the most utilized herbicides. PQ acts as a direct redox cycling agent to induce formation of free radicals and when administered to mice induces the cardinal symptoms of parkinsonism, including loss of TH+-positive dopaminergic (DA) neurons in the ventral midbrain's substantia nigra pars compacta (SNpc). Here we show that PQ-induced SNpc neuron loss is highly dependent on genetic background: C57BL/6J mice rapidly lose similar to 50% of their SNpc DA neurons, whereas inbred Swiss-Webster (SWR/J) mice do not show any significant loss. We intercrossed these two strains to map quantitative trait loci (QTLs) that underlie PQ-induced SNpc neuron loss. Using genome-wide linkage analysis we detected two significant QTLs. The first is located on chromosome 5 (Chr 5) centered near D5Mit338, whereas the second is on Chr 14 centered near D14Mit206. These two QTLs map to different loci than a previously identified QTL (Mptp1) that controls a significant portion of strain sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), suggesting that the mechanism of action of these two parkinsonian neurotoxins are different.	[Jiao, Yun; Smeyne, Richard J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Lu, Lu; Williams, Robert W.] Univ Tennessee Hlth Sci Ctr, Ctr Integrat & Translat Genom, Dept Anat & Neurobiol, Memphis, TN USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Jiao, Y (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	richard.smeyne@stjude.org	; Williams, Robert W./H-8789-2016	Smeyne, Richard/0000-0002-8459-5472; Williams, Robert W./0000-0001-8924-4447	American Lebanese Syrian Associated Charities (ALSAC); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the American Lebanese Syrian Associated Charities (ALSAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen J K, 2001, Novartis Found Symp, V235, P11; ANDERSEN JK, 2001, NOVART FDN SYMP, V235, P20; Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; BEISWANGER CM, 1995, NEUROTOXICOLOGY, V16, P425; Bonneh-Barkay D, 2005, MOL BRAIN RES, V134, P52, DOI 10.1016/j.molbrainres.2004.11.005; Bruinsma IB, 2011, PROTEINS STRUCTURE F; Brzozowski MJ, 2011, BRAIN RES, V1404, P21, DOI 10.1016/j.brainres.2011.05.063; Chan CS, 2010, MOVEMENT DISORD, V25, pS63, DOI 10.1002/mds.22801; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Cook R, 2003, MOL BRAIN RES, V110, P279, DOI 10.1016/S0169-328X(02)00659-9; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; Crusio Wim E., 1992, V8, P231; Dagnino-Subiabre A, 2000, BIOCHEM BIOPH RES CO, V274, P32, DOI 10.1006/bbrc.2000.3087; Damier P, 1996, NEUROLOGY, V46, P1262, DOI 10.1212/WNL.46.5.1262; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Dhillon Amanpreet S, 2008, J Agromedicine, V13, P37, DOI 10.1080/10599240801986215; Duda JE, 2000, J NEUROSCI RES, V61, P121, DOI 10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4; Dutheil F, 2010, EXPERT OPIN DRUG MET, V6, P1161, DOI 10.1517/17425255.2010.510832; Duvoisin R C, 1999, Adv Neurol, V80, P161; Ethell DW, 2009, ANTIOXID REDOX SIGN, V11, P529, DOI [10.1089/ars.2008.2228, 10.1089/ARS.2008.2228]; Faherty CJ, 2005, MOL BRAIN RES, V134, P170, DOI 10.1016/j.molbrainres.2004.08.008; FUKUSHIMA T, 1994, EXP TOXICOL PATHOL, V46, P437, DOI 10.1016/S0940-2993(11)80056-4; Gasser T, 2001, J NEUROL, V248, P833, DOI 10.1007/s004150170066; Gogvadze E, 2009, CELL MOL LIFE SCI, V66, P3727, DOI 10.1007/s00018-009-0107-2; Gross RE, 2007, CELL TRANSPLANT, V16, P245, DOI 10.3727/000000007783464740; Hamre K, 1999, BRAIN RES, V828, P91, DOI 10.1016/S0006-8993(99)01273-1; Hayes KR, 2009, DRUG METAB DISPOS, V37, P1269, DOI 10.1124/dmd.109.026856; Iczkiewicz J, 2006, BRAIN RES, V1118, P239, DOI 10.1016/j.brainres.2006.08.036; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Korneev SA, 1999, J NEUROSCI, V19, P7711; LAVOINNE A, 1987, BIOCHEM J, V246, P449, DOI 10.1042/bj2460449; Liou HH, 1996, TOXICOL APPL PHARM, V137, P34, DOI 10.1006/taap.1996.0054; LUND P, 1975, BIOCHEM J, V152, P593, DOI 10.1042/bj1520593; Maetzler W, 2007, NEUROBIOL DIS, V25, P473, DOI 10.1016/j.nbd.2006.10.020; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; MITRA N, 1994, J NEUROCHEM, V62, P1906; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Pavlicek A, 2006, TRENDS GENET, V22, P69, DOI 10.1016/j.tig.2005.11.005; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Payami H, 1998, J GERIATR PSYCH NEUR, V11, P98, DOI 10.1177/089198879801100207; Peng J, 2004, J BIOL CHEM, V279, P32626, DOI 10.1074/jbc.M404596200; PETER B, 1992, BIOCHEM PHARMACOL, V43, P705, DOI 10.1016/0006-2952(92)90234-A; POLLI JW, 1991, DEV BRAIN RES, V63, P105, DOI 10.1016/0165-3806(91)90071-P; Przedborski T, 2003, ADV NEUROL, V91, P83; RAICHI NJ, 1988, LIFE SCI, V42, P2359, DOI 10.1016/0024-3205(88)90189-0; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Richardson JR, 2005, TOXICOL SCI, V88, P193, DOI 10.1093/toxsci/kfi304; Sanchez M, 2008, TOXICOL SCI, V104, P352, DOI 10.1093/toxsci/kfn092; Sedelis M, 2000, NEUROREPORT, V11, P1093, DOI 10.1097/00001756-200004070-00037; Seidel K, 2011, NEUROPATHOL APPL NEU; Shahabi HN, 2008, SYNAPSE, V62, P379, DOI 10.1002/syn.20505; Shimizu K, 2001, BRAIN RES, V906, P135, DOI 10.1016/S0006-8993(01)02577-X; Simon-Sanchez J, 2011, EUR J HUM GENET, V19, P655, DOI 10.1038/ejhg.2010.254; Simpkins JW, 2009, FRONT NEUROENDOCRIN, V30, P93, DOI 10.1016/j.yfrne.2009.04.013; Smeyne M, 2001, GLIA, V34, P73, DOI 10.1002/glia.1042; Smeyne M, 2007, P NATL ACAD SCI USA, V104, P1977, DOI 10.1073/pnas.0610978104; Smeyne RJ, 2005, MOL BRAIN RES, V134, P57, DOI 10.1016/j.molbrainres.2004.09.017; SONSALLA PK, 1988, PROG NEURO-PSYCHOPH, V12, P345, DOI 10.1016/0278-5846(88)90054-1; SUNDSTROM E, 1987, BRAIN RES, V405, P26; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Vali S, 2007, NEUROSCIENCE, V149, P917, DOI 10.1016/j.neuroscience.2007.08.028; Werner A, 2009, RNA BIOL, V6, P43, DOI 10.4161/rna.6.1.7568; Williams A C, 1999, Adv Neurol, V80, P215; Williams RW, 1998, NEUROSCIENCE MEETS Q; Yi KD, 2008, J PHARMACOL EXP THER, V324, P1188, DOI 10.1124/jpet.107.132308; Yin LN, 2011, NEUROTOXICOL TERATOL, V33, P415, DOI 10.1016/j.ntt.2011.02.012; Yumino K, 2002, J BIOCHEM, V131, P565, DOI 10.1093/oxfordjournals.jbchem.a003135	69	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e29447	10.1371/journal.pone.0029447	http://dx.doi.org/10.1371/journal.pone.0029447			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291891	Green Submitted, Green Published, gold			2022-12-27	WOS:000301639600003
J	Liu, H; Ning, H; Men, HC; Hou, R; Fu, MG; Zhang, HL; Liu, JG				Liu, Huan; Ning, Huan; Men, Hongchao; Hou, Rong; Fu, Mingui; Zhang, Hailin; Liu, Jianguo			Regulation of CCL5 Expression in Smooth Muscle Cells Following Arterial Injury	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INTERFERON-INDUCIBLE PROTEIN-10; CARDIOVASCULAR RISK MARKERS; NATURAL-KILLER-CELLS; FACTOR-KAPPA-B; TRANSCRIPTION FACTOR; IN-VIVO; NEOINTIMA FORMATION; GENE-TRANSCRIPTION; IMMUNE-RESPONSES	Chemokines play a crucial role in inflammation and in the pathophysiology of atherosclerosis by recruiting inflammatory immune cells to the endothelium. Chemokine CCL5 has been shown to be involved in atherosclerosis progression. However, little is known about how CCL5 is regulated in vascular smooth muscle cells. In this study we report that CCL5 mRNA expression was induced and peaked in aorta at day 7 and then declined after balloon artery injury, whereas IP-10 and MCP-1 mRNA expression were induced and peaked at day 3 and then rapidly declined. The expression of CCL5 receptors (CCR1, 3 & 5) were also rapidly induced and then declined except CCR5 which expression was still relatively high at day 14 after balloon injury. In rat smooth muscle cells (SMCs), similar as in aorta CCL5 mRNA expression was induced and kept increasing after LPS plus IFN-gamma stimulation, whereas IP-10 mRNA expression was rapidly induced and then declined. Our data further indicate that induction of CCL5 expression in SMCs was mediated by IRF-1 via binding to the IRF-1 response element in CCL5 promoter. Moreover, p38 MAPK was involved in suppression of CCL5 and IP-10 expression in SMCs through common upstream molecule MKK3. The downstream molecule MK2 was required for p38-mediated CCL5 but not IP-10 inhibition. Our findings indicate that CCL5 induction in aorta and SMCs is mediated by IRF-1 while activation of p38 MAPK signaling inhibits CCL5 and IP-10 expression. Methods targeting MK2 expression could be used to selectively regulate CCL5 but not IP-10 expression in SMCs.	[Liu, Huan; Men, Hongchao; Zhang, Hailin] Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Peoples R China; [Liu, Huan] Heibei N Univ, Coll Med, Zhangjiakou, Peoples R China; [Ning, Huan; Hou, Rong; Liu, Jianguo] St Louis Univ, Sch Med, Dept Internal Med, Div Infect Dis Allergy & Immunol, St Louis, MO USA; [Fu, Mingui] Univ Missouri Kansas City, Sch Med, Dept Basic Med Sci, Kansas City, MO USA; [Fu, Mingui] Univ Missouri Kansas City, Shock Trauma Res Ctr, Kansas City, MO USA	Hebei Medical University; Saint Louis University; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Liu, H (corresponding author), Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Peoples R China.	zhanghl@hebmu.edu.cn; jliu9@slu.edu	NING, HUAN/R-4786-2018		National Natural Science Foundation of China [30730031]; 973 Program [2007CB512100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	Start-up fund to JL; National Natural Science Foundation of China (30730031) and the 973 Program (2007CB512100) to HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Bjorkbacka H, 2006, CURR OPIN LIPIDOL, V17, P527; Braunersreuther V, 2008, ARTERIOSCL THROM VAS, V28, P1090, DOI 10.1161/ATVBAHA.108.165423; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; CLOWES AW, 1983, LAB INVEST, V49, P208; Duncan GS, 1996, J EXP MED, V184, P2043, DOI 10.1084/jem.184.5.2043; Erickson L, 2004, TRANSPL IMMUNOL, V13, P169, DOI 10.1016/j.trim.2004.06.003; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Giese NA, 1997, J EXP MED, V186, P1535, DOI 10.1084/jem.186.9.1535; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GUNTHER S, 1982, J CELL BIOL, V92, P289, DOI 10.1083/jcb.92.2.289; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hertzog PJ, 2003, TRENDS IMMUNOL, V24, P534, DOI 10.1016/j.it.2003.08.006; Hou R, 2006, J CELL BIOL, V173, P417, DOI 10.1083/jcb.200508121; Hou R, 2009, J BIOL CHEM, V284, P6955, DOI 10.1074/jbc.M809333200; Koh SJ, 2009, INT J CARDIOL, V132, P102, DOI 10.1016/j.ijcard.2007.10.038; Kovacic JC, 2010, J CLIN INVEST, V120, P303, DOI 10.1172/JCI40364; Krohn R, 2007, CIRCULATION, V116, P1812, DOI 10.1161/CIRCULATIONAHA.107.708016; Lee AH, 2000, BIOCHEM J, V350, P131, DOI 10.1042/0264-6021:3500131; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Levy JA, 2009, J IMMUNOL, V182, P3945, DOI 10.4049/jimmunol.0990015; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu JG, 2005, J BIOL CHEM, V280, P24347, DOI 10.1074/jbc.M500973200; Liu JG, 2003, J EXP MED, V198, P1265, DOI 10.1084/jem.20030026; Liu JG, 2006, J BIOL CHEM, V281, P19188, DOI 10.1074/jbc.M602059200; Lohoff M, 2000, J EXP MED, V192, P325, DOI 10.1084/jem.192.3.325; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Ogasawara K, 1998, NATURE, V391, P700, DOI 10.1038/35636; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Ohteki T, 1998, J EXP MED, V187, P967, DOI 10.1084/jem.187.6.967; Raines EW, 2005, J LIPID RES, V46, P1081, DOI 10.1194/jlr.R500004-JLR200; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rothenbacher D, 2006, ARTERIOSCL THROM VAS, V26, P194, DOI 10.1161/01.ATV.0000191633.52585.14; SCHALL TJ, 1988, J IMMUNOL, V141, P1018; Schober A, 2002, CIRCULATION, V106, P1523, DOI 10.1161/01.CIR.0000028590.02477.6F; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sikorski K, 2011, AM J PHYSL CELL PHYS; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Torella D, 2007, AM J PHYSIOL-HEART C, V292, pH2935, DOI 10.1152/ajpheart.00887.2006; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772; Wang XK, 1996, J BIOL CHEM, V271, P24286, DOI 10.1074/jbc.271.39.24286; Weber KSC, 1999, EUR J IMMUNOL, V29, P700, DOI 10.1002/(SICI)1521-4141(199902)29:02<700::AID-IMMU700>3.0.CO;2-1; Zhang JD, 2010, J BIOL CHEM, V285, P21269, DOI 10.1074/jbc.M110.100818	51	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30873	10.1371/journal.pone.0030873	http://dx.doi.org/10.1371/journal.pone.0030873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292067	Green Submitted, gold, Green Published			2022-12-27	WOS:000301570600091
J	Okamoto, S; Sato, M; Toda, T; Yamamoto, M				Okamoto, Shin-ya; Sato, Masamitsu; Toda, Takashi; Yamamoto, Masayuki			SCF Ensures Meiotic Chromosome Segregation Through a Resolution of Meiotic Recombination Intermediates	PLOS ONE			English	Article							FISSION YEAST SKP1; BOX DNA HELICASE; F-BOX; SCHIZOSACCHAROMYCES-POMBE; RHP51-DEPENDENT RECOMBINATION; UBIQUITIN LIGASE; DISTINCT ROLES; PROTEIN; MEIOSIS; CENTROMERE	The SCF (Skp1-Cul1-F-box) complex contributes to a variety of cellular events including meiotic cell cycle control, but its function during meiosis is not understood well. Here we describe a novel function of SCF/Skp1 in meiotic recombination and subsequent chromosome segregation. The skp1 temperature-sensitive mutant exhibited abnormal distribution of spindle microtubules in meiosis II, which turned out to originate from abnormal bending of the spindle in meiosis I. Bent spindles were reported in mitosis of this mutant, but it remained unknown how SCF could affect spindle morphology. We found that the meiotic bent spindle in skp1 cells was due to a hypertension generated by chromosome entanglement. The spindle bending was suppressed by inhibiting double strand break (DSB) formation, indicating that the entanglement was generated by the meiotic recombination machinery. Consistently, Rhp51/Rad51-Rad22/Rad52 foci persisted until meiosis I in skp1 cells, proving accumulation of recombination intermediates. Intriguingly bent spindles were also observed in the mutant of Fbh1, an F-box protein containing the DNA helicase domain, which is involved in meiotic recombination. Genetic evidence suggested its cooperation with SCF/Skp1. Thus, SCF/Skp1 together with Fbh1 is likely to function in the resolution of meiotic recombination intermediates, thereby ensuring proper chromosome segregation.	[Okamoto, Shin-ya; Sato, Masamitsu; Yamamoto, Masayuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan; [Sato, Masamitsu] Japan Sci & Technol Agcy, PRESTO, Honcho Kawaguchi, Saitama, Japan; [Toda, Takashi] Lincolns Inn Fields Labs, Canc Res UK, Lab Cell Regulat, London Res Inst, London, England; [Yamamoto, Masayuki] Kazusa DNA Res Inst, Kisarazu, Chiba, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Cancer Research UK; Kazusa DNA Research Institute	Okamoto, S (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan.	masasato@biochem.s.u-tokyo.ac.jp	Okamoto, Shin-ya/C-8175-2017		Japan Society for the Promotion of Science (JSPS); PRESTO of JST; Global COE; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Cancer Research UK; Grants-in-Aid for Scientific Research [21227007] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); PRESTO of JST; Global COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cancer Research UK(Cancer Research UK); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MS and MY are supported by Grants-in-Aid from Japan Society for the Promotion of Science (JSPS) and also by a PRESTO program of JST (MS) and a Global COE program (MY) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. TT is supported by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu Y, 2007, EMBO J, V26, P1352, DOI 10.1038/sj.emboj.7601582; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barbour L, 2003, MUTAT RES-FUND MOL M, V532, P137, DOI 10.1016/j.mrfmmm.2003.08.014; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cromie GA, 2008, GENETICS, V179, P1157, DOI 10.1534/genetics.108.088955; Du LL, 2003, MOL CELL BIOL, V23, P6150, DOI 10.1128/MCB.23.17.6150-6158.2003; Harrison C, 2005, EMBO J, V24, P599, DOI 10.1038/sj.emboj.7600536; Hermand D, 2003, J BIOL CHEM, V278, P9671, DOI 10.1074/jbc.M211358200; Jallepalli PV, 1998, P NATL ACAD SCI USA, V95, P8159, DOI 10.1073/pnas.95.14.8159; Jourdain I, 2009, BIOCHEM J, V420, P169, DOI 10.1042/BJ20081659; Katayama S, 2002, MOL BIOL CELL, V13, P211, DOI 10.1091/mbc.01-07-0333; Kominami K, 1998, GENES CELLS, V3, P721, DOI 10.1046/j.1365-2443.1998.00225.x; Kominami K, 1997, GENE DEV, V11, P1548, DOI 10.1101/gad.11.12.1548; Kurokawa Y, 2008, PLOS BIOL, V6, P836, DOI 10.1371/journal.pbio.0060088; Lehmann A, 2004, GENES CELLS, V9, P367, DOI 10.1111/j.1356-9597.2004.00730.x; Lehmann A, 2004, FEBS LETT, V566, P77, DOI 10.1016/j.febslet.2004.04.022; LIN YK, 1994, GENETICS, V136, P769; Mamnun YM, 2006, BIOCHEM BIOPH RES CO, V350, P125, DOI 10.1016/j.bbrc.2006.09.024; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morishita T, 2005, MOL CELL BIOL, V25, P8074, DOI 10.1128/MCB.25.18.8074-8083.2005; MURIS DFR, 1993, NUCLEIC ACIDS RES, V21, P4586, DOI 10.1093/nar/21.19.4586; Octobre G, 2008, GENETICS, V178, P2399, DOI 10.1534/genetics.107.085696; Osman F, 2005, MOL CELL BIOL, V25, P8084, DOI 10.1128/MCB.25.18.8084-8096.2005; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Sakaguchi C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-27; Sakuno T, 2009, CHROMOSOME RES, V17, P239, DOI 10.1007/s10577-008-9013-y; Sato M, 2009, METHODS MOL BIOL, V545, P185, DOI 10.1007/978-1-60327-993-2_11; Sharif WD, 2002, CELL CHROMOSOME, V1, P1; Sun W, 2011, NUCLEIC ACIDS RES, V39, P1718, DOI 10.1093/nar/gkq977; Sunnerhagen P, 2007, MOL GENET GENOMICS, V277, P341, DOI 10.1007/s00438-007-0221-5; Takayama Y, 2010, DEV CELL, V18, P385, DOI 10.1016/j.devcel.2009.12.024; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Wolf DA, 1999, CURR BIOL, V9, P373, DOI 10.1016/S0960-9822(99)80165-1; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Young JA, 2004, GENETICS, V167, P593, DOI 10.1534/genetics.103.023762	40	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30622	10.1371/journal.pone.0030622	http://dx.doi.org/10.1371/journal.pone.0030622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292001	gold, Green Published, Green Submitted			2022-12-27	WOS:000301570600065
J	Viaux-Savelon, S; Dommergues, M; Rosenblum, O; Bodeau, N; Aidane, E; Philippon, O; Mazet, P; Vibert-Guigue, C; Vauthier-Brouzes, D; Feldman, R; Cohen, D				Viaux-Savelon, Sylvie; Dommergues, Marc; Rosenblum, Ouriel; Bodeau, Nicolas; Aidane, Elizabeth; Philippon, Odile; Mazet, Philippe; Vibert-Guigue, Claude; Vauthier-Brouzes, Daniele; Feldman, Ruth; Cohen, David			Prenatal Ultrasound Screening: False Positive Soft Markers May Alter Maternal Representations and Mother-Infant Interaction	PLOS ONE			English	Article							CHOROID-PLEXUS CYSTS; POSTPARTUM DEPRESSION; ANTENATAL ANXIETY; PREMATURE-INFANTS; 2ND TRIMESTER; PREGNANCY; PREVALENCE; HEALTH; RISK; INFORMATION	Background: In up to 5% of pregnancies, ultrasound screening detects a "soft marker" (SM) that places the foetus at risk for a severe abnormality. In most cases, prenatal diagnostic work-up rules out a severe defect. We aimed to study the effects of false positive SM on maternal emotional status, maternal representations of the infant, and mother-infant interaction. Methodology and Principal Findings: Utilizing an extreme-case prospective case control design, we selected from a group of 244 women undergoing ultrasound, 19 pregnant women whose foetus had a positive SM screening and a reassuring diagnostic work up, and 19 controls without SM matched for age and education. In the third trimester of pregnancy, within one week after delivery, and 2 months postpartum, we assessed anxiety, depression, and maternal representations. Mother-infant interactions were videotaped during feeding within one week after delivery and again at 2 months postpartum and coded blindly using the Coding Interactive Behavior (CIB) scales. Anxiety and depression scores were significantly higher at all assessment points in the SM group. Maternal representations were also different between SM and control groups at all study time. Perturbations to early mother-infant interactions were observed in the SM group. These dyads showed greater dysregulation, lower maternal sensitivity, higher maternal intrusive behaviour and higher infant avoidance. Multivariate analysis showed that maternal representation and depression at third trimester predicted mother-infant interaction. Conclusion: False positive ultrasound screenings for SM are not benign and negatively affect the developing maternal-infant attachment. Medical efforts should be directed to minimize as much as possible such false diagnoses, and to limit their psychological adverse consequences.	[Viaux-Savelon, Sylvie; Rosenblum, Ouriel; Bodeau, Nicolas; Aidane, Elizabeth; Mazet, Philippe; Cohen, David] GH Pitie Salpetriere, APHP, Dept Child & Adolescent Psychiat, Paris, France; [Viaux-Savelon, Sylvie; Cohen, David] Univ Paris 06, CNRS, Inst Syst Intelligents & Robot, UMR 7222, Paris, France; [Dommergues, Marc; Philippon, Odile; Vibert-Guigue, Claude; Vauthier-Brouzes, Daniele] Univ Paris 06, Grp Hosp Pitie Salpetriere, APHP, Serv Gynecol Obstet, Paris, France; [Rosenblum, Ouriel] Univ Bourgogne, Lab Psychopathol & Psychol Med, Dijon, France; [Feldman, Ruth] Bar Ilan Univ, Gonda Brain Res & Psychol Dept, Tel Aviv, Israel	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Bourgogne; Bar Ilan University	Viaux-Savelon, S (corresponding author), GH Pitie Salpetriere, APHP, Dept Child & Adolescent Psychiat, Paris, France.	david.cohen@psl.aphp.fr	sylvie, viaux/ABE-4705-2021	sylvie, viaux/0000-0002-4555-3499	Mustela Foundation	Mustela Foundation	S.V. received a Ph.D. grant from the Mustela Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammaniti M, 2006, INFANT MENT HEALTH J, V27, P70, DOI 10.1002/imhj.20081; BRAZELTON TB, 1983, NEUROPSYCHIAT ENFAN, V31, P61; Covi L, 1986, Md Med J, V35, P821; Dollberg D, 2010, EUR CHILD ADOLES PSY, V19, P25, DOI 10.1007/s00787-009-0036-5; Dubey C, 2011, INT J SOC PSYCHIAT; Ekelin M, 2009, PRENATAL DIAG, V29, P952, DOI 10.1002/pd.2324; Ekstrom A, 2006, PEDIATRICS, V118, pE309, DOI 10.1542/peds.2005-2064; Feldman R, 2004, J AM ACAD CHILD PSY, V43, P1089, DOI 10.1097/01.chi.0000132810.98922.83; Feldman R, 2003, DEV PSYCHOBIOL, V43, P109, DOI 10.1002/dev.10126; Feldman R, 2000, INT SOC INF STUD; Feldman R., 2005, BIENN M SOC RES CHIL; Feldman R, 2007, J CHILD PSYCHOL PSYC, V48, P329, DOI 10.1111/j.1469-7610.2006.01701.x; Field T, 2003, DEPRESS ANXIETY, V17, P140, DOI 10.1002/da.10071; FONAGY P, 1991, CHILD DEV, V62, P891, DOI 10.1111/j.1467-8624.1991.tb01578.x; Gerardin P., 2012, NEUROPSYCHIATR ENFAN, V60, P138, DOI [10.1016/j.neurenf.2011.10.006, DOI 10.1016/J.NEURENF.2011.10.006]; Gerardin P, 2011, J CLIN PSYCHIAT, V72, P378, DOI 10.4088/JCP.09m05724blu; Gotzmann L, 2002, ULTRASCHALL MED, V23, P333, DOI 10.1055/s-2002-35052; Gotzmann L, 2002, ULTRASCHALL MED, V23, P27, DOI 10.1055/s-2002-20072; Kaasen A, 2010, BJOG-INT J OBSTET GY, V117, P1127, DOI 10.1111/j.1471-0528.2010.02622.x; Kaiser S, 2003, PSYCHONEUROENDOCRINO, V28, P67, DOI 10.1016/S0306-4530(02)00010-0; Keren M, 2001, J AM ACAD CHILD PSY, V40, P27, DOI 10.1097/00004583-200101000-00013; Larsson AK, 2009, J PSYCHOSOM OBST GYN, V30, P95, DOI 10.1080/01674820903030173; Larsson AK, 2009, J PSYCHOSOM OBST GYN, V30, P48, DOI 10.1080/01674820802621775; Lauer JA, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-26; Mortensen EL, 2002, JAMA-J AM MED ASSOC, V287, P2365, DOI 10.1001/jama.287.18.2365; Nagy E, 2011, PSYCHIAT RES, V185, P113, DOI 10.1016/j.psychres.2010.05.005; Nicolaides KH, 2004, AM J OBSTET GYNECOL, V191, P45, DOI 10.1016/j.ajog.2004.03.090; O'Connor TG, 2002, J AM ACAD CHILD PSY, V41, P1470, DOI 10.1097/00004583-200212000-00019; O'Connor TG, 2002, BRIT J PSYCHIAT, V180, P502, DOI 10.1192/bjp.180.6.502; Ohman SG, 2004, ACTA OBSTET GYN SCAN, V83, P634; Petersen J, 2008, BIRTH-ISS PERINAT C, V35, P41, DOI 10.1111/j.1523-536X.2007.00210.x; POP VJM, 1993, ACTA OBSTET GYN SCAN, V72, P354, DOI 10.3109/00016349309021112; RASKIN A, 1976, J PSYCHIAT RES, V13, P31, DOI 10.1016/0022-3956(76)90007-8; Schonholzer SM, 2000, GYNAKOL GEBURT RUNDS, V40, P119, DOI 10.1159/000053012; Sethna F, 2011, OBSTET GYNECOL, V117, P867, DOI 10.1097/AOG.0b013e3182117471; Siddiqui A, 2000, EARLY HUM DEV, V59, P13, DOI 10.1016/S0378-3782(00)00076-1; Silberstein D, 2009, INFANCY, V14, P501, DOI 10.1080/15250000903144173; Smith-Bindman R, 2007, PRENATAL DIAG, V27, P535, DOI 10.1002/pd.1725; Stern D, 1998, Pediatrics, V102, P1250; Tordjman S., 2004, PRESENTATION VALIDAT; Van den Hof MC, 2005, J OBSTET GYNAECOL CA, V27, P592; Viaux-Savelon S., 2007, NEUROPSYCHIATRIE ENF, V55, P413; Watson MS, 2002, PRENATAL DIAG, V22, P569, DOI 10.1002/pd.373; Zeanah C, 2000, HDB INFANT MENTAL HL, P176	44	40	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30935	10.1371/journal.pone.0030935	http://dx.doi.org/10.1371/journal.pone.0030935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	909NE	22292077	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600097
J	Beyer, M; Schumak, B; Weihrauch, MR; Andres, B; Giese, T; Endl, E; Knolle, PA; Classen, S; Limmer, A; Schultze, JL				Beyer, Marc; Schumak, Beatrix; Weihrauch, Martin R.; Andres, Bettina; Giese, Thomas; Endl, Elmar; Knolle, Percy A.; Classen, Sabine; Limmer, Andreas; Schultze, Joachim L.			In vivo Expansion of Naive CD4(+)CD25(high) FOXP3(+) Regulatory T Cells in Patients with Colorectal Carcinoma after IL-2 Administration	PLOS ONE			English	Article							HIGH-DOSE INTERLEUKIN-2; EFFECTOR MEMORY PHENOTYPE; COLONY-STIMULATING FACTOR; CANCER-PATIENTS; TUMOR MICROENVIRONMENT; PERIPHERAL EXPANSION; ADVANCED MELANOMA; IMMUNE-RESPONSES; ACTIVATION; EXPRESSION	Regulatory T cells (T-reg cells) are increased in context of malignancies and their expansion can be correlated with higher disease burden and decreased survival. Initially, interleukin 2 (IL-2) has been used as T-cell growth factor in clinical vaccination trials. In murine models, however, a role of IL-2 in development, differentiation, homeostasis, and function of T-reg cells was established. In IL-2 treated cancer patients a further T-reg-cell expansion was described, yet, the mechanism of expansion is still elusive. Here we report that functional T-reg cells of a naive phenotype - as determined by CCR7 and CD45RA expression - are significantly expanded in colorectal cancer patients. Treatment of 15 UICC stage IV colorectal cancer patients with IL-2 in a phase I/II peptide vaccination trial further enlarges the already increased naive T-reg-cell pool. Higher frequencies of T-cell receptor excision circles in naive T-reg cells indicate IL-2 dependent thymic generation of naive T-reg cells as a mechanism leading to increased frequencies of T-reg cells post IL-2 treatment in cancer patients. This finding could be confirmed in naive murine T-reg cells after IL-2 administration. These results point to a more complex regulation of T-reg cells in context of IL-2 administration. Future strategies therefore might aim at combining IL-2 therapy with novel strategies to circumvent expansion and differentiation of naive T-reg cells.	[Beyer, Marc; Classen, Sabine; Schultze, Joachim L.] Univ Bonn, Life & Med Sci Inst, Bonn, Germany; [Schumak, Beatrix] Univ Bonn, IMMIP, Bonn, Germany; [Weihrauch, Martin R.; Andres, Bettina] Univ Cologne, Clin Internal Med 1, D-50931 Cologne, Germany; [Giese, Thomas] Heidelberg Univ, Inst Immunol, D-6900 Heidelberg, Germany; [Endl, Elmar; Knolle, Percy A.; Limmer, Andreas] Univ Bonn, Inst Mol Med & Expt Immunol, Bonn, Germany	University of Bonn; University of Bonn; University of Cologne; Ruprecht Karls University Heidelberg; University of Bonn	Beyer, M (corresponding author), Univ Bonn, Life & Med Sci Inst, Bonn, Germany.	marc.beyer@uni-bonn.de; j.schultze@uni-bonn.de	Beyer, Marc/ABE-1408-2021; Schultze, Joachim L./ABA-8176-2020; Schultze, Joachim L/D-7794-2011	Beyer, Marc/0000-0001-9704-148X; Schultze, Joachim L./0000-0003-2812-9853; Schultze, Joachim L/0000-0003-2812-9853; Knolle, Percy A./0000-0003-2983-0414	Alexander von Humboldt-Foundation; Wilhelm-Sander Stiftung; Deutsche-Jose-Carreras-Leukamie-Striftung; German Research Foundation [SFB 704, SFB 832, INST 217/576-1, INST 217/577-1]; Becton Dickinson	Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation); Wilhelm-Sander Stiftung; Deutsche-Jose-Carreras-Leukamie-Striftung; German Research Foundation(German Research Foundation (DFG)); Becton Dickinson	This work was supported by the Sofja Kovalevskaja Award of the Alexander von Humboldt-Foundation (JLS), the Wilhelm-Sander Stiftung (JLS and MB), the Deutsche-Jose-Carreras-Leukamie-Striftung (JLS and MB), and the German Research Foundation (SFB 704, SFB 832, INST 217/576-1, INST 217/577-1). JLS and MB have received support through a research grant from Becton Dickinson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2006, BLOOD, V107, P2409, DOI 10.1182/blood-2005-06-2399; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Baecher-Allan C, 2004, SEMIN IMMUNOL, V16, P89, DOI 10.1016/j.smim.2003.12.005; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Beyer M, 2005, BLOOD, V106, P2018, DOI 10.1182/blood-2005-02-0642; Beyer M, 2008, CURR ONCOL REP, V10, P130, DOI 10.1007/s11912-008-0021-z; Beyer M, 2007, J CLIN ONCOL, V25, P2628, DOI 10.1200/JCO.2006.08.0192; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Beyer M, 2006, BLOOD, V107, P3940, DOI 10.1182/blood-2005-09-3671; Beyer M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/734036; Beyer M, 2009, CURR PHARM DESIGN, V15, P1879, DOI 10.2174/138161209788453211; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Cesana GC, 2006, J CLIN ONCOL, V24, P1169, DOI 10.1200/JCO.2005.03.6830; Chen X, 2006, EUR J IMMUNOL, V36, P2139, DOI 10.1002/eji.200635873; Chu YW, 2004, BLOOD, V104, P1110, DOI 10.1182/blood-2003-10-3635; Clarke SL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000129; Correale P, 2005, J CLIN ONCOL, V23, P8950, DOI 10.1200/JCO.2005.12.147; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Ghiringhelli F, 2004, EUR J IMMUNOL, V34, P336, DOI 10.1002/eji.200324181; Hori S, 2002, EUR J IMMUNOL, V32, P3729, DOI 10.1002/1521-4141(200212)32:12<3729::AID-IMMU3729>3.0.CO;2-2; Jensen HK, 2009, CLIN CANCER RES, V15, P1052, DOI 10.1158/1078-0432.CCR-08-1296; Kasow KA, 2004, J IMMUNOL, V172, P6123, DOI 10.4049/jimmunol.172.10.6123; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Ling Khoon Lin, 2007, Cancer Immun, V7, P7; Mahnke K, 2007, INT J CANCER, V120, P2723, DOI 10.1002/ijc.22617; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Morse MA, 2008, BLOOD, V112, P610, DOI 10.1182/blood-2008-01-135319; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Santner-Nanan B, 2008, INT IMMUNOL, V20, P375, DOI 10.1093/intimm/dxm151; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; SEDDIKI N, 2005, BLOOD; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shevach EM, 2001, J EXP MED, V193, pF41, DOI 10.1084/jem.193.11.F41; Shimizu J, 1999, J IMMUNOL, V163, P5211; Sosman JA, 2008, J CLIN ONCOL, V26, P2292, DOI 10.1200/JCO.2007.13.3165; Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tosello V, 2008, CLIN IMMUNOL, V126, P291, DOI 10.1016/j.clim.2007.11.008; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; van der Vliet HJJ, 2007, CLIN CANCER RES, V13, P2100, DOI 10.1158/1078-0432.CCR-06-1662; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Wei S, 2007, CANCER RES, V67, P7487, DOI 10.1158/0008-5472.CAN-07-0565; Weihrauch MR, 2005, CLIN CANCER RES, V11, P5993, DOI 10.1158/1078-0432.CCR-05-0018; Yaqub S, 2008, CANCER IMMUNOL IMMUN, V57, P813, DOI 10.1007/s00262-007-0417-x; Zhang H, 2005, NAT MED, V11, P1238, DOI 10.1038/nm1312; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	58	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30422	10.1371/journal.pone.0030422	http://dx.doi.org/10.1371/journal.pone.0030422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276195	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100046
J	Spisak, BR; Dekker, PH; Kruger, M; van Vugt, M				Spisak, Brian R.; Dekker, Peter H.; Kruger, Max; van Vugt, Mark			Warriors and Peacekeepers: Testing a Biosocial Implicit Leadership Hypothesis of Intergroup Relations Using Masculine and Feminine Faces	PLOS ONE			English	Article							SEX-DIFFERENCES; TESTOSTERONE; COOPERATION; COMPETITION; INFERENCES; RESPONSES; GENDER	This paper examines the impact of facial cues on leadership emergence. Using evolutionary social psychology, we expand upon implicit and contingent theories of leadership and propose that different types of intergroup relations elicit different implicit cognitive leadership prototypes. It is argued that a biologically based hormonal connection between behavior and corresponding facial characteristics interacts with evolutionarily consistent social dynamics to influence leadership emergence. We predict that masculine-looking leaders are selected during intergroup conflict (war) and feminine-looking leaders during intergroup cooperation (peace). Across two experiments we show that a general categorization of leader versus nonleader is an initial implicit requirement for emergence, and at a context-specific level facial cues of masculinity and femininity contingently affect war versus peace leadership emergence in the predicted direction. In addition, we replicate our findings in Experiment 1 across culture using Western and East Asian samples. In Experiment 2, we also show that masculine-feminine facial cues are better predictors of leadership than male-female cues. Collectively, our results indicate a multi-level classification of context-specific leadership based on visual cues imbedded in the human face and challenge traditional distinctions of male and female leadership.	[Spisak, Brian R.; Dekker, Peter H.; Kruger, Max; van Vugt, Mark] Univ Amsterdam, Vrije Univ, Dept Social & Org Psychol, Amsterdam, Netherlands; [van Vugt, Mark] Univ Oxford, Inst Cognt & Evolutionary Anthropol, Oxford, England	University of Amsterdam; Vrije Universiteit Amsterdam; University of Oxford	Spisak, BR (corresponding author), Univ Amsterdam, Vrije Univ, Dept Social & Org Psychol, Amsterdam, Netherlands.	b.r.spisak@vu.nl		Kruger, Max/0000-0002-5686-0566; Spisak, Brian/0000-0002-6628-2034				[Anonymous], 2006, LEADERSHIP ORG; Antonakis J, 2009, SCIENCE, V323, P1183, DOI 10.1126/science.1167748; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Bass B. M., 1990, BASS STOGDILLS HDB L; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; Brown D. E., 1991, HUMAN UNIVERSALS; CASHDAN E, 1995, HORM BEHAV, V29, P354, DOI 10.1006/hbeh.1995.1025; CHAGNON NA, 1988, HUMAN REPRODUCTIVE B, P23; DABBS JM, 1995, PERS INDIV DIFFER, V18, P627, DOI 10.1016/0191-8869(94)00177-T; DeBruine LM, 2011, P NATL ACAD SCI USA, V108, P11710, DOI 10.1073/pnas.1105919108; Decety J, 2004, NEUROIMAGE, V23, P744, DOI 10.1016/j.neuroimage.2004.05.025; DEWAAL FBM, 1993, SOC ECON, P285; Dittrich R, 2002, COMPUT STAT DATA AN, V40, P39, DOI 10.1016/S0167-9473(01)00106-2; DUNBAR RIM, 1983, Z TIERPSYCHOL, V63, P265; EAGLY AH, 1990, PSYCHOL BULL, V108, P233, DOI 10.1037/0033-2909.108.2.233; Fiedler F.E., 1978, ADV EXPT SOCIAL PSYC, V11, P59, DOI DOI 10.1016/S0065-2601(08)60005-2; Gibson SJ, 2009, INT J ELECTRON SECUR, V2, P156, DOI 10.1504/IJESDF.2009.024900; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hogg MA, 2001, PERS SOC PSYCHOL REV, V5, P184, DOI 10.1207/S15327957PSPR0503_1; Johnson Allen, 2000, EVOLUTION HUMAN SOC; Johnson DDP, 2009, BEHAV BRAIN SCI, V32, P280, DOI 10.1017/S0140525X09990409; Jones BC, 2010, P ROY SOC B-BIOL SCI, V277, P617, DOI 10.1098/rspb.2009.1575; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; Keeley LH, 1996, WARFARE CIVILIZATION; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; LAMPRECHT J, 1992, BEHAVIOUR, V122, P105, DOI 10.1163/156853992X00336; Leca JB, 2003, ANIM BEHAV, V66, P1045, DOI 10.1006/anbe.2003.2276; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; LORD RG, 1984, ORGAN BEHAV HUM PERF, V34, P343, DOI 10.1016/0030-5073(84)90043-6; Maher KJ., 1991, LEADERSHIP INFORM PR; Mathew S, 2011, P NATL ACAD SCI USA, V108, P11375, DOI 10.1073/pnas.1105604108; Navarrete CD, 2010, J PERS SOC PSYCHOL, V98, P933, DOI 10.1037/a0017931; Ohman A, 2003, CURR DIR PSYCHOL SCI, V12, P5, DOI 10.1111/1467-8721.01211; Pound N, 2009, P ROY SOC B-BIOL SCI, V276, P153, DOI 10.1098/rspb.2008.0990; Quist MC, 2011, PERS INDIV DIFFER, V50, P1089, DOI 10.1016/j.paid.2011.01.032; REINHARDT V, 1983, BEHAVIOUR, V83, P251, DOI 10.1163/156853983X00183; Rule NO, 2008, PSYCHOL SCI, V19, P109, DOI 10.1111/j.1467-9280.2008.02054.x; Scott IML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013585; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Simon HA, 1955, Q J ECON, V69, P99, DOI 10.2307/1884852; Spisak BR, 2012, LEADERSHIP QUART, V23, P273, DOI 10.1016/j.leaqua.2011.08.006; Spisak BR, 2011, EVOLUTIONARY PSYCHOLOGY IN THE BUSINESS SCIENCES, P165, DOI 10.1007/978-3-540-92784-6_7; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Thornhill R, 1997, BIOL REV, V72, P497, DOI 10.1017/S0006323197005082; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Tooby J., 1988, 881 I EV STUD; Van Vugt M, 1999, J PERS SOC PSYCHOL, V76, P587, DOI 10.1037/0022-3514.76.4.587; Van Vugt M, 2008, PSYCHOL SCI, V19, P854, DOI 10.1111/j.1467-9280.2008.02168.x; Van Vugt M, 2007, PSYCHOL SCI, V18, P19, DOI 10.1111/j.1467-9280.2007.01842.x; Van Vugt M, 2006, PERS SOC PSYCHOL REV, V10, P354, DOI 10.1207/s15327957pspr1004_5; van Vugt M, 2007, SYD SYM SOC PSYCHOL, P229; Van Vugt M, 2009, AM PSYCHOL, V64, P54, DOI 10.1037/a0014178; Watkins CD, 2010, PERS INDIV DIFFER, V49, P967, DOI 10.1016/j.paid.2010.08.006; Wilson DS, 2008, CURR DIR PSYCHOL SCI, V17, P6, DOI 10.1111/j.1467-8721.2008.00538.x; Wrangham Richard, 1996, DEMONIC MALES APES O; ZEBROWITZ LA, 1997, PERSONALITY SOCIAL P, V1, P203; Zebrowitz LA, 2008, SOC PERSONAL PSYCHOL, V2, P1497, DOI 10.1111/j.1751-9004.2008.00109.x	58	75	75	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30399	10.1371/journal.pone.0030399	http://dx.doi.org/10.1371/journal.pone.0030399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	909MH	22276190	gold, Green Published, Green Submitted			2022-12-27	WOS:000301568100042
J	Turck, M; Bierbaum, G				Tuerck, Michael; Bierbaum, Gabriele			Purification and Activity Testing of the Full-Length YycFGHI Proteins of Staphylococcus aureus	PLOS ONE			English	Article							SENSOR HISTIDINE KINASE; 2-COMPONENT SIGNAL-TRANSDUCTION; BLUE NATIVE ELECTROPHORESIS; GRAM-POSITIVE BACTERIA; TRITON X-100 MICELLES; CELL-WALL METABOLISM; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; STREPTOCOCCUS-PNEUMONIAE; SOLVATION DYNAMICS	Background: The YycFG two-component regulatory system (TCS) of Staphylococcus aureus represents the only essential TCS that is almost ubiquitously distributed in Gram-positive bacteria with a low G+C-content. YycG (WalK/VicK) is a sensor histidine-kinase and YycF (WalR/VicR) is the cognate response regulator. Both proteins play an important role in the biosynthesis of the cell envelope and mutations in these proteins have been involved in development of vancomycin and daptomycin resistance. Methodology/Principal Findings: Here we present high yield expression and purification of the full-length YycG and YycF proteins as well as of the auxiliary proteins YycH and YycI of Staphylococcus aureus. Activity tests of the YycG kinase and a mutated version, that harbours an Y306N exchange in its cytoplasmic PAS domain, in a detergent-micelle-model and a phosholipid-liposome-model showed kinase activity (autophosphorylation and phosphoryl group transfer to YycF) only in the presence of elevated concentrations of alkali salts. A direct comparison of the activity of the kinases in the liposome-model indicated a higher activity of the mutated YycG kinase. Further experiments indicated that YycG responds to fluidity changes in its microenvironment. Conclusions/Significance: The combination of high yield expression, purification and activity testing of membrane and membrane-associated proteins provides an excellent experimental basis for further protein-protein interaction studies and for identification of all signals received by the YycFGHI system.	[Tuerck, Michael; Bierbaum, Gabriele] Univ Bonn, IMMIP, Bonn, Germany	University of Bonn	Turck, M (corresponding author), Univ Bonn, IMMIP, Bonn, Germany.	bierbaum@mibi03.meb.uni-bonn.de			DFG (Deutsche Forschungsgemeinschaft) [Bi504-8/1-8/3]; Medical Faculty of the University of Bonn	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Medical Faculty of the University of Bonn	This study was supported by a grant of the DFG to G. Bierbaum (Deutsche Forschungsgemeinschaft Bi504-8/1-8/3) and the Bonfor program of the Medical Faculty of the University of Bonn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMREIN KE, 1995, P NATL ACAD SCI USA, V92, P1048, DOI 10.1073/pnas.92.4.1048; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Charlton ID, 2000, J PHYS CHEM B, V104, P8327, DOI 10.1021/jp994424v; Clausen VA, 2003, J MOL MICROB BIOTECH, V5, P252, DOI 10.1159/000071077; Cybulski LE, 2010, CURR BIOL, V20, P1539, DOI 10.1016/j.cub.2010.06.074; Delaune A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017054; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; Fabret C, 1998, J BACTERIOL, V180, P6375; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Fukushima T, 2008, MOL MICROBIOL, V69, P621, DOI 10.1111/j.1365-2958.2008.06308.x; Fukushima T, 2011, MOL MICROBIOL, V79, P503, DOI 10.1111/j.1365-2958.2010.07464.x; Gurtovenko AA, 2008, J PHYS CHEM B, V112, P1953, DOI 10.1021/jp0750708; Gutu AD, 2010, J BACTERIOL, V192, P2346, DOI 10.1128/JB.01690-09; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Howell A, 2006, MOL MICROBIOL, V59, P1199, DOI 10.1111/j.1365-2958.2005.05017.x; Howell A, 2003, MOL MICROBIOL, V49, P1639, DOI 10.1046/j.1365-2958.2003.03661.x; Janausch IG, 2002, J BIOL CHEM, V277, P39809, DOI 10.1074/jbc.M204482200; Jansen A, 2007, INT J MED MICROBIOL, V297, P205, DOI 10.1016/j.ijmm.2007.02.002; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; Jung K, 1997, J BIOL CHEM, V272, P10847; Kumbhakar M, 2005, J PHYS CHEM B, V109, P18528, DOI 10.1021/jp0531356; Kumbhakar M, 2005, J PHYS CHEM B, V109, P14168, DOI 10.1021/jp0520291; Kumbhakar M, 2004, J PHYS CHEM B, V108, P19246, DOI 10.1021/jp0468004; Martin PK, 1999, J BACTERIOL, V181, P3666, DOI 10.1128/JB.181.12.3666-3673.1999; Matias VRF, 2007, MOL MICROBIOL, V64, P195, DOI 10.1111/j.1365-2958.2007.05634.x; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moker N, 2007, J BACTERIOL, V189, P3645, DOI 10.1128/JB.01920-06; Molina-Bolivar JA, 2002, J PHYS CHEM B, V106, P870, DOI 10.1021/jp0119936; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Ng WL, 2004, MICROBIOL-SGM, V150, P3096, DOI 10.1099/mic.0.27550-0; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Qin ZQ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-96; Reipert A, 2003, ANTIMICROB AGENTS CH, V47, P568, DOI 10.1128/AAC.47.2.568-576.2003; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Santelli E, 2007, J BACTERIOL, V189, P3290, DOI 10.1128/JB.01937-06; Sass P, 2007, APPL ENVIRON MICROB, V73, P347, DOI 10.1128/AEM.01616-06; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; STRELETZKY K, 1995, LANGMUIR, V11, P42, DOI 10.1021/la00001a011; Szurmant H, 2006, PROTEIN SCI, V15, P929, DOI 10.1110/ps.052064406; Szurmant H, 2005, J BACTERIOL, V187, P5419, DOI 10.1128/JB.187.15.5419-5426.2005; Szurmant H, 2008, P NATL ACAD SCI USA, V105, P5891, DOI 10.1073/pnas.0800247105; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; Szurmant H, 2007, J BACTERIOL, V189, P3280, DOI 10.1128/JB.01936-06; Winkler ME, 2008, J BACTERIOL, V190, P2645, DOI 10.1128/JB.01682-07; Yamamoto K, 2001, BIOSCI BIOTECH BIOCH, V65, P2306, DOI 10.1271/bbb.65.2306; Zhao W, 2008, BIOCHIMIE, V90, P930, DOI 10.1016/j.biochi.2008.02.025	50	27	28	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30403	10.1371/journal.pone.0030403	http://dx.doi.org/10.1371/journal.pone.0030403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276191	gold, Green Published, Green Submitted			2022-12-27	WOS:000301568100043
J	Clark, MR; Schlacher, TA; Rowden, AA; Stocks, KI; Consalvey, M				Clark, Malcolm R.; Schlacher, Thomas A.; Rowden, Ashley A.; Stocks, Karen I.; Consalvey, Mireille			Science Priorities for Seamounts: Research Links to Conservation and Management	PLOS ONE			English	Review							SPECIES RICHNESS; ORANGE ROUGHY; NEW-ZEALAND; HOPLOSTETHUS-ATLANTICUS; OCEAN ACIDIFICATION; COMMUNITY STRUCTURE; GLOBAL DISTRIBUTION; CONTINENTAL-MARGIN; PACIFIC-OCEAN; STONY CORALS	Seamounts shape the topography of all ocean basins and can be hotspots of biological activity in the deep sea. The Census of Marine Life on Seamounts (CenSeam) was a field program that examined seamounts as part of the global Census of Marine Life (CoML) initiative from 2005 to 2010. CenSeam progressed seamount science by collating historical data, collecting new data, undertaking regional and global analyses of seamount biodiversity, mapping species and habitat distributions, challenging established paradigms of seamount ecology, developing new hypotheses, and documenting the impacts of human activities on seamounts. However, because of the large number of seamounts globally, much about the structure, function and connectivity of seamount ecosystems remains unexplored and unknown. Continual, and potentially increasing, threats to seamount resources from fishing and seabed mining are creating a pressing demand for research to inform conservation and management strategies. To meet this need, intensive science effort in the following areas will be needed: 1) Improved physical and biological data; of particular importance is information on seamount location, physical characteristics (e. g. habitat heterogeneity and complexity), more complete and intensive biodiversity inventories, and increased understanding of seamount connectivity and faunal dispersal; 2) New human impact data; these shall encompass better studies on the effects of human activities on seamount ecosystems, as well as monitoring long-term changes in seamount assemblages following impacts (e. g. recovery); 3) Global data repositories; there is a pressing need for more comprehensive fisheries catch and effort data, especially on the high seas, and compilation or maintenance of geological and biodiversity databases that underpin regional and global analyses; 4) Application of support tools in a data-poor environment; conservation and management will have to increasingly rely on predictive modelling techniques, critical evaluation of environmental surrogates as faunal "proxies", and ecological risk assessment.	[Clark, Malcolm R.; Rowden, Ashley A.; Consalvey, Mireille] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Schlacher, Thomas A.] Univ Sunshine Coast, Maroochydore, Qld, Australia; [Stocks, Karen I.] Univ Calif San Diego, La Jolla, CA 92093 USA	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of the Sunshine Coast; University of California System; University of California San Diego	Clark, MR (corresponding author), Natl Inst Water & Atmospher Res, Wellington, New Zealand.	m.clark@niwa.co.nz	Rowden, Ashley/ABG-6010-2020; Stocks, Karen I/J-2393-2014; Rowden, Ashley/O-9358-2019; Schlacher, Thomas/J-4614-2016	Stocks, Karen I/0000-0002-1282-300X; Schlacher, Thomas/0000-0003-2184-9217; Rowden, Ashley/0000-0003-2975-2524	Census of Marine Life on Seamounts field project (CenSeam); Sloan Foundation; National Institute of Water & Atmospheric Research [CO1X0906]	Census of Marine Life on Seamounts field project (CenSeam); Sloan Foundation(Alfred P. Sloan Foundation); National Institute of Water & Atmospheric Research	This work was supported by the Census of Marine Life on Seamounts field project (CenSeam), as part of the Census of Marine Life programme funded by the Sloan Foundation. Additional support was given to MRC and AAR by the National Institute of Water & Atmospheric Research (project CO1X0906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain V, 2008, DEEP-SEA RES PT I, V55, P1035, DOI 10.1016/j.dsr.2008.04.004; Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Anderson OF, 2003, MAR FRESHWATER RES, V54, P643, DOI 10.1071/MF02163; Anderson TJ, 2011, DEEP-SEA RES PT II, V58, P979, DOI 10.1016/j.dsr2.2010.10.053; Auster PJ, 2011, ICES J MAR SCI, V68, P254, DOI 10.1093/icesjms/fsq074; Baba K, 2008, ZOOTAXA, P1; Baco AR, 2007, OCEANOGRAPHY, V20, P108, DOI 10.5670/oceanog.2007.11; Benn AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012730; Bensch A., 2008, FAO Fisheries and Aquaculture Technical Paper; Boehlert G.W., 1987, WILEY, V43, P319, DOI [DOI 10.1029/GM043P0319, 10.1029/GM043P0319]; Boero Ferdinando, 2010, Diversity, V2, P115; Bradbury IR, 2008, P ROY SOC B-BIOL SCI, V275, P1803, DOI 10.1098/rspb.2008.0216; Brewin PE, 2009, MAR ECOL PROG SER, V383, P225, DOI 10.3354/meps07987; Brodie S., 2003, AQUATIC PROTECTED AR, P664; Bryan TL, 2007, MAR ECOL PROG SER, V330, P113, DOI 10.3354/meps330113; Burgman M., 2005, RISKS DECISIONS CONS; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Castelin M, 2011, DEEP-SEA RES PT I, V58, P637, DOI 10.1016/j.dsr.2011.03.008; CBD, 2009, AZ SCI CRIT GUID ID; Cho W, 2010, MAR ECOL-EVOL PERSP, V31, P121, DOI 10.1111/j.1439-0485.2010.00395.x; Clark M, 1999, OCEANOL ACTA, V22, P593, DOI 10.1016/S0399-1784(00)88950-1; Clark M. R., 2010, 46 NZ AQ ENV BIOD; Clark M.R., 2007, SEAMOUNTS ECOL FISH, P361, DOI [10.1002/9780470691953.ch17, DOI 10.1002/9780470691953.CH17]; Clark M. R., 2007, SEAMOUNTS ECOLOGY FI, P413, DOI 10.1002/9780470691953.; Clark MR, 2011, OCEAN COAST MANAGE, V54, P19, DOI 10.1016/j.ocecoaman.2010.10.006; Clark MR, 2010, MAR ECOL-EVOL PERSP, V31, P39, DOI 10.1111/j.1439-0485.2010.00384.x; Clark MR, 2010, MAR ECOL-EVOL PERSP, V31, P200, DOI 10.1111/j.1439-0485.2010.00392.x; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Clark MR, 2009, LAT AM J AQUAT RES, V37, P501, DOI 10.3856/vol37-issue3-fulltext-17; Clark MR, 2009, DEEP-SEA RES PT I, V56, P1540, DOI 10.1016/j.dsr.2009.04.015; Clark MR, 1996, J FISH BIOL, V49, P114, DOI 10.1111/j.1095-8649.1996.tb06070.x; Clark MR, 2011, 74 NZ AQ ENV BIOD; Clark MR, 2011, 8 INT SEAB AUTH; Clark MR, 2004, 200451 NZ FISH ASS; Consalvey Mireille, 2010, P123, DOI 10.1002/9781444325508.ch7; Costello MJ, 2010, ENVIRON SCI TECHNOL, V44, P8821, DOI 10.1021/es1012752; Danovaro R, 2009, DEEP-SEA RES PT II, V56, P738, DOI 10.1016/j.dsr2.2008.10.011; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; FAO Food and Agriculture Organization of the United Nations; Rome, 2009, INT GUID MAN DEEP SE; Farnsworth KD, 2007, MAR ECOL PROG SER, V350, P223, DOI 10.3354/meps07190; Fletcher WJ, 2005, ICES J MAR SCI, V62, P1576, DOI 10.1016/j.icesjms.2005.06.005; Francis RICC, 2005, B MAR SCI, V76, P337; Freiwald A., 2004, COLD WATER CORAL REE; Gad G, 2004, ARCH FISH MAR RES, V51, P43; Gage JD, 2005, AM FISH S S, V41, P503; Galil Bella, 1998, Senckenbergiana Maritima, V28, P111; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; Glover AG, 2003, ENVIRON CONSERV, V30, P219, DOI 10.1017/S0376892903000225; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; GW Suter, ECOLOGICAL RISK ASSE; Hall-Spencer J, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P135; Hall-Spencer JM, 2009, MAR ECOL PROG SER, V397, P305, DOI 10.3354/meps08235; Hannington M.D., 1995, GEOPHYS MONOGRAPH, V91, P115, DOI DOI 10.1029/GM091P0115; Hein J.R., 2002, ISA TECHNICAL STUDY, V2, P36; Hein JR, 2010, OCEANOGRAPHY, V23, P184, DOI 10.5670/oceanog.2010.70; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; Holland Kim N., 2007, Fish and Aquatic Resources Series, V12, P189; Howell KL, 2010, MAR ECOL-EVOL PERSP, V31, P52, DOI 10.1111/j.1439-0485.2010.00368.x; HUBBS CARL L., 1959, PACIFIC SCI, V13, P311; Iosjpe M, 2011, J MARINE SYST, V88, P82, DOI 10.1016/j.jmarsys.2011.02.013; IUCN, 2010, APPL EC APPR FISH MA; Kitchingman A., 2004, CTR RES REP, P7; Kobyliansky S.G., 2010, J ICHTHYOL+, V50, P932, DOI [10.1134/S0032945210100036, DOI 10.1134/S0032945210100036]; Koppers AAP, 2010, OCEANOGRAPHY, V23, P37, DOI 10.5670/oceanog.2010.88; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267; LEVIN LA, 1994, J MAR RES, V52, P489, DOI 10.1357/0022240943077028; Lundsten L, 2009, MAR ECOL PROG SER, V374, P23, DOI 10.3354/meps07745; MAC ARTHUR ROBERT H., 1967; Marques da Silva Helder, 2007, Fish and Aquatic Resources Series, V12, P335; McClain CR, 2007, J BIOGEOGR, V34, P2001, DOI 10.1111/j.1365-2699.2007.01783.x; McClain CR, 2010, MAR ECOL-EVOL PERSP, V31, P14, DOI 10.1111/j.1439-0485.2010.00367.x; McClain CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004141; Meager JJ, 2011, MAR ECOL PROG SER, V428, P1, DOI 10.3354/meps09124; Mienis F, 2007, DEEP-SEA RES PT I, V54, P1655, DOI 10.1016/j.dsr.2007.05.013; Miller K, 2010, MAR ECOL-EVOL PERSP, V31, P144, DOI 10.1111/j.1439-0485.2010.00380.x; Miller KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019004; Mohn C, 2009, DEEP-SEA RES PT II, V56, P2582, DOI 10.1016/j.dsr2.2008.12.037; Morato T, 2006, J FISH BIOL, V68, P209, DOI 10.1111/j.0022-1112.2006.00894.x; MORATO T, 2007, BLACKWELL FISHERIES, V12, P170; Morato T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014453; Morato T, 2010, OCEANOGRAPHY, V23, P190, DOI 10.5670/oceanog.2010.71; Mortensen PB, 2008, DEEP-SEA RES PT II, V55, P142, DOI 10.1016/j.dsr2.2007.09.018; Niklitschek EJ, 2010, MAR ECOL-EVOL PERSP, V31, P168, DOI 10.1111/j.1439-0485.2010.00372.x; O'Hara TD, 2007, GLOBAL ECOL BIOGEOGR, V16, P720, DOI 10.1111/j.1466-8238.2007.00329.x; O'Hara TD, 2011, CURR BIOL, V21, P226, DOI 10.1016/j.cub.2011.01.002; O'Hara TD, 2010, MAR ECOL-EVOL PERSP, V31, P84, DOI 10.1111/j.1439-0485.2010.00379.x; O'Hara TD, 2010, MAR ECOL-EVOL PERSP, V31, P26, DOI 10.1111/j.1439-0485.2010.00373.x; Parin NV, 1997, ADV MAR BIOL, V32, P145; Pitcher Tony J., 2007, Fish and Aquatic Resources Series, V12, P476; Pitcher TJ, 2010, OCEANOGRAPHY, V23, P134, DOI 10.5670/oceanog.2010.66; Probert P. Keith, 2007, Fish and Aquatic Resources Series, V12, P442; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; RAYMORE PA, 1982, PAC SCI, V36, P15; Roark EB, 2006, MAR ECOL PROG SER, V327, P1, DOI 10.3354/meps327001; Rogers A.D., 2010, IMPLEMENTATION UNGA, P97; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; Rogers Alex D., 2007, Fish and Aquatic Resources Series, V12, P141; Rolinski S, 2001, DEEP-SEA RES PT II, V48, P3469, DOI 10.1016/S0967-0645(01)00053-4; Rowden AA, 2005, NEW ZEAL J MAR FRESH, V39, P1039, DOI 10.1080/00288330.2005.9517374; Rowden AA, 2010, NZ AQUAT ENV BIODIVE, V62, P31; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P95, DOI 10.1111/j.1439-0485.2010.00369.x; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P63, DOI 10.1111/j.1439-0485.2010.00374.x; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P226, DOI 10.1111/j.1439-0485.2010.00400.x; Samadi S, 2006, MAR BIOL, V149, P1463, DOI 10.1007/s00227-006-0306-4; Samadi Sarah, 2007, Fish and Aquatic Resources Series, V12, P119; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sandwell DT, 2010, OCEANOGRAPHY, V23, P34, DOI 10.5670/oceanog.2010.87; Schlacher TA, 2007, MAR ECOL PROG SER, V340, P73, DOI 10.3354/meps340073; Schlacher TA, 2010, MAR ECOL-EVOL PERSP, V31, P1, DOI 10.1111/j.1439-0485.2010.00396.x; Scott SD, 2007, PROCEEDINGS OF THE SEVENTH (2007) ISOPE OCEAN MINING (& GAS HYDRATES) SYMPOSIUM, P6; Shank TM, 2010, OCEANOGRAPHY, V23, P108, DOI 10.5670/oceanog.2010.65; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Sissenwine M.P., 2007, FAO Fisheries Reports, V838, P61; Smith Craig R., 2008, P334, DOI 10.1017/CBO9780511751790.030; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; Snelgrove PVR, 2010, DISCOVERIES CENSUS M, P286; Staudigel H, 2010, OCEANOGRAPHY, V23, P18, DOI 10.5670/oceanog.2010.59; Stocks KI, 2010, OCEANOGRAPHY, V23, P145, DOI 10.5670/oceanog.2010.94; Stocks Karen I., 2007, Fish and Aquatic Resources Series, V12, P255; Stocks KI, PLOS ONE IN PRESS; Sudek LA, 2009, GEOMICROBIOL J, V26, P581, DOI 10.1080/01490450903263400; Thoma JN, 2009, MAR ECOL PROG SER, V397, P25, DOI 10.3354/meps08318; Tittensor DP, 2010, MAR ECOL-EVOL PERSP, V31, P212, DOI 10.1111/j.1439-0485.2010.00393.x; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Tracey DM, 2011, MAR ECOL PROG SER, V430, P1, DOI 10.3354/meps09164; Tracey DM, 2004, NEW ZEAL J MAR FRESH, V38, P163, DOI 10.1080/00288330.2004.9517226; Tunnicliffe V, 1997, DEEP-SEA RES PT I, V44, P1627, DOI 10.1016/S0967-0637(97)00041-1; Tunnicliffe V, 2010, MAR ECOL-EVOL PERSP, V31, P158, DOI 10.1111/j.1439-0485.2010.00370.x; UNESCO, 2009, IOC TECHNICAL SERIES, V84, P87; van den Hove S, 2007, FUTURES, V39, P807, DOI 10.1016/j.futures.2006.12.004; Van Dover C.L., 2011, ISA TECHNICAL STUDY, P90; Van Dover CL, 2011, ICES J MAR SCI, V68, P341, DOI 10.1093/icesjms/fsq086; Watson R., 2007, SEAMOUNTS ECOLOGY FI, P400; Wessel P, 2001, J GEOPHYS RES-SOL EA, V106, P19431, DOI 10.1029/2000JB000083; Wessel P, 2010, OCEANOGRAPHY, V23, P24, DOI 10.5670/oceanog.2010.60; White M., 2007, BLACKWELL FISHERIES, V12, P65; Williams A, 2011, FISH RES, V112, P154, DOI 10.1016/j.fishres.2011.01.028; Williams A, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2010.00385.x; Wilson R. R., 1987, GEOPHYS MONOGR SER, P319; Woodby D, 2009, MAR ECOL PROG SER, V397, P227, DOI 10.3354/meps08358; Wright IC, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005138; Wright IC, 2001, MAR GEOL, V172, P287, DOI 10.1016/S0025-3227(00)00131-6; Wright SJ, 2009, CONSERV BIOL, V23, P1418, DOI 10.1111/j.1523-1739.2009.01337.x; Yesson C, 2011, DEEP-SEA RES PT I, V58, P442, DOI 10.1016/j.dsr.2011.02.004	148	88	91	0	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29232	10.1371/journal.pone.0029232	http://dx.doi.org/10.1371/journal.pone.0029232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279531	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900009
J	Ishihara, D; Dovas, A; Park, H; Isaac, BM; Cox, D				Ishihara, Dan; Dovas, Athanassios; Park, Haein; Isaac, Beth M.; Cox, Dianne			The Chemotactic Defect in Wiskott-Aldrich Syndrome Macrophages Is Due to the Reduced Persistence of Directional Protrusions	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; ACTIN POLYMERIZATION; CELL POLARIZATION; PHOSPHOLIPASE-C; LEADING-EDGE; WASP; RECEPTOR; MEMBRANE; PHAGOCYTOSIS; ACTIVATION	Wiskott-Aldrich syndrome protein (WASp) is an actin nucleation promoting factor that is required for macrophages to directionally migrate towards various chemoattractants. The chemotaxis defect of WASp-deficient cells and its activation by Cdc42 in vivo suggest that WASp plays a role in directional sensing, however, its precise role in macrophage chemotaxis is still unclear. Using shRNA-mediated downregulation of WASp in the murine monocyte/macrophage cell line RAW/LR5 (shWASp), we found that WASp was responsible for the initial wave of actin polymerization in response to global stimulation with CSF-1, which in Dictyostelium discoideum amoebae and carcinoma cells has been correlated with the ability to migrate towards chemoattractants. Real-time monitoring of shWASp cells, as well as WASp 2/2 bone marrow-derived macrophages (BMMs), in response to a CSF-1 gradient revealed that the protrusions from WASp-deficient cells were directional, showing intact directional sensing. However, the protrusions from WASp-deficient cells demonstrated reduced persistence compared to their respective control shRNA and wild-type cells. Further examination showed that tyrosine phosphorylation of WASp was required for both the first wave of actin polymerization following global CSF-1 stimulation and proper directional responses towards CSF-1. Importantly, the PI3K, Rac1 and WAVE2 proteins were incorporated normally in CSF-1 - elicited protrusions in the absence of WASp, suggesting that membrane protrusion driven by the WAVE2 complex signaling is intact. Collectively, these results suggest that WASp and its phosphorylation play critical roles in coordinating the actin cytoskeleton rearrangements necessary for the persistence of protrusions required for directional migration of macrophages towards CSF-1.	[Ishihara, Dan; Dovas, Athanassios; Park, Haein; Cox, Dianne] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA; [Isaac, Beth M.; Cox, Dianne] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Ishihara, D (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA.	dianne.cox@einstein.yu.edu		Cox, Dianne/0000-0002-0591-9767	National Institutes of Health [GM071828]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071828, T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM071828 to Dianne Cox). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Kheir W, 2005, J CELL SCI, V118, P5369, DOI 10.1242/jcs.02638; Abou-Kheir W, 2008, J CELL SCI, V121, P379, DOI 10.1242/jcs.010272; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Badolato R, 1998, J IMMUNOL, V161, P1026; Bailly M, 1998, EXP CELL RES, V241, P285, DOI 10.1006/excr.1998.4031; Bourette RP, 1997, EMBO J, V16, P5880, DOI 10.1093/emboj/16.19.5880; Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003; Cammer M, 2009, J BIOL CHEM, V284, P23302, DOI 10.1074/jbc.M109.036384; Chan AY, 1998, J CELL SCI, V111, P199; Cory GOC, 2002, J BIOL CHEM, V277, P45115, DOI 10.1074/jbc.M203346200; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Diakonova M, 2002, MOL BIOL CELL, V13, P402, DOI 10.1091/mbc.01-05-0273; Dovas A, 2009, J CELL SCI, V122, P3873, DOI 10.1242/jcs.051755; Eddy RJ, 1997, J CELL BIOL, V139, P1243, DOI 10.1083/jcb.139.5.1243; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gevrey JC, 2005, J IMMUNOL, V175, P3737, DOI 10.4049/jimmunol.175.6.3737; Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Millard TH, 2001, TRENDS BIOCHEM SCI, V26, P198, DOI 10.1016/S0968-0004(01)01788-1; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Myers SA, 2005, MOL BIOL CELL, V16, P2191, DOI 10.1091/mbc.E04-09-0844; Narang A, 2001, ANN BIOMED ENG, V29, P677, DOI 10.1114/1.1385805; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Park H, 2011, ARCH BIOCHEM BIOPHYS, V510, P101, DOI 10.1016/j.abb.2011.02.019; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Pixley FJ, 2001, MOL CELL BIOL, V21, P1795, DOI 10.1128/MCB.21.5.1795-1809.2001; Sampaio NG, 2011, J CELL SCI, V124, P2021, DOI 10.1242/jcs.075309; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Stanley E R, 1997, Methods Mol Biol, V75, P301; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Torres E, 2006, J BIOL CHEM, V281, P3513, DOI 10.1074/jbc.M509416200; Torres E, 2003, MOL CELL, V11, P1215, DOI 10.1016/S1097-2765(03)00139-4; Vedham V, 2005, MOL CELL BIOL, V25, P4211, DOI 10.1128/MCB.25.10.4211-4220.2005; WESSELS D, 1994, CELL MOTIL CYTOSKEL, V27, P1, DOI 10.1002/cm.970270102; Xiao Z, 1999, J BIOL CHEM, V274, P1440, DOI 10.1074/jbc.274.3.1440; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107; Zhelev DV, 2004, BIOPHYS J, V87, P688, DOI 10.1529/biophysj.103.036699; Zhu QL, 1997, BLOOD, V90, P2680, DOI 10.1182/blood.V90.7.2680.2680_2680_2689; Zicha D, 1998, BRIT J HAEMATOL, V101, P659, DOI 10.1046/j.1365-2141.1998.00767.x	50	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30033	10.1371/journal.pone.0030033	http://dx.doi.org/10.1371/journal.pone.0030033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279563	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900041
J	Kondapaka, KK; Prasad, SV; Satyanarayana, S; Kandi, S; Zachariah, R; Harries, AD; Nagaraja, SB; Tetali, S; Anchala, R; Kannuri, NK; Murthy, K; Koppu, D; Vangari, L; Rao, S				Kondapaka, Kiran Kumar; Prasad, Surapaneni Venkateswara; Satyanarayana, Srinath; Kandi, Subhakar; Zachariah, Rony; Harries, Anthony David; Nagaraja, Sharath Burugina; Tetali, Shailaja; Anchala, Raghupathy; Kannuri, Nanda Kishore; Murthy, Krishna; Koppu, Dhanamurthy; Vangari, Latha; Rao, Sreenivas			Are Tuberculosis Patients in a Tertiary Care Hospital in Hyderabad, India Being Managed According to National Guidelines?	PLOS ONE			English	Article								Setting: A tertiary health care facility (Government General and Chest hospital) in Hyderabad, India. Objectives: To assess a) the extent of compliance of specialists to standardized national (RNTCP) tuberculosis management guidelines and b) if patients on discharge from hospital were being appropriately linked up with peripheral health facilities for continuation of anti-Tuberculosis (TB) treatment. Methods: A descriptive study using routine programme data and involving all TB patients admitted to inpatient care from 1(st) January to 30(th) June, 2010. Results and Conclusions: There were a total of 3120 patients admitted of whom, 1218 (39%) required anti-TB treatment. Of these 1104 (98%) were treated with one of the RNTCP recommended regimens, while 28 (2%) were treated with non-RNTCP regimens. The latter included individually tailored MDR-TB treatment regimens for 19 patients and adhoc regimens for nine patients. A total of 957 (86%) patients were eventually discharged from the hospital of whom 921 (96%) had a referral form filled for continuing treatment at a peripheral health facility. Formal feedback from peripheral health facilities on continuation of TB treatment was received for 682 (74%) patients. In a tertiary health facility with specialists the great majority of TB patients are managed in line with national guidelines. However a number of short-comings were revealed and measures to rectify these are discussed.	[Kondapaka, Kiran Kumar; Prasad, Surapaneni Venkateswara; Kandi, Subhakar; Koppu, Dhanamurthy] Osmania Med Coll & Hosp, Dept Pulm Med, Hyderabad, Andhra Pradesh, India; [Satyanarayana, Srinath] Int Union TB & Lung Dis Union, SE Asia Reg Off, New Delhi, India; [Zachariah, Rony] Brussels Operat Ctr, Med Dept Operat Res, Brussels, Luxembourg; [Harries, Anthony David] Int Union TB & Lung Dis Union, Paris, France; [Harries, Anthony David] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Nagaraja, Sharath Burugina] Off WHO Representat India, New Delhi, India; [Tetali, Shailaja; Anchala, Raghupathy; Kannuri, Nanda Kishore] Indian Inst Publ Hlth Hyderabad, Publ Hlth Fdn India, Hyderabad, Andhra Pradesh, India; [Murthy, Krishna] Gandhi Med Coll, Dept Pulm Med, Hyderabad, Andhra Pradesh, India; [Vangari, Latha] Osmania Med Coll & Hosp, Dept Pediat, Hyderabad, Andhra Pradesh, India; [Rao, Sreenivas] State TB Off, Hyderabad, Andhra Pradesh, India	University of London; London School of Hygiene & Tropical Medicine; World Health Organization; Public Health Foundation of India; Gandhi Medical College & Hospital, Hyderabad	Kondapaka, KK (corresponding author), Osmania Med Coll & Hosp, Dept Pulm Med, Hyderabad, Andhra Pradesh, India.	kiran033@yahoo.com	Anchala, Raghupathy/AGD-8723-2022; Nagaraja, Sharath Burugina/ABD-7238-2021; Nagaraja, Sharath Burugina/ABD-7748-2021	Anchala, Raghupathy/0000-0003-4733-211X; Nagaraja, Sharath Burugina/0000-0002-6599-5753; Nagaraja, Sharath Burugina/0000-0002-6599-5753; zachariah, rony/0000-0002-2915-9328; Kannuri, Nanda Kishore/0000-0003-2352-6972; Satyanarayana, Srinath/0000-0002-5420-2551	Centre for Operational Research at The International Union Against Tuberculosis and Lung Disease (The Union); Public Health Foundation of India (PHFI)	Centre for Operational Research at The International Union Against Tuberculosis and Lung Disease (The Union); Public Health Foundation of India (PHFI)	This research was supported through an operational research course which was funded through a memorandum of understanding between the Centre for Operational Research at The International Union Against Tuberculosis and Lung Disease (The Union) and the Public Health Foundation of India (PHFI). The course was facilitated by faculty from the PHFI, The Union and The Operational Research Unit, Medecins sans Frontieres, Brussels Operational Centre, Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2007, LANCET, V370, P1453; [Anonymous], 2009, KEY BOTTL M XDR TB C; British Tuberculosis Association, 1950, TUBERCLE, V31, P121; Central Tuberculosis Division, 2005, TECHN OP GUID TUB CO; Central Tuberculosis Division (2010) Tuberculosis India, 2010, TUB IND 2010 ANN REP; Harlow T, 1999, AM J PUBLIC HEALTH, V89, P1581, DOI 10.2105/AJPH.89.10.1581; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; World Health Organization, 2010, WHOHTMTB20103	8	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30281	10.1371/journal.pone.0030281	http://dx.doi.org/10.1371/journal.pone.0030281			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272323	gold, Green Published, Green Submitted			2022-12-27	WOS:000301454400101
J	Veach, RA; Zienkiewicz, J; Collins, RD; Hawiger, J				Veach, Ruth Ann; Zienkiewicz, Jozef; Collins, Robert D.; Hawiger, Jacek			Lethality in a Murine Model of Pulmonary Anthrax is Reduced by Combining Nuclear Transport Modifier with Antimicrobial Therapy	PLOS ONE			English	Article							NF-KAPPA-B; BACILLUS-ANTHRACIS; INHALATIONAL ANTHRAX; DENDRITIC CELLS; CYCLIC-AMP; MACROPHAGE APOPTOSIS; FUNCTIONAL PEPTIDES; CYTOKINE RESPONSE; ADENYLATE-CYCLASE; IMPORT INHIBITOR	Background: In the last ten years, bioterrorism has become a serious threat and challenge to public health worldwide. Pulmonary anthrax caused by airborne Bacillus anthracis spores is a life-threatening disease often refractory to antimicrobial therapy. Inhaled spores germinate into vegetative forms that elaborate an anti-phagocytic capsule along with potent exotoxins which disrupt the signaling pathways governing the innate and adaptive immune responses and cause endothelial cell dysfunction leading to vascular injury in the lung, hypoxia, hemorrhage, and death. Methods/Principal Findings: Using a murine model of pulmonary anthrax disease, we showed that a nuclear transport modifier restored markers of the innate immune response in spore-infected animals. An 8-day protocol of single-dose ciprofloxacin had no significant effect on mortality (4% survival) of A/J mice lethally infected with B. anthracis Sterne. Strikingly, mice were much more likely to survive infection (52% survival) when treated with ciprofloxacin and a cell-penetrating peptide modifier of host nuclear transport, termed cSN50. In B. anthracis-infected animals treated with antibiotic alone, we detected a muted innate immune response manifested by cytokines, tumor necrosis factor alpha (TNF alpha), interleukin (IL)-6, and chemokine monocyte chemoattractant protein-1 (MCP-1), while the hypoxia biomarker, erythropoietin (EPO), was greatly elevated. In contrast, cSN50-treated mice receiving ciprofloxacin demonstrated a restored innate immune responsiveness and reduced EPO level. Consistent with this improvement of innate immunity response and suppression of hypoxia biomarker, surviving mice in the combination treatment group displayed minimal histopathologic signs of vascular injury and a marked reduction of anthrax bacilli in the lungs. Conclusions: We demonstrate, for the first time, that regulating nuclear transport with a cell-penetrating modifier provides a cytoprotective effect, which enables the host's immune system to reduce its susceptibility to lethal B. anthracis infection. Thus, by combining a nuclear transport modifier with antimicrobial therapy we offer a novel adjunctive measure to control florid pulmonary anthrax disease.	[Veach, Ruth Ann; Zienkiewicz, Jozef; Hawiger, Jacek] Vanderbilt Univ, Med Ctr, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Collins, Robert D.] Vanderbilt Univ, Med Ctr, Sch Med, Dept Pathol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Veach, RA (corresponding author), Vanderbilt Univ, Med Ctr, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA.	jacek.hawiger@vanderbilt.edu		Veach, Ruth Ann/0000-0003-0038-8802	National Institutes of Health [2 R01 HL069542]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (2 R01 HL069542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOVA FA, 1993, P NATL ACAD SCI USA, V90, P2291, DOI 10.1073/pnas.90.6.2291; Agrawal A, 2004, CELL MOL LIFE SCI, V61, P2859, DOI 10.1007/s00018-004-4251-4; Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; Alileche A, 2005, PLOS PATHOG, V1, P150, DOI 10.1371/journal.ppat.0010019; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Cleret A, 2006, J INFECT DIS, V194, P86, DOI 10.1086/504686; Comer JE, 2005, INFECT IMMUN, V73, P1879, DOI 10.1128/IAI.73.3.1879-1885.2005; Cummings RT, 2002, P NATL ACAD SCI USA, V99, P6603, DOI 10.1073/pnas.062171599; Daya M, 2005, CRIT CARE CLIN, V21, P747, DOI 10.1016/j.ccc.2005.06.009; Deziel MR, 2005, ANTIMICROB AGENTS CH, V49, P5099, DOI 10.1128/AAC.49.12.5099-5106.2005; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Erwin JL, 2001, INFECT IMMUN, V69, P1175, DOI 10.1128/IAI.69.2.1175-1177.2001; Fletcher TC, 2010, J BIOL CHEM, V285, P18727, DOI 10.1074/jbc.M109.095216; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Guarner J, 2003, AM J PATHOL, V163, P701, DOI 10.1016/S0002-9440(10)63697-8; Hawiger J, 1999, CURR OPIN CHEM BIOL, V3, P89, DOI 10.1016/S1367-5931(99)80016-7; Hawiger J, 2001, IMMUNOL RES, V23, P99, DOI 10.1385/IR:23:2-3:099; HOOVER DL, 1994, INFECT IMMUN, V62, P4432, DOI 10.1128/IAI.62.10.4432-4439.1994; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Joshi SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000588; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; LABRUYERE E, 1990, BIOCHEMISTRY-US, V29, P4922, DOI 10.1021/bi00472a024; Lacy DB, 2002, CURR TOP MICROBIOL, V271, P61; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Liu DY, 2009, MOL THER, V17, P796, DOI 10.1038/mt.2009.18; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; Liu DY, 2004, J BIOL CHEM, V279, P19239, DOI 10.1074/jbc.M313442200; Liu XY, 2000, J BIOL CHEM, V275, P16774; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Pickering AK, 2004, INFECT IMMUN, V72, P6382, DOI 10.1128/IAI.72.11.6382-6389.2004; Popov SG, 2002, BIOCHEM BIOPH RES CO, V293, P349, DOI 10.1016/S0006-291X(02)00227-9; ROSS JM, 1957, J PATHOL BACTERIOL, V73, P485, DOI 10.1002/path.1700730219; SHAFA F, 1966, J INFECT DIS, V116, P401, DOI 10.1093/infdis/116.4.401; Skaar EP, 2006, J BACTERIOL, V188, P1071, DOI 10.1128/JB.188.3.1071-1080.2006; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892; TANG WJ, 1991, J BIOL CHEM, V266, P8595; Torgerson TR, 1998, J IMMUNOL, V161, P6084; Tournier JN, 2005, J IMMUNOL, V174, P4934, DOI 10.4049/jimmunol.174.8.4934; Vaeth M, 2011, P NATL ACAD SCI USA, V108, P2480, DOI 10.1073/pnas.1009463108; Veach RA, 2004, J BIOL CHEM, V279, P11425, DOI 10.1074/jbc.M311089200; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; WELKOS SL, 1988, MICROB PATHOGENESIS, V4, P53, DOI 10.1016/0882-4010(88)90048-4; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Zanchi C, 2008, J IMMUNOL, V181, P1460, DOI 10.4049/jimmunol.181.2.1460; Zhang JY, 2006, MOL CELL BIOL, V26, P1223, DOI 10.1128/MCB.26.4.1223-1234.2006	51	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30527	10.1371/journal.pone.0030527	http://dx.doi.org/10.1371/journal.pone.0030527			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291977	Green Submitted, gold, Green Published			2022-12-27	WOS:000301703800018
J	Alam, A; Chauhan, VS				Alam, Asrar; Chauhan, Virander S.			Inhibitory Potential of Prodomain of Plasmodium falciparum Protease Serine Repeat Antigen 5 for Asexual Blood Stages of Parasite	PLOS ONE			English	Article							SERA MULTIGENE FAMILY; MALARIA PARASITE; INTRAMOLECULAR CHAPERONE; PROPEPTIDE; SUBTILISIN; LOCALIZATION; INFECTION; SEQUENCE; RELEASE; EGRESS	Plasmodium falciparum serine repeat antigen 5 (SERA5) is a target for both drug and vaccine intervention against malaria. SERA5 is secreted in the parasitophorous vacuole where it is proteolytically processed before schizont rupture. Among the processed products is a 50.8-kDa central domain of the protease, which possesses chymotrypsin-like activity and consists of a 28.9-kDa catalytic domain with a 21.9-kDa N-terminal prodomain, which remain attached together. Because SERA5 has been implicated in merozoite egress from host erythrocytes, the effect of the prodomain and a heptapeptide derived from its C-terminus spanning from D-560 to F-566 (DNSDNMF) on parasite growth was studied. When E. coli-expressed prodomain was incubated with parasite culture, a significant delay in transition from schizont to ring stages was observed up to nanomolar concentrations. The peptide, DNSDNMF also showed similar effects but at nearly 1000-fold higher concentrations. The peptide was also found to interact with the catalytic domain. These data demonstrate the crucial role of SERA5 prodomain for the egress process. Given the inhibitory potential of the prodomain for the parasite, we suggest that peptidomimetic inhibitors based on SERA5 prodomain sequences can be developed as future therapeutics against malaria.	[Alam, Asrar; Chauhan, Virander S.] Int Ctr Genet Engn & Biotechnol, Malaria Res Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Alam, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Res Grp, New Delhi, India.	virander@icgeb.res.in	Chauhan, Virander S./K-5276-2019	Alam, Asrar/0000-0002-8529-1761	ICGEB, New Delhi, India; Fogarty International Center, National Institutes of Health, USA [D43TW000924]; ICGEB; Fogarty International Center; Fogarty International Center at Seattle Biomedical Research Institute; FOGARTY INTERNATIONAL CENTER [D43TW000924] Funding Source: NIH RePORTER	ICGEB, New Delhi, India; Fogarty International Center, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); ICGEB; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Fogarty International Center at Seattle Biomedical Research Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by Malaria Core Fund, ICGEB, New Delhi, India and Award Number D43TW000924 from the Fogarty International Center, National Institutes of Health, USA. Major parts of the study were conducted at ICGEB, India by the support of Malaria Core Fund, ICGEB. Some parts of the study were conducted at Seattle Biomedical Research Institute, USA by Asrar Alam with the support of funding from Fogarty International Center. Asrar Alam was also supported with a postdoctoral fellowship by Fogarty International Center at Seattle Biomedical Research Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Fogarty International Center or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; Aoki S, 2002, J BIOL CHEM, V277, P47533, DOI 10.1074/jbc.M207145200; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Arisue N, 2007, J MOL EVOL, V65, P82, DOI 10.1007/s00239-006-0253-1; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; BZIK DJ, 1988, MOL BIOCHEM PARASIT, V30, P279, DOI 10.1016/0166-6851(88)90097-7; DEBRABANT A, 1992, MOL BIOCHEM PARASIT, V53, P89, DOI 10.1016/0166-6851(92)90010-H; DELPLACE P, 1987, MOL BIOCHEM PARASIT, V23, P193, DOI 10.1016/0166-6851(87)90026-0; Fairlie WD, 2008, INFECT IMMUN, V76, P4332, DOI 10.1128/IAI.00278-08; FOX BA, 1994, MOL BIOCHEM PARASIT, V68, P133, DOI 10.1016/0166-6851(94)00162-6; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Harper JM, 2006, MOL BIOL CELL, V17, P4551, DOI 10.1091/mbc.E06-01-0064; HIGGINS DG, 1989, NATURE, V340, P604, DOI 10.1038/340604a0; Hodder AN, 2003, J BIOL CHEM, V278, P48169, DOI 10.1074/jbc.M306755200; Hodder AN, 2009, J MOL BIOL, V392, P154, DOI 10.1016/j.jmb.2009.07.007; KNAPP B, 1989, MOL BIOCHEM PARASIT, V32, P73, DOI 10.1016/0166-6851(89)90131-X; Kojima S, 1998, J MOL BIOL, V277, P1007, DOI 10.1006/jmbi.1998.1671; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Li J, 2002, MOL BIOCHEM PARASIT, V120, P177, DOI 10.1016/S0166-6851(01)00452-2; McCoubrie JE, 2007, INFECT IMMUN, V75, P5565, DOI 10.1128/IAI.00405-07; Miller SK, 2002, J BIOL CHEM, V277, P47524, DOI 10.1074/jbc.M206974200; Nirasawa S, 1999, BIOCHEM J, V341, P25, DOI 10.1042/0264-6021:3410025; Pang XL, 1999, INFECT IMMUN, V67, P1821; Putrianti ED, 2010, CELL MICROBIOL, V12, P725, DOI 10.1111/j.1462-5822.2009.01419.x; Roy RS, 1998, CHEM BIOL, V5, P217, DOI 10.1016/S1074-5521(98)90635-4; Sato D, 2005, PARASITOL INT, V54, P261, DOI 10.1016/j.parint.2005.06.006; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Subbian E, 2005, J MOL BIOL, V347, P367, DOI 10.1016/j.jmb.2005.01.028; Trylska J, 2007, BIOPHYS J, V92, P4179, DOI 10.1529/biophysj.106.100560; Wanyiri JW, 2009, EUKARYOT CELL, V8, P470, DOI 10.1128/EC.00306-08; Wiederanders B, 2003, CURR PROTEIN PEPT SC, V4, P309, DOI 10.2174/1389203033487081; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	32	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30452	10.1371/journal.pone.0030452	http://dx.doi.org/10.1371/journal.pone.0030452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291957	Green Published, gold, Green Submitted			2022-12-27	WOS:000301639600021
J	Hjalten, J; Axelsson, EP; Whitham, TG; LeRoy, CJ; Julkunen-Tiitto, R; Wennstrom, A; Pilate, G				Hjalten, Joakim; Axelsson, E. Petter; Whitham, Thomas G.; LeRoy, Carri J.; Julkunen-Tiitto, Riitta; Wennstrom, Anders; Pilate, Gilles			Increased Resistance of Bt Aspens to Phratora vitellinae (Coleoptera) Leads to Increased Plant Growth under Experimental Conditions	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; CHRYSOMELA-TREMULAE; TRANSGENIC ASPEN; FOREST BIOTECH; CLIMATE-CHANGE; HERBIVORY; COSTS; POPLAR; TOLERANCE; TREES	One main aim with genetic modification (GM) of trees is to produce plants that are resistant to various types of pests. The effectiveness of GM-introduced toxins against specific pest species on trees has been shown in the laboratory. However, few attempts have been made to determine if the production of these toxins and reduced herbivory will translate into increased tree productivity. We established an experiment with two lines of potted aspens (Populus tremulaxPopulus tremuloides) which express Bt (Bacillus thuringiensis) toxins and the isogenic wildtype (Wt) in the lab. The goal was to explore how experimentally controlled levels of a targeted leaf beetle Phratora vitellinae (Coleoptera; Chrysomelidae) influenced leaf damage severity, leaf beetle performance and the growth of aspen. Four patterns emerged. Firstly, we found clear evidence that Bt toxins reduce leaf damage. The damage on the Bt lines was significantly lower than for the Wt line in high and low herbivory treatment, respectively. Secondly, Bt toxins had a significant negative effect on leaf beetle survival. Thirdly, the significant decrease in height of the Wt line with increasing herbivory and the relative increase in height of one of the Bt lines compared with the Wt line in the presence of herbivores suggest that this also might translate into increased biomass production of Bt trees. This realized benefit was context-dependent and is likely to be manifested only if herbivore pressure is sufficiently high. However, these herbivore induced patterns did not translate into significant affect on biomass, instead one Bt line overall produced less biomass than the Wt. Fourthly, compiled results suggest that the growth reduction in one Bt line as indicated here is likely due to events in the transformation process and that a hypothesized cost of producing Bt toxins is of subordinate significance.	[Hjalten, Joakim; Axelsson, E. Petter] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Whitham, Thomas G.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [LeRoy, Carri J.] Evergreen State Coll, Environm Studies Program, Olympia, WA 98505 USA; [Julkunen-Tiitto, Riitta] Univ Eastern Finland, Dept Biol, Joensuu, Finland; [Wennstrom, Anders] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Pilate, Gilles] INRA, Ameliorat UR0588, Orleans, France	Swedish University of Agricultural Sciences; Northern Arizona University; University of Eastern Finland; Umea University; INRAE	Hjalten, J (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden.	joakim.hjalten@slu.se	Pilate, Gilles/E-8784-2017; Julkunen-Tiitto, Riitta/GRR-9781-2022	Pilate, Gilles/0000-0003-4802-8849; Hjalten, Joakim/0000-0002-8279-6633	Swedish research council FORMAS [209-2006-1279]	Swedish research council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	This study was supported by the Swedish research council FORMAS (grant # 209-2006-1279 to Dr. Hjalten) http://www.formas.se/default_529.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttonen S, 2002, CAN J FOREST RES, V32, P498, DOI [10.1139/x01-217, 10.1139/X01-217]; Axelsson EP, 2012, FOREST ECOL MANAG, V264, P167, DOI 10.1016/j.foreco.2011.10.006; Ayres MP, 2000, SCI TOTAL ENVIRON, V262, P263, DOI 10.1016/S0048-9697(00)00528-3; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Balestrazzi A, 2006, TREE TRANSGENESIS: RECENT DEVELOPMENTS, P253, DOI 10.1007/3-540-32199-3_12; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; Brodeur-Campbell SE, 2006, ENVIRON ENTOMOL, V35, P1696, DOI 10.1603/0046-225X(2006)35[1696:IHOLTA]2.0.CO;2; Casler MD, 2002, THEOR APPL GENET, V104, P127, DOI 10.1007/s001220200015; CHELIAK WM, 1990, CAN J FOREST RES, V20, P452, DOI 10.1139/x90-062; COLEY PD, 1986, OECOLOGIA, V70, P238, DOI 10.1007/BF00379246; Coyle DR, 2002, AGR FOREST ENTOMOL, V4, P293, DOI 10.1046/j.1461-9563.2002.00149.x; *FAO, 2004, FGR59E FAO FOR RES D; Fenning TM, 2008, NAT BIOTECHNOL, V26, P615, DOI 10.1038/nbt0608-615; Genissel A, 2003, MOL BREEDING, V11, P103, DOI 10.1023/A:1022453220496; Genissel A, 2003, P ROY SOC B-BIOL SCI, V270, P791, DOI 10.1098/rspb.2002.2317; Groover AT, 2007, TRENDS PLANT SCI, V12, P234, DOI 10.1016/j.tplants.2007.04.005; Gruppe A, 1999, FOREST ECOL MANAG, V121, P113, DOI 10.1016/S0378-1127(98)00560-X; HJALTEN J, 1993, ECOLOGY, V74, P1136, DOI 10.2307/1940483; Hjalten J, 2007, BASIC APPL ECOL, V8, P434, DOI 10.1016/j.baae.2006.09.001; Hu JJ, 2001, EUPHYTICA, V121, P123, DOI 10.1023/A:1012015709363; Huhta AP, 2000, EVOL ECOL, V14, P353, DOI 10.1023/A:1010808925284; Hussein HM, 2005, PEST MANAG SCI, V61, P1186, DOI 10.1002/ps.1112; Kaldorf M, 2002, PLANTA, V214, P653, DOI 10.1007/s004250100658; KEARSLEY MJC, 1992, OECOLOGIA, V92, P556, DOI 10.1007/BF00317849; Kleiner KW, 2003, J CHEM ECOL, V29, P2585, DOI 10.1023/A:1026370220613; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; Orians CM, 2010, OECOLOGIA, V163, P283, DOI 10.1007/s00442-009-1521-8; PASTEELS JM, 1983, PHYSIOL ENTOMOL, V8, P307, DOI 10.1111/j.1365-3032.1983.tb00362.x; Paul-Victor C, 2010, NEW PHYTOL, V187, P1102, DOI 10.1111/j.1469-8137.2010.03325.x; Pena L, 2001, TRENDS BIOTECHNOL, V19, P500, DOI 10.1016/S0167-7799(01)01815-7; Persson IL, 2007, OIKOS, V116, P1639, DOI [10.1111/j.2007.0030-1299.15946.x, 10.1111/j.0030-1299.2007.15946.x]; Rank NE, 1998, ECOLOGY, V79, P618, DOI 10.1890/0012-9658(1998)079[0618:HPALPO]2.0.CO;2; ROWELLRAHIER M, 1984, OECOLOGIA, V64, P375, DOI 10.1007/BF00379136; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; SIMMS EL, 1987, AM NAT, V130, P570, DOI 10.1086/284731; Smeets EMW, 2007, CLIMATIC CHANGE, V81, P353, DOI 10.1007/s10584-006-9163-x; Stevens MT, 2007, EVOL ECOL, V21, P829, DOI 10.1007/s10682-006-9154-4; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Systat Software Inc, 2009, SYSTAT 12; Tomescu R, 2007, ANN FOREST SCI, V64, P99, DOI 10.1051/forest:2006093; Wenes AL, 2006, HEREDITY, V97, P127, DOI 10.1038/sj.hdy.6800845; Wise MJ, 2007, AM NAT, V169, P443, DOI 10.1086/512044; Zar J. H., 1996, BIOSTATISTICAL ANAL	44	15	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30640	10.1371/journal.pone.0030640	http://dx.doi.org/10.1371/journal.pone.0030640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292004	Green Submitted, Green Published, gold			2022-12-27	WOS:000301639600039
J	Yang, ZC; Dong, ZQ; Fu, CX				Yang, Zhicong; Dong, Zhiqiang; Fu, Chuanxi			Seasonal Influenza Vaccine Effectiveness among Children Aged 6 to 59 Months in Southern China	PLOS ONE			English	Article							YOUNG-CHILDREN; HOSPITALIZATIONS; BURDEN; VIRUS	In China the protective effect of seasonal influenza vaccine has only been assessed in controlled clinical trials and proven to be highly effective. However, the post-licensure effectiveness of influenza vaccine has not been examined. In our study all influenza cases from the 19 surveillance sites in Guangzhou were laboratory confirmed during 2009 and 2010. Controls were randomly selected from children aged 6 to 59 months in the Children's Expanded Programmed Immunization Administrative Computerized System. 2529 cases and 4539 controls were finally enrolled. After adjusting for gender, age and area of residence, the vaccine effectiveness of full vaccination was 51.79% and 57.78% in the 2009 and 2010 influenza season, respectively. Partial vaccination provided 39.38% and 35.98% protection to children aged 24 to 59 months in 2009 and 2010, respectively, and no protective effect was observed among younger children. Full vaccination is highly protective and partial vaccination is protective for older children. Influenza vaccination in general should be encouraged, and full vaccination should be particularly encouraged because its protective effect is much stronger than that of partial vaccination.	[Yang, Zhicong; Dong, Zhiqiang; Fu, Chuanxi] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China		Yang, ZC (corresponding author), Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	yangzc@gzcdc.org.cn; fuchuanxi@gmail.com	Fu, Chuanxi/K-5462-2016		Department of Health of Guangzhou [2009-ZDa-02, 201102A213026]; Science and Information Technology of Guangzhou [2009J1-c161]; Department of Health of Guangdong [A2011506]; Guangdong Provincial Department of Science and Technology [2011B050300001]	Department of Health of Guangzhou; Science and Information Technology of Guangzhou; Department of Health of Guangdong; Guangdong Provincial Department of Science and Technology	This work is supported by grants from the Department of Health of Guangzhou (grant: 2009-ZDa-02 and 201102A213026), Science and Information Technology of Guangzhou (grant: 2009J1-c161), Department of Health of Guangdong (grant: A2011506) and Guangdong Provincial Department of Science and Technology (grant:2011B050300001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian G, 2010, ZHEJIANG PREMED, V22, P12; Bian G.L., 2010, ADV MATER, V22, P19; Chen Y, 2010, CHINESE J DIS CONTRO, V14, P683; Clemens J, 1996, JAMA-J AM MED ASSOC, V275, P390, DOI 10.1001/jama.275.5.390; Coffin SE, 2007, PEDIATRICS, V119, P740, DOI 10.1542/peds.2006-2679; Eisenberg KW, 2008, PEDIATRICS, V122, P911, DOI 10.1542/peds.2007-3304; Fu CX, 2008, CLIN VACCINE IMMUNOL, V15, P1425, DOI 10.1128/CVI.00122-08; Fu CX, 2007, VACCINE, V25, P8756, DOI 10.1016/j.vaccine.2007.10.036; Fu CX, 2010, PEDIATR INFECT DIS J, V29, P690, DOI 10.1097/INF.0b013e3181d7380e; Guo R, 2008, CHIN J PUBLIC HLTH, V24, P843; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Jefferson T, 2008, COCHRANE DB SYST REV, pD4879; Joshi AY, 2009, VACCINE, V27, P4457, DOI 10.1016/j.vaccine.2009.05.038; Kelly H, 2011, PEDIATR INFECT DIS J, V30, P107, DOI 10.1097/INF.0b013e318201811c; Li TieGang, 2008, Disease Surveillance, V23, P478; Monto AS, 2002, AM J MED, V112, p4S; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Szilagyi PG, 2008, ARCH PEDIAT ADOL MED, V162, P943, DOI 10.1001/archpedi.162.10.943; Wang M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016809; Zhan Y, 2009, JIANGSU J PRE MED, V20, P14; Zhao Yan-Wei, 2009, Zhongguo Yi Miao He Mian Yi, V15, P19	24	19	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30424	10.1371/journal.pone.0030424	http://dx.doi.org/10.1371/journal.pone.0030424			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291953	gold, Green Submitted, Green Published			2022-12-27	WOS:000301639600019
J	Martinez-Canto, A; Castillejo, A; Mata-Balaguer, T; Castillejo, MI; Hernandez-Illan, E; Irles, E; Barbera, VM; Egoavil, C; Guarinos, C; Alenda, C; Ochoa, E; Lazaro, R; Fajardo, S; Lacueva, J; Calpena, R; Soto, JL				Martinez-Canto, Ana; Castillejo, Adela; Mata-Balaguer, Trinidad; Castillejo, Maria-Isabel; Hernandez-Illan, Eva; Irles, Esperanza; Manuel Barbera, Victor; Egoavil, Cecilia; Guarinos, Carla; Alenda, Cristina; Ochoa, Enrique; Lazaro, Rafael; Fajardo, Silvia; Lacueva, Javier; Calpena, Rafael; Luis Soto, Jose			TGFBR1 Intralocus Epistatic Interaction as a Risk Factor for Colorectal Cancer	PLOS ONE			English	Article							ALLELE-SPECIFIC EXPRESSION; GENETIC PREDISPOSITION; TGFBR1-ASTERISK-6A; SUSCEPTIBILITY; METAANALYSIS; POPULATION; GENOMICS; LOCUS	In colorectal cancer (CRC), an inherited susceptibility risk affects about 35% of patients, whereas high-penetrance germline mutations account for <6% of cases. A considerable proportion of sporadic tumors could be explained by the coinheritance of multiple low-penetrance variants, some of which are common. We assessed the susceptibility to CRC conferred by genetic variants at the TGFBR1 locus. We analyzed 14 polymorphisms and the allele-specific expression (ASE) of TGFBR1 in 1025 individuals from the Spanish population. A case-control study was undertaken with 504 controls and 521 patients with sporadic CRC. Fourteen polymorphisms located at the TGFBR1 locus were genotyped with the ipLEx Gold (MassARRAY-Sequenom) technology. Descriptive analyses of the polymorphisms and haplotypes and association studies were performed with the SNPator workpackage. No relevant associations were detected between individual polymorphisms or haplotypes and the risk of CRC. The TGFBR1*9A/6A polymorphism was used for the ASE analysis. Heterozygous individuals were analyzed for ASE by fragment analysis using cDNA from normal tissue. The relative level of allelic expression was extrapolated from a standard curve. The cutoff value was calculated with Youden's index. ASE was found in 25.4% of patients and 16.4% of controls. Considering both bimodal and continuous types of distribution, no significant differences between the ASE values of patients and controls were identified. Interestingly, a combined analysis of the polymorphisms and ASE for the association with CRC occurrence revealed that ASE-positive individuals carrying one of the most common haplotypes (H2: 20.7%) showed remarkable susceptibility to CRC (RR: 5.25; 95% CI: 2.547-5.250; p<0.001) with a synergy factor of 3.7. In our study, 54.1% of sporadic CRC cases were attributable to the coinheritance of the H2 haplotype and TGFBR1 ASE. These results support the hypothesis that the allelic architecture of cancer genes, rather than individual polymorphisms, more accurately defines the CRC risk.	[Martinez-Canto, Ana; Castillejo, Adela; Mata-Balaguer, Trinidad; Castillejo, Maria-Isabel; Hernandez-Illan, Eva; Irles, Esperanza; Manuel Barbera, Victor; Egoavil, Cecilia; Guarinos, Carla; Fajardo, Silvia; Luis Soto, Jose] Elche Univ Hosp, Mol Genet Lab, Elche, Spain; [Alenda, Cristina] Alicante Univ Hosp, Dept Pathol, Alicante, Spain; [Ochoa, Enrique] Castellon Prov Hosp, Castellon de La Plana, Spain; [Lazaro, Rafael] La Plana Hosp, Dept Pathol, Villareal, Spain; [Lacueva, Javier; Calpena, Rafael] Elche Univ Hosp, Dept Surg, Elche, Spain	General University Hospital of Alicante	Martinez-Canto, A (corresponding author), Elche Univ Hosp, Mol Genet Lab, Elche, Spain.	soto_jos@gva.es	Egoavil, Cecilia/X-5134-2018; Castillo, Adela Castillejo/AAD-3477-2020; Alenda, Cristina/AAR-3433-2020; Cantó, Ana Martínez/AAL-1354-2020; Egoavil, Cecilia/ABG-8531-2020; Soto, José Luis/AAC-6520-2020	Egoavil, Cecilia/0000-0003-0166-4901; Castillo, Adela Castillejo/0000-0002-9581-6285; Egoavil, Cecilia/0000-0003-0166-4901; Soto, Jose Luis/0000-0003-0234-9188; Castillejo Castillo, Maria Isabel/0000-0002-4545-6429; Barbera, Victor-Manuel/0000-0002-4012-6973; Irles, Esperanza/0000-0002-9184-9549; Alenda, Cristina/0000-0002-0560-1759; Fajardo Sebastian, Silvia Maria/0000-0003-4359-1202	Generalitat Valenciana in Spain [AP140/08]; Biomedical Research Foundation from the Hospital of Elche, Spain [FIBEIx0902]; Fundacion Juan Peran-Pikolinos; Fundacion Carolina-BBVA; Conselleria de Educacion (Generalitat Valenciana)	Generalitat Valenciana in Spain; Biomedical Research Foundation from the Hospital of Elche, Spain; Fundacion Juan Peran-Pikolinos; Fundacion Carolina-BBVA; Conselleria de Educacion (Generalitat Valenciana)(Center for Forestry Research & Experimentation (CIEF))	This action has been supported in part by grants from the Generalitat Valenciana in Spain (AP140/08) and the Biomedical Research Foundation from the Hospital of Elche, Spain (FIBEIx0902). AM-C, CE, and CG are recipients of fellowships from the Fundacion Juan Peran-Pikolinos; Fundacion Carolina-BBVA and Conselleria de Educacion (Generalitat Valenciana), respectivelly. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie C, 2011, BRIT J CANCER, V104, P1517, DOI 10.1038/bjc.2011.124; Bian Yansong, 2003, Cancer Treat Res, V115, P73; Carvajal-Carmona LG, 2010, P NATL ACAD SCI USA, V107, P7858, DOI 10.1073/pnas.1002816107; Castellsague E, 2010, GASTROENTEROLOGY, V139, P439, DOI 10.1053/j.gastro.2010.04.047; Castillejo A, 2009, INT J CANCER, V124, P608, DOI 10.1002/ijc.24013; Castillejo A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-193; de la Chapelle A, 2009, ONCOGENE, V28, P3345, DOI 10.1038/onc.2009.194; Fletcher O, 2010, NAT REV CANCER, V10, P353, DOI 10.1038/nrc2840; Forsti A, 2010, GENE CHROMOSOME CANC, V49, P270, DOI 10.1002/gcc.20738; Goldstein DB, 2001, CURR BIOL, V11, pR576, DOI 10.1016/S0960-9822(01)00348-7; Guda K, 2009, CANCER RES, V69, P4959, DOI 10.1158/0008-5472.CAN-09-0225; Hsieh AR, 2011, GENOMICS, V97, P77, DOI 10.1016/j.ygeno.2010.11.003; Knight JC, 2004, TRENDS GENET, V20, P113, DOI 10.1016/j.tig.2004.01.001; Liao RY, 2010, MOL BIOL REP, V37, P3227, DOI 10.1007/s11033-009-9906-7; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; Morcillo-Suarez C, 2008, BIOINFORMATICS, V24, P1643, DOI 10.1093/bioinformatics/btn241; Pasche B, 2004, J CLIN ONCOL, V22, P756, DOI 10.1200/JCO.2004.99.271; Pasche B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-57; Segui N, 2011, BRIT J CANCER, V104, P735, DOI 10.1038/sj.bjc.6606079; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Skelly DA, 2009, ANNU REV GENOM HUM G, V10, P313, DOI 10.1146/annurev-genom-082908-150121; Suriano G, 2007, HUM MOL GENET, V16, P2209, DOI 10.1093/hmg/ddm172; Tomlinson IPM, 2010, BRIT J CANCER, V102, P447, DOI 10.1038/sj.bjc.6605338; Tomsic J, 2010, CARCINOGENESIS, V31, P1800, DOI 10.1093/carcin/bgq165; Valle L, 2008, SCIENCE, V321, P1361, DOI 10.1126/science.1159397; Yan H, 2002, NAT GENET, V30, P25, DOI 10.1038/ng799	26	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30812	10.1371/journal.pone.0030812	http://dx.doi.org/10.1371/journal.pone.0030812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292045	Green Published, gold			2022-12-27	WOS:000301570600082
J	Zhang, J; Bowers, J; Liu, LY; Wei, SW; Gowda, GAN; Hammoud, Z; Raftery, D				Zhang, Jian; Bowers, Jeremiah; Liu, Lingyan; Wei, Siwei; Gowda, G. A. Nagana; Hammoud, Zane; Raftery, Daniel			Esophageal Cancer Metabolite Biomarkers Detected by LC-MS and NMR Methods	PLOS ONE			English	Article							HIGH-GRADE DYSPLASIA; BARRETTS-ESOPHAGUS; METABOLOMICS; CARCINOMA; H-1; SPECTROSCOPY; EXPRESSION; DIAGNOSIS; THERAPY; PROFILE	Background: Esophageal adenocarcinoma (EAC) is a rarely curable disease and is rapidly rising worldwide in incidence. Barret's esophagus (BE) and high-grade dysplasia (HGD) are considered major risk factors for invasive adenocarcinoma. In the current study, unbiased global metabolic profiling methods were applied to serum samples from patients with EAC, BE and HGD, and healthy individuals, in order to identify metabolite based biomarkers associated with the early stages of EAC with the goal of improving prognostication. Methodology/Principal Findings: Serum metabolite profiles from patients with EAC (n = 67), BE (n = 3), HGD (n = 9) and healthy volunteers (n = 34) were obtained using high performance liquid chromatography-mass spectrometry (LC-MS) methods. Twelve metabolites differed significantly (p, 0.05) between EAC patients and healthy controls. A partial least-squares discriminant analysis (PLS-DA) model had good accuracy with the area under the receiver operative characteristic curve (AUROC) of 0.82. However, when the results of LC-MS were combined with 8 metabolites detected by nuclear magnetic resonance (NMR) in a previous study, the combination of NMR and MS detected metabolites provided a much superior performance, with AUROC = 0.95. Further, mean values of 12 of these metabolites varied consistently from healthy controls to the high-risk individuals (BE and HGD patients) and EAC subjects. Altered metabolic pathways including a number of amino acid pathways and energy metabolism were identified based on altered levels of numerous metabolites. Conclusions/Significance: Metabolic profiles derived from the combination of LC-MS and NMR methods readily distinguish EAC patients and potentially promise important routes to understanding the carcinogenesis and detecting the cancer. Differences in the metabolic profiles between high-risk individuals and the EAC indicate the possibility of identifying the patients at risk much earlier to the development of the cancer.	[Zhang, Jian; Bowers, Jeremiah; Wei, Siwei; Gowda, G. A. Nagana; Raftery, Daniel] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Liu, Lingyan] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Hammoud, Zane] Henry Ford Hosp, Detroit, MI 48202 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Henry Ford Health System; Henry Ford Hospital	Zhang, J (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	raftery@purdue.edu			Purdue University Center for Cancer Research; Oncological Sciences Center in Discovery Park at Purdue	Purdue University Center for Cancer Research; Oncological Sciences Center in Discovery Park at Purdue	This study was supported by the Purdue University Center for Cancer Research and the Oncological Sciences Center in Discovery Park at Purdue. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asiago VM, 2010, CANCER RES, V70, P8309, DOI 10.1158/0008-5472.CAN-10-1319; Ayxiam Hasim, 2009, Zhonghua Yufang Yixue Zazhi, V43, P591, DOI 10.3760/cma.j.issn.0253-9624.2009.07.013; Boros LG, 2005, METABOLOMICS, V1, P11, DOI 10.1007/s11306-005-1103-7; Chen LQ, 1999, DIS ESOPHAGUS, V12, P161; Denkert C, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-72; Djukovic D, 2010, RAPID COMMUN MASS SP, V24, P3057, DOI 10.1002/rcm.4739; Duffy MJ, 2008, CLIN CHEM, V54, P1770, DOI 10.1373/clinchem.2008.110056; Ekman S, 2007, ONCOLOGIST, V12, P1165, DOI 10.1634/theoncologist.12-10-1165; Fan TWM, 2011, J BIOMOL NMR, V49, P267, DOI 10.1007/s10858-011-9484-6; Gowda GAN, 2008, EXPERT REV MOL DIAGN, V8, P617, DOI 10.1586/14737159.8.5.617; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Guo W, 2009, CURR GENOMICS, V10, P534, DOI 10.2174/138920209789503888; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lai HS, 2005, SEMIN CANCER BIOL, V15, P267, DOI 10.1016/j.semcancer.2005.04.003; LEAN CL, 1993, MAGNET RESON MED, V30, P525, DOI 10.1002/mrm.1910300502; Maguire G, 2006, EXPERT OPIN DRUG DIS, V1, P351, DOI 10.1517/17460441.1.4.351; Margulies Craig, 1996, Comprehensive Therapy, V22, P565; May A, 2006, CURR OPIN GASTROEN, V22, P433, DOI 10.1097/01.mog.0000231821.48890.e6; McCann P, 2011, CANCER TREAT REV, V37, P11, DOI 10.1016/j.ctrv.2010.04.006; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Pan ZZ, 2007, ANAL BIOANAL CHEM, V387, P525, DOI 10.1007/s00216-006-0687-8; Qiu YP, 2010, J PROTEOME RES, V9, P1627, DOI 10.1021/pr901081y; Qiu YP, 2009, J PROTEOME RES, V8, P4844, DOI 10.1021/pr9004162; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tew WP, 2005, ONCOLOGIST, V10, P590, DOI 10.1634/theoncologist.10-8-590; Thysell E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014175; Tiziani S, 2009, NEOPLASIA, V11, P269, DOI 10.1593/neo.81396; van Baal JWPM, 2008, DIS ESOPHAGUS, V21, P634, DOI 10.1111/j.1442-2050.2008.00853.x; Walenta S, 2004, CURR MED CHEM, V11, P2195, DOI 10.2174/0929867043364711; Wang David H, 2011, Gastrointest Endosc Clin N Am, V21, P25, DOI 10.1016/j.giec.2010.09.011; Wang HL, 2010, FUTURE ONCOL, V6, P1395, DOI 10.2217/FON.10.107; Waxman I, 2006, AM J GASTROENTEROL, V101, P1773, DOI 10.1111/j.1572-0241.2006.00617.x; Wu H, 2009, J CHROMATOGR B, V877, P3111, DOI 10.1016/j.jchromb.2009.07.039; Yakoub D, 2010, CANCER RES, V70, P9129, DOI 10.1158/0008-5472.CAN-10-1566; Yousef F, 2008, AM J EPIDEMIOL, V168, P237, DOI 10.1093/aje/kwn121; Zhang J, 2011, J THORAC CARDIOV SUR, V141, P469, DOI 10.1016/j.jtcvs.2010.08.025	39	99	113	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30181	10.1371/journal.pone.0030181	http://dx.doi.org/10.1371/journal.pone.0030181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291914	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600022
J	Berdjane-Brouk, Z; Kone, AK; Djimde, AA; Charrel, RN; Ravel, C; Delaunay, P; del Giudice, P; Diarra, AZ; Doumbo, S; Goita, S; Thera, MA; Depaquit, J; Marty, P; Doumbo, OK; Izri, A				Berdjane-Brouk, Zohra; Kone, Abdoulaye K.; Djimde, Abdoulaye A.; Charrel, Remi N.; Ravel, Christophe; Delaunay, Pascal; del Giudice, Pascal; Diarra, Adama Z.; Doumbo, Siala; Goita, Siaka; Thera, Mahamadou A.; Depaquit, Jerome; Marty, Pierre; Doumbo, Ogobara K.; Izri, Arezki			First Detection of Leishmania major DNA in Sergentomyia (Spelaeomyia) darlingi from Cutaneous Leishmaniasis Foci in Mali	PLOS ONE			English	Article							DUBOSCQI NEVEU-LEMAIRE; INFECTION	Background: Leishmania major complex is the main causative agent of zoonotic cutaneous leishmaniasis (ZCL) in the Old World. Phlebotomus papatasi and Phlebotomus duboscqi are recognized vectors of L. major complex in Northern and Southern Sahara, respectively. In Mali, ZCL due to L. major is an emerging public health problem, with several cases reported from different parts of the country. The main objective of the present study was to identify the vectors of Leishmania major in the Bandiagara area, in Mali. Methodology/Principal Findings: An entomological survey was carried out in the ZCL foci of Bandiagara area. Sandflies were collected using CDC miniature light traps and sticky papers. In the field, live female Phlebotomine sandflies were identified and examined for the presence of promastigotes. The remaining sandflies were identified morphologically and tested for Leishmania by PCR in the ITS2 gene. The source of blood meal of the engorged females was determined using the cyt-b sequence. Out of the 3,259 collected sandflies, 1,324 were identified morphologically, and consisted of 20 species, of which four belonged to the genus Phlebotomus and 16 to the genus Sergentomyia. Leishmania major DNA was detected by PCR in 7 of the 446 females (1.6%), specifically 2 out of 115 Phlebotomus duboscqi specimens, and 5 from 198 Sergentomyia darlingi specimens. Human DNA was detected in one blood-fed female S. darlingi positive for L. major DNA. Conclusion: Our data suggest the possible involvement of P. duboscqi and potentially S. darlingi in the transmission of ZCL in Mali.	[Berdjane-Brouk, Zohra; Izri, Arezki] Univ Paris 13, Hop Avicenne, Paris, France; [Kone, Abdoulaye K.; Djimde, Abdoulaye A.; Diarra, Adama Z.; Doumbo, Siala; Goita, Siaka; Thera, Mahamadou A.; Doumbo, Ogobara K.] Univ Bamako, UMI CRNS Pole Mali, Malaria Res & Training Ctr, Dept Epidemiol Affect Parasitaires,Fac Med Pharm, Bamako, Mali; [Berdjane-Brouk, Zohra; Charrel, Remi N.; Izri, Arezki] Aix Marseille Univ, Unite Virus Emergents, UMR 190, IRD,EHESP, Marseille, France; [Ravel, Christophe] Univ Montpellier I, Ctr Natl Reference Leishmaniose, CHRU Montpellier, UMR5290, Montpellier, France; [Delaunay, Pascal; Marty, Pierre] Univ Nice Sophia Antipolis, CHU Nice, INSERM, U895, Nice, France; [del Giudice, Pascal] Hop Bonnet, Unite Malad Infect & Trop, F-83700 Frejus, Frejus, France; [Depaquit, Jerome] Univ Reims, JE USC ANSES Transmiss Vectorielle & Epidemiosurv, Reims, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; University of Bamako; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Montpellier; CHU de Montpellier; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Universite de Reims Champagne-Ardenne	Berdjane-Brouk, Z (corresponding author), Univ Paris 13, Hop Avicenne, Paris, France.	arezki.izri@avc.aphp.fr	Ravel, Christophe/A-7369-2008; Depaquit, Jérôme/AAT-7586-2021	Depaquit, Jérôme/0000-0001-6995-0088; ravel, christophe/0000-0002-7590-582X; Thera, Mahamadou A/0000-0002-2679-035X; Charrel, Remi/0000-0002-7675-8251	Foundation MERIEUX	Foundation MERIEUX	The funding that supported this study was from the Foundation MERIEUX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABONNENC E., 1972, Mem. O. R. S. T. O. M.; Anderson JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001139; Ben-Ismail R, 1987, T R SOC TROP MED HYG, V5, P186; DEDET JP, 1982, B SOC PATHOL EXOT, V75, P588; Develoux M, 1996, T ROY SOC TROP MED H, V90, P396, DOI 10.1016/S0035-9203(96)90520-9; GARIN JP, 1985, ANN PARASIT HUM COMP, V60, P93, DOI 10.1051/parasite/198560193; Gebre-Michael T, 1993, T R SOC TROP MED HYG, V1, P118; Hanafi HA, 1996, AM J TROP MED HYG, V54, P644, DOI 10.4269/ajtmh.1996.54.644; Izri A, 1992, PARASITOL HUM COMP, V1, P31; IZRI MA, 1989, ANN PARASIT HUM COMP, V64, P510, DOI 10.1051/parasite/1989646510; IZRI MA, 1993, T ROY SOC TROP MED H, V87, P399, DOI 10.1016/0035-9203(93)90011-E; Kasiri H, 2000, B SOC PATHOL EXOT, V93, P129; Keita SFO, 2003, MALI MED, VXVIII, P3; Kervran P, 1946, ANN PARASITOL, V21, P153; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; LAWYER PG, 1990, AM J TROP MED HYG, V43, P31, DOI 10.4269/ajtmh.1990.43.31; LEGER N, 1983, ANN PARASIT HUM COMP, V58, P611, DOI 10.1051/parasite/1983586611; Mukherjee S, 1997, AM J TROP MED HYG, V57, P423, DOI 10.4269/ajtmh.1997.57.423; MUTINGA MJ, 1994, E AFR MED J, V71, P424; Niang AA, 2004, SANDFLIES AFRO TROPI; PARROT L., 1926, BULL SOC PATH EXOT, V19, P694; Parvizi P, 2008, IRAN J VET RES, V9, P9; Pratlong F, 2009, TROP MED INT HEALTH, V14, P1071, DOI 10.1111/j.1365-3156.2009.02336.x; Ranque P., 1975, Acta Tropica, V32, P348; Senghor MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014773; Sergent E, 1921, CR HEBD ACAD SCI, V173, P1030; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; World Health Organization, 2008, GLOB BURD DIS 2004 U	29	53	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e28266	10.1371/journal.pone.0028266	http://dx.doi.org/10.1371/journal.pone.0028266			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276095	Green Published, gold			2022-12-27	WOS:000301568100002
J	Mizuno, S; Yasuo, M; Bogaard, HJ; Kraskauskas, D; Alhussaini, A; Gomez-Arroyo, J; Farkas, D; Farkas, L; Voelkel, NF				Mizuno, Shiro; Yasuo, Masanori; Bogaard, Harm J.; Kraskauskas, Donatas; Alhussaini, Aysar; Gomez-Arroyo, Jose; Farkas, Daniela; Farkas, Laszlo; Voelkel, Norbert F.			Copper Deficiency Induced Emphysema Is Associated with Focal Adhesion Kinase Inactivation	PLOS ONE			English	Article							LYSYL OXIDASE; LUNG; SURVIVAL; ACTIVATION; EXPRESSION; APOPTOSIS; MIGRATION; MENKES; RAT	Background: Copper is an important regulator of hypoxia inducible factor 1 alpha (HIF-1 alpha) dependent vascular endothelial growth factor (VEGF) expression, and is also required for the activity of lysyl oxidase (LOX) to effect matrix protein cross-linking. Cell detachment from the extracellular matrix can induce apoptosis (anoikis) via inactivation of focal adhesion kinase (FAK). Methodology: To examine the molecular mechanisms whereby copper depletion causes the destruction of the normal alveolar architecture via anoikis, Male Sprague-Dawley rats were fed a copper deficient diet for 6 weeks while being treated with the copper chelator, tetrathiomolybdate. Other groups of rats were treated with the inhibitor of auto-phosphorylation of FAK, 1,2,4,5-benzenetetraamine tetrahydrochloride (1,2,4,5-BT) or FAK small interfering RNA (siRNA). Principal Findings: Copper depletion caused emphysematous changes, decreased HIF-1 alpha activity, and downregulated VEGF expression in the rat lungs. Cleaved caspase-3, caspase-8 and Bcl-2 interacting mediator of cell death (Bim) expression was increased, and the phosphorylation of FAK was decreased in copper depleted rat lungs. Administration of 1,2,4,5-BT and FAK siRNA caused emphysematous lung destruction associated with increased expression of cleaved capase-3, caspase-8 and Bim. Conclusions: These data indicate that copper-dependent mechanisms contribute to the pathogenesis of emphysema, which may be associated with decreased HIF-1 alpha and FAK activity in the lung.	[Mizuno, Shiro; Yasuo, Masanori; Kraskauskas, Donatas; Alhussaini, Aysar; Gomez-Arroyo, Jose; Farkas, Daniela; Farkas, Laszlo; Voelkel, Norbert F.] Virginia Commonwealth Univ, Div Pulm & Crit Care Med, Richmond, VA 23284 USA; [Mizuno, Shiro; Yasuo, Masanori; Kraskauskas, Donatas; Alhussaini, Aysar; Gomez-Arroyo, Jose; Farkas, Daniela; Farkas, Laszlo; Voelkel, Norbert F.] Virginia Commonwealth Univ, Victoria Johnson Ctr Obstruct Lung Dis, Richmond, VA USA; [Mizuno, Shiro] Kanazawa Med Univ, Div Resp Dis, Kanazawa, Ishikawa, Japan; [Bogaard, Harm J.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands	Virginia Commonwealth University; Virginia Commonwealth University; Kanazawa Medical University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Mizuno, S (corresponding author), Virginia Commonwealth Univ, Div Pulm & Crit Care Med, Richmond, VA 23284 USA.	nvoelkel@mcvh-vcu.edu		Bogaard, Harm Jan/0000-0001-5371-0346	Victoria Johnson Center for Lung Research of the Virginia Commonwealth University	Victoria Johnson Center for Lung Research of the Virginia Commonwealth University	This work was supported by the funds from the Victoria Johnson Center for Lung Research of the Virginia Commonwealth University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrendt CE, 2005, CHEST, V128, P1239, DOI 10.1378/chest.128.3.1239; Bouchard V, 2008, APOPTOSIS, V13, P531, DOI 10.1007/s10495-008-0192-y; Feng WK, 2009, MOL PHARMACOL, V75, P174, DOI 10.1124/mol.108.051516; GACHERU S, 1993, ARCH BIOCHEM BIOPHYS, V301, P325, DOI 10.1006/abbi.1993.1151; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Grange DK, 2005, AM J MED GENET A, V139A, P151, DOI 10.1002/ajmg.a.31001; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Hakim ZS, 2009, J MOL CELL CARDIOL, V46, P241, DOI 10.1016/j.yjmcc.2008.10.017; HUNT DM, 1974, NATURE, V249, P852, DOI 10.1038/249852a0; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Keledjian K, 2005, J CELL BIOCHEM, V94, P374, DOI 10.1002/jcb.20240; KIDA K, 1980, AM J PATHOL, V101, P693; Kostka G, 2001, MOL CELL BIOL, V21, P7025, DOI 10.1128/MCB.21.20.7025-7034.2001; Laser M, 2000, J BIOL CHEM, V275, P35624, DOI 10.1074/jbc.M006124200; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Martin F, 2005, BLOOD, V105, P4613, DOI 10.1182/blood-2004-10-3980; Noda T, 2009, APOPTOSIS, V14, P287, DOI 10.1007/s10495-009-0319-9; ODELL BL, 1978, AM J PATHOL, V91, P413; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; RANGA V, 1983, EXP LUNG RES, V4, P269, DOI 10.3109/01902148309055014; Rubio ML, 1998, AM J RESP CRIT CARE, V157, P237, DOI 10.1164/ajrccm.157.1.9704038; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Shinawi M, 2005, PEDIATR PULM, V39, P374, DOI 10.1002/ppul.20174; Song H, 2010, STEM CELLS, V28, P555, DOI 10.1002/stem.302; SOSKEL N T, 1984, Chest, V85, p70S, DOI 10.1378/chest.85.6.70S; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Taraseviciene-Stewart L, 2008, J CLIN INVEST, V118, P394, DOI 10.1172/JCI31811; Tuder Rubin M, 2006, Proc Am Thorac Soc, V3, P673, DOI 10.1513/pats.200605-124SF; Yasuo M, 2011, EUR RESPIR J, V37, P775, DOI 10.1183/09031936.00022910; Zhu J, 2009, EXP EYE RES, V88, P910, DOI 10.1016/j.exer.2008.11.034	32	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30678	10.1371/journal.pone.0030678	http://dx.doi.org/10.1371/journal.pone.0030678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276220	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100060
J	Srihirun, S; Sriwantana, T; Unchern, S; Kittikool, D; Noulsri, E; Pattanapanyasat, K; Fucharoen, S; Piknova, B; Schechter, AN; Sibmooh, N				Srihirun, Sirada; Sriwantana, Thanaporn; Unchern, Supeenun; Kittikool, Dusadee; Noulsri, Egarit; Pattanapanyasat, Kovit; Fucharoen, Suthat; Piknova, Barbora; Schechter, Alan N.; Sibmooh, Nathawut			Platelet Inhibition by Nitrite Is Dependent on Erythrocytes and Deoxygenation	PLOS ONE			English	Article							RED-BLOOD-CELLS; OXIDE SYNTHASE; CYTOPLASMIC DOMAIN; SMOOTH-MUSCLE; IN-VIVO; HEMOGLOBIN; NO; AGGREGATION; REDUCTION; DEOXYHEMOGLOBIN	Background: Nitrite is a nitric oxide (NO) metabolite in tissues and blood, which can be converted to NO under hypoxia to facilitate tissue perfusion. Although nitrite is known to cause vasodilation following its reduction to NO, the effect of nitrite on platelet activity remains unclear. In this study, the effect of nitrite and nitrite+erythrocytes, with and without deoxygenation, on platelet activity was investigated. Methodology/Finding: Platelet aggregation was studied in platelet-rich plasma (PRP) and PRP+erythrocytes by turbidimetric and impedance aggregometry, respectively. In PRP, DEANONOate inhibited platelet aggregation induced by ADP while nitrite had no effect on platelets. In PRP+erythrocytes, the inhibitory effect of DEANONOate on platelets decreased whereas nitrite at physiologic concentration (0.1 mu M) inhibited platelet aggregation and ATP release. The effect of nitrite+erythrocytes on platelets was abrogated by C-PTIO (a membrane-impermeable NO scavenger), suggesting an NO-mediated action. Furthermore, deoxygenation enhanced the effect of nitrite as observed from a decrease of P-selectin expression and increase of the cGMP levels in platelets. The ADP-induced platelet aggregation in whole blood showed inverse correlations with the nitrite levels in whole blood and erythrocytes. Conclusion: Nitrite alone at physiological levels has no effect on platelets in plasma. Nitrite in the presence of erythrocytes inhibits platelets through its reduction to NO, which is promoted by deoxygenation. Nitrite may have role in modulating platelet activity in the circulation, especially during hypoxia.	[Srihirun, Sirada; Sriwantana, Thanaporn; Unchern, Supeenun; Kittikool, Dusadee; Sibmooh, Nathawut] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok 10400, Thailand; [Noulsri, Egarit; Pattanapanyasat, Kovit] Mahidol Univ, Siriraj Hosp, Fac Med, Off Res & Dev, Bangkok 10700, Thailand; [Fucharoen, Suthat] Mahidol Univ, Thalassemia Res Ctr, Inst Sci & Technol Res & Dev, Nakhon Pathom, Thailand; [Piknova, Barbora; Schechter, Alan N.] NIDDK, Mol Med Branch, NIH, Bethesda, MD USA	Mahidol University; Mahidol University; Mahidol University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Srihirun, S (corresponding author), Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok 10400, Thailand.	scnsm@mahidol.ac.th	Noulsri, Egarit/AAW-9013-2021	Noulsri, Egarit/0000-0002-8557-8631; Srihirun, Sirada/0000-0003-1616-9487; Schechter, Alan N/0000-0002-5235-9408	Institute for the Promotion of Teaching of Science and Technology; Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Thailand Research Fund; National Institute of Diabetes, and Digestive, and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025093, ZIADK025104] Funding Source: NIH RePORTER	Institute for the Promotion of Teaching of Science and Technology; Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Thailand Research Fund(Thailand Research Fund (TRF)); National Institute of Diabetes, and Digestive, and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the Institute for the Promotion of Teaching of Science and Technology, the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative, the Thailand Research Fund - Senior Research Scholar, and the intramural program of the National Institute of Diabetes, and Digestive, and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsheye I, 2010, J CELL PHYSIOL, V224, P620, DOI 10.1002/jcp.22195; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; Broos K, 2011, BLOOD REV, V25, P155, DOI 10.1016/j.blre.2011.03.002; CASSOLY R, 1975, J MOL BIOL, V91, P301, DOI 10.1016/0022-2836(75)90382-4; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Dejam A, 2005, BLOOD, V106, P734, DOI 10.1182/blood-2005-02-0567; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; Garthwaite J, 2010, MOL CELL BIOCHEM, V334, P221, DOI 10.1007/s11010-009-0318-8; Gautier C, 2006, BIOCHEM BIOPH RES CO, V341, P816, DOI 10.1016/j.bbrc.2006.01.031; Goldstein S, 2003, J BIOL CHEM, V278, P50949, DOI 10.1074/jbc.M308317200; Grubina R, 2007, J BIOL CHEM, V282, P12916, DOI 10.1074/jbc.M700546200; GRUETTER CA, 1981, J PHARMACOL EXP THER, V219, P181; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; Jeffers A, 2005, COMP BIOCHEM PHYS A, V142, P130, DOI 10.1016/j.cbpb.2005.04.016; Jensen FB, 2010, AM J PHYSIOL-REG I, V298, pR972, DOI 10.1152/ajpregu.00813.2009; Keszler A, 2008, J BIOL CHEM, V283, P9615, DOI 10.1074/jbc.M705630200; Kleinbongard P, 2003, FREE RADICAL BIO MED, V35, P790, DOI 10.1016/S0891-5849(03)00406-4; LAUSTIOLA KE, 1991, PHARMACOL TOXICOL, V68, P60, DOI 10.1111/j.1600-0773.1991.tb01209.x; Li HT, 2001, J BIOL CHEM, V276, P24482, DOI 10.1074/jbc.M011648200; Megson IL, 2000, BRIT J PHARMACOL, V131, P1391, DOI 10.1038/sj.bjp.0703731; RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Salhany JM, 2008, BIOCHEMISTRY-US, V47, P6059, DOI 10.1021/bi8000819; Samouilov A, 2007, NITRIC OXIDE-BIOL CH, V16, P362, DOI 10.1016/j.niox.2006.12.006; Sibmooh N, 2008, BIOCHEMISTRY-US, V47, P2989, DOI 10.1021/bi702158d; Tymvios C, 2009, BRIT J PHARMACOL, V158, P1735, DOI 10.1111/j.1476-5381.2009.00408.x; van Faassen EE, 2009, MED RES REV, V29, P683, DOI 10.1002/med.20151; Vitturi DA, 2009, AM J PHYSIOL-HEART C, V296, pH1398, DOI 10.1152/ajpheart.01303.2008; WALDER JA, 1984, J BIOL CHEM, V259, P238; Webb AJ, 2008, CIRC RES, V103, P957, DOI 10.1161/CIRCRESAHA.108.175810; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; Yoshida S, 2008, BLOOD, V111, P2007, DOI 10.1182/blood-2007-06-097824	34	92	92	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30380	10.1371/journal.pone.0030380	http://dx.doi.org/10.1371/journal.pone.0030380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276188	Green Published, gold, Green Submitted			2022-12-27	WOS:000301568100041
J	Xu, P; Johnson, TL; Stoller-Conrad, JR; Schulz, RA				Xu, Peng; Johnson, Tamara L.; Stoller-Conrad, Jessica R.; Schulz, Robert A.			Spire, an Actin Nucleation Factor, Regulates Cell Division during Drosophila Heart Development	PLOS ONE			English	Article							CYCLIN-A; EARLY CARDIOGENESIS; DORSAL MESODERM; BOX GENES; MELANOGASTER; EXPRESSION; CAPPUCCINO; PANNIER; MICROTUBULE; REQUIREMENT	The Drosophila dorsal vessel is a beneficial model system for studying the regulation of early heart development. Spire (Spir), an actin-nucleation factor, regulates actin dynamics in many developmental processes, such as cell shape determination, intracellular transport, and locomotion. Through protein expression pattern analysis, we demonstrate that the absence of spir function affects cell division in Myocyte enhancer factor 2-, Tinman (Tin)-, Even-skipped-and Seven up (Svp)-positive heart cells. In addition, genetic interaction analysis shows that spir functionally interacts with Dorsocross, tin, and pannier to properly specify the cardiac fate. Furthermore, through visualization of double heterozygous embryos, we determines that spir cooperates with CycA for heart cell specification and division. Finally, when comparing the spir mutant phenotype with that of a CycA mutant, the results suggest that most Svp-positive progenitors in spir mutant embryos cannot undergo full cell division at cell cycle 15, and that Tin-positive progenitors are arrested at cell cycle 16 as double-nucleated cells. We conclude that Spir plays a crucial role in controlling dorsal vessel formation and has a function in cell division during heart tube morphogenesis.	[Xu, Peng; Johnson, Tamara L.; Stoller-Conrad, Jessica R.; Schulz, Robert A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Xu, P (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	px3x@virginia.edu			National Institutes of Health [HL059151]; American Heart Association [10POST2630076]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by a grant to R.A.S. from the National Institutes of Health (HL059151) and a Postdoctoral Fellow Award to P.X. from the American Heart Association (10POST2630076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AD, 2003, DEVELOPMENT, V130, P3015, DOI 10.1242/dev.00488; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; CAMPOSORTEGA JA, 1997, EMBRYONIC DEV DROSOP, P287; Dong XZ, 1997, GENE DEV, V11, P94, DOI 10.1101/gad.11.1.94; FOE VE, 1983, J CELL SCI, V61, P31; FOE VE, 1989, DEVELOPMENT, V107, P1; Gajewski K, 1999, DEVELOPMENT, V126, P5679; Han Z, 2006, DEVELOPMENT, V133, P1175, DOI 10.1242/dev.02285; Han Z, 2003, DEVELOPMENT, V130, P3039, DOI 10.1242/dev.00484; Jacobs HW, 1998, GENE DEV, V12, P3741, DOI 10.1101/gad.12.23.3741; Kerkhoff E, 2006, TRENDS CELL BIOL, V16, P477, DOI 10.1016/j.tcb.2006.07.005; Klinedinst SL, 2003, DEVELOPMENT, V130, P3027, DOI 10.1242/dev.00517; KNOBLICH JA, 1993, EMBO J, V12, P65, DOI 10.1002/j.1460-2075.1993.tb05632.x; LEE JK, 1993, J CELL BIOL, V123, P1797, DOI 10.1083/jcb.123.6.1797; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; Liu R, 2009, DEVELOPMENT, V136, P2849, DOI 10.1242/dev.035246; Lo PCH, 2001, MECH DEVELOP, V104, P49, DOI 10.1016/S0925-4773(01)00361-6; Mann T, 2009, DEVELOPMENT, V136, P317, DOI 10.1242/dev.022533; Medioni C, 2009, CURR OPIN GENET DEV, V19, P518, DOI 10.1016/j.gde.2009.07.004; OFARRELL PH, 1989, SCIENCE, V246, P635, DOI 10.1126/science.2683080; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Reim I, 2005, DEVELOPMENT, V132, P4911, DOI 10.1242/dev.02077; Reim I, 2003, DEVELOPMENT, V130, P3187, DOI 10.1242/dev.00548; Reim I, 2010, PEDIATR CARDIOL, V31, P325, DOI 10.1007/s00246-009-9612-1; Rosales-Nieves AE, 2006, NAT CELL BIOL, V8, P367, DOI 10.1038/ncb1385; Schumacher N, 2004, GENE EXPR PATTERNS, V4, P249, DOI 10.1016/j.modgep.2003.11.006; Tao Y, 2007, GENESIS, V45, P607, DOI 10.1002/dvg.20333; Tao Y, 2007, MOL CELL BIOL, V27, P3962, DOI 10.1128/MCB.00093-07; Tao Y, 2007, SEMIN CELL DEV BIOL, V18, P3, DOI 10.1016/j.semcdb.2006.12.001; THEURKAUF WE, 1994, SCIENCE, V265, P2093, DOI 10.1126/science.8091233; Wang JB, 2005, MOL CELL BIOL, V25, P4200, DOI 10.1128/MCB.25.10.4200-4210.2005; Ward EJ, 2000, DEVELOPMENT, V127, P4959; Wellington A, 1999, DEVELOPMENT, V126, P5267; Yin ZZ, 1998, DEV GENET, V22, P187	35	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30565	10.1371/journal.pone.0030565	http://dx.doi.org/10.1371/journal.pone.0030565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276214	Green Published, gold, Green Submitted			2022-12-27	WOS:000301568100056
J	Eaton, HE; Metcalf, J; Lacerda, AF; Brunetti, CR				Eaton, Heather E.; Metcalf, Julie; Lacerda, Andressa Ferreira; Brunetti, Craig R.			Accumulation of Endogenous LITAF in Aggresomes	PLOS ONE			English	Article							MARIE-TOOTH-DISEASE; PROTEIN-DEGRADATION; INCLUSION-BODIES; HEREDITARY MOTOR; NEUROPATHY; GENE; MUTATIONS; DOMINANT; MAPS; IMPAIRMENT	LITAF is a 161 amino acid cellular protein which includes a proline rich N-terminus and a conserved C-terminal domain known as the simple-like domain. Mutations in LITAF have been identified in Charcot-Marie tooth disease, a disease characterized by protein aggregates. Cells transfected with cellular LITAF reveal that LITAF is localized to late endosomes/ lysosomes. Here we investigated the intracellular localization of endogenous LITAF. We demonstrated that endogenous LITAF accumulates at a discrete cytoplasmic site in BGMK cells that we identify as the aggresome. To determine the domain within LITAF that is responsible for the localization of LITAF to aggresomes, we created a construct that contained the Cterminal simple-like domain of LITAF and found that this construct also localizes to aggresomes. These data suggest the simple-like domain is responsible for targeting endogenous LITAF to the aggresome.	[Eaton, Heather E.; Metcalf, Julie; Lacerda, Andressa Ferreira; Brunetti, Craig R.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada	Trent University	Eaton, HE (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.	craigbrunetti@trentu.ca			Natural Sciences and Engineering Research Council (NSERC) [288123-2009]	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded through a Natural Sciences and Engineering Research Council (NSERC) Discovery Grant to CRB (grant# 288123-2009). HEE is the recipient of a NSERC postgraduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann B, 2007, BIOMED TECH, V52, P200, DOI 10.1515/BMT.2007.037; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; CHANCE PF, 1990, AM J HUM GENET, V47, P915; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P619, DOI 10.1001/archneur.1968.00470360041003; Eaton HE, SIMPLE LITAF E UNPUB; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Fortun J, 2003, J NEUROSCI, V23, P10672; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jolliffe CN, 2000, BIOCHEM J, V351, P557, DOI 10.1042/0264-6021:3510557; Jordanova A, 2003, AM J HUM GENET, V73, P1423, DOI 10.1086/379792; Junn E, 2002, J BIOL CHEM, V277, P47870, DOI 10.1074/jbc.M203159200; Klein CJ, 2003, NEUROLOGY, V60, P1151, DOI 10.1212/01.WNL.0000055900.30217.EA; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Liu N, 2004, NEUROBIOL DIS, V17, P300, DOI 10.1016/j.nbd.2004.07.010; Lopez-Bigas N, 2001, HUM MOL GENET, V10, P947, DOI 10.1093/hmg/10.9.947; Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680; Moriwaki Y, 2001, J BIOL CHEM, V276, P23065, DOI 10.1074/jbc.M011660200; Myokai F, 1999, P NATL ACAD SCI USA, V96, P4518, DOI 10.1073/pnas.96.8.4518; Nelis E, 2004, J MED GENET, V41, P193, DOI 10.1136/jmg.2003.012633; Notterpek L, 1999, NEUROBIOL DIS, V6, P450, DOI 10.1006/nbdi.1999.0274; Raynaud-Messina B, 2007, CURR OPIN CELL BIOL, V19, P24, DOI 10.1016/j.ceb.2006.12.008; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Ryan MC, 2002, NEUROBIOL DIS, V10, P109, DOI 10.1006/nbdi.2002.0500; Saifi GM, 2003, J INVEST MED, V51, P261, DOI 10.1136/jim-51-05-14; Senderek J, 2003, AM J HUM GENET, V73, P1106, DOI 10.1086/379525; Shirk AJ, 2005, J NEUROSCI RES, V82, P43, DOI 10.1002/jnr.20628; Simmen T, 1999, J CELL SCI, V112, P45; Street VA, 2003, NEUROLOGY, V60, P22, DOI 10.1212/WNL.60.1.22; Tang BS, 2004, HUM GENET, V114, P527, DOI 10.1007/s00439-004-1102-1; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Varon R, 2003, NAT GENET, V35, P185, DOI 10.1038/ng1243; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	37	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30003	10.1371/journal.pone.0030003	http://dx.doi.org/10.1371/journal.pone.0030003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276139	Green Published, Green Submitted, gold			2022-12-27	WOS:000301457200027
J	Lonchamp, E; Gambino, F; Dupont, JL; Doussau, F; Valera, A; Poulain, B; Bossu, JL				Lonchamp, Etienne; Gambino, Frederic; Dupont, Jean Luc; Doussau, Frederic; Valera, Antoine; Poulain, Bernard; Bossu, Jean-Louis			Pre and Post Synaptic NMDA Effects Targeting Purkinje Cells in the Mouse Cerebellar Cortex	PLOS ONE			English	Article							METHYL-D-ASPARTATE; LONG-TERM DEPRESSION; PARALLEL FIBER; GABA RELEASE; RECEPTOR CHANNELS; RAT CEREBELLUM; AMPA RECEPTORS; STELLATE CELLS; NR2D SUBUNITS; GRANULE CELLS	N-methyl-D-aspartate (NMDA) receptors are associated with many forms of synaptic plasticity. Their expression level and subunit composition undergo developmental changes in several brain regions. In the mouse cerebellum, beside a developmental switch between NR2B and NR2A/C subunits in granule cells, functional postsynaptic NMDA receptors are seen in Purkinje cells of neonate and adult but not juvenile rat and mice. A presynaptic effect of NMDA on GABA release by cerebellar interneurons was identified recently. Nevertheless whereas NMDA receptor subunits are detected on parallel fiber terminals, a presynaptic effect of NMDA on spontaneous release of glutamate has not been demonstrated. Using mouse cerebellar cultures and patch-clamp recordings we show that NMDA facilitates glutamate release onto Purkinje cells in young cultures via a presynaptic mechanism, whereas NMDA activates extrasynaptic receptors in Purkinje cells recorded in old cultures. The presynaptic effect of NMDA on glutamate release is also observed in Purkinje cells recorded in acute slices prepared from juvenile but not from adult mice and requires a specific protocol of NMDA application.	[Lonchamp, Etienne; Gambino, Frederic; Dupont, Jean Luc; Doussau, Frederic; Valera, Antoine; Poulain, Bernard; Bossu, Jean-Louis] Univ Strasbourg, CNRS, Inst Neurosci Cellulaires & Integrat, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Lonchamp, E (corresponding author), Univ Strasbourg, CNRS, Inst Neurosci Cellulaires & Integrat, Strasbourg, France.	jlbossu@neurochem.u-strasbg.fr	Valera, Antoine/AAL-3519-2021; Valera, Antoine/G-9807-2014	Valera, Antoine/0000-0002-0230-9752; gambino, frederic/0000-0002-2981-5030; Doussau, Frederic/0000-0002-3769-1402	Mission pour la Recherche et l'Innovation Scientifique-Delegation Generale a l'Armement (M.R.I.S/D.G.A.-Gilles Vergnaud)	Mission pour la Recherche et l'Innovation Scientifique-Delegation Generale a l'Armement (M.R.I.S/D.G.A.-Gilles Vergnaud)	EL received a doctoral grant from the Mission pour la Recherche et l'Innovation Scientifique-Delegation Generale a l'Armement (M.R.I.S/D.G.A.-Gilles Vergnaud). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAZAWA C, 1994, J COMP NEUROL, V347, P150, DOI 10.1002/cne.903470112; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; Bidoret C, 2009, P NATL ACAD SCI USA, V106, P14126, DOI 10.1073/pnas.0904284106; Billups D, 2002, J NEUROPHYSIOL, V87, P1948, DOI 10.1152/jn.00599.2001; Brickley SG, 2003, J NEUROSCI, V23, P4958; Bureau I, 1998, J PHYSIOL-LONDON, V509, P817, DOI 10.1111/j.1469-7793.1998.817bm.x; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Casado M, 2000, P NATL ACAD SCI USA, V97, P11593, DOI 10.1073/pnas.200354297; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; Cathala L, 2000, J NEUROSCI, V20, P5899, DOI 10.1523/JNEUROSCI.20-16-05899.2000; Corlew R, 2008, NEUROSCIENTIST, V14, P609, DOI 10.1177/1073858408322675; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; Duguid I, 2006, CURR OPIN NEUROBIOL, V16, P312, DOI 10.1016/j.conb.2006.05.008; Dupont JL, 2006, CEREBELLUM, V5, P243, DOI 10.1080/14734220600905317; DUPONT JL, 1987, DEV BRAIN RES, V34, P59, DOI 10.1016/0165-3806(87)90195-7; Fiszman ML, 2005, J NEUROSCI, V25, P2024, DOI 10.1523/JNEUROSCI.4980-04.2005; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; Glitsch M, 1999, J NEUROSCI, V19, P511; Glitsch MD, 2008, NEUROSCIENCE, V151, P403, DOI 10.1016/j.neuroscience.2007.10.024; HOWE JR, 1991, J PHYSIOL-LONDON, V432, P143, DOI 10.1113/jphysiol.1991.sp018381; Iijima K, 2008, P NATL ACAD SCI USA, V105, P12010, DOI 10.1073/pnas.0805574105; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; KRUPA M, 1990, EUR J NEUROSCI, V2, P312, DOI 10.1111/j.1460-9568.1990.tb00423.x; Lachamp P, 2005, J PHYSIOL-LONDON, V564, P751, DOI 10.1113/jphysiol.2005.084517; Liu SQJ, 2007, J NEUROPHYSIOL, V98, P550, DOI 10.1152/jn.00352.2007; MACDONALD JF, 1990, TRENDS PHARMACOL SCI, V11, P167, DOI 10.1016/0165-6147(90)90070-O; Misra C, 2000, J PHYSIOL-LONDON, V524, P147, DOI 10.1111/j.1469-7793.2000.00147.x; Misra C, 2000, J PHYSIOL-LONDON, V525, P299, DOI 10.1111/j.1469-7793.2000.t01-1-00299.x; Momiyama A, 1996, J PHYSIOL-LONDON, V494, P479, DOI 10.1113/jphysiol.1996.sp021507; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; Piochon C, 2007, J NEUROSCI, V27, P10797, DOI 10.1523/JNEUROSCI.2422-07.2007; Piochon Claire, 2010, J Neurosci, V30, P15330, DOI 10.1523/JNEUROSCI.4344-10.2010; Qiu DL, 2007, J NEUROSCI, V27, P3408, DOI 10.1523/JNEUROSCI.4831-06.2007; Qiu DL, 2009, PFLUG ARCH EUR J PHY, V457, P865, DOI 10.1007/s00424-008-0555-9; Renzi M, 2007, J PHYSIOL-LONDON, V585, P91, DOI 10.1113/jphysiol.2007.141531; Thompson CL, 2000, NEUROSCI LETT, V283, P85, DOI 10.1016/S0304-3940(00)00930-7; Wee KSL, 2008, J COMP NEUROL, V509, P118, DOI 10.1002/cne.21747; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yuzaki M, 1996, J NEUROSCI, V16, P4651	40	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30180	10.1371/journal.pone.0030180	http://dx.doi.org/10.1371/journal.pone.0030180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276158	Green Submitted, Green Published, gold			2022-12-27	WOS:000301457200042
J	Vatish, M; Tesfa, L; Grammatopoulos, D; Yamada, E; Bastie, CC; Pessin, JE				Vatish, Manu; Tesfa, Lydia; Grammatopoulos, Dimitris; Yamada, Eijiro; Bastie, Claire C.; Pessin, Jeffrey E.			Inhibition of Akt Activity and Calcium Channel Function Coordinately Drive Cell-Cell Fusion in the BeWO Choriocarcinoma Placental Cell Line	PLOS ONE			English	Article							IN-VITRO; TROPHOBLAST FUSION; SYNCYTIAL FUSION; DIFFERENTIATION; MANIPULATION; EXPRESSION; ADAMS; ASSAY; CD98	To establish a simple and quantitative live cell fusion assay for placental syncytialization, we generated stable GFP and dsRed expressing fusogenic BeWo cell lines. Fluorescent Activated Cell Sorting was shown to provide a quantitative determination of forskolin (cAMP-mediated) fusion in a time and concentration dependent manner consistent with the increased secretion of beta human chorionic gonadotrophin (beta-HCG) and appearance of multi-nucleated cells. Analyses of the fusion process demonstrated that in addition to increased cAMP levels, simultaneous reduction of intracellular calcium and inhibition of Type 1 phosphatidylinositol 3 kinase (PI3K)/Akt signaling also resulted in cell fusion. Although individual blockade of calcium channel function or PI3K/Akt signaling was without effect, the combination with forskolin resulted in a potentiation of cell fusion. These data demonstrate syncytialization is a complex process that depends upon the regulation of distinct signaling inputs that function in concert with each other.	[Vatish, Manu; Grammatopoulos, Dimitris] Univ Warwick, Div Reprod, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Tesfa, Lydia; Yamada, Eijiro; Bastie, Claire C.; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med & Mol Pharmacol, Bronx, NY 10467 USA	University of Warwick; Yeshiva University; Albert Einstein College of Medicine	Vatish, M (corresponding author), Univ Warwick, Div Reprod, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	jeffrey.pessin@einstein.yu.edu	vatish, manu/AAY-8750-2020; Vatish, Manu/B-4458-2018	vatish, manu/0000-0002-6012-2574; Bastie, Claire/0000-0001-8178-4748; grammatopoulos, dimitris/0000-0002-6296-8290	National Institutes of Health [DK082694, DK020541, DK081412]; Fulbright Commission; Winston Churchill Memorial Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081412, R01DK082694, P30DK020541, P60DK020541] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fulbright Commission; Winston Churchill Memorial Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (DK082694, DK020541 and DK081412), The Fulbright Commission and The Winston Churchill Memorial Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaudeau S, 2006, J CELL PHYSIOL, V208, P435, DOI 10.1002/jcp.20679; Borges M, 2003, PLACENTA, V24, P959, DOI 10.1016/S0143-4004(03)00173-5; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Crocker IP, 2007, PLACENTA, V28, P408, DOI 10.1016/j.placenta.2006.05.009; Desforges M, 2010, INT J DEV BIOL, V54, P377, DOI 10.1387/ijdb.082765md; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Fujita D, 2010, J ENDOCRINOL, V206, P131, DOI 10.1677/JOE-10-0027; Hirsch E, 2007, J ENDOCRINOL, V194, P243, DOI 10.1677/JOE-07-0097; Huppertz B, 1998, HISTOCHEM CELL BIOL, V110, P495, DOI 10.1007/s004180050311; Huppertz B, 2006, MICRON, V37, P509, DOI 10.1016/j.micron.2005.12.011; Huppertz Berthold, 2008, V475, P135, DOI 10.1007/978-1-59745-250-2_8; Ito N, 2004, BIOCHEM BIOPH RES CO, V314, P1008, DOI 10.1016/j.bbrc.2003.12.183; KELLER PM, 1977, J CELL SCI, V28, P167; KIRBY MS, 1992, J BIOL CHEM, V267, P12545; Knofler M, 2001, PLACENTA, V22, pS83, DOI 10.1053/plac.2001.0648; Kudo Y, 2003, J PHYSIOL-LONDON, V550, P3, DOI 10.1113/jphysiol.2003.040550; Kudo Y, 2003, BBA-MOL CELL RES, V1640, P25, DOI 10.1016/S0167-4889(03)00004-1; LYDEN TW, 1993, PLACENTA, V14, P177, DOI 10.1016/S0143-4004(05)80259-0; Malassine A, 2002, ENDOCRINE, V19, P3, DOI 10.1385/ENDO:19:1:3; Massarwa R, 2007, DEV CELL, V12, P557, DOI 10.1016/j.devcel.2007.01.016; Mori K, 2004, MED MICROBIOL IMMUN, V193, P155, DOI 10.1007/s00430-003-0191-0; Ramos AJ, 2008, PLACENTA, V29, P492, DOI 10.1016/j.placenta.2008.02.013; Stadler B, 2010, J MICROSC-OXFORD, V237, P63, DOI 10.1111/j.1365-2818.2009.03302.x; Wersto RP, 2001, CYTOMETRY, V46, P296, DOI 10.1002/cyto.1171; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149	25	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29353	10.1371/journal.pone.0029353	http://dx.doi.org/10.1371/journal.pone.0029353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276109	Green Published, gold, Green Submitted			2022-12-27	WOS:000301457200010
J	Sucupira, MCA; Sanabani, S; Cortes, RM; Giret, MTM; Tomiyama, H; Sauer, MM; Sabino, EC; Janini, LM; Kallas, EG; Diaz, RS				Araripe Sucupira, Maria Cecilia; Sanabani, Sabri; Cortes, Rodrigo M.; Giret, Maria Teresa M.; Tomiyama, Helena; Sauer, Mariana M.; Sabino, Ester Cerdeira; Janini, Luiz Mario; Kallas, Esper Georges; Diaz, Ricardo Sobhie			Faster HIV-1 Disease Progression among Brazilian Individuals Recently Infected with CXCR4-Utilizing Strains	PLOS ONE			English	Article							VIRUS TYPE-1 SUBTYPES; T-CELL-ACTIVATION; HEPATITIS-G VIRUS; ANTIRETROVIRAL THERAPY; GENETIC RESTRICTION; ENZYME-IMMUNOASSAY; CORECEPTOR USAGE; PROGNOSTIC VALUE; AIDS; VARIANTS	Introduction: Primary HIV infection is usually caused by R5 viruses, and there is an association between the emergence of CCXR4-utilizing strains and faster disease progression. We characterized HIV-1 from a cohort of recently infected individuals in Brazil, predicted the virus's co-receptor use based on the env genotype and attempted to correlate virus profiles with disease progression. Methods: A total of 72 recently infected HIV patients were recruited based on the Serologic Testing Algorithm for Recent HIV Seroconversion and were followed every three to four months for up to 78 weeks. The HIV-1 V3 region was characterized by sequencing nine to twelve weeks after enrollment. Disease progression was characterized by CD4+ T-cell count decline to levels consistently below 350 cells/mu L. Results: Twelve out of 72 individuals (17%) were predicted to harbor CXCR4-utilizing strains; a baseline CD4,350 was more frequent among these individuals (p = 0.03). Fifty-seven individuals that were predicted to have CCR5-utilizing viruses and 10 individuals having CXCR4-utilizing strains presented with baseline CD4.350; after 78 weeks, 33 individuals with CCR5 strains and one individual with CXCR4 strains had CD4.350 (p = 0.001). There was no association between CD4 decline and demographic characteristics or HIV-1 subtype. Conclusions: Our findings confirm the presence of strains with higher in vitro pathogenicity during early HIV infection, suggesting that even among recently infected individuals, rapid progression may be a consequence of the early emergence of CXCR4-utilizing strains. Characterizing the HIV-1 V3 region by sequencing may be useful in predicting disease progression and guiding treatment initiation decisions.	[Araripe Sucupira, Maria Cecilia; Cortes, Rodrigo M.; Tomiyama, Helena; Sauer, Mariana M.; Diaz, Ricardo Sobhie] Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil; [Sanabani, Sabri] Fundacao Pro Sangue, Sao Paulo Blood Bank, Sao Paulo, Brazil; [Giret, Maria Teresa M.; Kallas, Esper Georges] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Sabino, Ester Cerdeira] Univ Sao Paulo, Div Infect Dis, Sao Paulo, Brazil; [Janini, Luiz Mario] Univ Fed Sao Paulo, Div Microbiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Sucupira, MCA (corresponding author), Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil.	rsdiaz@catg.com.br	Sabino, Ester C/F-7750-2010; Kallas, Esper G/C-9539-2012; Diaz, Ricardo/K-3978-2012; Sanabani, Sabri Saeed/F-5600-2012; Araripe Sucupira, Maria Cecilia/K-1931-2012; Janini, Luiz Mario R/E-9700-2012	Sabino, Ester C/0000-0003-2623-5126; Sanabani, Sabri Saeed/0000-0002-8876-8262; Araripe Sucupira, Maria Cecilia/0000-0002-1114-5382; Kallas, Esper/0000-0003-2026-6925; Janini, Luiz Mario/0000-0002-6186-6284	Brazilian Program for STD and AIDS; Ministry of Health [914/BRA/3014-UNESCO/Kallas]; Sao Paulo City Health Department [2004-0.168.922-7/Kallas]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [04/15856-9/Diaz]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Brazilian Ministry of Education	Brazilian Program for STD and AIDS; Ministry of Health; Sao Paulo City Health Department; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Ministry of Education	This study was supported with funding from the Brazilian Program for STD and AIDS, Ministry of Health (914/BRA/3014-UNESCO/Kallas), the Sao Paulo City Health Department (2004-0.168.922-7/Kallas), and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (04/15856-9/Diaz, Sabino, Janini & Kallas; M. C. A. S. was supported by the Programa Nacional de Pos Doutorado (PNPD) of the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) T. M. G. was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazilian Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accetturi CA, 2000, J ACQ IMMUN DEF SYND, V24, P399, DOI 10.1097/00126334-200008010-00016; Sucupira MCA, 2007, AIDS PATIENT CARE ST, V21, P116, DOI 10.1089/apc.2006.0079; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Casseb J, 2002, INT J INFECT DIS, V6, P164; Cavaleiro R, 2007, EUR J IMMUNOL, V37, P3435, DOI 10.1002/eji.200737511; Cecilia D, 2000, VIROLOGY, V271, P253, DOI 10.1006/viro.2000.0297; Cimerman S, 2007, AIDS PATIENT CARE ST, V21, P100, DOI 10.1089/apc.2006.0035; de Mendoza C, 2008, JAIDS-J ACQ IMM DEF, V48, P241, DOI 10.1097/QAI.0b013e3181734f0e; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Diaz RS, 1996, AIDS RES HUM RETROV, V12, P1291, DOI 10.1089/aid.1996.12.1291; Diaz RS, 1997, AIDS, V11, P415, DOI 10.1097/00002030-199704000-00003; Diaz RS, 2008, SELECTIVE R IN PRESS; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Frange P, 2009, J ANTIMICROB CHEMOTH, V64, P135, DOI 10.1093/jac/dkp151; Fusuma EE, 2005, AIDS RES HUM RETROV, V21, P965, DOI 10.1089/aid.2005.21.965; Hendel H, 1999, J IMMUNOL, V162, P6942; Huang W, 2009, AIDS RES HUM RETROV, V25, P795, DOI 10.1089/aid.2008.0252; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Ioannidis JPA, 2001, ANN INTERN MED, V135, P782, DOI 10.7326/0003-4819-135-9-200111060-00008; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Jarvis LM, 1996, LANCET, V348, P1352, DOI 10.1016/S0140-6736(96)04041-X; Kallas Esper Georges, 2004, Braz J Infect Dis, V8, P399, DOI 10.1590/S1413-86702004000600003; Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Leal E, 2008, RETROVIROLOGY RES TR, V1, P1; Maidana-Giret MT, 2009, AIDS, V23, P2277, DOI 10.1097/QAD.0b013e32832d7a11; Markowitz M, 2005, LANCET, V365, P1031, DOI 10.1016/S0140-6736(05)74227-6; McGovern RA, 2010, AIDS, V24, P2512, DOI 10.1097/QAD.0b013e32833e6cfb; Mellors JW, 2007, JAMA-J AM MED ASSOC, V297, P2349, DOI 10.1001/jama.297.21.2349; Montano MA, 1997, J VIROL, V71, P8657, DOI 10.1128/JVI.71.11.8657-8665.1997; Munerato Patrícia, 2003, Braz J Infect Dis, V7, P236, DOI 10.1590/S1413-86702003000400002; Ping LH, 1999, J VIROL, V73, P6271, DOI 10.1128/JVI.73.8.6271-6281.1999; Raymond S, 2010, AIDS, V24, P2305, DOI 10.1097/QAD.0b013e32833e50bb; Sanabani S, 2006, AIDS RES HUM RETROV, V22, P171, DOI 10.1089/aid.2006.22.171; Santoro-Lopes G, 2000, AIDS RES HUM RETROV, V16, P953, DOI 10.1089/08892220050058362; Schlueter V, 1996, J CLIN MICROBIOL, V34, P2660, DOI 10.1128/JCM.34.11.2660-2664.1996; Sing T, 2007, ANTIVIR THER, V12, P1097; Souza IE, 2006, HIV MED, V7, P25, DOI 10.1111/j.1468-1293.2005.00339.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tscherning C, 1998, VIROLOGY, V241, P181, DOI 10.1006/viro.1997.8980; Tucker TJ, 1999, J MED VIROL, V59, P52, DOI 10.1002/(SICI)1096-9071(199909)59:1&lt;52::AID-JMV9&gt;3.0.CO;2-D; Verhofstede C, 2009, JAIDS-J ACQ IMM DEF, V50, P126, DOI 10.1097/QAI.0b013e31819118fa; Westby M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364	49	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30292	10.1371/journal.pone.0030292	http://dx.doi.org/10.1371/journal.pone.0030292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291931	Green Published, Green Submitted, gold			2022-12-27	WOS:000301703800012
J	Hochmann, S; Kaslin, J; Hans, S; Weber, A; Machate, A; Geffarth, M; Funk, RHW; Brand, M				Hochmann, Sarah; Kaslin, Jan; Hans, Stefan; Weber, Anke; Machate, Anja; Geffarth, Michaela; Funk, Richard H. W.; Brand, Michael			Fgf Signaling is Required for Photoreceptor Maintenance in the Adult Zebrafish Retina	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; MIDBRAIN-HINDBRAIN BOUNDARY; MULLER GLIA; FIN REGENERATION; STEM-CELLS; TRANSGENIC MICE; NEURONAL PROGENITORS; INDUCED ANTAGONIST; PATTERN-FORMATION; ALBINO ZEBRAFISH	Fibroblast growth factors (Fgf) are secreted signaling molecules that have mitogenic, patterning, neurotrophic and angiogenic properties. Their importance during embryonic development in patterning and morphogenesis of the vertebrate eye is well known, but less is known about the role of Fgfs in the adult vertebrate retina. To address Fgf function in adult retina, we determined the spatial distribution of components of the Fgf signaling pathway in the adult zebrafish retina. We detected differential expression of Fgf receptors, ligands and downstream Fgf targets within specific retinal layers. Furthermore, we blocked Fgf signaling in the retina, by expressing a dominant negative variant of Fgf receptor 1 conditionally in transgenic animals. After blocking Fgf signaling we observe a fast and progressive photoreceptor degeneration and disorganization of retinal tissue, coupled with cell death in the outer nuclear layer. Following the degeneration of photoreceptors, a profound regeneration response is triggered that starts with proliferation in the inner nuclear layer. Ultimately, rod and cone photoreceptors are regenerated completely. Our study reveals the requirement of Fgf signaling to maintain photoreceptors and for proliferation during regeneration in the adult zebrafish retina.	[Hochmann, Sarah; Kaslin, Jan; Hans, Stefan; Weber, Anke; Machate, Anja; Geffarth, Michaela; Brand, Michael] Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden, Cluster Excellence CRTD, Ctr Biotechnol, D-01062 Dresden, Germany; [Funk, Richard H. W.] Tech Univ Dresden, Med Fac Carl Gustav Carus, D-01062 Dresden, Germany	German Research Foundation (DFG); Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Hochmann, S (corresponding author), Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden, Cluster Excellence CRTD, Ctr Biotechnol, D-01062 Dresden, Germany.	michael.brand@biotec.tu-dresden.de	Brand, Michael/A-5509-2010; Funk, Richard HW/I-1780-2013	Brand, Michael/0000-0001-5711-6512; Weber, Anke/0000-0003-2220-658X; Kaslin, Jan/0000-0002-6207-1889; Hochmann, Sarah/0000-0002-6766-4093	Deutsche Forschungsgemeinschaft [SFB 655]; European Union (ZF Health)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (ZF Health)(European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 655 and CRTD seed grant), and the European Union (ZF Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TJ, 2010, EXP EYE RES, V91, P601, DOI 10.1016/j.exer.2010.07.017; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; BRAISTED JE, 1992, DEVELOPMENT, V114, P913; Brand M., 2002, ZEBRAFISH PRACTICAL; CAMERON DA, 1995, J NEUROSCI, V15, P2255, DOI 10.1523/JNEUROSCI.15-03-02255.1995; Campochiaro PA, 1996, J NEUROSCI, V16, P1679; Cornish E, 2004, MOL VIS, V10, P1; Diep CQ, 2011, NATURE, V470, P95, DOI 10.1038/nature09669; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Eckenstein FP, 2006, EXP NEUROL, V198, P338, DOI 10.1016/j.expneurol.2005.12.020; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Fleisch VC, 2011, BBA-MOL BASIS DIS, V1812, P364, DOI 10.1016/j.bbadis.2010.10.012; Fontaine V, 1998, J NEUROSCI, V18, P9662; Furthauer M, 2002, NAT CELL BIOL, V4, P170, DOI 10.1038/ncb750; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Ganz J, 2010, GLIA, V58, P1345, DOI 10.1002/glia.21012; Gestri G., 2011, DEV NEUROBIOL; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Hamaoka T, 2002, GENESIS, V34, P215, DOI 10.1002/gene.10155; Hans S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004640; HITCHCOCK PF, 1994, VISUAL NEUROSCI, V11, P209, DOI 10.1017/S0952523800001577; Joly S, 2007, INVEST OPHTH VIS SCI, V48, P2311, DOI 10.1167/iovs.06-1205; Karl MO, 2010, TRENDS MOL MED, V16, P193, DOI 10.1016/j.molmed.2010.02.003; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kassen SC, 2007, DEV NEUROBIOL, V67, P1009, DOI 10.1002/dneu.20362; Kawakami Y, 2003, NAT CELL BIOL, V5, P513, DOI 10.1038/ncb989; Kinkl N, 2002, MOL VIS, V8, P149; Kizil C, 2011, DEV NEUROBIOL; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Martinez-Morales JR, 2005, DEV CELL, V8, P565, DOI 10.1016/j.devcel.2005.01.022; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; Molina GA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-62; Picker A, 2005, DEVELOPMENT, V132, P4951, DOI 10.1242/dev.02071; Picker A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000214; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Poss KD, 2007, SEMIN CELL DEV BIOL, V18, P36, DOI 10.1016/j.semcdb.2006.11.009; Qin Z, 2011, EXP EYE RES; Qin Z, 2009, P NATL ACAD SCI USA, V106, P9310, DOI 10.1073/pnas.0811186106; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; Raible F, 2004, TRENDS NEUROSCI, V27, P727, DOI 10.1016/j.tins.2004.10.003; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Reifers F, 1998, DEVELOPMENT, V125, P2381; Rousseau B, 2000, EXP EYE RES, V71, P395, DOI 10.1006/exer.2000.0892; Scholpp S, 2004, DEV GENES EVOL, V214, P285, DOI 10.1007/s00427-004-0409-1; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Takechi M, 2003, FEBS LETT, V553, P90, DOI 10.1016/S0014-5793(03)00977-3; Tawk M, 2002, GENESIS, V32, P27, DOI 10.1002/gene.10025; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Thummel R, 2008, EXP EYE RES, V87, P433, DOI 10.1016/j.exer.2008.07.009; Tonou-Fujimori Noriko, 2002, Gene Expression Patterns, V2, P183, DOI 10.1016/S0925-4773(02)00422-7; Vihtelic TS, 2000, J NEUROBIOL, V44, P289, DOI 10.1002/1097-4695(20000905)44:3<289::AID-NEU1>3.0.CO;2-H; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Wu DM, 2001, INVEST OPHTH VIS SCI, V42, P2115; Yang XH, 2004, SEMIN CELL DEV BIOL, V15, P91, DOI 10.1016/j.semcdb.2003.09.004; Yurco P, 2005, VISION RES, V45, P991, DOI 10.1016/j.visres.2004.10.022	61	51	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30365	10.1371/journal.pone.0030365	http://dx.doi.org/10.1371/journal.pone.0030365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291943	Green Submitted, Green Published, gold			2022-12-27	WOS:000301703800013
J	Mielecki, D; Zugaj, DL; Muszewska, A; Piwowarski, J; Chojnacka, A; Mielecki, M; Nieminuszczy, J; Grynberg, M; Grzesiuk, E				Mielecki, Damian; Zugaj, Dorota L.; Muszewska, Anna; Piwowarski, Jan; Chojnacka, Aleksandra; Mielecki, Marcin; Nieminuszczy, Jadwiga; Grynberg, Marcin; Grzesiuk, Elzbieta			Novel AlkB Dioxygenases-Alternative Models for In Silico and In Vivo Studies	PLOS ONE			English	Article							ESCHERICHIA-COLI; INDUCED MUTAGENESIS; REPAIR; DNA; PROTEIN; RNA; BACTERIAL; DAMAGE; GENES; 1-METHYLGUANINE	Background: ALKBH proteins, the homologs of Escherichia coli AlkB dioxygenase, constitute a direct, single-protein repair system, protecting cellular DNA and RNA against the cytotoxic and mutagenic activity of alkylating agents, chemicals significantly contributing to tumor formation and used in cancer therapy. In silico analysis and in vivo studies have shown the existence of AlkB homologs in almost all organisms. Nine AlkB homologs (ALKBH1-8 and FTO) have been identified in humans. High ALKBH levels have been found to encourage tumor development, questioning the use of alkylating agents in chemotherapy. The aim of this work was to assign biological significance to multiple AlkB homologs by characterizing their activity in the repair of nucleic acids in prokaryotes and their subcellular localization in eukaryotes. Methodology and Findings: Bioinformatic analysis of protein sequence databases identified 1943 AlkB sequences with eight new AlkB subfamilies. Since Cyanobacteria and Arabidopsis thaliana contain multiple AlkB homologs, they were selected as model organisms for in vivo research. Using E. coli alkB 2 mutant and plasmids expressing cyanobacterial AlkBs, we studied the repair of methyl methanesulfonate (MMS) and chloroacetaldehyde (CAA) induced lesions in ssDNA, ssRNA, and genomic DNA. On the basis of GFP fusions, we investigated the subcellular localization of ALKBHs in A. thaliana and established its mostly nucleo-cytoplasmic distribution. Some of the ALKBH proteins were found to change their localization upon MMS treatment. Conclusions: Our in vivo studies showed highly specific activity of cyanobacterial AlkB proteins towards lesions and nucleic acid type. Subcellular localization and translocation of ALKBHs in A. thaliana indicates a possible role for these proteins in the repair of alkyl lesions. We hypothesize that the multiplicity of ALKBHs is due to their involvement in the metabolism of nucleo-protein complexes; we find their repair by ALKBH proteins to be economical and effective alternative to degradation and de novo synthesis.	[Mielecki, Damian; Zugaj, Dorota L.; Muszewska, Anna; Piwowarski, Jan; Chojnacka, Aleksandra; Mielecki, Marcin; Nieminuszczy, Jadwiga; Grynberg, Marcin; Grzesiuk, Elzbieta] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Mielecki, D (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	greenb@ibb.waw.pl; elag@ibb.waw.pl	Chojnacka, Aleksandra/HGA-7394-2022; Muszewska, Anna/S-9406-2019	Muszewska, Anna/0000-0002-4578-844X; Chojnacka, Aleksandra/0000-0001-7802-1678; Grzesiuk, Elzbieta/0000-0002-7833-7602; Grynberg, Marcin/0000-0003-1887-7209; Mielecki, Damian/0000-0003-2929-4500	Polish State Committee for Scientific Research [N301 165835]; Polish-Norwegian Research Fund [PNRF-143-Al-1/079]	Polish State Committee for Scientific Research(Polish State Committee for Scientific Research); Polish-Norwegian Research Fund	This work was supported by a grant from Polish State Committee for Scientific Research N301 165835 and Polish-Norwegian Research Fund (Grant PNRF-143-Al-1/079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Bjornstad LG, 2011, BIOCHEM J, V434, P391, DOI 10.1042/BJ20101667; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Dinglay S, 2000, GENE DEV, V14, P2097; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P3456, DOI 10.1093/nar/gkh655; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Haasen D, 1999, PLANT J, V20, P695, DOI 10.1046/j.1365-313X.1999.00644.x; He Ping, 2007, Methods Mol Biol, V354, P1; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Iyer LM, 2001, GENOME BIOL, V2; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Korvald H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025188; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kuchta K, 2011, NUCL ACIDS RES; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lafontaine DLJ, 2010, TRENDS BIOCHEM SCI, V35, P267, DOI 10.1016/j.tibs.2009.12.006; Leihne V, 2011, NUCLEIC ACIDS RES, V39, P7688, DOI 10.1093/nar/gkr406; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; Maciejewska AM, 2011, MUTAGENESIS, V26, P401, DOI 10.1093/mutage/geq107; Maciejewska AM, 2010, MUTAT RES-FUND MOL M, V684, P24, DOI 10.1016/j.mrfmmm.2009.11.005; Muller TA, 2010, DNA REPAIR, V9, P58, DOI 10.1016/j.dnarep.2009.10.011; Nieminuszczy J, 2006, DNA REPAIR, V5, P181, DOI 10.1016/j.dnarep.2005.09.007; Nieminuszczy J, 2007, ACTA BIOCHIM POL, V54, P459, DOI 10.18388/abp.2007_3221; Nieminuszczy J, 2009, ENVIRON MOL MUTAGEN, V50, P791, DOI 10.1002/em.20497; Nordstrand LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013827; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Pan ZS, 2008, DEV DYNAM, V237, P316, DOI 10.1002/dvdy.21418; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Sambrook J., 2001, MOL CLONING LAB MANU; Sedgwick B, 2002, ONCOGENE, V21, P8886, DOI 10.1038/sj.onc.1205998; Stratigopoulos G, 2010, NAT GENET, V42, P1038, DOI 10.1038/ng1210-1038; Tasaki M, 2011, BRIT J CANCER, V104, P700, DOI 10.1038/sj.bjc.6606012; Thalhammer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016210; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; van den Born E, 2008, NUCLEIC ACIDS RES, V36, P5451, DOI 10.1093/nar/gkn519; van den Born E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1173; van den Born E, 2009, NUCLEIC ACIDS RES, V37, P7124, DOI 10.1093/nar/gkp774; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Wu SS, 2011, ACTA PHARMACOL SIN, V32, P393, DOI 10.1038/aps.2010.216	50	45	48	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30588	10.1371/journal.pone.0030588	http://dx.doi.org/10.1371/journal.pone.0030588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291995	Green Submitted, gold, Green Published			2022-12-27	WOS:000301639600035
J	Saman, DM; Cole, HP; Odoi, A; Myers, ML; Carey, DI; Westneat, SC				Saman, Daniel M.; Cole, Henry P.; Odoi, Agricola; Myers, Melvin L.; Carey, Daniel I.; Westneat, Susan C.			A Spatial Cluster Analysis of Tractor Overturns in Kentucky from 1960 to 2002	PLOS ONE			English	Article							FATALITIES; EPIDEMIOLOGY; INFECTION	Background: Agricultural tractor overturns without rollover protective structures are the leading cause of farm fatalities in the United States. To our knowledge, no studies have incorporated the spatial scan statistic in identifying high-risk areas for tractor overturns. The aim of this study was to determine whether tractor overturns cluster in certain parts of Kentucky and identify factors associated with tractor overturns. Methods: A spatial statistical analysis using Kulldorff's spatial scan statistic was performed to identify county clusters at greatest risk for tractor overturns. A regression analysis was then performed to identify factors associated with tractor overturns. Results: The spatial analysis revealed a cluster of higher than expected tractor overturns in four counties in northern Kentucky (RR = 2.55) and 10 counties in eastern Kentucky (RR = 1.97). Higher rates of tractor overturns were associated with steeper average percent slope of pasture land by county (p = 0.0002) and a greater percent of total tractors with less than 40 horsepower by county (p<0.0001). Conclusions: This study reveals that geographic hotspots of tractor overturns exist in Kentucky and identifies factors associated with overturns. This study provides policymakers a guide to targeted county-level interventions (e. g., roll-over protective structures promotion interventions) with the intention of reducing tractor overturns in the highest risk counties in Kentucky.	[Saman, Daniel M.] Univ Kentucky, Coll Publ Hlth, Dept Epidemiol, Lexington, KY 40536 USA; [Cole, Henry P.; Myers, Melvin L.; Westneat, Susan C.] Univ Kentucky, Coll Publ Hlth, Dept Prevent Med & Environm Hlth, SE Ctr Agr Hlth & Injury Prevent, Lexington, KY USA; [Odoi, Agricola] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN USA; [Carey, Daniel I.] Univ Kentucky, Dept Kentucky Geol Survey, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Kentucky	Saman, DM (corresponding author), Univ Kentucky, Coll Publ Hlth, Dept Epidemiol, Lexington, KY 40536 USA.	dmsama2@uky.edu	Odoi, Agricola/I-9532-2019	Odoi, Agricola/0000-0001-5050-6737; Saman, Daniel/0000-0002-8372-4615	CDC-NIOSH, Southeast Center for Agricultural Health and Injury Prevention, University of Kentucky College of Public Health [U50/OHO7547, U06/CCU412900]	CDC-NIOSH, Southeast Center for Agricultural Health and Injury Prevention, University of Kentucky College of Public Health	This study was supported by CDC-NIOSH Cooperative Agreement No. U50/OHO7547 and U06/CCU412900, Southeast Center for Agricultural Health and Injury Prevention, University of Kentucky College of Public Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC-NIOSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adoi A, 2003, INT J HEALTH GEOGR, V2, P5; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Anselin L, 2003, GEODA VERSION 0 95I; Appalachian Regional Commission (ARC), COUNT EC STAT APP FY; Bithell JF, 2000, STAT MED, V19, P2203, DOI 10.1002/1097-0258(20000915/30)19:17/18<2203::AID-SIM564>3.0.CO;2-U; Brewer C. A., COLORBREWER 2 0; Clayton D, 1997, GEOGRAPHICAL ENV EPI, P206; Cole HP, 2006, J AGRIC SAF HEALTH, V12, P127, DOI 10.13031/2013.20386; Cole HP, 2009, J AGROMEDICINE, V14, P164, DOI 10.1080/10599240902805991; Cole HP, 2007, J AGRIC SAF HEALTH, V13, P347, DOI 10.13031/2013.23927; Cuzick J, 1997, GEOGRAPHICAL ENV EPI, P14; Dogan KH, 2010, AM J FOREN MED PATH, V31, P64, DOI 10.1097/PAF.0b013e3181c21bf0; DWASS M, 1957, ANN MATH STAT, V28, P181, DOI 10.1214/aoms/1177707045; Ed Hsu Chiehwen, 2004, Int J Health Geogr, V3, P4; ESRI, 2011, ARCINFO GIS V10; GRIFFITH DA, 1983, J REGIONAL SCI, V23, P377, DOI 10.1111/j.1467-9787.1983.tb00996.x; Haddow AD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-29; Holowaty EJ, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-21; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Kempf AM, 2007, ANNU REV PUBL HEALTH, V28, P113, DOI 10.1146/annurev.publhealth.28.021406.144059; (KLC) Kentucky Land Cover, 2005, KENT 2005 LAND COV A; KTDGI, 2010, KENT COUNT DIG BAS M; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M., INFORM MANAGEMENT SE; Leffingwell R., 2000, FARM TRACTOR MILESTO; Murphy D., 1992, SAFETY HLTH PRODUCTI; Myers JR, 2010, AM J IND MED, V53, P662, DOI 10.1002/ajim.20775; Myers JR, 2007, NIOSH AGR TRACT SAF; Myers ML, 2008, J AGRIC SAF HEALTH, V14, P93, DOI 10.13031/2013.24126; Myers M. L., 1998, Journal of Agricultural Safety and Health, V4, P205; Myers ML, 2003, AGCONNECTIONS, V1, P1; National Institute for Occupational Safety and Health, 1996, CDC NIOSH PUBL; Odoi Agricola, 2004, Int J Health Geogr, V3, P11, DOI 10.1186/1476-072X-3-11; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P67; Reynolds SJ, 2000, AM J PREV MED, V18, P63, DOI 10.1016/S0749-3797(00)00142-2; Rogerson P, 2009, STAT DETECTION SURVE, P107; SAS Institute Inc, 2011, SAS 9 3; TOP (Tractor Overturn Prevention and Protection), 1968, SAF FARM FAM; U.S. Department of Agriculture, 2007, CENS AGR 2007 CENS P, P665; U.S. Department of Agriculture, 2007, CENS AGR 2007 CENS P, P249; US Census Bureau, 2010 CENS TIGER LIN; USGS, 2008, DIG EL MOD LEV 1 10; USGS and USEPA, 2003, NAT HYDR DAT; Waller L, 2004, APPL STATIAL STAT PU, P86; Walsh SJ, 2001, LUPUS, V10, P637, DOI 10.1191/096120301682430230; Wylie JL, 2005, J INFECT DIS, V191, P899, DOI 10.1086/427661	48	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30532	10.1371/journal.pone.0030532	http://dx.doi.org/10.1371/journal.pone.0030532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291980	Green Published, gold			2022-12-27	WOS:000301639600028
J	Bolotin, S; Pebody, R; White, PJ; McMenamin, J; Perera, L; Nguyen-Van-Tam, JS; Barlow, T; Watson, JM				Bolotin, Shelly; Pebody, Richard; White, Peter J.; McMenamin, James; Perera, Luke; Nguyen-Van-Tam, Jonathan S.; Barlow, Thomas; Watson, John M.		UK Severe Influenza Surveillance S	A New Sentinel Surveillance System for Severe Influenza in England Shows a Shift in Age Distribution of Hospitalised Cases in the Post-Pandemic Period	PLOS ONE			English	Article								Background: The World Health Organization and European Centre for Disease Prevention and Control have highlighted the importance of establishing systems to monitor severe influenza. Following the H1N1 (2009) influenza pandemic, a sentinel network of 23 Trusts, the UK Severe Influenza Surveillance System (USISS), was established to monitor hospitalisations due to confirmed seasonal influenza in England. This article presents the results of the first season of operation of USISS in 2010/11. Methodology/Principal Findings: A case was defined as a person hospitalised with confirmed influenza of any type. Weekly aggregate numbers of hospitalised influenza cases, broken down by flu type and level of care, were submitted by participating Trusts. Cases in 2010/11 were compared to cases during the 2009 pandemic in hospitals with available surveillance data for both time periods (n = 19). An unexpected resurgence in seasonal A/H1N1 (2009) influenza activity in England was observed in December 2010 with reports of severe disease. Reported cases over the period of 4 October 2010 to 13 February 2011 were mostly due to influenza A/H1N1 (2009). One thousand and seventy-one cases of influenza A/H1N1 (2009) occurred over this period compared to 409 at the same Trusts over the 2009/10 pandemic period (1 April 2009 to 6 January 2010). Median age of influenza A/H1N1 (2009) cases in 2010/11 was 35 years, compared with 20 years during the pandemic (p = <0.0001). Conclusions/Significance: The Health Protection Agency successfully established a sentinel surveillance system for severe influenza in 2010/11, detecting a rise in influenza cases mirroring other surveillance indicators. The data indicate an upward shift in the age-distribution of influenza A/H1N1 (2009) during the 2010/11 influenza season as compared to the 2009/10 pandemic. Systems to enable the ongoing surveillance of severe influenza will be a key component in understanding and responding to the evolving epidemiology of influenza in the post-pandemic era.	[Bolotin, Shelly; Pebody, Richard; White, Peter J.; Nguyen-Van-Tam, Jonathan S.; Watson, John M.] Hlth Protect Agcy, London, England; [White, Peter J.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC Ctr Outbreak Anal & Modelling, London, England; [McMenamin, James] NHS Natl Serv, Glasgow, Lanark, Scotland; [Perera, Luke; Barlow, Thomas] Dept Hlth, London SE1 6TE, England; [Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, City Hosp, Nottingham NG7 2RD, England; Publ Hlth Wales, Cardiff, S Glam, Wales; Publ Hlth Agcy, Belfast, Antrim, North Ireland; [UK Severe Influenza Surveillance S] Royal Coll Physicians, London NW1 4LE, England	Health Protection Agency; Imperial College London; NHS National Services Scotland; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Royal College of Physicians	Bolotin, S (corresponding author), Hlth Protect Agcy, London, England.	richard.pebody@hpa.org.uk	Nguyen-Van-Tam, Jonathan/I-2162-2019	Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Pebody, Richard/0000-0002-9069-2885	GlaxoSmithKline; Roche Products Ltd; Sanofi-Pasteur MSD; Kendle Healthcare; Elsevier; Medical Research Council [G0600719B] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); Roche Products Ltd; Sanofi-Pasteur MSD; Kendle Healthcare; Elsevier; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JSN-V-T has received funding to attend influenza related meetings, lecture and consultancy fees (ceasing in September 2010), and research funding from several influenza antiviral drug and vaccine manufacturers, and is a former employee of SmithKline Beecham plc. (now GlaxoSmithKline), Roche Products Ltd, and Aventis-Pasteur MSD (now Sanofi-Pasteur MSD). PJW has received funds from Kendle Healthcare for an expert opinion on influenza and has received funding from Elsevier in 2010 to attend an influenza-related meeting. No other relationships, activities, or nonfinancial competing interests exist that could appear to have influenced the submitted work. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Athanasiou M, 2011, EUROSURVEILLANCE, V16, P14; Bansal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009360; Campbell CN, 2010, EPIDEMIOL INFECT, V26, P1, DOI DOI 10.1017/S0950268810002657; *DEP HLTH, 2011, DEP HLTH WINT WINT H; Ellis J, 2011, EUROSURVEILLANCE, V16, P2; *EUR CDCP, 2009, OV SURV INFL 2009 20; GILBERT VE, 1962, AM J PUBLIC HEALTH N, V52, P1432, DOI 10.2105/AJPH.52.9.1432; Hardelid P, 2010, HEALTH TECHNOL ASSES, V14, P115, DOI 10.3310/hta14550-03; *HLTH PROT AG, 2010, HLTH PROT AG WEEKL N; *HLTH PROT AG, 2011, HLTH PROT AG WEEKL R; *HLTH PROT AG, 2010, HLTH PROT AG WEEKL I; *HLTH PROT SURV CT, 2011, HLTH PROT SURV CTR I; Office for National Statistics, 2009, POP EST UK ENGL WAL; Presanis AM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5408; *RCGP RES SURV CTR, 2010, COMM RESP DIS REP EN; Rothman K, 1986, MODERN EPIDEMIOLOGY; *WHO, 2009, REG OFF EUR GUID INF; Zakikhany K., 2011, EURO SURVEILL, V16, P19785	18	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30279	10.1371/journal.pone.0030279	http://dx.doi.org/10.1371/journal.pone.0030279			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291929	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000301570600030
J	Dommerich, S; Frickmann, H; Ostwald, J; Lindner, T; Zautner, AE; Arndt, K; Pau, HW; Podbielski, A				Dommerich, Steffen; Frickmann, Hagen; Ostwald, Juergen; Lindner, Tobias; Zautner, Andreas Erich; Arndt, Kathleen; Pau, Hans Wilhelm; Podbielski, Andreas			Effects of High Hydrostatic Pressure on Bacterial Growth on Human Ossicles Explanted from Cholesteatoma Patients	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; STAPHYLOCOCCUS-AUREUS; OSSICULAR CHAIN; CAMPYLOBACTER-JEJUNI; ESCHERICHIA-COLI; INACTIVATION; RESISTANCE; BIOFILMS; MACROMOLECULES; RECONSTRUCTION	Background: High hydrostatic pressure (HHP) treatment can eliminate cholesteatoma cells from explanted human ossicles prior to re-insertion. We analyzed the effects of HHP treatment on the microbial flora on ossicles and on the planktonic and biofilm states of selected isolates. Methodology: Twenty-six ossicles were explanted from cholesteatoma patients. Five ossicles were directly analyzed for microbial growth without further treatment. Fifteen ossicles were cut into two pieces. One piece was exposed to HHP of 350 MPa for 10 minutes. Both the treated and untreated (control) pieces were then assessed semi-quantitatively. Three ossicles were cut into two pieces and exposed to identical pressure conditions with or without the addition of one of two different combinations of antibiotics to the medium. Differential effects of 10-minute in vitro exposure of planktonic and biofilm bacteria to pressures of 100 MPa, 250 MPa, 400 MPa and 540 MPa in isotonic and hypotonic media were analyzed using two patient isolates of Staphylococcus epidermidis and Neisseria subflava. Bacterial cell inactivation and biofilm destruction were assessed by colony counting and electron microscopy. Principal Findings: A variety of microorganisms were isolated from the ossicles. Irrespective of the medium, HHP treatment at 350 MPa for 10 minutes led to satisfying but incomplete inactivation especially of Gram-negative bacteria. The addition of antibiotics increased the efficacy of elimination. A comparison of HHP treatment of planktonic and biofilm cells showed that the effects of HPP were reduced by about one decadic logarithmic unit when HPP was applied to biofilms. High hydrostatic pressure conditions that are suitable to inactivate cholesteatoma cells fail to completely sterilize ossicles even if antibiotics are added. As a result of the reduced microbial load and the viability loss of surviving bacteria, however, there is a lower risk of re-infection after re-insertion.	[Dommerich, Steffen; Ostwald, Juergen; Pau, Hans Wilhelm] Univ Rostock Hosp, Dept Otorhinolaryngol Head & Neck Surg, Rostock, Germany; [Frickmann, Hagen; Zautner, Andreas Erich; Arndt, Kathleen; Podbielski, Andreas] Univ Rostock Hosp, Inst Med Microbiol Virol & Hyg, Rostock, Germany; [Lindner, Tobias] Univ Rostock Hosp, Dept Orthoped, Biomech & Implant Technol Res Lab, Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	Dommerich, S (corresponding author), Univ Rostock Hosp, Dept Otorhinolaryngol Head & Neck Surg, Rostock, Germany.	Frickmann@bni-hamburg.de	Lindner, Tobias/B-6952-2014; Zautner, Andreas Erich/ABA-9655-2020; Zautner, Andreas Erich/AAE-7425-2019	Lindner, Tobias/0000-0001-7826-3132; Zautner, Andreas Erich/0000-0003-0984-013X; Zautner, Andreas Erich/0000-0003-0984-013X				Alpas H, 1999, APPL ENVIRON MICROB, V65, P4248; Balny C, 2002, BBA-PROTEIN STRUCT M, V1595, P3, DOI 10.1016/S0167-4838(01)00331-4; Baumann I, 1997, HNO, V45, P990, DOI 10.1007/s001060050184; Bieche C, 2009, LETT APPL MICROBIOL, V48, P198, DOI 10.1111/j.1472-765X.2008.02511.x; Brouillet M, 2009, J BIOMED MATER RES B, V91B, P348, DOI 10.1002/jbm.b.31408; Cebrian G, 2010, APPL ENVIRON MICROB, V76, P6982, DOI 10.1128/AEM.00900-10; Cheftel JC, 1995, FOOD SCI TECHNOL INT, V1, P75, DOI 10.1177/108201329500100203; Chole RA, 2002, ARCH OTOLARYNGOL, V128, P1129, DOI 10.1001/archotol.128.10.1129; Crenshaw HC, 1996, EXP CELL RES, V227, P285, DOI 10.1006/excr.1996.0278; Diehl P, 2005, INT J MOL MED, V16, P285; Diehl P, 2003, ONCOL REP, V10, P1851; Diehl P, 2006, J ORTHOP SCI, V11, P380, DOI 10.1007/s00776-006-1031-z; Dommerich S, 2010, LARYNGO RHINO OTOL, V89, P284, DOI 10.1055/s-0030-1248306; Dost P, 2000, LARYNGO RHINO OTOL, V79, P193; Eloe EA, 2008, APPL ENVIRON MICROB, V74, P6298, DOI 10.1128/AEM.01316-08; Geyer G, 2002, LARYNGO RHINO OTOL, V81, P164, DOI 10.1055/s-2002-25031; GLASSCOCK ME, 1988, ARCH OTOLARYNGOL, V114, P1252; Gollwitzer Hans, 2009, Open Orthop J, V3, P1, DOI 10.2174/1874325000903010001; GROSS M, 1994, EUR J BIOCHEM, V221, P617, DOI 10.1111/j.1432-1033.1994.tb18774.x; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hauben KJA, 1997, APPL ENVIRON MICROB, V63, P945, DOI 10.1128/AEM.63.3.945-950.1997; HILDMANN H, 1992, LARYNGO RHINO OTOL, V71, P5, DOI 10.1055/s-2007-997235; Hildmann H, 2000, LARYNGO RHINO OTOL, V79, pS73; Hormann S, 2006, PROTEOMICS, V6, P1878, DOI 10.1002/pmic.200402086; Igura N, 2003, APPL ENVIRON MICROB, V69, P6307, DOI 10.1128/AEM.69.10.6307-6310.2003; Jaryszak EM, 2009, OTOL NEUROTOL, V30, P1191, DOI 10.1097/MAO.0b013e3181be64b3; Jaryszak EM, 2009, AM J OTOLARYNG, V30, P367, DOI 10.1016/j.amjoto.2008.07.007; Jofre A, 2010, INT MICROBIOL, V13, P105, DOI 10.2436/20.1501.01.115; Juhn SK, 2008, CLIN EXP OTORHINOLAR, V1, P117, DOI 10.3342/ceo.2008.1.3.117; Kingsley DH, 2006, J FOOD PROTECT, V69, P2454, DOI 10.4315/0362-028X-69.10.2454; Koseki S, 2006, INT J FOOD MICROBIOL, V111, P175, DOI 10.1016/j.ijfoodmicro.2006.05.008; Lembke C, 2006, APPL ENVIRON MICROB, V72, P2864, DOI 10.1128/AEM.72.4.2864-2875.2006; Magdolen U, 2006, INT J MOL MED, V17, P1017; Masson Patrick, 2001, Journal of Biomedicine and Biotechnology, V1, P85, DOI 10.1155/S1110724301000158; Mentre P, 2001, INT REV CYTOL, V201, P1, DOI 10.1016/S0074-7696(01)01001-4; Nelson RRS, 1999, J HOSP INFECT, V42, P275, DOI 10.1053/jhin.1998.0605; Pavlovic M, 2005, ARCH MICROBIOL, V184, P11, DOI 10.1007/s00203-005-0021-4; Post J Christopher, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P185, DOI 10.1097/01.moo.0000124936.46948.6a; Ricciardiello F, 2009, ACTA OTORHINOLARYNGO, V29, P197; SADE J, 1993, EUR ARCH OTO-RHINO-L, V250, P193; Sagarzazu N, 2010, J APPL MICROBIOL, V109, P146, DOI 10.1111/j.1365-2672.2009.04639.x; Standar K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013135; Steinhauser E, 2006, J BIOMED MATER RES B, V76B, P130, DOI 10.1002/jbm.b.30343; THORNLEY MJ, 1968, J CELL SCI, V3, P273; Van Boeijen IKH, 2008, J FOOD PROTECT, V71, P2007, DOI 10.4315/0362-028X-71.10.2007; Van Boeijen IKH, 2010, APPL ENVIRON MICROB, V76, P2225, DOI 10.1128/AEM.02434-09; Van Opstal I, 2003, INT J FOOD MICROBIOL, V88, P1, DOI 10.1016/S0168-1605(03)00070-9; Vercammen A, 2011, INT J FOOD MICR 0319, V19; VOGEL RF, 2008, HIGH PRESSURE MICROB, P117; Weber P, 2008, BIOMED TECH, V53, P190, DOI 10.1515/BMT.2008.027; Welkoborsky HJ, 2011, LARYNGO RHINO OTOL, V90, P38, DOI 10.1055/s-0030-1268464; Wen J, 2009, APPL ENVIRON MICROB, V75, P1581, DOI 10.1128/AEM.01942-08; Zahnert T, 2005, HNO, V53, P89, DOI 10.1007/s00106-004-1168-z	53	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30150	10.1371/journal.pone.0030150	http://dx.doi.org/10.1371/journal.pone.0030150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291908	Green Submitted, Green Published, gold			2022-12-27	WOS:000301570600018
J	Hsu, YH; Chen, YC; Chen, TH; Sue, YM; Cheng, TH; Chen, JR; Chen, CH				Hsu, Yung-Ho; Chen, Yen-Cheng; Chen, Tso-Hsiao; Sue, Yuh-Mou; Cheng, Tzu-Hurng; Chen, Jia-Rung; Chen, Cheng-Hsien			Far-Infrared Therapy Induces the Nuclear Translocation of PLZF Which Inhibits VEGF-Induced Proliferation in Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ACUTE PROMYELOCYTIC LEUKEMIA; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; ZINC-FINGER; ARTERIOVENOUS-FISTULA; BALLOON ANGIOPLASTY; OXIDATIVE STRESS; VENOUS STENOSIS; HEMODIALYSIS	Many studies suggest that far-infrared (FIR) therapy can reduce the frequency of some vascular-related diseases. The non-thermal effect of FIR was recently found to play a role in the long-term protective effect on vascular function, but its molecular mechanism is still unknown. In the present study, we evaluated the biological effect of FIR on vascular endothelial growth factor (VEGF)-induced proliferation in human umbilical vein endothelial cells (HUVECs). We found that FIR ranging 3 similar to 10 mu m significantly inhibited VEGF-induced proliferation in HUVECs. According to intensity and time course analyses, the inhibitory effect of FIR peaked at an effective intensity of 0.13 mW/cm(2) at 30 min. On the other hand, a thermal effect did not inhibit VEGF-induced proliferation in HUVECs. FIR exposure also inhibited the VEGF-induced phosphorylation of extracellular signal-regulated kinases in HUVECs. FIR exposure further induced the phosphorylation of endothelial nitric oxide (NO) synthase (eNOS) and NO generation in VEGF-treated HUVECs. Both VEGF-induced NO and reactive oxygen species generation was involved in the inhibitory effect of FIR. Nitrotyrosine formation significantly increased in HUVECs treated with VEGF and FIR together. Inhibition of phosphoinositide 3-kinase (PI3K) by wortmannin abolished the FIR-induced phosphorylation of eNOS and Akt in HUVECs. FIR exposure upregulated the expression of PI3K p85 at the transcriptional level. We further found that FIR exposure induced the nuclear translocation of promyelocytic leukemia zinc finger protein (PLZF) in HUVECs. This induction was independent of a thermal effect. The small interfering RNA transfection of PLZF blocked FIR-increased PI3K levels and the inhibitory effect of FIR. These data suggest that FIR induces the nuclear translocation of PLZF which inhibits VEGF-induced proliferation in HUVECs.	[Hsu, Yung-Ho; Chen, Jia-Rung; Chen, Cheng-Hsien] Taipei Med Univ Shuang Ho Hosp, Dept Internal Med, New Taipei City, Taiwan; [Chen, Yen-Cheng; Chen, Tso-Hsiao; Sue, Yuh-Mou; Chen, Cheng-Hsien] Taipei Med Univ Wan Fang Hosp, Dept Internal Med, Taipei, Taiwan; [Cheng, Tzu-Hurng] China Med Univ, Coll Life Sci, Dept Biol Sci & Technol, Taichung, Taiwan	Taipei Medical University; Taipei Medical University; China Medical University Taiwan	Hsu, YH (corresponding author), Taipei Med Univ Shuang Ho Hosp, Dept Internal Med, New Taipei City, Taiwan.	hippy@tmu.edu.tw			Taipei Medical University-Wan Fang Hospital [99wf-eva-07]	Taipei Medical University-Wan Fang Hospital	This work was supported by Taipei Medical University-Wan Fang Hospital (grant no.: 99wf-eva-07). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbani E, 2011, TOXICOL IN VITRO; Akasaki Y, 2006, CIRC J, V70, P463, DOI 10.1253/circj.70.463; Bouloumie A, 1999, CARDIOVASC RES, V41, P773, DOI 10.1016/S0008-6363(98)00228-4; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Cheng TH, 2009, ANESTHESIOLOGY; Costoya JA, 2001, CURR OPIN HEMATOL, V8, P212, DOI 10.1097/00062752-200107000-00006; Couper LL, 1997, CIRC RES, V81, P932; Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2; Guarda E, 1996, J MOL CELL CARDIOL, V28, P699, DOI 10.1006/jmcc.1996.0065; Ikeda Y, 2005, CIRC J, V69, P722, DOI 10.1253/circj.69.722; Imamura M, 2001, J AM COLL CARDIOL, V38, P1083, DOI 10.1016/S0735-1097(01)01467-X; JAWIEN A, 1992, J CLIN INVEST, V89, P507, DOI 10.1172/JCI115613; Kihara T, 2004, CIRC J, V68, P1146, DOI 10.1253/circj.68.1146; Lin CC, 2007, J AM SOC NEPHROL, V18, P985, DOI 10.1681/ASN.2006050534; LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Misra S, 2008, AM J PHYSIOL-HEART C, V294, pH2219, DOI 10.1152/ajpheart.00650.2007; REKHTER M, 1993, ARTERIOSCLER THROMB, V13, P609, DOI 10.1161/01.ATV.13.4.609; Rosselli M, 1998, HUM REPROD UPDATE, V4, P3, DOI 10.1093/humupd/4.1.3; Roy-Chaudhury P, 2006, J AM SOC NEPHROL, V17, P1112, DOI 10.1681/ASN.2005050615; Rubbo H, 2005, TOXICOLOGY, V208, P305, DOI 10.1016/j.tox.2004.11.019; Rubbo H, 2009, ARCH BIOCHEM BIOPHYS, V484, P167, DOI 10.1016/j.abb.2008.11.007; Rush JWE, 2005, CAN J APPL PHYSIOL, V30, P442, DOI 10.1139/h05-133; Schefe JH, 2006, CIRC RES, V99, P1355, DOI 10.1161/01.RES.0000251700.00994.0d; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Senbonmatsu T, 2003, EMBO J, V22, P6471, DOI 10.1093/emboj/cdg637; Sukhatme VP, 1996, KIDNEY INT, V49, P1161, DOI 10.1038/ki.1996.167; Virag L, 2003, TOXICOL LETT, V140, P113, DOI 10.1016/S0378-4274(02)00508-8; Wang Y, 2008, NEPHROL DIAL TRANSPL, V23, P525, DOI 10.1093/ndt/gfm547; Yu SY, 2006, PHOTODERMATOL PHOTO, V22, P78, DOI 10.1111/j.1600-0781.2006.00208.x	30	46	46	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30674	10.1371/journal.pone.0030674	http://dx.doi.org/10.1371/journal.pone.0030674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292015	gold, Green Submitted, Green Published			2022-12-27	WOS:000301570600070
J	Jonassen, R; Endestad, T; Neumeister, A; Haug, KBF; Berg, JP; Landro, NI				Jonassen, Rune; Endestad, Tor; Neumeister, Alexander; Haug, Kari Bente Foss; Berg, Jens Petter; Landro, Nils Inge			Serotonin Transporter Polymorphism Modulates N-Back Task Performance and fMRI BOLD Signal Intensity in Healthy Women	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; 5-HTTLPR POLYMORPHISM; GENETIC-VARIATION; COGNITIVE MODEL; METAANALYSIS; REPLICATION; ACTIVATION; MODERATION; STRESS; ALLELE	Context: Exploring intermediate phenotypes within the human brain's functional and structural circuitry is a promising approach to explain the relative contributions of genetics, complex behaviors and neural mechanisms in the development of major depressive disorder (MDD). The polymorphic region 5-HTTLPR in the serotonin transporter gene (SLC6A4) has been shown to modulate MDD risk, but the neural underpinnings are incompletely understood. Objective: 37 right handed healthy women between 21 and 61 years of age were invited to participate in an fMRI modified n-back study. The functional polymorphism 5-HTTLPR located in the promoter region of the SLC6A4 gene was genotyped using polymerase chain reaction (PCR). Results: Short 5-HTTLPR allele carriers showed more blood-oxygen-level-dependent (BOLD) bilateral prefrontal cortex activation in the right [(F) under bar (2, 30) = 4.8, eta(2) =.25, (p) under bar =.026] and left [(F) under bar (2, 30) = 4.1, eta(2) =.22, (p) under bar =.015] inferior frontal gyrus pars triangularis with increasing n-back task difficulty relative to long 5-HTTLPR allele carriers. Short 5-HTTLPR allele carriers had inferior task performance on the most difficult n-back condition [(F) under bar (2, 30) = 4.9, eta(2) =.26, (p) under bar =.014]. Conclusions: This activation pattern found in healthy at risk individuals resembles an activation pattern that is typically found in patients suffering from acute MDD. Altered function in these areas may reflect intermediate phenotypes and may help explain the increased risk of depression in short 5-HTTLPR allele carriers.	[Jonassen, Rune; Endestad, Tor; Landro, Nils Inge] Ctr Study Human Cognit, Dept Psychol, Oslo, Norway; [Jonassen, Rune] Akershus Univ Hosp, Div Psychiat, Akershus, Norway; [Neumeister, Alexander] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Haug, Kari Bente Foss; Berg, Jens Petter] Oslo Univ Hosp, Dept Med Biochem, Sect Res, Ulleval, Norway; [Haug, Kari Bente Foss; Berg, Jens Petter] Inst Clin Med, Oslo, Norway	University of Oslo; Icahn School of Medicine at Mount Sinai; University of Oslo	Jonassen, R (corresponding author), Ctr Study Human Cognit, Dept Psychol, Oslo, Norway.	rune.jonassen@psykologi.uio.no	Berg, Jens P/G-1455-2012	Berg, Jens P/0000-0003-0157-5888; Jonassen, Rune/0000-0002-5611-4635	Research Council of Norway [175387/V50]	Research Council of Norway(Research Council of Norway)	This research was supported by a grant from the Research Council of Norway to Nils Inge Landro (project number 175387/V50). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Beevers CG, 2010, GENES BRAIN BEHAV, V9, P224, DOI 10.1111/j.1601-183X.2009.00550.x; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Denny BT, 2010, EMOTION REGULATION P, P59; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Gelernter J, 1997, HUM GENET, V101, P243, DOI 10.1007/s004390050624; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Matsuo K, 2007, MOL PSYCHIATR, V12, P158, DOI 10.1038/sj.mp.4001894; McGuffin P, 2011, BRIT J PSYCHIAT, V198, P424, DOI 10.1192/bjp.bp.110.085225; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pacheco J, 2009, J NEUROSCI, V29, P6229, DOI 10.1523/JNEUROSCI.0896-09.2009; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Selvaraj S, 2011, MOL PSYCHIATR, V16, P472, DOI 10.1038/mp.2010.112; Stein MB, 2006, PSYCHOPHARMACOLOGY, V187, P68, DOI 10.1007/s00213-006-0349-8; Uher R, 2010, MOL PSYCHIATR, V15, P18, DOI 10.1038/mp.2009.123; UNESCO IfS, 1997, INT STAND CLASS ED 1; Wechsler D, 2003, WECHSLER ADULT INTEL; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; World Medical Association WMA, 2008, DECL HELS ETH PRINC; Worsley K.J., 2001, FUNCTIONAL MRI AN IN, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]	29	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30564	10.1371/journal.pone.0030564	http://dx.doi.org/10.1371/journal.pone.0030564			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291990	gold, Green Submitted, Green Published			2022-12-27	WOS:000301570600060
J	Nem, D; Baranyai, D; Qiu, H; Godtel-Armbrust, U; Nestler, S; Wojnowski, L				Nem, Dieudonne; Baranyai, Dorothea; Qiu, Huan; Goedtel-Armbrust, Ute; Nestler, Sebastian; Wojnowski, Leszek			Pregnane X Receptor and Yin Yang 1 Contribute to the Differential Tissue Expression and Induction of CYP3A5 and CYP3A4	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; NUCLEAR RECEPTOR; CYTOCHROME-P450 3A; IN-VITRO; INDUCED OSTEOMALACIA; SIGNALING PATHWAY; BLOOD-PRESSURE; HUMAN PROSTATE; MESSENGER-RNA; HUMAN LIVER	The hepato-intestinal induction of the detoxifying enzymes CYP3A4 and CYP3A5 by the xenosensing pregnane X receptor (PXR) constitutes a key adaptive response to oral drugs and dietary xenobiotics. In contrast to CYP3A4, CYP3A5 is additionally expressed in several, mostly steroidogentc organs, which creates potential for induction-driven disturbances of the steroid homeostasis. Using cell lines and mice transgenic for a CYP3A5 promoter we demonstrate that the CYP3A5 expression in these organs is non-inducible and independent from PXR. Instead, it is enabled by the loss of a suppressing yin yang 1 (YY1)-binding site from the CYP3A5 promoter which occurred in haplorrhine primates. This YY1 site is conserved in CYP3A4, but its inhibitory effect can be offset by PXR acting on response elements such as XREM. Taken together, the loss of YY1 binding site from promoters of the CYP3A5 gene lineage during primate evolution may have enabled the utilization of CYP3A5 both in the adaptive hepato-intestinal response to xenobiotics and as a constitutively expressed gene in other organs. Our results thus constitute a first description of uncoupling induction from constitutive expression for a major detoxifying enzyme. They also suggest an explanation for he considerable tissue expression differences between CYP3A5 and CYP3A4.	[Nem, Dieudonne; Baranyai, Dorothea; Qiu, Huan; Goedtel-Armbrust, Ute; Nestler, Sebastian; Wojnowski, Leszek] Johannes Gutenberg Univ Mainz, Dept Pharmacol, Univ Med Ctr, D-6500 Mainz, Germany	Johannes Gutenberg University of Mainz	Wojnowski, L (corresponding author), Johannes Gutenberg Univ Mainz, Dept Pharmacol, Univ Med Ctr, D-6500 Mainz, Germany.	wojnowski@uni-mainz.de	Qiu, Huan/C-2671-2016		DFG (German Research Foundation) [WO505/2-2]; DAAD (German Academic Exchange Office)	DFG (German Research Foundation)(German Research Foundation (DFG)); DAAD (German Academic Exchange Office)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the DFG (German Research Foundation) grant WO505/2-2 and by a doctoral stipend of the DAAD (German Academic Exchange Office) to DN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksa K, 2005, PEDIATR NEPHROL, V20, P872, DOI 10.1007/s00467-004-1807-3; Arthur JM, 2000, TISSUE CELL, V32, P446, DOI 10.1054/tice.2000.0135; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Biggs JS, 2007, MOL PHARMACOL, V72, P514, DOI 10.1124/mol.106.033795; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; BRODIE MJ, 1980, CLIN PHARMACOL THER, V27, P810, DOI 10.1038/clpt.1980.115; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Burk O, 2004, J BIOL CHEM, V279, P38379, DOI 10.1074/jbc.M404949200; Cedrone E, 2009, ATCC CONNECTION, V29, P4; Cedrone E, 2009, ATCC CONNECTION, V29, P15; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Cheng XG, 2006, DRUG METAB DISPOS, V34, P1863, DOI 10.1124/dmd.106.010520; CLORE J, 1992, KIDNEY INT, V42, P1297, DOI 10.1038/ki.1992.421; Dai Y, 2006, DRUG METAB DISPOS, V34, P836, DOI 10.1124/dmd.105.008680; Dai Y, 2004, BIOCHEM PHARMACOL, V68, P1889, DOI 10.1016/j.bcp.2004.07.012; Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200; Gellner K, 2001, PHARMACOGENETICS, V11, P111, DOI 10.1097/00008571-200103000-00002; Godtel-Armbrust U, 2007, N-S ARCH PHARMACOL, V375, P377, DOI 10.1007/s00210-007-0172-8; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Greiner B, 1999, J CLIN INVEST, V104, P147, DOI 10.1172/JCI6663; Gupta RP, 2005, J CLIN ENDOCR METAB, V90, P1210, DOI 10.1210/jc.2004-0966; Gupta RP, 2004, J BONE MINER RES, V19, P680, DOI 10.1359/JBMR.0301257; Haehner BD, 1996, MOL PHARMACOL, V50, P52; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARIHARAN N, 1991, P NATL ACAD SCI USA, V88, P9799, DOI 10.1073/pnas.88.21.9799; HASHIMOTO H, 1993, EUR J BIOCHEM, V218, P585, DOI 10.1111/j.1432-1033.1993.tb18412.x; Heikamp Stephanie, 2008, THESIS J GUTENBERG U; Henshall J, 2008, DRUG METAB DISPOS, V36, P1332, DOI 10.1124/dmd.108.021279; Ho H, 2005, HYPERTENSION, V45, P294, DOI 10.1161/01.HYP.0000151361.31736.96; Hustert E, 2001, PHARMACOGENETICS, V11, P773, DOI 10.1097/00008571-200112000-00005; Hustert E, 2001, DRUG METAB DISPOS, V29, P1454; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Ihunnah CA, 2011, BBA-MOL BASIS DIS, V1812, P956, DOI 10.1016/j.bbadis.2011.01.014; Iwano S, 2001, BIOCHEM BIOPH RES CO, V286, P55, DOI 10.1006/bbrc.2001.5352; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Joy MS, 2007, NEPHROL DIAL TRANSPL, V22, P1963, DOI 10.1093/ndt/gfm133; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Koch I, 2002, DRUG METAB DISPOS, V30, P1108, DOI 10.1124/dmd.30.10.1108; Kreutz R, 2005, PHARMACOGENET GENOM, V15, P831, DOI 10.1097/01213011-200512000-00001; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lamba V, 2004, TOXICOL APPL PHARM, V199, P251, DOI 10.1016/j.taap.2003.12.027; Lash LH, 2008, TOXICOLOGY, V244, P56, DOI 10.1016/j.tox.2007.10.022; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; LI HC, 1995, J BIOCHEM TOXICOL, V10, P51; Lin YS, 2002, MOL PHARMACOL, V62, P162, DOI 10.1124/mol.62.1.162; Luke MPS, 2006, J BIOL CHEM, V281, P33226, DOI 10.1074/jbc.M606584200; Masuyama H, 2001, MOL CELL ENDOCRINOL, V172, P47, DOI 10.1016/S0303-7207(00)00395-6; MATSUZAKI K, 1995, STEROIDS, V60, P457, DOI 10.1016/0039-128X(95)00038-R; McCune JS, 2005, DRUG METAB DISPOS, V33, P1074, DOI 10.1124/dmd.104.002279; Moilanen AM, 2007, CARCINOGENESIS, V28, P916, DOI 10.1093/carcin/bgl222; Morris DJ, 1998, AM J PHYSIOL-CELL PH, V274, pC1245, DOI 10.1152/ajpcell.1998.274.5.C1245; Murray GI, 1999, BRIT J CANCER, V79, P1836, DOI 10.1038/sj.bjc.6690292; Nishimura Masuhiro, 2004, Drug Metab Pharmacokinet, V19, P135, DOI 10.2133/dmpk.19.135; Novotna A, 2010, EUR J PHARM SCI, V41, P276, DOI 10.1016/j.ejps.2010.06.019; Qiu H, 2008, PHARMACOGENET GENOM, V18, P53, DOI 10.1097/FPC.0b013e3282f313f8; Qiu H, 2010, PHARMACOGENET GENOM, V20, P167, DOI 10.1097/FPC.0b013e328336bbeb; Saito T, 2001, J BIOL CHEM, V276, P38010; SHAH SC, 1981, TUBERCLE, V62, P207, DOI 10.1016/0041-3879(81)90008-8; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Singer GAC, 2005, MOL BIOL EVOL, V22, P767, DOI 10.1093/molbev/msi062; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tegude H, 2007, DRUG METAB DISPOS, V35, P946, DOI 10.1124/dmd.106.013565; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; Verkoelen CF, 1999, KIDNEY INT, V55, P1426, DOI 10.1046/j.1523-1755.1999.00383.x; Weill L, 2003, J VIROL, V77, P2903, DOI 10.1128/JVI.77.5.2903-2914.2003; Xu Y, 2006, MOL PHARMACOL, V69, P56, DOI 10.1124/mol.105.017392; Yamakoshi Y, 1999, BIOCHEM BIOPH RES CO, V260, P676, DOI 10.1006/bbrc.1999.0960	69	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30895	10.1371/journal.pone.0030895	http://dx.doi.org/10.1371/journal.pone.0030895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292071	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600095
J	Wei, H; Hu, CX; Wang, M; van den Hoek, AM; Reijmers, TH; Wopereis, S; Bouwman, J; Ramaker, R; Korthout, HAAJ; Vennik, M; Hankemeier, T; Havekes, LM; Witkamp, RF; Verheij, ER; Xu, GW; van der Greef, J				Wei, Heng; Hu, Chunxiu; Wang, Mei; van den Hoek, Anita M.; Reijmers, Theo H.; Wopereis, Suzan; Bouwman, Jildau; Ramaker, Raymond; Korthout, Henrie A. A. J.; Vennik, Marco; Hankemeier, Thomas; Havekes, Louis M.; Witkamp, Renger F.; Verheij, Elwin R.; Xu, Guowang; van der Greef, Jan			Lipidomics Reveals Multiple Pathway Effects of a Multi-Components Preparation on Lipid Biochemistry in ApoE*3Leiden.CETP Mice	PLOS ONE			English	Article							CHOLESTERYL ESTER TRANSFER; SYSTEMS BIOLOGY; AGGRAVATES ATHEROSCLEROSIS; OVERWEIGHT PATIENTS; CHINESE MEDICINE; WEIGHT-REDUCTION; TRANSFER PROTEIN; HDL-CHOLESTEROL; INCREASES HDL; RISK-FACTORS	Background: Causes and consequences of the complex changes in lipids occurring in the metabolic syndrome are only partly understood. Several interconnected processes are deteriorating, which implies that multi-target approaches might be more successful than strategies based on a limited number of surrogate markers. Preparations from Chinese Medicine (CM) systems have been handed down with documented clinical features similar as metabolic syndrome, which might help developing new intervention for metabolic syndrome. The progress in systems biology and specific animal models created possibilities to assess the effects of such preparations. Here we report the plasma and liver lipidomics results of the intervention effects of a preparation SUB885C in apolipoprotein E3 Leiden cholesteryl ester transfer protein (ApoE*3Leiden.CETP) mice. SUB885C was developed according to the principles of CM for treatment of metabolic syndrome. The cannabinoid receptor type 1 blocker rimonabant was included as a general control for the evaluation of weight and metabolic responses. Methodology/Principal Findings: ApoE*3Leiden.CETP mice with mild hypercholesterolemia were divided into SUB885C-, rimonabant- and non-treated control groups. SUB885C caused no weight loss, but significantly reduced plasma cholesterol (-49%, p < 0.001), CETP levels (-31%, p<0.001), CETP activity (-74%, p<0.001) and increased HDL-C (39%, p<0.05). It influenced lipidomics classes of cholesterol esters and triglycerides the most. Rimonabant induced a weight loss (-9%, p<0.05), but only a moderate improvement of lipid profiles. In vitro, SUB885C extract caused adipolysis stimulation and adipogenesis inhibition in 3T3-L1 cells. Conclusions: SUB885C, a multi-components preparation, is able to produce anti-atherogenic changes in lipids of the ApoE*3Leiden.CETP mice, which are comparable to those obtained with compounds belonging to known drugs (e. g. rimonabant, atorvastatin, niacin). This study successfully illustrated the power of lipidomics in unraveling intervention effects and to help finding new targets or ingredients for lifestyle-related metabolic abnormality.	[Wei, Heng; Wopereis, Suzan; Bouwman, Jildau; Ramaker, Raymond; Verheij, Elwin R.; van der Greef, Jan] TNO, Dept Earth Environm & Life Sci, NL-3700 AJ Zeist, Netherlands; [Wei, Heng; Wang, Mei; Xu, Guowang; van der Greef, Jan] Sino Dutch Ctr Prevent & Personalized Med, Zeist, Netherlands; [Hu, Chunxiu; Reijmers, Theo H.; Hankemeier, Thomas; van der Greef, Jan] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Analyt Biosci, Leiden, Netherlands; [Hu, Chunxiu; Xu, Guowang] Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Wang, Mei; van der Greef, Jan] SU BioMed, Zeist, Netherlands; [Korthout, Henrie A. A. J.; Vennik, Marco] Fytagoras BV, Leiden, Netherlands; [Reijmers, Theo H.; Bouwman, Jildau; Hankemeier, Thomas] Leiden Univ, Netherlands Metabol Ctr, Leiden, Netherlands; [Havekes, Louis M.] Leiden Univ, Med Ctr, Dept Endocrinol & Cardiol, Leiden, Netherlands; [Witkamp, Renger F.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	Netherlands Organization Applied Science Research; Leiden University; Leiden University - Excl LUMC; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wageningen University & Research	Wei, H (corresponding author), TNO, Dept Earth Environm & Life Sci, NL-3700 AJ Zeist, Netherlands.	xugw@dicp.ac.cn; jan.vandergreef@tno.nl	Witkamp, Renger/I-7622-2012; Hankemeier, Thomas/V-5407-2019; Xu, Guowang/L-6910-2014	Witkamp, Renger/0000-0002-7935-8261; Hankemeier, Thomas/0000-0001-7871-2073; Xu, Guowang/0000-0003-4298-3554	Netherlands Genomics Initiative; Netherlands Metabolomics Centre; Sino-Dutch Centre for Preventive and Personalized Medicine; SU Biomedicine (SUB) [031.13097]	Netherlands Genomics Initiative; Netherlands Metabolomics Centre; Sino-Dutch Centre for Preventive and Personalized Medicine; SU Biomedicine (SUB)	This work was sponsored by the Netherlands Genomics Initiative, the Netherlands Metabolomics Centre, and the Sino-Dutch Centre for Preventive and Personalized Medicine. In addition, the work presented is part of a larger project with Project No. 031.13097 financially supported by SU Biomedicine (SUB). Authors employed by SUB (Mei Wang and Jan van der Greef) contributed to experimental conceiving and design, guidance and discussion of the project. All the other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand SS, 2011, LANCET, V377, P529, DOI 10.1016/S0140-6736(10)62346-X; Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Balakumar P, 2007, PHARMACOL RES, V56, P91, DOI 10.1016/j.phrs.2007.03.002; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bernatoniene J, 2009, PHYTOTHER RES, V23, P1701, DOI 10.1002/ptr.2815; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cannon CP, 2009, LANCET, V373, P1313, DOI 10.1016/S0140-6736(09)60652-8; Chau CF, 2006, TRENDS FOOD SCI TECH, V17, P313, DOI 10.1016/j.tifs.2005.12.005; Chui SH, 2008, J COMPLEMENTARY INTE, V5, P17; de Haan W, 2008, CIRCULATION, V117, P2515, DOI 10.1161/CIRCULATIONAHA.107.761965; de Haan W, 2008, ATHEROSCLEROSIS, V197, P57, DOI 10.1016/j.atherosclerosis.2007.08.001; de Haan W, 2009, BBA-MOL CELL BIOL L, V1791, P191, DOI 10.1016/j.bbalip.2008.12.008; de Vries-van der Weij J, 2009, ATHEROSCLEROSIS, V206, P153, DOI 10.1016/j.atherosclerosis.2009.02.038; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Dullaart RPF, 1999, EUR J CLIN INVEST, V29, P663; Feng Y, 2010, BRIT J PHARMACOL, V161, P113, DOI 10.1111/j.1476-5381.2010.00826.x; Franco OH, 2004, BMJ-BRIT MED J, V329, P1447, DOI 10.1136/bmj.329.7480.1447; Gary-Bobo M, 2006, MOL PHARMACOL, V69, P471, DOI 10.1124/mol.105.015040; German JB, 2007, CURR OPIN LIPIDOL, V18, P66; Grover JK, 2002, J ETHNOPHARMACOL, V81, P81, DOI 10.1016/S0378-8741(02)00059-4; Hu CX, 2008, J PROTEOME RES, V7, P4982, DOI 10.1021/pr800373m; Hu CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019423; James WPT, 2008, J INTERN MED, V263, P336, DOI 10.1111/j.1365-2796.2008.01922.x; Jones D, 2008, NAT REV DRUG DISCOV, V7, P961, DOI 10.1038/nrd2775; Liu J.P., 2002, COCHRANE DB SYST REV, VRev0, DOI [10.1002/14651858.cd003642.pub2, DOI 10.1002/14651858.CD003642.PUB2]; Lonn E, 2009, CURR OPIN LIPIDOL, V20, P453, DOI 10.1097/MOL.0b013e32833305a3; Mitchell PB, 2007, LANCET, V370, P1671, DOI 10.1016/S0140-6736(07)61705-X; Ng TB, 2005, BIOCHEM CELL BIOL, V83, P78, DOI [10.1139/o04-100, 10.1139/O04-100]; NISHINA PM, 1990, J LIPID RES, V31, P859; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; Niwano Y, 2009, PLANT FOOD HUM NUTR, V64, P6, DOI 10.1007/s11130-008-0102-z; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Smit S, 2007, ANAL CHIM ACTA, V592, P210, DOI 10.1016/j.aca.2007.04.043; Tadic VM, 2008, J AGR FOOD CHEM, V56, P7700, DOI 10.1021/jf801668c; Tian WX, 2004, LIFE SCI, V74, P2389, DOI 10.1016/j.lfs.2003.09.064; van der Greef J, 2007, J PROTEOME RES, V6, P1540, DOI 10.1021/pr0606530; van der Hoorn JWA, 2009, BRIT J PHARMACOL, V156, P1067, DOI 10.1111/j.1476-5381.2008.00109.x; van der Hoorn JWA, 2008, ARTERIOSCL THROM VAS, V28, P2016, DOI 10.1161/ATVBAHA.108.171363; van der Kloet FM, 2009, J PROTEOME RES, V8, P5132, DOI 10.1021/pr900499r; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; van Wietmarschen H, 2009, JCR-J CLIN RHEUMATOL, V15, P330, DOI 10.1097/RHU.0b013e3181ba3926; Vandeginste BGM., 1998, HDB CHEMOMETRICS Q B; VANVLIJMEN BJM, 1994, J CLIN INVEST, V93, P1403, DOI 10.1172/JCI117117; Verpoorte R, 2009, J ETHNOPHARMACOL, V121, P479, DOI 10.1016/j.jep.2008.11.005; Wang M, 2005, PHYTOTHER RES, V19, P173, DOI 10.1002/ptr.1624; Westerterp M, 2006, ARTERIOSCL THROM VAS, V26, P2552, DOI 10.1161/01.ATV.0000243925.65265.3c; Witkamp RF, 2011, PHARM RES-DORDR, V28, P1792, DOI 10.1007/s11095-010-0341-1; Witkamp RF, 2010, BIOL ACTIVE COMPOUND; Wopereis S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004525; Yuliana ND, 2011, FOOD CHEM, V126, P1724, DOI 10.1016/j.foodchem.2010.12.066; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	53	10	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30332	10.1371/journal.pone.0030332	http://dx.doi.org/10.1371/journal.pone.0030332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291936	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600031
J	Ji, ZW; Ma, YL; Li, W; Li, XX; Zhao, GY; Yun, Z; Qian, JX; Fan, QY				Ji, Zhenwei; Ma, Yunlei; Li, Wei; Li, Xiaoxiang; Zhao, Guangyi; Yun, Zhe; Qian, Jixian; Fan, Qingyu			The Healing Process of Intracorporeally and In Situ Devitalized Distal Femur by Microwave in a Dog Model and Its Mechanical Properties In Vitro	PLOS ONE			English	Article							LIMB SALVAGE SURGERY; TERM-FOLLOW-UP; AUTOGRAFT-PROSTHESIS COMPOSITE; MUSCULOSKELETAL TUMOR SURGERY; AUTOLOGOUS BONE-GRAFT; SOFT-TISSUE SARCOMA; OF-THE-LITERATURE; INDUCED HYPERTHERMIA; CLINICAL-EXPERIENCE; IRRADIATED BONE	Background: Limb-salvage surgery has been well recognized as a standard treatment and alternative to amputation for patients with malignant bone tumors. Various limb-sparing techniques have been developed including tumor prosthesis, allograft, autograft and graft-prosthesis composite. However, each of these methods has short-and long-term disadvantages such as nonunion, mechanical failures and poor limb function. The technique of intracorporeal devitalization of tumor-bearing bone segment in situ by microwave-induced hyperthermia after separating it from surrounding normal tissues with a safe margin is a promising limb-salvage method, which may avoid some shortcomings encountered by the above-mentioned conventional techniques. The purpose of this study is to assess the healing process and revitalization potential of the devitalized bone segment by this method in a dog model. In addition, the immediate effect of microwave on the biomechanical properties of bone tissue was also explored in an in vitro experiment. Methods: We applied the microwave-induced hyperthermia to devitalize the distal femurs of dogs in situ. Using a monopole microwave antenna, we could produce a necrotic bone of nearly 20 mm in length in distal femur. Radiography, bone scintigraphy, microangiography, histology and functional evaluation were performed at 2 weeks and 1, 2, 3, 6, 9 and 12 months postoperatively to assess the healing process. In a biomechanical study, two kinds of bone specimens, 3 and 6 cm in length, were used for compression and three-point bending test respectively immediately after extracorporeally devitalized by microwave. Findings: An in vivo study showed that intracorporeally and in situ devitalized bone segment by microwave had great revitalization potential. An in vitro study revealed that the initial mechanical strength of the extracorporeally devitalized bone specimen may not be affected by microwave. Conclusion: Our results suggest that the intracorporeal microwave devitalization of tumor-bearing bone segment in situ may be a promising limb-salvage method.	[Ji, Zhenwei; Ma, Yunlei; Li, Wei; Li, Xiaoxiang; Zhao, Guangyi; Yun, Zhe; Qian, Jixian; Fan, Qingyu] Fourth Mil Med Univ, Tangdu Hosp, Orthoped Oncol Inst Chinese PLA, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Ji, ZW (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Orthoped Oncol Inst Chinese PLA, Xian 710032, Shaanxi, Peoples R China.	bonetm@fmmu.edu.cn						Abed YY, 2009, J BONE JOINT SURG BR, V91B, P1366, DOI [10.1302/0301-620X.91B10.22212, 10.1302/0301-620V.91B10.22212]; Ahmed AR, 2009, ARCH ORTHOP TRAUM SU, V129, P475, DOI 10.1007/s00402-008-0659-x; Asada N, 1997, ACTA ORTHOP SCAND, V68, P392, DOI 10.3109/17453679708996184; Baumgart Rainer, 2009, V179, P59; Bohm P, 2003, LANGENBECK ARCH SURG, V387, P355, DOI 10.1007/s00423-002-0332-8; Bohm P, 1998, ARCH ORTHOP TRAUM SU, V118, P57, DOI 10.1007/s004020050312; Bullens PHJ, 2009, INT ORTHOP, V33, P757, DOI 10.1007/s00264-008-0700-2; CANADELL J, 1994, J BONE JOINT SURG BR, V76B, P127, DOI 10.1302/0301-620X.76B1.8300655; Carrafiello Gianpaolo, 2008, Int J Surg, V6 Suppl 1, pS65, DOI 10.1016/j.ijsu.2008.12.028; Chen CF, 2009, J SURG ONCOL, V100, P418, DOI 10.1002/jso.21351; Cho HS, 2009, J SURG ONCOL, V100, P227, DOI 10.1002/jso.21267; Ehara S, 2000, SKELETAL RADIOL, V29, P335, DOI 10.1007/s002560000205; Eisenschenk A, 2006, MICROSURG, V26, P412, DOI 10.1002/micr.20261; Enneking WE, 2001, J BONE JOINT SURG AM, V83A, P971, DOI 10.2106/00004623-200107000-00001; Fan QY, 2003, CLIN ORTHOP RELAT R, P165, DOI 10.1097/01.blo.0000037439.23683.9c; Fan QY, 1996, BIOELECTROMAGNETICS, V17, P218, DOI 10.1002/(SICI)1521-186X(1996)17:3<218::AID-BEM7>3.0.CO;2-6; Gillams Alice, 2008, Cancer Imaging, V8 Spec No A, pS1, DOI 10.1102/1470-7330.2008.9001; Jeon DG, 2007, J SURG ONCOL, V96, P590, DOI 10.1002/jso.20840; Jeon DG, 2007, J ORTHOP SCI, V12, P542, DOI 10.1007/s00776-007-1173-7; Jeys Lee, 2009, V179, P75; Kawaguchi N, 2004, CLIN ORTHOP RELAT R, P165, DOI 10.1097/01.blo.0000116308.86761.f5; Kinkel S, 2010, J SURG ONCOL, V101, P166, DOI 10.1002/jso.21441; KOLIOS MC, 1995, PHYS MED BIOL, V40, P477, DOI 10.1088/0031-9155/40/4/001; Kubo T, 2004, ANTICANCER RES, V24, P1893; Kumta SM, 2002, J PEDIATR ORTHOPED, V22, P244, DOI 10.1097/00004694-200203000-00023; Kumta SM, 1999, ARCH ORTHOP TRAUM SU, V119, P327, DOI 10.1007/s004020050420; Liapi E, 2007, J CLIN ONCOL, V25, P978, DOI 10.1200/JCO.2006.09.8657; Liebergall M, 1998, CLIN ORTHOP RELAT R, P242; Liebergall M, 2000, CLIN ORTHOP RELAT R, P272; Lu DSK, 2002, AM J ROENTGENOL, V178, P47, DOI 10.2214/ajr.178.1.1780047; Manabe J, 2004, CLIN ORTHOP RELAT R, P258, DOI 10.1097/01.blo.0000122665.47154.8f; MANKIN HJ, 1992, ORTHOPEDICS, V15, P1147; Mankin HJ, 1996, CLIN ORTHOP RELAT R, P86; Marulanda German A, 2008, Cancer Control, V15, P13; Moran M, 2009, ARCH ORTHOP TRAUM SU, V129, P1339, DOI 10.1007/s00402-008-0752-1; Morello E, 2001, J SMALL ANIM PRACT, V42, P61, DOI 10.1111/j.1748-5827.2001.tb01993.x; Muscolo DL, 2008, CLIN ORTHOP RELAT R, V466, P1856, DOI 10.1007/s11999-008-0303-7; Nielsen OS, 2001, EUR J CANCER, V37, P1587, DOI 10.1016/S0959-8049(01)00193-9; Ogilvie CM, 2009, CLIN ORTHOP RELAT R, V467, P2685, DOI 10.1007/s11999-009-0726-9; Ottaviani G, 2009, CANCER TREAT RES, V152, P421, DOI 10.1007/978-1-4419-0284-9_2; Poffyn B, 2010, SKELETAL RADIOL, V39, P999, DOI 10.1007/s00256-010-0889-1; Quan GMY, 2005, J SURG ONCOL, V91, P159, DOI 10.1002/jso.20268; RONG Y, 1995, CLIN ORTHOP RELAT R, P227; Saghieh S, 2010, PEDIATR BLOOD CANCER, V55, P457, DOI 10.1002/pbc.22598; Shimizu K, 1999, ARCH ORTHOP TRAUM SU, V119, P57, DOI 10.1007/s004020050355; Shin S, 2005, ARCH ORTHOP TRAUM SU, V125, P1, DOI 10.1007/s00402-004-0746-6; Simon CJ, 2006, SEMIN MUSCULOSKEL R, V10, P137, DOI 10.1055/s-2006-939031; Simon Caroline J, 2005, Surg Oncol Clin N Am, V14, P419, DOI 10.1016/j.soc.2004.11.005; Tyler WK, 2009, CLIN ORTHOP RELAT R, V467, P2800, DOI 10.1007/s11999-009-0946-z; Van Laere K, 1998, J NUCL MED, V39, P1563; Watanabe Hideomi, 2003, J Orthop Sci, V8, P180; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5; Zouari L, 2008, EUR RADIOL, V18, P2635, DOI 10.1007/s00330-008-1045-3	53	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30505	10.1371/journal.pone.0030505	http://dx.doi.org/10.1371/journal.pone.0030505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276207	Green Published, gold, Green Submitted			2022-12-27	WOS:000301568100051
J	Jin, YN; Hwang, WY; Jo, C; Johnson, GVW				Jin, Youngnam N.; Hwang, Woong Y.; Jo, Chulman; Johnson, Gail V. W.			Metabolic State Determines Sensitivity to Cellular Stress in Huntington Disease: Normalization by Activation of PPAR gamma	PLOS ONE			English	Article							MITOCHONDRIAL UNCOUPLING PROTEINS; PERMEABILITY TRANSITION PORE; R6/2 MOUSE MODEL; RECEPTOR-GAMMA; MUTANT HUNTINGTIN; STRIATAL CELLS; OXIDATIVE STRESS; PYRUVATE-DEHYDROGENASE; AGONIST PIOGLITAZONE; TRANSGENIC MICE	Impairments in mitochondria and transcription are important factors in the pathogenesis of Huntington disease (HD), a neurodegenerative disease caused by a polyglutamine expansion in the huntingtin protein. This study investigated the effect of different metabolic states and peroxisome proliferator-activated receptor gamma (PPAR gamma) activation on sensitivity to cellular stressors such as H2O2 or thapsigargin in HD. Striatal precursor cells expressing wild type (STHdh(Q7)) or mutant huntingtin (STHdh(Q111)) were prepared in different metabolic conditions (glucose vs. pyruvate). Due to the fact that STHdh(Q111) cells exhibit mitochondrial deficits, we expected that in the pyruvate condition, where ATP is generated primarily by the mitochondria, there would be greater differences in cell death between the two cell types compared to the glucose condition. Intriguingly, it was the glucose condition that gave rise to greater differences in cell death. In the glucose condition, thapsigargin treatment resulted in a more rapid loss of mitochondrial membrane potential (Delta psi m), a greater activation of caspases (3, 8, and 9), and a significant increase in superoxide/reactive oxygen species (ROS) in STHdh(Q111) compared to STHdh(Q7), while both cell types showed similar kinetics of Delta psi m-loss and similar levels of superoxide/ROS in the pyruvate condition. This suggests that bioenergetic deficiencies are not the primary contributor to the enhanced sensitivity of STHdh(Q111) cells to stressors compared to the STHdh(Q7) cells. PPAR gamma activation significantly attenuated thapsigargin-induced cell death, concomitant with an inhibition of caspase activation, a delay in Delta psi m loss, and a reduction of superoxide/ROS generation in STHdh(Q111) cells. Expression of mutant huntingtin in primary neurons induced superoxide/ROS, an effect that was significantly reduced by constitutively active PPAR gamma. These results provide significant insight into the bioenergetic disturbances in HD with PPAR gamma being a potential therapeutic target for HD.	[Jin, Youngnam N.; Hwang, Woong Y.; Johnson, Gail V. W.] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14627 USA; [Jo, Chulman; Johnson, Gail V. W.] Univ Rochester, Dept Anesthesiol, Rochester, NY USA	University of Rochester; University of Rochester	Jin, YN (corresponding author), Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14627 USA.	gail_johnsonvoll@urmc.rochester.edu	Jin, Youngnam/G-2655-2012; Johnson, Gail V.W./K-4723-2012	Johnson, Gail V.W./0000-0003-3464-0404	National Institutes of Health (NIH) [NS041744]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041744] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grant NS041744. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sorolla MA, 2010, FREE RADICAL BIO MED, V49, P612, DOI 10.1016/j.freeradbiomed.2010.05.016; Breidert T, 2002, J NEUROCHEM, V82, P615, DOI 10.1046/j.1471-4159.2002.00990.x; Browne SE, 1999, BRAIN PATHOL, V9, P147; BUTTERWORTH J, 1985, J NEUROL SCI, V67, P161, DOI 10.1016/0022-510X(85)90112-1; Chan SHH, 2009, CIRC RES, V105, P886, DOI 10.1161/CIRCRESAHA.109.199018; Chiang MC, 2010, HUM MOL GENET, V19, P4043, DOI 10.1093/hmg/ddq322; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; DeMarch Z, 2008, NEUROBIOL DIS, V30, P375, DOI 10.1016/j.nbd.2008.02.010; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Doonan F, 2009, J NEUROCHEM, V109, P631, DOI 10.1111/j.1471-4159.2009.05995.x; Du YF, 2009, NEUROBIOL DIS, V35, P302, DOI 10.1016/j.nbd.2009.05.015; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; FERRANTE RJ, 1991, J NEUROSCI, V11, P3877; Fong WH, 2010, MOL NEUROBIOL, V41, P180, DOI 10.1007/s12035-010-8103-y; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Gundemir S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006123; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Heneka MT, 2005, BRAIN, V128, P1442, DOI 10.1093/brain/awh452; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; Jin YN, 2010, J BIOENERG BIOMEMBR, V42, P199, DOI 10.1007/s10863-010-9286-7; Jo DG, 2004, MOL CELL BIOL, V24, P9763, DOI 10.1128/MCB.24.22.9763-9770.2004; Jucker BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1256, DOI 10.1152/ajpendo.00218.2007; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; King AL, 2010, AM J PHYSIOL-GASTR L, V299, pG954, DOI 10.1152/ajpgi.00246.2010; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Kress GJ, 2002, J NEUROSCI, V22, P5848; Luo YM, 2006, J NEUROCHEM, V97, P435, DOI 10.1111/j.1471-4159.2006.03758.x; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maglione V, 2006, MECH AGEING DEV, V127, P213, DOI 10.1016/j.mad.2005.09.011; Martinez JA, 2010, APOPTOSIS, V15, P1480, DOI 10.1007/s10495-010-0526-4; Matas J, 2009, J MOL CELL CARDIOL, V46, P420, DOI 10.1016/j.yjmcc.2008.10.020; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Milakovic T, 2006, J BIOL CHEM, V281, P34785, DOI 10.1074/jbc.M603845200; MURTHY VV, 1995, J CLIN LAB ANAL, V9, P225, DOI 10.1002/jcla.1860090402; Nasrallah R, 2010, AM J PHYSIOL-RENAL, V298, pF1105, DOI 10.1152/ajprenal.00735.2009; Niino M, 2001, J NEUROIMMUNOL, V116, P40, DOI 10.1016/S0165-5728(01)00285-5; Oliveira JMA, 2006, J NEUROSCI, V26, P11174, DOI 10.1523/JNEUROSCI.3004-06.2006; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Perluigi M, 2005, MOL CELL PROTEOMICS, V4, P1849, DOI 10.1074/mcp.M500090-MCP200; Perry GM, 2010, HUM MOL GENET, V19, P3354, DOI 10.1093/hmg/ddq247; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Quintanilla RA, 2008, J BIOL CHEM, V283, P25628, DOI 10.1074/jbc.M804291200; Rasola A, 2010, FEBS LETT, V584, P1989, DOI 10.1016/j.febslet.2010.02.022; Ross CA, 2006, NAT MED, V12, P1239, DOI 10.1038/nm1106-1239; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Sasaya H, 2008, J BIOCHEM, V144, P251, DOI 10.1093/jb/mvn063; Schock SC, 2008, J NEUROSCI, V28, P12433, DOI 10.1523/JNEUROSCI.2897-08.2008; Seong IS, 2005, HUM MOL GENET, V14, P2871, DOI 10.1093/hmg/ddi319; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; SORBI S, 1983, ANN NEUROL, V13, P72, DOI 10.1002/ana.410130116; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Troiano L, 2007, NAT PROTOC, V2, P2719, DOI 10.1038/nprot.2007.405; Wu ZF, 2009, ANTIOXID REDOX SIGN, V11, P1805, DOI [10.1089/ars.2009.2427, 10.1089/ARS.2009.2427]; Yamaguchi H, 2003, CANCER RES, V63, P1483; Zhang X, 2007, TOXICOL APPL PHARM, V223, P10, DOI 10.1016/j.taap.2007.05.002; Zhang Y, 2003, J NEUROCHEM, V87, P1184, DOI 10.1046/j.1471-4159.2003.02105.x; Zheng Z, 2010, DIABETES, V59, P2315, DOI 10.2337/db10-0638; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028	65	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30406	10.1371/journal.pone.0030406	http://dx.doi.org/10.1371/journal.pone.0030406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276192	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100044
J	Gong, HY; Kobayashi, K; Sugi, T; Takemae, H; Kurokawa, H; Horimoto, T; Akashi, H; Kato, K				Gong, Haiyan; Kobayashi, Kyousuke; Sugi, Tatsuki; Takemae, Hitoshi; Kurokawa, Hitomi; Horimoto, Taisuke; Akashi, Hiroomi; Kato, Kentaro			A Novel PAN/Apple Domain-Containing Protein from Toxoplasma gondii: Characterization and Receptor Identification	PLOS ONE			English	Article							MICRONEME PROTEINS; SULFATE PROTEOGLYCANS; CHONDROITIN SULFATE; MOLECULAR-CLONING; EIMERIA-TENELLA; CELL INVASION; APPLE DOMAINS; FC-RECEPTOR; BINDING; EXPRESSION	Toxoplasma gondii is an intracellular parasite that invades nucleated cells, causing toxoplasmosis in humans and animals worldwide. The extremely wide range of hosts susceptible to T. gondii is thought to be the result of interactions between T. gondii ligands and receptors on its target cells. In this study, a host cell-binding protein from T. gondii was characterized, and one of its receptors was identified. P104 (GenBank Access. No. CAJ20677) is 991 amino acids in length, containing a putative 26 amino acid signal peptide and 10 PAN/apple domains, and shows low homology to other identified PAN/apple domaincontaining molecules. A 104-kDa host cell-binding protein was detected in the T. gondii lysate. Immunofluorescence assays detected P104 at the apical end of extracellular T. gondii. An Fc-fusion protein of the P104 N-terminus, which contains two PAN/apple domains, showed strong affinity for the mammalian and insect cells evaluated. This binding was not related to protein-protein or protein-lipid interactions, but to a protein-glycosaminoglycan (GAG) interaction. Chondroitin sulfate (CS), a kind of GAG, was shown to be involved in adhesion of the Fc-P104 N-terminus fusion protein to host cells. These results suggest that P104, expressed at the apical end of the extracellular parasite, may function as a ligand in the attachment of T. gondii to CS or other receptors on the host cell, facilitating invasion by the parasite.	[Gong, Haiyan; Kobayashi, Kyousuke; Sugi, Tatsuki; Takemae, Hitoshi; Kurokawa, Hitomi; Horimoto, Taisuke; Akashi, Hiroomi; Kato, Kentaro] Univ Tokyo, Dept Vet Microbiol, Grad Sch Agr & Life Sci, Tokyo, Japan	University of Tokyo	Gong, HY (corresponding author), Univ Tokyo, Dept Vet Microbiol, Grad Sch Agr & Life Sci, Tokyo, Japan.	akkato@mail.ecc.u-tokyo.ac.jp	Sugi, Tatsuki/A-9110-2012; Takemae, Hitoshi/AEP-5503-2022	Kobayashi, Kyousuke/0000-0001-5501-8396	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan; Bio-Oriented Technology Research Advancement Institution (BRAIN)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bio-Oriented Technology Research Advancement Institution (BRAIN)	This study was supported by a grant from the Japan Society for the Promotion of Science (JSPS); Grant-in-Aid for Young Scientists from the Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan; and the Bio-Oriented Technology Research Advancement Institution (BRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMANN H, 1979, J BIOL CHEM, V254, P3935; Beghetto E, 2005, J INFECT DIS, V191, P637, DOI 10.1086/427660; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Bhopale GM, 2003, MICROBES INFECT, V5, P457, DOI 10.1016/S1286-4579(03)00048-0; Bir N, 2006, INFECT IMMUN, V74, P5955, DOI 10.1128/IAI.00481-06; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Brown PJ, 2000, MOL BIOCHEM PARASIT, V107, P91, DOI 10.1016/S0166-6851(00)00179-1; BULOW R, 1991, J IMMUNOL, V147, P3496; Carruthers BV, 2008, SUBCELL BIOCH, V47, P33; Carruthers VB, 2000, INFECT IMMUN, V68, P4005, DOI 10.1128/IAI.68.7.4005-4011.2000; Chen ZQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003611; CHIOFALO MS, 1988, CELL IMMUNOL, V114, P272, DOI 10.1016/0008-8749(88)90321-8; Crawford J, 2010, J BIOL CHEM, V285, P15644, DOI 10.1074/jbc.M109.092619; Deng MQ, 2002, INFECT IMMUN, V70, P6987, DOI 10.1128/IAI.70.12.6987-6995.2002; Dinglasan RR, 2007, P NATL ACAD SCI USA, V104, P15882, DOI 10.1073/pnas.0706340104; Fohl LM, 2003, MOL MICROBIOL, V50, P1319, DOI 10.1046/j.1365-2958.2003.03756.x; Friedrich N, 2010, J BIOL CHEM, V285, P2064, DOI 10.1074/jbc.M109.060988; Gong HY, 2007, J INSECT PHYSIOL, V53, P1079, DOI 10.1016/j.jinsphys.2007.06.008; Jacquet A, 2001, MOL BIOCHEM PARASIT, V116, P35, DOI 10.1016/S0166-6851(01)00297-3; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; KAUFMAN H E, 1960, Arch Ophthalmol, V64, P140; Keller N, 2004, INFECT IMMUN, V72, P4791, DOI 10.1128/IAI.72.8.4791-4800.2004; KHAN IA, 1991, J IMMUNOL, V147, P3501; Klein H, 1998, GLYCOCONJUGATE J, V15, P147, DOI 10.1023/A:1006964105349; Klein H, 1996, PARASITOL RES, V82, P230, DOI 10.1007/s004360050101; Kobayashi K, 2010, J BIOL CHEM, V285, P1716, DOI 10.1074/jbc.M109.021576; Mateos FV, 1997, MOL PLANT MICROBE IN, V10, P1045, DOI 10.1094/MPMI.1997.10.9.1045; Menard R, 2001, CELL MICROBIOL, V3, P63, DOI 10.1046/j.1462-5822.2001.00097.x; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; MIYAZAWA K, 1989, BIOCHEM BIOPH RES CO, V163, P967, DOI 10.1016/0006-291X(89)92316-4; Morrissette NS, 1998, EXP PARASITOL, V89, P296, DOI 10.1006/expr.1998.4277; Naguleswaran A, 2002, INT J PARASITOL, V32, P695, DOI 10.1016/S0020-7519(02)00014-0; NAKAMURA H, 1995, MECH DEVELOP, V49, P123, DOI 10.1016/0925-4773(94)00309-B; Ortega-Barria E, 1999, J BIOL CHEM, V274, P1267, DOI 10.1074/jbc.274.3.1267; ORTEGABARRIA E, 1991, CELL, V67, P411, DOI 10.1016/0092-8674(91)90192-2; PANCAKE SJ, 1992, J CELL BIOL, V117, P1351, DOI 10.1083/jcb.117.6.1351; Periz J, 2007, J BIOL CHEM, V282, P16891, DOI 10.1074/jbc.M702407200; Peyron F, 2009, MEM I OSWALDO CRUZ, V104, P316, DOI 10.1590/S0074-02762009000200028; Remington J. S., 2006, INFECT DIS FETUS NEW, P947, DOI DOI 10.1016/B0-72-160537-0/50033-5; Sheiner L, 2010, MOL MICROBIOL, V77, P912, DOI 10.1111/j.1365-2958.2010.07255.x; Shimojima M, 2004, SCIENCE, V303, P1192, DOI 10.1126/science.1092124; Shimojima M, 2007, J INFECT DIS, V196, pS259, DOI 10.1086/520594; Silva LCF, 2006, ADV PHARMACOL, V53, P21, DOI 10.1016/S1054-3589(05)53002-3; Striepen B., 2007, P391, DOI 10.1016/B978-012369542-0/50017-9; Sugi T, 2010, EUKARYOT CELL, V9, P667, DOI 10.1128/EC.00351-09; Sugi T, 2009, PARASITOL INT, V58, P416, DOI 10.1016/j.parint.2009.08.005; THERY C, 1995, DEV GENET, V17, P90, DOI 10.1002/dvg.1020170110; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; VAJDA T, 1976, ACTA BIOCHIM BIOPHYS, V11, P287; Varki A, 2008, ESSENTIALS GLYCOBIOL, P649; Velge-Roussel F, 1997, MOL IMMUNOL, V34, P1045, DOI 10.1016/S0161-5890(97)00133-8; Velge-Roussel F, 2000, INFECT IMMUN, V68, P969, DOI 10.1128/IAI.68.2.969-972.2000; Vercammen M, 1998, PARASITE IMMUNOL, V20, P37, DOI 10.1046/j.1365-3024.1998.00124.x; WALKER JC, 1990, NATURE, V345, P743, DOI 10.1038/345743a0; ZHANG JP, 1992, CELL, V69, P861, DOI 10.1016/0092-8674(92)90296-O	55	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30169	10.1371/journal.pone.0030169	http://dx.doi.org/10.1371/journal.pone.0030169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276154	Green Published, gold, Green Submitted			2022-12-27	WOS:000301457200038
J	Castro, PV; Khare, S; Young, BD; Clarke, SG				Castro, Paola V.; Khare, Shilpi; Young, Brian D.; Clarke, Steven G.			Caenorhabditis elegans Battling Starvation Stress: Low Levels of Ethanol Prolong Lifespan in L1 Larvae	PLOS ONE			English	Article							C-ELEGANS; INTERACTING GENES; CELL-CYCLE; LONGEVITY; GROWTH; EXPRESSION; RESISTANCE; GENETICS; TARGETS; DAUER	The nematode Caenorhabditis elegans arrests development at the first larval stage if food is not present upon hatching. Larvae in this stage provide an excellent model for studying stress responses during development. We found that supplementing starved larvae with ethanol markedly extends their lifespan within this L1 diapause. The effects of ethanol-induced lifespan extension can be observed when the ethanol is added to the medium at any time between 0 and 10 days after hatching. The lowest ethanol concentration that extended lifespan was 1 mM (0.005%); higher concentrations to 68 mM (0.4%) did not result in increased survival. In spite of their extended survival, larvae did not progress to the L2 stage. Supplementing starved cultures with n-propanol and n-butanol also extended lifespan, but methanol and isopropanol had no measurable effect. Mass spectrometry analysis of nematode fatty acids and amino acids revealed that L1 larvae can incorporate atoms from ethanol into both types of molecules. Based on these data, we suggest that ethanol supplementation may extend the lifespan of L1 larvae by either serving as a carbon and energy source and/or by inducing a stress response.	[Castro, Paola V.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Castro, PV (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	clarke@mbi.ucla.edu	Castro, Paola/GYU-9263-2022		National Institutes of Health [GM026020, AG032303]; Ellison Medical Foundation; University of California Los Angeles CLA MARC U*STAR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008563, R01GM026020, R37GM026020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); University of California Los Angeles CLA MARC U*STAR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants GM026020 and AG032303 and by an Ellison Medical Foundation Senior Scholar in Aging Award to SGC. PVC was supported in part by the University of California Los Angeles CLA MARC U*STAR program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Banfield KL, 2008, J GERONTOL A-BIOL, V63, P798, DOI 10.1093/gerona/63.8.798; Barclay JW, 2010, BIOCHEM SOC T, V38, P172, DOI 10.1042/BST0380172; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chandler RJ, 2006, MOL GENET METAB, V89, P64, DOI 10.1016/j.ymgme.2006.06.001; COX GN, 1981, DEV BIOL, V86, P456, DOI 10.1016/0012-1606(81)90204-9; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Davis JR, 2008, ALCOHOL CLIN EXP RES, V32, P853, DOI 10.1111/j.1530-0277.2008.00639.x; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Gomez TA, 2007, DEV BIOL, V303, P493, DOI 10.1016/j.ydbio.2006.11.023; Graham ME, 2009, MOL BIOL CELL, V20, P43, DOI 10.1091/mbc.E08-07-0689; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hill S, 2011, FREE RADICAL BIO MED, V50, P130, DOI 10.1016/j.freeradbiomed.2010.10.690; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Kapfhamer D, 2008, GENES BRAIN BEHAV, V7, P669, DOI 10.1111/j.1601-183X.2008.00404.x; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; LARSEN PL, 1995, GENETICS, V139, P1567; Liu FZ, 1997, BIOCHEMISTRY-US, V36, P255, DOI 10.1021/bi9623800; LU NC, 1978, P SOC EXP BIOL MED, V158, P187, DOI 10.3181/00379727-158-40168; Mitchell PH, 2007, PHARMACOGENOMICS J, V7, P411, DOI 10.1038/sj.tpj.6500440; Munoz MJ, 2003, GENETICS, V163, P171; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; RAIZEN DM, 1995, GENETICS, V141, P1365; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Sizova MV, 2011, APPL ENVIRON MICROB, V77, P2282, DOI 10.1128/AEM.01219-10; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Thompson G, 2005, J BIOCHEM MOL TOXIC, V19, P87, DOI 10.1002/jbt.20060; VALLEE BL, 1955, P NATL ACAD SCI USA, V41, P327, DOI 10.1073/pnas.41.6.327; Wang XM, 2010, BIOCHEM BIOPH RES CO, V400, P613, DOI 10.1016/j.bbrc.2010.08.113; Wang XW, 2011, INT J SYST EVOL MICR, V61, P1127, DOI 10.1099/ijs.0.025338-0; WHITE JG, 1984, PHILOS T R SOC LON B, V314, P1; Wolkow CA, 2006, EXP GERONTOL, V41, P1001, DOI 10.1016/j.exger.2006.06.033; Yen K, 2011, ANTIOXID REDOX SIGN, V14, P623, DOI 10.1089/ars.2010.3490; YU X, 2011, BIOCH BIOPH IN PRESS	42	31	31	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29984	10.1371/journal.pone.0029984	http://dx.doi.org/10.1371/journal.pone.0029984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279556	gold, Green Published			2022-12-27	WOS:000299771900034
J	Della Santina, L; Piano, I; Cangiano, L; Caputo, A; Ludwig, A; Cervetto, L; Gargini, C				Della Santina, Luca; Piano, Ilaria; Cangiano, Lorenzo; Caputo, Antonella; Ludwig, Andreas; Cervetto, Luigi; Gargini, Claudia			Processing of Retinal Signals in Normal and HCN Deficient Mice	PLOS ONE			English	Article							CONE PHOTORECEPTORS; TIGER SALAMANDER; INWARD RECTIFICATION; MEMBRANE-PROPERTIES; ROD PHOTORECEPTORS; INNER SEGMENT; CHANNELS; LIGHT; CURRENTS; PHOTORESPONSE	This study investigates the role of two different HCN channel isoforms in the light response of the outer retina. Taking advantage of HCN-deficient mice models and of in vitro (patch-clamp) and in vivo (ERG) recordings of retinal activity we show that HCN1 and HCN2 channels are expressed at distinct retinal sites and serve different functions. Specifically, HCN1 operate mainly at the level of the photoreceptor inner segment from where, together with other voltage sensitive channels, they control the time course of the response to bright light. Conversely, HCN2 channels are mainly expressed on the dendrites of bipolar cells and affect the response to dim lights. Single cell recordings in HCN1(-/-) mice or during a pharmacological blockade of I-h show that, contrary to previous reports, I-kx alone is able to generate the fast initial transient in the rod bright flash response. Here we demonstrate that the relative contribution of I-h and I-kx to the rods' temporal tuning depends on the membrane potential. This is the first instance in which the light response of normal and HCN1- or HCN2-deficient mice is analyzed in single cells in retinal slice preparations and in integrated full field ERG responses from intact animals. This comparison reveals a high degree of correlation between single cell current clamp data and ERG measurements. A novel picture emerges showing that the temporal profile of the visual response to dim and bright luminance changes is separately determined by the coordinated gating of distinct voltage dependent conductances in photoreceptors and bipolar cells.	[Della Santina, Luca; Cangiano, Lorenzo; Caputo, Antonella] Univ Pisa, Dept Physiol Sci, Pisa, Italy; [Piano, Ilaria] GB Bietti Fdn Ophthalmol, Rome, Italy; [Ludwig, Andreas] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany; [Cervetto, Luigi; Gargini, Claudia] Univ Pisa, Dept Psychiat & Neurobiol, Pisa, Italy	University of Pisa; IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia; University of Erlangen Nuremberg; University of Pisa	Della Santina, L (corresponding author), Univ Pisa, Dept Physiol Sci, Pisa, Italy.	gargini@farm.unipi.it	Cangiano, Lorenzo/F-1482-2019; Della Santina, Luca/J-9795-2016	Cangiano, Lorenzo/0000-0001-7145-1288; Della Santina, Luca/0000-0001-6036-1295; GARGINI, MARIA CLAUDIA/0000-0002-4992-9086; piano, ilaria/0000-0002-5073-7583	Italian Ministry of Research, Research Programme of National Relevance (PRIN), Ministery of Public Instruction of the University and Scientific Research (MIUR)	Italian Ministry of Research, Research Programme of National Relevance (PRIN), Ministery of Public Instruction of the University and Scientific Research (MIUR)	Financial support was provided by the Italian Ministry of Research, Research Programme of National Relevance (PRIN), Ministery of Public Instruction of the University and Scientific Research (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTWELL D, 1980, J PHYSIOL-LONDON, V309, P287, DOI 10.1113/jphysiol.1980.sp013509; BARNES S, 1989, J GEN PHYSIOL, V94, P719, DOI 10.1085/jgp.94.4.719; Barrow AJ, 2009, J NEUROSCI, V29, P5841, DOI 10.1523/JNEUROSCI.5746-08.2009; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; BAYLOR DA, 1984, J PHYSIOL-LONDON, V354, P203, DOI 10.1113/jphysiol.1984.sp015372; BEECH DJ, 1989, NEURON, V3, P573, DOI 10.1016/0896-6273(89)90267-5; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; BRETON ME, 1994, INVEST OPHTH VIS SCI, V35, P295; Cangiano L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001327; Chen XD, 2009, J NEUROPHYSIOL, V101, P129, DOI 10.1152/jn.01352.2007; Della Santina L, 2010, INVEST OPHTH VIS SCI, V51, P1016, DOI 10.1167/iovs.09-3680; Demontis GC, 2002, NEWS PHYSIOL SCI, V17, P110, DOI 10.1152/nips.01364.2001; Demontis GC, 2005, J NEUROSCI METH, V146, P13, DOI 10.1016/j.jneumeth.2005.01.007; Demontis GC, 1999, J PHYSIOL-LONDON, V515, P813, DOI 10.1111/j.1469-7793.1999.813ab.x; Demontis GC, 2009, INVEST OPHTH VIS SCI, V50, P1948, DOI 10.1167/iovs.08-2659; DETWILER PB, 1980, J PHYSIOL-LONDON, V300, P213, DOI 10.1113/jphysiol.1980.sp013159; FAIN GL, 1978, NATURE, V272, P467, DOI 10.1038/272467a0; Fyk-Kolodziej B, 2007, J COMP NEUROL, V501, P891, DOI 10.1002/cne.21287; Gargini C, 1999, VISION RES, V39, P1759, DOI 10.1016/S0042-6989(98)00281-8; HESTRIN S, 1987, J PHYSIOL-LONDON, V390, P319, DOI 10.1113/jphysiol.1987.sp016703; Kawai F, 2002, BRAIN RES, V943, P48, DOI 10.1016/S0006-8993(02)02531-3; Knop GC, 2008, EUR J NEUROSCI, V28, P2221, DOI 10.1111/j.1460-9568.2008.06512.x; Lauritzen I, 2003, J BIOL CHEM, V278, P32068, DOI 10.1074/jbc.M302631200; Liu XD, 2004, ANN BIOMED ENG, V32, P1428, DOI 10.1114/B:ABME.0000042230.99614.8d; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; MARICQ AV, 1990, J NEUROPHYSIOL, V64, P1917, DOI 10.1152/jn.1990.64.6.1917; Muller F, 2003, EUR J NEUROSCI, V17, P2084, DOI 10.1046/j.1460-9568.2003.02634.x; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; OWEN WG, 1983, BIOPHYS J, V41, P325, DOI 10.1016/S0006-3495(83)84444-0; PUIL E, 1986, J NEUROPHYSIOL, V55, P995, DOI 10.1152/jn.1986.55.5.995; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; TORRE V, 1983, BIOPHYS J, V41, P305, DOI 10.1016/S0006-3495(83)84443-9	33	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29812	10.1371/journal.pone.0029812	http://dx.doi.org/10.1371/journal.pone.0029812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279546	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900024
J	Li, H; Wang, JX; Wu, DD; Wang, HW; Tang, NLS; Zhang, YP				Li, Hui; Wang, Jia-Xin; Wu, Dong-Dong; Wang, Hua-Wei; Tang, Nelson Leung-Sang; Zhang, Ya-Ping			The Origin and Evolution of Variable Number Tandem Repeat of CLEC4M Gene in the Global Human Population	PLOS ONE			English	Article							HEPATITIS-C VIRUS; DC-SIGNR GENE; HIV-1 SUSCEPTIBILITY; REGION POLYMORPHISMS; ENDOTHELIAL-CELLS; NECK-REGION; INFECTION; NONINTEGRIN; RECEPTORS; DIVERSITY	CLEC4M is a C-type lectin gene serving as cell adhesion receptor and pathogen recognition receptor. It recognizes several pathogens of important public health concern. In particular, a highly polymorphic variable number tandem repeat (VNTR) at the neck-region of CLEC4M had been associated with genetic predisposition to some infectious diseases. To gain insight into the origin and evolution of this VNTR in CLEC4M, we studied 21 Africans, 20 Middle Easterns, 35 Europeans, 38 Asians, 13 Oceania, and 18 Americans (a total of 290 chromosomes) from the (Human Genome Diversity Panel) HGDP-CEPH panel; these samples covered most of alleles of this VNTR locus present in human populations. We identified a limited number of haplotypes among the basic repeat subunits that is 69 base pairs in length. Only 8 haplotypes were found. Their sequence identities were determined in the 290 chromosomes. VNTR alleles of different repeat length (from 4 to 9 repeats) were analyzed for composition and orientation of these subunits. Our results showed that the subunit configuration of the same repeat number of VNTR locus from different populations were, in fact, virtually identical. It implies that most of the VNTR alleles existed before dispersion of modern humans outside Africa. Further analyses indicate that the present diversity profile of this locus in worldwide populations is generated from the effect of migration of different tribes and neutral evolution. Our findings do not support the hypothesis that the origin of the VNTR alleles were arisen by independent (separate) mutation events and caused by differential allele advantage and natural selection as suggested by previous report based on SNP data.	[Li, Hui] Southeast Univ, Sch Med, Dept Genet & Dev Biol, Nanjing, Jiangsu, Peoples R China; [Li, Hui] Southeast Univ, Key Lab Dev Genes & Human Dis, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Li, Hui; Wu, Dong-Dong; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Wang, Jia-Xin; Wang, Hua-Wei; Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming, Peoples R China; [Wang, Jia-Xin; Wang, Hua-Wei; Zhang, Ya-Ping] Yunnan Univ, Key Lab Microbial Resources, Ministery Educ, Kunming, Peoples R China; [Wu, Dong-Dong; Tang, Nelson Leung-Sang; Zhang, Ya-Ping] KIZ CUHK Joint Lab Bioresources & Mol Res Common, Kunming, Peoples R China; [Tang, Nelson Leung-Sang] Chinese Univ Hong Kong, Dept Chem Pathol, Fac Med, Shatin, Hong Kong, Peoples R China; [Tang, Nelson Leung-Sang] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Tang, Nelson Leung-Sang] Chinese Univ Hong Kong, Shenzhen Res Inst, Funct Genom & Biostat Comp Lab, Shatin, Hong Kong, Peoples R China	Southeast University - China; Southeast University - China; Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Yunnan University; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Li, H (corresponding author), Southeast Univ, Sch Med, Dept Genet & Dev Biol, Nanjing, Jiangsu, Peoples R China.	nelsontang@cuhk.edu.hk; zhangyp1@263.net.cn	Tang, Nelson L/P-5018-2017; Wu, Dong-Dong/AAR-5615-2020	Tang, Nelson L/0000-0002-3607-5819; 	Science and Technology Committee of Yunnan Province; National Natural Science Foundation of China [31000955]	Science and Technology Committee of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Science and Technology Committee of Yunnan Province, and the National Natural Science Foundation of China (31000955). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Barreiro LB, 2005, AM J HUM GENET, V77, P869, DOI 10.1086/497613; Barreiro LB, 2007, HUM IMMUNOL, V68, P106, DOI 10.1016/j.humimm.2006.10.020; Barreiro LB, 2006, J INFECT DIS, V194, P1184, DOI 10.1086/507845; Bashirova AA, 2003, J VIROL, V77, P217, DOI 10.1128/JVI.77.1.217-227.2003; Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Boily-Larouche G, 2007, HUM IMMUNOL, V68, P523, DOI 10.1016/j.humimm.2007.02.002; Cann HM, 2002, SCIENCE, V296, P261; Chan VSF, 2006, NAT GENET, V38, P38, DOI 10.1038/ng1698; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Gardner JP, 2003, P NATL ACAD SCI USA, V100, P4498, DOI 10.1073/pnas.0831128100; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Li H, 2008, J MED GENET, V45, P752, DOI 10.1136/jmg.2008.058966; Lichterfeld M, 2003, CLIN IMMUNOL, V107, P55, DOI 10.1016/S1521-6616(02)00050-5; Liu HL, 2006, J INFECT DIS, V193, P698, DOI 10.1086/499820; Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200; Nattermann J, 2006, J VIRAL HEPATITIS, V13, P42, DOI 10.1111/j.1365-2893.2005.00652.x; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Soilleux EJ, 2003, CLIN SCI, V104, P437, DOI 10.1042/CS20020092; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Tang NLS, 2007, NAT GENET, V39, P690, DOI 10.1038/ng0607-692; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Weiss K M, 1997, Houst Law Rev, V33, P1431	25	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30268	10.1371/journal.pone.0030268	http://dx.doi.org/10.1371/journal.pone.0030268			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279577	gold, Green Submitted, Green Published			2022-12-27	WOS:000299771900054
J	Seeliger, JC; Topp, S; Sogi, KM; Previti, ML; Gallivan, JP; Bertozzi, CR				Seeliger, Jessica C.; Topp, Shana; Sogi, Kimberly M.; Previti, Mary L.; Gallivan, Justin P.; Bertozzi, Carolyn R.			A Riboswitch-Based Inducible Gene Expression System for Mycobacteria	PLOS ONE			English	Article							TUBERCULOSIS	Research on the human pathogen Mycobacterium tuberculosis (Mtb) would benefit from novel tools for regulated gene expression. Here we describe the characterization and application of a synthetic riboswitch-based system, which comprises a mycobacterial promoter for transcriptional control and a riboswitch for translational control. The system was used to induce and repress heterologous protein overexpression reversibly, to create a conditional gene knockdown, and to control gene expression in a macrophage infection model. Unlike existing systems for controlling gene expression in Mtb, the riboswitch does not require the co-expression of any accessory proteins: all of the regulatory machinery is encoded by a short DNA segment directly upstream of the target gene. The inducible riboswitch platform has the potential to be a powerful general strategy for creating customized gene regulation systems in Mtb.	[Seeliger, Jessica C.; Previti, Mary L.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Topp, Shana; Sogi, Kimberly M.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Gallivan, Justin P.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Gallivan, Justin P.] Emory Univ, Ctr Fundamental & Appl Mol Evolut, Atlanta, GA 30322 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Emory University; Emory University	Seeliger, JC (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	crb@berkeley.edu	Seeliger, Jessica/J-3344-2014	Seeliger, Jessica/0000-0001-7148-1073	Cancer Research Institute; National Institutes of Health [AI51622, GM074070]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051622, R37AI051622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074070] Funding Source: NIH RePORTER	Cancer Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ST was supported in part by a postdoctoral fellowship from the Cancer Research Institute (http://www.cancerresearch.org/). This work was funded by National Institutes of Health (http://www.nih.gov/) grants AI51622 (to CRB) and GM074070 (to JPG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Boldrin F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq235; Brown AC, 2006, PLASMID, V55, P81, DOI 10.1016/j.plasmid.2005.06.005; Carroll P, 2005, APPL ENVIRON MICROB, V71, P3077, DOI 10.1128/AEM.71.6.3077-3084.2005; Carroll P, 2007, FEMS MICROBIOL LETT, V274, P73, DOI 10.1111/j.1574-6968.2007.00842.x; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Hernandez-Abanto SM, 2006, ARCH MICROBIOL, V186, P459, DOI 10.1007/s00203-006-0160-2; Hillmann D, 2007, J BACTERIOL, V189, P958, DOI 10.1128/JB.01474-06; Hinds J, 1999, MICROBIOL-UK, V145, P519, DOI 10.1099/13500872-145-3-519; Judson N, 2000, TRENDS MICROBIOL, V8, P521, DOI 10.1016/S0966-842X(00)01865-5; Kaur P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005923; Klotzsche M, 2009, NUCLEIC ACIDS RES, V37, P1778, DOI 10.1093/nar/gkp015; Miesel L, 2003, NAT REV GENET, V4, P442, DOI 10.1038/nrg1086; P Balbas, 2004, RECOMBINANT GENE EXP, P494; Pandey AK, 2009, TUBERCULOSIS, V89, P12, DOI 10.1016/j.tube.2008.07.007; Parish T, 1997, MICROBIOL-UK, V143, P2267, DOI 10.1099/00221287-143-7-2267; Parish T, 1997, FEMS MICROBIOL LETT, V154, P151, DOI 10.1016/S0378-1097(97)00317-0; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Sassetti Christopher M., 2008, V465, P255, DOI 10.1007/978-1-59745-207-6_17; Slayden RA, 2000, MICROBES INFECT, V2, P659, DOI 10.1016/S1286-4579(00)00359-2; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Topp S, 2010, APPL ENVIRON MICROB, V76, P7881, DOI 10.1128/AEM.01537-10; Triccas JA, 1998, FEMS MICROBIOL LETT, V167, P151, DOI 10.1111/j.1574-6968.1998.tb13221.x; van Kessel JC, 2008, NAT REV MICROBIOL, V6, P851, DOI 10.1038/nrmicro2014; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139	28	42	44	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29266	10.1371/journal.pone.0029266	http://dx.doi.org/10.1371/journal.pone.0029266			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279533	gold, Green Submitted, Green Published			2022-12-27	WOS:000299771900011
J	Xie, XQ; Li, F; Ying, SH; Feng, MG				Xie, Xue-Qin; Li, Fang; Ying, Sheng-Hua; Feng, Ming-Guang			Additive Contributions of Two Manganese-Cored Superoxide Dismutases (MnSODs) to Antioxidation, UV Tolerance and Virulence of Beauveria bassiana	PLOS ONE			English	Article							CANDIDA-ALBICANS; CRYPTOCOCCUS-NEOFORMANS; AGROBACTERIUM-TUMEFACIENS; TRANSFORMATION SYSTEM; NEUROSPORA-CRASSA; GENE; STRESS; CONIDIATION; EXPRESSION; SEQUENCES	The biocontrol potential of entomopathogenic fungi against arthropod pests depends on not only their virulence to target pests but tolerance to outdoor high temperature and solar UV irradiation. Two Beauveria bassiana superoxide dismutases (SODs), BbSod2 and BbSod3, were characterized as cytosolic and mitochondrial manganese-cored isoenzymes (MnSODs) dominating the total SOD activity of the fungal entomopathogen under normal growth conditions. To probe their effects on the biocontrol potential of B. bassiana, Delta BbSod2, Delta BbSod3, and three hairpin RNA-interfered (RNAi) mutants with the transcripts of both BbSod2 and BbSod3 being suppressed by 91-97% were constructed and assayed for various phenotypic parameters in conjunction with Delta BbSod2/BbSod2, Delta BbSod3/BbSod3 and wild-type (control strains). In normal cultures, the knockout and RNAi mutants showed significant phenotypic alterations, including delayed sporulation, reduced conidial yields, and impaired conidial quality, but little change in colony morphology. Their mycelia or conidia became much more sensitive to menadione or H2O2-induced oxidative stress but had little change in sensitivity to the hyperosmolarity of NaCl and the high temperature of 45 degrees C. Accompanied with the decreased antioxidative capability, conidial tolerances to UV-A and UV-B irradiations were reduced by 16.8% and 45.4% for Delta BbSod2, 18.7% and 44.7% for Delta BbSod3, and,33.7% and,63.8% for the RNAi mutants, respectively. Their median lethal times (LT(50)s) against Myzus persicae apterae, which were topically inoculated under a standardized spray, were delayed by 18.8%, 14.5% and 37.1%, respectively. Remarkably, the effects of cytosolic BbSod2 and mitochondrial BbSod3 on the phenotypic parameters important for the fungal bioncontrol potential were additive, well in accordance with the decreased SOD activities and the increased superoxide levels in the knockout and RNAi mutants. Our findings highlight for the first time that the two MnSODs co-contribute to the biocontrol potential of B. bassiana by mediating cellular antioxidative response.	[Xie, Xue-Qin; Li, Fang; Ying, Sheng-Hua; Feng, Ming-Guang] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Xie, XQ (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	mgfeng@zju.edu.cn			Natural Science Foundation of China [30930018, 31021033]; Ministry of Science and Technology [2009CB118904, 2011AA10A204]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by the Natural Science Foundation of China (Grant Nos.: 30930018 and 31021033) and the Ministry of Science and Technology (Grant Nos.: 2009CB118904 and 2011AA10A204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba S, 2009, MOL PLANT MICROBE IN, V22, P1412, DOI 10.1094/MPMI-22-11-1412; Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; BANNISTER JV, 1987, CRC CR REV BIOCH MOL, V22, P111, DOI 10.3109/10409238709083738; Belozerskaya TA, 2006, MICROBIOLOGY+, V75, P427, DOI 10.1134/S0026261706040102; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Duarte RTD, 2007, LETT APPL MICROBIOL, V44, P248, DOI 10.1111/j.1472-765X.2006.02092.x; Dziadkowiec D, 2007, FOLIA MICROBIOL, V52, P120, DOI 10.1007/BF02932150; Fang GC, 2002, FUNGAL GENET BIOL, V36, P155, DOI 10.1016/S1087-1845(02)00008-7; Fang WG, 2006, CAN J MICROBIOL, V52, P623, DOI 10.1139/W06-014; FENG MG, 1994, BIOCONTROL SCI TECHN, V127, P3; Frealle E, 2006, MOL PHYLOGENET EVOL, V41, P28, DOI 10.1016/j.ympev.2006.05.001; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; Giles SS, 2005, EUKARYOT CELL, V4, P46, DOI 10.1128/EC.4.1.46-54.2005; Hwang CS, 2003, YEAST, V20, P929, DOI 10.1002/yea.1004; Hwang CS, 2002, MICROBIOL-SGM, V148, P3705, DOI 10.1099/00221287-148-11-3705; Jeong JH, 2001, BIOCHEM BIOPH RES CO, V283, P908, DOI 10.1006/bbrc.2001.4853; Karlsson M, 2005, PHYSIOL MOL PLANT P, V66, P99, DOI 10.1016/j.pmpp.2005.05.004; Khang CH, 2005, FUNGAL GENET BIOL, V42, P483, DOI 10.1016/j.fgb.2005.03.004; Lamarre C, 2001, J BIOL CHEM, V276, P43784, DOI 10.1074/jbc.M108095200; Lambou K, 2010, MOL MICROBIOL, V75, P910, DOI 10.1111/j.1365-2958.2009.07024.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu P, 2006, FEMS MICROBIOL LETT, V261, P224, DOI 10.1111/j.1574-6968.2006.00367.x; MARKLUND S, 1974, EUR J BIOCHEM, V47, P248; Moore S, 2002, MOL PLANT PATHOL, V3, P9, DOI 10.1046/j.1464-6722.2001.00088.x; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Narasipura SD, 2005, MOL MICROBIOL, V55, P1782, DOI 10.1111/j.1365-2958.2005.04503.x; PARKER MW, 1988, FEBS LETT, V229, P377, DOI 10.1016/0014-5793(88)81160-8; PFANNER N, 1990, ANNU REV BIOCHEM, V59, P331, DOI 10.1146/annurev.bi.59.070190.001555; Scott B, 2008, CURR OPIN MICROBIOL, V11, P488, DOI 10.1016/j.mib.2008.10.008; Wintjens R, 2004, J BIOL CHEM, V279, P9248, DOI 10.1074/jbc.M312329200; Xie XQ, 2010, APPL MICROBIOL BIOT, V86, P1543, DOI 10.1007/s00253-010-2437-2; Xie XQ, 2010, ENZYME MICROB TECH, V46, P217, DOI 10.1016/j.enzmictec.2009.09.005; Yao SL, 2010, BIOCONTROL, V55, P413, DOI 10.1007/s10526-009-9265-2; Ye SD, 2005, ANN APPL BIOL, V146, P459, DOI 10.1111/j.1744-7348.2005.040147.x; Ying SH, 2006, APPL MICROBIOL BIOT, V72, P206, DOI 10.1007/s00253-006-0447-x; Yoshida Y, 2008, MOL GENET GENOMICS, V279, P193, DOI 10.1007/s00438-007-0308-z; Zhang SZ, 2010, APPL MICROBIOL BIOT, V87, P1151, DOI 10.1007/s00253-010-2636-x; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	41	145	151	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30298	10.1371/journal.pone.0030298	http://dx.doi.org/10.1371/journal.pone.0030298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279579	Green Submitted, Green Published, gold			2022-12-27	WOS:000299771900056
J	Xiao, CX; He, MH; Nan, Y; Zhang, DJ; Chen, BY; Guan, YF; Pu, ML				Xiao, Chunxia; He, Meihua; Nan, Yan; Zhang, Dongjuan; Chen, Baiyu; Guan, Youfei; Pu, Mingliang			Physiological Effects of Superoxide Dismutase on Altered Visual Function of Retinal Ganglion Cells in db/db Mice	PLOS ONE			English	Article							OXIDATIVE STRESS; MITOCHONDRIAL SUPEROXIDE; DIABETIC-RETINOPATHY; RESPONSE PROPERTIES; BARRIER BREAKDOWN; ABNORMALITIES; APOPTOSIS; DYSFUNCTION; DEATH; RAT	Background: The C57BLKS/J db/db (db/db) mouse is a widely used type 2 diabetic animal model, and this model develops early inner retinal neuronal dysfunction beginning at 24 weeks. The neural mechanisms that mediate early stage retinal dysfunction in this model are unknown. We evaluated visual response properties of retinal ganglion cells (RGCs) during the early stage of diabetic insult (8, 12, and 20 wk) in db/db mice and determined if increased oxidative stress plays a role in impaired visual functions of RGCs in 20 wk old db/db mice. Methodology/Principal Findings: In vitro extracellular single-unit recordings from RGCs in wholemount retinas were performed. The receptive field size, luminance threshold, and contrast gain of the RGCs were investigated. Although ON- and OFF-RGCs showed a different time course of RF size reduction, by 20 wk, the RF of ON-and OFF-RGCs were similarly affected. The LT of ON-RGCs was significantly elevated in 12 and 20 wk db/db mice compared to the LT of OFF-RGCs. The diabetic injury also affected contrast gains of ON-and OFF-RGCs differently. The generation of reactive oxidative species (ROS) in fresh retina was estimated by dihydroethidium. Superoxide dismutase (SOD) (300 unit/ml) was applied in Ames medium to the retina, and visual responses of RGCs were recorded for five hours. ROS generation in the retinas of db/db mice increased at 8wk and continued to progress at 20 wk of ages. In vitro application of SOD improved visual functions in 20 wk db/db mice but the SOD treatment affected ON-and OFF-RGCs differently in db/m retina. Conclusions/Significance: The altered visual functions of RGCs were characterized by the reduced RF center size, elevated LT, and attenuated contrast gain in 12 and 20 wk db/db mice, respectively. These altered visual functions could, at least partly, be due to oxidative stress since in vitro application of SOD effectively improves visual functions.	[Xiao, Chunxia; He, Meihua; Nan, Yan; Chen, Baiyu; Pu, Mingliang] Peking Univ, Dept Anat, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Xiao, Chunxia; He, Meihua; Nan, Yan; Chen, Baiyu; Pu, Mingliang] Peking Univ, Key Lab Machine Percept, Beijing 100871, Peoples R China; [Xiao, Chunxia; He, Meihua; Nan, Yan; Pu, Mingliang] Peking Univ, Key Lab Visual Impairment & Restore, Beijing 100871, Peoples R China; [Zhang, Dongjuan; Guan, Youfei] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Xiao, CX (corresponding author), Peking Univ, Dept Anat, Sch Basic Med Sci, Beijing 100871, Peoples R China.	youfeiguan@bjmu.edu.cn; mpu@hsc.pku.edu.cn	He, Meihua/D-4312-2017	guan, youfei/0000-0002-5231-0209	National Science Foundation of China [30831160516, 30890041]; National Basic Research Program of China (973 Program) [2009CB320900, 2011CB510206, 2010CB912503]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by National Science Foundation of China grants (30831160516 to M. Pu and 30890041 to Y. Guan); National Basic Research Program of China (973 Program) (2009CB320900 and 2011CB510206 to M. Pu and 2010CB912503 to Y. Guan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho P, 1997, FASEB J, V11, P154, DOI 10.1096/fasebj.11.2.9039958; Al-Gayyar MMH, 2011, DIABETOLOGIA, V54, P657; Ali TK, 2011, DIABETOLOGIA, V54, P657, DOI 10.1007/s00125-010-1935-1; Ali TK, 2008, DIABETES, V57, P889, DOI 10.2337/db07-1669; AYLWARD GW, 1989, EYE, V3, P626, DOI 10.1038/eye.1989.97; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Barile GR, 2005, INVEST OPHTH VIS SCI, V46, P2916, DOI 10.1167/iovs.04-1409; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; BRESNICK GH, 1987, ARCH OPHTHALMOL-CHIC, V105, P810; BRESNICK GH, 1986, ARCH OPHTHALMOL-CHIC, V104, P989; Bui BV, 2009, EXP EYE RES, V88, P1076, DOI 10.1016/j.exer.2009.01.009; Bui BV, 2003, DIABETOLOGIA, V46, P401, DOI 10.1007/s00125-003-1042-7; Cheung AKH, 2005, DIABETES, V54, P3119, DOI 10.2337/diabetes.54.11.3119; Davies N, 2003, VISION RES, V43, P2377, DOI 10.1016/S0042-6989(03)00405-X; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; El-Remessy AB, 2006, AM J PATHOL, V168, P235, DOI 10.2353/ajpath.2006.050500; El-Remessy AB, 2010, EXP DIABETES RES, DOI 10.1155/2010/247861; Ewing FME, 1998, ENDOCR REV, V19, P462, DOI 10.1210/er.19.4.462; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Fukuda M, 2011, EXP EYE RES, V92, P195, DOI 10.1016/j.exer.2011.01.001; Gastinger MJ, 2008, INVEST OPHTH VIS SCI, V49, P2635, DOI 10.1167/iovs.07-0683; Gastinger MJ, 2006, INVEST OPHTH VIS SCI, V47, P3143, DOI 10.1167/iovs.05-1376; GREENSTEIN VC, 1993, OPTOMETRY VISION SCI, V70, P18, DOI 10.1097/00006324-199301000-00005; Han Y, 2004, INVEST OPHTH VIS SCI, V45, P948, DOI 10.1167/iovs.03-1101; Kanamori A, 2010, BRAIN, V133, P2612, DOI 10.1093/brain/awq105; Kern TS, 2008, J PHYSIOL-LONDON, V586, P4401, DOI 10.1113/jphysiol.2008.156695; KODAMA H, 1994, DIABETOLOGIA, V37, P739, DOI 10.1007/s001250050173; Kohzaki K, 2008, INVEST OPHTH VIS SCI, V49, P3595, DOI 10.1167/iovs.08-1679; Kowluru RA, 1997, FREE RADICAL BIO MED, V22, P587, DOI 10.1016/S0891-5849(96)00347-4; Li JM, 2010, DIABETES, V59, P1528, DOI 10.2337/db09-1057; Li WY, 1999, CELL MOL BIOL, V45, P59; Lieven CJ, 2006, INVEST OPHTH VIS SCI, V47, P1477, DOI 10.1167/iovs.05-0921; Maher P, 2005, INVEST OPHTH VIS SCI, V46, P749, DOI 10.1167/iovs.04-0883; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Nan Y, 2010, INVEST OPHTH VIS SCI, V51, P1208, DOI 10.1167/iovs.09-4179; Ng YK, 2004, BRAIN RES, V1018, P66, DOI 10.1016/j.brainres.2004.05.055; Ning X, 2004, INT J MOL MED, V13, P87; O'Connor JC, 2008, INVEST OPHTH VIS SCI, V49, P4237, DOI 10.1167/iovs.08-1963; Park SH, 2003, DIABETOLOGIA, V46, P1260, DOI 10.1007/s00125-003-1177-6; Peshavariya HM, 2007, FREE RADICAL RES, V41, P699, DOI 10.1080/10715760701297354; Phipps JA, 2006, INVEST OPHTH VIS SCI, V47, P3187, DOI 10.1167/iovs.05-1493; Pu ML, 2006, INVEST OPHTH VIS SCI, V47, P3579, DOI 10.1167/iovs.05-1450; Qi XP, 2003, INVEST OPHTH VIS SCI, V44, P1088, DOI 10.1167/iovs.02-0864; Qin YW, 2006, CURR EYE RES, V31, P967, DOI 10.1080/02713680600987674; Sagdullaev BT, 2005, VISUAL NEUROSCI, V22, P649, DOI 10.1017/S0952523805225142; Seki M, 2004, DIABETES, V53, P2412, DOI 10.2337/diabetes.53.9.2412; Semkova I, 2010, EXP EYE RES, V90, P244, DOI 10.1016/j.exer.2009.10.012; SOKOL S, 1985, ARCH OPHTHALMOL-CHIC, V103, P51; Sugimoto M, 2005, OPHTHALMOLOGICA, V219, P379, DOI 10.1159/000088382; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Tang L, 2011, EXP BIOL MED, V236, P1051, DOI 10.1258/ebm.2011.010400; Tzekov R, 1999, SURV OPHTHALMOL, V44, P53, DOI 10.1016/S0039-6257(99)00063-6; Vielma A, 2010, EXP EYE RES, V91, P700, DOI 10.1016/j.exer.2010.08.014	54	28	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30343	10.1371/journal.pone.0030343	http://dx.doi.org/10.1371/journal.pone.0030343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272340	Green Published, gold, Green Submitted			2022-12-27	WOS:000301454400118
J	Bolanos, JMG; Moran, AM; da Silva, CMB; Rodriguez, AM; Davila, MP; Aparicio, IM; Tapia, JA; Ferrusola, CO; Pena, FJ				Gallardo Bolanos, Juan M.; Miro Moran, Alvaro; Balao da Silva, Carolina M.; Morillo Rodriguez, Antolin; Plaza Davila, Maria; Aparicio, Ines M.; Tapia, Jose A.; Ortega Ferrusola, Cristina; Pena, Fernando J.			Autophagy and Apoptosis Have a Role in the Survival or Death of Stallion Spermatozoa during Conservation in Refrigeration	PLOS ONE			English	Article							SPERM MEMBRANE INTEGRITY; FIND-ME SIGNAL; CELL-DEATH; LIPID-PEROXIDATION; BOAR SPERMATOZOA; COLD SHOCK; CRYOPRESERVATION PROCESS; SEMEN TECHNOLOGIES; CASPASE ACTIVATION; SINGLE-LAYER	Apoptosis has been recognized as a cause of sperm death during cryopreservation and a cause of infertility in humans, however there is no data on its role in sperm death during conservation in refrigeration; autophagy has not been described to date in mature sperm. We investigated the role of apoptosis and autophagy during cooled storage of stallion spermatozoa. Samples from seven stallions were split; half of the ejaculate was processed by single layer centrifugation, while the other half was extended unprocessed, and stored at 5 degrees C for five days. During the time of storage, sperm motility (CASA, daily) and membrane integrity (flow cytometry, daily) were evaluated. Apoptosis was evaluated on days 1, 3 and 5 (active caspase 3, increase in membrane permeability, phosphatidylserine translocation and mitochondrial membrane potential) using flow cytometry. Furthermore, LC3B processing was investigated by western blotting at the beginning and at the end of the period of storage. The decrease in sperm quality over the period of storage was to a large extent due to apoptosis; single layer centrifugation selected non-apoptotic spermatozoa, but there were no differences in sperm motility between selected and unselected sperm. A high percentage of spermatozoa showed active caspase 3 upon ejaculation, and during the period of storage there was an increase of apoptotic spermatozoa but no changes in the percentage of live sperm, revealed by the SYBR-14/PI assay, were observed. LC3B was differentially processed in sperm after single layer centrifugation compared with native sperm. In processed sperm more LC3B-II was present than in non-processed samples; furthermore, in non-processed sperm there was an increase in LC3B-II after five days of cooled storage. These results indicate that apoptosis plays a major role in the sperm death during storage in refrigeration and that autophagy plays a role in the survival of spermatozoa representing a new pro-survival mechanism in spermatozoa not previously described.	[Gallardo Bolanos, Juan M.; Balao da Silva, Carolina M.; Morillo Rodriguez, Antolin; Plaza Davila, Maria; Ortega Ferrusola, Cristina; Pena, Fernando J.] Univ Extremadura Caceres, Vet Teaching Hosp, Lab Equine Reprod & Equine Spermatol, Caceres, Spain; [Miro Moran, Alvaro; Aparicio, Ines M.; Tapia, Jose A.] Univ Extremadura Caceres, Fac Vet Med, Dept Physiol, Caceres, Spain	Universidad de Extremadura; Universidad de Extremadura	Bolanos, JMG (corresponding author), Univ Extremadura Caceres, Vet Teaching Hosp, Lab Equine Reprod & Equine Spermatol, Caceres, Spain.	fjuanpvega@unex.es	Peña, Fernando J/D-8450-2012; Tapia, Jose A./C-5181-2008; Aparicio, Ines/AAH-2781-2021; Aparicio, Ines Maria/L-5775-2014; Ortega-Ferrusola, Cristina/AGI-8478-2022	Peña, Fernando J/0000-0002-1311-2947; Tapia, Jose A./0000-0002-3614-6867; Aparicio, Ines/0000-0003-0023-853X; Ortega-Ferrusola, Cristina/0000-0002-7698-8735; PLAZA DAVILA, MARIA/0000-0002-8522-5879; Balao da Silva, Carolina Maria/0000-0002-9230-3919	Ministerio de Ciencia e Innovacion-FEDER in Madrid, Spain [AGL 2010-20758, BFU2011-30261]; Junta de Extremadura-FEDER [GR 10010, PCE1002]; Junta de Extremadura-FEDER JUEX REI [09013]	Ministerio de Ciencia e Innovacion-FEDER in Madrid, Spain; Junta de Extremadura-FEDER; Junta de Extremadura-FEDER JUEX REI	The authors received financial support for this study from Ministerio de Ciencia e Innovacion-FEDER in Madrid, Spain, Grant AGL 2010-20758 (GAN), BFU2011-30261 and Junta de Extremadura-FEDER (GR 10010 and PCE1002). IMA is supported by Junta de Extremadura-FEDER JUEX REI 09013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2011, REPRODUCTION, V141, P139, DOI 10.1530/REP-10-0232; Aitken RJ, 2011, ASIAN J ANDROL, V13, P36, DOI 10.1038/aja.2010.68; Anzar M, 2002, BIOL REPROD, V66, P354, DOI 10.1095/biolreprod66.2.354; da Silva CMB, 2011, J PINEAL RES, V51, P172, DOI 10.1111/j.1600-079X.2011.00873.x; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Brum AM, 2008, THERIOGENOLOGY, V69, P1041, DOI 10.1016/j.theriogenology.2008.01.014; Chantler E, 2000, CRYOBIOLOGY, V41, P125, DOI 10.1006/cryo.2000.2274; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; DROBNIS EZ, 1993, J EXP ZOOL, V265, P432, DOI 10.1002/jez.1402650413; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gonzalez-Fernandez L, 2009, BIOL REPROD, V80, P1239, DOI 10.1095/biolreprod.108.073486; Grunewald S, 2009, MICROSC RES TECHNIQ, V72, P878, DOI 10.1002/jemt.20732; HALANGK W, 1980, ACTA BIOL MED GER, V39, P791; Holt WV, 2011, MOL REPROD DEV, V78, P464, DOI 10.1002/mrd.21347; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; Johannisson A, 2009, ANIM REPROD SCI, V116, P119, DOI 10.1016/j.anireprosci.2009.01.008; Koppers AJ, 2011, BIOCHEM J, V436, P687, DOI 10.1042/BJ20110114; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Garcia BM, 2009, ANIM REPROD SCI, V114, P193, DOI 10.1016/j.anireprosci.2008.08.025; Garcia BM, 2009, REPROD DOMEST ANIM, V44, P523, DOI 10.1111/j.1439-0531.2008.01276.x; Martin G, 2007, HUM REPROD, V22, P380, DOI 10.1093/humrep/del399; Martin G, 2004, BIOL REPROD, V71, P28, DOI 10.1095/biolreprod.103.024281; MORAN DM, 1992, THERIOGENOLOGY, V38, P999, DOI 10.1016/0093-691X(92)90114-7; Moran JM, 2008, THERIOGENOLOGY, V70, P91, DOI 10.1016/j.theriogenology.2008.02.010; Morrell JM, 2010, EQUINE VET J, V42, P579, DOI 10.1111/j.2042-3306.2010.00101.x; Martinez IN, 2006, J ANDROL, V27, P596, DOI 10.2164/jandrol.05153; Nunez-Martinez I, 2007, INT J ANDROL, V30, P182, DOI 10.1111/j.1365-2605.2007.00743.x; Ferrusola CO, 2009, BIOL REPROD, V81, P1106, DOI 10.1095/biolreprod.109.078220; Ferrusola CO, 2009, REPRODUCTION, V138, P55, DOI [10.1530/REP-08-0484, 10.1530/RFP-08-0484]; Ortega-Ferrusola C, 2008, J ANDROL, V29, P213, DOI 10.2164/jandrol.107.003640; Ortega-Ferrusola C, 2009, ANIM REPROD SCI, V114, P393, DOI 10.1016/j.anireprosci.2008.10.005; Ortega-Ferrusola C, 2009, REPROD DOMEST ANIM, V44, P518, DOI 10.1111/j.1439-0531.2008.01267.x; Ortega-Ferrusola C, 2009, REPROD DOMEST ANIM, V44, P419, DOI 10.1111/j.1439-0531.2008.01097.x; Paasch U, 2004, FERTIL STERIL, V81, P802, DOI 10.1016/j.fertnstert.2003.09.030; Paasch U, 2004, BIOL REPROD, V71, P1828, DOI 10.1095/biolreprod.103.025627; Pena FJ, 2006, REPROD DOMEST ANIM, V41, P21, DOI 10.1111/j.1439-0531.2006.00766.x; Pena FJ, 2007, ANIM REPROD SCI, V97, P74, DOI 10.1016/j.anireprosci.2005.12.014; Pena FJ, 2009, REPROD DOMEST ANIM, V44, P345, DOI 10.1111/j.1439-0531.2008.01211.x; Pena FJ, 2005, INT J ANDROL, V28, P107, DOI 10.1111/j.1365-2605.2005.00512.x; Pena FJ, 2003, ANIM REPROD SCI, V78, P85, DOI 10.1016/S0378-4320(03)00049-6; Pena FJ, 2003, THERIOGENOLOGY, V60, P677, DOI 10.1016/S0093-691X(03)00081-5; Peter AT, 2003, THERIOGENOLOGY, V59, P1525, DOI 10.1016/S0093-691X(02)01206-2; Petrunkina AM, 2010, THERIOGENOLOGY, V73, P995, DOI 10.1016/j.theriogenology.2009.12.006; Pujianto DA, 2010, ENDOCRINOLOGY, V151, P1269, DOI 10.1210/en.2009-0964; Purdy PH, 2010, THERIOGENOLOGY, V74, P1304, DOI 10.1016/j.theriogenology.2010.04.030; Rigby SL, 2001, ANIM REPROD SCI, V68, P171, DOI 10.1016/S0378-4320(01)00154-3; Said TM, 2010, REPROD BIOMED ONLINE, V21, P456, DOI 10.1016/j.rbmo.2010.05.011; Sakkas Denny, 2003, Reprod Biomed Online, V7, P428; WHITE IG, 1993, REPROD FERT DEVELOP, V5, P639, DOI 10.1071/RD9930639; WINDSOR DP, 1993, J REPROD FERTIL, V99, P359, DOI 10.1530/jrf.0.0990359; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yu L, 2004, CELL CYCLE, V3, P1124; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2008, AUTOPHAGY, V4, P567, DOI 10.4161/auto.5902; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	58	65	65	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30688	10.1371/journal.pone.0030688	http://dx.doi.org/10.1371/journal.pone.0030688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292020	Green Published, Green Submitted, gold			2022-12-27	WOS:000301703800025
J	Garcia-Martinez, J; Adam, AL; Avalos, J				Garcia-Martinez, Jorge; Adam, Attila L.; Avalos, Javier			Adenylyl Cyclase Plays a Regulatory Role in Development, Stress Resistance and Secondary Metabolism in Fusarium fujikuroi	PLOS ONE			English	Article							GIBBERELLA-FUJIKUROI; CAROTENOID OXYGENASE; SIGNALING PATHWAYS; GENE; PROTEIN; BIOSYNTHESIS; VIRULENCE; PATHOGENICITY; BIKAVERIN; MUTANTS	The ascomycete fungus Fusarium fujikuroi (Gibberella fujikuroi MP-C) produces secondary metabolites of biotechnological interest, such as gibberellins, bikaverin, and carotenoids. Production of these metabolites is regulated by nitrogen availability and, in a specific manner, by other environmental signals, such as light in the case of the carotenoid pathway. A complex regulatory network controlling these processes is recently emerging from the alterations of metabolite production found through the mutation of different regulatory genes. Here we show the effect of the targeted mutation of the acyA gene of F. fujikuroi, coding for adenylyl cyclase. Mutants lacking the catalytic domain of the AcyA protein showed different phenotypic alterations, including reduced growth, enhanced production of unidentified red pigments, reduced production of gibberellins and partially derepressed carotenoid biosynthesis in the dark. The phenotype differs in some aspects from that of similar mutants of the close relatives F. proliferatum and F. verticillioides: contrary to what was observed in these species, DacyA mutants of F. fujikuroi showed enhanced sensitivity to oxidative stress (H2O2), but no change in heavy metal resistance or in the ability to colonize tomato tissue, indicating a high versatility in the regulatory roles played by cAMP in this fungal group.	[Garcia-Martinez, Jorge; Avalos, Javier] Univ Seville, Fac Biol, Dept Genet, Seville, Spain; [Adam, Attila L.] Szent Istvan Univ, Inst Plant Protect, Hungarian Acad Sci, Mycol Grp,Agr Biotechnol Ctr, Godollo, Hungary	University of Sevilla; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian University of Agriculture & Life Sciences	Garcia-Martinez, J (corresponding author), Univ Seville, Fac Biol, Dept Genet, Seville, Spain.	avalos@us.es	Avalos, Javier/B-4218-2011	Avalos, Javier/0000-0001-5484-2893	European Union; Spanish Government (Ministerio de Ciencia y Tecnologia) [BIO2006-01323, BIO2009-11131]; Acciones Integradas Hispano-Hungaras [HH2008-0004]; Andalusian Government [P07-CVI-02813]; Hungarian Government (National Research Council of Hungary) [OTKA K 76067, OMFB-00666/2009]; Office for Subsidized Research Units of the Hungarian Academy of Sciences	European Union(European Commission); Spanish Government (Ministerio de Ciencia y Tecnologia)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Acciones Integradas Hispano-Hungaras; Andalusian Government; Hungarian Government (National Research Council of Hungary); Office for Subsidized Research Units of the Hungarian Academy of Sciences	This work was supported by the European Union (European Regional Development Fund, ERDF), the Spanish Government (Ministerio de Ciencia y Tecnologia, projects BIO2006-01323 and BIO2009-11131; Acciones Integradas Hispano-Hungaras, project HH2008-0004), the Andalusian Government (project P07-CVI-02813) and the Hungarian Government (National Research Council of Hungary, grant OTKA K 76067 and Hungarian-Spanish Bilateral S and T project OMFB-00666/2009). We thank the support from the Office for Subsidized Research Units of the Hungarian Academy of Sciences (A.L.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 2002, EUKARYOT CELL, V1, P75, DOI 10.1128/EC.1.1.75-84.2002; Arrach N, 2002, MOL GENET GENOMICS, V266, P914, DOI 10.1007/s00438-001-0626-5; Avalos J, 2007, CURR ORG CHEM, V11, P721, DOI 10.2174/138527207780598729; AVALOS J, 1985, APPL ENVIRON MICROB, V49, P187, DOI 10.1128/AEM.49.1.187-191.1985; Avalos J., 1987, CURR GENET, V25, P1837, DOI DOI 10.1007/BF00384613; Avalos J, 2010, FUNGAL GENET BIOL, V47, P930, DOI 10.1016/j.fgb.2010.05.001; Bhalla K, 2010, ENVIRON MONIT ASSESS, V167, P515, DOI 10.1007/s10661-009-1068-5; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bodor AM, 2012, ACTA PHYTOP IN PRESS, V47; Britton G., 1998, CAROTENOIDS; Calvo AM, 2008, FUNGAL GENET BIOL, V45, P1053, DOI 10.1016/j.fgb.2008.03.014; CAPPELLINI RA, 1965, MYCOLOGIA, V57, P962, DOI 10.2307/3756895; Limon MC, 2010, APPL MICROBIOL BIOT, V87, P21, DOI 10.1007/s00253-010-2551-1; Casas-Flores S, 2006, EUKARYOT CELL, V5, P499, DOI 10.1128/EC.5.3.499-506.2006; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; Choi YE, 2010, MOL PLANT MICROBE IN, V23, P522, DOI 10.1094/MPMI-23-4-0522; CORNFORTH JW, 1971, J CHEM SOC C, P2786, DOI 10.1039/j39710002786; D'Souza CA, 2001, FEMS MICROBIOL REV, V25, P349, DOI 10.1111/j.1574-6976.2001.tb00582.x; Di Pietro A, 2001, MOL MICROBIOL, V39, P1140, DOI 10.1111/j.1365-2958.2001.02307.x; Diaz-Sanchez V, 2011, FEBS J, V278, P3164, DOI 10.1111/j.1742-4658.2011.08242.x; Domenech CE, 1996, EUR J BIOCHEM, V239, P720, DOI 10.1111/j.1432-1033.1996.0720u.x; Estrada AF, 2008, FUNGAL GENET BIOL, V45, P705, DOI 10.1016/j.fgb.2007.12.003; Feldbrugge M, 2004, CURR OPIN MICROBIOL, V7, P666, DOI 10.1016/j.mib.2004.10.006; GEISSMAN TA, 1966, PHYTOCHEMISTRY, V5, P933, DOI 10.1016/S0031-9422(00)82790-9; Giordano W, 1999, FEMS MICROBIOL LETT, V173, P389, DOI 10.1111/j.1574-6968.1999.tb13530.x; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Ikner A, 2005, MUTAT RES-FUND MOL M, V569, P13, DOI 10.1016/j.mrfmmm.2004.09.006; Ivey FD, 2002, EUKARYOT CELL, V1, P634, DOI 10.1128/EC.1.4.634-642.2002; Jain S, 2005, FEMS MICROBIOL LETT, V243, P165, DOI 10.1016/j.femsle.2004.12.009; Jain S, 2002, CURR GENET, V41, P407, DOI 10.1007/s00294-002-0322-y; Jurick WM, 2007, FUNGAL GENET BIOL, V44, P521, DOI 10.1016/j.fgb.2006.11.005; Klimpel A, 2002, MOL PLANT PATHOL, V3, P439, DOI 10.1046/j.1364-3703.2002.00137.x; Kohut G, 2010, J BASIC MICROB, V50, P59, DOI 10.1002/jobm.200900113; KOLAROVA N, 1992, FEMS MICROBIOL LETT, V93, P275, DOI 10.1016/0378-1097(92)90474-3; Liebmann B, 2004, INFECT IMMUN, V72, P5193, DOI 10.1128/IAI.72.9.5193-5203.2004; Linnemannstons P, 2002, FUNGAL GENET BIOL, V37, P134, DOI 10.1016/S1087-1845(02)00501-7; Lory S, 2004, INT J MED MICROBIOL, V293, P479, DOI 10.1078/1438-4221-00297; Michielse CB, 2009, MOL PLANT PATHOL, V10, P311, DOI [10.1111/J.1364-3703.2009.00538.X, 10.1111/j.1364-3703.2009.00538.x]; Mihlan M, 2003, MOL MICROBIOL, V47, P975, DOI 10.1046/j.1365-2958.2003.03326.x; Nagygyorgy ED, 2011, FUNGICIDES; Nikolaou E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-44; Oller-Lopez JL, 2003, APPL MICROBIOL BIOT, V63, P282, DOI 10.1007/s00253-003-1376-6; Ortoneda M, 2004, INFECT IMMUN, V72, P1760, DOI 10.1128/IAI.72.3.1760-1766.2004; Prado MM, 2004, CURR GENET, V46, P47, DOI 10.1007/s00294-004-0508-6; Prado-Cabrero A, 2007, EUKARYOT CELL, V6, P650, DOI 10.1128/EC.00392-06; Prado-Cabrero A, 2007, MOL MICROBIOL, V64, P448, DOI 10.1111/j.1365-2958.2007.05665.x; Proctor RH, 1997, MICROBIOL-SGM, V143, P2583, DOI 10.1099/00221287-143-8-2583; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Rademacher W., 1997, FUNGAL BIOTECHNOLOGY, P193; Rocha CRC, 2001, MOL BIOL CELL, V12, P3631, DOI 10.1091/mbc.12.11.3631; Rodriguez-Ortiz R, 2009, APPL ENVIRON MICROB, V75, P405, DOI 10.1128/AEM.01089-08; Sambrook J., 2001, MOL CLONING LAB MANU; Telfer A, 2005, PHOTOCH PHOTOBIO SCI, V4, P950, DOI 10.1039/b507888c; Thewes S, 2005, MOL GENET GENOMICS, V274, P217, DOI 10.1007/s00438-005-0015-6; Tudzynski B, 2005, APPL MICROBIOL BIOT, V66, P597, DOI 10.1007/s00253-004-1805-1; Tudzynski B, 1998, FUNGAL GENET BIOL, V25, P157, DOI 10.1006/fgbi.1998.1095; Valiante V, 2008, FUNGAL GENET BIOL, V45, P618, DOI 10.1016/j.fgb.2007.09.006; Wagner D, 2010, EUKARYOT CELL, V9, P1588, DOI 10.1128/EC.00146-10; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x	60	23	25	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e28849	10.1371/journal.pone.0028849	http://dx.doi.org/10.1371/journal.pone.0028849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291883	Green Submitted, Green Published, gold			2022-12-27	WOS:000301703800003
J	Abou Chakra, CN; Pepin, J; Valiquette, L				Abou Chakra, Claire Nour; Pepin, Jacques; Valiquette, Louis			Prediction Tools for Unfavourable Outcomes in Clostridium difficile Infection: A Systematic Review	PLOS ONE			English	Review							RISK-FACTORS; DISEASE; METRONIDAZOLE; VANCOMYCIN; SEVERITY; FIDAXOMICIN; MORTALITY; COLITIS; RULES; MODEL	Context: Identifying patients at risk for adverse outcomes of Clostridium difficile infection (CDI), including recurrence and death, will become increasingly important as novel therapies emerge, which are more effective than traditional approaches but very expensive. Clinical prediction rules (CPRs) can improve the accuracy of medical decision-making. Several CPRs have been developed for CDI, but none has gained a widespread acceptance. Methods: We systematically reviewed studies describing the derivation or validation of CPRs for unfavourable outcomes of CDI, in medical databases (Medline, Embase, PubMed, Web of Science and Cochrane) and abstracts of conferences. Results: Of 2945 titles and abstracts screened, 13 studies on the derivation of a CPR were identified: two on recurrences, five on complications (including mortality), five on mortality alone and one on response to treatment. Two studies on the validation of different severity indices were also retrieved. Most CPRs were developed as secondary analyses using cohorts assembled for other purposes. CPRs presented several methodological limitations that could explain their limited use in clinical practice. Except for leukocytosis, albumin and age, there was much heterogeneity in the variables used, and most studies were limited by small sample sizes. Eight models used a retrospective design. Only four studies reported the incidence of the outcome of interest, even if this is essential to evaluate the potential usefulness of a model in other populations. Only five studies performed multivariate analyses to adjust for confounders. Conclusions: The lack of weighing variables, of validation, calibration and measures of reproducibility, the weak validities and performances when assessed, and the absence of sensitivity analyses, all led to suboptimal quality and debatable utility of those CPRs. Evidence-based tools developed through appropriate prospective cohorts would be more valuable for clinicians than empirically-developed CPRs.	[Abou Chakra, Claire Nour; Pepin, Jacques; Valiquette, Louis] Univ Sherbrooke, Dept Microbiol & Infect Dis, Quebec City, PQ, Canada	University of Sherbrooke	Abou Chakra, CN (corresponding author), Univ Sherbrooke, Dept Microbiol & Infect Dis, Quebec City, PQ, Canada.	louis.valiquette@usherbrooke.ca						Altman DG, 1998, BREAST CANCER RES TR, V52, P289, DOI 10.1023/A:1006193704132; BARTLETT JG, 1979, REV INFECT DIS, V1, P370; Belmares J, 2007, J INFECTION, V55, P495, DOI 10.1016/j.jinf.2007.09.015; Bhangu S, 2010, COLORECTAL DIS, V12, P241, DOI 10.1111/j.1463-1318.2009.01832.x; CHANG TW, 1978, INFECT IMMUN, V20, P526, DOI 10.1128/IAI.20.2.526-529.1978; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Drew RJ, 2009, J HOSP INFECT, V71, P93, DOI 10.1016/j.jhin.2008.09.020; Dubberke ER, 2007, AM J INFECT CONTROL, V35, P315, DOI 10.1016/j.ajic.2006.12.006; Ebell M.H, 2001, EVIDENCE BASED DIAGN; Fujitani S, 2011, INFECT CONT HOSP EP, V32, P220, DOI 10.1086/658336; Garey KW, 2008, J HOSP INFECT, V70, P298, DOI 10.1016/j.jhin.2008.08.012; Golan Y, 2011, GASTROENTEROLOGY, V140, pS360; Gujja D, 2009, ALIMENT PHARM THER, V29, P635, DOI 10.1111/j.1365-2036.2008.03914.x; Hu MY, 2008, CLIN GASTROENTEROL H, V6, P1354, DOI 10.1016/j.cgh.2008.06.024; Hu MY, 2009, GASTROENTEROLOGY, V136, P1206, DOI 10.1053/j.gastro.2008.12.038; Im GY, 2011, GASTROENTEROLOGY, V140, pS361; Indra A, 2009, EUROPEAN COMMUNICABL, V14; Johnson S, 2009, J INFECTION, V58, P403, DOI 10.1016/j.jinf.2009.03.010; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Louie TJ, 2006, CLIN INFECT DIS, V43, P411, DOI 10.1086/506349; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Lungulescu OA, 2011, J HOSP INFECT; May S, 2009, J MAN MANIP THER, V17, P36, DOI 10.1179/106698109790818214; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P265, DOI 10.1086/427113; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Moher David, 2009, Open Med, V3, pe123; Na X, 2011, GASTROENTEROLOGY, V140, pS326; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; RUBIN MS, 1995, DIS COLON RECTUM, V38, P350, DOI 10.1007/BF02054220; Toro DH., 2011, INFECT DIS CLIN PRAC, V19, P336, DOI DOI 10.1097/IPC.0B013E31821895A8; van Steenbergen J, 2005, EUROPEAN COMMUNICABL, V10; Velazquez-Gomez I., 2008, INFECT DIS CLIN PRAC, V16, P376, DOI DOI 10.1097/IPC.0B013E318182557F; Welfare MR, 2011, J HOSP INFECT; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265; Zilberberg MD, 2009, CRIT CARE MED, V37, P2583, DOI 10.1097/CCM.0b013e3181ab8388	40	58	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30258	10.1371/journal.pone.0030258	http://dx.doi.org/10.1371/journal.pone.0030258			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291926	Green Submitted, Green Published, gold			2022-12-27	WOS:000301639600009
J	Harmel, N; Cokic, B; Zolles, G; Berkefeld, H; Mauric, V; Fakler, B; Stein, V; Klocker, N				Harmel, Nadine; Cokic, Barbara; Zolles, Gerd; Berkefeld, Henrike; Mauric, Veronika; Fakler, Bernd; Stein, Valentin; Kloecker, Nikolaj			AMPA Receptors Commandeer an Ancient Cargo Exporter for Use as an Auxiliary Subunit for Signaling	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ENDOPLASMIC-RETICULUM; ER EXPORT; SYNAPTIC PLASTICITY; KINETIC-PROPERTIES; GLUTAMATE RECEPTORS; CORNICHON PROTEINS; LENTIVIRAL VECTORS; TRAFFICKING; CHANNELS	Fast excitatory neurotransmission in the mammalian central nervous system is mainly mediated by ionotropic glutamate receptors of the AMPA subtype (AMPARs). AMPARs are protein complexes of the pore-lining alpha-subunits GluA1-4 and auxiliary beta-subunits modulating their trafficking and gating. By a proteomic approach, two homologues of the cargo exporter cornichon, CNIH-2 and CNIH-3, have recently been identified as constituents of native AMPARs in mammalian brain. In heterologous reconstitution experiments, CNIH-2 promotes surface expression of GluAs and modulates their biophysical properties. However, its relevance in native AMPAR physiology remains controversial. Here, we have studied the role of CNIH-2 in GluA processing both in heterologous cells and primary rat neurons. Our data demonstrate that CNIH-2 serves an evolutionarily conserved role as a cargo exporter from the endoplasmic reticulum (ER). CNIH-2 cycles continuously between ER and Golgi complex to pick up cargo protein in the ER and then to mediate its preferential export in a coat protein complex (COP) II dependent manner. Interaction with GluA subunits breaks with this ancestral role of CNIH-2 confined to the early secretory pathway. While still taking advantage of being exported preferentially from the ER, GluAs recruit CNIH-2 to the cell surface. Thus, mammalian AMPARs commandeer CNIH-2 for use as a bona fide auxiliary subunit that is able to modify receptor signaling.	[Harmel, Nadine; Mauric, Veronika; Kloecker, Nikolaj] Univ Dusseldorf, Fac Med, Inst Neuro & Sensory Physiol, D-40225 Dusseldorf, Germany; [Cokic, Barbara] Max Planck Inst Neurobiol, Dept Synapt Receptor Trafficking, Martinsried, Germany; [Zolles, Gerd; Berkefeld, Henrike; Fakler, Bernd] Univ Freiburg, Inst Physiol, Freiburg, Germany; [Fakler, Bernd] Ctr Biol Signaling Studies BIOSS, Freiburg, Germany; [Stein, Valentin] Univ Bonn, Dept Physiol, Bonn, Germany	Heinrich Heine University Dusseldorf; Max Planck Society; University of Freiburg; University of Bonn	Harmel, N (corresponding author), Univ Dusseldorf, Fac Med, Inst Neuro & Sensory Physiol, D-40225 Dusseldorf, Germany.	nikolaj.kloecker@uni-duesseldorf.de	Stein, Valentin/A-8025-2008	Stein, Valentin/0000-0003-1222-4928	Deutsche Forschungs gemeinschaft (DFG) [SFB780 TP B04]	Deutsche Forschungs gemeinschaft (DFG)(German Research Foundation (DFG))	The work was funded by a grant of the Deutsche Forschungs gemeinschaft (DFG) to N.K. (SFB780 TP B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aridor M, 2004, J NEUROSCI, V24, P3770, DOI 10.1523/JNEUROSCI.4775-03.2004; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bokel C, 2006, DEVELOPMENT, V133, P459, DOI 10.1242/dev.02219; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Coleman SK, 2006, J NEUROSCI, V26, P11220, DOI 10.1523/JNEUROSCI.2301-06.2006; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DiCiommo DP, 1998, J BIOL CHEM, V273, P18060, DOI 10.1074/jbc.273.29.18060; Everts I, 1997, MOL PHARMACOL, V52, P861, DOI 10.1124/mol.52.5.861; GALLO V, 1992, J NEUROSCI, V12, P1010; Gill MB, 2011, J NEUROSCI, V31, P6928, DOI 10.1523/JNEUROSCI.6271-10.2011; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Grosskreutz J, 2003, EUR J NEUROSCI, V17, P1173, DOI 10.1046/j.1460-9568.2003.02531.x; Hoshino H, 2007, MOL BIOL CELL, V18, P1143, DOI 10.1091/mbc.E06-08-0733; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; KOHLER M, 1994, J BIOL CHEM, V269, P17367; Koike M, 2000, J NEUROSCI, V20, P2166; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Milstein AD, 2008, TRENDS PHARMACOL SCI, V29, P333, DOI 10.1016/j.tips.2008.04.004; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Perez Castro C, 2007, J CELL SCI, V120, P2454, DOI 10.1242/jcs.004200; Pfeifer A, 2001, MOL THER, V3, P319, DOI 10.1006/mthe.2001.0276; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Powers J, 1998, J CELL BIOL, V142, P1209, DOI 10.1083/jcb.142.5.1209; Powers J, 2002, MOL BIOL CELL, V13, P880, DOI 10.1091/mbc.01-10-0499; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Shi Y, 2010, P NATL ACAD SCI USA, V107, P16315, DOI 10.1073/pnas.1011706107; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Standley S, 1998, J NEUROCHEM, V70, P2434; Stein V, 2003, J NEUROSCI, V23, P5503; Stockklausner C, 2001, FEBS LETT, V493, P129, DOI 10.1016/S0014-5793(01)02286-4; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; von Engelhardt J, 2010, SCIENCE, V327, P1518, DOI 10.1126/science.1184178; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025	51	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30681	10.1371/journal.pone.0030681	http://dx.doi.org/10.1371/journal.pone.0030681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292017	Green Submitted, gold, Green Published			2022-12-27	WOS:000301639600046
J	Lassen, KG; Hebbeler, AM; Bhattacharyya, D; Lobritz, MA; Greene, WC				Lassen, Kara G.; Hebbeler, Andrew M.; Bhattacharyya, Darshana; Lobritz, Michael A.; Greene, Warner C.			A Flexible Model of HIV-1 Latency Permitting Evaluation of Many Primary CD4 T-Cell Reservoirs	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; IN-VITRO SYSTEM; ANTIRETROVIRAL THERAPY; TYPE-1; INFECTION; REPLICATION; ACTIVATION; EXPRESSION; INTEGRATION	Latently infected cells form the major obstacle to HIV eradication. Studies of HIV latency have been generally hindered by the lack of a robust and rapidly deployable cell model that involves primary human CD4 T lymphocytes. Latently infected cell lines have proven useful, but it is unclear how closely these proliferating cells recapitulate the conditions of viral latency in non-dividing CD4 T lymphocytes in vivo. Current primary lymphocyte models more closely reflect the in vivo state of HIV latency, but they are limited by protracted culture periods and often low cell yields. Additionally, these models are always established in a single latently infected cell type that may not reflect the heterogeneous nature of the latent reservoir. Here we describe a rapid, sensitive, and quantitative primary cell model of HIV-1 latency with replication competent proviruses and multiple reporters to enhance the flexibility of the system. In this model, post-integration HIV-1 latency can be established in all populations of CD4 T cells, and reactivation of latent provirus assessed within 7 days. The kinetics and magnitude of reactivation were evaluated after stimulation with various cytokines, small molecules, and T-cell receptor agonists. Reactivation of latent HIV proviruses was readily detected in the presence of strong activators of NF-kappa B. Latently infected transitional memory CD4 T cells proved more responsive to these T-cell activators than latently infected central memory cells. These findings reveal potentially important biological differences within the latently infected pool of memory CD4 T cells and describe a flexible primary CD4 T-cell system to evaluate novel antagonists of HIV latency.	[Lassen, Kara G.; Hebbeler, Andrew M.; Bhattacharyya, Darshana; Greene, Warner C.] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Lobritz, Michael A.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Case Western Reserve University	Lassen, KG (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA USA.	wgreene@gladstone.ucsf.edu			amfAR, the Foundation for AIDS Research [107395-43-RFRL]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	amfAR, the Foundation for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Kara Lassen was supported by the Mathilde Krim Fellowship from amfAR, the Foundation for AIDS Research (107395-43-RFRL; website: http://www.amfar.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosto LM, 2007, VIROLOGY, V368, P60, DOI 10.1016/j.virol.2007.06.001; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Brooks DG, 2003, P NATL ACAD SCI USA, V100, P12955, DOI 10.1073/pnas.2233345100; Burke B, 2007, J VIROL, V81, P7424, DOI 10.1128/JVI.02838-06; Burnett JC, 2010, J VIROL, V84, P5958, DOI 10.1128/JVI.00161-10; Carter CC, 2010, NAT MED, V16, P446, DOI 10.1038/nm.2109; CHEN BK, 1994, J VIROL, V68, P654, DOI 10.1128/JVI.68.2.654-660.1994; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; Church LD, 2005, J LEUKOCYTE BIOL, V78, P266, DOI 10.1189/jlb.1003456; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; Dai JH, 2009, J VIROL, V83, P4528, DOI 10.1128/JVI.01910-08; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Han YF, 2008, CELL HOST MICROBE, V4, P134, DOI 10.1016/j.chom.2008.06.008; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; He GC, 2002, MOL CELL BIOL, V22, P2965, DOI 10.1128/MCB.22.9.2965-2973.2002; Imamichi H, 2001, J INFECT DIS, V183, P36, DOI 10.1086/317641; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; Kulkosky J, 2004, AIDS RES HUM RETROV, V20, P497, DOI 10.1089/088922204323087741; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Lenasi T, 2008, CELL HOST MICROBE, V4, P123, DOI 10.1016/j.chom.2008.05.016; Liszewski MK, 2009, METHODS, V47, P254, DOI 10.1016/j.ymeth.2009.01.002; Marini A, 2008, J IMMUNOL, V181, P7713, DOI 10.4049/jimmunol.181.11.7713; Pace MJ, 2011, VIROLOGY, V411, P344, DOI 10.1016/j.virol.2010.12.041; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rossol M, 2007, J IMMUNOL, V179, P4239, DOI 10.4049/jimmunol.179.6.4239; Sahu GK, 2006, VIROLOGY, V355, P127, DOI 10.1016/j.virol.2006.07.020; Shan L, 2011, J VIROL, V85, P5384, DOI 10.1128/JVI.02536-10; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Swiggard WJ, 2005, J VIROL, V79, P14179, DOI 10.1128/JVI.79.22.14179-14188.2005; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Vatakis DN, 2007, J VIROL, V81, P3574, DOI 10.1128/JVI.02569-06; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Williams SA, 2007, J VIROL, V81, P6043, DOI 10.1128/JVI.02074-06; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Yang HC, 2011, CURR OPIN HIV AIDS, V6, P62, DOI 10.1097/COH.0b013e3283412568; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L	55	94	98	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30176	10.1371/journal.pone.0030176	http://dx.doi.org/10.1371/journal.pone.0030176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291913	Green Published, gold, Green Submitted			2022-12-27	WOS:000301639600006
J	Miu, AC; Baltes, FR				Miu, Andrei C.; Baltes, Felicia Rodica			Empathy Manipulation Impacts Music-Induced Emotions: A Psychophysiological Study on Opera	PLOS ONE			English	Article							FILM STIMULI; EXPERIENCE; RESPONSES; PERSPECTIVE	This study investigated the effects of voluntarily empathizing with a musical performer (i.e., cognitive empathy) on music-induced emotions and their underlying physiological activity. N = 56 participants watched video-clips of two operatic compositions performed in concerts, with low or high empathy instructions. Heart rate and heart rate variability, skin conductance level (SCL), and respiration rate (RR) were measured during music listening, and music-induced emotions were quantified using the Geneva Emotional Music Scale immediately after music listening. Listening to the aria with sad content in a high empathy condition facilitated the emotion of nostalgia and decreased SCL, in comparison to the low empathy condition. Listening to the song with happy content in a high empathy condition also facilitated the emotion of power and increased RR, in comparison to the low empathy condition. To our knowledge, this study offers the first experimental evidence that cognitive empathy influences emotion psychophysiology during music listening.	[Miu, Andrei C.; Baltes, Felicia Rodica] Univ Babes Bolyai, Dept Psychol, Cognit Neurosci Lab, R-3400 Cluj Napoca, Romania	Babes Bolyai University from Cluj	Miu, AC (corresponding author), Univ Babes Bolyai, Dept Psychol, Cognit Neurosci Lab, R-3400 Cluj Napoca, Romania.	andreimiu@psychology.ro	Miu, Andrei C./C-5184-2011	Miu, Andrei C./0000-0002-6459-5010	National University Research Council (CNCSIS) of Romania [411/2010]	National University Research Council (CNCSIS) of Romania(Consiliul National al Cercetarii Stiintifice (CNCS))	This research was supported by Grant No. 411/2010 from the National University Research Council (CNCSIS) of Romania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S. O., 2006, PSYCHOL MUSIC, V34, P511, DOI DOI 10.1177/0305735606067168; Bach DR, 2009, J NEUROSCI METH, V184, P224, DOI 10.1016/j.jneumeth.2009.08.005; Baltes FR, 2011, BRAIN COGNITION, V76, P146, DOI 10.1016/j.bandc.2011.01.012; Baltes FR, 2011, FIELD STUDY EMOTIONS; Batson CD, 1997, J PERS SOC PSYCHOL, V73, P495, DOI 10.1037/0022-3514.73.3.495; Bechara A, 1999, J NEUROSCI, V19, P5473; Bernardi L, 2009, CIRCULATION, V119, P3171, DOI 10.1161/CIRCULATIONAHA.108.806174; Camm AJ, 1996, CIRCULATION, V93, P1043; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Dahl S, 2007, MUSIC PERCEPT, V24, P433, DOI 10.1525/MP.2007.24.5.433; DAVIS MH, 1987, J PERS SOC PSYCHOL, V52, P126, DOI 10.1037/0022-3514.52.1.126; Decety J, 2006, CURR DIR PSYCHOL SCI, V15, P54, DOI 10.1111/j.0963-7214.2006.00406.x; Eckberg DL, 1997, CIRCULATION, V96, P3224, DOI 10.1161/01.CIR.96.9.3224; Garrido S, 2011, MUSIC PERCEPT, V28, P279, DOI 10.1525/MP.2011.28.3.279; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Hatfield E, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P19; Hunter PG, 2010, SPRINGER HANDB AUDIT, V36, P129, DOI 10.1007/978-1-4419-6114-3_5; Juslin P.N., 2010, SERIES AFFECTIVE SCI, P605, DOI DOI 10.1093/ACPROF:OSO/9780199230143.003.0022; Juslin PN, 2008, EMOTION, V8, P668, DOI 10.1037/a0013505; Khalfa S, 2002, NEUROSCI LETT, V328, P145, DOI 10.1016/S0304-3940(02)00462-7; KINGWELL BA, 1994, CIRCULATION, V90, P234, DOI 10.1161/01.CIR.90.1.234; Kreibig SD, 2007, PSYCHOPHYSIOLOGY, V44, P787, DOI 10.1111/j.1469-8986.2007.00550.x; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; LEVENSON RW, 1992, J PERS SOC PSYCHOL, V63, P234, DOI 10.1037/0022-3514.63.2.234; Livingstone SR, 2009, MUSIC SCI, P83, DOI 10.1177/1029864909013002061; Lundqvist LO, 2009, PSYCHOL MUSIC, V37, P61, DOI 10.1177/0305735607086048; Miu AC, 2008, BIOL PSYCHOL, V77, P353, DOI 10.1016/j.biopsycho.2007.11.010; Miu AC, 2009, AUTON NEUROSCI-BASIC, V145, P99, DOI 10.1016/j.autneu.2008.11.010; Molnar-Szakacs I, 2006, SOC COGN AFFECT NEUR, V1, P235, DOI 10.1093/scan/nsl029; Nyklicek I, 1997, J PSYCHOPHYSIOL, V11, P304; Overy K, 2009, MUSIC PERCEPT, V26, P489, DOI 10.1525/MP.2009.26.5.489; Preston SD, 2007, SOC NEUROSCI-UK, V2, P254, DOI 10.1080/17470910701376902; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; Scherer K. R., 2001, MUSIC EMOTION THEORY, DOI DOI 10.1016/j.jsams.2011.06.003; Spreng RN, 2009, J PERS ASSESS, V91, P62, DOI 10.1080/00223890802484381; Thompson WF, 2008, COGNITION EMOTION, V22, P1457, DOI 10.1080/02699930701813974; Trost W, 2012, CEREB CORTEX, V22, P2769, DOI 10.1093/cercor/bhr353; Van Lange PAM, 2008, EMOTION, V8, P766, DOI 10.1037/a0013967; WAINER H, 1991, PSYCHOL BULL, V109, P147, DOI 10.1037/0033-2909.109.1.147; Watson D., 1994, PANAS X MANUAL POSIT, DOI [10.17077/48vtm4t2, DOI 10.17077/48VTM4T2, DOI 10.13072/MIDSS.438]; Westbury HR, 2008, BIOL PSYCHOL, V78, P66, DOI 10.1016/j.biopsycho.2007.12.009; Zaki J, 2008, PSYCHOL SCI, V19, P399, DOI 10.1111/j.1467-9280.2008.02099.x; Zaki J, 2009, EMOTION, V9, P478, DOI 10.1037/a0016551; Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494	44	53	53	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30618	10.1371/journal.pone.0030618	http://dx.doi.org/10.1371/journal.pone.0030618			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	910LV	22292000	Green Published, gold, Green Submitted			2022-12-27	WOS:000301639600037
J	Okada, K; Roobthaisong, A; Nakagawa, I; Hamada, S; Chantaroj, S				Okada, Kazuhisa; Roobthaisong, Amonrattana; Nakagawa, Ichiro; Hamada, Shigeyuki; Chantaroj, Siriporn			Genotypic and PFGE/MLVA Analyses of Vibrio cholerae O1: Geographical Spread and Temporal Changes during the 2007-2010 Cholera Outbreaks in Thailand	PLOS ONE			English	Article							EL-TOR STRAINS; FIELD GEL-ELECTROPHORESIS; TANDEM-REPEAT ANALYSIS; VARIABLE-NUMBER; MOLECULAR CHARACTERIZATION; GENETIC DIVERSITY; COMPARATIVE GENOMICS; CLASSICAL CTXB; PCR ASSAY; TOXIN-B	Background: Vibrio cholerae O1 El Tor dominated the seventh cholera pandemic which occurred in the 1960s. For two decades, variants of V. cholerae O1 El Tor that produce classical cholera toxin have emerged and spread globally, replacing the prototypic El Tor biotype. This study aims to characterize V. cholerae O1 isolates from outbreaks in Thailand with special reference to genotypic variations over time. Methods/Findings: A total of 343 isolates of V. cholerae O1 from cholera outbreaks from 2007 to 2010 were investigated, and 99.4% were found to carry the classical cholera toxin B subunit (ctxB) and El Tor rstR genes. Pulsed-field gel electrophoresis (PFGE) differentiated the isolates into 10 distinct pulsotypes, clustered into two major groups, A and B, with an overall similarity of 88%. Ribotyping, multiple-locus variable-number tandem-repeat analysis (MLVA), and PCR to detect Vibrio seventh pandemic island II (VSP-II) related genes of randomly selected isolates from each pulsotype corresponded to the results obtained by PFGE. Epidemiological investigations revealed that MLVA type 2 was strongly associated with a cholera outbreak in northeastern Thailand in 2007, while MLVA type 7 dominated the outbreaks of the southern Gulf areas in 2009 and MLVA type 4 dominated the outbreaks of the central Gulf areas during 2009-2010. Only MLVA type 16 isolates were found in a Thai-Myanmar border area in 2010, whereas those of MLVA types 26, 39, and 41 predominated this border area in 2008. Type 39 then disappeared 1-2 years later as MLVA type 41 became prevalent. Type 41 was also found to infect an outbreak area. Conclusions: MLVA provided a high-throughput genetic typing tool for understanding the in-depth epidemiology of cholera outbreaks. Our epidemiological surveys suggest that some clones of V. cholerae O1 with similar but distinctive genetic traits circulate in outbreak sites, while others disappear over time.	[Okada, Kazuhisa; Roobthaisong, Amonrattana; Hamada, Shigeyuki] Thailand Japan Res Collaborat Ctr Emerging & Reem, Nonthaburi, Thailand; [Okada, Kazuhisa; Hamada, Shigeyuki] Osaka Univ, Microbial Dis Res Inst, Res Collaborat Ctr Emerging & Reemerging Infect, Osaka, Japan; [Nakagawa, Ichiro] Tokyo Med, Sect Bacterial Pathogenesis, Tokyo, Japan; [Nakagawa, Ichiro] Dent Univ, Grad Sch Med & Dent Sci, Tokyo, Japan; [Chantaroj, Siriporn] Natl Inst Hlth, Minist Publ Hlth, Dept Med Sci, Nonthaburi, Thailand	Osaka University; Ministry of Public Health - Thailand	Okada, K (corresponding author), Thailand Japan Res Collaborat Ctr Emerging & Reem, Nonthaburi, Thailand.	kazuhisa@biken.osaka-u.ac.jp		Okada, Kazuhisa/0000-0002-1225-7933	Japan Initiative for Global Research Network on Infectious Diseases; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [22710252]; Oyama Health foundation; Department of Medical Sciences; Ministry of Public Health, Thailand	Japan Initiative for Global Research Network on Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Oyama Health foundation; Department of Medical Sciences; Ministry of Public Health, Thailand	This work was supported by the program of Japan Initiative for Global Research Network on Infectious Diseases by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, by Grant-in-Aid for Young Scientists (B) (No. 22710252) from the MEXT of Japan, by the Oyama Health foundation, and by the Department of Medical Sciences, the Ministry of Public Health, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaruzzaman M, 2004, EMERG INFECT DIS, V10, P2057, DOI 10.3201/eid1011.040682; Arakawa E, 2000, J CLIN MICROBIOL, V38, P424; Bhattacharya T, 2006, ENVIRON MICROBIOL, V8, P526, DOI 10.1111/j.1462-2920.2005.00932.x; Binh MN, 2009, J CLIN MICROBIOL, V47, P1568, DOI 10.1128/JCM.02040-08; CAMERON DN, 1994, J CLIN MICROBIOL, V32, P1685, DOI 10.1128/JCM.32.7.1685-1690.1994; Ceccarelli D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-130; Ceccarelli D, 2011, INT J MED MICROBIOL, V301, P318, DOI 10.1016/j.ijmm.2010.11.005; Chatterjee S, 2009, J MED MICROBIOL, V58, P239, DOI 10.1099/jmm.0.003780-0; Choi SY, 2010, J MED MICROBIOL, V59, P763, DOI 10.1099/jmm.0.017939-0; Chow KH, 2001, J CLIN MICROBIOL, V39, P2594, DOI 10.1128/JCM.39.7.2594-2597.2001; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; Cooper KLF, 2006, FOODBORNE PATHOG DIS, V3, P51, DOI 10.1089/fpd.2006.3.51; Danin-Poleg Y, 2007, J CLIN MICROBIOL, V45, P736, DOI 10.1128/JCM.01895-06; Faruque SM, 2004, P NATL ACAD SCI USA, V101, P2123, DOI 10.1073/pnas.0308485100; Ghosh R, 2008, FEMS MICROBIOL LETT, V288, P196, DOI 10.1111/j.1574-6968.2008.01352.x; Goel AK, 2011, J MICROBIOL, V49, P280, DOI 10.1007/s12275-011-0317-9; Grim CJ, 2010, J BACTERIOL, V192, P3524, DOI 10.1128/JB.00040-10; Grim CJ, 2010, OMICS, V14, P1, DOI 10.1089/omi.2009.0087; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Islam MS, 2011, J CLIN MICROBIOL, V49, P2325, DOI 10.1128/JCM.00432-11; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kendall EA, 2010, J BACTERIOL, V192, P4367, DOI 10.1128/JB.00698-10; Kondo S, 2001, EPIDEMIOL INFECT, V127, P7, DOI 10.1017/S0950268801005660; Lindstedt BA, 2005, ELECTROPHORESIS, V26, P2567, DOI 10.1002/elps.200500096; Morita M, 2008, MICROBIOL IMMUNOL, V52, P314, DOI 10.1111/j.1348-0421.2008.00041.x; Morita M, 2010, J MED MICROBIOL, V59, P708, DOI 10.1099/jmm.0.017624-0; Na-Ubol M, 2011, INDIAN J MED RES, V133, P387; Nair GB, 2006, J CLIN MICROBIOL, V44, P4211, DOI 10.1128/JCM.01304-06; Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204; O'Shea YA, 2004, MICROBIOL-SGM, V150, P4053, DOI 10.1099/mic.0.27172-0; Okada K, 2010, AM J TROP MED HYG, V82, P875, DOI 10.4269/ajtmh.2010.09-0537; Okada K, 2010, DIAGN MICR INFEC DIS, V66, P135, DOI 10.1016/j.diagmicrobio.2009.09.004; POPOVIC T, 1993, J CLIN MICROBIOL, V31, P2474, DOI 10.1128/JCM.31.9.2474-2482.1993; Raychoudhuri A, 2009, EMERG INFECT DIS, V15, P131, DOI 10.3201/eid1501.080543; Raychoudhuri A, 2007, J INFECTION, V55, P431, DOI 10.1016/j.jinf.2007.07.020; Raychoudhuri A, 2008, INDIAN J MED RES, V128, P695; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Safa A, 2008, EMERG INFECT DIS, V14, P987, DOI 10.3201/eid1406.080129; Safa A, 2010, TRENDS MICROBIOL, V18, P46, DOI 10.1016/j.tim.2009.10.003; Sharma C, 1998, J CLIN MICROBIOL, V36, P843, DOI 10.1128/JCM.36.3.843-844.1998; Sharma C, 1997, J INFECT DIS, V175, P1134, DOI 10.1086/516453; Singh DV, 2002, J CLIN MICROBIOL, V40, P4321, DOI 10.1128/JCM.40.11.4321-4324.2002; Stine OC, 2008, EMERG INFECT DIS, V14, P831, DOI 10.3201/eid1405.071116; Swaddiwudhipong Witaya, 2008, Journal of the Medical Association of Thailand, V91, P1433; Tapchaisri P, 2007, J INFECTION, V55, P557, DOI 10.1016/j.jinf.2007.08.001; Taviani E, 2010, FEMS MICROBIOL LETT, V308, P130, DOI 10.1111/j.1574-6968.2010.02008.x; Wilson K., 1997, CURRENT PROTOCOLS MO; World Health Organization, 2009, WKLY EPIDEMIOL REC, P309	50	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30863	10.1371/journal.pone.0030863	http://dx.doi.org/10.1371/journal.pone.0030863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292065	Green Published, gold, Green Submitted			2022-12-27	WOS:000301639600064
J	Senft, D; Berking, C; Graf, SA; Kammerbauer, C; Ruzicka, T; Besch, R				Senft, Daniela; Berking, Carola; Graf, Saskia A.; Kammerbauer, Claudia; Ruzicka, Thomas; Besch, Robert			Selective Induction of Cell Death in Melanoma Cell Lines through Targeting of Mcl-1 and A1	PLOS ONE			English	Article							BCL-2 FAMILY-MEMBERS; HUMAN MELANOCYTES; APOPTOSIS; INHIBITION; EXPRESSION; RESISTANCE; PROTEINS	Melanoma is an often fatal form of skin cancer which is remarkably resistant against radio-and chemotherapy. Even new strategies that target RAS/RAF signaling and display unprecedented efficacy are characterized by resistance mechanisms. The targeting of survival pathways would be an attractive alternative strategy, if tumor-specific cell death can be achieved. Bcl-2 proteins play a central role in regulating survival of tumor cells. In this study, we systematically investigated the relevance of antiapoptotic Bcl-2 proteins, i.e., Bcl-2, Bcl-xL, Bcl-w, Mcl-1, and A1, in melanoma cell lines and non-malignant cells using RNAi. We found that melanoma cells required the presence of specific antiapoptotic Bcl-2 proteins: Inhibition of Mcl-1 and A1 strongly induced cell death in some melanoma cell lines, whereas non-malignant cells, i.e., primary human fibroblasts or keratinocytes were not affected. This specific sensitivity of melanoma cells was further enhanced by the combined inhibition of Mcl-1 and A1 and resulted in 60% to 80% cell death in all melanoma cell lines tested. This treatment was successfully combined with chemotherapy, which killed a substantial proportion of cells that survived Mcl-1 and A1 inhibition. Together, these results identify antiapoptotic proteins on which specifically melanoma cells rely on and, thus, provide a basis for the development of new Bcl-2 protein-targeting therapies.	[Senft, Daniela; Berking, Carola; Graf, Saskia A.; Kammerbauer, Claudia; Ruzicka, Thomas; Besch, Robert] Univ Munich, Dept Dermatol & Allergol, Munich, Germany	University of Munich	Besch, R (corresponding author), Univ Munich, Dept Dermatol & Allergol, Munich, Germany.	robert.besch@med.uni-muenchen.de	Senft, Daniela/O-6265-2018; Senft, Daniela/HII-5783-2022	Senft, Daniela/0000-0002-6953-8189; 	German Cancer Aid (Deutsche Krebshilfe); Mildred Scheel Foundation [107805, 109218]; German Research Funding Organization (Deutsche Forschungsgemeinschaft) [GK 1202]; Helmut-Legerlotz Foundation; Matthias-Lackas foundation	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); Mildred Scheel Foundation(Deutsche Krebshilfe); German Research Funding Organization (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Helmut-Legerlotz Foundation; Matthias-Lackas foundation	This study was funded by the German Cancer Aid (Deutsche Krebshilfe), Dr. Mildred Scheel Foundation grant 107805 and 109218 to R. B. and C. B., by the German Research Funding Organization (Deutsche Forschungsgemeinschaft) grant GK 1202 to D. S, C. B., and R. B. and by the Helmut-Legerlotz Foundation and Matthias-Lackas foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besch R, 2007, CELL DEATH DIFFER, V14, P818, DOI 10.1038/sj.cdd.4402065; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Boisvert-Adamo K, 2009, MOL CANCER RES, V7, P549, DOI 10.1158/1541-7786.MCR-08-0358; Bush JA, 2003, CLIN EXP METASTAS, V20, P531, DOI 10.1023/A:1025874502181; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen SQ, 2010, CANCER RES, V70, P4318, DOI 10.1158/0008-5472.CAN-09-4428; Chetoui N, 2008, MOL CANCER RES, V6, P42, DOI 10.1158/1541-7786.MCR-07-0080; Cragg MS, 2009, NAT REV CANCER, V9, P321, DOI 10.1038/nrc2615; Evan GI, 2006, CANCER CELL, V10, P345, DOI 10.1016/j.ccr.2006.10.013; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Hassan M, 2008, ONCOGENE, V27, P4557, DOI 10.1038/onc.2008.90; Jiang CC, 2008, CANCER RES, V68, P6708, DOI 10.1158/0008-5472.CAN-08-0349; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Lawson DH, 2004, SEMIN ONCOL, V31, P33, DOI 10.1053/j.seminoncol.2004.02.014; Lens MB, 2003, EXPERT OPIN PHARMACO, V4, P2205, DOI 10.1517/14656566.4.12.2205; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; PLETTENBERG A, 1995, AM J PATHOL, V146, P651; Selzer E, 1998, MELANOMA RES, V8, P197, DOI 10.1097/00008390-199806000-00001; Tang LR, 1998, CLIN CANCER RES, V4, P1865; Van Triest B, 2000, ANN ONCOL, V11, P385, DOI 10.1023/A:1008351221345; Weber A, 2009, TRANSL ONCOL, V2, P73, DOI 10.1593/tlo.08223; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	30	48	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30821	10.1371/journal.pone.0030821	http://dx.doi.org/10.1371/journal.pone.0030821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292048	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600056
J	Gu, XL; Vedvyas, Y; Chen, XY; Kaushik, T; Hwang, CI; Hu, XB; Nikitin, AY; Jin, MM				Gu, Xiaoling; Vedvyas, Yogindra; Chen, Xiaoyue; Kaushik, Tanwi; Hwang, Chang-Il; Hu, Xuebo; Nikitin, Alexander Y.; Jin, Moonsoo M.			Novel Strategy for Selection of Monoclonal Antibodies Against Highly Conserved Antigens: Phage Library Panning Against Ephrin-B2 Displayed on Yeast	PLOS ONE			English	Article							INHIBITS TUMOR-GROWTH; CARDIOVASCULAR DEVELOPMENT; VASCULAR MORPHOGENESIS; ENDOTHELIAL EPHRINB2; COLORECTAL-CANCER; ANGIOGENESIS; EPHB4; CARCINOMA; RECEPTORS; OVEREXPRESSION	Ephrin-B2 is predominately expressed in endothelium of arterial origin, involved in developmental angiogenesis and neovasculature formation through its interaction with EphB4. Despite its importance in physiology and pathological conditions, it has been challenging to produce monoclonal antibodies against ephrin-B2 due to its high conservation in sequence throughout human and rodents. Using a novel approach for antibody selection by panning a phage library of human antibody against antigens displayed in yeast, we have isolated high affinity antibodies against ephrin-B2. The function of one high affinity binder (named as 'EC8') was manifested in its ability to inhibit ephrin-B2 interaction with EphB4, to cross-react with murine ephrin-B2, and to induce internalization into ephrin-B2 expressing cells. EC8 was also compatible with immunoprecipitation and detection of ephrin-B2 expression in the tissue after standard chemical fixation procedure. Consistent with previous reports on ephrin-B2 induction in some epithelial tumors and tumor-associated vasculatures, EC8 specifically detected ephrin-B2 in tumors as well as the vasculature within and outside of the tumors. We envision that monoclonal antibody developed in this study may be used as a reagent to probe ephrin-B2 distribution in normal as well as in pathological conditions and to antagonize ephrin-B2 interaction with EphB4 for basic science and therapeutic applications.	[Gu, Xiaoling; Vedvyas, Yogindra; Chen, Xiaoyue; Kaushik, Tanwi; Hu, Xuebo; Jin, Moonsoo M.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA; [Hwang, Chang-Il; Nikitin, Alexander Y.] Cornell Univ, Dept Biomed Sci, Ithaca, NY USA	Cornell University; Cornell University	Gu, XL (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.	mj227@cornell.edu		Hwang, Chang-il/0000-0002-5710-7672	National Institutes of Health [AI179532, GM090320, CA96823, CA112354]; Northeast Biodefense Center [U54-AI057158]; NATIONAL CANCER INSTITUTE [R01CA112354, R56CA096823, R01CA096823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Biodefense Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant AI179532 (MMJ), GM090320 (MMJ), CA96823 (AYN), CA112354 (AYN) and Northeast Biodefense Center U54-AI057158 (Lipkin)(http://www.nih.gov/) (http://www.nbc.columbia.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X; Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Alam SM, 2008, BRIT J CANCER, V98, P845, DOI 10.1038/sj.bjc.6604216; Alam SM, 2007, ANN ONCOL, V18, P485, DOI 10.1093/annonc/mdl414; Andrievskaia O, 2006, CLIN VACCINE IMMUNOL, V13, P98, DOI 10.1128/CVI.13.1.98-105.2006; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Flesken-Nikitin A, 2003, CANCER RES, V63, P3459; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Germain S, 2010, NAT MED, V16, P752, DOI 10.1038/nm0710-752; Goettsch W, 2004, ENDOTHELIUM-J ENDOTH, V11, P259, DOI 10.1080/10623320490904151; Hainaud P, 2006, CANCER RES, V66, P8501, DOI 10.1158/0008-5472.CAN-05-4226; Hu XB, 2010, P NATL ACAD SCI USA, V107, P6252, DOI 10.1073/pnas.0914358107; Jackson D, 2008, CANCER RES, V68, P9367, DOI 10.1158/0008-5472.CAN-08-1933; Jin M, 2006, P NATL ACAD SCI USA, V103, P5758, DOI 10.1073/pnas.0601164103; Kertesz N, 2006, BLOOD, V107, P2330, DOI 10.1182/blood-2005-04-1655; Korff T, 2006, ARTERIOSCL THROM VAS, V26, P468, DOI 10.1161/01.ATV.0000200081.42064.e7; Krasnoperov V, 2010, AM J PATHOL, V176, P2029, DOI 10.2353/ajpath.2010.090755; Liu W, 2004, BRIT J CANCER, V90, P1620, DOI 10.1038/sj.bjc.6601723; Liu WB, 2002, CANCER, V94, P934, DOI 10.1002/cncr.10122; Mao WG, 2004, CANCER RES, V64, P781, DOI 10.1158/0008-5472.CAN-03-1047; Nakada M, 2010, INT J CANCER, V126, P1155, DOI 10.1002/ijc.24849; Owens RM, 2010, J BIOL CHEM, V285, P15906, DOI 10.1074/jbc.M110.104349; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; SEMPLE TU, 1978, CANCER RES, V38, P1345; Tachibana M, 2007, DIGEST LIVER DIS, V39, P725, DOI 10.1016/j.dld.2007.05.013; Varelias A, 2002, CANCER, V95, P862, DOI 10.1002/cncr.10749; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Xu ZH, 2009, EXPERT OPIN THER PAT, V19, P1035, DOI 10.1517/13543770902835525; Yamanda S, 2009, BLOOD, V113, P3631, DOI 10.1182/blood-2008-07-170381; Zhou HZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006087	34	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30680	10.1371/journal.pone.0030680	http://dx.doi.org/10.1371/journal.pone.0030680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292016	Green Submitted, Green Published, gold			2022-12-27	WOS:000301570600071
J	Hong, SL; Barton, SJ; Rebec, GV				Hong, S. Lee; Barton, Scott J.; Rebec, George V.			Altered Neural and Behavioral Dynamics in Huntington's Disease: An Entropy Conservation Approach	PLOS ONE			English	Article							MOUSE MODEL; DOPAMINE; PHENOTYPE; NEURONS	Background: Huntington's disease (HD) is an inherited condition that results in neurodegeneration of the striatum, the forebrain structure that processes cortical information for behavioral output. In the R6/2 transgenic mouse model of HD, striatal neurons exhibit aberrant firing patterns that are coupled with reduced flexibility in the motor system. The aim of this study was to test the patterns of unpredictability in brain and behavior in wild-type (WT) and R6/2 mice. Methodology/Principal Findings: Striatal local field potentials (LFP) were recorded from 18 WT and 17 R6/2 mice (aged 8 11 weeks) while the mice were exploring a plus-shaped maze. We targeted LFP activity for up to 2 s before and 2 s after each choice-point entry. Approximate Entropy (ApEn) was calculated for LFPs and Shannon Entropy was used to measure the probability of arm choice, as well as the likelihood of making consecutive 90-degree turns in the maze. We found that although the total number of choice-point crossings and entropy of arm-choice probability was similar in both groups, R6/2 mice had more predictable behavioral responses (i.e., were less likely to make 90-degree turns and perform them in alternation with running straight down the same arm), while exhibiting more unpredictable striatal activity, as indicated by higher ApEn values. In both WT and R6/2 mice, however, behavioral unpredictability was negatively correlated with LFP ApEn. Conclusions/Significance: HD results in a perseverative exploration of the environment, occurring in concert with more unpredictable brain activity. Our results support the entropy conservation hypothesis in which unpredictable behavioral patterns are coupled with more predictable brain activation patterns, suggesting that this may be a fundamental process unaffected by HD.	[Hong, S. Lee] Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA; [Barton, Scott J.; Rebec, George V.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Hong, SL (corresponding author), Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA.	rebec@indiana.edu	Hong, S./B-2390-2008	Hong, S./0000-0001-6044-2482	National Institute on Aging [R21 AG 039818, R21 AG 035158]; National Institute of Neurological Diseases and Stroke [R01 NS 35663]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG039818, R21AG035158] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by National Institute on Aging R21 AG 039818 and R21 AG 035158 and National Institute of Neurological Diseases and Stroke R01 NS 35663. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen J.E., 1988, STAT POWER ANAL BEHA; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fowler SC, 2009, BEHAV BRAIN RES, V202, P130, DOI 10.1016/j.bbr.2009.03.022; Hickey MA, 2002, J NEUROCHEM, V81, P46, DOI 10.1046/j.1471-4159.2002.00804.x; Hong S Lee, 2008, Nonlinear Dynamics Psychol Life Sci, V12, P163; Hong SL, 2010, NONLIN DYNAM PSYCHOL, V14, P291; Hong SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011461; Kelso J. A. S., 2006, COMPLEMENTARY NATURE; Kern DS, 2007, NEUROLOGIST, V13, P237, DOI 10.1097/NRL.0b013e3181492c48; Mandell AJ, 1997, CHAOS, V7, P67, DOI 10.1063/1.166241; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Miller BR, 2008, J NEUROPHYSIOL, V100, P2205, DOI 10.1152/jn.90606.2008; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Rebec GV, 2003, NEUROREPORT, V14, P1263, DOI 10.1097/00001756-200307010-00015; Schultz W, 1997, CURR OPIN NEUROBIOL, V7, P191, DOI 10.1016/S0959-4388(97)80007-4; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Smotherman WP, 1996, PSYCHONEUROENDOCRINO, V21, P173, DOI 10.1016/0306-4530(95)00040-2	18	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30879	10.1371/journal.pone.0030879	http://dx.doi.org/10.1371/journal.pone.0030879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292068	gold, Green Published, Green Submitted			2022-12-27	WOS:000301570600092
J	Kirchberger, I; Meisinger, C; Heier, M; Zimmermann, AK; Thorand, B; Autenrieth, CS; Peters, A; Ladwig, KH; Doring, A				Kirchberger, Inge; Meisinger, Christa; Heier, Margit; Zimmermann, Anja-Kerstin; Thorand, Barbara; Autenrieth, Christine S.; Peters, Annette; Ladwig, Karl-Heinz; Doering, Angela			Patterns of Multimorbidity in the Aged Population. Results from the KORA-Age Study	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; QUALITY-OF-LIFE; ELDERLY POPULATION; CHRONIC DISEASES; HEALTH RESEARCH; OLDER WOMEN; PREVALENCE; COMORBIDITY; IMPACT; COHORT	Multimorbidity is a common problem in aged populations with a wide range of individual and societal consequences. The objective of the study was to explore patterns of comorbidity and multimorbidity in an elderly population using different analytical approaches. Data were gathered from the population-based KORA-Age project, which included 4,127 persons aged 65-94 years living in the city of Augsburg and its two surrounding counties in Southern Germany. Information on the presence of 13 chronic conditions was collected in a standardized telephone interview and a self-administered questionnaire. Patterns of comorbidity and multimorbidity were analyzed using prevalence figures, logistic regression models and exploratory tetrachoric factor analysis. The prevalence of multimorbidity (>= 2 diseases) was 58.6% in the total sample. Hypertension and diabetes (Odds Ratio [OR] 2.95, 99.58% confidence interval [CI] [2.19-3.96]), as well as hypertension and stroke (OR 2.00, 99.58% CI [1.26-3.16]) most often occurred in combination. This association was independent of age, sex and the presence of other conditions. Using factor analysis, we identified four patterns of multimorbidity: the first pattern includes cardiovascular and metabolic diseases, the second includes joint, liver, lung and eye diseases, the third covers mental and neurologic diseases and the fourth pattern includes gastrointestinal diseases and cancer. 44% of the persons were assigned to at least one of the four multimorbidity patterns; 14% could be assigned to both the cardiovascular/metabolic and the joint/liver/lung/eye pattern. Further common pairs were the mental/neurologic pattern combined with the cardiovascular/metabolic pattern (7.2%) or the joint/liver/lung/eye pattern (5.3%), respectively. Our results confirmed the existence of co-occurrence of certain diseases in elderly persons, which is not caused by chance. Some of the identified patterns of multimorbidity and their overlap may indicate common underlying pathological mechanisms.	[Kirchberger, Inge; Meisinger, Christa; Heier, Margit; Zimmermann, Anja-Kerstin; Thorand, Barbara; Autenrieth, Christine S.; Peters, Annette; Ladwig, Karl-Heinz; Doering, Angela] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Kirchberger, Inge; Meisinger, Christa; Heier, Margit] Cent Hosp Augsburg, MONICA KORA Myocardial Infarct Registry, Augsburg, Germany; [Doering, Angela] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kirchberger, I (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany.	Inge.Kirchberger@helmholtz-muenchen.de	Ladwig, Karl-Heinz/B-5351-2014; Heier, Margit/AAT-5280-2020; Peters, Annette/A-6117-2011; Thorand, Barbara/B-5349-2014; Meisinger, Christine/B-5358-2014	Ladwig, Karl-Heinz/0000-0003-0710-1720; Peters, Annette/0000-0001-6645-0985; Thorand, Barbara/0000-0002-8416-6440; Meisinger, Christa/0000-0002-9026-6544	Helmholtz Zentrum Munchen-German Research Center for Environmental Health; German Federal Ministry of Education and Research; State of Bavaria; German Federal Ministry of Education and Research (BMBF) [FKZ 01ET0713]	Helmholtz Zentrum Munchen-German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen-German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. The KORA-Age project was financed by the German Federal Ministry of Education and Research (BMBF FKZ 01ET0713) as part of the "Health in old age" program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Britt HC, 2008, MED J AUSTRALIA, V189, P72, DOI 10.5694/j.1326-5377.2008.tb01919.x; Cates MJ, 2011, J STROKE CEREBROVASC; Chaudhry S, 2005, MED CARE, V43, P607, DOI 10.1097/01.mlr.0000163658.65008.ec; Cornell JE, 2007, APPL MULTIVARIATE RE, V2007, P163, DOI [10.22329/amr.v12i3.658, DOI 10.22329/AMR.V12I3.658]; Crentsil V, 2010, AM J GERIATR PHARMAC, V8, P215, DOI 10.1016/j.amjopharm.2010.06.003; Fortin M, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-52; Fortin M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-111; Fried LP, 1999, J CLIN EPIDEMIOL, V52, P27, DOI 10.1016/S0895-4356(98)00124-3; Fung CH, 2008, J GEN INTERN MED, V23, P788, DOI 10.1007/s11606-008-0602-4; Grauslund J, 2011, ACTA OPHTHALMOL, V89, P25, DOI [10.1111/j.1755-3768.2009.01619.x, 10.1111/j.1755-3768.2010.02105.x]; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; John R, 2003, GERONTOLOGIST, V43, P649, DOI 10.1093/geront/43.5.649; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P840, DOI 10.1001/archopht.126.6.840; Kubinger K., 2003, PSYCHOL SCI, V45, P106, DOI DOI 10.1177/014662169101500105; LAMERS F, 2011, J CLIN PSYCHIAT; Laux G, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-14; Long AN, 2011, J CLIN HYPERTENS, V13, P244, DOI 10.1111/j.1751-7176.2011.00434.x; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS13, DOI 10.1055/s-2005-858234; Loza E, 2009, SEMIN ARTHRITIS RHEU, V38, P312, DOI 10.1016/j.semarthrit.2008.01.004; MAES M, 2010, PROG NEUROPSYCHOPHAR; Maes M, 2011, NEUROENDOCRINOL LETT, V32, P7; Marengoni A, 2008, AM J PUBLIC HEALTH, V98, P1198, DOI 10.2105/AJPH.2007.121137; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Marengoni A, 2009, J AM GERIATR SOC, V57, P225, DOI 10.1111/j.1532-5415.2008.02109.x; Meisinger C, 2008, J HYPERTENS, V26, P1809, DOI 10.1097/HJH.0b013e328307c3e9; Moorthy S, 2011, AM J OPHTHALMOL, V151, P375, DOI 10.1016/j.ajo.2010.09.001; Nagel G, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-384; Ottman R, 2011, EPILEPSIA, V52, P308, DOI 10.1111/j.1528-1167.2010.02927.x; Prasad S, 2001, EYE, V15, P640, DOI 10.1038/eye.2001.200; Schafer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014060; Schneider F, 2008, EUR ARCH PSY CLIN N, V258, P55, DOI 10.1007/s00406-008-5012-4; Schoenberg NE, 2007, GERONTOLOGIST, V47, P423, DOI 10.1093/geront/47.4.423; Schoevers RA, 2003, INT J GERIATR PSYCH, V18, P994, DOI 10.1002/gps.1001; SHEIKH JI, 1985, HOSP COMMUNITY PSYCH, V36, P1160; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Taylor AW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-718; Turesson C, 2008, J RHEUMATOL, V35, P179; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; van den Bussche H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-101; VERBRUGGE LM, 1989, MILBANK Q, V67, P450, DOI 10.2307/3350223; Weatherall M, 2009, RESPIROLOGY, V14, P983, DOI 10.1111/j.1440-1843.2009.01589.x; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	43	159	164	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30556	10.1371/journal.pone.0030556	http://dx.doi.org/10.1371/journal.pone.0030556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	909NE	22291986	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600057
J	Wills, J; Credle, J; Oaks, AW; Duka, V; Lee, JH; Jones, J; Sidhu, A				Wills, Jonathan; Credle, Joel; Oaks, Adam W.; Duka, Valeriy; Lee, Jae-Hoon; Jones, Jessica; Sidhu, Anita			Paraquat, but Not Maneb, Induces Synucleinopathy and Tauopathy in Striata of Mice through Inhibition of Proteasomal and Autophagic Pathways	PLOS ONE			English	Article							ETHYLENE-BIS-DITHIOCARBAMATE; SPORADIC PARKINSONS-DISEASE; GENOME-WIDE ASSOCIATION; ALPHA-SYNUCLEIN; RISK-FACTORS; TAU PHOSPHORYLATION; HERBICIDE PARAQUAT; NEUROTOXICITY; EXPOSURE; ROTENONE	SNCA and MAPT genes and environmental factors are important risk factors of Parkinson's disease [PD], the second-most common neurodegenerative disease. The agrichemicals maneb and paraquat selectively target dopaminergic neurons, leading to parkinsonism, through ill-defined mechanisms. In the current studies we have analyzed the ability of maneb and paraquat, separately and together, to induce synucleinopathy and tauopathy in wild type mice. Maneb was ineffective in increasing a-synuclein [alpha-Syn] or p-Tau levels. By contrast, paraquat treatment of mice resulted in robust accumulation of alpha-Syn and hyperphosphorylation of Tau in striata, through activation of p-GSK-3 beta, a major Tau kinase. Co-treatment with maneb did not enhance the effects of paraquat. Increased hyperacetylation of alpha-tubulin was observed in paraquat-treated mice, suggesting cytoskeleton remodeling. Paraquat, but not maneb, inhibited soluble proteasomal activity on a peptide substrate but this was not associated with a decreased expression of 26S proteasome subunits. Both paraquat and maneb treatments increased levels of the autophagy inhibitor, mammalian target of rapamycin, mTOR, suggesting impaired axonal autophagy, despite increases in certain autophagic proteins, such as beclin 1 and Agt12. Autophagic flux was also impaired, as ratios of LC3 II to LC3 I were reduced in treated animals. Increased mTOR was also observed in postmortem human PD striata, where there was a reduction in the LC3 II to LC3 I ratio. Heat shock proteins were either increased or unchanged upon paraquat-treatment suggesting that chaperone-mediated autophagy is not hampered by the agrichemicals. These studies provide novel insight into the mechanisms of action of these agrichemicals, which indicate that paraquat is much more toxic than maneb, via its inhibitory effects on proteasomes and autophagy, which lead to accumulation of alpha-Syn and p-Tau.	[Wills, Jonathan; Credle, Joel; Oaks, Adam W.; Duka, Valeriy; Lee, Jae-Hoon; Jones, Jessica; Sidhu, Anita] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cell Biol, Washington, DC 20007 USA	Georgetown University	Wills, J (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cell Biol, Washington, DC 20007 USA.	sidhua@georgetown.edu			National Institutes of Health [R01AGO28108, RO1NS060041]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from National Institutes of Health R01AGO28108 and RO1NS060041 (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn TB, 2008, NEUROLOGY, V70, P43, DOI 10.1212/01.wnl.0000271080.53272.c7; Alonso AD, 2010, J BIOL CHEM, V285, P30851, DOI 10.1074/jbc.M110.110957; Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Baldereschi M, 2003, ACTA NEUROL SCAND, V108, P239, DOI 10.1034/j.1600-0404.2003.00128.x; Brooks AI, 1999, BRAIN RES, V823, P1, DOI 10.1016/S0006-8993(98)01192-5; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Chaves RS, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-144; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; Ding QX, 2001, J NEUROCHEM, V77, P1010, DOI 10.1046/j.1471-4159.2001.00302.x; Drechsel DA, 2008, FREE RADICAL BIO MED, V44, P1873, DOI 10.1016/j.freeradbiomed.2008.02.008; Duka T, 2006, FASEB J, V20, P2302, DOI 10.1096/fj.06-6092com; Duka T, 2009, FASEB J, V23, P2820, DOI 10.1096/fj.08-120410; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Fei QY, 2008, J NEUROCHEM, V105, P2091, DOI 10.1111/j.1471-4159.2008.05293.x; Garcia-Arencibia M, 2010, SEMIN CELL DEV BIOL, V21, P691, DOI 10.1016/j.semcdb.2010.02.008; Gonzalez-Polo RA, 2007, TOXICOL SCI, V97, P448, DOI 10.1093/toxsci/kfm040; Haggerty T, 2011, EUR J NEURO IN PRESS; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hashimoto M, 2004, J BIOL CHEM, V279, P23622, DOI 10.1074/jbc.M313784200; Hisahara S, 2010, PARKINSONS DIS, V2011; Hoglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x; HOLLENBECK PJ, 1993, J CELL BIOL, V121, P305, DOI 10.1083/jcb.121.2.305; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Kachroo A, 2010, EXP NEUROL, V223, P657, DOI 10.1016/j.expneurol.2010.02.007; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Kozikowski AP, 2006, CHEMMEDCHEM, V1, P256, DOI 10.1002/cmdc.200500039; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; Mata IF, 2011, MOVEMENT DISORD, V26, P819, DOI 10.1002/mds.23642; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; MECO G, 1994, SCAND J WORK ENV HEA, V20, P301, DOI 10.5271/sjweh.1394; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Perez M, 2009, J NEUROCHEM, V109, P1756, DOI 10.1111/j.1471-4159.2009.06102.x; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; TANNER CM, 1989, NEUROLOGY, V39, P660, DOI 10.1212/WNL.39.5.660; Thiruchelvam M, 2003, EUR J NEUROSCI, V18, P589, DOI 10.1046/j.1460-9568.2003.02781.x; Thiruchelvam M, 2000, J NEUROSCI, V20, P9207; Uversky VN, 2004, CELL TISSUE RES, V318, P225, DOI 10.1007/s00441-004-0937-z; Wills J, 2011, PLOS ONE IN PRESS; Wills J, 2010, EXP NEUROL, V225, P210, DOI 10.1016/j.expneurol.2010.06.017; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Wu GH, 2011, BRAIN RES, V1394, P105, DOI 10.1016/j.brainres.2011.04.013; Xilouri M, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001803; Yang W, 2007, HUM MOL GENET, V16, P2900, DOI 10.1093/hmg/ddm249; Yue ZY, 2009, BBA-MOL CELL RES, V1793, P1496, DOI 10.1016/j.bbamcr.2009.01.016; Zhou Y, 2004, NEUROSCIENCE, V128, P281, DOI 10.1016/j.neuroscience.2004.06.048	49	67	69	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30745	10.1371/journal.pone.0030745	http://dx.doi.org/10.1371/journal.pone.0030745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292029	Green Published, gold, Green Submitted			2022-12-27	WOS:000301570600075
J	Vathsala, PG; Dende, C; Nagaraj, VA; Bhattacharya, D; Das, G; Rangarajan, PN; Padmanaban, G				Vathsala, Palakkod G.; Dende, Chaitanya; Nagaraj, Viswanathan Arun; Bhattacharya, Debapriya; Das, Gobardhan; Rangarajan, Pundi N.; Padmanaban, Govindarajan			Curcumin-Arteether Combination Therapy of Plasmodium berghei-Infected Mice Prevents Recrudescence Through Immunomodulation	PLOS ONE			English	Article							ARTEMISININ RESISTANCE; CEREBRAL MALARIA; FALCIPARUM; IMMUNITY; RESPONSES; BLOOD; DIHYDROARTEMISININ; CHILDREN; ANTIBODY; CHABAUDI	Earlier studies in this laboratory have shown the potential of artemisinin-curcumin combination therapy in experimental malaria. In a parasite recrudescence model in mice infected with Plasmodium berghei (ANKA), a single dose of alpha, beta-arteether (ART) with three oral doses of curcumin prevented recrudescence, providing almost 95% protection. The parasites were completely cleared in blood with ART-alone (AE) or ART+curcumin (AC) treatments in the short-term, although the clearance was faster in the latter case involving increased ROS generation. But, parasites in liver and spleen were not cleared in AE or AC treatments, perhaps, serving as a reservoir for recrudescence. Parasitemia in blood reached up to 60% in AE-treated mice during the recrudescence phase, leading to death of animals. A transient increase of up to 2-3% parasitemia was observed in AC-treatment, leading to protection and reversal of splenomegaly. A striking increase in spleen mRNA levels for TLR2, IL-10 and IgG-subclass antibodies but a decrease in those for INF gamma and IL-12 was observed in AC-treatment. There was a striking increase in IL-10 and IgG subclass antibody levels but a decrease in INF gamma levels in sera leading to protection against recrudescence. AC-treatment failed to protect against recrudescence in TLR2(-/-) and IL-10(-/-) animals. IL-10 injection to AE-treated wild type mice and AC-treated TLR22/2 mice was able to prolong survival. Blood from the recrudescence phase in AE-treatment, but not from AC-treatment, was able to reinfect and kill naive animals. Sera from the recrudescence phase of AC-treated animals reacted with several parasite proteins compared to that from AE-treated animals. It is proposed that activation of TLR2-mediated innate immune response leading to enhanced IL-10 production and generation of anti-parasite antibodies contribute to protective immunity in AC-treated mice. These results indicate a potential for curcumin-based combination therapy to be tested for prevention of recrudescence in falciparum and relapse in vivax malaria.	[Vathsala, Palakkod G.; Dende, Chaitanya; Nagaraj, Viswanathan Arun; Rangarajan, Pundi N.; Padmanaban, Govindarajan] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Bhattacharya, Debapriya; Das, Gobardhan] Int Ctr Genet Engn & Biotechnol, New Delhi, India	Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Vathsala, PG (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	geepee@biochem.iisc.ernet.in	Dende, Chaitanya/AAC-8216-2022; Rangarajan, Pundi/A-7365-2009; Dende, Chaitanya/AAQ-1578-2021	Rangarajan, Pundi/0000-0002-6536-9891; Chaitanya, Dende/0000-0002-8135-5828	Department of Biotechnology, Government of India [BT/PR10541/Med/15/605/2008, BT/01/10/MPB/DT]; National Academy of Sciences, India-Chair	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); National Academy of Sciences, India-Chair	This study was supported by grants from the Department of Biotechnology, Government of India (BT/PR10541/Med/15/605/2008 and BT/01/10/MPB/DT). GP is supported by the National Academy of Sciences, India-Chair. VAN is a Ramanujan Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar F, 2011, BIOTECH ADV, V06408; Ang KKH, 2001, PARASITOL RES, V87, P715, DOI 10.1007/s004360000366; Awandare GA, 2006, J INFECT DIS, V194, P1438, DOI 10.1086/508547; Cui L, 2007, ANTIMICROB AGENTS CH, V51, P488, DOI 10.1128/AAC.01238-06; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Jagetia GC, 2007, J CLIN IMMUNOL, V27, P19, DOI 10.1007/s10875-006-9066-7; Joe B, 2004, CRIT REV FOOD SCI, V44, P97, DOI 10.1080/10408690490424702; Kamya Moses R, 2007, PLoS Clin Trials, V2, pe20, DOI 10.1371/journal.pctr.0020020; Karema C, 2006, T ROY SOC TROP MED H, V100, P1105, DOI 10.1016/j.trstmh.2006.01.001; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Landau I, 1999, PARASITE, V6, P311, DOI 10.1051/parasite/1999064311; Ma SH, 2007, EXP PARASITOL, V116, P266, DOI 10.1016/j.exppara.2007.01.007; Martinelli A, 2008, EXP PARASITOL, V119, P304, DOI 10.1016/j.exppara.2008.02.011; May LA, 2005, ANAL BIOCHEM, V337, P62, DOI 10.1016/j.ab.2004.10.037; Mimche PN, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S10; Mimche PN, 2011, MALARIA J S1, V10, P1; Nandakumar DN, 2006, ANTIMICROB AGENTS CH, V50, P1859, DOI 10.1128/AAC.50.5.1859-1860.2006; Nie CQ, 2007, INFECT IMMUN, V75, P2275, DOI 10.1128/IAI.01783-06; Niikura M, 2010, INT J PARASITOL, V40, P101, DOI 10.1016/j.ijpara.2009.08.009; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; Nunes JK, 2009, INFECT IMMUN, V77, P414, DOI 10.1128/IAI.00982-08; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Reddy RC, 2005, BIOCHEM BIOPH RES CO, V326, P472, DOI 10.1016/j.bbrc.2004.11.051; Riley EM, 2006, PARASITE IMMUNOL, V28, P35, DOI 10.1111/j.1365-3024.2006.00775.x; Ringman John M., 2005, Current Alzheimer Research, V2, P131, DOI 10.2174/1567205053585882; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sarciron ME, 2000, AM J TROP MED HYG, V62, P73, DOI 10.4269/ajtmh.2000.62.73; Shibui A, 2009, PARASITOL RES, V105, P281, DOI 10.1007/s00436-009-1435-8; Song YL, 2004, J BIOL CHEM, V279, P40629, DOI 10.1074/jbc.M407308200; Su Z, 2002, J IMMUNOL, V168, P1348, DOI 10.4049/jimmunol.168.3.1348; Tripathi AK, ANAL BIOCH, V325, P85; Waknine-Grinberg JH, 2010, EXP PARASITOL, V125, P141, DOI 10.1016/j.exppara.2010.01.005; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; Wykes MN, 2011, P NATL ACAD SCI USA, V108, P11205, DOI 10.1073/pnas.1108579108; Yeung S, 2004, AM J TROP MED HYG, V71, P179, DOI 10.4269/ajtmh.2004.71.179	40	51	53	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29442	10.1371/journal.pone.0029442	http://dx.doi.org/10.1371/journal.pone.0029442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276114	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000301568100011
J	Desmarais, BA; Cranmer, SJ				Desmarais, Bruce A.; Cranmer, Skyler J.			Statistical Inference for Valued-Edge Networks: The Generalized Exponential Random Graph Model	PLOS ONE			English	Article							INTERSTATE MIGRATION; LOGISTIC REGRESSIONS; COMMUNITY STRUCTURE; SOCIAL NETWORKS; LOGIT-MODELS; DISTRIBUTIONS; FRAMEWORK	Across the sciences, the statistical analysis of networks is central to the production of knowledge on relational phenomena. Because of their ability to model the structural generation of networks based on both endogenous and exogenous factors, exponential random graph models are a ubiquitous means of analysis. However, they are limited by an inability to model networks with valued edges. We address this problem by introducing a class of generalized exponential random graph models capable of modeling networks whose edges have continuous values (bounded or unbounded), thus greatly expanding the scope of networks applied researchers can subject to statistical analysis.	[Desmarais, Bruce A.] Univ Massachusetts, Dept Polit Sci, Amherst, MA 01003 USA; [Cranmer, Skyler J.] Univ N Carolina, Dept Polit Sci, Chapel Hill, NC USA	University of Massachusetts System; University of Massachusetts Amherst; University of North Carolina; University of North Carolina Chapel Hill	Desmarais, BA (corresponding author), Univ Massachusetts, Dept Polit Sci, Amherst, MA 01003 USA.	desmarais@polsci.umass.edu	Cranmer, Skyler/D-9414-2016	Cranmer, Skyler/0000-0002-6213-6400	University of Massachusetts Amherst College of Social and Behavioral Sciences; University of North Carolina at Chapel Hill's University Research Council	University of Massachusetts Amherst College of Social and Behavioral Sciences; University of North Carolina at Chapel Hill's University Research Council	This work was supported in part by a grant from the University of Massachusetts Amherst College of Social and Behavioral Sciences and by a grant from the University of North Carolina at Chapel Hill's University Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.228701; Bianconi G, 2001, PHYS REV LETT, V86, P5632, DOI 10.1103/PhysRevLett.86.5632; Butts CT, 2008, SOCIOL METHODOL, V38, P155, DOI 10.1111/j.1467-9531.2008.00203.x; Casella G, 2001, STAT INFERENCE, V2nd; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chun YW, 2008, J GEOGR SYST, V10, P317, DOI 10.1007/s10109-008-0068-2; CLARK GL, 1981, ECON GEOGR, V57, P95, DOI 10.2307/144135; Cranmer SJ, 2012, CONICT MANA IN PRESS; Cranmer SJ, 2011, POLIT ANAL, V19, P66, DOI 10.1093/pan/mpq037; FRANK O, 1986, J AM STAT ASSOC, V81, P832, DOI 10.2307/2289017; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A., 1996, MARKOV CHAIN MONTE C, P131, DOI DOI 10.1007/978-1-4899-4485-6_8; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; GENEST C, 1986, AM STAT, V40, P280, DOI 10.2307/2684602; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; GEYER CJ, 1992, J R STAT SOC B, V54, P657; Gill J, 2014, BAYESIAN METHODS SOC; Gimpel JG, 2001, J POLIT, V63, P207, DOI 10.1111/0022-3816.00065; Handcock Mark S, 2008, J Stat Softw, V24, P1548; Handcock MS., 2003, 39 U WASH CTR STAT S; HOLLAND PW, 1981, J AM STAT ASSOC, V76, P33, DOI 10.2307/2287037; Jian L, 2008, P 10 INT C EL COMM, p[4, 1]; Karrer B, 2010, PHYS REV E, P83; Karrer B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046110; Ke JH, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.028301; Ke JH, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056102; Kenett DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015032; Krivitsky PN, 2011, ARXIV11011359; Lee SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011233; Levine PB, 1999, J POPUL ECON, V12, P391, DOI 10.1007/s001480050105; Madi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017445; Mizera I, 2002, STAT PROBABIL LETT, V57, P79, DOI 10.1016/S0167-7152(02)00057-3; Mucha PJ, 2010, CHAOS, V20, DOI 10.1063/1.3518696; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Myers Seth, 2010, P INT C ADV NEURAL I, P1741; Newman MEJ, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.058701; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Park J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066146; Park J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066117; Plummer M., 2015, PACKAGE CODA; Preuhs RR, 1999, POLIT RES QUART, V52, P527; Richters O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018384; Rinaldo A, 2009, ELECTRON J STAT, V3, P446, DOI 10.1214/08-EJS350; Robins G, 1999, PSYCHOMETRIKA, V64, P371, DOI 10.1007/BF02294302; Saramaki J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.027105; Simpson SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020039; Snijders TAB., 2002, J SOCIAL STRUCTURE, V3(2), P1, DOI DOI 10.1016/j.socnet.2006.08.001; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; Stasinopoulos DM, 2007, J STAT SOFTW, V23; Vass JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018634; Villani M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017703; Wani JK, 1968, MATH P CAMBRIDGE PHI, V64, P481; Wasserman S, 1996, PSYCHOMETRIKA, V61, P401, DOI 10.1007/BF02294547; Wyatt D, 2010, AAAI CONF ARTIF INTE, P630; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang Y, 2008, PHYSICA A, V387, P1705, DOI 10.1016/j.physa.2007.11.004	57	65	65	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30136	10.1371/journal.pone.0030136	http://dx.doi.org/10.1371/journal.pone.0030136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	907YS	22276151	Green Published, Green Submitted, gold			2022-12-27	WOS:000301457200036
J	Joksimovic, M; Patel, M; Taketo, MM; Johnson, R; Awatramani, R				Joksimovic, Milan; Patel, Meera; Taketo, Makoto Mark; Johnson, Randy; Awatramani, Rajeshwar			Ectopic Wnt/Beta-Catenin Signaling Induces Neurogenesis in the Spinal Cord and Hindbrain Floor Plate	PLOS ONE			English	Article							MIDBRAIN DOPAMINE NEURONS; SONIC-HEDGEHOG; DEPENDENT MANNER; BETA-CATENIN; EXPRESSION; PROGENITORS; CELLS; DIFFERENTIATION; IDENTIFICATION; GENE	The most ventral structure of the developing neural tube, the floor plate (FP), differs in neurogenic capacity along the neuraxis. The FP is largely non-neurogenic at the hindbrain and spinal cord levels, but generates large numbers of dopamine (mDA) neurons at the midbrain levels. Wnt1, and other Wnts are expressed in the ventral midbrain, and Wnt/beta catenin signaling can at least in part account for the difference in neurogenic capacity of the FP between midbrain and hindbrain levels. To further develop the hypothesis that canonical Wnt signaling promotes mDA specification and FP neurogenesis, we have generated a model wherein beta-catenin is conditionally stabilized throughout the FP. Here, we unambiguously show by fate mapping FP cells in this mutant, that the hindbrain and spinal cord FP are rendered highly neurogenic, producing large numbers of neurons. We reveal that a neurogenic hindbrain FP results in the altered settling pattern of neighboring precerebellar neuronal clusters. Moreover, in this mutant, mDA progenitor markers are induced throughout the rostrocaudal axis of the hindbrain FP, although TH+ mDA neurons are produced only in the rostral aspect of rhombomere (r) 1. This is, at least in part, due to depressed Lmx1b levels by Wnt/ beta catenin signaling; indeed, when Lmx1b levels are restored in this mutant, mDA are observed not only in rostral r1, but also at more caudal axial levels in the hindbrain, but not in the spinal cord. Taken together, these data elucidate both patterning and neurogenic functions of Wnt/ beta catenin signaling in the FP, and thereby add to our understanding of the molecular logic of mDA specification and neurogenesis.	[Joksimovic, Milan; Patel, Meera; Awatramani, Rajeshwar] Northwestern Univ, Feinberg Med Sch, Dept Neurol, Chicago, IL 60611 USA; [Joksimovic, Milan; Patel, Meera; Awatramani, Rajeshwar] Northwestern Univ, Feinberg Med Sch, Ctr Genet Med, Chicago, IL 60611 USA; [Taketo, Makoto Mark] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Kyoto, Japan; [Johnson, Randy] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Kyoto University; University of Texas System; UTMD Anderson Cancer Center	Joksimovic, M (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	r-awatramani@northwestern.edu		Patel, Meera/0000-0003-3510-008X; Joksimovic, Milan/0000-0002-3936-4632	Whitehall Foundation; Brain Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052785] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Whitehall Foundation; Brain Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Whitehall Foundation and the Brain Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Moreno-Bravo JA, 2010, DEV DYNAM, V239, P2094, DOI 10.1002/dvdy.22327; Blaess S, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-29; Bonilla S, 2008, GLIA, V56, P809, DOI 10.1002/glia.20654; Cajanek L, 2009, STEM CELLS, V27, P2917, DOI 10.1002/stem.210; Castelo-Branco G, 2004, J CELL SCI, V117, P5731, DOI 10.1242/jcs.01505; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Chilov D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010881; Chung S, 2009, CELL STEM CELL, V5, P646, DOI 10.1016/j.stem.2009.09.015; Ferri ALM, 2007, DEVELOPMENT, V134, P2761, DOI 10.1242/dev.000141; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hayes L, 2011, J COMP NEUROL, V519, P3001, DOI 10.1002/cne.22711; Joksimovic M, 2009, P NATL ACAD SCI USA, V106, P19185, DOI 10.1073/pnas.0904285106; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; Kingsbury BF, 1920, J COMP NEUROL, V32, P113, DOI 10.1002/cne.900320106; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Li Y, 2010, DEVELOPMENT, V137, P1181, DOI 10.1242/dev.045237; Ono Y, 2007, DEVELOPMENT, V134, P3213, DOI 10.1242/dev.02879; Placzek M, 2005, NAT REV NEUROSCI, V6, P230, DOI 10.1038/nrn1628; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Ray RS, 2009, CURR OPIN CELL BIOL, V21, P741, DOI 10.1016/j.ceb.2009.10.003; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tang MZ, 2010, J NEUROSCI, V30, P9280, DOI 10.1523/JNEUROSCI.0860-10.2010; Tang MZ, 2009, DEVELOPMENT, V136, P2027, DOI 10.1242/dev.034330; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; Yu WY, 2008, DEVELOPMENT, V135, P3687, DOI 10.1242/dev.021899; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	31	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30266	10.1371/journal.pone.0030266	http://dx.doi.org/10.1371/journal.pone.0030266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276170	Green Published, Green Submitted, gold			2022-12-27	WOS:000301457200050
J	Katkoori, VR; Shanmugam, C; Jia, X; Vitta, SP; Sthanam, M; Callens, T; Messiaen, L; Chen, DQ; Zhang, B; Bumpers, HL; Samuel, T; Manne, U				Katkoori, Venkat R.; Shanmugam, Chandrakumar; Jia, Xu; Vitta, Swaroop P.; Sthanam, Meenakshi; Callens, Tom; Messiaen, Ludwine; Chen, Dongquan; Zhang, Bin; Bumpers, Harvey L.; Samuel, Temesgen; Manne, Upender			Prognostic Significance and Gene Expression Profiles of p53 Mutations in Microsatellite-Stable Stage III Colorectal Adenocarcinomas	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; NUCLEASE PROTECTION; CANCER; INSTABILITY; SURVIVAL; PROTEIN; BREAST; FAMILY; POLYMORPHISM; MECHANISM	Although the prognostic value of p53 abnormalities in Stage III microsatellite stable (MSS) colorectal cancers (CRCs) is known, the gene expression profiles specific to the p53 status in the MSS background are not known. Therefore, the current investigation has focused on identification and validation of the gene expression profiles associated with p53 mutant phenotypes in MSS Stage III CRCs. Genomic DNA extracted from 135 formalin-fixed paraffin-embedded tissues, was analyzed for microsatellite instability (MSI) and p53 mutations. Further, mRNA samples extracted from five p53-mutant and five p53-wild-type MSS-CRC snap-frozen tissues were profiled for differential gene expression by Affymetrix Human Genome U133 Plus 2.0 arrays. Differentially expressed genes were further validated by the high-throughput quantitative nuclease protection assay (qNPA), and confirmed by quantitative real-time polymerase chain reaction (qRT-PCR) and by immunohistochemistry (IHC). Survival rates were estimated by Kaplan-Meier and Cox regression analyses. A higher incidence of p53 mutations was found in MSS (58%) than in MSI (30%) phenotypes. Both univariate (log-rank, P = 0.025) and multivariate (hazard ratio, 2.52; 95% confidence interval, 1.25-5.08) analyses have demonstrated that patients with MSS-p53 mutant phenotypes had poor CRC-specific survival when compared to MSS-p53 wild-type phenotypes. Gene expression analyses identified 84 differentially expressed genes. Of 49 down-regulated genes, LPAR6, PDLIM3, and PLAT, and, of 35 upregulated genes, TRIM29, FUT3, IQGAP3, and SLC6A8 were confirmed by qNPA, qRT-PCR, and IHC platforms. p53 mutations are associated with poor survival of patients with Stage III MSS CRCs and p53-mutant and wild-type phenotypes have distinct gene expression profiles that might be helpful in identifying aggressive subsets.	[Katkoori, Venkat R.; Shanmugam, Chandrakumar; Jia, Xu; Vitta, Swaroop P.; Sthanam, Meenakshi; Manne, Upender] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Callens, Tom; Messiaen, Ludwine] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Chen, Dongquan] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; [Zhang, Bin] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Bumpers, Harvey L.] Morehouse Sch Med, Dept Surg, Atlanta, GA 30310 USA; [Samuel, Temesgen] Tuskegee Univ, Dept Pathol, Tuskegee, AL 36088 USA; [Manne, Upender] Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Morehouse School of Medicine; Tuskegee University; University of Alabama System; University of Alabama Birmingham	Katkoori, VR (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	manne@uab.edu	Vitta, Satish/K-7336-2015; Zhang, Bin/P-7459-2015	Vitta, Satish/0000-0003-4138-0022; 	National Institutes of Health/National Cancer Institute [U54-CA118948, R01-CA98932, R03-CA139629]; NATIONAL CANCER INSTITUTE [R03CA139629, U54CA118948, U54CA118623, R01CA098932] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds from the National Institutes of Health/National Cancer Institute (2U54-CA118948, R01-CA98932, and R03-CA139629) to Dr. Manne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; Allison PD, 1995, SURVIVAL ANAL USING, V292, pviii; Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Boland CR, 1998, CANCER RES, V58, P5248; Borresen-Dale AL, 1998, CLIN CANCER RES, V4, P203; Chittenden TW, 2008, GENOMICS, V91, P508, DOI 10.1016/j.ygeno.2008.03.002; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; COX DR, 1972, J R STAT SOC B, V34, P187; Dho SH, 2003, J BIOL CHEM, V278, P31902, DOI 10.1074/jbc.M304062200; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Edge SB, 2010, AJCC CANC STAGING MA; Elsaleh H, 2001, CLIN CANCER RES, V7, P1343; Fleiss J. L., 1981, STAT METHODS RATES P, V2; GOH HS, 1994, LANCET, V344, P233, DOI 10.1016/S0140-6736(94)93000-7; GREENBLATT MS, 1994, CANCER RES, V54, P4855; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jass JR, 2002, J GASTROEN HEPATOL, V17, P17, DOI 10.1046/j.1440-1746.2002.02635.x; JASS JR, 1995, LANCET, V346, P1200, DOI 10.1016/S0140-6736(95)92902-9; Jessup J, 1997, ARCH SURG-CHICAGO, V132, P374; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Jones AM, 2005, ONCOGENE, V24, P118, DOI 10.1038/sj.onc.1208194; Kaplan EL, 1958, J AM STAT ASSOC, P53; Katkoori VR, 2008, FRONT BIOSCI-LANDMRK, V13, P1050, DOI 10.2741/2742; Katkoori VR, 2009, CLIN CANCER RES, V15, P2406, DOI 10.1158/1078-0432.CCR-08-1719; Kopnin PB, 2007, CANCER RES, V67, P4671, DOI 10.1158/0008-5472.CAN-06-2466; Kosaka Y, 2007, ANN SURG ONCOL, V14, P2543, DOI 10.1245/s10434-007-9461-1; Kressner U, 1999, J CLIN ONCOL, V17, P593, DOI 10.1200/JCO.1999.17.2.593; Lee S, 2007, P NATL ACAD SCI USA, V104, P13732, DOI 10.1073/pnas.0701771104; Levine AJ, 2004, CELL, V116, pS69; Levine Arnold J., 2004, Cell, VS116, pS67, DOI 10.1016/S0092-8674(04)00036-4; Liu DP, 2010, ONCOGENE, V29, P949, DOI 10.1038/onc.2009.376; Loukola A, 2001, CANCER RES, V61, P4545; Manne U, 1997, INT J CANCER, V74, P346, DOI 10.1002/(SICI)1097-0215(19970620)74:3<346::AID-IJC19>3.0.CO;2-9; Martel RR, 2002, ASSAY DRUG DEV TECHN, V1, P61, DOI 10.1089/154065802761001310; Mollevi DG, 2007, CARCINOGENESIS, V28, P1241, DOI 10.1093/carcin/bgm012; Mooney CZ, 1993, BOOTSTRAPPING NONPAR, DOI DOI 10.4135/9781412983532; Nojima H, 2008, NAT CELL BIOL, V10, P971, DOI 10.1038/ncb1757; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Perucho M, 1996, BIOL CHEM, V377, P675; Popat S, 2005, EUR J CANCER, V41, P2060, DOI 10.1016/j.ejca.2005.04.039; Popat S, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-150; Powell B, 2000, CLIN CANCER RES, V6, P443; Pricolo VE, 1997, ARCH SURG-CHICAGO, V132, P371; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Roberts RA, 2007, LAB INVEST, V87, P979, DOI 10.1038/labinvest.3700665; Salahshor S, 2001, LAB INVEST, V81, P535, DOI 10.1038/labinvest.3780262; Samowitz WS, 2001, AM J PATHOL, V158, P1517, DOI 10.1016/S0002-9440(10)64102-8; Sanchez-Palencia A, 2010, INT J CANC EARLY ON; Shanmugam C, 2010, CANCER; Skaug V, 2000, CLIN CANCER RES, V6, P1031; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Sood AK, 1997, CANCER RES, V57, P1047; Stein L, 2010, THYROID, V20, P475, DOI 10.1089/thy.2009.0008; Su GH, 2001, P NATL ACAD SCI USA, V98, P3254, DOI 10.1073/pnas.051484398; Tang RP, 2004, CANCER LETT, V210, P101, DOI 10.1016/j.canlet.2004.01.006; Thakkar Arvind D, 2010, Biomark Cancer, V2, P1, DOI 10.4137/BIC.S3793; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wagner F, 2007, J BIOTECHNOL, V129, P628, DOI 10.1016/j.jbiotec.2007.02.015; Welter S, 2007, EUR J CARDIO-THORAC, V31, P167, DOI 10.1016/j.ejcts.2006.11.004; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; *WHO, 1990, INT CLASS DIS ONC; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yamashita H, 1997, CANCER, V80, P2268; Yin XY, 2010, CARBOHYD RES, V345, P2334, DOI 10.1016/j.carres.2010.07.028; Zaanan A, 2010, ANN ONCOL, V21, P772, DOI 10.1093/annonc/mdp383	68	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30020	10.1371/journal.pone.0030020	http://dx.doi.org/10.1371/journal.pone.0030020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276141	Green Published, Green Submitted, gold			2022-12-27	WOS:000301457200029
J	Rasmuson, A; Kock, A; Fuskevag, OM; Kruspig, B; Simon-Santamaria, J; Gogvadze, V; Johnsen, JI; Kogner, P; Sveinbjornsson, B				Rasmuson, Agnes; Kock, Anna; Fuskevag, Ole Martin; Kruspig, Bjorn; Simon-Santamaria, Jaione; Gogvadze, Vladimir; Johnsen, John Inge; Kogner, Per; Sveinbjornsson, Baldur			Autocrine Prostaglandin E-2 Signaling Promotes Tumor Cell Survival and Proliferation in Childhood Neuroblastoma	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; E-PROSTANOID RECEPTORS; GROWTH IN-VITRO; COLORECTAL-CANCER; DIFFERENTIAL EXPRESSION; COLON CARCINOGENESIS; KNOCKOUT MICE; MYCN PROTEIN; SUBTYPE EP1; PROGRESSION	Background: Prostaglandin E-2 (PGE(2)) is an important mediator in tumor-promoting inflammation. High expression of cyclooxygenase-2 (COX-2) has been detected in the embryonic childhood tumor neuroblastoma, and treatment with COX inhibitors significantly reduces tumor growth. Here, we have investigated the significance of a high COX-2 expression in neuroblastoma by analysis of PGE(2) production, the expression pattern and localization of PGE(2) receptors and intracellular signal transduction pathways activated by PGE(2). Principal Findings: A high expression of the PGE(2) receptors, EP1, EP2, EP3 and EP4 in primary neuroblastomas, independent of biological and clinical characteristics, was detected using immunohistochemistry. In addition, mRNA and protein corresponding to each of the receptors were detected in neuroblastoma cell lines. Immunofluorescent staining revealed localization of the receptors to the cellular membrane, in the cytoplasm, and in the nuclear compartment. Neuroblastoma cells produced PGE(2) and stimulation of serum-starved neuroblastoma cells with PGE(2) increased the intracellular concentration of calcium and cyclic AMP with subsequent phosphorylation of Akt. Addition of 16,16-dimethyl PGE(2) (dmPGE(2)) increased cell viability in a time, dose- and cell line-dependent manner. Treatment of neuroblastoma cells with a COX-2 inhibitor resulted in a diminished cell growth and viability that was reversed by the addition of dmPGE(2). Similarly, PGE(2) receptor antagonists caused a decrease in neuroblastoma cell viability in a dose- dependent manner. Conclusions: These findings demonstrate that PGE(2) acts as an autocrine and/or paracrine survival factor for neuroblastoma cells. Hence, specific targeting of PGE(2) signaling provides a novel strategy for the treatment of childhood neuroblastoma through the inhibition of important mediators of tumor-promoting inflammation.	[Rasmuson, Agnes; Kock, Anna; Johnsen, John Inge; Kogner, Per; Sveinbjornsson, Baldur] Karolinska Inst, Childhood Canc Res Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Fuskevag, Ole Martin] Univ Hosp N Norway, Dept Clin Pharmacol, Tromso, Norway; [Kruspig, Bjorn; Gogvadze, Vladimir] Karolinska Inst, Inst Environm Med, Div Toxicol, S-10401 Stockholm, Sweden; [Simon-Santamaria, Jaione] Univ Tromso, Vasc Biol Res Grp, Fac Med, Tromso, Norway; [Sveinbjornsson, Baldur] Univ Tromso, Div Immunol, Fac Hlth Sci, Tromso, Norway	Karolinska Institutet; UiT The Arctic University of Tromso; University Hospital of North Norway; Karolinska Institutet; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Rasmuson, A (corresponding author), Karolinska Inst, Childhood Canc Res Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden.	Agnes.Rasmuson@ki.se	Gogvadze, Vladimir/A-4392-2014	Kruspig, Bjorn/0000-0002-1712-5411; Johnsen, John Inge/0000-0003-1277-812X; Kogner, Per/0000-0002-2202-9694	Swedish Research Council; Swedish Children's Cancer Foundation; Swedish Cancer Society; Norwegian Cancer Society; Mary Beve Foundation; INTENT network; NBCNS network; ACT! thematic centre; Blix Family Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Children's Cancer Foundation; Swedish Cancer Society(Swedish Cancer Society); Norwegian Cancer Society(Norwegian Cancer Society); Mary Beve Foundation; INTENT network; NBCNS network; ACT! thematic centre; Blix Family Foundation	This work was supported by the Swedish Research Council, the Swedish Children's Cancer Foundation, the Swedish Cancer Society, the Norwegian Cancer Society, Mary Beve Foundation, the INTENT and NBCNS networks, the ACT! thematic centre and Blix Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN SZ, 1994, BIOCHEMISTRY-US, V33, P14496, DOI 10.1021/bi00252a016; Asano T, 2002, CLIN CANCER RES, V8, P1157; Baryawno N, 2008, NEURO-ONCOLOGY, V10, P661, DOI 10.1215/15228517-2008-035; Bhattacharya M, 1998, P NATL ACAD SCI USA, V95, P15792, DOI 10.1073/pnas.95.26.15792; Bhattacharya M, 1999, J BIOL CHEM, V274, P15719, DOI 10.1074/jbc.274.22.15719; Borland G, 2009, BRIT J PHARMACOL, V158, P70, DOI 10.1111/j.1476-5381.2008.00087.x; Breinig M, 2008, INT J CANCER, V122, P547, DOI 10.1002/ijc.23098; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Caren H, 2010, P NATL ACAD SCI USA, V107, P4323, DOI 10.1073/pnas.0910684107; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chell S, 2006, BBA-REV CANCER, V1766, P104, DOI 10.1016/j.bbcan.2006.05.002; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Choi SY, 2001, J NEUROCHEM, V79, P303; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Fischer SM, CANC PREV RES PHILA, V4, P1728; Gustafsson A, 2007, ACTA ONCOL, V46, P1107, DOI 10.1080/02841860701403061; Johnsen JI, 2008, ONCOGENE, V27, P2910, DOI 10.1038/sj.onc.1210938; Johnsen JI, 2004, CANCER RES, V64, P7210, DOI 10.1158/0008-5472.CAN-04-1795; Jones RL, 2009, BRIT J PHARMACOL, V158, P104, DOI 10.1111/j.1476-5381.2009.00317.x; Kaneko M, 2009, CANCER SCI, V100, P2193, DOI 10.1111/j.1349-7006.2009.01280.x; Kempen EC, 2001, ANAL BIOCHEM, V297, P183, DOI 10.1006/abio.2001.5325; Kitamura T, 2003, CANCER SCI, V94, P618, DOI 10.1111/j.1349-7006.2003.tb01492.x; Koch A, 2011, EUR J CANCER, V47, P1546, DOI 10.1016/j.ejca.2011.03.035; Koppen A, 2008, INT J CANCER, V122, P1455, DOI 10.1002/ijc.23180; Kryh H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-443; Lau L, 2007, ONCOGENE, V26, P1920, DOI 10.1038/sj.onc.1209981; Lee JL, 2005, J INVEST DERMATOL, V125, P818, DOI 10.1111/j.0022-202X.2005.23829.x; Li Z, 2010, CANCER; Ma XR, 2010, MOL CANCER RES, V8, P1310, DOI 10.1158/1541-7786.MCR-10-0003; Midgley RS, 2010, J CLIN ONCOL, V28, P4575, DOI 10.1200/JCO.2010.29.6244; Miyata Y, 2006, UROLOGY, V68, P1360, DOI 10.1016/j.urology.2006.09.035; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Mosmann T., 1983, J IMMUNOL METHODS, V65, P55, DOI DOI 10.1016/0022-1759(83)90303-4; Mutoh M, 2002, CANCER RES, V62, P28; Naviglio S, 2009, EXPERT OPIN THER TAR, V13, P83, DOI [10.1517/14728220802602349, 10.1517/14728220802602349 ]; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Ponthan F, 2007, CLIN CANCER RES, V13, P1036, DOI 10.1158/1078-0432.CCR-06-1908; Prasad KN, 2003, APOPTOSIS, V8, P579, DOI 10.1023/A:1026179324295; Rask K, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-62; Reynolds LM, 2001, NEUROSCI LETT, V309, P193, DOI 10.1016/S0304-3940(01)02071-7; Sartelet H, 2008, EXPERT REV ANTICANC, V8, P757, DOI 10.1586/14737140.8.5.757; Segerstrom L, 2011, INT J CANCER, V129, P2958, DOI 10.1002/ijc.26268; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; Sugino Y, 2007, ONCOGENE, V26, P7401, DOI 10.1038/sj.onc.1210550; Takafuji VA, 2002, PROSTAG LEUKOTR ESS, V66, P71, DOI 10.1054/plef.2001.0299; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang DZ, 2004, CANCER CELL, V6, P285, DOI 10.1016/j.ccr.2004.08.011; Watanabe K, 1999, CANCER RES, V59, P5093; Zhu T, 2006, CAN J PHYSIOL PHARM, V84, P377, DOI 10.1139/Y05-147	51	37	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29331	10.1371/journal.pone.0029331	http://dx.doi.org/10.1371/journal.pone.0029331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276108	Green Published, gold, Green Submitted			2022-12-27	WOS:000301457200009
J	Warrington, JP; Csiszar, A; Mitschelen, M; Lee, YW; Sonntag, WE				Warrington, Junie P.; Csiszar, Anna; Mitschelen, Matthew; Lee, Yong Woo; Sonntag, William E.			Whole Brain Radiation-Induced Impairments in Learning and Memory Are Time-Sensitive and Reversible by Systemic Hypoxia	PLOS ONE			English	Article							HIPPOCAMPAL NEUROGENESIS; COGNITIVE IMPAIRMENT; ADULT RATS; IONIZING-RADIATION; HYPOBARIC HYPOXIA; PERINATAL HYPOXIA; DENTATE GYRUS; STEM-CELLS; IRRADIATION; MICE	Whole brain radiation therapy (WBRT) is commonly used for treatment of primary and metastatic brain tumors; however, cognitive impairment occurs in 40-50% of brain tumor survivors. The etiology of the cognitive impairment following WBRT remains elusive. We recently reported that radiation-induced cerebrovascular rarefaction within hippocampal subregions could be completely reversed by systemic hypoxia. However, the effects of this intervention on learning and memory have not been reported. In this study, we assessed the time-course for WBRT-induced impairments in contextual and spatial learning and the capacity of systemic hypoxia to reverse WBRT-induced deficits in spatial memory. A clinical fractionated series of 4.5Gy WBRT was administered to mice twice weekly for 4 weeks, and after various periods of recovery, behavioral analyses were performed. To study the effects of systemic hypoxia, mice were subjected to 11% (hypoxia) or 21% oxygen (normoxia) for 28 days, initiated 1 month after the completion of WBRT. Our results indicate that WBRT induces a transient deficit in contextual learning, disruption of working memory, and progressive impairment of spatial learning. Additionally, systemic hypoxia completely reversed WBRT-induced impairments in learning and these behavioral effects as well as increased vessel density persisted for at least 2 months following hypoxia treatment. Our results provide critical support for the hypothesis that cerebrovascular rarefaction is a key component of cognitive impairment post-WBRT and indicate that processes of learning and memory, once thought to be permanently impaired after WBRT, can be restored.	[Warrington, Junie P.; Sonntag, William E.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Neurosci, Oklahoma City, OK 73190 USA; [Warrington, Junie P.; Csiszar, Anna; Mitschelen, Matthew; Sonntag, William E.] Univ Oklahoma, Hlth Sci Ctr, Reynolds Oklahoma Ctr Aging, Donald W Reynolds Dept Geriatr Med, Oklahoma City, OK USA; [Lee, Yong Woo] Virginia Tech, Sch Biomed Engn & Sci, Dept Biomed Sci & Pathobiol, Blacksburg, VA USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Virginia Polytechnic Institute & State University	Warrington, JP (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Neurosci, Oklahoma City, OK 73190 USA.	william-sonntag@ouhsc.edu	Warrington, Junie Paula/I-5782-2019	Warrington, Junie Paula/0000-0001-5626-8872; sonntag, William/0000-0003-1850-2407	National Institutes of Health [NS056218, AG11370]; American Heart Association; OUHSC GSA; Donald W. Reynolds Foundation; University of Oklahoma Health Sciences Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); OUHSC GSA; Donald W. Reynolds Foundation; University of Oklahoma Health Sciences Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the following grants: National Institutes of Health Grant: NS056218 and AG11370 (WES); American Heart Association Pre-doctoral Fellowship (JPW); OUHSC GSA Research Grant (JPW). The authors would like to express their gratitude for the support of the Donald W. Reynolds Foundation, which funds aging research at the University of Oklahoma Health Sciences Center under its Aging and Quality of Life Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta P, 2009, BEHAV NEUROSCI, V123, P1036, DOI 10.1037/a0016870; Acharya MM, 2009, P NATL ACAD SCI USA, V106, P19150, DOI 10.1073/pnas.0909293106; Akiyama K, 2001, NEUROL MED-CHIR, V41, P590, DOI 10.2176/nmc.41.590; American Brain Tumor Association, 2011, FACTS STAT; American Cancer Society, 2011, CANC FACTS FIG 2011; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BERTA S, 2007, PROTOCOL EXCHANGE; Brown WR, 2007, J NEUROL SCI, V257, P67, DOI 10.1016/j.jns.2007.01.014; Brown WR, 2005, RADIAT RES, V164, P662, DOI 10.1667/RR3453.1; Cao RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002748; Cengiz P, 2011, DEV NEUROSCI-BASEL, V33, P270, DOI 10.1159/000328430; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Clark PJ, 2009, HIPPOCAMPUS, V19, P937, DOI 10.1002/hipo.20543; Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9; Coremans V, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-2; DEANGELIS LM, 1989, NEUROLOGY, V39, P789, DOI 10.1212/WNL.39.6.789; Denko NC, 2008, NAT REV CANC; Fagel DM, 2006, EXP NEUROL, V199, P77, DOI 10.1016/j.expneurol.2005.04.006; Fisher M, 2009, STROKE, V40, pS13, DOI 10.1161/STROKEAHA.108.533117; Fishman K, 2009, FREE RADICAL BIO MED, V47, P1459, DOI 10.1016/j.freeradbiomed.2009.08.016; Hof PR, 2000, COMP CYTOACHITECTONI; Ingraham JP, 2008, J GERONTOL A-BIOL, V63, P12, DOI 10.1093/gerona/63.1.12; Jahanshahi M, 2011, FOLIA NEUROPATHOL, V49, P103; Jin K, 2002, J CLIN INVEST, V110, P311, DOI 10.1172/JCI200215251; Kamiryo T, 2001, NEUROSURGERY, V49, P409, DOI 10.1097/00006123-200108000-00026; Kang SG, 2010, NEUROSURGERY, V67, P711, DOI 10.1227/01.NEU.0000377859.06219.78; Khuntia D, 2006, J CLIN ONCOL, V24, P1295, DOI 10.1200/JCO.2005.04.6185; Kim S, 2011, NEUROSCI LETT, V498, P47, DOI 10.1016/j.neulet.2011.04.059; Koopmans G, 2003, PHYSIOL BEHAV, V79, P683, DOI 10.1016/S0031-9384(03)00171-9; LEE WH, 2011, INT J RAD ONCOLOGY B; Lee WH, 2010, INT J RADIAT BIOL, V86, P132, DOI 10.3109/09553000903419346; Li J, 2008, INT J RADIAT ONCOL, V71, P64, DOI 10.1016/j.ijrobp.2007.09.059; Li YQ, 2003, CANCER RES, V63, P5950; Li YQ, 2004, RADIAT RES, V161, P143, DOI 10.1667/RR3117; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Liu Y, 2010, AM J NEURORADIOL, V31, P383, DOI 10.3174/ajnr.A1801; Manda K, 2009, J PINEAL RES, V46, P71, DOI 10.1111/j.1600-079X.2008.00632.x; Marin-Burgin A., 2011, BEHAV BRAIN RES; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Monje M, 2008, DEV DISABIL RES REV, V14, P238, DOI 10.1002/ddrr.26; MUTHURAJU S, 2011, EUR J PHARM; Muthuraju S, 2011, INT J NEUROSCI, V121, P279, DOI 10.3109/00207454.2011.556279; Muthuraju S, 2010, EXP BRAIN RES, V203, P583, DOI 10.1007/s00221-010-2266-7; Nogues X., 2011, BEHAV BRAIN RES; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Shi L, 2008, INT J RADIAT ONCOL, V71, P526, DOI 10.1016/j.ijrobp.2008.02.015; Shi L, 2006, RADIAT RES, V166, P892, DOI 10.1667/RR0588.1; SILBER JH, 1992, J CLIN ONCOL, V10, P1390, DOI 10.1200/JCO.1992.10.9.1390; Titus ADJ, 2007, NEUROSCIENCE, V145, P265, DOI 10.1016/j.neuroscience.2006.11.037; Troen AM, 2008, P NATL ACAD SCI USA, V105, P12474, DOI 10.1073/pnas.0805350105; Udagawa T, 2007, CANCER RES, V67, P2040, DOI 10.1158/0008-5472.CAN-06-2877; Vilar J, 2008, CIRC RES, V103, P761, DOI 10.1161/CIRCRESAHA.108.182758; Warrington JP, 2011, AM J PHYSIOL-HEART C, V300, pH736, DOI 10.1152/ajpheart.01024.2010; Welzel G, 2008, STRAHLENTHER ONKOL, V184, P647, DOI 10.1007/s00066-008-1830-6; Welzel G, 2008, INT J RADIAT ONCOL, V72, P1311, DOI 10.1016/j.ijrobp.2008.03.009; Zhu CL, 2009, J NEUROCHEM, V111, P1447, DOI 10.1111/j.1471-4159.2009.06413.x; Zhu XH, 2010, J NEUROSCI, V30, P12653, DOI 10.1523/JNEUROSCI.6414-09.2010	60	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30444	10.1371/journal.pone.0030444	http://dx.doi.org/10.1371/journal.pone.0030444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279591	Green Submitted, gold, Green Published			2022-12-27	WOS:000299771900068
J	Fu, GL; Miles, A; Alphey, L				Fu, Guoliang; Miles, Andrea; Alphey, Luke			Multiplex Detection and SNP Genotyping in a Single Fluorescence Channel	PLOS ONE			English	Article							REAL-TIME PCR; DIAGNOSTIC VIROLOGY; PAPILLOMAVIRUS; MICROBIOLOGY; ASSAYS	Probe-based PCR is widely used for SNP (single nucleotide polymorphism) genotyping and pathogen nucleic acid detection due to its simplicity, sensitivity and cost-effectiveness. However, the multiplex capability of hydrolysis probe-based PCR is normally limited to one target (pathogen or allele) per fluorescence channel. Current fluorescence PCR machines typically have 4-6 channels. We present a strategy permitting the multiplex detection of multiple targets in a single detection channel. The technique is named Multiplex Probe Amplification (MPA). Polymorphisms of the CYP2C9 gene (cytochrome P450, family 2, subfamily C, polypeptide 9, CYP2C9*2) and human papillomavirus sequences HPV16, 18, 31, 52 and 59 were chosen as model targets for testing MPA. The allele status of the CYP2C9*2 determined by MPA was entirely concordant with the reference TaqMan (R) SNP Genotyping Assays. The four HPV strain sequences could be independently detected in a single fluorescence detection channel. The results validate the multiplex capacity, the simplicity and accuracy of MPA for SNP genotyping and multiplex detection using different probes labeled with the same fluorophore. The technique offers a new way to multiplex in a single detection channel of a closed-tube PCR.	[Fu, Guoliang; Miles, Andrea; Alphey, Luke] Oxitec Ltd, Oxford, England; [Fu, Guoliang; Alphey, Luke] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Fu, GL (corresponding author), Oxitec Ltd, Oxford, England.	guoliang.fu@genefirst.com; luke.alphey@oxitec.com		Alphey, Luke/0000-0002-2916-3802	Oxitec Ltd.	Oxitec Ltd.	This work is funded by Oxitec Ltd. As the authors are employed by the funder Oxitec Ltd, the funder did play a role in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Barken KB, 2007, CLIN CHIM ACTA, V384, P1, DOI 10.1016/j.cca.2007.07.004; Boulet GAV, 2008, CANCER EPIDEM BIOMAR, V17, P810, DOI 10.1158/1055-9965.EPI-07-2865; Butler JM, 2007, BIOTECHNIQUES, V43, P2; DURST M, 1987, P NATL ACAD SCI USA, V84, P1070, DOI 10.1073/pnas.84.4.1070; EDWARDS MC, 1994, PCR METH APPL, V3, pS65; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Gunson RN, 2006, J CLIN VIROL, V35, P355, DOI 10.1016/j.jcv.2005.12.006; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Huang QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016033; King CR, 2008, AM J CLIN PATHOL, V129, P876, DOI 10.1309/1E34UAPR06PJ6HML; Langley MR, 2009, J MOL DIAGN, V11, P216, DOI 10.2353/jmoldx.2009.080123; Mackay IM, 2004, CLIN MICROBIOL INFEC, V10, P190, DOI 10.1111/j.1198-743X.2004.00722.x; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; Molenkamp R, 2007, J VIROL METHODS, V141, P205, DOI 10.1016/j.jviromet.2006.12.007; Rooney Patrick H, 2005, Methods Mol Biol, V293, P27; Schmitt M, 2008, J CLIN MICROBIOL, V46, P1050, DOI 10.1128/JCM.02227-07; Settanni L, 2007, J MICROBIOL METH, V69, P1, DOI 10.1016/j.mimet.2006.12.008; Wittwer CT, 2001, METHODS, V25, P430, DOI 10.1006/meth.2001.1265; Yeh HY, 2009, SEMIN CELL DEV BIOL, V20, P49, DOI 10.1016/j.semcdb.2009.01.012	20	11	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30340	10.1371/journal.pone.0030340	http://dx.doi.org/10.1371/journal.pone.0030340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272339	Green Published, gold, Green Submitted			2022-12-27	WOS:000301454400117
J	Nagaraj, RH; Panda, AK; Shanthakumar, S; Santhoshkumar, P; Pasupuleti, N; Wang, BL; Biswas, A				Nagaraj, Ram H.; Panda, Alok Kumar; Shanthakumar, Shilpa; Santhoshkumar, Puttur; Pasupuleti, NagaRekha; Wang, Benlian; Biswas, Ashis			Hydroimidazolone Modification of the Conserved Arg12 in Small Heat Shock Proteins: Studies on the Structure and Chaperone Function Using Mutant Mimics	PLOS ONE			English	Article							ALPHA-A-CRYSTALLIN; HUMAN LENS PROTEINS; N-TERMINAL REGION; B-CRYSTALLIN; MOLECULAR CHAPERONE; METHYLGLYOXAL MODIFICATION; MAILLARD REACTION; POSTTRANSLATIONAL MODIFICATIONS; NONOCULAR TISSUES; HEAT-SHOCK-PROTEIN-27	Methylglyoxal (MGO) is an alpha-dicarbonyl compound present ubiquitously in the human body. MGO reacts with arginine residues in proteins and forms adducts such as hydroimidazolone and argpyrimidine in vivo. Previously, we showed that MGO-mediated modification of alpha A-crystallin increased its chaperone function. We identified MGO-modified arginine residues in alpha A-crystallin and found that replacing such arginine residues with alanine residues mimicked the effects of MGO on the chaperone function. Arginine 12 (R12) is a conserved amino acid residue in Hsp27 as well as alpha A- and alpha B-crystallin. When treated with MGO at or near physiological concentrations (2-10 mu M), R12 was modified to hydroimidazolone in all three small heat shock proteins. In this study, we determined the effect of arginine substitution with alanine at position 12 (R12A to mimic MGO modification) on the structure and chaperone function of these proteins. Among the three proteins, the R12A mutation improved the chaperone function of only alpha A-crystallin. This enhancement in the chaperone function was accompanied by subtle changes in the tertiary structure, which increased the thermodynamic stability of alpha A-crystallin. This mutation induced the exposure of additional client protein binding sites on alpha A-crystallin. Altogether, our data suggest that MGO-modification of the conserved R12 in alpha A-crystallin to hydroimidazolone may play an important role in reducing protein aggregation in the lens during aging and cataract formation.	[Nagaraj, Ram H.; Shanthakumar, Shilpa; Pasupuleti, NagaRekha] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Panda, Alok Kumar; Biswas, Ashis] Indian Inst Technol Bhubaneswar, Sch Basic Sci, Bhubaneswar, Orissa, India; [Santhoshkumar, Puttur] Univ Missouri, Dept Ophthalmol, Columbia, MO USA; [Wang, Benlian] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA	Case Western Reserve University; Indian Institute of Technology System (IIT System); Indian Institute of Technology Bhubaneswar; University of Missouri System; University of Missouri Columbia; Case Western Reserve University	Nagaraj, RH (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA.	ram.nagaraj@case.edu; abiswas@iitbbs.ac.in	Pasupuleti, Nagarekha/B-5763-2015; PANDA, ALOK/G-6818-2015; Santhoshkumar, Puttur/G-1798-2010	PANDA, ALOK/0000-0002-4452-993X; Santhoshkumar, Puttur/0000-0002-6897-7278	NIH [R01EY-016219, R01EY-09912, P30EY-11373]; Research to Prevent Blindness; Ohio Lions Eye Research Foundation; DST SERC FAST TRACK (Department of Science & Technology Science and Engineering Research Council) India [SR/FT/CS-039/2009]; NATIONAL EYE INSTITUTE [P30EY011373, R01EY016219, R01EY009912] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; DST SERC FAST TRACK (Department of Science & Technology Science and Engineering Research Council) India; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported from NIH grants R01EY-016219 and R01EY-09912 (RHN), P30EY-11373 (the Visual Sciences Research Center of CWRU); Research to Prevent Blindness, NY; the Ohio Lions Eye Research Foundation and a DST SERC FAST TRACK (Department of Science & Technology Science and Engineering Research Council), India grant SR/FT/CS-039/2009 (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2003, INVEST OPHTH VIS SCI, V44, P5287, DOI 10.1167/iovs.03-0573; Baynes JW, 2001, EXP GERONTOL, V36, P1527, DOI 10.1016/S0531-5565(01)00138-3; Bera S, 2002, BIOCHEMISTRY-US, V41, P12421, DOI 10.1021/bi0204140; Bhagyalaxmi SG, 2009, BBA-MOL BASIS DIS, V1792, P974, DOI 10.1016/j.bbadis.2009.06.011; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Bhattacharyya J, 2002, J PROTEIN CHEM, V21, P65, DOI 10.1023/A:1014187300930; Biswas A, 2007, PROTEIN J, V26, P247, DOI 10.1007/s10930-006-9066-8; Biswas A, 2006, BIOCHEMISTRY-US, V45, P4569, DOI 10.1021/bi052574s; Biswas A, 2004, J BIOL CHEM, V279, P42648, DOI 10.1074/jbc.M404444200; Biswas A, 2008, J BIOCHEM, V144, P21, DOI 10.1093/jb/mvn037; Biswas A, 2007, BIOPOLYMERS, V85, P189, DOI 10.1002/bip.20630; Biswas A, 2007, BIOCHEMISTRY-US, V46, P1117, DOI 10.1021/bi061323w; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Chellan P, 1999, ARCH BIOCHEM BIOPHYS, V368, P98, DOI 10.1006/abbi.1999.1291; CHERIAN M, 1995, BIOCHEM BIOPH RES CO, V208, P675, DOI 10.1006/bbrc.1995.1391; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Degenhardt TP, 1998, CELL MOL BIOL, V44, P1139; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; Derham BK, 1999, PROG RETIN EYE RES, V18, P463, DOI 10.1016/S1350-9462(98)00030-5; DUBIN RA, 1989, MOL CELL BIOL, V9, P1083, DOI 10.1128/MCB.9.3.1083; Fu XM, 2005, J BIOL CHEM, V280, P6337, DOI 10.1074/jbc.M406319200; Fujii N, 2001, PHOTOCHEM PHOTOBIOL, V74, P477, DOI 10.1562/0031-8655(2001)074<0477:CBTLOT>2.0.CO;2; Gangadhariah MH, 2010, BBA-MOL BASIS DIS, V1802, P432, DOI 10.1016/j.bbadis.2010.01.010; Ghosh JG, 2006, BIOCHEMISTRY-US, V45, P13847, DOI 10.1021/bi061471m; Gupta R, 2004, J BIOL CHEM, V279, P44258, DOI 10.1074/jbc.M405648200; HAIK GM, 1994, EXP EYE RES, V59, P497, DOI 10.1006/exer.1994.1135; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; HORWITZ J, 1993, INVEST OPHTH VIS SCI, V34, P10; Ito K, 2001, J BIOL CHEM, V276, P5346, DOI 10.1074/jbc.M009004200; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kumar MS, 2005, J BIOL CHEM, V280, P21726, DOI 10.1074/jbc.M500405200; Kumar MS, 2004, BIOCHEM J, V379, P273, DOI 10.1042/BJ20031633; Kumar P. A., 2011, J BIOPHYS STRUCTURAL, V3, P30; Kundu M, 2007, BIOPOLYMERS, V86, P177, DOI 10.1002/bip.20716; LO TWC, 1994, J BIOL CHEM, V269, P32299; Nagaraj RH, 2003, BIOCHEMISTRY-US, V42, P10746, DOI 10.1021/bi034541n; Nagaraj RH, 1996, FEBS LETT, V382, P234, DOI 10.1016/0014-5793(96)00142-1; Nagaraj RH, 2010, AMINO ACIDS IN PRESS; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Oya-Ito T, 2006, J CELL BIOCHEM, V99, P279, DOI 10.1002/jcb.20781; Oya-Ito T, 2011, BBA-MOL BASIS DIS, V1812, P769, DOI 10.1016/j.bbadis.2011.03.017; Padayatti PS, 2001, INVEST OPHTH VIS SCI, V42, P1299; Padival AK, 2003, FEBS LETT, V551, P113, DOI 10.1016/S0014-5793(03)00874-3; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Raju M, 2011, MOL VIS, V17, P7; RAMAN B, 1995, FEBS LETT, V365, P133, DOI 10.1016/0014-5793(95)00440-K; Rao CM, 1998, INT J BIOL MACROMOL, V22, P271; Reddy GB, 2000, J BIOL CHEM, V275, P4565, DOI 10.1074/jbc.275.7.4565; Saha S, 2004, PROTEINS, V57, P610, DOI 10.1002/prot.20230; Sakamoto H, 2002, J BIOL CHEM, V277, P45770, DOI 10.1074/jbc.M207485200; SPECTOR A, 1971, BIOCHEM J, V124, P337, DOI 10.1042/bj1240337; Sreelakshmi Y, 2005, BIOCHEMISTRY-US, V44, P12245, DOI 10.1021/bi051005h; SRINIVASAN AN, 1992, J BIOL CHEM, V267, P23337; Sun TX, 1999, J BIOL CHEM, V274, P34067, DOI 10.1074/jbc.274.48.34067; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; WellsKnecht KJ, 1996, NEPHROL DIAL TRANSPL, V11, P41; Wilker SC, 2001, ANAL BIOCHEM, V290, P353, DOI 10.1006/abio.2001.4992; Wilmarth PA, 2006, J PROTEOME RES, V5, P2554, DOI 10.1021/pr050473a	60	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30257	10.1371/journal.pone.0030257	http://dx.doi.org/10.1371/journal.pone.0030257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272318	Green Published, gold, Green Submitted			2022-12-27	WOS:000301454400096
J	Weng, JW; Fan, KN; Wang, WN				Weng, Jingwei; Fan, Kangnian; Wang, Wenning			The Conformational Transition Pathways of ATP-Binding Cassette Transporter BtuCD Revealed by Targeted Molecular Dynamics Simulation	PLOS ONE			English	Article							ABC TRANSPORTER; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURES; MECHANISM; PROTEIN; CYCLE; FLEXIBILITY; SUGGEST; DISEASE; SYSTEMS	BtuCD is a member of the ATP-binding cassette transporters in Escherichia coli that imports vitamin B-12 into the cell by utilizing the energy of ATP hydrolysis. Crystal structures of BtuCD and its homologous protein HI1470/1 in various conformational states support the "alternating access'' mechanism which proposes the conformational transitions of the substrate translocation pathway at transmembrane domain (TMD) between the outward-facing and inward-facing states. The conformational transition at TMD is assumed to couple with the movement of the cytoplasmic nucleotide-binding domains (NBDs) driven by ATP hydrolysis/binding. In this study, we performed targeted molecular dynamics (MD) simulations to explore the atomic details of the conformational transitions of BtuCD importer. The outward-facing to inward-facing (O -> I) transition was found to be initiated by the conformational movement of NBDs. The subsequent reorientation of the substrate translocation pathway at TMD began with the closing of the periplasmic gate, followed by the opening of the cytoplamic gate in the last stage of the conformational transition due to the extensive hydrophobic interactions at this region, consistent with the functional requirement of unidirectional transport of the substrates. The reverse inward-facing to outward-facing (I -> O) transition was found to exhibit intrinsic diversity of the conformational transition pathways and significant structural asymmetry, suggesting that the asymmetric crystal structure of BtuCD-F is an intermediate state in this process.	[Weng, Jingwei] Fudan Univ, Dept Chem, Shanghai Key Lab Mol Catalysis & Innovat Mat, Shanghai 200433, Peoples R China; Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Weng, JW (corresponding author), Fudan Univ, Dept Chem, Shanghai Key Lab Mol Catalysis & Innovat Mat, Shanghai 200433, Peoples R China.	wnwang@fudan.edu.cn	Fan, K/GXH-3734-2022		National Major Basic Research Program of China [2009CB918600, 2011CB808505]; National Science Foundation of China [20973040, 31070642]; Science and Technology Commission of Shanghai Municipality [08DZ2270500]; Shanghai Leading Academic Discipline Project [B108]	National Major Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the National Major Basic Research Program of China (2009CB918600, 2011CB808505), the National Science Foundation of China (20973040, 31070642), the Science and Technology Commission of Shanghai Municipality (08DZ2270500), and the Shanghai Leading Academic Discipline Project (B108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Feller SE, 1997, BIOPHYS J, V73, P2269, DOI 10.1016/S0006-3495(97)78259-6; Fiser A, 2003, MACROMOLECULAR CRYST; Fitzgerald ML, 2010, ATHEROSCLEROSIS, V211, P361, DOI 10.1016/j.atherosclerosis.2010.01.011; Goetz BA, 2009, FEBS LETT, V583, P266, DOI 10.1016/j.febslet.2008.12.020; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Huang H, 2009, J CHEM THEORY COMPUT, V5, P1304, DOI 10.1021/ct9000153; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Ivetac A, 2007, BIOCHEMISTRY-US, V46, P2767, DOI 10.1021/bi0622571; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joseph B, 2011, J BIOL CHEM, V286, P41008, DOI 10.1074/jbc.M111.269472; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Kandt C, 2010, PROTEINS, V78, P738, DOI 10.1002/prot.22606; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Law RJ, 2008, BIOPHYS J, V95, P2739, DOI 10.1529/biophysj.107.128025; Lewinson O, 2010, NAT STRUCT MOL BIOL, V17, P332, DOI 10.1038/nsmb.1770; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marco E, 2007, J BIOL CHEM, V282, P28779, DOI 10.1074/jbc.M700349200; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Oloo EO, 2004, J BIOL CHEM, V279, P45013, DOI 10.1074/jbc.M405084200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; SCHLITTER J, 1993, MOL SIMULAT, V10, P291, DOI 10.1080/08927029308022170; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sonne J, 2007, BIOPHYS J, V92, P2727, DOI 10.1529/biophysj.106.097972; Swift RV, 2008, BIOCHEMISTRY-US, V47, P4102, DOI 10.1021/bi8000209; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Weng JW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.056432; Weng JW, 2008, BIOPHYS J, V94, P612, DOI 10.1529/biophysj.107.110734; Weng JW, 2009, BIOPHYS J, V96, P1918, DOI 10.1016/j.bpj.2008.11.035	48	29	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30465	10.1371/journal.pone.0030465	http://dx.doi.org/10.1371/journal.pone.0030465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272354	gold, Green Published, Green Submitted			2022-12-27	WOS:000301454400132
J	Zhang, JT; Liu, H; Sun, J; Li, B; Zhu, Q; Chen, SL; Zhang, HX				Zhang, Jiantao; Liu, Hua; Sun, Jian; Li, Bei; Zhu, Qiang; Chen, Shaoliang; Zhang, Hongxia			Arabidopsis Fatty Acid Desaturase FAD2 Is Required for Salt Tolerance during Seed Germination and Early Seedling Growth	PLOS ONE			English	Article							CHLOROPLAST OMEGA-3-FATTY-ACID DESATURASE; STRESS TOLERANCE; LOW-TEMPERATURE; CALCIUM SENSOR; SACCHAROMYCES-CEREVISIAE; COLD TOLERANCE; PROTEIN-KINASE; GENE; EXPRESSION; PLANTS	Fatty acid desaturases play important role in plant responses to abiotic stresses. However, their exact function in plant resistance to salt stress is unknown. In this work, we provide the evidence that FAD2, an endoplasmic reticulum localized omega-desaturase, is required for salt tolerance in Arabidopsis. Using vacuolar and plasma membrane vesicles prepared from the leaves of wild-type (Col-0) and the loss-of-function Arabidopsis mutant, fad2, which lacks the functional FAD2, we examined the fatty acid composition and Na+-dependent H+ movements of the isolated vesicles. We observed that, when compared to Col-0, the level of vacuolar and plasma membrane polyunsaturation was lower, and the Na+/H+ exchange activity was reduced in vacuolar and plasma membrane vesicles isolated from fad2 mutant. Consistent with the reduced Na+/H+ exchange activity, fad2 accumulated more Na+ in the cytoplasm of root cells, and was more sensitive to salt stress during seed germination and early seedling growth, as indicated by CoroNa-Green staining, net NaNa+ efflux and salt tolerance analyses. Our results suggest that FAD2 mediated high-level vacuolar and plasma membrane fatty acid desaturation is essential for the proper function of membrane attached Na+/H+ exchangers, and thereby to maintain a low cytosolic NaNa+ concentration for salt tolerance during seed germination and early seedling growth in Arabidopsis.	[Zhang, Jiantao; Liu, Hua; Li, Bei; Zhu, Qiang; Zhang, Hongxia] Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Sun, Jian; Chen, Shaoliang] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Beijing Forestry University	Zhang, JT (corresponding author), Texas A&M Univ Syst, Texas AgriLife Res Ctr, Dept Plant Pathol & Microbiol, Weslaco, TX USA.	hxzhang@sippe.ac.cn	Zhang, Jiantao/I-5116-2014; LIU, HUA/M-7659-2019; Wang, Zhibo/GSD-3371-2022	Chen, Shaoliang/0000-0001-7511-3067; Zhang, Jiantao/0000-0002-2875-9743; Sun, Jian/0000-0002-1434-4029	National Natural Science Foundation of China [30872044, 30800880, 3100012, 31000288, 31171169, 31101154]; National Basic Research Program of China [2010CB126600]; National mega project of GMO crops [2008ZX08001-003, 2008ZX08004-002, 2008ZX08010-004]; Shanghai Science & Technology Development Fund [0853Z111C1, 08DZ2270800]; Fundamental Research Funds for the Central Universities [JC2011-2, BLYJ200903]; Foundation for the Supervisors of Excellent Doctoral Dissertations of Beijing [YB20081002201]; Beijing Natural Science Foundation [6112017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National mega project of GMO crops; Shanghai Science & Technology Development Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Foundation for the Supervisors of Excellent Doctoral Dissertations of Beijing; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the National Natural Science Foundation of China (30872044; 30800880; 3100012; 31000288; 31171169; 31101154); the National Basic Research Program of China (2010CB126600); the National mega project of GMO crops (2008ZX08001-003; 2008ZX08004-002; 2008ZX08010-004); Shanghai Science & Technology Development Fund (0853Z111C1; 08DZ2270800); the Fundamental Research Funds for the Central Universities (JC2011-2; BLYJ200903); Foundation for the Supervisors of Excellent Doctoral Dissertations of Beijing (YB20081002201); and Beijing Natural Science Foundation (6112017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdiev SI, 1999, P NATL ACAD SCI USA, V96, P5862, DOI 10.1073/pnas.96.10.5862; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Apse MP, 2002, CURR OPIN BIOTECH, V13, P146, DOI 10.1016/S0958-1669(02)00298-7; BLUMWALD E, 1987, PHYSIOL PLANTARUM, V69, P731, DOI 10.1111/j.1399-3054.1987.tb01993.x; BROWSE J, 1989, PLANT PHYSIOL, V90, P522, DOI 10.1104/pp.90.2.522; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COOKE DT, 1990, PHYSIOL PLANTARUM, V78, P153, DOI 10.1111/j.1399-3054.1990.tb08730.x; Covello PS, 1996, PLANT PHYSIOL, V111, P223, DOI 10.1104/pp.111.1.223; Craig W, 2008, TRANSGENIC RES, V17, P769, DOI 10.1007/s11248-008-9164-9; DEUTICKE B, 1987, ANNU REV PHYSIOL, V49, P221; Fiehn O, 2000, ANAL CHEM, V72, P3573, DOI 10.1021/ac991142i; Gevaudant F, 2007, PLANT PHYSIOL, V144, P1763, DOI 10.1104/pp.107.103762; GIBSON S, 1994, PLANT PHYSIOL, V106, P1615, DOI 10.1104/pp.106.4.1615; GRAHAM D, 1982, ANNU REV PLANT PHYS, V33, P347, DOI 10.1146/annurev.pp.33.060182.002023; Im YJ, 2002, MOL CELLS, V13, P264; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kajiwara S, 1996, APPL ENVIRON MICROB, V62, P4309, DOI 10.1128/AEM.62.12.4309-4313.1996; Kargiotidou A, 2008, J EXP BOT, V59, P2043, DOI 10.1093/jxb/ern065; Khodakovskaya M, 2006, PLANTA, V223, P1090, DOI 10.1007/s00425-005-0161-4; Kim KN, 2003, PLANT CELL, V15, P411, DOI 10.1105/tpc.006858; KODAMA H, 1994, PLANT PHYSIOL, V105, P601, DOI 10.1104/pp.105.2.601; KODAMA H, 1995, PLANT PHYSIOL, V107, P1177, DOI 10.1104/pp.107.4.1177; Liu W, 2003, PLANT J, V36, P189, DOI 10.1046/j.1365-313X.2003.01866.x; Liu XY, 2006, J INTEGR PLANT BIOL, V48, P1096, DOI 10.1111/j.1744-7909.2006.00335.x; Maeda H, 2008, PLANT CELL, V20, P452, DOI 10.1105/tpc.107.054718; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Mikami K, 2003, PROG LIPID RES, V42, P527, DOI 10.1016/S0163-7827(03)00036-5; MIQUEL M, 1993, P NATL ACAD SCI USA, V90, P6208, DOI 10.1073/pnas.90.13.6208; MIQUEL MF, 1994, PLANT PHYSIOL, V106, P421, DOI 10.1104/pp.106.2.421; Murakami Y, 2000, SCIENCE, V287, P476, DOI 10.1126/science.287.5452.476; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ogawa D, 2007, J EXP BOT, V58, P3373, DOI 10.1093/jxb/erm184; Oh DH, 2009, PLANT PHYSIOL, V151, P210, DOI 10.1104/pp.109.137802; Pandey GK, 2007, CELL RES, V17, P411, DOI 10.1038/cr.2007.39; Pandey GK, 2005, PLANT PHYSIOL, V139, P1185, DOI 10.1104/pp.105.066324; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Rodriguez-Vargas S, 2007, APPL ENVIRON MICROB, V73, P110, DOI 10.1128/AEM.01360-06; Routaboul JM, 2000, PLANT PHYSIOL, V124, P1697, DOI 10.1104/pp.124.4.1697; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Steponkus P.L., 1993, ADV LOW TEMPERATURE, V2, P211; Sun J, 2009, PLANT PHYSIOL, V149, P1141, DOI 10.1104/pp.108.129494; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; Verslues PE, 2007, PLANT MOL BIOL, V64, P205, DOI 10.1007/s11103-007-9145-z; Wallis JG, 2002, PROG LIPID RES, V41, P254, DOI 10.1016/S0163-7827(01)00027-3; Wang B, 2006, J EXP BOT, V57, P1161, DOI 10.1093/jxb/erj116; Wang B., 1995, PLANT PHYSL COMMUN, V31, P50; Yang L, 2008, PLANT MOL BIOL, V66, P329, DOI 10.1007/s11103-007-9267-3; Yoshimura K, 2004, PLANT J, V37, P21, DOI 10.1046/j.1365-313X.2003.01930.x; Zhang JT, 2009, BIOCHEM BIOPH RES CO, V390, P469, DOI 10.1016/j.bbrc.2009.09.095; Zhang M, 2005, PLANT J, V44, P361, DOI 10.1111/j.1365-313X.2005.02536.x	51	147	171	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30355	10.1371/journal.pone.0030355	http://dx.doi.org/10.1371/journal.pone.0030355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22848559	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900063
J	Miller, RJ; Bennett, S; Keller, AA; Pease, S; Lenihan, HS				Miller, Robert J.; Bennett, Samuel; Keller, Arturo A.; Pease, Scott; Lenihan, Hunter S.			TiO2 Nanoparticles Are Phototoxic to Marine Phytoplankton	PLOS ONE			English	Article							METAL-OXIDE NANOPARTICLES; ENGINEERED NANOPARTICLES; ULTRAVIOLET-RADIATION; STRESS; NANOMATERIALS; BIOCHEMISTRY; ENVIRONMENT; MECHANISMS; BEHAVIOR; SURFACE	Nanoparticulate titanium dioxide (TiO2) is highly photoactive, and its function as a photocatalyst drives much of the application demand for TiO2. Because TiO2 generates reactive oxygen species (ROS) when exposed to ultraviolet radiation (UVR), nanoparticulate TiO2 has been used in antibacterial coatings and wastewater disinfection, and has been investigated as an anti-cancer agent. Oxidative stress mediated by photoactive TiO2 is the likely mechanism of its toxicity, and experiments demonstrating cytotoxicity of TiO2 have used exposure to strong artificial sources of ultraviolet radiation (UVR). In vivo tests of TiO2 toxicity with aquatic organisms have typically shown low toxicity, and results across studies have been variable. No work has demonstrated that photoactivity causes environmental toxicity of TiO2 under natural levels of UVR. Here we show that relatively low levels of ultraviolet light, consistent with those found in nature, can induce toxicity of TiO2 nanoparticles to marine phytoplankton, the most important primary producers on Earth. No effect of TiO2 on phytoplankton was found in treatments where UV light was blocked. Under low intensity UVR, ROS in seawater increased with increasing nano-TiO2 concentration. These increases may lead to increased overall oxidative stress in seawater contaminated by TiO2, and cause decreased resiliency of marine ecosystems. Phototoxicity must be considered when evaluating environmental impacts of nanomaterials, many of which are photoactive.	[Miller, Robert J.; Bennett, Samuel; Keller, Arturo A.; Pease, Scott; Lenihan, Hunter S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Miller, Robert J.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Miller, Robert J.; Bennett, Samuel; Keller, Arturo A.; Lenihan, Hunter S.] Univ Calif Santa Barbara, Univ Calif Ctr Environm Implicat Nanotechnol, Santa Barbara, CA 93106 USA; [Pease, Scott] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Washington; University of Washington Seattle	Miller, RJ (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	miller@msi.ucsb.edu		Miller, Robert/0000-0002-8350-3759; Hocevar, John/0000-0002-8346-1341	National Science Foundation [EF-0742521]; United States Environmental Protection Agency [NSF-EF0830117]	National Science Foundation(National Science Foundation (NSF)); United States Environmental Protection Agency(United States Environmental Protection Agency)	This work was supported by the National Science Foundation and the United States Environmental Protection Agency under Cooperative Agreement # NSF-EF0830117, and by National Science Foundation grant EF-0742521. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel DL, 1999, HELGOLAND MAR RES, V53, P209; Battin TJ, 2009, ENVIRON SCI TECHNOL, V43, P8098, DOI 10.1021/es9017046; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bennett SW, 2011, APPL CATAL B-ENVIRON, V102, P600, DOI 10.1016/j.apcatb.2010.12.045; Berliner LJ, 2001, FREE RADICAL BIO MED, V30, P489, DOI 10.1016/S0891-5849(00)00491-3; Brunet L, 2009, ENVIRON SCI TECHNOL, V43, P4355, DOI 10.1021/es803093t; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; Carp O, 2004, PROG SOLID STATE CH, V32, P33, DOI 10.1016/j.progsolidstchem.2004.08.001; CHAMULITRAT W, 1992, ARCH BIOCHEM BIOPHYS, V296, P645, DOI 10.1016/0003-9861(92)90621-3; Collen J, 1999, PLANT CELL ENVIRON, V22, P1143, DOI 10.1046/j.1365-3040.1999.00477.x; Czili H, 2008, APPL CATAL B-ENVIRON, V81, P295, DOI 10.1016/j.apcatb.2008.01.001; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Farre M, 2009, ANAL BIOANAL CHEM, V393, P81, DOI 10.1007/s00216-008-2458-1; Fridovich I, 1998, J EXP BIOL, V201, P1203; Godwin HA, 2009, ENVIRON SCI TECHNOL, V43, P6453, DOI 10.1021/es8034544; Gopal NO, 2010, J AM CHEM SOC, V132, P10982, DOI 10.1021/ja909901f; Gottschalk F, 2010, ENVIRON TOXICOL CHEM, V29, P1036, DOI 10.1002/etc.135; Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553; He ZM, 2011, NANOSCALE, V3, P4977, DOI 10.1039/c1nr11126d; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hund-Rinke K, 2006, ENVIRON SCI POLLUT R, V13, P225, DOI 10.1065/espr2006.06.311; Johnston HJ, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-33; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Kim J, 2010, AQUAT TOXICOL, V97, P116, DOI 10.1016/j.aquatox.2009.12.022; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Konstantinou IK, 2004, APPL CATAL B-ENVIRON, V49, P1, DOI 10.1016/j.apcatb.2003.11.010; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; McKenzie RL, 2007, PHOTOCH PHOTOBIO SCI, V6, P218, DOI 10.1039/b700017k; Menard A, 2011, ENVIRON POLLUT, V159, P677, DOI 10.1016/j.envpol.2010.11.027; Miller RJ, 2010, ENVIRON SCI TECHNOL, V44, P7329, DOI 10.1021/es100247x; MOPPER K, 1990, SCIENCE, V250, P661, DOI 10.1126/science.250.4981.661; Musee N, 2011, J ENVIRON MONITOR, V13, P1164, DOI 10.1039/c1em10023h; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; ODA T, 1992, MAR BIOL, V112, P505, DOI 10.1007/BF00356297; Rozhkova EA, 2009, NANO LETT, V9, P3337, DOI 10.1021/nl901610f; Scown TM, 2010, CRIT REV TOXICOL, V40, P653, DOI 10.3109/10408444.2010.494174; Tedetti M, 2006, PHOTOCHEM PHOTOBIOL, V82, P389, DOI 10.1562/2005-11-09-IR-733; Theron J, 2008, CRIT REV MICROBIOL, V34, P43, DOI [10.1080/10408410701710442, 10.1080/10408410701710442 ]; YANG CZ, 1995, DIS AQUAT ORGAN, V23, P101, DOI 10.3354/dao023101; Zhang DQ, 2010, J MATER CHEM, V20, P4529, DOI 10.1039/b925342d; Zubia M, 2007, J APPL PHYCOL, V19, P449, DOI 10.1007/s10811-006-9152-5	44	231	242	7	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30321	10.1371/journal.pone.0030321	http://dx.doi.org/10.1371/journal.pone.0030321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22470486	Green Submitted, Green Published, gold			2022-12-27	WOS:000301568100035
J	Zhang, Y; Fan, SF; Yao, YY; Ding, J; Wang, Y; Zhao, Z; Liao, L; Li, PC; Zang, FC; Teng, GJ				Zhang, Yi; Fan, Shufeng; Yao, Yuyu; Ding, Jie; Wang, Yu; Zhao, Zhen; Liao, Lei; Li, Peicheng; Zang, Fengchao; Teng, Gao-Jun			In Vivo Near-Infrared Imaging of Fibrin Deposition in Thromboembolic Stroke in Mice	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; FACTOR-XIII; COAGULATION-FACTOR; CEREBRAL-ISCHEMIA; BRAIN-INJURY; MODEL	Objectives: Thrombus and secondary thrombosis plays a key role in stroke. Recent molecular imaging provides in vivo imaging of activated factor XIII (FXIIIa), an important mediator of thrombosis or fibrinolytic resistance. The present study was to investigate the fibrin deposition in a thromboembolic stroke mice model by FXIIIa-targeted near-infrared fluorescence (NIRF) imaging. Materials and Methods: The experimental protocol was approved by our institutional animal use committee. Seventy-six C57B/6J mice were subjected to thromboembolic middle cerebral artery occlusion or sham operation. Mice were either intravenously injected with the FXIIIa-targeted probe or control probe. In vivo and ex vivo NIRF imaging were performed thereafter. Probe distribution was assessed with fluorescence microscopy by spectral imaging and quantification system. MR scans were performed to measure lesion volumes in vivo, which were correlated with histology after animal euthanasia. Results: In vivo significant higher fluorescence intensity over the ischemia-affected hemisphere, compared to the contralateral side, was detected in mice that received FXIIIa-targeted probe, but not in the controlled mice. Significantly NIRF signals showed time-dependent processes from 8 to 96 hours after injection of FXIIIa-targeted probes. Ex vivo NIRF image showed an intense fluorescence within the ischemic territory only in mice injected with FXIIIa-targeted probe. The fluorescence microscopy demonstrated distribution of FXIIIa-targeted probe in the ischemic region and nearby micro-vessels, and FXIIIa-targeted probe signals showed good overlap with immune-fluorescent fibrin staining images. There was a significant correlation between total targeted signal from in vivo or ex vivo NIRF images and lesion volume. Conclusion: Non-invasive detection of fibrin deposition in ischemic mouse brain using NIRF imaging is feasible and this technique may provide an in vivo experimental tool in studying the role of fibrin in stroke.	[Zhang, Yi; Fan, Shufeng; Yao, Yuyu; Ding, Jie; Wang, Yu; Zhao, Zhen; Liao, Lei; Li, Peicheng; Zang, Fengchao; Teng, Gao-Jun] Southeast Univ, Jiangsu Key Lab Mol & Funct Imaging, Zhongda Hosp, Sch Med,Dept Radiol, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Zhang, Y (corresponding author), Southeast Univ, Jiangsu Key Lab Mol & Funct Imaging, Zhongda Hosp, Sch Med,Dept Radiol, Nanjing, Jiangsu, Peoples R China.	gjteng@seu.edu.cn	Zhang, Baohong/O-4948-2016	Ding, Jie/0000-0001-9162-7850	National Natural Science Foundation of China (NSFC) [90606007, 30910103905, 30830039]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This project is sponsored by National Natural Science Foundation of China (NSFC #90606007, #30910103905, and #30830039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2004, MOL INTERV, V4, P163; ALBERS GW, 1995, AM J CARDIOL, V75, pB34, DOI 10.1016/0002-9149(95)80008-G; Ariens RAS, 2002, BLOOD, V100, P743, DOI 10.1182/blood.V100.3.743; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Gerriets T, 2004, STROKE, V35, P566, DOI 10.1161/01.STR.0000113692.38574.57; Hare T, 2000, J CEREBR BLOOD F MET, V20, P1483, DOI 10.1097/00004647-200010000-00010; Heye N, 1996, STROKE, V27, P431, DOI 10.1161/01.STR.27.3.431; Hilderbrand SA, 2010, CURR OPIN CHEM BIOL, V14, P71, DOI 10.1016/j.cbpa.2009.09.029; Jaffer FA, 2004, CIRCULATION, V110, P170, DOI 10.1161/01.CIR.0000134484.11052.44; Kasahara K, 2010, BLOOD, V115, P1277, DOI 10.1182/blood-2009-06-227645; Kilic E, 1998, NEUROREPORT, V9, P2967, DOI 10.1097/00001756-199809140-00009; Kim DE, 2005, J CEREBR BLOOD F MET, V25, P226, DOI 10.1038/sj.jcbfm.9600023; Klohs J, 2008, STROKE, V39, P2845, DOI 10.1161/STROKEAHA.107.509844; Klohs J, 2006, MOL IMAGING, V5, P180; Klohs J, 2009, J CEREBR BLOOD F MET, V29, P1284, DOI 10.1038/jcbfm.2009.51; Miserus RJJHM, 2009, JACC-CARDIOVASC IMAG, V2, P987, DOI 10.1016/j.jcmg.2009.03.015; Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11; Muszbek L., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P190, DOI 10.2174/187152508784871990; Muszbek L, 2011, PHYSIOL REV, V91, P931, DOI 10.1152/physrev.00016.2010; OKADA Y, 1994, STROKE, V25, P1847, DOI 10.1161/01.STR.25.9.1847; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Ryu JK, 2009, J THROMB HAEMOST, V7, P151, DOI 10.1111/j.1538-7836.2009.03438.x; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; SIEBLER M, 1994, LANCET, V344, P555, DOI 10.1016/S0140-6736(94)91953-4; Tabrizi P, 1999, ARTERIOSCL THROM VAS, V19, P2801, DOI 10.1161/01.ATV.19.11.2801; Tung CH, 2003, CHEMBIOCHEM, V4, P897, DOI 10.1002/cbic.200300602; Uppal R, 2010, STROKE, V41, P1271, DOI 10.1161/STROKEAHA.109.575662; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; Wang L, 1997, J CEREBR BLOOD F MET, V17, P136, DOI 10.1097/00004647-199702000-00002; Zhang RL, 1997, BRAIN RES, V766, P83, DOI 10.1016/S0006-8993(97)00580-5; Zhang ZG, 1999, J NEUROSCI, V19, P10898, DOI 10.1523/JNEUROSCI.19-24-10898.1999	31	114	127	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30262	10.1371/journal.pone.0030262	http://dx.doi.org/10.1371/journal.pone.0030262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22438870	gold, Green Published, Green Submitted			2022-12-27	WOS:000301454400097
J	Collins, RA; Armstrong, KF; Meier, R; Yi, YG; Brown, SDJ; Cruickshank, RH; Keeling, S; Johnston, C				Collins, Rupert A.; Armstrong, Karen F.; Meier, Rudolf; Yi, Youguang; Brown, Samuel D. J.; Cruickshank, Robert H.; Keeling, Suzanne; Johnston, Colin			Barcoding and Border Biosecurity: Identifying Cyprinid Fishes in the Aquarium Trade	PLOS ONE			English	Article							FRESH-WATER FISHES; DNA BARCODES; MITOCHONDRIAL-DNA; ORNAMENTAL FISH; TUNA SUSHI; IDENTIFICATION; BIODIVERSITY; TELEOSTEI; HOMOGENIZATION; CONSEQUENCES	Background: Poorly regulated international trade in ornamental fishes poses risks to both biodiversity and economic activity via invasive alien species and exotic pathogens. Border security officials need robust tools to confirm identifications, often requiring hard-to-obtain taxonomic literature and expertise. DNA barcoding offers a potentially attractive tool for quarantine inspection, but has yet to be scrutinised for aquarium fishes. Here, we present a barcoding approach for ornamental cyprinid fishes by: (1) expanding current barcode reference libraries; (2) assessing barcode congruence with morphological identifications under numerous scenarios (e. g. inclusion of GenBank data, presence of singleton species, choice of analytical method); and (3) providing supplementary information to identify difficult species. Methodology/Principal Findings: We sampled 172 ornamental cyprinid fish species from the international trade, and provide data for 91 species currently unrepresented in reference libraries (GenBank/Bold). DNA barcodes were found to be highly congruent with our morphological assignments, achieving success rates of 90-99%, depending on the method used (neighbour-joining monophyly, bootstrap, nearest neighbour, GMYC, percent threshold). Inclusion of data from GenBank (additional 157 spp.) resulted in a more comprehensive library, but at a cost to success rate due to the increased number of singleton species. In addition to DNA barcodes, our study also provides supporting data in the form of specimen images, morphological characters, taxonomic bibliography, preserved vouchers, and nuclear rhodopsin sequences. Using this nuclear rhodopsin data we also uncovered evidence of interspecific hybridisation, and highlighted unrecognised diversity within popular aquarium species, including the endangered Indian barb Puntius denisonii. Conclusions/Significance: We demonstrate that DNA barcoding provides a highly effective biosecurity tool for rapidly identifying ornamental fishes. In cases where DNA barcodes are unable to offer an identification, we improve on previous studies by consolidating supplementary information from multiple data sources, and empower biosecurity agencies to confidently identify high-risk fishes in the aquarium trade.	[Collins, Rupert A.; Armstrong, Karen F.] Lincoln Univ, Bioprotect Res Ctr, Canterbury, New Zealand; [Meier, Rudolf; Yi, Youguang] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Meier, Rudolf; Yi, Youguang] Natl Univ Singapore, Univ Scholars Programme, Singapore 117548, Singapore; [Brown, Samuel D. J.; Cruickshank, Robert H.] Lincoln Univ, Dept Ecol, Fac Agr & Life Sci, Canterbury, New Zealand; [Keeling, Suzanne; Johnston, Colin] Minist Agr & Forestry, Hlth Anim Lab, Invest & Diagnost Ctr, Upper Hutt, New Zealand	Lincoln University - New Zealand; National University of Singapore; National University of Singapore; Lincoln University - New Zealand	Collins, RA (corresponding author), Lincoln Univ, Bioprotect Res Ctr, Canterbury, New Zealand.	rupertcollins@gmail.com	Meier, Rudolf/AAB-3848-2021; Meier, Rudolf/A-7099-2011; Brown, Samuel/P-8847-2017; Armstrong, Karen F/J-3460-2013; Schuler, Herwig/E-5751-2011; Arner, Elias/J-5832-2012	Meier, Rudolf/0000-0002-4452-2885; Meier, Rudolf/0000-0002-4452-2885; Brown, Samuel/0000-0001-7112-421X; Armstrong, Karen F/0000-0003-4973-2651; Hogbom, Martin/0000-0001-5574-9383; Schuler, Herwig/0000-0003-4059-3501; Collins, Rupert A./0000-0002-9135-1169; Arner, Elias/0000-0002-4807-6114	Ministry of Agriculture and Forestry Biosecurity New Zealand; Ministry of Education (Singapore) [R377-000-040-112]	Ministry of Agriculture and Forestry Biosecurity New Zealand; Ministry of Education (Singapore)(Ministry of Education, Singapore)	This work was supported by a Ministry of Agriculture and Forestry Biosecurity New Zealand scholarship for RAC; grant R377-000-040-112 by the Ministry of Education (Singapore) for RM and YY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2010, IUCN 2011 IUCN RED L; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Baensch HA, 2007, AQUARIUM ATLAS PHOTO; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Broughton RE, 2001, GENOME RES, V11, P1958, DOI 10.1101/gr.156801; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chen WJ, 2008, GENE, V423, P125, DOI 10.1016/j.gene.2008.07.016; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Cohen NJ, 2009, J FOOD PROTECT, V72, P810, DOI 10.4315/0362-028X-72.4.810; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Copp GH, 2010, AQUAT CONSERV, V20, P595, DOI 10.1002/aqc.1129; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Dasmahapatra KK, 2006, HEREDITY, V97, P254, DOI 10.1038/sj.hdy.6800858; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; deWaard JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014280; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Eschmeyer WN, 2010, CATALOG FISHES ELECT; Fang Fang, 2000, Ichthyological Exploration of Freshwaters, V11, P149; Fang F, 2009, ZOOL SCR, V38, P237, DOI 10.1111/j.1463-6409.2008.00373.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gerson H, 2008, CONSERV BIOL, V22, P4, DOI 10.1111/j.1523-1739.2007.00857.x; Gerstner CL, 2006, J FISH BIOL, V68, P862, DOI 10.1111/j.1095.8649.2006.00978.x; Glez-Pena D, 2010, NUCLEIC ACIDS RES, V38, pW14, DOI 10.1093/nar/gkq321; Go J, 2006, AQUACULTURE, V258, P140, DOI 10.1016/j.aquaculture.2006.04.033; Gozlan RE, 2005, NATURE, V435, P1046, DOI 10.1038/4351046a; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Harris DJ, 2003, TRENDS ECOL EVOL, V18, P317, DOI 10.1016/S0169-5347(03)00150-2; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hensen RR, 2010, STANDARD NAMES FRESH; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hui TH, 2008, RAFFLES B ZOOL, V56, P423; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kottelat M., 2007, HDB EUROPEAN FRESHWA, P646; Liao TY, 2011, RAFFLES B ZOOL, V59, P77; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Linthoingambi I., 2007, Zootaxa, V1450, P45; Lowenstein JH, 2010, BIOL LETTERS, V6, P692, DOI 10.1098/rsbl.2010.0156; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; MAF Biosecurity New Zealand, 2011, IMP HLTH STAND ORN F; McDowall RM, 2004, NEW ZEAL J MAR FRESH, V38, P503, DOI 10.1080/00288330.2004.9517256; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2008, SYST ASSOC SPEC VOL, V76, P95; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Nelson JS, 2006, FISHES WORLD; NG PKL, 1993, BIOL CONSERV, V64, P19, DOI 10.1016/0006-3207(93)90379-F; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Padilla DK, 2004, FRONT ECOL ENVIRON, V2, P131, DOI 10.1890/1540-9295(2004)002[0131:BBWAAO]2.0.CO;2; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Ploeg A, 2008, OFI J, V58, P21; Ploeg A, 2009, BIOSECURITY ORNAMENT; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2021, R LANGUAGE ENV STAT; Raghavan R, 2007, CURR SCI INDIA, V92, P1671; Rahel FJ, 2002, ANNU REV ECOL SYST, V33, P291, DOI 10.1146/annurev.ecolsys.33.010802.150429; Rahel FJ, 2007, FRESHWATER BIOL, V52, P696, DOI 10.1111/j.1365-2427.2006.01708.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Ross HA, 2003, J HERED, V94, P111, DOI 10.1093/jhered/esg027; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Rubinoff D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016361; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; Silva A, 2010, ICHTHYOL EXPLOR FRES, V21, P27; Smits SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012267; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang KL, 2010, MOL PHYLOGENET EVOL, V57, P189, DOI 10.1016/j.ympev.2010.05.021; Valdez-Moreno M, 2009, J FISH BIOL, V74, P377, DOI 10.1111/j.1095-8649.2008.02077.x; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Whittington RJ, 2007, PREV VET MED, V81, P92, DOI 10.1016/j.prevetmed.2007.04.007; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x; Wong YT, 2011, BIOL INVASIONS, V13, P341, DOI 10.1007/s10530-010-9825-5; YOKOYAMA R, 1995, INVEST OPHTH VIS SCI, V36, P939; Zemlak TS, 2009, MOL ECOL RESOUR, V9, P237, DOI 10.1111/j.1755-0998.2009.02649.x	99	110	115	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e28381	10.1371/journal.pone.0028381	http://dx.doi.org/10.1371/journal.pone.0028381			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276096	Green Published, gold, Green Submitted			2022-12-27	WOS:000301568100003
J	Liu, SY; Lin, JQ; Wu, HL; Wang, CC; Huang, SJ; Luo, YF; Sun, JH; Zhou, JX; Yan, SJ; He, JG; Wang, J; He, ZM				Liu, Si-Yang; Lin, Jian-Qing; Wu, Hong-Long; Wang, Cheng-Cheng; Huang, Shu-Jia; Luo, Yan-Feng; Sun, Ji-Hua; Zhou, Jian-Xiang; Yan, Shu-Jing; He, Jian-Guo; Wang, Jun; He, Zhu-Mei			Bisulfite Sequencing Reveals That Aspergillus flavus Holds a Hollow in DNA Methylation	PLOS ONE			English	Article							INDUCED POINT MUTATION; CYTOSINE METHYLTRANSFERASE HOMOLOG; SECONDARY METABOLISM; AFLATOXIN; CONTAINS; RIP; HETEROCHROMATIN; IDENTIFICATION; 5-AZACYTIDINE; ELEMENTS	Aspergillus flavus first gained scientific attention for its production of aflatoxin. The underlying regulation of aflatoxin biosynthesis has been serving as a theoretical model for biosynthesis of other microbial secondary metabolites. Nevertheless, for several decades, the DNA methylation status, one of the important epigenomic modifications involved in gene regulation, in A. flavus remains to be controversial. Here, we applied bisulfite sequencing in conjunction with a biological replicate strategy to investigate the DNA methylation profiling of A. flavus genome. Both the bisulfite sequencing data and the methylome comparisons with other fungi confirm that the DNA methylation level of this fungus is negligible. Further investigation into the DNA methyltransferase of Aspergillus uncovers its close relationship with RID-like enzymes as well as its divergence with the methyltransferase of species with validated DNA methylation. The lack of repeat contents of the A. flavus' genome and the high RIP-index of the small amount of remanent repeat potentially support our speculation that DNA methylation may be absent in A. flavus or that it may possess de novo DNA methylation which occurs very transiently during the obscure sexual stage of this fungal species. This work contributes to our understanding on the DNA methylation status of A. flavus, as well as reinforces our views on the DNA methylation in fungal species. In addition, our strategy of applying bisulfite sequencing to DNA methylation detection in species with low DNA methylation may serve as a reference for later scientific investigations in other hypomethylated species.	[Liu, Si-Yang; Lin, Jian-Qing; Wang, Cheng-Cheng; Luo, Yan-Feng; Zhou, Jian-Xiang; He, Jian-Guo; He, Zhu-Mei] Sun Yat Sen Univ, MOE Key Lab Aquat Prod Safety, Key Lab Gene Engn, Minist Educ,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Si-Yang; Wu, Hong-Long; Huang, Shu-Jia; Sun, Ji-Hua; Yan, Shu-Jing; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China	Sun Yat Sen University; Beijing Genomics Institute (BGI)	Liu, SY (corresponding author), Sun Yat Sen Univ, MOE Key Lab Aquat Prod Safety, Key Lab Gene Engn, Minist Educ,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	lsshjg@mail.sysu.edu.cn; wangj@genomics.org.cn; lsshezm@mail.sysu.edu.cn	贺, 竹梅/GVS-1592-2022; Huang, Shujia/GXG-8583-2022; Wang, Jun/A-7261-2013; Liu, Siyang/M-6127-2014; Lin, Jianqing/GYU-6251-2022; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Huang, Shujia/0000-0003-2100-2534; Liu, Siyang/0000-0001-6780-9419; Nettleton, Dan/0000-0002-6045-1036; Wang, Jun/0000-0002-2113-5874; Yeh, Cheng-Ting/0000-0002-1392-2018; Wang, Jun/0000-0002-8540-8931; Schnable, Patrick/0000-0001-9169-5204	National Natural Science Foundation of China [30870024, 31170044]; Natural Science Foundation of Guangdong Province of China [9151027501000113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province)	This work was supported by National Natural Science Foundation of China (grant no. 30870024 and grant no. 31170044), Natural Science Foundation of Guangdong Province of China (grant no. 9151027501000113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, no additional external funding received for this study.	ANTEQUERA F, 1984, J BIOL CHEM, V259, P8033; Aziz NH, 1997, NAHRUNG, V41, P150, DOI 10.1002/food.19970410307; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bestor TH, 1999, GENETICA, V107, P289, DOI 10.1023/A:1003990818251; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Cichewicz RH, 2010, NAT PROD REP, V27, P11, DOI 10.1039/b920860g; Cleveland TE, 2009, TRENDS BIOTECHNOL, V27, P151, DOI 10.1016/j.tibtech.2008.11.008; Clutterbuck AJ, 2011, FUNGAL GENET BIOL, V48, P306, DOI 10.1016/j.fgb.2010.09.002; Dahl C, 2003, BIOGERONTOLOGY, V4, P233, DOI 10.1023/A:1025103319328; Doiron KMJ, 1999, MUTAT RES-FUND MOL M, V429, P37, DOI 10.1016/S0027-5107(99)00099-8; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Freitag M, 2002, P NATL ACAD SCI USA, V99, P8802, DOI 10.1073/pnas.132212899; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Georgianna DR, 2010, MOL PLANT PATHOL, V11, P213, DOI 10.1111/j.1364-3703.2009.00594.x; Georgianna DR, 2009, FUNGAL GENET BIOL, V46, P113, DOI 10.1016/j.fgb.2008.10.011; Gowher H, 2001, FEMS MICROBIOL LETT, V205, P151, DOI 10.1111/j.1574-6968.2001.tb10939.x; Gowher H, 2000, EMBO J, V19, P6918, DOI 10.1093/emboj/19.24.6918; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Hayatsu Hikoya, 2006, Nucleic Acids Symp Ser (Oxf), P69, DOI 10.1093/nass/nrl034; He ZM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-104; Horn BW, 2009, MYCOLOGIA, V101, P423, DOI 10.3852/09-011; Kensler TW, 2011, TOXICOL SCI, V120, pS28, DOI 10.1093/toxsci/kfq283; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Komashko Vitalina M, 2010, Epigenetics, V5, P229; Lee DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002531; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; MAGILL JM, 1989, DEV GENET, V10, P63, DOI 10.1002/dvg.1020100202; Margolin BS, 1998, GENETICS, V149, P1787; Montiel MD, 2006, FUNGAL GENET BIOL, V43, P439, DOI 10.1016/j.fgb.2006.01.011; Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rountree MR, 2010, HEREDITY, V105, P38, DOI 10.1038/hdy.2010.44; Selker EU, 2003, NATURE, V422, P893, DOI 10.1038/nature01564; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; TAMAME M, 1983, MOL CELL BIOL, V3, P2287, DOI 10.1128/MCB.3.12.2287; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van West P, 2008, MICROBIOL-SGM, V154, P1482, DOI 10.1099/mic.0.2007/015545-0; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yu JJ, 2004, APPL ENVIRON MICROB, V70, P1253, DOI 10.1128/AEM.70.3.1253-1262.2004; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	49	121	129	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30349	10.1371/journal.pone.0030349	http://dx.doi.org/10.1371/journal.pone.0030349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22586469	Green Published, gold, Green Submitted			2022-12-27	WOS:000301568100036
J	Yang, SY; Keshavmurthy, S; Obura, D; Sheppard, CRC; Visram, S; Chen, CA				Yang, Sung-Yin; Keshavmurthy, Shashank; Obura, David; Sheppard, Charles R. C.; Visram, Shakil; Chen, Chaolun Allen			Diversity and Distribution of Symbiodinium Associated with Seven Common Coral Species in the Chagos Archipelago, Central Indian Ocean	PLOS ONE			English	Article							SYMBIOTIC ALGAE; CLIMATE-CHANGE; SCLERACTINIAN CORALS; MOLECULAR DIVERSITY; REEF CORALS; ZOOXANTHELLAE; HOST; PATTERNS; IDENTIFICATION; COMMUNITIES	The Chagos Archipelago designated as a no-take marine protected area in 2010, lying about 500 km south of the Maldives in the Indian Ocean, has a high conservation priority, particularly because of its fast recovery from the ocean-wide massive coral mortality following the 1998 coral bleaching event. The aims of this study were to examine Symbiodinium diversity and distribution associated with scleractinian corals in five atolls of the Chagos Archipelago, spread over 10,000 km(-2). Symbiodinium clade diversity in 262 samples of seven common coral species, Acropora muricata, Isopora palifera, Pocillopora damicornis, P. verrucosa, P. eydouxi, Seriatopora hystrix, and Stylophora pistillata were determined using PCR-SSCP of the ribosomal internal transcribed spacer 1 (ITS1), PCR-DDGE of ITS2, and phylogenetic analyses. The results indicated that Symbiodinium in clade C were the dominant symbiont group in the seven coral species. Our analysis revealed types of Symbiodinium clade C specific to coral species. Types C1 and C3 (with C3z and C3i variants) were dominant in Acroporidae and C1 and C1c were the dominant types in Pocilloporidae. We also found 2 novel ITS2 types in S. hystrix and 1 novel ITS2 type of Symbiodinium in A. muricata. Some colonies of A. muricata and I. palifera were also associated with Symbiodinium A1. These results suggest that corals in the Chagos Archipelago host different assemblages of Symbiodinium types then their conspecifics from other locations in the Indian Ocean; and that future research will show whether these patterns in Symbiodinium genotypes may be due to local adaptation to specific conditions in the Chagos.	[Yang, Sung-Yin; Keshavmurthy, Shashank; Visram, Shakil; Chen, Chaolun Allen] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Obura, David; Visram, Shakil] CORDIO, Mombasa, Kenya; [Obura, David; Sheppard, Charles R. C.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Chen, Chaolun Allen] Natl Taiwan Univ, Taipei 10764, Taiwan	Academia Sinica - Taiwan; University of Warwick; National Taiwan University	Yang, SY (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan.	cac@gate.sinica.edu.tw	Chen, Yu/Y-3292-2019; Keshavmurthy, Shashank/C-3672-2013; Chen, Yi/HIR-2608-2022; Yu, Hongjie/GZK-5351-2022; Xiao, Yonghong/AFS-9054-2022; Matz, Mikhail/K-4392-2017	Keshavmurthy, Shashank/0000-0002-2235-9132; Matz, Mikhail/0000-0001-5453-9819; sheppard, charles/0000-0002-2579-5124; Yang, Sung-Yin/0000-0001-7431-406X; Wang, Dao Wen/0000-0002-9774-3980; Rao, Xiaoquan/0000-0001-7316-4530; Obura, David/0000-0003-2256-6649	Academia Sinica Thematic Grants; CORDIO; Chagos Conservation Trust; National Science Council postdoctoral fellowship; Academia Sinica postdoctoral fellowship	Academia Sinica Thematic Grants; CORDIO; Chagos Conservation Trust; National Science Council postdoctoral fellowship; Academia Sinica postdoctoral fellowship(Academia Sinica - Taiwan)	This study was partly funded by Academia Sinica Thematic Grants (2005-2010), CORDIO and Chagos Conservation Trust. SK was supported by National Science Council postdoctoral fellowship (2008-2010) and Academia Sinica postdoctoral fellowship (2010-2012), SV by Academia Sinica postdoctoral fellowship (2007-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Baker AC, 2004, CORAL HEALTH AND DISEASE, P177; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Brown BE, 1997, ADV MAR BIOL, V31, P221, DOI 10.1016/S0065-2881(08)60224-2; BROWN BE, 1994, MAR ECOL PROG SER, V105, P219, DOI 10.3354/meps105219; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; Chen CA, 2005, MAR ECOL PROG SER, V295, P113, DOI 10.3354/meps295113; Chen CA, 2000, MAR BIOTECHNOL, V2, P146; Chen CA, 2005, CORAL REEFS, V24, P11, DOI 10.1007/s00338-004-0389-7; Chen CA, 2003, ZOOL STUD, V42, P540; COLES SL, 1977, MAR BIOL, V43, P209, DOI 10.1007/BF00402313; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; Garren M, 2006, CORAL REEFS, V25, P503, DOI 10.1007/s00338-006-0146-1; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Goulet TL, 2003, MAR BIOL, V142, P233, DOI 10.1007/s00227-002-0936-0; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Houlbreque F, 2003, J EXP MAR BIOL ECOL, V296, P145, DOI 10.1016/S0022-0981(03)00259-4; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Koldewey HJ, 2010, MAR POLLUT BULL, V60, P1906, DOI 10.1016/j.marpolbul.2010.10.002; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2000, BIOL BULL, V199, P126, DOI 10.2307/1542872; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; LaJeunesse TC, 2009, BIOL INVASIONS, V11, P995, DOI 10.1007/s10530-008-9311-5; Lien YT, 2007, CORAL REEFS, V26, P35, DOI 10.1007/s00338-006-0185-7; Loh WKW, 2001, MAR ECOL PROG SER, V222, P97, DOI 10.3354/meps222097; Magalon H, 2007, CORAL REEFS, V26, P551, DOI 10.1007/s00338-007-0215-0; Mangi S, 2010, WORKSH HELD 7 JAN 20; McPhaden MJ, 2009, B AM METEOROL SOC, V90, P459, DOI 10.1175/2008BAMS2608.1; Mieog JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006364; MUSCATINE L, 1991, MAR ECOL PROG SER, V77, P233, DOI 10.3354/meps077233; Oliver TA, 2009, MAR ECOL PROG SER, V378, P93, DOI 10.3354/meps07871; Pochon X, 2004, MAR BIOL, V146, P17, DOI 10.1007/s00227-004-1427-2; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; ROWAN R, 1991, MAR ECOL PROG SER, V71, P65, DOI 10.3354/meps071065; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Rowan R, 1998, J PHYCOL, V34, P407, DOI 10.1046/j.1529-8817.1998.340407.x; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Santos SR, 2003, MAR BIOTECHNOL, V5, P130, DOI 10.1007/s10126-002-0076-9; Sheppard C, 2005, J NAT HIST, V39, P103, DOI 10.1080/00222930310001657900; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Sheppard C, 2006, CONSERV BIOL SER, P264; Sheppard Charles R.C., 2000, P3; Sheppard CRC, 1999, AMBIO, V28, P472; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Sheppard CRC, 2012, MAR FRESHWATER RES, DOI [10.1002/aqc.1248, DOI 10.1002/AQC.1248]; Silverstein RN, 2011, MAR ECOL PROG SER, V422, P63, DOI 10.3354/meps08934; Stat M, 2008, CORAL REEFS, V27, P763, DOI 10.1007/s00338-008-0412-5; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; van Oppen Madeleine J. H., 2009, V205, P83; Van Woesik Robert, 2009, Galaxea - Tokyo, V11, P53; Visram S, 2006, J MAR BIOL ASSOC UK, V86, P1281, DOI 10.1017/S0025315406014299; Visram S, 2006, CORAL REEFS, V25, P172, DOI 10.1007/s00338-005-0079-0; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x	67	115	121	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35836	10.1371/journal.pone.0035836	http://dx.doi.org/10.1371/journal.pone.0035836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567113	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500031
J	Lin, YW; Lin, HY; Tsou, YL; Chitra, E; Hsiao, KN; Shao, HY; Liu, CC; Sia, C; Chong, P; Chow, YH				Lin, Yi-Wen; Lin, Hsiang-Yin; Tsou, Yueh-Liang; Chitra, Ebenezer; Hsiao, Kuang-Nan; Shao, Hsiao-Yun; Liu, Chia-Chyi; Sia, Charles; Chong, Pele; Chow, Yen-Hung			Human SCARB2-Mediated Entry and Endocytosis of EV71	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; RESPIRATORY SYNCYTIAL VIRUS; SELECTIN GLYCOPROTEIN LIGAND-1; NEUROGENIC PULMONARY-EDEMA; ENTEROVIRUS 71; CELLULAR RECEPTOR; P-SELECTIN; DEPENDENT ENDOCYTOSIS; MOUTH-DISEASE; PUBLIC-HEALTH	Enterovirus (EV) 71 infection is known to cause hand-foot-and-mouth disease (HFMD) and in severe cases, induces neurological disorders culminating in fatality. An outbreak of EV71 in South East Asia in 1997 affected over 120,000 people and caused neurological disorders in a few individuals. The control of EV71 infection through public health interventions remains minimal and treatments are only symptomatic. Recently, human scavenger receptor class B, member 2 (SCARB2) has been reported to be a cellular receptor of EV71. We expressed human SCARB2 gene in NIH3T3 cells (3T3-SCARB2) to study the mechanisms of EV71 entry and infection. We demonstrated that human SCARB2 serves as a cellular receptor for EV71 entry. Disruption of expression of SCARB2 using siRNAs can interfere EV71 infection and subsequent inhibit the expression of viral capsid proteins in RD and 3T3-SCARB2 but not Vero cells. SiRNAs specific to clathrin or dynamin or chemical inhibitor of clathrin-mediated endocytosis were all capable of interfering with the entry of EV71 into 3T3-SCARB2 cells. On the other hand, caveolin specific siRNA or inhibitors of caveolae-mediated endocytosis had no effect, confirming that only clathrin-mediated pathway was involved in EV71 infection. Endocytosis of EV71 was also found to be pH-dependent requiring endosomal acidification and also required intact membrane cholesterol. In summary, the mechanism of EV71 entry through SCARB2 as the receptor for attachment, and its cellular entry is through a clathrin-mediated and pHdependent endocytic pathway. This study on the receptor and endocytic mechanisms of EV71 infection is useful for the development of effective medications and prophylactic treatment against the enterovirus.	[Lin, Yi-Wen; Lin, Hsiang-Yin; Tsou, Yueh-Liang; Chitra, Ebenezer; Hsiao, Kuang-Nan; Shao, Hsiao-Yun; Liu, Chia-Chyi; Sia, Charles; Chong, Pele; Chow, Yen-Hung] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Taipei, Taiwan; [Lin, Yi-Wen] Natl Tsing Hua Univ, Inst Mol Med, Grad Program Biotechnol Med, Hsinchu, Taiwan; [Tsou, Yueh-Liang] Natl Def Med Ctr, Grad Sch Life Sci, Taipei, Taiwan; [Sia, Charles; Chong, Pele] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; National Defense Medical Center; China Medical University Taiwan	Lin, YW (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Taipei, Taiwan.	pelechong@nhri.org.tw; choeyenh@nhri.org.tw	Liu, Chia-Chyi/A-8215-2012; Sia, Dwo-Yuan/E-3860-2010; Chong, Pele/E-3855-2010; Chitra, Ebenezer/F-5984-2019; Chow, Yen-Hung/E-3863-2010	Liu, Chia-Chyi/0000-0002-6257-0389; Chitra, Ebenezer/0000-0002-5818-6587; 	National Health Research Institutes [99A1-VCPP08-014]; National Science Council (NSC) of Taiwan [99-2323-B-400-014-]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Health Research Institutes' intramural grant (99A1-VCPP08-014) (www.nhri.org.tw) and a grant (99-2323-B-400-014-) from the National Science Council (NSC) (http://web1.nsc.gov.tw) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652; Baba T, 1995, COLD SPRING HARB SYM, V60, P235, DOI 10.1101/SQB.1995.060.01.027; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Bayer N, 2001, J BIOL CHEM, V276, P3952, DOI 10.1074/jbc.M004722200; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; BROWN MS, 1980, J LIPID RES, V21, P505; Chang JY, 1998, BIOCHEM BIOPH RES CO, V249, P817, DOI 10.1006/bbrc.1998.9237; Chang LY, 1998, LANCET, V352, P367, DOI 10.1016/S0140-6736(98)24031-1; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Danthi P, 2004, J VIROL, V78, P33, DOI 10.1128/JVI.78.1.33-41.2004; De Tulleo L, 1998, EMBO J, V17, P4585, DOI 10.1093/emboj/17.16.4585; Eash S, 2004, J VIROL, V78, P11583, DOI 10.1128/JVI.78.21.11583-11590.2004; Eckhardt ERM, 2006, J BIOL CHEM, V281, P4348, DOI 10.1074/jbc.M513154200; Empig CJ, 2002, J VIROL, V76, P5266, DOI 10.1128/JVI.76.10.5266-5270.2002; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Gianni T, 2004, J VIROL, V78, P12268, DOI 10.1128/JVI.78.22.12268-12276.2004; Grove J, 2007, J VIROL, V81, P3162, DOI 10.1128/JVI.02356-06; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Hailstones D, 1998, J LIPID RES, V39, P369; He YN, 2000, P NATL ACAD SCI USA, V97, P79, DOI 10.1073/pnas.97.1.79; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hussain KM, 2011, J BIOL CHEM, V286, P309, DOI 10.1074/jbc.M110.168468; Inoue Y, 2007, J VIROL, V81, P8722, DOI 10.1128/JVI.00253-07; Kolokoltsov AA, 2007, J VIROL, V81, P7786, DOI 10.1128/JVI.02780-06; Kuronita T, 2002, J CELL SCI, V115, P4117, DOI 10.1242/jcs.00075; Laszik Z, 1996, BLOOD, V88, P3010, DOI 10.1182/blood.V88.8.3010.bloodjournal8883010; Lee DW, 2006, J CELL SCI, V119, P3502, DOI 10.1242/jcs.03092; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Lin YC, 2002, VACCINE, V20, P2485, DOI 10.1016/S0264-410X(02)00182-2; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Liu PS, 1999, BIOCHEM BIOPH RES CO, V261, P695, DOI 10.1006/bbrc.1999.1082; LONBERGHOLM K, 1972, J VIROL, V9, P29, DOI 10.1128/JVI.9.1.29-40.1972; Lu CH, 2008, PROTEINS, V72, P625, DOI 10.1002/prot.21954; Lum LCS, 1998, LANCET, V352, P1391, DOI 10.1016/S0140-6736(05)60789-1; Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; McMinn PC, 2003, NEUROL J SE ASIA, V8, P57; Melnick J L, 1980, Intervirology, V12, P297; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Nawa M, 2003, J GEN VIROL, V84, P1737, DOI 10.1099/vir.0.18883-0; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Parton RG, 1999, IMMUNOL REV, V168, P23, DOI 10.1111/j.1600-065X.1999.tb01280.x; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; Richterova Z, 2001, J VIROL, V75, P10880, DOI 10.1128/JVI.75.22.10880-10891.2001; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Shu LM, 2000, ARCH BIOCHEM BIOPHYS, V373, P83, DOI 10.1006/abbi.1999.1553; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002; Smaby JM, 1996, BIOPHYS J, V70, P868, DOI 10.1016/S0006-3495(96)79629-7; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; SRINIVASAKUMAR N, 1991, J VIROL, V65, P4063, DOI 10.1128/JVI.65.8.4063-4069.1991; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; Wu TN, 1999, EMERG INFECT DIS, V5, P458, DOI 10.3201/eid0503.990321; Xing L, 2000, EMBO J, V19, P1207, DOI 10.1093/emboj/19.6.1207; Yamayoshi S, 2011, J VIROL, V85, P4937, DOI 10.1128/JVI.02358-10; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992	83	76	89	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30507	10.1371/journal.pone.0030507	http://dx.doi.org/10.1371/journal.pone.0030507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272359	gold, Green Published, Green Submitted			2022-12-27	WOS:000301454400137
J	Shi, XD; Pan, Y; Wang, ML; Wang, DS; Li, WY; Jiang, T; Zhang, P; Chi, XM; Jiang, YF; Gao, YH; Zhong, J; Sun, B; Xu, DM; Jiang, J; Niu, JQ				Shi, Xiaodong; Pan, Yu; Wang, Moli; Wang, Dongsheng; Li, Wanyu; Jiang, Tao; Zhang, Peng; Chi, Xiumei; Jiang, Yanfang; Gao, Yanhang; Zhong, Jin; Sun, Bing; Xu, Damo; Jiang, Jing; Niu, Junqi			IL28B Genetic Variation Is Associated with Spontaneous Clearance of Hepatitis C Virus, Treatment Response, Serum IL-28B Levels in Chinese Population	PLOS ONE			English	Article							ALPHA-2B PLUS RIBAVIRIN; VIROLOGICAL RESPONSE; IFN-LAMBDA; INFECTION; THERAPY	Background: The interleukin-28B gene (IL28B) locus has been associated with host resistance to hepatitis C virus (HCV) infection and response to PEG-IFN/RBV treatment in western populations. This study was to determine whether this gene variant is also associated with spontaneous clearance of HCV infection, treatment response and IL-28B protein production in Chinese patients. Methods: We genotyped IL28B genetic variations (rs12980275, rs8103142, rs8099917 and rs12979860) by pyrosequencing DNA samples from cohorts consisting of 529 subjects with persistent HCV infection, 196 subjects who cleared the infection, 171 healthy individuals and 235 chronic HCV patients underwent IFN/RBV treatment. The expression of IL-28B were measured by ELISA and RT-PCR. Results: We found that the four IL28B variants were in complete linkage disequilibrium (r2 = 0.97-0.98). The rs12979860 CC genotype was strongly associated with spontaneously HCV clearance and successful IFN/RBV treatment compared to the CT/TT. IL-28B levels in persistent HCV patients were significantly lower than subjects who spontaneously resolved HCV and healthy controls and were also associated with high levels of ALT (alanine aminotransferase) and AST (aspartate aminotransferase). IL-28B levels were also significantly lower in individuals carrying T alleles than CC homozygous. Conclusions: Thus, the rs12979860-CC variant upstream of IL28B gene is associated with spontaneous clearance of HCV, susceptible to IFN/RBV treatment and increased IL-28B levels in this Chinese population.	[Shi, Xiaodong; Pan, Yu; Li, Wanyu; Zhang, Peng; Chi, Xiumei; Jiang, Yanfang; Gao, Yanhang; Niu, Junqi] Jilin Univ, Dept Hepatol, Hosp 1, Changchun 130023, Peoples R China; [Jiang, Jing] Jilin Univ, Dept Clin Epidemiol, Hosp 1, Changchun 130023, Peoples R China; [Zhong, Jin; Sun, Bing] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Wang, Dongsheng; Jiang, Tao] Hosp HepatologyBiliary Jilin Prov, Changchun, Peoples R China; [Xu, Damo] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Wang, Moli] Jilin Univ, Hosp 4, Changchun 130023, Peoples R China	Jilin University; Jilin University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); University of Glasgow; Jilin University	Shi, XD (corresponding author), Jilin Univ, Dept Hepatol, Hosp 1, Changchun 130023, Peoples R China.	jiangjing19702000@yahoo.cn; junqiniu@yahoo.cn	Zhong, Jin/J-4613-2019; Wang, Mengqiang/A-1215-2010; zhi, zhouzhi/J-8063-2013; Yue, Feng/S-6565-2017; Zhong, Jin/M-6859-2018	Wang, Mengqiang/0000-0003-4702-3309; Zhong, Jin/0000-0002-3554-1275	Shanghai Pasteur Health Research Foundation [SPHRF2009001]; Eleventh 5-year National Key Programs on Infectious Disease [2008ZX10002-014]; National Natural Science Foundation of China [81001312/H1005, 81072347/H2609]; Jilin University [20101036]	Shanghai Pasteur Health Research Foundation; Eleventh 5-year National Key Programs on Infectious Disease; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin University(Jilin University)	This study was supported by grants from the Shanghai Pasteur Health Research Foundation (SPHRF2009001), the Eleventh 5-year National Key Programs on Infectious Disease (2008ZX10002-014), the National Natural Science Foundation of China under grants No 81001312/H1005 and 81072347/H2609 and the Graduate Innovation Fund of Jilin University (No. 20101036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; [Anonymous], 2002, NIH Consens State Sci Statements, V19, P1; Aparicio E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013771; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Benvegnu L, 2004, GUT, V53, P744, DOI 10.1136/gut.2003.020263; Bruno S, 2008, ANN HEPATOL, V7, P114, DOI 10.1016/S1665-2681(19)31865-4; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Dolganiuc A, 2006, J IMMUNOL, V177, P6758, DOI 10.4049/jimmunol.177.10.6758; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hepburn MJ, 2004, AM J MED, V117, P163, DOI 10.1016/j.amjmed.2004.02.043; Huang CF, 2010, J GASTROEN HEPATOL, V25, P758, DOI 10.1111/j.1440-1746.2009.06148.x; Hwang SJ, 2001, J MED VIROL, V65, P505, DOI 10.1002/jmv.2064; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Missiha SB, 2008, GASTROENTEROLOGY, V134, P1699, DOI 10.1053/j.gastro.2008.02.069; Rauch A, 2010, EUR J CLIN INVEST, V40, P950, DOI 10.1111/j.1365-2362.2010.02337.x; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rauch A, 2009, PHARMACOGENOMICS, V10, P1819, DOI 10.2217/PGS.09.121; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shiina M, 2008, HEPATOLOGY, V47, P385, DOI 10.1002/hep.21996; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Spann KM, 2005, J VIROL, V79, P5353, DOI 10.1128/JVI.79.9.5353-5362.2005; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thio CL, 2000, HEPATOLOGY, V31, P819, DOI 10.1053/he.2000.4316; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x; Zechini B, 2004, EUR J GASTROEN HEPAT, V16, P891, DOI 10.1097/00042737-200409000-00013	40	101	108	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37054	10.1371/journal.pone.0037054	http://dx.doi.org/10.1371/journal.pone.0037054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649509	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305335800027
J	Yang, TZ; Rockett, IRH; Lv, QH; Cottrell, RR				Yang, Tingzhong; Rockett, Ian R. H.; Lv, Qiaohong; Cottrell, Randall R.			Stress Status and Related Characteristics among Urban Residents: A Six-Province Capital Cities Study in China	PLOS ONE			English	Article							MENTAL-HEALTH; INCOME INEQUALITY; PERCEIVED STRESS; ECONOMIC-GROWTH; WOMEN	Objectives: To estimate current prevalence levels of stress, and to identify related characteristics among urban residents in China. Design: A cross-sectional, multilevel study. Selected through multi-stage quota-sampling, survey participants were 4,735 urban residents aged 15 years and older who resided in one of six selected Chinese capital cities. Data were collected on stress levels and sociodemographic characteristics. Stress was assessed using the Perceived Stress Scale, Chinese version (CPSS). A multilevel variance component model was employed to analyze associations between sociodemographic variables and stress. Results: The mean stress score for urban residents was 22.34 (SD: 3.22), and 36.8% of those surveyed (95% CI: 33.5-40.2%) were severely stressed (>25). Multilevel regression analysis indicated that residents aged 55 years and older were less stressed than residents under age 25. The most educated and higher income earners had lower stress levels than the least educated and poorest. High levels of stress were apparent among all other occupational groups, relative to managers and clerks, except retirees and operational workers. Residents in the north of China exhibited higher stress levels than counterparts in the south. Conclusions: This study suggests that higher stress levels are positively associated with social class in China. Our findings could inform health policy, guide prevention strategies, and justify the design and implementation of targeted interventions.	[Yang, Tingzhong; Lv, Qiaohong] Zhejiang Univ, Sch Med, Ctr Tobacco Control Res, Hangzhou 310003, Zhejiang, Peoples R China; [Rockett, Ian R. H.] W Virginia Univ, Injury Control Res Ctr, Morgantown, WV 26506 USA; [Rockett, Ian R. H.] W Virginia Univ, Dept Community Med, Morgantown, WV 26506 USA; [Cottrell, Randall R.] Univ Cincinnati, Sch Human Serv, Hlth Promot & Educ Program, Cincinnati, OH USA	Zhejiang University; West Virginia University; West Virginia University; University System of Ohio; University of Cincinnati	Yang, TZ (corresponding author), Zhejiang Univ, Sch Med, Ctr Tobacco Control Res, Hangzhou 310003, Zhejiang, Peoples R China.	Ytingzhongyang@yahoo.com		Wu, Dan/0000-0003-0849-0297	World Health Organization (WHO) [WP/2002/IC/TFI/2.2/001/03.02.AW.03]; National Social Science Foundation of China [01BSH030]	World Health Organization (WHO)(World Health Organization); National Social Science Foundation of China	This study was partly funded by the World Health Organization (WHO) WP/2002/IC/TFI/2.2/001/03.02.AW.03) and the National Social Science Foundation of China (01BSH030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Charney Dennis S, 2004, Sci STKE, V2004, pre5, DOI 10.1126/stke.2252004re5; Chen BZ, 2000, CHINA ECON REV, V11, P1, DOI 10.1016/S1043-951X(99)00014-0; Chen WQ, 2005, OCCUP ENVIRON MED, V62, P251, DOI 10.1136/oem.2004.013680; Cochrane J, 2003, ALCOHOL ALCOHOLISM, V38, P537, DOI 10.1093/alcalc/agg111; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cottrell R., 2011, HLTH PROMOTION ED RE; Deckro GR, 2002, J AM COLL HEALTH, V50, P281, DOI 10.1080/07448480209603446; Department of Comprehensive Statistics of National Bureau of Statistics, 2009, CHIN STAT YB REG EC, P202; Edmondson KA, 2005, J RELIG HEALTH, V44, P161, DOI 10.1007/s10943-005-2774-0; Farley Tillman, 2005, J Immigr Health, V7, P213, DOI 10.1007/s10903-005-3678-5; Field TM, 1985, STRESS COPING, P11; Fone DL, 2006, HEALTH PLACE, V12, P332, DOI 10.1016/j.healthplace.2005.02.002; Gary TL, 2007, HEALTH PLACE, V13, P569, DOI 10.1016/j.healthplace.2006.06.001; Goldstein H., 1995, MULTILEVEL STAT MODE, P6; Guo J, 2001, CHINESE RURAL EC, V6, P26; Hao C, 2006, CHINA ECON REV, V17, P347, DOI 10.1016/j.chieco.2006.01.001; Hao W, 2004, ALCOHOL ALCOHOLISM, V39, P43, DOI 10.1093/alcalc/agh018; Lee Sing, 2000, CHINESE SOC CHANGE C; LIN JYF, 1992, AM ECON REV, V82, P34; Liu X, 2002, XU XI HE SHI JIAN, V3, P55; Liu XC, 2000, J CLIN PSYCHOL, V56, P1565, DOI 10.1002/1097-4679(200012)56:12<1565::AID-7>3.0.CO;2-U; Meng X, 2004, REV INCOME WEALTH, P357; National Bureau of Statistics of China, RES 6 NAT CENS; Paul K, 2008, J NATL MED ASSOC, V100, P540, DOI 10.1016/S0027-9684(15)31300-6; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Phillips MR, 1999, CULT MED PSYCHIAT, V23, P25, DOI 10.1023/A:1005462530658; Pu Y, 2008, CHIN J HLTH ED, V24, P139; Rashash J, 2001, USERS GUIDE MLINN VE; Ritter C, 2000, HEALTH PSYCHOL, V19, P576, DOI 10.1037/0278-6133.19.6.576; Tang CSK, 2001, J ORGAN BEHAV, V22, P887, DOI 10.1002/job.120; Tseng WS, 1985, CHINESE CULTURE MENT, P192; WHO, 2009, DEATH DALY EST 2004; Yang T, 2009, PUBLIC HEALTH, V123, P694, DOI 10.1016/j.puhe.2009.08.003; Yang Ting-zhong, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P760; Zhang S, 2003, AGR FARMER COUNTRYSI, P3; Zhou XG, 2000, AM J SOCIOL, V105, P1135, DOI 10.1086/210401	37	27	28	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30521	10.1371/journal.pone.0030521	http://dx.doi.org/10.1371/journal.pone.0030521			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	909MH	23152832	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100053
J	Cheng, J; Khan, MA; Qiu, WM; Li, J; Zhou, H; Zhang, QO; Guo, WW; Zhu, TT; Peng, JH; Sun, FJ; Li, SH; Korban, SS; Han, YP				Cheng, Jun; Khan, Muhammad Awais; Qiu, Wen-Ming; Li, Jing; Zhou, Hui; Zhang, Qiong; Guo, Wenwu; Zhu, Tingting; Peng, Junhua; Sun, Fengjie; Li, Shaohua; Korban, Schuyler S.; Han, Yuepeng			Diversification of Genes Encoding Granule-Bound Starch Synthase in Monocots and Dicots Is Marked by Multiple Genome-Wide Duplication Events	PLOS ONE			English	Article							MALUS X DOMESTICA; PROCESSED PSEUDOGENES; AMYLOPECTIN BIOSYNTHESIS; DEBRANCHING ENZYMES; RICE ENDOSPERM; WAXY LOCUS; 2 ISOFORMS; APPLE; ISOAMYLASE; EXPRESSION	Starch is one of the major components of cereals, tubers, and fruits. Genes encoding granule-bound starch synthase (GBSS), which is responsible for amylose synthesis, have been extensively studied in cereals but little is known about them in fruits. Due to their low copy gene number, GBSS genes have been used to study plant phylogenetic and evolutionary relationships. In this study, GBSS genes have been isolated and characterized in three fruit trees, including apple, peach, and orange. Moreover, a comprehensive evolutionary study of GBSS genes has also been conducted between both monocots and eudicots. Results have revealed that genomic structures of GBSS genes in plants are conserved, suggesting they all have evolved from a common ancestor. In addition, the GBSS gene in an ancestral angiosperm must have undergone genome duplication similar to 251 million years ago (MYA) to generate two families, GBSSI and GBSSII. Both GBSSI and GBSSII are found in monocots; however, GBSSI is absent in eudicots. The ancestral GBSSII must have undergone further divergence when monocots and eudicots split similar to 165 MYA. This is consistent with expression profiles of GBSS genes, wherein these profiles are more similar to those of GBSSII in eudicots than to those of GBSSI genes in monocots. In dicots, GBSSII must have undergone further divergence when rosids and asterids split from each other similar to 126 MYA. Taken together, these findings suggest that it is GBSSII rather than GBSSI of monocots that have orthologous relationships with GBSS genes of eudicots. Moreover, diversification of GBSS genes is mainly associated with genome-wide duplication events throughout the evolutionary course of history of monocots and eudicots.	[Cheng, Jun; Li, Jing; Zhou, Hui; Zhang, Qiong; Zhu, Tingting; Peng, Junhua; Li, Shaohua; Han, Yuepeng] Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China; [Khan, Muhammad Awais; Korban, Schuyler S.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Qiu, Wen-Ming; Guo, Wenwu] Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Hubei, Peoples R China; [Sun, Fengjie] Georgia Gwinnett Coll, Sch Sci & Technol, Lawrenceville, GA USA	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; University of Illinois System; University of Illinois Urbana-Champaign; Huazhong Agricultural University; University System of Georgia; Georgia Gwinnett College	Cheng, J (corresponding author), Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China.	korban@illinois.edu; yphan@wbgcas.cn	Peng, Junhua/HHZ-2344-2022; Zhu, Tingting/T-9997-2019; Zhu, Tingting/O-6989-2017	Peng, Junhua/0000-0002-8428-3137; Zhu, Tingting/0000-0003-3141-1884; Zhu, Tingting/0000-0003-3141-1884; Leung, Peter/0000-0003-3152-3800; Cheng, Jung-Chien/0000-0002-5399-9327; Khan, Muhammad Awais/0000-0002-0424-7727	National Program on Key Basic Research Project of China (973 Program) [2011CB100600]; CAS [XDA01020304]; Ministry of Agriculture of China	National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China); CAS(Chinese Academy of Sciences); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This research was jointly supported by National Program on Key Basic Research Project of China (973 Program, grant no. 2011CB100600), the CAS Strategic Priority Research Program (grant no. XDA01020304), and the National 948 Project from the Ministry of Agriculture of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blauth SL, 2001, PLANT PHYSIOL, V125, P1396, DOI 10.1104/pp.125.3.1396; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Burton RA, 2002, PLANT J, V31, P97, DOI 10.1046/j.1365-313X.2002.01339.x; Carrin ME, 2004, FOOD CHEM, V87, P173, DOI 10.1016/j.foodchem.2003.10.032; Denyer K, 1997, PLANT CELL ENVIRON, V20, P1566, DOI 10.1046/j.1365-3040.1997.d01-48.x; Dian WM, 2003, PLANTA, V218, P261, DOI 10.1007/s00425-003-1101-9; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; DRY I, 1992, PLANT J, V2, P193; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards A, 2002, PLANT CELL, V14, P1767, DOI 10.1105/tpc.002907; Ermolaeva MD, 2003, PLANT MOL BIOL, V51, P859, DOI 10.1023/A:1023001130337; Evans RC, 2000, MOL PHYLOGENET EVOL, V17, P388, DOI 10.1006/mpev.2000.0828; Gasic K., 2004, Plant Molecular Biology Reporter, V22, P437, DOI 10.1007/BF02772687; Goncalves I, 2000, GENOME RES, V10, P672, DOI 10.1101/gr.10.5.672; GRAUR D, 1989, J MOL EVOL, V28, P279, DOI 10.1007/BF02103423; Han YP, 2007, PLANTA, V226, P1265, DOI 10.1007/s00425-007-0555-6; Han Y, 2007, MOL PHYLOGENET EVOL, V43, P852, DOI 10.1016/j.ympev.2006.09.001; Han YP, 2011, J EXP BOT, V62, P5117, DOI 10.1093/jxb/err215; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hylton CM, 1996, PLANTA, V198, P230, DOI 10.1007/BF00206248; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Kelebek H, 2011, J SCI FOOD AGR, V91, P1855, DOI 10.1002/jsfa.4396; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Korban Schuyler S., 2009, V6, P85, DOI 10.1007/978-0-387-77491-6_5; Kubo A, 1999, PLANT PHYSIOL, V121, P399, DOI 10.1104/pp.121.2.399; Kubo A, 2010, PLANT PHYSIOL, V153, P956, DOI 10.1104/pp.110.155259; Lo Bianco R, 2002, J AM SOC HORTIC SCI, V127, P115, DOI 10.21273/JASHS.127.1.115; Long M, 2001, CURR OPIN GENET DEV, V11, P673, DOI 10.1016/S0959-437X(00)00252-5; Magein H., 2000, ACTA HORTIC, V517, P487; Matsumoto T, 2011, PLANT PHYSIOL, V156, P20, DOI 10.1104/pp.110.171579; McIntyre CL, 2008, GENOME, V51, P524, DOI 10.1139/G08-035; NAKAMURA T, 1995, MOL GEN GENET, V248, P253, DOI 10.1007/BF02191591; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; Noda T, 2003, CEREAL CHEM, V80, P193, DOI 10.1094/CCHEM.2003.80.2.193; Ophir R, 1997, GENE, V205, P191, DOI 10.1016/S0378-1119(97)00398-3; Pavlicek A, 2006, TRENDS GENET, V22, P69, DOI 10.1016/j.tig.2005.11.005; Rambaut A, 2011, TRACER V1 5 COMPUTER; Sattler SE, 2009, MOL BREEDING, V24, P349, DOI 10.1007/s11032-009-9296-5; Stevenson DG, 2006, CARBOHYD POLYM, V63, P432, DOI 10.1016/j.carbpol.2005.10.009; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vrinten PL, 2000, PLANT PHYSIOL, V122, P255, DOI 10.1104/pp.122.1.255; WANG ZY, 1995, PLANT J, V7, P613, DOI 10.1046/j.1365-313X.1995.7040613.x; Wattebled F, 2005, PLANT PHYSIOL, V138, P184, DOI 10.1104/pp.105.059295; WESSLER SR, 1985, P NATL ACAD SCI USA, V82, P4177, DOI 10.1073/pnas.82.12.4177; WOLFE J A, 1988, Aliso, V12, P177; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301	49	43	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30088	10.1371/journal.pone.0030088	http://dx.doi.org/10.1371/journal.pone.0030088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291904	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600014
J	Shi, XW; Zhou, Z; Wang, LL; Yue, F; Wang, MQ; Yang, CY; Song, LS				Shi, Xiaowei; Zhou, Zhi; Wang, Lingling; Yue, Feng; Wang, Mengqiang; Yang, Chuanyan; Song, Linsheng			The Immunomodulation of Acetylcholinesterase in Zhikong Scallop Chlamys farreri	PLOS ONE			English	Article							PERIPHERAL ANIONIC SITE; MOLECULAR CHARACTERIZATION; MUSCLE REGENERATION; INNATE IMMUNITY; NERVOUS-SYSTEM; RAT-BRAIN; EXPRESSION; INHIBITION; HEMOCYTES; RECEPTOR	Background: Acetycholinesterase (AChE; EC 3.1.1.7) is an essential hydrolytic enzyme in the cholinergic nervous system, which plays an important role during immunomodulation in vertebrates. Though AChEs have been identified in most invertebrates, the knowledge about immunomodulation function of AChE is still quite meagre in invertebrates. Methodology: A scallop AChE gene was identified from Chlamys farreri (designed as CfAChE), and its open reading frame encoded a polypeptide of 522 amino acids. A signal peptide, an active site triad, the choline binding site and the peripheral anionic sites (PAS) were identified in CfAChE. The recombinant mature polypeptide of CfAChE (rCfAChE) was expressed in Pichia pastoris GS115, and its activity was 71.3 +/- 1.3 U mg(-1) to catalyze the hydrolysis of acetylthiocholine iodide. The mRNA transcripts of CfAChE were detected in haemocytes, hepatopancreas, adductor muscle, mantle, gill, kidney and gonad, with the highest expression level in hepatopancreas. The relative expression level of CfAChE mRNA in haemocytes was both up-regulated after LPS (0.5 mg mL(-1)) and human TNF-alpha (50 ng mL(-1)) stimulations, and it reached the highest level at 12 h (10.4-fold, P<0.05) and 1 h (3.2-fold, P<0.05), respectively. After Dichlorvos (DDVP) (50 mg L-1) stimulation, the CfAChE activity in the supernatant of haemolymph decreased significantly from 0.16 U mg(-1) at 0 h to 0.03 U mg(-1) at 3 h, while the expression level of lysozyme in the haemocytes was up-regulated and reached the highest level at 6 h, which was 3.0-fold (P<0.05) of that in the blank group. Conclusions:The results collectively indicated that CfAChE had the acetylcholine-hydrolyzing activity, which was in line with the potential roles of AChE in the neuroimmune system of vertebrates which may help to re-balance the immune system after immune response.	[Shi, Xiaowei; Zhou, Zhi; Wang, Lingling; Yue, Feng; Wang, Mengqiang; Yang, Chuanyan; Song, Linsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Shi, Xiaowei; Zhou, Zhi; Yue, Feng; Wang, Mengqiang; Yang, Chuanyan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shi, XW (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	wanglingling@ms.qdio.ac.cn; lshsong@ms.qdio.ac.cn	Zhong, Jin/J-4613-2019; Wang, Mengqiang/A-1215-2010; zhi, zhouzhi/J-8063-2013; Yue, Feng/S-6565-2017; Zhong, Jin/M-6859-2018	Wang, Mengqiang/0000-0003-4702-3309; Zhong, Jin/0000-0002-3554-1275	Chinese Ministry of Science and Technology [2010CB126404]; National Natural Science Foundation of China [30925028, 30730070, 31072192]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Basic Research Program of China (973 program, no. 2010CB126404) from Chinese Ministry of Science and Technology, and grants (No. 30925028 and 30730070 to LS, and 31072192 to LW) from National Natural Science Foundation of China, http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini C, 2004, EUR J HISTOCHEM, V48, P235; Anguiano GA, 2010, ENVIRON TOXICOL, V25, P327, DOI 10.1002/tox.20491; Arpagaus M, 1998, J PHYSIOLOGY-PARIS, V92, P363, DOI 10.1016/S0928-4257(99)80006-0; Askar KA, 2011, APPL BIOCH BIOTECHNO; Azevedo-Pereira HMVS, 2011, ECOTOX ENVIRON SAFE, V74, P1210, DOI 10.1016/j.ecoenv.2011.03.018; Baxter GD, 1999, INT J PARASITOL, V29, P1765, DOI 10.1016/S0020-7519(99)00136-8; BERGMANN F, 1950, BIOCHIM BIOPHYS ACTA, V6, P217, DOI 10.1016/0006-3002(50)90094-1; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Boudinot E, 2009, RESP PHYSIOL NEUROBI, V165, P40, DOI 10.1016/j.resp.2008.10.003; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branduardi D, 2005, J AM CHEM SOC, V127, P9147, DOI 10.1021/ja0512780; BULBRING E, 1953, PROC R SOC SER B-BIO, V141, P445, DOI 10.1098/rspb.1953.0053; Cao A, 2007, INT IMMUNOPHARMACOL, V7, P1395, DOI 10.1016/j.intimp.2007.07.008; Cheng T.C., 1981, INVERTEBRATE BLOOD C, V1, P223; Cheng Thomas C., 1996, P299; Costa MM, 2009, FISH SHELLFISH IMMUN, V26, P515, DOI 10.1016/j.fsi.2009.02.001; CYMBOROWSKI B, 1970, COMP BIOCHEM PHYSIOL, V32, P367, DOI 10.1016/0010-406X(70)90950-3; Das UN, 2007, MED SCI MONITOR, V13, pRA214; De Zoysa M, 2009, FISH SHELLFISH IMMUN, V26, P625, DOI 10.1016/j.fsi.2008.10.004; DEWHURST SA, 1975, COMP BIOCHEM PHYS C, V50, P53; DOUGHERTY DA, 1990, SCIENCE, V250, P1558, DOI 10.1126/science.2274786; Dvir H, 2010, CHEM-BIOL INTERACT, V187, P10, DOI 10.1016/j.cbi.2010.01.042; ELBERMANI AWI, 1978, J EMBRYOL EXP MORPH, V48, P177; HORNSTEIN EP, 1994, VISUAL NEUROSCI, V11, P989, DOI 10.1017/S0952523800003928; Johnson G, 2006, CURR PHARM DESIGN, V12, P217, DOI 10.2174/138161206775193127; Johnson JL, 2003, BIOCHEMISTRY-US, V42, P5438, DOI 10.1021/bi027065u; Jones AK, 2002, FASEB J, V16, P441, DOI 10.1096/fj.01-0683fje; Kang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019063; Karczmar AG, 2010, CHEM-BIOL INTERACT, V187, P34, DOI 10.1016/j.cbi.2010.03.009; Kawli T, 2010, DIS MODEL MECH, V3, P721, DOI 10.1242/dmm.003871; KEYHANI E, 1981, J CELL SCI, V52, P327; KUSSATHE.E, 1967, HISTOCHEMISTRY, V8, P237, DOI 10.1007/BF00306086; Leone P, 2010, CHEM-BIOL INTERACT, V187, P49, DOI 10.1016/j.cbi.2010.01.030; Lin G, 2005, J BIOCHEM MOL TOXIC, V19, P234, DOI 10.1002/jbt.20087; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo CY, 2010, BIOCHEM PHARMACOL, V80, P1427, DOI 10.1016/j.bcp.2010.07.020; MCKENNA OC, 1968, CIRC RES, V23, P645, DOI 10.1161/01.RES.23.5.645; Monnet-Tschudi F, 2000, TOXICOL APPL PHARM, V165, P175, DOI 10.1006/taap.2000.8934; Nizri E, 2006, NEUROPHARMACOLOGY, V50, P540, DOI 10.1016/j.neuropharm.2005.10.013; ORON U, 1984, CELL MOL BIOL, V30, P411; Pegan K, 2010, CHEM-BIOL INTERACT, V187, P96, DOI 10.1016/j.cbi.2010.03.034; PITZURRA L, 1989, INFECT IMMUN, V57, P2452, DOI 10.1128/IAI.57.8.2452-2456.1989; QUAN N, 1994, J NEUROIMMUNOL, V49, P125, DOI 10.1016/0165-5728(94)90188-0; QUINN DM, 1987, CHEM REV, V87, P955, DOI 10.1021/cr00081a005; Rand James B, 2007, WormBook, P1; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; ROSENBERRY TL, 1975, ADV ENZYMOL RAMB, V43, P103; RYBICKA K, 1967, EXP PARASITOL, V20, P263, DOI 10.1016/0014-4894(67)90048-3; Salzet M, 2001, TRENDS IMMUNOL, V22, P285, DOI 10.1016/S1471-4906(01)01895-6; SCHWARTZ JH, 1975, J GEN PHYSIOL, V65, P255, DOI 10.1085/jgp.65.3.255; SERAVIN LN, 1965, DOKL AKAD NAUK SSSR+, V160, P486; STEITZ TA, 1982, ANNU REV BIOPHYS BIO, V11, P419, DOI 10.1146/annurev.bb.11.060182.002223; Szegletes T, 1998, BIOCHEMISTRY-US, V37, P4206, DOI 10.1021/bi972158a; Talesa V, 1999, J NEUROCHEM, V72, P1250, DOI 10.1046/j.1471-4159.1999.0721250.x; THIEDEMANN KU, 1986, CELL TISSUE RES, V244, P153; Travers MA, 2008, FISH SHELLFISH IMMUN, V24, P400, DOI 10.1016/j.fsi.2007.10.001; Tyagi E, 2010, EUR J PHARMACOL, V640, P206, DOI 10.1016/j.ejphar.2010.04.041; Tyagi E, 2008, J NEUROIMMUNOL, V205, P51, DOI 10.1016/j.jneuroim.2008.08.015; van Nierop P, 2006, J BIOL CHEM, V281, P1680, DOI 10.1074/jbc.M508571200; von Wachtendonk D., 1979, Comparative Biochemistry and Physiology C Comparative Pharmacology, V63, P279, DOI 10.1016/0306-4492(79)90074-1; Wang LL, 2009, FISH SHELLFISH IMMUN, V26, P744, DOI 10.1016/j.fsi.2009.03.002; WATSON JE, 1976, PFLUG ARCH EUR J PHY, V363, P161, DOI 10.1007/BF01062285; WHITTAKER JR, 1980, J EMBRYOL EXP MORPH, V55, P343; Wootton EC, 2003, FISH SHELLFISH IMMUN, V15, P195, DOI 10.1016/S1050-4648(02)00161-4; Xuereb B, 2009, AQUAT TOXICOL, V94, P114, DOI 10.1016/j.aquatox.2009.06.010; Yang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017089; Zaitseva O V, 2008, Morfologiia, V133, P55; Zhang HA, 2010, FISH SHELLFISH IMMUN, V29, P149, DOI 10.1016/j.fsi.2010.02.024; Zhao PC, 2010, J BIOCHEM MOL TOXIC, V24, P51, DOI 10.1002/jbt.20311; Zhou XX, 2011, PROTEIN EXPRES PURIF, V77, P62, DOI 10.1016/j.pep.2010.11.017	72	101	108	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30828	10.1371/journal.pone.0030828	http://dx.doi.org/10.1371/journal.pone.0030828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22649509	gold, Green Published, Green Submitted			2022-12-27	WOS:000301570600085
J	Li, XB; Yan, WG; Agrama, H; Jia, LM; Jackson, A; Moldenhauer, K; Yeater, K; McClung, A; Wu, DX				Li, Xiaobai; Yan, Wengui; Agrama, Hesham; Jia, Limeng; Jackson, Aaron; Moldenhauer, Karen; Yeater, Kathleen; McClung, Anna; Wu, Dianxing			Unraveling the Complex Trait of Harvest Index with Association Mapping in Rice (Oryza sativa L.)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; YIELD-RELATED TRAITS; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; QUANTITATIVE TRAITS; GENETIC DIVERSITY; GRAIN-YIELD; CORE SUBSET; QUALITY; MODEL	Harvest index is a measure of success in partitioning assimilated photosynthate. An improvement of harvest index means an increase in the economic portion of the plant. Our objective was to identify genetic markers associated with harvest index traits using 203 O. sativa accessions. The phenotyping for 14 traits was conducted in both temperate (Arkansas) and subtropical (Texas) climates and the genotyping used 154 SSRs and an indel marker. Heading, plant height and weight, and panicle length had negative correlations, while seed set and grain weight/panicle had positive correlations with harvest index across both locations. Subsequent genetic diversity and population structure analyses identified five groups in this collection, which corresponded to their geographic origins. Model comparisons revealed that different dimensions of principal components analysis (PCA) affected harvest index traits for mapping accuracy, and kinship did not help. In total, 36 markers in Arkansas and 28 markers in Texas were identified to be significantly associated with harvest index traits. Seven and two markers were consistently associated with two or more harvest index correlated traits in Arkansas and Texas, respectively. Additionally, four markers were constitutively identified at both locations, while 32 and 24 markers were identified specifically in Arkansas and Texas, respectively. Allelic analysis of four constitutive markers demonstrated that allele 253 bp of RM431 had significantly greater effect on decreasing plant height, and 390 bp of RM24011 had the greatest effect on decreasing panicle length across both locations. Many of these identified markers are located either nearby or flanking the regions where the QTLs for harvest index have been reported. Thus, the results from this association mapping study complement and enrich the information from linkage-based QTL studies and will be the basis for improving harvest index directly and indirectly in rice.	[Li, Xiaobai; Jia, Limeng; Wu, Dianxing] Zhejiang Univ, State Key Lab Rice Biol, Int Atom Energy Agcy, Collaborating Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Yan, Wengui; Jia, Limeng; Jackson, Aaron; McClung, Anna] ARS, USDA, Dale Bumpers Natl Rice Res Ctr, Stuttgart, AR USA; [Li, Xiaobai] Zhejiang Acad Agr Sci, Inst Hort, Hangzhou, Zhejiang, Peoples R China; [Agrama, Hesham; Jia, Limeng; Moldenhauer, Karen] Univ Arkansas, Rice Res & Extens Ctr, Stuttgart, AR USA; [Yeater, Kathleen] ARS, USDA, So Plains Area, College Stn, TX USA	Zhejiang University; United States Department of Agriculture (USDA); Zhejiang Academy of Agricultural Sciences; University of Arkansas System; University of Arkansas Fayetteville; United States Department of Agriculture (USDA)	Li, XB (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Int Atom Energy Agcy, Collaborating Ctr, Hangzhou 310003, Zhejiang, Peoples R China.	Wengui.Yan@ars.usda.gov; dxwu@zju.edu.cn	Li, Xiaobai/AAB-7604-2021; Yin, Minghao/E-9611-2015	Li, Xiaobai/0000-0001-9615-3543; Jackson, Aaron/0000-0002-5540-9255; Yin, Minghao/0000-0002-6226-2394	United States Department of Agriculture-Agricultural Research Service	United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding was provided by the United States Department of Agriculture-Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2008, EUPHYTICA, V160, P339, DOI 10.1007/s10681-007-9535-y; Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Agrama HA, 2009, CROP SCI, V49, P1336, DOI 10.2135/cropsci2008.06.0551; Ando T, 2008, THEOR APPL GENET, V116, P881, DOI 10.1007/s00122-008-0722-6; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; BORBA TCO, 2005, CROP BREED APPL BIOT, V2, P157; Breseghello F, 2006, CROP SCI, V46, P1323, DOI 10.2135/cropsci2005.09-0305; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Brondani C, 2006, GENET MOL BIOL, V29, P676, DOI 10.1590/S1415-47572006000400017; Can N. D., 1999, Plant Production Science, V2, P67; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Dalling M. J., 1985, EXPLOITATION PHYSL G, P55; Borba TCD, 2009, GENETICA, V137, P293, DOI 10.1007/s10709-009-9380-0; Din K., 2005, SAIC NEWSLETTER, V15, P4; Din RU, 2010, WHEAT PAK J BOT, V42, P899; DONALD CM, 1976, ADV AGRON, V28, P361, DOI 10.1016/S0065-2113(08)60559-3; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Franco J, 2006, CROP SCI, V46, P854, DOI 10.2135/cropsci2005.07-0201; Fu Q, 2010, J GENET GENOMICS, V37, P147, DOI 10.1016/S1673-8527(09)60033-3; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Gepts P., 2004, Plant Breeding Reviews, V24, P1, DOI 10.1002/9780470650288.ch1; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Hao ZF, 2010, EUPHYTICA, V174, P165, DOI 10.1007/s10681-009-0091-5; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HAY RKM, 1995, ANN APPL BIOL, V126, P197, DOI 10.1111/j.1744-7348.1995.tb05015.x; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Hemamalini GS, 2000, EUPHYTICA, V112, P69, DOI 10.1023/A:1003854224905; Hittalmani S, 2003, THEOR APPL GENET, V107, P679, DOI 10.1007/s00122-003-1269-1; Homma K, 2004, FIELD CROP RES, V88, P11, DOI 10.1016/j.fcr.2003.08.010; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Jain S, 2004, THEOR APPL GENET, V109, P965, DOI 10.1007/s00122-004-1700-2; Jun F, 1997, CROP RES, V2, P1; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kim S, 2006, GENETICS, V173, P1125, DOI 10.1534/genetics.105.052720; Koutroubas SD, 2003, FIELD CROP RES, V83, P251, DOI 10.1016/S0378-4290(03)00067-4; Lanceras JC, 2004, PLANT PHYSIOL, V135, P384, DOI 10.1104/pp.103.035527; Li Xiaobai, 2010, Genetica, V138, P1221, DOI 10.1007/s10709-010-9521-5; Li XB, 2011, PLANTA, V234, P347, DOI 10.1007/s00425-011-1405-0; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mao Bei-Bei, 2003, Acta Genetica Sinica, V30, P1118; Marri PR, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-33; Matsumoto TK, 2006, HORTSCIENCE, V41, P131, DOI 10.21273/HORTSCI.41.1.131; MOHAMMAD D, 1993, INDIAN J AGR SCI, V63, P92; Nei M., 1983, P 5 WORLD C GEN APPL, V21, P405; Parisseaux B, 2004, THEOR APPL GENET, V109, P508, DOI 10.1007/S00122-004-1666-0; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Prasad PVV, 2006, FIELD CROP RES, V95, P398, DOI 10.1016/j.fcr.2005.04.008; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Raes D, 2009, AGRON J, V101, P438, DOI 10.2134/agronj2008.0140s; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rohlf F, 2000, FNTSYS PC NUMERICAL; Rong J, 2007, GENETICS, V176, P2577, DOI 10.1534/genetics.107.074518; Sabouri H, 2009, AUST J CROP SCI, V3, P155; Saxton AM, 1998, PROCEEDINGS OF THE TWENTY-THIRD ANNUAL SAS USERS GROUP INTERNATIONAL CONFERENCE, P1243; Shao YF, 2011, THEOR APPL GENET, V122, P1005, DOI 10.1007/s00122-010-1505-4; SHPILER L, 1990, EUPHYTICA, V51, P257, DOI 10.1007/BF00039727; Shrotria PK, 1988, SORGHUM NEWSLETTER U, V31, P4; Sial MA, 2005, PAKISTAN J BOT, V37, P575; Sinclair TR, 1998, CROP SCI, V38, P638, DOI 10.2135/cropsci1998.0011183X003800030002x; Soltani A., 2001, Journal of Science and Technology of Agriculture and Natural Resources, V5, P127; Pinto RS, 2010, THEOR APPL GENET, V121, P1001, DOI 10.1007/s00122-010-1351-4; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang T, 2006, PLOS GENET, V2, P1824, DOI 10.1371/journal.pgen.0020199; Terao T, 2010, THEOR APPL GENET, V120, P875, DOI 10.1007/s00122-009-1218-8; Thomson MJ, 2007, THEOR APPL GENET, V114, P559, DOI 10.1007/s00122-006-0457-1; Thomson MJ, 2009, RICE, V2, P80, DOI 10.1007/s12284-009-9023-1; Tyagi AK, 2004, J GENET, V83, P79, DOI 10.1007/BF02715832; Vaughan DA, 2008, PLANT SCI, V174, P394, DOI 10.1016/j.plantsci.2008.01.016; Wang LQ, 2007, THEOR APPL GENET, V115, P463, DOI 10.1007/s00122-007-0580-7; Wang ML, 2009, THEOR APPL GENET, V120, P13, DOI 10.1007/s00122-009-1155-6; Xin ZG, 2003, BIOTECHNIQUES, V34, P820, DOI 10.2144/03344rr04; Xu YB, 2004, CROP SCI, V44, P1947, DOI 10.2135/cropsci2004.1947; XUE W, 2008, NAT GENET, V143, P1; Yan W, 2007, CROP SCI, V47, P869, DOI 10.2135/cropsci2006.07.0444; Yan WG, 2005, U AR AGRI EXP STA RE, P63; Yang XC, 2008, HEREDITY, V101, P396, DOI 10.1038/hdy.2008.90; Yoshida S., 1981, Fundamentals of rice crop science.; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang YM, 2005, GENETICS, V169, P2267, DOI 10.1534/genetics.104.033217; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhu CS, 2009, GENETICS, V182, P875, DOI 10.1534/genetics.108.098863; Zou JiangShi, 2003, Acta Agronomica Sinica, V29, P652	84	189	201	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e29350	10.1371/journal.pone.0029350	http://dx.doi.org/10.1371/journal.pone.0029350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	23240004	Green Published, gold			2022-12-27	WOS:000301570600005
J	Zeng, YJ; Yang, X; Wang, J; Fan, JJ; Kong, QY; Yu, XQ				Zeng, Youjia; Yang, Xiao; Wang, Juan; Fan, Jinjin; Kong, Qingyu; Yu, Xueqing			Aristolochic Acid I Induced Autophagy Extenuates Cell Apoptosis via ERK 1/2 Pathway in Renal Tubular Epithelial Cells	PLOS ONE			English	Article							HT-29 CELLS; INHIBITION; DEATH; MACROAUTOPHAGY; TOXICITY; INJURY; VITRO	Autophagy is a lysosomal degradation pathway that is essential for cell survival and tissue homeostasis. However, limited information is available about autophagy in aristolochic acid (AA) nephropathy. In this study, we investigated the role of autophagy and related signaling pathway during progression of AAI-induced injury to renal tubular epithelial cells (NRK52E cells). The results showed that autophagy in NRK52E cells was detected as early as 3-6 hrs after low dose of AAI (10 mu M) exposure as indicated by an up-regulated expression of LC3-II and Beclin 1 proteins. The appearance of AAI-induced punctated staining of autophagosome-associated LC3-II upon GFP-LC3 transfection in NRK52E cells provided further evidence for autophagy. However, cell apoptosis was not detected until 12 hrs after AAI treatment. Blockade of autophagy with Wortmannin or 3-Methyladenine (two inhibitors of phosphoinositede 3-kinases) or small-interfering RNA knockdown of Beclin 1 or Atg7 sensitized the tubular cells to apoptosis. Treatment of NRK52E cells with AAI caused a time-dependent increase in extracellular signal-regulated kinase 1 and 2 (ERK1/2) activity, but not c-Jun N-terminal kinase (JNK) and p38. Pharmacological inhibition of ERK1/2 phosphorylation with U0126 resulted in a decreased AAI-induced autophagy that was accompanied by an increased apoptosis. Taken together, our study demonstrated for the first time that autophagy occurred earlier than apoptosis during AAI-induced tubular epithelial cell injury. Autophagy induced by AAI via ERK1/2 pathway might attenuate apoptosis, which may provide a protective mechanism for cell survival under AAI-induced pathological condition.	[Zeng, Youjia; Yang, Xiao; Wang, Juan; Fan, Jinjin; Kong, Qingyu; Yu, Xueqing] Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 1, Key Lab Nephrol,Minist Hlth, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zeng, YJ (corresponding author), Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 1, Key Lab Nephrol,Minist Hlth, Guangzhou 510275, Guangdong, Peoples R China.	yangx826@yahoo.com.cn	; Zhao, Xiubo/AAZ-9058-2021	Yu, Hai/0000-0002-6386-9761; Wang, Jiqian/0000-0002-7525-5943; Zhao, Xiubo/0000-0002-4620-2893	Chinese National Natural Science Research Grant [30873432, 81073138]	Chinese National Natural Science Research Grant	This work is supported by the Chinese National Natural Science Research Grant (Grant number 30873432, 81073138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehrecke EH, 2003, CELL DEATH DIFFER, V10, P940, DOI 10.1038/sj.cdd.4401280; Bakhiya N, 2009, TOXICOLOGY, V264, P74, DOI 10.1016/j.tox.2009.07.014; Balachandran P, 2005, KIDNEY INT, V67, P1797, DOI 10.1111/j.1523-1755.2005.00277.x; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gao RT, 2000, CHINESE MED J-PEKING, V113, P418; Hsin YH, 2006, APOPTOSIS, V11, P2167, DOI 10.1007/s10495-006-0289-0; Inoue K, 2010, CLIN EXP NEPHROL, V14, P112, DOI 10.1007/s10157-009-0254-7; Ioset JR, 2003, FOOD CHEM TOXICOL, V41, P29, DOI 10.1016/S0278-6915(02)00219-3; Ito M, 2010, CANCER GENE THER, V17, P633, DOI 10.1038/cgt.2010.20; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kovacs AL, 2000, CELL TISSUE RES, V302, P253, DOI 10.1007/s004410000275; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Li J, 2010, TOXICOL IN VITRO, V24, P1092, DOI 10.1016/j.tiv.2010.03.012; Li L, 2010, AM J PATHOL, V176, P1767, DOI 10.2353/ajpath.2010.090345; Pallet N, 2008, AUTOPHAGY, V4, P783, DOI 10.4161/auto.6477; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; Periyasamy-Thandavan S, 2009, AM J PHYSIOL-RENAL, V297, pF244, DOI 10.1152/ajprenal.00033.2009; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pozdzik AA, 2008, KIDNEY INT, V73, P595, DOI 10.1038/sj.ki.5002714; Qi XM, 2007, TOXICOL APPL PHARM, V222, P105, DOI 10.1016/j.taap.2007.03.029; Sivaprasad U, 2008, J CELL MOL MED, V12, P1265, DOI 10.1111/j.1582-4934.2008.00282.x; VOM DS, 2001, BIOCHEM J, V354, P31; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Yang C, 2008, AM J PHYSIOL-RENAL, V294, pF777, DOI 10.1152/ajprenal.00590.2007; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0; Yu FY, 2011, TOXICOL IN VITRO, V25, P810, DOI 10.1016/j.tiv.2011.01.016	29	128	136	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30312	10.1371/journal.pone.0030312	http://dx.doi.org/10.1371/journal.pone.0030312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276178	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100034
J	Aaltonen, KJ; Virkki, LM; Malmivaara, A; Konttinen, YT; Nordstrom, DC; Blom, M				Aaltonen, Kalle J.; Virkki, Liisa M.; Malmivaara, Antti; Konttinen, Yrjo T.; Nordstrom, Dan C.; Blom, Marja			Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis	PLOS ONE			English	Review							ANTITUMOR NECROSIS FACTOR; ALPHA MONOCLONAL-ANTIBODY; RECEIVING CONCOMITANT METHOTREXATE; DOUBLE-BLIND; PLUS METHOTREXATE; PHASE-III; COMBINATION ETANERCEPT; INADEQUATE RESPONSE; TAIWANESE PATIENTS; DOSE METHOTREXATE	Background and Objectives: Five-tumour necrosis factor (TNF)-blockers (infliximab, etanercept, adalimumab, certolizumab pegol and golimumab) are available for treatment of rheumatoid arthritis. Only few clinical trials compare one TNF-blocker to another. Hence, a systematic review is required to indirectly compare the substances. The aim of our study is to estimate the efficacy and the safety of TNF-blockers in the treatment of rheumatoid arthritis (RA) and indirectly compare all five currently available blockers by combining the results from included randomized clinical trials (RCT). Methods: A systematic literature review was conducted using databases including: MEDLINE, SCOPUS (including EMBASE), Cochrane library and electronic search alerts. Only articles reporting double-blind RCTs of TNF-blockers vs. placebo, with or without concomitant methotrexate (MTX), in treatment of RA were selected. Data collected were information of patients, interventions, controls, outcomes, study methods and eventual sources of bias. Results: Forty-one articles reporting on 26 RCTs were included in the systematic review and meta-analysis. Five RCTs studied infliximab, seven etanercept, eight adalimumab, three golimumab and three certolizumab. TNF-blockers were more efficacious than placebo at all time points but were comparable to MTX. TNF-blocker and MTX combination was superior to either MTX or TNF-blocker alone. Increasing doses did not improve the efficacy. TNF-blockers were relatively safe compared to either MTX or placebo. Conclusions: No single substance clearly rose above others in efficacy, but the results of the safety analyses suggest that etanercept might be the safest alternative. Interestingly, MTX performs nearly identically considering both efficacy and safety aspects with a margin of costs.	[Aaltonen, Kalle J.; Blom, Marja] Univ Helsinki, Fac Pharm, Helsinki, Finland; [Aaltonen, Kalle J.; Virkki, Liisa M.; Konttinen, Yrjo T.] Univ Helsinki, Fac Med, Helsinki, Finland; [Malmivaara, Antti] Natl Inst Hlth & Welf THL, Ctr Hlth & Social Econ, Helsinki, Finland; [Konttinen, Yrjo T.] COXA Hosp Joint Replacement, Tampere, Finland; [Nordstrom, Dan C.] Univ Helsinki, Cent Hosp HUCH, Helsinki, Finland	University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Coxa Hospital for Joint Replacement; University of Helsinki	Aaltonen, KJ (corresponding author), Univ Helsinki, Fac Pharm, Helsinki, Finland.	yrjo.konttinen@helsinki.fi	; li, jiong/L-6534-2014; Obel, Carsten/H-9605-2016	li, jiong/0000-0003-1125-026X; li, jiong/0000-0002-1716-8067; Obel, Carsten/0000-0001-5004-1933; Kristensen, Jette Kolding/0000-0002-2648-5750	ORTON Orthopaedic Hospital of the ORTON Foundation; National PhD Graduate School in Musculoskeletal Diseases and Biomaterials	ORTON Orthopaedic Hospital of the ORTON Foundation; National PhD Graduate School in Musculoskeletal Diseases and Biomaterials	This study was supported by an unlimited grant from the ORTON Orthopaedic Hospital of the ORTON Foundation and by the National PhD Graduate School in Musculoskeletal Diseases and Biomaterials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2006, J RHEUMATOL, V33, P37; Aho K, 1998, SEMIN ARTHRITIS RHEU, V27, P325, DOI 10.1016/S0049-0172(98)80053-X; Allaart CF, 2006, CLIN EXP RHEUMATOL, V24, pS77; Alonso-Ruiz A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-52; Antoni C, 1999, CLIN EXP RHEUMATOL, V17, pS73; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bankhurst AD, 1999, CLIN EXP RHEUMATOL, V17, pS69; Bathon JM, 2003, CLIN EXP RHEUMATOL, V21, pS195; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Bessette L, 2007, J RHEUMATOL, V34, P1627; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Chen DY, 2009, J FORMOS MED ASSOC, V108, P310, DOI 10.1016/S0929-6646(09)60071-1; Chen Y-F, 2006, HEALTH TECHNOL ASSES, V10, P248; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Durez P, 2004, ANN RHEUM DIS, V63, P1069, DOI 10.1136/ard.2003.012914; Durez P, 2007, ARTHRITIS RHEUM-US, V56, P3919, DOI 10.1002/art.23055; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Emery P, 2010, ARTHRITIS RHEUM-US, V62, P674, DOI 10.1002/art.27268; Emery P, 2009, ARTHRITIS RHEUM-US, V60, P2272, DOI 10.1002/art.24638; Ericson ML, 1999, ARTHRITIS RHEUM, V42, pS82; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; Fleischmann R, 2009, ANN RHEUM DIS, V68, P805, DOI 10.1136/ard.2008.099291; Fleischmann RM, 2008, ARTHRITIS RHEUM, V58, pS530; Furst DE, 2003, J RHEUMATOL, V30, P2563; Gao Guo-hua, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P724; Genovese MC, 2002, ARTHRITIS RHEUM, V46, P1443, DOI 10.1002/art.10308; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Huang Feng, 2009, Zhonghua Nei Ke Za Zhi, V48, P916; Jamal S, 2009, CLIN RHEUMATOL, V28, P413, DOI 10.1007/s10067-008-1064-0; Kavanaugh A, 2008, ANN RHEUM DIS, V67, P1444, DOI 10.1136/ard.2008.094524; Kavanaugh A, 2000, J RHEUMATOL, V27, P841; Kavanaugh AF, 1996, ARTHRITIS RHEUM, V39, P575; Kay J, 2007, ANN RHEUM DIS, V66, P175; Kay J, 2006, ANN RHEUM DIS, V65, P323; Kay J, 2008, ARTHRITIS RHEUM-US, V58, P964, DOI 10.1002/art.23383; Keystone, 2009, ARTHRITIS RHEUM, V60, P1249, DOI 10.1002/art.24667; Keystone E, 2001, ARTHRITIS RHEUM, V44, pS213; Keystone EC, 2009, ANN RHEUM DIS, V68, P789, DOI 10.1136/ard.2008.099010; Keystone EC, 2003, CLIN EXP RHEUMATOL, V21, pS198; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P353, DOI 10.1002/art.20019; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Keystone E, 2008, ARTHRITIS RHEUM, V58, P3319, DOI 10.1002/art.23964; KIM HY, 2007, APLAR J RHEUMATOL, V10, P9, DOI DOI 10.1111/J.1479-8077.2007.00248.X; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Kristensen LE, 2007, SCAND J RHEUMATOL, V36, P411, DOI 10.1080/03009740701607067; Lan JL, 2004, J FORMOS MED ASSOC, V103, P618; Launois R, 2011, J RHEUMATOL, V38, P835, DOI 10.3899/jrheum.100665; Leombruno JP, 2009, ANN RHEUM DIS, V68, P1136, DOI 10.1136/ard.2008.091025; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; Maini RN, 2004, ARTHRITIS RHEUM-US, V50, P1051, DOI 10.1002/art.20159; Miceli-Richard C, 2008, ANN RHEUM DIS, V67, P478, DOI 10.1136/ard.2007.074104; Miyasaka N, 2008, MOD RHEUMATOL, V18, P252, DOI 10.1007/s10165-008-0045-0; Moreland LW, 1999, ANN INTERN MED, V130, P478, DOI 10.7326/0003-4819-130-6-199903160-00004; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; Neovius M, 2011, ANN RHEUM DIS, V70, P624, DOI 10.1136/ard.2010.133371; Quinn MA, 2005, ARTHRITIS RHEUM-US, V52, P27, DOI 10.1002/art.20712; Rahman MU, 2007, ANN RHEUM DIS, V66, P1233, DOI 10.1136/ard.2006.065995; Ronald VV, 2008, SCAND J RHEUMATOL, V37, P52; Schiff M, 2008, ANN RHEUM DIS, V67, P1096, DOI 10.1136/ard.2007.080002; Singh JA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007848.pub2; Smolen J, 2009, ANN RHEUM DIS, V68, P797, DOI 10.1136/ard.2008.101659; Smolen JS, 2009, LANCET, V374, P210, DOI 10.1016/S0140-6736(09)60506-7; Smolen JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982; Smolen JS, 2006, ARTHRITIS RHEUM-US, V54, P702, DOI 10.1002/art.21678; Symmons D, 2002, RHEUMATOLOGY, V41, P793, DOI 10.1093/rheumatology/41.7.793; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; van de Putte BA, 2004, ANN RHEUM DIS, V63, P508, DOI 10.1136/ard.2003.013052; van de Putte LBA, 2003, ANN RHEUM DIS, V62, P1168, DOI 10.1136/ard.2003.009563; van der Bijl AE, 2007, ARTHRITIS RHEUM-US, V56, P2129, DOI 10.1002/art.22718; van der Heijde D, 2007, ARTHRITIS RHEUM, V56, P3928, DOI 10.1002/art.23141; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P1063, DOI 10.1002/art.21655; van Riel PLCM, 2006, ANN RHEUM DIS, V65, P1478, DOI 10.1136/ard.2005.043299; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Weisman MH, 2007, RHEUMATOLOGY, V46, P1122, DOI 10.1093/rheumatology/kem033; Westhovens R, 2006, ARTHRITIS RHEUM-US, V54, P1075, DOI 10.1002/art.21734; Wiens A, 2010, PHARMACOTHERAPY, V30, P339, DOI 10.1592/phco.30.4.339; Wiens A, 2009, CLIN RHEUMATOL, V28, P1365, DOI 10.1007/s10067-009-1233-9; Wiens A, 2009, SCAND J IMMUNOL, V70, P337, DOI 10.1111/j.1365-3083.2009.02296.x; Yocum D, 2004, ARTHRITIS RHEUM, V50, pS659; Zhang F, 2006, APLAR J RHEUMATOL, V9, P127, DOI DOI 10.1111/J.1479-8077.2006.00186.X; Zhang Wen, 2009, Zhonghua Yi Xue Za Zhi, V89, P1876	87	197	206	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30275	10.1371/journal.pone.0030275	http://dx.doi.org/10.1371/journal.pone.0030275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22952698	Green Published, Green Submitted, gold			2022-12-27	WOS:000301454400100
J	Zhang, XL; Wang, GB; Zhao, LY; Sun, LL; Wang, J; Wu, P; Lu, L; Shi, J				Zhang, Xiao-Li; Wang, Gui-Bin; Zhao, Li-Yan; Sun, Li-Li; Wang, Jun; Wu, Ping; Lu, Lin; Shi, Jie			Clonidine Improved Laboratory-Measured Decision-Making Performance in Abstinent Heroin Addicts	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; VENTROMEDIAL PREFRONTAL CORTEX; EXECUTIVE FUNCTIONS; AGONIST CLONIDINE; IMPULSIVITY; COCAINE; DEFICIT; PERSONALITY; DYSFUNCTION; ANTAGONIST	Background: Impulsivity refers to a wide spectrum of actions characterized by quick and nonplanned reactions to external and internal stimuli, without taking into account the possible negative consequences for the individual or others, and decision-making is one of the biologically dissociated impulsive behaviors. Changes in impulsivity may be associated with norepinephrine. Various populations of drug addicts all performed impulsive decision making, which is a key risk factor in drug dependence and relapse. The present study investigated the effects of clonidine, which decreased norepinephrine release through presynaptic alpha-2 receptor activation, on the impaired decision-making performance in abstinent heroin addicts. Methodology/Principal Findings: Decision-making performance was assessed using the original version of Iowa Gambling Task (IGT). Both heroin addicts and normal controls were randomly assigned to three groups receiving clonidine, 0, 75 mu g or 150 mu g orally under double blind conditions. Psychiatric symptoms, including anxiety, depression and impulsivity, were rated on standardized scales. Heroin addicts reported higher scores on the Barratt Impulsiveness Scale and exhibited impaired decision-making on the IGT. A single high-dose of clonidine improved the decision-making performance in heroin addicts. Conclusions/Significance: Our results suggest clonidine may have a potential therapeutic role in heroin addicts by improving the impaired impulsive decision-making. The current findings have important implications for behavioral and pharmacological interventions targeting decision-making in heroin addiction.	[Zhang, Xiao-Li; Wang, Gui-Bin; Zhao, Li-Yan; Sun, Li-Li; Wang, Jun; Wu, Ping; Lu, Lin; Shi, Jie] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China	Peking University	Zhang, XL (corresponding author), Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China.	shijie@bjmu.edu.cn	SHI, JIE/GXG-3394-2022	ZHENG, GUIXI/0000-0003-2856-9592	National Basic Research Program of China [2009CB522000]; Natural Science Foundation of Beijing Municipality [7092058]; Natural Science Foundation of China [81000571, 91132719]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Beijing Municipality(Beijing Natural Science Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Basic Research Program of China (No. 2009CB522000), Natural Science Foundation of Beijing Municipality (No. 7092058) and Natural Science Foundation of China (No. 81000571 and 91132719). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TJ, 1998, DRUG ALCOHOL DEPEN, V50, P137, DOI 10.1016/S0376-8716(98)00023-4; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ANAVEKAR SN, 1989, J CLIN PHARMACOL, V29, P321, DOI 10.1002/j.1552-4604.1989.tb03335.x; Arnsten AFT, 1999, BIOL PSYCHIAT, V45, P26, DOI 10.1016/S0006-3223(98)00296-0; Arnsten AFT, 1996, ARCH GEN PSYCHIAT, V53, P448; Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.biopsych.2004.08.019; Arnsten AFT, 1997, PHARMACOL BIOCHEM BE, V58, P55, DOI 10.1016/S0091-3057(96)00477-7; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; Bolla KI, 2005, NEUROIMAGE, V26, P480, DOI 10.1016/j.neuroimage.2005.02.012; Brand M, 2008, DRUG ALCOHOL DEPEN, V97, P64, DOI 10.1016/j.drugalcdep.2008.03.017; Brand M, 2007, J CLIN EXP NEUROPSYC, V29, P86, DOI 10.1080/13803390500507196; CARLSON S, 1992, BEHAV NEURAL BIOL, V58, P113, DOI 10.1016/0163-1047(92)90327-Z; Clark L, 2006, BIOL PSYCHIAT, V60, P515, DOI 10.1016/j.biopsych.2005.11.007; Dobrydnjov I, 2004, ANESTH ANALG, V98, P738, DOI 10.1213/01.ANE.0000099719.97261.DA; Economidou D, 2009, BIOL PSYCHIAT, V65, P851, DOI 10.1016/j.biopsych.2008.12.008; Ersche KD, 2005, NEUROPSYCHOPHARMACOL, V30, P2115, DOI 10.1038/sj.npp.1300812; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; [杨会芹 YANG Huiqin], 2007, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V15, P4; KAWASAKI H, 1986, JPN J PHARMACOL, V42, P561, DOI 10.1254/jjp.42.561; Kim S, 2010, BIOL PSYCHIAT, V2010, P20; LI BM, 1994, BEHAV NEURAL BIOL, V62, P134, DOI 10.1016/S0163-1047(05)80034-2; Mazas CA, 2000, ALCOHOL CLIN EXP RES, V24, P1036, DOI 10.1111/j.1530-0277.2000.tb04647.x; Meana JJ, 1997, BRAIN RES, V744, P216, DOI 10.1016/S0006-8993(96)01080-3; Mintzer MZ, 2005, DRUG ALCOHOL DEPEN, V78, P225, DOI 10.1016/j.drugalcdep.2004.10.008; Morgan MJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1562, DOI 10.1038/sj.npp.1300953; Nieuwenhuis S, 2007, PSYCHOPHARMACOLOGY, V193, P261, DOI 10.1007/s00213-007-0770-7; Passetti F, 2008, DRUG ALCOHOL DEPEN, V94, P82, DOI 10.1016/j.drugalcdep.2007.10.008; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Paulus MP, 2003, BIOL PSYCHIAT, V53, P65, DOI 10.1016/S0006-3223(02)01442-7; Paulus MP, 2002, NEUROPSYCHOPHARMACOL, V26, P53, DOI 10.1016/S0893-133X(01)00334-7; Philipsen A, 2004, J CLIN PSYCHIAT, V65, P1414, DOI 10.4088/JCP.v65n1018; Riekkinen M, 1999, J CLIN PSYCHOPHARM, V19, P444, DOI 10.1097/00004714-199910000-00008; Riekkinen M, 1999, NEUROSCIENCE, V92, P983, DOI 10.1016/S0306-4522(99)00037-8; Shi J, 2007, PHARMACOL BIOCHEM BE, V87, P141, DOI 10.1016/j.pbb.2007.04.010; Sun HS, 2010, BIOL PSYCHIAT, V67, P649, DOI 10.1016/j.biopsych.2009.11.030; Swann AC, 2005, BIOL PSYCHIAT, V57, P1209, DOI 10.1016/j.biopsych.2005.02.007; Verdejo-Garcia A, 2009, NEUROPHARMACOLOGY, V56, P48, DOI 10.1016/j.neuropharm.2008.07.035; Verdejo-Garcia AJ, 2007, ADDICT BEHAV, V32, P950, DOI 10.1016/j.addbeh.2006.06.032; Volkow ND, 2004, NEUROPHARMACOLOGY, V47, P3, DOI 10.1016/j.neuropharm.2004.07.019; Wallis JD, 2007, ANN NY ACAD SCI, V1121, P447, DOI 10.1196/annals.1401.009; Watanabe T, 2006, ACTA ANAESTH SCAND, V50, P180, DOI 10.1111/j.1399-6576.2006.00910.x; Zhang XL, 2011, AM J PSYCHIAT, V168, P610, DOI 10.1176/appi.ajp.2010.10040499; Zhu XZ, 2007, CHINESE MENTAL HLTH, V21, P3	52	84	89	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e29084	10.1371/journal.pone.0029084	http://dx.doi.org/10.1371/journal.pone.0029084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22363757	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600002
J	Yang, SG; Cao, B; Liang, LR; Li, XL; Xiao, YH; Cao, ZX; Jia, HY; Yu, HJ; Xu, Z; Gu, L; Yang, YD; Chen, Y; Du, WB; Yan, XX; Liang, ZA; Zhang, W; Zhang, CL; Chen, W; Guo, CP; Jiang, XL; Yang, M; Deng, GM; Yu, KJ; Hu, K; Zou, Q; Li, LJ; Wang, C				Yang, Shi-gui; Cao, Bin; Liang, Li-rong; Li, Xiao-li; Xiao, Yong-hong; Cao, Zhi-xin; Jia, Hong-yu; Yu, Hong-jie; Xu, Zhen; Gu, Li; Yang, Yi-da; Chen, Yu; Du, Wei-bo; Yan, Xi-xin; Liang, Zong-an; Zhang, Wei; Zhang, Chang-le; Chen, Wei; Guo, Cai-ping; Jiang, Xun-liang; Yang, Ming; Deng, Guang-ming; Yu, Kai-jiang; Hu, Ke; Zou, Qi; Li, Lan-juan; Wang, Chen		Natl Influenza Pandemic H1N1 2009	Antiviral Therapy and Outcomes of Patients with Pneumonia Caused by Influenza A Pandemic (H1N1) Virus	PLOS ONE			English	Article							NEURAMINIDASE INHIBITORS; RISK-FACTORS; HOSPITALIZATION; OSELTAMIVIR; A(H1N1)	Background: There is limited data on the clinical outcome of patients with pandemic H1N1 (pH1N1) pneumonia who received oseltamivir treatment, especially when the treatment was administered more than 48 hours after symptom onset. Methods: During the pandemic in 2009, a cohort of pH1N1 influenza pneumonia was built in China, and their clinical information was collected systematically, and analyzed with Cox models. Results: 920 adults and 541 children with pneumonia who didn't receive corticosteroids were analyzed. In-hospital mortality was higher in adults who did not receive antiviral therapy (18.2%) than those with who received oseltamivir <= 2days (2.9%), between 2-5 days (4.6%) and >5 days after illness onset (4.9%), p<0.01. A similar trend was observed in pediatric patients. Cox regression showed that at 60 days after symptoms onset, 11 patients (10.8%) who did not receive antivirals died versus 4 (1.8%), 18 (3.3%), and 23 (3.7%) patients whose oseltamivir treatment was started <= 2days, between 2-5days, and >5 days, respectively. For males patients, aged >= 14 years and baseline PaO2/FiO(2)<200, oseltamivir administration reduced the mortality risk by 92.1%, 88% and 83.5%, respectively. Higher doses of oseltamivir (>3.8 mg/kg/d) did not improve clinical outcome (mortality, higher dose 2.5% vs standard dose 2.8%, p>0.05). Conclusions: Antiviral therapy might reduce mortality of patients with pH1N1 pneumonia, even when initiated more than 48 hours after onset of illness. Greater protective effects might be in males, patients aged 14-60 years, and patients with PaO2/FiO(2)<200.	[Yang, Shi-gui; Xiao, Yong-hong; Jia, Hong-yu; Yang, Yi-da; Chen, Yu; Du, Wei-bo; Li, Lan-juan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Key Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Cao, Bin; Liang, Li-rong; Li, Xiao-li; Cao, Zhi-xin; Gu, Li; Wang, Chen] Capital Med Univ, Beijing Chao Yang Hosp, Beijing Inst Resp Med, Beijing Key Lab Resp & Pulm Circulat, Beijing, Peoples R China; [Yu, Hong-jie; Xu, Zhen] Chinese Ctr Dis Control & Prevent, Dis Control & Emergency Response Off, Beijing, Peoples R China; [Yan, Xi-xin] Hebei Med Univ, Dept Resp Med, Hosp 2, Shijiazhuang, Peoples R China; [Liang, Zong-an] Sichuan Univ, W China Hosp, Chengdu 610064, Peoples R China; [Zhang, Wei] Nanchang Univ, Affiliated Hosp 1, Nanchang, Peoples R China; [Zhang, Chang-le] Wenzhou 2 Peoples Hosp, Wenzhou, Peoples R China; [Chen, Wei] China Med Univ, Shengjing Hosp, Shenyang, Peoples R China; [Guo, Cai-ping] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China; [Jiang, Xun-liang] Childrens Hosp Hunan Prov, Changsha, Hunan, Peoples R China; [Yang, Ming] Beijing Childrens Hosp, Beijing, Peoples R China; [Deng, Guang-ming] Shaoyang Cent Hosp, Shaoyang, Peoples R China; [Yu, Kai-jiang] Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China; [Hu, Ke] Wuhan Univ, Remin Hosp, Wuhan 430072, Peoples R China; [Zou, Qi] Fujian Med Univ, Union Hosp, Fuzhou, Peoples R China	Zhejiang University; Capital Medical University; Chinese Center for Disease Control & Prevention; Hebei Medical University; Sichuan University; Nanchang University; China Medical University; Capital Medical University; Capital Medical University; Harbin Medical University; Wuhan University; Fujian Medical University	Yang, SG (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Key Lab, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn; cyh-birm@263.net	Chen, Yu/Y-3292-2019; Keshavmurthy, Shashank/C-3672-2013; Chen, Yi/HIR-2608-2022; Yu, Hongjie/GZK-5351-2022; Xiao, Yonghong/AFS-9054-2022; Matz, Mikhail/K-4392-2017	Keshavmurthy, Shashank/0000-0002-2235-9132; Matz, Mikhail/0000-0001-5453-9819; sheppard, charles/0000-0002-2579-5124; Yang, Sung-Yin/0000-0001-7431-406X; Wang, Dao Wen/0000-0002-9774-3980; Rao, Xiaoquan/0000-0001-7316-4530; Obura, David/0000-0003-2256-6649	Ministry of Health of People's Republic of China; World Health Organization on clinical study for the influenza A pandemic A; Beijing Science Technology [Z09000700090903]; Major State Basic Research Development Program [2009CB522107]; Mega-projects of Science Research for the 11th Five-Year Plan of China [2009ZX10004-901, 2009ZX10004-210]; National Natural Science Foundation of China [81001271]	Ministry of Health of People's Republic of China; World Health Organization on clinical study for the influenza A pandemic A; Beijing Science Technology; Major State Basic Research Development Program(National Basic Research Program of China); Mega-projects of Science Research for the 11th Five-Year Plan of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the Ministry of Health of People's Republic of China and the World Health Organization on clinical study for the influenza A pandemic A (H1N1) 2009, grants from the Beijing Science & Technology (Z09000700090903), and Major State Basic Research Development Program (2009CB522107), Mega-projects of Science Research for the 11th Five-Year Plan of China (2009ZX10004-901, 2009ZX10004-210), and the National Natural Science Foundation of China (81001271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, PAND INFL H1N1 2009; [Anonymous], 2010, H1N1 2009 UPD 94; Bai L, 2011, CHEST, V139, P1156, DOI 10.1378/chest.10-1036; *CDCP, 2009, CDC EST 2009 H1N1 IN; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P431; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; KLIMOV AI, 1995, J INFECT DIS, V172, P1352, DOI 10.1093/infdis/172.5.1352; Lee EH, 2010, CLIN INFECT DIS, V50, P1498, DOI 10.1086/652446; Lee N, 2008, CLIN INFECT DIS, V46, P1323, DOI 10.1086/533477; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Slopen M. E., 2010, Morbidity and Mortality Weekly Report, V58, P1436; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Weinstock DM, 2003, NEW ENGL J MED, V348, P867, DOI 10.1056/NEJM200302273480923; WHO, CDC PROT REALT RTPCR; WHO, 2009, WHO GUID PHARM MAN P; Writing Committee of the WHO Consultation on Pandemic (H1N1), 2009, NEW ENGL J MED, V362, P1708	30	115	121	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29652	10.1371/journal.pone.0029652	http://dx.doi.org/10.1371/journal.pone.0029652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22567113	Green Published, gold, Green Submitted			2022-12-27	WOS:000301568100014
J	Zhang, YQ; Chen, DL; Smith, MA; Zhang, BH; Pan, XP				Zhang, Yanqiong; Chen, Dongliang; Smith, Michael A.; Zhang, Baohong; Pan, Xiaoping			Selection of Reliable Reference Genes in Caenorhabditis elegans for Analysis of Nanotoxicity	PLOS ONE			English	Article							TRANSCRIPTION-PCR DATA; NANOPARTICLES; NORMALIZATION; MODEL; SET	Despite rapid development and application of a wide range of manufactured metal oxide nanoparticles (NPs), the understanding of potential risks of using NPs is less completed, especially at the molecular level. The nematode Caenorhabditis elegans (C. elegans) has been emerging as an environmental model to study the molecular mechanism of environmental contaminations, using standard genetic tools such as the real-time quantitative PCR (RT-qPCR). The most important factor that may affect the accuracy of RT-qPCR is to choose appropriate genes for normalization. In this study, we selected 13 reference gene candidates (act-1, cdc-42, pmp-3, eif-3. C, actin, act-2, csq-1, Y45F10D. 4, tba-1, mdh-1, ama-1, F35G12.2, and rbd-1) to test their expression stability under different doses of nano-copper oxide (CuO 0, 1, 10, and 50 mu g/mL) using RT-qPCR. Four algorithms, geNorm, NormFinder, BestKeeper, and the comparative DCt method, were employed to evaluate these 13 candidates expressions. As a result, tba-1, Y45F10D. 4 and pmp-3 were the most reliable, which may be used as reference genes in future study of nanoparticle-induced genetic response using C. elegans.	[Zhang, Yanqiong; Chen, Dongliang; Smith, Michael A.; Zhang, Baohong; Pan, Xiaoping] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Zhang, YQ (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	Panx@ecu.edu	Zhang, Baohong/O-4948-2016	Ding, Jie/0000-0001-9162-7850	East Carolina University; North Carolina Biotechnology Center	East Carolina University; North Carolina Biotechnology Center	This work was supported partially by the new faculty startup fund of East Carolina University, and partially by the North Carolina Biotechnology Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BRENNER S, 1974, GENETICS, V77, P71; Chen D, 2011, J CELL PHYSL; Cole RD, 2004, TOXICOL APPL PHARM, V194, P248, DOI 10.1016/j.taap.2003.09.013; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Fahmy B, 2009, TOXICOL IN VITRO, V23, P1365, DOI 10.1016/j.tiv.2009.08.005; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hoss S, 2003, TRACE METALS OTHER, V6, P529; Huang CC, 2010, TOXICOL IN VITRO, V24, P45, DOI 10.1016/j.tiv.2009.09.007; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ivask A, 2010, ANAL BIOANAL CHEM, V398, P701, DOI 10.1007/s00216-010-3962-7; Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j; Murray AR, 2009, TOXICOLOGY, V257, P161, DOI 10.1016/j.tox.2008.12.023; Pan XP, 2010, CHEMOSPHERE, V79, P113, DOI 10.1016/j.chemosphere.2009.12.056; Park EJ, 2008, TOXICOL LETT, V180, P222, DOI 10.1016/j.toxlet.2008.06.869; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Roh JY, 2010, ENVIRON TOXICOL PHAR, V29, P167, DOI 10.1016/j.etap.2009.12.003; Sayes CM, 2005, BIOMATERIALS, V26, P7587, DOI 10.1016/j.biomaterials.2005.05.027; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sochova I, 2007, ENVIRON INT, V33, P798, DOI 10.1016/j.envint.2007.03.001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang DY, 2008, J ENVIRON SCI-CHINA, V20, P1132, DOI 10.1016/S1001-0742(08)62160-9	23	114	127	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e31849	10.1371/journal.pone.0031849	http://dx.doi.org/10.1371/journal.pone.0031849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438870	Green Published, Green Submitted, gold			2022-12-27	WOS:000303309000004
J	Zhang, J; Wang, SX; Li, HH; Hu, BB; Yang, XF; Wang, ZB				Zhang, Jing; Wang, Shuxia; Li, Houhun; Hu, Bingbing; Yang, Xiaofei; Wang, Zhibo			Diffuse Coevolution between Two Epicephala Species (Gracillariidae) and Two Breynia Species (Phyllanthaceae)	PLOS ONE			English	Article							OBLIGATE POLLINATION MUTUALISM; PLASTID MATK; YUCCA MOTHS; GLOCHIDION; PHYLOGENETICS; SPECIFICITY; ASSOCIATION; FIGS	The diffuse coevolution between two moth species (Epicephala lativalvaris and E. mirivalvata) and two plant species (Breynia fruticosa and B. rostrata) is reported based on field observations and indoor experiments conducted in Hainan and Fujian, China. Study results showed that the two Epicephala species jointly pollinated the two Breynia species, which led to a unique obligate pollination mutualism of two-to-two species specificity. A single Epicephala larva exclusively fed on seeds of host plants and developed to maturity by consuming all six seeds of each fruit, whereas a fraction of intact fruits were left to ensure the reproduction of plants within the whole population. Larvae of the two Epicephala species are competitive for resources; the population of E. mirivalvata is much smaller than that of E. lativalvaris, which has resulted from the differences in the female ovipositor structures and oviposition mode. The life history of Epicephala species highly coincides with the phenology of Breynia plants, and different phenology of B. fruticosa resulted in the different life history of the two Epicephala species in Hainan and Fujian. The natural hybridization of two host plants, possibly induced by the alternate pollination of two Epicephala species, is briefly discussed.	[Zhang, Jing; Wang, Shuxia; Li, Houhun; Hu, Bingbing; Yang, Xiaofei; Wang, Zhibo] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University	Zhang, J (corresponding author), Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.	lihouhun@nankai.edu.cn	Zhang, Jiantao/I-5116-2014; LIU, HUA/M-7659-2019; Wang, Zhibo/GSD-3371-2022	Chen, Shaoliang/0000-0001-7511-3067; Zhang, Jiantao/0000-0002-2875-9743; Sun, Jian/0000-0002-1434-4029	National Natural Science Foundation of China [30930014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (No. 30930014). Funder's website: http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Caterino MS, 1999, MOL PHYLOGENET EVOL, V11, P122, DOI 10.1006/mpev.1998.0549; CORLETT RT, 1993, J TROP ECOL, V9, P501, DOI 10.1017/S0266467400007574; Doyle J. J., 1987, PHYTOCHEM B, P11; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; JANZEN DH, 1979, BIOTROPICA, V11, P48, DOI 10.2307/2388172; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; Kathriarachchi H, 2006, AM J BOT, V93, P637, DOI 10.3732/ajb.93.4.637; Kato M, 2003, P NATL ACAD SCI USA, V100, P5264, DOI 10.1073/pnas.0837153100; Kawakita A, 2004, AM J BOT, V91, P1319, DOI 10.3732/ajb.91.9.1319; Kawakita A, 2009, P R SOC B, V276, P417, DOI 10.1098/rspb.2008.1226; Kawakita A, 2006, MOL ECOL, V15, P3567, DOI 10.1111/j.1365-294X.2006.03037.x; Kawakita A, 2010, PLANT SPEC BIOL, V25, P3, DOI 10.1111/j.1442-1984.2009.00266.x; Li B.T., 2008, FLORA CHINA, V11, P216; Machado CA, 2005, P NATL ACAD SCI USA, V102, P6558, DOI 10.1073/pnas.0501840102; Okamoto T, 2007, J CHEM ECOL, V33, P1065, DOI 10.1007/s10886-007-9287-0; Park DS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-423; Pellmyr O, 1996, NATURE, V380, P155, DOI 10.1038/380155a0; Pellmyr O, 2003, ANN MO BOT GARD, V90, P35, DOI 10.2307/3298524; Samuel R, 2005, AM J BOT, V92, P132, DOI 10.3732/ajb.92.1.132; Svensson GP, 2010, NEW PHYTOL, V186, P995, DOI 10.1111/j.1469-8137.2010.03227.x; Swofford DL, 2005, PAUP PHYLOGENETIC AN; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; WIEBES JT, 1979, ANNU REV ECOL SYST, V10, P1, DOI 10.1146/annurev.es.10.110179.000245; Zhang J, 2012, ZOOTAXA, P43, DOI 10.11646/zootaxa.3275.1.4	25	147	171	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41657	10.1371/journal.pone.0041657	http://dx.doi.org/10.1371/journal.pone.0041657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848559	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200085
J	Zhang, L; Ren, G				Zhang, Lei; Ren, Gang			IPET and FETR: Experimental Approach for Studying Molecular Structure Dynamics by Cryo-Electron Tomography of a Single-Molecule Structure	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; NEGATIVE-STAINING PROTOCOL; APOLIPOPROTEIN-A-I; ELECTRON-MICROSCOPY; RADIATION-DAMAGE; 3-DIMENSIONAL RECONSTRUCTION; SCATTERING FACTORS; DIFFERENT SIZES; RESOLUTION; PROTEIN	The dynamic personalities and structural heterogeneity of proteins are essential for proper functioning. Structural determination of dynamic/heterogeneous proteins is limited by conventional approaches of X-ray and electron microscopy (EM) of single-particle reconstruction that require an average from thousands to millions different molecules. Cryo-electron tomography (cryoET) is an approach to determine three-dimensional (3D) reconstruction of a single and unique biological object such as bacteria and cells, by imaging the object from a series of tilting angles. However, cconventional reconstruction methods use large-size whole-micrographs that are limited by reconstruction resolution (lower than 20 A), especially for small and low-symmetric molecule (<400 kDa). In this study, we demonstrated the adverse effects from image distortion and the measuring tilt-errors (including tilt-axis and tilt-angle errors) both play a major role in limiting the reconstruction resolution. Therefore, we developed a "focused electron tomography reconstruction" (FETR) algorithm to improve the resolution by decreasing the reconstructing image size so that it contains only a single-instance protein. FETR can tolerate certain levels of image-distortion and measuring tilt-errors, and can also precisely determine the translational parameters via an iterative refinement process that contains a series of automatically generated dynamic filters and masks. To describe this method, a set of simulated cryoET images was employed; to validate this approach, the real experimental images from negative-staining and cryoET were used. Since this approach can obtain the structure of a single-instance molecule/particle, we named it individual-particle electron tomography (IPET) as a new robust strategy/approach that does not require a pre-given initial model, class averaging of multiple molecules or an extended ordered lattice, but can tolerate small tilt-errors for high-resolution single "snapshot" molecule structure determination. Thus, FETR/IPET provides a completely new opportunity for a single-molecule structure determination, and could be used to study the dynamic character and equilibrium fluctuation of macromolecules.	[Zhang, Lei; Ren, Gang] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zhang, L (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA.	gren@lbl.gov	Zhang, Lei/G-6427-2012; Ren, Gang/B-1567-2012	Zhang, Lei/0000-0002-4880-824X; Ren, Gang/0000-0002-8036-2321; Liu, Guangwei/0000-0002-6008-2891	Office of Science, Office of Basic Energy Sciences of the United States Department of Energy [DE-AC02-05CH11231]; William Myron Keck Foundation [011808]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104427] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); William Myron Keck Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Office of Science, Office of Basic Energy Sciences of the United States Department of Energy (contract no. DE-AC02-05CH11231) and partially supported by the William Myron Keck Foundation (#011808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker LA, 2010, J STRUCT BIOL, V169, P431, DOI 10.1016/j.jsb.2009.11.014; Bammes BE, 2010, J STRUCT BIOL, V169, P331, DOI 10.1016/j.jsb.2009.11.001; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; BRACEWELL RN, 1967, ASTROPHYS J, V150, P427, DOI 10.1086/149346; Cantele F, 2007, J STRUCT BIOL, V158, P59, DOI 10.1016/j.jsb.2006.10.015; Cardone G, 2007, VIROLOGY, V361, P426, DOI 10.1016/j.virol.2006.10.047; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Chen B, 2009, PROTEIN SCI, V18, P921, DOI 10.1002/pro.101; Chen H, 1996, J STRUCT BIOL, V116, P56, DOI 10.1006/jsbi.1996.0010; Chen JZ, 2008, J STRUCT BIOL, V161, P92, DOI 10.1016/j.jsb.2007.09.017; CONWAY JF, 1993, J STRUCT BIOL, V111, P222, DOI 10.1006/jsbi.1993.1052; Cowley JM, 2006, INT TABLES CRYSTALLO, P262; CROWTHER RA, 1971, PHILOS T R SOC B, V261, P221, DOI 10.1098/rstb.1971.0054; Fernandez JJ, 2006, ULTRAMICROSCOPY, V106, P587, DOI 10.1016/j.ultramic.2006.02.004; Fernando KV, 2008, J STRUCT BIOL, V164, P49, DOI 10.1016/j.jsb.2008.06.012; Frank J, 2002, J STRUCT BIOL, V138, P85, DOI 10.1016/S1047-8477(02)00019-9; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frauenfelder H, 2009, P NATL ACAD SCI USA, V106, P5129, DOI 10.1073/pnas.0900336106; Frey TG, 2006, ANNU REV BIOPH BIOM, V35, P199, DOI 10.1146/annurev.biophys.35.040405.102039; Fung JC, 1996, J STRUCT BIOL, V116, P181, DOI 10.1006/jsbi.1996.0029; Gil D, 2006, J STRUCT BIOL, V156, P546, DOI 10.1016/j.jsb.2006.07.012; GILBERT P, 1972, J THEOR BIOL, V36, P105, DOI 10.1016/0022-5193(72)90180-4; GLAESER RM, 1979, J MICROSC-OXFORD, V117, P77, DOI 10.1111/j.1365-2818.1979.tb00232.x; GLAESER RM, 1971, J ULTRA MOL STRUCT R, V36, P466, DOI 10.1016/S0022-5320(71)80118-1; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Grimm R, 1998, BIOPHYS J, V74, P1031, DOI 10.1016/S0006-3495(98)74028-7; HARRIS JR, 1994, MICRON, V25, P5; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; HERMAN GT, 1973, J THEOR BIOL, V42, P1, DOI 10.1016/0022-5193(73)90145-8; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hue F, 2005, J ELECTRON MICROSC, V54, P181, DOI 10.1093/jmicro/dfi042; Jiang W, 2003, NAT STRUCT BIOL, V10, P131, DOI 10.1038/nsb891; Jiang W, 2008, NATURE, V451, P1130, DOI 10.1038/nature06665; Jones MK, 2010, J BIOL CHEM, V285, P41161, DOI 10.1074/jbc.M110.187799; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; KLUG A, 1972, NATURE, V238, P435, DOI 10.1038/238435a0; KONING RI, 2009, ANN ANAT; Leschziner AE, 2006, J STRUCT BIOL, V153, P284, DOI 10.1016/j.jsb.2005.10.012; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mastronarde DN, 2008, J MICROSC-OXFORD, V230, P212, DOI 10.1111/j.1365-2818.2008.01977.x; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Milne JLS, 2009, NAT REV MICROBIOL, V7, P666, DOI 10.1038/nrmicro2183; Peng LM, 1996, ACTA CRYSTALLOGR A, V52, P456, DOI 10.1107/S010876739600089X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ren G, 2000, J MOL BIOL, V301, P369, DOI 10.1006/jmbi.2000.3949; Ren G, 1997, MICRON, V28, P459, DOI 10.1016/S0968-4328(97)00034-6; Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198; Ren G, 1996, ACTA PHYS SINICA, V45, P1344; Ren G, 2010, P NATL ACAD SCI USA, V107, P1059, DOI 10.1073/pnas.0908004107; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sandberg K, 2003, J STRUCT BIOL, V144, P61, DOI 10.1016/j.jsb.2003.09.013; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Schaffer B, 2006, ULTRAMICROSCOPY, V106, P1129, DOI 10.1016/j.ultramic.2006.04.028; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; Stagg SM, 2006, J STRUCT BIOL, V155, P470, DOI 10.1016/j.jsb.2006.04.005; STOKROOS I, 1983, J BIOL BUCCALE, V11, P339; Suloway C, 2009, J STRUCT BIOL, V167, P11, DOI 10.1016/j.jsb.2009.03.019; TAYLOR KA, 1976, J ULTRA MOL STRUCT R, V55, P448, DOI 10.1016/S0022-5320(76)80099-8; UNSER M, 1987, ULTRAMICROSCOPY, V23, P39, DOI 10.1016/0304-3991(87)90225-7; UNWIN PNT, 1975, J MOL BIOL, V94, P425, DOI 10.1016/0022-2836(75)90212-0; vanAntwerpen R, 1997, J LIPID RES, V38, P659; VANHEEL M, 1985, EMBO J, V4, P2389, DOI 10.1002/j.1460-2075.1985.tb03944.x; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Walz J, 1997, J STRUCT BIOL, V120, P387, DOI 10.1006/jsbi.1997.3934; Winkler H, 2007, J STRUCT BIOL, V157, P126, DOI 10.1016/j.jsb.2006.07.014; XIANG SB, 1993, ACTA CRYSTALLOGR D, V49, P193, DOI 10.1107/S0907444992008540; Zhang L, 2010, BIOPHYSICAL J, V98, p440a; Zhang L, 2010, BIOPHYSICAL J, V98, p441a; Zhang L, 2011, J LIPID RES, V52, P175, DOI 10.1194/jlr.D010959; Zhang L, 2010, J LIPID RES, V51, P1228, DOI 10.1194/jlr.D002493	77	104	106	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30249	10.1371/journal.pone.0030249	http://dx.doi.org/10.1371/journal.pone.0030249			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291925	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600008
J	Lichius, A; Yanez-Gutierrez, ME; Read, ND; Castro-Longoria, E				Lichius, Alexander; Yanez-Gutierrez, Mario E.; Read, Nick D.; Castro-Longoria, Ernestina			Comparative Live-Cell Imaging Analyses of SPA-2, BUD-6 and BNI-1 in Neurospora crassa Reveal Novel Features of the Filamentous Fungal Polarisome	PLOS ONE			English	Article							PENICILLIUM-CHRYSOGENUM HYPHAE; CANDIDA-ALBICANS HYPHAE; ASPERGILLUS-NIDULANS; SACCHAROMYCES-CEREVISIAE; SEPTAL PORES; ACTIN CYTOSKELETON; POLARIZED GROWTH; FISSION YEAST; FUNCTIONAL-CHARACTERIZATION; ASHBYA-GOSSYPII	A key multiprotein complex involved in regulating the actin cytoskeleton and secretory machinery required for polarized growth in fungi, is the polarisome. Recognized core constituents in budding yeast are the proteins Spa2, Pea2, Aip3/Bud6, and the key effector Bni1. Multicellular fungi display a more complex polarized morphogenesis than yeasts, suggesting that the filamentous fungal polarisome might fulfill additional functions. In this study, we compared the subcellular organization and dynamics of the putative polarisome components BUD-6 and BNI-1 with those of the bona fide polarisome marker SPA-2 at various developmental stages of Neurospora crassa. All three proteins exhibited a yeast-like polarisome configuration during polarized germ tube growth, cell fusion, septal pore plugging and tip repolarization. However, the localization patterns of all three proteins showed spatiotemporally distinct characteristics during the establishment of new polar axes, septum formation and cytokinesis, and maintained hyphal tip growth. Most notably, in vegetative hyphal tips BUD-6 accumulated as a subapical cloud excluded from the Spitzenkorper (Spk), whereas BNI-1 and SPA-2 partially colocalized with the Spk and the tip apex. Novel roles during septal plugging and cytokinesis, connected to the reinitiation of tip growth upon physical injury and conidial maturation, were identified for BUD-6 and BNI-1, respectively. Phenotypic analyses of gene deletion mutants revealed additional functions for BUD-6 and BNI-1 in cell fusion regulation, and the maintenance of Spk integrity. Considered together, our findings reveal novel polarisome-independent functions of BUD-6 and BNI-1 in Neurospora, but also suggest that all three proteins cooperate at plugged septal pores, and their complex arrangement within the apical dome of mature hypha might represent a novel aspect of filamentous fungal polarisome architecture.	[Lichius, Alexander; Yanez-Gutierrez, Mario E.; Castro-Longoria, Ernestina] Ctr Sci Res & Higher Educ Ensenada CICESE, Dept Microbiol, Ensenada, Baja California, Mexico; [Lichius, Alexander; Read, Nick D.] Univ Edinburgh, Inst Cell Biol, Fungal Cell Biol Grp, Edinburgh, Midlothian, Scotland	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; University of Edinburgh	Lichius, A (corresponding author), Ctr Sci Res & Higher Educ Ensenada CICESE, Dept Microbiol, Ensenada, Baja California, Mexico.	ecastro@cicese.mx	Castro-Longoria, Ernestina/GYV-4776-2022; Lichius, Alexander/M-3808-2017	Lichius, Alexander/0000-0002-2971-9604; Read, Nick/0000-0002-2286-2862; Jeffree, Christopher/0000-0002-3838-8720; Lord, Kathryn/0000-0002-2144-6269	SEP-CONACyT [CB-2006-1-61524]; Biotechnology and Biological Sciences Research Council [BB/E010741/1]; CONACyT; BBSRC [BB/E010741/1] Funding Source: UKRI	SEP-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for this project was provided by a SEP-CONACyT (www.conacyt.mx) grant (CB-2006-1-61524) to EC-L and a Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) grant (# BB/E010741/1) to NDR. We thank CONACyT for a grant to MEY-G., and a postdoctoral fellowship to AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg DC, 1997, MOL BIOL CELL, V8, P729, DOI 10.1091/mbc.8.4.729; Araujo-Bazan L, 2008, MOL MICROBIOL, V67, P891, DOI 10.1111/j.1365-2958.2007.06102.x; Araujo-Palomares CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027148; Araujo-Palomares CL, 2009, FUNGAL GENET BIOL, V46, P551, DOI 10.1016/j.fgb.2009.02.009; Beltran-Aguilar A, 2006, CARACTERIZACION MACR; Berepiki A, 2011, NATURE REV IN PRESS; Berepiki A, 2010, EUKARYOT CELL, V9, P547, DOI 10.1128/EC.00253-09; Bidlingmaier S, 2004, J CELL BIOL, V164, P207, DOI 10.1083/jcb.200307065; Bornens M, 2008, NAT REV MOL CELL BIO, V9, P874, DOI 10.1038/nrm2524; Buller A.H.R., 1933, RES FUNGI; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Carbo N, 2008, FUNGAL GENET BIOL, V45, P1315, DOI 10.1016/j.fgb.2008.06.010; Chapa-Y-Lazo B, 2011, FUNGAL BIOL-UK, V115, P547, DOI 10.1016/j.funbio.2011.02.001; CHENEVERT J, 1994, GENETICS, V136, P1287; COLLINGE AJ, 1987, FEMS MICROBIOL LETT, V40, P165; COLLINGE AJ, 1985, EXP MYCOL, V9, P80, DOI 10.1016/0147-5975(85)90051-9; Crampin H, 2005, J CELL SCI, V118, P2935, DOI 10.1242/jcs.02414; Davis RH, 2002, NAT REV GENET, V3, P397, DOI 10.1038/nrg797; Davis RH, 2000, NEUROSPORA CONTRIBUT, P333; Delgado-Alvarez DL, 2010, FUNGAL GENET BIOL, V47, P573, DOI 10.1016/j.fgb.2010.03.004; Delgehyr N, 2008, J CELL SCI, V121, P3803, DOI 10.1242/jcs.036269; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Fleissner A, 2005, EUKARYOT CELL, V4, P920, DOI 10.1128/EC.4.5.920-930.2005; Fleissner A, 2007, EUKARYOT CELL, V6, P84, DOI 10.1128/EC.00268-06; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Fujiwara T, 1998, MOL BIOL CELL, V9, P1221, DOI 10.1091/mbc.9.5.1221; Gammie AE, 1998, MOL BIOL CELL, V9, P1395, DOI 10.1091/mbc.9.6.1395; Glynn JM, 2001, CURR BIOL, V11, P836, DOI 10.1016/S0960-9822(01)00235-4; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Harris SD, 2004, FUNGAL GENET BIOL, V41, P391, DOI 10.1016/j.fgb.2003.11.007; Harris SD, 1997, EMBO J, V16, P3474, DOI 10.1093/emboj/16.12.3474; Harris SD, 2006, INT REV CYTOL, V251, P41, DOI 10.1016/S0074-7696(06)51002-2; Harris SD, 2009, MOL MICROBIOL, V73, P733, DOI 10.1111/j.1365-2958.2009.06803.x; Harris SD, 2008, MYCOLOGIA, V100, P823, DOI 10.3852/08-177; Hickey PC, 2005, METHOD MICROBIOL, V34, P63, DOI 10.1016/S0580-8517(04)3403-1; Hickey PC, 2002, FUNGAL GENET BIOL, V37, P109, DOI 10.1016/S1087-1845(02)00035-X; Jedd G, 2000, NAT CELL BIOL, V2, P226, DOI 10.1038/35008652; Jedd G, 2011, TRENDS CELL BIOL, V21, P12, DOI 10.1016/j.tcb.2010.09.001; Jones LA, 2010, EUKARYOT CELL, V9, P1455, DOI 10.1128/EC.00109-10; Justa-Schuch D, 2010, MOL MICROBIOL, V76, P220, DOI 10.1111/j.1365-2958.2010.07093.x; Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167; Koehli M, 2008, J CELL SCI, V121, P3878, DOI 10.1242/jcs.033852; Leeder AC, 2008, FUNGAL GENET BIOL, V45, P897, DOI 10.1016/j.fgb.2007.12.001; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Lichius A., 2010, FUNGAL GENET, V57, P8, DOI [10.4148/1941-4765.1070, DOI 10.4148/1941-4765.1070]; Lichius A, 2010, CELL FUSION NEUROSPO; Lichius A., 2010, DISTINGUISH CONIDIAL, P1; Lichius A, 2011, EUKARYOTIC CEL UNPUB; Lichius A, 2011, FUNGAL BIOL-UK, V115, P518, DOI 10.1016/j.funbio.2011.02.014; Liu YJ, 2004, P NATL ACAD SCI USA, V101, P4507, DOI 10.1073/pnas.0400938101; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; MARKHAM P, 1987, FEMS MICROBIOL LETT, V46, P1; MARKHAM P, 1994, MYCOL RES, V98, P1089, DOI 10.1016/S0953-7562(09)80195-0; Martin R, 2005, EUKARYOT CELL, V4, P1712, DOI 10.1128/EC.4.10.1712-1724.2005; MCNALLY MT, 1988, CURR GENET, V14, P545, DOI 10.1007/BF00434079; Meyer V, 2008, FUNGAL GENET BIOL, V45, P152, DOI 10.1016/j.fgb.2007.07.006; Momany M, 2002, CURR OPIN MICROBIOL, V5, P580, DOI 10.1016/S1369-5274(02)00368-5; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Nolan S, 2006, MOL BIOL CELL, V17, P2439, DOI 10.1091/mbc.E05-11-1015; Ozaki-Kuroda K, 2011, MOL CELL BIOL, V21, P827; Perez P, 2010, BIOCHEM J, V426, P243, DOI 10.1042/BJ20091823; Piel M, 2009, CURR BIOL, V19, pR823, DOI 10.1016/j.cub.2009.08.012; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Ramos-Garcia SL, 2009, EUKARYOT CELL, V8, P1880, DOI 10.1128/EC.00062-09; Rasmussen CG, 2007, EUKARYOT CELL, V6, P1097, DOI 10.1128/EC.00050-07; Rasmussen CG, 2005, EUKARYOT CELL, V4, P1913, DOI 10.1128/EC.4.11.1913-1925.2005; RAYNER ADM, 1991, MYCOLOGIA, V83, P48, DOI 10.2307/3759832; Read ND, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P260; Read ND, 2009, CURR OPIN MICROBIOL, V12, P608, DOI 10.1016/j.mib.2009.09.008; Riquelme M, 2011, FUNGAL BIOL-UK, V115, P446, DOI 10.1016/j.funbio.2011.02.008; Roca M. G., 2010, ANAL QUANTIFY CONIDI, P1; Roca MG, 2005, FEMS MICROBIOL LETT, V249, P191, DOI 10.1016/j.femsle.2005.06.048; Roca MG, 2005, EUKARYOT CELL, V4, P911, DOI 10.1128/EC.4.5.911-919.2005; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Sambrook J., 2001, MOL CLONING LAB MANU; Schmitz HP, 2006, MOL BIOL CELL, V17, P130, DOI 10.1091/mbc.e05-06-0479; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; Sharpless KE, 2002, MOL BIOL CELL, V13, P469, DOI 10.1091/mbc.01-07-0356; Shaw BD, 2011, FUNGAL BIOL-UK, V115, P541, DOI 10.1016/j.funbio.2011.02.010; Sheu YJ, 1998, MOL CELL BIOL, V18, P4053, DOI 10.1128/MCB.18.7.4053; Slaughter BD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003384; Sudbery P, 2011, FUNGAL GENET BIOL, V48, P849, DOI 10.1016/j.fgb.2011.02.004; Taheri-Talesh N, 2008, MOL BIOL CELL, V19, P1439, DOI 10.1091/mbc.E07-05-0464; Tcheperegine SE, 2005, MOL CELL BIOL, V25, P8567, DOI 10.1128/MCB.25.19.8567-8580.2005; TRINCI APJ, 1973, PROTOPLASMA, V80, P57, DOI 10.1007/BF01666351; TRINCI APJ, 1973, ARCH MIKROBIOL, V91, P113, DOI 10.1007/BF00424755; Upadhyay S, 2008, MOL MICROBIOL, V68, P690, DOI 10.1111/j.1365-2958.2008.06178.x; Valtz N, 1996, J CELL BIOL, V135, P725, DOI 10.1083/jcb.135.3.725; van Drogen F, 2002, CURR BIOL, V12, P1698, DOI 10.1016/S0960-9822(02)01186-7; Verdin J, 2009, MOL MICROBIOL, V74, P1044, DOI 10.1111/j.1365-2958.2009.06917.x; Virag A, 2006, EUKARYOT CELL, V5, P881, DOI 10.1128/EC.00036-06; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wedlich-Soldner R, 2008, SEMIN CELL DEV BIOL, V19, P224, DOI 10.1016/j.semcdb.2008.01.003	94	42	46	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30372	10.1371/journal.pone.0030372	http://dx.doi.org/10.1371/journal.pone.0030372			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22900028	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600018
J	Kim, SS; Williams, DR				Kim, Seung-Sup; Williams, David R.			Perceived Discrimination and Self-Rated Health in South Korea: A Nationally Representative Survey	PLOS ONE			English	Article							ASIAN-AMERICANS NATIONWIDE; WHITEHALL-II; RACIAL-DISCRIMINATION; ETHNIC-MINORITIES; MENTAL-DISORDERS; SON PREFERENCE; GENDER; WORK; MORTALITY; WOMEN	Background: There is mounting evidence that discriminatory experiences can harm health. However, previous research has mainly focused on the health effects of racial discrimination in U.S. or European countries although there is pervasive discrimination by gender, age, education and other factors in Asian countries. Methods: We analyzed the data from the 7th wave of Korean Labor and Income Panel Study to investigate the association between perceived discriminatory experience and poor self-rated health in South Korea. Perceived discriminatory experiences were measured in eight situations through a modified Experience of Discrimination questionnaire. In each of eight situations, the lifetime prevalence of perceived discriminatory experience was compared between men and women and the main causes of those experiences were identified separately by gender. After adjusting for potential confounders, we examined the association between perceived discriminatory experience and poor self-rated health in each of eight social situations and also checked the association using the number of situations of perceived discriminatory experiences. Results: For both men and women, education level and age were the main sources of work-related perceived discriminatory experiences. Gender was one of the main causes among women across eight situations and more than 90% of women reported their gender as a main cause of discriminatory experience in getting higher education and at home. Discriminatory experiences in four situations were positively associated with poor self-rated health. The odds ratio for poor self-rated health for those exposed to one, two, three or four or more social situations of perceived discrimination were respectively 1.06 (95% CI : 0.87-1.29), 1.15 (95% CI : 0.96-1.55), 1.59 (95% CI : 1.19-2.14), and 1.78 (95% CI : 1.26-2.51). Conclusion: There is consistent association between perceived discriminatory experience and poor self-rated health across eight social situations in South Korea.	[Kim, Seung-Sup] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Environm & Occupat Hlth, Washington, DC 20052 USA; [Williams, David R.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	George Washington University; Harvard University; Harvard T.H. Chan School of Public Health	Kim, SS (corresponding author), George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Environm & Occupat Hlth, Washington, DC 20052 USA.	sskim@gwu.edu	Tinker, Martin/D-3249-2018	Tinker, Martin/0000-0002-3314-839X				Albert MA, 2008, AM HEART J, V156, P1103, DOI 10.1016/j.ahj.2008.07.027; Amnesty Internatonal, 2006, S KOR MIGR WORK HUM; Asakura T, 2008, AM J PUBLIC HEALTH, V98, P743, DOI 10.2105/AJPH.2007.117309; Berik G., 2004, REV DEV ECON, V8, P237, DOI [10.1111/j.1467-9361.2004.00230.x, DOI 10.1111/J.1467-9361.2004.00230.X]; Bhui K, 2005, AM J PUBLIC HEALTH, V95, P496, DOI 10.2105/AJPH.2003.033274; Borrell C, 2010, PREV MED, V50, P86, DOI 10.1016/j.ypmed.2009.10.016; Chang D-H, 2007, COMMITTEE ELIMINATIO; Choe S-H, 2009, NY TIMES SEOUL; Choi Jang Jip, 1993, STATE SOC CONT KOREA; Chun H, 2006, INT J HEALTH SERV, V36, P575, DOI 10.2190/6GUV-FBBA-W1B5-U79B; Chung W, 2007, J BIOSOC SCI, V39, P707, DOI 10.1017/s0021932007001988; CROSBY F, 1984, AM BEHAV SCI, V27, P371, DOI 10.1177/000276484027003008; de Castro AB, 2008, AM J PUBLIC HEALTH, V98, P520, DOI 10.2105/AJPH.2007.110163; De Vogli R, 2007, J PSYCHOSOM RES, V63, P413, DOI 10.1016/j.jpsychores.2007.04.006; De Vogli R, 2007, J EPIDEMIOL COMMUN H, V61, P513, DOI 10.1136/jech.2006.052563; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Din-Dzietham R, 2004, SOC SCI MED, V58, P449, DOI 10.1016/S0277-9536(03)00211-9; Ferrie JE, 2006, OCCUP ENVIRON MED, V63, P443, DOI 10.1136/oem.2005.022269; Gee GC, 2007, SOC SCI MED, V64, P1984, DOI 10.1016/j.socscimed.2007.02.013; Gee GC, 2009, EPIDEMIOL REV, V31, P130, DOI 10.1093/epirev/mxp009; Hahm HC, 2010, WOMEN HEALTH ISS, V20, P350, DOI 10.1016/j.whi.2010.05.002; Hanam SP, 2004, KOREA J, V44, P42; Hunte HER, 2009, AM J PUBLIC HEALTH, V99, P1285, DOI 10.2105/AJPH.2007.128090; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jang SN, 2009, J GERONTOL B-PSYCHOL, V64, P677, DOI 10.1093/geronb/gbp014; Jean A, 2003, NEW POLIT SCI, V25, P159; Jones RS, 2005, EC DEP WORKING PAPER; Khang YH, 2004, INT J EPIDEMIOL, V33, P299, DOI 10.1093/ije/dyg244; Kim IH, 2008, AM J IND MED, V51, P748, DOI 10.1002/ajim.20626; Kim MH, 2007, NEW SOLUT, V17, P325, DOI 10.2190/NS.17.4.h; Kim MH, 2008, SOC SCI MED, V67, P1982, DOI 10.1016/j.socscimed.2008.09.051; Kim S, 2004, HAKBUL SOC; Kim Y, 2010, MAGNITUDE REALITY PR; KRIEGER N, 1990, SOC SCI MED, V30, P1273, DOI 10.1016/0277-9536(90)90307-E; Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006; Lam Amy Mong Chow, 2005, Int J Adolesc Med Health, V17, P157; Larsen U, 1998, POP STUD-J DEMOG, V52, P317, DOI 10.1080/0032472031000150496; Lin D, 2009, COMMUNITY MENT HLTH; Liu JX, 2006, AIDS BEHAV, V10, pS25, DOI 10.1007/s10461-006-9123-5; MONKTURNER E, 1994, AM J ECON SOCIOL, V53, P433, DOI 10.1111/j.1536-7150.1994.tb02615.x; Moomal H, 2009, SAMJ S AFR MED J, V99, P383; OECD, 2010, SICKN DIS WORK BREAK; Paradies Y, 2006, INT J EPIDEMIOL, V35, P888, DOI 10.1093/ije/dyl056; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Pavalko EK, 2003, J HEALTH SOC BEHAV, V44, P18, DOI 10.2307/1519813; Rogers AE, 2004, HEALTH AFFAIR, V23, P202, DOI 10.1377/hlthaff.23.4.202; Rogers WH, 1993, STATA TECHNICAL B, P19; Seguino S, 1997, J DEV STUD, V34, P102, DOI 10.1080/00220389708422513; Shin Gi-Wook, 2006, ETHNIC NATL KOREA GE; SOH CHS, 1993, SEX ROLES, V28, P73, DOI 10.1007/BF00289748; Son M, 2004, INT J EPIDEMIOL, V33, P308, DOI 10.1093/ije/dyh017; TAYLOR DM, 1994, ONT SYMP P, V7, P233; TAYLOR DM, 1991, J SOC PSYCHOL, V131, P847, DOI 10.1080/00224545.1991.9924672; Veling W, 2008, SOC PSYCH PSYCH EPID, V43, P953, DOI 10.1007/s00127-008-0381-6; Veling W, 2007, INT J EPIDEMIOL, V36, P761, DOI 10.1093/ije/dym085; Williams DR, 2008, SOC SCI MED, V67, P441, DOI 10.1016/j.socscimed.2008.03.021; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x	58	177	182	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30501	10.1371/journal.pone.0030501	http://dx.doi.org/10.1371/journal.pone.0030501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	907XU	23028766	Green Published, gold, Green Submitted			2022-12-27	WOS:000301454400135
J	Chen, YX; Zheng, SP; Qi, D; Zheng, SJ; Guo, JL; Zhang, SL; Weng, ZH				Chen, Yixiong; Zheng, Shaoping; Qi, Dan; Zheng, Shaojiang; Guo, Junli; Zhang, Shuling; Weng, Zhihong			Inhibition of Notch Signaling by a gamma-Secretase Inhibitor Attenuates Hepatic Fibrosis in Rats	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; STELLATE CELLS; MAMMALIAN NOTCH; LIVER FIBROSIS; MYOFIBROBLAST DIFFERENTIATION; PLASMINOGEN-ACTIVATOR; GENE-EXPRESSION; DEFICIENT MICE; PATHWAY	Notch signaling is essential to the regulation of cell differentiation, and aberrant activation of this pathway is implicated in human fibrotic diseases, such as pulmonary, renal, and peritoneal fibrosis. However, the role of Notch signaling in hepatic fibrosis has not been fully investigated. In the present study, we show Notch signaling to be highly activated in a rat model of liver fibrosis induced by carbon tetrachloride (CCl4), as indicated by increased expression of Jagged1, Notch3, and Hes1. Blocking Notch signaling activation by a gamma-secretase inhibitor, DAPT, significantly attenuated liver fibrosis and decreased the expression of snail, vimentin, and TGF-beta 1 in association with the enhanced expression of E-cadherin. The study in vitro revealed that DAPT treatment could suppress the EMT process of rat hepatic stellate cell line (HSC-T6). Interestingly, DAPT treatment was found not to affect hepatocyte proliferation in vivo. In contrast, DAPT can inhibit hepatocyte apoptosis to some degree. Our study provides the first evidence that Notch signaling is implicated in hepatic fibrogenesis and DAPT treatment has a protective effect on hepatocytes and ameliorates liver fibrosis. These findings suggest that the inhibition of Notch signaling might present a novel therapeutic approach for hepatic fibrosis.	[Chen, Yixiong; Qi, Dan; Zhang, Shuling; Weng, Zhihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China; [Zheng, Shaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Ultrasonog, Wuhan 430074, Peoples R China; [Zheng, Shaojiang; Guo, Junli] Hainan Med Coll, Dept Pathol, Haikou, Peoples R China; [Zheng, Shaojiang; Guo, Junli] Hainan Med Coll, Hainan Prov Key Lab Trop Med, Haikou, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Hainan Medical University; Hainan Medical University	Weng, ZH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China.	wzh941@126.com	Hocher, Berthold/AAC-3510-2020	Hocher, Berthold/0000-0001-8143-0579; Kassis, Judith/0000-0001-9268-3213	National Natural Science Foundation of China [30900663]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant from the National Natural Science Foundation of China (30900663). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi-Ikeda K, 2011, AM J RESP CELL MOL, V45, P136, DOI 10.1165/rcmb.2010-0140OC; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558; BETTENHAUSEN B, 1995, GENOMICS, V28, P436, DOI 10.1006/geno.1995.1172; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Chen SW, 2008, GENE THER, V15, P1424, DOI 10.1038/gt.2008.93; Chen YX, 2012, WORLD J GASTROENTERO, V18, P1397, DOI 10.3748/wjg.v18.i12.1397; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kinoshita K, 2007, GUT, V56, P396, DOI 10.1136/gut.2005.085704; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Lin Y, 2005, LIVER INT, V25, P796, DOI 10.1111/j.1478-3231.2005.01098.x; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Liu TJ, 2009, AM J PATHOL, V174, P1745, DOI 10.2353/ajpath.2009.080618; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Miele L, 1999, J CELL PHYSIOL, V181, P393, DOI 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Nijjar SS, 2002, AM J PATHOL, V160, P1695, DOI 10.1016/S0002-9440(10)61116-9; Nijjar SS, 2001, HEPATOLOGY, V34, P1184, DOI 10.1053/jhep.2001.29399; Pan Q, 2007, DIGEST DIS SCI, V52, P2591, DOI 10.1007/s10620-006-9676-1; Rao PK, 2000, EXP CELL RES, V260, P379, DOI 10.1006/excr.2000.5034; Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702; Rygiel KA, 2008, LAB INVEST, V88, P112, DOI 10.1038/labinvest.3700704; Sawitza I, 2009, HEPATOLOGY, V50, P1617, DOI 10.1002/hep.23184; Shawber C, 1996, DEVELOPMENT, V122, P3765; Sheahan S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-191; Shimizu M, 2001, HEPATOLOGY, V33, P569, DOI 10.1053/jhep.2001.22650; Teng YQ, 2007, J CLIN INVEST, V117, P304, DOI 10.1172/JCI31200; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Wei P, 2010, MOL CANCER THER, V9, P1618, DOI 10.1158/1535-7163.MCT-10-0034; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Xia JL, 2006, AM J PATHOL, V168, P1500, DOI 10.2353/ajpath.2006.050747; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhu FX, 2010, AM J PATHOL, V176, P650, DOI 10.2353/ajpath.2010.090447	50	180	195	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46512	10.1371/journal.pone.0046512	http://dx.doi.org/10.1371/journal.pone.0046512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	22276200	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000052
J	Zhang, ZJ; Ng, R; Man, SC; Li, TYJ; Wong, W; Tan, QR; Wong, HK; Chung, KF; Wong, MT; Tsang, WKA; Yip, KC; Ziea, E; Wong, VT				Zhang, Zhang-Jin; Ng, Roger; Man, Sui Cheung; Li, Tsui Yin Jade; Wong, Wendy; Tan, Qing-Rong; Wong, Hei Kiu; Chung, Ka-Fai; Wong, Man-Tak; Tsang, Wai-Kiu Alfert; Yip, Ka-chee; Ziea, Eric; Wong, Vivian Taam			Dense Cranial Electroacupuncture Stimulation for Major Depressive Disorder-A Single-Blind, Randomized, Controlled Study	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; PLACEBO NEEDLE; ACUPUNCTURE; FLUOXETINE; MECHANISMS; BRAIN; TOLERABILITY; EXPRESSION; PROJECTION; EFFICACY	Background: Previous studies suggest that electroacupuncture possesses therapeutic benefits for depressive disorders. The purpose of this study was to determine whether dense cranial electroacupuncture stimulation (DCEAS) could enhance the antidepressant efficacy in the early phase of selective serotonin reuptake inhibitor (SSRI) treatment of major depressive disorder (MDD). Methods: In this single-blind, randomized, controlled study, patients with MDD were randomly assigned to 9-session DCEAS or noninvasive electroacupuncture (n-EA) control procedure in combination with fluoxetine (FLX) for 3 weeks. Clinical outcomes were measured using the 17-item Hamilton Depression Rating Scale (HAMD-17), Clinical Global Impression-severity (CGI-S), and Self-rating Depression Scale (SDS) as well as the response and remission rates. Results: Seventy-three patients were randomly assigned to n-EA (n = 35) and DCEAS (n = 38), of whom 34 in n-EA and 36 in DCEAS group were analyzed. DCEAS-treated patients displayed a significantly greater reduction from baseline in HAMD-17 scores at Day 3 through Day 21 and in SDS scores at Day 3 and Day 21 compared to patients receiving n-EA. DCEAS intervention also produced a higher rate of clinically significant response compared to n-EA procedure (19.4% (7/36) vs. 8.8% (3/34)). The incidence of adverse events was similar in the two groups. Conclusions: DCEAS is a safe and effective intervention that augments the antidepressant efficacy. It can be considered as an additional therapy in the early phase of SSRI treatment of depressed patients. Trail Registration:Controlled-Trials.com ISRCTN88008690	[Zhang, Zhang-Jin; Ng, Roger; Man, Sui Cheung; Li, Tsui Yin Jade; Wong, Wendy; Wong, Hei Kiu] Univ Hong Kong, LKS Fac Med, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Man-Tak; Tsang, Wai-Kiu Alfert; Yip, Ka-chee] Kowloon Hosp, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Tan, Qing-Rong] Fourth Mil Med Univ, Dept Psychiat, Xian 710032, Shaanxi, Peoples R China; [Chung, Ka-Fai] Univ Hong Kong, LKS Fac Med, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Ziea, Eric; Wong, Vivian Taam] Hosp Author, Chinese Med Sect, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Air Force Military Medical University; University of Hong Kong	Zhang, ZJ (corresponding author), Univ Hong Kong, LKS Fac Med, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China.	zhangzj@hku.hk	Wong, Wendy/H-3939-2016; zhang, zheng/HCH-9684-2022; zhang, zhang/GQZ-6804-2022	Wong, Wendy/0000-0001-8731-0498; wang, li/0000-0002-1459-3412	Food and Health Bureau of Hong Kong [06070831]	Food and Health Bureau of Hong Kong	This study was supported by Health and Health Services Research Fund (HHSRF) from Food and Health Bureau of Hong Kong (ref.No.: 06070831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell A, 2005, DRUG DISCOV TODAY, V10, P578, DOI 10.1016/S1359-6446(05)03398-2; Allen JJB, 2006, J CLIN PSYCHIAT, V67, P1665, DOI 10.4088/JCP.v67n1101; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andreescu C, 2011, J CLIN PSYCHIAT, V72, P1129, DOI 10.4088/JCP.10m06105; ARBAB MAR, 1988, J CEREBR BLOOD F MET, V8, P54, DOI 10.1038/jcbfm.1988.8; Arroll B, 2005, ANN FAM MED, V3, P449, DOI 10.1370/afm.349; Barnes Patricia M, 2004, Adv Data, P1; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Benham A, 2009, ACUPUNCT MED, V27, P65, DOI 10.1136/aim.2008.000174; Blier P, 2003, EUR NEUROPSYCHOPHARM, V13, P57, DOI 10.1016/S0924-977X(02)00173-6; BLIER P, 1994, TRENDS PHARMACOL SCI, V15, P220, DOI 10.1016/0165-6147(94)90315-8; Clark L, 2009, ANNU REV NEUROSCI, V32, P57, DOI 10.1146/annurev.neuro.31.060407.125618; Dhond RP, 2007, J ALTERN COMPLEM MED, V13, P603, DOI 10.1089/acm.2007.7040; Enck P, 2010, AUTON NEUROSCI-BASIC, V157, P68, DOI 10.1016/j.autneu.2010.03.005; Fink M, 2001, FORSCH KOMP KLAS NAT, V8, P368, DOI 10.1159/000057254; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Han JS, 2003, TRENDS NEUROSCI, V26, P17, DOI 10.1016/S0166-2236(02)00006-1; Hong CJ, 2003, J CLIN PSYCHIAT, V64, P921, DOI 10.4088/JCP.v64n0810; Huang Y, 2004, SHANGHAI ZHEN JIU ZA, V23, P5; Keller Martin B, 2002, Psychopharmacol Bull, V36 Suppl 2, P133; Kirkcaldie M, 1997, CONVULSIVE THER, V13, P83; KUBOTA K, 1988, ANAT ANZEIGER, V165, P229; Kwon YB, 2000, AM J CHINESE MED, V28, P435, DOI 10.1142/S0192415X00000519; La Marca R, 2010, CLIN SCI, V118, P537, DOI 10.1042/CS20090264; LEE HC, 1994, J GERIATR PSYCH NEUR, V7, P216, DOI 10.1177/089198879400700404; Lee HJ, 2004, AM J CHINESE MED, V32, P795, DOI 10.1142/S0192415X04002405; Li A, 2007, BRAIN RES, V1186, P171, DOI 10.1016/j.brainres.2007.10.022; Li Hong-Jie, 2011, Zhongguo Zhen Jiu, V31, P3; Simpson KL, 1997, J COMP NEUROL, V385, P135; Simpson KL, 1999, J COMP NEUROL, V411, P524, DOI 10.1002/(SICI)1096-9861(19990830)411:3<524::AID-CNE13>3.0.CO;2-X; Smith CA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004046.pub3; STARK P, 1985, J CLIN PSYCHIAT, V46, P53; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Takahashi T, 2010, NEUROSCI RES, V68, P103, DOI 10.1016/j.neures.2010.06.012; Takahashi T, 2006, J GASTROENTEROL, V41, P408, DOI 10.1007/s00535-006-1773-6; Ulett GA, 1998, BIOL PSYCHIAT, V44, P129, DOI 10.1016/S0006-3223(97)00394-6; van Dijk KRA, 2002, REV NEUROSCIENCE, V13, P257; Wang H, 2008, J AFFECT DISORDERS, V111, P125, DOI 10.1016/j.jad.2008.04.020; Yeung WF, 2011, SLEEP, V34, P807, DOI 10.5665/SLEEP.1056; Yu YWY, 2006, EUR NEUROPSYCHOPHARM, V16, P498, DOI 10.1016/j.euroneuro.2005.12.004; Zhang WJ, 2009, J ALTERN COMPLEM MED, V15, P837, DOI 10.1089/acm.2008.0607; Zhang ZJ, 2010, J AFFECT DISORDERS, V124, P9, DOI 10.1016/j.jad.2009.07.005; Zhang ZJ, 2009, J NERV MENT DIS, V197, P619, DOI 10.1097/NMD.0b013e3181b05fd1; Zhang ZJ, 2011, ECAM IN PRESS; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004; Zhou F, 2010, ACUPUNCTURE THERAPY FOR NEUROLOGICAL DISEASES: A NEUROBIOLOGICAL VIEW, P32, DOI 10.1007/978-3-642-10857-0_2	48	102	105	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29651	10.1371/journal.pone.0029651	http://dx.doi.org/10.1371/journal.pone.0029651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238631	gold, Green Submitted, Green Published			2022-12-27	WOS:000301188800023
J	Wang, HK; Yan, YH; Wang, JM; Zhang, HP; Qi, W				Wang, HaiKuan; Yan, YanHua; Wang, JiaMing; Zhang, HePing; Qi, Wei			Production and Characterization of Antifungal Compounds Produced by Lactobacillus plantarum IMAU10014	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; ANTIBIOTICS; SPOILAGE; BREAD; FOOD	Lactobacillus plantarum IMAU10014 was isolated from koumiss that produces a broad spectrum of antifungal compounds, all of which were active against plant pathogenic fungi in an agar plate assay. Two major antifungal compounds were extracted from the cell-free supernatant broth of L. plantarum IMAU10014. 3-phenyllactic acid and Benzeneacetic acid, 2-propenyl ester were carried out by HPLC, LC-MS, GC-MS, NMR analysis. It is the first report that lactic acid bacteria produce antifungal Benzeneacetic acid, 2-propenyl ester. Of these, the antifungal products also have a broad spectrum of antifungal activity, namely against Botrytis cinerea, Glomerella cingulate, Phytophthora drechsleri Tucker, Penicillium citrinum, Penicillium digitatum and Fusarium oxysporum, which was identified by the overlay and well-diffusion assay. F. oxysporum, P. citrinum and P. drechsleri Tucker were the most sensitive among molds.	[Wang, HaiKuan; Yan, YanHua; Wang, JiaMing; Qi, Wei] Tianjin Univ Sci & Technol, Key Lab Ind Fermentat Microbiol, Minist Educ, Coll Biotechnol, Tianjin, Peoples R China; [Zhang, HePing] Inner Mongolia Agr Univ, Key Lab Dairy Biotechnol & Engn, Minist Educ, Hohhot, Peoples R China	Tianjin University Science & Technology; Inner Mongolia Agricultural University	Wang, HK (corresponding author), Tianjin Univ Sci & Technol, Key Lab Ind Fermentat Microbiol, Minist Educ, Coll Biotechnol, Tianjin, Peoples R China.	haikuanwangcn@yahoo.com.cn; hepingdd@vip.sina.com	Zhang, He/GXN-0028-2022		National Natural Science Foundation of China [30900961, 20876116]; Key Laboratory of Dairy Biotechnology; Engineering, Ministry of Education; Inner Mongolia Agricultural University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Dairy Biotechnology; Engineering, Ministry of Education; Inner Mongolia Agricultural University	This work was supported by the National Natural Science Foundation of China (No. 30900961 and No. 20876116), the Key Laboratory of Dairy Biotechnology, the Engineering, Ministry of Education, the Inner Mongolia Agricultural University for helpful contributions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen H, 2008, LETT APPL MICROBIOL, V47, P180, DOI 10.1111/j.1472-765X.2008.02412.x; Coloretti F, 2007, FEMS MICROBIOL LETT, V271, P245, DOI 10.1111/j.1574-6968.2007.00723.x; Dal Bello F, 2007, J CEREAL SCI, V45, P309, DOI 10.1016/j.jcs.2006.09.004; Dalie DKD, 2010, FOOD CONTROL, V21, P370, DOI 10.1016/j.foodcont.2009.07.011; Lavermicocca P, 2000, APPL ENVIRON MICROB, V66, P4084, DOI 10.1128/AEM.66.9.4084-4090.2000; LINDGREN SE, 1990, FEMS MICROBIOL LETT, V87, P149; Gerez CL, 2009, FOOD CONTROL, V20, P144, DOI 10.1016/j.foodcont.2008.03.005; Magnusson J, 2001, APPL ENVIRON MICROB, V67, P1, DOI 10.1128/AEM.67.1.1-5.2001; Martens C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-353; MATSUDA T, 1994, J JPN SOC FOOD SCI, V41, P687; Mauch A, 2010, INT J FOOD MICROBIOL, V141, P116, DOI 10.1016/j.ijfoodmicro.2010.05.002; Niku-Paavola ML, 1999, J APPL MICROBIOL, V86, P29, DOI 10.1046/j.1365-2672.1999.00632.x; Prema P, 2010, FOOD BIOPROCESS TECH, V3, P379, DOI 10.1007/s11947-008-0127-1; Rouse S, 2008, J APPL MICROBIOL, V104, P915, DOI 10.1111/j.1365-2672.2007.03619.x; Schnurer J, 2005, TRENDS FOOD SCI TECH, V16, P70, DOI 10.1016/j.tifs.2004.02.014; Schwenninger SM, 2008, J FOOD PROTECT, V71, P2481, DOI 10.4315/0362-028X-71.12.2481; Sjogren J, 2003, APPL ENVIRON MICROB, V69, P7554, DOI 10.1128/AEM.69.12.7554-7557.2003; Strom K, 2002, APPL ENVIRON MICROB, V68, P4322, DOI 10.1128/AEM.68.9.4322-4327.2002; Sun TS, 2009, EUR FOOD RES TECHNOL, V228, P607, DOI 10.1007/s00217-008-0969-9; Vermeulen N, 2006, J AGR FOOD CHEM, V54, P3832, DOI 10.1021/jf052733e; Wang HK, 2011, ANN MICROBIOL, V61, P879, DOI 10.1007/s13213-011-0209-6; Yang LP, 2008, WORLD J MICROB BIOT, V24, P909, DOI 10.1007/s11274-007-9626-x	22	374	401	7	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29452	10.1371/journal.pone.0029452	http://dx.doi.org/10.1371/journal.pone.0029452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22844460	Green Published, Green Submitted, gold			2022-12-27	WOS:000301457200014
J	Chen, YP; Xiao, XM; Li, J; Reichetzeder, C; Wang, ZN; Hocher, B				Chen, You-Peng; Xiao, Xiao-Min; Li, Jian; Reichetzeder, Christoph; Wang, Zi-Neng; Hocher, Berthold			Paternal Body Mass Index (BMI) Is Associated with Offspring Intrauterine Growth in a Gender Dependent Manner	PLOS ONE			English	Article							HIGH-FAT DIET; IMPAIRED GLUCOSE-TOLERANCE; BIRTH-WEIGHT; FOOD-INTAKE; METABOLIC SYNDROME; SEX-DIFFERENCES; DEVELOPMENTAL ORIGINS; BLOOD-PRESSURE; PROTEIN-DIET; PREGNANCY	Background: Environmental alternations leading to fetal programming of cardiovascular diseases in later life have been attributed to maternal factors. However, animal studies showed that paternal obesity may program cardio-metabolic diseases in the offspring. In the current study we tested the hypothesis that paternal BMI may be associated with fetal growth. Methods and Results: We analyzed the relationship between paternal body mass index (BMI) and birth weight, ultrasound parameters describing the newborn's body shape as well as parameters describing the newborns endocrine system such as cortisol, aldosterone, renin activity and fetal glycated serum protein in a birth cohort of 899 father/mother/child triplets. Since fetal programming is an offspring sex specific process, male and female offspring were analyzed separately. Multivariable regression analyses considering maternal BMI, paternal and maternal age, hypertension during pregnancy, maternal total glycated serum protein, parity and either gestational age (for birth weight) or time of ultrasound investigation (for ultrasound parameters) as confounding showed that paternal BMI is associated with growth of the male but not female offspring. Paternal BMI correlated with birth parameters of male offspring only: birth weight; biparietal diameter, head circumference; abdominal diameter, abdominal circumference; and pectoral diameter. Cortisol was likewise significantly correlated with paternal BMI in male newborns only. Conclusions: Paternal BMI affects growth of the male but not female offspring. Paternal BMI may thus represent a risk factor for cardiovascular diseases of male offspring in later life. It remains to be demonstrated whether this is linked to an offspring sex specific paternal programming of cortisol secretion.	[Chen, You-Peng; Hocher, Berthold] Jinan Univ, Affiliated Hosp 1, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Xiao, Xiao-Min; Li, Jian; Wang, Zi-Neng] Jinan Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China; [Reichetzeder, Christoph; Hocher, Berthold] Univ Potsdam, Inst Nutr Sci, Nuthetal Potsdam, Germany; [Reichetzeder, Christoph; Hocher, Berthold] Inst Pharmacol, Cardiovasc Res Ctr, Berlin, Germany	Jinan University; Jinan University; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Chen, YP (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China.	hocher@uni-potsdam.de	Hocher, Berthold/AAC-3510-2020	Hocher, Berthold/0000-0001-8143-0579; Kassis, Judith/0000-0001-9268-3213	Hoffmann La Roche Ltd, Basel, Switzerland	Hoffmann La Roche Ltd, Basel, Switzerland(Hoffmann-La Roche)	This study was supported by a grant from Hoffmann La Roche Ltd, Basel, Switzerland to Dr. B. Hocher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LM, 2006, NUTRITION, V22, P327, DOI 10.1016/j.nut.2005.09.006; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Aufdenblatten M, 2009, PEDIATR RES, V65, P198, DOI 10.1203/PDR.0b013e31818d6c24; Augustyniak RA, 2010, AM J PHYSIOL-REG I, V298, pR1375, DOI 10.1152/ajpregu.00848.2009; Barker DJP, 2003, EUR J EPIDEMIOL, V18, P733, DOI 10.1023/A:1025388901248; Brunton PJ, 2010, J NEUROENDOCRINOL, V22, P1198, DOI 10.1111/j.1365-2826.2010.02067.x; Clausen JO, 1997, AM J EPIDEMIOL, V146, P23, DOI 10.1093/oxfordjournals.aje.a009188; Cooper R, 2010, AM J CLIN NUTR, V92, P946, DOI 10.3945/ajcn.2010.29477; Figueroa-Colon R, 2000, AM J CLIN NUTR, V71, P829, DOI 10.1093/ajcn/71.3.829; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gilbert JS, 2008, AM J PHYSIOL-REG I, V295, pR1941, DOI 10.1152/ajpregu.90724.2008; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hocher B, 2000, LANCET, V355, P1241, DOI 10.1016/S0140-6736(00)02094-8; Hocher B, 2007, J PHYSIOL-LONDON, V579, P287, DOI 10.1113/jphysiol.2007.127738; Hogberg U, 2000, GYNECOL OBSTET INVES, V49, P160, DOI 10.1159/000010239; Jahan-Mihan A, 2011, NUTR RES, V31, P644, DOI 10.1016/j.nutres.2011.08.003; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Leon DA, 2005, CIRCULATION, V112, P3478, DOI 10.1161/CIRCULATIONAHA.104.497610; Li J, 2012, NEUROSCI BIOBEHAV R, V36, P1085, DOI 10.1016/j.neubiorev.2011.12.006; Li J, 2011, J HYPERTENS, V29, P1712, DOI 10.1097/HJH.0b013e328349a2e6; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; LUCAS A, 1994, ARCH DIS CHILD, V71, P288, DOI 10.1136/adc.71.4.288; Manabe M, 2005, PEDIATR INT, V47, P60, DOI 10.1111/j.1442-200x.2004.02002.x; Mi J, 2000, ANN INTERN MED, V132, P253, DOI 10.7326/0003-4819-132-4-200002150-00002; Murphy SK, 2012, GENE, V494, P36, DOI 10.1016/j.gene.2011.11.062; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Page KC, 2009, AM J PHYSIOL-REG I, V297, pR1049, DOI 10.1152/ajpregu.90585.2008; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; PHIPPS K, 1993, DIABETOLOGIA, V36, P225, DOI 10.1007/BF00399954; Rich-Edwards JW, 1999, ANN INTERN MED, V130, P278, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00005; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Szeto IMY, 2008, AM J PHYSIOL-REG I, V295, pR575, DOI 10.1152/ajpregu.90354.2008; Tang C, 2010, CHIN J BIRTH HLTH HE, P4; Taylor PD, 2004, J PHYSIOL-LONDON, V558, P943, DOI 10.1113/jphysiol.2002.018879; Thone-Reineke C, 2006, AM J PHYSIOL-REG I, V291, pR1025, DOI 10.1152/ajpregu.00898.2005; Wang XB, 2002, JAMA-J AM MED ASSOC, V287, P195, DOI 10.1001/jama.287.2.195; WIDDOWSON EM, 1975, PEDIATR RES, V9, P154, DOI 10.1203/00006450-197503000-00010; Xie Y, 2007, PROG OBSTET GYNECOL, V16, P440; Yazbek SN, 2010, HUM MOL GENET, V19, P4134, DOI 10.1093/hmg/ddq332; Zambrano E, 2006, J PHYSIOL-LONDON, V571, P221, DOI 10.1113/jphysiol.2005.100313; Zambrano E, 2005, J PHYSIOL-LONDON, V566, P225, DOI 10.1113/jphysiol.2005.086462	45	180	195	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36329	10.1371/journal.pone.0036329	http://dx.doi.org/10.1371/journal.pone.0036329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22276200	Green Published, gold			2022-12-27	WOS:000305343400019
J	Zhang, Z; Wang, WZ; Shi, ZB; Wang, L; Zhang, JX				Zhang, Zhen; Wang, Wenzhong; Shi, Zhanbiao; Wang, Li; Zhang, Jianxin			Mental Health Problems among the Survivors in the Hard-Hit Areas of the Yushu Earthquake	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HOPKINS SYMPTOM CHECKLIST-25; TRAUMATIC STRESS; ADULT SURVIVORS; PTSD CHECKLIST; GENDER; INSTRUMENTS; PREVALENCE; EXPOSURE; VICTIMS	Background: On April 14, 2010, an earthquake registering 7.1 on the Richter scale shook Qinghai Province in southwest China. The earthquake caused numerous casualties and much damage. The epicenter, Yushu County, suffered the most severe damage. As a part of the psychological relief work, the present study evaluated the mental health statuses of the people affected and identified the mental disorder risk factors related to earthquakes. Methods: Five hundred and five earthquake survivors living in Yushu County were investigated 3-4 months after the earthquake. Participant demographic data including gender, age, marital status, ethnicity, educational level, and religious beliefs were collected. The Earthquake-Specific Trauma Exposure Indicators assessed the intensity of exposure to trauma during the earthquake. The PTSD Checklist-Civilian version (PCL-C) and the Hopkins Symptoms Checklist-25 (HSCL-25) assessed the symptoms and prevalence rates of probable Posttraumatic Stress Disorder (PTSD) as well as anxiety and depression, respectively. The Perceived Social Support Scale (PSSS) evaluated subjective social support. Results: The prevalence rates of probable PTSD, anxiety, and depression were 33.7%, 43.8% and 38.6%, respectively. Approximately one fifth of participants suffered from all three conditions. Individuals who were female, felt initial fear during the earthquake, and had less social support were the most likely to have poor mental health. Conclusions: The present study revealed that there are serious mental problems among the hard-hit survivors of the Yushu earthquake. Survivors at high risk for mental disorders should be specifically considered. The present study provides useful information for rebuilding and relief work.	[Zhang, Zhen; Wang, Wenzhong; Shi, Zhanbiao; Wang, Li; Zhang, Jianxin] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS	Zhang, JX (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	zhangjx@psych.an.cn	Wong, Wendy/H-3939-2016; zhang, zheng/HCH-9684-2022; zhang, zhang/GQZ-6804-2022	Wong, Wendy/0000-0001-8731-0498; wang, li/0000-0002-1459-3412	Youth Foundation of the Institute of Psychology, CAS [Y0CX441S01]; Development Foundation of the Institute of Psychology, CAS [O9CX143014]	Youth Foundation of the Institute of Psychology, CAS; Development Foundation of the Institute of Psychology, CAS	The Youth Foundation of the Institute of Psychology, CAS (No. Y0CX441S01) and the Development Foundation of the Institute of Psychology, CAS (No. O9CX143014) supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acierno Ron, 2007, Am J Public Health, V97 Suppl 1, pS103, DOI 10.2105/AJPH.2006.087007; Altindag A, 2005, COMPR PSYCHIAT, V46, P328, DOI 10.1016/j.comppsych.2005.01.005; Armenian HK, 2000, ACTA PSYCHIAT SCAND, V102, P58, DOI 10.1034/j.1600-0447.2000.102001058.x; Basoglu M, 2004, J TRAUMA STRESS, V17, P133, DOI 10.1023/B:JOTS.0000022619.31615.e8; Bland SH, 1997, J NERV MENT DIS, V185, P188, DOI 10.1097/00005053-199703000-00008; BLUMENTHAL JA, 1987, PSYCHOSOM MED, V49, P331, DOI 10.1097/00006842-198707000-00002; Bramsen I, 2000, AM J PSYCHIAT, V157, P1115, DOI 10.1176/appi.ajp.157.7.1115; BROMET E, 1995, EPIDEMIOL REV, V17, P113, DOI 10.1093/oxfordjournals.epirev.a036166; Chen CH, 2007, COMPR PSYCHIAT, V48, P269, DOI 10.1016/j.comppsych.2006.12.003; Chen YY, 2006, J RELIG HEALTH, V45, P371, DOI 10.1007/s10943-006-9040-y; Cook J.D., 1990, J TRAUMA STRESS, V3, P541, DOI [10.1002/jts.2490030406, DOI 10.1002/JTS.2490030406, 10.1007/BF02039587]; Cox BJ, 2004, BEHAV RES THER, V42, P105, DOI 10.1016/S0005-7967(03)00105-0; David D, 1996, J TRAUMA STRESS, V9, P607, DOI 10.1002/jts.2490090316; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; DiGrande L, 2008, J TRAUMA STRESS, V21, P264, DOI 10.1002/jts.20345; Elhai JD, 2005, J TRAUMA STRESS, V18, P541, DOI 10.1002/jts.20062; Falsetti SA, 2003, J TRAUMA STRESS, V16, P391, DOI 10.1023/A:1024422220163; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Gavranidou M, 2003, DEPRESS ANXIETY, V17, P130, DOI 10.1002/da.10103; Grant DM, 2008, J ABNORM PSYCHOL, V117, P662, DOI 10.1037/a0012591; GREEN BL, 1992, J NERV MENT DIS, V180, P760, DOI 10.1097/00005053-199212000-00004; Huang L., 1996, CHIN MENT HLTH J, V10, P160; Kumar MS, 2007, AM J PUBLIC HEALTH, V97, P99, DOI 10.2105/AJPH.2005.071167; Kun P, 2009, PUBLIC HEALTH, V123, P703, DOI 10.1016/j.puhe.2009.09.017; Li HH, 2010, PSYCHOL REP, V107, P733, DOI 10.2466/03.15.20.PR0.107.6.733-739; Lilly MM, 2009, J ANXIETY DISORD, V23, P767, DOI 10.1016/j.janxdis.2009.02.015; Liu AZ, 2006, CAN J PSYCHIAT, V51, P350, DOI 10.1177/070674370605100603; Liu MX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014706; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Sharan P, 1996, AM J PSYCHIAT, V153, P556; Shi Qi-chang, 2005, Zhonghua Yufang Yixue Zazhi, V39, P229; Solomon Z, 2005, SOC PSYCH PSYCH EPID, V40, P947, DOI 10.1007/s00127-005-0973-3; Stratta P, 2012, J RELIG HLT IN PRESS; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Tsai KY, 2007, J PSYCHIATR RES, V41, P90, DOI 10.1016/j.jpsychires.2005.10.004; van Griensven F, 2006, JAMA-J AM MED ASSOC, V296, P537, DOI 10.1001/jama.296.5.537; Ventevogel P, 2007, SOC PSYCH PSYCH EPID, V42, P328, DOI 10.1007/s00127-007-0161-8; Wang L, 2009, J TRAUMA STRESS, V22, P444, DOI 10.1002/jts.20439; [王婷 WANG Ting], 2009, [中国老年学杂志, Chinese Journal of Gerontology], V29, P1272; Wang XD, 2000, AM J PSYCHIAT, V157, P1260, DOI 10.1176/appi.ajp.157.8.1260; [王相兰 WANG Xianglan], 2008, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V29, P367; Weathers F., 1993, P ANN C INT SOC TRAU; Wu KK., 2008, HONG KONG J PSYCHIAT, V18, P144; Xu JJ, 2011, INT J PSYCHIAT MED, V42, P167, DOI 10.2190/PM.42.2.e; Yu S., 2011, J SICHUAN NORMAL U S, V38, P45; Zhang YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022371; Zhang Z, 2011, PUBLIC HEALTH, V125, P293, DOI 10.1016/j.puhe.2010.12.008; Zhangs W., 1998, CHINESE J PSYCHIAT, V31, P69	50	102	105	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46449	10.1371/journal.pone.0046449	http://dx.doi.org/10.1371/journal.pone.0046449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	020RP	22238631	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500041
J	Li, CF; Zhou, DN; Kou, ZK; Zhang, ZS; Wang, JP; Cai, ML; Cao, CG				Li Cheng-Fang; Zhou Dan-Na; Kou Zhi-Kui; Zhang Zhi-Sheng; Wang Jin-Ping; Cai Ming-Li; Cao Cou-Gui			Effects of Tillage and Nitrogen Fertilizers on CH4 and CO2 Emissions and Soil Organic Carbon in Paddy Fields of Central China	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; LONG-TERM APPLICATION; RICE FIELDS; NO-TILLAGE; METHANE EMISSIONS; CHEMICAL FERTILIZER; SYSTEMS; SEQUESTRATION; FLUXES; DIOXIDE	Quantifying carbon (C) sequestration in paddy soils is necessary to help better understand the effect of agricultural practices on the C cycle. The objective of the present study was to assess the effects of tillage practices [conventional tillage (CT) and no-tillage (NT)] and the application of nitrogen (N) fertilizer (0 and 210 kg N ha(-1)) on fluxes of CH4 and CO2, and soil organic C (SOC) sequestration during the 2009 and 2010 rice growing seasons in central China. Application of N fertilizer significantly increased CH4 emissions by 13%-66% and SOC by 21%-94% irrespective of soil sampling depths, but had no effect on CO2 emissions in either year. Tillage significantly affected CH4 and CO2 emissions, where NT significantly decreased CH4 emissions by 10%-36% but increased CO2 emissions by 22%-40% in both years. The effects of tillage on the SOC varied with the depth of soil sampling. NT significantly increased the SOC by 7%-48% in the 0-5 cm layer compared with CT. However, there was no significant difference in the SOC between NT and CT across the entire 0-20 cm layer. Hence, our results suggest that the potential of SOC sequestration in NT paddy fields may be overestimated in central China if only surface soil samples are considered.	[Li Cheng-Fang; Kou Zhi-Kui; Zhang Zhi-Sheng; Wang Jin-Ping; Cai Ming-Li; Cao Cou-Gui] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Zhou Dan-Na] Hubei Acad Agr Sci, Inst Anim Husb & Vet Sci, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Hubei Academy of Agricultural Sciences	Li, CF (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China.	ccgui@mail.hzau.edu.cn		Li, Chaozheng/0000-0001-7639-7831; Yu, Xiao-Qiang/0000-0003-1419-9009; Puddick, Jonathan/0000-0001-7000-9180	National Technology Project for High Food Yield of China [2011BAD16B02]; National Natural Science Foundation of China [31100319]; Fundamental Research Funds for the Central Universities [2010QC032]; Foundation of Hubei Key Laboratory of Animal Embryo Engineering and Molecular Breeding [2011ZD152]	National Technology Project for High Food Yield of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Foundation of Hubei Key Laboratory of Animal Embryo Engineering and Molecular Breeding	The study was supported by the National Technology Project for High Food Yield of China (2011BAD16B02), National Natural Science Foundation of China (31100319), Fundamental Research Funds for the Central Universities (2010QC032) and the Foundation of Hubei Key Laboratory of Animal Embryo Engineering and Molecular Breeding (2011ZD152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaraz JJ, 2009, SOIL TILL RES, V104, P134, DOI 10.1016/j.still.2009.02.003; Alvarez R, 2005, SOIL USE MANAGE, V21, P38, DOI 10.1079/SUM2005291; Angers DA, 2008, SOIL SCI SOC AM J, V72, P1370, DOI 10.2136/sssaj2007.0342; Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Ball BC, 1999, SOIL TILL RES, V53, P29, DOI 10.1016/S0167-1987(99)00074-4; BAO SD, 2000, ANAL SOIL AGR CHEM, P42; Burton AJ, 2004, GLOBAL CHANGE BIOL, V10, P1080, DOI 10.1111/j.1365-2486.2004.00737.x; ButterbachBahl K, 1997, PLANT CELL ENVIRON, V20, P1175, DOI 10.1046/j.1365-3040.1997.d01-142.x; Causarano HJ, 2006, J ENVIRON QUAL, V35, P1374, DOI 10.2134/jeq2005.0150; Christopher SF, 2009, SOIL SCI SOC AM J, V73, P207, DOI 10.2136/sssaj2007.0336; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P330, DOI 10.1016/j.soilbio.2006.08.003; Crill PM, 1988, GLOBAL BIOGEOCHEM CY, V2, P371, DOI 10.1029/GB002i004p00371; Deen W, 2003, SOIL TILL RES, V74, P143, DOI 10.1016/S0167-1987(03)00162-4; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; DeLuca TH, 2011, FRONT ECOL ENVIRON, V9, P407, DOI 10.1890/100063; DICK RP, 1992, AGR ECOSYST ENVIRON, V40, P25, DOI 10.1016/0167-8809(92)90081-L; Dolan MS, 2006, SOIL TILL RES, V89, P221, DOI 10.1016/j.still.2005.07.015; Drury CF, 2006, SOIL SCI SOC AM J, V70, P570, DOI 10.2136/sssaj2005.0042; Gao YJ, 2000, SOIL ENV SCI, V9, P27; GREEN CJ, 1995, SOIL SCI SOC AM J, V59, P453, DOI 10.2136/sssaj1995.03615995005900020026x; Guo JP, 2007, AGR FOREST METEOROL, V142, P270, DOI 10.1016/j.agrformet.2006.03.029; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; Harada H, 2007, SOIL SCI PLANT NUTR, V53, P668, DOI 10.1111/j.1747-0765.2007.00174.x; He YingYing, 2010, Journal of Agro-Environment Science, V29, P200; Hutsch BW, 1998, BIOL FERT SOILS, V27, P284, DOI 10.1007/s003740050435; IPCC, 2007, CONTRIBUTION WORKING; Iqbal J, 2009, AGR ECOSYST ENVIRON, V131, P292, DOI 10.1016/j.agee.2009.02.001; [IRRI] International Rice Research Institute, 2004, RIC STAT DAT; Khan SA, 2007, J ENVIRON QUAL, V36, P1821, DOI 10.2134/jeq2007.0099; 郑循华, 1998, Advances in Atmospheric Sciences, V15, P569; Kroon PS, 2008, NUTR CYCL AGROECOSYS, V82, P175, DOI 10.1007/s10705-008-9179-x; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lee DK, 2007, SOIL BIOL BIOCHEM, V39, P178, DOI 10.1016/j.soilbio.2006.07.004; Li CF, 2010, ATMOS ENVIRON, V44, P2696, DOI 10.1016/j.atmosenv.2010.04.045; Li CF, 2009, ARCH ENVIRON CON TOX, V56, P21, DOI 10.1007/s00244-008-9159-9; Li JT, 2007, PEDOSPHERE, V17, P568, DOI 10.1016/S1002-0160(07)60067-8; Liang W, 2007, PEDOSPHERE, V17, P630, DOI 10.1016/S1002-0160(07)60075-7; LINDAU CW, 1993, SOIL SCI, V156, P42, DOI 10.1097/00010694-199307000-00006; Liu XJ, 2006, PLANT SOIL, V280, P177, DOI 10.1007/s11104-005-2950-8; Lopez-Bellido RJ, 2010, AGRON J, V102, P310, DOI 10.2134/agronj2009.0165; Lou YL, 2011, SOIL TILL RES, V113, P70, DOI 10.1016/j.still.2011.01.007; Lou YS, 2003, WATER AIR SOIL POLL, V149, P281, DOI 10.1023/A:1025727504841; Lu F, 2009, GLOBAL CHANGE BIOL, V15, P281, DOI 10.1111/j.1365-2486.2008.01743.x; Lu WF, 2000, NUTR CYCL AGROECOSYS, V58, P65, DOI 10.1023/A:1009830232650; MINAMI K, 1995, FERT RES, V40, P71, DOI 10.1007/BF00749864; Mitra S, 2005, SOIL SCI SOC AM J, V69, P563, DOI 10.2136/sssaj2005.0563; Mosier AR, 2005, NUTR CYCL AGROECOSYS, V72, P67, DOI 10.1007/s10705-004-7356-0; Nayak P, 2009, NUTR CYCL AGROECOSYS, V83, P259, DOI 10.1007/s10705-008-9217-8; Neue HU, 2000, ATMOSPHERIC METHANE, P134; Nyamadzawo G, 2008, NUTR CYCL AGROECOSYS, V81, P85, DOI 10.1007/s10705-007-9154-y; OECD, 2000, ENV IND AGR METH AGR; Omonode RA, 2007, SOIL TILL RES, V95, P182, DOI 10.1016/j.still.2006.12.004; Oorts K, 2007, SOIL TILL RES, V95, P133, DOI 10.1016/j.still.2006.12.002; Pan GX, 2009, AGR ECOSYST ENVIRON, V131, P274, DOI 10.1016/j.agee.2009.01.020; Pan GX, 2004, GLOBAL CHANGE BIOL, V10, P79, DOI 10.1111/j.1365-2486.2003.00717.x; PARKINSON KJ, 1981, J APPL ECOL, V18, P221, DOI 10.2307/2402491; Paustian K., 1997, SOIL ORGANIC MATTER; Reicosky DC, 1997, SOIL TILL RES, V41, P105, DOI 10.1016/S0167-1987(96)01080-X; Roberson T, 2008, J ENVIRON QUAL, V37, P535, DOI 10.2134/jeq2006.0386; SCHUTZ H, 1989, J GEOPHYS RES-ATMOS, V94, P16405, DOI 10.1029/JD094iD13p16405; Shang QY, 2011, GLOBAL CHANGE BIOL, V17, P2196, DOI 10.1111/j.1365-2486.2010.02374.x; Six J, 1999, SOIL SCI SOC AM J, V63, P1350, DOI 10.2136/sssaj1999.6351350x; Six J, 2002, AGRONOMIE, V22, P755, DOI 10.1051/agro:2002043; Su YZ, 2007, SOIL TILL RES, V92, P181, DOI 10.1016/j.still.2006.03.001; Tang Xiao-hong, 2007, Yingyong Shengtai Xuebao, V18, P1027; Tong CL, 2009, SOIL TILL RES, V106, P8, DOI 10.1016/j.still.2009.09.003; Ussiri DAN, 2009, SOIL TILL RES, V104, P247, DOI 10.1016/j.still.2009.03.001; Wang CJ, 2010, SCI CHINA LIFE SCI, V53, P858, DOI 10.1007/s11427-010-4028-y; Wang MX, 2002, NUTR CYCL AGROECOSYS, V64, P43, DOI 10.1023/A:1021183706235; Wang SX, 2012, J ZHEJIANG UNIV-SC B, V13, P274, DOI 10.1631/jzus.B1100145; WASSMANN R, 1993, BIOGEOCHEMISTRY, V20, P83, DOI 10.1007/BF00004136; Wassmann R, 2000, BIOL FERT SOILS, V31, P20, DOI 10.1007/s003740050619; Wilson HM, 2008, APPL SOIL ECOL, V39, P264, DOI 10.1016/j.apsoil.2007.12.013; Wright AL, 2005, BIOL FERT SOILS, V41, P95, DOI 10.1007/s00374-004-0819-2; Wright AL, 2008, APPL SOIL ECOL, V38, P168, DOI 10.1016/j.apsoil.2007.10.006; Xiao Y, 2005, AGR ECOSYST ENVIRON, V109, P273, DOI 10.1016/j.agee.2005.03.016; Xu H, 2000, NUTR CYCL AGROECOSYS, V58, P12, DOI DOI 10.1023/A:1009823425806; Zhan M, 2011, NUTR CYCL AGROECOSYS, V89, P1, DOI 10.1007/s10705-010-9371-7	78	180	206	28	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e34642	10.1371/journal.pone.0034642	http://dx.doi.org/10.1371/journal.pone.0034642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574109	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800005
J	Li, CY; Harper, A; Puddick, J; Wang, WY; McMahon, C				Li, Chunyi; Harper, Anne; Puddick, Jonathan; Wang, Wenying; McMahon, Chris			Proteomes and Signalling Pathways of Antler Stem Cells	PLOS ONE			English	Article							RETINOIC ACID; PROTEIN S100A4; EMBRYONAL CARCINOMA; DEER ANTLER; C-MYC; EXPRESSION; GENE; REGENERATION; GROWTH; PEDICLE	As the only known example of complete organ regeneration in mammals, deer antler in the growing or velvet phase is of major interest in developmental biology. This regeneration event initiates from self-renewing antler stem cells that exhibit pluripotency. At present, it remains unclear how the activation and quiescence of antler stem cells are regulated. Therefore, in the present study proteins that were differentially expressed between the antler stem cells and somatic cells (facial periosteum) were identified by a gel-based proteomic technique, and analysed using Ingenuity Pathway Analysis software. Several molecular pathways (PI3K/Akt, ERK/MAPK, p38 MAPK, etc.) were found to be activated during proliferation. Also expressed were the transcription factors POU5F1, SOX2, NANOG and MYC, which are key markers of embryonic stem cells. Expression of these proteins was confirmed in both cultured cells and fresh tissues by Western blot analysis. Therefore, the molecular pathways and transcription factors identified in the current study are common to embryonic and adult stem cells. However, expression of embryonic stem cell transcription factors would suggest that antler stem cells are, potentially, an intermediary stem cell type between embryonic and the more specialized tissue-specific stem cells like those residing in muscle, fat or from a hematopoietic origin. The retention of this embryonic, pluripotent lineage may be of fundamental importance for the subsequent regenerative capacity of antlers.	[Li, Chunyi; Harper, Anne; Wang, Wenying] AgResearch Ltd, Dev Biol Grp, Invermay Agr Ctr, Mosgiel, New Zealand; [Li, Chunyi] State Key Lab Mol Biol Special Econ Anim, Changchun, Peoples R China; [Puddick, Jonathan] Univ Waikato, Waikato Mass Spectrometry Facil, Hamilton, New Zealand; [McMahon, Chris] AgResearch Ltd, Dev Biol Grp, Ruakura Agr Ctr, Hamilton, New Zealand	AgResearch - New Zealand; University of Waikato; AgResearch - New Zealand	Li, CY (corresponding author), AgResearch Ltd, Dev Biol Grp, Invermay Agr Ctr, Mosgiel, New Zealand.	chris.mcmahon@agresearch.co.nz		Li, Chaozheng/0000-0001-7639-7831; Yu, Xiao-Qiang/0000-0003-1419-9009; Puddick, Jonathan/0000-0001-7000-9180	Foundation for Research, Science and Technology, New Zealand [C10X0207]	Foundation for Research, Science and Technology, New Zealand(New Zealand Foundation for Research, Science and Technology)	The work was funded by Foundation for Research, Science and Technology, New Zealand (C10X0207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambartsumian N, 2001, ONCOGENE, V20, P4685, DOI 10.1038/sj.onc.1204636; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Banks WJ, 1982, LIGHT MICROSCOPIC ST, P231; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Berg DK, 2007, BIOL REPROD, V77, P384, DOI 10.1095/biolreprod.106.058172; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Brown R.D., 1982, ANTLER DEV CERVIDAE, P61; Bubenik GA, 1982, ENDOCRINE REGULATION, P73; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Clark DE, 2006, ANAT REC PART A, V288A, P1281, DOI 10.1002/ar.a.20393; Colitti M, 2005, J ANAT, V207, P339, DOI 10.1111/j.1469-7580.2005.00464.x; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Fennessy P.F., 1985, Royal Society of New Zealand Bulletin, P239; Filipenko NR, 2004, J BIOL CHEM, V279, P8723, DOI 10.1074/jbc.M311951200; Freemantle SJ, 2002, ONCOGENE, V21, P2880, DOI 10.1038/sj.onc.1205408; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Giguere V, 1990, MOL CLONING CDNA ENC, P6233; Gil CD, 2006, CELL BIOL INT, V30, P338, DOI 10.1016/j.cellbi.2005.12.010; Gilbert SF, 2003, DEV BIOL, P143; Goss R.J., 1983, DEER ANTLERS REGENER; GOSS RJ, 1985, J EXP ZOOL, V235, P359, DOI 10.1002/jez.1402350307; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Gyurjan I, 2007, MOL GENET GENOMICS, V277, P221, DOI 10.1007/s00438-006-0190-0; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Horie H, 1999, J NEUROSCI, V19, P9964; Kamal AM, 2005, MEM I OSWALDO CRUZ, V100, P39, DOI 10.1590/S0074-02762005000900008; Kami K, 2005, CURR DRUG TARGETS, V6, P395, DOI 10.2174/1389450054021918; Kierdorf U, 2003, ANAT REC PART A, V273A, P741, DOI 10.1002/ar.a.10082; Kierdorf U, 2007, J MORPHOL, V268, P726, DOI 10.1002/jmor.10546; Klingelhofer J, 1997, DEV DYNAM, V210, P87, DOI 10.1002/(SICI)1097-0177(199710)210:2<87::AID-AJA2>3.0.CO;2-5; Kriajevska M, 2002, J BIOL CHEM, V277, P5229, DOI 10.1074/jbc.M110976200; Lai AKW, 2007, TISSUE CELL, V39, P35, DOI 10.1016/j.tice.2007.01.001; LATERVEER L, 1995, BLOOD, V85, P2269, DOI 10.1182/blood.V85.8.2269.bloodjournal8582269; Li C., 2003, European Journal of Morphology, V41, P23, DOI 10.1076/ejom.41.1.23.28106; Li C, 2003, GEN COMP ENDOCR, V131, P21, DOI 10.1016/S0016-6480(02)00625-1; Li C, 2006, RECENT PROGR ANTLER; Li CY, 2007, CELL TISSUE RES, V328, P65, DOI 10.1007/s00441-006-0333-y; Li CY, 2009, CURR STEM CELL RES T, V4, P237, DOI 10.2174/157488809789057446; LI CY, 1994, ANAT REC, V239, P198, DOI 10.1002/ar.1092390211; Li CY, 2005, ANAT REC PART A, V282A, P163, DOI 10.1002/ar.a.20148; Li CY, 2002, ANAT REC, V268, P125, DOI 10.1002/ar.10120; Li CY, 2001, ANAT EMBRYOL, V204, P375, DOI 10.1007/s004290100204; Li CY, 1999, J EXP ZOOL, V284, P82, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;82::AID-JEZ11&gt;3.0.CO;2-K; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; LINCOLN GA, 1973, J EMBRYOL EXP MORPH, V29, P431; LINCOLN GA, 1976, J EXP ZOOL, V195, P247, DOI 10.1002/jez.1401950209; Liu FT, 2005, INT ARCH ALLERGY IMM, V136, P385, DOI 10.1159/000084545; Louro ID, 2002, CANCER RES, V62, P5867; Lu Y, 2000, BBA-GENE STRUCT EXPR, V1491, P13, DOI 10.1016/S0167-4781(00)00055-5; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Melnikova VO, 2006, PIGM CELL RES, V19, P395, DOI 10.1111/j.1600-0749.2006.00331.x; Molnar A, 2007, MOL GENET GENOMICS, V277, P237, DOI 10.1007/s00438-006-0193-x; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Park HJ, 2004, PROTEOMICS, V4, P3642, DOI 10.1002/pmic.200401027; Phan E, 2007, MED SCI MONITOR, V13, pRA25; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; REED MJ, 1994, J CELL PHYSIOL, V158, P169, DOI 10.1002/jcp.1041580121; Rolf HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002064; Rosenkilde MM, 2004, APMIS, V112, P481, DOI 10.1111/j.1600-0463.2004.apm11207-0808.x; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; Solito E, 2006, FASEB J, V20, P1498, DOI 10.1096/fj.05-5319fje; Stocum DL, 2006, REGENERATIVE BIOL ME; SUTTIE JM, 1995, J EXP ZOOL, V271, P120, DOI 10.1002/jez.1402710207; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; WATANABE Y, 1993, FEBS LETT, V324, P51, DOI 10.1016/0014-5793(93)81530-D; Welstead GG, 2008, CURR OPIN GENET DEV, V18, P123, DOI 10.1016/j.gde.2008.01.013	71	180	206	28	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30026	10.1371/journal.pone.0030026	http://dx.doi.org/10.1371/journal.pone.0030026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22574109	gold, Green Submitted, Green Published			2022-12-27	WOS:000299771900039
J	Wang, JA; Gao, F; Liu, ZZ; Qiao, M; Niu, XM; Zhang, KQ; Huang, XW				Wang, Ji'ai; Gao, Feng; Liu, Zhongzhong; Qiao, Min; Niu, Xuemei; Zhang, Ke-Qin; Huang, Xiaowei			Pathway and Molecular Mechanisms for Malachite Green Biodegradation in Exiguobacterium sp MG2	PLOS ONE			English	Article							CRYSTAL VIOLET; TRIPHENYLMETHANE; DECOLORIZATION; DYES; DEGRADATION; AZO	Malachite green (MG), N-methylated diaminotriphenylmethane, is one of the most common dyes in textile industry and has also been used as an effective antifungal agent. However, due to its negative impact on the environment and carcinogenic effects to mammalian cells, there is a significant interest in developing microbial agents to degrade this type of recalcitrant molecules. Here, an Exiguobacterium sp. MG2 was isolated from a river in Yunnan Province of China as one of the best malachite green degraders. This strain had a high decolorization capability even at the concentration of 2500 mg/l and maintained its stable activity within the pH range from 5.0 to 9.0. High-pressure liquid chromatography, liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry were employed to detect the catabolic pathway of MG. Six intermediate products were identified and a potential biodegradation pathway was proposed. This pathway involves a series of reactions of N-demethylation, reduction, benzene ring-removal, and oxidation, which eventually converted N-methylated diaminotriphenylmethane into N, N-dimethylaniline that is the key precursor to MG. Furthermore, our molecular biology experiments suggested that both triphenylmethane reductase gene tmr and cytochrome P450 participated in MG degradation, consistent with their roles in the proposed pathway. Collectively, our investigation is the first report on a biodegradation pathway of triphenylmethane dye MG in bacteria. Citation: Wang J, Gao F, Liu Z, Qiao M, Niu X, et al. (2012) Pathway and Molecular Mechanisms for Malachite Green Biodegradation in Exiguobacterium sp. MG2. PLoS ONE 7(12): e51808. doi:10.1371/journal.pone.0051808	[Huang, Xiaowei] Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China; Yunnan Univ, Minist Educ, Key Lab Microbial Resources, Kunming, Yunnan, Peoples R China	Yunnan University; Yunnan University	Huang, XW (corresponding author), Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China.	xwhuang@ynu.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	National Basic Research Program of China (Program 973) [2010CB134503]; Department of Science and Technology of Yunnan Province, China [2010GA012]	National Basic Research Program of China (Program 973)(National Basic Research Program of China); Department of Science and Technology of Yunnan Province, China	This work was supported by the National Basic Research Program of China (Program 973, grant No. 2010CB134503), and the Department of Science and Technology of Yunnan Province, China (grant No 2010GA012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SY, 2002, BIOTECHNOL LETT, V24, P1037, DOI 10.1023/A:1015610018103; Azmi W, 1998, ENZYME MICROB TECH, V22, P185, DOI 10.1016/S0141-0229(97)00159-2; BUMPUS JA, 1988, APPL ENVIRON MICROB, V54, P1143, DOI 10.1128/AEM.54.5.1143-1150.1988; Cha CJ, 2001, APPL ENVIRON MICROB, V67, P4358, DOI 10.1128/AEM.67.9.4358-4360.2001; COOPER P, 1993, J SOC DYERS COLOUR, V109, P97; Deng DY, 2008, INT BIODETER BIODEGR, V62, P263, DOI 10.1016/j.ibiod.2008.01.017; Doerge DR, 1998, RAPID COMMUN MASS SP, V12, P1625, DOI 10.1002/(SICI)1097-0231(19981115)12:21<1625::AID-RCM373>3.0.CO;2-I; Gao GD, 2008, CHINESE J CATAL, V29, P426, DOI 10.1016/S1872-2067(08)60043-1; GEORGE KL, 1989, CAN J MICROBIOL, V35, P529, DOI 10.1139/m89-084; Guerra-Lopez D, 2007, MICROBIOL-SGM, V153, P2724, DOI 10.1099/mic.0.2006/009241-0; Jang MS, 2005, APPL ENVIRON MICROB, V71, P7955, DOI 10.1128/AEM.71.12.7955-7960.2005; Jones JJ, 2003, ANTIMICROB AGENTS CH, V47, P2323, DOI 10.1128/AAC.47.7.2323-2326.2003; Ju KS, 2010, MICROBIOL MOL BIOL R, V74, P250, DOI 10.1128/MMBR.00006-10; Ortega-Calvo JJ, 2010, APPL ENVIRON MICROB, V76, P4430, DOI 10.1128/AEM.00461-10; Ren SZ, 2006, APPL MICROBIOL BIOT, V72, P1316, DOI 10.1007/s00253-006-0418-2; Sani RK, 1999, ENZYME MICROB TECH, V24, P433, DOI 10.1016/S0141-0229(98)00159-8; Wang JA, 2011, J MOL MICROB BIOTECH, V20, P220, DOI 10.1159/000330669; Wu J, 2009, J ENVIRON SCI-CHINA, V21, P960, DOI 10.1016/S1001-0742(08)62368-2; YATOME C, 1993, APPL MICROBIOL BIOT, V38, P565; YATOME C, 1991, J ENVIRON SCI HEAL A, V26, P75, DOI 10.1080/10934529109375621; Yoon JH, 1998, INT J SYST BACTERIOL, V48, P187, DOI 10.1099/00207713-48-1-187	21	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51808	10.1371/journal.pone.0051808	http://dx.doi.org/10.1371/journal.pone.0051808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	22629437	gold, Green Submitted, Green Published			2022-12-27	WOS:000312386800088
J	Wang, J; Hopkins, CJ; Hou, JN; Zou, XX; Wang, CN; Long, Y; Kurup, S; King, GJ; Meng, JL				Wang, Jing; Hopkins, Clare J.; Hou, Jinna; Zou, Xiaoxiao; Wang, Chongnan; Long, Yan; Kurup, Smita; King, Graham J.; Meng, Jinling			Promoter Variation and Transcript Divergence in Brassicaceae Lineages of FLOWERING LOCUS T	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; TRANSPOSABLE ELEMENTS; FUNCTIONAL DIVERGENCE; COMPARATIVE GENOMICS; FLORAL INDUCTION; GENE-EXPRESSION; EVOLUTION; NAPUS; MECHANISMS; OLERACEA	Brassica napus (AACC, 2n = 38), an oil crop of world-wide importance, originated from interspecific hybridization of B. rapa (AA, 2n = 20) and B. oleracea (CC, 2n = 18), and has six FLOWERING LOCUS T (FT) paralogues. Two located on the homeologous chromosomes A2 and C2 arose from a lineage distinct from four located on A7 and C6. A set of three conserved blocks A, B and C, which were found to be essential for FT activation by CONSTANS (CO) in Arabidopsis, was identified within the FT upstream region in B. napus and its progenitor diploids. However, on chromosome C2, insertion of a DNA transposable element (TE) and a retro-element in FT upstream blocks A and B contributed to significant structural divergence between the A and C genome orthologues. Phylogenetic analysis of upstream block A indicated the conserved evolutionary relationships of distinct FT genes within Brassicaceae. We conclude that the ancient At-a whole genome duplication contributed to distinct ancestral lineages for this key adaptive gene, which co-exist within the same genus. FT-A2 was found to be transcribed in all leaf samples from different developmental stages in both B. rapa and B. napus, whereas FT-C2 was not transcribed in either B. napus or B. oleracea. Silencing of FT-C2 appeared to result from TE insertion and consequent high levels of cytosine methylation in TE sequences within upstream block A. Interestingly, FT-A7/C6 paralogues were specifically silenced in winter type B. napus but abundantly expressed in spring type cultivars under vernalization-free conditions. Motif prediction indicated the presence of two CO protein binding sites within all Brassica block A and additional sites for FT activation in block C. We propose that the ancestral whole genome duplications have contributed to more complex mechanisms of floral regulation and niche adaptation in Brassica compared to Arabidopsis.	[King, Graham J.] So Cross Univ, So Cross Plant Sci, Lismore, NSW 2480, Australia; [Wang, Jing; Hou, Jinna; Zou, Xiaoxiao; Wang, Chongnan; Long, Yan; Meng, Jinling] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Hopkins, Clare J.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Kurup, Smita] Rothamsted Res, Harpenden, Herts, England	Southern Cross University; Huazhong Agricultural University; University of Melbourne; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	King, GJ (corresponding author), So Cross Univ, So Cross Plant Sci, Lismore, NSW 2480, Australia.	graham.king@scu.edu.au; jmeng@mail.hzau.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	Postdoctoral Science Foundation [20100480915]; 111 Project in China [B07041]; UK Biotechnology and Biological Sciences Research Council	Postdoctoral Science Foundation(China Postdoctoral Science Foundation); 111 Project in China(Ministry of Education, China - 111 Project); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Postdoctoral Science Foundation (20100480915) and 111 Project (B07041) in China. Rothamsted Research receives grant-aided funds from the UK Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Alix K, 2008, PLANT J, V56, P1030, DOI 10.1111/j.1365-313X.2008.03660.x; Bailey CD, 2006, MOL BIOL EVOL, V23, P2142, DOI 10.1093/molbev/msl087; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cardenas PD, 2012, THEOR APPL GENET, V124, P1215, DOI 10.1007/s00122-011-1781-7; Casacuberta JM, 2003, GENE, V311, P1, DOI 10.1016/S0378-1119(03)00557-2; Chen X, 2011, PLANT PHYSIOL, V155, P851, DOI 10.1104/pp.110.169482; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Chopra S, 1999, P NATL ACAD SCI USA, V96, P15330, DOI 10.1073/pnas.96.26.15330; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Fedoroff N, 2000, P NATL ACAD SCI USA, V97, P7002, DOI 10.1073/pnas.97.13.7002; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Henry Y, 2006, TRENDS PLANT SCI, V11, P267, DOI 10.1016/j.tplants.2006.04.002; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Howell EC, 2005, GENOME, V48, P1093, DOI 10.1139/G05-069; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Jack T, 2004, PLANT CELL, V16, pS1, DOI 10.1105/tpc.017038; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Keller MM, 2011, PLANT J, V67, P195, DOI 10.1111/j.1365-313X.2011.04598.x; Kinoshita T, 2011, CURR BIOL, V21, P1232, DOI 10.1016/j.cub.2011.06.025; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Lagercrantz U, 1998, GENETICS, V150, P1217; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Lukens L, 2003, GENETICS, V164, P359; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lysak MA, 2006, PLANT SYST EVOL, V259, P175, DOI 10.1007/s00606-006-0418-9; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Lysak MA, 2007, PLANT PHYSIOL, V145, P402, DOI 10.1104/pp.107.104380; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martynov VV, 2005, RUSS J PLANT PHYSL+, V52, P242, DOI 10.1007/s11183-005-0037-2; Moon J, 2005, PLANT CELL PHYSIOL, V46, P292, DOI 10.1093/pcp/pci024; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; PEREIRA A, 1986, EMBO J, V5, P835, DOI 10.1002/j.1460-2075.1986.tb04292.x; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Qiu D, 2009, PLANT CELL REP, V28, P649, DOI 10.1007/s00299-008-0661-3; Rana D, 2004, PLANT J, V40, P725, DOI 10.1111/j.1365-313X.2004.02244.x; Robert LS, 1998, PLANT MOL BIOL, V37, P763, DOI 10.1023/A:1006064514311; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; UN, 1953, JPN J BOT, V7, P389; Wang J, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-39; Wang J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-271; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-101; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Whittle CA, 2009, PLANT CELL, V21, P2203, DOI 10.1105/tpc.109.068411; Wicker T, 2003, PLANT CELL, V15, P1186, DOI 10.1105/tpc.011023; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Xu M, 2010, GENETICS, V184, P53, DOI 10.1534/genetics.109.107904; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Zabala G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-124; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang XY, 2004, P NATL ACAD SCI USA, V101, P5589, DOI 10.1073/pnas.0401243101	73	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47127	10.1371/journal.pone.0047127	http://dx.doi.org/10.1371/journal.pone.0047127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	22629437	Green Published, gold, Green Submitted			2022-12-27	WOS:000309807700058
J	Wang, JK; Xu, MY; Zhu, K; Li, L; Liu, XQ				Wang, Juke; Xu, Mengyuan; Zhu, Kai; Li, Lei; Liu, Xinqi			The N-terminus of FILIA Forms an Atypical KH Domain with a Unique Extension Involved in Interaction with RNA	PLOS ONE			English	Article							MATERNAL EFFECT GENE; BINDING PROTEIN; STRUCTURAL BASIS; CELLS; EXPRESSION; SEQUENCE; COMPLEX; ANTIGEN; NOVA; RECOGNITION	FILIA is a member of the recently identified oocyte/embryo expressed gene family in eutherian mammals, which is characterized by containing an N-terminal atypical KH domain. Here we report the structure of the N-terminal fragment of FILIA (FILIA-N), which represents the first reported three-dimensional structure of a KH domain in the oocyte/embryo expressed gene family of proteins. The structure of FILIA-N revealed a unique N-terminal extension beyond the canonical KH region, which plays important roles in interaction with RNA. By co-incubation with the lysates of mice ovaries, FILIA and FILIA-N could sequester specific RNA components, supporting the critical roles of FILIA in regulation of RNA transcripts during mouse oogenesis and early embryogenesis.	[Wang, Juke; Xu, Mengyuan; Liu, Xinqi] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Zhu, Kai; Li, Lei] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China	Nankai University; Chinese Academy of Sciences; Institute of Zoology, CAS	Wang, JK (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	lil@ioz.ac.cn; liu2008@nankai.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	Ministry of Science and Technology, China [2010CB911800]; National Basic Research Program of China [2011CB944501]; Chinese Academy of Sciences [XDA01010103]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	Liu X is supported by National Basic Research Program of China (973 program) (2010CB911800) from Ministry of Science and Technology, China. Li L is funded by National Basic Research Program of China (2011CB944501) and the Chinese Academy of Sciences (XDA01010103 and the Hundred Talents Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amano H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-11; Amarasinghe AK, 2001, RNA, V7, P1239, DOI 10.1017/S1355838201010603; ASTIGIANO S, 1991, DIFFERENTIATION, V46, P61, DOI 10.1111/j.1432-0436.1991.tb00866.x; Braddock DT, 2002, NATURE, V415, P1051, DOI 10.1038/4151051a; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; BUCKANOVICH RJ, 1993, NEURON, V11, P657, DOI 10.1016/0896-6273(93)90077-5; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Cai CL, 2010, MOL BIOL CELL, V21, P3137, DOI 10.1091/mbc.E10-03-0255; CLEGG KB, 1983, DEV BIOL, V95, P331, DOI 10.1016/0012-1606(83)90034-9; Dauter Z, 2002, ACTA CRYSTALLOGR D, V58, P494, DOI 10.1107/S090744490200118X; Dejgaard K, 1996, EUR J BIOCHEM, V241, P425, DOI 10.1111/j.1432-1033.1996.00425.x; DELEON V, 1983, DEV BIOL, V98, P400, DOI 10.1016/0012-1606(83)90369-X; Diaz-Moreno I, 2009, NAT STRUCT MOL BIOL, V16, P238, DOI 10.1038/nsmb.1558; Du ZH, 2005, J BIOL CHEM, V280, P38823, DOI 10.1074/jbc.M508183200; GIBSON TJ, 1993, FEBS LETT, V324, P361, DOI 10.1016/0014-5793(93)80152-K; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Herr JC, 2008, DEV BIOL, V314, P300, DOI 10.1016/j.ydbio.2007.11.027; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JANIN J, 1990, J BIOL CHEM, V265, P16027; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lewis HA, 1999, STRUCTURE, V7, P191, DOI 10.1016/S0969-2126(99)80025-2; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Meyer NH, 2010, J BIOL CHEM, V285, P28893, DOI 10.1074/jbc.M110.126185; MuellerPillasch F, 1997, ONCOGENE, V14, P2729, DOI 10.1038/sj.onc.1201110; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; NEUYILIK G, 1993, EUR J BIOCHEM, V213, P727, DOI 10.1111/j.1432-1033.1993.tb17813.x; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pierre A, 2007, GENOMICS, V90, P583, DOI 10.1016/j.ygeno.2007.06.003; Pozdnyakova I, 2005, FEBS J, V272, P872, DOI 10.1111/j.1742-4658.2004.04527.x; Racki WJ, 2006, DEVELOPMENT, V133, P4527, DOI 10.1242/dev.02651; Rajpal A, 2003, EMBO J, V22, P6526, DOI 10.1093/emboj/cdg620; Ramos A, 2002, BIOCHEMISTRY-US, V41, P4193, DOI 10.1021/bi011994o; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; SCHMIDT C, 1992, EUR J BIOCHEM, V206, P625, DOI 10.1111/j.1432-1033.1992.tb16967.x; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shain KH, 2002, J IMMUNOL, V168, P2544, DOI 10.4049/jimmunol.168.5.2544; Siomi H, 1997, CURR OPIN GENET DEV, V7, P345, DOI 10.1016/S0959-437X(97)80148-7; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Spingola M, 2004, NUCLEIC ACIDS RES, V32, P1242, DOI 10.1093/nar/gkh281; Tanaka TS, 2006, DEV GROWTH DIFFER, V48, P381, DOI 10.1111/j.1440-169x.2006.00875.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tong ZB, 1999, ENDOCRINOLOGY, V140, P3720, DOI 10.1210/en.140.8.3720; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Valverde R, 2007, STRUCTURE, V15, P1090, DOI 10.1016/j.str.2007.06.022; Vitale AM, 2007, MOL REPROD DEV, V74, P608, DOI 10.1002/mrd.20648; Western P, 2005, STEM CELLS, V23, P1436, DOI 10.1634/stemcells.2005-0146; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106; Zhu JH, 2000, MOL CELL BIOL, V20, P5602, DOI 10.1128/MCB.20.15.5602-5618.2000	60	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30209	10.1371/journal.pone.0030209	http://dx.doi.org/10.1371/journal.pone.0030209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22629437	Green Published, gold, Green Submitted			2022-12-27	WOS:000301457200043
J	Lee, HP; Pancholi, N; Esposito, L; Previll, LA; Wang, XL; Zhu, XW; Smith, MA; Lee, HG				Lee, Hyun-Pil; Pancholi, Neel; Esposito, Luke; Previll, Laura A.; Wang, Xinglong; Zhu, Xiongwei; Smith, Mark A.; Lee, Hyoung-gon			Early Induction of Oxidative Stress in Mouse Model of Alzheimer Disease with Reduced Mitochondrial Superoxide Dismutase Activity	PLOS ONE			English	Article							LIPID-PEROXIDATION; TRANSGENIC MICE; NEURODEGENERATIVE DISEASES; PLAQUE-FORMATION; DNA-DAMAGE; IN-VIVO; REDUCTION; PATHOLOGY; PROTEINS; DYSFUNCTION	While oxidative stress has been linked to Alzheimer's disease, the underlying pathophysiological relationship is unclear. To examine this relationship, we induced oxidative stress through the genetic ablation of one copy of mitochondrial antioxidant superoxide dismutase 2 (Sod2) allele in mutant human amyloid precursor protein (hAPP) transgenic mice. The brains of young (5-7 months of age) and old (25-30 months of age) mice with the four genotypes, wild-type (Sod2(+/+)), hemizygous Sod2 (Sod2(+/-)), hAPP/wild-type (Sod2(+/+)), and hAPP/hemizygous (Sod2(+/-)) were examined to assess levels of oxidative stress markers 4-hydroxy-2-nonenal and heme oxygenase-1. Sod2 reduction in young hAPP mice resulted in significantly increased oxidative stress in the pyramidal neurons of the hippocampus. Interestingly, while differences resulting from hAPP expression or Sod2 reduction were not apparent in the neurons in old mice, oxidative stress was increased in astrocytes in old, but not young hAPP mice with either Sod2(+/+) or Sod2(+/-). Our study shows the specific changes in oxidative stress and the causal relationship with the pathological progression of these mice. These results suggest that the early neuronal susceptibility to oxidative stress in the hAPP/Sod2(+/-) mice may contribute to the pathological and behavioral changes seen in this animal model.	[Lee, Hyun-Pil; Pancholi, Neel; Previll, Laura A.; Wang, Xinglong; Zhu, Xiongwei; Smith, Mark A.; Lee, Hyoung-gon] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Esposito, Luke] Univ Calif San Francisco, Dept Neurol & Neurosci, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA	Case Western Reserve University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Lee, HP (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	hyoung-gon.lee@case.edu	Lee, Hyoung-gon/A-9637-2009; Meyer, Axel/C-9826-2009	Wang, Xinglong/0000-0001-8657-0159; Meyer, Axel/0000-0002-0888-8193; WU, LI-TZY/0000-0002-5909-2259; Oh, Yu-Kyoung/0000-0002-0969-3339; Previll, Laura/0000-0001-5541-8111	National Institutes of Health [AG028679]; Alzheimer's Association [NIRG-09-132727]; Dr. Robert M. Kohrman Memorial Fund; NATIONAL INSTITUTE ON AGING [R01AG028679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Dr. Robert M. Kohrman Memorial Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Work in the authors' laboratories is supported by the National Institutes of Health (AG028679 to Dr. Hyoung-gon Lee), the Alzheimer's Association (NIRG-09-132727 to Dr. Hyoung-gon Lee), and the Dr. Robert M. Kohrman Memorial Fund (to Dr. Zhu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Dumont M, 2009, FASEB J, V23, P2459, DOI 10.1096/fj.09-132928; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Keating DJ, 2008, J NEUROCHEM, V104, P298, DOI 10.1111/j.1471-4159.2007.04997.x; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Lee HG, 2006, J NEUROSCI RES, V84, P1856, DOI 10.1002/jnr.21072; Li F, 2004, J NEUROCHEM, V89, P1308, DOI 10.1111/j.1471-4159.2004.02455.x; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Massaad CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010561; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Myung NH, 2008, AGE, V30, P209, DOI 10.1007/s11357-008-9050-7; Nunomura A, 1999, J NEUROSCI, V19, P1959; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Omar Rawhi A., 1999, J Alzheimers Dis, V1, P139; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Pappolla MA, 1998, AM J PATHOL, V152, P871; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Pratico D, 2000, ANN NEUROL, V48, P809, DOI 10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9; Reed TT, 2009, BRAIN RES, V1274, P66, DOI 10.1016/j.brainres.2009.04.009; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Sayre LM, 1996, CHEM RES TOXICOL, V9, P1194, DOI 10.1021/tx960094j; Simpson JE, 2010, NEUROPATH APPL NEURO, V36, P25, DOI 10.1111/j.1365-2990.2009.01030.x; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; SMITH MA, 1995, TRENDS NEUROSCI, V18, P172, DOI 10.1016/0166-2236(95)93897-7; SMITH MA, 1994, AM J PATHOL, V145, P42; Smith MA, 2010, J ALZHEIMERS DIS, V19, P363, DOI 10.3233/JAD-2010-1239; STEELE ML, 2010, NEUROBIOL A IN PRESS; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x; Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132	36	113	115	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e28033	10.1371/journal.pone.0028033	http://dx.doi.org/10.1371/journal.pone.0028033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22970282	Green Submitted, Green Published, gold			2022-12-27	WOS:000301457200001
J	Li, Y; Farooq, M; Sheng, DL; Chandramouli, C; Lan, T; Mahajan, NK; Kini, RM; Hong, YH; Lisowsky, T; Ge, RW				Li, Yan; Farooq, Muhammad; Sheng, Donglai; Chandramouli, Chanchal; Lan, Tian; Mahajan, Nilesh K.; Kini, R. Manjunatha; Hong, Yunhan; Lisowsky, Thomas; Ge, Ruowen			Augmenter of Liver Regeneration (alr) Promotes Liver Outgrowth during Zebrafish Hepatogenesis	PLOS ONE			English	Article							HEPATIC STIMULATOR SUBSTANCE; DISULFIDE RELAY SYSTEM; MITOCHONDRIAL SULFHYDRYL OXIDASE; INTERMEMBRANE SPACE; RESPIRATORY-CHAIN; PROTEIN IMPORT; CYTOCHROME-C; GENE; HEPATOPOIETIN; YEAST	Augmenter of Liver Regeneration (ALR) is a sulfhydryl oxidase carrying out fundamental functions facilitating protein disulfide bond formation. In mammals, it also functions as a hepatotrophic growth factor that specifically stimulates hepatocyte proliferation and promotes liver regeneration after liver damage or partial hepatectomy. Whether ALR also plays a role during vertebrate hepatogenesis is unknown. In this work, we investigated the function of alr in liver organogenesis in zebrafish model. We showed that alr is expressed in liver throughout hepatogenesis. Knockdown of alr through morpholino antisense oligonucleotide (MO) leads to suppression of liver outgrowth while overexpression of alr promotes liver growth. The small-liver phenotype in alr morphants results from a reduction of hepatocyte proliferation without affecting apoptosis. When expressed in cultured cells, zebrafish Alr exists as dimer and is localized in mitochondria as well as cytosol but not in nucleus or secreted outside of the cell. Similar to mammalian ALR, zebrafish Alr is a flavin-linked sulfhydryl oxidase and mutation of the conserved cysteine in the CxxC motif abolishes its enzymatic activity. Interestingly, overexpression of either wild type Alr or enzyme-inactive Alr(C131S) mutant promoted liver growth and rescued the liver growth defect of alr morphants. Nevertheless, alr(C131S) is less efficacious in both functions. Meantime, high doses of alr MOs lead to widespread developmental defects and early embryonic death in an alr sequence-dependent manner. These results suggest that alr promotes zebrafish liver outgrowth using mechanisms that are dependent as well as independent of its sulfhydryl oxidase activity. This is the first demonstration of a developmental role of alr in vertebrate. It exemplifies that a low-level sulfhydryl oxidase activity of Alr is essential for embryonic development and cellular survival. The dose-dependent and partial suppression of alr expression through MO-mediated knockdown allows the identification of its late developmental role in vertebrate liver organogenesis.	[Li, Yan; Farooq, Muhammad; Sheng, Donglai; Chandramouli, Chanchal; Lan, Tian; Mahajan, Nilesh K.; Kini, R. Manjunatha; Hong, Yunhan; Ge, Ruowen] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Farooq, Muhammad] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Kini, R. Manjunatha] Virginia Commonwealth Univ, Med Coll Virginia, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Lisowsky, Thomas] MultiBIND Biotec GmbH, Cologne, Germany	National University of Singapore; King Saud University; Virginia Commonwealth University	Li, Y (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsgerw@nus.edu.sg	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	Singapore Biomedical Research Council [BMRC/01/1/21/18/068]; Ministry of Education [R-154-000-475-112]; NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Ministry of Education; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the Singapore Biomedical Research Council grant BMRC/01/1/21/18/068 and Ministry of Education grant R-154-000-475-112 to Dr. Ge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Cao Y, 2009, FREE RADICAL BIO MED, V47, P1057, DOI 10.1016/j.freeradbiomed.2009.07.017; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen XX, 2003, J BIOL CHEM, V278, P49022, DOI 10.1074/jbc.M304057200; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Daithankar VN, 2010, BIOCHEMISTRY-US, V49, P6737, DOI 10.1021/bi100912m; Daithankar VN, 2009, BIOCHEMISTRY-US, V48, P4828, DOI 10.1021/bi900347v; Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004; Farooq M, 2008, DEV BIOL, V317, P336, DOI 10.1016/j.ydbio.2008.02.034; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Gandhi CR, 1999, HEPATOLOGY, V29, P1435, DOI 10.1002/hep.510290522; Gandhi CR, 2009, J CELL PHYSL; Gatzidou E, 2006, WORLD J GASTROENTERO, V12, P4951, DOI 10.3748/wjg.v12.i31.4951; GHOSH C, 1994, CELL BIOL TOXICOL, V10, P167, DOI 10.1007/BF00757560; HAGIYA M, 1994, P NATL ACAD SCI USA, V91, P8142, DOI 10.1073/pnas.91.17.8142; HE FH, 1993, HEPATOLOGY, V17, P225, DOI 10.1016/0270-9139(93)90081-W; Hofhaus G, 1999, EUR J CELL BIOL, V78, P349, DOI 10.1016/S0171-9335(99)80069-7; Ilowski M, 2011, BIOCHEM BIOPH RES CO, V404, P148, DOI 10.1016/j.bbrc.2010.11.083; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kondili VG, 2005, DIGEST DIS SCI, V50, P297, DOI 10.1007/s10620-005-1598-9; Korzh S, 2001, MECH DEVELOP, V103, P137, DOI 10.1016/S0925-4773(01)00330-6; LABRECQUE DR, 1975, J PHYSIOL-LONDON, V248, P273, DOI 10.1113/jphysiol.1975.sp010973; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; Li Y, 2002, EUR J BIOCHEM, V269, P3888, DOI 10.1046/j.1432-1033.2002.03054.x; Li Y, 2000, J BIOL CHEM, V275, P37443, DOI 10.1074/jbc.M004373200; Liatsos GD, 2003, DIGEST DIS SCI, V48, P1929, DOI 10.1023/A:1026157901805; LISOWSKY T, 1995, GENOMICS, V29, P690, DOI 10.1006/geno.1995.9950; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Lisowsky T, 2001, DIGEST LIVER DIS, V33, P173, DOI 10.1016/S1590-8658(01)80074-8; Lu CR, 2002, FASEB J, V16, P90, DOI 10.1096/fj.01-0506fje; Lu J, 2002, WORLD J GASTROENTERO, V8, P353; McClure KD, 2008, DEV BIOL, V319, P68, DOI 10.1016/j.ydbio.2008.04.004; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Passeri MJ, 2009, HEPATOLOGY, V49, P443, DOI 10.1002/hep.22667; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Tanigawa K, 2000, J GASTROENTEROL, V35, P112, DOI 10.1007/s005350050023; Thasler WE, 2005, HISTOPATHOLOGY, V47, P57, DOI 10.1111/j.1365-2559.2005.02172.x; Thirunavukkarasu C, 2008, J HEPATOL, V48, P578, DOI 10.1016/j.jhep.2007.12.010; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; Wang CP, 2006, WORLD J GASTROENTERO, V12, P4859; Wang G, 1999, J BIOL CHEM, V274, P11469, DOI 10.1074/jbc.274.17.11469; Wang WZ, 2007, BIOCHEMISTRY-US, V46, P3246, DOI 10.1021/bi602499t; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wiedenmann J, 2009, IUBMB LIFE, V61, P1029, DOI 10.1002/iub.256; Yabu T, 2001, FISHERIES SCI, V67, P333, DOI 10.1046/j.1444-2906.2001.00233.x; Yang XM, 1997, SCI CHINA SER C, V40, P642, DOI 10.1007/BF02882695	52	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30835	10.1371/journal.pone.0030835	http://dx.doi.org/10.1371/journal.pone.0030835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22905149	gold, Green Published			2022-12-27	WOS:000301703800034
J	Li, YY; Zhu, RN; Qian, Y; Deng, J				Li, Yuyun; Zhu, Runan; Qian, Yuan; Deng, Jie			The Characteristics of Blood Glucose and WBC Counts in Peripheral Blood of Cases of Hand Foot and Mouth Disease in China: A Systematic Review	PLOS ONE			English	Review							ENTEROVIRUS 71; OUTBREAK; INFECTIONS; MALAYSIA; TAIWAN; MANIFESTATIONS	Background: Outbreaks of Hand Foot and Mouth Disease (HFMD) have occurred in many parts of the world especially in China. We aimed to summarize the characteristics of the levels of blood glucose and white blood cell (WBC) counts in cases of HFMD in Mainland China and Taiwan, using meta-analysis based on systematic review of published articles. Methods: We systematically reviewed published studies, from the MEDLINE and WANFANG Data, about the levels of blood glucose and WBC counts in cases of HFMD until 15(th) June 2011, and quantitatively summarized the characteristics of them using meta-analysis. Results: In total, 37 studies were included in this review. In Mainland China and Taiwan, generally, the average level of blood glucose, the prevalence of hyperglycemia, WBC counts and the prevalence of leukocytosis increased with the severity of the illness. There was no significant difference in the prevalence of leukocytosis between ANS (autonomic nervous system dysregulation)/PE (pulmonary edema) group and CNS (central nervous system) group, and in the average level of blood glucose between healthy controls and mild cases of HFMD. WBC counts in cases infected by EV71 were less than those in cases infected by CA16. Conclusions: our analyses indicated that blood glucose and WBC counts increased with the severity of HFMD disease, which would help doctors to manage patients efficiently.	[Li, Yuyun; Zhu, Runan; Qian, Yuan; Deng, Jie] Capital Inst Pediat, Virol Lab, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP)	Li, YY (corresponding author), Capital Inst Pediat, Virol Lab, Beijing, Peoples R China.	qybds1129@163.com	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abubakar S, 1999, SCAND J INFECT DIS, V31, P331, DOI 10.1080/00365549950163734; AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Ahmad K, 2000, LANCET, V356, P1338, DOI 10.1016/S0140-6736(05)74253-7; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chen JH, 2010, ACTA ACAD MEDICINAE, V32, P363; Chen WB, 2000, 5 DIAGNOSTICS; Chu PY, 2001, ARCH VIROL, V146, P589, DOI 10.1007/s007050170164; Cui LD, 2011, CHINA PRAC MED, V6, P50; Dai W, 2011, CHINESE COMMUNITY DO, V13, P88; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding NZ, 2009, VIRUS RES, V145, P157, DOI 10.1016/j.virusres.2009.06.006; Fan XC, 2009, ANHUI MED J, V30, P253; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsia SH, 2005, PEDIATR INFECT DIS J, V24, P331, DOI 10.1097/01.inf.0000157219.19674.98; Huang S, 2008, ANHUI MED J, V29, P361; Huang YF, 2003, J INFECTION, V46, P238, DOI 10.1053/jinf.2002.1117; Jiang J, 2010, J QILU NURSING, V16, P119; Kehle J, 2003, J NEUROVIROL, V9, P126, DOI 10.1080/13550280390173364; Li CC, 2002, SCAND J INFECT DIS, V34, P104, DOI 10.1080/00365540110077119; Li JM, 2009, CHIN PEDIAT EMERG ME, V16, P142; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li Q., 2010, ANHUI MED J, V31, P1410; Li SH, 2010, CHIN PECIATR EMERG M, V17, P49; Li SH, 2010, CHIN J CLIN INFECT D, V3, P337; [李玉芬 Li Yufen], 2010, [临床儿科杂志, Journal of Chinical Pediatrics], V28, P1011; Liao Y, 2010, JILIN MED J, P4075; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Liu J, 2009, ANHUI MED J, V30, P261; Liu X, 2010, CHIN J MED ULTRASOUN, V7, P1844; Liu Ying-xia, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P475; Lu CY, 2002, J MED VIROL, V67, P217, DOI 10.1002/jmv.2210; Luo LP, 2010, J N CHINA COAL MED U, V12, P356; Mai LL, 2011, CHINESE J NEW CLIN M, V4, P356; MANTEL N, 1959, J NATL CANCER I, V22, P719; [毛国顺 MAO Guoshun], 2008, [中华传染病杂志, Chinese Journal of Infections Diseases], V26, P387; [毛月燕 MAO Yue-yan], 2009, [中华传染病杂志, Chinese Journal of Infections Diseases], V27, P35; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Qian N, 2010, THESIS QINGDAO U, P17; Shen Q, 2011, J MED RES, V40, P93; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Tang LP, 2009, CHIN J M ISDIAGN, V9, P6840; Verbruggen SCAT, 2007, CLIN NUTR, V26, P677, DOI 10.1016/j.clnu.2007.08.012; Wang HC, 2010, CHINA CLIN PRAC MED, V4, P155; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wei XL, 2010, SHANDONG MED J, V50, P70; World Health Organization, 2017, GUID DRINK WAT QUAL, VFourth, DOI 10.1016/S1462-0758(00)00006-6; Yan ZW, 2011, CHIN J GEN PRACT, V10, P343; Yang T, 2010, ACTA MEDCINAE SINICA, V23, P68; Yu LX, 2011, CHIN PEDIAT EMERG ME, V18, P57; [岳保珠 Yue Baozhu], 2010, [中国全科医学, Chinese General Practice], V13, P2239; Zhang GH, 2010, CHINA CLIN PRAC MED, V4, P132; Zhang JH, 2010, CHINESE FOREIGN MED, V8, P12; Zhang Shou-Bin, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P38; Zhao H., 2008, J CLIN PEDIAT, V26, P467; Zheng NH, 2011, CHINA MODERN DOCTOR, V49, P126; Zhou AR, 2000, 5 BIOCH; [周大明 Zhou Daming], 2010, [重庆医科大学学报, Acta Universitatis Scientiae Medicinae Chongqing], V35, P1724	63	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29003	10.1371/journal.pone.0029003	http://dx.doi.org/10.1371/journal.pone.0029003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22905149	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400018
J	Li, YQ; He, ZG				Li, Yuqing; He, Zheng-Guo			The Mycobacterial LysR-Type Regulator OxyS Responds to Oxidative Stress and Negatively Regulates Expression of the Catalase-Peroxidase Gene	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATOR; PATHOGENIC MYCOBACTERIA; TUBERCULOSIS; KATG; FURA; SENSITIVITY; SMEGMATIS; MACROPHAGES; RESISTANCE; PROTEINS	Protection against oxidative stress is one of the primary defense mechanisms contributing to the survival of Mycobacterium tuberculosis in the host. In this study, we provide evidence that OxyS, a LysR-type transcriptional regulator functions as an oxidative stress response regulator in mycobacteria. Overexpression of OxyS lowers expression of the catalase-peroxidase (KatG) gene in M. smegmatis. OxyS binds directly with the katG promoter region and a conserved, GC-rich T-N-11-A motif for OxyS binding was successfully characterized in the core binding site. Interestingly, the DNA-binding activity of OxyS was inhibited by H2O2, but not by dithiothreitol. Cys25, which is situated at the DNA-binding domain of OxyS, was found to have a regulatory role for the DNA-binding ability of OxyS in response to oxidative stress. In contrast, the other three cysteine residues in OxyS do not appear to have this function. Furthermore, the mycobacterial strain over-expressing OxyS had a higher sensitivity to H2O2. Thus, OxyS responds to oxidative stress through a unique cysteine residue situated in its DNA-binding domain and negatively regulates expression of the katG gene. These findings uncover a specific regulatory mechanism for mycobacterial adaptation to oxidative stress.	[Li, Yuqing; He, Zheng-Guo] Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China.	hezhengguo@mail.hzau.edu.cn	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	National Natural Science Foundation of China [31025002, 30930003]; Fundamental Research Funds for the Central Universities [2011PY140]; Hubei Chutian Scholar Program; NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Chutian Scholar Program; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Natural Science Foundation of China (31025002, 30930003), the Fundamental Research Funds for the Central Universities (2011PY140) and Hubei Chutian Scholar Program (to Z-GH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Chen H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001602; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; DERETIC V, 1995, MOL MICROBIOL, V17, P889, DOI 10.1111/j.1365-2958.1995.mmi_17050889.x; Dhandayuthapani S, 1996, J BACTERIOL, V178, P3641, DOI 10.1128/jb.178.12.3641-3649.1996; Domenech P, 2001, MICROBES INFECT, V3, P713, DOI 10.1016/S1286-4579(01)01422-8; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Italiani VCS, 2011, J BACTERIOL, V193, P1734, DOI 10.1128/JB.01339-10; Jittawuttipoka T, 2009, J BACTERIOL, V191, P7372, DOI 10.1128/JB.00788-09; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Lee HI, 2010, J BIOCHEM, V147, P511, DOI 10.1093/jb/mvp197; Li YQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Master S, 2001, J BACTERIOL, V183, P4033, DOI 10.1128/JB.183.13.4033-4039.2001; Milano A, 2001, J BACTERIOL, V183, P6801, DOI 10.1128/JB.183.23.6801-6806.2001; Muraoka S, 2003, J MOL BIOL, V328, P555, DOI 10.1016/S0022-2836(03)00312-7; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Pagan-Ramos E, 1998, J BACTERIOL, V180, P4856; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; Sala C, 2003, J BACTERIOL, V185, P5357, DOI 10.1128/JB.185.18.5357-5362.2003; Sala C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-33; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Sreevatsan S, 1996, J CLIN MICROBIOL, V34, P2007, DOI 10.1128/JCM.34.8.2007-2010.1996; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Yu K., 1999, Tubercle and Lung Disease, V79, P191, DOI 10.1054/tuld.1998.0203; Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x; Zhang H, 2008, FEBS J, V275, P753, DOI 10.1111/j.1742-4658.2007.06241.x; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	36	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30186	10.1371/journal.pone.0030186	http://dx.doi.org/10.1371/journal.pone.0030186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22905149	Green Published, gold, Green Submitted			2022-12-27	WOS:000301454400077
